<SEC-DOCUMENT>0000105770-20-000015.txt : 20200224
<SEC-HEADER>0000105770-20-000015.hdr.sgml : 20200224
<ACCEPTANCE-DATETIME>20200221185652
ACCESSION NUMBER:		0000105770-20-000015
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		126
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200224
DATE AS OF CHANGE:		20200221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		20641598

	BUSINESS ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>wst-20191231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:b5520f3c-bdfb-4aa1-98ba-ba1f6a92b1c8,g:f267b37f-edf1-4d21-84ed-4e7cdfb1cf2c,d:04af1ad4569d49aa97eb83ccd57b06d7--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:wst="http://www.westpharma.com/20191231" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>wst-20191231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8zLTEtMS0xLTA_37596e15-32a8-47ef-ae13-037ef6b13199">WEST PHARMACEUTICAL SERVICES, INC.</ix:nonNumeric><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl80LTEtMS0xLTA_01928443-d96e-40d3-81e0-a289f7cce8b0">0000105770</ix:nonNumeric><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl81LTEtMS0xLTA_114e6d36-d13b-41d8-8328-00adf7531682">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl84LTItMS0xLTEwOTI4_450b1b14-ddac-4b9a-9606-cbc2dc6e8088">December 31, 2019</ix:nonNumeric><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl85LTEtMS0xLTA_36f648e9-9e30-47cc-8817-d7ab3c6a8f0e">2019</ix:nonNumeric><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8xMC0xLTEtMS0w_c16aeb1e-73f4-4641-aefe-83b6f7677eba">FY</ix:nonNumeric><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8xMS0xLTEtMS0w_be04e75b-5cb9-4cc9-ac9f-1fb67570ad66">false</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="i1ecebe1ac085442a9fcafcfcb6dea5b9_I20200131" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8xNS0yLTEtMS0w_edd0e3f4-b596-471e-99fa-49bf21029e64">73,837,449</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i8f56fa522aba4347a769ceb8b2131331_I20190630" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8yMS0zLTEtMS0w_78b9a4e4-e8d9-4597-be29-c1ef5e5d0030">9,218,126,218</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMi0xLTEtMS0w_236aeb8d-8a39-4706-8b34-e96d3762af65">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMi0yLTEtMS0w_3ab20adb-7a05-4297-9799-c8ada719253f">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMi0zLTEtMS0w_dc760296-bad6-4eae-931f-f317a290f471">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMy0xLTEtMS0w_33787d4c-efa8-4dff-b1f7-95659bf757de">0.3</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMy0yLTEtMS0w_0f2e0dc6-e4d5-4ae0-ac3e-7b1dc343c07b">0.2</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMy0zLTEtMS0w_b735b1ff-41ad-4717-91be-0a6d40ac0dd3">1.3</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNC0xLTEtMS0w_1d1fed4d-799f-40e9-8f84-211b0ce9e964">0.8</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNC0yLTEtMS0w_525d983e-1111-4d2b-a219-5bc0fd888fda">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNC0zLTEtMS0w_cbfedf8b-8583-4f6c-aafc-a14b4d1e815a">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNS0xLTEtMS0w_0ebabdc3-35dd-477c-8323-fc2d1de20b1a">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNS0yLTEtMS0w_4637c023-477e-4027-946c-53f53b9446f0">0.3</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNS0zLTEtMS0w_89331ab2-79d1-4d3c-bb7f-88baf24299db">0.5</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNi0xLTEtMS0w_7d96e327-c6bd-4d98-ac5f-09b5804ab610">0.1</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNi0yLTEtMS0w_c9768323-0f9a-47c0-9479-705eaec48147">0.5</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNi0zLTEtMS0w_17c23cef-80a2-485c-8bcc-099e26b2292c">0.5</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNy0xLTEtMS0w_f2896b85-ce66-4cb6-82c7-2a78def150c7">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNy0yLTEtMS0w_dfb947a8-669d-451d-80ae-f0eeddf5c051">0.1</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNy0zLTEtMS0w_829672eb-e81a-40c6-8125-ad52560d65a2">2.5</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfOC0xLTEtMS0w_8d690bce-6172-4c4a-bccf-c9a0720a577e">0.2</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfOC0yLTEtMS0w_236b9042-5f5c-4975-96e0-e33cc73717ee">1.5</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfOC0zLTEtMS0w_7bffd9ec-b485-4c62-9f91-a4c39e8d02c9">0.1</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMi0xLTEtMS0w_c18810c9-c524-4087-bd46-33c878cb66e5">3.0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMi0yLTEtMS0w_b624cd06-c9c7-4d15-b872-c18a4eeb409f">3.0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMy0xLTEtMS0w_98da3c9f-748a-440b-8aa8-207f693f1d34">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMy0yLTEtMS0w_aa540c3f-b538-40d3-82c6-444565d37dca">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNC0xLTEtMS0w_fd69efae-75b1-4b49-b069-5dfc16a5f4bb">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNC0yLTEtMS0w_3092d46f-b621-475b-bdf7-13c317a67c54">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNS0xLTEtMS0w_eb7fd6b5-2d5c-4c9a-b728-6ade6dd4fb35">0.25</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNS0yLTEtMS0w_f876bd49-b78c-4595-8f62-5faf1d2774a0">0.25</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNi0xLTEtMS0w_bf932e19-5c5e-490c-931f-548a6d790c32">100.0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNi0yLTEtMS0w_71ff901f-2c37-476b-b5af-8da49b78c98e">100.0</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNy0xLTEtMS0w_ef778bf7-7c0b-4876-b23e-6fbcfc5e309a">75.3</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNy0yLTEtMS0w_cfc5bbf5-41eb-4db4-818c-876c73bc87f0">75.3</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOC0xLTEtMS0w_a8b1ad92-7df8-45df-87b8-82aa8d2abdaa">74.1</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOC0yLTEtMS0w_32eb0dd8-283e-49ab-975a-3cab46cdd65b">74.1</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOS0xLTEtMS0w_eed10ac7-4ba9-47cc-b7d3-938a301f05e0">1.2</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOS0yLTEtMS0w_ab31ece4-fa83-4db7-ac69-9ea9d414a39e">1.2</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjU3L2ZyYWc6M2U3ZWE0MjhmY2E1NGMwNWFlZGExNThlNWNmNDE0NTMvdGFibGU6NzczNjQ3ZDVhM2UzNGNkMzliOGY0YTA4MTI4YmU4YzcvdGFibGVyYW5nZTo3NzM2NDdkNWEzZTM0Y2QzOWI4ZjRhMDgxMjhiZThjN18xLTEtMS0xLTk4MDg_c5f954ca-fe7d-41e1-b80d-2ee2806ab583">0.62</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjU3L2ZyYWc6M2U3ZWE0MjhmY2E1NGMwNWFlZGExNThlNWNmNDE0NTMvdGFibGU6NzczNjQ3ZDVhM2UzNGNkMzliOGY0YTA4MTI4YmU4YzcvdGFibGVyYW5nZTo3NzM2NDdkNWEzZTM0Y2QzOWI4ZjRhMDgxMjhiZThjN18xLTItMS0xLTk4MTE_9ddc69a8-3d67-4781-ae5b-a243d03acc26">0.58</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjU3L2ZyYWc6M2U3ZWE0MjhmY2E1NGMwNWFlZGExNThlNWNmNDE0NTMvdGFibGU6NzczNjQ3ZDVhM2UzNGNkMzliOGY0YTA4MTI4YmU4YzcvdGFibGVyYW5nZTo3NzM2NDdkNWEzZTM0Y2QzOWI4ZjRhMDgxMjhiZThjN18xLTMtMS0xLTk4MTE_97154482-fde3-4041-8848-3009ace4687c">0.54</ix:nonFraction><ix:nonNumeric contextRef="ibfb480f0f96a47448a5795388ca43da9_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzItMS0xLTEtMA_9868b72c-5b00-453a-aedd-4b371624675e">15</ix:nonNumeric><ix:nonNumeric contextRef="i70792108505c44a39433fc64251bb816_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzMtMS0xLTEtMA_50df2b46-23c5-4e47-8981-252024c9bdb8">35</ix:nonNumeric><ix:nonNumeric contextRef="i2dafa88e942442b4b0e84b4bbaa57641_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzYtMS0xLTEtMA_e0a3dcda-b298-4d60-830a-e670abdf659e">5</ix:nonNumeric><ix:nonNumeric contextRef="i35452878f20d488ca8c0c5945f7c5a56_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzctMS0xLTEtMA_640c6db9-7d08-4f52-9931-0c9da70fb442">12</ix:nonNumeric><ix:nonNumeric contextRef="ie4538d252d0f4c568c400e1ed7914057_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzEwLTEtMS0xLTA_d2d240c0-5c5f-487e-9e80-d6a86c150c55">4</ix:nonNumeric><ix:nonNumeric contextRef="i63edb0c1b14e4ce8928a6297cfb75091_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzExLTEtMS0xLTA_a4dbeaaa-25b7-47ba-816a-3b34d3b7c6d2">7</ix:nonNumeric><ix:nonNumeric contextRef="i33000cbc9d234e3199e997271c9fa20a_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzE0LTEtMS0xLTA_794b04a6-8a67-4bd1-b312-d37711085217">3</ix:nonNumeric><ix:nonNumeric contextRef="i231518ba36c64c4092eb780bf33ded51_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzE1LTEtMS0xLTA_16dea48c-700a-481a-858b-954876c50794">10</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="0" format="ixt:zerodash" name="us-gaap:CapitalLeasedAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZTo3MzBjNjJmOWU3MmU0YzM4ODk4ZGJhZDBlYjcyNjNkNi90YWJsZXJhbmdlOjczMGM2MmY5ZTcyZTRjMzg4OThkYmFkMGViNzI2M2Q2XzEtMS0xLTEtMA_1ac7aa87-33bd-44e2-a80a-1ae14b531d5b">&#8212;</ix:nonFraction><ix:nonNumeric contextRef="i7d7f3d86824a4066a23c46e16851c996_I20191231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5MzQz_3df9f4a3-52e4-45a8-8ae6-d4e15b74807d">P5Y0M0D</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CostMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDYvZnJhZzowNjEzNTFiMjg2OTk0ZmIzYWMyZGIzNmUyYThiMjViZi90YWJsZTpmYWNiMjg1ODcwZDM0YmM0OGU2OTdkM2NiMWQ5YWQwZC90YWJsZXJhbmdlOmZhY2IyODU4NzBkMzRiYzQ4ZTY5N2QzY2IxZDlhZDBkXzItMS0xLTEtMA_12b14206-5c40-4bf8-bd5b-4f9fcf9d614e">13.4</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzUtMS0xLTEtMTE5NjM_220a4eee-0ef1-41a6-a098-538f91ce8b2e">2.78</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i830343e85a824475b975c25156e43753_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzUtMS0xLTEtMA_2ef602db-f703-45a7-bddc-e5ae10510a12">3.67</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ifde5cb3bbd874edd8d0787db92019d6f_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzYtMS0xLTEtMA_1f09d08d-0a0b-48bc-b928-4c00b129d53d">3.82</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i11599bc1fbc343258d69e5c0fd059879_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzctMS0xLTEtMA_1931cb79-3e81-4cdc-8301-339a81390e50">4.02</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzktMS0xLTEtMTAzNzc_528f9a6e-895f-4817-a690-486e55f17f95">2.3</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjY1L2ZyYWc6ODk2Y2RiMTZhZWQ1NGU3NGFiMjc5MzI1YzgzNDQ1ODUvdGFibGU6ZmQ1MzU1MTBlNzY5NGY0N2IyOGEwZGMxNWYyZTRhMjEvdGFibGVyYW5nZTpmZDUzNTUxMGU3Njk0ZjQ3YjI4YTBkYzE1ZjJlNGEyMV8xLTEtMS0xLTEwNzAy_313a1867-32e5-4c91-93eb-a83f04ba338f">&#8212;</ix:nonFraction><ix:nonNumeric contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU1MjU_5649237d-81f3-42ad-be9c-00e04ab34944">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzEtMS0xLTEtMA_1f69504e-9722-46d1-9921-a3b81f5bb574">6</ix:nonNumeric><ix:nonNumeric contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzEtMi0xLTEtMA_a8160fbd-d2e0-4a5d-af8e-fa8b5ed5596e">6</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i3b7feba544854c48a311d6c134d52a58_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzQtMS0xLTEtMA_721eeab5-88cc-4639-a7da-42cbed405dd1">&#8212;</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id9e1503f92494d249bddbebe72901fbf_D20190101-20191231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzQtMi0xLTEtMA_ade047f6-2741-47c4-ae57-4f61a8555a00">200</ix:nonFraction><ix:nonNumeric contextRef="i551f76dde6ca4da6bd01b58607183318_D20190101-20191231" name="us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzEtMS0xLTEtMA_5b871705-2aaf-47ec-b746-606f418e3588">0.27</ix:nonNumeric><ix:nonNumeric contextRef="ibef8133166a844e388b00a88119d4a66_D20190101-20191231" name="us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzEtMi0xLTEtMA_26d66bf9-9d0d-4343-8499-745e250fbd74">0.33</ix:nonNumeric><ix:nonNumeric contextRef="i0a698e5c8f8b445582c108fd424dc99f_D20190101-20191231" name="us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzItMS0xLTEtMA_88517aba-68ed-47f1-b7c0-cb6c07005935">0.67</ix:nonNumeric><ix:nonNumeric contextRef="id309afa6d90f4b3ca6e334c040f495a5_D20190101-20191231" name="us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzItMi0xLTEtMA_03b21684-4f35-4048-8e24-7b6234446ead">0.73</ix:nonNumeric><ix:nonNumeric contextRef="i20418919ecf14b199ebd3c21c8ead300_D20190101-20191231" name="us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzMtMS0xLTEtMA_ef0c26b6-5e00-4559-92be-a9ec065e6ca2">&#8212;</ix:nonNumeric><ix:nonNumeric contextRef="i3b4e26d82c6947d6ac866551afe0974e_D20190101-20191231" name="us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzMtMi0xLTEtMA_ae2d9c45-106a-4ca4-aaa0-67733c3b19cb">0.03</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i9313d976ef2b4f7b845722c3a2d91a03_I20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTplZDQzNzMzMThhMWU0NDk5YmYwODI2Y2M2MTU3ZmE4Yi90YWJsZXJhbmdlOmVkNDM3MzMxOGExZTQ0OTliZjA4MjZjYzYxNTdmYThiXzEtMS0xLTEtMA_e46706e2-6726-4e17-a96a-bbc8fe62148a">4.25</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ib48ea9474bfe4c5d806349adbf636277_D20180101-20181231" decimals="-5" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDUvZnJhZzphNGEzZmFlZDY1YWQ0YjZmYmM1MjEzOTgxM2IyZDJkZC90YWJsZTpmOGY2MTY5MmNjY2E0OGQ4YWFmMDE0OTE5NjQxM2ZlNy90YWJsZXJhbmdlOmY4ZjYxNjkyY2NjYTQ4ZDhhYWYwMTQ5MTk2NDEzZmU3XzEtMS0xLTEtMA_0d07c737-e6c6-4c6f-8dba-fc16c2b95f74">0.9</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i6760c6eadf5e4027ab3c48a8a4c417ad_D20170101-20171231" decimals="-5" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDUvZnJhZzphNGEzZmFlZDY1YWQ0YjZmYmM1MjEzOTgxM2IyZDJkZC90YWJsZTpmOGY2MTY5MmNjY2E0OGQ4YWFmMDE0OTE5NjQxM2ZlNy90YWJsZXJhbmdlOmY4ZjYxNjkyY2NjYTQ4ZDhhYWYwMTQ5MTk2NDEzZmU3XzEtMi0xLTEtMA_947e5923-1427-492a-bfc7-bd81000ef4f1">1.5</ix:nonFraction><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="wst:ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzExOTk_3f334523-3b30-4be6-b24a-5b3930387693">P5Y</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="wst-20191231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i8f56fa522aba4347a769ceb8b2131331_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1ecebe1ac085442a9fcafcfcb6dea5b9_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i710deda8952743be8f828089af9cd00d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieecec5a0e59d4a618aff5d091e295a63_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93edb6fbbea140fbb4c158d60be85402_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac89a5ed6468416b954a6d59e93629c9_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib69c911484784ff7a59966d8a7af0ed0_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f31229f62de404da8827c5ece21e752_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18dd631cd0f04e0ba55e512d49411755_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68b43b173ce141aebdc6cada18dd16ec_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ac7a64b1174ffdbf7756a30346e4c6_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4575754faab44617861e28e31c5333e6_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22926bbe0d8140baae5202df1227e9e9_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bb2237e0bf456cbd5e22b740b8ee66_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i345008dff47d4290a0527300056fd7e4_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i112779a33c9549a2a1e6ad79daa2521c_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e529adeb51c4013a1e2867fc2c654a8_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a9668a28ec340d18d524b415f8ae63c_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2a7c56a3d9349b585ddce443188576b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaabf64c6efeb4ff68ff50ae560a0e2a1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2593d47d63744a01ad1ef0a31243b137_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie83aebbd70244c51b7c3c99d188dfa54_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98bb331ce4d3451dbc548acf205baab6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2125fc186e24ff583ffd6d2cbfeeabf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34ea6f372d13421d9d8f0f909df6b05f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fd4b9307ef443f8b750812dd815616b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1c0bfc76dab4660a6dee12ff3e6f75a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dbdcdd33a9544e0b1ff9915c052d4b4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8619d0eee6a4571ae753f283f316223_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6de079702a446a909c0761fb4355a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id147ab88ff2d492590eb6168cdcfbc21_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1cf95202daf4d82a61721c34a7388af_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33c93a4501344846964d319fe27f7071_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a596f80b14841c4a875b755bfc6bdd8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29ada30e40a84d7f9ccb23e70b3c3f64_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449c08ea3f444ab2a681565eeb8cd351_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e2483f32b14044bd9f5d96ac49cac9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e7523417a4c4eb7954baff026cc2dc7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6dc1473063042a993f976b7cad5d115_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbcb7101f4b347c386f48f408e3ef92f_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d77cb69d6a14565b31edce03b6c02c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ae050fec07a41a1ad0d8ace81bbadbd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i233817b047df4ab4a84d4b14575f9f25_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2868b8c8554bf08566aa6693065131_I20130630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i206cd48a54414476aa718a6e0111302f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib3cfed53a74b468cb29ff189c2377269_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94338860cdfc4c5c8a8a280138f4eec0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17b4a6ef0fda43fc8f9f9d4f83f071a9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9deaff27fd544743b1c994ebf17f9064_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if213b8734da249fd94de624effacc125_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fea264d5e3a41b6b564f9b5e494a691_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f203ca7692647f9ad837576643bf7b8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb2cefdf0cf432eb6f5b7d915d85fc5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if87ccca3baba4a5395c1b9dc357f28b1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c242a3de0ae43649e6e851b01494740_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18bdeec0a55048dda5a14c6fef41b7a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dfa01f2e8de483cb3ee9d49bc79dc3e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac8f1d1fb3f74df2a85e394a8eb7560e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i282d10e015594727b9481e65e9dc6cc3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8848d2f515c4077b4f7260b808d43f9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8472c3bc9a9d4f95b15a5c727249f384_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id71e4d3f80ab475b8388901e312bddb1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5498ad1a414e15bf91e6c05c11a237_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c247c9265104fd983758887d598a274_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14a6633405de48c18ad9dd4624d66563_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbec786ebf7d48a3b104bb1d4b9fcd56_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1d3206f6ead449095a75f97c9ea7d4a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46836a3158d542afb32cd1e654a0c77d_D20190101-20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ecf186e93644ab891c8d431739b0932_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bb40d435fa14466b3b81d438b389a9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f3de1c6f6fe45f6b458941cbcce9c89_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i072cba6507a54b579148c043620aac02_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bad24d1776a40448ef8b8ec4302b349_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9a6eb4dd6a7413aa8ceaa3c09928e24_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80e9aba82fbc4331be3320b17f956428_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28f45a82c6a848438e8a0997d7c86692_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i444fecb15f1e48779e2506de06cd3906_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65529b8816d44f1e8f82c472ecfd4c41_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic95407f4963a4c28b32add928e5039ed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd7312c6ba844d1aa28e958e6af15331_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic729fd36e94941198d96cc6d4ce68a25_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb480f0f96a47448a5795388ca43da9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70792108505c44a39433fc64251bb816_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dafa88e942442b4b0e84b4bbaa57641_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35452878f20d488ca8c0c5945f7c5a56_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4538d252d0f4c568c400e1ed7914057_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63edb0c1b14e4ce8928a6297cfb75091_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33000cbc9d234e3199e997271c9fa20a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i231518ba36c64c4092eb780bf33ded51_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7f3d86824a4066a23c46e16851c996_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i317d53aa6f2d4db580df360452af00b7_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89cf005616044c5e8e5067ff128a6379_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:WestCompanyMexicoSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1e7eb7b421641b6b38d74b93995f136_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:AluplastSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i649d27b290864823b58120ef0a909e69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaTapSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8604ed7fa7ef45dfa5249a8547428da8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaRubberSADeCVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff6398961be24db984f094bedc419067_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:IWPharmaGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e7adf4b261e42b0ba535696463b6408_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34154b71394444eea4aac71d4bd6a886_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03c963f83384e04af745078ed7c6c28_I20191101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i135f442ad6834fb6b1c797458a39a2ee_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10b2bd972c5247c89ad526ba8664ceea_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b16d7361925410886eeb15e971ce722_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2afcfd5d059438e8bc7bc4552794714_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i529afefe3a5146a8ae99168ace63b1f5_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if22f0c39a4254fd9831626f40147da4c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2831b7068f5415993b76a543c279df1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i745e6936945c4146b553af9a8d7a2d88_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90dd87315fb54344b4f25c4ac0d5be42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id025bdb034db45568a0aa20c7a5a88e0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bb357a5970a432e8774216e7e63f9a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i370687821342468aa0b202a3b92a0f3a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930683f0ef754186a359e86df7c8ec95_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38e99e04c054de492c86997ca5d77b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a4a99992a34bbfbd4970a826236a2a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0002a699af14295b2302af2a16bab97_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:NotePayableDue2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1cf0309fce4ebd9ef5c548ba5929a5_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:Revolvingcreditfacilitydue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6676f9d8fa624212a28167a0b290deb2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Domain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9eb640c923f4733a19388100c5bbed7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91c99566b2144913acb7f361f5c22294_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b05261cd00424e9002e44c4d03c23e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b22bd295c93485fb2d2ff977a010756_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i303951a1d742421f9ca04aef7b201e68_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib25bd41fa2f6434989c8b30e7094cd66_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42fb76fda75b4b14a4664b19c1e784dc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ec845a2a624436a8201d02881d6167_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d2da44a3ca41a68e529adf0d248f25_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i984913c14dbf4de19cd8e36ccae92f15_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9d7d55f956d49e2be8ad5e98d032270_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife43bfe94fc749d880537b4733fda5a9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78e7486b947f4f99a466314587751bc2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56b5019b842b48aa8fa6565a51c3f1cd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie079f1f282e8458c9a8cdce88d50af68_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf55a0f044ed4e1a852eca470f62e0d8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6121497184640d09c106918c72a6948_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04ab47ee62a5494f909f92a95cc7c70c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b82a1b8c6a41898a7270bcd13e5504_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4fca98c38414a20b353c860de269825_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb4ecdaaaca7414f9a37335a909966d2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bdb4a99fe0e4bd7a545168d11cbeb80_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73656a3ae59a40a38eba7861eb07cd4a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f68633b1e54492a14344435d453361_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fb56017b0b444b684e46fe8935ceb60_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d6333665a945df9a67c0096b0b8f50_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i342543b0c2f347e9b92ff37b1a7384ad_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b648773fa64e1a87127b924772b46e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i830343e85a824475b975c25156e43753_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifde5cb3bbd874edd8d0787db92019d6f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11599bc1fbc343258d69e5c0fd059879_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sgd"><xbrli:measure>iso4217:SGD</xbrli:measure></xbrli:unit><xbrli:context id="i3aeebc15e0d840ad96d6c9b1d2194147_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f67399f84d54d7d9030ffcf5f5c6ac4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i9eb6fafaba61400aa82fd9842455a69a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd10e01ebd64b78a96cb615682a5c6e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06d9d35bbb0409183e672452771280d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i823dde1ddb5c418a9c33b324e0c85370_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad4d547d2e35453f98a85f299454f00a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="ieafbd5812ce143ef926bb1c0787dfbc6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0350a757f15d45c69e08b7eb2c4328de_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91724d6f39f459f886db959578117c7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f0ad8b423640e7ab03461e54ef5610_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b88e6dc60f545a3bf0b56c374eb3e15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida576a4da2ec47b5b4725b7e5768d696_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5e9aa415d9a4ae0894a28edad8214aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="bbl"><xbrli:measure>utr:bbl</xbrli:measure></xbrli:unit><xbrli:context id="ib8c160a1ee5b40b5815b9d3cfcebe527_I20171122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d648861366e4cdba756d7642ed7befe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerBbl"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>wst:bbl</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffca62c03c8741448a75a7f9e1f891ef_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie04ce0467d524a8b80a1b327747a40f3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b51d389a3a949c1a96cb422c48a5fe8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6516bd8d8ea049f183846349a305264f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7e1e117b2f4ca4b60537b7871e437a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88d7a3c0aeba474fab1d76fe62b33c49_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b1d512dc5f74c76b6f5691e47874f8c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardTreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cea4779b5e94dd0a2b87c75a76cf6ff_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardTreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83d0a9a392814a039ab15f60e9215923_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f8b7ccbfafd42afab343384ad715db3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e81e564ed5e4b758e644f7a48f8ab95_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifad6e6da551a403b9f68328ad4a2647e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb86356e282f48e09566b38bfd145856_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4786eb20ae494021a5b1565f7a6b78cb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7230a373ea8c425db7fc49d912890ad7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a0f779ffd67404fadb2c88b38a8fdc2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5444a6541e6a4839bba8118e13149c48_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4590db188d460db03346773c2dfbe4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06546c728f1b443790dab4e6acbc50dd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb34bb0d2724fb1baccf7a4fa927eef_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5398fe0e5da44d5c9cda165e14f5d41d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i938788ff937e43d487f7bb5a02deca1f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72df90269a054543b29d4dd406291594_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c77ba79e344403eb264810bc01f9141_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icefa72050c4e4056afec90fa88e94c46_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56943e3e899240ba88693a4605ca6bff_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i241e5f10a4ee4e61ae7e0c26389d98fd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icff6c5eae2bf4042940d49d48243f475_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5dac4480e07412789c6a00d0537966a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49fc1eac9a9a44988c05ab15c2b63dfc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d4ee3958e024ea9be2a4c855879a06a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i328f95c25c924ece85bbcd0f93f45e60_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30b7e14d051044b6b066bd549c53bd4b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c1d0f284e747c89538b5a73987ad3d_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d70b978d8424d62a3d315bd9abaa763_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5b5ea0ff6242348184786c3aa961a1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61530ee5d64a43f0808f912144af8669_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20cc775951344c239b53db6971de8efc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d3c7ebb49d2493aae018dd123c22d48_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53303cfc86bc4dff961279511a95e263_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c9924dfc84f437e82ad7ec265e9ce95_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226a4aed358e47e7960939567dde9022_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e147e1374f4056b910aed673effca0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de8a9a6e8a94858b2a73224b4e7f5fa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if438f100318e4fa3a354238bdb515b75_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cec6a2db0f04eb8ace95c800f171e3f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2e238f2cc9d40cb97384f851a4ea42e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f47dbaaaf6d430698b26cb6d8506727_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee4a569c86594ed29bf4011534feefa3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fe96b1532ac40c18a9abf4c6908270f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52141f7b63cf445d8c4a8244666efd47_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d9afa908f244094a5308013f6de9d86_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebf8f5c36fb64d06aff88d876051dba3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec88e31a4b8432c9b702366e072bcb8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09ac587c6b034ba186fc3c9de00c5b88_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907bb151930c472cb4617e8718b30e96_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b4b4807f6a4884893b217405bc6fea_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b919d55672f4707aaf1d62ddfc9503d_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i867e15a5465644589509da385c3661da_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f53f5cc02db4483948008576a947179_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied22694c54d942dbbe6f33ff6b1dcfa0_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bc4c67901ce44cc8ef5352dc9cb7c54_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i567d1eac07af4457b1dd2b7b2b50501d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf6f7b5a95fd4d168630008ee5f37653_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6077149f426d4ae8a0b5fd6b074a7a43_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9df6a38179044003b818ff0f67bc84c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d97e40c7db14ee0809a960d3d36fb39_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2bf2b4179734ec29b0e706a4dd04b3c_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1169a473b724d8d93c956648282e54b_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa59b208a4dc470ead37d30735e6af30_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia961f06db9c748b8981269960022f06a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f7c7e71c7f49ec88d39755fd192a57_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f756b7f10140c7a667c59d6aed2b9d_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i335850f837034b4f92801e3e27dcb7c9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59d999a99954d12bc5b0af492454ea2_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice189043bdb14f77817f481da434b9f6_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7986a8931ce14e87a14397225a1db358_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2930b7a825204376adcd1aaccfb3a4e3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8c24828a0f4b248dd1d741a061b3ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id624f0b918514c1fa67d18292cb0f592_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3248006f27a44046a786ecae30f2c7b9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if424c5cbb6af4281b20e4f9016d91f87_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba2d66afdb1b460b9bc719352ac92b1b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a36423c0a44b9986aa0cbeabb16721_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia14da4b7cdb047cd878899fb992151cf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plan"><xbrli:measure>wst:plan</xbrli:measure></xbrli:unit><xbrli:context id="if56b24e99d71498ab539bcd0ec6f2c84_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680ad925db4e48d78b3237fca4762bf7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8169a62ce26b42908772007e3660188a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b7feba544854c48a311d6c134d52a58_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9e1503f92494d249bddbebe72901fbf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcf3086a15804eef96196b34fe5f6a29_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3372ec3c59ed4ec6845462cf9a97844d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if02e282f48e34ea9924bc5e936dee280_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec2956a56fea4665ac7855ee4d00856a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i691d61af8bdb48d58e96be31e865a8f0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05084a034d864aaab4d454ef2374f73d_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia045884eabdd4675b086f7cbe1088331_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i482e7650de754ebd863450ff98ddd102_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bc0be5f11db4f4b96289239a9c31f9b_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437e493b76d849dab6516dfc8137e7a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic213450143c643fcabdf167b9544dd56_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c070b0619d84059924fa1fee46ec2a9_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6298ee303c464f0bbd0097078dcab7e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81168432177b4e14899b98a50ad8eb27_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f2d011f88041df81ed72918d912b28_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a63732b565e43618a5fad775146f15b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d13573002854b4794e6d272dc9f023d_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief24d588abd841029d2aa9c0845ad0d7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i026dfb891cba455ab72f03d27baf78a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc6ad07586d04905b438308adf2938bc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf432c4ed1ca4ca8826cfc7b51ce110f_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad1e003ca731453b8c13de225178286f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71005f2a08e3495aa5b8b71712dd46e7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef51169ca6c490e91fd071db31d7686_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff94b3c95ef4cdf82dcbfbe15cce239_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae5ec6c92f2841c58c748c66b981c526_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe9d51b887b49898618b0e671ee0909_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a035cec19e4b06b8a0a0f2b1507211_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i059f6519363e4795ac9e2b62228928ea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6b75ff5856344798be8d09feba9d76c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b6fc1c55ae4f2c8edcfa03284c2531_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i872e47c6d50b462c8e589892b0d54db5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0ee7d7ac4d4a6dbfcb60f511f35cc1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7f540d9be17469abb37970c9409c4b0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if92ca63024e94955aa542248e84899d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83e89bb3731949e9b811eea8345a785d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1671a272484847b0a73c5e28afdbbc6e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa3a175482f741ac9a27d320bfda7d20_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3c5104f4fc949a7b5a23bb9ae7a2280_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9ab3e1be7b43a6a9aed789c9de3fe0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0443f666d5124baa94d26af15d452b44_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionplanassetsmeasuredatNAVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7973d3e744414be78965041980c27ae2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id865d211c82f481ba1e8e730281c3396_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2590f85ac39247ee8575a025ddfafb6e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85ff1c02db44ef69cddfb8fa9561ced_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2cfb2df0ba2490e8bc77e8e71719012_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i049d668d485c4a138de851c7ad4dd119_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia16d87c6eeea4a8a9a6aeceadbe8a2e9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide50b00aea9546c98b500e0e9ab6663d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c5adfefdd0a41bc979246bd31ec015f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionplanassetsmeasuredatNAVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i551f76dde6ca4da6bd01b58607183318_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibef8133166a844e388b00a88119d4a66_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a698e5c8f8b445582c108fd424dc99f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id309afa6d90f4b3ca6e334c040f495a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20418919ecf14b199ebd3c21c8ead300_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b4e26d82c6947d6ac866551afe0974e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9313d976ef2b4f7b845722c3a2d91a03_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e49cb2c7f3a4e50aac7c89a7a0d7753_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i617f29de38554e598979b53825165b3f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e0171741848480aabaad6cf352a5967_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3b94bf9830453eb8c83e9fe89297ed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff067a80b3c0472aafbb0d3d5e4c92ad_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63038b37ba3f4411817f0419317cd970_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a770acf6d014af1b07375d85b007733_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0e8452d0cd54d09bd29f966f85d7796_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic58d406b08ad4b8ea3459ce6ee377143_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09af60c60dee44a093e76f37f68e79e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i508d135f28ec440fa57fc415a1e8cc42_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2016RestructuringPlanMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67268793d14a4d86b86841792ac25b2a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2016RestructuringPlanMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a2c29927a97445985c175fb950377a6_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17de35ea5588457687be31c78183d563_I20160217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e11b27427cd46d590025400238fdb38_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib48ea9474bfe4c5d806349adbf636277_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6760c6eadf5e4027ab3c48a8a4c417ad_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica512f947d5545b0a280adcd3765b3af_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0a47ab88878443fa4e6adac51e1e3c3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafeae8bf38a74e0390f625e332ddc2d6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77e352a3c93e42ae8d803009dcc77900_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29b000bedbc74b059850aa72d8e23d8a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57428a739d8c47e29c71f898beabc22b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d6aec77c75b4f37a744be6b762f91c7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49459769fb524550871915ef2336f3bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315770c7cae047a4a1c795627dca7961_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d27b8c83d9e4aed8e3bf7c54c872328_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c33648dc8604a2e97bec4df1cd23f1f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6eefab0034b46c0afd45df41bf8245f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a3ac6bafdc43978ec3c7db0603a567_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>wst:segment</xbrli:measure></xbrli:unit><xbrli:context id="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078c4378a1b84554a97a59aedf1dfea7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0e5799d11f4ece904985f859626f83_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2ea62dcc46049b7b44a7e372ea6a995_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7f8ebed49c04cffb17e7209463597e7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e4f0863e8134660bc06abb0a0554e60_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11483b8c07b24a0285c429890af29b9b_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id465de2bff9a44b58c23173587870451_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d5c2cd9d804dc19f76970e86ae5660_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30dc74ba8e0b46938ade75bfad703ec4_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f4a7e1e4f344e59acb8e316afa24ca7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02b772a610de4ee59ff680dfeb546f55_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdf9bc802dfc4329a0be62772f1a8f6b_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f86ebc34b44436088bdd5978d8e3e07_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fc499a8a70a4e75bdc070421802e388_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie056e2b910a94d86a17d8e9f6a20dc06_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i476449ab4421489bb9b91517a6fc7efe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85b512abe143458ebeb74749610bb670_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe71ee072f1e4070b5fe8ef25b5b4c68_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief76596d19a14b5699a2fde2cb8e562b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ef689740fa64b5883e5e5174f62fe1d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i048c1c583b8248d7a9ab445c65149f1e_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903f49cdebbd412fb6eb73679c880d2e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c04b723e3b410593ed485b6a229bfc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i917cb1338bde49fd8e568f601fd1e22a_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6dd3862267a4178a471745a2b35ad9e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92da6f6ed734f7aa39fcd3fd2e821c3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a7d300fbe84c79a997b01a28de9fb5_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc09f1765984af1a548e59801303ef6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53739c8ad7af43158f8713882ca97f50_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe7421492df04bb4bddbdcbf7176b677_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib228924631aa44288381badfd1e2059e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29700e0161cf4255a1c0d184517c3f32_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319915b8ecd44b91bcc26caf2f45657e_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9b2e0330857436684b723ea8478ec77_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb96f50eb494612ba0edad271cb1096_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafe47744d2e84db7a253c53f75362e62_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b9f65fe26504bfe928b879458ca9505_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if148c501c02e4e2c97646022381c7196_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib47295db1ad64e7c8b1a5e5f348d4c2b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a1c2431d80b42aead2763d611b9d0e5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i509b63e47a3144be9248957ca04eda93_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3960c7889746f797e090bc457710a9_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1350bd4286de44cfbac587447b6169de_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c8f0dd6fd44e0192bbca698c80730d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6ac79d82bd448c79b4fdc95685aab8b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafcda053ab8e47e38f791920cd9cf950_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e8d9cf8ecf49a8bb93848beaa81037_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee5aa6955d81437b952a802f4ada2d98_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee0f05c56c248109cf70bf6a1dfcf1d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabc48380a0f84fafbbd805cba9caddec_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b41e0d9c7ef435a9edc553f82a3fba8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48adb9af41f141dbba997f45f6e7b647_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61105e0ada8748f28fbbec27f4b1f63c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8e071d9eab748839372112a8d75b384_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7003c1f4ab54e5c92dc94b3582d241f_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0bb2326a07b4350912a6c72afbe1a89_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i935b128fab324f209cb4528dec5e49f2_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTMtMS0xLTA_1007089b-9d27-441e-bd00-216b4604dd58 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMy0xLTEtMA_80119c0b-b71e-4a84-8eb1-c0fb0bd36c76 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMy0xLTEtMA_d28125c4-92ec-47d3-8406-117689e3d175 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTMtMS0xLTA_40b54a96-0396-4421-b1ce-2b3cd96225a7 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTMtMS0xLTA_c8b5599a-24dd-434b-9e3b-f259fbca00b5 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMy0xLTEtMA_38657aef-b525-480d-ae9a-9bf7c414bf14 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMy0xLTEtMA_8bbf7b11-8cee-4068-a724-6a2935eb53d1 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTMtMS0xLTA_08aeb46f-574a-49bf-9d28-ed099cac5446 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTMtMS0xLTA_b6229983-91ed-4fba-917e-f767735942c0" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTQtMS0xLTA_39b1e72d-a910-4547-84e9-4db1b28ffa44 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTItMS0xLTA_158e1055-5fdf-4a12-9fe0-387a2cc0fd98 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTItMS0xLTA_1381ba37-693b-4a76-81c2-d76f8f336004 id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTQtMS0xLTA_6ce887dc-fdf2-48fb-a49b-0c1d0da55efb" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i_0_1"></div><div style="height:49.5pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.851%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:11pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Washington, D.C.&#160;&#160;20549</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.851%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;">FORM <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NTUzN2IyYTQ2ZGUzNDU1ZjlhOTI3Mzg1YzE0ZGYyMjcvdGFibGVyYW5nZTo1NTM3YjJhNDZkZTM0NTVmOWE5MjczODVjMTRkZjIyN18wLTAtMS0xLTE5Ni90ZXh0cmVnaW9uOmQwY2I4OWRmZjExNjQ1NmNiZjQxZGZjZTFmYzQ3YWQyXzEwOTk1MTE2Mjc3OTM_d699d2a0-35cf-4d98-ad7d-f0b409efd2a8">10-K</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">(Mark One)</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.017%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:93.983%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NzE4MzkwNjdlYTU3NDRkMmEzNTA1NDU0NDc4YTA1MzEvdGFibGVyYW5nZTo3MTgzOTA2N2VhNTc0NGQyYTM1MDU0NTQ0NzhhMDUzMV8wLTAtMS0xLTE5OQ_825288f5-8547-4e0d-8528-512a2af94f89">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">For the fiscal year ended <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjM0NTA5_450b1b14-ddac-4b9a-9606-cbc2dc6e8088">December 31, 2019</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">or</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:2.017%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:93.983%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6YmFkZTEzMWNmNjFlNGZjN2FjYWNmYWVmNTczZDFlMDEvdGFibGVyYW5nZTpiYWRlMTMxY2Y2MWU0ZmM3YWNhY2ZhZWY1NzNkMWUwMV8wLTAtMS0xLTIwMg_9548a4a6-45a5-4ecb-a6a8-6c39fa5062ee">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">Commission File Number <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTU3_b0b18d63-3839-4586-a7c6-aa83d01906a8">1-8036</ix:nonNumeric></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.851%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6ZWQ2OGFhY2Q5YTE3NDYxMzg2NzdmOGM5YmQxZWZjZjkvdGFibGVyYW5nZTplZDY4YWFjZDlhMTc0NjEzODY3N2Y4YzliZDFlZmNmOV8wLTAtMS0xLTIxNi90ZXh0cmVnaW9uOmIxY2M3YWQxMmI5YTQyZTFiZjFhM2Q1N2QzYzg3NzU2XzEwOTk1MTE2Mjc5MDU_37596e15-32a8-47ef-ae13-037ef6b13199">WEST PHARMACEUTICAL SERVICES, INC.</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">(Exact name of registrant as specified in its charter)</span></div></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.851%;"><tr><td style="width:1.0%;"></td><td style="width:48.074%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:47.926%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8wLTAtMS0xLTI2Mw_53c08fb5-12f3-473b-9b71-34518f19329a">Pennsylvania</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8wLTEtMS0xLTI2Ng_b75bed8c-f6ef-4df7-9e74-e4f2d1ef876f">23-1210010</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(I.R.S. Employer Identification Number)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTAtMS0xLTE3NC90ZXh0cmVnaW9uOmNkODY0Y2I5MDU0MjRjMGNiYzlmNDJjYzY3ZDVjMzcyXzEwOTk1MTE2Mjc4Mzk_1f119f99-c0cb-45ad-aa9f-ed3186ef00c8">530 Herman O. West Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTAtMS0xLTE3NC90ZXh0cmVnaW9uOmNkODY0Y2I5MDU0MjRjMGNiYzlmNDJjYzY3ZDVjMzcyXzEwOTk1MTE2Mjc4NzA_4659685c-bbaa-4174-8a09-4c1ba0fa1ca3">Exton</ix:nonNumeric>, <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTAtMS0xLTE3NC90ZXh0cmVnaW9uOmNkODY0Y2I5MDU0MjRjMGNiYzlmNDJjYzY3ZDVjMzcyXzEwOTk1MTE2Mjc4NzQ_ffa85ced-4010-4552-9f90-1a1e0d8199f4">PA</ix:nonNumeric></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTEtMS0xLTI2OA_52ee64c6-c26d-4df2-9b1e-c3ce9afb1859">19341-0645</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Address of principal executive offices)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Zip Code)</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Registrant&#8217;s telephone number, including area code: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTA0_7e93ccc5-a936-4269-943a-158489fa556e">610</ix:nonNumeric>-<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTA5_d49982ba-f60c-4e82-b854-4b2bc9c934ff">594-2900</ix:nonNumeric></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:98.958%;"><tr><td style="width:1.0%;"></td><td style="width:41.157%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.285%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:40.558%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWM5Y2I3YzUwNTlhNGY2YzhiMWQ5YTM1MGY5NTNiNWQvdGFibGVyYW5nZTo1YzljYjdjNTA1OWE0ZjZjOGIxZDlhMzUwZjk1M2I1ZF8xLTAtMS0xLTI3Mg_2a03776c-eb50-4f37-8a77-9d15c479f8f3">Common Stock, par value $.25 per share</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWM5Y2I3YzUwNTlhNGY2YzhiMWQ5YTM1MGY5NTNiNWQvdGFibGVyYW5nZTo1YzljYjdjNTA1OWE0ZjZjOGIxZDlhMzUwZjk1M2I1ZF8xLTEtMS0xLTI3NQ_d7595ef5-a1ad-486a-b7ba-9c2a6deedaa1">WST</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWM5Y2I3YzUwNTlhNGY2YzhiMWQ5YTM1MGY5NTNiNWQvdGFibGVyYW5nZTo1YzljYjdjNTA1OWE0ZjZjOGIxZDlhMzUwZjk1M2I1ZF8xLTItMS0xLTI4MA_9a8e8214-d8f8-43b1-9f1b-5c8ca8fea52e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">Securities registered pursuant to Section 12(g) of the Act:   </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">None</span></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc1_46bc29c2-a7a3-4f2f-ad53-8c86bdd0972b">Yes</ix:nonNumeric>  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">&#9745;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">No  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">&#9744;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;Yes  &#9744;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc5_df455388-3caf-44da-82d7-aa6bc122a56f">No</ix:nonNumeric>  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">&#9745;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc2_9489b403-032c-489b-b66c-4b24942ea16b">Yes</ix:nonNumeric> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">&#254; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">No&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">o</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc3_2b0e2bb9-f2e2-4f62-b0fe-17ea86903729">Yes</ix:nonNumeric>&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">&#254; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">No&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">o</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:92.113%;"><tr><td style="width:1.0%;"></td><td style="width:20.778%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.361%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:41.134%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:23.363%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.364%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6MTFjNTJhMDgzNTMyNDBiMjk5OWMyMDZmZWYyMDc0OWMvdGFibGVyYW5nZToxMWM1MmEwODM1MzI0MGIyOTk5YzIwNmZlZjIwNzQ5Y18wLTAtMS0xLTI5MQ_6957b5a8-4724-4331-8f19-d2452be269c5">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9745;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated filer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-accelerated filer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Smaller reporting company</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6MTFjNTJhMDgzNTMyNDBiMjk5OWMyMDZmZWYyMDc0OWMvdGFibGVyYW5nZToxMWM1MmEwODM1MzI0MGIyOTk5YzIwNmZlZjIwNzQ5Y18xLTQtMS0xLTI5NA_faa0e977-2513-43ee-9bcb-52df9656354e">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Emerging growth company</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Wingdings',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6MTFjNTJhMDgzNTMyNDBiMjk5OWMyMDZmZWYyMDc0OWMvdGFibGVyYW5nZToxMWM1MmEwODM1MzI0MGIyOTk5YzIwNmZlZjIwNzQ5Y18yLTQtMS0xLTI5Ng_8f49f925-c57a-4772-b36b-b78e9d643b0a">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#160;&#9744;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;Yes&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc4_412c576b-3f54-48c3-a1b4-4727d41c5283">&#9744;</ix:nonNumeric>&#160;No  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings 2',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">&#9745;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">The aggregate market value of the voting stock held by non-affiliates of the registrant as of June&#160;30, 2019 was approximately $<ix:nonFraction unitRef="usd" contextRef="i8f56fa522aba4347a769ceb8b2131331_I20190630" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8yNTE4_78b9a4e4-e8d9-4597-be29-c1ef5e5d0030">9,218,126,218</ix:nonFraction> based on the closing price as reported on the New York Stock Exchange.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">As of January&#160;31, 2020, there were <ix:nonFraction unitRef="shares" contextRef="i1ecebe1ac085442a9fcafcfcb6dea5b9_I20200131" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8yNjE0_edd0e3f4-b596-471e-99fa-49bf21029e64">73,837,449</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%;">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:92.261%;"><tr><td style="width:1.0%;"></td><td style="width:67.516%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:28.484%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Document</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Parts Into Which Incorporated</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proxy Statement for the Annual Meeting of Shareholders to be held May 5, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Part III</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div id="i_0_7"></div><div style="position:relative;width:100%;height:49.5pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">TABLE OF CONTENTS</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.198%;"><tr><td style="width:1.0%;"></td><td style="width:9.631%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:76.190%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.179%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_10">PART I</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Page</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_13">ITEM 1.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">BUSINESS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_16">ITEM 1A.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RISK FACTORS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_16">7</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_19">ITEM 1B.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">UNRESOLVED STAFF COMMENTS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_19">15</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_22">ITEM 2.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PROPERTIES</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_22">15</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_25">ITEM 3.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">LEGAL PROCEEDINGS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_25">16</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_28">ITEM 4.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MINE SAFETY DISCLOSURES</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_28">16</a></span></div></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_31">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_31">16</a></span></div></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_34">PART II</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_37">ITEM 5.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_37">18</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_40">ITEM 6.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SELECTED FINANCIAL DATA</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_40">20</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_43">ITEM 7.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_43">21</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_52">ITEM 7A.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_52">35</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_55">ITEM 8.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_55">38</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_166">ITEM 9.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_166">85</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_169">ITEM 9A.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CONTROLS AND PROCEDURES</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_169">85</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_172">ITEM 9B.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTHER INFORMATION</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_172">86</a></span></div></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_175">PART III</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_178">ITEM 10.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_178">86</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_181">ITEM 11.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EXECUTIVE COMPENSATION</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_181">86</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_184">ITEM 12.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_184">86</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_187">ITEM 13.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_187">87</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_190">ITEM 14.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PRINCIPAL ACCOUNTING FEES AND SERVICES</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_190">88</a></span></div></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_193">PART IV</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_196">ITEM 15.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EXHIBITS, FINANCIAL STATEMENT SCHEDULES</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_196">88</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_199">ITEM 16.</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">FORM 10-K SUMMARY</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_199">89</a></span></div></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_202">SIGNATURES</a></span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_202">90</a></span></div></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><a style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: none;" href="#i_0_205">EXHIBIT INDEX</a></span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_205">F-</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration: underline;" href="#i_0_205">1</a></span></div></td></tr></table></div><div><span><br/></span></div><div id="i_0_10"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PART I</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unless otherwise indicated, or the context otherwise requires, references in this report to &#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; and &#8220;West&#8221; refer to West Pharmaceutical Services, Inc.  and its majority-owned subsidiaries. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All trademarks and registered trademarks used in this report are our property, either directly or indirectly through our subsidiaries, unless noted otherwise. Daikyo Crystal Zenith</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (&#8220;Crystal Zenith&#8221;) is a registered trademark of Daikyo Seiko, Ltd. (&#8220;Daikyo&#8221;).</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Throughout this report, references to &#8220;Notes&#8221; refer to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K (&#8220;Form 10-K&#8221;), unless otherwise indicated.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Information in this Form 10-K is current as of February&#160;21, 2020, unless otherwise specified. </span></div><div><span><br/></span></div><div id="i_0_13"></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 1.  BUSINESS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">General</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and additional medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, and enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Business Segments</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and integrated solutions, primarily to biologic, generic and pharmaceutical drug customers. Our packaging products include stoppers and seals for injectable packaging systems, which are designed to help ensure drug compatibility and stability with active drug products, while also supporting operational efficiency for customers. This product portfolio also includes syringe and cartridge components, including custom solutions for the specific needs of injectable drug applications, as well as administration systems that can enhance the safe delivery of drugs through advanced reconstitution, mixing and transfer technologies. We also provide films, coatings, washing and sterilization processes and services to enhance the quality of packaging components and mitigate the risk of contamination and compatibility issues.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This segment&#8217;s product portfolio also includes drug containment solutions, including Crystal Zenith, a cyclic olefin polymer, in the form of vials, syringes and cartridges. These products can&#160;provide a&#160;high-quality solution to glass incompatibility issues and can stand up to cold storage environments, while reducing the risk of breakage that exists with glass. In addition, we offer a variety of self-injection devices, designed to address the need to provide at-home delivery of injectable therapies. These devices are patient-centric technologies that are easy-to-use and can be combined with connected health technologies that have the potential to increase adherence. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to our Proprietary Products product portfolio, we provide our customers with a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. Offering the combination of primary packaging components, containment solutions, and drug delivery devices, as well as a broad range of integrated services, helps to position us as a leader in the integrated containment and delivery of injectable medicines.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This reportable segment has manufacturing facilities in North and South America, Europe, and Asia Pacific, with affiliated companies in Mexico and Japan. Please refer to Item 2, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Properties</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. These products include a variety of custom contract-manufacturing and assembly solutions, which use such technologies as multi-component molding, in-mold labeling, ultrasonic welding, clean room molding and device assembly. We manufacture customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have vast expertise in product design and development, including in-house mold design, process design and validation and high-speed automated assemblies.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This reportable segment has manufacturing operations in North America and Europe. Please refer to Item 2, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Properties</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">International</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have significant operations outside of the United States (&#8220;U.S.&#8221;), which are managed through the same business segments as our U.S. operations &#8211; Proprietary Products and Contract-Manufactured Products. Sales outside of the U.S. accounted for 55.7% of our consolidated net sales in 2019. Please refer to Item 2, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Properties</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information on our manufacturing and other sites.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Although the general business processes are similar to the domestic business, international operations are exposed to additional risks. These risks include currency fluctuations relative to the U.S. Dollar (&#8220;USD&#8221;), multiple tax jurisdictions and, particularly in South America, Israel and the Middle East, uncertain or changing regulatory regimes, or political and social issues, that could destabilize local markets and affect the demand for our products.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See further discussion of our international operations, the risks associated with our international operations, and our attempt to minimize some of these risks in Part I, Item 1A, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Risk Factors;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Part II, Item 7, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Condition, Liquidity and Capital Resources; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Part II, Item 7A, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Quantitative and Qualitative Disclosures About Market Risk;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Note 1</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">under the captions </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Foreign Currency Translation; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and Note 11, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Derivative Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Raw Materials</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We use three basic raw materials in the manufacture of our products: elastomers, aluminum and plastic. Elastomers include both natural and synthetic materials. We currently have access to adequate supplies of these raw materials to meet our production needs through agreements with suppliers.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We employ a supply chain management strategy in our business segments, which involves purchasing from integrated suppliers that control their own sources of supply. Due to regulatory control over our production processes, sole source availability, and the cost and time involved in qualifying suppliers, we rely on single-source suppliers for many critical raw materials. We generally purchase certain raw materials in the open market. This strategy increases the risk that our supply chain may be interrupted in the event of a supplier production or </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">distribution problem. These risks are managed, when and where possible, by selecting suppliers with multiple manufacturing sites, rigorous quality control systems, surplus inventory levels and other methods of maintaining supply in case of an interruption in production or distribution.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Intellectual Property</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intellectual property, including patents, trademarks, copyrights, trade secrets, and know-how, is important to our business. We own or license intellectual property rights, including issued patents and pending patent applications in the U.S. and in other countries, that relate to various aspects of our products. In 2019, more than 150 patents were issued to West across the globe. Some key value-added and proprietary products and processes are licensed from Daikyo. Our intellectual property rights have been useful in establishing our market position and in the growth of our business, and are expected to continue to be of value in the future. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Seasonality</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business is not inherently seasonal.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Working Capital</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are required to carry significant amounts of inventory to meet customer requirements. In addition, some of our supply agreements require us to purchase inventory in bulk orders, which increases inventory levels but decreases the risk of supply interruption. For a more detailed discussion of working capital, please refer to the discussion in Part II, Item 7, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Condition, Liquidity and Capital Resource</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">s.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Marketing</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Proprietary Products customers primarily include many of the major biologic, generic, and pharmaceutical drug companies in the world, which incorporate our components and other offerings into their injectable products for distribution to the point of care and ultimate end-user - the patient.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Contract-Manufactured Products customers include many of the world&#8217;s largest pharmaceutical, diagnostic, and medical device companies. Contract-Manufactured Products components generally are incorporated into our customers&#8217; manufacturing lines for further processing or assembly.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our products and services are sold and distributed primarily through our own sales force and distribution network, with limited use of contract sales agents and regional distributors. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our ten largest customers accounted for 44.3% of our consolidated net sales in 2019, but none of these customers individually accounted for more than 10% of consolidated net sales. Please refer to Note 3, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and Note 19, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Segment Information</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information on our consolidated net sales.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Order Backlog</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Order backlog includes firm orders placed by customers for manufacture over a period of time according to their schedule or upon confirmation by the customer. We also have contractual arrangements with a number of our customers. Products covered by these contracts are included in our backlog only as orders are received. Order backlog may be positively or negatively impacted by several factors, including customer ordering patterns and the necessary lead-time to deliver customer orders. Order backlog is one of many measures we use to understand future demand, and should not be considered in isolation to predict future sales growth. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">At December&#160;31, 2019 and 2018, the order backlog for Proprietary Products was $587.9 million and $407.3 million, respectively. The increase in backlog primarily reflects increases in demand for our products due to several successful customer launches in 2019 and expansion of current customer programs due to the success of their drug </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">products. The majority of the order backlog for Proprietary Products at December&#160;31, 2019 is expected to be filled during 2020. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The majority of Contract-Manufactured Products manufacturing activity is governed by contractual volume expectations, subject to periodic revisions based on customer requirements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Competition</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">With our range of proprietary technologies, we compete with several companies across our Proprietary Products product lines. Due to the special nature of our pharmaceutical packaging components and our long-standing participation in the market, competition for these components is based primarily on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost-control programs across their operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, there are a number of competitors supplying medical devices and medical device components, including a number of pharmaceutical manufacturers who are also potential customers of our medical devices. We compete in this market on the basis of our reputation for quality and reliability in engineering and project management, as well as our knowledge of, and experience in, compliance with regulatory requirements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have specialized knowledge of container closure components, which is integral to developing delivery systems. With our range of proprietary technologies, we compete with new and established companies in the area of drug delivery devices, including suppliers of prefillable syringes, auto-injectors, safety needles, and other proprietary systems.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We seek to differentiate ourselves from our competition by serving as an integrated drug containment and delivery systems global supplier that can provide pre-approval primary packaging support and engineering development, analytical lab services and integrated solutions, regulatory expertise, and after-sale technical support. Customers also appreciate the global scope of our manufacturing capability and our ability to produce many products at multiple sites.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Contract-Manufactured Products business operates in very competitive markets for its products. The competition varies from smaller regional companies to large global assembly manufacturers. Given the cost pressures they face, many of our customers look to reduce costs by sourcing from low-cost locations. We seek to differentiate ourselves by leveraging our global capabilities and by employing new technologies such as high-speed automated assembly, insert-molding, multi-shot precision molding, and expertise with multiple-piece closure systems.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development Activities</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We maintain our own research-scale production facilities and laboratories for developing new products, and offer contract engineering design and development services to assist customers with new product development. Our quality control, regulatory and laboratory testing capabilities are used to ensure compliance with applicable manufacturing and regulatory standards for primary and secondary pharmaceutical packaging components and delivery systems.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Commercial development of our new products and services for medical and pharmaceutical applications commonly requires several years. New products that we develop may require separate approval as medical devices, and products that are intended to be used in the packaging and delivery of pharmaceutical products are subject to both customer acceptance of our products and regulatory approval of the customer&#8217;s products following our development period.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We continue to pursue innovative strategic platforms in prefillable syringes, injectable containers, advanced injection, and safety and administration systems.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">6</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also continue to seek new innovative opportunities for acquisition, licensing, partnering or development of products, services and technologies that serve the injectable drug containment and delivery market.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Environmental Regulations</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are subject to various national, state and local provisions regulating the discharge of materials into the environment or otherwise relating to the protection of the environment. Our compliance with these laws and regulations has not had a material impact on our financial position, results of operations or cash flows. There were no required material capital expenditures for environmental controls in our facilities in 2019 and there are currently no needed or planned material expenditures for 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Employees</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we employed approximately 8,200 people in our operations throughout the world.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Available Information</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We maintain a website at </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">www.westpharma.com</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Our Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) are available on our website under the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Investors - SEC Filings</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> caption as soon as reasonably practical after we electronically file the material with, or furnish it to, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). These filings are also available to the public over the Internet at the SEC&#8217;s website at </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">www.sec.gov</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Throughout this Form 10-K, we incorporate by reference certain information from parts of other documents filed with the SEC and from our Proxy Statement for the 2020 Annual Meeting of Shareholders (&#8220;2020 Proxy Statement&#8221;), which will be filed with the SEC within 120 days following the end of our 2019 fiscal year. Our 2020 Proxy Statement will be available on our website on or about March 31, 2020, under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Investors - Annual Reports &amp; Proxy</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Information about our corporate governance, including our Corporate Governance Principles and Code of Business Conduct, as well as information about our Directors, Board Committees, Committee Charters, and instructions on how to contact the Board, is available on our website under the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Investors - Corporate Governance </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">heading. We intend to make any required disclosures regarding any amendments of our Code of Business Conduct or waivers granted to any of our directors or executive officers under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Code of Business Conduct </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">on our website. Information relating to the West Pharmaceutical Services Dividend Reinvestment Plan is also available on our website under the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Investors - Transfer Agent/Dividend Reinvestment</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> caption. Information on our website does not constitute part of this document.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We will provide any of the foregoing information without charge upon written request to our Corporate Secretary, West Pharmaceutical Services, Inc., 530 Herman O. West Drive, Exton, PA 19341.</span></div><div><span><br/></span></div><div id="i_0_16"></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 1A.  RISK FACTORS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The statements in this section describe major risks to our business and should be considered carefully. In addition, these statements constitute our cautionary statements under the Private Securities Litigation Reform Act of 1995. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Our disclosure and analysis in this Form 10-K contains some forward-looking statements that are based on management&#8217;s beliefs and assumptions, current expectations, estimates and forecasts. We also provide forward-looking statements in other materials we release to the public as well as oral forward-looking statements. Such statements give our current expectations or forecasts of future events. They do not relate strictly to historical or current facts. We have attempted, wherever possible, to identify forward-looking statements by using words such as &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;anticipate&#8221; and other words and phrases of similar meaning. In particular, these include statements relating to future actions, business plans and prospects, new products, future </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">7</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">performance or results of current or anticipated products, sales efforts, expenses, interest rates, foreign-exchange rates, economic effects, the outcome of contingencies, such as legal proceedings, and financial results. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Many of the factors that will determine our future results are beyond our ability to control or predict. Achievement of future results is subject to known or unknown risks or uncertainties, including, without limitation, the risks set forth below. Therefore, actual results could differ materially from past results and those expressed or implied in any forward-looking statement. You should bear this in mind as you consider forward-looking statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Unless required by applicable securities law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. We also refer you to further disclosures we make on related subjects in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K to the SEC.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our operating results may be adversely affected by unfavorable economic and market conditions.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The current uncertainty in the global economy, including the effects of recession or slow economic growth in the U.S., Europe, and emerging markets in Asia and South America, may negatively affect our operating results. Examples of the effects of these global economic challenges include: our suppliers&#8217; and our customers&#8217; inability to access the credit markets at commercially reasonable rates; reduction in sales due to customers decreasing their inventories in the near-term or long-term or due to liquidity difficulties; reduction in sales due to shortages of materials we purchase from our suppliers; reduction in research and development efforts and expenditures by our customers; our inability to hedge our currency and raw material risks sufficiently or at commercially reasonable prices; insolvency of suppliers or customers; inflationary pressures on our supplies or our products; and increased expenses due to growing global taxation of corporate profits or revenues or changes in, or expirations of, a country&#8217;s tax laws or regulations. Our operating results in one or more geographic regions may also be affected by uncertain or changing economic conditions within that region. If economic and market conditions in the U.S. or Europe, or in emerging markets, weaken further, we may experience material adverse impacts on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our sales and profitability are largely dependent on the sale of drug products delivered by injection and the packaging of drug products. If the drug products developed by our customers in the future use another delivery system or are reconfigured to require less frequent dosing, our sales and profitability could suffer. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business depends to a substantial extent on customers&#8217; continued sales and development of products that are delivered by injection. If (i) our customers fail to continue to sell, develop and deploy injectable products; (ii) our customers reconfigure their drug product or develop new drug products requiring less frequent dosing; or (iii) we are unable to develop new products that assist in the delivery of drugs by alternative methods, our sales and profitability may suffer. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Changes in foreign currency exchange rates could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business is subject to foreign currency exchange rate fluctuations. Sales outside of the U.S. accounted for 55.7% of our consolidated net sales in 2019 and we anticipate that sales from international operations will continue to represent a significant portion of our total sales in the future. In addition, many of our manufacturing facilities and suppliers are located outside of the U.S. Further, we intend to continue our expansion into emerging and/or faster-growing markets outside of the U.S. in the future. Virtually all of our international sales, assets and related operating costs and expenses are earned, valued or incurred in the currency of the local country, primarily the Euro, the Singapore Dollar (&#8220;SGD&#8221;), and the Danish Krone. In addition, we are exposed to Japanese Yen (&#8220;Yen&#8221;), as we maintain a 49% ownership interest in, and we purchase finished goods and other materials from, Daikyo. We are also exposed to currencies in emerging market countries, such as the Chinese Yuan, the Indian Rupee, the South Korean Won, and various South American currencies. Our consolidated financial statements are presented in USD, and, therefore, we must translate the reported values of our foreign assets, liabilities, revenues, and expenses into USD, which can result in significant fluctuations in the amount of those assets, liabilities, revenues, or expenses. The </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">8</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">exchange rates between these foreign currencies and USD in recent years have fluctuated significantly and may continue to do so in the future. Increases or decreases in the value of USD compared to these foreign currencies may negatively affect the value of these items in our consolidated financial statements, which could have a material adverse effect on our operating results.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to translation risks, we incur currency transaction risk when we or one of our subsidiaries enters into a purchase or sales transaction in a currency other than that entity&#8217;s local currency. In order to reduce our exposure to fluctuations in certain exchange rates, we have entered, and expect to continue to enter, into hedging arrangements, including the use of financial derivatives. There can be no certainty that we will be able to enter into or maintain hedges of these currency risks, or that our hedges will be effective, which could have a significant effect on our financial condition and operating results.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">If we are unable to provide comparative value advantages, timely fulfill customer orders, or resist pricing pressure, we will have to reduce our prices, which may reduce our profit margins. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We compete with several companies across our major product lines. Because of the special nature of these products, competition is based primarily on product design and performance, although total cost is becoming increasingly important as pharmaceutical companies continue with aggressive cost-control programs across their operations. Companies often compete on the basis of price. We aim to differentiate ourselves from our competition by being a &#8220;full-service, value-added&#8221; global supplier that is able to provide pre-sale compatibility studies, engineering support, and other services and sophisticated post-sale technical support on a global basis. However, we face continued pricing pressure from our customers and competitors. If we are unable to resist or offset the effects of continued pricing pressure through our value-added services, improved operating efficiencies and reduced expenditures, or if we have to reduce our prices, our sales and profitability may suffer. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Consolidation in the pharmaceutical and healthcare industries could adversely affect our future revenues and operating income.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The pharmaceutical and healthcare industries have experienced a significant amount of consolidation. As a result of this consolidation, competition to provide goods and services to customers has increased. In addition, group purchasing organizations and integrated health delivery networks have served to concentrate purchasing decisions for some customers, which has placed pricing pressure on suppliers. Further consolidation within the industries we serve could exert additional pressure on the prices of our products. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">We are subject to regulation by governments around the world, and if these regulations are not complied with, existing and future operations may be curtailed, and we could be subject to liability. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The design, development, manufacturing, marketing and labeling of certain of our products and our customers&#8217; products that incorporate our products are subject to regulation by governmental authorities in the U.S., Europe and other countries, including the U.S. Food and Drug Administration (&#8220;FDA&#8221;), the European Medicines Agency and the National Medical Products Administration (China). Complying with governmental regulation can be costly and can result in required modification or withdrawal of existing products and a substantial delay in the introduction of new products. Failure to comply with applicable regulatory requirements or failure to obtain regulatory approval for a new product could result in expenses and actions that could adversely affect our business and financial performance. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Products that incorporate our technologies and medical devices that we produce are subject to regulations and extensive approval or clearance processes, which make the timing and success of new-product commercialization difficult to predict.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The process of obtaining and maintaining FDA and other required regulatory approvals is expensive and time-consuming. Historically, most medical devices that incorporate our technologies and medical devices that we produce have been subject to the FDA&#8217;s 510(k) marketing approval process, which typically lasts from six to nine months.&#160;Supplemental or full pre-market approval reviews require a significantly longer period, delaying </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">9</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">commercialization. Changes in regulation on a global scale must be monitored and actions taken to ensure ongoing compliance. Pharmaceutical products that incorporate our technologies and medical devices that we produce are subject to the FDA&#8217;s New Drug Application process, which typically takes a number of years to complete. Additionally, biotechnology products that incorporate our technologies and medical devices that we produce are subject to the FDA&#8217;s Biologics License Application process, which also typically takes a number of years to complete.&#160;Outside of the U.S., sales of medical devices and pharmaceutical or biotechnology products are subject to international regulatory requirements that vary from country to country. The time required to obtain approval for sale internationally may be longer or shorter than that required for FDA approval. There is no certainty that any regulatory approval may be obtained or maintained indefinitely, and our ability to launch products on to the market and maintain market presence is not guaranteed.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Changes in the regulation of drug products and devices may increase competitive pressure and adversely affect our business.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">An effect of the governmental regulation of our medical devices and our customers&#8217; drug products, devices, and manufacturing processes is that compliance with regulations makes it difficult to change components and devices produced by one supplier with those from another supplier, due to the large amount of data and information that customers must generate to demonstrate that the components and devices are equivalent and pose no additional risk to the patient. The regulation of our medical devices and our customers&#8217; products that incorporate our components and devices has increased over time. If the applicable regulations were to be modified in a way that reduced the level of data and information needed to prove equivalency for a change from one supplier&#8217;s components or devices to those made by another, it is likely that the competitive pressure would increase and adversely affect our sales and profitability.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">If we are not successful in protecting our intellectual property rights, our ability to compete may be affected.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our patents, trademarks and other intellectual property are important to our business. We rely on patent, trademark, copyright, trade secret, and other intellectual property laws, as well as nondisclosure and confidentiality agreements and other methods, to protect our proprietary products, information, technologies and processes. We also have obligations with respect to the non-use and non-disclosure of third-party intellectual property. We may need to engage in litigation or similar activities to enforce our intellectual property rights, to protect our trade secrets or to determine the validity and scope of proprietary rights of others. Any such litigation could require us to expend significant resources and divert the efforts and attention of our management and other personnel from our business operations. There can be no assurance that the steps we will take to prevent misappropriation, infringement or other violation of our intellectual property or the intellectual property of others will be successful. In addition, effective patent, copyright, trademark, and trade secret protection may be unavailable or limited for some of our proprietary products in some countries. Failure to protect our intellectual property or successfully invalidate or defend against intellectual property protections of third parties could harm our business and results of operations. In addition, if relevant and effective patent protection is not available or has expired, we may not be able to prevent competitors from independently developing products and services similar or duplicative to ours. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Disruption in our manufacturing facilities could have a material adverse effect on our ability to make and sell products and have a negative impact on our reputation, performance or financial condition.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have manufacturing sites throughout the world. In some instances, however, the manufacturing of certain product lines is concentrated in one or only a few of our plants.&#160;The functioning of our manufacturing and distribution assets and systems could be disrupted for reasons either within or beyond our control, including, without limitation: extreme weather or longer-term climatic changes; natural disasters; pandemic; war; accidental damage; disruption to the supply of material or services; product quality and safety issues; systems failure; workforce actions; or environmental contamination. There is a risk that incident management systems in place may prove inadequate and that any disruption may materially adversely affect our ability to make and sell products and, therefore, materially adversely affect our reputation, performance or financial condition. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">The medical technology industry is very competitive and customer demands and/or new products in the marketplace could cause a reduction in demand. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The medical technology industry is subject to rapid technological changes, and we face significant competition across our product lines and in each market in which our products are sold. We face this competition from a wide range of companies, including large medical device companies, some of which have greater financial and marketing resources than we do. We also face competition from firms that are more specialized than we are with respect to particular markets. In some instances, competitors, including pharmaceutical companies, also offer, or are attempting to develop, alternative therapies for diseases that may be delivered via their own, or without, a medical device. The development of new or improved products, processes or technologies by other companies (such as needle-free injection technology) may reduce customer demand for our products or render some of our products or proposed products obsolete or less competitive. In addition, any failure or inability to meet increased customer quality expectations could cause a reduction in demand.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Significant developments in U.S. policies could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Changes in U.S. social, political, regulatory, and economic conditions, or in laws and policies governing foreign trade, manufacturing, development, immigration, and investment, could have an adverse effect on our financial condition, results of operations and cash flows.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our international sales and operations are subject to risks and uncertainties that vary by country and which could have a material adverse effect on our business and/or results of operations. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We conduct business in most of the major pharmaceutical markets in the world. Our international operations and our ability to implement our overall business strategy (including our plan to continue expanding into emerging and/or faster-growing markets outside of the U.S.) are subject to risks and uncertainties that can vary by country, and include: transportation delays and interruptions; political and economic instability and disruptions, including the United Kingdom&#8217;s referendum on withdrawal from the European Union; imposition of duties and tariffs; import and export controls; the risks of divergent business expectations or cultural incompatibility inherent in establishing and maintaining operations in foreign countries; difficulties in staffing and managing multi-national operations; labor strikes and/or disputes; and potentially adverse tax consequences. Limitations on our ability to enforce legal rights and remedies with third parties or our joint venture partners outside of the U.S. could also create exposure. In addition, we may not be able to operate in compliance with foreign laws and regulations, or comply with applicable customs, currency exchange control regulations, transfer pricing regulations or any other laws or regulations to which we may be subject, in the event that these laws or regulations change. Any of these events could have an adverse effect on our international operations in the future by reducing the demand for our products or decreasing the prices at which we can sell our products, or otherwise have an adverse effect on our financial condition, results of operations and cash flows. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Disruptions in the supply of key raw materials could adversely impact our operations. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We generally purchase our raw materials and supplies required for the production of our products in the open market. For reasons of quality assurance, sole source availability or cost effectiveness, many components and raw materials are available and/or purchased only from a single supplier. Due to the stringent regulations and requirements of the FDA and other regulatory authorities regarding the manufacture of our products and the availability of such raw materials, we may not be able to quickly establish additional or replacement sources for these components or raw materials or do so without excessive cost. As a result, a reduction or interruption in supply, or an inability to secure alternative sources of raw materials or components, could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">11</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Unauthorized access to our or our customers</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8217;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> information and systems could negatively impact our business.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our systems and networks, as well as those of our customers, suppliers, service providers, and banks, have and may in the future become the target of cyberattacks or information security breaches which, in turn, could result in the unauthorized release and misuse of confidential or proprietary information about our company, our employees or our customers, as well as disrupt our operations or damage our facilities or those of third parties. Additionally, our systems are subject to regulation to preserve the privacy of certain data held on those systems. We maintain an extensive network of technical security controls, policy enforcement mechanisms and monitoring systems, in order to address these threats. While these measures are designed to prevent, detect and respond to unauthorized activity in our systems, certain types of attacks could result in financial or information losses and/or reputational harm. If we cannot comply with regulations or prevent the unauthorized access, release and/or corruption of our or our customers&#8217; confidential, classified or personally identifiable information, our reputation could be damaged, and/or we could face financial losses. We may also be required to incur additional costs to modify or enhance our systems, or to try to prevent or remediate any such attacks. Modifying or enhancing our systems may result in unanticipated or prolonged disruption events, which could have a material adverse effect on our business and/or results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Raw material and energy prices have a significant impact on our profitability. If raw material and/or energy prices increase, and we cannot pass those price increases on to our customers, our profitability and financial condition may suffer. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We use three basic raw materials in the manufacture of our products: elastomers (which include synthetic and natural material), aluminum and plastic. In addition, our manufacturing facilities consume a wide variety of energy products to fuel, heat and cool our operations. Supply and demand factors, which are beyond our control, generally affect the price of our raw materials and utility costs. If we are unable to pass along increased raw material prices and energy costs to our customers, our profitability, and thus our financial condition, may be adversely affected. The prices of many of these raw materials and utilities are cyclical and volatile. For example, the prices of certain commodities, particularly petroleum-based raw materials, have in the recent past exhibited rapid changes, affecting the cost of synthetic elastomers and plastic. While we generally attempt to pass along increased costs to our customers in the form of sales price increases, historically there has been a time delay between raw material and/or energy price increases and our ability to increase the prices of our products. In some circumstances, we may not be able to increase the prices of our products due to competitive pressure and other factors.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">If we are not timely or successful in new-product innovation or the development and commercialization of proprietary multi-component systems, our future revenues and operating income could be adversely affected.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our growth partly depends on new-product innovation and the development and commercialization of proprietary multi-component systems for injectable drug administration and other healthcare applications. Product development and commercialization is inherently uncertain and is subject to a number of factors outside of our control, including any necessary regulatory approvals and commercial acceptance for the products.&#160;The ultimate timing and successful commercialization of new products and systems requires substantial evaluations of the functional, operational, clinical, and economic viability of our products.&#160;In addition, the timely and adequate availability of filling capacity is essential to both conducting definitive stability trials and the timing of commercialization of customers&#8217; products in Crystal Zenith vials, syringes and cartridges.&#160;Delays, interruptions or failures in developing and commercializing new-product innovations or proprietary multi-component systems could adversely affect future revenues and operating income. In addition, adverse conditions may also result in future charges to recognize impairment in the carrying value of our goodwill and other intangible assets, which could have a material adverse effect on our financial results.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">We may not succeed in finding and completing acquisitions or other strategic transactions, which could have an adverse effect on our business and results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have historically engaged in acquisition activity and we may in the future engage in acquisitions or other strategic transactions, such as joint ventures or investments in other entities. We may be unable to identify suitable </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">12</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">targets, opportunistic or otherwise, for acquisitions or other strategic transactions in the future. If we identify a suitable candidate, our ability to successfully implement the strategic transaction would depend on a variety of factors, including our ability to obtain financing on acceptable terms and to comply with the restrictions contained in our debt agreements. Strategic transactions involve risks, including those associated with integrating the operations or maintaining the operations as separate (as applicable), financial reporting, disparate technologies, and personnel of acquired companies, joint ventures or related companies; managing geographically dispersed operations or other strategic investments; the diversion of management&#8217;s attention from other business concerns; the inherent risks in entering markets or lines of business in which we have either limited or no direct experience; the potential loss of key employees, customers and strategic partners of acquired companies, joint ventures or companies in which we may make strategic investments; and potentially other unknown risks. We may not successfully integrate any businesses or technologies we may acquire or strategically develop in the future and may not achieve anticipated revenue and cost benefits relating to any such strategic transactions. Strategic transactions may be expensive, time consuming and may strain our resources. Strategic transactions may not be accretive to our earnings and may negatively impact our results of operations as a result of, among other things, the incurrence of debt, one-time write-offs of goodwill, additional carrying costs of patent or trademark portfolios, and amortization expenses of other intangible assets. In addition, strategic transactions that we may pursue could result in dilutive issuances of equity securities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Product defects could adversely affect the results of our operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The design, manufacture and marketing of pharmaceutical packaging and medical devices involve certain inherent risks. Manufacturing or design defects, unanticipated use of our products, or inadequate disclosure of risks relating to the use of our products can lead to injury or other adverse events. These events could lead to recalls or safety alerts relating to our products (either voluntary or required by the FDA or similar governmental authorities in other countries), and could result, in certain cases, in the removal of a product from the market. A recall could result in significant costs, as well as negative publicity and damage to our reputation that could reduce demand for our products. Personal injuries relating to the use of our products can also result in product liability claims being brought against us. In some circumstances, such adverse events could also cause delays in new product approvals. Please refer to Note 3, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for the discussion of the voluntary recall of our Vial2Bag</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> product line.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our operations must comply with environmental statutes and regulations, and any failure to comply could result in extensive costs which would harm our business.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The manufacture of some of our products has involved, and may continue to involve, the use, transportation, storage, and disposal of hazardous or toxic materials and is subject to various environmental protection and occupational health and safety laws and regulations in the countries in which we operate. This has exposed us in the past, and could expose us in the future, to risks of accidental contamination and events of non-compliance with environmental laws. Any such occurrences could result in regulatory enforcement or personal injury and property damage claims or could lead to a shutdown of some of our operations, which could have an adverse effect on our business and results of operations. We currently incur costs to comply with environmental laws and regulations and these costs may become more significant.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">A loss of key personnel or highly skilled employees could disrupt our operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our future success depends, in large part, on our ability to retain key employees, including our executive officers and individuals in technical, marketing, sales, and research positions. Competition for experienced employees, particularly for persons with specialized skills, can be intense. Our ability to recruit such talent will depend on a number of factors, including compensation and benefits, work location and work environment. If we cannot effectively recruit and retain qualified executives and employees, our business could be adversely affected. Although we believe that we will be able to attract and retain talented personnel and replace key personnel should the need arise, our inability to do so on a timely basis could disrupt the operations of the unit affected or our overall operations. In addition, because of the complex nature of many of our products and programs, we are generally </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">13</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">dependent on an educated and highly skilled engineering staff and workforce. Our operations could be disrupted by a shortage of available skilled employees.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">The uncertain effects of climate change and potential climate change legislation could lead to business interruption, significantly increased costs and/or other adverse consequences to our business. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Climate change and potential climate change legislation may present risks to our operations, including business interruption, significantly increased costs and/or other adverse consequences to our business. Some of the potential impacts of climate change to our business include physical risks to our facilities, water and energy supply limitations or interruptions, disruptions to our supply chain and impairment of other resources. In addition, if legislation or regulations are enacted or promulgated in the U.S., Europe or Asia or any other jurisdictions in which we do business that limit or reduce allowable greenhouse gas emissions and other emissions, such restrictions could have a significant effect on our operating and financial decisions, including those involving capital expenditures to reduce emissions, and our results of operations. Our manufacturing operations may not be able to operate as planned if we are not able to comply with new legal and regulatory legislation around climate change, or it may become too costly to operate in a profitable manner. Additionally, suppliers&#8217; added expenses could be passed on to us in the form of higher prices and we may not be able to pass on such expenses to our customers through price increases.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Healthcare reform may adversely affect our results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Changes in the U.S. or international healthcare systems, including the Patient Protection and Affordable Care Act (the &#8220;PPACA&#8221;), could result in reduced demand for our products, as our sales depend, in part, on the extent to which pharmaceutical companies and healthcare providers and facilities are reimbursed by government authorities, private insurers and other third-party payers for the costs of our products. The coverage policies and reimbursement levels of third-party payers, which can vary among public and private sources, may affect which products customers purchase and the prices they are willing to pay for these products in a particular jurisdiction. Legislative or administrative reforms to reimbursement systems in the U.S. (including the possible termination of the PPACA and potential replacement thereafter with a different system) or abroad (for example, those under consideration in France, Germany, Italy and the United Kingdom) could significantly reduce reimbursement for our customers&#8217; products, which could in turn reduce the demand for our products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Moreover, in the coming years, additional changes could be made to global governmental healthcare programs that could significantly impact the success of our products. We will continue to evaluate the PPACA, as amended, the implementation of regulations or guidance related to various provisions of the PPACA by federal agencies, the potential repeal and replacement of the PPACA, as well as trends and changes that may be encouraged by the legislation and other healthcare legislation globally and that may potentially impact our business over time.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">LIBOR reform may adversely affect our financial condition, results of operations and cash flows.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Our variable-rate debt, which includes our new senior unsecured, multi-currency revolving credit facility agreement (the &#8220;Credit Agreement&#8221;) and our new term loan (the &#8220;Term Loan&#8221;), currently use the London Interbank Offered Rate ("LIBOR") as a benchmark for establishing the interest rate. LIBOR is the subject of recent national, international and other regulatory guidance and proposals for reform. These proposals for reform and other pressures may cause LIBOR to disappear entirely or to perform differently than in the past. If the method for calculation of LIBOR changes, if LIBOR is no longer available or if lenders have increased costs due to changes in LIBOR, we may suffer from potential increases in interest rates on our variable-rate debt, which could have a material adverse effect on our financial condition, results of operations and cash flows. Further, we may need to amend our Credit Agreement and Term Loan as a factor in determining the interest rate to replace LIBOR with the new standard that is established. We will continue to monitor the proposals for reform relating to LIBOR.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">No assurance can be given that we will continue to pay or declare dividends. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have historically paid dividends. However, there can be no assurance that we will pay or declare dividends in the future. The actual declaration and payment of future dividends, the amount of any such dividends, and the </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">14</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">establishment of record and payment dates, if any, are subject to determination by our Board of Directors each quarter after its review of our then-current strategy, applicable debt covenants and financial performance and position, among other things. Our declaration and payment of future dividends is subject to risks and uncertainties, including: deterioration of our financial performance or position; inability to declare a dividend in compliance with applicable laws or debt covenants; an increase in our cash needs or decrease in available cash; and the business judgment of the Board of Directors that a declaration of a dividend is not in our best interest.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our results of operations and earnings may not meet guidance or expectations</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We provide public guidance on our expected results of operations for future periods. This guidance is comprised of forward-looking statements subject to risks and uncertainties, including the risks and uncertainties described in this Form 10-K and in our other public filings and public statements, and is based necessarily on assumptions we make at the time we provide such guidance. Our guidance may not always be accurate. If, in the future, our results of operations for a particular period do not meet our guidance or the expectations of investment analysts, or if we reduce our guidance for future periods, the market price of our common stock could decline significantly. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">We are exposed to credit risk on accounts receivable and certain prepayments made in the normal course of business. This risk is heightened during periods when economic conditions worsen.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A substantial majority of our outstanding trade receivables are not covered by collateral or credit insurance. In addition, we have made prepayments associated with insurance premiums and other advances in the normal course of business. While we have procedures to monitor and limit exposure to credit risk on trade receivables and other current assets, there can be no assurance such procedures will effectively limit our credit risk and avoid losses, which could have a material adverse effect on our financial condition and operating results.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">If we fail to comply with our obligations under our distributorship or license agreements with Daikyo, the agreements are terminated early or we are unable to renew these agreements on the same or substantially similar terms, we could lose license rights that are important to our business.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Key value-added and proprietary products and processes are licensed from our affiliate, Daikyo, including but not limited to, Crystal Zenith, FluroTec</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and B2-coating technologies. Our rights to these products and processes are licensed pursuant to agreements that expire in 2027. However, if the agreements are terminated early, our business could be adversely impacted. Please refer to Note 7, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Affiliated Companies,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> for information relating to the increase in our ownership interest in Daikyo in 2019.</span></div><div><span><br/></span></div><div id="i_0_19"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM IB.  UNRESOLVED STAFF COMMENTS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of the filing of this Form 10-K, there were no unresolved comments from the Staff of the SEC.</span></div><div><span><br/></span></div><div id="i_0_22"></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 2.  PROPERTIES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our corporate headquarters are located at 530 Herman O. West Drive, Exton, Pennsylvania.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes production facilities by segment and geographic region. All facilities shown are owned except where otherwise noted.</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:90.865%;"><tr><td style="width:1.0%;"></td><td style="width:27.629%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:3.467%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:23.396%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.056%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:33.452%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Manufacturing:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">North American Operations</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">European Operations</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia Pacific Operations</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Denmark</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">China</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jersey Shore, PA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Horsens</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Qingpu</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Kearney, NE</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">England</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">India</span></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">15</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:90.865%;"><tr><td style="width:1.0%;"></td><td style="width:27.629%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:3.467%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:23.396%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.056%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:33.452%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Kinston, NC</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">St. Austell</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sri City</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Scottsdale, AZ (2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Singapore</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">St. Petersburg, FL (1)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Le Nouvion</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Jurong</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Le Vaudreuil</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">South American Operations</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Brazil</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Eschweiler (1) (2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sao Paulo</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stolberg</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Waterford</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Serbia</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Kovin</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Mold-and-Die Tool Shop:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Contract Analytical Laboratory:</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">North American Operations</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">European Operations</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">North American Operations</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">England</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Upper Darby, PA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bodmin (2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exton, PA</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Manufacturing:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">North American Operations</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">European Operations</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Grand Rapids, MI</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dublin (2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Phoenix, AZ (2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tempe, AZ (2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Williamsport, PA</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Puerto Rico</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cayey</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">This manufacturing facility is also used for research and development activities.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">This facility is leased in whole or in part.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Proprietary Products reportable segment leases facilities located in Germany and Israel for research and development, as well as other activities. Sales offices in various locations are leased under short-term arrangements.</span></div><div><span><br/></span></div><div id="i_0_25"></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 3.  LEGAL PROCEEDINGS </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div><span><br/></span></div><div id="i_0_28"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 4.  MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Not applicable.</span></div><div><span><br/></span></div><div id="i_0_31"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The executive officers of the Company are set forth in this table. Generally, executive officers are elected by the Board of Directors annually at the regular meeting of the Board of Directors following the Annual Meeting of Shareholders. Additionally, executive officers may be elected upon hire or due to a promotion.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">16</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:21.237%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.692%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:67.071%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Name</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Age</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Position</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Silji Abraham</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Senior Vice President, Chief Digital and Transformation Officer since February 2018. Prior to joining West, he most recently served as Executive Vice President and Chief Information Officer of MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt, Germany. Prior to this role, he served as Chief Information Officer at Sigma-Aldrich Corporation, a leading life science and technology company, and worked in various leadership roles at Invensys Operations Management, ArvinMeritor and Chrysler Group.</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bernard J. Birkett</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Senior Vice President and Chief Financial Officer since June 2018. In addition, Treasurer from June 2018 to December 2019. Principal Accounting Officer since October 2019. Prior to joining West, he spent more than 20 years at Merit Medical Systems, Inc., a leading manufacturer of disposable medical devices, where he served in a number of senior global leadership roles, including Chief Financial Officer and Treasurer, Controller for Europe, Middle East and Africa (EMEA) and Vice President of International Finance.</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Annette F. Favorite</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Senior Vice President and Chief Human Resources Officer since October 2015. Prior to joining West, she spent more than 25 years at IBM Corporation, an information technology services company, in a number of strategic and global human resources roles, including Vice President, Global Talent Management, Vice President of Human Resources for Worldwide Software Sales, and Human Resources Leader for the company&#8217;s Southwest European Region, based out of Spain.</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Eric M. Green</span></div><div><span><br/></span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Executive Officer since April 2015 and President since December 2015. Prior to joining West, he was Executive Vice President and President of the Research Markets business unit at Sigma-Aldrich Corporation from 2013 to 2015. From 2009 to 2013, he served as Vice President and Managing Director, International, where he was responsible for Asia Pacific and Latin America, and prior thereto, held various commercial and operational roles.</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Quintin J. Lai</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vice President, Corporate Development, Strategy and Investor Relations since January 2016. Prior to joining West, he was Vice President of Investor Relations and Corporate Strategy at Sigma-Aldrich Corporation from 2012 to 2015. From 2002 to 2012, he was at Robert W. Baird &amp; Company, where he held various roles, including Managing Director and Senior Equity Research Analyst of the Life Science Tools and Diagnostic sector and Associate Director of Equity Research. </span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">George L. Miller</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Senior Vice President, General Counsel and Corporate Secretary since joining West in November 2015. Previously, he served as Senior Vice President, General Counsel and Corporate Secretary for Sigma-Aldrich Corporation from 2009 to 2015. Prior to working at Sigma-Aldrich, he held senior legal positions with Novartis AG, a global healthcare company.</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">David A. Montecalvo</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Senior Vice President and Chief Operations and Supply Chain Officer since February 2019. Senior Vice President, Global Operations and Supply Chain from September 2016 until February 2019. Prior to joining West, he served in a number of senior leadership roles at Medtronic plc, including Vice President, Contract Manufacturing Operations, for the company&#8217;s Restorative Therapies Group, Vice President, Business Operations Integration, where he was responsible for directing and leading the global operations integration of Covidien plc into Medtronic, and Vice President, Product Development and Operations for Medtronic Cardiovascular. Prior thereto, he held senior operations and product development roles at Urologix, Inc. and LecTec Corporation.</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">17</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:21.237%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.692%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:67.071%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Eric Resnick</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vice President and Chief Technology Officer since March 2016. Previously, he served as Vice President and General Manager of Integrated Packaging and Delivery within West&#8217;s Innovation and Technology Team and President Proprietary Products - Pharmaceutical Delivery Systems from March 2015 until March 2016. He served as Vice President Research and Development and Self-Injection Systems from March 2014 until March 2015, and Vice President and General Manager of West&#8217;s Contract Manufacturing Delivery Devices division from 2008 until March 2014. Prior thereto, he held various positions since joining The Tech Group in 2001, and held engineering and operating roles with Eastman Kodak Company and Ortho Clinical Diagnostics.</span></td></tr></table></div><div><span><br/></span></div><div id="i_0_34"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PART II</span></div><div><span><br/></span></div><div id="i_0_37"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 5.&#160;&#160;MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our common stock is listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;WST.&#8221;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 31, 2020, we had 756 shareholders of record, which excludes shareholders whose shares were held by brokerage firms, depositaries and other institutional firms in &#8220;street names&#8221; for their customers.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On November 1, 2019, in connection with the amendment of certain commercial agreements with Daikyo, we increased our ownership interest from 25% to 49% in Daikyo in exchange for $85.1 million in cash and $4.9 million in shares of our treasury stock to certain stockholders of Daikyo (the &#8220;Stock Consideration&#8221;). Please refer to Note 7, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Affiliated Companies,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> for additional information on our ownership interest in Daikyo. The issuance of the Stock Consideration is exempt from registration under the Securities Act of 1933 (the &#8220;Securities Act&#8221;) pursuant to Section 4(a)(2) under the Securities Act. Our reliance upon Section 4(a)(2) of the Securities Act in issuing the securities was based upon the following factors: (a) the issuance of the securities was an isolated private transaction by us which did not involve a public offering; (b) there were only a limited number of recipients; (c) the negotiations for the issuance of the securities took place directly between the recipients and the Company; and (d) the recipients of the securities were sophisticated, accredited investors.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Dividends</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our common stock paid a quarterly dividend of $0.14 per share in each of the first three quarters of 2018; $0.15 per share in the fourth quarter of 2018 and each of the first three quarters of 2019; and $0.16 per share in the fourth quarter of 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended December&#160;31, 2019, there were no purchases of our common stock made by us or any of our &#8220;affiliated purchasers&#8221; as defined in Rule 10b-18(a)(3) under the Exchange Act. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. There were no shares purchased during the three months ended December 31, 2019. During the year ended December 31, 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">18</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Performance Graph</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following performance graph compares the cumulative total return to holders of our common stock with the cumulative total return of the following Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) indices, for the five years ended December 31, 2019: 500 and MidCap 400 Index. The performance graph does not necessarily reflect management's opinion that such indices are an appropriate measure of the relative performance of the stock involved, and is not intended to forecast or be indicative of possible future performance of the Company&#8217;s common stock.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cumulative total return to shareholders is measured by dividing total dividends (assuming dividend reinvestment) plus the per-share price change for the period by the share price at the beginning of the period. The Company&#8217;s cumulative shareholder return is based on an investment of $100 on December 31, 2014 and is compared to the cumulative total return of the S&amp;P indices mentioned above over the period with a like amount invested.</span></div><div><span><br/></span></div><div style="text-align:center;"><img src="wst-20191231_g1.jpg" alt="wst-20191231_g1.jpg" style="height:515px;width:532px;"/></div><div style="text-align:justify;"><span><br/></span></div><div id="i_0_40"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">19</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 6.  SELECTED FINANCIAL DATA</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">FIVE-YEAR SUMMARY</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">West Pharmaceutical Services, Inc. and Subsidiaries</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.697%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.460%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.460%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.460%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.460%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.463%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions, except per share data)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2016</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2015</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SUMMARY OF OPERATIONS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,509.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,399.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit &#8224;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">225.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">195.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">177.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">143.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">95.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income per share:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic (1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.80&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.04&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted (2)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.99&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.30&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common shares outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares assuming dilution</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends declared per common share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.62&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.58&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.54&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">YEAR-END FINANCIAL POSITION</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">439.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">337.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">274.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Working capital</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">717.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">610.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">464.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">400.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">359.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,341.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,978.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,695.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total invested capital:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">257.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">197.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">228.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">298.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total equity</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,573.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,396.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,279.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,117.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,023.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total invested capital</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,830.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,592.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,476.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,346.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,322.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PERFORMANCE MEASUREMENTS (3)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross margin (a)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profitability (b) &#8224;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effective tax rate (4)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Return on invested capital (c) &#8224;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net debt-to-total invested capital (d)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">N/A&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expenses</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating cash flow</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">367.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">288.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">263.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">219.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">212.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock price range</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$152.12-93.08</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$125.09-82.74</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$103.36-77.97</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$86.50-53.88</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$64.59-48.66</span></td></tr></table></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span><br/></span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1) Based on weighted average common shares outstanding.</span></div><div><span><br/></span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(2) Based on weighted average shares, assuming dilution.</span></div><div><span><br/></span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(3) Performance measurements represent indicators commonly used in the financial community. The following performance measures are not in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are included as management uses them in evaluating our results of operations and believes that this information provides users with a valuable insight into our overall performance and financial position.</span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span><br/></span></div><div style="text-indent:-13.5pt;padding-left:31.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) Net sales minus cost of goods and services sold, including applicable depreciation and amortization, divided by net sales.</span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b) Operating profit divided by net sales.</span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(c) Operating profit multiplied by one minus the effective tax rate divided by average total invested capital. </span></div><div style="text-indent:-13.5pt;padding-left:31.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(d) Net debt (total debt less cash and cash equivalents) divided by total invested capital less cash and cash equivalents.</span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">20</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(4) As a result of the Tax Cuts and Jobs Act (the &#8220;2017 Tax Act&#8221;), the federal statutory rate was reduced from 35.0% to 21.0% effective for tax years beginning after December 31, 2017. Please refer to Note 17, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">for further discussion of the 2017 Tax Act.</span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span><br/></span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8224;   Reflects our adoption of the guidance issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) regarding the presentation of net periodic pension and postretirement benefit cost (net benefit cost).</span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span><br/></span></div><div style="text-indent:-13.5pt;padding-left:13.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Factors affecting the comparability of the information reflected in the selected financial data:</span></div><div style="padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9642;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">Net income in 2019 included the impact of restructuring and related charges of $3.7 million (net of $1.2 million in tax), a gain on the sale of fixed assets as a result of our restructuring plan of $1.3 million (net of $0.4 million in tax), a pension settlement charge of $2.7 million (net of $0.8 million in tax), a charge of $1.0 million related to the continued devaluation of Argentina&#8217;s currency, a tax recovery of $2.9 million (net of $1.5 million in tax) related to previously-paid international excise taxes, a net tax benefit of $0.3 million related to the impact of federal law changes enacted during the year, and a tax benefit of $10.3 million associated with stock-based compensation.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9642;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">Net income in 2018 included the impact of restructuring and related charges of $7.2 million (net of $1.9 million in tax), a gain on the sale of fixed assets as a result of our restructuring plans of $0.9 million (net of $0.2 million in tax), a charge of $1.1 million related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018, a net tax benefit of $2.5 million for the estimated impact of the 2017 Tax Act, and a tax benefit of $14.3 million associated with stock-based compensation.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9642;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">Net income in 2017 included the impact of a discrete tax charge of $48.8 million related to the 2017 Tax Act and the impact of changes in enacted international tax rates on previously-recorded deferred tax asset and liability balances, as well as a tax benefit of $33.1 million associated with stock-based compensation and a charge of $11.1 million related to the deconsolidation of our Venezuelan subsidiary.</span></div><div style="padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9642;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">Net income in 2016 included the impact of restructuring and related charges of $17.4 million (net of $9.0 million in tax), a charge related to the devaluation of the Venezuelan Bolivar of $2.7 million, a pension curtailment gain of $1.3 million (net of $0.8 million in tax), and a discrete tax charge of $1.0 million.</span></div><div style="padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9642;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt;">Net income in 2015 included the impact of a pension settlement charge of $32.0 million (net of $18.4 million in tax), a charge for executive retirement and related costs of $6.9 million (net of $4.0 million in tax) and a discrete tax charge of $0.8 million.</span></div><div style="padding-left:18pt;"><span><br/></span></div><div id="i_0_43"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 7.&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">OVERVIEW</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following discussion is intended to further the reader&#8217;s understanding of the consolidated financial condition and results of operations of our Company. It should be read in conjunction with our consolidated financial statements and the accompanying footnotes included in Part II, Item 8 of this Form 10-K. These historical financial statements may not be indicative of our future performance. This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks discussed in Part I, Item 1A of this Form 10-K.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Non-U.S. GAAP Financial Measures</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the purpose of aiding the comparison of our year-over-year results, we may refer to net sales and other financial results excluding the effects of changes in foreign currency exchange rates. The constant-currency amounts are </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">21</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">calculated by translating the current year&#8217;s functional currency results at the prior-year period&#8217;s exchange rate. We may also refer to consolidated operating profit and consolidated operating profit margin excluding the effects of unallocated items. The re-measured results excluding effects from currency translation and excluding the effects of unallocated items are not in conformity with U.S. GAAP and should not be used as a substitute for the comparable U.S. GAAP financial measures. The non-U.S. GAAP financial measures are included in our discussion and analysis as management uses them in evaluating our results of operations and believes that this information provides users with a valuable insight into our overall performance and financial position.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Our Operations</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include the leading biologic, generic, pharmaceutical, diagnostic, and additional medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, and enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently. The Company was incorporated under the laws of the Commonwealth of Pennsylvania on July 27, 1923.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and integrated solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. We also maintain collaborations to share technologies and market products with affiliates in Japan and Mexico.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2019 Financial Performance Summary</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated net sales increased by $122.5 million, or 7.1%, in 2019. Excluding foreign currency translation effects of $52.2 million, as well as incremental sales of $3.3 million from our recent acquisition, consolidated net sales increased by $171.4, or 10.0%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net income in 2019 was $241.7 million, or $3.21 per diluted share, compared to $206.9 million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180My9mcmFnOjdjNWMxZmM5ZTE5ODRlNTA4YmU0ZTdkOWJlZTQ4ZDllL3RleHRyZWdpb246N2M1YzFmYzllMTk4NGU1MDhiZTRlN2Q5YmVlNDhkOWVfMzc0Nw_f8210b56-772b-4426-bf39-e0569cee3338">2.74</ix:nonFraction> per diluted share, in 2018. Net income in 2019 included the impact of restructuring and related charges of $3.7 million (net of $1.2 million in tax), or $0.04 per diluted share, a gain on the sale of fixed assets as a result of our restructuring plan of $1.3 million (net of $0.4 million in tax), or $0.02 per diluted share, a pension settlement charge of $2.7 million (net of $0.8 million in tax), or $0.04 per diluted share, a charge of $1.0 million related to the continued devaluation of Argentina&#8217;s currency, or $0.01 per diluted share, a tax recovery related to previously-paid international excise taxes of $2.9 million (net of $1.5 million in tax), or $0.04 per diluted share, a net tax benefit of $0.3 million related to the impact of federal law changes enacted during the year, and a tax benefit of $10.3 million, or $0.14 per diluted share, associated with stock-based compensation. Net income in 2018 included the impact of restructuring and related charges of $7.2 million (net of $1.9 million in tax), or $0.09 per diluted share, a gain on the sale of fixed assets as a result of our restructuring plans of $0.9 million (net of $0.2 million in tax), or $0.01 per diluted share, a charge of $1.1 million, or $0.02 per diluted share, related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018, a net tax benefit of $2.5 million, or $0.03 per diluted share, for the estimated impact of the 2017 Tax Act, and a tax benefit of $14.3 million, or $0.19 per diluted share, associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, our cash and cash equivalents balance totaled $439.1 and our available borrowing capacity under our $300.0 million multi-currency revolving credit facility (the &#8220;Credit Facility&#8221;) was $297.5 million.</span></div><div><span><br/></span></div><div id="i_0_46"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">22</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Percentages in the following tables and throughout this </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Results of Operations</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> section may reflect rounding adjustments.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Sales</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents net sales, consolidated and by reportable segment:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:34.816%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.744%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">% Change</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019/2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018/2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,398.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,308.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,236.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">362.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intersegment sales elimination</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated net sales increased by $122.5 million, or 7.1%, in 2019, including an unfavorable foreign currency translation impact of $52.2 million. Excluding foreign currency translation effects, as well as incremental sales of $3.3 million from our recent acquisition, consolidated net sales increased by $171.4 million, or 10.0%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Proprietary Products net sales increased by $90.0 million, or 6.9%, in 2019, including an unfavorable foreign currency translation impact of $43.1 million. Excluding foreign currency translation effects, as well as incremental sales of $3.3 million from our recent acquisition, net sales increased by $129.8 million, or 9.9%, primarily due to growth in our high-value product offerings, including our Daikyo components, our ready-to-use seals, stoppers, and plungers, our NovaPure</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> components and Crystal Zenith products, and our self-injection systems and FluroTec-coated components.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contract-Manufactured Products net sales increased by $32.4 million, or 7.9%, in 2019, including an unfavorable foreign currency translation impact of $9.1 million. Excluding foreign currency translation effects, net sales increased by $41.5 million, or 10.1%, due to an increase in the sale of healthcare-related injection and diagnostic devices.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated net sales increased by $118.3 million, or 7.4%, in 2018, including a favorable foreign currency translation impact of $28.6 million. Excluding foreign currency translation effects, consolidated net sales increased by $89.7 million, or 5.6%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#8211; Proprietary Products net sales increased by $71.7 million, or 5.8%, in 2018, including a favorable foreign currency translation impact of $23.8 million. Excluding foreign currency translation effects, net sales increased by $47.9 million, or 3.9%, as growth in our high-value product offerings, including our Westar</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">23</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">FluroTec-coated components, our ready-to-use seals, stoppers, and plungers, and our NovaPure products, as well as sales price increases, partially offset the impact of the voluntary recall of Vial2Bag products and the deconsolidation of our Venezuelan subsidiary as of April 1, 2017.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#8211; Contract-Manufactured Products net sales increased by $46.6 million, or 12.9%, in 2018, including a favorable foreign currency translation impact of $4.8 million. Excluding foreign currency translation effects, net sales increased by $41.8 million, or 11.6%, despite the impact of the loss of a consumer-product customer in early 2018. Higher sales volume, particularly in Ireland, contributed 10.4 percentage points of the increase, and sales price increases contributed 1.2 percentage points of the increase.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Gross Profit</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents gross profit and related gross margins, consolidated and by reportable segment:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.339%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.702%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">% Change</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019/2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018/2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">540.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">485.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">449.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit margin</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit margin</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unallocated items</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated gross profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">605.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">545.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">512.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated gross profit margin</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated gross profit increased by $60.3 million, or 11.1%, in 2019, including an unfavorable foreign currency translation impact of $15.7 million. Consolidated gross profit margin increased by 1.1 margin points in 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Proprietary Products gross profit increased by $55.0 million, or 11.3%, in 2019, including an unfavorable foreign currency translation impact of $14.3 million. Proprietary Products gross profit margin increased by 1.5 margin points in 2019, due to a favorable mix of products sold, production efficiencies, and sales price increases, partially offset by increased overhead costs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contract-Manufactured Products gross profit increased by $5.5 million, or 9.2%, in 2019, including an unfavorable foreign currency translation impact of $1.4 million. Contract-Manufactured Products gross profit margin increased by 0.1 margin points in 2019, due to production efficiencies and lower raw material costs, partially offset by increased overhead costs and an unfavorable mix of products sold.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated gross profit increased by $32.5 million, or 6.3%, in 2018, including a favorable foreign currency translation impact of $9.3 million. Consolidated gross profit margin decreased by 0.3 margin points in 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#8211; Proprietary Products gross profit increased by $36.1 million, or 8.0%, in 2018, including a favorable foreign currency translation impact of $8.5 million. Proprietary Products gross profit margin increased by 0.8 margin points in 2018, as production efficiencies, a favorable mix of products sold, and sales price increases were partially offset by the impact of under-absorbed overhead costs from our new facility in Waterford, Ireland and the deconsolidation of our Venezuelan subsidiary as of April 1, 2017, as well as increased labor and depreciation costs and higher raw material costs.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">24</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#8211; Contract-Manufactured Products gross profit decreased by $3.6 million, or 5.7%, in 2018, including a favorable foreign currency translation impact of $0.8 million. Contract-Manufactured Products gross profit margin decreased by 2.8 margin points in 2018, due to unabsorbed overhead from plant consolidation activities, start-up costs associated with the launch of new programs, an unfavorable mix of product sales, and lower profitability on development and tooling agreements, and higher raw material costs, partially offset by sales price increases and production efficiencies.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development (&#8220;R&amp;D&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents R&amp;D costs, consolidated and by reportable segment:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.339%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.702%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">% Change</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019/2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018/2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated R&amp;D costs</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated R&amp;D costs decreased by $1.4 million, or 3.5%, in 2019, primarily due to an increase in customer-funded R&amp;D projects via customer development agreements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated R&amp;D costs increased by $1.2 million, or 3.1%, in 2018. Efforts remained focused on the continued investment in self-injection systems development, elastomeric packaging components, and formulation development.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All of the R&amp;D costs incurred during 2019, 2018 and 2017 related to Proprietary Products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Selling, General and Administrative (&#8220;SG&amp;A&#8221;) Costs</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents SG&amp;A costs, consolidated and by reportable segment and corporate:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:34.698%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.022%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31, </span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">% Change</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019/2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018/2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">189.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate and unallocated items</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated SG&amp;A costs</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">272.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">246.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SG&amp;A as a % of net sales</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated SG&amp;A costs increased by $9.8 million, or 3.7%, in 2019, including the impact of foreign currency translation, which decreased SG&amp;A costs by $0.3 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Proprietary Products SG&amp;A costs increased by $4.9 million, or 2.6%, in 2019, primarily due to an increase in compensation costs and incremental costs associated with our voluntary recall and the acquisition of our distributor in South Korea, partially offset by ongoing cost control measures. Foreign currency translation decreased Proprietary Products SG&amp;A costs by $0.3 million.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">25</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contract-Manufactured Products SG&amp;A costs decreased by $0.3 million, or 1.8%, in 2019, due to ongoing cost control measures.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate and unallocated items &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Corporate SG&amp;A costs increased by $5.2 million, or 8.5%, in 2019, primarily due to increases in stock-based compensation costs and incentive compensation costs, partially offset by a decrease in U.S. pension costs due to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting) and ongoing cost control measures.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated SG&amp;A costs increased by $16.9 million, or 6.9%, in 2018, including the impact of foreign currency translation, which increased SG&amp;A costs by $2.4 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Proprietary Products SG&amp;A costs increased by $9.7 million, or 5.5%, in 2018, due to higher commercial sales compensation costs and legal costs. Foreign currency translation increased Proprietary Products SG&amp;A costs by $2.3 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contract-Manufactured Products SG&amp;A costs increased by $1.1 million, or 7.1%, in 2018, due to increases in compensation and miscellaneous costs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate and unallocated items &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Corporate SG&amp;A costs increased by $6.1 million, or 11.0%, in 2018, primarily due to the impact of higher achievement levels on incentive compensation costs and increased personnel costs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other (Income) Expense</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents other income and expense items, consolidated and by reportable segment and unallocated items:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:60.218%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.062%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Income) Expense</span></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions) </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate and unallocated items</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated other (income) expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other income and expense items, consisting of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, development and licensing income, contingent consideration, and miscellaneous income and charges, are generally recorded within segment results.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated other (income) expense changed by $4.4 million in 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Proprietary Products other income decreased by $4.3 million in 2019, primarily due to increased contingent consideration costs. Please refer to Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of this item.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contract-Manufactured Products other expense (income) changed by $1.0 million in 2019, primarily due to a decrease in gains on the sale of fixed assets during 2019. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate and unallocated items &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Corporate and unallocated items changed by $9.7 million in 2019. During 2019, we recorded $4.9 million in restructuring and related charges, a $1.9 million gain on the sale of fixed assets as a result of our restructuring plan, and a charge of $1.0 million as a result of the continued devaluation of Argentina&#8217;s currency. We expect that our 2018 restructuring plan, which is now considered complete, will provide annualized </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">26</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">savings of approximately $14.0 million. In addition, during 2019, we recognized a tax recovery of $4.7 million related to previously-paid international excise taxes, following a favorable court ruling. Please refer to Note 16, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of these items.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated other expense decreased by $0.1 million in 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Proprietary Products other income decreased by $2.6 million in 2018, primarily as we recorded income of $9.1 million attributable to the reimbursement of certain costs related to a technology that we subsequently licensed to a third party in 2017, partially offset by foreign exchange transaction gains in Europe in 2018. Please refer to Note 16, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of the $9.1 million attributable to the reimbursement of certain costs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contract-Manufactured Products other income increased by $0.7 million in 2018, due to gains on the sale of fixed assets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate and unallocated items &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Corporate and unallocated items changed by $2.0 million in 2018. During 2018, we recorded $9.1 million in restructuring and related charges, a $1.1 million gain on the sale of fixed assets as a result of our restructuring plans, and a charge of $1.1 million related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018. Please refer to Note 16, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of these items.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Operating Profit</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents adjusted operating profit, consolidated and by reportable segment, corporate and unallocated items:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.025%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.378%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.378%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.217%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.897%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.901%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">% Change</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019/2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018/2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">266.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(66.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjusted consolidated operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">249.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjusted consolidated operating profit margin</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unallocated items</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">225.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated operating profit margin</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated operating profit increased by $56.3 million, or 23.4%, in 2019, including a favorable foreign currency translation impact of $0.6 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Proprietary Products operating profit increased by $47.2 million, or 17.7%, in 2019, including a favorable foreign currency translation impact of $0.6 million, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contract-Manufactured Products operating profit increased by $4.8 million, or 10.8%, in 2019, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Corporate costs increased by $5.0 million, or 8.2%, in 2019, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Unallocated items &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please refer to the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">section for details.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">27</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Excluding the unallocated items, our adjusted consolidated operating profit margin increased by 1.6 margin points in 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated operating profit increased by $14.5 million, or 6.4%, in 2018, including a favorable foreign currency translation impact of $6.6 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Proprietary Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Proprietary Products operating profit increased by $22.6 million, or 9.3%, in 2018, including a favorable foreign currency translation impact of $5.9 million, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract-Manufactured Products &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contract-Manufactured Products operating profit decreased by $4.0 million, or 8.3%, in 2018, including a favorable foreign currency translation impact of $0.7 million, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Corporate &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Corporate costs increased by $6.1 million, or 11.1%, in 2018, due to the factors described above.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Unallocated items &#8211; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please refer to the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">section for details.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Excluding the unallocated items, our adjusted consolidated operating profit margin decreased by 0.3 margin points in 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents interest expense, net, by significant component:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:34.698%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.019%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.022%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year Ended December 31,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">% Change</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019/2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018/2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capitalized interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(66.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest expense, net, decreased by $1.6 million, or 25.4%, in 2019, due to an increase in interest income in 2019 resulting from higher interest rates on our deposit accounts and higher average cash and cash equivalents balances.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest expense, net, decreased by $0.2 million, or 3.1%, in 2018, due to lower interest expense resulting from less average debt outstanding during 2018, as compared to 2017, and an increase in interest income, partially offset by a decrease in capitalized interest due to the completion of several major projects in 2017, including certain components of our new facility in Waterford, Ireland. The Waterford facility began commercial production during the second half of 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other Nonoperating Expense (Income)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other nonoperating expense (income) changed by $6.8&#160;million in 2019, primarily due to a decrease in the expected return on pension plan assets and a pension settlement charge of $3.5 million recorded in 2019, as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">28</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other nonoperating income increased by $3.6 million in 2018, due to an increase in the expected return on pension plan assets and a decrease in recognized actuarial losses for 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The provision for income taxes was $59.0 million, $41.4 million, and $80.9 million for the years 2019, 2018, and 2017, respectively, and the effective tax rate was 20.2%, 17.2%, and 36.4%, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded a net tax benefit of $0.3 million due to the impact of federal law changes enacted during the year, as well as a tax benefit of $10.3 million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2018, we recorded a net tax benefit of $2.5 million for the estimated impact of the 2017 Tax Act and a tax benefit of $14.3 million associated with stock-based compensation. Please refer to Note 17, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of the 2017 Tax Act.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2017, we recorded a discrete tax charge of $48.8 million related to the 2017 Tax Act and the impact of changes in enacted international tax rates on previously-recorded deferred tax asset and liability balances, as well as a tax benefit of $33.1 million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please refer to Note 17, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of our income taxes.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Equity in Net Income of Affiliated Companies</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Equity in net income of affiliated companies represents the contribution to earnings from our 25% ownership interest in Daikyo, which increased to 49% during the fourth quarter of 2019, and our 49% ownership interest in five companies majority-owned by a long-time partner located in Mexico. Please refer to Note 7, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Affiliated Companies</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion. Equity in net income of affiliated companies was $8.9 million, $7.6 million, and $9.2 million for the years 2019, 2018, and 2017, respectively. Equity in net income of affiliated companies increased by $1.3 million, or 17.1%, in 2019, primarily due to favorable operating results at Daikyo. Equity in net income of affiliated companies decreased by $1.6 million, or 17.4%, in 2018, primarily due to the impact of gains on the sale of investment securities by Daikyo in 2017.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Income</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net income in 2019 was $241.7 million, or $3.21 per diluted share, compared to $206.9 million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180Ni9mcmFnOmM3NDE0YTczMTJmMTRkZjg4MWFmYzAxYjE0MTBhMjRkL3RleHRyZWdpb246Yzc0MTRhNzMxMmYxNGRmODgxYWZjMDFiMTQxMGEyNGRfMTcwMTI_f8210b56-772b-4426-bf39-e0569cee3338">2.74</ix:nonFraction> per diluted share, in 2018. Our 2019 results included the impact of restructuring and related charges of $3.7 million (net of $1.2 million in tax), a gain on the sale of fixed assets as a result of our restructuring plan of $1.3 million (net of $0.4 million in tax), a pension settlement charge of $2.7 million (net of $0.8 million in tax), a charge of $1.0 million related to the continued devaluation of Argentina&#8217;s currency, a tax recovery of $2.9 million (net of $1.5 million in tax) related to previously-paid international excise taxes, a net tax benefit of $0.3 million related to the impact of federal law changes enacted during the year, and a tax benefit of $10.3 million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net income in 2018 was $206.9 million, or $2.74 per diluted share, compared to $150.7 million, or $1.99 per diluted share, in 2017. Our 2018 results included the impact of restructuring and related charges of $7.2 million (net of $1.9 million in tax), a gain on the sale of fixed assets as a result of our restructuring plans of $0.9 million (net of $0.2 million in tax), a charge of $1.1 million related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018, a net tax benefit of $2.5 million for the estimated impact of the 2017 Tax Act, and a tax benefit of $14.3 million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net income in 2017 was $150.7 million, or $1.99 per diluted share, compared to $143.6 million, or $1.91 per diluted share, in 2016. Our 2017 results included the impact of a discrete tax charge of $48.8 million related to the 2017 Tax Act and the impact of changes in enacted international tax rates on previously-recorded deferred tax asset and </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">29</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">liability balances, as well as a tax benefit of $33.1 million associated with stock-based compensation and a charge of $11.1 million related to the deconsolidation of our Venezuelan subsidiary.</span></div><div><span><br/></span></div><div id="i_0_49"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash Flows</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents cash flow data for the years ended December&#160;31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:60.218%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.057%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.062%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by operating activities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">367.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">288.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">263.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(228.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(100.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(133.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in financing activities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(80.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(109.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Cash Provided by Operating Activities </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash provided by operating activities increased by $78.6 million in 2019, primarily due to improved operating results and changes in assets and liabilities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash provided by operating activities increased by $25.3 million in 2018, primarily due to improved operating results and a decrease in pension plan contributions in 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Cash Used in Investing Activities</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in investing activities increased by $127.2 million in 2019, primarily due to the increase in our ownership interest in Daikyo, an increase in capital expenditures, and the acquisition of our distributor in South Korea.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in investing activities decreased by $32.8 million in 2018, mostly due to a $26.1 million decrease in capital spending due to the completion of several major projects in 2017, including certain components of our new facility in Waterford, Ireland.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Cash Used in Financing Activities </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2019 compared to 2018</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in financing activities decreased by $43.9 million in 2019, primarily due to borrowings of $90.0 million under our Term Loan, partially offset by net repayments of our outstanding long-term borrowings under our Credit Facility and increases in purchases under our share repurchases programs and dividend payments.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">2018 compared to 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in financing activities decreased by $28.3 million in 2018, primarily due to lower debt repayment activity in 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We paid cash dividends totaling $45.1 million ($0.61 per share), $42.1 million ($0.57 per share), and $39.1 million ($0.53 per share) during 2019, 2018, and 2017, respectively.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">30</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The table below presents selected liquidity and capital measures as of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:68.578%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.308%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.311%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">439.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">337.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">319.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">288.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">257.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,573.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,396.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Working Capital</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">717.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">610.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash and cash equivalents include all instruments that have maturities of ninety days or less when purchased. Working capital is defined as current assets less current liabilities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash and cash equivalents &#8211;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our cash and cash equivalents balance at December&#160;31, 2019 consisted of cash held in depository accounts with banks around the world and cash invested in high-quality, short-term investments.  The cash and cash equivalents balance at December&#160;31, 2019 included $217.2 million of cash held by subsidiaries within the U.S. and $221.9 million of cash held by subsidiaries outside of the U.S. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $214.2 million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Working capital -</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Working capital at December&#160;31, 2019 increased by $106.4 million, or 17.4%, as compared to December&#160;31, 2018, including an increase of $11.3 million due to foreign currency translation. Excluding the impact of currency exchange rates, cash and cash equivalents, accounts receivable, inventories, and total current liabilities increased by $102.4 million, $33.3 million, $23.2 million, and $60.0 million, respectively. The increase in accounts receivable was due to increased sales activity and longer customer payment terms. The increase in total current liabilities was primarily due to increases in accounts payable, accrued salaries, wages and benefits, and other current liabilities, as well as our adoption of Accounting Standards Codification (&#8220;ASC&#8221;) Topic 842 (&#8220;ASC 842&#8221;), which required us to record operating lease liabilities for operating leases where we are the lessee in our consolidated balance sheet as of December&#160;31, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Debt and credit facilities -</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The $61.2 million increase in total debt at December&#160;31, 2019, as compared to December&#160;31, 2018, primarily resulted from borrowings of $90.0 million under our Term Loan, partially offset by net repayments of our outstanding long-term borrowings under our Credit Facility, foreign currency rate fluctuations, and an increase in unamortized debt issuance costs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our sources of liquidity include our Credit Facility. At December 31, 2019, we had no outstanding borrowings under the Credit Facility, as we repaid the outstanding long-term borrowings denominated in Euro and Yen in November </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">31</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and December 2019, respectively. There was no material gain or loss on the repayment under the Credit Facility. At December 31, 2019, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.5 million, was $297.5 million. We do not expect any significant limitations on our ability to access this source of funds. Please refer to Note 10,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> Debt</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of our Credit Facility.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2019, we were in compliance with all of our debt covenants, and we expect to continue to be in compliance with the terms of these agreements throughout 2020. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that cash on hand and cash generated from operations, together with availability under our Credit Facility, will be adequate to address our foreseeable liquidity needs based on our current expectations of our business operations, capital expenditures and scheduled payments of debt obligations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Commitments and Contractual Obligations</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our commitments and contractual obligations at December&#160;31, 2019. These obligations are not expected to have a material impact on liquidity.</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:98.878%;"><tr><td style="width:1.0%;"></td><td style="width:45.487%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.724%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.669%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.724%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.724%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.672%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments Due By Period</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less than 1 year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1 - 3 years</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 - 5 years</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">More than 5 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Purchase obligations </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">249.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt (excluding unamortized debt issuance costs)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">258.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest on debt and interest rate swaps </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease obligations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Other long-term liabilities </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Total contractual obligations </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">639.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">Our business creates a need to enter into various commitments with suppliers, including for the purchase of raw materials and finished goods. In accordance with U.S. GAAP, these purchase obligations are not reflected in the accompanying consolidated balance sheets. These purchase commitments do not exceed our projected requirements and are in the normal course of business.  </span></div><div style="padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">For fixed-rate long-term debt, interest was based on principal amounts and fixed coupon rates at year-end. Future interest payments on variable-rate debt were calculated using principal amounts and the applicable ending interest rate at year-end. Interest on fixed-rate derivative instruments was based on notional amounts and fixed interest rates contractually obligated at year-end.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(3)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">Represents acquisition-related contingencies. In connection with certain business acquisitions, we agreed to make payments to the sellers if and when certain operating milestones are achieved, such as sales and operating income targets. </span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(4)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">This table does not include obligations pertaining to pension and postretirement benefits because the actual amount and timing of future contributions may vary significantly depending upon plan asset performance, benefit payments, and other factors. Contributions to our plans are expected to be $1.4 million in 2020. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for estimated benefit payments over the next ten years.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Reserves for uncertain tax positions</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> - The table above does not include $5.0 million of total gross unrecognized tax benefits as of December&#160;31, 2019. Due to the high degree of uncertainty regarding the timing of potential cash flows, we cannot reasonably estimate the settlement periods for amounts which may be paid.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">32</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Letters of credit</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> - We have letters of credit totaling $2.5 million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.2 million at December&#160;31, 2019, of which $0.9 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">OFF-BALANCE SHEET ARRANGEMENTS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, we had no off-balance sheet financing arrangements other than unconditional purchase obligations incurred in the ordinary course of business and outstanding letters of credit related to various insurance programs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Management&#8217;s discussion and analysis addresses consolidated financial statements that are prepared in accordance with U.S. GAAP. The application of these principles requires management to make estimates and assumptions, some of which are subjective and complex, that affect the amounts reported in the consolidated financial statements. We believe the following accounting policies and estimates are critical to understanding and evaluating our results of operations and financial position: </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC Topic 606 (&#8220;ASC 606&#8221;). Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> technology platform within a specific therapeutic area. As of December&#160;31, 2019, there was $5.6 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $4.7 million was included in other long-term </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">33</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contract assets and liabilities result from transactions with revenue recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet in other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Long-Lived Assets: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other (income) expense for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Goodwill and Other Intangible Assets:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Considerable management judgment is necessary to estimate fair value. Amounts and assumptions used in our goodwill impairment test, such as future sales, future cash flows and long-term growth rates, are consistent with internal projections and operating plans. Amounts and assumptions used in our goodwill impairment test are also largely dependent on the continued sale of drug products delivered by injection and the packaging of drug products, as well as our timeliness and success in new-product innovation or the development and commercialization of proprietary multi-component systems. Changes in the estimate of fair value, including the estimate of future cash flows, could have a material impact on our future results of operations and financial position. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our 2017, 2018, and 2019 annual impairment tests. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment tests in 2017, 2018, and 2019.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">34</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Employee Benefits:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> We maintain funded and unfunded defined benefit pension plans in the U.S. and a number of other countries that cover employees who meet eligibility requirements. In addition, we sponsor postretirement benefit plans which provide healthcare benefits for eligible employees who retire or become disabled. Postretirement benefit plans are limited to only those active employees who met the eligibility requirements as of January 1, 2017. The measurement of annual cost and obligations under these defined benefit postretirement plans is subject to a number of assumptions, which are specific for each of our U.S. and foreign plans. The assumptions, which are reviewed at least annually, are relevant to both the plan assets (where applicable) and the obligation for benefits that will ultimately be provided to our employees. Two of the most critical assumptions in determining pension and retiree medical plan expense are the discount rate and expected long-term rate of return on plan assets. Other assumptions reflect demographic factors such as retirement age, rates of compensation increases, mortality and turnover and are evaluated periodically and updated to reflect our actual experience. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. Under U.S. GAAP, differences between actual and expected results are generally accumulated in other comprehensive income (loss) as actuarial gains or losses and subsequently amortized into earnings over future periods. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Changes in key assumptions could have a material impact on our future results of operations and financial position. We estimate that every 25-basis point reduction in our long-term rate of return assumption would increase pension expense by $0.4 million, and every 25-basis point reduction in our discount rate would decrease pension expense by $0.1 million. A decrease in the discount rate increases the present value of benefit obligations. Our net pension underfunded balance at December&#160;31, 2019 was $43.8 million, compared to $52.5 million at December&#160;31, 2018.  Our underfunded balance for other postretirement benefits was $6.6 million at December&#160;31, 2019, compared to $6.0 million at December&#160;31, 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> We estimate income taxes payable based upon current domestic and international tax legislation. In addition, deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and country level. Changes in tax legislation, business plans and other factors may affect the ultimate recoverability of tax assets or final tax payments, which could result in adjustments to tax expense in the period such change is determined.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">When accounting for uncertainty in income taxes recognized in our financial statements, we apply a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please refer to Note 1, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Summary of Significant Accounting Policies</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and Note 2, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">New Accounting Standards</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, to our consolidated financial statements for additional information on our significant accounting policies, recently adopted accounting standards, and accounting standards issued but not yet adopted.</span></div><div><span><br/></span></div><div id="i_0_52"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 7A.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. These risk factors can impact our results of operations, cash flows and financial position. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">35</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales outside of the U.S. accounted for 55.7% of our consolidated net sales in 2019. Virtually all of these sales and related operating costs are denominated in the currency of the local country and translated into USD for consolidated reporting purposes. Although the majority of the assets and liabilities of these subsidiaries are denominated in the functional currency of the subsidiary, they may also hold assets or liabilities denominated in other currencies. These items may give rise to foreign currency transaction gains and losses. As a result, our results of operations and financial position are exposed to changing currency exchange rates. We periodically use forward exchange contracts to hedge certain transactions or to manage month-end balance sheet exposures on cross-currency intercompany loans.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2019, the total amount of these forward exchange contracts was SGD 601.5 million and $13.4 million. As of December&#160;31, 2018, the total amount of these forward exchange contracts was &#8364;10.0 million, SGD 601.5 million and $13.4 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:52.487%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.906%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sell</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Euro</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Yen</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,550.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SGD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as a cumulative translation adjustment in accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2019, we entered into a five-year floating-to-floating forward-starting cross-currency swap (the &#8220;cross-currency swap&#8221;) for $90 million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;9.8 billion ($90 million) and the swap termination date is December 31, 2024. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration: underline;">Interest Rate Risk</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">As a result of our normal borrowing activities, we have long-term debt with both fixed and variable interest rates. Long-term debt consists of our Term Loan and Series A, B and C notes. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">36</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our interest rate risk-sensitive instruments (excluding unamortized debt issuance costs):  </span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:98.237%;"><tr><td style="width:1.0%;"></td><td style="width:32.747%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.340%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.340%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.340%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.340%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.340%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.092%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.135%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.326%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Debt:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. dollar denominated</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average interest rate - variable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-Term Debt:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. dollar denominated</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">168.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average interest rate - fixed</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. dollar denominated</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average interest rate - variable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. In recent years, raw material costs have fluctuated due to crude oil price fluctuations. We expect this volatility to continue. We will continue to pursue pricing and hedging strategies, and ongoing cost control initiatives, to offset the effects on gross profit. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From November 2017 through October 2019, we purchased several series of call options for a total of 352,682 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, the loss recorded in cost of goods and services sold related to these options was $0.4 million. During 2018, the gain recorded in cost of goods and services sold related to these options was $0.1 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, we had outstanding contracts to purchase 135,967 barrels of crude oil from January 2020 to June 2021, at a weighted-average strike price of $70.71 per barrel.</span></div><div id="i_0_55"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">37</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 8.&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div><span><br/></span></div><div id="i_0_58"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENTS OF INCOME</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2019, 2018 and 2017 </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(in millions, except per share data)</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:53.769%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.944%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMS0yLTEtMS0w_56c61f3d-9087-475a-9d56-a0fe8b5f36fa">1,839.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMi0yLTEtMS0w_acb286bf-135b-41b3-a485-557730243c0d">1,234.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMi00LTEtMS0w_a3134226-00ef-402e-8671-7cbc498b8612">1,172.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMi02LTEtMS0w_179847e6-5989-4afd-8024-b25b3f8e9062">1,086.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMy0yLTEtMS0w_cd77a5a9-2b25-4609-8123-9e032186c922">605.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMy00LTEtMS0w_d4940563-3906-4576-8d10-7af9d293469b">545.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMy02LTEtMS0w_71555182-593c-4c81-a408-90bb17137a06">512.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNC0yLTEtMS0w_e3d30e9e-3297-49b3-be88-e7b693fd67c5">38.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNC00LTEtMS0w_a7caaf17-9961-42c6-a177-219560e784b4">40.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNC02LTEtMS0w_2f59efdb-cbb8-4c21-8460-07f9655342a1">39.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNS0yLTEtMS0w_f37a2384-5153-4537-b30f-aee58cadff3b">272.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNS00LTEtMS0w_116d8158-2506-488b-a049-20e6a499db57">262.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNS02LTEtMS0w_7aaec093-3182-4c17-baf2-0e882250e69d">246.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense (Note 16)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNi0yLTEtMS0w_78ce33bc-680d-497b-a784-c74c748a749d">2.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNi00LTEtMS0w_82dafc0a-6e0a-44c7-ad20-7d2d40e5050e">1.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNi02LTEtMS0w_7d04ccda-a475-4a28-a06f-6091163fde15">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNy0yLTEtMS0w_40eebd30-5487-47b1-9da9-06bd167dc3f5">296.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNy00LTEtMS0w_66f009ec-f26d-4ff5-97db-beb948f36f64">240.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNy02LTEtMS0w_20054cd5-77ef-46b2-a70f-cbc0dc3c6274">225.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOC0yLTEtMS0w_88247766-e004-48ce-8f1a-6c5090bd5a51">8.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOC00LTEtMS0w_5108c44b-7f86-4fee-9859-e8a714180028">8.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOC02LTEtMS0w_aadf4505-2456-4613-a3e6-92a079c5d73c">7.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOS0yLTEtMS0w_708ea232-1c6f-448a-9a43-16733187b766">3.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOS00LTEtMS0w_263789ac-2877-48e6-86f4-e2636eed9918">2.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOS02LTEtMS0w_bbe11c31-e392-47d0-b035-ea85dcd1e869">1.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating expense (income)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTAtMi0xLTEtMA_871e7edb-4934-4d6f-8734-d5fbaf1adb21">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTAtNC0xLTEtMA_65da68f6-b3f1-4f02-993f-4929ba3d8043">6.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTAtNi0xLTEtMA_1f662d87-90d4-4803-9c3e-9ca07f03161a">3.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTEtMi0xLTEtMA_af03d508-869d-4828-ba67-455030f59f3d">291.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTEtNC0xLTEtMA_eab5584c-a8e0-49ad-8ae2-9004e877363c">240.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTEtNi0xLTEtMA_61c3f5cf-c443-4bab-8003-b73589de57a0">222.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTItMi0xLTEtMA_5d9d24ce-9699-4867-a3ab-1954497d7104">59.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTItNC0xLTEtMA_017d040c-5bea-4992-bc40-ff0f92ca7526">41.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTItNi0xLTEtMA_d012ce75-ec98-486e-9848-8404ff224311">80.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity in net income of affiliated companies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTMtMi0xLTEtMA_197d6001-3bfc-411a-b525-c730bc01eb50">8.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTMtNC0xLTEtMA_692d22a3-83a0-4f67-9545-a7ae85e4571e">7.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTMtNi0xLTEtMA_dd50a2a7-0ac7-48db-879d-4e2e1a03d702">9.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTQtMi0xLTEtMA_7e166ac3-7b96-4a4b-b587-62af52768db6">241.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTQtNC0xLTEtMA_013312ed-4d24-4caa-8a3f-8d28f8055e87">206.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTQtNi0xLTEtMA_a1dcfb73-4359-42ea-95fb-5aba15c63179">150.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTctMi0xLTEtMA_315054ec-f00c-49bc-92f2-5a2c0ab15eeb">3.27</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTctNC0xLTEtMA_de0da35b-e97b-44e5-af30-a845e04eec55">2.80</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTctNi0xLTEtMA_e45d508c-0aa7-4dd5-a50a-ee127dbffa5f">2.04</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTgtMi0xLTEtMA_f5ebeb37-1ca2-45aa-b5e0-1e9de0281831">3.21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTgtNC0xLTEtMA_f8210b56-772b-4426-bf39-e0569cee3338">2.74</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTgtNi0xLTEtMA_af9386f8-c891-4d0b-a616-fb015f5a52f6">1.99</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjEtMi0xLTEtMA_0d61fbe5-c372-4879-bef0-c6e4828f9f58">74.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjEtNC0xLTEtMA_2b1bba6c-8e73-462f-8bc7-723d193602bd">73.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjEtNi0xLTEtMA_1140bcf4-8a3b-4d64-9cb8-a2cc687443b6">73.9</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjItMi0xLTEtMA_3102190d-8742-427b-b412-3e9fa019df56">75.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjItNC0xLTEtMA_a57c73fe-cf01-4530-b3b2-67f0a9f56de7">75.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjItNi0xLTEtMA_ad1bea1e-9213-46c4-8880-75d5ad2e8432">75.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div id="i_0_61"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">38</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2019, 2018 and 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(in millions)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:61.402%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.717%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.556%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.721%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMS0xLTEtMS0w_630dae50-57b3-4c26-ab71-5c19cf9ef472">241.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMS0zLTEtMS0w_07a81b4e-2a6e-43dc-abda-f8560cc7c00b">206.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMS01LTEtMS0w_e4f01d7c-875c-4f43-91b2-77638b55de0e">150.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation adjustments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMy0xLTEtMS0w_dc5bbe3b-170b-48a1-bc69-c1aa40e9c89f">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMy0zLTEtMS0w_0a8eb58e-feaa-4f5d-8f4d-07de3a85db2d">39.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMy01LTEtMS0w_d8075d63-7a44-43a7-a658-c6ed30661cbf">68.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service cost arising during period, net of tax of $0</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNS0xLTEtMS0w_c139c86d-7fe7-4822-89e8-eb8316f04749">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNS0zLTEtMS0w_edcb2751-beb8-4b51-9c37-ef8a33fbebce">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNS01LTEtMS0w_c563c42c-c8c7-4fbf-98f9-873904d7ff35">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net actuarial (loss) gain arising during period, net of tax of $(0.3), $(0.2) and $1.3</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNi0xLTEtMS0w_81a63a9b-64f1-47ad-bbd2-5738789b134c">1.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNi0zLTEtMS0w_946cb833-afb6-4ccb-a1b1-273654c7242a">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNi01LTEtMS0w_015217d8-e990-4013-8819-7a014ca45205">6.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects arising during period, net of tax of $0.8</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNy0xLTEtMS0w_084fff51-0845-4d9e-bd49-579c92c3610b">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNy0zLTEtMS0w_c5ed380e-8415-4608-806f-5d88dd1f0f26">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNy01LTEtMS0w_93a3f503-89c4-4b83-8f92-25d10fa454b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: amortization of actuarial (gain) loss, net of tax of $0, $0.3 and $0.5</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOC0xLTEtMS0w_ef954d40-7936-43cf-972f-cefc386265eb">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOC0zLTEtMS0w_b67b53cc-c50a-4ff8-976e-bf60825432a9">1.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOC01LTEtMS0w_14482154-6bda-49c7-8a40-b29dd7d09193">3.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: amortization of prior service credit, net of tax of $(0.1), $(0.5) and $(0.5)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOS0xLTEtMS0w_63fb42d3-578d-4d66-9220-188d04580925">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOS0zLTEtMS0w_34c3218c-c251-4bc0-98fb-dd9117d1f23c">1.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOS01LTEtMS0w_dab44749-0bb2-45e8-9aec-7d8a3b07e2ec">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss on investment securities, net of tax of $0, $(0.1) and $(2.5)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTEtMS0xLTEtMA_49f0152e-1e92-4fbf-8048-2a846839792d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTEtMy0xLTEtMA_ff594325-90ef-4846-ab29-4006df1b66a9">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTEtNS0xLTEtMA_c524b0fe-4b3b-4875-a79a-c98bccf1ba9d">4.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net (loss) gain on derivatives, net of tax of $(0.2), $1.5 and $(0.1)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTItMS0xLTEtMA_8faaa371-4783-4bd7-87f7-b23e408474ca">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTItMy0xLTEtMA_ffe595dd-8d0d-4ec3-873b-457050f9a0e3">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTItNS0xLTEtMA_e2e6a1b2-1d7a-4566-8b63-5c1f468c4427">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTMtMS0xLTEtMA_69786a86-9f00-4646-ab9b-6a706d974f2c">4.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTMtMy0xLTEtMA_241fba10-2b3a-4f3e-97b0-ff7eaeed47ad">36.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTMtNS0xLTEtMA_f6e47f09-aa4a-48bd-86c1-447fe4b1317b">69.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTQtMS0xLTEtMA_b682766c-2cc0-49c2-8c1e-7485907c7760">246.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTQtMy0xLTEtMA_d33f48ab-ffcd-444c-864d-b8be4a271b19">170.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTQtNS0xLTEtMA_f5d95bf2-c11c-4736-ab67-76123f94c6b4">220.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div id="i_0_67"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">39</span></div></div></div><hr style="page-break-after:always"/><div style="height:45pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%;">CONSOLIDATED BALANCE SHEETS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;">West Pharmaceutical Services, Inc. and Subsidiaries at December&#160;31, 2019 and 2018 </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;">(in millions, except per share data)</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:71.472%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.861%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.864%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ASSETS</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMy0xLTEtMS0w_5cc5d622-b530-4746-8ac5-f3269aca00f4">439.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMy0zLTEtMS0w_46733361-7a9e-4b59-b242-c5bea0f42c92">337.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNC0xLTEtMS0w_10c49013-abab-4e09-845e-a2fc3c6ba5a9">319.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNC0zLTEtMS0w_04843306-fba9-4b6a-8572-1ae5e478ec86">288.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNS0xLTEtMS0w_8e6f81df-f7cf-4181-a1cf-3457b455562a">235.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNS0zLTEtMS0w_0a40856a-c03e-4ee7-a9e9-26c802cdc2ff">214.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNi0xLTEtMS0w_68a9f9c4-9d25-40c8-85eb-a8b1c255c442">64.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNi0zLTEtMS0w_693afb72-124e-43f2-bd1c-261e547f3195">54.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNy0xLTEtMS0w_7e461640-3886-4683-9208-675a20f238e1">1,058.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNy0zLTEtMS0w_c0d31fb2-ad62-47e6-90df-a3aa3c72ecf1">894.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOC0xLTEtMS0w_5d070695-b871-448c-ba41-03bedacb5762">1,820.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOC0zLTEtMS0w_f88ad533-ea84-4da5-b57f-5844b2bce690">1,752.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOS0xLTEtMS0w_b3ff9ef2-efad-4cf9-b3eb-28fdc742c9df">980.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOS0zLTEtMS0w_2410f6ba-87a6-4687-ac8d-a6408b8ec5b4">930.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant and equipment, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTAtMS0xLTEtMA_5b254dec-7295-4e3d-b472-84cf48310f33">839.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTAtMy0xLTEtMA_8450a920-5296-4513-bd7c-f6afa0e61c28">822.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMS0xLTEtMjI0MQ_57499681-3e58-463b-a647-b502cdf53feb">70.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMy0xLTEtMjI0MQ_4e8afec3-83e1-484b-b158-3952e4ad3d48">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Investments in affiliated companies</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMS0xLTEtMA_52b42f24-652f-48e0-9b0b-7d5c5d598cb9">192.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMy0xLTEtMA_ed8a8e85-01e0-470c-b374-fb49fc6d6e83">91.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTItMS0xLTEtMA_565827a8-cbfc-4d6e-ae37-95d20bd3b9c4">107.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTItMy0xLTEtMA_e10edf07-297e-49e2-a723-6252d6046ef8">105.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income taxes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsNetNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTMtMS0xLTEtMA_4b173a27-706b-4f7b-a39a-bb640394be0d">14.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsNetNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTMtMy0xLTEtMA_bf9eaa1d-8124-4ebe-a4db-8267eeab4ae7">24.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTQtMS0xLTEtMA_f638759a-6e03-4c2d-8cb2-2baa15ca5f85">29.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTQtMy0xLTEtMA_91e4b503-5602-4616-ab54-f917d3c324f1">20.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension and other postretirement benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMS0xLTEtNzg5NQ_3d92312a-336e-4d91-89b0-b1d75fe10112">4.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMy0xLTEtNzg5NQ_5fd611f1-9c6f-4432-96f2-33b38ec902e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other noncurrent assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTUtMS0xLTEtMA_95e111e3-fa85-4fb3-8e84-968dae00a8e1">24.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTUtMy0xLTEtMA_4ba9e4f7-497c-42e3-9db5-bfc3fbd64f9c">20.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMS0xLTEtMA_d39dd829-b533-4111-8b47-8dcb007ca476">2,341.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMy0xLTEtMA_28e67e73-e285-48c6-9e07-6cafa73d2cec">1,978.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">LIABILITIES AND EQUITY</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notes payable and other current debt</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjAtMS0xLTEtMA_0793cdfe-08f2-42f5-a925-1251071f6f57">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="wst:NotesPayableAndOtherDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjAtMy0xLTEtMA_84ec082c-79c6-4d52-908a-deb965e56e11">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjEtMS0xLTEtMA_d6882556-ed40-4d1c-bfd9-8ca1c8950a48">156.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjEtMy0xLTEtMA_caee27dc-cf9c-40b8-8a46-9757dc06fadd">130.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension and other postretirement benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjItMS0xLTEtMA_a712cea0-0275-499b-991b-b3f806f307b3">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjItMy0xLTEtMA_ab2958d8-342b-4ac2-9fd5-a0adcb8371bb">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued salaries, wages and benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjMtMS0xLTEtMA_36fd792f-9fc1-49d6-b70d-1f6acd8db21b">73.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="wst:AccruedSalariesWagesAndBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjMtMy0xLTEtMA_d9db981f-33d6-48e3-87a1-88b60d122090">64.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income taxes payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjQtMS0xLTEtMA_a6ad9517-69ef-45f1-8800-0f5537cf3e6b">6.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjQtMy0xLTEtMA_a4be8b74-7712-4a7b-89ca-d5046b2fa6ef">9.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMS0xLTEtMjI0Ng_551ad84c-52f2-4401-ae93-9d8d336c173f">9.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMy0xLTEtMjI0Ng_b762f923-19be-4e86-885d-1b2d77a66fc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjUtMS0xLTEtMA_9801dd14-5e2d-483d-a904-357c45c1c089">91.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjUtMy0xLTEtMA_43eaa3c5-e14e-4f61-b837-7a29380cc7b3">76.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMS0xLTEtMA_7aeccf2d-7335-43cb-a175-582362d24931">341.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMy0xLTEtMA_841f7c51-3517-44d3-8bd0-1d2bd227e451">283.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjctMS0xLTEtMA_01a6e307-a1e7-4e6a-bdc0-ebfc29c56ec2">255.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjctMy0xLTEtMA_79dad11e-dc8a-4bbc-baa5-4a94dad0b214">196.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income taxes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjgtMS0xLTEtMA_24e82301-cf57-48ad-b5da-41164cbb354c">15.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjgtMy0xLTEtMA_e041a2aa-85af-4a51-af00-0f95b6642c22">13.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension and other postretirement benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjktMS0xLTEtMA_1f6b297f-99ca-4afb-bdad-0c513dfd8103">52.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjktMy0xLTEtMA_32eee9af-6469-4d1b-923a-bc40a86ab8e2">56.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzItMS0xLTEtMjI1MQ_cf3b6288-b940-47c3-b0d8-7b5707fa4e63">62.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzItMy0xLTEtMjI1MQ_5c12ce9b-39bd-47dc-9d6d-a2d15885a344">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzAtMS0xLTEtMA_78495612-26c4-41c8-86d8-0f7d9bc5b592">41.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzAtMy0xLTEtMA_a1a962a1-e785-426a-9dbb-1ce37d8532d0">33.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzEtMS0xLTEtMA_3ae5f39b-7ea0-4f07-a28d-1ef6278b2b97">768.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzEtMy0xLTEtMA_12c54b61-a63d-42cc-a905-a7f280889232">582.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitments and contingencies (Note 18)</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzMtMS0xLTEtMA_aff6ea24-6dc4-40ca-b964-1e083851414d"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzMtMy0xLTEtMA_62e3d9c0-ce7d-4b52-9adb-0fdb86a82822"></ix:nonFraction></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:20.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;">Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding in 2019 and 2018</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzYtMS0xLTEtMA_8efdf3b9-b8ba-49dd-a889-c1126c86833d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzYtMy0xLTEtMA_ebc0cf84-d25e-4946-81a4-b103c91027cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock, par value $.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million in 2019 and 2018; shares outstanding: 74.1 million and 74.1 million in 2019 and 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzctMS0xLTEtMA_81b5a892-33cd-47f8-a9ab-79fbac1844c8">18.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzctMy0xLTEtMA_10ddf62b-decb-48e1-975f-f419b52d1ea1">18.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital in excess of par value</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzgtMS0xLTEtMA_3a51287a-8199-4d9e-bd5b-67cbe49e01f8">272.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzgtMy0xLTEtMA_7e943e57-cca3-4a3f-8da3-45a2100ecc90">282.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzktMS0xLTEtMA_e5426fc2-7e82-4343-bfff-a697b308ae85">1,549.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzktMy0xLTEtMA_622e0d5d-fca9-4099-a62a-33a9303a5a17">1,353.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDAtMS0xLTEtMA_36950e43-ccee-4493-8d92-317fed0df87d">149.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDAtMy0xLTEtMA_70577095-741b-4b67-9834-4cebdeb796e0">154.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury stock, at cost (1.2 million and 1.2 million shares in 2019 and 2018)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDEtMS0xLTEtMA_da5fa51f-af3a-43be-9fe2-9370474cc960">118.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDEtMy0xLTEtMA_7320bcdc-cd79-4449-8f44-f386820577ab">103.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Equity</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDItMS0xLTEtMA_02ea0a4c-4736-44a9-9c38-810380de4cb9">1,573.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDItMy0xLTEtMA_d9426690-c84d-440e-9117-7d4843ceb018">1,396.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Liabilities and Equity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDMtMS0xLTEtMA_a80b38a3-23ff-440d-a01e-76e717bcc2cf">2,341.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDMtMy0xLTEtMA_775d59ad-2908-4324-8f7d-288c50dc09dc">1,978.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:9.5pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div id="i_0_73"></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">40</span></div></div></div><hr style="page-break-after:always"/><div style="height:54pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENT OF EQUITY</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2019, 2018 and 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(in millions)</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.305%;"><tr><td style="width:1.0%;"></td><td style="width:30.634%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:4.876%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.382%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.876%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.382%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.459%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.382%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.808%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.382%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.526%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.382%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.876%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.382%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.053%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.382%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.818%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Shares Issued</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital in Excess of Par Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Treasury Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury Stock</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2016</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i93edb6fbbea140fbb4c158d60be85402_I20161231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xLTEtMS0w_1a87c10b-fd50-4ef2-aea6-07a87bde6430">73.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i93edb6fbbea140fbb4c158d60be85402_I20161231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0zLTEtMS0w_23361287-b571-4074-9c6c-45960f94506b">18.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac89a5ed6468416b954a6d59e93629c9_I20161231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS01LTEtMS0w_8267ac68-da90-48eb-b486-fa77630619a0">260.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib69c911484784ff7a59966d8a7af0ed0_I20161231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS03LTEtMS0w_fe4258b7-cddf-4e3f-bb69-d7a13442ebe2">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib69c911484784ff7a59966d8a7af0ed0_I20161231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS05LTEtMS0w_9a351a65-8c26-4bb4-918a-6a030d33489f">46.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5f31229f62de404da8827c5ece21e752_I20161231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xMS0xLTEtMA_aa893f95-43e6-44a1-bf5c-0a3dc3b779ad">1,071.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i18dd631cd0f04e0ba55e512d49411755_I20161231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xMy0xLTEtMA_64899fee-1973-4ed9-a5a1-81d214810099">186.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xNS0xLTEtMA_de8f0023-848b-4bfb-b5ee-005768e2430d">1,117.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of modified retrospective application of a new accounting standard</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i28ac7a64b1174ffdbf7756a30346e4c6_I20171231" decimals="-5" sign="-" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMi0xMS0xLTEtMA_fe5f05d1-9aaa-485f-8860-49b187c35bc4">4.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" sign="-" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMi0xNS0xLTEtMA_f0ae5603-b881-4f75-9f90-cefd81570427">4.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4575754faab44617861e28e31c5333e6_D20170101-20171231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMy0xMS0xLTEtMA_66b856c8-147d-4558-97cb-97c8f3517e37">150.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMy0xNS0xLTEtMA_91e0cdbb-c468-470f-9685-9289a67d8dfa">150.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Activity related to stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i22926bbe0d8140baae5202df1227e9e9_D20170101-20171231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC0xLTEtMS0w_cb4f04f3-896b-45cc-b6a8-77a1837a6899">1.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i22926bbe0d8140baae5202df1227e9e9_D20170101-20171231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC0zLTEtMS0w_b91e89f6-3466-44fc-890c-7145e29020b0">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia2bb2237e0bf456cbd5e22b740b8ee66_D20170101-20171231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC01LTEtMS0w_1a50057e-86e7-4960-93f1-18340569504a">44.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC03LTEtMS0w_0cca6c8c-35cb-4858-8522-566dee9e54b3">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC05LTEtMS0w_7832099d-3a7e-4e4d-b4f5-a50921185494">11.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC0xNS0xLTEtMA_d09a9a32-c1a0-477e-a07f-fce178ab667d">55.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares purchased under share repurchase program</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNS03LTEtMS0w_1d232ea7-2717-47f9-8d24-099f1cb29de3">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNS05LTEtMS0w_c95d9459-366b-4ee5-8db1-c9b8204fb4e9">74.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNS0xNS0xLTEtMA_1cd0c535-97c5-4b9e-97a7-3385f095e55f">74.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends declared ($0.54 per share)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4575754faab44617861e28e31c5333e6_D20170101-20171231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNy0xMS0xLTEtMA_163aed75-6eb6-4181-86b7-82bbcf91288a">40.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNy0xNS0xLTEtMA_1c5aca11-88c8-486c-ae31-27ea41230911">40.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other adjustments to capital in excess of par value</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia2bb2237e0bf456cbd5e22b740b8ee66_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOC01LTEtMS0w_b7f3161d-1a9b-43df-84e6-f8c43d0b2326">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOC0xNS0xLTEtMA_96594e83-9be0-4d1f-9a79-98bf16e4c997">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income, net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i112779a33c9549a2a1e6ad79daa2521c_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOS0xMy0xLTEtMA_598d4c63-98df-4833-b6ae-cb7b0d06127b">69.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOS0xNS0xLTEtMA_c17c96d8-718c-4539-ac52-fbf8b26fbf2d">69.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i6e529adeb51c4013a1e2867fc2c654a8_I20171231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMS0xLTEtMA_a7582dd3-70f6-4671-8f1f-64a6d2923de9">75.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e529adeb51c4013a1e2867fc2c654a8_I20171231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMy0xLTEtMA_ce0fe200-f9d6-4c8f-8ee6-73ed0b23aac2">18.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a9668a28ec340d18d524b415f8ae63c_I20171231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtNS0xLTEtMA_e31152f1-16c4-4ff6-b62a-70cb52514196">309.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if2a7c56a3d9349b585ddce443188576b_I20171231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtNy0xLTEtMA_c9304863-0ee6-436f-9755-9d66706bbff9">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if2a7c56a3d9349b585ddce443188576b_I20171231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtOS0xLTEtMA_7883cbc8-8f08-4d63-87f3-ff97fd592c60">109.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28ac7a64b1174ffdbf7756a30346e4c6_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMTEtMS0xLTA_b7ebbb2a-d657-42da-a0e7-db2d99e3a248">1,178.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iaabf64c6efeb4ff68ff50ae560a0e2a1_I20171231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMTMtMS0xLTA_f43e604f-f03b-436b-98c7-02b775a2b7a6">117.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMTUtMS0xLTA_b02fe1de-3ba0-48ce-b4d6-affc3fff498b">1,279.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of modified retrospective application of a new accounting standard (see Note 3)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2593d47d63744a01ad1ef0a31243b137_I20181231" decimals="-5" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTEtMTEtMS0xLTA_3305c04b-126e-40c3-9421-90112546dd9f">11.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTEtMTUtMS0xLTA_7aa70283-f2c4-43df-8e56-2a9b1d4d94a2">11.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie83aebbd70244c51b7c3c99d188dfa54_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTItMTEtMS0xLTA_2e2161b9-2c60-4b93-aaa0-1b39e415688e">206.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTItMTUtMS0xLTA_7ef9555e-bba7-4c1e-95b3-b8d6616cf6e3">206.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Activity related to stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i98bb331ce4d3451dbc548acf205baab6_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtMS0xLTEtMA_c03a5002-1a75-4c19-8c36-71639ebb87e3">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i98bb331ce4d3451dbc548acf205baab6_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtMy0xLTEtMA_895a60c7-6743-4c5c-b6d3-353e8cc6b8a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia2125fc186e24ff583ffd6d2cbfeeabf_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtNS0xLTEtMA_8dd196df-08ae-4f5e-b7f0-496deba110a4">27.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtNy0xLTEtMA_2b864f91-4699-4b11-8a1e-b6d38e971fc2">0.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtOS0xLTEtMA_c81b1253-5302-48cb-848e-4e86969330a6">76.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtMTUtMS0xLTA_e207b638-3e6e-431f-b771-50729812437b">48.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares purchased under share repurchase program</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTUtNy0xLTEtMA_4a0f7c2c-2d4a-4147-ad23-94e3c2f2e7f5">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTUtOS0xLTEtMA_3f83495f-f3f0-41f9-99b0-ef727f76943c">70.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTUtMTUtMS0xLTA_f4590c68-cc2a-46f5-8f99-6de853d4234b">70.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends declared ($0.58 per share)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie83aebbd70244c51b7c3c99d188dfa54_D20180101-20181231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTctMTEtMS0xLTA_0d31a3c3-bad1-4b32-86b6-99a3539bf808">43.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTctMTUtMS0xLTA_364bdfba-d7fd-4079-8a03-327c0e94fadf">43.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive loss, net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i34ea6f372d13421d9d8f0f909df6b05f_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTktMTMtMS0xLTA_0273f577-6111-493c-b3ec-ab4856ef19df">36.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTktMTUtMS0xLTA_86a4b9cf-96c6-4fcf-a373-ed2cfc10a00c">36.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9fd4b9307ef443f8b750812dd815616b_I20181231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMS0xLTEtMA_679c0a67-7ee2-4349-9e49-ec7cdb303275">75.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9fd4b9307ef443f8b750812dd815616b_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMy0xLTEtMA_13136dcb-7749-45e3-be8b-61e21806216f">18.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie1c0bfc76dab4660a6dee12ff3e6f75a_I20181231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtNS0xLTEtMA_04d34b1e-4fc2-4a98-ab1e-c02c8231a23b">282.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5dbdcdd33a9544e0b1ff9915c052d4b4_I20181231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtNy0xLTEtMA_bd6797a7-7e80-40da-b44e-6ec278bed95b">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5dbdcdd33a9544e0b1ff9915c052d4b4_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtOS0xLTEtMA_742612fd-9688-42c1-af81-f7185d76a9a3">103.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2593d47d63744a01ad1ef0a31243b137_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMTEtMS0xLTA_df69bfd0-95b5-40a0-a9c9-019dc4a68cb4">1,353.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic8619d0eee6a4571ae753f283f316223_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMTMtMS0xLTA_08086913-d3cf-4a26-af92-2f97153135eb">154.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMTUtMS0xLTA_e1c8f84b-8814-4240-b5ce-0fbb09caf810">1,396.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ife6de079702a446a909c0761fb4355a4_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjItMTEtMS0xLTA_67db4e41-6260-4cd3-b894-5f946b816287">241.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjItMTUtMS0xLTA_9c84f994-38dd-40d4-9c9f-a78af8f335d2">241.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Activity related to stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id147ab88ff2d492590eb6168cdcfbc21_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtMy0xLTEtMA_39e97c82-c162-4f30-bccc-cddb57b78601">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib1cf95202daf4d82a61721c34a7388af_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtNS0xLTEtMA_b6897663-82d9-489d-85d1-7a0a718921d2">11.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtNy0xLTEtMA_af743212-bbba-44a3-ac6e-778ed0180c3b">0.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtOS0xLTEtMA_77fb5aec-b0ba-4143-92de-db1f02fdd04c">65.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtMTUtMS0xLTA_42f03a10-fe24-4938-a86f-049ab3fc404b">54.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares purchased under share repurchase program</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjUtNy0xLTEtMA_1705fa64-7285-42cd-8503-60d7cfbb3e82">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjUtOS0xLTEtMA_ab9ca0bc-3986-408e-83ac-fc10e4306236">83.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjUtMTUtMS0xLTA_4af88bef-201b-4c8f-ba24-811914402287">83.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of investment in affiliated companies</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="id147ab88ff2d492590eb6168cdcfbc21_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtMS0xLTEtMA_3800910e-fd1f-4c53-af7f-548e44c91ea1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1cf95202daf4d82a61721c34a7388af_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtNS0xLTEtMA_19eed388-3713-4360-8e07-f9301e59e9dd">1.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtOS0xLTEtMA_e51fcf61-455f-43af-8bde-bb1245be675d">3.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtMTUtMS0xLTA_18791fc6-8f81-4cad-aa11-7b8e032d5792">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends declared ($0.62 per share)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ife6de079702a446a909c0761fb4355a4_D20190101-20191231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjctMTEtMS0xLTA_0e83bbed-c306-471c-ae0d-10a521eb01ca">45.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjctMTUtMS0xLTA_5c160eda-d62d-40fc-9f75-4bb12936155d">45.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income, net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a596f80b14841c4a875b755bfc6bdd8_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjktMTMtMS0xLTA_274d1948-4654-4c8c-a5c0-a6f5037536f6">4.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjktMTUtMS0xLTA_5104d2ad-e22a-453d-845d-d4077e59de60">4.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i29ada30e40a84d7f9ccb23e70b3c3f64_I20191231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMS0xLTEtMA_1368f481-4648-41b0-9307-c222b7b8c2df">75.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i29ada30e40a84d7f9ccb23e70b3c3f64_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMy0xLTEtMA_12bfc45b-7848-43ff-bb0d-664ceb25c79a">18.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i449c08ea3f444ab2a681565eeb8cd351_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtNS0xLTEtMA_c35382fc-da72-49c2-8ef5-42c0cf642271">272.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5e2483f32b14044bd9f5d96ac49cac9_I20191231" decimals="-5" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtNy0xLTEtMA_9cc92d62-a135-44fa-969c-eb813ed1e975">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5e2483f32b14044bd9f5d96ac49cac9_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtOS0xLTEtMA_ab10e23e-118b-4f0b-814a-e2d014af8864">118.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5e7523417a4c4eb7954baff026cc2dc7_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMTEtMS0xLTA_b092a5fc-3a25-43c6-a2e3-d9d18ee873e3">1,549.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia6dc1473063042a993f976b7cad5d115_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMTMtMS0xLTA_b13065ba-c859-4598-8e1d-4124f5cc41ed">149.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMTUtMS0xLTA_b2fd4168-a55c-440f-b08a-36a12153720c">1,573.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div id="i_0_76"></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">41</span></div></div></div><hr style="page-break-after:always"/><div style="height:58.5pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">West Pharmaceutical Services, Inc. and Subsidiaries for the years ended December&#160;31, 2019, 2018 and 2017</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(in millions)</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:63.489%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.914%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.914%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.079%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from operating activities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMi0xLTEtMS0w_3c895fea-4ca7-4215-901c-8ffa096ff676">241.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMi0zLTEtMS0w_de18469c-0ffa-4e55-bb38-6e36c1d56350">206.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMi01LTEtMS0w_23392cd3-ce3a-46f3-b000-d56c12e2b016">150.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-4.5pt;padding-left:15.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Adjustments to reconcile net income to net cash provided by operating activities:</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNC0xLTEtMS0w_dc719e13-9846-4259-9771-ee0eacec7646">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNC0zLTEtMS0w_53d212de-440e-44e1-8971-cf4cb2fd65b2">101.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNC01LTEtMS0w_b4e74a73-ffa0-4347-8307-ff4e45c3f483">94.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNS0xLTEtMS0w_da9bb333-fcc9-4b10-96cb-71b089b42e78">3.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNS0zLTEtMS0w_a597816c-b147-4987-8a03-c9b06b2fc41a">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNS01LTEtMS0w_f96dd2f7-430d-430e-84f6-41fbe80aeca5">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNi0xLTEtMS0w_f4aabac2-6ad6-41de-8269-f284a3461e83">24.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNi0zLTEtMS0w_94ed56ba-b87c-4810-a173-5807e3f0d11d">15.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNi01LTEtMS0w_be02d5e3-978e-429c-b9bd-4d4e9dc10bfc">16.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash restructuring charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNy0xLTEtMS0w_64f5eae6-b735-4208-ac0e-ad943b3dcddb">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNy0zLTEtMS0w_ed07f056-af1e-44bb-8a8e-b2b744fea65b">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNy01LTEtMS0w_c2880dab-bb0c-4951-9db4-6e54ffcf3427">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension settlement charge</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOC0xLTEtMS0w_13fa0d68-8eda-401d-acb8-f0ba13704e8f">3.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOC0zLTEtMS0w_50efae7d-0454-4160-bb5a-3f15859d75b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOC01LTEtMS0w_e7e3b0dc-7d28-46f8-9956-ce3e5c069122">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela deconsolidation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOS0xLTEtMS0w_8ce006c6-89bd-4c4e-aab4-eb9c40de00ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOS0zLTEtMS0w_ab1785d9-c9f8-43d3-8586-9222d92816c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOS01LTEtMS0w_02936386-3a2e-45c3-a23f-eb5984a93c90">11.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration payments in excess of acquisition-date liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTAtMS0xLTEtMA_f2c1b1cd-3dc6-42fc-8965-3320bf4cf435">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTAtMy0xLTEtMA_89dc2c33-0b77-4512-a796-02e2937327f2">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTAtNS0xLTEtMA_056261b3-2d35-441b-b4ec-f8b12ad8a43c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss on sales of equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTEtMS0xLTEtMA_f9450ede-ba91-4927-942a-588ee1fbb7db">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTEtMy0xLTEtMA_7b79a4b8-86f2-4415-b2d9-3e4b5770f6fb">1.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTEtNS0xLTEtMA_fd5323b4-debe-40ff-8329-81a0400bb543">1.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income taxes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTItMS0xLTEtMA_2cfc91b9-4131-44d7-849b-9835d7957751">15.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTItMy0xLTEtMA_746db006-420c-48c9-9850-29f039ee9ad0">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTItNS0xLTEtMA_6d7895ea-ae62-40ea-b530-50c6fecbdab4">41.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension and other retirement plans, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="wst:PensionandOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTMtMS0xLTEtMA_7baf46d8-7446-4afa-95cd-1504992ca063">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="wst:PensionandOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTMtMy0xLTEtMA_e3a2c787-08aa-4dc5-8484-8958e0acb160">7.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="wst:PensionandOtherPostretirementBenefitExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTMtNS0xLTEtMA_2a7a8619-ed37-46f9-ac38-2448e220228e">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity in undistributed earnings of affiliates, net of dividends</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTQtMS0xLTEtMA_6efd92d0-1ad6-4d19-859b-c6a42b9085ff">6.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTQtMy0xLTEtMA_e9fe3215-cd1c-41de-9591-d1dd66e722bf">5.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTQtNS0xLTEtMA_27610b37-adb9-491d-8a94-f0f42d9027b8">7.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in accounts receivable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTYtMS0xLTEtMA_671851ca-4a9a-4b07-b36d-073516afe52a">33.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTYtMy0xLTEtMA_25e3a836-50e6-4464-9bb1-e33961a30148">43.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTYtNS0xLTEtMA_61e7b5ad-e183-44dc-b335-212cc5a685e8">39.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in inventories</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTctMS0xLTEtMA_74382795-a48c-430c-84fc-d050a3f78e98">18.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTctMy0xLTEtMA_96ee05a0-a0bb-43d1-bdd1-eb07276bbb74">7.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTctNS0xLTEtMA_76049bcc-7325-468b-a3b4-831079afcb74">3.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease (increase) in other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTgtMS0xLTEtMA_b47769de-b07b-4639-90e8-8f781234ba4e">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTgtMy0xLTEtMA_360c817b-38e2-41b0-a9ae-e8e28c79b6f2">6.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTgtNS0xLTEtMA_4535c323-8e7c-47de-baa4-f937ca7c22a0">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in accounts payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTktMS0xLTEtMA_89a35c39-7287-4454-9a09-e61039302118">25.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTktMy0xLTEtMA_361571eb-19e0-439a-a0cd-4f8ac5d8193c">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTktNS0xLTEtMA_23dfc7f8-be8d-4728-b590-24fafa4c8b6f">12.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:29.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes in other assets and liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjAtMS0xLTEtMA_6f3da0c3-3c2a-4faf-aa01-65585b37cf98">9.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjAtMy0xLTEtMA_d8ffe0f9-54d0-4208-82f8-044b795c9359">28.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjAtNS0xLTEtMA_dd6b696c-f952-4005-b296-2f9c4873f0fa">11.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by operating activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjEtMS0xLTEtMA_47f2551f-1255-444b-8778-a5bf53b75566">367.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjEtMy0xLTEtMA_3eb93533-3498-4cd7-a59c-7baafa33d9d5">288.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjEtNS0xLTEtMA_edbb6aa8-b5b5-4f10-a850-9032fa7cc507">263.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from investing activities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjMtMS0xLTEtMA_21747297-ef78-456d-8bf6-b2cb29525aba">126.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjMtMy0xLTEtMA_0fb2d122-f62d-488d-b4f7-4854bbdfe679">104.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjMtNS0xLTEtMA_f103c8c1-8585-4ec1-a9da-ba70ca2ac9c5">130.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of investment in affiliated companies</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjQtMS0xLTEtMA_918405f7-6c44-4036-9b6b-6db839c98f03">85.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjQtMy0xLTEtMA_24c90445-dfa8-47e9-ae4c-9e94392b11e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjQtNS0xLTEtMA_7c14adb3-2640-4778-a80e-c121f3772922">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition of business</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjUtMS0xLTEtMA_2eeb67f4-c1fe-4957-849a-3525ddd43eab">18.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjUtMy0xLTEtMA_c91a340d-17c4-40f3-a1ea-0f92627bbb1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjUtNS0xLTEtMA_b41231d1-3033-48f5-b6f9-09999abb877f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash related to deconsolidated Venezuelan subsidiary</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:CashDivestedFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjgtMS0xLTEtMA_e5cb68bf-26b2-42c9-b736-25bac975dcbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:CashDivestedFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjgtMy0xLTEtMA_ac3780d7-5793-49bc-8ef4-55644d4dfa6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:CashDivestedFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjgtNS0xLTEtMA_d20b6725-0a8d-49a7-b4a0-c3beddbf4c53">6.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjktMS0xLTEtMA_0e3780ef-9cda-4f17-be79-a1fd68c9bf22">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjktMy0xLTEtMA_47db92d7-1f6f-4e26-bbd8-52b8ca8be44e">3.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjktNS0xLTEtMA_028d2369-89af-4481-8bec-091ace22de2b">3.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzAtMS0xLTEtMA_d1e7bcb3-336b-4f8d-b9a7-3eaf4ee05461">228.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzAtMy0xLTEtMA_cf85351f-7df3-4a25-9b9b-db4bbdf0e083">100.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzAtNS0xLTEtMA_462f9331-df73-4abd-b37f-4f7400a9e953">133.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash flows from financing activities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Borrowings under revolving credit agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzItMS0xLTEtMA_1fa19243-9764-451f-af6c-53c47d609ccf">108.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzItMy0xLTEtMA_1edd0966-8ffd-4fc7-aeef-62b40ddc9200">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzItNS0xLTEtMA_1e902061-75de-4a88-b75d-283f4402ab2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repayments under revolving credit agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzMtMS0xLTEtMA_5dbb36ad-5152-4dd4-9677-a7aef424ab88">136.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzMtMy0xLTEtMA_c74d3e5f-117d-4136-b922-1aa99420e359">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzMtNS0xLTEtMA_1cb39708-c02a-479a-acd2-81918ad4bd92">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMS0xLTEtNjI0Ng_8d36be0c-9135-43db-bd6b-6e0be01998c6">90.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMy0xLTEtNjI0Ng_de1dfb95-3775-472b-beb0-ab06910505e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtNS0xLTEtNjI0Ng_418e7f99-d5cb-4586-b1cb-f01c1cab0a75">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repayments of long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMS0xLTEtMA_d9dec62e-e36e-4e59-a8fd-148f12d460ee">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMy0xLTEtMA_fb648155-fb24-4435-88ae-641dbfa60764">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtNS0xLTEtMA_b59fd916-5904-4da7-96e5-a7df6c61f1a4">34.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt issuance costs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzUtMS0xLTEtMA_01570fa0-8603-477e-a329-9920800a9142">1.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzUtMy0xLTEtMA_b9d7e481-e100-41d5-abbe-b977dbdd5b9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzUtNS0xLTEtMA_609cee66-46f9-499b-9bd1-fe7b3242fdd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividend payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzYtMS0xLTEtMA_911538df-d101-488b-878e-9c7f3973735c">45.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzYtMy0xLTEtMA_0d616981-f23d-4058-8caa-81ed8d39f8f1">42.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzYtNS0xLTEtMA_edb7e16a-478d-4242-a37e-bf00b72a85ba">39.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration payments up to amount of acquisition-date liability</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzctMS0xLTEtMA_5a695b21-0ecb-4e6d-8ca2-3276539b9df0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzctMy0xLTEtMA_afc1db44-6105-43d1-988d-ff1c51ae87cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzctNS0xLTEtMA_bdf29df8-17fd-4525-9423-9c813cb1b9af">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from stock-based compensation awards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzgtMS0xLTEtMA_bf489a5e-a42a-4ea6-9d66-3d712667a188">25.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzgtMy0xLTEtMA_641c530c-5506-4d3a-881e-e587d7f4d9c8">27.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzgtNS0xLTEtMA_6cfea85a-7396-4a9c-9d56-672450923d1f">35.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee stock purchase plan contributions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzktMS0xLTEtMA_5db5ffb8-da87-4dfe-966d-e0a16d2d3dba">5.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzktMy0xLTEtMA_341d286b-0e09-4810-bd18-86ad5ed808da">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ProceedsFromOtherEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzktNS0xLTEtMA_a663d8b2-ca04-410e-8529-a5a5503d595d">4.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares purchased under share repurchase programs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDItMS0xLTEtMA_b5f68074-2010-4a54-975f-6de5cbac81b4">83.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDItMy0xLTEtMA_889b2dc5-fd1b-4bdd-af54-6ae8419ff681">70.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDItNS0xLTEtMA_d0210e3e-8cfd-4ba7-9a3f-d57fd67a535f">74.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in financing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDMtMS0xLTEtMA_2b7eed5a-96da-4d18-9ade-4cd1753436da">36.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDMtMy0xLTEtMA_ff52e281-8149-4c37-846c-323afd5654f3">80.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDMtNS0xLTEtMA_9902d580-0424-4eba-930a-5c6b89a11f1b">109.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of exchange rates on cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDQtMS0xLTEtMA_0c418228-dd2a-4331-8db6-b099e0559852">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDQtMy0xLTEtMA_31044a96-94ab-4059-8add-66623c382ce9">5.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDQtNS0xLTEtMA_5884f02d-56bc-46e8-8c0a-41e621800fa1">12.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net increase in cash and cash equivalents</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDUtMS0xLTEtMA_217a4f28-6a8f-4574-91bf-4296c0500481">101.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDUtMy0xLTEtMA_98f199e5-f623-4721-a7b4-f06a396e6b6e">101.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDUtNS0xLTEtMA_6826c9f6-a870-4aeb-92a1-95f168046b5a">32.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash, including cash equivalents at beginning of period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDYtMS0xLTEtMA_12b9edd9-4095-4b43-8b6e-d23920e8a663">337.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDYtMy0xLTEtMA_2e5fdf43-8005-44fd-9f5a-1c99ecdc6d12">235.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDYtNS0xLTEtMA_8143aa0e-deb0-4fb1-a3e6-35715490f534">203.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash, including cash equivalents at end of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDctMS0xLTEtMA_bb2f6a77-14d9-41dd-bd35-a75a6e19c2f0">439.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDctMy0xLTEtMA_13144556-227d-4262-9623-c0e9d61bd86f">337.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDctNS0xLTEtMA_078f4720-9e77-4a03-8873-2e2ca53e151d">235.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest paid, net of amounts capitalized</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTAtMS0xLTEtMA_abc00c51-d709-4d3b-a06b-ce98cf72833a">8.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTAtMy0xLTEtMA_d309114c-544b-498f-b856-29ab3ad0a237">8.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTAtNS0xLTEtMA_d6e2340d-0dd9-47ff-8c70-b2044a9e24df">8.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income taxes paid, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTEtMS0xLTEtMA_3ded77e8-84ae-44e5-babb-6c5345dd4ee7">47.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTEtMy0xLTEtMA_8aab1205-1e1c-4bbc-b80b-8cb60f53f100">42.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTEtNS0xLTEtMA_d68649d7-5b9c-4ca5-96cf-0bac2e79a568">31.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued capital expenditures</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTItMS0xLTEtMA_346a3f00-d06c-4e5e-8152-10f2f9a514fa">17.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTItMy0xLTEtMA_e534e869-15b0-4556-b865-532b9efd1e16">15.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTItNS0xLTEtMA_500d0fe8-5734-48ab-a795-1e049a9e0e7b">20.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends declared, not paid</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMS0xLTEtMA_a6998059-86fe-471e-8d0e-a0b584b0a6df">11.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMy0xLTEtMA_e74256c6-f6ce-43af-aad9-83273d4e5d6a">11.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtNS0xLTEtMA_6cce7a5d-6161-4ff3-979c-0d0bc5148483">10.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase of investment in affiliated companies, treasury stock</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMS0xLTEtODQ4MQ_0cc9a64e-4e45-4763-bacf-22c3e7094151">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMy0xLTEtODQ4MQ_d12ab61e-610b-4a54-967b-7275c7ad1970">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtNS0xLTEtODQ4MQ_64875146-ebae-440e-9d91-c8e35f9595ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div id="i_0_79"></div><div style="position:relative;width:100%;height:58.5pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">42</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i_0_82"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 1:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzODU_3cb4856b-482b-472c-975b-d9ffc8f17f85" continuedAt="i0bbd0d76600b443d91cd78388c69b0e7" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0bbd0d76600b443d91cd78388c69b0e7" continuedAt="i970db0435e01493da7a31887957724e2"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0MDU_ade5f825-a3a4-4365-8647-11c44def6d3e" continuedAt="i8db8179cd8b548749476b349c64605c3" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Principles of Consolidation:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we acquired the business of our distributor in South Korea for $<ix:nonFraction unitRef="usd" contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjE3MA_632d6723-8d20-41b1-b692-ebd849879a11">18.9</ix:nonFraction>&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $<ix:nonFraction unitRef="usd" contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjE4NQ_ff106e9d-82b7-4be9-adaf-9d7878e00207">4.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjE5OQ_93b74281-7700-40a8-bfdc-ed9294f003d9">0.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjIxMw_81b8ff2c-b7c9-43cd-93d7-ddd986d5f2e2">2.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjIyNw_b57e5918-a197-4112-92d3-f05e61470d81">11.2</ix:nonFraction>&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:continuation id="i8db8179cd8b548749476b349c64605c3" continuedAt="i729b6a2130fb4c749ca97b7e0816fa79"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 16, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense</span></ix:continuation><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i729b6a2130fb4c749ca97b7e0816fa79">, for further discussion.</ix:continuation> </span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNDg_81764d37-5909-483b-a80c-b5dc4bb25d09" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0OTI_958dc590-ab54-444f-8b73-ef2af6bdb066" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash and Cash Equivalents:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with maturities of three months or less at the time of purchase.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NzQ_52fb9378-c759-4a95-8be1-83aa6d4d47fd" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our accounts receivable balance was net of an allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTExMA_e8946901-a823-4eab-8aef-5270d5666303">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTExNw_10fcb8ed-1421-466a-a783-c8f5fb94142a">2.0</ix:nonFraction> million at December&#160;31, 2019 and 2018, respectively. We record the allowance based on a specific identification methodology.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzOTI_e0f2e7fe-2e7d-4d87-96df-8f36ff0aa6ef" continuedAt="i5c64e59589e54e0689da5df69f49a027" escape="true">Inventories:</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i5c64e59589e54e0689da5df69f49a027"> Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value.</ix:continuation> <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NjA_91a564ad-fa08-4e35-99ce-4c222e56a033" continuedAt="iacbec4044df64ba0984b070bbbabee7e" escape="true">The following is a summary of inventories at December 31:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><ix:continuation id="iacbec4044df64ba0984b070bbbabee7e"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"><tr><td style="width:1.0%;"></td><td style="width:67.404%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.975%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.605%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.816%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMS0xLTEtMS0w_0204e91f-67a3-4ab2-bfea-9ab3e02b811a">100.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMS0zLTEtMS0w_30ddb22f-a6cc-4c14-8801-784615332c76">90.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work in process</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMi0xLTEtMS0w_37303f0f-cd0a-4740-b477-f46fd745b9ea">37.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMi0zLTEtMS0w_8e1b9607-59d6-47e0-8e18-db25cf2e6da1">42.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMy0xLTEtMS0w_51e12e50-b765-4956-a7cb-ea8f4bf57710">97.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMy0zLTEtMS0w_22908ae9-8709-4fb6-8894-20137fa398cf">81.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfNC0xLTEtMS0w_7273bcac-2aa6-471a-a9e4-77043f2a161b">235.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfNC0zLTEtMS0w_64f824ce-7379-4f89-b0ef-7420eef00a28">214.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTA5OTUxMTY1MDEyNg_d35da491-6b99-470d-b5b4-117ba72d6f3d" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property, Plant and Equipment</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other (income) expense. Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTA5OTUxMTY1MDEyNw_cd052648-f6f8-4686-86dc-4060aa4692c6" continuedAt="i96920ee78fa743cd86553e6417ef782f" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured </span></ix:nonNumeric></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">43</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i970db0435e01493da7a31887957724e2" continuedAt="i1d63c67e8ab24fa5a1c0b2f4457430aa"><div><ix:continuation id="i96920ee78fa743cd86553e6417ef782f"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2019. Please refer to Note 6, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Leases</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information.</span></ix:continuation></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNjc_d5115c8b-4a2e-4264-aeb2-3d00e7d4e8b8" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Long-Lived Assets</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other (income) expense for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTA5OTUxMTY1MDEyOA_7924a8e1-fdc7-4b6b-a3a2-e6c3a7162fa4" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Goodwill and Other Intangible Assets:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our 2017, 2018, and 2019 annual impairment tests. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment tests in 2017, 2018, and 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of <ix:nonNumeric contextRef="i8d77cb69d6a14565b31edce03b6c02c8_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfNTYzMQ_5747060e-7b97-4c4b-96ea-2be8d3bb6810">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i8ae050fec07a41a1ad0d8ace81bbadbd_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfNTYzNw_0ca7b1f0-9d0c-424e-872b-489c896b6215">25</ix:nonNumeric> years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNzQ_be29edd5-c322-4ddb-95a2-876483f666e3" continuedAt="i639b9c8cd8484dbdb9e75a6928ba51b4" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Employee Benefits:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span></ix:nonNumeric><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i639b9c8cd8484dbdb9e75a6928ba51b4">, for a more detailed discussion of our pension and other retirement plans.</ix:continuation> </span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NDY_f0e2267a-4661-467e-8a0c-facf3144dee9" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span></ix:nonNumeric></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">44</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i1d63c67e8ab24fa5a1c0b2f4457430aa" continuedAt="i55c4abe38e954fae8b1843b4d417a5e6"><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NDc_108f6960-ee27-47fb-a085-0b59ada0f048" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency Translation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NTM_f48fa3ed-4763-404a-8cbf-76759a8ceed1" continuedAt="i8dca979035854ffda36fb5ff76d95558" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience. Please refer to Note 3, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue</span></ix:nonNumeric><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i8dca979035854ffda36fb5ff76d95558">, for additional information.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNjQ_f618950f-8048-4f08-ba50-05be36e38fbb" continuedAt="i7428840e119c4d6288f0c5a29eec9920" escape="true">Shipping and Handling Costs</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i7428840e119c4d6288f0c5a29eec9920">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzOTc_8196e56c-cafb-4ea3-bb45-c476e0e23c65" continuedAt="i6ccadadb76034db3949232ce86f9e212" escape="true">Research and Development</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i6ccadadb76034db3949232ce86f9e212">: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are expensed as incurred.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:EnvironmentalCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0MTc_bed3d50a-a8b1-4ed1-bf2f-156fd3931f0d" continuedAt="i6305dfbbe5c94f4bb251c1846034f630" escape="true">Environmental Remediation and Compliance Costs</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i6305dfbbe5c94f4bb251c1846034f630">: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.</ix:continuation>  </span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0ODQ_c245bd81-f394-4b92-a509-6ddccd7c3197" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzODg_fa3139fa-ace3-4666-a7e2-6041a904ffc9" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other (income) expense. The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNjU_f0409d84-ddb5-4907-97ed-60bb5cefbb62" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for a more detailed discussion of our stock-based compensation plans.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">45</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><ix:continuation id="i55c4abe38e954fae8b1843b4d417a5e6"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzODk_bc47c7c4-1094-4cb0-9bfe-e435772a8ac3" escape="true"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Income Per Share</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span></ix:nonNumeric></ix:continuation></div><div><span><br/></span></div><div id="i_0_85"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 2:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184NS9mcmFnOmJkN2RiMDAzOTNjMDQ3ZTRhZTQyOTU1NDFjMzc0MGY0L3RleHRyZWdpb246YmQ3ZGIwMDM5M2MwNDdlNGFlNDI5NTU0MWMzNzQwZjRfMTY0OTI2NzQ2MzY0Mg_b6433339-e416-44f5-81f7-2fe2f9246769" continuedAt="i63833a346d1f4a2f8b7b1150349317ce" escape="true">New Accounting Standards</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i63833a346d1f4a2f8b7b1150349317ce" continuedAt="ief3316d8e3034777867dea9863f95488"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Standards</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, the FASB issued guidance which clarifies or improves a variety of ASC disclosure and presentation requirements by aligning them with the SEC&#8217;s regulations, thereby eliminating redundancies and making the codification easier to apply. This guidance was effective upon issuance. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, the FASB issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, the FASB issued guidance to address a specific consequence of the&#160;2017 Tax Act by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act&#8217;s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act&#8217;s reduction of the U.S. federal corporate income tax rate.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued guidance on the accounting for leases, ASC 842. This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Leases</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 (&#8220;ASC 740&#8221;) and by clarifying and amending existing ASC 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">46</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ief3316d8e3034777867dea9863f95488"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under current guidance, an entity reflects credit losses on financial assets measured on an amortized cost basis only when it is probable that losses have been incurred, generally considering only past events and current conditions in determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements, primarily as we have not historically had a material amount of accounts receivable write-offs.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_91"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 3:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODg4Mw_15ae0aa0-3d1b-4045-aae4-fe2ab73f2412" continuedAt="i266fe654e71c4566bb73e64692db712d" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i266fe654e71c4566bb73e64692db712d" continuedAt="ib03e7fdfbd4d4e45a44fb2319158b36a"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adoption of ASC 606</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2018, we adopted ASC 606, on a modified retrospective basis, applied to those contracts which were not completed as of January 1, 2018. As a result of our adoption, we recorded a cumulative-effect adjustment of $<ix:nonFraction unitRef="usd" contextRef="i233817b047df4ab4a84d4b14575f9f25_I20180101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfMzg0ODI5MDcxMzEzOQ_e59ac37d-4ebe-4356-b3b6-f2929a708ae1">11.4</ix:nonFraction>&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2018, to reflect a change in the timing of revenue recognition under ASC 606, from point in time to over time, on our Contract-Manufactured Products product sales, certain Proprietary Products product sales, development and tooling agreements, as well as an acceleration on a portion of the remaining unearned income from a nonrefundable customer payment.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards in effect for those periods.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">47</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ib03e7fdfbd4d4e45a44fb2319158b36a" continuedAt="i614a4c87a5694974abbfca52fa5dd8f7"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $<ix:nonFraction unitRef="usd" contextRef="i2a2868b8c8554bf08566aa6693065131_I20130630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfMzg4MQ_f73b269c-6e13-4205-a3c5-9f95507a210f">20.0</ix:nonFraction> million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. As of December&#160;31, 2019, there was $<ix:nonFraction unitRef="usd" contextRef="i206cd48a54414476aa718a6e0111302f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDAzMQ_d4a87874-b352-4270-9392-4875f1eeaee7">5.6</ix:nonFraction> million of unearned income related to this payment, of which $<ix:nonFraction unitRef="usd" contextRef="i206cd48a54414476aa718a6e0111302f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDA4Nw_728fc4da-795c-4f3b-878d-77c21d0dd59e">0.9</ix:nonFraction> million was included in other current liabilities and $<ix:nonFraction unitRef="usd" contextRef="i206cd48a54414476aa718a6e0111302f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDEzNg_b52f1bbb-21ec-435d-a952-4843e7b77801">4.7</ix:nonFraction> million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODg3OQ_026c91af-fae7-451a-a2ac-2a6f874293a2" continuedAt="i17c2fc312c48429799c616ad4de53fff" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by market group:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:67.292%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.951%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.954%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Biologics</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib3cfed53a74b468cb29ff189c2377269_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMS0xLTEtMS0w_24957fc3-808c-4d7b-b574-45bec3ba48ae">25</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i94338860cdfc4c5c8a8a280138f4eec0_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMS0zLTEtMS0w_4a705cec-e123-4c64-afa2-a827cc35b489">21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Generics</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i17b4a6ef0fda43fc8f9f9d4f83f071a9_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMi0xLTEtMS0w_fcf86948-d5c7-4b6b-a4ac-4fdbf339916b">20</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9deaff27fd544743b1c994ebf17f9064_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMi0zLTEtMS0w_8d63c7ce-44fe-4deb-b180-40a8053e7557">21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if213b8734da249fd94de624effacc125_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMy0xLTEtMS0w_39f947d5-c65a-499f-96c9-d21603dd5ee7">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4fea264d5e3a41b6b564f9b5e494a691_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMy0zLTEtMS0w_5422de09-0d2f-4812-aa72-d6be314a444b">34</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3f203ca7692647f9ad837576643bf7b8_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNC0xLTEtMS0w_043180f0-ff81-431a-9d2a-f97f0b57bdd5">24</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ibeb2cefdf0cf432eb6f5b7d915d85fc5_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNC0zLTEtMS0w_dcce5b59-1472-4a32-9536-70449b215734">24</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNS0xLTEtMS0w_2d1eab4f-6767-4f98-8ac9-efabd920b324">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNS0zLTEtMS0w_dc17d7dc-6540-4e44-859a-c99e8c7f57d7">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">48</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i614a4c87a5694974abbfca52fa5dd8f7" continuedAt="i54a8db670776413ebee1daa3bea74cf0"><ix:continuation id="i17c2fc312c48429799c616ad4de53fff"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by product category: </span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:67.292%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.951%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.954%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High-Value Components</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if87ccca3baba4a5395c1b9dc357f28b1_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMS0xLTEtMS0w_b73aeb75-8b39-4d87-a2af-974ee9ccba85">42</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9c242a3de0ae43649e6e851b01494740_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMS0zLTEtMS0w_685aa894-7cb9-4a88-a76a-c04adf6f012d">41</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Standard Packaging</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i18bdeec0a55048dda5a14c6fef41b7a5_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMi0xLTEtMS0w_6689cca9-c936-4d72-bdd9-cec598e2d38b">29</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9dfa01f2e8de483cb3ee9d49bc79dc3e_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMi0zLTEtMS0w_98ed6413-3f02-4c26-a067-d6fb3f9c2af6">32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delivery Devices</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iac8f1d1fb3f74df2a85e394a8eb7560e_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMy0xLTEtMS0w_93c84056-4510-4926-b617-503b7f2752c8">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i282d10e015594727b9481e65e9dc6cc3_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMy0zLTEtMS0w_a45c5198-6653-4e10-933b-a4c681fd40b2">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id8848d2f515c4077b4f7260b808d43f9_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNC0xLTEtMS0w_087e73c6-7e61-4110-b2d9-6d33b1f340cd">24</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8472c3bc9a9d4f95b15a5c727249f384_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNC0zLTEtMS0w_167f3d7a-ea4e-4438-9d4f-adb36c6c4993">24</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNS0xLTEtMS0w_453d8c8d-2140-4067-9e7e-91405a38f668">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNS0zLTEtMS0w_e0dd4c87-8f20-4410-b0ff-4f6dd9d7b788">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:67.292%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.951%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.954%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Americas</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id71e4d3f80ab475b8388901e312bddb1_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMS0xLTEtMS0w_38729dd2-02a8-4d0b-bd71-e18c90870c1f">48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icc5498ad1a414e15bf91e6c05c11a237_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMS0zLTEtMS0w_12cf6364-0c47-4b70-aec4-93d17a29073f">48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe, Middle East, Africa</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8c247c9265104fd983758887d598a274_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMi0xLTEtMS0w_11f15b35-2241-4285-b9fe-89d04b111e4a">44</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i14a6633405de48c18ad9dd4624d66563_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMi0zLTEtMS0w_106c12ea-c133-4e12-9a55-5f18b4b2e78d">44</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia Pacific</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ifbec786ebf7d48a3b104bb1d4b9fcd56_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMy0xLTEtMS0w_076c163d-f405-45be-bcef-4f2c5eab6c99">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie1d3206f6ead449095a75f97c9ea7d4a_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMy0zLTEtMS0w_6a809022-e69f-4c74-8d76-b5b66c73e2cb">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfNC0xLTEtMS0w_ce83afdc-4cdb-4c28-8848-12e6448e811d">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfNC0zLTEtMS0w_476b62cd-ec90-433c-aa12-fab2b96a2712">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract Assets and Liabilities</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contract assets and liabilities result from transactions with revenue recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet in other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODg4MQ_cd38ba6d-396b-46e7-ad92-a9f7cbe0f012" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:83.048%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.952%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract assets, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfMS0xLTEtMS0w_29379038-65d3-47a7-b01c-c6f14344ecc5">9.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract assets, December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfMi0xLTEtMS0w_fcf50d51-c747-485c-bf1f-33afe9dfe135">9.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in contract assets - increase (decrease)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="wst:ContractwithCustomerAssetIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfMy0xLTEtMS0w_413e699c-ed8b-4bee-9c2d-0728a13083cb">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfNS0xLTEtMS0w_ee102ca0-dda4-477e-a75e-e853c455b033">33.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income, December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfNi0xLTEtMS0w_6b457cf7-8e10-43ef-9146-f801956df7c0">34.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in deferred income - (increase) decrease</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfNy0xLTEtMS0w_d2a8170b-95a6-47ef-86a7-c187440bcac1">1.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The increase in deferred income during 2019 was primarily due to additional cash payments of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDM5ODA0NjUyMzk0NQ_79e3d26c-2197-4d91-a75d-af8b6b0d15f3">114.4</ix:nonFraction>&#160;million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNjY5Mg_55babc0e-e7af-49ba-9b93-62bf9bc7d528">110.4</ix:nonFraction> million, including $<ix:nonFraction unitRef="usd" contextRef="i46836a3158d542afb32cd1e654a0c77d_D20190101-20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNjcwNg_d494862b-1504-4e76-95ca-8585ecd744f5">20.8</ix:nonFraction> million of revenue that was included in deferred income at the beginning of the year, and $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfMzg0ODI5MDcwOTg4Nw_23dd36bb-b9c0-41b7-a21a-57ddca1ec224">2.5</ix:nonFraction>&#160;million in other adjustments. </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">49</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i54a8db670776413ebee1daa3bea74cf0"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Supply Chain Financing</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of December&#160;31, 2019 and 2018, we derecognized accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODExNA_19634fff-21ae-4968-8387-f3dceeb1392f">10.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDk0NzgwMjMzNjM4NQ_56fa0d5a-9e37-46c9-8334-d86bd79a8b35">5.7</ix:nonFraction>&#160;million, respectively,  under these agreements. Discount fees related to the sale of such accounts receivable on our consolidated income statements for 2019 and 2018 were not material.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Voluntary Recall</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 24, 2019, we issued a voluntary recall of our Vial2Bag product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $<ix:nonFraction unitRef="usd" contextRef="i4ecf186e93644ab891c8d431739b0932_D20181001-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:ProvisionForProductReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODUwNA_b33bbd1e-0265-41a8-8132-772b7681a0f2">11.3</ix:nonFraction> million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During 2019, we recorded a net provision of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:ProvisionForProductReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDk0NzgwMjMzNjI4Ng_171d798e-a981-4dd4-860b-6bd60793583c">5.4</ix:nonFraction>&#160;million for inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_94"></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMTA2NQ_ee6db0ac-6332-4e17-9aeb-d1f90006b4d3" continuedAt="i5c0faf71b92e4f05ad8c34af069533ad" escape="true"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 4:&#160;&#160;Net Income Per Share</span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMTA3MQ_8bbe7e44-8531-4032-a950-73ac1f580053" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:61.942%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.060%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMS0xLTEtMS0w_f7de0149-91f0-456d-9519-4d1f9f4ede00">241.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMS0zLTEtMS0w_76c77c4f-2242-44a1-b956-39805a3907e7">206.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMS01LTEtMS0w_5f0554e6-4bdd-409e-a90c-90a36fc8647c">150.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common shares outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMi0xLTEtMS0w_d0c12105-9da4-4867-9a6f-107944eb904f">74.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMi0zLTEtMS0w_9e120079-41af-4f0b-bdac-31454a7e3c70">73.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMi01LTEtMS0w_7109ac0b-1314-4336-9e79-2a5b80494547">73.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMy0xLTEtMS0w_6f709f1d-5708-4eec-bd99-f2f1411964b5">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMy0zLTEtMS0w_4d0336a6-1d98-411f-9f4b-02f13b548cc5">1.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMy01LTEtMS0w_7558a52b-e77d-4917-b389-ba8a94646fd2">1.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares assuming dilution</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfNS0xLTEtMS0w_134ab346-ea98-4c00-9781-6bf1e6661ae2">75.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfNS0zLTEtMS0w_b00e1cf7-551b-48d4-965a-64a77cc203e2">75.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfNS01LTEtMS0w_cb9fd29d-c869-4f8c-8f47-dfef00b69d70">75.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, 2018 and 2017, there were <ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMjE2_983e919f-45fb-47b4-9770-239cd756d2b6">0.1</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMjIw_ade0bf8d-62fb-4044-a0a7-475a92fb9de3">0.4</ix:nonFraction> million, and <ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMjI4_0be090ee-10d4-49eb-b95d-9ab18537c6a0">0.4</ix:nonFraction> million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to <ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfNTEx_b7436178-f615-4d87-964a-dbec5f284f11">800,000</ix:nonFraction> shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. During 2019, we purchased <ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfODQ0_a5175a3c-7ce3-4af5-8618-941f3fa0fa3f">800,000</ix:nonFraction> shares of our common stock under the now-completed program at a cost of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfOTA1_3edd52b2-a6df-4434-b93f-005efeb280e0">83.1</ix:nonFraction> million, or an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfOTMy_a0633744-b610-4ff1-8807-517964ac86da">103.89</ix:nonFraction> per share. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to <ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMzg0ODI5MDY5OTI3NQ_a578d7d7-7f1d-4b0f-8ec5-84b840fb1dea">848,000</ix:nonFraction> shares of our common stock from time to time on the open market or in privately-negotiated </span></div></ix:nonNumeric><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">50</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i5c0faf71b92e4f05ad8c34af069533ad">transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2020.</ix:continuation></span></div><div><span><br/></span></div><div id="i_0_97"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 5: <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTAxOA_b9e72b93-1cec-4a34-b834-610e25937f7e" continuedAt="i14a2f8be7005492182c1a72419e03a40" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i14a2f8be7005492182c1a72419e03a40"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTAyMQ_b0823f6d-3574-4232-b34b-ff65e4602ec3" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:55.692%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:15.307%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.701%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected useful lives (years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Land</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0bb40d435fa14466b3b81d438b389a9f_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMS0zLTEtMS0w_823bab4c-dc09-4f00-9821-5d6bd21354d8">22.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f3de1c6f6fe45f6b458941cbcce9c89_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMS01LTEtMS0w_1b97ebc7-d1cb-4b12-9fce-452c0371da5c">20.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Buildings and improvements</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15-35</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i072cba6507a54b579148c043620aac02_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMi0zLTEtMS0w_b0d1a004-648b-4300-a187-26d4d6eb445b">572.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8bad24d1776a40448ef8b8ec4302b349_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMi01LTEtMS0w_8be3b63c-210f-4db7-a8f0-6401cbe90aea">569.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Machinery and equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5-12</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9a6eb4dd6a7413aa8ceaa3c09928e24_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMy0zLTEtMS0w_21fa3c77-c5e2-48ba-bd89-a6ec3edb2891">817.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80e9aba82fbc4331be3320b17f956428_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMy01LTEtMS0w_5c2ad04f-b3dd-4314-a570-ccd2c2b34ef1">806.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Molds and dies</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4-7</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28f45a82c6a848438e8a0997d7c86692_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNC0zLTEtMS0w_9a019ec1-fa18-4099-b785-0f1a125bafdd">123.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i444fecb15f1e48779e2506de06cd3906_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNC01LTEtMS0w_2d706307-9704-42f6-9a2b-3ded47b8fc15">115.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer hardware and software</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3-10</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i65529b8816d44f1e8f82c472ecfd4c41_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNS0zLTEtMS0w_97b94e2e-74fe-4ab6-ae7f-b8c51867fe9e">155.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic95407f4963a4c28b32add928e5039ed_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNS01LTEtMS0w_82309e4a-88b1-4721-865a-7693915de61a">151.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd7312c6ba844d1aa28e958e6af15331_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNi0zLTEtMS0w_e21e3a5d-feeb-403f-9b83-523b808d9b2a">128.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic729fd36e94941198d96cc6d4ce68a25_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNi01LTEtMS0w_8bb2510b-8f5e-4e4a-bb35-5e115a628a28">89.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNy0zLTEtMS0w_69825b8a-2db0-44b4-8c92-fda1ef10eed3">1,820.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNy01LTEtMS0w_e0e9e15b-23a6-4925-b5ea-45736863f9a3">1,752.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciation expense for the years ended December&#160;31, 2019, 2018 and 2017 was $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjA3_b567debb-b6e3-4583-affe-84ce2f9158f8">100.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjEx_d0d68e3f-7323-4cfa-8e2f-4534ba7de978">101.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjE4_f8ecd50c-c6bc-41da-9cce-05e91a0867d3">94.3</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were <ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CapitalLeasedAssetsGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjQ4_794d4beb-f44e-4798-a1e0-66e02b895096">no</ix:nonFraction> capitalized leases included in buildings and improvements and machinery and equipment at December&#160;31, 2019 and 2018. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2019, 2018 and 2017 was $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNjM3_505f1752-3d35-4d61-a680-f585995dcc30">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNjQx_9723dc61-050c-4bb7-afea-3c02e1177c58">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNjQ4_b525f258-3919-4eb7-8c27-20460fd7243a">2.7</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019 and 2018, as part of our 2018 restructuring plan, we recorded within other (income) expense $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTA5OTUxMTYyOTI4Ng_464e2fca-65d1-4f13-b23e-7da10da7f58c">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTA5OTUxMTYyOTMwMg_9bd2a908-709a-4120-b792-e090bf1aefca">2.2</ix:nonFraction> million, respectively, for non-cash asset write-downs associated with the discontinued use of certain equipment. During 2019 and 2018, as part of our restructuring plans, we recorded within other (income) expense $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNDk0NzgwMjMyNzMxMw_c797fc17-1636-4399-8a92-f90dad128d9f">1.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNDk0NzgwMjMyNzMyNw_933077c7-1c43-434b-8dfa-2c3a31b1eb34">1.1</ix:nonFraction>&#160;million, respectively, for gains on the sale of fixed assets.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_2196"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 6: <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:LeasesOfLesseeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xNjQ5MjY3NDUzMjI4_94480ea9-eb06-4433-b3b8-2f1e18ce7476" continuedAt="i737fbc38d3424e8299c75280e00ee09b" escape="true">Leases</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i737fbc38d3424e8299c75280e00ee09b" continuedAt="ie3c83c0c0845445f8532f0c05f589da0"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adoption of ASC 842</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of December&#160;31, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5MzQz_3df9f4a3-52e4-45a8-8ae6-d4e15b74807d">five</span> years, and certain of our operating leases include options to terminate the leases within <ix:nonFraction unitRef="number" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="1" format="ixt-sec:numwordsen" name="wst:LeaseOperatingLeaseTerminateTerm" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8zODQ4MjkwNzA4OTAx_5a819785-b212-4311-bc6a-c5ee4b2cd46e">one</ix:nonFraction> year. We had <ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:FinanceLeaseLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NTE5_f6196daa-5591-4200-a411-8a18ef62190d">no</ix:nonFraction> finance leases as of December&#160;31, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="i317d53aa6f2d4db580df360452af00b7_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5MzU5_8d912966-2888-493c-9677-a5c8e5730acf">71.0</ix:nonFraction>&#160;million and operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="i317d53aa6f2d4db580df360452af00b7_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5Mzc1_f24a9f64-4c34-4ba5-b913-6c85925fbe56">73.1</ix:nonFraction>&#160;million for operating leases where we are the lessee in our consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">51</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ie3c83c0c0845445f8532f0c05f589da0" continuedAt="i381211df66d64d7d96a665cea7cc4de9"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5Mzg5_d54ca4e1-8814-4c05-80ec-80157f1ba04f" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of lease expense were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:83.096%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.904%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF8xLTEtMS0xLTk5MTE_ab9fb55b-776e-4b35-8904-e19d4ce63a24">12.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term lease cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF8yLTEtMS0xLTk5MTQ_d1d87cb5-5dff-4231-a616-72ea2d7a272e">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Variable lease cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF8zLTEtMS0xLTk5MjM_8283be18-9f21-4c07-843e-6dadff577a97">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF80LTEtMS0xLTk5MjU_648bdea8-8324-4a6c-8a4b-495ac07298f8">17.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Lease expense for 2018 and 2017 was $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5Mzkx_f838b0ae-6740-4415-bca7-27ccf1e80f4f">14.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDA2_7048d75b-bbfd-4f00-9368-ddfbcb16b479">13.3</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDIw_c8581382-b4c5-4bf2-864e-1a036a2414b2" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Supplemental information related to leases was as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:83.096%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.904%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating cash flows from operating leases</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ODhmOTg0ZGRkZTRhNDM4Y2EyZWJjNmJlMTMzNzQ2YTYvdGFibGVyYW5nZTo4OGY5ODRkZGRlNGE0MzhjYTJlYmM2YmUxMzM3NDZhNl8yLTEtMS0xLTk5NDQ_dd846379-56e2-4a3f-86a9-f9d3d11a3aa7">12.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ODhmOTg0ZGRkZTRhNDM4Y2EyZWJjNmJlMTMzNzQ2YTYvdGFibGVyYW5nZTo4OGY5ODRkZGRlNGE0MzhjYTJlYmM2YmUxMzM3NDZhNl80LTEtMS0xLTk5NDk_18a4df37-09bc-4cec-9cc6-61c3f56c575e">9.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the weighted average remaining lease term for operating leases was <ix:nonNumeric contextRef="i710deda8952743be8f828089af9cd00d_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDIy_65b2f2af-65a4-4cad-b945-7fa1e514222e">11.7</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDQ1_1e6477fc-3d81-4a05-8986-cf0d00fa12cf">3.76</ix:nonFraction>%.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">52</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i381211df66d64d7d96a665cea7cc4de9"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDUx_9de7bebc-910c-4875-81f2-4218880863a0" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Maturities of lease liabilities as of December&#160;31, 2019 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:83.096%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.904%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF8yLTEtMS0xLTk5ODg_f0f1d60d-d31a-48ec-a418-4038f86785b5">12.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF8zLTEtMS0xLTk5OTU_f10176df-bcff-4efe-ba73-7b6678b3864b">10.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF80LTEtMS0xLTEwMDAx_8eb55dad-145b-4d0c-a8e1-b5b62c71c1d7">8.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF81LTEtMS0xLTEwMDA3_90aa31e9-568f-4287-ba8b-37e329e7e856">7.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF82LTEtMS0xLTEwMDEz_a11f6803-1e00-4269-9b38-3db8323d74d8">7.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF83LTEtMS0xLTEwMDE5_919bc387-8429-4455-b438-3fd1d073f052">41.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF84LTEtMS0xLTEwMDI0_50213b57-2695-4900-8e71-49b48be470fd">88.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed lease interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF85LTEtMS0xLTEwMDI4_6064f224-2b1f-4b9e-ac86-c8bd6230dbef">16.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF8xMC0xLTEtMS0xMDAzMw_d09c41ca-5210-468a-b774-e6b93903a2da">72.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDUy_68ba25a8-5f70-4393-913c-e6d8c7397c88" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Maturities of future minimum rental payments under non-cancelable operating leases as of December&#160;31, 2018 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:83.096%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.904%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl8yLTEtMS0xLTEwMDQy_6abf93c3-b82d-46a1-b521-113526ab3c02">13.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl8zLTEtMS0xLTEwMDQ4_22d6b117-44a1-46f4-96ff-d7b4a63c8f18">10.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl80LTEtMS0xLTEwMDUy_1ee67179-5206-401f-b7e1-dd4e489a237b">7.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl81LTEtMS0xLTEwMDU2_186d6106-3e25-491d-88a9-42dc4ca228c5">6.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl82LTEtMS0xLTEwMDU4_695c66f1-3e68-4d8a-a51a-80710a9f6817">5.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl83LTEtMS0xLTEwMDY0_04bed17a-3466-498c-989a-000d4129fdc2">37.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl84LTEtMS0xLTEwMDY5_b294cf16-b9f2-4ef1-8ab6-c486b342c7d5">81.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Practical Expedients and Exemptions</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have elected to adopt the leasing package of practical expedients, which allows us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of <ix:nonNumeric contextRef="i7d7f3d86824a4066a23c46e16851c996_I20191231" format="ixt-sec:durmonth" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NTAy_10310327-4fda-4ba2-a359-6cb630851354">12</ix:nonNumeric> months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_103"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">53</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 7: <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzE2NzQ_5f03fc38-66b8-43eb-a21a-4c56364e6a19" continuedAt="i4660595e7feb4004ba293d2ec09e3d1e" escape="true">Affiliated Companies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4660595e7feb4004ba293d2ec09e3d1e"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzE2Nzg_2cd9aa8f-7f79-40f1-a135-d93b422020db" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the following affiliated companies were accounted for under the equity method:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:55.371%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:19.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:19.315%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ownership interest</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i89cf005616044c5e8e5067ff128a6379_I20191231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzEtMi0xLTEtMA_2561d5b4-d888-4ac2-b662-21aa13953870">49</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aluplast S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie1e7eb7b421641b6b38d74b93995f136_I20191231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzItMi0xLTEtMA_880ccbef-68e7-4916-af85-801a5e63730e">49</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i649d27b290864823b58120ef0a909e69_I20191231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzMtMi0xLTEtMA_500f66a0-ac77-4d5e-9a68-27851b335a33">49</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8604ed7fa7ef45dfa5249a8547428da8_I20191231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzQtMi0xLTEtMA_f0e69855-37f1-4ca9-bf31-784dcc820c79">49</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">I&amp;W Pharma Group LLC</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iff6398961be24db984f094bedc419067_I20191231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzUtMi0xLTEtMTA2MDk_20e6f53c-59db-4c9c-98d0-46735605a3f4">49</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Daikyo</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4e7adf4b261e42b0ba535696463b6408_I20191231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzUtMi0xLTEtMA_7920e1fa-f6fe-4f36-9d69-c2e314cba0e1">49</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On November 1, 2019, in connection with the amendment of certain commercial agreements with Daikyo, we increased our ownership interest from <ix:nonFraction unitRef="number" contextRef="i34154b71394444eea4aac71d4bd6a886_I20181231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzM4NDgyOTA3MDUwNjg_38aa05be-125b-4dec-93b5-34c0078fbf61">25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib03c963f83384e04af745078ed7c6c28_I20191101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEwOTk1MTE2MzU2MjM_487bd870-3adf-4a46-8d4d-11eb3566ad94">49</ix:nonFraction>% in Daikyo in exchange for $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEwOTk1MTE2MzU1OTQ_ab1dba1a-d113-46d0-abc0-a6a9520bbff3">85.1</ix:nonFraction>&#160;million in cash and $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEwOTk1MTE2MzU2MDk_2311a5c8-f29c-404d-81ac-8e80c8b9489d">4.9</ix:nonFraction>&#160;million in shares of our treasury stock to certain stockholders of Daikyo. We believe that the increase in ownership interest will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unremitted income of affiliated companies included in consolidated retained earnings amounted to $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzIyMQ_ab7a3cc4-92b8-4f7b-825e-d2ae953d9895">82.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzIyNQ_1af935b6-be57-4086-8d90-f4607c23539b">75.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzIzMg_a3b1e5b7-62ff-4452-825f-ebd4a7c19f39">69.9</ix:nonFraction> million at December&#160;31, 2019, 2018 and 2017, respectively. Dividends received from affiliated companies were $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzMxNw_1514fdae-0688-40b0-88bc-5b2a5ebbd69c">2.2</ix:nonFraction> million in 2019, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzMyNw_5dbbd8a5-5f37-4301-af6f-b4712909af77">1.7</ix:nonFraction> million in 2018 and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzM0MA_1746b86f-5907-4313-a3bd-334e2a3d2b38">2.2</ix:nonFraction> million in 2017.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our equity in net unrealized gains of Daikyo&#8217;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $<ix:nonFraction unitRef="usd" contextRef="i4e7adf4b261e42b0ba535696463b6408_I20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzUzMw_4a0caa06-8a24-476f-abde-321d9865c17d">0.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i34154b71394444eea4aac71d4bd6a886_I20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzUzNw_3c281d57-d53b-4aa7-9e53-7b70250b89ba">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i135f442ad6834fb6b1c797458a39a2ee_I20171231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzU0NA_d1ec2ba8-0d3a-4522-b086-4aee9aa5e00c">0.5</ix:nonFraction> million at December&#160;31, 2019, 2018 and 2017, respectively. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our purchases from, and royalty payments made to, affiliates totaled $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzY1MA_1ec207b3-a9cb-4fd2-b60a-fab9fffb1b69">115.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzY1NA_2fc9c4b8-5b4a-4c88-8da6-ce737bb4a1ee">86.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzY2MQ_e6116031-0083-4a7b-a5ec-a573b599a0b6">86.7</ix:nonFraction> million, respectively, in 2019, 2018 and 2017, of which $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzcwNg_1c56a54b-1e79-4fb1-af26-4bbd1db19abd">20.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzcxMw_e640c14f-71f4-43e5-a297-a91bceb12eae">12.9</ix:nonFraction> million was due and payable as of December&#160;31, 2019 and 2018, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:SalesToEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzkzNA_c60721f7-5a33-4396-a459-5d4d5636c74b">9.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:SalesToEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzkzOA_df499ae5-b151-4cd2-8059-156584980901">9.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="wst:SalesToEquityMethodInvestees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3Xzk0NQ_80504f53-3da6-47bd-979d-d12c73cb4431">8.1</ix:nonFraction> million, respectively, in 2019, 2018 and 2017, of which $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3Xzk5MA_84159e54-6d41-418e-9211-64eccb339e26">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueFromAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3Xzk5Nw_6a14872d-0e59-4b13-a73d-ba898b5044a0">1.6</ix:nonFraction> million was receivable as of December&#160;31, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019 and 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzExODQ_371a0612-28ea-4563-8e7a-cd4c33d32ac8">179.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzExOTE_8db68614-2318-4346-b2d3-69452d0ce68c">77.8</ix:nonFraction> million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEzNTA_6b33270d-d24e-4ca6-9a33-f0864e8b2f59">13.4</ix:nonFraction> million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_109"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">54</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 8: <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzk2MQ_874e8695-3ba2-4b3c-848f-e3cd9fd71c8c" continuedAt="i0c64aae96c7045678ff0ebdf2f949fc4" escape="true">Goodwill and Intangible Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0c64aae96c7045678ff0ebdf2f949fc4" continuedAt="i3b6a8df326c141e98ebb0aa1353b3c60"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzk1Mw_a2b12c68-e1f5-470c-b0f2-32cb90d854fa" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i10b2bd972c5247c89ad526ba8664ceea_I20171231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzEtMS0xLTEtMA_159ad944-a73c-49c3-9cba-169346be3658">77.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9b16d7361925410886eeb15e971ce722_I20171231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzEtMy0xLTEtMA_82bcc04b-6eeb-4baa-8588-1211ada81b1e">30.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzEtNS0xLTEtMA_f5e1c641-fd94-4253-bd4d-f70a29365bb0">107.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzMtMS0xLTEtMA_1efafbff-fe00-4b8c-8a51-8e48cdeb007b">1.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzMtMy0xLTEtMA_4f188b58-f3ac-4515-a1b6-2abef3f73e60">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzMtNS0xLTEtMA_26613f3c-9402-4bdf-b482-5d986f6ad86f">1.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2afcfd5d059438e8bc7bc4552794714_I20181231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzQtMS0xLTEtMA_d5ae1d7c-67cc-41ab-a117-babfa8c4fed2">76.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i529afefe3a5146a8ae99168ace63b1f5_I20181231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzQtMy0xLTEtMA_4b3ad35d-54ad-47a8-a72f-c1b545ef02a3">29.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzQtNS0xLTEtMA_8124b9b5-bf76-4e16-8b16-ba3b6b0164bd">105.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill recorded due to acquisition</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzUtMS0xLTEtMA_0481c20f-0664-4c70-98c2-f29c577d6be5">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="5" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzUtMy0xLTEtMA_b9a71497-13ce-448d-8c81-a9d732aa6fe9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzUtNS0xLTEtMA_3b6cb02e-cac7-4802-ac26-1237d355e779">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzYtMS0xLTEtMA_a46ab0e1-7bad-4e10-b72e-5e7451871b17">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzYtMy0xLTEtMA_325b8083-f49c-4cde-a97a-eb0237992af0">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzYtNS0xLTEtMA_31ee2a7c-1f84-4bb0-969f-8b07edb63fa3">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if22f0c39a4254fd9831626f40147da4c_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzctMS0xLTEtMA_8fa91e16-b950-4bbb-bcee-dbcd99258f53">78.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2831b7068f5415993b76a543c279df1_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzctMy0xLTEtMA_dd71895c-e5fd-48f5-af63-9ab59bd8777a">29.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzctNS0xLTEtMA_d5d9781c-5751-4ad3-90b6-936366ca73ee">107.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzEwOTk1MTE2MzA3NDA_ecafaa34-2763-406f-84e2-1bcd6a28e40f">2.6</ix:nonFraction>&#160;million. The goodwill was recorded within our Proprietary Products reportable segment. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we had no accumulated goodwill impairment losses.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzk1NQ_2807703b-b7a5-46b8-910f-b07db38ee078" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:24.121%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.461%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.461%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.741%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and licensing</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i745e6936945c4146b553af9a8d7a2d88_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItMS0xLTEtMA_5a5f5875-6421-4cd5-ab9c-9ea8884c270e">21.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i745e6936945c4146b553af9a8d7a2d88_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItMy0xLTEtMA_7b29ece8-c387-44de-ae06-c49beac25e19">16.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i745e6936945c4146b553af9a8d7a2d88_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItNS0xLTEtMA_654c5453-bb7b-4dd5-b03f-640247793236">5.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItNy0xLTEtMA_2aa4cf23-a85c-4ca5-812d-d0eeed202aca">19.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItOS0xLTEtMA_5133fa82-e89a-4119-bb57-f5b61d349cf6">15.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItMTEtMS0xLTA_563f5503-56c2-4e6c-9843-d32925f525a7">4.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technology</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i90dd87315fb54344b4f25c4ac0d5be42_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtMS0xLTEtMA_025ee948-51ce-47a0-8591-e7366298480d">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i90dd87315fb54344b4f25c4ac0d5be42_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtMy0xLTEtMA_e91966f5-86c3-4ffc-a0a6-9da33819e91f">1.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i90dd87315fb54344b4f25c4ac0d5be42_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtNS0xLTEtMA_8bc78c29-ea4d-41b8-a896-12791c35c50f">1.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id025bdb034db45568a0aa20c7a5a88e0_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtNy0xLTEtMA_fd700507-587f-4592-ac81-8a78c8b45b3b">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id025bdb034db45568a0aa20c7a5a88e0_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtOS0xLTEtMA_346fe9be-0d7f-49ea-9a22-14b4af36197f">1.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id025bdb034db45568a0aa20c7a5a88e0_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtMTEtMS0xLTA_4ed87045-3e3f-4740-8073-0f4c8159a4ad">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6bb357a5970a432e8774216e7e63f9a8_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtMS0xLTEtMA_dff30abc-5e06-49f0-941f-125823671c7f">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6bb357a5970a432e8774216e7e63f9a8_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtMy0xLTEtMA_102379ef-6348-410a-b670-9b5d3df04b8a">1.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6bb357a5970a432e8774216e7e63f9a8_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtNS0xLTEtMA_840cec84-fa0e-48bb-9e39-4886eee1f1f3">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i370687821342468aa0b202a3b92a0f3a_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtNy0xLTEtMA_fbb5f9cb-7e82-4b4c-903e-46c2a2aba4bf">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i370687821342468aa0b202a3b92a0f3a_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtOS0xLTEtMA_a632992d-686b-4f3f-b385-667e9f3668fa">1.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i370687821342468aa0b202a3b92a0f3a_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtMTEtMS0xLTA_948c4fc0-74d7-49d6-b8cd-c5decad14f91">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtMS0xLTEtMA_bcd6569b-79d0-46ac-a4ee-204f51fda090">40.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtMy0xLTEtMA_5c7231c7-64c5-461a-9675-2f93a2e9ee32">21.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtNS0xLTEtMA_a4d933a7-e928-48e4-9a30-23f0cb649538">18.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i930683f0ef754186a359e86df7c8ec95_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtNy0xLTEtMA_cc47eb27-06c0-4c6e-8517-5e9a1a020025">29.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i930683f0ef754186a359e86df7c8ec95_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtOS0xLTEtMA_fc1f954f-bfc4-4dcb-97f7-a085067be608">20.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i930683f0ef754186a359e86df7c8ec95_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtMTEtMS0xLTA_71b65269-1a48-46d5-82f1-75c5505ab7fb">9.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie38e99e04c054de492c86997ca5d77b1_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtMS0xLTEtMA_992125b0-37ca-499d-9f2c-502908956018">11.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie38e99e04c054de492c86997ca5d77b1_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtMy0xLTEtMA_8d4c9490-7c63-46b4-ada9-9dbbe38358e4">7.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie38e99e04c054de492c86997ca5d77b1_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtNS0xLTEtMA_5828d8fc-2dc8-45ba-aa19-3c399741f0bd">3.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib9a4a99992a34bbfbd4970a826236a2a_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtNy0xLTEtMA_4ff215d8-3dd3-4632-96bc-938eecbcced0">11.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib9a4a99992a34bbfbd4970a826236a2a_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtOS0xLTEtMA_216b4048-dc5a-41bb-8f00-7f086aa78091">6.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib9a4a99992a34bbfbd4970a826236a2a_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtMTEtMS0xLTA_db2d1598-134c-47b4-a975-45599e7f30a8">4.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctMS0xLTEtMA_6a234a2d-1354-44a5-9075-c75d73eaa6ef">78.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctMy0xLTEtMA_84ff1b3e-6dd0-4a79-bf5b-3253f8970131">48.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctNS0xLTEtMA_8cdd5724-7182-455a-8221-3237a04e80c5">29.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctNy0xLTEtMA_6c93cc9b-c845-4d4e-a7bc-5fcaea0fd547">65.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctOS0xLTEtMA_ea922a5f-a076-4a8a-b580-15ac7b7c19e5">44.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctMTEtMS0xLTA_9d01c814-1a82-4e08-9583-ff62f979059a">20.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded a customer relationships intangible asset of $<ix:nonFraction unitRef="usd" contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzEwOTk1MTE2MzA3MjI_4763a09a-ceaa-4f64-91f9-e92ed9cc247c">11.2</ix:nonFraction>&#160;million, which is being amortized over ten years. </span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i3b6a8df326c141e98ebb0aa1353b3c60">The cost basis of intangible assets includes a foreign currency translation loss of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzM2Mg_4c57f8dc-8cd7-4a50-a2e5-d9fb04a4f0a4">0.3</ix:nonFraction> million and a foreign currency translation loss of $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzQwNg_afb38810-edad-4a26-978c-0eadbe29a6d9">0.3</ix:nonFraction> million for the years ended December&#160;31, 2019 and 2018, respectively. Amortization expense for the years ended December&#160;31, 2019, 2018 and 2017 was $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzUxMw_9c2933b5-9f6e-4773-9343-85ad6253cc83">3.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzUxNw_7e9c0cce-2e73-4c18-a604-312ebd8d34d7">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzUyNA_22a8129d-6693-42b6-92b1-60baca0c4847">2.4</ix:nonFraction> million, respectively. Estimated annual amortization expense for the next five years is as follows: 2020 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzYyNA_b6d3ff8d-aacc-4326-8a24-249e333cecb0">4.0</ix:nonFraction> million, 2021 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzYzMw_26ce8aff-c65e-4ca3-ab6c-538dcbe562c6">3.5</ix:nonFraction> million, 2022 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzY0Mg_1aed4256-3498-4581-9ce9-c44e62e02e75">3.5</ix:nonFraction> million, 2023 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzY1MQ_e46b5ba2-ffcb-40f4-b090-ec97b02b3689">2.9</ix:nonFraction> million and 2024 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzY2Mw_242c0be5-5cdb-40d2-9e2b-04dcb1b1b6fb">2.6</ix:nonFraction> million.</ix:continuation> </span></div><div><span><br/></span></div><div id="i_0_112"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">55</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 9:&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90ZXh0cmVnaW9uOjZlMTRjYjJiMmVlNTQ0N2FhZWFmYjE2YTE1NTM3YmFjXzIwMg_224b47f3-95d7-412a-a87e-47c089f2e1ac" continuedAt="i356d07fc2c584e0aa873d288dc358278" escape="true">Other Current Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i356d07fc2c584e0aa873d288dc358278"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other current liabilities as of December 31 included the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90ZXh0cmVnaW9uOjZlMTRjYjJiMmVlNTQ0N2FhZWFmYjE2YTE1NTM3YmFjXzIwNQ_d4ddb900-ff52-4673-a3e1-f2270bba01d0" escape="true"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.391%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.905%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzEtMS0xLTEtMA_ac25f32a-c9fb-42ea-88ec-44e52f89bd64">27.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzEtMy0xLTEtMA_3bb0c417-7204-401e-af5b-4916db344040">25.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzItMS0xLTEtNzM1Mg_7ced1359-2377-43e1-b2b6-a28b0c9c25c0">11.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzItMy0xLTEtNzM1OA_749b2b9e-2d40-4e7b-a542-47a2cb303226">11.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzMtMS0xLTEtNzM1Mg_e8eed48d-9393-4cd0-bd3a-e68b8c7628e8">9.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzMtMy0xLTEtNzM1OA_fc40f9d6-9535-42af-b798-819c5107ea44">5.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMS0xLTEtNzM1Mg_dd211bd2-6ecb-40e5-9ed6-66630f1afc4e">7.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMy0xLTEtNzM1OA_8f6490ae-fd2e-4890-959d-4fb957d98766">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued taxes other than income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMS0xLTEtODMyMw_ac486d73-bb51-4af2-ad13-1eedca248e5c">6.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMy0xLTEtODMyNQ_2b3ed93e-91d3-4d63-a4ff-079c79990f4a">5.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued professional services</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMS0xLTEtNzM1Mg_34e871d8-97d8-4428-b27e-f7263044a5ad">5.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMy0xLTEtNzM1OA_318c403f-acd9-4f29-8fa8-295447699917">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMS0xLTEtNzM1Mg_fdcbc05d-1d17-4eff-9441-f6d34967bed5">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMy0xLTEtNzM1OA_b41c01f7-8b34-4947-9a7c-95d44b3210b4">3.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring obligations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzctMS0xLTEtNzM1Mg_208f9087-531e-4851-9b42-b031ec913788">1.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzctMy0xLTEtNzM1OA_f3794338-e1e0-40ca-8f3d-fd4017eaa18f">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMS0xLTEtMA_91a56d36-04ff-4291-a69e-f6c256248a39">17.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMy0xLTEtMA_31e79f9e-fa97-4e68-91f9-44b564ee5ddf">14.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other current liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMS0xLTEtMA_04d1dbcf-1f54-450f-a025-95ad31f693b1">91.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMy0xLTEtMA_d688edfb-a773-48fc-80e9-bef2d45b3bb2">76.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i_0_115"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 10:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzM1NDE_7f573999-dbe0-4581-bdd8-b9225fc3674e" continuedAt="i7366f330382e4f9789865e6b955eb2a9" escape="true">Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7366f330382e4f9789865e6b955eb2a9" continuedAt="i8c957ee3e50e48109c8dee250f8988e8"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzM1NDY_cc6a77f8-0faa-4506-8f44-96bc4a540fec" escape="true"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2019. </span></div><div style="text-align:justify;"><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.711%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.585%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Note payable, due December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0002a699af14295b2302af2a16bab97_I20181231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzUtMy0xLTEtMA_15519acd-86e5-43d9-bdb8-cd0648796352">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Facility, due October 15, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ife1cf0309fce4ebd9ef5c548ba5929a5_I20181231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzYtMy0xLTEtMA_ed25d306-7a04-45e4-9ae9-9f513a69a53b">28.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Term Loan, due December 31, 2024 (2.78%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6676f9d8fa624212a28167a0b290deb2_I20191231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzgtMS0xLTEtMTI4OQ_d568276a-ed74-4a0a-a5ce-32b5a251d2b2">90.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A notes, due July 5, 2022 (3.67%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9eb640c923f4733a19388100c5bbed7_I20191231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzgtMS0xLTEtMA_d241fad2-c023-41e8-8b2a-d2d936cae2f2">42.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i91c99566b2144913acb7f361f5c22294_I20181231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzgtMy0xLTEtMA_a835057d-b52d-41d2-b059-fc1d35fd24c8">42.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B notes, due July 5, 2024 (3.82%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i88b05261cd00424e9002e44c4d03c23e_I20191231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzktMS0xLTEtMA_be941942-b3fc-4ddc-9712-c16dcc17abb3">53.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7b22bd295c93485fb2d2ff977a010756_I20181231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzktMy0xLTEtMA_41a5e76a-3674-4c29-86c4-b3d534ec7261">53.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series C notes, due July 5, 2027 (4.02%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEwLTEtMS0xLTA_ffd78425-4e8b-465e-b4aa-22a7d6dd6976">73.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i303951a1d742421f9ca04aef7b201e68_I20181231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEwLTMtMS0xLTA_bfc63e8b-6df7-4b51-9bd8-48444c1cc119">73.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">258.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: unamortized debt issuance costs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEyLTEtMS0xLTA_8227d11d-26f1-4f6b-8f2f-faecbea6e6e7">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEyLTMtMS0xLTA_bb7a5e84-1141-474c-8ecb-9c760fdeee47">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">257.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current portion of long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzE1LTEtMS0xLTA_bb805765-f325-438b-91e6-fda28cd03e56">255.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzE1LTMtMS0xLTA_1a3d0ea0-b10c-43ab-b692-4b02705cc57f">196.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Credit Agreement - Credit Facility </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains the Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwMTI_a40b5439-ffde-4945-8052-12460f56b881">300.0</ix:nonFraction>&#160;million, with sublimits of up to $<ix:nonFraction unitRef="usd" contextRef="ib25bd41fa2f6434989c8b30e7094cd66_I20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:CreditFacilityIsAvailableForSwingLineLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwMjc_9d72fb91-4fd5-4f50-b8df-53f70c066147">30.0</ix:nonFraction>&#160;million for swing line loans for domestic borrowers in USD and a $<ix:nonFraction unitRef="usd" contextRef="i42fb76fda75b4b14a4664b19c1e784dc_I20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:CreditFacilityIsAvailableForSwingLineLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwNDI_7eb8e014-6cc7-4c2b-8c64-68455c5f81cc">20.0</ix:nonFraction>&#160;million swing line loan for our German Holding Company and up to $<ix:nonFraction unitRef="usd" contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:CreditAvailableForIssuanceOfLettersOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwNTc_2b328650-960b-444e-996f-615af8bc1989">30.0</ix:nonFraction>&#160;million for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of $<ix:nonFraction unitRef="usd" contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:LineofCreditFacilityAdditionalBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwNzI_a09ec0e3-3d09-4321-8e83-391060c7d385">350.0</ix:nonFraction>&#160;million and earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="i24ec845a2a624436a8201d02881d6167_D20190101-20191231" decimals="1" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwODg_60862198-72b7-4f78-a13f-9935be44fd0c">50</ix:nonFraction> basis points or the daily LIBOR, plus <ix:nonFraction unitRef="number" contextRef="i28d2da44a3ca41a68e529adf0d248f25_D20190101-20191231" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwOTY_ab614191-0f62-497b-bfe7-62c8fe5e4403">1.00</ix:nonFraction>%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from <ix:nonFraction unitRef="number" contextRef="i984913c14dbf4de19cd8e36ccae92f15_D20190101-20191231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMDM_ac8fd147-ede5-458b-89ed-0c8e91736679">0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ib9d7d55f956d49e2be8ad5e98d032270_D20190101-20191231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMDY_d6a30319-97a2-47ee-8284-b875d22101b8">37.5</ix:nonFraction> basis points for base rate loans and <ix:nonFraction unitRef="number" contextRef="ife43bfe94fc749d880537b4733fda5a9_D20190101-20191231" decimals="1" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMTI_c686d509-01d2-4ce0-9524-4b86e68f3877">87.5</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i78e7486b947f4f99a466314587751bc2_D20190101-20191231" decimals="1" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMTg_9ce2c187-4738-4d14-a6a4-0a672b207352">137.5</ix:nonFraction> basis points for LIBOR rate loans. The Credit </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">56</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i8c957ee3e50e48109c8dee250f8988e8"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than <ix:nonFraction unitRef="number" contextRef="i56b5019b842b48aa8fa6565a51c3f1cd_D20190101-20191231" decimals="1" name="wst:RatioOfDebtToEBITDA" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMjU_970e9a06-d77c-4e1b-beac-37d1fa4e6f76">3.5</ix:nonFraction> to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to <ix:nonFraction unitRef="number" contextRef="ie079f1f282e8458c9a8cdce88d50af68_D20190101-20191231" decimals="1" name="wst:RatioOfDebtToEBITDA" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMzA_2ca5f829-3207-4629-bff4-e6f9e75b9fb5">4.0</ix:nonFraction> to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December 31, 2019 and 2018, total unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="iaf55a0f044ed4e1a852eca470f62e0d8_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMzU_1575df8f-b93a-49b2-93e5-8fc4fbcba9d0">1.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie6121497184640d09c106918c72a6948_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxNDk_6de14bd3-eb9b-4ad4-a2dd-aad0b573b571">0.6</ix:nonFraction>&#160;million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December 31, 2019, we had <ix:nonFraction unitRef="usd" contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:LongTermLineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIzMDc_77eeecbd-4da7-4434-867b-0b70b567024f">no</ix:nonFraction> outstanding borrowings under the Credit Facility, as we repaid the outstanding long-term borrowings denominated in Euro and Yen in November and December 2019, respectively. There was <ix:nonFraction unitRef="usd" contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:LongTermLineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIzMjI_8c1a11b6-fc48-400d-85d2-3cc9e65dd3f6">no</ix:nonFraction> material gain or loss on the repayment under the Credit Facility. At December 31, 2019, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i04ab47ee62a5494f909f92a95cc7c70c_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzEwOTk1MTE2NDM3MzY_917ace18-9c09-4ddc-9c47-ed86cd39166f">2.5</ix:nonFraction> million, was $<ix:nonFraction unitRef="usd" contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzEwOTk1MTE2NDM3NDI_955de4a6-e195-4409-b9d1-a5d0a180033a">297.5</ix:nonFraction> million. Please refer to Note 11, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Derivative Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for a discussion of the foreign currency hedges that had been associated with this facility.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Credit Agreement Amendment - Term Loan</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#8220;First Amendment&#8221;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $<ix:nonFraction unitRef="usd" contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxNjM_8117d9e2-658b-44df-85e6-0d89a6a89516">90.0</ix:nonFraction>&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month LIBOR plus <ix:nonFraction unitRef="number" contextRef="id4fca98c38414a20b353c860de269825_D20190101-20191231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxNzg_2ffad452-7964-4a28-901b-22f3487935fa">87.5</ix:nonFraction> basis points. As of December 31, 2019, there were unamortized debt issuance costs remaining of $<ix:nonFraction unitRef="usd" contextRef="ieb4ecdaaaca7414f9a37335a909966d2_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxODQ_7c4c35e2-8798-4574-9c0d-2fd17cedf963">0.2</ix:nonFraction>&#160;million, which are being amortized as additional interest expense over the term of the Term Loan.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">At December 31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyMDQ_7cc0d1a3-39c7-4fa7-aa41-901cf9f21bf7">90.0</ix:nonFraction>&#160;million in borrowings under the Term Loan, of which $<ix:nonFraction unitRef="usd" contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyMTk_347d5c12-fddd-4c46-bd09-1874c72d51eb">2.3</ix:nonFraction>&#160;million was classified as current and $<ix:nonFraction unitRef="usd" contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyMzM_43c2c86b-c482-4c41-ae19-f7636ab17a48">87.7</ix:nonFraction>&#160;million was classified as long-term. Please refer to Note 11, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Derivative Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Private Placement</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2012, we concluded a private placement issuance of $<ix:nonFraction unitRef="usd" contextRef="i8bdb4a99fe0e4bd7a545168d11cbeb80_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzIyNzI_8c6f0183-86a0-4603-96f9-72b25ef7c1f9">168.0</ix:nonFraction> million in senior unsecured notes. The total amount of the private placement issuance was divided into three tranches - $<ix:nonFraction unitRef="usd" contextRef="i73656a3ae59a40a38eba7861eb07cd4a_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzIzODc_e22aaaf6-a65a-45ba-911f-cb49ab85bf82">42.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i73656a3ae59a40a38eba7861eb07cd4a_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzIzOTA_b677b073-15a2-4889-9467-175d293cd6df">3.67</ix:nonFraction>% Series A Notes due <ix:nonNumeric contextRef="i39f68633b1e54492a14344435d453361_D20190101-20191231" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0MTI_d8f249c1-ed12-4eea-99dd-7e4df2109921">July 5, 2022</ix:nonNumeric>, $<ix:nonFraction unitRef="usd" contextRef="i88b05261cd00424e9002e44c4d03c23e_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0MTY_a2a9b4a2-a208-421c-a9b3-b4a3a5b662e1">53.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i88b05261cd00424e9002e44c4d03c23e_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0MTk_2e6ee604-a104-42a9-b729-988bc663366b">3.82</ix:nonFraction>% Series B Notes due <ix:nonNumeric contextRef="i1fb56017b0b444b684e46fe8935ceb60_D20190101-20191231" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NDE_038cfac0-eb7f-40af-b0ee-f35427314b06">July 5, 2024</ix:nonNumeric>, and $<ix:nonFraction unitRef="usd" contextRef="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NDk_cb28cac6-8770-4e7d-9c54-897e15912917">73.0</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NTI_27f7ab50-d3b3-4c69-bae9-3eac895e6b17">4.02</ix:nonFraction>% Series C Notes due <ix:nonNumeric contextRef="i74d6333665a945df9a67c0096b0b8f50_D20190101-20191231" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NzQ_701a3a03-283d-400b-9feb-07d0c251ab1d">July 5, 2027</ix:nonNumeric> (the &#8220;Notes&#8221;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes is <ix:nonFraction unitRef="number" contextRef="i8bdb4a99fe0e4bd7a545168d11cbeb80_I20191231" decimals="INF" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI2MjI_70c9ac38-99c0-48d2-8c27-05f5a25e88cd">3.87</ix:nonFraction>%. As of December&#160;31, 2019 and 2018, there were unamortized debt issuance costs remaining of $<ix:nonNumeric contextRef="i342543b0c2f347e9b92ff37b1a7384ad_D20190101-20191231" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI2OTk_37365b5f-2ee8-451e-a637-09931cceeaf9">0.5 million</ix:nonNumeric> and $<ix:nonNumeric contextRef="ia7b648773fa64e1a87127b924772b46e_D20180101-20181231" name="us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI3MDY_96d4ce90-1a0d-4331-86dd-63dfb74b2d14">0.6 million</ix:nonNumeric>, respectively, which are being amortized as additional interest expense over the term of the Notes.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Covenants</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2019, we were in compliance with all of our debt covenants, and we expect to continue to be in compliance with the terms of these agreements throughout 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest costs incurred during 2019, 2018 and 2017 were $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzMzMjM_3e23c11b-f2fe-4c0f-8947-70eddf2586e0">9.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzMzMjc_1792df5e-d65d-490b-9de4-784274aeb1cb">9.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzMzMzQ_a8906ec6-6466-4140-b790-d8346fbb3cc6">10.5</ix:nonFraction> million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, were as follows: </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">$<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyNDg_53f48b2e-022a-42d8-b46f-ea6f593779bb">2.3</ix:nonFraction>&#160;million in 2020 and 2021, 2022 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyNjI_d7bb71af-9376-44ca-9a0d-920d53f5c9f9">44.3</ix:nonFraction>&#160;million, 2023 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyNzc_8afbdd37-e301-40c0-9319-85b06c0708b0">2.3</ix:nonFraction>&#160;million, 2024 - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyOTE_8bb375d2-a510-445a-9b79-cb2f1d7426a4">133.8</ix:nonFraction>&#160;million, and thereafter - $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzM1Mjk_ba8ebaa8-3786-4172-8b08-1f5a84849e4e">73.0</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_121"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">57</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 11:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM3MDQ_032c506a-a5f7-4e25-aef0-24d5c6a2d193" continuedAt="ibb9592cd9efe45fdb4265df21abb0f0f" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibb9592cd9efe45fdb4265df21abb0f0f" continuedAt="i3cc1766f889f414e96fed3412dacef64"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2019, the total amount of these forward exchange contracts was SGD <ix:nonFraction unitRef="sgd" contextRef="i3aeebc15e0d840ad96d6c9b1d2194147_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE0OTM_1c30abed-c3fa-40ed-ac90-b39b583e1f10">601.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8f67399f84d54d7d9030ffcf5f5c6ac4_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE1MDA_d39010e6-93d1-44a0-9213-f68d0daeba9a">13.4</ix:nonFraction> million. As of December&#160;31, 2018, the total amount of these forward exchange contracts was &#8364;<ix:nonFraction unitRef="eur" contextRef="i9eb6fafaba61400aa82fd9842455a69a_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE1ODY_9034306e-15d3-4805-9182-212a4752b5bb">10.0</ix:nonFraction> million, SGD <ix:nonFraction unitRef="sgd" contextRef="iffd10e01ebd64b78a96cb615682a5c6e_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE1OTQ_c728419b-ac57-4312-af9e-6df2d3276cd5">601.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if06d9d35bbb0409183e672452771280d_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2MDE_7de3b27b-aa54-4996-afb9-508abc1138e2">13.4</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM3Mjk_355c7fb9-4ae4-43a9-80c6-6fa0e40a2686" continuedAt="i0c6517c9fa5b4dd4bf0b5fcc239618e3" escape="true">As of December&#160;31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><ix:continuation id="i0c6517c9fa5b4dd4bf0b5fcc239618e3"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:52.487%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.906%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sell</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Euro</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i823dde1ddb5c418a9c33b324e0c85370_I20191231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzItMS0xLTEtMA_5a0a1f8c-237b-433a-85b9-a388fe9eeffb">38.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad4d547d2e35453f98a85f299454f00a_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzItMy0xLTEtMA_bf2b311b-86fd-4d82-b998-e11be13e0127">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="eur" contextRef="iad4d547d2e35453f98a85f299454f00a_I20191231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzItNC0xLTEtMA_763ad8a1-3fcb-4cfb-831e-895c34792e06">33.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Yen</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="jpy" contextRef="ieafbd5812ce143ef926bb1c0787dfbc6_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzMtMS0xLTEtMA_4678b5c2-1821-4ecb-b9d1-650f0de9d43e">6,550.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0350a757f15d45c69e08b7eb2c4328de_I20191231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzMtMy0xLTEtMA_9d8de139-b290-4cfa-98a4-98d013dcca5d">37.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="eur" contextRef="i0350a757f15d45c69e08b7eb2c4328de_I20191231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzMtNC0xLTEtMA_9667ba8f-8e0f-4fe5-8599-afccbe8e286a">20.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SGD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="sgd" contextRef="ie91724d6f39f459f886db959578117c7_I20191231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzQtMS0xLTEtMA_e3d195a2-2d89-4d8e-a551-1e922bff9b0d">29.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i41f0ad8b423640e7ab03461e54ef5610_I20191231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzQtMy0xLTEtMA_2ce9d53b-bebe-4361-a42b-f669cb64c119">16.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="eur" contextRef="i41f0ad8b423640e7ab03461e54ef5610_I20191231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzQtNC0xLTEtMA_ba01b575-fa80-463f-8eb3-1333f4e14acf">4.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2019, we entered into the cross-currency swap for $<ix:nonFraction unitRef="usd" contextRef="i5b88e6dc60f545a3bf0b56c374eb3e15_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyNzU_ed1009b7-705c-49a3-9803-5b504b17ede4">90</ix:nonFraction>&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;<ix:nonFraction unitRef="jpy" contextRef="ida576a4da2ec47b5b4725b7e5768d696_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyMjQ_dc3ee007-0528-4637-b37d-634b55b33eb9">9.8</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="ia5e9aa415d9a4ae0894a28edad8214aa_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyMzg_58c35b6c-9f8f-41d2-8c5c-fb71060cbf93">90</ix:nonFraction>&#160;million) and the swap termination date is December 31, 2024. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">58</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i3cc1766f889f414e96fed3412dacef64" continuedAt="i12d050be35a543c59cb54ec7d73d26ef"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From November 2017 through October 2019, we purchased several series of call options for a total of <ix:nonFraction unitRef="bbl" contextRef="ib8c160a1ee5b40b5815b9d3cfcebe527_I20171122" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DerivativeNonmonetaryNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzMyODQ_114820d9-9b94-48b5-ad68-9e0ee25c074d">352,682</ix:nonFraction> barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we had outstanding contracts to purchase <ix:nonFraction unitRef="bbl" contextRef="i2d648861366e4cdba756d7642ed7befe_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DerivativeNonmonetaryNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzM5OTM_d9c53c1a-f21d-4722-9ab4-bbd7167da3e3">135,967</ix:nonFraction> barrels of crude oil from January 2020 to June 2021 at a weighted-average strike price of $<ix:nonFraction unitRef="usdPerBbl" contextRef="i2d648861366e4cdba756d7642ed7befe_I20191231" decimals="2" name="us-gaap:DerivativeAveragePriceRiskOptionStrikePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzQwODg_65c52eac-f12f-47dc-a0c0-88b7f3de76a2">70.71</ix:nonFraction> per barrel.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please refer to Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2019 and 2018.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0NTg_46b2b432-9698-40bd-8321-746dbcfe4395" continuedAt="ia6a57ec99ca74bcba463fe7b4200f001" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:30.692%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:16.269%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.429%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:27.328%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain Recognized in Income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzMtMS0xLTEtMTU5OQ_90d17fa8-a8cf-44cd-aabd-85958a6aea7d">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iffca62c03c8741448a75a7f9e1f891ef_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzMtMy0xLTEtMTU5OQ_5ea89a94-381b-4118-a9fe-6ff28d2a9630">6.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzQtMS0xLTEtMTU5MA_e7da8bbb-6ec8-4dbc-b25e-377277d04def">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie04ce0467d524a8b80a1b327747a40f3_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzQtMy0xLTEtMTU5MA_bf4e17e0-3e56-4001-a880-2ad7f1cbc394">6.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December 31, 2019 and 2018 were $<ix:nonFraction unitRef="usd" contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyOTA_9d61ece6-abe3-40e4-903d-6edb92dd59ec">8.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ie04ce0467d524a8b80a1b327747a40f3_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0MTY_938cdfad-50f8-43b8-a95a-0e79c6df2994">3.7</ix:nonFraction>&#160;million, respectively. We expect to recognize $<ix:nonFraction unitRef="usd" contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0MzA_f5e6d2ce-c53f-4392-acb0-59e2c35f7e30">5.6</ix:nonFraction>&#160;million in earnings, pre-tax, for forward point components in 2020.</span></div><div><span><br/></span></div><ix:continuation id="ia6a57ec99ca74bcba463fe7b4200f001" continuedAt="i62f7c2f1ed9b4ebf887eea8f516bc8b5"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:30.587%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.306%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.598%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.466%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.598%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.105%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.598%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.105%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.598%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:27.239%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Hedges:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtMS0xLTEtMTU2Nw_977c0cbf-6ec5-4015-aaa1-8a58d4b5c778">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtNS0xLTEtMTU2Nw_1bbe5c8c-9fb1-467e-a2e3-764ca1415cf9">4.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtMS0xLTEtMTU1Mg_794ead37-01e9-4310-a891-4a746f29da92">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtNS0xLTEtMTU1Mg_24846cda-7d9e-48fc-88fe-04944a274695">4.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash Flow Hedges:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b51d389a3a949c1a96cb422c48a5fe8_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtMS0xLTEtMA_b125ca8e-4e7a-49ec-ac8e-ff2dad7d0a9b">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6516bd8d8ea049f183846349a305264f_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtMy0xLTEtMA_a8aedff1-3f53-4f76-99cc-d254f66ba8fe">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b51d389a3a949c1a96cb422c48a5fe8_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtNS0xLTEtMA_34de6f85-0619-4e59-a5e8-2c0d4a71e90e">0.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6516bd8d8ea049f183846349a305264f_D20180101-20181231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtNy0xLTEtMA_80d71a24-9256-4941-a345-04ac92b2da15">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iab7e1e117b2f4ca4b60537b7871e437a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtMS0xLTEtMA_13bbaf49-6f2a-4f90-a6c0-9e475e474d7d">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i88d7a3c0aeba474fab1d76fe62b33c49_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtMy0xLTEtMA_6efefbbe-22ab-4591-a960-cee054e8582d">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iab7e1e117b2f4ca4b60537b7871e437a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtNS0xLTEtMA_6ddef50c-bedf-41c9-8be5-b9337980e4fb">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i88d7a3c0aeba474fab1d76fe62b33c49_D20180101-20181231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtNy0xLTEtMA_ffa79441-10f7-4dba-8e18-8b8d870a3188">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward treasury locks</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b1d512dc5f74c76b6f5691e47874f8c_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtMS0xLTEtMA_75444b03-ed63-44c0-8c5e-18363796cc01">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0cea4779b5e94dd0a2b87c75a76cf6ff_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtMy0xLTEtMA_45ca6772-33aa-4784-8227-7d8b0829bc7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b1d512dc5f74c76b6f5691e47874f8c_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtNS0xLTEtMA_3fe419d1-ebb5-43a9-a427-0c9705c99daa">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0cea4779b5e94dd0a2b87c75a76cf6ff_D20180101-20181231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtNy0xLTEtMA_f656de71-ab56-48aa-9969-e720add3361c">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83d0a9a392814a039ab15f60e9215923_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctMS0xLTEtMA_b88680a3-3857-48b9-ae75-212d3a6274b5">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8f8b7ccbfafd42afab343384ad715db3_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctMy0xLTEtMA_25745918-2f48-47ee-9d7d-c8618bf41a04">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i83d0a9a392814a039ab15f60e9215923_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctNS0xLTEtMA_62852698-52bd-4352-b00d-af5171783dca">1.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8f8b7ccbfafd42afab343384ad715db3_D20180101-20181231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctNy0xLTEtMA_214c63f8-3b0f-4c30-bff5-2accea90ab08">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Investment Hedges:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency-denominated debt</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e81e564ed5e4b758e644f7a48f8ab95_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktMS0xLTEtMA_8191fe74-8fbf-4738-9ba7-9030ac9c4899">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifad6e6da551a403b9f68328ad4a2647e_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktMy0xLTEtMA_07f44b7d-0a49-4fc1-a549-d41d7eea9e60">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e81e564ed5e4b758e644f7a48f8ab95_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktNS0xLTEtMA_632218bd-490f-49e9-a4fd-d346b6a7fbe0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifad6e6da551a403b9f68328ad4a2647e_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktNy0xLTEtMA_54b4b712-aba6-4a39-810a-03eb70b74353">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross-currency swap</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifb86356e282f48e09566b38bfd145856_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEzLTEtMS0xLTEwNjE4_0f0d7c2c-ca9f-49b6-b2d9-4ae56a09d2c0">1.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4786eb20ae494021a5b1565f7a6b78cb_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTEtMS0xLTA_f24b5373-2399-49c5-af08-164acbb6cfa2">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7230a373ea8c425db7fc49d912890ad7_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTMtMS0xLTA_0ba407cf-b122-477f-a49b-15fac8c337b1">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4786eb20ae494021a5b1565f7a6b78cb_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTUtMS0xLTA_e49140c9-7ab5-44ca-b2f7-a9d34c5a7589">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7230a373ea8c425db7fc49d912890ad7_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTctMS0xLTA_c58dd9cf-b54d-4d12-a3ed-1fb1ed0f15e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">59</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i12d050be35a543c59cb54ec7d73d26ef"><ix:continuation id="i62f7c2f1ed9b4ebf887eea8f516bc8b5"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:57.455%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:17.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.873%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3a0f779ffd67404fadb2c88b38a8fdc2_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzEtMS0xLTEtMTA2NDM_0e1a0779-d6ff-43b8-be17-766dd73178d7">0.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5444a6541e6a4839bba8118e13149c48_D20180101-20181231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzEtMy0xLTEtMTA2NDY_13aba5da-02e3-4371-815f-5723289c4c2e">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifc4590db188d460db03346773c2dfbe4_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzItMS0xLTEtMTA2NDg_906ada70-443f-4d91-904f-37f1b845af17">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i06546c728f1b443790dab4e6acbc50dd_D20180101-20181231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzItMy0xLTEtMTA2NTA_7770ce5d-722c-44fe-ba8f-3667f92989f5">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifcb34bb0d2724fb1baccf7a4fa927eef_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzMtMS0xLTEtMTA2NTI_c998dad9-64c8-45a4-a5b4-7a49d84be0bc">4.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5398fe0e5da44d5c9cda165e14f5d41d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzMtMy0xLTEtMTA2NTQ_dcdeba6f-c2ca-4b63-8f31-f25c10144bae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i938788ff937e43d487f7bb5a02deca1f_D20190101-20191231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzQtMS0xLTEtMTA2NTY_eb74c345-e111-47f8-b6b3-ed0b993748e4">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i72df90269a054543b29d4dd406291594_D20180101-20181231" decimals="-5" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzQtMy0xLTEtMTA2NTg_6d8c15a0-ae84-4f30-ab04-129ab4814419">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyODc_67ce2a44-3bba-4d3c-abc3-279a955c9298" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:30.692%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:16.429%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.429%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:27.168%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Loss (Gain) Recognized in Income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commodity call options</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9c77ba79e344403eb264810bc01f9141_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzItMS0xLTEtNDgzNA_84812f97-3b64-4e41-8ccb-f51e963b121c">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icefa72050c4e4056afec90fa88e94c46_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzItMy0xLTEtMTA0OTk_43b26923-4da8-4a3b-a3c3-40b3f9e2f9a2">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56943e3e899240ba88693a4605ca6bff_D20190101-20191231" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzMtMS0xLTEtMTYzNw_8cbd98dd-bc28-4c3c-b69c-ee94fdd4661e">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i241e5f10a4ee4e61ae7e0c26389d98fd_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzMtMy0xLTEtMTYzNw_797b3137-753f-4a40-a129-9deb61c59b9a">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019 and 2018, there was <ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0NDY_cb0b843e-06cf-4516-826a-2e8dd324adc3">no</ix:nonFraction> material ineffectiveness related to our hedges.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i_0_124"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 12:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2ODI_b63d934b-8e15-4711-898c-e7d3698a8eeb" continuedAt="i48ea8cb7237e434bbeceb10d97a8b0f1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i48ea8cb7237e434bbeceb10d97a8b0f1" continuedAt="iaeaa4cd88c2a4c63a869a81a85067f73"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;">Level 1</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;">Level 2</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;">Level 3</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">60</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="iaeaa4cd88c2a4c63a869a81a85067f73" continuedAt="i7deaa9bcc2e347d3a8bc61dbb72a9dff"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2Nzc_e8471896-74fb-4ba1-a27e-6f91ad6b5b6b" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.826%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.945%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzQtMS0xLTEtMA_42a7fbcb-eaa1-442b-8a4a-9dee00963173">11.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231" decimals="-5" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzQtMy0xLTEtMA_cf5b9d7a-b59f-4622-a3c1-5aac9380cf06">11.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzUtMS0xLTEtMA_d7e88487-09e8-4eff-965c-de2c1b3819c7">7.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzUtNS0xLTEtMA_6d84cf68-9d67-4404-990c-b34819421e54">7.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commodity call options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtMS0xLTEtMTY3OQ_abf30767-141c-4009-a6ca-6f7999bf9efb">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtNS0xLTEtMTY4Nw_8b947695-bf04-4e39-98f6-a81ea58225b8">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtMS0xLTEtMA_b67e8bae-307c-478c-8325-2db24c1e7064">19.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtMy0xLTEtMA_bf1df221-1e74-4b78-8621-e1bb6fe44ec6">11.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtNS0xLTEtMA_5221a1e8-1f9f-4f51-9ee3-939435d11534">7.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzgtMS0xLTEtMA_715ee649-aa92-4bc4-9728-70bf70213822">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5dac4480e07412789c6a00d0537966a_I20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzgtNy0xLTEtMA_101a1bc2-44c9-4fd8-8fd9-5e9b2025834c">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzktMS0xLTEtMA_7e796fbf-81b0-45af-a716-0d5045cc35ac">12.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzktMy0xLTEtMA_2abf6fc0-16c9-44c2-a0da-1900ba4bf693">12.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross-currency swap</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49fc1eac9a9a44988c05ab15c2b63dfc_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzExLTEtMS0xLTExMzM3_4f16def1-bb35-4820-ba9a-58fb373e93a2">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d4ee3958e024ea9be2a4c855879a06a_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEwLTUtMS0xLTA_8b1b396e-b916-4007-8480-e2f940af1b6a">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzExLTEtMS0xLTA_d15bdf3e-3de0-4479-8843-892691491a36">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzExLTUtMS0xLTA_2655395e-c973-4118-94f6-a8f61104f011">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTEtMS0xLTA_314f262f-0e83-4093-9409-90762a82302b">17.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTMtMS0xLTA_f1c3377e-e5bd-4020-8f10-46926e63be2e">12.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTUtMS0xLTA_fd491452-0dd0-4364-9b28-77be4cd706a9">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5dac4480e07412789c6a00d0537966a_I20191231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTctMS0xLTA_684592e6-2898-4e5e-9330-dc815f7c2a1d">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.826%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.945%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,<br/>2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzQtMS0xLTEtMA_a600f498-3845-4e0b-82e8-4d108a057c44">8.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231" decimals="-5" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzQtMy0xLTEtMA_2f51ba68-2d35-458c-b9f9-75da07908ab3">8.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzUtMS0xLTEtMA_81a5886e-d1f2-41fd-881e-8ffb81e999f0">6.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzUtNS0xLTEtMA_60bbddd3-a745-4a98-897c-2438ae0518b8">6.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzYtMS0xLTEtMA_006e4b2d-5f18-4106-bab8-c3ad7cea5483">15.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzYtMy0xLTEtMA_ef35d77a-f2d4-48e7-8a27-10cd33338130">8.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzYtNS0xLTEtMA_8bb3270d-7eed-4258-954b-c17eaf2ede2a">6.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzgtMS0xLTEtMA_f4ee4068-dcd4-4418-afbf-b006290da113">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30b7e14d051044b6b066bd549c53bd4b_I20181231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzgtNy0xLTEtMA_e357c02e-0537-4e5f-bd9c-0d2324346b97">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzktMS0xLTEtMA_c5c737ba-d6e1-465f-a82f-5493424e2c8c">9.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzktMy0xLTEtMA_7eaf053d-c871-4e3e-a7ec-ad4f8b798e34">9.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzExLTEtMS0xLTA_11e85d33-f11d-43d0-95b0-c49ef2574439">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzExLTUtMS0xLTA_4306032e-5122-4655-9541-2be36d00ee5d">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTEtMS0xLTA_7cacc8ab-e956-4535-8f93-6166a18bf320">11.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTMtMS0xLTA_fb8d26ee-0912-4076-90bc-16eca0977ad8">9.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTUtMS0xLTA_f5793629-861a-4a8c-b0f8-34ec3c0b3565">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30b7e14d051044b6b066bd549c53bd4b_I20181231" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTctMS0xLTA_21618da6-a91d-45f5-a6e9-992d21069874">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term liabilities, is valued using a market approach. Please refer to Note 11, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Derivative Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of our derivatives.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Level 3 Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the contingent consideration liability related to the SmartDose technology platform (the "SmartDose contingent consideration") was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">61</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i7deaa9bcc2e347d3a8bc61dbb72a9dff"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">obligation are recorded as income or expense within other (income) expense in our consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2OTU_4b8afd70-99f1-48a0-9eff-d646b3f52f2a" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:83.096%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.904%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzEtMS0xLTEtMA_8045479d-972f-484c-8c29-119f47a24788">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease in fair value recorded in earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzItMS0xLTEtMA_3ff21b17-fcd1-4444-93d2-fd352ca248f4">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzMtMS0xLTEtMA_01a53986-8763-4257-87b2-4393b99c3218">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzQtMS0xLTEtMA_dcbc5a84-ead0-4dbe-bce9-3898f0378fc5">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in fair value recorded in earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzUtMS0xLTEtMA_3c3d5828-3d5b-4ab1-afc3-4f6695d214f4">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzYtMS0xLTEtMA_5a5afcee-4049-4fc5-927f-da783905eb23">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzctMS0xLTEtMA_109ffb2b-3bc2-466f-86f9-27e66c1a2098">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2019, the estimated fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM1NDg_c08b9dae-88fe-4f76-85b7-4da0b08b8ae0">263.3</ix:nonFraction> million compared to a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM1ODQ_538d15f7-886e-46bf-8f91-34d82ea27aaf">255.0</ix:nonFraction> million. At December&#160;31, 2018, the estimated fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2NDI_966660fd-0e03-40be-b1bc-63a3a0f6b312">192.6</ix:nonFraction> million and the carrying amount was $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2NzM_f1a63bf4-28f6-49d7-844c-1e7fbb46e95e">196.0</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_127"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 13: <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ2Mg_db1af4a0-9a4b-4285-acef-df595bd8a006" continuedAt="i51cf2d35c86840ab9a837ee8af014ddb" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i51cf2d35c86840ab9a837ee8af014ddb" continuedAt="ic5230ecc59424de8b1a3351f97cb16ca"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ3Mg_c47ec4c7-9e91-4874-a6d6-498fa31438da" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:27.487%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.025%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.750%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.378%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.419%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Losses) gains on derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gains on investment securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i54c1d0f284e747c89538b5a73987ad3d_I20171231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtMS0xLTEtMA_657e0fd6-c33c-4fb8-8362-0fae0ff1eb18">4.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d70b978d8424d62a3d315bd9abaa763_I20171231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtMy0xLTEtMA_ed5a24bb-8c59-41bf-8968-0c1ae25c467b">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icd5b5ea0ff6242348184786c3aa961a1_I20171231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtNS0xLTEtMA_51a17dee-4d20-4476-bfea-aa0c5afe2cc4">39.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i61530ee5d64a43f0808f912144af8669_I20171231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtNy0xLTEtMA_e169f64e-6544-41fe-87a6-03ceea3a530f">74.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtOS0xLTEtMA_6022c937-9116-49f4-984f-0efb26937299">117.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItMS0xLTEtMA_c395c110-1bd5-42ae-8625-d2c568a04430">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItMy0xLTEtMA_7b5d942e-957b-434e-b1c7-fa4f763d69a2">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i20cc775951344c239b53db6971de8efc_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItNS0xLTEtMA_610bbb2a-6505-43ba-927d-54ceca23d76d">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItNy0xLTEtMA_7dd81524-678f-4e2b-a612-0b55d1c341f6">39.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItOS0xLTEtMA_0cc58a01-72fb-4f4b-a81f-7d1eb8a3aae7">37.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtMS0xLTEtMA_ca51b5ad-767b-4505-ad87-2257468dacc4">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtMy0xLTEtMA_c7101e0d-29d5-4e3f-b875-a4d3d95798c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i20cc775951344c239b53db6971de8efc_D20180101-20181231" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtNS0xLTEtMA_ea291d41-f746-45ed-9bdd-d60c447ab2e9">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtNy0xLTEtMA_85cc130b-7014-40cb-abbb-084bcedf0f7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtOS0xLTEtMA_9af03166-703a-40d6-b134-642f5a574eaf">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtMS0xLTEtMA_bf01411b-c6a2-4eb1-9452-72b641c2f4e8">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtMy0xLTEtMA_74cd3f48-fb9f-464a-9df9-d24b037154b6">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i20cc775951344c239b53db6971de8efc_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtNS0xLTEtMA_58025b5e-799f-454b-b055-3cb571fe264e">1.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtNy0xLTEtMA_69783bd2-f4d1-4ada-ad2f-1707ca4e3cd1">39.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtOS0xLTEtMA_00f47f83-7298-4e4d-a481-b22fa8083751">36.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0d3c7ebb49d2493aae018dd123c22d48_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtMS0xLTEtMA_8fb2d078-c74c-401e-806d-c806cc85ed96">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53303cfc86bc4dff961279511a95e263_I20181231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtMy0xLTEtMA_95001cd9-1cd6-4552-8030-2bd21ac3eada">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5c9924dfc84f437e82ad7ec265e9ce95_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtNS0xLTEtMA_6bbc7510-2b58-45d0-9cbd-3796b669825b">40.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i226a4aed358e47e7960939567dde9022_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtNy0xLTEtMA_ad01551e-7068-49b0-acfd-08a95e7beea3">113.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtOS0xLTEtMA_7fae33ce-8b46-49fb-b9dc-27750b08814a">154.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtMS0xLTEtMA_5bec7570-b996-4507-9f5f-cb49b945e891">5.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtMy0xLTEtMA_5b2c8af0-2c04-409b-a756-e72b1ddc32b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtNS0xLTEtMA_67386bc1-49ec-4ffd-ab44-933eb82edb88">1.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtNy0xLTEtMA_adcc390b-7c3a-4407-8b0b-d091e9525755">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtOS0xLTEtMA_a043402d-b5e9-4dc6-aaf9-cadd2cf30af5">8.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctMS0xLTEtMA_48ea6b3a-55a7-489e-8057-30f24183450a">5.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctMy0xLTEtMA_517c4be5-a306-4c74-9775-ebcf775c35cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctNS0xLTEtMA_34562731-3ca7-46b9-8f2d-aa828eb0d7b3">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctNy0xLTEtMA_3144883e-8878-4846-b24d-ae15553daeed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctOS0xLTEtMA_6bc4fe8d-d77f-469c-956d-efec81f979cc">3.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtMS0xLTEtMA_d6e81488-d827-4abf-b712-91a2926a7cd7">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtMy0xLTEtMA_81ae05d8-806d-40b6-8f04-cd35cf627ea6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtNS0xLTEtMA_149f2428-6676-41ab-8bca-1f5013c1f5fc">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtNy0xLTEtMA_0caffcbb-623f-4752-a75d-19b04ec740fb">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtOS0xLTEtMA_4dfb3ed4-b0f1-4fe3-9d06-df782bac784f">4.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i61e147e1374f4056b910aed673effca0_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktMS0xLTEtMA_5f73fd52-8a4c-4ecb-bec8-35f91b73d874">0.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3de8a9a6e8a94858b2a73224b4e7f5fa_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktMy0xLTEtMA_a6f16a62-49fc-47cf-833b-d3cc98b2977a">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if438f100318e4fa3a354238bdb515b75_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktNS0xLTEtMA_095c1d9e-d9cd-4e62-8f77-a887b2a585a7">40.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4cec6a2db0f04eb8ace95c800f171e3f_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktNy0xLTEtMA_5e11250e-87d0-446a-94d9-b305e1300547">108.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktOS0xLTEtMA_648d6b2f-b506-44dc-b2f0-73fb26240b6c">149.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">62</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ic5230ecc59424de8b1a3351f97cb16ca"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ2Nw_ca5d1085-1ac1-440e-a4af-f37177ec0d35" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.987%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:32.136%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Detail of components</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gains (losses) on derivatives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2e238f2cc9d40cb97384f851a4ea42e_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzItMi0xLTEtMA_b34d9f97-6763-4609-83f2-70e919dc3f48">1.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6f47dbaaaf6d430698b26cb6d8506727_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzItNC0xLTEtMA_7f2a450c-d0a5-4f9e-9e88-73f1023e0752">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2e238f2cc9d40cb97384f851a4ea42e_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzMtMi0xLTEtMA_45f933a9-cfcf-45fe-9422-8c8bc31df6f9">1.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6f47dbaaaf6d430698b26cb6d8506727_D20180101-20181231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzMtNC0xLTEtMA_e27a1aea-0a5e-4327-8415-b6a82e578199">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee4a569c86594ed29bf4011534feefa3_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzQtMi0xLTEtMA_33e7d8df-0117-4ca3-94c9-2821c81cf502">6.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7fe96b1532ac40c18a9abf4c6908270f_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzQtNC0xLTEtMA_6a3262d7-4bd7-4fae-ab26-3cb6c1e2e1fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other expense&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i52141f7b63cf445d8c4a8244666efd47_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzUtMi0xLTEtMA_64adedde-c33f-46c4-87c4-983658455a05">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3d9afa908f244094a5308013f6de9d86_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzUtNC0xLTEtMA_1d711a33-83ca-49a8-b2b6-4f7d447dac77">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzYtMi0xLTEtMA_892485c3-98f2-43f8-a93c-cb0321765a13">8.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzYtNC0xLTEtMA_be43faf7-c2aa-4888-ab33-f4e224d353b7">1.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzctMi0xLTEtMA_6c657fa9-5484-4b5c-8706-cf8c0ef23911">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzctNC0xLTEtMA_db2b88d8-1f59-4806-a063-369ae57fe4f3">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzgtMi0xLTEtMA_9c96cf7b-7c0b-40b2-9ed7-63ea1504cba9">5.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzgtNC0xLTEtMA_74374af8-0bff-4f93-9d34-837f65b30a71">1.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTItMS0xLTA_158e1055-5fdf-4a12-9fe0-387a2cc0fd98">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTQtMS0xLTA_39b1e72d-a910-4547-84e9-4db1b28ffa44">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTItMS0xLTA_1381ba37-693b-4a76-81c2-d76f8f336004">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTQtMS0xLTA_6ce887dc-fdf2-48fb-a49b-0c1d0da55efb">1.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE1LTItMS0xLTA_c66574e5-20cd-43d0-bc1a-d1107d8ade46">2.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE1LTQtMS0xLTA_25461cab-041f-46bc-a4a5-160a8a78dd37">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE2LTItMS0xLTA_9363c5cb-fde6-4604-be8a-b10d1e3e7d6c">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE2LTQtMS0xLTA_2618c5cf-748e-40d4-96da-b45cbe30abe3">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE3LTItMS0xLTA_6066a7de-25e2-48fc-a160-dfd6346a4b99">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE3LTQtMS0xLTA_bf42023f-3691-4f5e-99d3-22943d5643b9">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iebf8f5c36fb64d06aff88d876051dba3_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE4LTItMS0xLTA_41b4ab9a-0c39-455a-a75c-95d8868b1608">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9ec88e31a4b8432c9b702366e072bcb8_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE4LTQtMS0xLTA_c3c2d237-2940-4d9a-9b04-81e4fab08e4c">0.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c" xml:lang="en-US" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></ix:footnote></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i_0_130"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 14:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxOTY_3e803897-09a3-4826-a545-268adbf5b401" continuedAt="i4b52355d75de48f9a1cc5f22db6cab2a" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4b52355d75de48f9a1cc5f22db6cab2a" continuedAt="i775ff3fcb28d4f5d8978d18799b589b2"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2019, there were <ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzQ1MQ_fc743844-282b-4217-9673-23f25bb95ef1">3,119,314</ix:nonFraction> shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock options and stock appreciation rights reduce the number of shares available by <ix:nonFraction unitRef="shares" contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="wst:ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU5Mw_f9c6d23c-0b1f-4bac-b593-25ff14fc8479">one</ix:nonFraction> share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to <ix:nonFraction unitRef="shares" contextRef="i09ac587c6b034ba186fc3c9de00c5b88_D20190101-20191231" decimals="1" name="wst:ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc0NA_03d3b278-0403-4a8e-8a16-b3558e107ef8">2.5</ix:nonFraction> times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">63</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i775ff3fcb28d4f5d8978d18799b589b2" continuedAt="i7dd017b434654bc19cc9c89c0385629e"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMjg_e23fb6ce-a263-4b76-899e-7a794cd1e259" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock option and appreciation rights</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i907bb151930c472cb4617e8718b30e96_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzEtMS0xLTEtMA_9ef28373-8611-4095-b61b-57ddbe121e65">9.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia7b4b4807f6a4884893b217405bc6fea_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzEtMy0xLTEtMA_b03f9d76-263d-4325-b41b-2d5a39ef9de5">8.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b919d55672f4707aaf1d62ddfc9503d_D20170101-20171231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzEtNS0xLTEtMA_38174cc5-406d-4332-a314-aaf4f8cdf80f">7.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, stock-settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i867e15a5465644589509da385c3661da_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzItMS0xLTEtMA_32782d80-388a-4bff-9b1e-16e6149cf519">9.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6f53f5cc02db4483948008576a947179_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzItMy0xLTEtMA_c6579dec-cb1b-4a6d-89dd-2bca0b30efc4">2.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ied22694c54d942dbbe6f33ff6b1dcfa0_D20170101-20171231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzItNS0xLTEtMA_87af2e9b-7eb0-4ce3-aa9e-673fe5edd676">4.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, cash-settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzMtMS0xLTEtMA_5033af42-c203-4570-b328-151c89ec9910">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzMtMy0xLTEtMA_46c2515f-3657-4872-bbdc-e85c8737de9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzMtNS0xLTEtMA_9f51ea2b-132e-4d50-ad0e-6e5d26d060b9">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, dividend equivalents</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7bc4c67901ce44cc8ef5352dc9cb7c54_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzQtMS0xLTEtMA_90309627-9368-497b-8fc8-e16387e5c7f2">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i567d1eac07af4457b1dd2b7b2b50501d_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzQtMy0xLTEtMA_e6f37a40-320c-4000-90c4-cf39118f4ee4">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf6f7b5a95fd4d168630008ee5f37653_D20170101-20171231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzQtNS0xLTEtMA_0fc4ff61-1f44-4b2c-aaf3-bf10ec8d5f01">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzUtMS0xLTEtMA_5f8b2796-ae9f-4c23-b773-4bed6af25b56">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzUtMy0xLTEtMA_a76ffd5a-f28d-4a28-b208-05138dcf2087">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6077149f426d4ae8a0b5fd6b074a7a43_D20170101-20171231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzUtNS0xLTEtMA_d0a78f76-db8b-44d1-85d8-61c8dde7036b">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9df6a38179044003b818ff0f67bc84c1_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzYtMS0xLTEtMA_78460ff7-d242-41af-bffc-9a721dcb65d9">4.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d97e40c7db14ee0809a960d3d36fb39_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzYtMy0xLTEtMA_a5df1573-f0d7-45a9-b13f-6eeee951abd9">3.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2bf2b4179734ec29b0e706a4dd04b3c_D20170101-20171231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzYtNS0xLTEtMA_c8899587-aa1b-4dec-8e0e-4bf72e939978">3.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stock-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzctMS0xLTEtMA_165382f1-8857-4367-b5ac-cd50f1a4d309">24.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzctMy0xLTEtMA_b88227eb-c27c-4a4e-b4cf-245147a25047">15.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzctNS0xLTEtMA_4a96b748-7882-425f-a75c-c78846126941">16.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2019 was approximately $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE0OTc_ffbe1204-28f2-4a3c-b63c-9ef45c1b7237">21.2</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE1NzA_7ac9ec5c-e81a-499b-b86c-ea39768a798d">1.6</ix:nonNumeric> years. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock options granted to employees vest in equal increments. All awards expire <ix:nonNumeric contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE2NzY_3eb4ab3f-289b-4565-b8c8-ce5b195aff73">10</ix:nonNumeric> years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxOTE_df97f676-8676-4b06-82eb-8f072915fd28" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in outstanding options:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions, except per share data)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzEtMS0xLTEtMA_72e49cc8-a945-422c-9d93-5849d9133a36">3.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzEtMy0xLTEtMA_90e4c761-d9df-47d3-b9ba-711f37ab5d2e">3.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzEtNS0xLTEtMA_c2a1797f-38e2-40c2-96c7-86c5e5449a07">4.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzItMS0xLTEtMA_d7f7eb6c-94df-41b2-9fe5-678bc2f89326">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzItMy0xLTEtMA_3eebc4d5-b510-4004-b7f9-b89f60446191">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzItNS0xLTEtMA_eb1e804a-d358-4d9d-8e41-1af39de6955e">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzMtMS0xLTEtMA_221aa90e-458e-4bb4-b89f-1dd30df19851">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzMtMy0xLTEtMA_c2b85bc8-895f-4ecf-9c8e-28ff3de78a89">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzMtNS0xLTEtMA_340f5b5b-a15e-4283-9287-977d8f1481f8">1.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzQtMS0xLTEtMA_5bebb62a-b54d-45bc-9dd9-066ef3a234bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzQtMy0xLTEtMA_231985c5-c443-45b5-8e90-caecfdde5e9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzQtNS0xLTEtMA_d676da17-47a3-47be-aa83-56454a74727c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzUtMS0xLTEtMA_1ff39b3e-5d08-4b1d-96b1-f75ea3473fa9">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzUtMy0xLTEtMA_56010730-2896-46b2-84e4-b547f9596822">3.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzUtNS0xLTEtMA_39a978f7-a3fe-4967-8846-d4775447c808">3.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercisable, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzYtMS0xLTEtMA_a2bc60b7-54f9-45ee-bcf6-f5ef9de87c32">1.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzYtMy0xLTEtMA_80661460-723e-4601-a511-a7c066cfeef4">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzYtNS0xLTEtMA_d81c481d-5afd-4d19-a4fd-3be2b6ee04c5">1.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzEtMS0xLTEtMA_f372fe02-b180-488c-91d8-c05e3be9c7a3">58.93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzEtMy0xLTEtMA_95880d67-0c85-48f2-9ccc-9b4995ea90c3">48.76</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzEtNS0xLTEtMA_f37a8080-0d84-47d5-8e24-f9f55d92e4f1">38.11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzItMS0xLTEtMA_7af707f5-4e78-4f0f-ab04-f1802e50a321">103.40</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzItMy0xLTEtMA_d4400d97-5d40-4cec-8bec-375b020c117e">90.36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzItNS0xLTEtMA_11a4ebf8-af28-40d1-9319-abb0bd01284e">84.09</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzMtMS0xLTEtMA_42d0c037-80c6-461f-a216-097d5428018f">46.42</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzMtMy0xLTEtMA_4b2d4b32-cf56-4738-a63e-190a074b78e9">35.95</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzMtNS0xLTEtMA_230000dd-e4b4-4c98-afe7-049a60a01722">26.15</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzQtMS0xLTEtMA_fd33d44c-3c52-4408-890f-6a5fe2c4bb84">92.71</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzQtMy0xLTEtMA_14d3047a-107e-43fd-9e6d-bc4362be6cc8">75.32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzQtNS0xLTEtMA_774bf8b2-1eb1-4d48-85ad-25d40fd2fd48">60.92</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzUtMS0xLTEtMA_87b72374-072c-4609-bac8-4e6983c2e609">67.02</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzUtMy0xLTEtMA_b9a84233-dbdc-4731-8ae9-2b69efea9580">58.93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzUtNS0xLTEtMA_d5b39d90-1cf1-454f-a96d-8eb94634c87c">48.76</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercisable, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzYtMS0xLTEtMA_41ecfba5-8707-4ab6-ad6a-a35c50fb7dc8">53.12</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzYtMy0xLTEtMA_12fda810-2609-411e-8a38-36d1783436e5">45.32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzYtNS0xLTEtMA_0707d264-d444-4067-9c17-128f732ff596">35.44</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the weighted average remaining contractual life of options outstanding and of options exercisable was <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE5OTc_26094358-6d9a-4536-8af3-5f03322b6377">6.1</ix:nonNumeric> years and <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIwMTA_c9b042dc-bf25-4d1f-9efc-24838cfacf9d">5.0</ix:nonNumeric> years, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the aggregate intrinsic value of total options outstanding was $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIxMDg_7fe12f23-e64b-4b56-a840-eb4b4ebb6896">227.8</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIxMjE_8fd65330-7480-4ab2-a221-b08b2593c655">158.6</ix:nonFraction> million represented vested options.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2019, 2018 and 2017: a risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIzNjM_01ab2f04-82e6-4907-a74e-e743e4b837de">2.3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIzNjc_0c4412e4-7873-47f0-b1a5-346c4d4b4fdc">2.7</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIzNzU_616c1596-d9f6-4931-ba9a-cb1b2b86d04c">2.0</ix:nonFraction>%, respectively; stock volatility of <ix:nonFraction unitRef="number" contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0MTM_c116c98c-bee4-41ea-9c40-c5da92d711c7">22.5</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0MTc_a065695d-255c-4b84-bdaf-8f934ec28156">19.8</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0MjU_17c37cff-f619-4e22-9f4c-58e28833091d">19.9</ix:nonFraction>%, respectively; and dividend yields of <ix:nonFraction unitRef="number" contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0NjY_b5eebd5d-87aa-4d13-a974-e2f90f8cdf4c">0.7</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0NzA_8362ffe4-8fe1-4640-9d4e-741d3a7caabf">0.7</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0Nzg_88521cc3-9ede-4090-ac74-a63312f2c0ac">0.7</ix:nonFraction>%, respectively. Stock volatility is estimated based on historical data and the impact from expected </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">64</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i7dd017b434654bc19cc9c89c0385629e" continuedAt="ib35b7736ec2d4dbfb61092b22e87e5f2"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">future trends. Expected lives, which are based on prior experience, averaged <ix:nonNumeric contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI2NTc_1c4d3b47-8519-47b2-89ce-16573180fc8a">6</ix:nonNumeric> years for 2019, 2018 and 2017. The weighted average grant date fair value of options granted in 2019, 2018 and 2017 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI3NjI_20718057-279b-4239-8b5f-b40c7ca20080">24.72</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI3NjY_58688213-44d3-4e56-9a53-fab15ee0a7d6">20.16</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI3NzM_7f4db4d0-ebb5-4589-8938-41c3fd81dd1c">18.08</ix:nonFraction>, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the years ended December 31, 2019, 2018 and 2017, the intrinsic value of options exercised was $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI5NjU_b39e362c-82ca-47a1-a5d9-87f14788042a">46.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI5Njk_6a27a8af-f8f3-4e9f-bb0b-98019e0ecaeb">61.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI5NzY_65d61cac-e837-4508-90cb-39e029a2f619">91.7</ix:nonFraction> million, respectively. The grant date fair value of options vested during those same periods was $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMwNjg_552f7b76-de1d-4262-a23c-34b6aea9a94c">7.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMwNzI_e61b8603-9354-4c30-af2e-cc573d5a19bc">8.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMwNzk_f4e708a3-dfca-4bcf-8eb8-e01961122632">6.7</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Appreciation Rights</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock appreciation rights (&#8220;SARs&#8221;) granted to eligible international employees vest in equal annual increments over <ix:nonNumeric contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMyNDE_095b4be3-8b05-497e-ac03-b84e2d9c4575">4</ix:nonNumeric> years of continuous service. All awards expire <ix:nonNumeric contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMyODU_944bf1c9-ec22-4d75-9dfc-c76f14e5d2b3">10</ix:nonNumeric> years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2019, SARs outstanding were <ix:nonFraction unitRef="shares" contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM0ODE_b9e0bf40-dae2-4c92-9380-ab71662d2d40">35,993</ix:nonFraction>, of which <ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="0" format="ixt:numdotdecimal" name="wst:CashSettledStockAppreciationRIghtsOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM0OTQ_f90af6ce-e870-4ac2-9f78-9af6e83bb850">23,833</ix:nonFraction> were cash-settled and <ix:nonFraction unitRef="shares" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="0" format="ixt:numdotdecimal" name="wst:StockSettledStockAppreciationRightsOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM1MTk_80e05907-cb3b-4499-a7e3-743491bfd980">12,160</ix:nonFraction> were stock-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#8217;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMjM_e1414b51-ab18-45d8-a0fe-094489011e86" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in outstanding SARs:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia961f06db9c748b8981269960022f06a_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzEtMS0xLTEtMA_4a1adbe0-2bf5-49bd-bdce-8f01526ea776">39,819</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzEtMy0xLTEtMA_0a72ea5c-a003-4e1c-b0bc-c4aea8af4690">51,368</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib0f756b7f10140c7a667c59d6aed2b9d_I20161231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzEtNS0xLTEtMA_72e67c3c-f2ff-4687-84b1-ce8e2abda25b">116,087</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzItMS0xLTEtMA_ad4ccded-53ef-43c8-a5be-9445ce87c340">3,364</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzItMy0xLTEtMA_96c20b32-d0f4-44d0-9af2-5e1985f75fe0">3,480</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzItNS0xLTEtMA_5451d1ca-443d-4c25-aebc-3de899aeadc2">2,792</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzMtMS0xLTEtMA_b1da9434-f2b8-4c1d-9720-a5ba369948b2">6,790</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzMtMy0xLTEtMA_79c63807-f977-461d-97cf-6b1f535061bb">14,629</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzMtNS0xLTEtMA_ee7622cd-ffe1-4e50-9bf0-0a8b95bd7123">67,511</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzQtMS0xLTEtMA_882add3b-0587-47e9-9bb4-e59854654736">400</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzQtMy0xLTEtMA_3aab3d85-334c-4475-a545-28e46148e183">400</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231" decimals="0" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzQtNS0xLTEtMA_b802ee9e-a15f-4d93-abae-37bc522be411">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzUtMS0xLTEtMA_901b95c2-2e45-4eab-bc59-adc05619e440">35,993</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia961f06db9c748b8981269960022f06a_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzUtMy0xLTEtMA_f82d5c34-2d63-4ba9-a590-050742556cba">39,819</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzUtNS0xLTEtMA_0f8ae15f-ce52-4627-a172-a6a085e9dafc">51,368</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs exercisable, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231" decimals="0" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzYtMS0xLTEtMA_3b1762b7-d5e0-4333-8565-639d2cb275e1">27,781</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia961f06db9c748b8981269960022f06a_I20181231" decimals="0" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzYtMy0xLTEtMA_9385d115-ed5f-4c21-b7a2-bddffc23494c">30,285</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231" decimals="0" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzYtNS0xLTEtMA_89f66225-f79f-4853-924d-ec269e81f4df">39,769</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ia961f06db9c748b8981269960022f06a_I20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzItMS0xLTEtMA_e3cb9a00-c16a-4065-84af-ad40c817f83d">46.48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzItMy0xLTEtMA_6cfbc909-b19d-43d4-ad14-d09beec9ccb8">38.55</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0f756b7f10140c7a667c59d6aed2b9d_I20161231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzItNS0xLTEtMA_75915e5a-8f42-4578-89a2-5ed39a253308">31.13</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzMtMS0xLTEtMA_8e0cd1bf-2d32-46bc-bdc5-8cb6d329d475">102.51</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzMtMy0xLTEtMA_c0ef48b4-160e-4f2a-978a-313b6a1b15a4">89.64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzMtNS0xLTEtMA_78d20735-3ea5-4c34-a3cf-15268447e5c0">83.47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzQtMS0xLTEtMA_eef6110e-4c39-411e-801b-c2522237fbfd">42.08</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzQtMy0xLTEtMA_59b30006-cda7-433f-a5c6-817757738a2a">28.45</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzQtNS0xLTEtMA_b611e1f5-f0d6-43a8-844a-f57b8be8637b">27.65</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzUtMS0xLTEtMA_4f28c712-e4f8-4c03-8780-4ae0c2578468">63.43</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzUtMy0xLTEtMA_25b9ce2a-9d05-47c0-9a49-1a4ba192bf60">63.43</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231" decimals="2" format="ixt:zerodash" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzUtNS0xLTEtMA_c7129fc4-42b4-402d-832d-3ac00d55abe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzYtMS0xLTEtMA_7ccd5646-05bc-49a2-b09d-17fa04a42b36">52.36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ia961f06db9c748b8981269960022f06a_I20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzYtMy0xLTEtMA_24bcd81e-60b2-4900-8df9-1e37a3886e42">46.48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzYtNS0xLTEtMA_fa37729c-c693-4b05-ae34-1bea66e517c7">38.55</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs exercisable, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzctMS0xLTEtMA_9d6b3abb-9533-4831-8693-7416b2533f60">40.73</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ia961f06db9c748b8981269960022f06a_I20181231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzctMy0xLTEtMA_0ac8701d-05b8-4013-a65c-4d33bae87ebf">36.91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231" decimals="2" name="wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzctNS0xLTEtMA_fcc77b7c-721a-45df-bb1e-8374a300a242">30.77</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Performance Awards</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to stock options and SAR awards, we grant performance share unit (&#8220;PSU&#8221;) awards to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.  </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">65</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ib35b7736ec2d4dbfb61092b22e87e5f2" continuedAt="i35c50cd1fbc3481f9ff6a1d4ace22226"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMTc_47ec3c8b-c9fb-4683-819e-eae5fca2da3e" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEtMS0xLTEtMA_fdd66d6c-fc5c-4fb5-b1f9-874a89c0a01f">296,037</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEtMy0xLTEtMA_197b2532-f992-4195-af53-46aae68557e3">341,944</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ice189043bdb14f77817f481da434b9f6_I20161231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEtNS0xLTEtMA_420e8792-5a85-4040-aca5-0fe0f7aea297">378,062</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzItMS0xLTEtMA_8887a3be-ab75-4057-bcb4-abb881ce9225">84,309</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzItMy0xLTEtMA_b95c5793-5011-4a83-8729-3a3c8b33f861">102,307</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzItNS0xLTEtMA_706a4c66-b8f7-4b0e-87c6-1a4fc49a1758">92,045</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="0" sign="-" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzMtMS0xLTEtMA_c75205e0-00da-4d01-adee-ba83d75386da">50,556</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="0" sign="-" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzMtMy0xLTEtMA_d6ba4f35-c28b-4aa9-a4f4-a0c3ee85447d">2,284</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="0" sign="-" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzMtNS0xLTEtMA_ebb7429c-3df4-4827-bcb4-ab4d0bdc5cfb">11,369</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzQtMS0xLTEtMA_09e42e6a-5268-435b-b7ce-e5ae366b6be1">48,964</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzQtMy0xLTEtMA_8f7f2582-f263-4dd4-b39d-c3aa83d34baf">121,984</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzQtNS0xLTEtMA_75fcb7cf-6898-47f6-8b69-48d2c23b7e07">116,684</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzUtMS0xLTEtMA_5c9910a2-cc7d-4559-bf89-3c21100cc6d2">16,204</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzUtMy0xLTEtMA_f268dbc3-6841-415d-8564-693a47a069b9">23,946</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzUtNS0xLTEtMA_4a696b37-85d9-486a-a989-e7b0fee2d843">110</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7986a8931ce14e87a14397225a1db358_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzYtMS0xLTEtMA_6365836f-64a8-4e94-8e16-2fe99f68f267">264,622</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzYtMy0xLTEtMA_1c339440-8cb5-4d83-8bec-9abeac43ae09">296,037</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzYtNS0xLTEtMA_0fab9599-bf44-40f0-bf5b-89a2e606fee1">341,944</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzktMS0xLTEtMA_1406d244-3d49-47f5-a174-905ca6738869">76.84</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzktMy0xLTEtMA_421d87d2-457b-4079-a963-1bdbffa5878c">64.38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ice189043bdb14f77817f481da434b9f6_I20161231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzktNS0xLTEtMA_ae64c7f2-3ea9-422b-8455-10009f30fee6">54.47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEwLTEtMS0xLTA_a774e748-c6b8-43f8-aa3d-bc8f6a6981a3">103.40</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEwLTMtMS0xLTA_4c110963-601a-4a7a-9fa5-26e2382db8d8">90.45</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEwLTUtMS0xLTA_da160ea8-720c-4886-9da8-611925479b06">84.01</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzExLTEtMS0xLTA_28e3a356-cd5d-402f-8aaf-24cb546333f7">83.89</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzExLTMtMS0xLTA_22df9040-c070-4531-9eaa-4bbf124d6e85">33.86</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzExLTUtMS0xLTA_b8e160e5-338b-4951-aa4b-481b5ebc4191">42.85</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEyLTEtMS0xLTA_418e9388-b92d-4c98-b39f-52a2a086de87">102.51</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEyLTMtMS0xLTA_fdbf9f3d-6c92-45a2-a130-c38b6934e6d6">93.00</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEyLTUtMS0xLTA_6c983f8e-3497-46e7-8909-536c5394a2e7">50.06</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEzLTEtMS0xLTA_b239a1d1-e554-46ff-97a1-3c7eef6c3215">69.09</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEzLTMtMS0xLTA_6cc21106-8026-4d29-8c83-bd3994cb35f4">68.65</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEzLTUtMS0xLTA_d0d7b353-3d4e-413b-adfe-bb2212fd2ec6">73.64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7986a8931ce14e87a14397225a1db358_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzE0LTEtMS0xLTA_4bfae260-41b8-427f-9144-f8e644adf95a">66.03</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzE0LTMtMS0xLTA_498e7e1f-1cef-4546-8d40-832b8f1c68c6">76.84</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzE0LTUtMS0xLTA_984cede5-3d48-413b-b628-0931aef8504c">64.38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Shares earned under PSU awards may vary from <ix:nonFraction unitRef="number" contextRef="i2930b7a825204376adcd1aaccfb3a4e3_D20190101-20191231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzQ5MzU_41ae99b7-986d-4c84-b868-acfe08f25334">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4e8c24828a0f4b248dd1d741a061b3ae_D20190101-20191231" decimals="INF" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzQ5NDE_db8a1955-14c0-4589-bf35-cb1239f81ddf">200</ix:nonFraction>% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2019, 2018 and 2017 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzUzMTU_5d195945-9306-4b20-a8ac-949f7c9e3fe6">103.40</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzUzMTk_86bcd621-79f9-4b59-95df-2684e9d2aec4">90.45</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzUzMjY_7ece278e-87a1-423a-8d2d-99e2b6672039">84.01</ix:nonFraction>, respectively. Including forfeiture and below-target achievement expectations, we expect that the stock-settled PSU awards will convert to <ix:nonFraction unitRef="shares" contextRef="i7986a8931ce14e87a14397225a1db358_I20191231" decimals="INF" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU0Njg_f5214f74-3d4a-442c-b386-128d60e3e752">84,670</ix:nonFraction> shares to be issued over an average remaining term of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU1MjU_5649237d-81f3-42ad-be9c-00e04ab34944">one</span> year.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMjY_420df7cc-2dc4-4a6e-993a-eafca167950d" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzEtMS0xLTEtMA_bc195cee-a56a-4c74-bac4-648a23bf9646">1,592</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzEtMy0xLTEtMA_b74de860-7410-4865-9fe3-c8bee9a23f12">1,972</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if424c5cbb6af4281b20e4f9016d91f87_I20161231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzEtNS0xLTEtMA_3536348f-8bd3-4460-9bac-31f334c0887c">2,451</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzItMS0xLTEtMA_5f278996-42c3-4f62-8d14-6862a5cb0d89">806</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzItMy0xLTEtMA_3977d772-aad1-4118-8b32-c485fda394aa">560</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzItNS0xLTEtMA_33d16f1d-6d21-46dc-8481-e8b7c2fcec22">598</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="0" sign="-" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzMtMS0xLTEtMA_abe82727-e551-42a8-aa18-d28aed5f8984">206</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="0" sign="-" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzMtMy0xLTEtMA_7a8d7aa7-fccc-4665-aa19-05ce3068bc5f">30</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="0" sign="-" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzMtNS0xLTEtMA_170b334d-e649-4094-a44f-56589eaa1d60">107</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzQtMS0xLTEtMA_a8f66a03-006b-4f74-afff-0a0e638bdbf7">211</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzQtMy0xLTEtMA_aba9a939-c08b-4e46-87c1-297c57d6985b">910</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzQtNS0xLTEtMA_3deebc37-899d-4c98-bcd1-172b4e59c6c0">970</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzUtMS0xLTEtMA_20252c7f-4a57-457d-8bda-0d811d4194d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzUtMy0xLTEtMA_2f5dd7b4-3286-4a43-b753-64365c2c114a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="0" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzUtNS0xLTEtMA_888959d4-4c06-43d8-870c-9b26a38132c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iba2d66afdb1b460b9bc719352ac92b1b_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzYtMS0xLTEtMA_ed65ecf5-efe0-4398-b891-f13c938b1ccc">1,981</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzYtMy0xLTEtMA_53749193-b955-40c3-a846-6bfc58fcd6de">1,592</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzYtNS0xLTEtMA_b49a0ba7-e21f-4d8e-9487-1fcc6218ec91">1,972</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzEtMS0xLTEtMA_27d6c4e3-8a4d-48ab-a4e7-a2b32ddf38ce">79.48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzEtMy0xLTEtMA_90a8036e-cb8d-48ed-b743-a321edb5633f">92.25</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="if424c5cbb6af4281b20e4f9016d91f87_I20161231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzEtNS0xLTEtMA_15dfe7f6-ddf5-4457-9b93-6efcee67c216">25.28</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzItMS0xLTEtMA_16dc931a-ba98-4765-8847-9dce886129f7">102.51</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzItMy0xLTEtMA_db1530ab-aecf-4f7a-9e48-b5f3069537f7">89.64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzItNS0xLTEtMA_04a82f15-e297-4b25-885d-87eb8afb5b7b">83.47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzMtMS0xLTEtMA_2ee815f2-5bed-4cac-ad29-e11392b91ba7">56.95</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzMtMy0xLTEtMA_bae2095f-7c5e-4bb5-8344-3d3edbc4cf7e">41.53</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="2" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzMtNS0xLTEtMA_2c5336d5-a764-4cfa-b8af-ff112a311cd6">66.61</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzQtMS0xLTEtMA_14bfeed9-46bd-47e8-88bd-fa9be9f1bd96">102.51</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzQtMy0xLTEtMA_3fbc74b7-b517-4f82-9b79-9cc47482093e">93.00</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzQtNS0xLTEtMA_8a0bfe58-fa21-499e-8296-671db6ceed21">86.93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzUtMS0xLTEtMA_9449fb0c-ddea-4f97-84b6-30c3499e9d45">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzUtMy0xLTEtMA_d869adf6-8579-442d-8c20-9c22072a2862">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzUtNS0xLTEtMA_65ad5a65-fc32-4832-8866-bd6cf1a1d2b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iba2d66afdb1b460b9bc719352ac92b1b_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzYtMS0xLTEtMA_60b5bc54-1c8b-4141-b5bc-5efc24be7324">150.33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzYtMy0xLTEtMA_830c9bde-ad5a-46a7-a6fb-6f57d305daf9">79.48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzYtNS0xLTEtMA_05e4bb3c-fbd1-4735-9539-da308399f029">92.25</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">66</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i35c50cd1fbc3481f9ff6a1d4ace22226"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also offer an Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which provides for the sale of our common stock to eligible employees at <ix:nonFraction unitRef="number" contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYwOTk_7a89b2eb-752d-4bb7-9d5f-91cb63c4cd15">85</ix:nonFraction>% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to <ix:nonFraction unitRef="number" contextRef="i90a36423c0a44b9986aa0cbeabb16721_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYyMjM_944b9822-2052-400c-98b1-fb62137199ea">25</ix:nonFraction>% of the employee&#8217;s base salary, not to exceed $<ix:nonFraction unitRef="usd" contextRef="i90a36423c0a44b9986aa0cbeabb16721_I20191231" decimals="0" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYyNzE_f7957a16-447d-4bae-a900-85dae9980fe2">25,000</ix:nonFraction> in any one calendar year. In addition, employees may not buy more than <ix:nonFraction unitRef="shares" contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYzNDU_de3dc4bb-6ad8-4e02-a86c-6ea00a3ebeb2">2,000</ix:nonFraction> shares during any offering period (<ix:nonFraction unitRef="shares" contextRef="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYzODM_c58ea93d-5c82-4af0-8e3d-f843201e9b4a">8,000</ix:nonFraction> shares per year). Purchases under the ESPP were <ix:nonFraction unitRef="shares" contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY0MzQ_d629de68-579e-4d3c-a4ef-81b5e0a45cc7">51,391</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY0NDU_3aa3a1c7-c503-4776-b913-0071a5722404">55,669</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i6077149f426d4ae8a0b5fd6b074a7a43_D20170101-20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY0NTk_98fbe147-efd9-4e6b-a1bb-7f0d22921f0d">56,218</ix:nonFraction> shares for the years 2019, 2018 and 2017, respectively. At December&#160;31, 2019, there were approximately <ix:nonFraction unitRef="shares" contextRef="i90a36423c0a44b9986aa0cbeabb16721_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY1NDQ_e17fe3e5-84ad-49aa-9251-e1e004654e0b">3.8</ix:nonFraction> million shares available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Deferred Compensation Plans and Restricted Share Awards</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of <ix:nonFraction unitRef="shares" contextRef="ia14da4b7cdb047cd878899fb992151cf_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="wst:DeferredCompensationArrangementwithIndividualConversionUnit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY5OTU_81aad15d-b8cd-45f7-bc9a-8996091689a7">one</ix:nonFraction> share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2019, we granted <ix:nonFraction unitRef="shares" contextRef="i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc0MjA_7f12c10c-d637-4db8-9288-ff4fa9108dc7">14,579</ix:nonFraction> deferred stock awards, with a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc0Nzg_a28200b6-1448-4d1b-bada-f0aa8b3b3530">121.40</ix:nonFraction>. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. As of December&#160;31, 2019, the <ix:nonFraction unitRef="plan" contextRef="if56b24e99d71498ab539bcd0ec6f2c84_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="wst:DeferredCompensationArrangementWithIndividualNumberOfPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc2NDQ_2a9d63cd-6fb1-4795-94d1-28ec38020290">two</ix:nonFraction> deferred compensation plans held a total of <ix:nonFraction unitRef="shares" contextRef="if56b24e99d71498ab539bcd0ec6f2c84_I20191231" decimals="INF" format="ixt:numdotdecimal" name="wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc2OTE_cc011361-83e4-4d1f-9f41-64beadf76453">366,159</ix:nonFraction> deferred stock units, including <ix:nonFraction unitRef="shares" contextRef="if56b24e99d71498ab539bcd0ec6f2c84_I20191231" decimals="0" format="ixt:numdotdecimal" name="wst:DeferredStockUnitsPayableinCash" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc3MjY_7714182d-9dce-4f13-9ac4-0efc94e86b1d">6,274</ix:nonFraction> units to be paid in cash.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, during 2019, we granted <ix:nonFraction unitRef="shares" contextRef="i680ad925db4e48d78b3237fca4762bf7_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM4NDgyOTA3MDcxMzU_aa934b64-0217-4a1f-8996-9ecff454ebc6">13,308</ix:nonFraction> restricted share awards at a weighted grant-date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i680ad925db4e48d78b3237fca4762bf7_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc4NTc_19af4801-4a8e-4db6-a348-581b8d22303c">116.39</ix:nonFraction> per share to employees under the 2016 Plan. During 2018, we granted 15,942 restricted share awards at a weighted grant-date fair value of $96.77 per share to employees under the 2016 Plan. There were <ix:nonFraction unitRef="shares" contextRef="i8169a62ce26b42908772007e3660188a_D20180101-20181231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc5Mjg_d9313f3a-99cc-45fb-8379-8f62d5a20423">no</ix:nonFraction> grants of restricted share awards in 2017. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Annual Incentive Plan</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under our annual incentive plan, participants are paid bonuses on the attainment of certain financial goals, which they can elect to receive in either cash or shares of our common stock. If the employee elects payment in shares, they are also given a restricted incentive stock award equal to one share for each four bonus shares issued. The incentive stock awards vest at the end of <ix:nonNumeric contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg2NzQ_7d1105b4-5ff7-4238-90a7-58f3b618c1aa">four years</ix:nonNumeric> provided that the participant has not made a disqualifying disposition of their bonus shares. Incentive stock award grants were <ix:nonFraction unitRef="shares" contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg4MDU_2af9e235-a351-47ab-b55c-6dccf3206633">1,300</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg4MTY_e580bcb0-57b4-4c34-a20f-fb48fca8b85d">1,500</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg4MzA_4ef72a5b-9edb-4306-b1f1-16bfacc4b42f">1,800</ix:nonFraction> shares in 2019, 2018 and 2017, respectively. There were <ix:nonFraction unitRef="shares" contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzEwOTk1MTE2Mzc4NjM_cbae5d64-5922-45ba-b1a7-5a7333711e4c">no</ix:nonFraction> incentive stock forfeitures in 2019. Incentive stock forfeitures of <ix:nonFraction unitRef="shares" contextRef="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg5MTQ_f4e37c1c-1efe-4c42-9b97-b532bc5883a6">200</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg5Mjg_dc331344-e7b8-4cd8-9ca6-507082394dcc">800</ix:nonFraction> shares occurred in 2018 and 2017, respectively. Compensation expense is recognized over the vesting period based on the fair market value of common stock on the award date: $<ix:nonFraction unitRef="usdPerShare" contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxMDQ_cc863306-363c-4083-a782-e758ea50bea0">106.14</ix:nonFraction> per share granted in 2019, $<ix:nonFraction unitRef="usdPerShare" contextRef="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxMzI_103a41a2-f325-4cfd-9e3c-3da0e50e29bc">93.00</ix:nonFraction> per share granted in 2018 and $<ix:nonFraction unitRef="usdPerShare" contextRef="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxNjM_7b2b62a8-0708-4388-81da-1004272cf041">86.93</ix:nonFraction> per share granted in 2017.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_136"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 15:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNjE_9e6e833b-3abd-4139-990f-a1702a911507" continuedAt="ib8594a67a8ec422f8ec4e32e75a7f19c" escape="true">Benefit Plans </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ib8594a67a8ec422f8ec4e32e75a7f19c" continuedAt="id0a03db52a474b1a9d6ca55c5dea6d13">Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzU5OA_9413e721-32ae-4b96-b057-2a949994447a">15.6</ix:nonFraction> million for 2019, $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzYwOQ_c5320517-c5de-407a-90c0-664714c667a4">6.5</ix:nonFraction> million for 2018 and $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzYyMw_93898c0e-6553-4628-9ba3-fb5b942c4f88">5.7</ix:nonFraction> million for 2017. The increase in 401(k) plan contributions in 2019 was in response to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting).</ix:continuation></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">67</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="id0a03db52a474b1a9d6ca55c5dea6d13" continuedAt="idac622f137c043c89e9983193038c2ea"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Pension and Other Retirement Benefits</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNjQ_2706e5eb-3e3e-46b0-8326-64c239244ef0" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:43.032%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.498%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtMS0xLTEtMA_ddc43a27-0c80-43eb-aa40-7849ebcc46b5">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtMy0xLTEtMA_674a5e98-e2e9-4895-8f5e-14c60895d2f8">10.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtNS0xLTEtMA_d278d62b-2d09-4f72-abd1-66e91f3d3bc2">10.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtNy0xLTEtMA_2f943e18-e9ba-410a-b7f9-9b2c5a904a83">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtOS0xLTEtMA_75366780-9d93-4119-9528-f04013cf8ad2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtMTEtMS0xLTA_4cb697d3-3740-4709-abc9-65efd213a17a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtMS0xLTEtMA_fd1ba9b7-8280-4029-9918-0e2e8046af3b">9.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtMy0xLTEtMA_a9211ed4-f10c-47c6-9a63-1368c0ccf443">9.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtNS0xLTEtMA_f65d19bf-fd90-4384-bb38-ae1fe85a56ff">9.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtNy0xLTEtMA_d4ea4c84-81e6-49aa-8e34-cd3b58831e17">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtOS0xLTEtMA_6e709c13-7eee-48d6-b482-ff0335ddc55e">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtMTEtMS0xLTA_80dc0242-e5b5-4eb1-b8a9-96e6d38e8189">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtMS0xLTEtMA_9300f93e-7c7f-4028-a6e6-a78adc025062">12.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtMy0xLTEtMA_86f9b88d-2db9-4a46-a3ee-02a487989a64">15.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtNS0xLTEtMA_c78d7cba-f52f-4eef-b9db-bbf117e581be">13.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtNy0xLTEtMA_5d2fb151-4a35-470c-9a2b-b0155671038a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtOS0xLTEtMA_2cf3a5ca-90ff-429f-af2b-26da60d57239">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtMTEtMS0xLTA_93219eb3-ac24-4175-ab6c-2a7e942bbc0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service credit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtMS0xLTEtMA_7b4da0af-6216-4435-99ef-9c710b4e6e57">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtMy0xLTEtMA_916d2c29-abe7-4737-8b76-474d5549ce93">1.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtNS0xLTEtMA_622224aa-f0d1-415b-b9d2-82e914d3e709">1.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtNy0xLTEtMA_679e1284-da03-4cc7-bb71-08464f388a4d">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtOS0xLTEtMA_1514b0a1-62a8-4bce-a027-db7cef421c04">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtMTEtMS0xLTA_78b97aaf-ee25-475d-a314-178a2730cfa2">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtMS0xLTEtMA_0a801571-c5d3-4b21-bfae-a063c46b9a4f">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtMy0xLTEtMA_8fd424ac-756e-4501-99ed-ccfced40c8ed">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtNS0xLTEtMA_1064ea27-d577-43b3-abf7-2285cb6a2892">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtNy0xLTEtMA_c96940e5-ebba-43e2-9007-cfa506746945">2.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtOS0xLTEtMA_0661adf7-8846-4da2-968e-5008b5080f1f">2.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtMTEtMS0xLTA_b264107d-c824-476d-9faf-c99317fd74ab">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEwLTEtMS0xLTA_604c46b7-d43e-47b2-97b2-782ed4325fa5">3.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTEtMS0xLTA_91ac93d7-f25d-4dc0-be51-9c746d981109">4.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTMtMS0xLTA_5d493e2b-8c1b-41df-9124-ab92299df2c3">7.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTUtMS0xLTA_6a482336-c87f-4ae6-95d7-6a316881ceb0">10.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTctMS0xLTA_89bb05c7-5c7f-431d-8f30-6f3278e913b9">2.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTktMS0xLTA_9a5c7bd1-62b0-4657-bff0-eedeae4d25cf">2.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTExLTEtMS0w_4e1cbbad-7d40-40ce-b977-e83d925ae4fa">3.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss (gain) arising during period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTEtMS0xLTA_a940122f-02d3-4ddc-b81a-4ae405ca27d6">1.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTMtMS0xLTA_e5a407c4-40bf-462f-bfe8-f7d9a8a6a3bf">3.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTUtMS0xLTA_58791d51-9de2-45bc-8b1d-098fe7ba7d5d">9.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTctMS0xLTA_6b10b20e-e514-48a2-8d29-378f96873ede">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTktMS0xLTA_4651efa0-993c-4312-b53c-c0d52c746386">1.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTExLTEtMS0w_2fdbe748-2c81-439e-bff0-b4670a5005cf">1.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service credit arising during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTEtMS0xLTA_0b17e39d-829b-41b7-9477-07de91c6e495">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTMtMS0xLTA_35e7adf1-6bbb-44c6-a4c2-67ebeadf0911">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTUtMS0xLTA_0d69a512-358f-4847-9b37-3df58b28926c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTctMS0xLTA_0c0ccf1c-a083-4bad-8471-225fe057a860">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTktMS0xLTA_f34c3219-429f-44e8-9379-597bfe990830">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTExLTEtMS0w_55fa89e1-8f6d-4d8f-bbad-50455409713b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service credit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTEtMS0xLTA_ace16995-17b5-415f-924d-0dc2ec6fe2dc">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTMtMS0xLTA_a80b08cd-a100-48b1-b2d3-fb8b816db365">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTUtMS0xLTA_9b045f67-ad1e-4d35-a69a-9ab13f555dd2">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTctMS0xLTA_94e3b670-3c29-4bbc-8b18-2b7c269acf0d">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTktMS0xLTA_44ff6bc3-ee27-46f7-9742-66c59ed0d5af">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTExLTEtMS0w_c761a340-17d3-496f-b6a5-1053268a67fc">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTEtMS0xLTA_718db9dc-77e9-4a6e-b9ee-9b9ab61968e2">2.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTMtMS0xLTA_a5615df5-0450-4810-981f-cec43add2367">3.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTUtMS0xLTA_2a7e8c00-e63f-41c0-aa13-aa744e3d5ecb">4.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTctMS0xLTA_44f67b8d-9aba-402b-a9f0-76b85831ef8f">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTktMS0xLTA_1564c97c-ea2e-4420-8e9d-79c0f0219121">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTExLTEtMS0w_737f5a42-2bd2-410d-b01b-b3b479da9968">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE5LTEtMS0xLTA_1795f524-b4f3-40e0-a94c-b109cf921ed7">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTEtMS0xLTA_06281319-6767-4e43-a509-94fa33415b97">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTMtMS0xLTA_6471bfed-c54a-4f10-b3df-038cbb85bbbf">1.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" sign="-" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTUtMS0xLTA_41155e6f-54d2-4b8b-8a7e-5f3240c917a8">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTctMS0xLTA_ce8b2dfb-20f1-484a-b58e-a24740b3204e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTktMS0xLTA_c239e3cd-bba0-458a-82e7-0be4cbb5de8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTExLTEtMS0w_637f927d-1abc-4b62-9769-eba7c2350dbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total recognized in OCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTEtMS0xLTA_24df26ee-a0e5-4815-9e06-036297e200dc">3.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTMtMS0xLTA_586b6cb6-8983-4bad-8c53-3ce930348c8c">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTUtMS0xLTA_d47915b1-e472-4eea-ba0e-615c2f42772a">10.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTctMS0xLTA_d99b513a-7fc9-4c4a-99f9-c83d1e4794c7">3.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTktMS0xLTA_e6f2df1d-3ffc-4473-8e7e-1b023666e59c">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTExLTEtMS0w_a37ae895-8ba3-4ff4-8568-131506aa11f5">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total recognized in net periodic benefit cost and OCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTEtMS0xLTA_439f9ba2-c340-487c-8203-61cbe30678f9">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTMtMS0xLTA_86edbf60-ec80-4340-813d-ae27c7a663cb">7.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" name="wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTUtMS0xLTA_50454445-ca98-4f3b-99e3-933a3fc4f6a5">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTctMS0xLTA_35d77d40-77a1-488d-9b1c-7b5a8b49bb9a">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" sign="-" name="wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTktMS0xLTA_01318cc5-1d68-4034-8fa7-0fab1a20fa1f">1.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" sign="-" name="wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTExLTEtMS0w_4bad959f-86d5-4c8c-83ec-122b6ad23ec9">0.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit cost by geographic location is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.711%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.082%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.333%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.493%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.498%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. plans</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibcf3086a15804eef96196b34fe5f6a29_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItMS0xLTEtMA_ba6f8c5e-a8c3-46a5-b5fe-41b3bd6e3ad4">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3372ec3c59ed4ec6845462cf9a97844d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItMy0xLTEtMA_cd1c4e31-90e8-4f2b-9744-b0ecfef8db99">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if02e282f48e34ea9924bc5e936dee280_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItNS0xLTEtMA_b4e77bc3-3c16-4e38-9c60-5a360b1e984b">7.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iec2956a56fea4665ac7855ee4d00856a_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItNy0xLTEtMA_5b0c7a99-f0f2-4821-b6da-2276d6ba3998">2.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i691d61af8bdb48d58e96be31e865a8f0_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItOS0xLTEtMA_32ae29ea-f6e5-40a1-82d1-547a24459287">2.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i05084a034d864aaab4d454ef2374f73d_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItMTEtMS0xLTA_63c8dd25-44aa-4d9b-9f4e-db65b7de24cc">3.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia045884eabdd4675b086f7cbe1088331_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtMS0xLTEtMA_6510dff1-6759-4817-9b2f-01e10c5a8d01">1.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i482e7650de754ebd863450ff98ddd102_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtMy0xLTEtMA_1d9ff695-ee7f-49f6-8d96-1b8d8489d0f4">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3bc0be5f11db4f4b96289239a9c31f9b_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtNS0xLTEtMA_472caeca-00ff-48ec-b7e9-c7ef861f85e7">3.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i437e493b76d849dab6516dfc8137e7a5_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtNy0xLTEtMA_c77729e1-43f2-4ab9-be04-2685fc053dd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic213450143c643fcabdf167b9544dd56_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtOS0xLTEtMA_eef57264-2518-4f28-bbf4-a93e274a8429">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c070b0619d84059924fa1fee46ec2a9_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtMTEtMS0xLTA_a78d42a7-81c3-4ef7-9912-4618c3a01540">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtMS0xLTEtMA_71d9f4d5-6d1f-4116-979c-4925ee7c8a59">4.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtMy0xLTEtMA_24c1486c-9592-455e-a12d-83d682080663">7.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtNS0xLTEtMA_7c2bd00e-a800-40b8-b711-d88133b2ab3d">10.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtNy0xLTEtMA_bc3f5d7a-1f95-4405-93f2-cd6f69915845">2.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtOS0xLTEtMA_a131492e-30cd-4180-9b68-3a7026ddf094">2.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtMTEtMS0xLTA_98e2d11b-8add-4fe7-9e3a-7fed056471bc">3.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i6298ee303c464f0bbd0097078dcab7e1_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NDgyOTA3MDYxMzY_bf1fb8c8-d76c-41b8-884a-ab24e7256aad">3.5</ix:nonFraction>&#160;million pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we contributed $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NDgyOTA3MDYxMTc_d8b6d5db-7788-4bef-89d1-7b9ec385342f">2.6</ix:nonFraction>&#160;million to our U.S. qualified defined benefit pension plan.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">68</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="idac622f137c043c89e9983193038c2ea" continuedAt="i21982c8a190449b0b87eee6951be7372"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNDY_f3f52b76-0e08-4915-a5c8-b7b6405b14b3" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.826%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.945%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in benefit obligation:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit obligation, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtMS0xLTEtMA_a40d812d-d63a-47fd-b3af-5e884eb3c2b4">267.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib0f2d011f88041df81ed72918d912b28_I20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtMy0xLTEtMA_3c918482-2877-49cf-86a6-95ba44a2ddc6">288.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtNS0xLTEtMA_95892df2-534d-4db6-89d0-f2d545c3f2fa">6.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i8d13573002854b4794e6d272dc9f023d_I20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtNy0xLTEtMA_5325666c-eb09-4d6e-9ee1-a48a871fed84">7.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtMS0xLTEtMA_cdc209f9-bada-406d-b3c1-9ee0f4619646">1.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtMy0xLTEtMA_422719f0-af68-439f-bac1-998a7c320501">10.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtNS0xLTEtMA_9c502e1f-f234-427b-be2c-2c4f7e065ca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtNy0xLTEtMA_8ee8b724-5bcc-4e64-ba54-9dac394d3663">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtMS0xLTEtMA_c000e25b-3fff-4b1a-b161-a922743268cf">9.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtMy0xLTEtMA_31dc6b89-8fff-44c9-a888-ad4e6e7f23b6">9.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtNS0xLTEtMA_712b053e-5f20-4b4a-88fe-0c4efa117850">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtNy0xLTEtMA_fe0dc577-a494-4699-8a06-a6838f1ded56">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Participants&#8217; contributions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtMS0xLTEtMA_9917ca6a-7757-48fa-a10c-13e6082d1e75">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtMy0xLTEtMA_90cdbe6d-5eed-444c-846c-678483e837cd">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtNS0xLTEtMA_68bee6e8-32c9-49fc-ab36-11a2a15aaa01">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtNy0xLTEtMA_bdbcfc59-c78d-4a62-85c7-7f1d801b23ac">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actuarial (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctMS0xLTEtMA_e4adde59-cdea-4a5f-86bd-03f94057bd1f">30.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctMy0xLTEtMA_5a903278-da51-4a04-acd7-eae9360159e6">20.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctNS0xLTEtMA_a646cb2d-e084-43f4-9d89-c4c42f6d655b">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctNy0xLTEtMA_6674b461-5451-45d6-a708-7bc6757f5b5b">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amendments/transfers in</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtMS0xLTEtMA_4b9e270f-c55b-4fee-9677-786bc31c594b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtMy0xLTEtMA_1d3543dd-aa09-4cea-b176-e14694bd6b9f">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtNS0xLTEtMA_10706ab2-0f67-4e36-bcad-3d2588838354">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtNy0xLTEtMA_d0e2e885-bba7-4bd4-9d12-79e5926e9c90">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefits/expenses paid</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktMS0xLTEtMA_afd98e36-f5f3-46b0-b594-5d2f9c136316">6.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktMy0xLTEtMA_70611554-9c54-4239-bb08-e0361cd4fac7">18.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktNS0xLTEtMA_5111bd33-8454-4c1b-9505-4d07b4bd21e4">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktNy0xLTEtMA_286cd207-cf34-4927-a3f1-1025ad6216fe">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTEtMS0xLTA_b800ddac-3bd3-4f78-aab2-ec4b1bef9b2c">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTMtMS0xLTA_f8d27ae6-35f3-4a7d-9531-eff2702aff77">3.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTUtMS0xLTA_5a56bf56-a8de-4e57-8170-77268ef1877d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTctMS0xLTA_811dc77a-aa53-4eb9-a94a-5c32a80cbecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit obligation, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTEtMS0xLTA_43ab5b66-482b-469f-a15c-60f63131bd17">287.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTMtMS0xLTA_49f808b3-2c83-4781-879a-6552ba91faee">267.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTUtMS0xLTA_6a717cfb-53b2-4d6b-9ede-eef12f80cabb">6.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTctMS0xLTA_293085ff-44ab-44a8-ab76-b26d005a6a20">6.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTEtMS0xLTA_0254ac8f-2976-4ab8-84a2-5665465d65d7">214.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib0f2d011f88041df81ed72918d912b28_I20171231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTMtMS0xLTA_bea8703b-d44e-4e04-8409-800afaf46add">239.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8d13573002854b4794e6d272dc9f023d_I20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTUtMS0xLTA_379159bc-c9a9-4ded-859a-29e6f5cd23a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8d13573002854b4794e6d272dc9f023d_I20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTctMS0xLTA_93f23ab6-9cbc-431b-aaa5-865dfe8c76af">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actual return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTEtMS0xLTA_c092ca53-58d4-40ba-ad5f-ec99e1f5196d">41.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTMtMS0xLTA_c85096dc-9371-4c9b-bac5-0fc391b85bb0">8.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTUtMS0xLTA_c675b094-33b2-49ab-9c38-2d99cb47a37b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTctMS0xLTA_13c39f6e-7ab7-4f3f-a322-af930becf1a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employer contribution</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTEtMS0xLTA_417a8a86-5ca8-41a1-830f-ec5200170f0b">8.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTMtMS0xLTA_4ad4c9d7-5f91-4a65-b58a-34b112cbe82e">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTUtMS0xLTA_04c9f87b-355e-4eed-9022-e8a0665bb8d6">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTctMS0xLTA_00db019f-222a-4b2e-a20e-474089a4dab5">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Participants&#8217; contributions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTEtMS0xLTA_1f62d8a7-669c-4156-bdf6-21dcd157d03b">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTMtMS0xLTA_5be06997-59bd-4668-8117-42e8bc0dd5fc">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTUtMS0xLTA_f54dbe75-77f4-4d9d-84e6-fd4526f930eb">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTctMS0xLTA_477fb118-537f-4571-aed7-f05aeb625c51">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefits/expenses paid</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTEtMS0xLTA_31689d4a-6361-4f4d-8173-36fa2a1928d1">6.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTMtMS0xLTA_9ab1f015-0174-4549-b519-b6d98977d4cd">18.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTUtMS0xLTA_030f9d3f-19e1-4df0-8f26-0fcac46cdda0">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTctMS0xLTA_7b73720c-99c5-4c12-aa57-0c8a5c97b3be">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTEtMS0xLTA_650655d3-06be-475d-8b14-9bdf9834b8ff">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTMtMS0xLTA_0630708a-4687-45d9-80dd-3979b4ca899c">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTUtMS0xLTA_717a5278-bdec-4bf7-8536-e4d369e8359f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTctMS0xLTA_a90de3b6-83c1-47d9-95d6-2b74d283e1ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTEtMS0xLTA_d349dd35-4643-4afb-bbbb-d58ff3ae62b4">244.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTMtMS0xLTA_fab25878-e735-49f8-8209-d45a50a8fbf9">214.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTUtMS0xLTA_4a59f901-b1fd-467e-b7e9-0b29ce1879ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTctMS0xLTA_7fac5f42-f3c4-4353-b879-0b9dcd89b944">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Funded status at end of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTEtMS0xLTA_d20abe7c-0501-4302-adad-6a5edfcbc3c5">43.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTMtMS0xLTA_3446c812-b288-4748-9f22-02f5e8ae9f93">52.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTUtMS0xLTA_17720fd7-ac66-4ad0-8d19-20b2d05a000b">6.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTctMS0xLTA_1c561513-189d-4e70-9b13-dd5d0f330cc0">6.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">International pension plan assets, at fair value, included in the preceding table were $<ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzE3MjM_d4827015-993f-4052-b9cc-ada8cd4027bb">39.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzE3MzA_d0f92dca-39b2-4224-9368-c117b2f615a5">33.4</ix:nonFraction> million at December&#160;31, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwMzQ_fc335e7b-e189-4f91-b735-109ffb53f313" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amounts recognized in the balance sheet were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.826%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.945%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Noncurrent assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="wst:AssetsDefinedBenefitPlansNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItMS0xLTEtNzkwMQ_6be8242e-9b6d-4478-8235-1982413d12f6">4.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItMS0xLTEtMA_43b26b0f-0b02-4ef0-98be-cafc64c323e7">1.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItMy0xLTEtMA_1ed26a84-6f5a-4f80-ba9f-64115ff31e0e">1.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItNS0xLTEtMA_10892aa8-82d0-4f73-b2bc-140a391e8ad4">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItNy0xLTEtMA_b57ac3e0-a66b-4ccc-9ac8-c56864dc7b58">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Noncurrent liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtMS0xLTEtMA_212e83a5-af26-4260-9f4e-d3c41ad4f81e">46.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtMy0xLTEtMA_960ebf94-1302-46a2-a55d-84cf906e2d54">50.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtNS0xLTEtMA_6d478aba-08e6-42ae-bf47-77df1547faf7">5.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtNy0xLTEtMA_b9e0606b-2454-4bb8-8989-f4a7b33f9fc9">5.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtMS0xLTEtMA_2636a2f9-ab81-4396-a8ce-9b965380c17b">43.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtMy0xLTEtMA_e15e0b7d-4eb6-4ddf-9e5f-7d78eb390ba5">52.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtNS0xLTEtMA_4f5044d9-cb32-498e-99b2-6b8322614c1c">6.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtNy0xLTEtMA_ba895559-2a71-4e9e-b5d7-c760a093f2a5">6.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">69</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i21982c8a190449b0b87eee6951be7372" continuedAt="i327c37d272254626a8a999ce30b6e232"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwMTk_22c32aee-8873-4a63-9802-25ec385784ae" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:39.826%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.942%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.945%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net actuarial loss (gain)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItMS0xLTEtMA_47f655af-5f80-4536-a607-422ee1d0f3fb">69.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItMy0xLTEtMA_98c93583-fcf8-4d59-8ce0-61908ccaff11">73.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItNS0xLTEtMA_0e9c3d79-4de7-44e3-93a7-a6c04cfc4362">7.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItNy0xLTEtMA_b7c57762-80a4-412d-bb25-8976dd496e9a">9.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service cost (credit)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtMS0xLTEtMA_4619cc4f-7ea2-4afd-bf03-19f1c01f17bf">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtMy0xLTEtMA_dfec4f28-8999-48ea-b10a-203f6aeec7a9">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtNS0xLTEtMA_e33f3892-04c4-41ea-b3c4-011524fbc582">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtNy0xLTEtMA_214d25d9-6ce2-4d58-ba62-bc3d6f599a31">1.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtMS0xLTEtMA_fad46037-83e3-41b3-85ae-59a40383776a">70.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtMy0xLTEtMA_c22330fe-befc-4795-9892-97332587a7de">73.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtNS0xLTEtMA_c1dc7abd-ab89-4f40-a6c0-633debef2620">8.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtNy0xLTEtMA_4b940acd-583e-46d1-b936-b4141d9bafcf">11.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The net actuarial loss and prior service credit for the defined benefit pension plans that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year are $<ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIxMTM_783202dc-424f-4133-b1c6-43b0f60dbdb9">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIxMjA_d033df02-7bc5-4887-85c1-b01f971ef1f1">0.1</ix:nonFraction> million, respectively. The net actuarial gain and prior service credit for the other retirement benefits plan that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year is $<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIzNTA_8e2a0882-f6d5-41a6-ae7d-14914ba6c157">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIzNTc_e7f996ed-c988-4b45-8342-c8d9217036bf">0.7</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accumulated benefit obligation for all defined benefit pension plans was $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0NDA_d79ad76b-d999-4495-8412-61091639fffb">283.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0NDc_ff06383e-c20d-4a54-8291-685804f5528b">263.0</ix:nonFraction> million at December&#160;31, 2019 and 2018, respectively, including $<ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0ODg_aa98b2a9-6da2-4f26-9777-19a43b036660">73.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0OTU_df194a12-53a0-47f7-9f79-d276bf262a54">64.0</ix:nonFraction> million, respectively, for international pension plans.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, our U.S. qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2019, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All of the defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets as of December&#160;31, 2018.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNTc_0c8b60a5-8ccc-4a55-a260-96da87a60c97" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:44.955%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:15.147%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.147%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.149%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Domestic </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzEtMS0xLTEtMA_85e9adf8-f667-4d74-b7b9-caf990f814c0">21.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzEtMy0xLTEtMA_a67a5e82-061d-4498-b344-522de2f13cb5">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzEtNS0xLTEtMA_1aefad2f-4ec7-401c-9f36-cc6a194de6cb">22.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzItMS0xLTEtMA_7590f655-3a26-44f6-963f-cf0dea4e14d7">13.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzItMy0xLTEtMA_d0547ff4-797c-4d75-9acd-e31596a9e612">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzItNS0xLTEtMA_8b9412e4-1ae0-4475-a0fb-ed7a0b834967">14.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzMtMS0xLTEtMA_36ad0269-fca0-41bc-8466-73b1c8c09c90">15.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzMtMy0xLTEtMA_1a400bc8-2cd2-4457-bdd1-4adfc95a725e">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzMtNS0xLTEtMA_b351d187-6df9-4d07-bfb8-7cc312709e2f">17.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzQtMS0xLTEtMA_b62fca68-9b41-4e98-8a2b-2e73e33e6d84">13.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzQtMy0xLTEtMA_df0f7293-00bc-46b3-9f1d-ca0c7cbeb0c0">1.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzQtNS0xLTEtMA_8eefb399-0251-40fc-93d4-bc8943119061">15.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzUtMS0xLTEtMA_576c5378-e9f8-4214-90c9-602485d8043f">13.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzUtMy0xLTEtMA_52f867bf-2853-4f23-ae59-2dc2fabcab61">1.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzUtNS0xLTEtMA_78949892-f5b2-4deb-868b-747752a18699">15.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2025 to 2029</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzYtMS0xLTEtMA_f612112b-a945-4647-85ff-01c2d54c3431">60.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzYtMy0xLTEtMA_a5b6f6e0-5b0e-4f36-b89f-9702172de29f">13.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzYtNS0xLTEtMA_91021317-56e4-40f8-92f7-dbbd528990e6">73.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzctMS0xLTEtMA_7f2a5186-c7f3-40a1-b1a3-73bd64e80657">137.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzctMy0xLTEtMA_364cc3c2-29d0-426a-aa37-9b01e475b5bf">21.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="wst:DefinedBenefitPlanExpectedFutureBenefitPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzctNS0xLTEtMA_a5598d1b-2e6c-49a2-9d9a-eb851ab98e0a">158.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2020, we expect to contribute $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI4ODM_bed383b8-2734-4c59-b1af-b00afd562315">0.7</ix:nonFraction> million to pension plans, none of which is for international plans. In addition, we expect to contribute $<ix:nonFraction unitRef="usd" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI5ODE_bb0b7e2f-e0ea-4d3a-b6b0-c487de764b65">0.7</ix:nonFraction> million for other retirement benefits in 2020. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNTg_a1623fa0-5156-4c7e-8af1-1e8ade029372" continuedAt="icd53cca73d784102893cb2d6d7d510d1" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:29.570%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.740%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItMS0xLTEtMA_ea157cae-7db5-405b-b37e-e292d8ce2ccb">2.70</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItMy0xLTEtMA_1621b55d-b2f0-4e55-87f4-6ac3d120998e">2.91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItNS0xLTEtMA_f22dd13f-5ef7-4fa1-84c0-643032ed30c6">3.48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItNy0xLTEtMA_2b77d21a-a0f0-4c8a-9963-0d0d1afd1702">4.20</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItOS0xLTEtMA_0b74f582-1ae1-473d-9a62-1d0d0839f08a">3.45</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItMTEtMS0xLTA_71fe43aa-cd0e-4f9c-af0b-51883937d835">3.90</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of compensation increase</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzMtMS0xLTEtMA_e7b136ef-816e-4840-a7a7-0c93a5268ad0">2.41</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzMtMy0xLTEtMA_78939a2e-0a5a-48bf-8a27-4395bb568a43">4.00</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzMtNS0xLTEtMA_d7e39d92-edb1-4b80-b27c-77941fc95abf">4.01</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term rate of return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzQtMS0xLTEtMA_770cd75d-b9a6-4359-8695-43f61b528b72">5.54</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzQtMy0xLTEtMA_4ab6b23e-0411-40b5-a665-88948fa66b6c">6.71</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzQtNS0xLTEtMA_73844a68-f4e1-4085-88f1-c9d5294d3cad">6.47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">70</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i327c37d272254626a8a999ce30b6e232" continuedAt="i99ad5d66d28744339274bc7ce698cc66"><ix:continuation id="icd53cca73d784102893cb2d6d7d510d1"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:44.314%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.823%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItMS0xLTEtMA_a68f5ba1-9fe6-4681-93d0-2f5a280479c2">2.79</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItMy0xLTEtMA_1195989f-371c-4973-a7b9-29a4a2889742">3.76</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItNS0xLTEtMA_f1d12619-cd44-414b-a4c3-0432d25acc5e">3.20</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a63732b565e43618a5fad775146f15b_I20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItNy0xLTEtMA_4f910e70-9573-45de-b55d-e1b9ec4cbb46">4.20</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of compensation increase</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzMtMS0xLTEtMA_014f77a6-9b20-445f-b885-7f1cd2b6af95">2.49</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzMtMy0xLTEtMA_1cee9bdb-f84b-430b-ab34-1feaf265cd1c">4.01</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The discount rate used to determine the benefit obligations for U.S. pension plans was <ix:nonFraction unitRef="number" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM0ODc_7ed072c3-52fb-4e58-b96d-4f70df3d8ca4">3.35</ix:nonFraction>% and 4.30% as of December 31, 2019 and 2018, respectively.  The weighted average discount rate used to determine the benefit obligations for all international plans was <ix:nonFraction unitRef="number" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM2NTE_c9bcd193-7c6b-4716-9351-18568db29740">1.28</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM2NTg_1ca154ef-2fa1-414a-9166-2be504e72c9c">2.19</ix:nonFraction>% as of December 31, 2019 and 2018, respectively. The rate of compensation increase for U.S. plans was <ix:nonFraction unitRef="number" contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM3NTg_f3121b53-2445-4cae-be9b-59d36c899c07">4.25</ix:nonFraction>% for 2018, while the weighted average rate for all international plans was <ix:nonFraction unitRef="number" contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NDA_4593e754-f9ee-4d3c-a9f7-32306033e349">2.49</ix:nonFraction>% for 2019 and <ix:nonFraction unitRef="number" contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NTQ_e33e277e-200b-4c72-bfd0-ced6744a4e9f">2.60</ix:nonFraction>% for 2018. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans, which accounts for <ix:nonFraction unitRef="number" contextRef="i026dfb891cba455ab72f03d27baf78a4_D20190101-20191231" decimals="4" name="wst:DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwMDM_8752db2e-b788-4c49-bb26-d086a7d968a0">83.86</ix:nonFraction>% of global plan assets, was <ix:nonFraction unitRef="number" contextRef="i026dfb891cba455ab72f03d27baf78a4_D20190101-20191231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwMzM_0edd44b5-9a8e-4a15-986b-fcb82bce1c44">5.60</ix:nonFraction>% for 2019, <ix:nonFraction unitRef="number" contextRef="icc6ad07586d04905b438308adf2938bc_D20180101-20181231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwNDQ_3d07c4f6-bdce-495a-af49-9a7351750e7d">7.00</ix:nonFraction>% for 2018 and <ix:nonFraction unitRef="number" contextRef="icf432c4ed1ca4ca8826cfc7b51ce110f_D20170101-20171231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwNTg_5c8bce52-b65b-4c8e-8bf7-6bced2b73a74">7.00</ix:nonFraction>% for 2017. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The assumed healthcare cost trend rate used to determine benefit obligations was <ix:nonFraction unitRef="number" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQxNTI_871781cf-0d1b-4dad-b3f5-4cb0ac366817">6.25</ix:nonFraction>% for all participants in 2019, decreasing to <ix:nonFraction unitRef="number" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="4" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQxOTc_4d227384-4a07-4447-aa91-2e4e7792a29a">5.00</ix:nonFraction>% by 2024. A change in the assumed healthcare cost trend rate by one percentage point would have an immaterial impact in the postretirement obligation. The assumed healthcare cost trend rate used to determine net periodic benefit cost was <ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="4" name="wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQ0Mzc_829ff318-ae18-4a43-9d26-622e82922857">6.25</ix:nonFraction>% for all participants in 2019, decreasing to <ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="4" name="wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQ0ODI_c8c445fe-f94a-40c4-8f46-81a9e53b80f8">5.00</ix:nonFraction>% by 2024. The effect of a one percentage point increase or decrease in the rate would have an immaterial impact in the aggregate service and interest cost components.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNjU_28d71652-c4c0-4a27-9f7d-961bbd117452" continuedAt="i8710479dc4494d22bc1fa68421c756d8" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.391%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.905%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iad1e003ca731453b8c13de225178286f_I20191231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzEtMS0xLTEtMA_22f1cfb3-22ba-4ca4-a65a-99650d4d869b">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i71005f2a08e3495aa5b8b71712dd46e7_I20181231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzEtMy0xLTEtMA_4af8d027-bb3b-46c8-8760-adee95b373cd">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icef51169ca6c490e91fd071db31d7686_I20191231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzItMS0xLTEtMA_98b8fbf3-d74c-42f1-94ac-8388d7f1ec08">65</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2ff94b3c95ef4cdf82dcbfbe15cce239_I20181231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzItMy0xLTEtMA_e5f47e16-6321-4835-887b-6a2882581f9b">74</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iae5ec6c92f2841c58c748c66b981c526_I20191231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzMtMS0xLTEtMA_86f62a0b-beec-46b8-b0b1-b6a28ca99842">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ibfe9d51b887b49898618b0e671ee0909_I20181231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzMtMy0xLTEtMA_eda1a2c8-f720-4091-a8c5-1e0c99b836f2">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzQtMS0xLTEtMA_de6110d3-0389-44e9-b1c1-1be6c87fe362">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzQtMy0xLTEtMA_aaf26544-e1c2-42ec-8372-946e5b653854">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our U.S. pension plan is managed as a balanced portfolio comprised of two components: equity and fixed income debt securities. Equity investments are used to maximize the long-term real growth of fund assets, while fixed income investments are used to generate current income, provide for a more stable periodic return and provide some protection against a prolonged decline in the market value of equity investments. Temporary funds may be held as cash. We maintain a long-term strategic asset allocation policy which provides guidelines for ensuring that the fund&#8217;s investments are managed with the short-term and long-term financial goals of the fund, while allowing the flexibility to react to unexpected changes in capital markets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended December 31, 2018, in anticipation of benefit accruals under our U.S. qualified and non-qualified defined benefit pension plans ceasing effective January 1, 2019, except for interest crediting, we changed the U.S. target asset allocations from <ix:nonFraction unitRef="number" contextRef="i71005f2a08e3495aa5b8b71712dd46e7_I20181231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1MDE_3ba10ec2-f950-423a-9c8f-3ab160d53316">65</ix:nonFraction>% equity securities and <ix:nonFraction unitRef="number" contextRef="i2ff94b3c95ef4cdf82dcbfbe15cce239_I20181231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1MjY_4239b90d-9dc6-4197-873a-b8bc9d6ceed6">35</ix:nonFraction>% debt securities to <ix:nonFraction unitRef="number" contextRef="iad1e003ca731453b8c13de225178286f_I20191231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1NDg_45030913-cf59-4afe-bb61-78ad37e62a34">30</ix:nonFraction>% equity securities and <ix:nonFraction unitRef="number" contextRef="icef51169ca6c490e91fd071db31d7686_I20191231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1NzM_fb278048-adf0-4a38-b89f-ab2b305d91f2">70</ix:nonFraction>% debt securities.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">71</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i99ad5d66d28744339274bc7ce698cc66"><ix:continuation id="i8710479dc4494d22bc1fa68421c756d8"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following are the U.S. target asset allocations and acceptable allocation ranges:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.391%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.905%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Target allocation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allocation range</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iad1e003ca731453b8c13de225178286f_I20191231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTpjZTNhODZjYWJkNGE0MjcwYjc0NTgxMzQ5Yjc2Yzc2OS90YWJsZXJhbmdlOmNlM2E4NmNhYmQ0YTQyNzBiNzQ1ODEzNDliNzZjNzY5XzEtMS0xLTEtMA_904bb64b-99f5-48e0-b0ac-5e779f623ac9">30</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27% - 33%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icef51169ca6c490e91fd071db31d7686_I20191231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTpjZTNhODZjYWJkNGE0MjcwYjc0NTgxMzQ5Yjc2Yzc2OS90YWJsZXJhbmdlOmNlM2E4NmNhYmQ0YTQyNzBiNzQ1ODEzNDliNzZjNzY5XzItMS0xLTEtMA_4df82120-0040-4ac4-bf69-2e8be59f5df7">70</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67% - 73%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iae5ec6c92f2841c58c748c66b981c526_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTpjZTNhODZjYWJkNGE0MjcwYjc0NTgxMzQ5Yjc2Yzc2OS90YWJsZXJhbmdlOmNlM2E4NmNhYmQ0YTQyNzBiNzQ1ODEzNDliNzZjNzY5XzMtMS0xLTEtMA_4af35454-d399-406d-8fdc-ff059c86b564">&#8212;</ix:nonFraction>%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0% - 3%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.070%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.980%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.824%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib2a035cec19e4b06b8a0a0f2b1507211_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzMtMS0xLTEtMA_c2cfa95b-54e3-4083-83c6-d7a61b356a7e">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i059f6519363e4795ac9e2b62228928ea_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzMtMy0xLTEtMA_7b66b033-87d8-49ad-835d-d834c0dd574f">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic6b75ff5856344798be8d09feba9d76c_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtMS0xLTEtMA_01c5d949-cd5d-41ea-aaf5-301d29334fc0">15.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6b6fc1c55ae4f2c8edcfa03284c2531_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtMy0xLTEtMA_669d5458-6286-4a91-9d35-cfa7b5e41dbe">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i872e47c6d50b462c8e589892b0d54db5_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtNS0xLTEtMA_c4ec0492-0f32-48cb-b921-52e9546c90f8">14.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3c0ee7d7ac4d4a6dbfcb60f511f35cc1_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtNy0xLTEtMA_7725f551-6f1e-47c6-8a2f-8b42bf49e3a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7f540d9be17469abb37970c9409c4b0_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtMS0xLTEtMA_fd6800d9-0bdc-40f3-b951-ff8beed080c9">21.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if92ca63024e94955aa542248e84899d6_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtMy0xLTEtMA_a63cd9b7-4fb6-44d2-8175-14fb9dfa5a07">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83e89bb3731949e9b811eea8345a785d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtNS0xLTEtMA_c3722eef-2f8d-42fa-b273-4bdf31c60660">17.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1671a272484847b0a73c5e28afdbbc6e_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtNy0xLTEtMA_9a6e0e29-4835-4652-8d11-4e61b066971f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets in the fair value hierarchy</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa3a175482f741ac9a27d320bfda7d20_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzExLTEtMS0xLTA_adeb8b17-dda6-4262-af2e-1137514ab789">39.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib3c5104f4fc949a7b5a23bb9ae7a2280_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzExLTMtMS0xLTA_af6f8d1c-dd74-4b00-bc0e-50d98d4d7baf">7.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2d9ab3e1be7b43a6a9aed789c9de3fe0_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzExLTUtMS0xLTA_c5379d17-0c82-43f9-9ec9-5cb349fbec63">32.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets measured at NAV</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0443f666d5124baa94d26af15d452b44_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzEyLTEtMS0xLTA_af4a0439-d237-4aca-9427-f4285929a44e">204.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets at fair value</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzEzLTEtMS0xLTA_217c6c44-db17-415d-ba88-27f9aeb23b09">244.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.230%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.824%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7973d3e744414be78965041980c27ae2_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzMtMS0xLTEtMA_171f7c5a-6426-469e-883b-6048f132208c">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id865d211c82f481ba1e8e730281c3396_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzMtMy0xLTEtMA_392b70b2-9235-4369-a174-b501b5ea6079">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2590f85ac39247ee8575a025ddfafb6e_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzYtMS0xLTEtMA_5f7b5b37-3e3c-4856-99d2-ef7a8b420d8a">17.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id85ff1c02db44ef69cddfb8fa9561ced_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzYtMy0xLTEtMA_1422e73f-52d1-41a5-bd42-74b9d9b206bc">17.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2cfb2df0ba2490e8bc77e8e71719012_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzgtMS0xLTEtMA_91bdf293-b530-4d5e-8b2a-1f11796f96e9">13.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i049d668d485c4a138de851c7ad4dd119_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzgtMy0xLTEtMA_734ca602-1212-4c18-984f-1989144ab6ad">13.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets in the fair value hierarchy</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia16d87c6eeea4a8a9a6aeceadbe8a2e9_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzExLTEtMS0xLTA_16b7e856-d639-43ac-acd4-28fe85b96891">33.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ide50b00aea9546c98b500e0e9ab6663d_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzExLTMtMS0xLTA_0fffc0d8-f849-4187-bf7c-67d960c8e8d2">33.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzExLTUtMS0xLTA_613346f3-097f-4bba-be77-aeb5b881fe46">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets measured at NAV</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1c5adfefdd0a41bc979246bd31ec015f_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzEyLTEtMS0xLTA_ec768a62-4f5e-4746-b6df-278bf0b52868">181.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets at fair value</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzEzLTEtMS0xLTA_05cc541a-d9d8-42db-9079-dfaa92768f9b">214.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i_0_142"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">72</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 16:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NTE_8c576dcc-d402-465b-b59d-c325bbb23f6e" continuedAt="if4dabefd5a0b4ee993b2f395fe9520c8" escape="true">Other (Income) Expense </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if4dabefd5a0b4ee993b2f395fe9520c8" continuedAt="ib9121c0dea23408e94b3eb05f1c87986"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NDk_6fe1c1c1-cc0e-4d55-8d12-6aad9109aa38" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other (income) expense consisted of:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring and related charges:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance and post-employment benefits</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzItMS0xLTEtMA_875b4bed-877c-4610-a04a-c07c7e8d9d32">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzItMy0xLTEtMA_736fad03-4358-4c80-aaed-6066b26d6207">3.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzItNS0xLTEtMA_22a02831-25f5-4524-a0ab-4145fe16cd4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-related charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzMtMS0xLTEtMA_464e2fca-65d1-4f13-b23e-7da10da7f58c">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzMtMy0xLTEtMA_9bd2a908-709a-4120-b792-e090bf1aefca">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzMtNS0xLTEtMA_2293e62d-b64c-4a52-9a63-65b1168e2b71">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzQtMS0xLTEtMA_a29b2d29-263d-487c-ac5a-384d146c73c0">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzQtMy0xLTEtMA_764feb47-6c80-4da7-95fd-3270cdda9a1b">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzQtNS0xLTEtMA_9bc0c45f-ecd9-4c14-9e72-4932749e6ea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total restructuring and related charges</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzUtMS0xLTEtMA_1483ac72-4d32-4cd5-8fa4-f3f7f6dd24cd">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzUtMy0xLTEtMA_778567c8-5920-4424-9790-17bff71f15e4">9.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzUtNS0xLTEtMA_5e1c1b9d-340a-456a-96e5-c66dd41e23a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Argentina currency devaluation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzctMS0xLTEtMA_7e09f33f-9bff-4540-a5ba-e85bea7630ac">1.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzctMy0xLTEtMA_7a9323e2-b2fc-4ad8-80e7-46f3bf8a29e6">1.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzctNS0xLTEtMA_bc11505a-5987-4b0d-bcea-956f59fcdaad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax recovery</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela deconsolidation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzgtMS0xLTEtMA_dbaeed01-3937-433b-98ba-d3495a72775b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzgtMy0xLTEtMA_1ad34e09-a2d8-4b3a-8fe9-658f28b50c12">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzgtNS0xLTEtMA_4b420556-3c5f-4528-be6a-c76eddc22497">11.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Development and licensing income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEwLTEtMS0xLTA_0592e19d-b84d-48e5-ae50-d334ad1177cc">0.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEwLTMtMS0xLTA_6f77df2a-24bf-449b-a797-8617c047c724">0.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEwLTUtMS0xLTA_5c0162ca-acee-418b-af73-2cafd707be00">10.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzExLTEtMS0xLTA_1898ae51-9ece-46ce-a91b-24e41a05e787">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzExLTMtMS0xLTA_afdfcc01-4463-41d8-9ea6-8e5d950b02f9">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzExLTUtMS0xLTA_8377b951-268d-41d7-a338-4b89b62fa313">2.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other items</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEyLTEtMS0xLTA_cb66da2a-2eda-45c5-9cef-3eb0c05e412b">4.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEyLTMtMS0xLTA_cd8a82c2-e9b1-4bfe-87d1-c4f3b58c6a80">4.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEyLTUtMS0xLTA_70b1cb4e-d71d-4483-9328-04076690c9fc">3.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other (income) expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEzLTEtMS0xLTA_c6eeeea7-e4b3-40f9-bf17-026e4a62fab1">2.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEzLTMtMS0xLTA_7333dffb-ae10-40e8-89bc-bab84f623728">1.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="wst:OtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEzLTUtMS0xLTA_29eedb81-f4b7-4ba7-93b1-9c2002654941">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes were expected to be implemented over a period of up to twenty-four months from the date of the approval. The plan was expected to require restructuring and related charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i0e49cb2c7f3a4e50aac7c89a7a0d7753_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzQwMA_2b2f75b4-0cda-4dfd-bd2f-7cb75e6146f3">16.0</ix:nonFraction> million. Since its approval, we recorded $13.7&#160;million in restructuring and related charges associated with this plan. The plan is now considered complete.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded $<ix:nonFraction unitRef="usd" contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzQ4MA_11cf3e5b-adb0-47c1-989a-e2084d72ff12">4.9</ix:nonFraction> million in restructuring and related charges associated with this plan, consisting of $<ix:nonFraction unitRef="usd" contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzU2MQ_7316c62a-3da8-4487-83b9-ccc52a44df15">2.6</ix:nonFraction> million for severance charges, $<ix:nonFraction unitRef="usd" contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:AssetImpairmentChargesPatentandEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzU4Nw_3925967a-df71-4441-aaa2-b5e0b4160fa7">0.3</ix:nonFraction> million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $<ix:nonFraction unitRef="usd" contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzY4NA_c9c65c98-4b7d-4b10-928e-be2724e887db">2.0</ix:nonFraction> million for other non-cash charges. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2018, we recorded $8.8&#160;million in restructuring and related charges associated with this plan, consisting of $3.1&#160;million for severance charges, $2.2&#160;million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $3.5&#160;million for other non-cash charges. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NDM_a13933ac-2717-4a23-955e-ed328dcff280" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.980%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.908%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance    and benefits</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-related charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash asset write-downs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8e0171741848480aabaad6cf352a5967_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtMS0xLTEtMA_32b5eac8-a2da-4ffb-a21e-5741374c6735">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5c3b94bf9830453eb8c83e9fe89297ed_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtMy0xLTEtMA_a529c5e4-5cfd-43a7-b325-9a7f23e1ccb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iff067a80b3c0472aafbb0d3d5e4c92ad_I20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtNS0xLTEtMA_c90462d2-b445-4bf1-9ca8-638628ac1ca0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63038b37ba3f4411817f0419317cd970_I20181231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtNy0xLTEtMA_078c7581-441f-4310-8f96-c46debeb501e">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtMS0xLTEtMA_eb3a7c9f-79f8-4eea-bf4e-26b59de5f862">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtMy0xLTEtMA_3776807c-eeb7-4063-b5fb-ab80c4a55043">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtNS0xLTEtMA_69ad6fad-7899-4280-ac59-1d088ef74e26">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtNy0xLTEtMA_33939694-604f-45a9-9935-4afaceba180b">4.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctMS0xLTEtMA_80a8ef22-85d0-4866-91fd-9721b7b48646">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctMy0xLTEtMA_2c67ddbe-783a-464e-91f8-b0ca64e87cd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctNS0xLTEtMA_3402df23-fe01-4c2b-9a4e-f2518083c3b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctNy0xLTEtMA_af07d00e-ee84-4449-a705-003d0957ae52">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash asset write-downs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtMS0xLTEtMA_7d8066fe-6892-4e6b-816d-965014301ba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtMy0xLTEtMA_2c03b315-d309-4109-99f8-5f6a2889fb0e">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtNS0xLTEtMA_28e671f2-98aa-4d55-bc45-52014b406ae3">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231" decimals="-5" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtNy0xLTEtMA_98517233-03b3-4bf9-9f74-a13b70ad7b55">2.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a770acf6d014af1b07375d85b007733_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktMS0xLTEtMA_375c24e5-bcd9-4bb7-9cf6-53876bd00acb">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0e8452d0cd54d09bd29f966f85d7796_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktMy0xLTEtMA_22360fa6-96da-41c2-8fdd-d41f9816cfa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic58d406b08ad4b8ea3459ce6ee377143_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktNS0xLTEtMA_f4ab4b11-2ac5-42c3-87bb-d1199e9d43d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09af60c60dee44a093e76f37f68e79e4_I20191231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktNy0xLTEtMA_82f95535-ec80-4cd6-8e62-6393cdbd3291">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">73</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ib9121c0dea23408e94b3eb05f1c87986" continuedAt="iee2013246db147b19c9e61ca32c097e5"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. During 2018, we recorded $<ix:nonFraction unitRef="usd" contextRef="i508d135f28ec440fa57fc415a1e8cc42_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzExNjU_bbfc0e49-5230-4404-b182-883783c4f6a9">0.3</ix:nonFraction> million in additional charges related to this restructuring plan. Our remaining restructuring obligations related to our 2016 restructuring plan as of December 31, 2019 were $<ix:nonFraction unitRef="usd" contextRef="i67268793d14a4d86b86841792ac25b2a_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzEzMzQ_3cb0a917-6bd6-4f8f-b5c7-04e739020e23">0.1</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Items</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NDgyOTA3MDIzMjk_24039d91-2e78-44a1-9061-9d6b31d47f8d">1.0</ix:nonFraction>&#160;million as a result of the continued devaluation of Argentina&#8217;s currency. During 2018, we recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzEzODk_74201a86-9d10-4a38-856f-9023ed301b93">1.1</ix:nonFraction> million related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recognized a tax recovery of $4.7&#160;million related to previously-paid international excise taxes, following a favorable court ruling.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On February 17, 2016, the Venezuelan government announced a devaluation of the Bolivar, from the previously-prevailing official exchange rate of <ix:nonFraction unitRef="number" contextRef="i9a2c29927a97445985c175fb950377a6_I20161231" decimals="1" name="us-gaap:ForeignCurrencyExchangeRateRemeasurement1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzE2NTA_9a001709-9072-4407-a3a8-bcfe14fdfe11">6.3</ix:nonFraction> Bolivars to USD to <ix:nonFraction unitRef="number" contextRef="i17de35ea5588457687be31c78183d563_I20160217" decimals="1" name="us-gaap:ForeignCurrencyExchangeRateRemeasurement1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzE2NzI_e236d4a8-afed-400a-aef5-9c8eaf9ccd9b">10.0</ix:nonFraction> Bolivars to USD, and streamlined the previous three-tiered currency exchange mechanism into a dual currency exchange mechanism. In 2017, as a result of the continued deterioration of conditions in Venezuela as well as our continued reduced access to USD settlement controlled by the Venezuelan government, we recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeconsolidationGainOrLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzIwNTY_9fa18103-6968-4833-96b7-bc8a7449d08d">11.1</ix:nonFraction> million related to the deconsolidation of our Venezuelan subsidiary, following our determination that we no longer met the U.S. GAAP criteria for control of that subsidiary. This charge included the derecognition of the carrying amounts of our Venezuelan subsidiary&#8217;s assets and liabilities, as well as the write-off of our investment in our Venezuelan subsidiary, related unrealized translation adjustments and the elimination of intercompany accounts. As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, 2018 and 2017, we recorded development income of $<ix:nonFraction unitRef="usd" contextRef="i1e11b27427cd46d590025400238fdb38_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI2NzE_72bce79b-40b7-4d9a-9e2d-fe46212a6a7e">0.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib48ea9474bfe4c5d806349adbf636277_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI2NzU_0d07c737-e6c6-4c6f-8dba-fc16c2b95f74">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6760c6eadf5e4027ab3c48a8a4c417ad_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI2ODI_947e5923-1427-492a-bfc7-bd81000ef4f1">1.5</ix:nonFraction> million, respectively, related to a nonrefundable customer payment of $<ix:nonFraction unitRef="usd" contextRef="i2a2868b8c8554bf08566aa6693065131_I20130630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI3NDc_b45ea467-95d9-4ed7-91ba-29ee9675442e">20.0</ix:nonFraction> million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information. In addition, during 2017, we recorded income of $<ix:nonFraction unitRef="usd" contextRef="ica512f947d5545b0a280adcd3765b3af_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="wst:Developmentandlicensingincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI5ODQ_f0ff6ab1-0994-4bf3-80bb-278c0da83f9e">9.1</ix:nonFraction> million attributable to the reimbursement of certain costs related to a technology that we subsequently licensed to a third party. The license of technology to the third party may result in additional income in the future, contingent on commercialization of the related product. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.   </span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="iee2013246db147b19c9e61ca32c097e5">Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items primarily changed in 2019 as a result of foreign exchange transaction gains of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM2Nzg_a597c5b1-d5ca-4dae-8db5-123f686fbef8">5.6</ix:nonFraction> million in 2019 and a $1.9&#160;million gain on the sale of fixed assets as a result of our restructuring plan, as compared to foreign exchange transaction gains of $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM3NDQ_1053260e-7e79-4953-ac9e-05dc5276eab9">5.5</ix:nonFraction> million in 2018 and a $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM3NjI_b7165203-d31f-4078-8b46-76e918111a3c">1.1</ix:nonFraction> million gain on the sale of fixed assets as a result of our restructuring plans.</ix:continuation> </span></div><div><span><br/></span></div><div id="i_0_148"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 17:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODc_518dc7b6-d6d2-4efd-a0b9-e1beb8f79bdd" continuedAt="ifed15328fe0c4a8d8441bb443edfeb96" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ifed15328fe0c4a8d8441bb443edfeb96" continuedAt="iacc05e09022f4f8294cad536ccb64342">As a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. During 2019, the statute of limitations for the 2015 U.S. federal tax year lapsed, leaving tax years 2016 through 2019 open to examination. For U.S. state and local jurisdictions, tax years 2015 through 2019 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2012 through 2019.</ix:continuation></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">74</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="iacc05e09022f4f8294cad536ccb64342" continuedAt="ib22a992ceeda40faa559fe4640b09653"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1Nzg_874e11d9-d9e7-4f78-b11c-c53678861278" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.391%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.905%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzEtMS0xLTEtMA_19a5fc86-26b8-4f10-a41c-3a060abd277e">3.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzEtMy0xLTEtMA_e6f1b78e-9ab7-4079-a3a8-586b650f387f">3.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase due to current year position</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzItMS0xLTEtMA_b41d7152-c67a-4fbf-baef-96d73cfaffca">1.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzItMy0xLTEtMA_a40a71b6-1ff0-4a59-ad2f-f505da88f4a1">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase due to prior year position</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzMtMS0xLTEtMA_77f61432-d7ae-49b6-a7f4-f295a3f22133">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzMtMy0xLTEtMA_19fe271a-06fd-4152-b29e-a3a397ab42f1">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzQtMS0xLTEtMA_879abeb3-182c-45c4-a27c-8b141c610a11">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzQtMy0xLTEtMA_c9e90baa-60e9-4ce5-b46e-442b6ca4b6d6">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzUtMS0xLTEtMA_4186fafa-996e-4512-b77f-03e07bea91c8">5.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzUtMy0xLTEtMA_f26431a6-115a-48e8-8044-7293709300a0">3.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we had balances in accrued liabilities for interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzcwNw_5ee46983-94a8-4e30-a3df-6975f4c7d029">0.2</ix:nonFraction> million at both December&#160;31, 2019 and 2018. As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc2Mg_2a5659dd-9bbb-4e68-8581-834ee5483b92">5.0</ix:nonFraction> million of total gross unrecognized tax benefits, which, if recognized, would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzEwNTg_2a05ecce-063c-4eec-925b-7db3a34f53d1">0.5</ix:nonFraction> million during the next twelve months, which would favorably impact our effective tax rate.</span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODA_88e4ceb5-cd07-4bd6-b96a-8b98ecc92e63" escape="true"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of income before income taxes are:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzEtMS0xLTEtMA_4786ccd2-87b1-4b47-8a75-dfc152d9b9d8">161.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzEtMy0xLTEtMA_e24cf7ef-55b1-49b3-b70c-743e26735c75">132.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzEtNS0xLTEtMA_e094ecb1-9996-4e4d-8d55-e2e36c365673">96.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzItMS0xLTEtMA_fef0780b-dfc1-4b60-a5b6-46d589eab104">130.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzItMy0xLTEtMA_c3881f49-bea5-45a9-b626-3db2fc042c6b">107.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzItNS0xLTEtMA_ad4b4099-778c-4c85-b253-68681220dadc">125.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzMtMS0xLTEtMA_60fd26ea-dd41-4167-9822-c0d9fc0a5c8f">291.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzMtMy0xLTEtMA_645b3188-5670-4f7d-a514-8750afd3d35d">240.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzMtNS0xLTEtMA_8c3028d5-fc9d-44ab-8068-752edd50faf2">222.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODQ_0f305864-03be-447b-a864-d2de7f107b1a" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The related provision for income taxes consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Federal</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzItMS0xLTEtMA_0794312d-feb5-48be-af60-09f225b399b3">10.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzItMy0xLTEtMA_21182017-4160-4fab-a633-0d74404dee55">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzItNS0xLTEtMA_373cdc25-56d2-48f7-90fa-b0b5570d4234">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzMtMS0xLTEtMA_d6707815-e7c3-489d-a516-f2f82ce18acc">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzMtMy0xLTEtMA_9c4d5257-0a42-4149-8aa1-d8f51b5db771">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzMtNS0xLTEtMA_9fb32e2b-61c5-493d-88d1-715f8d2f8dcb">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzQtMS0xLTEtMA_5e71e52b-0a91-4693-b573-735302cb2242">30.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzQtMy0xLTEtMA_4defc10c-c65f-4c7c-98c2-c5c4b422ec64">35.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzQtNS0xLTEtMA_2f135024-3cae-4c74-8a3f-63f47195cf33">37.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current income tax provision</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzUtMS0xLTEtMA_e44cc86c-993d-444a-973d-6cb6ca353a63">43.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzUtMy0xLTEtMA_d863b90d-5791-4d77-99c4-99b0ac5b75b0">40.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzUtNS0xLTEtMA_5280f598-158a-40c7-a054-7bbc4f6bf893">39.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Federal and state</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzctMS0xLTEtMA_7b82f2fb-d7e7-4637-976d-8c2fda4ecdfc">10.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzctMy0xLTEtMA_9940e69c-d1af-40a5-aa30-2a0634489948">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzctNS0xLTEtMA_0f31ab0e-f00e-4e7e-9a20-17c83b4f2e05">41.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzgtMS0xLTEtMA_f6b98b50-8a58-43f2-9312-3bbe36d7c78d">5.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzgtMy0xLTEtMA_dd590d50-5f72-4d1b-b813-4b213a5b341a">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzgtNS0xLTEtMA_031ee769-67c7-453b-9b59-6a0c196460c2">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income tax provision</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzktMS0xLTEtMA_703728e3-f76a-4185-afa3-ca48ea5b7463">15.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzktMy0xLTEtMA_2391b5e1-6959-4d0f-b53a-0785c9d4cc9f">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzktNS0xLTEtMA_e294813f-5dc1-4e87-beaf-b9ba4b0dbc48">41.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzEwLTEtMS0xLTA_209c2e16-b903-4448-ba91-d8c81f215a82">59.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzEwLTMtMS0xLTA_5495207d-3d1d-4f9a-9f04-be88b101fe42">41.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzEwLTUtMS0xLTA_0da13680-1437-481a-8b1e-a4baaec89acc">80.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">75</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ib22a992ceeda40faa559fe4640b09653" continuedAt="iaaa26ea48a9a4bb49c8a5d8697bc034d"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODk_fd53de44-988f-4b89-87ac-9210dd7fd1b3" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:67.391%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.905%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net operating loss carryforwards</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzItMS0xLTEtMA_31db1c0c-3822-426b-a2ce-4d0dc58bd1d8">21.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzItMy0xLTEtMA_95ae4a6a-aa2a-46ac-914f-a72f3fdd7a13">18.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax credit carryforwards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzMtMS0xLTEtMA_f32d87d0-7bd6-4760-9bab-394ce403e267">2.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzMtMy0xLTEtMA_c02fa2fe-f1f1-4343-8bcf-4353befd4360">10.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension and deferred compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzUtMS0xLTEtMA_9e78744a-744d-4847-8271-803404abe241">25.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzUtMy0xLTEtMA_dd79b1d4-3deb-43d2-896a-41cd92d0747a">27.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzYtMS0xLTEtMA_28cdd020-7c37-456c-9fa7-7c38eae9b3a9">9.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzYtMy0xLTEtMA_f1fe2b7e-afd4-41d1-9fa5-bebfee9149b4">11.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzctMS0xLTEtMA_e193d016-2d02-48db-95a4-82f0f41773d9">15.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzctMy0xLTEtMA_2b71c7b2-9251-4a97-80c5-044b110a31b0">16.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzgtMS0xLTEtMA_c5d77167-f014-4bea-a6c8-6a645cf9167c">43.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzgtMy0xLTEtMA_a5f0eec4-b677-4816-b040-8348af05bca9">51.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated depreciation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEwLTEtMS0xLTA_469036b6-10d6-4146-b562-f1db646d59db">37.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEwLTMtMS0xLTA_c5ae723e-8b7a-4e56-bd06-416027a37330">31.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzExLTEtMS0xLTA_d81b6c31-7b7b-403c-9756-3e5dda204552">6.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzExLTMtMS0xLTA_6364a29c-dfde-4a4f-9f5b-27e351465397">6.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEyLTEtMS0xLTA_9a239a37-491e-4721-aed6-c785e76b422b">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEyLTMtMS0xLTA_b262f9a8-464c-4040-bef7-a37468f6e72b">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEzLTEtMS0xLTA_a1d12f7f-4ae1-4471-ad67-446f5e01114a">45.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEzLTMtMS0xLTA_cd03a418-6411-4169-b8fe-38b9b79f19e5">39.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net deferred tax (liability) asset</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" sign="-" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzE0LTEtMS0xLTA_464615a7-4886-445e-8421-07f2a9a6e808">1.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzE0LTMtMS0xLTA_83e48b07-a8bf-4ce0-8f4c-19b8fc688195">11.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1OTE_f8d742a5-9536-4e95-8717-71255668ffe4" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.365%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.227%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. federal corporate tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEtMS0xLTEtMA_3d0fdf6b-d756-4be1-93f1-c6219dfe57c7">21.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEtMy0xLTEtMA_8f96db11-dac6-4de4-a4d3-a27a00c68861">21.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEtNS0xLTEtMA_f3081ffc-591e-4e25-bdbd-87981af40ee1">35.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzItMS0xLTEtMA_e8e3173e-d0d6-4467-9779-558ed683c1a0">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzItMy0xLTEtMA_6fc85578-72a1-4e08-b3ba-c7a1a124d0e2">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzItNS0xLTEtMA_667dce16-9c47-4a9d-ae23-0b1a22840ca5">4.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reversal of prior valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzQtMS0xLTEtMA_0214b257-ae89-44bb-84e6-503f3ef47ef5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzQtMy0xLTEtMA_30ab28e2-a719-4e0d-8c1e-3bfc689cb23a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzQtNS0xLTEtMA_a0686328-3268-4bce-8724-a42aeb600a1d">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzUtMS0xLTEtMA_867214df-4fd1-4809-bd8b-cadd1e51ba99">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzUtMy0xLTEtMA_470f97a3-e4c9-4715-adc4-1a72cb9f15af">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzUtNS0xLTEtMA_1d53599b-8691-4be9-9803-cc849a94588c">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzYtMS0xLTEtMA_5c589b37-9d6c-4c03-81ff-3d93a55483f4">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzYtMy0xLTEtMA_be1844a0-7f89-4483-8df5-2e7e1d6bffc7">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzYtNS0xLTEtMA_49e92896-0341-48da-9d1f-0483f4ec4b9f">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State income taxes, net of federal tax effect</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzctMS0xLTEtMA_160011ae-5f0c-4934-b24d-3671902049a1">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzctMy0xLTEtMA_56eddb58-ce1f-404e-8ca4-a4a97a1b7973">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzctNS0xLTEtMA_d7d343e6-93b8-40d3-a60f-ec9a10d623b5">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. research and development credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzgtMS0xLTEtMA_befb4756-aaa4-4175-beb7-1c33b5748b18">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzgtMy0xLTEtMA_bff2ce7f-c5ad-47a7-8fe3-100f259eb3c6">0.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzgtNS0xLTEtMA_c41a0355-d1aa-4d5f-976b-1feafffb5784">0.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Excess tax benefits on share-based payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzktMS0xLTEtMA_f9b4b306-bdc0-4fd3-95fb-47267d95b5ac">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzktMy0xLTEtMA_da72f2fb-e8b9-429d-b697-d74e1095e77f">6.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzktNS0xLTEtMA_21c81a0c-0e3e-4a6d-a0b6-4ca417ea81b5">14.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impact of 2017 Tax Act</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEwLTEtMS0xLTA_91295d93-32c5-4f91-ae44-5fd7f3b2a57d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEwLTMtMS0xLTA_c2ece6b2-b634-4d0c-89c1-989fbc1aedb2">2.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEwLTUtMS0xLTA_1bc740bb-ca49-4a44-bf63-4127b53b6a86">15.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzExLTEtMS0xLTA_a75e2513-6dfd-4b6e-8b62-2a8e555191bf">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzExLTMtMS0xLTA_1982b5cb-a9c4-4344-934f-bc43727a61d4">1.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzExLTUtMS0xLTA_cd38eea7-52e9-4df6-9f59-feffc2867492">4.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela deconsolidation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEyLTEtMS0xLTA_c9336990-b4d9-4489-b40e-b95583611acd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEyLTMtMS0xLTA_16642bb2-cf5a-440f-ad06-74fcd3b697fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEyLTUtMS0xLTA_9f85f9bb-9018-4b42-abab-c4a7462da143">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other business credits and Section 199 Deduction</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" format="ixt:zerodash" name="wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEzLTEtMS0xLTA_cad54187-0767-4415-a19a-ddc78f2b6440">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" format="ixt:zerodash" name="wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEzLTMtMS0xLTA_71c1941a-311f-4173-8187-1bd0cf445cb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" sign="-" name="wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEzLTUtMS0xLTA_beda39e2-3779-4224-aec2-3294613f9ca9">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE2LTEtMS0xLTA_c07071ac-dcd1-4d5a-998e-e340efe8b208">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE2LTMtMS0xLTA_2838d9a0-4424-4c0d-8d2d-1d3875c825ea">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE2LTUtMS0xLTA_980f827e-4036-4af8-a625-afbc2f88ffd0">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effective tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE3LTEtMS0xLTA_9f439049-3c51-4489-aaf7-e0da1e6aaa7c">20.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE3LTMtMS0xLTA_5bffa510-5f56-42ed-a305-e1ce36b1f8aa">17.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE3LTUtMS0xLTA_902dd60b-d727-486e-a9d1-207d3a71fe3c">36.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzM4NDgyOTA3MDYxMjI_7506801f-9297-49b6-a775-acadfef3d6dc">0.3</ix:nonFraction>&#160;million due to the impact of federal law changes enacted during the year, as well as a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="ia0a47ab88878443fa4e6adac51e1e3c3_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzM4NDgyOTA3MDYxMzY_b6ee0136-e782-4f97-b4d9-b5c6ee7f76e2">10.3</ix:nonFraction>&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2018, we recorded a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="wst:TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzE2ODQ_039f9441-49c1-4f60-9ee5-bdd3ea14fce2">2.5</ix:nonFraction> million for the estimated impact of the 2017 Tax Act and a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="iafeae8bf38a74e0390f625e332ddc2d6_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzE3NzE_d7a89978-cd2e-4391-86f8-ea6ef87a8c8b">14.3</ix:nonFraction> million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2017, we recorded a discrete tax charge of $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="wst:TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzE5Mzc_224285a2-57b5-4df1-b359-cdd533ffc380">48.8</ix:nonFraction> million related to the 2017 Tax Act and the impact of changes in enacted international tax rates on previously-recorded deferred tax asset and liability balances, as well as a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i77e352a3c93e42ae8d803009dcc77900_D20170101-20171231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzIxMjM_688723bc-1d69-43e0-bde6-3561bb7b746b">33.1</ix:nonFraction> million associated with stock-based compensation.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">76</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="iaaa26ea48a9a4bb49c8a5d8697bc034d"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2017 Tax Act, which was signed into law on December 22, 2017, has resulted in significant changes to the U.S. corporate income tax system. These changes include, but are not limited to, a federal statutory rate reduction from <ix:nonFraction unitRef="number" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzI0NjU_22f4b76d-8846-44f6-aa7b-3931ec64b16f">35.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzI0NzE_b7058c57-26d7-46f2-81a5-d025e44dafe7">21.0</ix:nonFraction>% effective for tax years beginning after December 31, 2017. Changes in tax rates and tax laws are accounted for in the period of enactment. As a result, during the year ended December 31, 2017, we recorded a discrete charge based upon our understanding of the 2017 Tax Act and the guidance available as of the date of that filing. A significant portion of the discrete tax liability was attributable to a one-time mandatory deemed repatriation tax of post-1986 undistributed foreign subsidiary earnings and profits (the &#8220;Transition Toll Tax&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzMwMTk_f8d79002-2ffc-4f4c-9030-e5ba8410e01e">27.9</ix:nonFraction> million. Additionally, due to the reduction of the federal statutory rate, we revalued our deferred assets and liabilities and recorded a provisional $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="wst:TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzMxNjQ_e8db94c9-fa2e-4fdf-9ebc-bf24989436ff">11.4</ix:nonFraction> million federal tax expense, net of state tax impact, during the year ended December 31, 2017.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Tax Act. We recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in our consolidated financial statements for the year ended December 31, 2017. As of December 31, 2018, we finalized our calculations and tax positions used in our analysis of the impact of the 2017 Tax Act in consideration of proposed regulations and other guidance issued during 2018. As a result, we recorded a $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQwODM_7130ef9d-4ce5-4d77-b837-60bc45f7e4f0">7.5</ix:nonFraction> million tax benefit related to a reduction of the Transition Toll Tax and an incremental tax expense of $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQxODI_7d48250c-327b-4a36-a034-a3ad5a624eba">4.0</ix:nonFraction> million related to other adjustments. The final measurement reduced the Transition Toll Tax expense to $<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQyODA_7ef53a2a-dd6d-45c3-a7a5-b9e0b713233c">20.4</ix:nonFraction> million from $<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQyODg_da1f7a49-1a6f-4781-832f-61023724c23f">27.9</ix:nonFraction> million. The net impact of these adjustments resulted in a benefit of <ix:nonFraction unitRef="number" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="4" sign="-" name="us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQzNTM_71e3e489-ca43-47f4-a495-3f91bb1a892b">1.45</ix:nonFraction>% to the 2018 effective tax rate. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2017 Tax Act created a provision known as global intangible low-tax income (&#8220;GILTI&#8221;) that imposes a U.S. tax on certain earnings of controlled foreign subsidiaries. We made an accounting policy election to reflect GILTI taxes, if any, as a current income tax expense in the period incurred. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we have fully utilized all of our U.S. federal net operating loss carryforwards. State operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i29b000bedbc74b059850aa72d8e23d8a_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUxNTc_a6b31016-bf5a-4a79-803d-2d5996ac7ff4">226.9</ix:nonFraction> million created a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUxOTI_531a0400-b8fa-4c67-95fe-af9779ce0c19">15.5</ix:nonFraction> million, while foreign operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i57428a739d8c47e29c71f898beabc22b_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUyNDI_13acd4ec-ea0e-4e35-ab5e-283c6d8d361a">49.4</ix:nonFraction> million created a deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUyNzc_58cd31b4-fda9-4979-8efb-25b8d17a14fc">6.4</ix:nonFraction> million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been fully reserved. State loss carryforwards expire as follows: $<ix:nonFraction unitRef="usd" contextRef="i0d6aec77c75b4f37a744be6b762f91c7_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU0OTk_e0da2ba5-4956-4252-ad04-1e428dbddc67">15.4</ix:nonFraction> million in 2020 and $<ix:nonFraction unitRef="usd" contextRef="i49459769fb524550871915ef2336f3bb_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU1MTI_9d44910e-94cd-4fa1-b007-6a24a99f1581">211.5</ix:nonFraction> million thereafter. Foreign loss carryforwards will begin to expire in 2027, while $<ix:nonFraction unitRef="usd" contextRef="i57428a739d8c47e29c71f898beabc22b_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU1OTA_56a1c588-b803-4909-839b-352fa67ee20b">48.7</ix:nonFraction> million of the total $<ix:nonFraction unitRef="usd" contextRef="i57428a739d8c47e29c71f898beabc22b_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU2MDY_13acd4ec-ea0e-4e35-ab5e-283c6d8d361a">49.4</ix:nonFraction> million will not expire.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we have utilized all available foreign tax credit carryforwards against the Transition Toll Tax. During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. The $<ix:nonFraction unitRef="usd" contextRef="i315770c7cae047a4a1c795627dca7961_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU5NzU_b71fef6f-f2f0-4d4c-bdb8-1b60e671b4f4">2.0</ix:nonFraction> million of state research and development credits expire as follows: $<ix:nonFraction unitRef="usd" contextRef="i2d27b8c83d9e4aed8e3bf7c54c872328_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzYwMzk_d0a4a769-bdfd-4271-b490-8ba23e7c4d48">0.5</ix:nonFraction> million expire in 2023, $<ix:nonFraction unitRef="usd" contextRef="i6c33648dc8604a2e97bec4df1cd23f1f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzYwNTY_0d710319-22d6-46f1-afd5-862bb6770ebd">0.5</ix:nonFraction> million expire in 2024, and $<ix:nonFraction unitRef="usd" contextRef="ia6eefab0034b46c0afd45df41bf8245f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzYwNzc_6299e8b5-400d-4704-b928-5885c9dc8cd0">1.0</ix:nonFraction> million expire after 2024.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzcwMTY_518a1ddc-acdc-45d8-a1a5-285dd6ebee38">214.2</ix:nonFraction> million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_151"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">77</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 18:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEyNDA_06a47781-b637-40b1-ba4c-56481b030d7a" continuedAt="ibf7e30e6f6634d639d237bb998cfec5f" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibf7e30e6f6634d639d237bb998cfec5f"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, we were obligated under various operating lease agreements. Please refer to Note 6, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Leases</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements.  Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEwOTk1MTE2Mjk2Njk_4cd95390-b6b2-43f5-b216-ab9ca78e45b0">249.1</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEwOTk1MTE2Mjk2NzM_b6e086b0-fa5e-4731-a6a7-4d3c33023a71">61.3</ix:nonFraction> million is due to be paid in 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i04ab47ee62a5494f909f92a95cc7c70c_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzQ2Ng_917ace18-9c09-4ddc-9c47-ed86cd39166f">2.5</ix:nonFraction> million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $<ix:nonFraction unitRef="usd" contextRef="ia4a3ac6bafdc43978ec3c7db0603a567_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzYyNA_b5ee57e9-c1a1-41f9-bda8-c35dc6fae796">3.2</ix:nonFraction> million at December&#160;31, 2019, of which $<ix:nonFraction unitRef="usd" contextRef="ia4a3ac6bafdc43978ec3c7db0603a567_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzY0Mw_4feaafd6-1482-438a-b686-2ba58e39dda5">0.9</ix:nonFraction> million is in excess of our deductible and, therefore, is reimbursable by the insurance company.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our SmartDose contingent consideration is payable to the selling shareholders based upon a percentage of product sales over the life of the underlying product patent, with no cap on total payments. Given the length of the earnout period and the uncertainty in forecasted product sales, we do not believe it is meaningful to estimate the upper end of the range over the entire period. However, our estimated probable range which could become payable over the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzExOTk_3f334523-3b30-4be6-b24a-5b3930387693">five</span> years is between <ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEyMTk_0978cd46-8eb1-455f-88d3-7495c11c7bd5">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEyMjY_d9a83a61-f000-47d9-b6e9-2640de1008da">3.7</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div id="i_0_154"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 19:&#160;&#160;<ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzE5ODk_a6c5a025-9f80-4fbf-8dbf-05d62fbbe1e1" continuedAt="id01e816ef8b246c7bc2797713c30d07d" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id01e816ef8b246c7bc2797713c30d07d" continuedAt="i6a3e676c5841489697235c0cd9618fb6"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business operations are organized into <ix:nonFraction unitRef="segment" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzc5_cababdff-312c-4c8c-a61c-8a040585158b">two</ix:nonFraction> reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and integrated solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzIwMDI_7acf8b5c-b61d-4f27-a804-1da53de11e19" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:51.685%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzItMS0xLTEtMA_a3f2aa48-606f-403d-91ea-74053d0a459d">1,398.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzItMy0xLTEtMA_690e7f34-bf32-4e6d-90ab-2fe3acf7202b">1,308.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzItNS0xLTEtMA_c1f35164-1828-4a6d-a68c-1e3557a1f5cc">1,236.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzMtMS0xLTEtMA_383c33b8-22ae-4274-98d6-d4f4dad3e3b0">441.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzMtMy0xLTEtMA_27bb0d19-bba9-44fc-b67a-1672a97a3fac">409.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzMtNS0xLTEtMA_3873e713-3e28-431b-99f5-0220924e6732">362.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intersegment sales elimination</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i078c4378a1b84554a97a59aedf1dfea7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzQtMS0xLTEtMA_f6d3fd67-3d15-4e8d-a7c2-847842f0f3ad">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iec0e5799d11f4ece904985f859626f83_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzQtMy0xLTEtMA_060e837e-0677-4ec6-b000-2f47e6aded56">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib2ea62dcc46049b7b44a7e372ea6a995_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzQtNS0xLTEtMA_420762c3-beb9-4ef3-88b7-c405fc4321f6">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzUtMS0xLTEtMA_5fea618a-6fe7-4871-92b2-2495c84d0ccf">1,839.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzUtMy0xLTEtMA_1254adb2-46bd-4052-9682-88f4c80f8228">1,717.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzUtNS0xLTEtMA_fcabb45d-ea77-42a9-8312-6652a38e2017">1,599.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">78</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i6a3e676c5841489697235c0cd9618fb6" continuedAt="i728e874014344fbc9cc4af6ddf9028fe"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We do not have any customers accounting for greater than <ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:SegmentReportingDisclosureOfMajorCustomers" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzE3MTE_c55c4211-1f9d-45e8-bbf2-709facda50d0">10</ix:nonNumeric>% of consolidated net sales.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzE5OTk_8d8cabee-e6cb-4d41-b609-8668a032392a" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents net sales and property, plant and equipment, net, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:23.801%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.704%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, Plant and Equipment, Net</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic7f8ebed49c04cffb17e7209463597e7_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItMS0xLTEtMA_f936fca0-36b9-43de-95a0-eaebc467f97f">814.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e4f0863e8134660bc06abb0a0554e60_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItMy0xLTEtMA_2894458f-4ba8-46b7-a2a8-fede9d52d23d">766.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i11483b8c07b24a0285c429890af29b9b_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItNS0xLTEtMA_40ae6ceb-5e46-4659-9656-c8d2ff4d9bff">734.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id465de2bff9a44b58c23173587870451_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItNy0xLTEtMA_3f0e5cfc-b7a6-4439-9c6d-c701bc587d05">337.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie7d5c2cd9d804dc19f76970e86ae5660_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItOS0xLTEtMA_a20ae904-1d9e-41db-8a02-ab09af69110b">315.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30dc74ba8e0b46938ade75bfad703ec4_I20171231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItMTEtMS0xLTA_d3d4f5ab-4421-4db4-a55d-ab9713b677e2">323.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f4a7e1e4f344e59acb8e316afa24ca7_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtMS0xLTEtMA_b4b5236b-aed1-4e5e-991d-bed6786e8002">236.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02b772a610de4ee59ff680dfeb546f55_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtMy0xLTEtMA_9cd667c8-9ae3-40a0-b98f-de07ba703442">235.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdf9bc802dfc4329a0be62772f1a8f6b_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtNS0xLTEtMA_85ec246f-d7ed-41b3-ba3c-8432f1a41cb4">226.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2f86ebc34b44436088bdd5978d8e3e07_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtNy0xLTEtMA_8ab12592-b394-4e0e-a9e1-fb41835359dd">95.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2fc499a8a70a4e75bdc070421802e388_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtOS0xLTEtMA_8730ff25-50c0-43a6-9acc-6425bca1b32b">99.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie056e2b910a94d86a17d8e9f6a20dc06_I20171231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtMTEtMS0xLTA_3c5a8d7f-1d7b-484b-b354-05f848285863">108.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i476449ab4421489bb9b91517a6fc7efe_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtMS0xLTEtMA_915e3a1e-f824-4d4f-91f5-73860bf8888a">173.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i85b512abe143458ebeb74749610bb670_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtMy0xLTEtMA_bf3b1952-a856-4393-979f-4099b5b17d97">138.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe71ee072f1e4070b5fe8ef25b5b4c68_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtNS0xLTEtMA_d8cc9888-bd83-43fc-aff9-98246544829a">100.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief76596d19a14b5699a2fde2cb8e562b_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtNy0xLTEtMA_e75262ea-ab5b-4b9b-b108-d0575ad93bf1">162.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ef689740fa64b5883e5e5174f62fe1d_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtOS0xLTEtMA_26598d62-c8bf-4b3f-9b39-b190d5cc4d69">165.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i048c1c583b8248d7a9ab445c65149f1e_I20171231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtMTEtMS0xLTA_c349ab71-977e-4109-83ad-dce46601207d">173.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i903f49cdebbd412fb6eb73679c880d2e_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMS0xLTEtODg2NA_0855c538-2e25-4ed5-bfa5-ac4e0a4254b0">150.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i29c04b723e3b410593ed485b6a229bfc_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMy0xLTEtODg2NA_bdd5ea6e-5764-43a8-8eaa-c7b9a61fe466">145.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i917cb1338bde49fd8e568f601fd1e22a_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNS0xLTEtODg2NA_1825e40e-ef11-40ea-9848-37909e0b9602">142.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6dd3862267a4178a471745a2b35ad9e_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNy0xLTEtODg2OA_fcb0d708-9985-42be-b771-dc3e84b6af72">53.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id92da6f6ed734f7aa39fcd3fd2e821c3_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtOS0xLTEtODg2OA_d945740a-b4bd-4b9f-9b06-c87400a5ce03">50.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id9a7d300fbe84c79a997b01a28de9fb5_I20171231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMTEtMS0xLTg4Njg_e5812013-7ba2-4c0b-8320-fc9b8df144e4">51.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other European countries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibbc09f1765984af1a548e59801303ef6_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMS0xLTEtMA_cbc4aa36-8c36-4158-8303-1fe0311530e6">251.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53739c8ad7af43158f8713882ca97f50_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMy0xLTEtMA_bc72a35c-2b25-4e55-885c-4412117174d7">230.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe7421492df04bb4bddbdcbf7176b677_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNS0xLTEtMA_3096abcf-9c07-4134-8e73-fe74a585fe18">201.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib228924631aa44288381badfd1e2059e_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNy0xLTEtMA_f296c8f6-840d-4ae1-b9db-8d3c79cb2ee6">59.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i29700e0161cf4255a1c0d184517c3f32_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtOS0xLTEtMA_62eabea1-5b13-4e15-a249-85b187eaf1c6">59.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i319915b8ecd44b91bcc26caf2f45657e_I20171231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMTEtMS0xLTA_32c7b716-9e20-434a-892a-b495250ebc19">63.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9b2e0330857436684b723ea8478ec77_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtMS0xLTEtMA_b42b7f3b-0edb-4c91-a9e9-8c180325807a">213.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibcb96f50eb494612ba0edad271cb1096_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtMy0xLTEtMA_82072016-13de-4a21-a3c6-ebd77d7a7ba2">201.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iafe47744d2e84db7a253c53f75362e62_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtNS0xLTEtMA_cf88004a-7a75-4e81-9617-a33a3eef0d8d">194.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b9f65fe26504bfe928b879458ca9505_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtNy0xLTEtMA_2f9cd854-7016-421e-bae8-942a27a74db9">132.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if148c501c02e4e2c97646022381c7196_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtOS0xLTEtMA_b61f65a0-5a18-4cdf-b837-afde2c7efbf7">132.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib47295db1ad64e7c8b1a5e5f348d4c2b_I20171231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtMTEtMS0xLTA_a374f4be-0180-456d-8e0c-ad0bab65ca0d">134.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctMS0xLTEtMA_b1e82a54-c9c6-4c9a-87ef-3806f55dcbd3">1,839.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctMy0xLTEtMA_9eb513ad-17be-43cb-bc22-68b56120ae77">1,717.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctNS0xLTEtMA_f8dc49f8-0635-4b50-84c5-7d012664a9bc">1,599.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctNy0xLTEtMA_c51d3d9b-5a93-4136-8a84-e4508e533f97">839.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctOS0xLTEtMA_0e08f0d3-e48f-48c0-9d86-f80e86512d64">822.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctMTEtMS0xLTA_9a1f6b66-961a-474f-ab02-6230e9010975">855.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">79</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i728e874014344fbc9cc4af6ddf9028fe"><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzIwMDk_cb4e0dbd-7e47-427b-bb15-67908ae6d081" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.980%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.908%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate/ Elimination/ Unallocated Items</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItMS0xLTEtMA_5e9481da-bd1b-44a1-9a6b-0968a9ba9cdf">1,398.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItMy0xLTEtMA_f3517c6b-ae69-43a5-9954-4071d799188a">441.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItNS0xLTEtMA_a0cc80fd-9824-4755-806a-c2eda2896768">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItNy0xLTEtMA_08b41de4-6f19-42f8-a009-b5ea64a95d06">1,839.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtMS0xLTEtMA_544fc080-d606-416e-83b6-51dae2dd57d9">313.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtMy0xLTEtMA_893f9676-6f68-414c-9add-7e27b7a7f3c5">49.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtNS0xLTEtMA_a1505e39-d7ac-448d-84db-be0ed89f6e78">66.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtNy0xLTEtMA_d31db43d-1258-4ef1-8d68-cfcd73632bdb">296.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtMS0xLTEtMA_967958ba-f8f7-43d5-972f-97f9803e64f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtMy0xLTEtMA_7ad7cd51-986b-4282-9db7-5b31ecb8d07e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtNS0xLTEtMA_2a4f3111-ca8b-46cb-807f-0d7a3bf5d242">8.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtNy0xLTEtMA_f4d8c29b-0273-4c77-9d6c-fe00766bb95c">8.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtMS0xLTEtMA_20475c29-44c0-4572-8b74-fa6de4559e86">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtMy0xLTEtMA_c432e4b6-356c-47bf-8cc1-861db0624ce1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtNS0xLTEtMA_91fb0643-ed0c-48c0-8058-da2860e14b91">3.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtNy0xLTEtMA_98ab21a2-4993-41ca-99db-2ddfdf3bbf3d">3.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating expense (income)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtMS0xLTEtMA_8841c043-0d77-4c98-a1ff-c6555b31995f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtMy0xLTEtMA_f89c268a-2128-4cbe-8364-263b57390ef5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtNS0xLTEtMA_fae760a1-238d-4c17-9587-986b8394e5fd">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtNy0xLTEtMA_46f88898-6073-4469-b7e7-dfb754fd3c2e">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctMS0xLTEtMA_02aac925-decb-4831-bc84-9d357f6a30af">313.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctMy0xLTEtMA_bdb163a5-7478-41ec-ba2d-c771167352ea">49.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctNS0xLTEtMA_5cde523c-4bda-4b89-9885-fd477a0657c0">70.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctNy0xLTEtMA_893d97b3-e46c-4707-92ca-b9a63be43464">291.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if22f0c39a4254fd9831626f40147da4c_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtMS0xLTEtMA_7b2bd9bd-66ae-410a-a2dd-dd1bbba2d3e9">1,480.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2831b7068f5415993b76a543c279df1_I20191231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtMy0xLTEtMA_2a34ba0f-9a86-445a-b736-12945c98cf7b">386.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a1c2431d80b42aead2763d611b9d0e5_I20191231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtNS0xLTEtMA_0cc32862-499b-48a2-8b50-beee87ad936e">474.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtNy0xLTEtMA_ffeb3309-5f66-4136-b34f-7d332339c59d">2,341.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktMS0xLTEtMA_b533c28a-b7fb-4474-9bba-c21650c2edf9">91.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktMy0xLTEtMA_3fd40fa8-be9b-4e1e-98cb-73166e17336d">37.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktNS0xLTEtMA_027f924b-0350-4627-ae69-7908ae7349d2">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktNy0xLTEtMA_c52ba3cf-d4c1-46ec-8ee6-871774e38191">126.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTEtMS0xLTA_a1e36da5-10a2-4c01-afe6-51f6f2d32ba2">82.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTMtMS0xLTA_509dc088-0d66-4016-83c5-9f7b133e8c4c">17.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTUtMS0xLTA_d400bd9e-2255-4a1c-b85f-66de6bbc8e8b">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTctMS0xLTA_aad1f39c-a7cf-4130-9cfb-9b832c6ca09b">103.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTEtMS0xLTA_406c71bd-e7fc-4272-9196-9098fda90081">1,308.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTMtMS0xLTA_ce54aadc-dd9c-46b8-af2d-236531bcbbba">409.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTUtMS0xLTA_7632dcce-3f6d-496d-81c8-56c0692e88ca">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTctMS0xLTA_a4bc5cb0-7527-42b8-a09f-6c77bf7f80f0">1,717.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTEtMS0xLTA_c2065ec6-98e7-4ff9-a8b1-a68750ce8b5d">266.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTMtMS0xLTA_d65d564b-96e4-42db-8a40-3a6ae7590d20">44.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTUtMS0xLTA_907cc4ed-c94e-4792-80e2-e8b5844461a0">70.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTctMS0xLTA_9c39957b-2380-4a26-8714-6cb962f41f06">240.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTEtMS0xLTA_a893545b-1d0c-4990-bf0e-dbee7637c704">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTMtMS0xLTA_e9cc6e85-cb77-47df-bb2e-4a13cd9565cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTUtMS0xLTA_b4a3e25e-15b3-46d2-965a-8dffd1f3f266">8.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTctMS0xLTA_3c8d844b-bd9e-4cf6-908a-5c0a86a5cb08">8.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTEtMS0xLTA_685a8610-eb2a-43cc-8eba-4a2a842f4126">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTMtMS0xLTA_3b850ced-ed54-4c32-a414-7668beb14e8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTUtMS0xLTA_ba4894ed-4688-4201-ac3e-36e9a8a94b04">2.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTctMS0xLTA_bb312602-3595-46ba-a24a-9d4458b5752a">2.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTEtMS0xLTA_a8b3b7cc-b0fb-410f-af5e-6beefbc03149">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTMtMS0xLTA_c3351bc0-3c4c-4406-a984-20086da3404d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTUtMS0xLTA_a1e9cbfb-afa5-427e-b489-f7025e1ca7ec">6.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTctMS0xLTA_f9cab5c3-ec73-44aa-9594-676c3bd32599">6.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTEtMS0xLTA_74a5fcb3-7490-4287-8a30-e109507dd9f7">266.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTMtMS0xLTA_73ecf48b-5bf5-4975-beb7-7e0ab245a09a">44.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTUtMS0xLTA_e0d6f351-a7b5-4f7d-9fcd-2707e485c24d">70.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTctMS0xLTA_3946b44d-01ed-463c-9ddf-d6f69912504f">240.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2afcfd5d059438e8bc7bc4552794714_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTEtMS0xLTA_7e7fd325-2932-40c4-9b28-82bba6248599">1,342.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i529afefe3a5146a8ae99168ace63b1f5_I20181231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTMtMS0xLTA_dcfe813f-8b1f-47e6-8963-e79d51ba4220">301.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i509b63e47a3144be9248957ca04eda93_I20181231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTUtMS0xLTA_bb084e6f-d845-46c1-9bba-9f041da1f059">335.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTctMS0xLTA_ebf13f64-3574-42bd-8446-60a5623a35cd">1,978.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTEtMS0xLTA_d30b3e4c-3028-4a9f-ba6a-6a242a5bd517">77.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTMtMS0xLTA_06445584-2146-440a-8b88-dbc65aab04b1">20.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTUtMS0xLTA_c745c858-44bd-4d07-97cf-5d9e009c6375">7.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTctMS0xLTA_44b5263a-18f4-4237-aa09-ca45a99c6485">104.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTEtMS0xLTA_87dad0eb-fce1-4087-9339-4adf8c9cf88e">83.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTMtMS0xLTA_fb6a1f31-83f3-438d-9d07-3205a65b2cc9">17.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTUtMS0xLTA_6997ac95-ddb0-4ff8-8a1d-a40c420673ea">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTctMS0xLTA_a5405084-ed51-4733-85cc-37c4465420c2">104.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTEtMS0xLTA_4138456f-edca-45d6-bcc3-06f262aaba26">1,236.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTMtMS0xLTA_36eafd30-076c-4d77-9746-5ee98a80525e">362.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTUtMS0xLTA_98923c6a-dfd3-45b5-ba83-09c2c48cc8c4">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTctMS0xLTA_0661c876-f61f-4c5b-a553-c8a17113c841">1,599.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTEtMS0xLTA_6cce2df5-19c7-4ced-a2b7-79b0992d6590">243.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTMtMS0xLTA_488b109d-9d1d-417d-9daf-03f099ccc954">48.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTUtMS0xLTA_4f0e9b53-96c4-43e4-a485-069dd4661a33">66.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTctMS0xLTA_78e8cbe0-8231-4920-804e-ae8009a79a0b">225.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTEtMS0xLTA_268d8939-b23e-402c-a158-9d8b50eb9dbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTMtMS0xLTA_d19030d7-be2b-4508-b5db-0aae845062b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTUtMS0xLTA_8d345aac-2768-4d79-af56-6244b04c7d3e">7.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTctMS0xLTA_72936c96-265e-4f97-8cd4-ccbc65ff9834">7.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTEtMS0xLTA_80b73294-4dc7-41dc-aa8a-4136660ce872">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTMtMS0xLTA_d20f1aba-d582-48ce-8b7c-53d2169280d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTUtMS0xLTA_906a2120-51cd-425e-807b-7b1dfe5eeebf">1.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTctMS0xLTA_99201847-be02-407f-8403-7622c13ee4e4">1.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTEtMS0xLTA_6f604e1d-1cca-48c1-9df6-314ecff3f4ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTMtMS0xLTA_1a6a5ffe-ef9e-4c0e-875d-14b15db191f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTUtMS0xLTA_0e7a683a-8132-4df2-aecb-dec88e1e030b">3.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTctMS0xLTA_462f287b-c280-4865-bf59-a31dce079f0e">3.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTEtMS0xLTA_80519bdb-5fa5-4793-98bb-1bead5dba429">243.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTMtMS0xLTA_26bf1261-1741-4a11-a81f-9f05c61215a3">48.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTUtMS0xLTA_fe98bb7a-5a03-4432-bc2f-0b77e9e4c41f">69.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTctMS0xLTA_d676c6fa-3428-40d8-abdd-6045d9007a40">222.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i10b2bd972c5247c89ad526ba8664ceea_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTEtMS0xLTA_6fa36d7a-1443-4b41-b54e-c2342e6f6cd1">1,321.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9b16d7361925410886eeb15e971ce722_I20171231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTMtMS0xLTA_5378e85b-7f50-4375-abec-31ba56a8c2e5">286.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1350bd4286de44cfbac587447b6169de_I20171231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTUtMS0xLTA_1219de57-7774-4453-9bd7-0c4cde9e40ce">255.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTctMS0xLTA_49fa7636-5e06-4745-8435-4eac938148f9">1,862.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTEtMS0xLTA_5f87344a-41de-43b4-aecb-a76dbcc13b32">107.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTMtMS0xLTA_e1b4b294-3422-4994-be80-654dedc173cc">18.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTUtMS0xLTA_aaabb261-2f28-4942-9124-6987d4b71d2c">5.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTctMS0xLTA_0ee52c76-ddfe-441e-8f4b-dc47d3c30598">130.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTEtMS0xLTA_a0ca18d5-6577-4b4f-a7c7-7b2472da9552">77.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTMtMS0xLTA_6cf29657-688b-412c-9d41-c1dc64c9d079">16.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTUtMS0xLTA_7f35deeb-3ec8-4f8b-9713-4158e59b4b8c">3.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTctMS0xLTA_eeab6535-0273-4f86-be87-a166125a2262">96.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please refer to Note 16, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for a discussion of unallocated items. </span></div><div id="i_0_160"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">80</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the Shareholders and Board of Directors of West Pharmaceutical Services, Inc.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have audited the accompanying consolidated balance sheets of West Pharmaceutical Services, Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2019 and 2018,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and the related consolidated statements of income, comprehensive income, equity and cash flows</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">for each of the three years in the period ended December 31, 2019, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended December 31, 2019 appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;).</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also have audited the Company&#8217;s internal control over financial reporting as of December 31, 2019, based on criteria established in </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Internal Control - Integrated Framework</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In our opinion, the consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and the results of its</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">operations and its cash flows for each of the three years in the period ended December 31, 2019</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in conformity with accounting principles generally accepted in the United States of America.  Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Internal Control - Integrated Framework</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (2013) issued by the COSO.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Changes in Accounting Principles</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019, and as discussed in Note 3 to the consolidated financial statements, the Company changed the manner in which it accounts for revenues from contracts with customers in 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control over Financial Reporting appearing under Item 9A.  Our responsibility is to express opinions on the Company&#8217;s consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements and on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our audits of the consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements included performing procedures to assess the risks of material misstatement of the consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements.  Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.  Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">81</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company&#8217;s internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">As described in Notes 1 and 17 to the consolidated financial statements, the Company&#8217;s consolidated deferred tax assets were $43.6 million, net of a valuation allowance of $15.9 million, as of December 31, 2019, and income tax expense was $59.0 million for the year ended December 31, 2019.  As a global organization, the Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions.  Management estimates income tax payable based upon current domestic and international tax legislation.  Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference.  Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized.  The realizability of deferred tax assets is subject to estimates of future taxable income, generally at the respective subsidiary company and the country level. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The principal considerations for our determination that performing procedures relating to income taxes is a critical audit matter are that there was significant judgment by management in determining the income tax provision due to the Company&#8217;s global footprint and the complexity in the various tax laws applicable in determining the Company&#8217;s effective tax rate and in assessing the realizability of deferred tax assets.  This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures and in evaluating audit evidence related to the income tax provision and significant assumptions used in management&#8217;s assessment of the realizability of deferred tax assets, including projections of future taxable income.  Also, our audit effort involved the use of professionals with specialized skill and knowledge to assist in performing procedures and evaluating the audit evidence obtained from these procedures.  </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">82</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to income taxes, including controls over the determination of the income tax provision and the realizability of deferred tax assets.  These procedures also included, among others, (i) testing the income tax provision, including performing procedures over the Company&#8217;s rate reconciliation, return to provision adjustments, permanent and temporary differences, and financial data used in the income tax provision calculation, (ii) testing the accuracy of the income tax rates utilized in the provision, and (iii) evaluating  management&#8217;s assessment of the realizability of deferred tax assets, which included evaluating the reasonableness of assumptions underlying management&#8217;s projections of future taxable income.  Evaluating the reasonableness of the assumptions related to projected future taxable income involved evaluating whether the assumptions used by management were reasonable considering the current and past performance of the Company and evidence obtained in other areas of the audit.  Professionals with specialized skill and knowledge were used to assist in evaluating the appropriateness of management&#8217;s application of relevant income tax law in certain jurisdictions. </span></div><div style="margin-bottom:12pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">/s/ PricewaterhouseCoopers LLP</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Philadelphia, Pennsylvania</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">February&#160;21, 2020 </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have served as the Company&#8217;s auditor since 1963.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i_0_163"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">83</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Quarterly Operating and Per Share Data (Unaudited)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:36.301%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.698%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.703%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions, except per share data)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">First</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Quarter</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">(1)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Second</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Quarter</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">(2)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Third</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Quarter</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">(3) </span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Fourth</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Quarter</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">(4)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Full Year</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">443.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">469.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">456.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">470.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">157.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzMtOS0xLTEtMA_cd77a5a9-2b25-4609-8123-9e032186c922">605.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzQtOS0xLTEtMA_7e166ac3-7b96-4a4b-b587-62af52768db6">241.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.90&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.73&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.88&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">415.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">431.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">422.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">142.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">135.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">133.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzExLTktMS0xLTA_d4940563-3906-4576-8d10-7af9d293469b">545.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzEyLTktMS0xLTA_013312ed-4d24-4caa-8a3f-8d28f8055e87">206.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzE0LTktMS0xLTA_de0da35b-e97b-44e5-af30-a845e04eec55">2.80</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.58&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.73&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzE1LTktMS0xLTA_f8210b56-772b-4426-bf39-e0569cee3338">2.74</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The sum of the quarterly amounts may not equal full year due to rounding. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Factors affecting the comparability of the information reflected in the quarterly data:</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">Net income for the first quarter of 2019 included the impact of restructuring and related charges of $0.4 million ($0.01 per diluted share) and a tax benefit of $1.4 million ($0.02 per diluted share) associated with stock-based compensation. Net income for the first quarter of 2018 included the impact of restructuring and related charges of $2.7 million ($0.03 per diluted share), a net tax charge of $0.3 million ($0.01 per diluted share) for the estimated impact of the 2017 Tax Act, and a tax benefit of $2.1 million ($0.03 per diluted share) associated with stock-based compensation. </span></div><div style="padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(2)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">Second quarter 2019 net income included the impact of restructuring and related charges of $1.1 million ($0.01 per diluted share) and a tax benefit of $3.8 million ($0.05 per diluted share) associated with stock-based compensation. Second quarter 2018 net income included the impact of restructuring and related charges of $1.6 million ($0.01 per diluted share), a net tax benefit of $4.8 million ($0.06 per diluted share) for the estimated impact of the 2017 Tax Act, and a tax benefit of $3.4 million ($0.04 per diluted share) associated with stock-based compensation. </span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(3)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">Net income for the third quarter of 2019 included the impact of restructuring and related charges of $1.4 million ($0.01 per diluted share), a pension settlement charge of $2.1 million ($0.03 per diluted share), a charge of $0.7 million ($0.01 per diluted share) related to the continued devaluation of Argentina&#8217;s currency, a tax benefit of $1.0 million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $4.0 million ($0.05 per diluted share) associated with stock-based compensation. Net income for the third quarter of 2018 included the impact of restructuring and related charges of $0.9 million ($0.01 per diluted share), a net tax charge of $0.4 million for the estimated impact of the 2017 Tax Act, a tax benefit of $7.7 million ($0.10 per diluted share) associated with stock-based compensation, and a charge of $1.1 million ($0.02 per diluted share) related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">84</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(4)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">Fourth quarter 2019 net income included the impact of restructuring and related charges of $0.8 million ($0.02 per diluted share), a gain on the sale of fixed assets as a result of our restructuring plan of $1.3 million ($0.02 per diluted share), a pension settlement charge of $0.6 million ($0.01 per diluted share), a tax recovery related to previously-paid international excise taxes of $2.9 million ($0.04 per diluted share), a tax charge of $0.7 million ($0.01 per diluted share) related to the impact of federal law changes enacted during the quarter, and a tax benefit of $1.1 million ($0.02 per diluted share) associated with stock-based compensation. Fourth quarter 2018 net income included the impact of restructuring and related charges of $2.1 million ($0.02 per diluted share), a gain on the sale of fixed assets as a result of our restructuring plans of $0.9 million ($0.01 per diluted share), a net tax charge of $1.6 million ($0.03 per diluted share) for the estimated impact of the 2017 Tax Act, and a tax benefit of $1.1 million ($0.02 per diluted share) associated with stock-based compensation.</span></div><div><span><br/></span></div><div id="i_0_166"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div><span><br/></span></div><div id="i_0_169"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 9A</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this annual report, is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our CEO and Chief Financial Officer (&#8220;CFO&#8221;), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Our disclosure controls include some, but not all, components of our internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Evaluation of Disclosure Controls and Procedures</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">An evaluation was performed under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934), as of the end of the period covered by this Form 10-K.  Based on this evaluation, our CEO and CFO have concluded that, as of December&#160;31, 2019, our disclosure controls and procedures are effective.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934.  Our internal control over financial reporting is a process designed under the supervision of our CEO and CFO to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2019 based on the framework established in &#8220;Internal Control-Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  Based on this assessment, management has determined that our internal control over financial reporting was effective as of December&#160;31, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. No evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within West have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Also projections of any evaluation of effectiveness to future periods are subject to the risks that controls </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">85</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The effectiveness of our internal control over financial reporting as of December&#160;31, 2019 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which is included herein.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Changes in Internal Controls</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fourth quarter ended December&#160;31, 2019, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2019, we adopted ASC 842. Although our adoption of ASC 842 resulted in no change to our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, we did implement changes to our internal controls relating to leases. These changes included the development of new policies, enhanced contract review requirements, and other ongoing monitoring activities. These controls were designed to provide assurance at a reasonable level of the fair presentation of our consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div id="i_0_172"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 9B.  OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div><span><br/></span></div><div id="i_0_175"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PART III</span></div><div><span><br/></span></div><div id="i_0_178"></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Information is incorporated by reference from the discussion under the heading </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Proposal 1 - Election of Directors</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Corporate Governance Documents and Policies - Ethics and Our Code of Business Conduct</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Voting and Other Information - 2021 Shareholder Proposals or Nominations; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> Board and Director Information and Policies - Committees - Audit Committee </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in our 2020 Proxy Statement. The balance of the information required by this item is contained in the discussion entitled </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Information About Our Executive Officers </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in Part&#160;I of this Form 10-K.</span></div><div><span><br/></span></div><div id="i_0_181"></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 11.  EXECUTIVE COMPENSATION</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Information about director and executive compensation is incorporated by reference from the discussion under the headings </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Director Compensation, Compensation Committee Report, Compensation Discussion and Analysis,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Compensation Tables</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> in our 2020 Proxy Statement. </span></div><div><span><br/></span></div><div id="i_0_184"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="text-indent:-6.75pt;padding-left:9pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Information required by this Item is incorporated by reference from the discussion under the heading </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock Ownership </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in our 2020 Proxy Statement. </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">86</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Equity Compensation Plan Information Table</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth information about the grants of stock options, restricted stock or other rights under all of the Company&#8217;s equity compensation plans as of the close of business on December&#160;31, 2019. The table does not include information about tax-qualified plans such as the West 401(k) Plan or the West Contract Manufacturing Savings and Retirement Plan.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:21.397%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:21.557%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.044%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:14.666%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.205%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:25.083%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.048%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plan Category</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Number of Securities</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">to be Issued Upon</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Exercise of</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Outstanding Options,</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Warrants and Rights (a)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Weighted-Average</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Exercise Price of</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Outstanding Options,</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Warrants and Rights (b)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Number of Securities</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Remaining Available for</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Future Issuance Under</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Equity Compensation</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Plans (Excluding Securities</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Reflected in Columns (a)) (c)</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity compensation plans approved by security holders</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,281,507&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67.05&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,226,236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity compensation plans not approved by security holders</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,281,507&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67.05&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,226,236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Includes 1,207,157 outstanding stock options, 264,691 restricted performance share units, 25,892 restricted retention share units, 64,544 deferred stock-equivalents units, and 494 restricted stock-equivalents units granted to directors under the 2016 Plan. Includes 1,462,578 outstanding stock options, 12,160 outstanding stock-settled stock appreciation rights, 13,459 restricted retention share units, and 108,074 deferred stock-equivalents units under the 2011 Plan (which was terminated in 2016). Includes 68,400 outstanding stock options and 54,058 deferred stock-equivalents units granted to directors under the Non-Qualified Deferred Compensation Plan for Non-Employee Directors under the 2007 Omnibus Incentive Compensation Plan (which was terminated in 2011). The average term of remaining options and stock-settled stock appreciation rights granted is 5.9 years. No future grants or awards may be made under the terminated plans.&#160;The total includes restricted performance share units at 100% of grant. The restricted performance share unit payouts were at 49.39%, 96.6%, and 89.8% in 2019, 2018 and 2017, respectively. The total does not include stock-equivalent units granted or credited to directors under the Non-Qualified Deferred Compensation Plan for Non-Employee Directors to be settled only in cash.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Restricted performance share and deferred stock-equivalent units are excluded when determining the weighted-average exercise price of outstanding options. </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Represents 3,829,712 shares reserved under the Company&#8217;s Employee Stock Purchase Plan and 3,119,314 shares remaining available for issuance under the 2016 Plan.&#160;The estimated number of shares that could be issued for 2019 from the Employee Stock Purchase Plan is 277,210.&#160;This number of shares is calculated by multiplying the 190 shares per offering period per participant limit by 1,459, the number of current participants in the plan. </span></div><div><span><br/></span></div><div id="i_0_187"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Information called for by this Item is incorporated by reference from the discussion under the heading </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Corporate Governance Documents and Policies - Related Person Transactions and Procedures</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> in our 2020 Proxy Statement. Information about director independence is incorporated by reference from the discussion under the heading </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Corporate Governance Documents and Policies - Director Independence </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in our 2020 Proxy Statement.</span></div><div><span><br/></span></div><div id="i_0_190"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">87</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 14.  PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Information is incorporated by reference from the discussion under the heading </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Independent Auditors and Fees - Fees Paid to PricewaterhouseCoopers LLP</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Independent Auditors and Fees - Audit Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> in our 2020 Proxy Statement.</span></div><div><span><br/></span></div><div id="i_0_193"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PART IV</span></div><div><span><br/></span></div><div id="i_0_196"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 15.&#160;&#160;EXHIBITS, FINANCIAL STATEMENT SCHEDULES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) 1.  Financial Statements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following documents are included in Part II, Item 8:</span></div><div><span><br/></span></div><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated Statements of Income for the years ended December&#160;31, 2019, 2018 and 2017 </span></div><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated Statements of Comprehensive Income for the years ended December&#160;31, 2019, 2018 and 2017 </span></div><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated Balance Sheets at December&#160;31, 2019 and 2018 </span></div><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated Statement of Equity for the years ended December&#160;31, 2019, 2018 and 2017 </span></div><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2019, 2018 and 2017 </span></div><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Notes to Consolidated Financial Statements</span></div><div style="padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">88</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) 2.  Financial Statement Schedules</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzQ_fd2a536d-a943-41e0-a4df-a7f259c2c2b3" continuedAt="ia1d7f9d272714782a3057e311ccc866e" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Schedule II - Valuation and Qualifying Accounts</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:96.153%;"><tr><td style="width:1.0%;"></td><td style="width:42.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Balance at</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">beginning of</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">period</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Charged</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">to costs</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">and </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">expenses</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deductions (1)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Balance at</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">end of</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">period</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax asset valuation allowance</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63c8f0dd6fd44e0192bbca698c80730d_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMS0xLTEtMA_a21f777c-4c10-42b6-90cb-a9d6b552ba82">16.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id6ac79d82bd448c79b4fdc95685aab8b_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMi0xLTEtMA_dd2c6814-54bb-4b53-9d70-8923f2ccbd79">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id6ac79d82bd448c79b4fdc95685aab8b_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMy0xLTEtMA_38657aef-b525-480d-ae9a-9bf7c414bf14">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iafcda053ab8e47e38f791920cd9cf950_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtNC0xLTEtMA_2ea91aa9-619d-4161-8c8d-30521ccc78db">15.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09e8d9cf8ecf49a8bb93848beaa81037_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMS0xLTEtMA_6c98d1c4-e4fc-4476-8a89-eb1e08973370">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee5aa6955d81437b952a802f4ada2d98_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMi0xLTEtMA_ed4c9d1e-1c51-4d63-9800-ef91e83c5c63">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iee5aa6955d81437b952a802f4ada2d98_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMy0xLTEtMA_8bbf7b11-8cee-4068-a724-6a2935eb53d1">1.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ee0f05c56c248109cf70bf6a1dfcf1d_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtNC0xLTEtMA_a8be44b8-664d-4bc6-8002-48617151b29a">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total allowances deducted from assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMS0xLTEtMA_0c1b4d81-9d7a-4efa-89e5-9e61bbec7274">18.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMi0xLTEtMA_2f2b0c0b-5a64-4fd6-bfd2-adcac0f72115">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMy0xLTEtMA_80119c0b-b71e-4a84-8eb1-c0fb0bd36c76">1.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i710deda8952743be8f828089af9cd00d_I20191231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtNC0xLTEtMA_4065f5d2-c9eb-446a-b4e3-8f0756511108">16.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax asset valuation allowance</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iabc48380a0f84fafbbd805cba9caddec_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMS0xLTEtMA_0e3aa81a-ca9b-4f81-825d-45e3e4418402">20.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b41e0d9c7ef435a9edc553f82a3fba8_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMi0xLTEtMA_be71ba87-e6e9-4010-9ad1-739522749d9e">3.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b41e0d9c7ef435a9edc553f82a3fba8_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMy0xLTEtMA_d28125c4-92ec-47d3-8406-117689e3d175">1.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63c8f0dd6fd44e0192bbca698c80730d_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktNC0xLTEtMA_ee58b25c-94f0-4d37-bc02-139f74106e87">16.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i48adb9af41f141dbba997f45f6e7b647_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTEtMS0xLTA_1ad1470a-b8d4-406d-a69e-16e36f1905a5">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61105e0ada8748f28fbbec27f4b1f63c_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTItMS0xLTA_69c2dda4-0528-45c5-964a-7061da5e8a4e">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61105e0ada8748f28fbbec27f4b1f63c_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTMtMS0xLTA_1007089b-9d27-441e-bd00-216b4604dd58">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09e8d9cf8ecf49a8bb93848beaa81037_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTQtMS0xLTA_4c003ab6-d9e8-4362-8237-cc65dda80034">2.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total allowances deducted from assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTEtMS0xLTA_7e94eea1-9abe-41f1-ab77-441d1802a22d">21.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTItMS0xLTA_f6a274cf-7b32-48e3-a784-c78f7a92c217">2.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTMtMS0xLTA_b6229983-91ed-4fba-917e-f767735942c0">1.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTQtMS0xLTA_ab66eac3-0fc3-4deb-9110-f62db6ca5782">18.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the year ended December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax asset valuation allowance</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib8e071d9eab748839372112a8d75b384_I20161231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTEtMS0xLTA_89295f54-ba5d-4c99-a58d-62c8346c7d79">18.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic7003c1f4ab54e5c92dc94b3582d241f_D20170101-20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTItMS0xLTA_868c1a3b-83e8-42ce-b0bf-35f2a3b11eb1">2.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic7003c1f4ab54e5c92dc94b3582d241f_D20170101-20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTMtMS0xLTA_c8b5599a-24dd-434b-9e3b-f259fbca00b5">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iabc48380a0f84fafbbd805cba9caddec_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTQtMS0xLTA_92e1f9ea-c465-4278-a046-bcdc34603581">20.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0bb2326a07b4350912a6c72afbe1a89_I20161231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTEtMS0xLTA_b8911633-67b4-4a98-9d5a-0c74fecf7da9">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i935b128fab324f209cb4528dec5e49f2_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTItMS0xLTA_06e88b3b-375b-4043-a0f2-5f6327bbc4ac">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i935b128fab324f209cb4528dec5e49f2_D20170101-20171231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTMtMS0xLTA_08aeb46f-574a-49bf-9d28-ed099cac5446">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i48adb9af41f141dbba997f45f6e7b647_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTQtMS0xLTA_259d45e7-a57c-49ef-98a1-ff6fa0229ee9">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total allowances deducted from assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTEtMS0xLTA_241f4f76-d056-4751-a0f7-ab89e23214a1">19.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTItMS0xLTA_f2c12642-977f-4596-9caa-bbc83097bf17">2.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231" decimals="-5" format="ixt:zerodash" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTMtMS0xLTA_40b54a96-0396-4421-b1ce-2b3cd96225a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTQtMS0xLTA_10b0297b-b2d7-4dd8-9e38-1c41e34f1e1c">21.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="padding-left:27pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">__________________________</span></div></ix:nonNumeric><div style="text-indent:-18pt;padding-left:45pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ia1d7f9d272714782a3057e311ccc866e" continuedAt="i6f4c24749da141428a395c4a8ec02137">(1)</ix:continuation></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439" xml:lang="en-US" footnoteRole="http://www.xbrl.org/2003/role/footnote"><ix:continuation id="i6f4c24749da141428a395c4a8ec02137">Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.</ix:continuation> </ix:footnote></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All other schedules are omitted because they are either not applicable, not required or because the information required is contained in the consolidated financial statements or notes thereto.</span></div><div><span><br/></span></div><div style="text-indent:-36pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) 3.&#160;Exhibits - An index of the exhibits included in this Form 10-K is contained on pages F-1 through F-3 and is incorporated herein by reference.</span></div><div style="text-indent:-36pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b)&#160;See subsection (a) 3. above.</span></div><div style="text-indent:-36pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(c)&#160;Financial Statements of affiliates are omitted because they do not meet the tests of a significant subsidiary at the 20% level.</span></div><div><span><br/></span></div><div id="i_0_199"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 16. FORM 10-K SUMMARY</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">89</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div id="i_0_202"></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">SIGNATURES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">WEST PHARMACEUTICAL SERVICES, INC.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Registrant)</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">By: /s/ Bernard J. Birkett</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Bernard J. Birkett</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Senior Vice President and Chief Financial Officer</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">February&#160;21, 2020 </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">90</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of West Pharmaceutical Services, Inc. in the capacities and on the dates indicated.</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:96.474%;"><tr><td style="width:1.0%;"></td><td style="width:31.720%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:44.511%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:17.769%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Signature</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Title</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Date</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Eric M. Green</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director, President and Chief Executive Officer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 21, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Eric M. Green</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Principal Executive Officer)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Bernard J. Birkett</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Senior Vice President and Chief Financial Officer</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 21, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bernard J. Birkett</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Principal Financial Officer and Principal Accounting Officer)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Mark A. Buthman</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mark A. Buthman</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ William F. Feehery, Ph.D.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">William F. Feehery, Ph.D.</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Robert F. Friel</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Robert F. Friel</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Thomas W. Hofmann</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thomas W. Hofmann</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Paula A. Johnson, M.D., MPH</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Paula A. Johnson, M.D., MPH</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Deborah L.V. Keller</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deborah L.V. Keller</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Myla P. Lai-Goldman, M.D.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Myla P. Lai-Goldman, M.D.</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Douglas A. Michels</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Douglas A. Michels</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Paolo Pucci</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Paolo Pucci</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Patrick J. Zenner</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Director and Chairman of the Board</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">February 18, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patrick J. Zenner</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div id="i_0_205"></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">91</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">EXHIBIT INDEX</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:85.180%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Exhibit Number</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Description</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000015/ex31amendedarticles.htm">Our Amended and Restated Articles of Incorporation are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000015/ex32bylaws.htm">Our Bylaws, as amended through May 5, 2015, are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/0000105770-99-000016-index.html">Form of stock certificate for common stock is incorporated by reference from our 1998 Form 10-K.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000015/ex31amendedarticles.htm">Article 5, 6, 8(c) and 9 of our Amended and Restated Articles of Incorporation are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000015/ex32bylaws.htm">Article I and V of our Bylaws, as amended through May 5, 2015, are incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2015.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex44descriptionofregis.htm">Description of Registered Securities.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.5 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1) </sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instruments defining the rights of holders of long-term debt securities of West and its subsidiaries have been omitted.</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000016/exh101march282019creditagr.htm">Credit Agreement, dated as of March 28, 2019, between West, certain of its subsidiaries, the lenders party thereto from time to time, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender; Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, Wells Fargo Securities, LLC, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Wells Fargo Bank, National Association, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Co-Syndication Agents, is incorporated by reference from our Form 8-K dated April 1, 2019.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex102firstamendmentand.htm">First Amendment and Incremental Facility Amendment, dated as of December 30, 2019, between West, each of the lenders party thereto from time to time, and Bank of America, N.A., as Administrative Agent.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577012000048/exh10_1.htm">Note Purchase Agreement, dated July 5, 2012, among the Company and the Purchasers named therein is incorporated by reference from our Form 8-K filed on July 10, 2012.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.4 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000011/exhibit101executiveemploym.htm">Employment Agreement, dated as of April 13, 2015, between us and Eric M. Green, is incorporated by reference from our Form 8-K dated April 15, 2015. </a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.5 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000013/exh101indemnificationagree.htm">Indemnification Agreement, dated as of April 24, 2015, between us and Eric M. Green, is incorporated by reference from our Form 8-K dated April 30, 2015.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.6 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577015000013/exh102retentionawardagreem.htm">Sign-On Retention Award Notice, dated as of April 24, 2015, from us to Eric M. Green, is incorporated by reference from our Form 8-K dated April 30, 2015.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.7 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577018000022/exh101employmentagreement.htm">Employment Agreement, dated May 29, 2018, between us and Bernard J. Birkett, is incorporated by reference from our Form 8-K dated June 21, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.8 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577016000101/ex101employmentagreement.htm">Employment Agreement, dated August 28, 2016, between David Montecalvo and us, incorporated by reference from our Form 10-Q report for the quarter ended September 30, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.9 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000016/exhibit1017.htm">Supplemental Employees&#8217; Retirement Plan, as amended and restated effective January 1, 2008, is incorporated by reference from our 2008 Form 10-K report.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.10 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000012/ex1010nqdcplanamended2018.htm">Non-Qualified Deferred Compensation Plan for Designated Employees, as amended and restated effective December 1, 2018, is incorporated by reference from our 2018 Form 10-K report.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.11 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000005/ex1026nqdeferredcompensati.htm">Deferred Compensation Plan for Outside Directors, as amended and restated effective June 30, 2013, is incorporated by reference from our 2013 Form 10-K report.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.12 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000110465916117151/a16-10405_1s8.htm">2016 Omnibus Incentive Compensation Plan is incorporated by reference from our Form S-8 filed on May 3, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.13 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577011000025/inctiveplan.htm">2011 Omnibus Incentive Compensation Plan is incorporated by reference from our Form 8-K filed on May 6, 2011.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.14 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000110465907023945/a07-6354_2def14a.htm#a2007OmnibusIncentiveCompensation_015515">2007 Omnibus Incentive Compensation Plan effective as of May 1, 2007, is incorporated by reference to Exhibit 99.1 of the Company&#8217;s Form 8-K dated May 4, 2007.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.15 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906032995/a06-10941_1ex10d2.htm">Form of Executive 2006 Non-Qualified Stock Option Award is incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2006.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.16 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906051878/a06-15767_1ex10d1.htm">Form of Director 2006 Non-Qualified Stock Option Award Notice is incorporated by reference from our Form 10-Q report for the quarter ended June 30, 2006.</a></span></div></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">F-1</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:85.180%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Exhibit Number</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Description</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.17 (2)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000110465906051878/a06-15767_1ex10d2.htm">Form of Director 2006 Stock Unit Award Notice is incorporated by reference from our Form 10-Q report for the quarter ended June 30, 2006.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.18  (2)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000110465907058768/a07-19128_1ex10d2.htm">Form of Director 2007 Deferred Stock Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan, is incorporated by reference from our Form 10-Q report for the quarter ended June 30, 2007.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.19 (2)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000110465908031034/a08-11514_1ex10d2.htm">Form of 2008 Non-Qualified Stock Option and Performance-Vesting Share Unit Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan, is incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2008.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.20 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000016/exhibit1041.htm">Form of Director 2008 Deferred Stock Award, issued pursuant to the 2007 Omnibus Incentive Compensation Plan, is incorporated by reference from our 2008 Form 10-K report.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.21 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000049/exhibit101.htm">Form of 2009 Supplemental Long-Term Incentive Award, is incorporated by reference from our Form 10-Q report for the quarter ended September 30, 2009.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.22 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000016/ex1012014ltipaward.htm">Form of 2014 Long-Term Incentive Plan Award is incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2014.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.23 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577014000046/ex1012014rsuawardletter.htm">Form of 2014 Stock-Settled Restricted Stock Unit Award is incorporated by reference from our Form 10-Q report for the quarter ended June 30, 2014.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.24 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1022019psuawardagreement.htm">Form of 2019 Performance Stock Unit (PSU) Award issued under the 2016 Omnibus Incentive Compensation Plan</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1022019psuawardagreement.htm">, is incorporated by reference from our Form 10-Q report for the quarter ende</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1022019psuawardagreement.htm">d</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1022019psuawardagreement.htm"> March 31, 2019</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1022019psuawardagreement.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.25 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1032019stockoptionawarda.htm">Form of 2019 Stock Option Award issued under the 2016 Omnibus Incentive Compensation Plan</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1032019stockoptionawarda.htm">, is incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2019</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000020/ex1032019stockoptionawarda.htm">,</a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"> </span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.26&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000002/exh10.htm">Indemnification agreements between us and each of our directors in the form of Exhibit 10.1 to our Form 8-K report dated January 6, 2009, which is incorporated by reference.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.27 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000050/ex101change-inxcontrolagre.htm">Form of Change-in-Control Agreement between us and certain of our executive officers, is incorporated by reference from our Form 10-Q report for the quarter ended September 30, 2017.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.28 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577005000400/exh10d.htm">Agreement, effective as of January 1, 2005, between us and The Goodyear Tire &amp; Rubber Company is incorporated by reference from our Form 10-Q report for the quarter ended June 30, 2005.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.29 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577009000027/exhibit101.htm">First Agreement, effective as of July 1, 2008, to amend Agreement between us and The Goodyear Tire &amp; Rubber Company is incorporated by reference from our Form 10-Q report for the quarter ended March 31, 2009.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.30 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577016000101/ex102goodyearamendment.htm">Second Agreement, dated August 16, 2016, to amend Agreement between us and The Goodyear Tire &amp; Rubber Company and us, incorporated by reference from our Form 10-Q report for the quarter ended September 30, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.31 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1039distributoragreement.htm">Distributorship Agreement, dated and effective January 18, 2017, between Daikyo Seiko, Ltd. and us is incorporate</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1039distributoragreement.htm">d</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1039distributoragreement.htm"> by reference from our 2016 Form 10-K report.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.32 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577017000011/ex1040licenseagreement_2016.htm">Amended and Restated Technology Exchange and CrossLicense Agreement, dated and effective January 18, 2017, between Daikyo Seiko, Ltd. and us, incorporated by reference from our 2016 Form 10-K report.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.33 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577018000032/ex102amendedagreement.htm">Amended Agreement, dated and effective July 2, 2018, between Daikyo Seiko, Ltd. and us, is incorporated by reference from Form 10-Q report for the quarter ended June 30, 2018.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.34 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577019000040/exh101amendmentagreeme.htm">Amendment Agreement, dated as of October 15, 2019, between us and Daikyo Seiko, Ltd., is incorporated by reference from our Form 8-K dated October 16, 2019.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">10.35 </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/105770/000010577020000002/exh101exxonsupplyagree.htm">Global Master Supply Agreement by and between ExxonMobil Chemical Company and us, entered into on January 10, 2020, and effective January 1, 2019 through December 31, 2023 is incorporated by reference from our Form 8-K report filed on January 16, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex21listofsubsidiaries.htm">Subsidiaries of the Company.</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex23consent2019.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex311ceo302certificati.htm">Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex312cfo302certificati.htm">Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="height:72pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:10.820%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:85.180%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Exhibit Number</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Description</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.1*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex321ceo906certificati.htm">Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.2*&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex322cfo906certificati.htm">Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.INS&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.SCH&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.CAL&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.LAB&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.PRE&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.DEF&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104**&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL for the cover page of this Annual Report on Form 10-K, included in the Exhibit 101 Inline XBRL Document Set.</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;We agree to furnish to the SEC, upon request, a copy of each instrument with respect to issuances of long-term debt of the Company and its subsidiaries.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Management compensatory plan.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Certain portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment order of the SEC. </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(4)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Portions of this exhibit (indicated therein by asterisks) have been omitted for confidential treatment. </span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">*&#160;Furnished, not filed.      </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">F-3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>2
<FILENAME>ex44descriptionofregis.htm
<DESCRIPTION>EX-4.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_21"></div><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Exhibit 4.4</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">WEST PHARMACEUTICAL SERVICES, INC.</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;">DESCRIPTION OF SECURITIES</font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">As of December 31, 2019, the common stock of West Pharmaceutical Services, Inc. (&#8220;West&#8221; or the &#8220;Company&#8221;) is registered under Section 12(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">The summary of the general terms and provisions of the Company&#8217;s common stock set forth below does not purport to be complete and is subject to, and qualified by, reference to the Company&#8217;s Articles of Incorporation (as amended, the &#8220;Articles&#8221;) and Bylaws (as amended, the &#8220;Bylaws,&#8221; and together with the Articles, the &#8220;Charter Documents&#8221;), each of which is incorporated by reference as an exhibit to the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission of which this Exhibit is a part. For additional information, please read the Company&#8217;s Charter Documents and the applicable provisions of the Pennsylvania Business Corporation Law of 1988 (as amended from time to time, the &#8220;PBCL&#8221;)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Description of Capital Stock</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Authorized Capital Stock</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. The Company is authorized under the Articles to issue 103,000,000 shares, divided into 100,000,000 shares of common stock, par value $.25 per share, and 3,000,000 shares of preferred stock, par value $.25 per share. As of December 31, 2019, the Company had 74,085,095 shares of common stock outstanding and zero shares of preferred stock outstanding. The outstanding shares of the Company&#8217;s common stock are fully paid and nonassessable.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Voting Rights</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. Except as otherwise provided by law or any certificate creating any series of preferred stock, the holders of common stock have the exclusive voting power, and every holder of common stock is entitled to one vote for every share of common stock standing in the name of the shareholder on the Company&#8217;s books. Except as otherwise provided in the PBCL or the Charter Documents, whenever any corporate action is to be taken by vote of the shareholders of the Company (other than the election of directors), it shall be authorized by the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter. Subject to the Charter Documents, the persons receiving a majority of the votes cast shall be elected as directors&#59; provided, that in contested elections, directors shall be elected by a plurality of the votes of the shares represented in person or represented by proxy at such meeting and entitled to vote on the election of directors. The Board of Directors of the Company (the &#8220;Board&#8221;) shall have the full authority permitted by law to determine the voting rights, if any, and designations, preferences, limitations, and special rights of any class or any series of any class of preferred stock that may be desired to the extent not determined by the Charter Documents.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Holders of common stock do not have cumulative voting rights in the election of directors, except upon&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the public announcement by West or a shareholder that such shareholder has become a 40% Shareholder (as described below), and</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">such 40% Shareholder engages, directly or indirectly, in a proxy solicitation or participates in an election contest, seeks to advise or influence any person with respect to voting shares of the Company, or executes a written consent in lieu of a shareholder meeting of the Company.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">A &#8220;40% Shareholder&#8221; means any person who, together with affiliates and associates, beneficially owns 40% or more of the voting stock of the Company, other than the Company or its wholly-owned subsidiaries or employee benefit plans.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Dividend Rights</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. Holders of common stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by the Board, in its discretion, out of funds legally available therefor, subject to any preferential dividend rights of outstanding preferred stock.</font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Liquidation Rights</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. In the event of a liquidation, dissolution or winding up of the Company, the holders of the Company&#8217;s common stock are entitled to share ratably in all assets remaining after the payment of all of the Company&#8217;s liabilities and after all amounts to which holders of any outstanding preferred stock are entitled have been paid or set aside for payment.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Other Rights and Preferences</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. The Company&#8217;s common stock does not carry preemptive rights, is not redeemable, does not have any conversion rights, is not subject to further calls and is not subject to any sinking fund provisions. The rights and preferences of holders of the Company&#8217;s common stock are subject to the rights of any series of preferred stock that the Company may issue.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Listing</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. The Company&#8217;s common stock is listed on The New York Stock Exchange under the trading symbol &#8220;WST&#8221;.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Certain Anti-Takeover Provisions</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Vote Required for Certain Significant Transactions.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">  The Articles require that, in addition to any vote required by law or the Articles, the affirmative vote of the holders of at least 80% of the voting power of then outstanding shares of voting stock, voting as a single class, is required for any of the following transactions (each, a &#8220;Significant Transaction&#8221;)&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">any merger or consolidation of the Company or any of its subsidiaries with any Related Person (as defined below) or any other corporation which is or would be an affiliate of a Related Person&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">any sale, lease or other disposition to or with any Related Person or any of its affiliates of any assets of the Company or any of its subsidiaries having a fair market value of $1.0 million or more&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the issuance or transfer by the Company or any of its subsidiaries of any of their securities to any Related Person or any of its affiliates in exchange for cash, securities or other property having a fair market value of $1.0 million or more&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the purchase by the Company or any of its subsidiaries of any shares of voting stock of the Company in exchange for cash, securities or other property having a fair market value of $1.0 million or more&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the adoption of a plan or proposal for the liquidation or dissolution of the Company proposed by or on behalf of a Related Person or any of its affiliates&#59; or</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">any reclassification of securities or recapitalization of the Company, or any merger or consolidation of the Company with any of its subsidiaries or any other transaction which has the effect, directly or indirectly, or increasing the proportionate share of the outstanding shares of any class of equity or convertible securities of the Company or any of its subsidiaries which is directly or indirectly owned by any Related Person or any of its affiliates.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The higher vote requirement described above does not apply to a Significant Transaction if it is approved by a majority of Continuing Directors (as defined below) and certain fair price provisions and other requirements set forth in Article 6 of the Articles are satisfied.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;Related Person&#8221; means any person (other than the Company or any its subsidiaries) who (i) beneficially owns more than 10% of the voting power of outstanding voting stock or (ii) is an affiliate of the Company and at any time during the preceding two years beneficially owned 10% or more of such voting power, or (iii) is an assignee or has otherwise succeeded to any shares of voting stock which were at any time during the preceding two years beneficially owned by any Related Person, if such assignment or succession occurred in the course of a transaction not involving a public offering.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;Continuing Director&#8221; means any member of the Board who (i) was a member as of May 5, 1983, or (ii) is not affiliated with a Related Person and was a member of the Board prior to the time the Related Person became a </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Related Person, or (iii) is a successor of a Continuing Director who is unaffiliated with the Related Person and is recommended to succeed a Continuing Director by a majority of the Continuing Directors.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Evaluation of Certain Proposals by the Board.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">  The Articles provide that the Board, when evaluating a proposal from another party to acquire the Company or engage in a similar transaction, shall give due consideration to the following when exercising its judgment in determining what is in the best interests of the Company and its shareholders&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the character, integrity, business philosophy and financial status of the other party or parties to the transaction&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the consideration to be received by the Company or its shareholders in connection with such transaction, as compared to&#58; (i) the current market price or value of the Company&#8217;s properties or securities&#59; (ii) the estimated future value of the Company, its properties or securities&#59; and (iii) such other measures of the value of the Company, its properties or securities as the directors may deem appropriate.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the projected social, legal and economic effects of the proposed action or transaction upon the Company, its employees, suppliers and customers and the communities in which the Company does business&#59;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">the general desirability of the Company&#8217;s continuing as an independent entity&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">such other factors as the Board may deem relevant. </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Potential Issuances of the Company&#8217;s Preferred Stock</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. Although the Company does not currently have any shares of preferred stock outstanding, it is authorized under the Articles to issue 3,000,000 shares of preferred stock, and the rights, preferences and privileges of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any series of preferred stock that the Company may designate and issue in the future. The Articles also authorize the Board to establish, from the authorized but unissued shares, one or more series of the shares of preferred stock and to determine, with respect to any such series of the Company&#8217;s preferred shares, the terms and rights of such series, including, for example, the designation, the number of shares, the dividend rate of the shares, the right, if any, of the Company to redeem shares, the voting power, if any, the obligation, if any, of the Company to retire shares, the terms and conditions, if any, upon which shares shall be convertible into or exchangeable for shares of stock of any other class or classes, and any other rights, preferences or limitations of the shares of such series.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Board has authorized the issuance of 50,000 shares of preferred stock as Series A junior participating preferred stock in connection with its adoption of a shareholder rights plan that has expired. No shares of the Series A preferred stock are outstanding, and the Company does not intend to issue any of these shares. </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The authorized shares of the Company, including shares of preferred stock and common stock, will be available for issuance without further action by the Company&#8217;s shareholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which the Company&#8217;s securities may be listed or traded.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Provisions for Shareholder Nominations and Shareholder Proposals at Annual Meetings</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. The Company&#8217;s Bylaws establish an advance notice procedure for shareholders to nominate candidates for election as directors or to bring other business before annual meetings of the Company&#8217;s shareholders (the &#8220;Shareholder Notice Procedure&#8221;). The Shareholder Notice Procedure requires that written notice of nominations or proposals for substantive business must be delivered to the Company not less than 90 days prior to the first anniversary of the date of the prior year&#8217;s annual meeting of shareholders&#59; provided, that if less than 21 days&#8217; notice or prior public disclosure of the meeting date is given, the notice must be delivered not later than the earlier of (1) the 7</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">th</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> day after notice of the meeting date was mailed or disclosed,  or (2) the 4</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">th</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> day prior to the meeting. The nomination must contain information about the nominees as specified in the Bylaws. The notice must include information specified in the Bylaws, including, among other things, information concerning the nominee or proposal, as the case may be, and information about the shareholder's ownership of and agreements related to shares of the Company&#8217;s common stock.</font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">A shareholder who wishes to recommend a candidate to be considered by the Nominating and Corporate Governance Committee of the Board for nomination as a Director must deliver the recommendation in writing to the Secretary of the Company following the Shareholder Notice Procedure described above and include the information set forth in the Bylaws. The Nominating and Corporate Governance Committee will consider all recommended candidates when making its recommendation to the full Board to nominate a slate of Directors for election. </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Provisions Relating to the Election of the Company&#8217;s Board of Directors</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. Under the Articles, shareholders are entitled to only one vote for each share held in all elections for directors. Directors are elected by a majority of votes cast, except in the case of contested elections, as described above. Holders of common stock do not have cumulative voting rights in the election of directors, except upon certain circumstances described above.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Director Vacancies</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. Under the Articles, vacancies in the Board of Directors, including vacancies resulting from an increase in the number of Directors, shall be filled only by a majority vote of the remaining members of the Board though less than a quorum, and each person so selected shall be a Director to serve until the next annual meeting of shareholders, and until a successor has been duly elected and qualified.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Amendment to Articles.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Any amendment to the articles requires the affirmative vote of a majority of the votes cast by all shareholders entitled to vote thereon and, if any class or series of shares is entitled to vote thereon as a class, the affirmative vote of a majority of the votes cast in each such class vote, except for amendments on matters specified in Section 1914(c) of the PBCL that do not require shareholder approval&#59; provided that alteration, amendment supplementing or repeal of the following provisions of the Articles requires the affirmative vote of the holders of at least 80% of the outstanding shares of capital stock entitled to vote generally in the election of directors, considered as one class&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Article 6, which relates to the vote required for certain significant transactions, as described in &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Vote Required for Certain Significant Transactions</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; above</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Article 7, which relates to the evaluation of certain proposals by the Board, as described in &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Evaluation of Certain Proposals by the Board</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; above</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Article 8, which relates the Board, including vacancies and cumulative voting in certain circumstances</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Article 10, which relates to the vote required to amend the Articles</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Amendment to Bylaws. </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Except as restricted by applicable law, authority to adopt, amend and repeal the Bylaws is expressly vested in the Board, subject to the power of the shareholders to change such action.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Special Meeting of Company Shareholders</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. The Charter Documents do not contain a provision permitting shareholders to call a special meeting.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Shareholder Action by Written Consent</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. The Charter Documents do not contain a provision permitting action by written consent of the shareholders.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Pennsylvania Anti-Takeover Statutes.  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Under Section 1715 of the PBCL, directors stand in a fiduciary relation to their corporation. In discharging their duties, directors may, in considering the best interests of their corporation, consider various constituencies, including, shareholders, employees, suppliers, customers and creditors of the corporation, and upon communities in which offices or other establishments of the corporation are located. Absent a breach of fiduciary duty, a lack of good faith or self-dealing, any act of the Board of Directors, a committee thereof or an individual director is presumed to be in the best interests of the corporation. The PBCL expressly provides that the fiduciary duty of directors does not require them to (i) redeem or otherwise render inapplicable outstanding rights issued under any shareholder rights plan&#59; (ii) render inapplicable certain of the anti-takeover statutes set forth in Chapter 25 of the PBCL described below&#59; or (iii) take any action solely because of the effect it may have on a proposed acquisition or the consideration to be received by shareholders in such a transaction.</font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Chapter 25 of the PBCL contains several anti-takeover statutes applicable to publicly-traded corporations. Corporations may opt-out of such anti-takeover statutes under certain circumstances. The Company has not opted-out of any of the following statutes.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Section 2538 of Subchapter 25D of the PBCL requires certain transactions with an &#8220;interested shareholder&#8221; to be approved by a majority of disinterested shareholders. &#8220;Interested shareholder&#8221; is defined broadly to include any shareholder who is a party to the transaction or who is treated differently than other shareholders and affiliates of the corporation.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subchapter 25E of the PBCL requires a person or group of persons acting in concert which acquires 20% or more of the voting shares of the corporation to offer to purchase the shares of any other shareholder at &#8220;fair value.&#8221; &#8220;Fair value&#8221; means the value not less than the highest price paid by the controlling person or group during the 90-day period prior to the control transaction, plus a control premium. Among other exceptions, Subchapter 25E does not apply to shares acquired directly from the corporation in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subchapter 25F of the PBCL applies to a transaction with an interested shareholder (defined generally to be any beneficial owner of 20% or more of the corporation&#8217;s voting stock). Subchapter F prohibits such a corporation from engaging in a &#8220;business combination&#8221; (as defined in the PBCL) with an interested shareholder unless (i) the board of directors of such corporation gives approval to the proposed transaction or gives approval to the interested shareholder&#8217;s acquisition of 20% of the shares entitled to vote in an election of directors of such corporation, in either case prior to the date on which the shareholder first becomes an interested shareholder (the &#8220;Share Acquisition Date&#8221;)&#59; (ii) the interested shareholder owns at least 80% of the stock of such corporation entitled to vote in an election of directors of such corporation, and no earlier than three months after such interested shareholder reaches such 80% level, the majority of the remaining shareholders approve the proposed transaction, shareholders receive a minimum &#8220;fair price&#8221; for their shares (as set forth in the PBCL) in the transaction and the other conditions of Subchapter F are met&#59; (iii) holders of all outstanding shares of common stock of the corporation approve the transaction&#59; (iv) no earlier than five years after the Share Acquisition Date, a majority of the holders of the remaining shares entitled to vote in an election of directors approve the transaction&#59; or (v) no earlier than five years after the Share Acquisition Date, a majority of all holders of the shares of the corporation approve the transaction, all shareholders receive a minimum &#8220;fair price&#8221; for their shares (as set forth in the PBCL) and the other conditions of Subchapter F are met.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subchapter 25G of the PBCL provides that &#8220;control shares&#8221; lose voting rights unless such rights are restored by the affirmative vote of a majority of (i) the disinterested shares (generally, shares held by persons other than the acquirer, executive officers of the corporation and certain employee stock plans) and (ii) the outstanding voting shares of the corporation. &#8220;Control shares&#8221; are defined as shares which, upon acquisition, will result in a person or group acquiring for the first time voting control of (a) at least 20%, (b) at least 33-1&#47;3% or (c) 50% or more of the outstanding shares, together with shares acquired within 180 days of attaining the applicable threshold and shares purchased with the intention of attaining such threshold. A corporation may redeem control shares if the acquiring person does not request restoration of voting rights as permitted by Subchapter 25G. Among other exceptions, Subchapter 25G does not apply to a merger, consolidation or a share exchange if the corporation is a party to the transaction agreement.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subchapter 25I of the PBCL mandates severance compensation for eligible employees who are terminated within 24 months after the approval of a control share acquisition. Eligible employees generally are all employees employed in Pennsylvania for at least two years prior to the control share approval. Severance equals the weekly compensation of the employee multiplied by the employee's years of service (up to 26 years), less payments made due to the termination.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subchapter 25J of the PBCL requires the continuation of certain labor contracts relating to business operations owned at the time of a control share approval.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company has opted out of Subchapter 25H of the PBCL, which relates to disgorgement by certain controlling shareholders following attempts to acquire control.</font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102firstamendmentand.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_21"></div><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Exhibit 10.2</font></div><div style="text-align:right;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">FIRST AMENDMENT AND INCREMENTAL FACILITY AMENDMENT</font></div><div style="text-align:center;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">THIS FIRST AMENDMENT AND INCREMENTAL FACILITY AMENDMENT (this &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;) is entered into as of December 30, 2019 (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Incremental Term Loan Effective Date</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;) among WEST PHARMACEUTICAL SERVICES, INC., a Pennsylvania corporation (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Compan</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">y&#8221; or &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Borrowers&#8217; Representative</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), each of the Lenders party hereto (including each Incremental Lender), and Bank of America, N.A., as Administrative Agent.  All capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed thereto in the Credit Agreement (as defined below) or in the Amended Credit Agreement (as defined below), as the case may be.</font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">W I T N E S S E T H</font></div><div style="text-align:center;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">WHEREAS, pursuant to that certain Credit Agreement, dated as of March 28, 2019 (as amended, restated, extended, supplemented or otherwise modified in writing from time to time, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Credit Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), among the Company, certain subsidiaries of the Company party thereto (together with the Company, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; and each a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Borrower</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender, the Lenders have agreed to provide the Borrowers with the credit facilities provided for therein&#59;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">WHEREAS, the Company has requested pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.14(d)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement that each Lender party hereto with a commitment in respect of the Incremental Term Facility (each, an &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Incremental Lender</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;) provide a portion of an Incremental Term Facility to the Company under the Credit Agreement&#59;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">WHEREAS, the Borrowers&#8217; Representative, in such capacity, has requested that the Lenders make certain amendments to the Credit Agreement&#59; and</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">WHEREAS, each Incremental Lender has agreed to provide a portion of an Incremental Term Facility to the Company and the Required Lenders have agreed to amend the Credit Agreement as provided herein with such amendments not constituting a novation of the Credit Agreement (the Credit Agreement, as amended hereby, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Amended Credit Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;).</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows&#58;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;padding-left:28.5pt;">Establishment of Incremental Term Facility</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  </font></div><div><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(a)&#160;Subject to the terms and conditions set forth herein, a new term loan in the original principal amount of $90,000,000 (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Incremental Term A Loan</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;) is hereby established as an Incremental Term Facility pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.14(d)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement.</font></div><div><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(b)&#160;Subject to the terms and conditions set forth herein, each Incremental Lender severally agrees to make its portion of the Incremental Term A Loan in a single advance in Dollars to the Company on the Incremental Term Loan Effective Date in an amount not to exceed such Incremental Lender&#8217;s Incremental Term A Loan Commitment to such Incremental Term Facility&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, after giving effect to such advances, the outstanding amount of the Incremental Term A Loan shall not exceed the aggregate amount of Incremental Term A Loan Commitments of the Incremental Lenders.  The Incremental Term A Loan Commitments of each Incremental Lender and the Commitment Percentage of each Incremental Lender&#8217;s portion of such Incremental Term Facility, in each case as of the Incremental Term Loan Effective Date, shall be as set forth on </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Schedule 1.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> attached hereto.  The Incremental Term A Loan may from time to time be (i) LIBOR Loans, (ii) Base Rate Loans or (iii) a combination thereof, as determined by the Company and notified to the Administrative Agent in accordance with </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Sections 2.04</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">2.05</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement.</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(c)&#160;The Incremental Term A Loan shall be subject to mandatory prepayment as set forth in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.15(g)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement.</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">2.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Amendments to Credit Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(a)&#160;The reference to &#8220;MERRILL LYNCH, PIERCE, FENNER &#38; SMITH INCORPORATED&#8221; on the cover page of the Credit Agreement is hereby amended to read as &#8220;BOFA SECURITIES, INC.&#8221;.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(b)&#160;Each reference to &#8220;MLPFS&#8221; in the Credit Agreement is hereby amended to read as &#8220;BofA Securities&#8221;.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(c)&#160;The following new definitions are hereby added to Section 1.01 of the Credit Agreement in the appropriate alphabetical order to read as follows&#58;</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">BHC Act Affiliate</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; of a party means an &#8220;affiliate&#8221; (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">BofA Securities</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means BofA Securities, Inc. (as successor to Merrill Lynch, Pierce, Fenner &#38; Smith Incorporated), in its capacity as a joint lead arranger and joint bookrunner.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Covered Entity</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means any of the following&#58;  (a) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59; (b) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; or (c) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Covered Party</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; has the meaning provided in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 9.21</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Default Right</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means as defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">First Amendment</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means that certain First Amendment and Incremental Facility Amendment, dated as of the First Amendment Effective Date, by and among the Borrowers&#8217; Representative, the Lenders party thereto and the Administrative Agent.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">First Amendment Effective Date</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means December 30, 2019.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Incremental Term A Loan</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means the term loan made to the Company pursuant to the First Amendment.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Incremental Term A Loan Commitment</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means, as to each Lender providing the Incremental Term A Loan, its obligation to make its portion of the Incremental Term A Loan to the Company pursuant to the First Amendment in the principal amount set forth opposite such Lender&#8217;s name on </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Schedule 1.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  The aggregate principal amount of the Incremental Term A Loan Commitment of all of the Lenders in effect on the First Amendment Effective Date is NINETY MILLION DOLLARS ($90,000,000).</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Incremental Term Loan Commitments</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means the Incremental Term A Loan Commitment and any other obligation of a Lender to make its portion of a term loan to a Borrower pursuant to an Incremental Term Facility.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Incremental Term Loans</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means any term loans which have been incurred pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.14(d)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> under a then existing or additional Incremental Term Facility, including the Incremental Term A Loan.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Net Cash Proceeds</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; has the meaning provided in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.15(g)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Permitted Transfers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means (a) sales or dispositions of assets permitted by </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 6.04(a)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> - </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">(i)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#59; (b) licenses, sublicenses, leases or subleases granted to others not interfering in any material respect with the business of the Borrowers and their Subsidiaries&#59; and (c) the sale or disposition of Cash Equivalents for fair market value.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">QFC</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means a &#8220;qualified financial contract&#8221; (as defined in, and interpreted in accordance with, 12 U.S.C. &#167; 5390(c)(8)(D)).</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">QFC Credit Support</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; has the meaning provided in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 9.21</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Relevant Governmental Body</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York for the purpose of recommending a benchmark rate to replace LIBOR in loan agreements similar to this Agreement.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">SOFR</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"> </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">with respect to any day means the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark (or a successor administrator) on the Federal Reserve Bank of New York&#8217;s website (or any successor source) and, in each case, that has been selected or recommended by the Relevant Governmental Body.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">SOFR-Based Rate</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means SOFR or Term SOFR.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Supported QFC</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; has the meaning provided in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 9.21</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Term SOFR</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"> </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">means the forward-looking term rate for any period that is approximately (as determined by the Administrative Agent) as long as any of the Interest Period options set forth in the definition of &#8220;Interest Period&#8221; and that is based on SOFR and that has been selected or recommended by the Relevant Governmental Body, in each case as published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">U.S. Special Resolution Regimes</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; has the meaning provided in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 9.21</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(d)&#160;The definition of &#8220;Commitment Percentage&#8221; in Section 1.01 of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Commitment Percentage</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means with respect to any Lender at any time, (a) with respect to such Lender&#8217;s Revolving Credit Commitment, the percentage (carried out to the ninth decimal place) of the Commitments represented by such Lender&#8217;s Revolving Credit Commitment at such time&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, if the commitment of each Lender to make Revolver Loans and the obligation of each Issuing Lender to make L&#47;C Credit Extensions have been terminated pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 7.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> or if the Commitments have expired, then the Commitment Percentage of each Lender shall be determined based on the Commitment Percentage of such Lender most recently in effect, giving effect to any subsequent assignments and to any Lender&#8217;s status as a Defaulting Lender at the time of determination and (b) with respect to such Lender&#8217;s portion of any outstanding Incremental Term Loan, the percentage (carried out to the ninth decimal place) of the outstanding principal amount of such Incremental Term Loan held by such Lender at such time.  The initial Commitment Percentage of each Lender is set forth opposite the name of such Lender on </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Schedule 1.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, or in the Assignment and Assumption, any documentation executed by such Lender pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.14(d)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, or other documentation pursuant to which such Lender becomes a party hereto, as applicable.  The Commitment Percentages shall be subject to adjustment as provided in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.25</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(e)&#160;The definition of &#8220;LIBOR Successor Rate Conforming Changes&#8221; in Section 1.01 of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">LIBOR Successor Rate Conforming Changes</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means, with respect to any proposed LIBOR Successor Rate, any conforming changes to the definition of Base Rate, the definition of Interest Period, the timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters as may be appropriate, in the discretion of the Administrative Agent, to reflect the adoption and implementation of such LIBOR Successor Rate and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such LIBOR Successor Rate exists, in such other manner of administration as the Administrative Agent determines is reasonably necessary in connection with the administration of this Agreement).</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(f)&#160;The definition of &#8220;Loans&#8221; in Section 1.01 of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Loans</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means an extension of credit by a Lender to a Borrower in the form of a Revolver Loan, a Swing Line Loan or an Incremental Term Loan, as the context may require.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(g)&#160;The definition of &#8220;MLPFS&#8221; in Section 1.01 of the Credit Agreement is hereby deleted.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(h)&#160;The definition of &#8220;Required Lenders&#8221; in Section 1.01 of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Required Lenders</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means, at any time, those non-Defaulting Lenders holding more than 50% of the unused Commitments, Total Exposure, outstanding amount of Incremental Term Loans, and unfunded Incremental Term Loan Commitments of such non-Defaulting Lenders&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, the amount of any participation in any Swing Line Loan or Letter of Credit that a Defaulting Lender has failed to fund that has not been reallocated to and funded by another Lender shall be deemed to be held by the Lender that is the Swing Line Lender or the applicable Issuing Lender, as the case may be, in making such determination.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(i)&#160;The definition of &#8220;Termination Date&#8221; in Section 1.01 of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Termination Date</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means, (a) with respect to the Revolver Loans, Letters of Credit, and Swing Line Loans, subject to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.26</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, the earlier of (i) March 28, 2024 and (ii) the date the Commitments are terminated as provided herein&#59; and (b) with respect to the Incremental Term A Loan, December 31, 2024.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(j)&#160;The definition of &#8220;Tranche&#8221; in Section 1.01 of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Tranche</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; means specified portions of Loans outstanding as follows&#58; (a) any Loans to which a LIBOR Rate applies which become subject to the same LIBOR Rate under the same Notice of Borrowing and which have the same Interest Period, which are denominated either in Dollars or, in the case of Revolver Loans, in the same Optional Currency, shall constitute one Tranche, (b) all Revolver Loans to which the Base Rate applies shall constitute one Tranche and (c) all Incremental Term Loans to which the Base Rate applies shall constitute one Tranche.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(k)&#160;The instances of &#8220;Revolver Loans&#8221; in Section 2.02 of the Credit Agreement are hereby replaced with &#8220;Loans&#8221;.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(l)&#160;The instances of &#8220;Revolver Loans&#8221; in Section 2.04 of the Credit Agreement (including the title thereof) are hereby replaced with &#8220;Loans&#8221;.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(m)&#160;The following clause (d) is hereby added to the end of Section 2.04 of the Credit Agreement to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(d)&#160;This </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.04</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> shall not apply to Swing Line Loans.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(n)&#160;Section 2.09(g) of the Credit Agreement shall be amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(g)&#160;Subject to the provisions of this Agreement, the Borrowers may select different interest rates and different Interest Periods to apply simultaneously to Loans comprising different Tranches and may convert to or renew one or more interest rates with respect to all or any portion of Loans comprising any Tranche, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, there shall not be at any one time outstanding more than (i) six (6) Tranches in the aggregate with respect to Revolver Loans (excluding Swing Line Loans and with Base Rate Loans being considered, to the extent any such Loans are outstanding, one Tranche) and (ii) six (6) Tranches in the aggregate with respect to the Incremental Term Loans.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(o)&#160;Section 2.13(c) of the Credit Agreement is hereby amended to read as follows&#58; </font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(c)&#160;Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Company or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Company) that the Company or Required Lenders (as applicable) have determined, that&#58;</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(i)&#160;adequate and reasonable means do not exist for ascertaining LIBOR for the applicable currency for any requested Interest Period, including, without limitation, because the LIBOR Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary&#59; </font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(ii)&#160;the administrator of the LIBOR Screen Rate for the applicable currency or a Governmental Authority having or purporting to have jurisdiction over the Administrative Agent has made a public statement identifying a specific date after which LIBOR for the applicable currency or the LIBOR Screen Rate for the applicable currency shall no longer be made available, or used for determining the interest rate of loans, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide LIBOR for the applicable currency after such specific date (such specific date, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Scheduled Unavailability Date</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), or</font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(iii)&#160;syndicated loans currently being executed, or that include language similar to that contained in this </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace LIBOR for the applicable currency,</font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">then, reasonably promptly after such determination by the Administrative Agent or receipt by the Administrative Agent of such notice, as applicable, the Administrative Agent and the Company may amend this Agreement to replace LIBOR for the applicable currency with (x) for Dollars only, one or more SOFR-Based Rates or (y) another alternate benchmark rate, giving due consideration to any evolving or then existing convention for similar syndicated credit facilities denominated in the applicable currency for such alternative benchmarks and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar syndicated credit facilities for such benchmarks, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Adjustment</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#59;&#8221; and any such proposed rate, a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">LIBOR Successor Rate</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), and any such amendment shall become effective at 5&#58;00 p.m. on </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Company unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders (A) in the case of an amendment to replace LIBOR for Dollars with a rate described in clause (x), object to the Adjustment&#59; or (B) in the case of an amendment to replace LIBOR for the applicable currency with a rate described in clause (y), object to such amendment&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, for the avoidance of doubt, in the case of clause (A), the Required Lenders shall not be entitled to object to any SOFR-Based Rate contained in any such amendment.  Such LIBOR Successor Rate shall be applied in a manner consistent with market practice&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, to the extent such market practice is not administratively feasible for the Administrative Agent, such LIBOR Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">If no LIBOR Successor Rate has been determined and the circumstances under </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">clause (i)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> above exist or the Scheduled Unavailability Date has occurred (as applicable), the Administrative Agent will promptly so notify the Company and each Lender.  Thereafter, (x) the obligation of the Lenders to make or maintain LIBOR Loans shall be suspended (to the extent of the affected LIBOR Loans or Interest Periods), and (y) if the applicable currency is Dollars, then the LIBOR Rate component shall no longer be utilized in determining the Base Rate.  Upon receipt of such notice, the applicable Borrower may revoke any pending request for a Borrowing of, conversion to or continuation of LIBOR Loans denominated in the applicable currency (to the extent of the affected LIBOR Loans or Interest Periods) or, failing that, will be deemed to have converted such request into a request for a Borrowing of Base Rate Loans (subject to the foregoing </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">clause (y)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">) in the amount specified therein.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Notwithstanding anything else herein, any definition of LIBOR Successor Rate shall provide that in no event shall such LIBOR Successor Rate be less than zero for purposes of this Agreement.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In connection with the implementation of a LIBOR Successor Rate, the Administrative Agent will have the right to make LIBOR Successor Rate Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such LIBOR Successor Rate Conforming Changes will become effective without any further action or consent of any other party to this Agreement.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(p)&#160;Section 2.14(a) of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(a)&#160;(i)&#160;The Revolving Credit Commitments and the Swing Line Commitment shall be automatically terminated on the Termination Date whereupon all Revolver Loans and Swing Line Loans and accrued interest thereon shall become due and payable, except as provided in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.26</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> in respect of any Extended Revolving Credit Commitments.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(ii)       The Company shall repay the outstanding principal amount of the Incremental Term A Loan in installments on the dates and in the amounts set forth in the table below (as such installments may hereafter be adjusted as a result of prepayments made pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.15</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">), unless accelerated sooner pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 7.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#58;</font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="padding-left:72pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:57.692%;"><tr><td style="width:1.0%;"></td><td style="width:54.666%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:41.334%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payment Dates (the last Business Day of the fiscal quarter of the Company ending)</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Principal Amortization Payment</font></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2020</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2020</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2020</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2021</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2021</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2021</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2021</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2022</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2022</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2022</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2022</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2023</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2023</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2023</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2023</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 31, 2024</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2024</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 30, 2024</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$562,500</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Termination Date</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><font style="font-size:11pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unpaid principal balance of the Incremental Term A Loan.</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(q)&#160;Clause (i) of Section 2.14(d) of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(i)&#160;the aggregate amount of all Incremental Facilities effected after the First Amendment Effective Date pursuant to this </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.14(d)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> shall not exceed the greater of (A) $350,000,000 and (B) EBITDA for the most recent period for which financial statements have theretofore been delivered to the Lenders pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 5.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#59;</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(r)&#160;Section 2.15(a) of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(a)&#160;The Borrowers shall have the right at any time and from time to time to prepay Loans in the currency or currencies in which such Loans were made, in whole or in part, without premium or penalty (but in any event subject to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.18</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">), upon delivery of a Notice of Loan Prepayment to the Administrative Agent given, in the case of Base Rate Loans denominated in Dollars, no later than 11&#58;00 a.m. on the day of any proposed prepayment, in the case of LIBOR Loans denominated in Dollars, no later than 11&#58;00 a.m. three (3) Business Days before any proposed prepayment, and in the case of Optional Currency Loans, no later than 11&#58;00 a.m. four (4) Business Days before any such proposed prepayment (or such shorter period as the Administrative Agent shall agree in its discretion). In each case the notice shall specify (i) the date, amount and currency of each such prepayment, (ii) whether the prepayment is of Revolver Loans or Incremental Term Loans (and, if applicable, the specific Tranche(s) of Incremental Term Loans to be prepaid), and (iii) whether the prepayment is of LIBOR Loans or Base Rate Loans, or </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">a combination thereof, and, if a combination thereof, the amount allocable to each&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">however</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">that</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, each such partial prepayment shall be in the principal amount of at least (x) with respect to prepayments of Base Rate Loans, $1,000,000 or in whole multiples of $100,000 in excess thereof, and (y) with respect to prepayments of Revolver Loans in Dollars that bear interest at the LIBOR Rate, $3,000,000 or in whole multiples of $100,000 in excess thereof, (z) with respect to prepayment of Revolver Loans in an Optional Currency, the Dollar Equivalent of $3,000,000 or in whole multiples of the Dollar Equivalent of $100,000 in excess thereof (or, with respect to Revolver Loans in an Optional Currency, such other minimum and increments as the Administrative Agent and the Borrowers shall agree).  Any prepayment of an Incremental Term Loan shall be applied to the remaining principal amortization payments of such Incremental Term Loan in inverse order of maturity.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(s)&#160;Section 2.15(f) of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(f)&#160;Prepayments of Revolver Loans pursuant to this </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> (other than </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">subsection (b)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> hereof) may be reborrowed, subject to the terms and conditions hereof.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(t)&#160;A new clause (g) is hereby added to Section 2.15 of the Credit Agreement to read as follows&#58; </font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(g)&#160;(i)&#160;The Company shall prepay Incremental Term Loans as hereinafter provided in an aggregate amount equal to 100% of the aggregate cash or Cash Equivalents proceeds (including any cash or Cash Equivalents received upon the sale or other disposition of any non&#8209;cash consideration received by any Domestic Borrower or Domestic Subsidiary in connection therewith) net of (A) direct costs incurred in connection therewith (including, without limitation, legal, accounting and investment banking fees and sales commissions), (B) taxes paid or payable as a result thereof, (C)  the amount necessary to retire any Indebtedness secured by a Permitted Lien (ranking senior to any Lien of the Administrative Agent) on the related property and (D) the amount of any prepayment required to be made to comply with the terms of Section 10.3 of the Note Purchase Agreement as in effect on the First Amendment Effective Date (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Net Cash Proceeds</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), received by any Domestic Borrower or Domestic Subsidiary in respect of any asset sale, disposition or involuntary disposition (other than a Permitted Transfer) within three hundred sixty (360) days of the date of such disposition&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">however</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, that so long as no Default shall have occurred and be continuing, such Net Cash Proceeds shall not be required to be so applied at the election of the Company (as notified by the Company to the Administrative Agent) to the extent the Company or such Domestic Borrower or Domestic Subsidiary reinvests all or any portion of such Net Cash Proceeds in operating assets (but specifically excluding current assets as classified by GAAP) within three hundred sixty (360) days after the receipt of such Net Cash Proceeds&#59; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">provided</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> that, if such Net Cash Proceeds shall have not been so reinvested, such Net Cash Proceeds shall be immediately applied to prepay Incremental Term Loans.   </font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(ii)       Immediately upon the receipt by any Domestic Borrower of Net Cash Proceeds received from the issuance by any Domestic Borrower of any Indebtedness (other than Indebtedness permitted hereunder), such Domestic Borrower shall prepay Incremental Term Loans as hereinafter provided in an aggregate amount equal to 100% of such Net Cash Proceeds.</font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(iii)      Each prepayment of Incremental Term Loans pursuant to this </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">clause (g</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">) shall be applied to the principal repayment installments of outstanding Incremental Term Loans</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;"> </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">in inverse order of maturity.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">  </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subject to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.25</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, such prepayments shall be paid to the Incremental Lenders in accordance with their respective percentage (carried out to the ninth decimal place) of the outstanding principal amount of Incremental Term Loans at such time.</font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(u)        The instance of &#8220;Term Loans&#8221; in Section 9.06(b)(ii) is hereby replaced with &#8220;Incremental Term Loan&#8221;.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(v)&#160;Section 9.19 of the Credit Agreement is hereby amended to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">9.19&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration: underline;">Joint and Several Liability of Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  Notwithstanding anything to the contrary in this Agreement (other than </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.22</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">), all Obligations shall be joint and several, subject to the limitations set forth in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.22</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(w)&#160;A new Section 9.21 is hereby added to the Credit Agreement to read as follows&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">9.21</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration: underline;">cknowledgement Regarding Any Supported QFCs.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">  To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any interest rate cap agreement, interest rate swap agreement, foreign currency exchange agreement, netting agreement, hedging agreement or any other agreement or instrument that is a QFC (such support, &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">QFC Credit Support</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;, and each such QFC, a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Supported QFC</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">U.S. Special Resolution Regimes</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and&#47;or of the United States or any other state of the United States)&#58;  In the event a Covered Entity that is party to a Supported QFC (each, a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Covered Party</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.</font></div><div><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(x)&#160;Schedule 1.01 to the Credit Agreement is hereby amended to read as Schedule 1.01 attached hereto.</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(y)&#160;Exhibit C to the Credit Agreement is hereby amended to read as Exhibit C attached hereto.</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(z)&#160;Exhibit I to the Credit Agreement is hereby amended to read as Exhibit I attached hereto. </font></div><div><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">3.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Conditions Precedent</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  This Agreement shall be effective on the Incremental Term Loan Effective Date upon&#58;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(a)&#160;receipt by the Administrative Agent of executed counterparts of this Agreement duly executed by the Borrowers&#8217; Representative, the Required Lenders, each Incremental Lender, and the Administrative Agent&#59;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(b)&#160;receipt by the Administrative Agent of satisfactory opinions of legal counsel to the Company (as requested by the Administrative Agent), addressed to the Administrative Agent and the Lenders, dated as of the Incremental Term Loan Effective Date&#59;</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(c)&#160;receipt by the Administrative Agent of (i) copies of the Organization Documents of each Domestic Borrower certified to be true and complete as of a recent date by the appropriate Governmental Authority of the state or other jurisdiction of its incorporation or organization, where applicable (or, as to any such Organization Documents that have not been amended, modified or terminated since the Closing Date, a certification that such Organization Documents have not been amended, modified or terminated since the Closing Date and remain in full force and effect, and remain true and complete, in the form delivered to the Administrative Agent on the Closing Date), and certified by a secretary, assistant secretary or other Responsible Officer of such Domestic Borrower to be true and correct as of the Incremental Term Loan Effective Date, (ii) such certificates of resolutions or other action, incumbency certificates (including specimen signatures) and&#47;or other certificates of Responsible Officers of each Domestic Borrower as the Administrative Agent may reasonably require evidencing the identity, authority and capacity of each Responsible Officer thereof authorized to act as a Responsible Officer in connection with this Agreement and the other Loan Documents to which such Domestic Borrower is a party, and (iii) such documents and certifications as the Administrative Agent may reasonably require to evidence that each Domestic Borrower is duly organized or formed, and is validly existing, in good standing and qualified to engage in business in its state of organization or formation&#59;</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(d)&#160;receipt by the Administrative Agent with respect to the Incremental Term A Loan of (i) a Notice of Borrowing and (ii) funds disbursement instructions&#59;</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(e)&#160; receipt by the Administrative Agent of certificate dated as of the Incremental Term Loan Effective Date and executed by a Responsible Officer of the Borrowers&#8217; Representative certifying that after giving effect to the incurrence of the Incremental Term A Loan, on a pro forma basis, the Borrowers are in compliance with the financial covenant set forth in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 6.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement for the most recently completed four fiscal quarter period for which financial statements have been delivered to the Lenders pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 5.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement&#59;</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(f)&#160;(i) receipt by the Lenders and the Administrative Agent of all documentation and other information that the Administrative Agent or any Lender determines is required by regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including, without limitation, the PATRIOT Act, and that the Administrative Agent or any Lender has requested at least five (5) Business Days prior to the Incremental Term Loan Effective Date, and (ii) if any Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, receipt by the Administrative Agent and any Lender requesting the same of a Beneficial Ownership Certification with respect to such Borrower to the extent requested by the Administrable Agent or such Lender at least five (5) Business Days prior to the Incremental Term Loan Effective Date&#59; and</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(g)&#160;receipt by the Administrative Agent and the Lenders of all fees required to be paid on or prior to the Incremental Term Loan Effective Date, and receipt by the Administrative Agent of all expenses (including the fees and expenses of counsel (including any local counsel) for the Administrative Agent).</font></div><div style="text-indent:36pt;padding-left:36pt;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">4.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Representations and Warranties of the Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  The Borrowers&#8217; Representative hereby represents and warrants to the Administrative Agent and each Lender that (a) the representations and warranties of each Borrower contained in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 3</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement or any other Loan Document are (i) with respect to representations and warranties that contain a materiality qualification or are qualified by Material Adverse Effect, true and correct and (ii) with respect to representations and warranties that do not contain a materiality qualification and are not qualified by Material Adverse Effect, true and correct in all material respects, except to the extent that such representations and warranties specifically refer to an earlier date, in which case such representations and warranties are (1) with respect to representations and warranties that contain a materiality qualification or are qualified by Material Adverse Effect, true and correct and (2) with respect to representations and warranties that do not contain a materiality qualification and are not qualified by Material Adverse Effect, true and correct in all </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">material respects, in each case, as of such earlier date&#59; and (b) no Default or Event of Default exists, or will result from the extension of the extension of the Incremental Term A Loan.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">5.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Authority&#47;Enforceability</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  The Borrowers&#8217; Representative represents and warrants as follows&#58;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(a)&#160;It has taken all necessary corporate or other action to authorize the execution, delivery and performance of this Agreement.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(b)&#160;This Agreement has been duly executed and delivered by the Borrowers&#8217; Representative and constitutes legal, valid and binding obligations, enforceable in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law).</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(c)&#160;No consent or authorization of, filing with or other act by or in respect of, any Governmental Authority or any other Person (including stockholders and creditors of the Borrowers) is required in connection with the execution, delivery, performance, validity or enforceability of this Agreement, except to the extent that such consent or authorization has been obtained or such filing or action has been completed prior to the Incremental Term Loan Effective Date.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(d)&#160;The execution and delivery of this Agreement does not violate any Requirement of Law or material Contractual Obligation of any Borrower or any of its Subsidiaries.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">6.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Reaffirmation</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  The Amended Credit Agreement and the obligations of the Borrowers thereunder and under the other Loan Documents are hereby ratified and confirmed and shall remain in full force and effect according to their terms.  </font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">7.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Counterparts</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be an original, but all of which shall constitute one and the same instrument.  Delivery of executed counterparts of this Agreement by facsimile or other secure electronic format (.pdf) shall be effective as an original.</font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">8.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">GOVERNING LAW</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  THIS AGREEMENT AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.  </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">9.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Successors and Assigns</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">10.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Headings</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  The headings of the sections hereof are provided for convenience only and shall not in any way affect the meaning or construction of any provision of this Agreement.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">11.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Severability</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  If any provision of this Agreement is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Agreement shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions.  The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">signature pages follow</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#93;</font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered as of the date first above written.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">BORROWERS&#8217; REPRESENTATIVE&#58;&#160;&#160;WEST PHARMACEUTICAL SERVICES, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:216pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:216pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">ADMINISTRATIVE AGENT&#58;&#160;&#160;&#160;BANK OF AMERICA, N.A.,</font></div><div style="text-indent:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">as Administrative Agent</font></div><div style="text-indent:216pt;text-align:justify;"><font><br></font></div><div style="text-indent:216pt;text-align:justify;"><font><br></font></div><div style="text-indent:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:216pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:216pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:-144pt;padding-left:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">LENDERS&#58;&#160;&#160;&#160;BANK OF AMERICA, N.A., as a Lender, Swing Line Lender and an Issuing Lender</font></div><div style="text-indent:-144pt;padding-left:144pt;"><font><br></font></div><div style="text-indent:-144pt;padding-left:144pt;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="padding-left:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">JPMORGAN CHASE BANK, N.A., as a Lender</font></div><div style="padding-left:144pt;text-align:justify;"><font><br></font></div><div style="padding-left:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div style="text-indent:144pt;"><font><br></font></div><div style="text-indent:144pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">MUFG BANK, LTD., as a Lender</font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div style="text-indent:144pt;"><font><br></font></div><div style="text-indent:144pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Lender</font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div style="text-indent:144pt;"><font><br></font></div><div style="text-indent:144pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">HSBC BANK USA, NATIONAL ASSOCIATION, as a Lender</font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div style="text-indent:144pt;"><font><br></font></div><div style="text-indent:144pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">PNC BANK, NATIONAL ASSOCIATION, as a Lender and an Issuing Lender</font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div style="text-indent:144pt;"><font><br></font></div><div style="text-indent:144pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">U.S. BANK NATIONAL ASSOCIATION, as a Lender </font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font><br></font></div><div style="text-indent:144pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58; ________________________________</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;"><font><br></font></div><div id="i_0_39"></div><div style="text-align:center;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-indent:36pt;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration: underline;">Schedule 1.01</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Lender and commitment Information</font></div><div><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"><tr><td style="width:1.0%;"></td><td style="width:18.450%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:16.840%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:17.323%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:18.289%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:19.098%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#e7e6e6;text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Lender</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#e7e6e6;text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revolving Credit Commitment</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#e7e6e6;text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitment Percentage of Revolving Credit Commitments</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#e7e6e6;text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Incremental Term A Loan Commitment</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#e7e6e6;text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitment Percentage of Incremental Term A Loan Commitments</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Bank of America, N.A.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$75,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$22,500,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.000000000%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">JPMorgan Chase Bank, N.A.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$45,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$13,500,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.000000000%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MUFG Bank, Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$45,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$13,500,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.000000000%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wells Fargo Bank, National Association</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$45,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$13,500,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.000000000%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">HSBC Bank USA, National Association</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$30,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.000000000%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PNC Bank, National Association</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$30,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.000000000%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Bank National Association</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$30,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$9,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.000000000%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total&#58;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$300,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.000000000%</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$90,000,000.00</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><font style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.000000000%</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div id="i_0_47"></div><div style="text-align:center;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">EXHIBIT C</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">&#91;FORM OF&#93;</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">NOTICE OF BORROWING</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">TO&#58;&#160;BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">FROM&#58;&#160;WEST PHARMACEUTICAL SERVICES, INC.</font></div><div><font><br></font></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">RE&#58;&#160;Credit Agreement (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), dated as of March 28, 2019 by and among West Pharmaceutical Services, Inc. (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Company</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), certain subsidiaries of the Company party thereto (together with the Company, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; and each a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Borrower</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender. Capitalized terms used but not defined herein shall have the meanings given to them in the Agreement.</font></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Pursuant to </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.01(c)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> or </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">2.04</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Agreement, as applicable, the undersigned hereby makes the following request&#58;</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">1.   This request is for (choose one)&#58;</font></div><div><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  A Borrowing of &#91;Revolver&#93;&#91;Incremental Term&#93; Loans</font></div><div style="text-indent:72pt;"><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  A Borrowing or &#91;U.S.&#93; &#91;Euro&#93; Swing Line Loans</font></div><div style="text-indent:72pt;"><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  A &#91;conversion&#93; or &#91;continuation&#93; of &#91;Revolver&#93;&#91;Incremental Term&#93; Loans</font></div><div style="text-indent:72pt;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">---</font></div><div style="text-align:center;"><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">1.&#160;On </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">                               </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">  (a Business Day)</font></div><div style="text-indent:72pt;"><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">2.&#160;In the amount of &#91;$&#93;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">                              </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> &#91;in the following currency&#58;  _______&#93;.</font></div><div style="text-indent:72pt;"><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">3.&#160;Comprised of&#58;&#160;&#9744;  Base Rate Loans</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  LIBOR Loans</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="text-indent:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">4.&#160;For LIBOR Loans&#58;  with an Interest Period of __ month&#91;s&#93;.</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">5.&#160;On behalf of ____________________________ </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">&#91;insert name of applicable Borrower&#93;</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;With respect to such Borrowing, the Borrowers&#8217; Representative hereby represents and warrants that &#91;(i) such request complies with the requirements of </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.01</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement&#93;</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"> 1</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and (ii) each of the conditions set forth in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 4.02</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement has been satisfied on and as of the date of such Borrowing.&#93;</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">2</sup></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;With respect to such Borrowing of Swing Line Loans, the Borrowers&#8217; Representative hereby represents and warrants that (i) such request complies with the requirements of the first proviso to the first sentence of </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.01(c) </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">or </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">2.01 (d)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement, as applicable and (ii) each of the conditions set forth in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 4.02</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement has been satisfied on and as of the date of such Borrowing of Swing Line Loans.&#93;</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">3</sup></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">&#91;signature page follow&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;vertical-align:top;">1</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;"> Include for Borrowings of Revolver Loans.</font></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;vertical-align:top;">2</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;"> Include for Borrowings.</font></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;vertical-align:top;">3</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;"> Include for Borrowings of Swing Line Loans.</font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The undersigned certifies to the accuracy of the foregoing.</font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;"><font><br></font></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"></td><td style="width:46.070%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:49.930%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date&#58;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">WEST PHARMACEUTICAL SERVICES, INC.,</font></div><div style="text-indent:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">as Borrowers&#8217; Representative</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________</font></div><div style="text-indent:18.4pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58;</font></div><div style="text-indent:18.4pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58;</font></div></td></tr></table></div><div style="text-indent:36pt;"><font><br></font></div><div id="i_0_54"></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration: underline;">Exhibit I</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">&#91;FORM OF&#93;</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Notice of Loan Prepayment</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">TO&#58;&#160;&#160;Bank of America, N.A., as &#91;Administrative Agent&#93;&#91;Swing Line Lender&#93;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:-72pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">RE&#58;&#160;&#160;Credit Agreement, dated as of March 28, 2019 by and among West Pharmaceutical Services, Inc., a Pennsylvania corporation (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Company</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), certain subsidiaries of the Company party thereto, (together with the Company,</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;"> </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221; and each a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Borrower</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;), the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender (as amended, modified, extended, restated, replaced, or supplemented from time to time, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Credit Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8221;&#59; capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Credit Agreement)</font></div><div style="text-indent:-36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">DATE&#58;&#160;&#160;&#91;Date&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Borrower hereby notifies the Administrative Agent that on </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">_____________</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;vertical-align:top;">4</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;"> </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">pursuant to the terms of </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">Section 2.15</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> of the Credit Agreement, the undersigned intends to prepay&#47;repay the following Loans as more specifically set forth below&#58;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  Optional prepayment of &#91;Revolver&#93;&#91;Incremental Term&#93; Loans in the following amount(s)&#58;</font></div><div><font><br></font></div><div style="text-indent:108pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  LIBOR Loans&#58; $</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">                             </font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration: underline;vertical-align:top;">5</sup></div><div style="text-indent:216pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In the following Optional Currency&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">                            </font></div><div style="text-indent:144pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Applicable Interest Period&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">                                    </font></div><div><font><br></font></div><div style="text-indent:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  Base Rate Loans&#58;  $</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">                                  </font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;text-decoration: underline;vertical-align:top;">6</sup></div><div style="text-indent:180pt;"><font><br></font></div><div style="text-indent:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#9744;  Optional prepayment of Swing Line Loans in the following amount&#58; $</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration: underline;">                     </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Delivery of an executed counterpart of a signature page of this notice by fax transmission or other electronic mail transmission (e.g. &#8220;pdf&#8221; or &#8220;tif&#8221;) shall be effective as delivery of a manually executed counterpart of this notice.</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">signature page follows</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST PHARMACEUTICAL SERVICES, INC.,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">a Pennsylvania corporation</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST PHARMACEUTICAL SERVICES OF FLORIDA, INC.,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">a Florida corporation</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST PHARMACEUTICAL SERVICES GROUP LIMITED,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">an entity organized under the laws of England &#38; Wales</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST ANALYTICAL SERVICES, LLC,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">a Delaware limited liability company</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST PHARMACEUTICAL SERVICES OF DELAWARE, INC.,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">a Delaware corporation</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;TECH GROUP NORTH AMERICA, INC.,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">an Arizona corporation</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;TECH GROUP GRAND RAPIDS, INC.,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">a Delaware corporation</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST CONTRACT MANUFACTURING, LLC,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">a Delaware limited liability company</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST PHARMACEUTICAL SERVICES  DANMARK A&#47;S,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">an entity organized under the laws of Denmark</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST PHARMACEUTICAL SERVICES HOLDING GMBH,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">an entity organized under the laws of Germany</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#91;WEST PHARMACEUTICAL SERVICES SINGAPORE PTE. LTD.,</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">an entity organized under the laws of Singapore</font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font><br></font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">By&#58;_____________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Name&#58; __________________________________</font></div><div style="padding-left:180pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Title&#58; ___________________________________ &#93;</font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>ex21listofsubsidiaries.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_1"></div><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 21</font></div><div style="text-align:right;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">SUBSIDIARIES OF THE COMPANY</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:66.081%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.080%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.713%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:3.126%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Jurisdiction of </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;">Incorporation</font></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Stock </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;">Ownership</font></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pennsylvania</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Parent Co.</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Citation Plastics Co.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">New Jersey</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tech Group Europe Limited (dba West)</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tech Group Grand Rapids, Inc. (dba West)</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TGPR Holdings Limited</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">W.P.S.F. Limited</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">England</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">WD SG Pte. Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Singapore</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Analytical Services, LLC</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Contract Manufacturing, LLC</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharma. Services IL, Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Packaging (China) Company Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">China</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Packaging India Private Limited</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">India</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Products Ireland, Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Argentina S.A.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Argentina</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Asia, Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Taiwan</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Australia Pty. Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Australia</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services AZ, Inc.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Arizona</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Beograd d.o.o.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Serbia</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Brasil Ltda.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Brasil</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Colombia S.A.S.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Colombia</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Cornwall Limited</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">England</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Danmark A&#47;S</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Denmark</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Delaware Acquisition, Inc.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Deutschland GmbH Co KG</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services France S.A.S.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.9&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Group Limited</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">England</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Hispania S.A.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Spain</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holding Danmark ApS</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Denmark</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holding France SAS</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holding GmbH</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holding II GmbH</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holding Ireland North, Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holding Ireland South, Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holding Japan, GK</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japan</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Holdings Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Israel</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Italia S.r.L.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Italy</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Korea Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">South Korea</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Lakewood, Inc.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Normandie SAS</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services of Delaware, Inc.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services of Florida, Inc.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Florida</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Shanghai Medical Rubber Products Co., Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">China</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Singapore (Holding) Pte. Limited</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Singapore</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Singapore Pte. Ltd.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Singapore</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Venezuela C.A.</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">West Pharmaceutical Services Verwaltungs GmbH</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</font></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.0&#160;</font></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>5
<FILENAME>ex23consent2019.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_1"></div><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 23</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-133863 and 333-145186) and Form S-8 (No. 333-106977, 333-143129, 333-156492, 333-171453, 333-174153 and 333-211088) of West Pharmaceutical Services, Inc. of our report</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">dated February&#160;21, 2020 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font><sup style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Philadelphia, Pennsylvania</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">February&#160;21, 2020&#160;</font></div><div style="margin-bottom:12pt;"><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>ex311ceo302certificati.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_1"></div><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">EXHIBIT 31.1</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">CERTIFICATION</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, Eric M. Green, certify that&#58;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">I have reviewed this Annual Report on Form 10-K of West Pharmaceutical Services, Inc.&#59;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">&#47;s&#47; Eric M. Green           </font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Eric M. Green</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">President and Chief Executive Officer</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; February&#160;21, 2020 </font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>ex312cfo302certificati.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_1"></div><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">EXHIBIT 31.2</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">CERTIFICATION</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, Bernard J. Birkett, certify that&#58;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">I have reviewed this Annual Report on Form 10-K of West Pharmaceutical Services, Inc.&#59;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:-18pt;padding-left:72pt;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">b.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Bernard J. Birkett</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Senior Vice President and Chief Financial Officer</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; February&#160;21, 2020 </font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>ex321ceo906certificati.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_1"></div><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">EXHIBIT 32.1</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the Annual Report on Form 10-K of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended December&#160;31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Eric M. Green, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">&#47;s&#47; Eric M. Green</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Eric M. Green</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">President and Chief Executive Officer</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; February&#160;21, 2020</font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>ex322cfo906certificati.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i_0_1"></div><div style="height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">EXHIBIT 32.2</font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">AS ADOPTED PURSUANT TO SECTION 906 OF</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the Annual Report on Form 10-K of West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) for the period ended December&#160;31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Bernard J. Birkett, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">&#47;s&#47; Bernard J. Birkett</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Bernard J. Birkett</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Senior Vice President and Chief Financial Officer</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; February&#160;21, 2020</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>wst-20191231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b5520f3c-bdfb-4aa1-98ba-ba1f6a92b1c8,g:f267b37f-edf1-4d21-84ed-4e7cdfb1cf2c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:wst="http://www.westpharma.com/20191231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:link="http://www.xbrl.org/2003/linkbase" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.westpharma.com/20191231">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:element id="wst_YearAfter2019Member" abstract="true" name="YearAfter2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherEuropeCountriesMember" abstract="true" name="OtherEuropeCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" abstract="false" name="DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_VoluntaryRecallAbstract" abstract="true" name="VoluntaryRecallAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" abstract="false" name="DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_OtherExpenseIncomeAbstract" abstract="true" name="OtherExpenseIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" abstract="false" name="ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="wst_Year2023Member" abstract="true" name="Year2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_A2018RestructuringPlanMember" abstract="true" name="A2018RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ContractManufacturedCustomersMember" abstract="true" name="ContractManufacturedCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" abstract="false" name="EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="wst_ProprietaryProductsMember" abstract="true" name="ProprietaryProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_TermLoanDue2024Member" abstract="true" name="TermLoanDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_EmployeeStockPurchasePlanEsppMember" abstract="true" name="EmployeeStockPurchasePlanEsppMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_RevolvingCreditFacilityDue2017Member" abstract="true" name="RevolvingCreditFacilityDue2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" abstract="false" name="LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_ProvisionForProductReturns" abstract="false" name="ProvisionForProductReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_IWPharmaGroupLLCMember" abstract="true" name="IWPharmaGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" abstract="false" name="ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_AccruedSalariesWagesAndBenefitsCurrent" abstract="false" name="AccruedSalariesWagesAndBenefitsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_SeniorNotesDue2022Member" abstract="true" name="SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PharmaTapSADeCVMember" abstract="true" name="PharmaTapSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" abstract="true" name="ScheduleOfIntangibleAssetsByMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" abstract="false" name="TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DefinedBenefitPlanExpectedFutureBenefitPayments" abstract="false" name="DefinedBenefitPlanExpectedFutureBenefitPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" abstract="false" name="ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AssetImpairmentChargesPatentandEquipment" abstract="false" name="AssetImpairmentChargesPatentandEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_BalancedMutualFundMember" abstract="true" name="BalancedMutualFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" abstract="false" name="LegalMattersContingenciesAndLegalCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_ForwardTreasuryLockMember" abstract="true" name="ForwardTreasuryLockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" abstract="false" name="DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_StandardPackagingMember" abstract="true" name="StandardPackagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_A2016RestructuringPlanMemberMember" abstract="true" name="A2016RestructuringPlanMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherFinancialInstrumentsAbstract" abstract="true" name="OtherFinancialInstrumentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_AluplastSADeCVMember" abstract="true" name="AluplastSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_CashSettledStockAppreciationRIghtsOutstanding" abstract="false" name="CashSettledStockAppreciationRIghtsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_DeliveryDevicesMember" abstract="true" name="DeliveryDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" abstract="false" name="DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" abstract="false" name="ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" abstract="false" name="OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" abstract="false" name="ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_DevelopmentandlicensingincomeTable" abstract="true" name="DevelopmentandlicensingincomeTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="wst_YearAfter2023Member" abstract="true" name="YearAfter2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DaikyoSeikoLtdDaikyoMember" abstract="true" name="DaikyoSeikoLtdDaikyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_StockOptionAndAppreciationRightsMember" abstract="true" name="StockOptionAndAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_RevolvingCreditFacilityDue2024Member" abstract="true" name="RevolvingCreditFacilityDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_Revolvingcreditfacilitydue2020Member" abstract="true" name="Revolvingcreditfacilitydue2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_StockSettledStockAppreciationRightsOutstanding" abstract="false" name="StockSettledStockAppreciationRightsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" abstract="false" name="EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_ExpirationPeriodDomain" abstract="true" name="ExpirationPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_Developmentandlicensingincome" abstract="false" name="Developmentandlicensingincome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" abstract="false" name="DeferredCompensationArrangementWithIndividualNumberOfPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="wst_AssetImpairmentChargesPatent" abstract="false" name="AssetImpairmentChargesPatent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_Year2039Member" abstract="true" name="Year2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_Year2037Member" abstract="true" name="Year2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_ExpirationPeriodAxis" abstract="true" name="ExpirationPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" abstract="false" name="DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_TermLoanDue2024Domain" abstract="true" name="TermLoanDue2024Domain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherIncomeExpense" abstract="false" name="OtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_CashSettledPSUAwardsMember" abstract="true" name="CashSettledPSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PharmaCustomersMember" abstract="true" name="PharmaCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_Year2019Member" abstract="true" name="Year2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_HighValueComponentsMember" abstract="true" name="HighValueComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_MutualFundsMember" abstract="true" name="MutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_GenericsCustomersMember" abstract="true" name="GenericsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ContractManufacturedProductsMember" abstract="true" name="ContractManufacturedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ContractwithCustomerAssetIncreaseDecrease" abstract="false" name="ContractwithCustomerAssetIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ForwardStartInterestRateSwapMember" abstract="true" name="ForwardStartInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherSecuritiesMember" abstract="true" name="OtherSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DeferredStockUnitsPayableinCash" abstract="false" name="DeferredStockUnitsPayableinCash" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_Year2022Member" abstract="true" name="Year2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PensionandOtherPostretirementBenefitExpenseNet" abstract="false" name="PensionandOtherPostretirementBenefitExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ComputerHardwareAndSoftwareMember" abstract="true" name="ComputerHardwareAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_ContractsandLiabilitiesAbstract" abstract="true" name="ContractsandLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_CreditAvailableForIssuanceOfLettersOfCredit" abstract="false" name="CreditAvailableForIssuanceOfLettersOfCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_Year2020Member" abstract="true" name="Year2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PatentsAndLicensingMember" abstract="true" name="PatentsAndLicensingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_RevenueAbstract" abstract="true" name="RevenueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PensionPlanAssetsInTheFairValueHierarchyMember" abstract="true" name="PensionPlanAssetsInTheFairValueHierarchyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_SupplyChainFinancingAbstract" abstract="true" name="SupplyChainFinancingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_EuroDenominatedRevolverMember" abstract="true" name="EuroDenominatedRevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_CorporateAndEliminationsMember" abstract="true" name="CorporateAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_SalesToEquityMethodInvestees" abstract="false" name="SalesToEquityMethodInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PensionplanassetsmeasuredatNAVMember" abstract="true" name="PensionplanassetsmeasuredatNAVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="wst_NotesPayableAndOtherDebtCurrent" abstract="false" name="NotesPayableAndOtherDebtCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AssetRelatedChargesMember" abstract="true" name="AssetRelatedChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_CreditFacilityIsAvailableForSwingLineLoans" abstract="false" name="CreditFacilityIsAvailableForSwingLineLoans" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AssetsDefinedBenefitPlansNoncurrent" abstract="false" name="AssetsDefinedBenefitPlansNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_LeaseOperatingLeaseTerminateTerm" abstract="false" name="LeaseOperatingLeaseTerminateTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="wst_DevelopmentandlicensingincomeLineItems" abstract="true" name="DevelopmentandlicensingincomeLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_NotePayableDue2019Member" abstract="true" name="NotePayableDue2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="wst_IndexedMutualFundsMember" abstract="true" name="IndexedMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_RatioOfDebtToEBITDA" abstract="false" name="RatioOfDebtToEBITDA" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="wst_OtherCurrentLiabilitiesAbstract" abstract="true" name="OtherCurrentLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_StockSettledPSUAwardsMember" abstract="true" name="StockSettledPSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_WestCompanyMexicoSADeCVMember" abstract="true" name="WestCompanyMexicoSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_SeniorCNotesDue2027Member" abstract="true" name="SeniorCNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DebtYenDenominatedMember" abstract="true" name="DebtYenDenominatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" abstract="true" name="PerformanceVestingSharesOrUnitsDividendEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_Year2038Member" abstract="true" name="Year2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_SmartDoseMember" abstract="true" name="SmartDoseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" abstract="false" name="PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementwithIndividualConversionUnit" abstract="false" name="DeferredCompensationArrangementwithIndividualConversionUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_SeniorBNotesDue2024Member" abstract="true" name="SeniorBNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_AssetImpairmentChargesTrademark" abstract="false" name="AssetImpairmentChargesTrademark" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" abstract="true" name="AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_NetSalesMember" abstract="true" name="NetSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_IncentiveStockAwardsMember" abstract="true" name="IncentiveStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_WeightedAverageSharesOutstandingAbstract" abstract="true" name="WeightedAverageSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="wst_LineofCreditFacilityAdditionalBorrowingCapacity" abstract="false" name="LineofCreditFacilityAdditionalBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_InternationalMutualFundsMember" abstract="true" name="InternationalMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" abstract="false" name="DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_BiologicsCustomersMember" abstract="true" name="BiologicsCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" abstract="false" name="DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="wst_PharmaRubberSADeCVMember" abstract="true" name="PharmaRubberSADeCVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" abstract="false" name="ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" abstract="false" name="TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.westpharma.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical">
        <link:definition>1003004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1005006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>2404401 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingStandards" roleURI="http://www.westpharma.com/role/NewAccountingStandards">
        <link:definition>2105102 - Disclosure - New Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingStandardsDetails" roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails">
        <link:definition>2406402 - Disclosure - New Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenue" roleURI="http://www.westpharma.com/role/RevenueRevenue">
        <link:definition>2107103 - Disclosure - Revenue Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenueTables" roleURI="http://www.westpharma.com/role/RevenueRevenueTables">
        <link:definition>2308302 - Disclosure - Revenue Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueAdoptionofASC606Details" roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details">
        <link:definition>2409403 - Disclosure - Revenue Adoption of ASC 606 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenueRecognitionDetails" roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails">
        <link:definition>2410404 - Disclosure - Revenue Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractsAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails">
        <link:definition>2411405 - Disclosure - Revenue Contracts Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSupplyChainFinancingDetails" roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails">
        <link:definition>2412406 - Disclosure - Revenue Supply Chain Financing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueVoluntaryRecallDetails" roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails">
        <link:definition>2413407 - Disclosure - Revenue Voluntary Recall (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.westpharma.com/role/NetIncomePerShare">
        <link:definition>2114104 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.westpharma.com/role/NetIncomePerShareTables">
        <link:definition>2315303 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails" roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails">
        <link:definition>2416408 - Disclosure - Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment">
        <link:definition>2117105 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables">
        <link:definition>2318304 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails">
        <link:definition>2419409 - Disclosure - Property, Plant and Equipment (Property, Plant and Equipment, Gross) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTextualsDetails" roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails">
        <link:definition>2420410 - Disclosure - Property, Plant and Equipment (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.westpharma.com/role/Leases">
        <link:definition>2121106 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.westpharma.com/role/LeasesTables">
        <link:definition>2322305 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdoptionofASC842Details" roleURI="http://www.westpharma.com/role/AdoptionofASC842Details">
        <link:definition>2423411 - Disclosure - Adoption of ASC 842 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeaseCostDetails" roleURI="http://www.westpharma.com/role/LeaseCostDetails">
        <link:definition>2424412 - Disclosure - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeaseCashFlowandSupplementalInformationDetails" roleURI="http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails">
        <link:definition>2425413 - Disclosure - Lease Cash Flow and Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeaseWeightedAverageDetail" roleURI="http://www.westpharma.com/role/LeaseWeightedAverageDetail">
        <link:definition>2426414 - Disclosure - Lease Weighted Average (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>2427415 - Disclosure - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompanies" roleURI="http://www.westpharma.com/role/AffiliatedCompanies">
        <link:definition>2128107 - Disclosure - Affiliated Companies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesTables" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables">
        <link:definition>2329306 - Disclosure - Affiliated Companies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesDetails" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails">
        <link:definition>2430416 - Disclosure - Affiliated Companies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AffiliatedCompaniesTextualsDetails" roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails">
        <link:definition>2431417 - Disclosure - Affiliated Companies (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets">
        <link:definition>2132108 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>2333307 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails">
        <link:definition>2434418 - Disclosure - Goodwill and Intangible Assets (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails">
        <link:definition>2435419 - Disclosure - Goodwill and Intangible Assets (Intangible Assets by Major Class) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTextualsDetails" roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails">
        <link:definition>2436420 - Disclosure - Goodwill and Intangible Assets (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilities" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities">
        <link:definition>2137109 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesTables" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables">
        <link:definition>2338308 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesDetails" roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails">
        <link:definition>2439421 - Disclosure - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.westpharma.com/role/Debt">
        <link:definition>2140110 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.westpharma.com/role/DebtTables">
        <link:definition>2341309 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.westpharma.com/role/DebtDetails">
        <link:definition>2442422 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTextualsDetails" roleURI="http://www.westpharma.com/role/DebtTextualsDetails">
        <link:definition>2443423 - Disclosure - Debt (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments">
        <link:definition>2144111 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>2345310 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTextualsDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails">
        <link:definition>2446424 - Disclosure - Derivative Financial Instruments (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails" roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails">
        <link:definition>2447425 - Disclosure - Derivative Financial Instruments (Effects of Derivative Instruments Designated as Hedges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.westpharma.com/role/FairValueMeasurements">
        <link:definition>2148112 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables">
        <link:definition>2349311 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails">
        <link:definition>2450426 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails">
        <link:definition>2451427 - Disclosure - Fair Value Measurements (Changes in Level 3 Fair Value Measurements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsOtherFinancialInstrumentsDetails" roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails">
        <link:definition>2452428 - Disclosure - Fair Value Measurements Other Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2153113 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2354312 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComponentsofAOCIDetails" roleURI="http://www.westpharma.com/role/ComponentsofAOCIDetails">
        <link:definition>2455429 - Disclosure - (Components of AOCI) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReclassificationsAOCIDetails" roleURI="http://www.westpharma.com/role/ReclassificationsAOCIDetails">
        <link:definition>2456430 - Disclosure - (Reclassifications AOCI) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.westpharma.com/role/StockBasedCompensation">
        <link:definition>2157114 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.westpharma.com/role/StockBasedCompensationTables">
        <link:definition>2358313 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTextualsDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationTextualsDetails">
        <link:definition>2459431 - Disclosure - Stock-Based Compensation (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails">
        <link:definition>2460432 - Disclosure - Stock-Based Compensation (Allocation of Share-based Compensation Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionsActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails">
        <link:definition>2461433 - Disclosure - Stock-Based Compensation (Stock Options Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockAppreciationRightsAwardActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails">
        <link:definition>2462434 - Disclosure - Stock-Based Compensation (Stock Appreciation Rights Award Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails">
        <link:definition>2463435 - Disclosure - Stock-Based Compensation (Nonvested Performance-based Award Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.westpharma.com/role/BenefitPlans">
        <link:definition>2164115 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.westpharma.com/role/BenefitPlansTables">
        <link:definition>2365314 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTextualsDetails" roleURI="http://www.westpharma.com/role/BenefitPlansTextualsDetails">
        <link:definition>2466436 - Disclosure - Benefit Plans (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>2467437 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails">
        <link:definition>2468438 - Disclosure - Benefit Plans (Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAmountsRecognizedinBalanceSheetDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails">
        <link:definition>2469439 - Disclosure - Benefit Plans (Amounts Recognized in Balance Sheet) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
        <link:definition>2470440 - Disclosure - Benefit Plans (Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansExpectedBenefitPaymentsDetails" roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails">
        <link:definition>2471441 - Disclosure - Benefit Plans (Expected Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAssumptionsUsedDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails">
        <link:definition>2472442 - Disclosure - Benefit Plans (Assumptions Used) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAllocationofPlanAssetsDetails" roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails">
        <link:definition>2473443 - Disclosure - Benefit Plans (Allocation of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpense" roleURI="http://www.westpharma.com/role/OtherExpense">
        <link:definition>2174116 - Disclosure - Other Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseTables" roleURI="http://www.westpharma.com/role/OtherExpenseTables">
        <link:definition>2375315 - Disclosure - Other Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseDetails" roleURI="http://www.westpharma.com/role/OtherExpenseDetails">
        <link:definition>2476444 - Disclosure - Other Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseRestructuringandRelatedChargesDetails" roleURI="http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails">
        <link:definition>2477445 - Disclosure - Other Expense Restructuring and Related Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseOtherItemsTextualsDetails" roleURI="http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails">
        <link:definition>2478446 - Disclosure - Other Expense Other Items (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherExpenseDevelopmentandLicensingIncomeDetails" roleURI="http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails">
        <link:definition>2479447 - Disclosure - Other Expense Development and Licensing Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.westpharma.com/role/IncomeTaxes">
        <link:definition>2180117 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.westpharma.com/role/IncomeTaxesTables">
        <link:definition>2381316 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTextualsDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesTextualsDetails">
        <link:definition>2482448 - Disclosure - Income Taxes (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>2483449 - Disclosure - Income Taxes (Unrecognized Tax Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeIncomeTaxesDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails">
        <link:definition>2484450 - Disclosure - Income Taxes (Income Before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails">
        <link:definition>2485451 - Disclosure - Income Taxes (Components of Income Tax Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2486452 - Disclosure - Income Taxes (Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveIncomeTaxReconciliationDetails" roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails">
        <link:definition>2487453 - Disclosure - Income Taxes (Effective Income Tax Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.westpharma.com/role/CommitmentsandContingencies">
        <link:definition>2188118 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTextualsDetails" roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails">
        <link:definition>2489454 - Disclosure - Commitments and Contingencies (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.westpharma.com/role/SegmentInformation">
        <link:definition>2190119 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.westpharma.com/role/SegmentInformationTables">
        <link:definition>2391317 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTextualsDetails" roleURI="http://www.westpharma.com/role/SegmentInformationTextualsDetails">
        <link:definition>2492455 - Disclosure - Segment Information (Textuals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSalesbyProductGroupDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails">
        <link:definition>2493456 - Disclosure - Segment Information (Sales by Product Group) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSalesandPPEbyGeographicLocationDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails">
        <link:definition>2494457 - Disclosure - Segment Information (Sales and PPE by Geographic Location) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentFinancialInformationDetails" roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails">
        <link:definition>2495458 - Disclosure - Segment Information (Segment Financial Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsNotes" roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes">
        <link:definition>2196120 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsDetails" roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails">
        <link:definition>2497459 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>wst-20191231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b5520f3c-bdfb-4aa1-98ba-ba1f6a92b1c8,g:f267b37f-edf1-4d21-84ed-4e7cdfb1cf2c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="wst-20191231.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DocumentandEntityInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_638579db-4cbf-4faf-8d24-58c894138073" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f5590503-b44f-4afb-905d-946d9c283505" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_638579db-4cbf-4faf-8d24-58c894138073" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f5590503-b44f-4afb-905d-946d9c283505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_85a3118f-b246-4f0e-98fc-359826bb576a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_638579db-4cbf-4faf-8d24-58c894138073" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_85a3118f-b246-4f0e-98fc-359826bb576a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5c074b8f-9cdd-42bb-81dc-f04ab7cec75e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_638579db-4cbf-4faf-8d24-58c894138073" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5c074b8f-9cdd-42bb-81dc-f04ab7cec75e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0a610450-a0c4-4bfb-bf63-d18010a9881b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_86f8993a-0817-4413-b3c7-9b3c89680183" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0a610450-a0c4-4bfb-bf63-d18010a9881b" xlink:to="loc_us-gaap_Revenues_86f8993a-0817-4413-b3c7-9b3c89680183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a3116baa-d8fb-4882-90d2-70364a43043f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0a610450-a0c4-4bfb-bf63-d18010a9881b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a3116baa-d8fb-4882-90d2-70364a43043f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_555b4c89-71d8-4320-9e57-8ca487158af5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b27fdbb8-4bd1-4105-b761-3a8d98ddf018" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_555b4c89-71d8-4320-9e57-8ca487158af5" xlink:to="loc_us-gaap_OperatingIncomeLoss_b27fdbb8-4bd1-4105-b761-3a8d98ddf018" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ecd1e606-bfab-405a-b9f1-9d3dc3ea7677" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_555b4c89-71d8-4320-9e57-8ca487158af5" xlink:to="loc_us-gaap_InterestExpense_ecd1e606-bfab-405a-b9f1-9d3dc3ea7677" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_52da5db2-f2fa-4823-9308-3fe427abc1b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_555b4c89-71d8-4320-9e57-8ca487158af5" xlink:to="loc_us-gaap_InvestmentIncomeNet_52da5db2-f2fa-4823-9308-3fe427abc1b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f7e590ea-6b14-4a7b-98a9-d63ca1f6e507" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_555b4c89-71d8-4320-9e57-8ca487158af5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f7e590ea-6b14-4a7b-98a9-d63ca1f6e507" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9a88ae21-09b0-4109-bcc8-35de8c011dba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f35814ff-6323-4687-973c-8a1e85a57e55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a88ae21-09b0-4109-bcc8-35de8c011dba" xlink:to="loc_us-gaap_GrossProfit_f35814ff-6323-4687-973c-8a1e85a57e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f114b383-17fc-4661-9af9-d2306af86554" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a88ae21-09b0-4109-bcc8-35de8c011dba" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f114b383-17fc-4661-9af9-d2306af86554" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_729c56ca-857c-4a15-bc47-546a84f9c5e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a88ae21-09b0-4109-bcc8-35de8c011dba" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_729c56ca-857c-4a15-bc47-546a84f9c5e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_d1971104-7621-41fc-9e69-7650ce45e85c" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a88ae21-09b0-4109-bcc8-35de8c011dba" xlink:to="loc_wst_OtherIncomeExpense_d1971104-7621-41fc-9e69-7650ce45e85c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f274de62-a739-495d-abbe-b8c5e83c39e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3e1a9959-8d9d-4577-9c83-7770fcad79f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f274de62-a739-495d-abbe-b8c5e83c39e1" xlink:to="loc_us-gaap_ProfitLoss_3e1a9959-8d9d-4577-9c83-7770fcad79f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7a83498-5c2d-455b-9871-a5f60fe703e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f274de62-a739-495d-abbe-b8c5e83c39e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c7a83498-5c2d-455b-9871-a5f60fe703e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_18a98a87-39f8-4986-a2d4-5fbdf902f741" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_18a98a87-39f8-4986-a2d4-5fbdf902f741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_26c5219f-1efe-45cb-ab99-beff21f8a960" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_26c5219f-1efe-45cb-ab99-beff21f8a960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_7f144b95-a75c-43f5-8a82-f127ccce14e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_7f144b95-a75c-43f5-8a82-f127ccce14e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax_707cb216-4f2c-4aa1-a6d7-e017155560ec" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax_707cb216-4f2c-4aa1-a6d7-e017155560ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_117f78df-8f02-4e6e-881c-dc03a67a1229" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_117f78df-8f02-4e6e-881c-dc03a67a1229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_e9ca5e83-b8b9-4b37-b475-7104e0fb85ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_e9ca5e83-b8b9-4b37-b475-7104e0fb85ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_d891126f-3628-43be-a43d-8045e45aa44c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_d891126f-3628-43be-a43d-8045e45aa44c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c6d23a01-2b7c-42a8-b150-0a4d94c30bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c6d23a01-2b7c-42a8-b150-0a4d94c30bb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8b0292e5-0df4-4b93-aa22-7e2be4cf5b33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3bf4fd35-39c3-48a3-9e54-a693cae371fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8b0292e5-0df4-4b93-aa22-7e2be4cf5b33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ea801b67-f767-474c-b279-fca3d8f433ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e04696d9-fd62-4039-ad11-03d0bd72f586" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ea801b67-f767-474c-b279-fca3d8f433ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e04696d9-fd62-4039-ad11-03d0bd72f586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fd6c40c1-4143-4bf4-b974-d1a223cc5d89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ea801b67-f767-474c-b279-fca3d8f433ee" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fd6c40c1-4143-4bf4-b974-d1a223cc5d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a7f4d0e2-a987-4569-92a6-b161bfd378c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_591e68f2-3896-4a0a-a6b2-bce956e17ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a7f4d0e2-a987-4569-92a6-b161bfd378c2" xlink:to="loc_us-gaap_Liabilities_591e68f2-3896-4a0a-a6b2-bce956e17ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_46f4ece9-e27a-474d-a642-cf62668aa51c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a7f4d0e2-a987-4569-92a6-b161bfd378c2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_46f4ece9-e27a-474d-a642-cf62668aa51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_94350fa0-3235-452f-9f7b-a1d25b3c0a54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a7f4d0e2-a987-4569-92a6-b161bfd378c2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_94350fa0-3235-452f-9f7b-a1d25b3c0a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_112eb485-cf4a-4b50-9db6-d41c0e9affd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_112eb485-cf4a-4b50-9db6-d41c0e9affd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_85a6248c-e34d-463f-ae42-e323bfa7cb38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:to="loc_us-gaap_AccountsPayableCurrent_85a6248c-e34d-463f-ae42-e323bfa7cb38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_79fd3e6f-d4a5-413b-8a1e-71d6152fc81b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_79fd3e6f-d4a5-413b-8a1e-71d6152fc81b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_9f8ab6df-452d-4a0a-8f7e-93a918e8f783" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_9f8ab6df-452d-4a0a-8f7e-93a918e8f783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_afb86d79-2e8b-4d7d-a3f1-d96a71f1d84e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_afb86d79-2e8b-4d7d-a3f1-d96a71f1d84e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_72beeb4f-d4de-460c-bbc6-4fc6ff1af7c3" xlink:href="wst-20191231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_72beeb4f-d4de-460c-bbc6-4fc6ff1af7c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_e4859aa2-24ab-4c2c-9ff5-044ecd59c360" xlink:href="wst-20191231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f1997b86-06d8-468e-998c-36b848c81ca7" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_e4859aa2-24ab-4c2c-9ff5-044ecd59c360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b4f2bd33-f73e-468f-9637-91d8d1ed86b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca7e230b-08ed-4c50-bb10-5eb242a9ff39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b4f2bd33-f73e-468f-9637-91d8d1ed86b0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca7e230b-08ed-4c50-bb10-5eb242a9ff39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_39318035-9cfd-4f47-b72b-fbe8ac0bdef8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b4f2bd33-f73e-468f-9637-91d8d1ed86b0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_39318035-9cfd-4f47-b72b-fbe8ac0bdef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_814bc168-6ade-4a2e-8a4b-c12fe669e525" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b4f2bd33-f73e-468f-9637-91d8d1ed86b0" xlink:to="loc_us-gaap_InventoryNet_814bc168-6ade-4a2e-8a4b-c12fe669e525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a118d55b-8203-41f1-bfa7-988b5a645a68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b4f2bd33-f73e-468f-9637-91d8d1ed86b0" xlink:to="loc_us-gaap_OtherAssetsCurrent_a118d55b-8203-41f1-bfa7-988b5a645a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c23c4004-b6b3-498d-a2ed-2fd76c352d22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_df1f8ce9-7824-49e2-91c0-31415290074c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c23c4004-b6b3-498d-a2ed-2fd76c352d22" xlink:to="loc_us-gaap_LiabilitiesCurrent_df1f8ce9-7824-49e2-91c0-31415290074c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_92b7e740-cb7e-452a-aad4-aeada01e6469" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c23c4004-b6b3-498d-a2ed-2fd76c352d22" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_92b7e740-cb7e-452a-aad4-aeada01e6469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_f4e7bb0c-311a-4caa-89cb-67dac88beb9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c23c4004-b6b3-498d-a2ed-2fd76c352d22" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_f4e7bb0c-311a-4caa-89cb-67dac88beb9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_52aa0e96-3891-471d-99d9-9c45bd42b1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c23c4004-b6b3-498d-a2ed-2fd76c352d22" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_52aa0e96-3891-471d-99d9-9c45bd42b1aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c3b3d0c6-8efc-416c-898b-1453bee66f89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c23c4004-b6b3-498d-a2ed-2fd76c352d22" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c3b3d0c6-8efc-416c-898b-1453bee66f89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_006d2c80-8702-4401-88ff-ef53f140179d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c23c4004-b6b3-498d-a2ed-2fd76c352d22" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_006d2c80-8702-4401-88ff-ef53f140179d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_aa686dc1-2ef3-4d1a-bc07-1d0dbfc69073" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:to="loc_us-gaap_AssetsCurrent_aa686dc1-2ef3-4d1a-bc07-1d0dbfc69073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_72e76c38-039a-4d65-aa22-d45e5b0c017b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_72e76c38-039a-4d65-aa22-d45e5b0c017b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1191b10e-55db-451e-90f5-678ef15e87cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1191b10e-55db-451e-90f5-678ef15e87cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a5b44880-8dfd-407c-b9b4-ab8a62911ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:to="loc_us-gaap_Goodwill_a5b44880-8dfd-407c-b9b4-ab8a62911ff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetNoncurrent_15fef924-b449-4192-a66e-cb6c9adf0457" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:to="loc_us-gaap_DeferredTaxAssetsNetNoncurrent_15fef924-b449-4192-a66e-cb6c9adf0457" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_79932c6a-229c-48b7-8150-ef4f904357d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_79932c6a-229c-48b7-8150-ef4f904357d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7aa33801-734f-47c6-9eb6-d050cd978b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8b754d6e-3c4e-43b0-9d66-22494a511531" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7aa33801-734f-47c6-9eb6-d050cd978b0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_382c93a9-8ed8-48c1-b4db-7d6acac1164f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a3d21a16-ec33-4ad4-beec-4877e8e8708a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_382c93a9-8ed8-48c1-b4db-7d6acac1164f" xlink:to="loc_us-gaap_PreferredStockValue_a3d21a16-ec33-4ad4-beec-4877e8e8708a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7d39509c-ac5d-4ac0-b172-0e8f4e5390e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_382c93a9-8ed8-48c1-b4db-7d6acac1164f" xlink:to="loc_us-gaap_CommonStockValue_7d39509c-ac5d-4ac0-b172-0e8f4e5390e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ea32df1b-eb77-47cc-8b04-2cc8bd52b228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_382c93a9-8ed8-48c1-b4db-7d6acac1164f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ea32df1b-eb77-47cc-8b04-2cc8bd52b228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5491669a-76ab-4164-934a-3844690fb2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_382c93a9-8ed8-48c1-b4db-7d6acac1164f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5491669a-76ab-4164-934a-3844690fb2c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_45dc4cf3-c1e2-4bc3-9f47-08782d749b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_382c93a9-8ed8-48c1-b4db-7d6acac1164f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_45dc4cf3-c1e2-4bc3-9f47-08782d749b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_bf0cae62-e708-4669-aa08-54677c2054c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_382c93a9-8ed8-48c1-b4db-7d6acac1164f" xlink:to="loc_us-gaap_TreasuryStockValue_bf0cae62-e708-4669-aa08-54677c2054c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_7c520610-6131-4388-b404-b9715baa31e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_7c520610-6131-4388-b404-b9715baa31e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_40cf2ebd-b8f6-4ad6-adc1-188c3166d3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_40cf2ebd-b8f6-4ad6-adc1-188c3166d3dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_218fb964-8afa-40b5-ae89-aad55b29ffd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_218fb964-8afa-40b5-ae89-aad55b29ffd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_92035adc-e4f3-44c7-ac27-33f2fc7af8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_92035adc-e4f3-44c7-ac27-33f2fc7af8c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_e2999874-a4af-4782-9487-9cf45cfc8163" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_e2999874-a4af-4782-9487-9cf45cfc8163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d37f13c0-433e-49e7-b4e9-f10c120573ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d37f13c0-433e-49e7-b4e9-f10c120573ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7baec40f-6232-47fa-b193-eca3f01ddf81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7baec40f-6232-47fa-b193-eca3f01ddf81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2a18e86c-cb69-4f72-be1b-19727e6507ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2a18e86c-cb69-4f72-be1b-19727e6507ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_5254674d-240f-43b8-8487-9ba03bc27552" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_5254674d-240f-43b8-8487-9ba03bc27552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b6bf1d06-ca16-4da4-905e-8057fd9b9d73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e0d088d-f588-4630-b1c2-63559370f200" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b6bf1d06-ca16-4da4-905e-8057fd9b9d73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb3eec-2cd4-4e14-a0a9-a30762fb3a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4a0b7e39-39f5-4e6f-8466-e235c312ef7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb3eec-2cd4-4e14-a0a9-a30762fb3a2a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4a0b7e39-39f5-4e6f-8466-e235c312ef7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_9681aaf2-de14-4a90-9d64-64f43d69d887" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb3eec-2cd4-4e14-a0a9-a30762fb3a2a" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_9681aaf2-de14-4a90-9d64-64f43d69d887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e4a200b5-1435-498f-9862-a9ac6272a557" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb3eec-2cd4-4e14-a0a9-a30762fb3a2a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e4a200b5-1435-498f-9862-a9ac6272a557" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_38ef6e31-901f-45b7-bda1-36bac9f43dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb3eec-2cd4-4e14-a0a9-a30762fb3a2a" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_38ef6e31-901f-45b7-bda1-36bac9f43dc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3daef016-55d7-463e-88a5-61f539fda895" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3deb3eec-2cd4-4e14-a0a9-a30762fb3a2a" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3daef016-55d7-463e-88a5-61f539fda895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5411aa99-4e41-4cac-b4ad-404c8b340e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_ProfitLoss_5411aa99-4e41-4cac-b4ad-404c8b340e0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ca6b0769-c1ad-416c-b03a-d43b8a647e12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_Depreciation_ca6b0769-c1ad-416c-b03a-d43b8a647e12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_ff486fbf-1596-4c52-a90a-69b030cc2323" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_AdjustmentForAmortization_ff486fbf-1596-4c52-a90a-69b030cc2323" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9e00edf0-1eab-42e5-bc84-45c1693c2d85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_ShareBasedCompensation_9e00edf0-1eab-42e5-bc84-45c1693c2d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_d19963dc-9a1e-49be-adab-686319236de2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_d19963dc-9a1e-49be-adab-686319236de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_804f6ae3-6b5e-4ef1-9565-fcea0889d76d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_804f6ae3-6b5e-4ef1-9565-fcea0889d76d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_6a69b074-823c-4651-8568-9dd1259bc801" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_6a69b074-823c-4651-8568-9dd1259bc801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_b0d537dc-2333-4c64-b623-2c31ee0c4b56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_b0d537dc-2333-4c64-b623-2c31ee0c4b56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_7d07ea3b-72ef-464e-8cb0-e8f9a86cd2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_7d07ea3b-72ef-464e-8cb0-e8f9a86cd2f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9178d38a-e419-4b42-939a-08c055e7e723" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9178d38a-e419-4b42-939a-08c055e7e723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionandOtherPostretirementBenefitExpenseNet_fae6eb9d-8830-4bff-863e-fa3c9260488b" xlink:href="wst-20191231.xsd#wst_PensionandOtherPostretirementBenefitExpenseNet"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_wst_PensionandOtherPostretirementBenefitExpenseNet_fae6eb9d-8830-4bff-863e-fa3c9260488b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_28aaea84-c3a7-4d47-bbeb-098c1d242da4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_28aaea84-c3a7-4d47-bbeb-098c1d242da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0a9dc8e1-12f4-4560-9723-d1efda1d0070" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0a9dc8e1-12f4-4560-9723-d1efda1d0070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3397b97f-7f06-45f1-b639-e9267892a26d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3397b97f-7f06-45f1-b639-e9267892a26d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_a3eb783d-6698-4b3c-bec5-40d9e9b44762" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_a3eb783d-6698-4b3c-bec5-40d9e9b44762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b6d0d0d9-ebb6-42e0-9b40-2be59c228583" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b6d0d0d9-ebb6-42e0-9b40-2be59c228583" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d5f84633-0b55-4a51-bc72-c10790a41c40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35c27b03-9889-48ac-ae9b-e2992c1a38d5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d5f84633-0b55-4a51-bc72-c10790a41c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d7039a-4f0d-4cf1-8b88-422bd9b2413c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d7236b5-2aae-4cf3-8f8a-3ce5ea5c9a74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d7039a-4f0d-4cf1-8b88-422bd9b2413c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d7236b5-2aae-4cf3-8f8a-3ce5ea5c9a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec6b56a1-a9b8-42cb-ad6e-979c6b359133" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d7039a-4f0d-4cf1-8b88-422bd9b2413c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec6b56a1-a9b8-42cb-ad6e-979c6b359133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d33bee19-4f16-4653-94bb-726affdd6d64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d7039a-4f0d-4cf1-8b88-422bd9b2413c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d33bee19-4f16-4653-94bb-726affdd6d64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7cc7b776-862d-4b62-b6fa-1864e87593a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28d7039a-4f0d-4cf1-8b88-422bd9b2413c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7cc7b776-862d-4b62-b6fa-1864e87593a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5a8c3d17-1268-4200-bec4-38f62f176a31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9d4a79a2-0b97-4eb5-bbbb-9b6187ebee73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_5a8c3d17-1268-4200-bec4-38f62f176a31" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9d4a79a2-0b97-4eb5-bbbb-9b6187ebee73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_756dd2bb-c2df-4bd8-b040-de81c2353f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_5a8c3d17-1268-4200-bec4-38f62f176a31" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_756dd2bb-c2df-4bd8-b040-de81c2353f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_57080e04-0ee0-4364-8e3d-a7005f6aacc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_5a8c3d17-1268-4200-bec4-38f62f176a31" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_57080e04-0ee0-4364-8e3d-a7005f6aacc1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20191231.xsd#NewAccountingStandards"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#NewAccountingStandardsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenue" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenue"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueRevenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueTables" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenueTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueAdoptionofASC606Details"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueSupplyChainFinancingDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueVoluntaryRecallDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShare"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShareTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_05d43642-9316-4261-9156-fa6fdb000aba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d664e295-f11b-4281-ab08-294f33886321" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_05d43642-9316-4261-9156-fa6fdb000aba" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d664e295-f11b-4281-ab08-294f33886321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cca233ea-1828-451b-a02e-071377fccc89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_05d43642-9316-4261-9156-fa6fdb000aba" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cca233ea-1828-451b-a02e-071377fccc89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipment"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20191231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AdoptionofASC842Details" xlink:type="simple" xlink:href="wst-20191231.xsd#AdoptionofASC842Details"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AdoptionofASC842Details" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseCostDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_328d6f10-f70d-4ec2-9ea5-b2d41ad9360d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_018f4a56-8cba-41b3-beea-ccb5bd4d8791" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_328d6f10-f70d-4ec2-9ea5-b2d41ad9360d" xlink:to="loc_us-gaap_OperatingLeaseCost_018f4a56-8cba-41b3-beea-ccb5bd4d8791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_ff562303-c92e-46a1-aea6-b93db142af05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_328d6f10-f70d-4ec2-9ea5-b2d41ad9360d" xlink:to="loc_us-gaap_ShortTermLeaseCost_ff562303-c92e-46a1-aea6-b93db142af05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_4a89b56c-26eb-4152-98a5-0e51328df210" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_328d6f10-f70d-4ec2-9ea5-b2d41ad9360d" xlink:to="loc_us-gaap_VariableLeaseCost_4a89b56c-26eb-4152-98a5-0e51328df210" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseCashFlowandSupplementalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseWeightedAverageDetail" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseWeightedAverageDetail"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeaseWeightedAverageDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#MaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0e990470-a66a-4f84-adfa-51467fe41e0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_5e4dfff5-14d3-4a97-ada8-4f453b029b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0e990470-a66a-4f84-adfa-51467fe41e0d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_5e4dfff5-14d3-4a97-ada8-4f453b029b0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_8475befb-20e1-4505-a6d4-9764cd83760b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0e990470-a66a-4f84-adfa-51467fe41e0d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_8475befb-20e1-4505-a6d4-9764cd83760b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_a2ee56cb-fb9e-4841-aaf7-db11323ca310" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0e990470-a66a-4f84-adfa-51467fe41e0d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_a2ee56cb-fb9e-4841-aaf7-db11323ca310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9814006a-d0fd-47ef-b667-7ecd44887de3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0e990470-a66a-4f84-adfa-51467fe41e0d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9814006a-d0fd-47ef-b667-7ecd44887de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_30ed9760-0483-4b9c-b99a-5cbad4531050" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0e990470-a66a-4f84-adfa-51467fe41e0d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_30ed9760-0483-4b9c-b99a-5cbad4531050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_ed98fa16-a9e3-495a-a5bd-2202c0650e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0e990470-a66a-4f84-adfa-51467fe41e0d" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_ed98fa16-a9e3-495a-a5bd-2202c0650e2a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompanies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8f7ee5b-3383-4f2a-82d0-c64a9f464de3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1b53e152-d1be-451e-b308-9ae8db4c2ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8f7ee5b-3383-4f2a-82d0-c64a9f464de3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1b53e152-d1be-451e-b308-9ae8db4c2ccf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bd43f771-0268-4512-9709-19bd449eeaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8f7ee5b-3383-4f2a-82d0-c64a9f464de3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bd43f771-0268-4512-9709-19bd449eeaa3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilities"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20191231.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_15883976-c6fb-49fc-b2d7-255d4ca0a42c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_fea52083-fbd1-4d87-a109-db2ac80ee4da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_15883976-c6fb-49fc-b2d7-255d4ca0a42c" xlink:to="loc_us-gaap_DebtCurrent_fea52083-fbd1-4d87-a109-db2ac80ee4da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1ffa0f98-491e-48aa-a2e3-abc940d07d60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_15883976-c6fb-49fc-b2d7-255d4ca0a42c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1ffa0f98-491e-48aa-a2e3-abc940d07d60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9b145bda-9547-46b2-a6ba-1e6a9c419f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e19c8104-222c-432e-bafc-45f259e84b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9b145bda-9547-46b2-a6ba-1e6a9c419f0b" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_e19c8104-222c-432e-bafc-45f259e84b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_4ffcaef9-550b-4026-9b51-55c2df2454aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9b145bda-9547-46b2-a6ba-1e6a9c419f0b" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_4ffcaef9-550b-4026-9b51-55c2df2454aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_41cadb05-f833-43ab-ab6a-52e3874a1d89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9b145bda-9547-46b2-a6ba-1e6a9c419f0b" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_41cadb05-f833-43ab-ab6a-52e3874a1d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e9390598-8992-4983-a3d1-f3fd7b53bdb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9a07ad16-d827-49b2-82e1-1408d4b3ee9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e9390598-8992-4983-a3d1-f3fd7b53bdb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9a07ad16-d827-49b2-82e1-1408d4b3ee9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_0189e705-e780-4cc2-b593-f23a75a958ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e9390598-8992-4983-a3d1-f3fd7b53bdb2" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_0189e705-e780-4cc2-b593-f23a75a958ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_fffe9c3f-26ab-443e-9723-e30631fe9e14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e9390598-8992-4983-a3d1-f3fd7b53bdb2" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_fffe9c3f-26ab-443e-9723-e30631fe9e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f3156f6b-7f60-4d7a-bfc2-16c3ffe6b814" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e9390598-8992-4983-a3d1-f3fd7b53bdb2" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f3156f6b-7f60-4d7a-bfc2-16c3ffe6b814" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20191231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20191231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ComponentsofAOCIDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ComponentsofAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ComponentsofAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1a95b3fa-cf9f-4a41-b008-f9abc63ca2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_508c7bb7-7eb3-4c7b-addb-fd6c634ff11e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1a95b3fa-cf9f-4a41-b008-f9abc63ca2c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_508c7bb7-7eb3-4c7b-addb-fd6c634ff11e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1d649a43-081a-48aa-9faf-068631a50128" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1a95b3fa-cf9f-4a41-b008-f9abc63ca2c0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1d649a43-081a-48aa-9faf-068631a50128" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ReclassificationsAOCIDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ReclassificationsAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ReclassificationsAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_91a9dd83-631f-4d64-b848-6ddaeb7ef614" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_44cddfa8-17ad-47b1-b5aa-d78746ad1fac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_91a9dd83-631f-4d64-b848-6ddaeb7ef614" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_44cddfa8-17ad-47b1-b5aa-d78746ad1fac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3f2c11bb-823b-4518-af11-712832dc2995" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_91a9dd83-631f-4d64-b848-6ddaeb7ef614" xlink:to="loc_us-gaap_InterestExpense_3f2c11bb-823b-4518-af11-712832dc2995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_699aad6d-1893-4735-a7c6-fa5d89b12ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ee62851d-17d1-438a-a981-e1fd873df8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_699aad6d-1893-4735-a7c6-fa5d89b12ec4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ee62851d-17d1-438a-a981-e1fd873df8b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_eccdc419-7b0d-49fd-b169-51c1e7dfbb57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_699aad6d-1893-4735-a7c6-fa5d89b12ec4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_eccdc419-7b0d-49fd-b169-51c1e7dfbb57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlans"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d9d18a93-2996-43fb-9dbf-bc5938550f25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_3ed9c8e4-bd00-4d6f-80cb-d3d1ccd016d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d9d18a93-2996-43fb-9dbf-bc5938550f25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_3ed9c8e4-bd00-4d6f-80cb-d3d1ccd016d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_68ebde6e-2b9f-4e3e-9e2d-c65c279edb18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d9d18a93-2996-43fb-9dbf-bc5938550f25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_68ebde6e-2b9f-4e3e-9e2d-c65c279edb18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b4c7d4c5-9c89-4584-a894-97cc9853adaa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d9d18a93-2996-43fb-9dbf-bc5938550f25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b4c7d4c5-9c89-4584-a894-97cc9853adaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e0729ee1-2f71-418b-a268-a290acc89e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d9d18a93-2996-43fb-9dbf-bc5938550f25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e0729ee1-2f71-418b-a268-a290acc89e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_b658f9be-4768-46b3-a478-bb53e560bd83" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d9d18a93-2996-43fb-9dbf-bc5938550f25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_b658f9be-4768-46b3-a478-bb53e560bd83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_601ce08a-e9d9-4e8b-b598-2013dc1cdf5a" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d9d18a93-2996-43fb-9dbf-bc5938550f25" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_601ce08a-e9d9-4e8b-b598-2013dc1cdf5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_3be1fea9-5068-4b48-ba46-c22c847cc111" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_3be1fea9-5068-4b48-ba46-c22c847cc111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_cb6b6072-7e92-4c5f-9957-f5c1886c6bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_cb6b6072-7e92-4c5f-9957-f5c1886c6bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f4cf2196-02e7-4206-bdb5-0961e2b4f52c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f4cf2196-02e7-4206-bdb5-0961e2b4f52c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_9213eb02-c165-442e-a723-57cf0ac475c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_9213eb02-c165-442e-a723-57cf0ac475c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_801e7ea9-90ae-4f3c-ad4a-dc7238096a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_801e7ea9-90ae-4f3c-ad4a-dc7238096a9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_822516d4-e7ea-4c97-887a-cabebe4a0054" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_822516d4-e7ea-4c97-887a-cabebe4a0054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0300b991-1c1a-499f-aec4-f79b9b10d809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2033f716-936a-44a5-9a77-19918b1de278" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0300b991-1c1a-499f-aec4-f79b9b10d809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_019548c8-4f1a-4551-ae13-cd7d7a57e84a" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ce66764a-9c6b-4935-b1c3-7f52c6d3a46c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_019548c8-4f1a-4551-ae13-cd7d7a57e84a" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ce66764a-9c6b-4935-b1c3-7f52c6d3a46c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_fdfa71df-6188-487b-8e78-05aff97ffefb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_019548c8-4f1a-4551-ae13-cd7d7a57e84a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_fdfa71df-6188-487b-8e78-05aff97ffefb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_fc32a11f-0bc7-42ad-9696-6cb2218d0e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_81fdfe20-ed3f-4c7c-869a-0b3c145ae4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_fc32a11f-0bc7-42ad-9696-6cb2218d0e8e" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_81fdfe20-ed3f-4c7c-869a-0b3c145ae4cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ba78133-7674-40e1-b14c-60f0f4a35947" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_fc32a11f-0bc7-42ad-9696-6cb2218d0e8e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ba78133-7674-40e1-b14c-60f0f4a35947" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_be779755-a5d6-49cc-97ea-64e53279f68e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_74bfd72c-d888-4ea9-ba21-47d9c9296e70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_be779755-a5d6-49cc-97ea-64e53279f68e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_74bfd72c-d888-4ea9-ba21-47d9c9296e70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7792040c-a8f0-4738-8f56-99761a102d51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_be779755-a5d6-49cc-97ea-64e53279f68e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7792040c-a8f0-4738-8f56-99761a102d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_54b9a741-c54c-41a5-b4cf-b710647b44dd" xlink:href="wst-20191231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_be779755-a5d6-49cc-97ea-64e53279f68e" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_54b9a741-c54c-41a5-b4cf-b710647b44dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_57bbcd9a-d7f6-4a97-a9be-efe73b51c0c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2bd73c5e-aed4-49ad-9914-406c41f75c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_57bbcd9a-d7f6-4a97-a9be-efe73b51c0c9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2bd73c5e-aed4-49ad-9914-406c41f75c5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_bc39c5e8-fc53-4d01-8988-9f99bcb057c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_57bbcd9a-d7f6-4a97-a9be-efe73b51c0c9" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_bc39c5e8-fc53-4d01-8988-9f99bcb057c2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_c437cb50-9545-4a03-b982-e1197ec3dfcf" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2f9d7e59-e361-4403-b9c1-ba53a662094e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_c437cb50-9545-4a03-b982-e1197ec3dfcf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2f9d7e59-e361-4403-b9c1-ba53a662094e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_96ea4c01-4933-409e-b282-c4387686d43a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_c437cb50-9545-4a03-b982-e1197ec3dfcf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_96ea4c01-4933-409e-b282-c4387686d43a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e9847bd1-3cbe-43ac-8ba8-4a8ffc726f90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_c437cb50-9545-4a03-b982-e1197ec3dfcf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_e9847bd1-3cbe-43ac-8ba8-4a8ffc726f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7edd17f5-5453-49ce-aedf-5e2b063baf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_c437cb50-9545-4a03-b982-e1197ec3dfcf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7edd17f5-5453-49ce-aedf-5e2b063baf5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_1e8b852d-3600-4f97-84a3-925f491dc3ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_c437cb50-9545-4a03-b982-e1197ec3dfcf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_1e8b852d-3600-4f97-84a3-925f491dc3ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_720fd0a6-abad-4101-be8d-e4338b39d145" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_c437cb50-9545-4a03-b982-e1197ec3dfcf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_720fd0a6-abad-4101-be8d-e4338b39d145" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpense" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpense"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpense" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseTables" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_531a6682-26c8-40fa-92f3-02bd601f588c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_e7e5e3fc-d8d2-48ab-a4fd-0a5f4c76565e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_531a6682-26c8-40fa-92f3-02bd601f588c" xlink:to="loc_us-gaap_SeveranceCosts1_e7e5e3fc-d8d2-48ab-a4fd-0a5f4c76565e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b1280a97-2ba5-4a52-985a-ded68923d10b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_531a6682-26c8-40fa-92f3-02bd601f588c" xlink:to="loc_us-gaap_AssetImpairmentCharges_b1280a97-2ba5-4a52-985a-ded68923d10b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5b65f736-4efd-4d61-b043-22a0b800abd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_531a6682-26c8-40fa-92f3-02bd601f588c" xlink:to="loc_us-gaap_OtherRestructuringCosts_5b65f736-4efd-4d61-b043-22a0b800abd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_1fa65c60-cabf-43e1-88ff-0be1f0538429" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_1fa65c60-cabf-43e1-88ff-0be1f0538429" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_bba5a68b-f553-4ceb-91ce-82741d2569c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_bba5a68b-f553-4ceb-91ce-82741d2569c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_bf4e5ed5-b68a-48e9-ad30-78d57b0f8e43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_bf4e5ed5-b68a-48e9-ad30-78d57b0f8e43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3bfc2c18-4d16-40c8-9dfb-24faf050caa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3bfc2c18-4d16-40c8-9dfb-24faf050caa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Developmentandlicensingincome_7a58c783-0159-45a4-864b-9ee9226abe25" xlink:href="wst-20191231.xsd#wst_Developmentandlicensingincome"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:to="loc_wst_Developmentandlicensingincome_7a58c783-0159-45a4-864b-9ee9226abe25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c47117c3-d433-4a56-b194-2bede2c7e68a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c47117c3-d433-4a56-b194-2bede2c7e68a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_2b61a60d-ba14-4ec1-93c7-289005dc1fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_5137b961-f970-4fd2-b770-8246f2a295cb" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_2b61a60d-ba14-4ec1-93c7-289005dc1fed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseRestructuringandRelatedChargesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseOtherItemsTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseDevelopmentandLicensingIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_40c039e1-a237-45d7-ba5a-359c59c3580e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_69868157-cbf8-4cf6-ae17-a233fcae57e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_40c039e1-a237-45d7-ba5a-359c59c3580e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_69868157-cbf8-4cf6-ae17-a233fcae57e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4d522922-5356-4339-87b0-a1e5f11517bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_40c039e1-a237-45d7-ba5a-359c59c3580e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4d522922-5356-4339-87b0-a1e5f11517bb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2020dbdc-8e36-4fd9-9746-e8001f117a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4dd0b8b7-a884-4620-a0cd-23cd149001ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2020dbdc-8e36-4fd9-9746-e8001f117a7b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4dd0b8b7-a884-4620-a0cd-23cd149001ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5526e8a0-b996-4352-90b9-ad093ee5678d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2020dbdc-8e36-4fd9-9746-e8001f117a7b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5526e8a0-b996-4352-90b9-ad093ee5678d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4d87b3b-3662-4e28-902d-1592cf9408d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0c32f315-b43c-45af-8d10-51d7d88156b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4d87b3b-3662-4e28-902d-1592cf9408d8" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0c32f315-b43c-45af-8d10-51d7d88156b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1c87b5fb-f0d0-4a7b-a537-acd74b8a9109" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4d87b3b-3662-4e28-902d-1592cf9408d8" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1c87b5fb-f0d0-4a7b-a537-acd74b8a9109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f124e3dc-2998-4a11-aa65-ca25d79dccb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b4d87b3b-3662-4e28-902d-1592cf9408d8" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_f124e3dc-2998-4a11-aa65-ca25d79dccb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b3e932da-9daf-4f06-b3fc-4a3913740c86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_e4e3f682-b07b-4231-8f44-b8749780afef" xlink:href="wst-20191231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b3e932da-9daf-4f06-b3fc-4a3913740c86" xlink:to="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_e4e3f682-b07b-4231-8f44-b8749780afef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_166be454-3787-460b-b83e-fb50b57726e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b3e932da-9daf-4f06-b3fc-4a3913740c86" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_166be454-3787-460b-b83e-fb50b57726e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f2178e74-3f9b-403a-a5cf-7357e4fecaf1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f74d9233-f5f6-45c3-9079-f5219290dff3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f2178e74-3f9b-403a-a5cf-7357e4fecaf1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_f74d9233-f5f6-45c3-9079-f5219290dff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fdbbfe80-06f9-4e7f-9f3e-38a03c67b8f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f2178e74-3f9b-403a-a5cf-7357e4fecaf1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_fdbbfe80-06f9-4e7f-9f3e-38a03c67b8f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6f8abae6-83d2-43ec-a3b6-8d68d56be917" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_92e8ba24-ec43-4304-ae53-fed992462aba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6f8abae6-83d2-43ec-a3b6-8d68d56be917" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_92e8ba24-ec43-4304-ae53-fed992462aba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_60b42444-898f-4d7e-8c82-b31caabcf0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6f8abae6-83d2-43ec-a3b6-8d68d56be917" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_60b42444-898f-4d7e-8c82-b31caabcf0f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_03009cca-9292-42ad-ab12-c6985d175f15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6f8abae6-83d2-43ec-a3b6-8d68d56be917" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_03009cca-9292-42ad-ab12-c6985d175f15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_85fe498a-20bc-4e85-a549-74cea5150100" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_65b1a3f3-b078-4533-a021-3028e933d1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_85fe498a-20bc-4e85-a549-74cea5150100" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_65b1a3f3-b078-4533-a021-3028e933d1ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a54f1740-48a0-4d4f-bb5d-25165f415270" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_85fe498a-20bc-4e85-a549-74cea5150100" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a54f1740-48a0-4d4f-bb5d-25165f415270" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_a46d1783-c85f-46c3-8506-92b6a5deb56d" xlink:href="wst-20191231.xsd#wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_85fe498a-20bc-4e85-a549-74cea5150100" xlink:to="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_a46d1783-c85f-46c3-8506-92b6a5deb56d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_defae42b-97ae-4a03-acda-6856667c6878" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_85fe498a-20bc-4e85-a549-74cea5150100" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_defae42b-97ae-4a03-acda-6856667c6878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_1165cc22-2f2b-45e0-be95-0d08c82b9ff6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_85fe498a-20bc-4e85-a549-74cea5150100" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_1165cc22-2f2b-45e0-be95-0d08c82b9ff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8b100138-bbc9-4b5e-8828-e4ac0ca2cd23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_85fe498a-20bc-4e85-a549-74cea5150100" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8b100138-bbc9-4b5e-8828-e4ac0ca2cd23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_30202e28-4493-4c39-8e01-3033c3c9f38a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_30202e28-4493-4c39-8e01-3033c3c9f38a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_30df0dcf-0178-4132-84b4-151e21ea5ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_30df0dcf-0178-4132-84b4-151e21ea5ef3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_799a9f02-bea6-4abc-bdb8-dc1c5ad88e65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_799a9f02-bea6-4abc-bdb8-dc1c5ad88e65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a445742b-9061-45a5-b885-21cf9a044d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a445742b-9061-45a5-b885-21cf9a044d9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_d7143436-c541-47a1-9f35-7faa7a4ec2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_d7143436-c541-47a1-9f35-7faa7a4ec2c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d0f8e53d-5dc3-439a-894b-301b270cabba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d0f8e53d-5dc3-439a-894b-301b270cabba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_2105edeb-22da-4a5f-b2dd-c9452d315488" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_2105edeb-22da-4a5f-b2dd-c9452d315488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_263b48dd-c0f6-4e9d-85fa-718d7b12c858" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_263b48dd-c0f6-4e9d-85fa-718d7b12c858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_95e5ef46-6c20-4f2d-a961-4d0fbab6534f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_95e5ef46-6c20-4f2d-a961-4d0fbab6534f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage_27986ae5-d568-443c-aa52-d7a1d2fbe3e9" xlink:href="wst-20191231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage_27986ae5-d568-443c-aa52-d7a1d2fbe3e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_825f4d51-c2f0-4a90-8c10-202a62eb7f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_825f4d51-c2f0-4a90-8c10-202a62eb7f5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction_b07b9788-4ebe-427c-85b8-efb459944439" xlink:href="wst-20191231.xsd#wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction_b07b9788-4ebe-427c-85b8-efb459944439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2ab2638c-85e6-41b6-b55c-49a38f777615" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9cb86260-51cd-42fc-bd75-15be8860933e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2ab2638c-85e6-41b6-b55c-49a38f777615" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20191231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#CommitmentsandContingenciesTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformation"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationTextualsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTextualsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSalesandPPEbyGeographicLocationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="simple" xlink:href="wst-20191231.xsd#ScheduleIIValuationandQualifyingAccountsNotes"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>wst-20191231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b5520f3c-bdfb-4aa1-98ba-ba1f6a92b1c8,g:f267b37f-edf1-4d21-84ed-4e7cdfb1cf2c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="wst-20191231.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DocumentandEntityInformation" xlink:type="extended" id="i2522c7d84f35436ab0bf8976b7820dc0_859bdfb7-0af9-4f30-a515-fd1088487389"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended" id="i99e1b55676b246568923801aec6ea9c1_a5170d39-0976-44db-9f8a-dacd97523a2a">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ff60c8f2-c870-47b6-95aa-cbeebadc9c45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_Revenues_ff60c8f2-c870-47b6-95aa-cbeebadc9c45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_76d0b9a0-c967-4ab9-8f15-7778eb27cba9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_76d0b9a0-c967-4ab9-8f15-7778eb27cba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d93fbfee-555e-4899-ab8c-e623be97b1f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_GrossProfit_d93fbfee-555e-4899-ab8c-e623be97b1f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c6b1dade-af74-4757-83ee-3e0c84fd998b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c6b1dade-af74-4757-83ee-3e0c84fd998b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_78c8562b-2389-4878-ab9d-56ce814d0b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_78c8562b-2389-4878-ab9d-56ce814d0b7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_e77d573f-8667-4754-a186-9fcd4f826e94" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_wst_OtherIncomeExpense_e77d573f-8667-4754-a186-9fcd4f826e94" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5641dc9e-b620-4bcd-9dbe-ff0d105ae870" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_OperatingIncomeLoss_5641dc9e-b620-4bcd-9dbe-ff0d105ae870" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f2cec27e-002e-4440-8002-d1ac629fc515" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_InterestExpense_f2cec27e-002e-4440-8002-d1ac629fc515" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_b32bcf84-0e76-4cb3-b58e-a75d7dc2f3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_InvestmentIncomeNet_b32bcf84-0e76-4cb3-b58e-a75d7dc2f3b2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f49ca98f-73de-4bdd-8685-5f6a2a4ee5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f49ca98f-73de-4bdd-8685-5f6a2a4ee5f3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_af087ce5-1743-4591-96a3-7dd9f3b2d24e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_af087ce5-1743-4591-96a3-7dd9f3b2d24e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_85276aa3-53c1-46d6-a928-a831830f08fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_85276aa3-53c1-46d6-a928-a831830f08fb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f15334cb-623e-404b-8a0f-080dd1c2cc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f15334cb-623e-404b-8a0f-080dd1c2cc4d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fab8f082-51fd-45eb-aca0-b8caf4bdeba0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_ProfitLoss_fab8f082-51fd-45eb-aca0-b8caf4bdeba0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1a59107f-b61a-4158-90ba-2d7a669f0c67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:to="loc_us-gaap_EarningsPerShareBasic_1a59107f-b61a-4158-90ba-2d7a669f0c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7092a72b-dd6a-4fb7-8671-27ad4b9e5716" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7092a72b-dd6a-4fb7-8671-27ad4b9e5716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:href="wst-20191231.xsd#wst_WeightedAverageSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d61c9970-f76c-4a2b-943c-2d25ca92fbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d61c9970-f76c-4a2b-943c-2d25ca92fbfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_953ffde8-f4b8-437a-8082-128c4d873437" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_953ffde8-f4b8-437a-8082-128c4d873437" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_df946562-0b20-4715-8969-d5d479cdc073" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_StatementTable_df946562-0b20-4715-8969-d5d479cdc073" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_89a658c5-f054-4f5f-9b76-85fae048fe7a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_df946562-0b20-4715-8969-d5d479cdc073" xlink:to="loc_srt_StatementScenarioAxis_89a658c5-f054-4f5f-9b76-85fae048fe7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_89a658c5-f054-4f5f-9b76-85fae048fe7a_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_89a658c5-f054-4f5f-9b76-85fae048fe7a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_89a658c5-f054-4f5f-9b76-85fae048fe7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_434c36f9-9d02-49a4-8b53-4476480ad9f0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_89a658c5-f054-4f5f-9b76-85fae048fe7a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_434c36f9-9d02-49a4-8b53-4476480ad9f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended" id="i391150500b914633ab057f91959224d1_6545437f-cc8c-4eb7-b38d-4d6ccd2ba2bf"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended" id="i0127394bd6c94cada0cc0a0e35452e2a_12f5cc7a-68f8-49ff-8a1d-ef47c0af2a91"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i5818ab37b47940e6b70f0ef9e0eb612d_430b73ec-10f1-4c1a-8b21-7f23a5260b32"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i1563f8aab53640b3834481385105fd45_a3e5811b-d80c-4a15-afa8-8e0b05235d60"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended" id="ifba37a57cacb487e9c4b3e75ed81578a_66ef7529-cc0e-42ce-8e48-90466d1e2e42">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7d24e208-f9db-4c25-8b79-42a09db843dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d24e208-f9db-4c25-8b79-42a09db843dd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40ffa5c6-d473-41e6-aefb-7a1407ba9792" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40ffa5c6-d473-41e6-aefb-7a1407ba9792" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_edb94da6-a355-4013-995a-2bdcf19158ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_SharesIssued_edb94da6-a355-4013-995a-2bdcf19158ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_cd34585b-828e-410f-8c76-1f9c3d1d8a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_cd34585b-828e-410f-8c76-1f9c3d1d8a8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_93dc2004-8061-418e-b2b0-f88a5714dd64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_ProfitLoss_93dc2004-8061-418e-b2b0-f88a5714dd64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1cd46601-98e1-47bf-adba-a0bf4e148a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1cd46601-98e1-47bf-adba-a0bf4e148a8c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0788b054-9fb4-4c75-a227-9a4e09e85c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0788b054-9fb4-4c75-a227-9a4e09e85c5a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3fd22a36-98d4-47db-a560-5a1f6a48ff42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3fd22a36-98d4-47db-a560-5a1f6a48ff42" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6fd46ec0-50a9-4fb8-a462-e9fabd99f7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6fd46ec0-50a9-4fb8-a462-e9fabd99f7dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2eab2d4a-b83b-4b24-b30d-3218bd40139f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2eab2d4a-b83b-4b24-b30d-3218bd40139f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dc9c92fc-fa27-4f61-97d5-47337971f045" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dc9c92fc-fa27-4f61-97d5-47337971f045" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_30bda3e8-2f47-4378-aa33-420f63385c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_30bda3e8-2f47-4378-aa33-420f63385c0b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_d19ac3ff-7111-47f9-90d6-9452044b6471" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_DividendsCommonStockCash_d19ac3ff-7111-47f9-90d6-9452044b6471" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_f77e33ef-45df-455e-b800-6599579cf8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_f77e33ef-45df-455e-b800-6599579cf8bd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_5a6a638e-e1e0-4358-b165-2e0384363069" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_5a6a638e-e1e0-4358-b165-2e0384363069" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3e65b7e-d1ca-4b48-98a3-a90e6dea6de3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3e65b7e-d1ca-4b48-98a3-a90e6dea6de3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8a451cc3-5705-428f-be75-07785fbdae57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6e2e145f-5161-4e46-936c-74bb8b91da89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3f9244b5-f7f0-4e0f-8558-637f09ad9cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7d24e208-f9db-4c25-8b79-42a09db843dd" xlink:to="loc_us-gaap_StatementTable_3f9244b5-f7f0-4e0f-8558-637f09ad9cdc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_40a9c773-e407-4ca1-973a-7ce295e61a96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3f9244b5-f7f0-4e0f-8558-637f09ad9cdc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_40a9c773-e407-4ca1-973a-7ce295e61a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_40a9c773-e407-4ca1-973a-7ce295e61a96_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_40a9c773-e407-4ca1-973a-7ce295e61a96" xlink:to="loc_us-gaap_EquityComponentDomain_40a9c773-e407-4ca1-973a-7ce295e61a96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_40a9c773-e407-4ca1-973a-7ce295e61a96" xlink:to="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_638c722c-0bde-479e-b461-0e5c7e2cc00c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_CommonStockMember_638c722c-0bde-479e-b461-0e5c7e2cc00c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2890e541-8ac5-4b0d-811c-4b0e0969114d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2890e541-8ac5-4b0d-811c-4b0e0969114d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a7a05aab-18a3-43d0-bedd-e3cbdb01ba0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_TreasuryStockMember_a7a05aab-18a3-43d0-bedd-e3cbdb01ba0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_04e37a60-5b84-4447-a3a6-53ab20d11b68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_RetainedEarningsMember_04e37a60-5b84-4447-a3a6-53ab20d11b68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0bf3904-8d60-472c-9498-666049569675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0bf3904-8d60-472c-9498-666049569675" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="ie05ac49ca13a4d41a6136fed259d6d0a_c68cbf19-343c-4a30-a02f-80f8948e21ff"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="i5f559d3aeb09439e9141f5be8acefce3_2aabab34-87d5-4d07-b7ce-d10c4853971c"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="icb14081867084b568ea9e6a0bca29983_e06bd3be-d7ab-4b35-b10a-19a097b1a278"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="if07900ec3c7f4b06b634964928b0798e_52311595-c634-4c83-8285-f9c0de218420"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="i80948e6907d0449980cb01ca8b28489c_55b6420d-4b9e-4c9b-a4a3-0075794b373d">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d1d9b02-e577-4c61-9ab4-d861e10efd8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8222c600-300c-4f5b-97b1-b624cbb8d0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d1d9b02-e577-4c61-9ab4-d861e10efd8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8222c600-300c-4f5b-97b1-b624cbb8d0ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_59de287e-9aad-4bfb-9706-c9638f727a64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d1d9b02-e577-4c61-9ab4-d861e10efd8b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_59de287e-9aad-4bfb-9706-c9638f727a64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e72859e2-a01e-4b92-ac63-dee32eb737ca" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_59de287e-9aad-4bfb-9706-c9638f727a64" xlink:to="loc_srt_RangeAxis_e72859e2-a01e-4b92-ac63-dee32eb737ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e72859e2-a01e-4b92-ac63-dee32eb737ca_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e72859e2-a01e-4b92-ac63-dee32eb737ca" xlink:to="loc_srt_RangeMember_e72859e2-a01e-4b92-ac63-dee32eb737ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e72859e2-a01e-4b92-ac63-dee32eb737ca" xlink:to="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_19dc256f-5f1e-423b-8b22-fc08b5b65206" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:to="loc_srt_MinimumMember_19dc256f-5f1e-423b-8b22-fc08b5b65206" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0a4f0bcc-cb2b-404c-bff7-95cc1672aca3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:to="loc_srt_MaximumMember_0a4f0bcc-cb2b-404c-bff7-95cc1672aca3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20191231.xsd#NewAccountingStandards"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended" id="ie563635b6d5448a69fe2b2662119bbb4_38e79e88-384b-45b0-9d11-3126d0e652c4"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#NewAccountingStandardsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="extended" id="i2c1ea70ad73d45b18b9bf9216abd4b55_f5a730ea-5323-4051-9037-dbfd63827be9">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_f79b2575-83e6-4bfd-b90b-9f7bc9f14caa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_f79b2575-83e6-4bfd-b90b-9f7bc9f14caa" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_984d3113-100f-46e3-b4f6-e0b1ef3cd35d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_984d3113-100f-46e3-b4f6-e0b1ef3cd35d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_984d3113-100f-46e3-b4f6-e0b1ef3cd35d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_984d3113-100f-46e3-b4f6-e0b1ef3cd35d" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_984d3113-100f-46e3-b4f6-e0b1ef3cd35d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_775f0d4c-54e0-4cef-b440-e0b22bf276fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_984d3113-100f-46e3-b4f6-e0b1ef3cd35d" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_775f0d4c-54e0-4cef-b440-e0b22bf276fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1fbfc1db-41b2-476d-b5e6-4a050c78af8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1fbfc1db-41b2-476d-b5e6-4a050c78af8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_1fbfc1db-41b2-476d-b5e6-4a050c78af8c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1fbfc1db-41b2-476d-b5e6-4a050c78af8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_1fbfc1db-41b2-476d-b5e6-4a050c78af8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1fbfc1db-41b2-476d-b5e6-4a050c78af8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_58690d32-0f62-4fd9-90d2-5a0510146c37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_58690d32-0f62-4fd9-90d2-5a0510146c37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201707Member_57b8fe07-3f74-4a6f-b5be-c96e856d9344" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201707Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:to="loc_us-gaap_AccountingStandardsUpdate201707Member_57b8fe07-3f74-4a6f-b5be-c96e856d9344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_94709381-0ea8-47a6-8a21-24769e5da16e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_94709381-0ea8-47a6-8a21-24769e5da16e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenue" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenue"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueRevenue" xlink:type="extended" id="ib062ed3e4a0241d58963024263565c76_c2a1c82f-f4fc-420e-9826-fc2a5f645a95"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueTables" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenueTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueRevenueTables" xlink:type="extended" id="ic38dcccc7d16475dae3cb056d4c8659b_cbc0e8bd-75d0-42ea-893e-c8eea347d2f2"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueAdoptionofASC606Details"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="extended" id="i4ee26466df504e71bd3dffa169606279_975ec2a1-7e98-4a7f-8372-f8daa828a0d7">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0aa5d8db-15ad-4ee0-be1c-1aadce915008" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8126de79-1aef-4fb7-9449-f650c90c27bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0aa5d8db-15ad-4ee0-be1c-1aadce915008" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8126de79-1aef-4fb7-9449-f650c90c27bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0aa5d8db-15ad-4ee0-be1c-1aadce915008" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_1304e5cf-42b6-497e-8164-dbda93cfbd29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_1304e5cf-42b6-497e-8164-dbda93cfbd29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_1304e5cf-42b6-497e-8164-dbda93cfbd29_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_1304e5cf-42b6-497e-8164-dbda93cfbd29" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_1304e5cf-42b6-497e-8164-dbda93cfbd29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_5b862059-5bcc-45b7-aa64-960ed022ad85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_1304e5cf-42b6-497e-8164-dbda93cfbd29" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_5b862059-5bcc-45b7-aa64-960ed022ad85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e6cacd17-9afd-4990-8ce0-963e64a8fdab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_5b862059-5bcc-45b7-aa64-960ed022ad85" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e6cacd17-9afd-4990-8ce0-963e64a8fdab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f7c14949-59c1-4e54-882d-8b2c9915a8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f7c14949-59c1-4e54-882d-8b2c9915a8c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f7c14949-59c1-4e54-882d-8b2c9915a8c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f7c14949-59c1-4e54-882d-8b2c9915a8c1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f7c14949-59c1-4e54-882d-8b2c9915a8c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_95c86afb-bb4a-421c-adfd-920830902e70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f7c14949-59c1-4e54-882d-8b2c9915a8c1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_95c86afb-bb4a-421c-adfd-920830902e70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_66a09fec-218d-41cd-b490-9dd55b216d26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_95c86afb-bb4a-421c-adfd-920830902e70" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_66a09fec-218d-41cd-b490-9dd55b216d26" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended" id="ie110f4f4c7ef4ac284a025fa55456914_f665eea6-e199-46ff-973d-9c94319adfc9">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_98adf13e-4f55-4071-8985-9d1d43fec8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:to="loc_us-gaap_ContractWithCustomerLiability_98adf13e-4f55-4071-8985-9d1d43fec8ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_441c9e70-e282-4fe7-8d15-805f8a250bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_441c9e70-e282-4fe7-8d15-805f8a250bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_srt_StatementGeographicalAxis_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f" xlink:to="loc_srt_SegmentGeographicalDomain_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f" xlink:to="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_409b5705-a5ae-4dab-92ea-1dbf66737a9f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:to="loc_srt_AmericasMember_409b5705-a5ae-4dab-92ea-1dbf66737a9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_6608f637-764f-45bb-a46a-c962ec942f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:to="loc_us-gaap_EMEAMember_6608f637-764f-45bb-a46a-c962ec942f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_505ed046-bb83-443f-a32c-bb6b4348b5f8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:to="loc_srt_AsiaPacificMember_505ed046-bb83-443f-a32c-bb6b4348b5f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_aa250523-1e01-4195-b841-488030321877" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_srt_MajorCustomersAxis_aa250523-1e01-4195-b841-488030321877" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_aa250523-1e01-4195-b841-488030321877_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_aa250523-1e01-4195-b841-488030321877" xlink:to="loc_srt_NameOfMajorCustomerDomain_aa250523-1e01-4195-b841-488030321877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_aa250523-1e01-4195-b841-488030321877" xlink:to="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_120fe701-b75b-40e6-ad34-e66f88402534" xlink:href="wst-20191231.xsd#wst_BiologicsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_BiologicsCustomersMember_120fe701-b75b-40e6-ad34-e66f88402534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_800ea45c-71a0-400e-a607-c5d49bdf6ec7" xlink:href="wst-20191231.xsd#wst_GenericsCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_GenericsCustomersMember_800ea45c-71a0-400e-a607-c5d49bdf6ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_a794b2de-b61d-4388-bc8e-bbcb185f1c54" xlink:href="wst-20191231.xsd#wst_PharmaCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_PharmaCustomersMember_a794b2de-b61d-4388-bc8e-bbcb185f1c54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_5b9eb979-3a81-4b1d-a5cf-e8ea4124dfa3" xlink:href="wst-20191231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_ContractManufacturedCustomersMember_5b9eb979-3a81-4b1d-a5cf-e8ea4124dfa3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d8ead353-77fc-41c2-8706-af69beaa9946" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d8ead353-77fc-41c2-8706-af69beaa9946" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d8ead353-77fc-41c2-8706-af69beaa9946_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d8ead353-77fc-41c2-8706-af69beaa9946" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d8ead353-77fc-41c2-8706-af69beaa9946_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d8ead353-77fc-41c2-8706-af69beaa9946" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_4488f4ef-2d78-4eba-b4fc-3a3318eb46c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_4488f4ef-2d78-4eba-b4fc-3a3318eb46c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_dd8f2ea7-3dca-4ea6-856e-6a37bb185ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_dd8f2ea7-3dca-4ea6-856e-6a37bb185ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5f783d90-bc39-4594-8723-459bc0942bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5f783d90-bc39-4594-8723-459bc0942bb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_653e955f-9601-4a5e-87af-de610f9c515c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_653e955f-9601-4a5e-87af-de610f9c515c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_653e955f-9601-4a5e-87af-de610f9c515c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_653e955f-9601-4a5e-87af-de610f9c515c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_653e955f-9601-4a5e-87af-de610f9c515c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762444fc-10ad-408f-9c9f-2ecd97ee9806" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_653e955f-9601-4a5e-87af-de610f9c515c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762444fc-10ad-408f-9c9f-2ecd97ee9806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_33c22451-3935-455f-b38f-be0cf35d0948" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762444fc-10ad-408f-9c9f-2ecd97ee9806" xlink:to="loc_us-gaap_SalesRevenueNetMember_33c22451-3935-455f-b38f-be0cf35d0948" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_srt_ProductOrServiceAxis_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b" xlink:to="loc_srt_ProductsAndServicesDomain_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b" xlink:to="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_4cf93ee6-3782-4762-95c9-03cc4f2e0c57" xlink:href="wst-20191231.xsd#wst_SmartDoseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_SmartDoseMember_4cf93ee6-3782-4762-95c9-03cc4f2e0c57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueComponentsMember_0b9200ff-c80d-48ae-9f81-35ef27731836" xlink:href="wst-20191231.xsd#wst_HighValueComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_HighValueComponentsMember_0b9200ff-c80d-48ae-9f81-35ef27731836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_40c6268e-e384-40ad-b69b-2b0aa37a117b" xlink:href="wst-20191231.xsd#wst_StandardPackagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_StandardPackagingMember_40c6268e-e384-40ad-b69b-2b0aa37a117b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeliveryDevicesMember_68ec1af7-6246-4492-a1ab-f73aa6794cb7" xlink:href="wst-20191231.xsd#wst_DeliveryDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_DeliveryDevicesMember_68ec1af7-6246-4492-a1ab-f73aa6794cb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_ffe3206b-37d9-40ec-97a1-b8f717a567c6" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_ContractManufacturedProductsMember_ffe3206b-37d9-40ec-97a1-b8f717a567c6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="extended" id="i7591987a3bcd48949ab75207147617aa_4a37cd35-0cfc-42a2-9f80-8f62471cfbff">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_b6421f39-4476-4754-8fea-f881645e095f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_b6421f39-4476-4754-8fea-f881645e095f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_9c75eabb-0e6a-430a-9d35-ec22cedefd41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractwithCustomerAssetIncreaseDecrease_325a4dec-cddd-41e9-bcc5-11327bee2985" xlink:href="wst-20191231.xsd#wst_ContractwithCustomerAssetIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_wst_ContractwithCustomerAssetIncreaseDecrease_325a4dec-cddd-41e9-bcc5-11327bee2985" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d91918e5-a8c5-4e08-a0d5-2b4a90c0bbdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d91918e5-a8c5-4e08-a0d5-2b4a90c0bbdc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_11351418-dd3e-4113-98a5-658e7ae576bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_550a74b8-a95b-45f7-9f0f-e4df4bf950e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_550a74b8-a95b-45f7-9f0f-e4df4bf950e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_6212ed56-e659-404b-9bbd-8cb73df969d0" xlink:href="wst-20191231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_6212ed56-e659-404b-9bbd-8cb73df969d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_47286406-d431-4554-a2c6-510746619717" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_47286406-d431-4554-a2c6-510746619717" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3b116f59-5914-418f-b99f-639b05c1c006" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3b116f59-5914-418f-b99f-639b05c1c006" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bd3f83fc-3347-4b95-88e8-863168813ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bd3f83fc-3347-4b95-88e8-863168813ce9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInCustomerAdvances_fde61db3-d229-4c23-a058-e4e087da6a25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_IncreaseDecreaseInCustomerAdvances_fde61db3-d229-4c23-a058-e4e087da6a25" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_07d6473b-4c36-4ffa-b4d3-ec2ee77a002f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_07d6473b-4c36-4ffa-b4d3-ec2ee77a002f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9e5410eb-9aa1-46e7-94f3-f9dc33821a53" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:to="loc_srt_ProductOrServiceAxis_9e5410eb-9aa1-46e7-94f3-f9dc33821a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9e5410eb-9aa1-46e7-94f3-f9dc33821a53_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9e5410eb-9aa1-46e7-94f3-f9dc33821a53" xlink:to="loc_srt_ProductsAndServicesDomain_9e5410eb-9aa1-46e7-94f3-f9dc33821a53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7332aa16-a7cd-4550-b052-c33cab3959ee" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9e5410eb-9aa1-46e7-94f3-f9dc33821a53" xlink:to="loc_srt_ProductsAndServicesDomain_7332aa16-a7cd-4550-b052-c33cab3959ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_159c6c3e-84dc-400f-925a-e14ff10f05d4" xlink:href="wst-20191231.xsd#wst_SmartDoseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7332aa16-a7cd-4550-b052-c33cab3959ee" xlink:to="loc_wst_SmartDoseMember_159c6c3e-84dc-400f-925a-e14ff10f05d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d174d8b5-3f65-424f-8553-8b4c60acd44c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d174d8b5-3f65-424f-8553-8b4c60acd44c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_d174d8b5-3f65-424f-8553-8b4c60acd44c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d174d8b5-3f65-424f-8553-8b4c60acd44c" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_d174d8b5-3f65-424f-8553-8b4c60acd44c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ba013ccb-7185-4373-b9ba-4d777da47c12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d174d8b5-3f65-424f-8553-8b4c60acd44c" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ba013ccb-7185-4373-b9ba-4d777da47c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_18a975b1-6a22-48af-a9f9-e2a1447e176d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ba013ccb-7185-4373-b9ba-4d777da47c12" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_18a975b1-6a22-48af-a9f9-e2a1447e176d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7bf02900-2da8-48ec-9681-ac23b3e51aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7bf02900-2da8-48ec-9681-ac23b3e51aa1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7bf02900-2da8-48ec-9681-ac23b3e51aa1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7bf02900-2da8-48ec-9681-ac23b3e51aa1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7bf02900-2da8-48ec-9681-ac23b3e51aa1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_76c95c9c-13f8-471b-9a9f-cddf8c386371" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7bf02900-2da8-48ec-9681-ac23b3e51aa1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_76c95c9c-13f8-471b-9a9f-cddf8c386371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_152f1737-bdc4-4c61-9a9f-bcd665cd66c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_76c95c9c-13f8-471b-9a9f-cddf8c386371" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_152f1737-bdc4-4c61-9a9f-bcd665cd66c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueSupplyChainFinancingDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="extended" id="icb7d109af1984337b080c96d8db55aea_d1dbef59-e27a-4f5a-99d5-ba8e3c5334dc"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueVoluntaryRecallDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="extended" id="i47f2888e6f714aaf89c6a00ce54a296c_7fb2aadd-3e26-4c1f-913c-ddb86e884940"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShare"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended" id="if7bde08c978a407fb0c4918a64c4c33c_0c222cfd-0d55-4fee-a83d-86c0db8b594d"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShareTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended" id="i3cec070bee554de58eb76cb980302cf3_abc8d5d7-c541-4c27-bb43-2e378871dcdc"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="extended" id="i675a31f4b6154c668af3d8259d404e74_a5f46140-4bd8-4278-aff7-5e2d984e41b1"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipment"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="extended" id="i313a140fd6094f96a45b5d16c7cf6171_4e1814e9-0b51-4dec-8103-fcf07bf8ba4b"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended" id="i1d49a764721d41249d5bfc51e004aae5_db00c7c5-7775-46b7-b0b7-f139b7549818"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended" id="ica7ee783a57748098078031cea71b9c1_e8c94e55-e36e-4c0a-81a4-14a6259b0a7e">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_98f03a49-7a47-44f7-a4df-058fae29b0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_98f03a49-7a47-44f7-a4df-058fae29b0fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6e79a361-7278-4df7-8f3a-8d1547341feb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6e79a361-7278-4df7-8f3a-8d1547341feb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_242462bf-2203-49de-9f8c-cea31346c965" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_242462bf-2203-49de-9f8c-cea31346c965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_242462bf-2203-49de-9f8c-cea31346c965_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_242462bf-2203-49de-9f8c-cea31346c965" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_242462bf-2203-49de-9f8c-cea31346c965_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_242462bf-2203-49de-9f8c-cea31346c965" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_a1ebcb33-6c55-4543-80b4-08ae36f8424f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_LandMember_a1ebcb33-6c55-4543-80b4-08ae36f8424f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_141212aa-e869-4ff8-b69b-0952eca9ea5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_141212aa-e869-4ff8-b69b-0952eca9ea5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_6aaa4296-7de9-4459-b2ae-b4c3184363a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_6aaa4296-7de9-4459-b2ae-b4c3184363a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_3c979d9f-a350-43f4-a04f-c8fcca721302" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_3c979d9f-a350-43f4-a04f-c8fcca721302" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember_09477af9-12dc-484a-877c-646c398c9718" xlink:href="wst-20191231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_wst_ComputerHardwareAndSoftwareMember_09477af9-12dc-484a-877c-646c398c9718" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_53e48561-bc9e-43db-93f0-a6dd413f0d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_ConstructionInProgressMember_53e48561-bc9e-43db-93f0-a6dd413f0d6f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_45135d39-3bfc-4459-8258-71cb1f739011" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:to="loc_srt_RangeAxis_45135d39-3bfc-4459-8258-71cb1f739011" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_45135d39-3bfc-4459-8258-71cb1f739011_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_45135d39-3bfc-4459-8258-71cb1f739011" xlink:to="loc_srt_RangeMember_45135d39-3bfc-4459-8258-71cb1f739011_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_45135d39-3bfc-4459-8258-71cb1f739011" xlink:to="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8fff8b53-0036-4594-99d6-699f5b69522f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:to="loc_srt_MinimumMember_8fff8b53-0036-4594-99d6-699f5b69522f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d2e855a-c46f-448a-b480-4b7eecaf1d2b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:to="loc_srt_MaximumMember_2d2e855a-c46f-448a-b480-4b7eecaf1d2b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails" xlink:type="extended" id="ia6bda57fe50845babad0fddbdfea0983_77131feb-4452-4b62-9caa-9c06370fac65">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_55a3823c-d605-4d6a-9ad8-db813a23e11e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_Depreciation_55a3823c-d605-4d6a-9ad8-db813a23e11e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsGross_6fe5453c-6f69-40f3-bc1d-d4f04beb7e58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasedAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_CapitalLeasedAssetsGross_6fe5453c-6f69-40f3-bc1d-d4f04beb7e58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_6f596cd3-8fc8-4769-87b2-66489677776f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_InterestCostsCapitalized_6f596cd3-8fc8-4769-87b2-66489677776f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatentandEquipment_1c378746-3285-48ee-b38f-f3b3b074cec6" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatentandEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_wst_AssetImpairmentChargesPatentandEquipment_1c378746-3285-48ee-b38f-f3b3b074cec6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_88693167-e5dc-4d05-a4ce-1d5f7a177a22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_88693167-e5dc-4d05-a4ce-1d5f7a177a22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_24dd4ab5-74df-40e5-8bfd-2da13582d1db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_AssetImpairmentCharges_24dd4ab5-74df-40e5-8bfd-2da13582d1db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5e09582f-1ad1-463e-a2e3-fc5b592ab992" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:to="loc_us-gaap_RestructuringPlanAxis_5e09582f-1ad1-463e-a2e3-fc5b592ab992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5e09582f-1ad1-463e-a2e3-fc5b592ab992_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_5e09582f-1ad1-463e-a2e3-fc5b592ab992" xlink:to="loc_us-gaap_RestructuringPlanDomain_5e09582f-1ad1-463e-a2e3-fc5b592ab992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_5e09582f-1ad1-463e-a2e3-fc5b592ab992" xlink:to="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2018RestructuringPlanMember_84a3bcc1-a26c-400f-86ac-26ab36f61894" xlink:href="wst-20191231.xsd#wst_A2018RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:to="loc_wst_A2018RestructuringPlanMember_84a3bcc1-a26c-400f-86ac-26ab36f61894" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2016RestructuringPlanMemberMember_621e88d3-c4fa-41ae-8353-778b9b16b97f" xlink:href="wst-20191231.xsd#wst_A2016RestructuringPlanMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:to="loc_wst_A2016RestructuringPlanMemberMember_621e88d3-c4fa-41ae-8353-778b9b16b97f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7accbf1a-e8eb-4762-8589-8b840f290391" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7accbf1a-e8eb-4762-8589-8b840f290391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7accbf1a-e8eb-4762-8589-8b840f290391_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7accbf1a-e8eb-4762-8589-8b840f290391" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7accbf1a-e8eb-4762-8589-8b840f290391_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7accbf1a-e8eb-4762-8589-8b840f290391" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_d701c5f0-5788-4d72-bcf0-ec8ce4c227ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_d701c5f0-5788-4d72-bcf0-ec8ce4c227ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_85b28b8a-4359-40ce-af14-42133c65594e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_85b28b8a-4359-40ce-af14-42133c65594e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20191231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended" id="id1aefebd053745d1902ce67237ac00cf_1e8cf297-e540-4ba2-9c56-daa120896cd4"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended" id="i4af59c1c99ab41d4a9cad1d6696f21be_b0d6e7ae-80f5-4b8b-b6cc-a81cb9e83082"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AdoptionofASC842Details" xlink:type="simple" xlink:href="wst-20191231.xsd#AdoptionofASC842Details"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AdoptionofASC842Details" xlink:type="extended" id="i28c7617fb3854991bb646216eda2d559_0aef079b-5a90-44bc-b13f-deaa75c943ab">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_291d38b6-b95f-4f62-b7df-92a8dabe87ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_OperatingLeaseLiability_291d38b6-b95f-4f62-b7df-92a8dabe87ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ccb9b5d6-23f0-4b70-b365-fd940433046f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ccb9b5d6-23f0-4b70-b365-fd940433046f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_319579d3-6830-4858-8994-394c58259357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_319579d3-6830-4858-8994-394c58259357" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0ece5ec9-c3cc-43ad-9eb5-24f671b87ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0ece5ec9-c3cc-43ad-9eb5-24f671b87ff9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_38d95611-fd1c-4d8f-bb09-3ee9f8446497" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_FinanceLeaseLiability_38d95611-fd1c-4d8f-bb09-3ee9f8446497" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LeaseOperatingLeaseTerminateTerm_6438e20f-1f37-43cd-bd61-280a97d43c6a" xlink:href="wst-20191231.xsd#wst_LeaseOperatingLeaseTerminateTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_wst_LeaseOperatingLeaseTerminateTerm_6438e20f-1f37-43cd-bd61-280a97d43c6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9ab01f62-9de2-45a7-8ded-71c0af0aec46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9ab01f62-9de2-45a7-8ded-71c0af0aec46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9ab01f62-9de2-45a7-8ded-71c0af0aec46_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9ab01f62-9de2-45a7-8ded-71c0af0aec46" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9ab01f62-9de2-45a7-8ded-71c0af0aec46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_d86a5530-d259-4272-86ba-db32fe603f55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9ab01f62-9de2-45a7-8ded-71c0af0aec46" xlink:to="loc_us-gaap_TypeOfAdoptionMember_d86a5530-d259-4272-86ba-db32fe603f55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_010d9f87-6d88-4391-bd64-63524514abd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_d86a5530-d259-4272-86ba-db32fe603f55" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_010d9f87-6d88-4391-bd64-63524514abd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_115cf22b-a9fc-4516-afd7-f5401feb0dbe" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:to="loc_srt_RangeAxis_115cf22b-a9fc-4516-afd7-f5401feb0dbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_115cf22b-a9fc-4516-afd7-f5401feb0dbe_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_115cf22b-a9fc-4516-afd7-f5401feb0dbe" xlink:to="loc_srt_RangeMember_115cf22b-a9fc-4516-afd7-f5401feb0dbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_41d40aa9-3bca-469e-9a4b-e55650604731" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_115cf22b-a9fc-4516-afd7-f5401feb0dbe" xlink:to="loc_srt_RangeMember_41d40aa9-3bca-469e-9a4b-e55650604731" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6dd6b7f3-1224-4062-a9ef-0a90f0b758bb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_41d40aa9-3bca-469e-9a4b-e55650604731" xlink:to="loc_srt_MaximumMember_6dd6b7f3-1224-4062-a9ef-0a90f0b758bb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseCostDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseCostDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeaseCostDetails" xlink:type="extended" id="i175a31e7da864ea0a776cadc86599f02_10488d2d-bc23-4a09-9e06-85e854ae5765"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseCashFlowandSupplementalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails" xlink:type="extended" id="i393bae7c9b6d4ac7ac2438445697f319_4f11438d-6f30-4644-8b44-2430c0eb42ef"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseWeightedAverageDetail" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseWeightedAverageDetail"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/LeaseWeightedAverageDetail" xlink:type="extended" id="i3b62e957e101460a8eaf77a9fffdeb2b_2c65a69c-03fb-4d97-9845-c1b9f78f7f22"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#MaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended" id="i99921890a0d74f46bb453733a6c703af_ad742274-21c1-41ff-8541-7445b3951000"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompanies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended" id="i8f308bb033844d87a920cc861fdeee63_89d7e18d-fc86-4810-9e3d-5aca54bbc727"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="extended" id="ibe8ae0752a1b4cafaa83e813e99372c1_ac4d33b5-c526-408b-b2af-89d79796a666"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="extended" id="i3f5494c36ba4423db3a5b3c07f5a640c_61f17679-8d07-4721-8fbd-bccbc7671652">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a1977914-e212-44ae-8401-05c93bf85a18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a1977914-e212-44ae-8401-05c93bf85a18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_aa1901d3-88b9-42d1-a7b6-479d6ec78893" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_aa1901d3-88b9-42d1-a7b6-479d6ec78893" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44653049-32f1-4a74-891c-f8ffe35360b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44653049-32f1-4a74-891c-f8ffe35360b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fe6fde8f-738f-4b6c-a497-aa3cc7955f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fe6fde8f-738f-4b6c-a497-aa3cc7955f3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86112379-5489-4e92-9f92-10cff8c99fa0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fe6fde8f-738f-4b6c-a497-aa3cc7955f3e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86112379-5489-4e92-9f92-10cff8c99fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_86112379-5489-4e92-9f92-10cff8c99fa0_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86112379-5489-4e92-9f92-10cff8c99fa0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_86112379-5489-4e92-9f92-10cff8c99fa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86112379-5489-4e92-9f92-10cff8c99fa0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember_10cb7305-0df4-4b1c-80d1-f8d37362760b" xlink:href="wst-20191231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_WestCompanyMexicoSADeCVMember_10cb7305-0df4-4b1c-80d1-f8d37362760b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember_3e5a3644-6730-4f9d-a617-06d5c92032aa" xlink:href="wst-20191231.xsd#wst_AluplastSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_AluplastSADeCVMember_3e5a3644-6730-4f9d-a617-06d5c92032aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember_a88d78b8-7982-46bd-bf36-e1e2ebf88991" xlink:href="wst-20191231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_PharmaTapSADeCVMember_a88d78b8-7982-46bd-bf36-e1e2ebf88991" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember_0dee225f-97be-4477-a7f0-fbaf0b9bec86" xlink:href="wst-20191231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_PharmaRubberSADeCVMember_0dee225f-97be-4477-a7f0-fbaf0b9bec86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_bb51ff57-2d38-42bb-a4d8-96617b5e306d" xlink:href="wst-20191231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_bb51ff57-2d38-42bb-a4d8-96617b5e306d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IWPharmaGroupLLCMember_3cca1c30-163a-49da-ad7a-b3a3bd3680fa" xlink:href="wst-20191231.xsd#wst_IWPharmaGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_IWPharmaGroupLLCMember_3cca1c30-163a-49da-ad7a-b3a3bd3680fa" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails" xlink:type="extended" id="i0902ae3f192c4f6e81e787c1ee04c8b6_b3348b3a-624a-4289-9751-cabd479b9b26">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_11f08135-e3bd-407d-9cea-faaf566e12e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_11f08135-e3bd-407d-9cea-faaf566e12e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d58a95ae-c572-4302-b0b2-b176bd49ca40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d58a95ae-c572-4302-b0b2-b176bd49ca40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_f621f683-cea2-41c9-9d61-e11115d1fb72" xlink:href="wst-20191231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_f621f683-cea2-41c9-9d61-e11115d1fb72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_46d50d0c-bbda-4ce7-af09-0a0a252fbf77" xlink:href="wst-20191231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_46d50d0c-bbda-4ce7-af09-0a0a252fbf77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_bd5ceed4-4b3a-4a90-b99c-38b17c57acd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_bd5ceed4-4b3a-4a90-b99c-38b17c57acd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees_69684b46-b81e-49a7-b093-8dd5667c72c7" xlink:href="wst-20191231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_wst_SalesToEquityMethodInvestees_69684b46-b81e-49a7-b093-8dd5667c72c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_88afebf1-0d08-444b-a495-f396ba2b7890" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueFromAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_DueFromAffiliates_88afebf1-0d08-444b-a495-f396ba2b7890" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_07991da6-cdb2-42f1-8615-8b30ce5e5994" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_EquityMethodInvestments_07991da6-cdb2-42f1-8615-8b30ce5e5994" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostMethodInvestments_3f13c9c9-0dce-4d7b-8135-952e12640e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_CostMethodInvestments_3f13c9c9-0dce-4d7b-8135-952e12640e4c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ce889269-6350-4cc0-bee1-4bdf0614a3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ce889269-6350-4cc0-bee1-4bdf0614a3d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1309143b-0ded-4a3d-adc9-545e0ea404b2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ce889269-6350-4cc0-bee1-4bdf0614a3d1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1309143b-0ded-4a3d-adc9-545e0ea404b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1309143b-0ded-4a3d-adc9-545e0ea404b2_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1309143b-0ded-4a3d-adc9-545e0ea404b2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1309143b-0ded-4a3d-adc9-545e0ea404b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_da390cbc-f806-46ec-9d21-0bbed676398f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1309143b-0ded-4a3d-adc9-545e0ea404b2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_da390cbc-f806-46ec-9d21-0bbed676398f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_5a9bff39-c0cc-4584-88da-87e8b99dfd51" xlink:href="wst-20191231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_da390cbc-f806-46ec-9d21-0bbed676398f" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_5a9bff39-c0cc-4584-88da-87e8b99dfd51" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended" id="i32f4599fc44e4eeaa81444b0010d0678_9928aae3-4c20-4283-a52a-24bc08676e95"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended" id="i68ce40a11b164922bc31e5412764e74e_407fbf48-0c38-407b-ad30-5fce0331fbee"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i21355773709942ec925ee1ffcaec00f6_46464752-ef22-4f47-9729-95736397456c">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_892c41e5-3ce2-4f98-abd4-bd98c15065ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_892c41e5-3ce2-4f98-abd4-bd98c15065ef" xlink:to="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b758635d-01d9-44a6-975f-b55f4c163774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:to="loc_us-gaap_Goodwill_b758635d-01d9-44a6-975f-b55f4c163774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8fb93a2d-b272-48ac-b044-9b2c1e85dae4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8fb93a2d-b272-48ac-b044-9b2c1e85dae4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_979466ef-2151-4d8e-9e61-1414849fd90e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_979466ef-2151-4d8e-9e61-1414849fd90e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2dc0239-4f5f-494c-9d29-50153a0e8088" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2ff17722-43e7-4a7b-b20b-cf46addc5311" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_892c41e5-3ce2-4f98-abd4-bd98c15065ef" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2ff17722-43e7-4a7b-b20b-cf46addc5311" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab260d2d-3216-46db-be99-202cdad7ddbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2ff17722-43e7-4a7b-b20b-cf46addc5311" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab260d2d-3216-46db-be99-202cdad7ddbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ab260d2d-3216-46db-be99-202cdad7ddbe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab260d2d-3216-46db-be99-202cdad7ddbe" xlink:to="loc_us-gaap_SegmentDomain_ab260d2d-3216-46db-be99-202cdad7ddbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab260d2d-3216-46db-be99-202cdad7ddbe" xlink:to="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_151aefc4-48b8-448f-8659-4ed50ad5adbf" xlink:href="wst-20191231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:to="loc_wst_ProprietaryProductsMember_151aefc4-48b8-448f-8659-4ed50ad5adbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_d2428b8d-c265-454a-854a-c702900eb70d" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:to="loc_wst_ContractManufacturedProductsMember_d2428b8d-c265-454a-854a-c702900eb70d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended" id="i13276ad7840740819fb59e0df6c4f224_007fc5fb-48db-4229-a004-a4e629c3dc1f">
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_aecfb4b4-d86b-432b-a40a-a88ea49748a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_aecfb4b4-d86b-432b-a40a-a88ea49748a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_afc5f806-b374-4ba8-bc33-d85e5383c200" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_afc5f806-b374-4ba8-bc33-d85e5383c200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914ce17b-f8fd-43d9-8ffb-da030c291b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914ce17b-f8fd-43d9-8ffb-da030c291b6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_6cb02951-5bfa-4c88-898f-687c1633f68e" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_6cb02951-5bfa-4c88-898f-687c1633f68e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_18da69b5-fcdb-464a-adbd-7996921feeca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_6cb02951-5bfa-4c88-898f-687c1633f68e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_18da69b5-fcdb-464a-adbd-7996921feeca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18da69b5-fcdb-464a-adbd-7996921feeca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_18da69b5-fcdb-464a-adbd-7996921feeca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_18da69b5-fcdb-464a-adbd-7996921feeca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_18da69b5-fcdb-464a-adbd-7996921feeca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember_663cb0a0-437c-4335-8ffa-6f156f6d45fc" xlink:href="wst-20191231.xsd#wst_PatentsAndLicensingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_wst_PatentsAndLicensingMember_663cb0a0-437c-4335-8ffa-6f156f6d45fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6ac8887d-452d-4313-8687-6d151690275a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6ac8887d-452d-4313-8687-6d151690275a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4fb68892-8888-4c97-8a8d-1d785cc60dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_TrademarksMember_4fb68892-8888-4c97-8a8d-1d785cc60dc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6339b88a-47b8-4be2-b9c4-f1181804fa39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6339b88a-47b8-4be2-b9c4-f1181804fa39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_23f76b29-1f09-4582-9231-ba3be9d475c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_CustomerContractsMember_23f76b29-1f09-4582-9231-ba3be9d475c3" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails" xlink:type="extended" id="iea49e364732a4752b336d00167880356_9d073b29-42f4-49bd-be98-c64ec78b5cf1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatent_c799abf2-b0c4-4bcf-8181-e33043c659b6" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_wst_AssetImpairmentChargesPatent_c799abf2-b0c4-4bcf-8181-e33043c659b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesTrademark_3d746f7d-2a4d-4e3c-8818-61595fa36d4c" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesTrademark"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_wst_AssetImpairmentChargesTrademark_3d746f7d-2a4d-4e3c-8818-61595fa36d4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_6c8f3f5c-b21e-4590-9fa5-d99910200bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_6c8f3f5c-b21e-4590-9fa5-d99910200bf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_88e83309-a0b4-46d3-90e3-5625c47ab963" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_88e83309-a0b4-46d3-90e3-5625c47ab963" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1eaa510c-9cee-42bc-a1b1-4972a1017729" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1eaa510c-9cee-42bc-a1b1-4972a1017729" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_df618263-2023-4137-97a8-4b07cc3fd852" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_df618263-2023-4137-97a8-4b07cc3fd852" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7fb92298-fecf-423a-ba03-ff36340ff04a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7fb92298-fecf-423a-ba03-ff36340ff04a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50ea0050-a212-48b1-817a-2d5cbb071609" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50ea0050-a212-48b1-817a-2d5cbb071609" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ac77d5af-9265-4e92-b2d2-1bec89c58626" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ac77d5af-9265-4e92-b2d2-1bec89c58626" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_16400a1e-42d4-4466-b8b7-401f9b90664a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:to="loc_us-gaap_RestructuringPlanAxis_16400a1e-42d4-4466-b8b7-401f9b90664a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_16400a1e-42d4-4466-b8b7-401f9b90664a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_16400a1e-42d4-4466-b8b7-401f9b90664a" xlink:to="loc_us-gaap_RestructuringPlanDomain_16400a1e-42d4-4466-b8b7-401f9b90664a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_03860fc9-9819-41f6-9c39-0d7724ab728f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_16400a1e-42d4-4466-b8b7-401f9b90664a" xlink:to="loc_us-gaap_RestructuringPlanDomain_03860fc9-9819-41f6-9c39-0d7724ab728f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2016RestructuringPlanMemberMember_07e18670-cd13-486f-83fa-2fbed7002e4d" xlink:href="wst-20191231.xsd#wst_A2016RestructuringPlanMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_03860fc9-9819-41f6-9c39-0d7724ab728f" xlink:to="loc_wst_A2016RestructuringPlanMemberMember_07e18670-cd13-486f-83fa-2fbed7002e4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1b086568-ea86-4632-8fe4-63f36b1d6809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1b086568-ea86-4632-8fe4-63f36b1d6809" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b086568-ea86-4632-8fe4-63f36b1d6809_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1b086568-ea86-4632-8fe4-63f36b1d6809" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b086568-ea86-4632-8fe4-63f36b1d6809_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_29f7bcec-e8e3-4dad-87ab-dbb662cfb646" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1b086568-ea86-4632-8fe4-63f36b1d6809" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_29f7bcec-e8e3-4dad-87ab-dbb662cfb646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_b016278b-d514-4857-a265-bb081e0822fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_29f7bcec-e8e3-4dad-87ab-dbb662cfb646" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_b016278b-d514-4857-a265-bb081e0822fb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilities"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="extended" id="i89aad2d918164340a22b5d34375178d1_ffa146cd-414c-4e89-b728-e1129fda5088"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended" id="i1c50e740357f4739b305bb1ddc3940a3_70a0b81c-aedd-449a-b09b-d9616b9763e0"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended" id="i8b32d4eab8574e5e8936979804588bbb_6af959ff-d7fa-4372-a9d3-15b192a4a5d5"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20191231.xsd#Debt"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended" id="id7cda4f19d554af782af38725096f781_60f40674-21ba-48e0-82d2-0ce84cfaf859"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended" id="i1055f3a07a094fa79ffae50945f54a02_15da202d-94a9-4b7b-9166-d10e9caa3f2c"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtDetails" xlink:type="extended" id="i74935ef188aa43e99238d1011c726119_349092e9-9d2f-4c7d-82a7-35b759ed903d">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1504959e-0e27-467e-b3ef-6e0eb8572580" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1504959e-0e27-467e-b3ef-6e0eb8572580" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_807b490f-eb48-4a75-803a-f592d8ee2277" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_LongTermDebt_807b490f-eb48-4a75-803a-f592d8ee2277" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_fcf6f39b-4e26-4818-9e5a-62df14172121" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_fcf6f39b-4e26-4818-9e5a-62df14172121" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_30127c77-484f-4c12-9d38-a91dc90e2f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_LongTermLineOfCredit_30127c77-484f-4c12-9d38-a91dc90e2f5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_c382075d-0ae8-4c8d-bf16-b0cad9528691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtCurrent_c382075d-0ae8-4c8d-bf16-b0cad9528691" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5dcf617e-5cea-4a05-820a-74e59194459f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5dcf617e-5cea-4a05-820a-74e59194459f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1707acf2-fe30-4952-b920-9df1b38fc83f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1707acf2-fe30-4952-b920-9df1b38fc83f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_71babc19-5129-4aa0-ad14-b0ab5f0d1735" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_71babc19-5129-4aa0-ad14-b0ab5f0d1735" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_82f61a49-eb08-498e-adae-a00a58db3fb0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:to="loc_srt_RangeAxis_82f61a49-eb08-498e-adae-a00a58db3fb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_82f61a49-eb08-498e-adae-a00a58db3fb0_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_82f61a49-eb08-498e-adae-a00a58db3fb0" xlink:to="loc_srt_RangeMember_82f61a49-eb08-498e-adae-a00a58db3fb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_82f61a49-eb08-498e-adae-a00a58db3fb0" xlink:to="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31d40d68-d7b0-4268-a064-a30ddca78cdb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:to="loc_srt_MinimumMember_31d40d68-d7b0-4268-a064-a30ddca78cdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a9eadd5f-a0c4-4553-808c-1afa801006fb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:to="loc_srt_MaximumMember_a9eadd5f-a0c4-4553-808c-1afa801006fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_be22783d-d290-46aa-b1dd-b7f6ab732d92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_be22783d-d290-46aa-b1dd-b7f6ab732d92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_be22783d-d290-46aa-b1dd-b7f6ab732d92_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_be22783d-d290-46aa-b1dd-b7f6ab732d92" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_be22783d-d290-46aa-b1dd-b7f6ab732d92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_be22783d-d290-46aa-b1dd-b7f6ab732d92" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2017Member_efb1da26-6cb8-49c6-a590-1e02f68ef872" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_RevolvingCreditFacilityDue2017Member_efb1da26-6cb8-49c6-a590-1e02f68ef872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotePayableDue2019Member_1385398d-ee1e-427e-82b6-8f2ea5c3f1a3" xlink:href="wst-20191231.xsd#wst_NotePayableDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_NotePayableDue2019Member_1385398d-ee1e-427e-82b6-8f2ea5c3f1a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Revolvingcreditfacilitydue2020Member_f4d1906a-f05a-4643-bd78-f0bfeb83879c" xlink:href="wst-20191231.xsd#wst_Revolvingcreditfacilitydue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_Revolvingcreditfacilitydue2020Member_f4d1906a-f05a-4643-bd78-f0bfeb83879c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_527795bf-dc7d-4180-a476-b2813204688b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_us-gaap_SeniorNotesMember_527795bf-dc7d-4180-a476-b2813204688b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Domain_8f8c2a10-d318-48af-8f52-bd7b18258cff" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_TermLoanDue2024Domain_8f8c2a10-d318-48af-8f52-bd7b18258cff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_c76981af-571a-470d-afc3-0815c6aa398b" xlink:href="wst-20191231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_SeniorNotesDue2022Member_c76981af-571a-470d-afc3-0815c6aa398b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_883abb0f-e4f7-44a1-adfb-97e10ba997c9" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_TermLoanDue2024Member_883abb0f-e4f7-44a1-adfb-97e10ba997c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d1f291d1-e3a6-4227-9331-6033d908ca4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:to="loc_us-gaap_DebtInstrumentAxis_d1f291d1-e3a6-4227-9331-6033d908ca4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d1f291d1-e3a6-4227-9331-6033d908ca4b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d1f291d1-e3a6-4227-9331-6033d908ca4b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d1f291d1-e3a6-4227-9331-6033d908ca4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d1f291d1-e3a6-4227-9331-6033d908ca4b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_722205a6-0445-4d28-8d99-b8a4631fa7bd" xlink:href="wst-20191231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:to="loc_wst_SeniorNotesDue2022Member_722205a6-0445-4d28-8d99-b8a4631fa7bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_5d7e3c4d-e389-44af-be0a-527a9583d2d9" xlink:href="wst-20191231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:to="loc_wst_SeniorBNotesDue2024Member_5d7e3c4d-e389-44af-be0a-527a9583d2d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_ea5baf96-0503-4f79-9cb3-c426f65d53d8" xlink:href="wst-20191231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:to="loc_wst_SeniorCNotesDue2027Member_ea5baf96-0503-4f79-9cb3-c426f65d53d8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DebtTextualsDetails" xlink:type="extended" id="i87d348c6648b475eb188fd4d63c467f8_d53ca392-b8c9-47c9-986a-bd9bfbbdffe4">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9d75ab53-5b64-4f1f-937a-b7dcc1e3fe49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9d75ab53-5b64-4f1f-937a-b7dcc1e3fe49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineofCreditFacilityAdditionalBorrowingCapacity_b1978545-a493-4bed-8ba3-a617f60050b1" xlink:href="wst-20191231.xsd#wst_LineofCreditFacilityAdditionalBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_LineofCreditFacilityAdditionalBorrowingCapacity_b1978545-a493-4bed-8ba3-a617f60050b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_e18088c5-9210-4d00-8ac5-e556b4318aa2" xlink:href="wst-20191231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_e18088c5-9210-4d00-8ac5-e556b4318aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_f0cce2cf-7fa1-4a34-bfd1-fee71a6b16e1" xlink:href="wst-20191231.xsd#wst_CreditAvailableForIssuanceOfLettersOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_f0cce2cf-7fa1-4a34-bfd1-fee71a6b16e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4d700345-eb44-45cf-8463-8fb41223a3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebt_4d700345-eb44-45cf-8463-8fb41223a3c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8e03ab05-3b36-4e05-9313-0c8ff2b9aef6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebtCurrent_8e03ab05-3b36-4e05-9313-0c8ff2b9aef6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_04374da6-6ecf-480b-91fe-9f81fc8444f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_04374da6-6ecf-480b-91fe-9f81fc8444f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_40695d2b-07e5-4ad8-82c9-270c3e98d949" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermLineOfCredit_40695d2b-07e5-4ad8-82c9-270c3e98d949" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotionalAmountOfNonderivativeInstruments_2463fc6d-1fa8-468c-9a66-27e0092d4abf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotionalAmountOfNonderivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_NotionalAmountOfNonderivativeInstruments_2463fc6d-1fa8-468c-9a66-27e0092d4abf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_406bed39-8527-49b9-b16e-ff5106723626" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LineOfCredit_406bed39-8527-49b9-b16e-ff5106723626" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9f755acb-b77c-410c-bc7f-9e9cf8f5d71b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9f755acb-b77c-410c-bc7f-9e9cf8f5d71b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_99a12ac6-c660-49ff-b242-13eba24e72bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_99a12ac6-c660-49ff-b242-13eba24e72bb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_934a4312-6d4b-4195-830d-de00ae17ada9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_934a4312-6d4b-4195-830d-de00ae17ada9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2235eb35-3a58-4daf-9305-1a00ef4e4415" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2235eb35-3a58-4daf-9305-1a00ef4e4415" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_97a96dc6-2383-45e9-89fd-9b29ffc652ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_97a96dc6-2383-45e9-89fd-9b29ffc652ab" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f55ee5ae-a87e-4ce8-ae66-00ca5e3ef7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f55ee5ae-a87e-4ce8-ae66-00ca5e3ef7e7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_dbe8fa17-7d16-462f-b02c-6dbaf07789d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentTerm_dbe8fa17-7d16-462f-b02c-6dbaf07789d5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_ffb0c416-dcc4-450d-a581-308f35b1a846" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_ffb0c416-dcc4-450d-a581-308f35b1a846" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a82a185b-01a0-48df-a3ed-189017969212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a82a185b-01a0-48df-a3ed-189017969212" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e840a7ba-d3c6-4c74-a110-5520793a78be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e840a7ba-d3c6-4c74-a110-5520793a78be" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c49f4ffc-0aef-4939-9948-1be63a5437f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c49f4ffc-0aef-4939-9948-1be63a5437f5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification_437edb11-3ac8-4be9-87c9-8f333eb11a86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification_437edb11-3ac8-4be9-87c9-8f333eb11a86" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_ac7ffd46-238a-449a-9478-6b3e0fd78092" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_ac7ffd46-238a-449a-9478-6b3e0fd78092" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_79eafca1-aff7-4c29-9d36-238e1997fcb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_InterestExpenseDebt_79eafca1-aff7-4c29-9d36-238e1997fcb6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_57748f4a-17fe-4b92-9c49-d401cce39378" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_57748f4a-17fe-4b92-9c49-d401cce39378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_88591a59-3e07-4de2-8458-9af299a4cfee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_88591a59-3e07-4de2-8458-9af299a4cfee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8ff37681-175a-4e74-bd84-5651c06fb016" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8ff37681-175a-4e74-bd84-5651c06fb016" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5401a9d0-1c78-4e89-b388-5f287b1d2e21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5401a9d0-1c78-4e89-b388-5f287b1d2e21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a9aa475a-069a-4681-b0e2-d6881d1595d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a9aa475a-069a-4681-b0e2-d6881d1595d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d9a85014-da05-4b28-8ad3-15c33b68f2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d9a85014-da05-4b28-8ad3-15c33b68f2c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RatioOfDebtToEBITDA_6809b513-8c5b-4cf5-be66-b7ba48965e70" xlink:href="wst-20191231.xsd#wst_RatioOfDebtToEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_RatioOfDebtToEBITDA_6809b513-8c5b-4cf5-be66-b7ba48965e70" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_812674dd-5de9-45a4-a917-34afd6fd2c37" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_srt_RangeAxis_812674dd-5de9-45a4-a917-34afd6fd2c37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_812674dd-5de9-45a4-a917-34afd6fd2c37_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_812674dd-5de9-45a4-a917-34afd6fd2c37" xlink:to="loc_srt_RangeMember_812674dd-5de9-45a4-a917-34afd6fd2c37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_812674dd-5de9-45a4-a917-34afd6fd2c37" xlink:to="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1537409b-cc2c-4618-9b08-5788eb3364fe" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:to="loc_srt_MinimumMember_1537409b-cc2c-4618-9b08-5788eb3364fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a88a25c-9a8e-4ecb-8d14-8436bb87a092" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:to="loc_srt_MaximumMember_6a88a25c-9a8e-4ecb-8d14-8436bb87a092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c594df43-6817-45d8-a07b-d1abb9475382" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c594df43-6817-45d8-a07b-d1abb9475382" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c594df43-6817-45d8-a07b-d1abb9475382_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c594df43-6817-45d8-a07b-d1abb9475382" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c594df43-6817-45d8-a07b-d1abb9475382_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_024e91f1-e223-43d9-975a-aa7ad24675ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c594df43-6817-45d8-a07b-d1abb9475382" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_024e91f1-e223-43d9-975a-aa7ad24675ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_497fb106-6099-4338-9cb5-df774229e868" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_CreditFacilityAxis_497fb106-6099-4338-9cb5-df774229e868" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_497fb106-6099-4338-9cb5-df774229e868_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_497fb106-6099-4338-9cb5-df774229e868" xlink:to="loc_us-gaap_CreditFacilityDomain_497fb106-6099-4338-9cb5-df774229e868_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_497fb106-6099-4338-9cb5-df774229e868" xlink:to="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_110d0027-7f29-443a-91f5-058c0d130804" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_BaseRateMember_110d0027-7f29-443a-91f5-058c0d130804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_883bc111-b264-4090-89bd-1cc263da83db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_883bc111-b264-4090-89bd-1cc263da83db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_52180ad9-d5d1-4f34-bb1f-d2c1544da31f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_LetterOfCreditMember_52180ad9-d5d1-4f34-bb1f-d2c1544da31f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_735d03df-9d08-42a7-8704-b4274796ad29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_735d03df-9d08-42a7-8704-b4274796ad29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_3afe1202-2980-4a5d-83e0-958c7e9c3c9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_3afe1202-2980-4a5d-83e0-958c7e9c3c9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_86fe8442-3bdd-4ec4-9423-563db1ae4b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_86fe8442-3bdd-4ec4-9423-563db1ae4b9e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0a7a22c6-6607-4976-9406-8f8f617654cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0a7a22c6-6607-4976-9406-8f8f617654cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a7a22c6-6607-4976-9406-8f8f617654cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0a7a22c6-6607-4976-9406-8f8f617654cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a7a22c6-6607-4976-9406-8f8f617654cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0a7a22c6-6607-4976-9406-8f8f617654cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Revolvingcreditfacilitydue2020Member_f14b881d-6314-44af-8edb-b836b906ac9e" xlink:href="wst-20191231.xsd#wst_Revolvingcreditfacilitydue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_wst_Revolvingcreditfacilitydue2020Member_f14b881d-6314-44af-8edb-b836b906ac9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6d7d841e-1d8c-424a-83c2-bbe91670c1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_us-gaap_SeniorNotesMember_6d7d841e-1d8c-424a-83c2-bbe91670c1b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_971c9e2b-ecbc-47b7-ae64-3e56fee7a43b" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_971c9e2b-ecbc-47b7-ae64-3e56fee7a43b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_ad7814f7-b057-4020-a206-34ec9f833aa9" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_wst_TermLoanDue2024Member_ad7814f7-b057-4020-a206-34ec9f833aa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_292c7db8-943e-4bdd-844d-1780eda25add" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_DebtInstrumentAxis_292c7db8-943e-4bdd-844d-1780eda25add" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_292c7db8-943e-4bdd-844d-1780eda25add_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_292c7db8-943e-4bdd-844d-1780eda25add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_292c7db8-943e-4bdd-844d-1780eda25add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_292c7db8-943e-4bdd-844d-1780eda25add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_fc7abc39-3ca6-497f-9b1e-a809f131456a" xlink:href="wst-20191231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:to="loc_wst_SeniorNotesDue2022Member_fc7abc39-3ca6-497f-9b1e-a809f131456a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_d8ac171f-5950-441d-b84a-e6268e7d5c35" xlink:href="wst-20191231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:to="loc_wst_SeniorBNotesDue2024Member_d8ac171f-5950-441d-b84a-e6268e7d5c35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_92ef2da0-d934-4b2b-9e0f-72013d925455" xlink:href="wst-20191231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:to="loc_wst_SeniorCNotesDue2027Member_92ef2da0-d934-4b2b-9e0f-72013d925455" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended" id="i0c33f3658dbf4e1c928d73e6d05c79d6_4cc52c80-2a71-4a5b-ba20-3a64e31cd5e6"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended" id="ic78ab65c436f4886adb439b2208ee747_26a4353d-4a0a-49b6-9971-8100c2f66b36"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" xlink:type="extended" id="ia9db558a554d41bca4a0cf382bd0d6c0_89c14fd4-e25b-4668-9e90-61b3bf79785f">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_8f63ef6c-6af8-4fb3-b592-05f46fe71c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_8f63ef6c-6af8-4fb3-b592-05f46fe71c7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_3388aa64-a1f1-4fd9-bff9-2a4857631b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_3388aa64-a1f1-4fd9-bff9-2a4857631b5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_adee1b0a-38c5-49ac-92e4-afb68961efe6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:to="loc_us-gaap_DerivativeNotionalAmount_adee1b0a-38c5-49ac-92e4-afb68961efe6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:to="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_8a6e6772-9f39-4870-be36-4d306971bc81" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_srt_CurrencyAxis_8a6e6772-9f39-4870-be36-4d306971bc81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_8a6e6772-9f39-4870-be36-4d306971bc81_default" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_8a6e6772-9f39-4870-be36-4d306971bc81" xlink:to="loc_currency_AllCurrenciesDomain_8a6e6772-9f39-4870-be36-4d306971bc81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_8a6e6772-9f39-4870-be36-4d306971bc81" xlink:to="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_1b2ddad9-6b84-4268-954d-661a7d9feeb9" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_EUR_1b2ddad9-6b84-4268-954d-661a7d9feeb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_cad45503-3fb7-405d-bf2a-99cd6532f720" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_USD_cad45503-3fb7-405d-bf2a-99cd6532f720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_a7482d44-db99-4045-a592-277b90b5c15a" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_JPY_a7482d44-db99-4045-a592-277b90b5c15a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_798ce367-a6f3-4f20-96d3-0a858ee7218a" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_SGD_798ce367-a6f3-4f20-96d3-0a858ee7218a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_04dac43a-2a95-412f-9d74-2dfcfdad64e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_PositionAxis_04dac43a-2a95-412f-9d74-2dfcfdad64e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_04dac43a-2a95-412f-9d74-2dfcfdad64e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_04dac43a-2a95-412f-9d74-2dfcfdad64e1" xlink:to="loc_us-gaap_PositionDomain_04dac43a-2a95-412f-9d74-2dfcfdad64e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_04dac43a-2a95-412f-9d74-2dfcfdad64e1" xlink:to="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_3b23a227-1977-494a-a9fc-9036e9706243" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:to="loc_us-gaap_LongMember_3b23a227-1977-494a-a9fc-9036e9706243" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_f4f1ddeb-daf9-4a51-9456-3b84a113634c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:to="loc_us-gaap_ShortMember_f4f1ddeb-daf9-4a51-9456-3b84a113634c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40b4f0dc-10ab-452e-b7f2-5f209f1a4387" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40b4f0dc-10ab-452e-b7f2-5f209f1a4387" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_40b4f0dc-10ab-452e-b7f2-5f209f1a4387_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40b4f0dc-10ab-452e-b7f2-5f209f1a4387" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_40b4f0dc-10ab-452e-b7f2-5f209f1a4387_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40b4f0dc-10ab-452e-b7f2-5f209f1a4387" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6169cf59-6301-4144-8529-15b3b034b9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6169cf59-6301-4144-8529-15b3b034b9b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_aaa3712d-27c1-4322-a016-c85651480f69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_TreasuryLockMember_aaa3712d-27c1-4322-a016-c85651480f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardStartInterestRateSwapMember_29115ecc-36a8-40d2-b5b4-b3e1fef19494" xlink:href="wst-20191231.xsd#wst_ForwardStartInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_wst_ForwardStartInterestRateSwapMember_29115ecc-36a8-40d2-b5b4-b3e1fef19494" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_922976fd-c7d5-46d8-8ba5-6897d522108c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_ForwardContractsMember_922976fd-c7d5-46d8-8ba5-6897d522108c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_8d7cd253-f914-411e-9648-49c1cb27d377" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_DebtMember_8d7cd253-f914-411e-9648-49c1cb27d377" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EuroDenominatedRevolverMember_812209eb-54c0-461e-9c71-a1b4765461ab" xlink:href="wst-20191231.xsd#wst_EuroDenominatedRevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_wst_EuroDenominatedRevolverMember_812209eb-54c0-461e-9c71-a1b4765461ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtYenDenominatedMember_a727d2b5-c93a-49fe-93cc-bd99de38a4ef" xlink:href="wst-20191231.xsd#wst_DebtYenDenominatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_wst_DebtYenDenominatedMember_a727d2b5-c93a-49fe-93cc-bd99de38a4ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_7f2dfe2d-ebe0-45da-a413-7cfa2ee2f60d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_CommodityOptionMember_7f2dfe2d-ebe0-45da-a413-7cfa2ee2f60d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_389ed045-016d-4336-8f31-aafa2b346841" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_OptionMember_389ed045-016d-4336-8f31-aafa2b346841" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_b3fc90d4-f893-411f-ac7e-f8dab4403c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_b3fc90d4-f893-411f-ac7e-f8dab4403c2c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd" xlink:to="loc_us-gaap_HedgingDesignationDomain_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9735cb8e-3d42-4b92-837c-19cfd5627548" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd" xlink:to="loc_us-gaap_HedgingDesignationDomain_9735cb8e-3d42-4b92-837c-19cfd5627548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aad22edf-89f7-49a4-a889-d5e8f86f5397" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9735cb8e-3d42-4b92-837c-19cfd5627548" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aad22edf-89f7-49a4-a889-d5e8f86f5397" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0f149bcc-4691-473a-91be-f2bd7deeb849" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0f149bcc-4691-473a-91be-f2bd7deeb849" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0f149bcc-4691-473a-91be-f2bd7deeb849_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0f149bcc-4691-473a-91be-f2bd7deeb849" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0f149bcc-4691-473a-91be-f2bd7deeb849_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_62fa4852-7a57-485b-a92c-11c446977840" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0f149bcc-4691-473a-91be-f2bd7deeb849" xlink:to="loc_us-gaap_HedgingRelationshipDomain_62fa4852-7a57-485b-a92c-11c446977840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a60d95cb-0481-4a38-bcc9-97992ec45958" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_62fa4852-7a57-485b-a92c-11c446977840" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a60d95cb-0481-4a38-bcc9-97992ec45958" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails" xlink:type="extended" id="id37a5f94b00848aa81d52e7ddc9ddaef_b5c584ed-680f-481c-8465-3cbf366412ec">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_966d72ba-6dba-4842-aac4-c4a7361500f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_966d72ba-6dba-4842-aac4-c4a7361500f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_9e454a49-a342-45fd-9006-f6d0753a1de5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_9e454a49-a342-45fd-9006-f6d0753a1de5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_04cfb798-fe5e-4cef-ba46-a64955b50241" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_04cfb798-fe5e-4cef-ba46-a64955b50241" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_73c3470d-d52a-4095-84a6-542ad5e18df3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_73c3470d-d52a-4095-84a6-542ad5e18df3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_9fb23f7a-3b56-4599-be80-30cbed1da12d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_9fb23f7a-3b56-4599-be80-30cbed1da12d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_93e23c90-08c4-4476-a572-23beccd66c54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_93e23c90-08c4-4476-a572-23beccd66c54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_f605a68e-f684-4b29-9a00-91515e47fa90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_f605a68e-f684-4b29-9a00-91515e47fa90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths_9f481d7f-cf6f-4c2f-9c03-1e98e3149b07" xlink:href="wst-20191231.xsd#wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths_9f481d7f-cf6f-4c2f-9c03-1e98e3149b07" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_99fe0131-5a42-4223-8e1d-0b7c690b7a93" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_srt_CurrencyAxis_99fe0131-5a42-4223-8e1d-0b7c690b7a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_99fe0131-5a42-4223-8e1d-0b7c690b7a93_default" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_99fe0131-5a42-4223-8e1d-0b7c690b7a93" xlink:to="loc_currency_AllCurrenciesDomain_99fe0131-5a42-4223-8e1d-0b7c690b7a93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_99fe0131-5a42-4223-8e1d-0b7c690b7a93" xlink:to="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_562ddcd5-7846-4ebe-89b8-3c04012f3f90" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_EUR_562ddcd5-7846-4ebe-89b8-3c04012f3f90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_0b253a89-0771-4503-b9c3-72a3f3a79d66" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_SGD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_SGD_0b253a89-0771-4503-b9c3-72a3f3a79d66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_8093101b-4734-4c73-a83a-94d687b32616" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_USD_8093101b-4734-4c73-a83a-94d687b32616" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_6fa80e35-0477-4c65-91f5-1559a4bd6fd0" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_JPY_6fa80e35-0477-4c65-91f5-1559a4bd6fd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_713020d8-0f71-4346-a398-1991217993e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_713020d8-0f71-4346-a398-1991217993e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_713020d8-0f71-4346-a398-1991217993e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713020d8-0f71-4346-a398-1991217993e6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_713020d8-0f71-4346-a398-1991217993e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713020d8-0f71-4346-a398-1991217993e6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_bd82fec4-eae2-42d8-98bd-84722d980f56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_ForwardContractsMember_bd82fec4-eae2-42d8-98bd-84722d980f56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_694aa323-ecbf-475d-874f-c147eb834de1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_OptionMember_694aa323-ecbf-475d-874f-c147eb834de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_45dd37b3-f076-41be-bad5-894d2f533f22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_ForeignExchangeContractMember_45dd37b3-f076-41be-bad5-894d2f533f22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_dfcfcab2-c88f-4ff5-a69c-b4b25566f729" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_InterestRateSwapMember_dfcfcab2-c88f-4ff5-a69c-b4b25566f729" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardTreasuryLockMember_0fb99b4c-7679-4e9f-b2ab-833aee303e69" xlink:href="wst-20191231.xsd#wst_ForwardTreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_wst_ForwardTreasuryLockMember_0fb99b4c-7679-4e9f-b2ab-833aee303e69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyDenominatedDebtMember_1a9ebff7-2a31-470b-b6bd-ec942a0760e6" xlink:href="wst-20191231.xsd#wst_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_wst_ForeignCurrencyDenominatedDebtMember_1a9ebff7-2a31-470b-b6bd-ec942a0760e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_23183b8f-a04f-4e40-965e-33adcb7836e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_CommodityOptionMember_23183b8f-a04f-4e40-965e-33adcb7836e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b12e5d70-f21f-40c4-a6ba-1bf746bf94a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_CurrencySwapMember_b12e5d70-f21f-40c4-a6ba-1bf746bf94a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_41a9ae54-19d5-47a9-b7df-182aa3cdaaed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_41a9ae54-19d5-47a9-b7df-182aa3cdaaed" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_33322f7d-5db8-4029-87fd-01b673eea16a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_33322f7d-5db8-4029-87fd-01b673eea16a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_33322f7d-5db8-4029-87fd-01b673eea16a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_33322f7d-5db8-4029-87fd-01b673eea16a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_33322f7d-5db8-4029-87fd-01b673eea16a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_33322f7d-5db8-4029-87fd-01b673eea16a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_df76cff1-dee2-4d55-b308-51493fdce320" xlink:href="wst-20191231.xsd#wst_NetSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_wst_NetSalesMember_df76cff1-dee2-4d55-b308-51493fdce320" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_91c2c4a0-d3f5-42dd-8053-498ca60cf5fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_CostOfSalesMember_91c2c4a0-d3f5-42dd-8053-498ca60cf5fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_bc6952e6-7d99-422a-8504-f2d7adc4cdce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_InterestExpenseMember_bc6952e6-7d99-422a-8504-f2d7adc4cdce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_82e525d7-5a2e-4de9-b10b-7ebb1c3cc911" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_82e525d7-5a2e-4de9-b10b-7ebb1c3cc911" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_54fcf87f-dcbf-40fc-b575-2cc18bbab766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_54fcf87f-dcbf-40fc-b575-2cc18bbab766" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_7e8e41e4-bf96-4b61-91de-1f94dcac28f2" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_wst_OtherIncomeExpense_7e8e41e4-bf96-4b61-91de-1f94dcac28f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_41d1b859-ce7f-4251-9f7f-026cc55f709d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_41d1b859-ce7f-4251-9f7f-026cc55f709d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_41d1b859-ce7f-4251-9f7f-026cc55f709d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_41d1b859-ce7f-4251-9f7f-026cc55f709d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_41d1b859-ce7f-4251-9f7f-026cc55f709d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_41d1b859-ce7f-4251-9f7f-026cc55f709d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c6f5aadf-50df-43df-8720-a72c86254039" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_CashFlowHedgingMember_c6f5aadf-50df-43df-8720-a72c86254039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e5d83d63-4497-49f7-9b70-ea4260057d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e5d83d63-4497-49f7-9b70-ea4260057d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1222ef41-e99a-4a84-92d9-c94ea7f38cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_NondesignatedMember_1222ef41-e99a-4a84-92d9-c94ea7f38cbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_8124945b-e89c-4713-9074-8242c2670f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_FairValueHedgingMember_8124945b-e89c-4713-9074-8242c2670f74" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended" id="ie327a46d22ee45e8a1d65d978692bd27_1da31b8b-98d9-4075-b40f-1bc862a58bd3"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i0d8a9264d01d41cc9b64d578231b7a09_40c4bb1f-e7ec-45a7-8564-03d2d99a82f3"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended" id="idd89bb8abcc747a78233579bb13dbcfe_32066d7b-9220-4f68-a346-6f5f435385e9">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_513656f0-c95f-4dce-b790-a62948c8ee87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_513656f0-c95f-4dce-b790-a62948c8ee87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_3cc76752-b456-451b-a741-b6c34a46461d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_3cc76752-b456-451b-a741-b6c34a46461d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_c8240c41-1a14-479b-8784-7cc1177d595a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_c8240c41-1a14-479b-8784-7cc1177d595a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_84b290ac-f075-49a2-8a73-72439bef46f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_84b290ac-f075-49a2-8a73-72439bef46f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5ab7ac32-60af-47c5-a87a-13479f275f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5ab7ac32-60af-47c5-a87a-13479f275f7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_34faae9a-7ada-4f4a-bdea-587f13d412c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_34faae9a-7ada-4f4a-bdea-587f13d412c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_9081bb6e-b1d8-41fd-810a-8ca0471be5ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_9081bb6e-b1d8-41fd-810a-8ca0471be5ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_dea036ec-85fb-4b91-aea2-9689c53ab4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_dea036ec-85fb-4b91-aea2-9689c53ab4ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_511c33c2-d4fd-42ac-bf1f-b32c94fffc0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_511c33c2-d4fd-42ac-bf1f-b32c94fffc0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bf18015-f514-4dc8-848f-faa9369239b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bf18015-f514-4dc8-848f-faa9369239b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bf18015-f514-4dc8-848f-faa9369239b0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bf18015-f514-4dc8-848f-faa9369239b0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7bf18015-f514-4dc8-848f-faa9369239b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bf18015-f514-4dc8-848f-faa9369239b0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4d713af6-f131-4b96-bc0f-d7f02e3cfa77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4d713af6-f131-4b96-bc0f-d7f02e3cfa77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_152d8fab-8cba-4f9c-a880-8eec4e81c36b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_152d8fab-8cba-4f9c-a880-8eec4e81c36b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a0a070bb-0486-4825-9d12-d618607e64ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a0a070bb-0486-4825-9d12-d618607e64ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0dc59397-beaa-4353-9495-b81f2381c824" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0dc59397-beaa-4353-9495-b81f2381c824" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0dc59397-beaa-4353-9495-b81f2381c824_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0dc59397-beaa-4353-9495-b81f2381c824" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0dc59397-beaa-4353-9495-b81f2381c824_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_87bc413e-ff85-40db-abaf-54607b1dd2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0dc59397-beaa-4353-9495-b81f2381c824" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_87bc413e-ff85-40db-abaf-54607b1dd2c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2994c7e6-5de8-4b98-8d9c-653c4d6fda6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87bc413e-ff85-40db-abaf-54607b1dd2c5" xlink:to="loc_us-gaap_CurrencySwapMember_2994c7e6-5de8-4b98-8d9c-653c4d6fda6b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="extended" id="ibe17b76487a9401c9fab7ff66133aba1_ea74608b-20bc-4858-b785-8c4cefead57b"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended" id="i050049dd287043d09913e40d05de19f0_efc8f7f9-6df5-412f-9eb1-c5d56d35d28a"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20191231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" id="i6630f5d813f74bc19cf63510b010034a_487a50a9-a9f1-4eed-be3d-01fb51423857"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20191231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" id="ifdf108983fd549f6a4709e9cdeaaa9d2_529ed310-d243-4add-8785-91419a5f2b10"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ComponentsofAOCIDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ComponentsofAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ComponentsofAOCIDetails" xlink:type="extended" id="i291eb66f60874d0f817d8d911052906f_0d7f02f9-0512-4459-b149-ef867b91921e">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dd9f429e-92f9-4b39-af4f-56a0e0dd8dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:to="loc_us-gaap_Revenues_dd9f429e-92f9-4b39-af4f-56a0e0dd8dd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d2c40135-fbc9-4606-bfb4-77ccfde84af2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d2c40135-fbc9-4606-bfb4-77ccfde84af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48465e92-ce17-439d-9208-c95e47d2e5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48465e92-ce17-439d-9208-c95e47d2e5f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6e07fd8b-f493-4df7-a2ee-e69a849408ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6e07fd8b-f493-4df7-a2ee-e69a849408ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d2256bc-7cd7-4d31-a2ce-59706274af74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d2256bc-7cd7-4d31-a2ce-59706274af74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7033bbc8-7d6c-478c-81e7-d933631ab203" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_db8d4315-a429-456f-bbc9-af8bc3c489b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_db8d4315-a429-456f-bbc9-af8bc3c489b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0397bc31-5f5f-4ea1-a3f8-141e520b9da1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_db8d4315-a429-456f-bbc9-af8bc3c489b8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0397bc31-5f5f-4ea1-a3f8-141e520b9da1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0397bc31-5f5f-4ea1-a3f8-141e520b9da1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0397bc31-5f5f-4ea1-a3f8-141e520b9da1" xlink:to="loc_us-gaap_EquityComponentDomain_0397bc31-5f5f-4ea1-a3f8-141e520b9da1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0397bc31-5f5f-4ea1-a3f8-141e520b9da1" xlink:to="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2cd87358-ab64-47f4-8e24-b557424125cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2cd87358-ab64-47f4-8e24-b557424125cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0cdbf850-57b2-4798-9ebc-64d51c6f8ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0cdbf850-57b2-4798-9ebc-64d51c6f8ec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d061df7c-328d-428c-88bf-7efeaaa6467e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d061df7c-328d-428c-88bf-7efeaaa6467e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b311296-fd04-4670-8306-215df9a8237c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b311296-fd04-4670-8306-215df9a8237c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ReclassificationsAOCIDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ReclassificationsAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ReclassificationsAOCIDetails" xlink:type="extended" id="ic518fa4079f248fd81613fcfcc946db4_57ae6486-a7b2-4e07-a293-fbba113645bd">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9b3a44d2-042d-4fce-96da-43a2644d565b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_Revenues_9b3a44d2-042d-4fce-96da-43a2644d565b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_46514718-96a1-4553-b7d2-d6fd6ae698b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_46514718-96a1-4553-b7d2-d6fd6ae698b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_18883ff7-ab24-4bac-a59a-fce46ef28c87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_InterestExpense_18883ff7-ab24-4bac-a59a-fce46ef28c87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_07043c3d-a032-4b4b-9d7a-08cc091ce5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_07043c3d-a032-4b4b-9d7a-08cc091ce5e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4a5391f7-3b80-4b05-b6f3-d74055072b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4a5391f7-3b80-4b05-b6f3-d74055072b1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e98ca6b8-f3be-476d-8535-eb7c9a80c70b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e98ca6b8-f3be-476d-8535-eb7c9a80c70b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_421a1120-a025-42e6-8a53-263bf3c3af1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_421a1120-a025-42e6-8a53-263bf3c3af1d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_27a680e3-309c-48af-9ed5-a5b13102f187" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_27a680e3-309c-48af-9ed5-a5b13102f187" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fcbc2ab8-9d3b-4e4c-b29e-56d6d3ffe36a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fcbc2ab8-9d3b-4e4c-b29e-56d6d3ffe36a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_86cbf603-b70a-4a2e-97d2-b3361c7d1c07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_ProfitLoss_86cbf603-b70a-4a2e-97d2-b3361c7d1c07" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9974eb17-fe8b-4627-8195-c215d207ec72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9974eb17-fe8b-4627-8195-c215d207ec72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_9974eb17-fe8b-4627-8195-c215d207ec72_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9974eb17-fe8b-4627-8195-c215d207ec72" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_9974eb17-fe8b-4627-8195-c215d207ec72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fbd162a8-f115-4801-b373-132b5440dc00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9974eb17-fe8b-4627-8195-c215d207ec72" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fbd162a8-f115-4801-b373-132b5440dc00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ea9b115b-750c-4448-a389-9a867d49cd60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fbd162a8-f115-4801-b373-132b5440dc00" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ea9b115b-750c-4448-a389-9a867d49cd60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b526e99c-80f6-4660-8a2f-f5962088a022" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b526e99c-80f6-4660-8a2f-f5962088a022" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b526e99c-80f6-4660-8a2f-f5962088a022_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b526e99c-80f6-4660-8a2f-f5962088a022" xlink:to="loc_us-gaap_EquityComponentDomain_b526e99c-80f6-4660-8a2f-f5962088a022_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b526e99c-80f6-4660-8a2f-f5962088a022" xlink:to="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_488cc582-7588-4855-a0b5-3028bc36fda5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_488cc582-7588-4855-a0b5-3028bc36fda5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_1a1b9780-811c-4339-b6e7-9ff87c425937" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_1a1b9780-811c-4339-b6e7-9ff87c425937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e0864109-c34f-4aed-a1d1-667303770a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e0864109-c34f-4aed-a1d1-667303770a5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e0864109-c34f-4aed-a1d1-667303770a5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0864109-c34f-4aed-a1d1-667303770a5e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e0864109-c34f-4aed-a1d1-667303770a5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0864109-c34f-4aed-a1d1-667303770a5e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f4dd1ae8-025a-4409-b43c-a02d346a0b24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f4dd1ae8-025a-4409-b43c-a02d346a0b24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a3f28c76-024f-4696-b7ee-fa09b0cbfc69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:to="loc_us-gaap_InterestRateSwapMember_a3f28c76-024f-4696-b7ee-fa09b0cbfc69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_455aab12-6dd2-461f-8c1a-6dedde6c42a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:to="loc_us-gaap_TreasuryLockMember_455aab12-6dd2-461f-8c1a-6dedde6c42a5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended" id="i8ae9c42397af4c5f96aca13059a1ba6a_7ec472c3-4763-46c3-858f-51c7d16a66de"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="extended" id="i1e15f3cbabe14938a0016c44a1dfbaaf_cf527aba-3fde-41b9-a802-b9cd1a2cc197"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTextualsDetails" xlink:type="extended" id="i81c42b093c434c5f86a0c8a67b4fa3f2_3b0d5f5e-9fa9-4514-8d11-66b7fcd44c53">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cf0563d7-1860-4a2c-962f-e9a631f7fed8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cf0563d7-1860-4a2c-962f-e9a631f7fed8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementwithIndividualConversionUnit_c4048676-be5c-4b98-abba-98c789c6ee02" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementwithIndividualConversionUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredCompensationArrangementwithIndividualConversionUnit_c4048676-be5c-4b98-abba-98c789c6ee02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04733065-4748-4364-8c24-4bfe277b1b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04733065-4748-4364-8c24-4bfe277b1b9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7493e07f-ec55-4f46-a889-4a1ec9a0792c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7493e07f-ec55-4f46-a889-4a1ec9a0792c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1a837683-1313-4fe0-84cf-1863032be5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1a837683-1313-4fe0-84cf-1863032be5fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted_f12dcafe-2bed-4e84-af93-90f8b991bc93" xlink:href="wst-20191231.xsd#wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted_f12dcafe-2bed-4e84-af93-90f8b991bc93" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1187fecf-8fb2-4c78-8643-d77d3d7d2fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1187fecf-8fb2-4c78-8643-d77d3d7d2fe8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_815d19be-7be6-4fad-924e-d9ba1f0a9942" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_815d19be-7be6-4fad-924e-d9ba1f0a9942" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_f1b5b8d0-69fb-4b3a-9273-814884da5abd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_f1b5b8d0-69fb-4b3a-9273-814884da5abd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d9090b7e-9c52-47bb-9d1e-62e7d0f7a015" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d9090b7e-9c52-47bb-9d1e-62e7d0f7a015" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_4dc4f8a3-20f8-4fcb-ae1d-1159b74395a9" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_4dc4f8a3-20f8-4fcb-ae1d-1159b74395a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_f736b814-dad8-4f20-b4e7-2e1348ad7d77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_f736b814-dad8-4f20-b4e7-2e1348ad7d77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_d8800a85-7649-4815-bd68-23b96154e8ac" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_d8800a85-7649-4815-bd68-23b96154e8ac" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e9f4c4d1-dc10-4a5a-99f8-8b3c00ee6042" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e9f4c4d1-dc10-4a5a-99f8-8b3c00ee6042" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6a6d15c3-2333-40a1-9f3e-f25e41980362" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6a6d15c3-2333-40a1-9f3e-f25e41980362" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_ce074cbe-f1a4-4869-8183-dbcb31e55eab" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_ce074cbe-f1a4-4869-8183-dbcb31e55eab" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableinCash_84d0f9be-37b6-429f-be5d-c8f2328bea53" xlink:href="wst-20191231.xsd#wst_DeferredStockUnitsPayableinCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredStockUnitsPayableinCash_84d0f9be-37b6-429f-be5d-c8f2328bea53" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ad92b962-957a-4ec1-bf01-a43596f33d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ad92b962-957a-4ec1-bf01-a43596f33d44" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e9c5b9b-1b64-4d15-b85f-a567fb61af86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e9c5b9b-1b64-4d15-b85f-a567fb61af86" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d7c291c7-7d25-4fca-b2a2-72f324e34f84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d7c291c7-7d25-4fca-b2a2-72f324e34f84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d7c291c7-7d25-4fca-b2a2-72f324e34f84_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d7c291c7-7d25-4fca-b2a2-72f324e34f84" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d7c291c7-7d25-4fca-b2a2-72f324e34f84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d1350b3e-45f4-483f-8c21-5e598698e189" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d7c291c7-7d25-4fca-b2a2-72f324e34f84" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d1350b3e-45f4-483f-8c21-5e598698e189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_8f51dccb-2cb5-4ec5-aa90-a34ad495e1df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d1350b3e-45f4-483f-8c21-5e598698e189" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_8f51dccb-2cb5-4ec5-aa90-a34ad495e1df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_557adfd3-dda1-4e62-9a7d-622b352567f3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_srt_RangeAxis_557adfd3-dda1-4e62-9a7d-622b352567f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_557adfd3-dda1-4e62-9a7d-622b352567f3_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_557adfd3-dda1-4e62-9a7d-622b352567f3" xlink:to="loc_srt_RangeMember_557adfd3-dda1-4e62-9a7d-622b352567f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_557adfd3-dda1-4e62-9a7d-622b352567f3" xlink:to="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1e2c1f50-102b-4f7b-a3ab-a683ef4a69ef" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:to="loc_srt_MinimumMember_1e2c1f50-102b-4f7b-a3ab-a683ef4a69ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7f862f53-a60c-45fe-ab1b-537c9a65a4aa" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:to="loc_srt_MaximumMember_7f862f53-a60c-45fe-ab1b-537c9a65a4aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_58fa24fb-9418-4a97-b363-2fbbeb43a068" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_srt_TitleOfIndividualAxis_58fa24fb-9418-4a97-b363-2fbbeb43a068" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_58fa24fb-9418-4a97-b363-2fbbeb43a068_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_58fa24fb-9418-4a97-b363-2fbbeb43a068" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_58fa24fb-9418-4a97-b363-2fbbeb43a068_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_85b8f98c-7496-4c95-8e61-97ffa31f7732" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_58fa24fb-9418-4a97-b363-2fbbeb43a068" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_85b8f98c-7496-4c95-8e61-97ffa31f7732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_3618d132-83da-4aa1-83e9-d2f65ed426a0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_85b8f98c-7496-4c95-8e61-97ffa31f7732" xlink:to="loc_srt_DirectorMember_3618d132-83da-4aa1-83e9-d2f65ed426a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a6b53f10-6cef-4760-b3ea-c1d399d12989" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_us-gaap_AwardTypeAxis_a6b53f10-6cef-4760-b3ea-c1d399d12989" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6b53f10-6cef-4760-b3ea-c1d399d12989_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a6b53f10-6cef-4760-b3ea-c1d399d12989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6b53f10-6cef-4760-b3ea-c1d399d12989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a6b53f10-6cef-4760-b3ea-c1d399d12989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a9fde8ea-f162-4513-8dc6-fbcd4df4da66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a9fde8ea-f162-4513-8dc6-fbcd4df4da66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_0e12ff50-2820-4bc1-b4e8-80340501b618" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_0e12ff50-2820-4bc1-b4e8-80340501b618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_9f30221d-a5a0-4bd3-924e-eb2c42407c38" xlink:href="wst-20191231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_9f30221d-a5a0-4bd3-924e-eb2c42407c38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b8dcabe6-30e0-4a20-b037-6a10c207f8c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_PerformanceSharesMember_b8dcabe6-30e0-4a20-b037-6a10c207f8c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_fb2e9aac-e7d5-434b-8291-9bf9980ea8f5" xlink:href="wst-20191231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_fb2e9aac-e7d5-434b-8291-9bf9980ea8f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a878b8c6-c8c4-4b54-8474-58fc2db0caa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_RestrictedStockMember_a878b8c6-c8c4-4b54-8474-58fc2db0caa8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_ea3ecbda-7d3e-498d-a67f-332d07268f70" xlink:href="wst-20191231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_IncentiveStockAwardsMember_ea3ecbda-7d3e-498d-a67f-332d07268f70" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_4fc13c85-5fcc-417d-a3c5-8b9bf7fc9c0e" xlink:href="wst-20191231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_CashSettledPSUAwardsMember_4fc13c85-5fcc-417d-a3c5-8b9bf7fc9c0e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_d7a3816c-f805-4b58-9a19-2a6e0eeb7b96" xlink:href="wst-20191231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_StockSettledPSUAwardsMember_d7a3816c-f805-4b58-9a19-2a6e0eeb7b96" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended" id="ia8a0bb51f0794e83b6a0207f64071ce2_3febc05e-f7f8-4bb1-a420-48dd64136bfe">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22dc7b93-7d6f-4485-930d-010b5c46d3ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22dc7b93-7d6f-4485-930d-010b5c46d3ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_293f5850-e45d-4efb-88b3-cf71644f204c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_293f5850-e45d-4efb-88b3-cf71644f204c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff0d412-1163-4f74-92db-32f8264ca285" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff0d412-1163-4f74-92db-32f8264ca285" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff0d412-1163-4f74-92db-32f8264ca285" xlink:to="loc_us-gaap_AwardTypeAxis_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember_68f68b7d-ba9f-48e9-9c4f-2e51845aaa4c" xlink:href="wst-20191231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_StockOptionAndAppreciationRightsMember_68f68b7d-ba9f-48e9-9c4f-2e51845aaa4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_46793fe0-5b99-44f9-8467-b874809a487a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_us-gaap_PerformanceSharesMember_46793fe0-5b99-44f9-8467-b874809a487a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_c2eca391-41a3-4f61-a0a1-8b9aa668c217" xlink:href="wst-20191231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_CashSettledPSUAwardsMember_c2eca391-41a3-4f61-a0a1-8b9aa668c217" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_46d75fa6-4e2c-45aa-8ff0-81f8f10093b7" xlink:href="wst-20191231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_46d75fa6-4e2c-45aa-8ff0-81f8f10093b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_74b3a89a-872d-49da-a9d6-3a927047fb6f" xlink:href="wst-20191231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_74b3a89a-872d-49da-a9d6-3a927047fb6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_0f8c5a71-c944-4728-a235-67bb1d6c4a33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_0f8c5a71-c944-4728-a235-67bb1d6c4a33" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended" id="i1e257bc5841a4a76ad781ae3006ddea5_654a6a69-a318-4bc5-8313-3bd885a006f0">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec751c6f-61b0-49f9-8b47-ffec6e72310f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec751c6f-61b0-49f9-8b47-ffec6e72310f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0f6f7ce6-70ca-44b5-8485-46bcc361777c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0f6f7ce6-70ca-44b5-8485-46bcc361777c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2aaa9161-9c17-4f2f-92f2-192c624adf0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2aaa9161-9c17-4f2f-92f2-192c624adf0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_47adc052-363a-4988-bf2b-44020740a279" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_47adc052-363a-4988-bf2b-44020740a279" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2e99a3c9-d1f4-4fe3-9a3b-f302a4c0435f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2e99a3c9-d1f4-4fe3-9a3b-f302a4c0435f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_PlanNameAxis_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a" xlink:to="loc_us-gaap_PlanNameDomain_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_262b0f10-a39d-4c23-82a2-6af524059979" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a" xlink:to="loc_us-gaap_PlanNameDomain_262b0f10-a39d-4c23-82a2-6af524059979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_210137bc-e775-415e-87d0-91e177fb7168" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_AwardDateAxis_210137bc-e775-415e-87d0-91e177fb7168" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_210137bc-e775-415e-87d0-91e177fb7168_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_210137bc-e775-415e-87d0-91e177fb7168" xlink:to="loc_us-gaap_AwardDateDomain_210137bc-e775-415e-87d0-91e177fb7168_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_130a1363-8a0b-4278-acd1-b0ce241518f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_210137bc-e775-415e-87d0-91e177fb7168" xlink:to="loc_us-gaap_AwardDateDomain_130a1363-8a0b-4278-acd1-b0ce241518f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_21205553-2fdb-4515-90ca-5da94b4d5541" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_AwardTypeAxis_21205553-2fdb-4515-90ca-5da94b4d5541" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21205553-2fdb-4515-90ca-5da94b4d5541_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_21205553-2fdb-4515-90ca-5da94b4d5541" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21205553-2fdb-4515-90ca-5da94b4d5541_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69f15114-b202-4e4a-86fc-ded02cec3053" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_21205553-2fdb-4515-90ca-5da94b4d5541" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69f15114-b202-4e4a-86fc-ded02cec3053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bd5b57fd-08d0-4cd2-9305-de7bb822dbe0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69f15114-b202-4e4a-86fc-ded02cec3053" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bd5b57fd-08d0-4cd2-9305-de7bb822dbe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_61f24652-a3b7-4ad9-a881-e2153ed1ad75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_StatementClassOfStockAxis_61f24652-a3b7-4ad9-a881-e2153ed1ad75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_61f24652-a3b7-4ad9-a881-e2153ed1ad75_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_61f24652-a3b7-4ad9-a881-e2153ed1ad75" xlink:to="loc_us-gaap_ClassOfStockDomain_61f24652-a3b7-4ad9-a881-e2153ed1ad75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a8048f6b-c03c-4fc1-85fb-a4740adf5f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_61f24652-a3b7-4ad9-a881-e2153ed1ad75" xlink:to="loc_us-gaap_ClassOfStockDomain_a8048f6b-c03c-4fc1-85fb-a4740adf5f5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_srt_RangeAxis_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c" xlink:to="loc_srt_RangeMember_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c8b8741-b3d9-4553-b337-39c6362cf3a4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c" xlink:to="loc_srt_RangeMember_3c8b8741-b3d9-4553-b337-39c6362cf3a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_0be2d3f8-726d-4224-8384-c8e3ed625382" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_VestingAxis_0be2d3f8-726d-4224-8384-c8e3ed625382" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_0be2d3f8-726d-4224-8384-c8e3ed625382_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_0be2d3f8-726d-4224-8384-c8e3ed625382" xlink:to="loc_us-gaap_VestingDomain_0be2d3f8-726d-4224-8384-c8e3ed625382_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_fc2f9a2c-7187-4b49-95c4-5dc91ccf8077" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_0be2d3f8-726d-4224-8384-c8e3ed625382" xlink:to="loc_us-gaap_VestingDomain_fc2f9a2c-7187-4b49-95c4-5dc91ccf8077" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended" id="i95b0481e08c449dcbeb0b9feb5241be9_3aeddfee-4e46-4dcf-88b3-993e808508dc">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be2e25d0-9063-4d8c-bec3-617d5ae8f3d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be2e25d0-9063-4d8c-bec3-617d5ae8f3d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f183e887-f795-43ac-b5f8-b3136d4498ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f183e887-f795-43ac-b5f8-b3136d4498ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_14f61ad5-ea73-42c8-b24c-10f2395fd764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_14f61ad5-ea73-42c8-b24c-10f2395fd764" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_a3cba50f-02ee-4eaa-b0e0-c8ff1f553980" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_a3cba50f-02ee-4eaa-b0e0-c8ff1f553980" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2808d3f2-7233-4125-8e51-7f2e3fd021c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2808d3f2-7233-4125-8e51-7f2e3fd021c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d4c116c8-dc06-4cd1-8032-b3f246bea278" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_faf182b0-27e0-4857-9325-8f5a6fa27d6a" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_faf182b0-27e0-4857-9325-8f5a6fa27d6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_a114ddcf-a9ea-4714-bf0f-3cc7ae8d7776" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_a114ddcf-a9ea-4714-bf0f-3cc7ae8d7776" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_04c718b6-7d2f-40db-a838-b2e03216ebf3" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_04c718b6-7d2f-40db-a838-b2e03216ebf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_44c3c699-0c4d-42ce-a79a-fb05f513c608" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_44c3c699-0c4d-42ce-a79a-fb05f513c608" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_89486014-e517-49db-a198-21e3cd52acae" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_89486014-e517-49db-a198-21e3cd52acae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_b1d6a462-ce47-4fad-8ead-8e87bd46c721" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_76dac07d-c852-4f39-a075-15665c73eee9" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_76dac07d-c852-4f39-a075-15665c73eee9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledStockAppreciationRIghtsOutstanding_b4a81007-1bb9-44ce-bbab-5139f23be9c7" xlink:href="wst-20191231.xsd#wst_CashSettledStockAppreciationRIghtsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_CashSettledStockAppreciationRIghtsOutstanding_b4a81007-1bb9-44ce-bbab-5139f23be9c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledStockAppreciationRightsOutstanding_7d8da21e-9416-4c3a-864a-f522b2f8f1f8" xlink:href="wst-20191231.xsd#wst_StockSettledStockAppreciationRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_StockSettledStockAppreciationRightsOutstanding_7d8da21e-9416-4c3a-864a-f522b2f8f1f8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_178a95ba-d8a5-431f-990f-543d24e64243" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_178a95ba-d8a5-431f-990f-543d24e64243" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eb9102de-e22a-46bf-9124-968dfe6cc5df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_178a95ba-d8a5-431f-990f-543d24e64243" xlink:to="loc_us-gaap_AwardTypeAxis_eb9102de-e22a-46bf-9124-968dfe6cc5df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb9102de-e22a-46bf-9124-968dfe6cc5df_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_eb9102de-e22a-46bf-9124-968dfe6cc5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eb9102de-e22a-46bf-9124-968dfe6cc5df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a85a78d2-0556-49ee-87ad-8d4c275871d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_eb9102de-e22a-46bf-9124-968dfe6cc5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a85a78d2-0556-49ee-87ad-8d4c275871d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_79d43ded-9e1a-44ba-a37d-b15ab1a077c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a85a78d2-0556-49ee-87ad-8d4c275871d9" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_79d43ded-9e1a-44ba-a37d-b15ab1a077c6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended" id="i10a1c29716d842a6969773019f33c488_c6b53236-05b1-4933-aed2-0b7b8905d6da">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_2c9285d6-d83d-402f-bb1c-4831f5c9d045" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_2c9285d6-d83d-402f-bb1c-4831f5c9d045" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_0c20c0bc-84ac-4ed1-8834-adf656ebae3e" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_0c20c0bc-84ac-4ed1-8834-adf656ebae3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d6fe4abf-5332-45e9-9676-9f641707cd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d6fe4abf-5332-45e9-9676-9f641707cd2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67ed1daa-d975-4c05-b4fa-6bc8954dda34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67ed1daa-d975-4c05-b4fa-6bc8954dda34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_93595c49-78af-4b95-b532-99588508d04c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_93595c49-78af-4b95-b532-99588508d04c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_2816ab59-b704-49ec-884a-533540121cf6" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_2816ab59-b704-49ec-884a-533540121cf6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4406a938-3ca1-4a9b-8d85-58ae5e59d957" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4406a938-3ca1-4a9b-8d85-58ae5e59d957" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d9ea946a-1470-434d-8f99-c6dc2526a9ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d9ea946a-1470-434d-8f99-c6dc2526a9ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1ba4c257-3cb6-4f8c-962f-bf248b4d0183" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c50bf412-8902-4179-b7d7-882571df2b94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c50bf412-8902-4179-b7d7-882571df2b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab9d9540-3ede-4898-b96b-c745a8bc7300" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab9d9540-3ede-4898-b96b-c745a8bc7300" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_3ba041dd-8075-4c9d-b2c2-63d59229aab6" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_3ba041dd-8075-4c9d-b2c2-63d59229aab6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2e117f3f-650a-4b3b-8156-bc9ff08be4de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2e117f3f-650a-4b3b-8156-bc9ff08be4de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_161eb517-1cbc-43f4-bfbc-7a727e99ee6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_161eb517-1cbc-43f4-bfbc-7a727e99ee6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9bbac2fc-cd02-48f1-97e2-fe64d99e492e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_srt_RangeAxis_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e" xlink:to="loc_srt_RangeMember_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e" xlink:to="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3b2533d8-5949-4376-b34a-b67bd9581881" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:to="loc_srt_MinimumMember_3b2533d8-5949-4376-b34a-b67bd9581881" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5e3dc6da-692f-4c5e-a906-7e805195d423" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:to="loc_srt_MaximumMember_5e3dc6da-692f-4c5e-a906-7e805195d423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81f4724c-10ac-441d-9f3d-8d7d399bc102" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_us-gaap_AwardTypeAxis_81f4724c-10ac-441d-9f3d-8d7d399bc102" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81f4724c-10ac-441d-9f3d-8d7d399bc102_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_81f4724c-10ac-441d-9f3d-8d7d399bc102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81f4724c-10ac-441d-9f3d-8d7d399bc102_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_81f4724c-10ac-441d-9f3d-8d7d399bc102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_84c6670a-93bf-415c-8534-382c96bcf7d8" xlink:href="wst-20191231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_wst_IncentiveStockAwardsMember_84c6670a-93bf-415c-8534-382c96bcf7d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_4b4570ab-dbde-4cea-9803-41c9659f763a" xlink:href="wst-20191231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_wst_CashSettledPSUAwardsMember_4b4570ab-dbde-4cea-9803-41c9659f763a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_ff08f4d3-bbd4-46c6-9fee-ff05d9edb452" xlink:href="wst-20191231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_wst_StockSettledPSUAwardsMember_ff08f4d3-bbd4-46c6-9fee-ff05d9edb452" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9b78f123-0f3a-4670-8a9e-277a1b5a3a24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_us-gaap_RestrictedStockMember_9b78f123-0f3a-4670-8a9e-277a1b5a3a24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_af32f328-2fa6-4692-95ca-721ce8d24f84" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_srt_TitleOfIndividualAxis_af32f328-2fa6-4692-95ca-721ce8d24f84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_af32f328-2fa6-4692-95ca-721ce8d24f84_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_af32f328-2fa6-4692-95ca-721ce8d24f84" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_af32f328-2fa6-4692-95ca-721ce8d24f84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2353de8d-ffa1-40b3-9596-dd472bbf2898" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_af32f328-2fa6-4692-95ca-721ce8d24f84" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2353de8d-ffa1-40b3-9596-dd472bbf2898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c7ac6b50-815a-4bc5-9856-e02d8b01e5b5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2353de8d-ffa1-40b3-9596-dd472bbf2898" xlink:to="loc_srt_DirectorMember_c7ac6b50-815a-4bc5-9856-e02d8b01e5b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d12f8511-92b6-40c3-8ba0-f110fd91c68f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d12f8511-92b6-40c3-8ba0-f110fd91c68f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d12f8511-92b6-40c3-8ba0-f110fd91c68f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d12f8511-92b6-40c3-8ba0-f110fd91c68f" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d12f8511-92b6-40c3-8ba0-f110fd91c68f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_3cbd6015-b7c2-42b4-80ce-58258ab843ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d12f8511-92b6-40c3-8ba0-f110fd91c68f" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_3cbd6015-b7c2-42b4-80ce-58258ab843ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4bf887e9-f5e2-49b6-8ec9-2a22a304cf8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_3cbd6015-b7c2-42b4-80ce-58258ab843ba" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4bf887e9-f5e2-49b6-8ec9-2a22a304cf8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlans"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended" id="i4b097a4e9b6e4af4a15edd8a13431d65_8e94e71c-f01a-4478-842e-f0f440bb39c7"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended" id="i12799adcb1974e93a51f8e1783cfe440_a67230c9-9641-46a4-ad3c-7ed9e1e02927"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansTextualsDetails" xlink:type="extended" id="ibc6d8490936b467ebbe12e122d44599b_99724592-3f4a-4a0d-be22-fea8bcc83ce7">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_a10c80aa-382e-4092-bbbe-e502bee01225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_a10c80aa-382e-4092-bbbe-e502bee01225" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fe0e3f52-06d5-4f92-ac09-a71fc0cc8fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fe0e3f52-06d5-4f92-ac09-a71fc0cc8fb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0fc89bf2-496a-4083-b589-ae93403265bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0fc89bf2-496a-4083-b589-ae93403265bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_48ce7bf6-8b70-4cd2-97cf-cfabeed64582" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_48ce7bf6-8b70-4cd2-97cf-cfabeed64582" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_056448ac-4ff8-45b5-8e1b-cd6431910bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_056448ac-4ff8-45b5-8e1b-cd6431910bfa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_d8fb9b09-5bf1-4ac3-8242-260e3c6fee3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_d8fb9b09-5bf1-4ac3-8242-260e3c6fee3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_03199d7a-e164-4ba1-8bb0-446ee90c917a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_03199d7a-e164-4ba1-8bb0-446ee90c917a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_98472628-7e99-4fcc-99c5-f90235c23db1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_98472628-7e99-4fcc-99c5-f90235c23db1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e3d1c057-8772-4dcf-ac5d-c1fafe9b6ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e3d1c057-8772-4dcf-ac5d-c1fafe9b6ee5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ed2dfef4-d1a9-4b77-afea-22b95b7e59cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ed2dfef4-d1a9-4b77-afea-22b95b7e59cd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_bc18d192-44df-483b-9c4a-4577e8518718" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_bc18d192-44df-483b-9c4a-4577e8518718" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_142a7aa1-6764-4475-b457-61abe015cab4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_142a7aa1-6764-4475-b457-61abe015cab4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_4a35b51e-2930-4f80-821c-388c41624fef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_4a35b51e-2930-4f80-821c-388c41624fef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_320142c2-4205-4627-a7c4-968c2f0fbe4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_320142c2-4205-4627-a7c4-968c2f0fbe4a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_407151bf-99b3-448f-8c2b-28ba3c8b23e2" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_407151bf-99b3-448f-8c2b-28ba3c8b23e2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_a2f55d6e-d98d-4fff-9fcb-41cb04cfe52f" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_a2f55d6e-d98d-4fff-9fcb-41cb04cfe52f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f7581ead-6ebe-479f-874c-13b69b269118" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f7581ead-6ebe-479f-874c-13b69b269118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f7581ead-6ebe-479f-874c-13b69b269118_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f7581ead-6ebe-479f-874c-13b69b269118" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f7581ead-6ebe-479f-874c-13b69b269118_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f7581ead-6ebe-479f-874c-13b69b269118" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d42fdc69-1489-4712-9112-fab4c11c6cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:to="loc_us-gaap_EquitySecuritiesMember_d42fdc69-1489-4712-9112-fab4c11c6cc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_9a2e9a0e-aca9-4c05-997f-b26fbdfa7576" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:to="loc_us-gaap_DebtSecuritiesMember_9a2e9a0e-aca9-4c05-997f-b26fbdfa7576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_be666443-fa1d-42c7-a5ba-6f415a9ceadd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_be666443-fa1d-42c7-a5ba-6f415a9ceadd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_be666443-fa1d-42c7-a5ba-6f415a9ceadd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_be666443-fa1d-42c7-a5ba-6f415a9ceadd" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_be666443-fa1d-42c7-a5ba-6f415a9ceadd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_be666443-fa1d-42c7-a5ba-6f415a9ceadd" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_29e76f09-f606-444e-9fa2-4cef24d611ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_29e76f09-f606-444e-9fa2-4cef24d611ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ba33ee67-7950-47b8-8fe7-666499e64f57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ba33ee67-7950-47b8-8fe7-666499e64f57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_28b524e7-7e35-4744-9312-48e44609c607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_28b524e7-7e35-4744-9312-48e44609c607" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_28b524e7-7e35-4744-9312-48e44609c607_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_28b524e7-7e35-4744-9312-48e44609c607" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_28b524e7-7e35-4744-9312-48e44609c607_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_28b524e7-7e35-4744-9312-48e44609c607" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_cccd3c3c-c304-4cb6-8c6c-a8b81b7a4b31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:to="loc_us-gaap_ForeignPlanMember_cccd3c3c-c304-4cb6-8c6c-a8b81b7a4b31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_476c6a90-8f4c-49b2-8dff-ddeb37b8545b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:to="loc_us-gaap_DomesticPlanMember_476c6a90-8f4c-49b2-8dff-ddeb37b8545b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b9b35893-0ef7-40c2-a3f8-0428d4fc383d" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:to="loc_country_US_b9b35893-0ef7-40c2-a3f8-0428d4fc383d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="id29b8abc67204150849dbab937e870e0_4f05384f-8cdb-457f-85e8-de464107a1c5">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_bc614479-a5df-4f40-805f-72f3c73ecdb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_bc614479-a5df-4f40-805f-72f3c73ecdb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6059a1aa-0b9c-4de4-8da9-d67f4568518f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6059a1aa-0b9c-4de4-8da9-d67f4568518f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e02a6ae6-3602-4ce4-b9e8-58ba25adca51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e02a6ae6-3602-4ce4-b9e8-58ba25adca51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6aeb09e8-8f61-4a72-9182-558351822058" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6aeb09e8-8f61-4a72-9182-558351822058" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_a5e45532-b66b-4770-bb09-85c944810cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_a5e45532-b66b-4770-bb09-85c944810cb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_838f0961-159f-403d-8051-595ca1acd447" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_838f0961-159f-403d-8051-595ca1acd447" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f6f12bc6-18f9-411e-bdb4-3921654cc0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f6f12bc6-18f9-411e-bdb4-3921654cc0a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_427e6262-d2c5-4178-8569-df86aa462de7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_427e6262-d2c5-4178-8569-df86aa462de7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_2dddb995-2e57-4ef9-8231-d0ba232bee2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_2dddb995-2e57-4ef9-8231-d0ba232bee2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_621b825c-3b27-423c-b36b-aa5e2b632029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_621b825c-3b27-423c-b36b-aa5e2b632029" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_afd596ab-deda-4682-8e3d-ff62cc3e37a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_afd596ab-deda-4682-8e3d-ff62cc3e37a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_9d65c980-d465-4277-8ae3-c909370c8534" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_9d65c980-d465-4277-8ae3-c909370c8534" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d6c6ecd0-5fdc-4cae-be54-25592252096d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d6c6ecd0-5fdc-4cae-be54-25592252096d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_0c069717-9eaa-4e55-a0d0-ce7226665f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_0c069717-9eaa-4e55-a0d0-ce7226665f6b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_d8c0504a-033b-4ba6-9728-2bfe2b0d9df3" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_d8c0504a-033b-4ba6-9728-2bfe2b0d9df3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_122aee44-3886-4cf1-a568-216cee0943c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_122aee44-3886-4cf1-a568-216cee0943c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_cc458de2-0d96-42e5-9212-4b45bd71218a" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_cc458de2-0d96-42e5-9212-4b45bd71218a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_2ed2ce03-d438-4b0a-bf7f-2de95dc44c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_2ed2ce03-d438-4b0a-bf7f-2de95dc44c6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_756dfe54-cac5-470a-805b-735d3a56c793" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_756dfe54-cac5-470a-805b-735d3a56c793" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0afcb7a6-488b-4331-a803-ea93bf2c3b12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0afcb7a6-488b-4331-a803-ea93bf2c3b12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_998600bc-490f-4d52-b916-55f28fdf021a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_998600bc-490f-4d52-b916-55f28fdf021a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_998600bc-490f-4d52-b916-55f28fdf021a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_998600bc-490f-4d52-b916-55f28fdf021a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_998600bc-490f-4d52-b916-55f28fdf021a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_998600bc-490f-4d52-b916-55f28fdf021a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_da94b863-a093-4cdf-96c5-c470ec850fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:to="loc_us-gaap_DomesticPlanMember_da94b863-a093-4cdf-96c5-c470ec850fe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_242f3d00-270e-4d13-bd6e-c142c8e04337" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:to="loc_us-gaap_ForeignPlanMember_242f3d00-270e-4d13-bd6e-c142c8e04337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_855ffcdd-038a-4b24-b242-8d5e4480f54d" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:to="loc_country_US_855ffcdd-038a-4b24-b242-8d5e4480f54d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ee9afb7d-4562-4864-90be-14a63665a74c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ee9afb7d-4562-4864-90be-14a63665a74c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ee9afb7d-4562-4864-90be-14a63665a74c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ee9afb7d-4562-4864-90be-14a63665a74c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ee9afb7d-4562-4864-90be-14a63665a74c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ee9afb7d-4562-4864-90be-14a63665a74c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4f2df76b-bbb1-4692-896e-52fb839a6020" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4f2df76b-bbb1-4692-896e-52fb839a6020" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_45cad695-8266-49f7-9f5f-204e03ec9fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_45cad695-8266-49f7-9f5f-204e03ec9fe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f4f65312-c681-40f9-95da-0c7b2ca93a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f4f65312-c681-40f9-95da-0c7b2ca93a4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f4f65312-c681-40f9-95da-0c7b2ca93a4e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f4f65312-c681-40f9-95da-0c7b2ca93a4e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f4f65312-c681-40f9-95da-0c7b2ca93a4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c158b674-6628-4f4a-9340-6fadbcc383ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f4f65312-c681-40f9-95da-0c7b2ca93a4e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c158b674-6628-4f4a-9340-6fadbcc383ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c6e619f4-188f-4f71-910c-0ab6ab129ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c158b674-6628-4f4a-9340-6fadbcc383ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c6e619f4-188f-4f71-910c-0ab6ab129ec9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended" id="i77cacc6546a8464a9f14a1919dc1225f_9404613d-e8cc-4445-b769-7218df6e5e52">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_28f4062c-e740-49de-9921-053df4675e89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_28f4062c-e740-49de-9921-053df4675e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_20f66b7a-60ae-4f88-8316-4cfd842b97f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_20f66b7a-60ae-4f88-8316-4cfd842b97f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6a2c8741-fbf5-44e5-a2bb-73090e518da6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6a2c8741-fbf5-44e5-a2bb-73090e518da6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d9df2d61-80c3-4e8e-af88-faaa7ec0e757" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d9df2d61-80c3-4e8e-af88-faaa7ec0e757" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_9c539200-1a73-4e60-95ad-8ee752fa9563" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_9c539200-1a73-4e60-95ad-8ee752fa9563" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_c18d00b9-7f7a-4243-b6d7-862c9ac4092d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_c18d00b9-7f7a-4243-b6d7-862c9ac4092d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_25f08cc1-b177-4453-8924-06895284a8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_25f08cc1-b177-4453-8924-06895284a8ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_2b090181-f0e1-4d0c-8657-be75df2bab0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_2b090181-f0e1-4d0c-8657-be75df2bab0a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_b831ce15-ad5c-460a-93b5-27474f24b5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_b831ce15-ad5c-460a-93b5-27474f24b5dc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d4a3884e-f968-4914-987d-7409a4571eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_beb33599-5080-4e09-ae9d-9f29f33c35cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_beb33599-5080-4e09-ae9d-9f29f33c35cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_57411c4c-6bd1-4ca1-ba62-34645511b2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_57411c4c-6bd1-4ca1-ba62-34645511b2b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7805ad90-588e-418d-8adf-3d1f63926cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7805ad90-588e-418d-8adf-3d1f63926cbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_ec6df79d-70d9-4acc-9807-9fa6f84b73a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_ec6df79d-70d9-4acc-9807-9fa6f84b73a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3e3c7c8f-6d75-487e-a6a4-b740282250fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3e3c7c8f-6d75-487e-a6a4-b740282250fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_91556062-4b21-45bc-a43c-ab52956f88de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_91556062-4b21-45bc-a43c-ab52956f88de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7179648e-4fb0-47cd-b9cf-c4af23ae27c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c069da62-ee9f-4eee-bdbf-c03d157b4b87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c069da62-ee9f-4eee-bdbf-c03d157b4b87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_05fc90ee-4f17-4956-b1a4-52a84d08f07c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_05fc90ee-4f17-4956-b1a4-52a84d08f07c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3f73372a-7f33-43de-90f6-57b2d011a1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_05fc90ee-4f17-4956-b1a4-52a84d08f07c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3f73372a-7f33-43de-90f6-57b2d011a1b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3f73372a-7f33-43de-90f6-57b2d011a1b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3f73372a-7f33-43de-90f6-57b2d011a1b9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3f73372a-7f33-43de-90f6-57b2d011a1b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3f73372a-7f33-43de-90f6-57b2d011a1b9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f305cb98-2e2b-41fb-a585-3abb61d3018a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f305cb98-2e2b-41fb-a585-3abb61d3018a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_56d23bb2-9100-4b9d-be63-5445104b064a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_56d23bb2-9100-4b9d-be63-5445104b064a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended" id="i2722ea97f9d84b3db14ab894a2de0c6e_4f0c4b8b-d19b-47dd-ba22-ad3be9c6a603">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_7ce2c01c-e1d0-4dfa-b059-3560e1dd3ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_7ce2c01c-e1d0-4dfa-b059-3560e1dd3ad7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_83ecf475-ae9c-47ce-b4bb-ec05b0dd1a89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_83ecf475-ae9c-47ce-b4bb-ec05b0dd1a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_10b35957-5818-4fc2-8999-35fc190e4a36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_10b35957-5818-4fc2-8999-35fc190e4a36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_a523794b-4315-45b0-bd22-0b1ccdc8207f" xlink:href="wst-20191231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_a523794b-4315-45b0-bd22-0b1ccdc8207f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_1c84f524-84ea-4e6b-a209-f34bc006666e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_1c84f524-84ea-4e6b-a209-f34bc006666e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_af3cd85d-36fe-41db-af68-aca1b8ea2904" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_1c84f524-84ea-4e6b-a209-f34bc006666e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_af3cd85d-36fe-41db-af68-aca1b8ea2904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_af3cd85d-36fe-41db-af68-aca1b8ea2904_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_af3cd85d-36fe-41db-af68-aca1b8ea2904" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_af3cd85d-36fe-41db-af68-aca1b8ea2904_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_af3cd85d-36fe-41db-af68-aca1b8ea2904" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e7c62e22-5596-48e0-ae16-acbf30182b81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e7c62e22-5596-48e0-ae16-acbf30182b81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0184fee5-4708-4f8f-88ac-43f410ac5e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0184fee5-4708-4f8f-88ac-43f410ac5e4f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i6546c6c6b6d447228b14f65a67b26fd5_b45a54d1-e0be-4f63-afd6-1dbb88a62726">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4d5a4258-8485-41de-ab6d-30373b0a4e85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4d5a4258-8485-41de-ab6d-30373b0a4e85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_61f37ad2-bb36-4f08-bffb-33c56baa25e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_61f37ad2-bb36-4f08-bffb-33c56baa25e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0dafe1a7-8375-4a75-9f9f-798f1ee9dba4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0dafe1a7-8375-4a75-9f9f-798f1ee9dba4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_1c1196cf-0146-49a7-b5fe-b7ac54d549bd" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_1c1196cf-0146-49a7-b5fe-b7ac54d549bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_baba6856-f602-4589-a3d3-8dbc73e7dc3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_baba6856-f602-4589-a3d3-8dbc73e7dc3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a97490d8-84d4-4a34-9b8e-3baa079b6171" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_baba6856-f602-4589-a3d3-8dbc73e7dc3c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a97490d8-84d4-4a34-9b8e-3baa079b6171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a97490d8-84d4-4a34-9b8e-3baa079b6171_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a97490d8-84d4-4a34-9b8e-3baa079b6171" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a97490d8-84d4-4a34-9b8e-3baa079b6171_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a97490d8-84d4-4a34-9b8e-3baa079b6171" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_edab0bc4-88b6-4e14-a3df-20d79e510d11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_edab0bc4-88b6-4e14-a3df-20d79e510d11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_580f81ac-c1a0-4064-878f-19c7e618378e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_580f81ac-c1a0-4064-878f-19c7e618378e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended" id="i108222bc9fb8463b8bfbdae963c57aaa_0d4c0cfe-eaff-4302-bda5-b186cd745e8b">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_541e104b-7b59-4272-a073-ec204c24614d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_541e104b-7b59-4272-a073-ec204c24614d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_c9b53bc9-a138-40fe-9e48-fd06967121a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_c9b53bc9-a138-40fe-9e48-fd06967121a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b17fe0fa-5f3b-42f1-8603-0a1e1d1508d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b17fe0fa-5f3b-42f1-8603-0a1e1d1508d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7f19f56b-5ceb-4975-83aa-2473760853f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7f19f56b-5ceb-4975-83aa-2473760853f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ec88de19-37fa-4d91-9aa7-55e6912c8ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ec88de19-37fa-4d91-9aa7-55e6912c8ff4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_3ac690ff-8921-4cd1-8ce6-e41f083eee2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_3ac690ff-8921-4cd1-8ce6-e41f083eee2d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_654d7b15-c905-4cab-b389-ac87effd9bdc" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_654d7b15-c905-4cab-b389-ac87effd9bdc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_059b4cde-65f3-4512-8d8e-fc2d11c028c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_059b4cde-65f3-4512-8d8e-fc2d11c028c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_059b4cde-65f3-4512-8d8e-fc2d11c028c5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_059b4cde-65f3-4512-8d8e-fc2d11c028c5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_059b4cde-65f3-4512-8d8e-fc2d11c028c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_059b4cde-65f3-4512-8d8e-fc2d11c028c5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_e63796f8-ff88-4e19-8bff-7ad4b5cd2c80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:to="loc_us-gaap_DomesticPlanMember_e63796f8-ff88-4e19-8bff-7ad4b5cd2c80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_54246960-00bc-494e-bb67-373bcddb10b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:to="loc_us-gaap_ForeignPlanMember_54246960-00bc-494e-bb67-373bcddb10b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d64124a6-520d-44e0-9d0a-cfb2a61ae694" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:to="loc_country_US_d64124a6-520d-44e0-9d0a-cfb2a61ae694" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1277df5e-4f04-4bdd-99f2-15624f34fb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1277df5e-4f04-4bdd-99f2-15624f34fb9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1277df5e-4f04-4bdd-99f2-15624f34fb9d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1277df5e-4f04-4bdd-99f2-15624f34fb9d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1277df5e-4f04-4bdd-99f2-15624f34fb9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0bb7c53d-0f95-4824-9243-c75342cc8c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1277df5e-4f04-4bdd-99f2-15624f34fb9d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0bb7c53d-0f95-4824-9243-c75342cc8c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e2cf48d4-4190-45ea-bd41-d2cf3d08c996" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0bb7c53d-0f95-4824-9243-c75342cc8c1c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e2cf48d4-4190-45ea-bd41-d2cf3d08c996" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended" id="i2b98a025047c40318feaccb8f4526b32_046acba0-75f7-43e4-95e4-8932a60c34ee">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4f87835-230f-47e5-bdaf-1a9a237a9d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4f87835-230f-47e5-bdaf-1a9a237a9d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_a6995835-1657-4e58-8d0c-beac4e96ce7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_a6995835-1657-4e58-8d0c-beac4e96ce7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_1918c6a2-0025-4820-8f34-bd580059584c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_1918c6a2-0025-4820-8f34-bd580059584c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a3c79f83-0d69-4c65-98bd-615b0919b059" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a3c79f83-0d69-4c65-98bd-615b0919b059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_df53402b-1532-4868-8575-2cb0bddf0f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_df53402b-1532-4868-8575-2cb0bddf0f0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83b4c54b-99d0-4268-80d6-ce0bbe92c2df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83b4c54b-99d0-4268-80d6-ce0bbe92c2df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e3003d25-64c1-427b-a912-9f733123ebc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83b4c54b-99d0-4268-80d6-ce0bbe92c2df" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e3003d25-64c1-427b-a912-9f733123ebc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e3003d25-64c1-427b-a912-9f733123ebc3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e3003d25-64c1-427b-a912-9f733123ebc3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e3003d25-64c1-427b-a912-9f733123ebc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e3003d25-64c1-427b-a912-9f733123ebc3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_93252d8d-ddde-4581-b206-987132b689a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_93252d8d-ddde-4581-b206-987132b689a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_71fcaaa8-c8e8-4459-8c2a-66ec92f6c569" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_71fcaaa8-c8e8-4459-8c2a-66ec92f6c569" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended" id="i19026200cd114519b1a881f1455f4190_4befba47-2941-469f-bba6-98a75f1a2478">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription_f4e3ba87-3a49-4c2c-ac30-8de6f184dc0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription_f4e3ba87-3a49-4c2c-ac30-8de6f184dc0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_03e86556-cb22-4fc3-a003-f99d16a84256" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_03e86556-cb22-4fc3-a003-f99d16a84256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_c5b0a647-3d25-400a-81fa-2abf46c6ee07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_c5b0a647-3d25-400a-81fa-2abf46c6ee07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0fbe7d8d-0cae-4760-a08f-17c90a46fd51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0fbe7d8d-0cae-4760-a08f-17c90a46fd51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2949812-59d5-436b-88b1-7a68303074c5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:to="loc_srt_RangeAxis_c2949812-59d5-436b-88b1-7a68303074c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c2949812-59d5-436b-88b1-7a68303074c5_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c2949812-59d5-436b-88b1-7a68303074c5" xlink:to="loc_srt_RangeMember_c2949812-59d5-436b-88b1-7a68303074c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c2949812-59d5-436b-88b1-7a68303074c5" xlink:to="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c05ff02-b221-49fc-ae08-c509123fd17b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:to="loc_srt_MinimumMember_0c05ff02-b221-49fc-ae08-c509123fd17b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_70d673bf-2180-4528-8381-7980de5c88cd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:to="loc_srt_MaximumMember_70d673bf-2180-4528-8381-7980de5c88cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bf97f5ba-3917-4641-b92a-80642802c72b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bf97f5ba-3917-4641-b92a-80642802c72b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_bf97f5ba-3917-4641-b92a-80642802c72b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bf97f5ba-3917-4641-b92a-80642802c72b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_bf97f5ba-3917-4641-b92a-80642802c72b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bf97f5ba-3917-4641-b92a-80642802c72b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_ae3343b3-c993-4a34-ab4a-50e4f5211da0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_ae3343b3-c993-4a34-ab4a-50e4f5211da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IndexedMutualFundsMember_bcc7c5a7-a729-4ebe-af27-63c238f0447b" xlink:href="wst-20191231.xsd#wst_IndexedMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:to="loc_wst_IndexedMutualFundsMember_bcc7c5a7-a729-4ebe-af27-63c238f0447b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_InternationalMutualFundsMember_e5fa676a-a84f-4ddf-a780-7fce5bf8c5f3" xlink:href="wst-20191231.xsd#wst_InternationalMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:to="loc_wst_InternationalMutualFundsMember_e5fa676a-a84f-4ddf-a780-7fce5bf8c5f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_1505ff85-6d10-4782-962c-1f1a14332960" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_us-gaap_DebtSecuritiesMember_1505ff85-6d10-4782-962c-1f1a14332960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherSecuritiesMember_dd338ad2-016b-48bd-9a50-2860f7820d8c" xlink:href="wst-20191231.xsd#wst_OtherSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_OtherSecuritiesMember_dd338ad2-016b-48bd-9a50-2860f7820d8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_MutualFundsMember_0e73a5f9-32b2-4516-b512-251d0155a75a" xlink:href="wst-20191231.xsd#wst_MutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_MutualFundsMember_0e73a5f9-32b2-4516-b512-251d0155a75a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BalancedMutualFundMember_07ee6321-09d7-4f70-a1c8-a797bc3a1ddc" xlink:href="wst-20191231.xsd#wst_BalancedMutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_BalancedMutualFundMember_07ee6321-09d7-4f70-a1c8-a797bc3a1ddc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionPlanAssetsInTheFairValueHierarchyMember_9d22d10c-2df0-430a-a562-2363f9ec06f5" xlink:href="wst-20191231.xsd#wst_PensionPlanAssetsInTheFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_PensionPlanAssetsInTheFairValueHierarchyMember_9d22d10c-2df0-430a-a562-2363f9ec06f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionplanassetsmeasuredatNAVMember_c876f4c5-3ffc-44c6-88e6-f7ba00894a80" xlink:href="wst-20191231.xsd#wst_PensionplanassetsmeasuredatNAVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_PensionplanassetsmeasuredatNAVMember_c876f4c5-3ffc-44c6-88e6-f7ba00894a80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04ab734f-50e4-4b6e-80d0-530327019ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04ab734f-50e4-4b6e-80d0-530327019ab1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04ab734f-50e4-4b6e-80d0-530327019ab1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04ab734f-50e4-4b6e-80d0-530327019ab1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04ab734f-50e4-4b6e-80d0-530327019ab1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04ab734f-50e4-4b6e-80d0-530327019ab1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9997b528-7dfc-4e15-b705-249d9556215a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9997b528-7dfc-4e15-b705-249d9556215a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a2ebaf4c-e107-4c01-a5c0-1a3dbb287878" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a2ebaf4c-e107-4c01-a5c0-1a3dbb287878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7a1869a6-240d-4eea-ab80-2ad85daf1890" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7a1869a6-240d-4eea-ab80-2ad85daf1890" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpense" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpense"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpense" xlink:type="extended" id="if63439cc76094c4e927fd09a129a1fa6_83769bde-628a-4cca-aadd-f8a6d6f6625c"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseTables" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseTables" xlink:type="extended" id="ib1cf846582aa45869df688ffc31e69f6_d78491e2-7bdd-4d8c-9eff-8a9063a5169d"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseDetails" xlink:type="extended" id="i0a720bb06f9b4bf4ac91141a2ec4c89e_d32f6f98-917b-487d-a807-1071c04f09f0"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseRestructuringandRelatedChargesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails" xlink:type="extended" id="i6deff01ec28543d5ae50efa5e2d5ec0e_45216e06-bd38-4844-92a8-e087ec40bb49">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_df510687-4cf8-4191-a98a-2f0c1c493e02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_df510687-4cf8-4191-a98a-2f0c1c493e02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8851ff6b-f6e1-4e39-a21a-3ddff68f00a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8851ff6b-f6e1-4e39-a21a-3ddff68f00a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f9b400c9-fece-4399-9820-257ce9aeaac1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_RestructuringCharges_f9b400c9-fece-4399-9820-257ce9aeaac1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_11ebeb7a-d669-4557-9e41-bef11b8572cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_SeveranceCosts1_11ebeb7a-d669-4557-9e41-bef11b8572cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatentandEquipment_05e4074c-37ca-4991-9945-cd7b65b72d4c" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatentandEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_wst_AssetImpairmentChargesPatentandEquipment_05e4074c-37ca-4991-9945-cd7b65b72d4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_0cdbf7cb-df7a-4a32-8c4b-6621db4262a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_OtherRestructuringCosts_0cdbf7cb-df7a-4a32-8c4b-6621db4262a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b2d633a8-6d08-41df-b344-a0f523cbb6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_RestructuringReserve_b2d633a8-6d08-41df-b344-a0f523cbb6cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2bfec495-351e-47b6-970f-ef108586ace6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2bfec495-351e-47b6-970f-ef108586ace6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_0f2c8cda-71bb-49d3-b412-5ac52692a96b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_PaymentsForRestructuring_0f2c8cda-71bb-49d3-b412-5ac52692a96b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_62002afe-64f1-4074-9d26-8087cbbc6982" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_62002afe-64f1-4074-9d26-8087cbbc6982" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b5065214-840b-4e01-bb59-568903c2eca1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3556d519-5556-49e1-9882-03de19b6c403" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:to="loc_srt_RangeAxis_3556d519-5556-49e1-9882-03de19b6c403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3556d519-5556-49e1-9882-03de19b6c403_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3556d519-5556-49e1-9882-03de19b6c403" xlink:to="loc_srt_RangeMember_3556d519-5556-49e1-9882-03de19b6c403_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3556d519-5556-49e1-9882-03de19b6c403" xlink:to="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c78439a3-b46b-4ed1-b9bf-2b1b734860dc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:to="loc_srt_MinimumMember_c78439a3-b46b-4ed1-b9bf-2b1b734860dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0533a9b9-17a3-47cb-ad25-5164afd99dbd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:to="loc_srt_MaximumMember_0533a9b9-17a3-47cb-ad25-5164afd99dbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_1f86c16d-84b7-48f9-b437-306090f660b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:to="loc_us-gaap_RestructuringPlanAxis_1f86c16d-84b7-48f9-b437-306090f660b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1f86c16d-84b7-48f9-b437-306090f660b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_1f86c16d-84b7-48f9-b437-306090f660b4" xlink:to="loc_us-gaap_RestructuringPlanDomain_1f86c16d-84b7-48f9-b437-306090f660b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_1f86c16d-84b7-48f9-b437-306090f660b4" xlink:to="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2018RestructuringPlanMember_80950b5f-8c2f-429e-b5ab-8d866038d821" xlink:href="wst-20191231.xsd#wst_A2018RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:to="loc_wst_A2018RestructuringPlanMember_80950b5f-8c2f-429e-b5ab-8d866038d821" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2016RestructuringPlanMemberMember_8a13cff1-83de-4c2e-b134-58dbf1de0725" xlink:href="wst-20191231.xsd#wst_A2016RestructuringPlanMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:to="loc_wst_A2016RestructuringPlanMemberMember_8a13cff1-83de-4c2e-b134-58dbf1de0725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_67f363df-b7d3-47f0-bc05-80fac241ad4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_67f363df-b7d3-47f0-bc05-80fac241ad4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_67f363df-b7d3-47f0-bc05-80fac241ad4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_67f363df-b7d3-47f0-bc05-80fac241ad4c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_67f363df-b7d3-47f0-bc05-80fac241ad4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_67f363df-b7d3-47f0-bc05-80fac241ad4c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_021af1fc-3aa9-4407-b386-00c2962e7818" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:to="loc_us-gaap_EmployeeSeveranceMember_021af1fc-3aa9-4407-b386-00c2962e7818" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_dd5564d3-0d55-426e-a22a-6669469e4f1c" xlink:href="wst-20191231.xsd#wst_AssetRelatedChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:to="loc_wst_AssetRelatedChargesMember_dd5564d3-0d55-426e-a22a-6669469e4f1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_0ed84575-725e-4bc7-9012-8a003f51a8de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:to="loc_us-gaap_OtherRestructuringMember_0ed84575-725e-4bc7-9012-8a003f51a8de" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseOtherItemsTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails" xlink:type="extended" id="i5e5123b0c54042a4b41d45b02c10864f_682adef7-4061-4eab-a090-a5433e9bf8a1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_a911fc97-b72d-495a-8da7-a050e01b610f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_55399c18-4bd6-40bf-b295-f73363298857" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_a911fc97-b72d-495a-8da7-a050e01b610f" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_55399c18-4bd6-40bf-b295-f73363298857" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_b1db7e0a-4bc9-472b-a738-e7bb1505ce49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_a911fc97-b72d-495a-8da7-a050e01b610f" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_b1db7e0a-4bc9-472b-a738-e7bb1505ce49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_38563ec5-dea9-4ea6-97e6-4788501d80ef" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_b1db7e0a-4bc9-472b-a738-e7bb1505ce49" xlink:to="loc_srt_StatementGeographicalAxis_38563ec5-dea9-4ea6-97e6-4788501d80ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_38563ec5-dea9-4ea6-97e6-4788501d80ef_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_38563ec5-dea9-4ea6-97e6-4788501d80ef" xlink:to="loc_srt_SegmentGeographicalDomain_38563ec5-dea9-4ea6-97e6-4788501d80ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1a87f6a2-8176-4f54-8909-8069e7f0ef7d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_38563ec5-dea9-4ea6-97e6-4788501d80ef" xlink:to="loc_srt_SegmentGeographicalDomain_1a87f6a2-8176-4f54-8909-8069e7f0ef7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_VE_7b2126b7-873c-4a9f-a0a4-f9064ebb4a5c" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_VE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1a87f6a2-8176-4f54-8909-8069e7f0ef7d" xlink:to="loc_country_VE_7b2126b7-873c-4a9f-a0a4-f9064ebb4a5c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseDevelopmentandLicensingIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails" xlink:type="extended" id="iea7651e1870f46318b2bc069be763934_0a9eb122-045d-4dcc-bcad-54b3467f1423">
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:href="wst-20191231.xsd#wst_DevelopmentandlicensingincomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Developmentandlicensingincome_acda4c03-973e-4243-94a3-5113d47c38a4" xlink:href="wst-20191231.xsd#wst_Developmentandlicensingincome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:to="loc_wst_Developmentandlicensingincome_acda4c03-973e-4243-94a3-5113d47c38a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3a592fd0-9036-40f5-bba2-80498c6675ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3a592fd0-9036-40f5-bba2-80498c6675ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentandlicensingincomeTable_e6a09995-a7fd-4565-ae29-16adf2005919" xlink:href="wst-20191231.xsd#wst_DevelopmentandlicensingincomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:to="loc_wst_DevelopmentandlicensingincomeTable_e6a09995-a7fd-4565-ae29-16adf2005919" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_a3f5e369-479f-44f0-aaf0-7d9c7b0de144" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_wst_DevelopmentandlicensingincomeTable_e6a09995-a7fd-4565-ae29-16adf2005919" xlink:to="loc_us-gaap_NatureOfExpenseAxis_a3f5e369-479f-44f0-aaf0-7d9c7b0de144" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_a3f5e369-479f-44f0-aaf0-7d9c7b0de144_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_a3f5e369-479f-44f0-aaf0-7d9c7b0de144" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_a3f5e369-479f-44f0-aaf0-7d9c7b0de144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_a3f5e369-479f-44f0-aaf0-7d9c7b0de144" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_a57a9c4b-a4b7-4a3f-8582-d39eabe83364" xlink:href="wst-20191231.xsd#wst_SmartDoseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:to="loc_wst_SmartDoseMember_a57a9c4b-a4b7-4a3f-8582-d39eabe83364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMember_ddf200e6-5165-43a5-b578-f2471212723f" xlink:href="wst-20191231.xsd#wst_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:to="loc_wst_OtherMember_ddf200e6-5165-43a5-b578-f2471212723f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended" id="icf8646b81bfb4bca8ebd1448770cfe52_feaded87-7672-47c4-a7e0-2d08f5314e82"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="extended" id="iae6e4438500e48fcbe16ea10df4a2ccd_28bcfc12-1146-4a5d-8392-9d3d95e96a3c"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTextualsDetails" xlink:type="extended" id="i4f2ed75940aa49f6bafa016a48b3287f_578a51b9-991a-4ab6-b603-16eec4d4a865">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3d2ee4fb-57c6-435f-9c7f-5ddf5fd59d18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3d2ee4fb-57c6-435f-9c7f-5ddf5fd59d18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_281c8a2b-c049-47f9-a98f-b76864c73394" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:to="loc_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_281c8a2b-c049-47f9-a98f-b76864c73394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_10d8456c-dae3-43fc-a5b6-fc92f5680ac2" xlink:href="wst-20191231.xsd#wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:to="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_10d8456c-dae3-43fc-a5b6-fc92f5680ac2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ae8593b9-7d2a-406b-8b26-9933a325256a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:to="loc_us-gaap_StatementTable_ae8593b9-7d2a-406b-8b26-9933a325256a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_80c8c491-4e53-4831-a6ff-5e46e6f08c01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ae8593b9-7d2a-406b-8b26-9933a325256a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_80c8c491-4e53-4831-a6ff-5e46e6f08c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_80c8c491-4e53-4831-a6ff-5e46e6f08c01_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_80c8c491-4e53-4831-a6ff-5e46e6f08c01" xlink:to="loc_us-gaap_TypeOfAdoptionMember_80c8c491-4e53-4831-a6ff-5e46e6f08c01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_88a31f11-3a09-40a2-8c5a-f6189bf1e3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_80c8c491-4e53-4831-a6ff-5e46e6f08c01" xlink:to="loc_us-gaap_TypeOfAdoptionMember_88a31f11-3a09-40a2-8c5a-f6189bf1e3d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_7d6401ca-d621-4698-b934-89edbaa3ef91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_88a31f11-3a09-40a2-8c5a-f6189bf1e3d4" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_7d6401ca-d621-4698-b934-89edbaa3ef91" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i89c4934eb0594735a232555090caa372_40a95c68-d01e-4ada-b1c4-40b47c0b124a"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended" id="i81b33a15bca74cb7978e4c7d8a132ad6_12ab2aaa-d6e2-4a3d-92a1-b3d90213c20a"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended" id="i331d21acd00f4660995e6a587ce6a179_f4e424a0-9dbf-4db3-acc1-5daf1b7feb7c"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i4b9172fa34d54f669178e498597af5cd_a474740a-780e-4984-867f-a864c57a10b1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ddd8cde7-17f2-4ac7-b53a-976541eb018e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ddd8cde7-17f2-4ac7-b53a-976541eb018e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_415149ec-65f3-47e9-b094-f9cccc6be78f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_415149ec-65f3-47e9-b094-f9cccc6be78f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_b14914be-a47a-4798-8121-462f09b4df9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_b14914be-a47a-4798-8121-462f09b4df9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_a192c24a-ee9a-4ab0-804f-32f10db457fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_a192c24a-ee9a-4ab0-804f-32f10db457fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_dd5d7115-9ec1-40aa-b6b6-7af9d37010a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_dd5d7115-9ec1-40aa-b6b6-7af9d37010a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_0e1128d5-1618-456f-9008-b5583cd8bd32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_0e1128d5-1618-456f-9008-b5583cd8bd32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_0e1128d5-1618-456f-9008-b5583cd8bd32_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0e1128d5-1618-456f-9008-b5583cd8bd32" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_0e1128d5-1618-456f-9008-b5583cd8bd32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_5d7aa21b-b8e9-4601-9829-e978f98041ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0e1128d5-1618-456f-9008-b5583cd8bd32" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_5d7aa21b-b8e9-4601-9829-e978f98041ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_e6c179be-b70a-4ea5-916c-676f74c834c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_5d7aa21b-b8e9-4601-9829-e978f98041ef" xlink:to="loc_us-gaap_ResearchMember_e6c179be-b70a-4ea5-916c-676f74c834c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis_fd97a704-ad74-4067-9b11-26ec8e085295" xlink:href="wst-20191231.xsd#wst_ExpirationPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:to="loc_wst_ExpirationPeriodAxis_fd97a704-ad74-4067-9b11-26ec8e085295" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_fd97a704-ad74-4067-9b11-26ec8e085295_default" xlink:href="wst-20191231.xsd#wst_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_wst_ExpirationPeriodAxis_fd97a704-ad74-4067-9b11-26ec8e085295" xlink:to="loc_wst_ExpirationPeriodDomain_fd97a704-ad74-4067-9b11-26ec8e085295_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:href="wst-20191231.xsd#wst_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_wst_ExpirationPeriodAxis_fd97a704-ad74-4067-9b11-26ec8e085295" xlink:to="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2019Member_6c76e484-aec0-4667-ae59-46c9435400ff" xlink:href="wst-20191231.xsd#wst_Year2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2019Member_6c76e484-aec0-4667-ae59-46c9435400ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2019Member_9ed5b54a-472d-439d-b175-9a3c26edb145" xlink:href="wst-20191231.xsd#wst_YearAfter2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_YearAfter2019Member_9ed5b54a-472d-439d-b175-9a3c26edb145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2037Member_cccc71c7-c229-4cee-aebc-884b45c1993e" xlink:href="wst-20191231.xsd#wst_Year2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2037Member_cccc71c7-c229-4cee-aebc-884b45c1993e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2038Member_3640809e-c7ae-465e-a15f-10a33485d37c" xlink:href="wst-20191231.xsd#wst_Year2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2038Member_3640809e-c7ae-465e-a15f-10a33485d37c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2039Member_9602b348-865f-450a-9b1b-eb16cb0e9dac" xlink:href="wst-20191231.xsd#wst_Year2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2039Member_9602b348-865f-450a-9b1b-eb16cb0e9dac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2020Member_cf64c51f-71ca-43ff-9f67-89e780651b5f" xlink:href="wst-20191231.xsd#wst_Year2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2020Member_cf64c51f-71ca-43ff-9f67-89e780651b5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2022Member_d49df58c-66ff-41b9-8b6d-e01e0d1717e0" xlink:href="wst-20191231.xsd#wst_Year2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2022Member_d49df58c-66ff-41b9-8b6d-e01e0d1717e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2023Member_517e8c49-2958-4c20-8a0b-b5f613796eb1" xlink:href="wst-20191231.xsd#wst_Year2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2023Member_517e8c49-2958-4c20-8a0b-b5f613796eb1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2023Member_fc542331-5345-4a23-a9aa-32b79c6445a9" xlink:href="wst-20191231.xsd#wst_YearAfter2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_YearAfter2023Member_fc542331-5345-4a23-a9aa-32b79c6445a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_890a97bf-7c7d-43ea-8b43-7faa73245eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_890a97bf-7c7d-43ea-8b43-7faa73245eb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_890a97bf-7c7d-43ea-8b43-7faa73245eb2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_890a97bf-7c7d-43ea-8b43-7faa73245eb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_890a97bf-7c7d-43ea-8b43-7faa73245eb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_890a97bf-7c7d-43ea-8b43-7faa73245eb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_79f9fca5-c209-4d2e-b98f-35a1372fc7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_79f9fca5-c209-4d2e-b98f-35a1372fc7a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f8987a24-2c8d-42e3-b9ae-92e1671ad4fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:to="loc_us-gaap_ForeignCountryMember_f8987a24-2c8d-42e3-b9ae-92e1671ad4fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_0a8a173d-3190-42fb-a2c9-cf74d608f91e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_0a8a173d-3190-42fb-a2c9-cf74d608f91e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended" id="id3834fa77b5e43349a3752f0b1d4aa02_1ecba4f9-08fc-4895-bec1-905d1bc5ba01"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20191231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended" id="i3b152510484c4b4db2ae1054f1f8ec9f_8e7a5493-af28-422c-a193-f5e80c9e48b4"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#CommitmentsandContingenciesTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails" xlink:type="extended" id="icd0d4a9535e24ae48bd407d9304d4d9e_e74280b0-29a0-46b4-bc43-2a71bb57223c">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod_74206acd-d27d-44ad-bc66-57b2df29f4e0" xlink:href="wst-20191231.xsd#wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:to="loc_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod_74206acd-d27d-44ad-bc66-57b2df29f4e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_1898417d-125e-4b64-9c88-0dbd2e9853c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_1898417d-125e-4b64-9c88-0dbd2e9853c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_846f5aee-8423-4611-967e-7cafd648c4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_846f5aee-8423-4611-967e-7cafd648c4e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cccdf710-2b32-46b6-83a4-df68b0ea0906" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cccdf710-2b32-46b6-83a4-df68b0ea0906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cccdf710-2b32-46b6-83a4-df68b0ea0906_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cccdf710-2b32-46b6-83a4-df68b0ea0906" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cccdf710-2b32-46b6-83a4-df68b0ea0906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cccdf710-2b32-46b6-83a4-df68b0ea0906" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Revolvingcreditfacilitydue2020Member_4c5f96e6-e9ad-428f-ae0e-127598c0a8ea" xlink:href="wst-20191231.xsd#wst_Revolvingcreditfacilitydue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:to="loc_wst_Revolvingcreditfacilitydue2020Member_4c5f96e6-e9ad-428f-ae0e-127598c0a8ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_ea93e9fe-bd5f-49bc-9a2c-1c1b657b3ef2" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_ea93e9fe-bd5f-49bc-9a2c-1c1b657b3ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_672ebed3-1893-4e7a-ac30-5dfd915938ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_us-gaap_CreditFacilityAxis_672ebed3-1893-4e7a-ac30-5dfd915938ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_672ebed3-1893-4e7a-ac30-5dfd915938ab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_672ebed3-1893-4e7a-ac30-5dfd915938ab" xlink:to="loc_us-gaap_CreditFacilityDomain_672ebed3-1893-4e7a-ac30-5dfd915938ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2c9e1ff5-1297-4117-9bdd-6be413542f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_672ebed3-1893-4e7a-ac30-5dfd915938ab" xlink:to="loc_us-gaap_CreditFacilityDomain_2c9e1ff5-1297-4117-9bdd-6be413542f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_87d49cee-a244-4a6e-b1cc-d5bd1b032f06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2c9e1ff5-1297-4117-9bdd-6be413542f0c" xlink:to="loc_us-gaap_LetterOfCreditMember_87d49cee-a244-4a6e-b1cc-d5bd1b032f06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_29c7bea2-afc0-4191-990b-c014ad9045c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_29c7bea2-afc0-4191-990b-c014ad9045c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6ebed752-ecfc-410a-9239-dae5b394378d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_29c7bea2-afc0-4191-990b-c014ad9045c8" xlink:to="loc_us-gaap_ForeignCountryMember_6ebed752-ecfc-410a-9239-dae5b394378d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a12d62e4-1cd7-457b-98e8-4616f4ecb24e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_srt_RangeAxis_a12d62e4-1cd7-457b-98e8-4616f4ecb24e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a12d62e4-1cd7-457b-98e8-4616f4ecb24e_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a12d62e4-1cd7-457b-98e8-4616f4ecb24e" xlink:to="loc_srt_RangeMember_a12d62e4-1cd7-457b-98e8-4616f4ecb24e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a12d62e4-1cd7-457b-98e8-4616f4ecb24e" xlink:to="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_613f3424-4204-47c1-bfa5-94c280643039" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:to="loc_srt_MinimumMember_613f3424-4204-47c1-bfa5-94c280643039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_caf2c00a-d12e-45c2-ab29-28224b845476" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:to="loc_srt_MaximumMember_caf2c00a-d12e-45c2-ab29-28224b845476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_84cee936-10bf-47b2-8243-ba27ed3de57b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_84cee936-10bf-47b2-8243-ba27ed3de57b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_34e0ae0e-7edb-4069-bb90-158fd398eade" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_34e0ae0e-7edb-4069-bb90-158fd398eade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationTable_80b0e2a3-9ef1-4d97-8c8b-c9a73b68dbd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationTable_80b0e2a3-9ef1-4d97-8c8b-c9a73b68dbd3" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_42326b5a-93d4-4cc8-b13e-75c0684b69c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_42326b5a-93d4-4cc8-b13e-75c0684b69c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable_a8f9ca19-a82b-4085-91ee-1735124437e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:to="loc_us-gaap_LossContingencyReceivable_a8f9ca19-a82b-4085-91ee-1735124437e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_56b5e4f1-1532-45dc-9fdc-1aa535bfc802" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:to="loc_us-gaap_LineOfCredit_56b5e4f1-1532-45dc-9fdc-1aa535bfc802" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_415c68fc-2d48-4425-b936-786afa755731" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:to="loc_us-gaap_LossContingenciesTable_415c68fc-2d48-4425-b936-786afa755731" xlink:type="arc" order="3" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_15b9742b-52d2-4e58-92b0-b1c33218b45c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_415c68fc-2d48-4425-b936-786afa755731" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_15b9742b-52d2-4e58-92b0-b1c33218b45c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_15b9742b-52d2-4e58-92b0-b1c33218b45c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_15b9742b-52d2-4e58-92b0-b1c33218b45c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_15b9742b-52d2-4e58-92b0-b1c33218b45c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1a7d9542-d935-4134-9ceb-f2f13eb21a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_15b9742b-52d2-4e58-92b0-b1c33218b45c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1a7d9542-d935-4134-9ceb-f2f13eb21a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember_ad69dc42-cb54-477c-adff-86ca367b031b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_1a7d9542-d935-4134-9ceb-f2f13eb21a7d" xlink:to="loc_us-gaap_InsuranceClaimsMember_ad69dc42-cb54-477c-adff-86ca367b031b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformation"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended" id="ic0471db2c923497e8a4d159c3e9c47c7_7314a4e4-3419-479c-877f-f1fe7f3f49a0"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationTables"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended" id="ibc972b4ecf6f432196f38d5c0c5badce_e1337900-15ee-4b80-970f-b8168aff49d7"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationTextualsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationTextualsDetails" xlink:type="extended" id="ida9ded937035480c9925529c3042d2b8_e3a5d476-3e2a-43ff-b1e1-e96807f23b28"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended" id="i01e19f4bf72640098d099554d8477464_51942b6a-c033-4409-b808-db6addc158c6">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_78dbf8c0-8204-4047-a549-0f4ed60e8e42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c582fe81-a85c-44e6-994f-26f2c4db1e66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_78dbf8c0-8204-4047-a549-0f4ed60e8e42" xlink:to="loc_us-gaap_Revenues_c582fe81-a85c-44e6-994f-26f2c4db1e66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fb5371a7-c7a1-4150-b6ee-01c680fa0e53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_78dbf8c0-8204-4047-a549-0f4ed60e8e42" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fb5371a7-c7a1-4150-b6ee-01c680fa0e53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dc72b50c-b8fe-4c45-9b71-32ee6e05aded" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fb5371a7-c7a1-4150-b6ee-01c680fa0e53" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dc72b50c-b8fe-4c45-9b71-32ee6e05aded" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dc72b50c-b8fe-4c45-9b71-32ee6e05aded_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dc72b50c-b8fe-4c45-9b71-32ee6e05aded" xlink:to="loc_us-gaap_SegmentDomain_dc72b50c-b8fe-4c45-9b71-32ee6e05aded_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dc72b50c-b8fe-4c45-9b71-32ee6e05aded" xlink:to="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_f0ee9242-faea-4297-85d7-d710e6dfc25b" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:to="loc_wst_ContractManufacturedProductsMember_f0ee9242-faea-4297-85d7-d710e6dfc25b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_6bb66ce5-fa66-4831-aba2-2b7f2d2090dd" xlink:href="wst-20191231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:to="loc_wst_ProprietaryProductsMember_6bb66ce5-fa66-4831-aba2-2b7f2d2090dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_55a9eda6-6491-48d0-b1ec-db759de40fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_55a9eda6-6491-48d0-b1ec-db759de40fb8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSalesandPPEbyGeographicLocationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails" xlink:type="extended" id="i143410b65ad84dd682413f364037be69_5a6f452f-b221-4906-8411-35ec83176b9a">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cb5c87d1-b595-4f37-a23f-eb6f9de1b7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:to="loc_us-gaap_Revenues_cb5c87d1-b595-4f37-a23f-eb6f9de1b7a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c7ada741-6fd5-45b4-9f17-fa6855de403d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c7ada741-6fd5-45b4-9f17-fa6855de403d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_967108ea-418a-425a-b274-76007bee60cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_967108ea-418a-425a-b274-76007bee60cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_51be5e67-d0b9-4f1a-9a1f-9e40907be009" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_967108ea-418a-425a-b274-76007bee60cd" xlink:to="loc_srt_StatementGeographicalAxis_51be5e67-d0b9-4f1a-9a1f-9e40907be009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_51be5e67-d0b9-4f1a-9a1f-9e40907be009_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_51be5e67-d0b9-4f1a-9a1f-9e40907be009" xlink:to="loc_srt_SegmentGeographicalDomain_51be5e67-d0b9-4f1a-9a1f-9e40907be009_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_51be5e67-d0b9-4f1a-9a1f-9e40907be009" xlink:to="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9c891ac5-c8ca-46f0-8056-a36423d75194" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_US_9c891ac5-c8ca-46f0-8056-a36423d75194" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_36464644-f6ab-45eb-934c-b24aa6f90a74" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_DE_36464644-f6ab-45eb-934c-b24aa6f90a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_dfd3c2cb-e580-43f6-bc36-a89d97f20adf" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_FR_dfd3c2cb-e580-43f6-bc36-a89d97f20adf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember_66959032-bd37-47b9-9da7-23559246947c" xlink:href="wst-20191231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_wst_OtherEuropeCountriesMember_66959032-bd37-47b9-9da7-23559246947c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember_57314f87-fa59-4eda-960f-77f0e92f3896" xlink:href="wst-20191231.xsd#wst_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_wst_OtherCountriesMember_57314f87-fa59-4eda-960f-77f0e92f3896" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_6e35f6b8-6156-42b2-8d28-3861f65925d7" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_IE_6e35f6b8-6156-42b2-8d28-3861f65925d7" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended" id="ida41267be5474e8aa67afe09701bb297_995063a4-08b2-42b4-9946-2c3f9f5fa337">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a29f1075-4369-463d-8326-63181046e09a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_Revenues_a29f1075-4369-463d-8326-63181046e09a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0c8779c7-4de6-42b3-9c5a-e91092880458" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_OperatingIncomeLoss_0c8779c7-4de6-42b3-9c5a-e91092880458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1065365c-14f1-4ab9-b62d-a7f94c62fd19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_InterestExpense_1065365c-14f1-4ab9-b62d-a7f94c62fd19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_d530a23a-69eb-4541-928b-9f364af9ea10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_InvestmentIncomeNet_d530a23a-69eb-4541-928b-9f364af9ea10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8eb51ab5-c423-48f2-8fb3-881abceedefc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8eb51ab5-c423-48f2-8fb3-881abceedefc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c54c5f4f-0407-4678-8e7b-b83ef0febf07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c54c5f4f-0407-4678-8e7b-b83ef0febf07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b2324999-9560-4506-8263-8e4cebf993b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_Assets_b2324999-9560-4506-8263-8e4cebf993b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49c0d9f8-fba3-4cc0-a727-8027110e15b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49c0d9f8-fba3-4cc0-a727-8027110e15b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3eeeb028-6591-4c19-bc21-9feb7c30966c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3eeeb028-6591-4c19-bc21-9feb7c30966c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f34a0236-068c-4c16-8440-7317695db7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f34a0236-068c-4c16-8440-7317695db7c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f34a0236-068c-4c16-8440-7317695db7c8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682" xlink:to="loc_us-gaap_SegmentDomain_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682" xlink:to="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_0ba47ea6-11cc-4043-9d39-6771fa7b9052" xlink:href="wst-20191231.xsd#wst_ProprietaryProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:to="loc_wst_ProprietaryProductsMember_0ba47ea6-11cc-4043-9d39-6771fa7b9052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_817502b2-9c51-4128-b98b-44a11c70e003" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:to="loc_wst_ContractManufacturedProductsMember_817502b2-9c51-4128-b98b-44a11c70e003" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CorporateAndEliminationsMember_83347f01-a33b-46d2-af9a-ae4fcb883780" xlink:href="wst-20191231.xsd#wst_CorporateAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:to="loc_wst_CorporateAndEliminationsMember_83347f01-a33b-46d2-af9a-ae4fcb883780" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="simple" xlink:href="wst-20191231.xsd#ScheduleIIValuationandQualifyingAccountsNotes"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="extended" id="i221733ae78c449e582fb73f04f2fd415_775951a9-b147-4b7e-96a1-94fdd0c72d81"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended" id="iff525c6e39a246efaa208c997ba59779_e08f63eb-dede-4703-8f15-9e3c66c2df66">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a1b5c347-f3b0-419f-862e-987f58b93846" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a1b5c347-f3b0-419f-862e-987f58b93846" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_9df3763e-b083-4d78-b44e-27d3fb153d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_9df3763e-b083-4d78-b44e-27d3fb153d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_45d36738-c736-4c51-afea-b080ba2e0c16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_45d36738-c736-4c51-afea-b080ba2e0c16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8ec2812a-f9d9-471f-9f97-ce22e47f66fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8ec2812a-f9d9-471f-9f97-ce22e47f66fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_f47129f3-355d-4bdf-a5a6-f8ad9befed3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f475ab0c-e962-4130-9073-f0f64525e937" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a1b5c347-f3b0-419f-862e-987f58b93846" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f475ab0c-e962-4130-9073-f0f64525e937" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f475ab0c-e962-4130-9073-f0f64525e937" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_ef81e268-a73f-40b9-8f6c-12a66e761cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_ef81e268-a73f-40b9-8f6c-12a66e761cfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_1e80bc03-708b-43f4-a88b-dbe4b1caeaec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_1e80bc03-708b-43f4-a88b-dbe4b1caeaec" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>wst-20191231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b5520f3c-bdfb-4aa1-98ba-ba1f6a92b1c8,g:f267b37f-edf1-4d21-84ed-4e7cdfb1cf2c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_99203dd6-dd44-4313-86a9-cd15146627e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1223b49a-f886-4767-ae0f-2b4fd3259faa_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of current market price for sales to eligible employees</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_96afd8e4-3b01-45c7-80be-b0c7976e0e2e_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6ad5e75c-ad70-4f61-9aee-a645025fc4ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetNoncurrent_e2474a41-d23f-4926-b8a6-f8e2b5ef8910_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:to="lab_us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_e6bfa2f8-5453-4a38-87cb-8d80bdfb7cd2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_32848821-95c4-4417-a972-9fe657e4392d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received from affiliated companies</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_f6ebb9ba-2278-44d0-8dc1-f72ae9c61c95_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, foreign</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_5029f740-6fc7-4f06-b581-c8c9ee8bd994_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under revolving credit agreements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_f86cf6b5-9f19-41c1-b0e5-ca3a84f9ebab_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromAffiliates_0ac5d020-0d17-477c-8515-4b1eba608bd1_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount receivable from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromAffiliates_label_en-US" xlink:label="lab_us-gaap_DueFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromAffiliates" xlink:to="lab_us-gaap_DueFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_4b2881fd-22c5-4b95-a63a-7f82e02d1517_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_89ac2042-ef3e-4436-a349-7a7f08006cc4_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense for all nonvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_6762674c-1c73-4eb4-995f-34e426ad10e8_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Vesting Shares [Member]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_ca2d72fb-2618-4c11-8c79-b76920b1a60e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted_718f85cd-fd3c-413a-a266-3591d5685844_terseLabel_en-US" xlink:label="lab_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reduced for each award granted</link:label>
    <link:label id="lab_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted_label_en-US" xlink:label="lab_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Number of Shares Available for Grant For Each Award Granted</link:label>
    <link:label id="lab_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted_documentation_en-US" xlink:label="lab_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in number of shares available for grant for each award granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" xlink:href="wst-20191231.xsd#wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" xlink:to="lab_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_59cda6a9-dd76-42e9-97ac-1fb12fc70ee7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_74f5f34c-f4d8-4e77-8856-8afe7ed6927f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory balance for recalled product</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_4147673a-aa71-4650-a268-99fc90631e18_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6dc74528-9f61-4118-b3a1-4f53e266996a_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification_a26050d4-1ba8-4456-9f01-78eff2c59228_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net, Classification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification" xlink:to="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LeaseOperatingLeaseTerminateTerm_a94875a7-8afb-4cdd-8da6-535a1957b5f2_terseLabel_en-US" xlink:label="lab_wst_LeaseOperatingLeaseTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, operating lease, terminate term</link:label>
    <link:label id="lab_wst_LeaseOperatingLeaseTerminateTerm_label_en-US" xlink:label="lab_wst_LeaseOperatingLeaseTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, operating lease, terminate term</link:label>
    <link:label id="lab_wst_LeaseOperatingLeaseTerminateTerm_documentation_en-US" xlink:label="lab_wst_LeaseOperatingLeaseTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lease, operating lease, terminate term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LeaseOperatingLeaseTerminateTerm" xlink:href="wst-20191231.xsd#wst_LeaseOperatingLeaseTerminateTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LeaseOperatingLeaseTerminateTerm" xlink:to="lab_wst_LeaseOperatingLeaseTerminateTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_669c333b-4489-466d-8257-8e24e4841fdf_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in affiliated companies</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_bd9e6f15-3ee1-4c0e-a6d4-059bc8e9982e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase in investment in affiliated companies in cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_cbd4f029-83df-4049-b63d-d9e27f089b0b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_757b257e-a13e-4bad-96e9-d02fe009c6d4_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_72af341e-9dc2-40f9-9fbd-b7506ad2cda8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7c043633-2bdc-46f5-9a46-e6b4a588b70c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_1b17fc13-c454-44dc-ab1f-697682b238fe_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_b7eaec35-083b-4872-bc28-10d4bd9ebc07_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_2ca6d64b-9833-4110-921a-51b51f9a1a3a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_2b7a4019-5e9b-4fe5-b955-11f7e3b3d5c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlement charge</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_b291bb1d-72f1-42b9-a0d3-aa1c10236c8c_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension curtailment gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_1c50c52c-9590-4ae9-8460-13b3af523062_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_d146de9a-9489-40a4-9efd-400fa0ce01f3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5055960f-9d1e-4013-a8bc-5deaed0e318b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0c35df0a-66a0-4956-8601-bed1afa8d029_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was included in the deferred income balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2c793cc9-34b9-4bb8-8653-7acc7a6efd19_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b2f7b19b-2f9b-4ed7-9f87-a90f2fcf11b5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongMember_73d46d1e-ceee-41ea-bbc3-23f66c361dfa_terseLabel_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:label id="lab_us-gaap_LongMember_label_en-US" xlink:label="lab_us-gaap_LongMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongMember" xlink:to="lab_us-gaap_LongMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2072d786-851f-4820-8c69-1ff24411318f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of total options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_8ce19573-b94e-47d7-ba37-a751f2e883f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5062ca17-1ae4-4270-add3-c39b02ee6a56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f198746d-0483-4f42-bbdd-54c779657246_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and converted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_58e59e7a-cdc2-4154-a9f2-ca1993602386_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_9b3e51d5-acd7-47b1-b74c-928e793f3dbb_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_591bbafc-4a0e-4072-92db-9d9dec254b5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_1e77bd77-77c6-40f0-8e02-aad303fed4f7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_62cd4ad7-7f99-4e75-8174-c0641455070b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_76229781-1b5e-4ffe-8996-6543bce267a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8ba8fb48-cfb5-4e83-b968-3b5e8fee199a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_37285501-42ff-4494-ae70-d5c21cbadd35_terseLabel_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_label_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:label id="lab_wst_EmployeeStockPurchasePlanEsppMember_documentation_en-US" xlink:label="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan (ESPP) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember" xlink:href="wst-20191231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EmployeeStockPurchasePlanEsppMember" xlink:to="lab_wst_EmployeeStockPurchasePlanEsppMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_1ab2a58b-4a01-4bb1-931f-8fb2a3da12a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (loss) arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_2eb169ff-6733-4b3b-9ba3-2735ae0da9fa_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process Research and Development (IPR&amp;D) [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_77915069-fd0e-4d10-97ec-10c043599838_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_87ca9e13-a907-4648-8109-49ebe85d9044_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_98f52fc2-5c8c-41ae-83f5-c86719b26517_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7aef3224-424f-4675-848d-0519f981c2a5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_49968a33-8ea7-44ce-b563-f9cf2e0c60c2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8e1c65dc-eb42-431b-8b35-7f490e8df2b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_SGD_9574adf5-6955-4076-b92d-14ded6e7b4a9_terseLabel_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:label id="lab_currency_SGD_label_en-US" xlink:label="lab_currency_SGD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_SGD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SGD" xlink:to="lab_currency_SGD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f91dfd43-cc8e-4885-bb45-96eaa32e3539_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets/liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ffac05b0-f89d-4907-9c73-b1ec86ae87c6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant/issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredStockUnitsPayableinCash_bd0e0d3c-953f-45c8-8fdc-a9711dee9f25_terseLabel_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableinCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred stock units payable in cash</link:label>
    <link:label id="lab_wst_DeferredStockUnitsPayableinCash_label_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableinCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units Payable in Cash</link:label>
    <link:label id="lab_wst_DeferredStockUnitsPayableinCash_documentation_en-US" xlink:label="lab_wst_DeferredStockUnitsPayableinCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Units Payable in Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableinCash" xlink:href="wst-20191231.xsd#wst_DeferredStockUnitsPayableinCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredStockUnitsPayableinCash" xlink:to="lab_wst_DeferredStockUnitsPayableinCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_74ae1ab0-bb0e-47e9-b74b-617950203219_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction for expiration of statute of limitations/audits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7fddcecb-1591-4ebc-8f09-751674d9108b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and earnings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_a232f1f7-de8e-4932-9da5-72781c874b91_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_e789b268-cf5e-4162-a2a7-01444d835563_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ab3e1b27-9a5c-4bd1-9eb1-bf9966464065_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ExpirationPeriodAxis_1c95b3f4-fe23-4450-a84b-f13e93d9411f_terseLabel_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_wst_ExpirationPeriodAxis_label_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_wst_ExpirationPeriodAxis_documentation_en-US" xlink:label="lab_wst_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis" xlink:href="wst-20191231.xsd#wst_ExpirationPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ExpirationPeriodAxis" xlink:to="lab_wst_ExpirationPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_DE_49d46afb-1fc5-44cf-985a-f331112d19f3_terseLabel_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Germany [Member]</link:label>
    <link:label id="lab_country_DE_label_en-US" xlink:label="lab_country_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GERMANY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE" xlink:to="lab_country_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_500e2dff-ea66-45fe-8f9e-bc7555e494a5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers_b1ef6ca7-01ff-4d6d-a84f-60c774ec7a70_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of major customers</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Disclosure of Major Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureOfMajorCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:to="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_5fe400c1-1b13-4b76-ba21-db0a9e0d5988_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:to="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c6eafaaa-82ed-497a-8fa3-0b02537e229b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other nonoperating expense (income)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_6d0c01f9-dba2-4390-a788-c322510960b7_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset Valuation Allowance [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_c8cc7785-5a90-4c19-828f-3157eea7cfb5_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in USD per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_c69b147a-fac7-4f34-8b2f-f7fa2bb8802c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_MutualFundsMember_31d7bbc0-810b-465c-a84e-3cf67e5f2249_terseLabel_en-US" xlink:label="lab_wst_MutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_MutualFundsMember_label_en-US" xlink:label="lab_wst_MutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_MutualFundsMember_documentation_en-US" xlink:label="lab_wst_MutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_MutualFundsMember" xlink:href="wst-20191231.xsd#wst_MutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_MutualFundsMember" xlink:to="lab_wst_MutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_adca10cb-c4f4-479c-8094-6264fb87089c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net impact to the 2018 effective tax rate, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Increase (Decrease) in Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c25e94d1-f08e-443d-801b-988042182f0e_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_525f6894-ca2c-46af-b6f4-2fa257681f38_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc799cc7-ad01-417b-a24f-2a93aa546106_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1db3f0a5-9aa9-4afc-ad12-b7377991962a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_53005631-1da6-48e7-90c1-f5e7e2269456_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_d81764c5-68b3-41a3-a97f-bc41e0a48bd9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:to="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DevelopmentandlicensingincomeLineItems_797a71a4-287a-43f9-b7cb-b2c9f4f2151a_terseLabel_en-US" xlink:label="lab_wst_DevelopmentandlicensingincomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income [Line Items]</link:label>
    <link:label id="lab_wst_DevelopmentandlicensingincomeLineItems_label_en-US" xlink:label="lab_wst_DevelopmentandlicensingincomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income [Line Items]</link:label>
    <link:label id="lab_wst_DevelopmentandlicensingincomeLineItems_documentation_en-US" xlink:label="lab_wst_DevelopmentandlicensingincomeLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Development and licensing income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentandlicensingincomeLineItems" xlink:href="wst-20191231.xsd#wst_DevelopmentandlicensingincomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DevelopmentandlicensingincomeLineItems" xlink:to="lab_wst_DevelopmentandlicensingincomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bfe0a329-1207-47b6-954f-ff6a0595d8e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_5458ec39-3760-419a-9624-d512ea80c577_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_0bf7c0d2-225b-4d4b-8384-166e16cd9cec_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_05c94c9f-55ba-4e5e-be5b-6d5d3265d6d3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities for interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_99f32a2c-c7f3-4407-b8e9-97e04306f8cc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_916deadd-106b-498d-aeba-cb6c945a4aa3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_bc380c0d-3dd5-47e0-81de-fd55d9476dac_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_86721092-6271-44c7-abf2-65f4969a6c19_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0c06b474-a3e4-4dc1-b9fa-cecf848e0c71_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotionalAmountOfNonderivativeInstruments_b6f3b467-d99a-4c07-a8dd-90c625dc52b5_terseLabel_en-US" xlink:label="lab_us-gaap_NotionalAmountOfNonderivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount, nonderivative instruments</link:label>
    <link:label id="lab_us-gaap_NotionalAmountOfNonderivativeInstruments_label_en-US" xlink:label="lab_us-gaap_NotionalAmountOfNonderivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount of Nonderivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotionalAmountOfNonderivativeInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotionalAmountOfNonderivativeInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotionalAmountOfNonderivativeInstruments" xlink:to="lab_us-gaap_NotionalAmountOfNonderivativeInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_6ab1b726-e085-4cfe-92d7-778bd456983f_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_284b5c82-9979-4520-9c6a-1203de2b71c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_49c52a4e-b75b-4aa7-a84a-a8ffac148d13_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cf8d905-6c06-405f-8902-1d1022a20283_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e6b736d-dbfc-410d-b4a4-47e0685b14ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, including cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_481f8c4e-1db9-486c-9e3d-f5fff155d842_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, including cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_d7bb1a6e-11a8-4c1e-bff5-ca1e761af04d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_b3ca70a4-e0d7-47fb-b5c4-e462d8e9c005_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_c4020cf9-f348-403d-8940-e8a88dc6ea1e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_11ef460c-71fd-4769-8153-22911fb1ef53_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation on payroll deductions of employee's base salary, amount</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_25fb7924-ccf1-470b-8dc4-1ba12a05cc6e_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit_f6d4fe99-f606-4d5e-a414-fd4d794165dc_terseLabel_en-US" xlink:label="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit available for the issuance of letters of credit</link:label>
    <link:label id="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit_label_en-US" xlink:label="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit available for the issuance of letters of credit</link:label>
    <link:label id="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit_documentation_en-US" xlink:label="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">this refers to Credit available for the issuance of letters of credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:href="wst-20191231.xsd#wst_CreditAvailableForIssuanceOfLettersOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:to="lab_wst_CreditAvailableForIssuanceOfLettersOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_3529fd64-da27-4b5b-b681-0dd6de475673_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France [Member]</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_280c57d7-7703-41cc-9372-01a6312bf378_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0b6ca6e0-0f84-4c43-8bf0-4d01c29faaff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_274ae4e1-4866-4ea6-9d19-64ddccd5b49d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_aaa4ded4-0f0d-41a9-91b1-0a66d914b6bf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_e5db18aa-2d8e-4c04-a6f8-295a6867a9fd_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid, net of amounts capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_4d314f3b-22ad-4ae6-b947-9251aed5abcc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_abd5362e-6fa4-44c8-b030-c5687b65c2aa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_2b2e8d4c-6b5b-49f7-8d6c-f2c5b6d64ff5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash related to deconsolidated Venezuelan subsidiary</link:label>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:to="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a960b3fe-78e3-4095-a664-6676e94d7b9a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaCustomersMember_7f3e5c6b-c1af-421a-8ba3-0f6caa0b8cf6_terseLabel_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_label_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:label id="lab_wst_PharmaCustomersMember_documentation_en-US" xlink:label="lab_wst_PharmaCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember" xlink:href="wst-20191231.xsd#wst_PharmaCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaCustomersMember" xlink:to="lab_wst_PharmaCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnOilAndGasHedgingActivity_588f7d47-f412-492e-b709-0bc47b2e1d43_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Hedging Activity</link:label>
    <link:label id="lab_us-gaap_GainLossOnOilAndGasHedgingActivity_label_en-US" xlink:label="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Hedging Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:to="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_e8803aef-0e53-4f0e-a03a-97e99c4f4568_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction (Loss)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherIncomeExpense_6aacc670-d36d-4ed7-88ae-d1a1ce9ad428_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_5dc595ae-4ae1-412c-9a0a-7a787bca42ad_terseLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_6e371a56-0cfa-4c85-949f-19f5f9076c6c_negatedTotalLabel_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_label_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense</link:label>
    <link:label id="lab_wst_OtherIncomeExpense_documentation_en-US" xlink:label="lab_wst_OtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherIncomeExpense" xlink:to="lab_wst_OtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ExpirationPeriodDomain_88c79aa5-d1cb-4b85-a29e-fe3271644fd1_terseLabel_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_wst_ExpirationPeriodDomain_label_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_wst_ExpirationPeriodDomain_documentation_en-US" xlink:label="lab_wst_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Expiration Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain" xlink:href="wst-20191231.xsd#wst_ExpirationPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ExpirationPeriodDomain" xlink:to="lab_wst_ExpirationPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInCustomerAdvances_7b5f56cd-fabd-4129-9172-bf29187ccc7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer advance cash payments</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInCustomerAdvances_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Customer Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="lab_us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_e381b917-5c94-4135-966b-fc5ed3db0b59_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_15aa1c77-bee6-45e9-83de-e4a16cdb737c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_527a06b3-8c54-469d-bada-09e657d01089_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_201fba4f-1e89-42f2-a0fd-dd527aea093a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_217a9115-44d9-4d8d-bbbb-6f69bddda97c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_f96af976-9b00-468f-b512-e06729fa8f10_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_e36a670b-33e0-4081-ac0d-94061d468cbc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_ac20ca2f-4af8-46af-af0e-6ab964996df6_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_e8cc3e30-4717-43da-af5f-009e76991e20_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0be38341-83ff-481d-bfe1-e4708aa008ad_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_61baddc2-e16b-4d97-bd26-d3fc6ade6b77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f7402c7d-db4d-4346-a35f-b872205b30b3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive options excluded from computation of diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d1066fee-e727-48b3-976b-debcc33acd56_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_1c12dd26-2b79-404c-96d6-de3688a7b25f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1aa286d4-ab7b-426c-92a5-6beb2362105a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_e2f0752e-6bad-4c75-8d90-8e7b86b8d804_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_7e8bde18-f16b-4db6-99a2-7bf95b2de3c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt Obligations , Net of Current Maturities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_4e561079-a0d7-4ae1-8bea-b3e7413c5e5e_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6d68362e-d6b1-4f60-bd8f-99245e12f791_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability payments due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8704d2cf-bcc1-4d8d-8f0e-45b1f60cc147_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconcilliation of Basic to Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_c777d187-6d34-4a51-98d6-e9bdaf7637e1_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_ab58c3d4-1d26-4739-8dae-328e9b6592ce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b1fa7b02-059f-4341-bc4b-f4aaa8b27c38_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_9a4977e8-6477-494c-8069-5f148d432734_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_HighValueComponentsMember_83b38f28-40e8-453a-a291-faff0c8b6f80_terseLabel_en-US" xlink:label="lab_wst_HighValueComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Components [Member]</link:label>
    <link:label id="lab_wst_HighValueComponentsMember_label_en-US" xlink:label="lab_wst_HighValueComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Components [Member]</link:label>
    <link:label id="lab_wst_HighValueComponentsMember_documentation_en-US" xlink:label="lab_wst_HighValueComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High-Value Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueComponentsMember" xlink:href="wst-20191231.xsd#wst_HighValueComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_HighValueComponentsMember" xlink:to="lab_wst_HighValueComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b6892f4-4176-4637-9477-f5592fbf1529_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76554a2c-f4f5-43b1-919b-2894c678ed40_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_09782ce1-1b8a-4e30-bbd1-00c9ddc9bfc6_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54a583f2-277d-4e0c-8265-e8d46a648571_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_24e573d8-4ca2-4c52-8c12-f94af43b01f6_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_11553018-4272-4283-917e-7d7193a6a196_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_bb70dbc5-d119-492f-9a8b-b3fcd1cd825e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3223e271-1ab0-4b53-a589-3e88873ad5d5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_72bad1af-e1ed-4915-81a7-7f4aa12e79a3_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6c41980d-886c-4035-821b-d3488dffae48_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AluplastSADeCVMember_c204bb3c-f969-4346-aa11-68d77089ff79_terseLabel_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_AluplastSADeCVMember_label_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_AluplastSADeCVMember_documentation_en-US" xlink:label="lab_wst_AluplastSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aluplast S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember" xlink:href="wst-20191231.xsd#wst_AluplastSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AluplastSADeCVMember" xlink:to="lab_wst_AluplastSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_5d6a8f2c-619d-4996-9290-5bb55614a146_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_34188956-a84e-45eb-ae31-4e4ef1baa61b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income) Expense</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_28a52b9b-6050-4fd8-92e9-7cfc4f15e744_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fb3b43d5-c160-4616-9a9b-196c958839ef_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_bf310169-a3c8-4aa0-b90b-7ae55b67f31f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_01b0fc8a-3dd5-44b0-83dd-e172d0a2a895_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_6a18f474-0457-4225-b4f6-e4026f462407_terseLabel_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and royalty payments made to affiliates</link:label>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_label_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Royalty Payments from Equity Method Investees</link:label>
    <link:label id="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_documentation_en-US" xlink:label="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases and Royalty Payments from Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:href="wst-20191231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:to="lab_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_714291da-d373-4cbe-8de3-8d4c1825fdb2_terseLabel_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_label_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_WestCompanyMexicoSADeCVMember_documentation_en-US" xlink:label="lab_wst_WestCompanyMexicoSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The West Company Mexico, S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember" xlink:href="wst-20191231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_WestCompanyMexicoSADeCVMember" xlink:to="lab_wst_WestCompanyMexicoSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1aab064f-186e-4697-bda4-d5ab63cd1a44_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_3f7e2249-5361-436a-8b7c-0b0823240484_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_0622906a-aeb6-4a2c-b1fa-cf381ae18ba1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201707Member_437148e1-b55b-4f2a-b9e9-779611f4341a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201707Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2017-07 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201707Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201707Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2017-07 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201707Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201707Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201707Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201707Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_e735de26-1ad8-49b3-ad45-8eeae12c27a4_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2038Member_c13562d9-b834-46c0-9f18-66cc4f65a775_terseLabel_en-US" xlink:label="lab_wst_Year2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2038 [Member]</link:label>
    <link:label id="lab_wst_Year2038Member_label_en-US" xlink:label="lab_wst_Year2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2038 [Member]</link:label>
    <link:label id="lab_wst_Year2038Member_documentation_en-US" xlink:label="lab_wst_Year2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2038Member" xlink:href="wst-20191231.xsd#wst_Year2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2038Member" xlink:to="lab_wst_Year2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_b41dd3ef-2cdc-4010-bf3a-5b590f523681_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_5ce72c3c-8698-4dd6-837a-7012cd1ed458_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_3165c1e1-b89e-49d9-8aad-86cf7acc3e66_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period adjustment, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_9c899cca-3ff4-48d5-81fc-d748aa8ec1b1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_d307a6b8-4e96-4765-90d3-6a3bada6b820_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d4f30158-8c3e-40e8-b422-88d34b05e2e7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to prior year position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_769b2b07-88e1-42b1-a671-1e556c65d7ca_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401 (k) plan contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_a5a80928-d7c2-4e44-acac-8958c5b56c88_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1f0c97b8-ec73-4ef3-bb46-6654be24aa7c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SupplyChainFinancingAbstract_ece03b74-733c-4c9d-a138-ae503b9d77d0_terseLabel_en-US" xlink:label="lab_wst_SupplyChainFinancingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Financing [Abstract]</link:label>
    <link:label id="lab_wst_SupplyChainFinancingAbstract_label_en-US" xlink:label="lab_wst_SupplyChainFinancingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Financing [Abstract]</link:label>
    <link:label id="lab_wst_SupplyChainFinancingAbstract_documentation_en-US" xlink:label="lab_wst_SupplyChainFinancingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain Financing [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SupplyChainFinancingAbstract" xlink:href="wst-20191231.xsd#wst_SupplyChainFinancingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SupplyChainFinancingAbstract" xlink:to="lab_wst_SupplyChainFinancingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_82164821-696e-454a-913c-1805a6de625d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs Activity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_e3473fe4-1e83-4d92-b5ad-042012f88fa5_terseLabel_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and state</link:label>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:href="wst-20191231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4ba5405a-dc07-49a7-97d4-2a93392fd979_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_3818404b-8744-41ed-8ba9-82b1f387a82b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses on Cash Flow Hedges [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_feb0ca67-80be-4e46-b28e-83b43a19f90a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_d10cd7d3-88b3-424d-9183-0851ccf482a8_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance expense</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_0b798629-711f-4438-b6a2-39e3ebda6f28_terseLabel_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between Revenue Guidance in Effect before and after Topic 606 [Member]</link:label>
    <link:label id="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_label_en-US" xlink:label="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between Revenue Guidance in Effect before and after Topic 606 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:to="lab_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_37fd27cb-20e8-4e95-878b-e3dd5f1f0d28_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_e4a97910-2d21-47b9-952e-d4d861aacf49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_e1d9e245-e9a6-407a-bdde-111d043da511_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_GenericsCustomersMember_35863a4b-8c6a-467c-b743-6ec708f6ff7e_terseLabel_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_label_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:label id="lab_wst_GenericsCustomersMember_documentation_en-US" xlink:label="lab_wst_GenericsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember" xlink:href="wst-20191231.xsd#wst_GenericsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_GenericsCustomersMember" xlink:to="lab_wst_GenericsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetRelatedChargesMember_5a1d6f87-14bb-4414-ac61-6d913c09dea7_terseLabel_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-related charges [Member]</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_label_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:label id="lab_wst_AssetRelatedChargesMember_documentation_en-US" xlink:label="lab_wst_AssetRelatedChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Related Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember" xlink:href="wst-20191231.xsd#wst_AssetRelatedChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetRelatedChargesMember" xlink:to="lab_wst_AssetRelatedChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_6bfcb5f2-50d8-4ea1-ac8f-47d6aa7097de_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_ede9b31e-7f7c-492e-99a8-a9b7e4fa9b12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in undistributed earnings of affiliates, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_223b8b63-ef91-4c8c-8c65-79135103cbe8_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_59f5698c-e52c-491a-b1a9-59400e9b7223_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f9ef620b-6163-415b-8665-19e13a7e7d6a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorNotesDue2022Member_b2b9ff57-44aa-4fa1-a0b7-00478ea2a8ee_terseLabel_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes Due 2022 [Member]</link:label>
    <link:label id="lab_wst_SeniorNotesDue2022Member_label_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes Due 2022 [Member]</link:label>
    <link:label id="lab_wst_SeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_wst_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior A Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member" xlink:href="wst-20191231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorNotesDue2022Member" xlink:to="lab_wst_SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractwithCustomerAssetIncreaseDecrease_1a577217-c97c-43c5-8481-fa6475a3b175_terseLabel_en-US" xlink:label="lab_wst_ContractwithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contract assets - increase (decrease)</link:label>
    <link:label id="lab_wst_ContractwithCustomerAssetIncreaseDecrease_label_en-US" xlink:label="lab_wst_ContractwithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Increase (Decrease)</link:label>
    <link:label id="lab_wst_ContractwithCustomerAssetIncreaseDecrease_documentation_en-US" xlink:label="lab_wst_ContractwithCustomerAssetIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractwithCustomerAssetIncreaseDecrease" xlink:href="wst-20191231.xsd#wst_ContractwithCustomerAssetIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractwithCustomerAssetIncreaseDecrease" xlink:to="lab_wst_ContractwithCustomerAssetIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1074bedd-dbf0-4436-abcd-ed548c755dfc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss on investment securities, net of tax of $0, $(0.1) and $(2.5)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_274a234b-c400-45b1-b44a-ba76cc55ecbb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_e3d7a0ea-e8e9-4673-a267-8073dc4bfcb3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_f51ba5db-a97d-4069-b259-7c6479f2f487_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainBeforeTax_4ca851e6-0c60-4d42-81de-52e6c8ef79de_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_61815b37-d8c1-46b8-aab1-8b841f5351d0_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_bcb9d906-3e41-49d6-8f80-4452c6f3b1ff_terseLabel_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansAssetsNoncurrent</link:label>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_label_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Defined Benefit Plans, Noncurrent</link:label>
    <link:label id="lab_wst_AssetsDefinedBenefitPlansNoncurrent_documentation_en-US" xlink:label="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:href="wst-20191231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:to="lab_wst_AssetsDefinedBenefitPlansNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e7924f35-24fc-45db-a772-df0c39af91ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_ac1a62bf-37d0-4c00-8a0a-461d7cc2c664_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_351e5b9a-2188-4004-8dee-6b91a5f4e9e7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_642b6410-e93d-4575-9013-748e26d4eeaf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other charges</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_30681a60-34a3-41f8-bf81-a649d50eb54e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other restructuring charges</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_93e6a6f9-324c-4149-85d4-edae897b1d0b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7fc26149-072c-40c8-98a3-16f813290336_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_5b141b49-1b22-48f5-9ab1-bdcc3f7b64ab_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IndexedMutualFundsMember_0740fa6e-ac8f-414d-a4aa-c2b0f6b9eea3_terseLabel_en-US" xlink:label="lab_wst_IndexedMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_IndexedMutualFundsMember_label_en-US" xlink:label="lab_wst_IndexedMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_IndexedMutualFundsMember_documentation_en-US" xlink:label="lab_wst_IndexedMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed Mutual Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IndexedMutualFundsMember" xlink:href="wst-20191231.xsd#wst_IndexedMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IndexedMutualFundsMember" xlink:to="lab_wst_IndexedMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_b7ccfef6-99d4-4989-9ea9-a530ed89d5c5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity call options</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_d9f7fd08-182c-42c0-aa0a-b506fe5e3f31_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2039Member_c6f221fc-1729-40d5-b528-e681103efe40_terseLabel_en-US" xlink:label="lab_wst_Year2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2039 [Member]</link:label>
    <link:label id="lab_wst_Year2039Member_label_en-US" xlink:label="lab_wst_Year2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2039 [Member]</link:label>
    <link:label id="lab_wst_Year2039Member_documentation_en-US" xlink:label="lab_wst_Year2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2039Member" xlink:href="wst-20191231.xsd#wst_Year2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2039Member" xlink:to="lab_wst_Year2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DebtYenDenominatedMember_9d83d612-3631-4140-b044-a38c12e38fdc_verboseLabel_en-US" xlink:label="lab_wst_DebtYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Yen Denominated [Member]</link:label>
    <link:label id="lab_wst_DebtYenDenominatedMember_label_en-US" xlink:label="lab_wst_DebtYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Yen Denominated [Member]</link:label>
    <link:label id="lab_wst_DebtYenDenominatedMember_documentation_en-US" xlink:label="lab_wst_DebtYenDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An obligation resulting from borrowing money.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtYenDenominatedMember" xlink:href="wst-20191231.xsd#wst_DebtYenDenominatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DebtYenDenominatedMember" xlink:to="lab_wst_DebtYenDenominatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f5834bd5-197e-4498-91c5-b4b3f880092d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_86efb010-f3db-4c62-8fe5-46c7f6346036_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c9b4ecee-e9d7-4e44-b524-e77e37902e2d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5ba22f5-46e8-4d09-ba3a-d39b8b87a753_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_96eb38bd-a057-4545-b10c-a8884a854b91_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_BiologicsCustomersMember_5eb1f66e-6743-4892-bfaa-941d06a2f9e9_terseLabel_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_label_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:label id="lab_wst_BiologicsCustomersMember_documentation_en-US" xlink:label="lab_wst_BiologicsCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember" xlink:href="wst-20191231.xsd#wst_BiologicsCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_BiologicsCustomersMember" xlink:to="lab_wst_BiologicsCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_80601d70-a426-480b-a7c3-a80c6ca225a6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to current year position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_f49c13cd-d960-4794-99cd-0da670c76422_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_8b9306cc-98b3-45d1-8448-81280d413725_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a50fb12c-d83e-4b00-acea-024bf3b8dccb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_93cffad0-e0b6-44ee-8f75-bf4b85f22c7a_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes other than income</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Developmentandlicensingincome_7691ffaa-9bf1-4fed-976f-67f30cc3fb36_negatedTerseLabel_en-US" xlink:label="lab_wst_Developmentandlicensingincome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income</link:label>
    <link:label id="lab_wst_Developmentandlicensingincome_921c99d4-afb0-4e71-b085-30c0ea8e3c07_terseLabel_en-US" xlink:label="lab_wst_Developmentandlicensingincome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income</link:label>
    <link:label id="lab_wst_Developmentandlicensingincome_label_en-US" xlink:label="lab_wst_Developmentandlicensingincome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income</link:label>
    <link:label id="lab_wst_Developmentandlicensingincome_documentation_en-US" xlink:label="lab_wst_Developmentandlicensingincome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Developmentandlicensingincome" xlink:href="wst-20191231.xsd#wst_Developmentandlicensingincome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Developmentandlicensingincome" xlink:to="lab_wst_Developmentandlicensingincome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4fd50b96-fc8a-452d-a4ec-9e0c582395fb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_023678e2-99f2-4fe1-adae-608a71782d30_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_67d37804-feff-43ed-a396-0791d55d866a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Activity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CorporateAndEliminationsMember_a4470227-d80b-4e07-967e-358465594ad8_terseLabel_en-US" xlink:label="lab_wst_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations [Member]</link:label>
    <link:label id="lab_wst_CorporateAndEliminationsMember_label_en-US" xlink:label="lab_wst_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations [Member]</link:label>
    <link:label id="lab_wst_CorporateAndEliminationsMember_documentation_en-US" xlink:label="lab_wst_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate headquarter items not allocated to segments and intersegment transactions (e.g. intersegment profits). Reconciliation of the total of reportable segments' amounts of revenues, measures of profits or loss, assets, or amounts for every other significant item of information disclosed, to the consolidated amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CorporateAndEliminationsMember" xlink:href="wst-20191231.xsd#wst_CorporateAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CorporateAndEliminationsMember" xlink:to="lab_wst_CorporateAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PensionPlanAssetsInTheFairValueHierarchyMember_186bfe03-5ad9-452c-a49f-543e916934de_terseLabel_en-US" xlink:label="lab_wst_PensionPlanAssetsInTheFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan Assets In The Fair Value Hierarchy [Member]</link:label>
    <link:label id="lab_wst_PensionPlanAssetsInTheFairValueHierarchyMember_label_en-US" xlink:label="lab_wst_PensionPlanAssetsInTheFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan Assets In The Fair Value Hierarchy [Member]</link:label>
    <link:label id="lab_wst_PensionPlanAssetsInTheFairValueHierarchyMember_documentation_en-US" xlink:label="lab_wst_PensionPlanAssetsInTheFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan Assets In The Fair Value Hierarchy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionPlanAssetsInTheFairValueHierarchyMember" xlink:href="wst-20191231.xsd#wst_PensionPlanAssetsInTheFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PensionPlanAssetsInTheFairValueHierarchyMember" xlink:to="lab_wst_PensionPlanAssetsInTheFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_49f0537f-2095-4523-896c-95972145f5b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_f29b7060-3285-490a-a020-c06bec93c998_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, state and local</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0b02ee8e-7923-4ebe-ad68-4f01d763b4c4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_fef141ce-f82d-4952-a59b-cd0454f47441_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate healthcare cost trend rate, benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:to="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3b042c58-73ad-4611-be7a-2c4686f47e54_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in affiliated companies</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_46bbda54-5bd2-431f-88dd-eebc89704eff_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec155e1e-bdec-477a-bef6-78cc0dba202a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_dc367681-0f86-44c8-8ae1-6ebb37b9dd03_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_99535da8-bcea-46bc-952e-dc4d91bcea40_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venezuela currency devaluation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_6b3b8d07-8448-4f59-8e8e-f5ff30bc0051_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PensionandOtherPostretirementBenefitExpenseNet_41397046-24ca-411d-937f-7729b47cfd84_terseLabel_en-US" xlink:label="lab_wst_PensionandOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other retirement plans, net</link:label>
    <link:label id="lab_wst_PensionandOtherPostretirementBenefitExpenseNet_label_en-US" xlink:label="lab_wst_PensionandOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefit Expense, Net</link:label>
    <link:label id="lab_wst_PensionandOtherPostretirementBenefitExpenseNet_documentation_en-US" xlink:label="lab_wst_PensionandOtherPostretirementBenefitExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionandOtherPostretirementBenefitExpenseNet" xlink:href="wst-20191231.xsd#wst_PensionandOtherPostretirementBenefitExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PensionandOtherPostretirementBenefitExpenseNet" xlink:to="lab_wst_PensionandOtherPostretirementBenefitExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_20ae3762-be97-4d49-bf21-1c0a1d842c15_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3c32ee1f-6b71-49cd-a39a-db6d2a19fc8c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_b5b03a30-b6bd-493a-ba2c-f8129895aa2a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5b652283-6bec-491c-991f-477e43c9d267_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription_e9c6c638-78a3-4338-9010-55cb0e1a615e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" xlink:to="lab_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_8bcb4aa9-3818-4120-990a-e998e32a0020_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedges [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_49a509a5-6dbb-4058-83ab-15276d7767ac_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetImpairmentChargesPatent_de816b4c-baa3-4bd1-9218-650fda89b799_terseLabel_en-US" xlink:label="lab_wst_AssetImpairmentChargesPatent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges, patent</link:label>
    <link:label id="lab_wst_AssetImpairmentChargesPatent_label_en-US" xlink:label="lab_wst_AssetImpairmentChargesPatent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Patent</link:label>
    <link:label id="lab_wst_AssetImpairmentChargesPatent_documentation_en-US" xlink:label="lab_wst_AssetImpairmentChargesPatent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of write-down of patent recognized in the income statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatent" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetImpairmentChargesPatent" xlink:to="lab_wst_AssetImpairmentChargesPatent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ebff1289-201d-4667-94dd-f53fb9e5306e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_dda9edc9-c34f-4194-a230-4d4fd6529f5c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldInTrustNoncurrent_0f548d3b-91e8-4d70-b770-274c20fa204e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation assets</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrustNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrustNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-in-trust, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="lab_us-gaap_AssetsHeldInTrustNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ca06e8d9-0546-4614-bddc-c988703cf18f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_fa666c21-5476-4c32-a89a-944d17c16d3e_terseLabel_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_label_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaRubberSADeCVMember_documentation_en-US" xlink:label="lab_wst_PharmaRubberSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Rubber S.A. de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember" xlink:href="wst-20191231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaRubberSADeCVMember" xlink:to="lab_wst_PharmaRubberSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_4ada4955-f27d-4e78-a1ff-1926327837a4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d718e1d6-4b63-47b0-a0ce-158d8ca72a92_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_a46aca07-e469-4d2c-8b8e-30c70b55d3a0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Hedge Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_875ad79a-04d0-4f28-a5ad-4eee7ffe6265_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3020759c-14ee-4a15-8bc3-e822616c82d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of actuarial (gain) loss, net of tax of $0, $0.3 and $0.5</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4e9e9030-3933-4788-bf24-7b10830558b8_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_de9dce42-b2a5-4c1d-9e80-7c30a881e9df_verboseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6d612681-2ab7-43ce-9174-511f5da4fd3f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits on share-based payments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_a1c8c2b6-a233-4d95-8b63-9933151e52a1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring obligations</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_fc995bb7-05de-4db5-bd1e-65b1acd3d70b_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31, 2017</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_c90ef8db-b1ef-4034-a116-71e34889ea0b_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31, 2018</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_d38a6cca-0f7f-49d8-8871-2d51ed91b6b5_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual with Relationship to Entity [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_61656907-fdec-44fd-b2df-8063fba1d360_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_6545bda2-57ca-430b-8280-5df5f135def4_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_b6bca3c8-6f66-4eee-8214-433761940319_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_7268161a-7417-485b-91f2-cd18d63e1be3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_24f050b3-3d0c-48a1-b511-76021eaa34f8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_098829db-0d42-4c92-9bbf-c1e8af53fa7f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_008b6528-5ba1-4e6c-96b3-036bdbe6f854_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage_35f3aaee-dc6d-4a92-b026-97e00f5766dd_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on undistributed earnings of subsidiaries</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Earnings of Subsidiaries, Percentage</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Earnings of Subsidiaries, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" xlink:href="wst-20191231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_fe5a88ab-115c-4953-adba-ba296c84e906_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_79d62197-8425-4651-9718-1521ac079bcd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_109664f1-be1b-453c-a3d3-f5f8bd0cc46f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_330f9e4f-0a19-456c-ab7f-27ff3d343fd6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_241c05de-65e8-4784-85d0-94a8179c5455_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits/expenses paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_c8a965c4-9c1a-4742-bc25-74f760c83d33_totalLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and OCI</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_90154f40-6ced-4423-91b2-248f139b94b4_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" xlink:to="lab_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e9114901-d78f-4cd8-bcb7-a8e4d9a2a4bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_51c54e02-ab66-4403-b3ae-a62259d33252_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock-based compensation awards</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_A2018RestructuringPlanMember_c2b8f146-8c8e-45d5-96b4-34a96db0089b_terseLabel_en-US" xlink:label="lab_wst_A2018RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_A2018RestructuringPlanMember_label_en-US" xlink:label="lab_wst_A2018RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Restructuring Plan [Member]</link:label>
    <link:label id="lab_wst_A2018RestructuringPlanMember_documentation_en-US" xlink:label="lab_wst_A2018RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Restructuring Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2018RestructuringPlanMember" xlink:href="wst-20191231.xsd#wst_A2018RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_A2018RestructuringPlanMember" xlink:to="lab_wst_A2018RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_8702343f-0137-4090-a3dd-2856526a79d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_9fead38a-5ae3-4271-8985-f128fc1c470e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, December 31, 2018</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_9fd89b03-8ebf-4ccf-9190-d01178fbf6cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets, December 31, 2019</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_ab3df198-2b7b-4310-af85-1a3a6d4e2102_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceClaimsMember_f8b96b21-9338-4567-a39b-a1daf28a6536_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Claims [Member]</link:label>
    <link:label id="lab_us-gaap_InsuranceClaimsMember_label_en-US" xlink:label="lab_us-gaap_InsuranceClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceClaimsMember" xlink:to="lab_us-gaap_InsuranceClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6dcf90f0-8e94-4cc8-887a-fd25839946ee_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_BalancedMutualFundMember_8ec119b8-9382-4fa7-abc8-9cd3a104cc13_terseLabel_en-US" xlink:label="lab_wst_BalancedMutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balanced Mutual Fund [Member]</link:label>
    <link:label id="lab_wst_BalancedMutualFundMember_label_en-US" xlink:label="lab_wst_BalancedMutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balanced Mutual Fund [Member]</link:label>
    <link:label id="lab_wst_BalancedMutualFundMember_documentation_en-US" xlink:label="lab_wst_BalancedMutualFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balanced Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BalancedMutualFundMember" xlink:href="wst-20191231.xsd#wst_BalancedMutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_BalancedMutualFundMember" xlink:to="lab_wst_BalancedMutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_50ff6364-e2e9-4c8e-9aaa-dabef8f38573_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9a43e010-49c6-4361-bf60-17b7734e346b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_68529c38-473a-4c82-852c-ec1ce0f0c408_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Pension and Other Postretirement Plans [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1b3000c9-1283-4251-86f4-dc4f0054dcdb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3b5c335-324e-42fd-92f8-53632c6e0ead_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a3f5fb67-9b6f-4040-92cc-a1005ffa1e06_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_c98b2cb4-1fba-4046-9dd5-c35fe4866e10_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_6cdb931c-d46a-4bf3-aff7-f083f7718d0a_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_40e091bc-fd1a-44dd-b896-b0c8974674b9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_d3b7402c-2d90-46c3-ad10-9edec9d09a29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_aebe72f5-5b8d-4512-8efd-0a921c883fe6_terseLabel_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable and other current debt</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_label_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:label id="lab_wst_NotesPayableAndOtherDebtCurrent_documentation_en-US" xlink:label="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Other Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:href="wst-20191231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NotesPayableAndOtherDebtCurrent" xlink:to="lab_wst_NotesPayableAndOtherDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_739f8f98-6d32-4a00-a4bb-08c53d6ed6da_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9c831508-c666-4b00-8af5-73fec4647ecc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_4bd8caa2-a389-478d-93bc-c798fde22e62_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_66fc8fb8-e3c5-443d-b73a-15e1e280bad5_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation and Compliance Costs</link:label>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_label_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalCostsPolicy" xlink:to="lab_us-gaap_EnvironmentalCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_11a010bf-db34-43c7-b3f6-4c5e00959174_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding uncondintional contractual commitments due to be paid in 2020</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_76751897-2730-4ee7-80a5-776a74861316_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Argentina currency devaluation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2022Member_49d69bee-b83d-4fed-92c3-55973ecdfdc3_terseLabel_en-US" xlink:label="lab_wst_Year2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2022 [Member]</link:label>
    <link:label id="lab_wst_Year2022Member_label_en-US" xlink:label="lab_wst_Year2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2022 [Member]</link:label>
    <link:label id="lab_wst_Year2022Member_documentation_en-US" xlink:label="lab_wst_Year2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2022Member" xlink:href="wst-20191231.xsd#wst_Year2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2022Member" xlink:to="lab_wst_Year2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4747b8be-b14a-458c-b1c0-5a264405786f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9dad0e73-945c-47ad-8c34-9a002abdf3e0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_195e3937-8303-4622-9cb8-56aea92c3a33_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on investment securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_09bfa24e-0cd0-46fd-8eed-8ebf5357cb67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DevelopmentandlicensingincomeTable_477b0671-df6b-4ff7-8087-b1763e9cdddb_terseLabel_en-US" xlink:label="lab_wst_DevelopmentandlicensingincomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income [Table]</link:label>
    <link:label id="lab_wst_DevelopmentandlicensingincomeTable_label_en-US" xlink:label="lab_wst_DevelopmentandlicensingincomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income [Table]</link:label>
    <link:label id="lab_wst_DevelopmentandlicensingincomeTable_documentation_en-US" xlink:label="lab_wst_DevelopmentandlicensingincomeTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and licensing income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentandlicensingincomeTable" xlink:href="wst-20191231.xsd#wst_DevelopmentandlicensingincomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DevelopmentandlicensingincomeTable" xlink:to="lab_wst_DevelopmentandlicensingincomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_df878fbf-6010-476b-83f7-b3ba215da3f1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherMember_661c50ff-4e41-4f6b-abe4-5a72478b6ea3_terseLabel_en-US" xlink:label="lab_wst_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_wst_OtherMember_label_en-US" xlink:label="lab_wst_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_wst_OtherMember_documentation_en-US" xlink:label="lab_wst_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMember" xlink:href="wst-20191231.xsd#wst_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherMember" xlink:to="lab_wst_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_18f76f8e-c71e-4b47-a01a-37d25c05b932_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_de4cc2da-545f-46fc-96b6-f32206574676_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8778e924-e03f-4df1-ab25-b51f61686de8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6c518929-2e01-4ce5-9a8a-1ac87cace93b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments up to amount of acquisition-date liability</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_2592b990-9386-4864-b9db-4b6df51b8682_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of transition obligation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForwardStartInterestRateSwapMember_be53f9a2-25a3-4164-bbff-7c20e062ab72_terseLabel_en-US" xlink:label="lab_wst_ForwardStartInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward-Start Interest Rate Swap [Member]</link:label>
    <link:label id="lab_wst_ForwardStartInterestRateSwapMember_label_en-US" xlink:label="lab_wst_ForwardStartInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Start Interest Rate Swap [Member]</link:label>
    <link:label id="lab_wst_ForwardStartInterestRateSwapMember_documentation_en-US" xlink:label="lab_wst_ForwardStartInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward-start interest rate swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardStartInterestRateSwapMember" xlink:href="wst-20191231.xsd#wst_ForwardStartInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForwardStartInterestRateSwapMember" xlink:to="lab_wst_ForwardStartInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_59481f87-6554-4394-8379-00eba4dc1170_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_5490f7ec-ba44-4b5d-8100-abcf282fdc4d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_7a5b7afc-d9d9-48c7-9f16-7c9c08af08ba_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_ca54570c-3d51-4338-9084-7dedcc809aab_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_d9669e5d-e255-47e6-9ebd-6af0f7980492_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States [Member]</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_99031040-883a-4710-8326-c7a2298e2c7b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_d1d1620b-81ba-427b-9932-309360e97af0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target allocation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_436e3e00-c1c2-4fe6-a317-e8973b655c4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_05391e0d-9b05-44c6-8d16-5d84ae1f2428_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_139e626b-5334-4ebe-9111-0c243d3300cc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (loss) gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_c5106ea6-1f40-4ada-86f6-67e55f8da5f7_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (loss) gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_269ef4fe-88b5-4701-9612-ae3d179d4153_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of prior service credit, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_aee92ef1-7f83-4b33-804e-529d3e0680d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockSettledStockAppreciationRightsOutstanding_11f9ec7e-25d3-43b3-b065-21dc2da7fcaa_terseLabel_en-US" xlink:label="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled SARs, outstanding</link:label>
    <link:label id="lab_wst_StockSettledStockAppreciationRightsOutstanding_label_en-US" xlink:label="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Settled Stock Appreciation Rights, Outstanding</link:label>
    <link:label id="lab_wst_StockSettledStockAppreciationRightsOutstanding_documentation_en-US" xlink:label="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stock-settled stock appreciation rights outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledStockAppreciationRightsOutstanding" xlink:href="wst-20191231.xsd#wst_StockSettledStockAppreciationRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockSettledStockAppreciationRightsOutstanding" xlink:to="lab_wst_StockSettledStockAppreciationRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_53971c8c-a933-488e-b543-53a746906e5a_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred compensation plans</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Number of Plans</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Number of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d254bb2d-db1f-40c8-8e1b-f4cfdd3f0de3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_country_VE_75c9659d-33ca-45f7-9645-3b7eb22b56fd_terseLabel_en-US" xlink:label="lab_country_VE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VENEZUELA</link:label>
    <link:label id="lab_country_VE_label_en-US" xlink:label="lab_country_VE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VENEZUELA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_VE" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_VE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_VE" xlink:to="lab_country_VE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_7b41cb60-86c0-4201-a662-bff04cf56db9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_184ace8a-813a-4490-9d8e-d6ddf7ab67f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, estimated outcome, low</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5d41f1e9-1b61-47dd-8493-3ec2132dbc8e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_a5aca80d-7c16-436e-93b3-318af9a80f10_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_24d5e6b2-df78-421b-8dbd-3f22663fcb63_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_384f2a97-7632-4b4a-ac71-487f4e3034b2_terseLabel_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_label_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:label id="lab_wst_AccruedSalariesWagesAndBenefitsCurrent_documentation_en-US" xlink:label="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Wages, and Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:href="wst-20191231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:to="lab_wst_AccruedSalariesWagesAndBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_f83119fd-16d7-4510-a7cb-7377b84e71d6_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Directors [Member]</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_aa6bf143-1772-4421-a2a4-784b670a20c8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_f8120393-147e-420d-ba58-0a0580cd254e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (1.2 million and 1.2 million shares in 2019 and 2018)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_48ac63a5-12b9-4275-ab67-052e6288bec6_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_fbe168f2-9530-4797-8be3-72f5a40de8c1_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8c541604-48cc-46a1-92fc-b9e9a704b2a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_57e03355-dae2-4b96-b077-5175faeeb6e1_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of deferred stock units</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Share Equivalents Balance</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Share Equivalents Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:to="lab_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_34ed825a-53df-40f2-9124-6988609231bf_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_ForeignLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignLineOfCreditMember" xlink:to="lab_us-gaap_ForeignLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_18950d6b-c4c7-478a-8d3e-7b109b36df67_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_53249758-d2fa-4920-ba9a-a8d2b3a81dda_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_486b7b8b-c327-4a8e-93ed-1df99e083e50_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_819bcc43-b723-4e51-a38d-f438c28012f1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. tax on international earnings, net of foreign tax credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_727493fe-8337-43c1-a451-c8637ad1d51f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_2ebd15df-08b9-47e9-8fc3-54fd9c57261b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_4f95bab3-2af7-47be-aada-6c65a921dc31_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SmartDoseMember_20c0ea21-529b-4cc0-a53c-3ba8718041dd_terseLabel_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose [Member]</link:label>
    <link:label id="lab_wst_SmartDoseMember_label_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose [Member]</link:label>
    <link:label id="lab_wst_SmartDoseMember_documentation_en-US" xlink:label="lab_wst_SmartDoseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmartDose [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember" xlink:href="wst-20191231.xsd#wst_SmartDoseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SmartDoseMember" xlink:to="lab_wst_SmartDoseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9592cc48-b990-46fb-bddd-687a0f004755_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_6f86aa11-8cbd-4359-b48d-62961800eb7a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b0f50b2b-fa6c-45e9-95cc-e87438f173dd_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_be7dd02a-b47a-46d6-804e-9dae06791904_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a5c6842c-3231-4a90-af5e-3bced26ccc70_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax effect</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_1633ccd4-a8fe-497e-ac1d-3d1301346bdd_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_836274dc-630f-4a92-a37a-9eebe46b83f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7764e567-b89b-4d15-bfa1-658b9dd0a395_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_23aa7b09-1478-4d81-bcc3-14b810568e7c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d21d196c-eb79-439b-b3a9-dba0b73f6402_terseLabel_en-US" xlink:label="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Deferred Compensation, All Types [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_64a8b2a4-c900-41fa-8533-fd87ba8446c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b82147ec-3218-4540-a534-31ba96e3432f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_b0451caa-d5eb-44d6-ba32-2203042a33b0_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2f54ad38-e145-42ca-9b85-2be119cec649_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (reduction) in fair value recorded in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_737254f3-abc1-47ca-955f-174a7d55c425_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_72b9216d-8b52-4b14-a057-73e1fa8f7ad0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_fac00e32-3cfd-4f58-850e-ee34261284aa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on international operations other than U.S. tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2baa07ae-557b-449e-8988-591059cca166_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_224444a1-d581-4f4c-a3f2-70cf48ee31c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_83acbef0-264b-435c-8b86-78946cbfa1c0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e1fe4f32-5990-4269-8455-8f60a96ac2cb_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_2bf69309-29d9-4260-95d5-e1a85989b9db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_dccef1ac-f913-4c9a-8cb2-995075c3038e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_614644eb-bff8-478b-a269-47c466706a42_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_1375b470-6c28-4da5-a8eb-05ee7a89940a_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_71b42a11-71bb-48be-9274-7183469cc71f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherSecuritiesMember_d6fd1cfc-6e40-456f-bd2a-3527566734b4_terseLabel_en-US" xlink:label="lab_wst_OtherSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_wst_OtherSecuritiesMember_label_en-US" xlink:label="lab_wst_OtherSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Securities [Member]</link:label>
    <link:label id="lab_wst_OtherSecuritiesMember_documentation_en-US" xlink:label="lab_wst_OtherSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherSecuritiesMember" xlink:href="wst-20191231.xsd#wst_OtherSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherSecuritiesMember" xlink:to="lab_wst_OtherSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_7d3403ed-7bb5-477a-a46c-a0ae24b69045_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_55039ad1-1eb9-453e-a95b-805ed933b1d6_terseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement effects arising during period, tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201609Member_9b41f051-0673-43e6-bc43-eca64d7015bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201609Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201609Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201609Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201609Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201609Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_51d474ba-8f6b-4a48-9d19-1386db689e56_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_31b95692-f040-4032-9a56-82e269000ada_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_53955784-b7b7-45bc-b721-30d260c931e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_1dc7df3f-b2f1-446f-998d-06fddd4ed152_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TermLoanDue2024Member_2463b226-d2eb-4ba3-9f35-d245eb169e71_terseLabel_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024 [Member]</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_label_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024 [Member]</link:label>
    <link:label id="lab_wst_TermLoanDue2024Member_documentation_en-US" xlink:label="lab_wst_TermLoanDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TermLoanDue2024Member" xlink:to="lab_wst_TermLoanDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LineofCreditFacilityAdditionalBorrowingCapacity_8e35e95b-562d-4d40-8838-c8f74931b134_terseLabel_en-US" xlink:label="lab_wst_LineofCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, additional borrowing capacity</link:label>
    <link:label id="lab_wst_LineofCreditFacilityAdditionalBorrowingCapacity_label_en-US" xlink:label="lab_wst_LineofCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility Additional Borrowing Capacity</link:label>
    <link:label id="lab_wst_LineofCreditFacilityAdditionalBorrowingCapacity_documentation_en-US" xlink:label="lab_wst_LineofCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional borrowing capacity under the credit facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineofCreditFacilityAdditionalBorrowingCapacity" xlink:href="wst-20191231.xsd#wst_LineofCreditFacilityAdditionalBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LineofCreditFacilityAdditionalBorrowingCapacity" xlink:to="lab_wst_LineofCreditFacilityAdditionalBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5fed620d-6af1-4392-80aa-04cda34f4e23_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_88b1b67c-f7bd-441d-a66f-d14d65682fa7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_09589be7-3d0f-4847-9fd8-0d269ecc71c6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d7129b01-246e-416a-a01a-ace185acfa12_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of prior valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_56bd34b3-6cf2-40c0-9221-3c555774b30d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4e40f9d8-fda7-4dfd-b030-f0c006c7707e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0f5f8347-2f1d-48e6-8686-8576abad20b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e2aada14-d7b1-4180-9d8d-8cbace056240_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a13f259a-387f-4f9d-bbe7-74dd299d4dc1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_8e74b36a-47f3-4d5c-88e8-067e88158c14_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed healthcare cost trend rate, benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_838dfab8-a14b-4dc9-bebb-d7775c994fe2_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b0218c30-3634-469e-9314-a941cf078e79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of Share-based Compensation Costs by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0c906de5-6c7e-4b16-a4d2-8509933b1c6a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits/expenses paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyReceivable_75e5b2e9-e014-4221-a016-efc154d034a4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reimbursable by the insurance company</link:label>
    <link:label id="lab_us-gaap_LossContingencyReceivable_label_en-US" xlink:label="lab_us-gaap_LossContingencyReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyReceivable" xlink:to="lab_us-gaap_LossContingencyReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_30af7c33-30d6-403a-9071-fe618a7f4097_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) gain on derivatives, net of tax of $(0.2), $1.5 and $(0.1)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cb737637-4b19-4680-9864-390e6a8ca732_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_f2ee7799-8cea-417b-b96e-bec9738f6651_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in USD per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_b8923683-ec34-431f-934b-3033bc23e31e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_4796e43b-e7ec-48a3-b1df-f89ef56c8d01_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination [Member]</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_666cc449-6ba0-4e64-82b8-3116bc0e8819_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_42d7d8d3-ecbc-4cfe-bb75-6c9459da4542_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_859927e3-547c-4d72-a14c-c11f7323e6f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_6743101e-1d2e-4f2e-8fc0-f7da2663e51d_terseLabel_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_OtherCurrentLiabilitiesAbstract_documentation_en-US" xlink:label="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract" xlink:href="wst-20191231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract" xlink:to="lab_wst_OtherCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_a97e4d51-3110-4c89-94a4-ef91ca5d5cf3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of transition obligation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_03677c9c-96a2-49a5-9a63-0e1788a42387_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_63770750-231f-4a22-aa46-0d5774a4f8c2_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_4993530b-9759-4685-b68b-a4ff06f87764_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_a9bfb26b-50da-4b0b-88d5-2c31f7da2715_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of accounts receivable under supply chain financing agreements</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_7a01decc-a33a-4295-89b8-76d3355c6095_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sales by Significant Product Group</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_ebb65c18-e579-4e35-bfba-4b70d46dcaf7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted income of affiliated companies</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings, Undistributed Earnings from Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:to="lab_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3afe2ae0-3df1-4a0b-82e8-56daba4d0688_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_18b6c41c-2545-4871-9865-81f6b3c5db87_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_3e092a68-927c-4134-a58e-67fa12c6280c_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_bc901e30-78b6-401c-82c0-ea30b24f4fd4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c7f5eb13-5f2c-4338-89c4-1dffeb4e04a9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding in 2019 and 2018</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_31a74a15-97ec-47a3-b611-2b2e144fbfc8_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maturity date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_c81e3641-5698-4317-b598-e61ece77b41a_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_9298441f-b2a3-4683-8b42-bafd87635d3a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average of the coupon interest rate</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_94fa8ead-7d14-49ec-91c8-f8b67a5e200f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b51d71e-f9e3-4746-b43b-d00d6ecd01e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_90d44e7a-4a25-462d-b98e-6615385fc1eb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_fb6d803b-2991-4f2f-bb0b-f5a86eb8b2ee_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_bd16c19a-e37f-4207-8fe1-e880a0bfa463_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b35a20b2-c702-4dc0-bb97-c433a4b96e7d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_4cdfb016-599e-4b1a-8111-424ff0b60056_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_77b4d17f-fc5f-4a9d-9ff1-7350b0ab4949_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_6a6b32d4-4cea-4a5c-91da-c8b2a9d68e8b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_b1b0e7e1-4ebc-4682-9bbf-9d1e7c256eff_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_86c86368-c03a-4e1d-ad04-7a618ed4d887_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_7583b2b9-d924-4e3e-91e3-5bfc5ae305ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payments in excess of acquisition-date liability</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8ad0e902-2386-42b9-814e-63c02404c6be_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_d889faad-e793-4991-a903-40d68a75d16f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_1773570e-c0e3-4d96-b65f-478f9ff8a20c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f569cccf-a4c5-41ff-b778-c015bbc91b93_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_76bb75f0-ff97-4e5e-9c17-dc8e4f167b7f_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased for employee tax withholdings (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f46eba8c-689c-43c1-a00c-0ba30d5b0464_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_664e5c45-b277-4794-b83d-78b5b30ed4b8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_7f6b4885-d072-4426-b4f7-2fc9d6a271e9_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_a2a61dfb-7ce0-450f-bfe3-036860e99f08_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan contributions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity" xlink:to="lab_us-gaap_ProceedsFromOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_dd648965-9634-4b99-8b60-cab4d1d7e992_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6ef546be-5328-4751-97fc-cd916aaf9a00_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a153f7fe-63e2-4423-a0c3-e3d9a7fb83b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_YearAfter2023Member_a33fa308-edf3-4b24-9ce8-7a25d4f12dd7_terseLabel_en-US" xlink:label="lab_wst_YearAfter2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2023 [Member]</link:label>
    <link:label id="lab_wst_YearAfter2023Member_label_en-US" xlink:label="lab_wst_YearAfter2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2023 [Member]</link:label>
    <link:label id="lab_wst_YearAfter2023Member_documentation_en-US" xlink:label="lab_wst_YearAfter2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2023Member" xlink:href="wst-20191231.xsd#wst_YearAfter2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_YearAfter2023Member" xlink:to="lab_wst_YearAfter2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7ac2c85e-7dca-4bf2-8f7f-163885a2dcd8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9782b1e3-b91a-4f1c-84fc-77a31e8a17ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increase (decrease) in deferred income</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_60ae2e1b-a16d-4c9a-bcd2-38b9c74e72ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_107fc245-fd35-46db-ae2f-fed0f6d908d7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit that will be amortized from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4687f8c9-54d7-41c0-b023-4ab548ade985_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_68e591f5-4c5a-4468-bb96-50ce504b18f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_ae473275-a022-41a6-a5bb-5e0368ccde44_terseLabel_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Instruments [Abstract]</link:label>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_label_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Financial Instruments [Abstract]</link:label>
    <link:label id="lab_wst_OtherFinancialInstrumentsAbstract_documentation_en-US" xlink:label="lab_wst_OtherFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherFinancialInstrumentsAbstract" xlink:href="wst-20191231.xsd#wst_OtherFinancialInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract" xlink:to="lab_wst_OtherFinancialInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_ae173108-2802-4075-acd8-dc70e65f98fb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_16ee3e42-9bd1-487e-80b3-c5d62e063475_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_cc9f6784-c929-46a7-a190-3afe2efdd160_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2020Member_d92e261f-400a-4cac-bcd2-e6b591a81b5b_terseLabel_en-US" xlink:label="lab_wst_Year2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2020 [Member]</link:label>
    <link:label id="lab_wst_Year2020Member_label_en-US" xlink:label="lab_wst_Year2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2020 [Member]</link:label>
    <link:label id="lab_wst_Year2020Member_documentation_en-US" xlink:label="lab_wst_Year2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2020Member" xlink:href="wst-20191231.xsd#wst_Year2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2020Member" xlink:to="lab_wst_Year2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PharmaTapSADeCVMember_a5f53d87-8dfc-4500-b40e-b16d31f5e9ff_terseLabel_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaTapSADeCVMember_label_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A de C.V. [Member]</link:label>
    <link:label id="lab_wst_PharmaTapSADeCVMember_documentation_en-US" xlink:label="lab_wst_PharmaTapSADeCVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharma Tap S.A de C.V. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember" xlink:href="wst-20191231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PharmaTapSADeCVMember" xlink:to="lab_wst_PharmaTapSADeCVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_79ae28e7-6bfc-4978-81a4-023f77b24f92_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_7134c906-e7dd-4301-9758-f1bfabebe8a5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_9b21b426-4a50-41d8-a250-23afc2e30100_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for insurance obligations</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d97e9bb3-5eb6-456c-899f-5be42fa38a6b_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c6d170e3-d6c0-4509-a65a-fd39b4a37e64_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommodityOptionMember_76737506-2d6e-4538-881d-d61348650c6f_terseLabel_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Call Options [Member]</link:label>
    <link:label id="lab_us-gaap_CommodityOptionMember_label_en-US" xlink:label="lab_us-gaap_CommodityOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommodityOptionMember" xlink:to="lab_us-gaap_CommodityOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d30a9005-35ca-47e9-b898-c0c956e79b2f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_0b615b71-d4df-4640-a17b-ec59952d0be7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_75fbb541-8008-4f44-9bc8-174553c8256a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_82029750-62f9-464e-8de4-2dcf30ac214e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation gains (losses)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_797c62da-ad33-4ae4-9a2b-19de1c72ba02_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program, number of shares authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_29da27ff-0471-42f3-aa34-151b7fd2e869_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_0f736a2c-11d9-4d6f-a10f-1bddc024e59c_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_041ccb33-1794-4fbf-a0d2-0844176cb432_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1ee3a273-7458-4a05-832c-bd1239f960ce_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_48b9fc9f-6e44-4ba7-aa65-f97c04900d6d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_c85ec722-797e-41b2-8da3-607d0234d16d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange (Gains) Losses and Other [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:to="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2f4bdc9a-978f-4be7-b152-c26ca4d64a47_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_7ae9cc4a-51fd-4d9f-a2ee-52e2f96a0566_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_fabe85fb-aae1-49a5-a000-085dff9b504e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_884dd0ed-fe43-4dbf-8ef7-a9fbdeaad278_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_2bb19b66-70f2-4466-b7ed-964a754689da_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_InternationalMutualFundsMember_3cd8b360-fc36-4d2b-b7af-6dc3d19a4d8f_terseLabel_en-US" xlink:label="lab_wst_InternationalMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_InternationalMutualFundsMember_label_en-US" xlink:label="lab_wst_InternationalMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Mutual Funds [Member]</link:label>
    <link:label id="lab_wst_InternationalMutualFundsMember_documentation_en-US" xlink:label="lab_wst_InternationalMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Mutual Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_InternationalMutualFundsMember" xlink:href="wst-20191231.xsd#wst_InternationalMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_InternationalMutualFundsMember" xlink:to="lab_wst_InternationalMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2b22382b-7be3-497a-be2e-040b3e1c7ed6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_c066c021-9864-40c8-a90c-a9a2c5855302_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial (loss) gain arising during period, net of tax of $(0.3), $(0.2) and $1.3</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_0fa8897e-6f76-4526-870b-803b58ff5424_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_78f2b66b-363f-49a2-bad5-07e527dae6ba_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_9dad3a41-793f-488e-b808-fb349787de2d_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_56ef2587-c43b-45d6-8c37-4010cc54cb0e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_85a53404-e59f-4e8f-8d04-c26cffd61912_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths_d8570422-eb4e-4bca-936f-2cdbc3a9cd5a_terseLabel_en-US" xlink:label="lab_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings within Twelve Months</link:label>
    <link:label id="lab_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths_label_en-US" xlink:label="lab_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings within Twelve Months</link:label>
    <link:label id="lab_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths_documentation_en-US" xlink:label="lab_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings within the next 12 months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" xlink:href="wst-20191231.xsd#wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" xlink:to="lab_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DocumentAndEntityInformationAbstract_de0ac981-2562-4ffa-b1e0-84a10bb8df41_terseLabel_en-US" xlink:label="lab_wst_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_wst_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_wst_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_wst_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_wst_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DocumentAndEntityInformationAbstract" xlink:href="wst-20191231.xsd#wst_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DocumentAndEntityInformationAbstract" xlink:to="lab_wst_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_c6401771-2b2b-4199-8044-e4c54e5186ff_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_ad70e64d-b494-4715-87d4-7f9a75938f71_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_642b7904-ac39-4d2d-a543-28889fbe0526_terseLabel_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments</link:label>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_label_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</link:label>
    <link:label id="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_documentation_en-US" xlink:label="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:href="wst-20191231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:to="lab_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_42adb083-1e3d-49db-91b8-786e3c6a58d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_787d5890-d345-43b0-9da9-ee9dde4b27a8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_6ad62f99-9303-4c94-8c23-343a0d607df5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7113cc11-df33-446e-8e75-6925c52910d3_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_339c2277-94a1-432c-ae2d-90601913e50d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill recorded due to acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RevenueAbstract_1e4343e5-9243-42a6-a46a-d9872f308467_terseLabel_en-US" xlink:label="lab_wst_RevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Abstract]</link:label>
    <link:label id="lab_wst_RevenueAbstract_label_en-US" xlink:label="lab_wst_RevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Abstract]</link:label>
    <link:label id="lab_wst_RevenueAbstract_documentation_en-US" xlink:label="lab_wst_RevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevenueAbstract" xlink:href="wst-20191231.xsd#wst_RevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RevenueAbstract" xlink:to="lab_wst_RevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_0bd18f22-2d39-4b3c-a093-9cddfbdbb747_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation on payroll deductions of employee's base salary, percent</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_228d1ca9-a1af-44c6-b70f-4d7faf763b94_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual maturities of long-term debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_a733cc9e-e891-44a9-b16c-b02a13d3bc5e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_e297f88e-ead9-44b6-b27d-011c3065e711_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other charges [Member]</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_7a950cba-c25b-48a1-a921-c30db625825b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected contribution to the plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_e4cc4184-d3b0-4889-bfad-e2c24ee0245f_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_98eed22a-9466-414c-8ed4-7e840c793a19_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticLineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_DomesticLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticLineOfCreditMember" xlink:to="lab_us-gaap_DomesticLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmount_069d4beb-f781-401c-87d8-36d99510cbdd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Nonmonetary Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNonmonetaryNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Nonmonetary Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:to="lab_us-gaap_DerivativeNonmonetaryNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_c00ee737-4191-4e74-ac67-aa18f1bc3f6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForeignCurrencyDenominatedDebtMember_f8a1bd0f-999e-487c-822f-28e94effaea2_terseLabel_en-US" xlink:label="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency - Denominated Debt [Member]</link:label>
    <link:label id="lab_wst_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency, Denominated Debt [Member]</link:label>
    <link:label id="lab_wst_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency-denominated debt designated as a hedge of our net investments in foreign operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyDenominatedDebtMember" xlink:href="wst-20191231.xsd#wst_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_wst_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_674bf6a5-c957-42b9-ba98-6018eda4dc0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0280cb88-f4ac-48df-8b50-c34a91d09c5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_20eb7389-ec3c-42ce-960d-2702cd7742d1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2dcd2458-19bd-4fe4-b48c-8f0f6855d44c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_2c717479-2cd9-4dc5-a661-09b9d002717e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ab98b689-56bd-4811-93fa-485ae9aa23ce_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_11d971c8-5c0b-461f-ad89-4dad6d65f96a_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_83ee4ef4-83c7-4004-b49c-5d5f5810803e_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_bfdeeee0-432c-48f4-8dab-f6a9cc781101_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostMethodInvestments_7f4998af-5aeb-4fc7-8a16-e4c4ffff1af5_verboseLabel_en-US" xlink:label="lab_us-gaap_CostMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method</link:label>
    <link:label id="lab_us-gaap_CostMethodInvestments_label_en-US" xlink:label="lab_us-gaap_CostMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostMethodInvestments" xlink:to="lab_us-gaap_CostMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cefca4e2-b272-4b18-8484-5163761ea9e9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b5dd53fb-acfc-4ffa-8713-b9a87f2bef2c_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87306835-ce97-4367-9f03-6e5c8f2ddc32_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_18faf894-ee80-466d-8607-9399962ceac5_totalLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total benefit payments expected</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:to="lab_wst_DefinedBenefitPlanExpectedFutureBenefitPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_60b781ba-2bfe-43aa-b51a-c24918c639f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PatentsAndLicensingMember_f9582727-338d-481f-a49a-62dc243811da_terseLabel_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licensing [Member]</link:label>
    <link:label id="lab_wst_PatentsAndLicensingMember_label_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licensing [Member]</link:label>
    <link:label id="lab_wst_PatentsAndLicensingMember_documentation_en-US" xlink:label="lab_wst_PatentsAndLicensingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licensing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember" xlink:href="wst-20191231.xsd#wst_PatentsAndLicensingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PatentsAndLicensingMember" xlink:to="lab_wst_PatentsAndLicensingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_992aa755-dfc9-4bde-9b5d-970b210d1c1e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess of Par Value [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_86a1745e-f91f-44cb-b8e8-42712163b732_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_939322bb-bd1d-49be-a1e4-d3c156ce90c4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation [Line Items]</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_284d1f87-4cc9-46ef-a603-4b424a252825_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_c76ad579-37cb-4d0d-8d62-ed8a6bb05c4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venezuela deconsolidation</link:label>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_77a1c974-8162-4fb1-a0de-37b26837a07e_terseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venezuela deconsolidation</link:label>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_label_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Gain (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:to="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_c37ac037-d97b-4040-b249-169ff8920854_periodStartLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oustanding, beginning (in USD per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_da3e73af-b9bb-4160-81e4-9a299c60067d_periodEndLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oustanding, ending (in USD per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a4e3ff2d-820f-4575-8f05-9a0dc2b5f020_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_a65f3706-927e-4dd0-a049-db6a040b32a2_terseLabel_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2024 [Domain]</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_label_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2024 [Member]</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2024Member_documentation_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RevolvingCreditFacilityDue2024Member" xlink:to="lab_wst_RevolvingCreditFacilityDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_c2196632-3e84-44a6-a796-4dedf7ce7df1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_7be6b610-1311-4e4b-b1a4-560cbe58278e_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_97d1e8aa-64f4-4483-b744-06b5ad3c755c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_9b0189aa-2800-4ec3-89ad-2df89b985f71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_668526f1-e7c6-4846-a215-3faa13da9f19_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b4c03d0f-519c-4bb8-97e8-2818412c3819_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_0cf204a0-2c74-46a0-9760-9105c9442f02_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_Goodwill_07a89fbf-8518-4767-a7c8-c83bf7b1ef06_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1ff4c441-8add-4e0d-a857-3f52a504d2f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_c560bf0e-975b-4bef-acb3-fa96b9ff2857_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_b58bb6c6-4a60-4177-9109-0b46897a672a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reserves for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_3684ce62-75c0-4322-8a40-d264b6dd06f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendments/transfers in</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_295141b3-456b-4754-916a-9267deeab56e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_d3a9e00b-29ad-463f-80ed-41c616b709de_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of 2017 Tax Act</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f68959b2-b116-4638-8176-c282eeefbf29_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NotePayableDue2019Member_31ec4635-2b3b-4e40-b47c-6dfa7475efe3_terseLabel_en-US" xlink:label="lab_wst_NotePayableDue2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Payable Due 2019 [Member]</link:label>
    <link:label id="lab_wst_NotePayableDue2019Member_label_en-US" xlink:label="lab_wst_NotePayableDue2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Payable Due 2019 [Member]</link:label>
    <link:label id="lab_wst_NotePayableDue2019Member_documentation_en-US" xlink:label="lab_wst_NotePayableDue2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Payable Due 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotePayableDue2019Member" xlink:href="wst-20191231.xsd#wst_NotePayableDue2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NotePayableDue2019Member" xlink:to="lab_wst_NotePayableDue2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_88eec2fc-380b-454f-89c6-af3cb9e1134d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_9135e02c-4868-4bd7-bc92-bd195ca4b531_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee, per year</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_5a4ad1b1-5c89-4df3-9383-25efb6981fea_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_5b0dbb31-20a7-44ca-bca7-3e25c13dcfc6_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in USD per share)</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:to="lab_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0b753da2-c1a3-4b3c-9c67-7a1504932995_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_83f98c3c-c80d-457a-976c-9e2929c2a616_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, unused commitment level</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasedAssetsGross_826e68d8-659d-4878-9056-494d9ee150ea_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasedAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized leases</link:label>
    <link:label id="lab_us-gaap_CapitalLeasedAssetsGross_label_en-US" xlink:label="lab_us-gaap_CapitalLeasedAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leased Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasedAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasedAssetsGross" xlink:to="lab_us-gaap_CapitalLeasedAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4f4ea7cd-6f86-428c-91a6-86d30cef44bf_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_96b2ee64-24d7-479f-bd46-dab09b41e3a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_52f260f1-1598-4421-be51-b3cf3a4c16b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c26500e2-767e-4dc1-9026-a857541a06d4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_9a2dbe1c-bc91-4571-8274-728fd920c87e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_89460b44-805a-4b61-a354-3d62f9fda02d_terseLabel_en-US" xlink:label="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and impairment charges</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_label_en-US" xlink:label="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges</link:label>
    <link:label id="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_documentation_en-US" xlink:label="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:href="wst-20191231.xsd#wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:to="lab_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_e3e14625-f168-42b9-ba6c-7699840534e6_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ae040929-0f9f-4ce0-9552-4acf6144e6cf_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_38874b41-1dc7-4ba2-962f-9832b92dffd3_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual payout range</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Actual Payout, Percentage</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Actual Payout, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1852a9ae-a6e5-4c06-9a17-1f5c288bd0f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_cca53476-bc27-4e58-b5ab-e3eba119428b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-related charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionMember_60f67755-74ae-4acd-b4b5-36b7df119529_verboseLabel_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Call Options Held [Member]</link:label>
    <link:label id="lab_us-gaap_OptionMember_f25f1863-0761-49ad-9df3-eb78dc376284_terseLabel_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commodity Call Options [Member]</link:label>
    <link:label id="lab_us-gaap_OptionMember_label_en-US" xlink:label="lab_us-gaap_OptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Held [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionMember" xlink:to="lab_us-gaap_OptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_0f442653-5660-4500-a328-b742326f6f26_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedProductsMember_340cc3d5-41e5-4ad7-ac11-d6a7adda4409_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_d8775c89-ec6a-42ae-a84d-5db8e1e5bf61_verboseLabel_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Products [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_label_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedProductsMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Manufactured Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedProductsMember" xlink:to="lab_wst_ContractManufacturedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_290e758e-3d65-4d02-b938-d1f46eda3ca6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_923da39b-b6e8-4bbb-9c5e-c35e993acef8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_42c0dbfe-436f-4edb-bc97-ce397af6e432_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate, remeasurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Exchange Rate, Remeasurement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:to="lab_us-gaap_ForeignCurrencyExchangeRateRemeasurement1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_db26990d-04ed-447a-a6fe-a57f8018576d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationTable_3074a957-244f-4877-90eb-f20e05f625af_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation [Table]</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationTable_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationTable" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_19528cd6-7459-46f6-8386-72926494f690_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_5178f47c-61d8-4425-9be7-c83306373238_terseLabel_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software [Member]</link:label>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_label_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software [Member]</link:label>
    <link:label id="lab_wst_ComputerHardwareAndSoftwareMember_documentation_en-US" xlink:label="lab_wst_ComputerHardwareAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember" xlink:href="wst-20191231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ComputerHardwareAndSoftwareMember" xlink:to="lab_wst_ComputerHardwareAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax_2de833f1-ee6c-4986-927c-bfe9114f9d3b_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement effects arising during period, net of tax of $0.8</link:label>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax_label_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Loss, Defined Benefit Plans Settlement Effects, Net of Tax</link:label>
    <link:label id="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" xlink:to="lab_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_87e9cc0e-b5c1-44fa-992e-9781222626e8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_cfaba7c3-3f55-4ec0-b191-4c6066a8aefa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_b4e3f5fb-fab3-466b-8769-f654ebae3b9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of total options vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_e411e3cd-e716-4746-88ad-b962492ea172_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_f38bbe8f-948b-4bce-9c87-623a6a494786_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherExpenseIncomeAbstract_5997173f-8737-46fe-93b3-6227c2119458_terseLabel_en-US" xlink:label="lab_wst_OtherExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income) [Abstract]</link:label>
    <link:label id="lab_wst_OtherExpenseIncomeAbstract_label_en-US" xlink:label="lab_wst_OtherExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income) [Abstract]</link:label>
    <link:label id="lab_wst_OtherExpenseIncomeAbstract_documentation_en-US" xlink:label="lab_wst_OtherExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense (Income) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeAbstract" xlink:href="wst-20191231.xsd#wst_OtherExpenseIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherExpenseIncomeAbstract" xlink:to="lab_wst_OtherExpenseIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_c8fad9d7-3d7e-40e1-ba18-0acbfb636a5d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of actuarial loss, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_8b5f5230-c3d4-4817-843c-f0277a394fb8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term rate of return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a9a70260-b468-4303-8cff-9d192482dceb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_da826542-0a97-4313-843e-2f1e37a4ddca_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_058cb999-d33a-4399-a5e9-8b3d246d892d_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_1453879c-ad7b-4453-bd5e-a2cf2a8bae23_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_518cc731-c8dc-45b2-997b-a663a24054a3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_7fb11799-5da7-4d1f-a06a-0f21539d25b0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_41766269-671e-412a-8451-d87e65ae7ff7_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_95a46e02-723e-4b86-a695-2cba151a8fb0_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_771d4b17-e4f7-4471-bd50-306c102e0490_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_409158c8-487a-4bb1-9eec-5a033d3ed64f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_a43cd922-711f-493d-a7b0-d8a88d2bd5f8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e6d0d61d-270c-40e8-91b1-c7886cc9b1a7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_c0ffbb5f-d512-4eb3-8c45-9c6f6382b006_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_7f693c67-057f-41fe-89c8-221f1b643494_terseLabel_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled PSU awards [Member]</link:label>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_label_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled PSU awards [Member]</link:label>
    <link:label id="lab_wst_StockSettledPSUAwardsMember_documentation_en-US" xlink:label="lab_wst_StockSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled PSU awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember" xlink:href="wst-20191231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockSettledPSUAwardsMember" xlink:to="lab_wst_StockSettledPSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractsandLiabilitiesAbstract_046f01e4-1f18-4695-befa-2bf1fe116c11_terseLabel_en-US" xlink:label="lab_wst_ContractsandLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts and Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_ContractsandLiabilitiesAbstract_label_en-US" xlink:label="lab_wst_ContractsandLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts and Liabilities [Abstract]</link:label>
    <link:label id="lab_wst_ContractsandLiabilitiesAbstract_documentation_en-US" xlink:label="lab_wst_ContractsandLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractsandLiabilitiesAbstract" xlink:href="wst-20191231.xsd#wst_ContractsandLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractsandLiabilitiesAbstract" xlink:to="lab_wst_ContractsandLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2023Member_08ee24ef-ac84-40ff-a86a-05f577d2d523_terseLabel_en-US" xlink:label="lab_wst_Year2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2023 [Member]</link:label>
    <link:label id="lab_wst_Year2023Member_label_en-US" xlink:label="lab_wst_Year2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2023 [Member]</link:label>
    <link:label id="lab_wst_Year2023Member_documentation_en-US" xlink:label="lab_wst_Year2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2023Member" xlink:href="wst-20191231.xsd#wst_Year2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2023Member" xlink:to="lab_wst_Year2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_7ea646b4-1451-447c-8dff-dae3d76fc7a4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_d1ac608d-452c-4c26-b08b-043b0398da8a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_214ad016-da44-4bd7-bc5a-ef128ae3e082_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments to capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_dc65552a-bd7a-4dae-820b-4def5bc2fc4c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax (liability) asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1db99b89-a85c-4a62-9bbd-17c5a58ad73d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b27f5cbf-c229-4b80-a189-8c76af424119_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_d02eb584-14b3-4b04-b8db-17672174e520_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_b3937911-2f0d-45c4-b700-05efb37766c0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_f3ee65a7-b369-4021-9fff-49c5c77868d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_b624c1c3-2ac7-4b1a-b16e-5730cbbeada1_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ff997072-d601-4712-ad0a-8d9526597d07_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_874bda6f-9fcb-4e53-b770-5d25f02bf2bf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_2146bfcc-f211-4fb8-b3a6-ffe4fe58a4a2_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed healthcare cost trend rate, net periodic benefit cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:to="lab_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3ee4f6d4-eeef-45aa-b357-668f2a7dfc3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_01721d8f-ef9f-473c-8c59-4b79db572e5c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_A2016RestructuringPlanMemberMember_60487a90-4bd5-4137-8336-425d69bd5288_terseLabel_en-US" xlink:label="lab_wst_A2016RestructuringPlanMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member] [Member]</link:label>
    <link:label id="lab_wst_A2016RestructuringPlanMemberMember_label_en-US" xlink:label="lab_wst_A2016RestructuringPlanMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member] [Member]</link:label>
    <link:label id="lab_wst_A2016RestructuringPlanMemberMember_documentation_en-US" xlink:label="lab_wst_A2016RestructuringPlanMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Restructuring Plan [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2016RestructuringPlanMemberMember" xlink:href="wst-20191231.xsd#wst_A2016RestructuringPlanMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_A2016RestructuringPlanMemberMember" xlink:to="lab_wst_A2016RestructuringPlanMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_557dae08-1c0a-4dd5-92de-d5ff5fe5ffa8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_dfc6e46b-ad4c-4fd1-9add-3f64c85eeed4_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_0fd9bef4-9da3-496e-a8fa-384b9fbd14de_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ebca47b9-9129-49a1-a0dd-474efb2314d7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Level 3 Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_e8a50d90-12df-44c9-8f14-30f1587e08df_terseLabel_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility is available for swing-line loans</link:label>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_label_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility is available for swing-line loans</link:label>
    <link:label id="lab_wst_CreditFacilityIsAvailableForSwingLineLoans_documentation_en-US" xlink:label="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This refers to credit facility is available for swing-line loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:href="wst-20191231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:to="lab_wst_CreditFacilityIsAvailableForSwingLineLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f0ee0d1b-412c-41f4-a911-5a22448c94cb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_c1369744-910d-4b94-b555-54c87291b507_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76b63dfc-8464-4bbc-ae22-0fc64959c105_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7a041173-73d7-4b00-8d4f-6f09c8afc731_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtMember_39adb4d7-3784-4832-9e1b-ebc114cde480_terseLabel_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Note B [Member]</link:label>
    <link:label id="lab_us-gaap_DebtMember_label_en-US" xlink:label="lab_us-gaap_DebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtMember" xlink:to="lab_us-gaap_DebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_633dcee2-5573-4815-9bb3-3e9b3e98d932_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_c7987c9a-6e8a-43f2-8420-bd773e45f5c2_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_17dcf31b-12d6-4c1d-b2fe-3c09947e9880_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_fa749a1a-2989-41c0-b4dd-59da5097f929_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_cba32a12-fcd0-42fc-83c5-e09abb0b9abb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 to 2029</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_38c7d85c-a96c-46c1-a045-1f0a7366aee9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_dd0eb645-ab30-452e-a572-912dd60a57c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_41ef49ed-01b7-4a7c-bc0d-473b30f375d9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in benefit obligations:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_2283007a-856e-4923-8331-1c4acbebe03b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, option to extend</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_276ede5f-d58a-401d-9aae-11edabc92ea2_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_b0973610-2edb-4810-865f-a1a353acb6e7_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_4d7958b7-85b1-49bf-9d48-555481afd0db_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of global plan assets</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:to="lab_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2eb5dcb-6b8a-4678-8849-6f6cd357095a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e1e0c708-eeb3-4bd2-9182-ed1016510772_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity related to stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_3774b9f1-4350-4008-8334-5caa1d93715f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amortization of prior service credit, net of tax of $(0.1), $(0.5) and $(0.5)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_c434f210-0e9b-4104-af01-58875151eb3f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_66a42d3c-e567-45e6-8fc2-c7931dbf7b71_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a999a1bf-6110-4ce2-a978-a96f93b7d601_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fda5436f-0811-42b9-a8d3-6e35e32b8851_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_284193dd-dc1d-4add-83d2-96ab492de40d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_388d3380-18a6-49e7-a255-a8ea9a27edde_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_1748d749-850a-4a7c-a2e7-d29f2a0d43ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_01895df4-5d10-40fb-a093-08891d8eef37_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 Fair Value Measurements [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_53951e74-f4cb-49b3-82e1-458a3a30be99_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9bc72975-3552-43a1-8525-37f5360c2cf9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and converted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3e8c503e-78db-4124-b60d-8540b32bd074_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_995d3c76-6852-49f7-8c0e-a880fac3d4a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_6b0b0439-7829-4b9e-8b04-4db97a4f866e_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c5007689-70d8-4bb6-85d2-162017273932_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c8a4078a-b8a5-429d-bb5c-3ddc8b84c812_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Venezuela deconsolidation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_fbfd6bd5-5760-44cd-a299-b5b5dce2292c_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and post-employment benefits</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_97fed696-4aeb-4315-b79b-0ba13c03be48_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance charges</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_fe0e3941-6f18-4c1c-aa3b-689cc743e599_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5cd244d7-5bd5-46ef-a4ff-1a3944444d1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetImpairmentChargesPatentandEquipment_2716f72b-4a81-4720-8bdf-24f1a5b8332e_verboseLabel_en-US" xlink:label="lab_wst_AssetImpairmentChargesPatentandEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges, patent and equipment</link:label>
    <link:label id="lab_wst_AssetImpairmentChargesPatentandEquipment_label_en-US" xlink:label="lab_wst_AssetImpairmentChargesPatentandEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Patent and Equipment</link:label>
    <link:label id="lab_wst_AssetImpairmentChargesPatentandEquipment_documentation_en-US" xlink:label="lab_wst_AssetImpairmentChargesPatentandEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of write-down of a patent and certain equipment, recognized in the income statement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatentandEquipment" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatentandEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetImpairmentChargesPatentandEquipment" xlink:to="lab_wst_AssetImpairmentChargesPatentandEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_e05bd28b-d5f4-4350-a1c1-de431abd1ec7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax on undistributed earnings of subsidiaries</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_c06533fb-97f5-4ed7-8a03-51cb7f134119_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_19a272b0-4ecd-4361-802f-8edcd1598c9a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ToolsDiesAndMoldsMember_57dcd03a-162b-4b2f-b0e6-b52642cdd6e7_terseLabel_en-US" xlink:label="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds and Dies [Member]</link:label>
    <link:label id="lab_us-gaap_ToolsDiesAndMoldsMember_label_en-US" xlink:label="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tools, Dies and Molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ToolsDiesAndMoldsMember" xlink:to="lab_us-gaap_ToolsDiesAndMoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_b5e457fd-3294-4ee0-ac50-548ac18154d0_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5a204850-b2e6-4a20-9ffb-90100e967b8a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_dd24fc34-b5d6-42a4-9073-61b8d83553c3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6c3cf258-b651-4e2f-8f86-a426dbad559c_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_90793197-ddb4-49c1-af0a-ebac057ea1e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_b0234a41-814a-478a-970b-bb5a5e2febcd_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_45b9b397-218a-41ab-8cec-a62de2cf3c4a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_09a0eb47-1f88-4e2f-b6b3-f5146f2ff745_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d716133-259d-4bd7-859a-83a90076f49f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_530b72a0-2311-4f85-bb9f-7febfbae8734_terseLabel_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_label_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:label id="lab_wst_ContractManufacturedCustomersMember_documentation_en-US" xlink:label="lab_wst_ContractManufacturedCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Manufactured Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember" xlink:href="wst-20191231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractManufacturedCustomersMember" xlink:to="lab_wst_ContractManufacturedCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_169f4ce1-35ee-420c-b38d-35e5a7be2e61_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_089ec9a1-9c44-4f9e-8461-cd2a8951671c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_5a1635a1-622d-4778-801f-8996cc7ddf8c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_99bc6c03-d66a-4855-8c81-b50c014ab1b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f5b392c-9ba9-4bc6-9d49-7a511466dc0a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_6489d935-a84b-4432-8b40-f48bcfa3e277_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2e64784b-47ef-4861-8c99-bfbd7adeb0c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e6ceb2f9-8f52-4ad2-97fe-84dc8d812b1d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8125e994-89b7-4e36-9030-43146b9afd26_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_b4f88446-4d1d-4bf0-863a-3a3efa8a2fdf_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_03d98fdc-16ff-4bb3-a114-d3b481e1cbed_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction_4186d5ba-66f5-4876-82ee-2ed980df032e_terseLabel_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other business credits and Section 199 Deduction</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction_label_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, General Business Credits and Section 199 Deduction</link:label>
    <link:label id="lab_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction_documentation_en-US" xlink:label="lab_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, General Business Credits and Section 199 Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" xlink:href="wst-20191231.xsd#wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" xlink:to="lab_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_cabafdc4-cb8c-483c-b750-62cf522b8ce0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6ee12f48-3ff0-4b6e-8725-44f116f333af_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_cfabc326-6606-4580-b270-fcd4c62f50e3_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_6b17007b-e8ea-4c3f-bf0c-fed6fb78e96d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_67912a56-db14-4c2d-a06f-d7959ad20e9c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains on Investment Securities [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_8fb33dd2-2057-4fa1-978f-c8e773a1bd7f_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets by Major Class [Line Items]</link:label>
    <link:label id="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_documentation_en-US" xlink:label="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:to="lab_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_a14ba699-3cfd-41b9-848a-d75770f78903_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_f7c384ad-d499-4237-b164-798ee442f44f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense_15b04074-112b-4179-bdb8-eb4837d8dd5e_terseLabel_en-US" xlink:label="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisional tax charge, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense_label_en-US" xlink:label="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Deferred Tax Liability, Provisional Income Tax Expense</link:label>
    <link:label id="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense_documentation_en-US" xlink:label="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Deferred Tax Liability, Provisional Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" xlink:href="wst-20191231.xsd#wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" xlink:to="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b62dc9b8-c195-4b3a-b7fd-ae73c81c50c6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_9be5d359-1fd0-4eb9-ba34-caa485ad1880_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in affiliated companies, treasury stock</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_c5fa43a2-88cd-44fc-a7bd-81b5b27be7f4_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_71c23dfd-a626-445f-988b-233a426e07a0_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_91fe959c-b0a8-4717-8e6b-b14815b9f236_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_e91c3647-f2f4-44b1-8ae6-fb23051123e6_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_10e026d1-cb2b-45e6-b935-4899a024c595_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CashSettledStockAppreciationRIghtsOutstanding_27706d4d-dad1-45d9-a0fb-02bec75af642_terseLabel_en-US" xlink:label="lab_wst_CashSettledStockAppreciationRIghtsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-settled SARs, outstanding</link:label>
    <link:label id="lab_wst_CashSettledStockAppreciationRIghtsOutstanding_label_en-US" xlink:label="lab_wst_CashSettledStockAppreciationRIghtsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-Settled Stock Appreciation RIghts, Outstanding</link:label>
    <link:label id="lab_wst_CashSettledStockAppreciationRIghtsOutstanding_documentation_en-US" xlink:label="lab_wst_CashSettledStockAppreciationRIghtsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cash-settled stock appreciation rights outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledStockAppreciationRIghtsOutstanding" xlink:href="wst-20191231.xsd#wst_CashSettledStockAppreciationRIghtsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CashSettledStockAppreciationRIghtsOutstanding" xlink:to="lab_wst_CashSettledStockAppreciationRIghtsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_5dc378dd-761e-4617-823f-df2e07ab82a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b783e371-9cd8-426a-a952-09b6dbc8d338_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_bcaaa500-1170-407c-8ee3-3a2b1e5a26ba_verboseLabel_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_label_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding: [Abstract]</link:label>
    <link:label id="lab_wst_WeightedAverageSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WeightedAverageSharesOutstandingAbstract" xlink:href="wst-20191231.xsd#wst_WeightedAverageSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract" xlink:to="lab_wst_WeightedAverageSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ba50d3eb-5a09-4436-b30f-37c451c52777_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_cd415a2f-6603-4657-b647-7f41e5aa7b9a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_41c853c1-f958-47e8-bc85-7c380f0bd64a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_3d1735f4-d00c-4408-bce8-2ef288bfa279_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_c6fc881f-65ac-477a-923a-f1b547963c83_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_fe710828-30bf-457c-b42f-0df9915a646f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, estimated outcome, high</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_551f8989-bb73-47ab-b245-f330569b713f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Revolvingcreditfacilitydue2020Member_bb6629f4-42eb-4cec-b1ed-739f687a0b2f_terseLabel_en-US" xlink:label="lab_wst_Revolvingcreditfacilitydue2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2020 [Member]</link:label>
    <link:label id="lab_wst_Revolvingcreditfacilitydue2020Member_label_en-US" xlink:label="lab_wst_Revolvingcreditfacilitydue2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2020 [Member]</link:label>
    <link:label id="lab_wst_Revolvingcreditfacilitydue2020Member_documentation_en-US" xlink:label="lab_wst_Revolvingcreditfacilitydue2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2020.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Revolvingcreditfacilitydue2020Member" xlink:href="wst-20191231.xsd#wst_Revolvingcreditfacilitydue2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Revolvingcreditfacilitydue2020Member" xlink:to="lab_wst_Revolvingcreditfacilitydue2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_62ca2d7e-6fa1-46aa-ab48-785207c2486d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on derivatives, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_de7ac077-cb75-4dcb-b1fe-c522af2c9a71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_bcdf8915-6fde-4038-b00d-2f75cc751fa8_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_fde3ddd8-cefb-4185-95f2-d231965eedea_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_602daba6-9f69-4a9e-9467-289fbbe89752_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_2441396a-7e0c-420d-8d64-fe846506d4d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued retirement plans (excluding pension)</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Other Retirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_0bb86af4-3aba-4d00-add4-b688995d8796_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_32ebf3a7-79dc-4f8a-899e-910e826958a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_5bfc7e41-51f9-4bdb-ade7-906945506b34_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate basis</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_21200d72-7f7d-4d57-9ef3-d901baed404a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e64afeb0-14f6-40b6-a702-f5026d3518bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_39b97c62-45ab-4668-8016-c2af08e0d68b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisional Transition Tax, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_90f2f93c-224b-457e-8c2b-709e0e3079ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sales of equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeliveryDevicesMember_8cbfb136-9542-4952-a7e7-4d983aad140b_terseLabel_en-US" xlink:label="lab_wst_DeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delivery Devices [Member]</link:label>
    <link:label id="lab_wst_DeliveryDevicesMember_label_en-US" xlink:label="lab_wst_DeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delivery Devices [Member]</link:label>
    <link:label id="lab_wst_DeliveryDevicesMember_documentation_en-US" xlink:label="lab_wst_DeliveryDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delivery Devices [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeliveryDevicesMember" xlink:href="wst-20191231.xsd#wst_DeliveryDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeliveryDevicesMember" xlink:to="lab_wst_DeliveryDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_42e96890-70f6-4288-b3ca-f47c04a446fd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_255f799b-c71c-4011-9de4-ff899a26b2e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_be5d3829-9fca-4178-a6bd-8b3efa985bcd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred income - (increase) decrease</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_0eb70ebd-04d4-4193-a216-00736da3ea01_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1f997b8b-bca6-4c66-8707-aa66a685f4ae_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_f389c8b2-a799-48e6-b670-95621dc198ac_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_78ad554f-a29a-4000-8c8a-b1d27111a421_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PensionplanassetsmeasuredatNAVMember_707689d9-4f75-4e50-a7f9-e61487a56e2a_terseLabel_en-US" xlink:label="lab_wst_PensionplanassetsmeasuredatNAVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets measured at NAV [Member]</link:label>
    <link:label id="lab_wst_PensionplanassetsmeasuredatNAVMember_label_en-US" xlink:label="lab_wst_PensionplanassetsmeasuredatNAVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets measured at NAV [Member]</link:label>
    <link:label id="lab_wst_PensionplanassetsmeasuredatNAVMember_documentation_en-US" xlink:label="lab_wst_PensionplanassetsmeasuredatNAVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan assets measured at NAV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionplanassetsmeasuredatNAVMember" xlink:href="wst-20191231.xsd#wst_PensionplanassetsmeasuredatNAVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PensionplanassetsmeasuredatNAVMember" xlink:to="lab_wst_PensionplanassetsmeasuredatNAVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_8c8f397a-a68e-4b49-a9ac-6190b2d7ef47_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_dbea9e75-db22-4409-ac6f-64e954703e03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9040471a-94d9-496d-8068-1330923b9e9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased for employee tax withholdings</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_c9fdc51d-dfcb-4781-a1fd-02e9ecc0694e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_15f08534-59cc-441b-a186-5e8c9f7a37f4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ForwardTreasuryLockMember_a0c4ccb9-77f6-4635-9c9e-93576faabb1b_terseLabel_en-US" xlink:label="lab_wst_ForwardTreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Treasury Lock [Member]</link:label>
    <link:label id="lab_wst_ForwardTreasuryLockMember_label_en-US" xlink:label="lab_wst_ForwardTreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward treasury lock [Member]</link:label>
    <link:label id="lab_wst_ForwardTreasuryLockMember_documentation_en-US" xlink:label="lab_wst_ForwardTreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardTreasuryLockMember" xlink:href="wst-20191231.xsd#wst_ForwardTreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ForwardTreasuryLockMember" xlink:to="lab_wst_ForwardTreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a8cc32b1-35c2-4274-9e1a-1ef11e4d632e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_ba7b5e7a-4009-439d-a6fa-0eeb91b5bc97_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherEuropeCountriesMember_38f85c06-e43c-4a35-92f6-245d88d75d9f_terseLabel_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other European countries [Member]</link:label>
    <link:label id="lab_wst_OtherEuropeCountriesMember_label_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Europe Countries [Member]</link:label>
    <link:label id="lab_wst_OtherEuropeCountriesMember_documentation_en-US" xlink:label="lab_wst_OtherEuropeCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Europe Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember" xlink:href="wst-20191231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherEuropeCountriesMember" xlink:to="lab_wst_OtherEuropeCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_VoluntaryRecallAbstract_99a16c54-8180-4a34-82f9-6370bd57ed7a_terseLabel_en-US" xlink:label="lab_wst_VoluntaryRecallAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Recall [Abstract]</link:label>
    <link:label id="lab_wst_VoluntaryRecallAbstract_label_en-US" xlink:label="lab_wst_VoluntaryRecallAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Recall [Abstract]</link:label>
    <link:label id="lab_wst_VoluntaryRecallAbstract_documentation_en-US" xlink:label="lab_wst_VoluntaryRecallAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voluntary Recall [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_VoluntaryRecallAbstract" xlink:href="wst-20191231.xsd#wst_VoluntaryRecallAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_VoluntaryRecallAbstract" xlink:to="lab_wst_VoluntaryRecallAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2037Member_63486253-445d-4076-9217-d934746781fa_terseLabel_en-US" xlink:label="lab_wst_Year2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2037 [Member]</link:label>
    <link:label id="lab_wst_Year2037Member_label_en-US" xlink:label="lab_wst_Year2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2037 [Member]</link:label>
    <link:label id="lab_wst_Year2037Member_documentation_en-US" xlink:label="lab_wst_Year2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2037Member" xlink:href="wst-20191231.xsd#wst_Year2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2037Member" xlink:to="lab_wst_Year2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c0b88bee-1555-49fa-9c6b-fb074b1bc9bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_28abeca1-a38a-4db1-b83c-65abebe0f3c3_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_41269c08-5bd1-4e4a-bfc0-94801de32bc2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_dde9e69a-f144-4254-8b8a-17f7da8ba88b_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_3503fb1c-dc75-4adc-bac5-53890967ac79_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_f6b22599-52b0-4a98-a090-1db696bbd381_negatedLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash asset write-downs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_4281bca8-86e7-4852-b18c-93aa221a6f3e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_f48c7cc4-1a88-4c40-95ab-3bd99d333942_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6da9d328-52c2-4b52-b8b0-1e533e4d5c92_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_811983fa-833b-4fd0-b9ba-a2033aa66d58_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_40ea6a2e-9529-4493-83fe-f4bc4f66824c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d617efcd-64c1-47d7-a179-44d38c9a1c8e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_53785552-0a1f-4135-a5e4-75b12e2b22da_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_6a74677c-f92b-4f40-86d2-a692cd1dae04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock_b05a8690-e6e6-4c17-ba11-dc07de9dc4f2_terseLabel_en-US" xlink:label="lab_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income and Expense</link:label>
    <link:label id="lab_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income and Expense, by Component [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Income and Expense, by Component [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" xlink:href="wst-20191231.xsd#wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" xlink:to="lab_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_23175b31-54a2-4f4c-a1dc-cade63db8b61_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_d5876a14-a565-4625-9415-54b0ba929829_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_ebf28b69-179f-4a6f-9079-86ea7ac25a7b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RatioOfDebtToEBITDA_fc6990cb-70bf-4a48-9a13-7664bd4e284f_terseLabel_en-US" xlink:label="lab_wst_RatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA</link:label>
    <link:label id="lab_wst_RatioOfDebtToEBITDA_label_en-US" xlink:label="lab_wst_RatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA</link:label>
    <link:label id="lab_wst_RatioOfDebtToEBITDA_documentation_en-US" xlink:label="lab_wst_RatioOfDebtToEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio of debt to EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RatioOfDebtToEBITDA" xlink:href="wst-20191231.xsd#wst_RatioOfDebtToEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RatioOfDebtToEBITDA" xlink:to="lab_wst_RatioOfDebtToEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9b59243e-0504-45db-8d8a-9887a8c9196c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_NetSalesMember_30b3bc5d-60fa-4a08-bcc1-a9289de82fba_terseLabel_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales [Member]</link:label>
    <link:label id="lab_wst_NetSalesMember_label_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales [Member]</link:label>
    <link:label id="lab_wst_NetSalesMember_documentation_en-US" xlink:label="lab_wst_NetSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember" xlink:href="wst-20191231.xsd#wst_NetSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_NetSalesMember" xlink:to="lab_wst_NetSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_abae76b0-1a2e-42b2-a677-a2f982879c43_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_d3ead7f7-0046-4d5d-bdf7-b5478883a178_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_168fa4fa-ed21-41b7-ad4b-75fee43eb787_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c06ec859-d725-4cf7-9b77-e6c6d28af673_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_2d6ef627-9e88-4ef9-9ec7-2884ad5ae768_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_535d651a-47a3-4fe6-ae74-646fa7e81afa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IncentiveStockAwardsMember_bb7ad1ec-e88e-425e-96c4-195ed5db3d63_verboseLabel_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incentive Plan [Member]</link:label>
    <link:label id="lab_wst_IncentiveStockAwardsMember_92079a25-713d-4534-944b-a29db2e75e00_terseLabel_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Awards [Member]</link:label>
    <link:label id="lab_wst_IncentiveStockAwardsMember_label_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Awards [Member]</link:label>
    <link:label id="lab_wst_IncentiveStockAwardsMember_documentation_en-US" xlink:label="lab_wst_IncentiveStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Stock Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember" xlink:href="wst-20191231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IncentiveStockAwardsMember" xlink:to="lab_wst_IncentiveStockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_c5e7be48-7cfb-4b63-b158-4297783ea847_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_36099641-654b-453e-86ae-d5769b31fbea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Foreign Currency Contracts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_f6b9fcd9-6d95-4988-9475-c8032fdd127b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_e3cfb6e2-dcb4-4f3b-93fc-b855ad4256d0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Companies</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f0a75ded-59bc-469b-86db-a0b32b312d15_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted at target level</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_a09029b4-4907-4bb0-bd3e-ce79a32ad446_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_be3f11e2-45c0-4b7b-ae33-82f93af3ab99_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_395ef813-7874-4d10-90c5-254b3dd23492_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_8393cef9-d2f2-41e9-ac87-be09a3ef2dca_negatedTerseLabel_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_label_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges</link:label>
    <link:label id="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_documentation_en-US" xlink:label="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:to="lab_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_a2332056-bb57-4a51-9061-b61ec3efaf02_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_26e3ddde-212e-4e64-88db-21389e3cf023_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_33a8dbfe-13f8-4658-ad13-e1f629f60488_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Treasury Locks [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_793e6174-873d-46a9-ae38-a79eb98dac6a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a1509b33-fbc8-4ef0-86ed-b835904f3dbe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eab6fa17-2aaa-4788-87e6-f8739358634d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_559f67dc-a447-4abd-90a4-3cefd3d843ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1d285eee-5f7d-4266-9d1d-cb580fe172f6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_98535d42-6fc0-4613-a487-4bf06189da7b_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TermLoanDue2024Domain_66e2624f-a7dc-4d21-934c-640e3ab2a3bb_terseLabel_en-US" xlink:label="lab_wst_TermLoanDue2024Domain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024 [Domain]</link:label>
    <link:label id="lab_wst_TermLoanDue2024Domain_label_en-US" xlink:label="lab_wst_TermLoanDue2024Domain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024 [Domain]</link:label>
    <link:label id="lab_wst_TermLoanDue2024Domain_documentation_en-US" xlink:label="lab_wst_TermLoanDue2024Domain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Domain" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Domain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TermLoanDue2024Domain" xlink:to="lab_wst_TermLoanDue2024Domain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_699ab678-7177-4ae9-a8ab-f75ec3c44e3c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_a20f249a-aae0-4a76-a7fc-8bb0551fa50e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_1df8c7d7-8463-4aa9-865e-fdcd71ea07fd_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_73e6f740-8dd3-437a-90de-c41dd4cb9e9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sales and Net Property, Plant and Equipment, by Geographical Areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_e8422c4d-722c-4342-89d1-ae5ad6309fa8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_387e1cc1-3bc0-4070-abec-a4a9aa26c663_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f4b58632-df3c-41d8-baa6-c15563a0279a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_1a74050b-d60b-41a5-aeff-99f2c1f6f113_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated reduction in the liability for unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_779e32d6-64e4-4221-b088-4c13c273c784_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_7175c069-e6c8-44bb-bff7-371d79cb5f58_terseLabel_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-settled PSU awards [Member]</link:label>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_label_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-settled PSU awards [Member]</link:label>
    <link:label id="lab_wst_CashSettledPSUAwardsMember_documentation_en-US" xlink:label="lab_wst_CashSettledPSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-settled PSU awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember" xlink:href="wst-20191231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_CashSettledPSUAwardsMember" xlink:to="lab_wst_CashSettledPSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d88015c-33cc-4696-8dac-0ae28ba049e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AssetImpairmentChargesTrademark_030bce41-dd34-432f-8de3-b0d07e9c2506_terseLabel_en-US" xlink:label="lab_wst_AssetImpairmentChargesTrademark" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges, trademark</link:label>
    <link:label id="lab_wst_AssetImpairmentChargesTrademark_label_en-US" xlink:label="lab_wst_AssetImpairmentChargesTrademark" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Trademark</link:label>
    <link:label id="lab_wst_AssetImpairmentChargesTrademark_documentation_en-US" xlink:label="lab_wst_AssetImpairmentChargesTrademark" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of write-down of trademark recognized in the income statement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesTrademark" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesTrademark"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AssetImpairmentChargesTrademark" xlink:to="lab_wst_AssetImpairmentChargesTrademark" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0cb861d2-67d8-460f-822f-362bf277db3d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program, average cost per share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_d23d3343-0680-4604-bb05-115987cb6474_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b337e4cf-8cbb-45a3-9766-e5aa275cf73e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2017Member_32be3d36-5e4c-4328-8e87-d2b58f9ef68a_terseLabel_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due 2017 [Member]</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2017Member_label_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, due 2017 [Member]</link:label>
    <link:label id="lab_wst_RevolvingCreditFacilityDue2017Member_documentation_en-US" xlink:label="lab_wst_RevolvingCreditFacilityDue2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility due on second date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2017Member" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_RevolvingCreditFacilityDue2017Member" xlink:to="lab_wst_RevolvingCreditFacilityDue2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_6a2b4b2c-3d29-4ce3-a9b9-944b9f71449e_terseLabel_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents [Member]</link:label>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_label_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents [Member]</link:label>
    <link:label id="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_documentation_en-US" xlink:label="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-vesting Shares or Units Dividend Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:href="wst-20191231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:to="lab_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_a56dbc02-4b4f-4d47-92d1-54376cf4473c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Appreciation Rights Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0baeaaa8-53ea-4195-9bf9-4ac63c7e4638_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_1cde49f2-cdd3-4549-9854-31f976de0963_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa0c3fe6-ac9a-4dc1-bbbd-582f74e462d2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_f326a09e-1c0e-4292-a42f-3d37f9c109fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_d988048e-6f37-4d08-a4a2-0c5ec0ebd680_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5bc0bc70-2f6d-4355-bc74-7ca7d4ba21f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_3eb18ed5-9683-45d5-9a2a-8e6558596258_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_3add8c44-9b43-49ff-8ce3-6621269a3c33_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_dd85227e-4e57-42cb-a533-d2e367429d3d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_97bf5491-767c-49f9-b4f2-d894f94fdc84_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0b2b5348-9958-424f-adc7-a396629a07d1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_16f1f37a-4702-460f-b786-b933cd500a19_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_172d2255-0444-4950-afd6-cdf6d51d631c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_7da82a4e-8f63-4d0f-ba41-3d49e1ba143c_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_71b3d034-0159-4582-ae67-762dfd28053b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_a0992f39-5eff-4698-ab0f-86b0aff52c9b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5d5adbe9-cfe3-4f91-8d73-d98a42e22451_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_ed2dd9c6-869f-4311-b016-0f53862da943_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_59e31cbc-021e-4cbb-b32b-3ce1c6d80873_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_Year2019Member_eba93cb8-fd75-496d-9657-a8b345017c5f_terseLabel_en-US" xlink:label="lab_wst_Year2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2018 [Member]</link:label>
    <link:label id="lab_wst_Year2019Member_label_en-US" xlink:label="lab_wst_Year2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2019 [Member]</link:label>
    <link:label id="lab_wst_Year2019Member_documentation_en-US" xlink:label="lab_wst_Year2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2019Member" xlink:href="wst-20191231.xsd#wst_Year2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_Year2019Member" xlink:to="lab_wst_Year2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0f143a43-629a-4be4-815e-c2eade802944_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_50253e3b-2204-4532-b93e-6b79f7e4379e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed lease interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_09b60d2c-034b-4fe7-bdbe-fcc760944ee0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_ab2f5edc-8b70-4aeb-b280-2c10538fa91f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_bee12a5e-0ebc-4c3e-9055-4bf27118d60e_negatedTerseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments above/(below) target</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8eb4aea7-e739-47be-8274-da9ecd5d7b23_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_631f89c3-fcea-4452-9b82-137bd168f5c6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_713c6851-cc7e-4099-9381-0ce2e89c6928_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_154c98b3-c63d-4ab5-8b56-dcfd00479301_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_cb0dd370-a216-4b91-82eb-f2705443c448_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, December 31, 2018</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_eb22266a-3bac-423c-8713-446a5dcb675d_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, December 31, 2019</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_df4f029a-56fb-485b-bac2-304859373cea_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_77d4ecca-4e35-44c6-a4e8-c765f594d6aa_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_6d195f29-ed36-4aa6-90fb-60ec699745a3_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_796a5824-bf93-4892-9640-8eb47b67ddc5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_babad447-5dc8-4553-a9dc-fd3d40d8a823_verboseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of modified retrospective application of new accounting standard</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d6dc072-d219-4bb4-a90f-96f8ea1384c1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_da11ebb8-a2ee-4807-a5c2-79a4ae761743_terseLabel_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to affiliates</link:label>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_label_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to Equity Method Investees</link:label>
    <link:label id="lab_wst_SalesToEquityMethodInvestees_documentation_en-US" xlink:label="lab_wst_SalesToEquityMethodInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to Equity Method Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees" xlink:href="wst-20191231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SalesToEquityMethodInvestees" xlink:to="lab_wst_SalesToEquityMethodInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_9e9d222c-7f90-4543-8698-d91998f8ef1b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million in 2019 and 2018; shares outstanding: 74.1 million and 74.1 million in 2019 and 2018</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DeferredCompensationArrangementwithIndividualConversionUnit_c67cf8fb-8cfe-487d-a2ea-3ebbf34ed4b3_terseLabel_en-US" xlink:label="lab_wst_DeferredCompensationArrangementwithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation conversion unit</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementwithIndividualConversionUnit_label_en-US" xlink:label="lab_wst_DeferredCompensationArrangementwithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Conversion Unit</link:label>
    <link:label id="lab_wst_DeferredCompensationArrangementwithIndividualConversionUnit_documentation_en-US" xlink:label="lab_wst_DeferredCompensationArrangementwithIndividualConversionUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion unit of deferred stock units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementwithIndividualConversionUnit" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementwithIndividualConversionUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DeferredCompensationArrangementwithIndividualConversionUnit" xlink:to="lab_wst_DeferredCompensationArrangementwithIndividualConversionUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_f190f2b7-c241-4737-8d2a-aa19de4936ae_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_cf64b661-741c-4343-94c5-9bbdda07d703_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:to="lab_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a84ffc7f-8cdc-4889-abf4-bdb26235bf08_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_045ab6aa-45c3-4996-b6f3-8b1e9fc8300f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_09d7088d-b9c5-4f58-8338-114cab0f2136_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transitional Tax, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_38c27634-3d6e-42db-a5d0-de4961978bbb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2d4ea899-dc32-4048-9484-48af487930f1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investment in affiliated companies</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_1338d33d-0d48-42ec-9534-e9de0fe61d68_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and benefits [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_f3e73519-c3f8-45c1-a25b-85582c8d956a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cc48b006-9f9c-4ac0-a251-21cb02f70a2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_434704f1-1208-4f7f-bf32-2b53332e92c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_915e115c-8fae-4a62-a0b7-859f6d0eea3b_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c4ae8905-cc69-4e07-98fe-46b12f2e026e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5ed62bf3-4f95-4ff2-bf82-06c00399b434_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProprietaryProductsMember_8aeecdb7-3379-45fb-a690-5ae53524530a_terseLabel_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_label_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:label id="lab_wst_ProprietaryProductsMember_documentation_en-US" xlink:label="lab_wst_ProprietaryProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember" xlink:href="wst-20191231.xsd#wst_ProprietaryProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProprietaryProductsMember" xlink:to="lab_wst_ProprietaryProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_0287beb4-3ea1-42fa-b8ef-8fe950d5c2c3_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_6f5eef16-9bbf-4bb4-adb5-2bae13ad86b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_7505168a-166f-4659-9d86-902ed80978ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_256a3fee-aa02-45e7-b4be-3becbbfb323d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_4897233f-a246-4819-b239-3491d271e92a_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_90b035ed-76e1-4d67-a560-6b84d527c6af_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_ba5c3e65-838c-490e-a8ee-d0ceedc43a30_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income, as reported, for basic net income per share</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_016b00d3-328f-44f8-9422-46495a112034_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_c46d3f00-2ede-47b1-92ee-05589935e321_terseLabel_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_label_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_StockOptionAndAppreciationRightsMember_documentation_en-US" xlink:label="lab_wst_StockOptionAndAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember" xlink:href="wst-20191231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StockOptionAndAppreciationRightsMember" xlink:to="lab_wst_StockOptionAndAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_IWPharmaGroupLLCMember_313c2879-1cd6-43e7-8649-dcbf4598e77a_terseLabel_en-US" xlink:label="lab_wst_IWPharmaGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I&amp;W Pharma Group LLC</link:label>
    <link:label id="lab_wst_IWPharmaGroupLLCMember_label_en-US" xlink:label="lab_wst_IWPharmaGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I&amp;W Pharma Group LLC [Member]</link:label>
    <link:label id="lab_wst_IWPharmaGroupLLCMember_documentation_en-US" xlink:label="lab_wst_IWPharmaGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I&amp;W Pharma Group LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IWPharmaGroupLLCMember" xlink:href="wst-20191231.xsd#wst_IWPharmaGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_IWPharmaGroupLLCMember" xlink:to="lab_wst_IWPharmaGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_b96b2454-60ca-4615-b71a-8062d82468bc_terseLabel_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters, Contingencies and Legal Costs [Policy Text Block]</link:label>
    <link:label id="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters, Contingencies and Legal Costs [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:href="wst-20191231.xsd#wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:to="lab_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6de5163c-39cd-4765-a957-b4e357f30681_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_63a599cd-24e3-4a9e-a314-53aa2028fe6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fb1134ee-29e5-48b1-b793-78f484a77706_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b436764f-2978-4d90-91a1-4ad13e6f405c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a9b3494e-d744-4697-8bc4-a35f725b0428_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b5f84117-dded-418b-92b9-39b08774087b_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_4486e599-8def-4775-be7b-84c2255f41cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_8341037a-8edd-4ca4-9fac-f5853680a656_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a3d77304-c7a0-4553-b3b2-ac55536aa68b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_5e229440-47bc-4531-add6-2fb81c533847_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_35c1afbf-b0bc-4dd8-b987-ca918998971c_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed stock options exercised and awards vested, based on the treasury stock method (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_59d98183-0e95-4cbd-b065-119e2fed429e_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4e78c111-4b89-4ca0-a476-15d3c3fb7181_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_37e01125-5bb9-413a-b11b-902d35641b8e_terseLabel_en-US" xlink:label="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax charge, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_label_en-US" xlink:label="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense</link:label>
    <link:label id="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_documentation_en-US" xlink:label="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" xlink:href="wst-20191231.xsd#wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" xlink:to="lab_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_5ee9ebf0-abb4-44d5-b2a4-03dc58e08660_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_501a19e2-59aa-4702-bb11-57fa76716420_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1edcb20a-0261-403d-b1fa-1eeb57b31e23_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_465e74bc-d588-4299-95fb-08f539f90358_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_35a6abb5-086b-48eb-8c17-df7764b76ead_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Average Price Risk Option Strike Price</link:label>
    <link:label id="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_label_en-US" xlink:label="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Average Price Risk Option Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:to="lab_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_6805cd2c-a500-484d-9945-d729678925bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_09273771-e148-4482-8fea-a834889b77d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_f2163051-11dc-4d8a-806b-c9e0464b7487_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_eec1515e-f57c-48b5-80a0-b9c23cc9140a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_9d68063e-84a7-4609-b611-c77a203b65d2_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a3cd65c6-14a3-4507-ac99-ed375e1ee9bd_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4dd215b7-37f4-47b6-8560-0d256d6e8f63_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod_651ea588-84e0-4b2b-9c3f-3d8b625f5377_terseLabel_en-US" xlink:label="lab_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, payable period</link:label>
    <link:label id="lab_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod_label_en-US" xlink:label="lab_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangements, Range of Outcomes, Payable Period</link:label>
    <link:label id="lab_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod_documentation_en-US" xlink:label="lab_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangements, Range of Outcomes, Payable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" xlink:href="wst-20191231.xsd#wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" xlink:to="lab_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_ef3d41d5-8c82-4c56-ac20-e07b5755501d_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a7f04245-36f3-40c0-b339-1df3838b1154_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_aede3dd3-f38d-4329-bd56-60c654012f40_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_fd986dff-6be2-4887-883d-06b50d2a0599_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eddd9196-b2bf-4e8d-ace5-ff12a3015c3a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_b14964f2-f0e9-4687-82a0-c3e9fecbf10f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure</link:label>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_bce1e714-9667-48b0-9f51-16deb966f28a_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared, not paid</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_55e5246a-ed40-4d0b-b3fe-df3d3419a59e_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9922b29c-31ce-419f-bed3-89ff6b9a5e68_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_84d893de-ca62-4e55-9228-b0e8d7214abf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax_b3aca191-9cd9-4d4f-83a8-061fa6212c2d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Transition Tax, Tax Cuts and Jobs Act of 2017</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_918834ab-0eb5-4aac-9020-172bf244579e_terseLabel_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:href="wst-20191231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:to="lab_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1588456d-3083-4788-ba80-ecf8ee31fa1c_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c22d1dd4-8df2-4834-9a63-9a2f1f114a6f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_7201192b-1b9e-4938-b807-5fbcbd643ce1_terseLabel_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessee, lease Cash Flow and Supplemental information</link:label>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_label_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessee, lease Cash Flow and Supplemental information [Table Text Block]</link:label>
    <link:label id="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_documentation_en-US" xlink:label="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessee, lease Cash Flow and Supplemental information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:href="wst-20191231.xsd#wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:to="lab_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cec1f95c-308d-4d46-8b98-313114b9247d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal corporate tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_ae231701-4010-4103-ba8a-6139187e7652_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount due and payable to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_e08519c2-70b5-49e8-b509-9c16c32f66c9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_3b8ed0e3-6206-4180-86ea-d80bf1dfe916_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_label_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:to="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5eb46984-f61c-42de-a3cc-34852b0ae82b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b1140558-bfc3-41c3-9868-856742df1bb5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares assuming dilution (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_a4e6577c-fa5b-48a8-8215-79726d76e9ad_verboseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares to be issued upon conversion</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_6f7ccd68-63fa-439a-9d71-70de6547aaea_terseLabel_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate healthcare cost trend rate, net periodic benefit cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_label_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</link:label>
    <link:label id="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_documentation_en-US" xlink:label="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:to="lab_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c1c1f429-8992-418f-9dbf-447a4ac9bd7f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_af2b1317-de5e-4e47-8c4a-b58ebb306040_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:label id="lab_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_1f35a188-d704-4ca1-b067-1ae6661a8abc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_62b8b1f6-732a-453c-a9b4-c939dae978ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2d4e890c-8131-4a5f-bf28-bb87e642aede_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated depreciation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ab467020-4e78-4233-8a63-591681578927_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_eac96415-96e2-4df1-8449-7bfb72792b8d_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_46ef0d32-f7cc-4462-adbb-892a715dd78a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_238b85fd-eab8-4ec6-911f-669786a980bc_terseLabel_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments above/(below) target</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:to="lab_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2404ba8a-2481-4432-b903-1ca3257f1c50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested PSU Awards [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_097700d0-0615-4e77-b7c1-1b3741da0d1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_4b8a267f-b22b-4e27-a1d3-885241c332b9_terseLabel_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_label_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:label id="lab_wst_SeniorCNotesDue2027Member_documentation_en-US" xlink:label="lab_wst_SeniorCNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior C Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member" xlink:href="wst-20191231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorCNotesDue2027Member" xlink:to="lab_wst_SeniorCNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_17bf1cbb-4f3e-4ccb-99e9-1b9707a02f5b_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_020a755d-2246-43a4-8ab8-08c90719a884_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial net loss that will be amortized from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_OtherCountriesMember_6afe5734-a49a-4694-ae09-280810f5a49c_terseLabel_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_wst_OtherCountriesMember_label_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_wst_OtherCountriesMember_documentation_en-US" xlink:label="lab_wst_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-European Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember" xlink:href="wst-20191231.xsd#wst_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_OtherCountriesMember" xlink:to="lab_wst_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_65b5f6bd-6b77-4895-a075-9e1ae156af46_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d4e0d33e-5831-46df-bad7-bba41f09a2c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_fab64731-e109-4824-95cc-692a39203d74_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_0c42c918-4879-478d-86ba-9866aafa1268_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1f67bc1b-62a4-4cd1-8d8a-626d1c5cb0b3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_c3b29696-2974-4b2d-8156-0a5c63f6cbf4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6f4c8a70-b20f-426b-b843-fb0d5097f962_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_bc28aff7-be92-4e47-8f4a-4ff7aeefcf34_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b8a5e0c9-9e58-497e-8dd1-104ba39bc02f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_cce846df-6f2b-41c6-b7a2-d53d396f6fa9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2125ebcd-3d63-4c55-a56d-2f1520a46475_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_1cc53cf6-1e05-44d8-b8fd-bbf1ad742a6d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_79029dda-3028-4b94-9ec0-6759474d8278_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_acb13c75-13da-46dc-80b0-73947eb66227_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortMember_31d9fe68-5150-4338-aeb0-051e8c028d28_terseLabel_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:label id="lab_us-gaap_ShortMember_label_en-US" xlink:label="lab_us-gaap_ShortMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortMember" xlink:to="lab_us-gaap_ShortMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_d95b4fec-3434-48de-8521-93fd6f6be41d_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_4e776ccb-eaee-4e4f-af50-5b73bc13230e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_a2d63267-df14-415e-abc4-a724a9612760_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in net periodic benefit cost:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_87fbf660-6ad1-4e00-a8bb-f54224225424_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_29a4e806-8007-430a-aa44-f0d0afba9223_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_535ece23-9d27-4d5d-a8a2-9484784d5cb6_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_bbfc9391-9904-4622-a62f-ba2a277d665b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_a702e55a-8c1f-4903-bdf2-9918dfe44373_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of transition obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Transition Asset (Obligation)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_362e8afb-dacc-4720-a8a7-9405c55c30be_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_954d807b-6f3c-4e67-a88c-619da2077c9c_terseLabel_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_label_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:label id="lab_wst_SeniorBNotesDue2024Member_documentation_en-US" xlink:label="lab_wst_SeniorBNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior B Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member" xlink:href="wst-20191231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_SeniorBNotesDue2024Member" xlink:to="lab_wst_SeniorBNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_790bd69f-edb5-43c6-adc2-9babc3d7eb53_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e40d7b7d-fd73-4be8-a14f-233d25bb3088_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_StandardPackagingMember_8a5533ab-539d-4d31-8167-76be5f7c14a4_terseLabel_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:label id="lab_wst_StandardPackagingMember_label_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:label id="lab_wst_StandardPackagingMember_documentation_en-US" xlink:label="lab_wst_StandardPackagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Packaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember" xlink:href="wst-20191231.xsd#wst_StandardPackagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_StandardPackagingMember" xlink:to="lab_wst_StandardPackagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_25f66c4a-2e8b-477a-ae27-5400b89937f1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_9a5f07ce-ed8f-41f8-ac73-0cdd4ba4bef5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service credit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c725db6a-3b95-4936-b8e6-b40cf06dbf2c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_1156c573-3f1c-4a63-b34e-85eef437e570_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_a54c1987-9faf-4508-bb99-f98b71ce8bef_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_467c5342-de21-48a1-95cf-87a7d7faa017_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_eedfab74-7b39-4713-8d68-1535ecc52a96_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10d1a655-195a-4b0c-8f67-4368b9cf6513_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_f4788957-4fc8-4c23-9937-c5775a5860c4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4a503980-a0ca-4d09-a999-968bbcb891d1_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_baddfe7c-dc6c-4bca-9afa-636bd9c114d7_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_89c5961b-d7e5-43e1-b425-63a8f4169afd_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_7fa5be57-333c-4ed7-a2db-5914a98d69a9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_444f6cac-e947-4902-a633-d2eb7ff83a0e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_c763fda3-e8d4-47c2-8f55-48fa8fc32673_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_cb3640b3-9ffa-4abf-bfc3-59a569493b68_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain (Loss) Recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2ee13b00-0926-463a-b9e8-e94e19d6e891_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3cfca628-cee0-429c-82f9-4283332c2555_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_bfd604cd-0c7a-40cb-ab52-53befb500f3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1aba1fbe-34d0-460c-a83b-90cc280fd2f0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_EuroDenominatedRevolverMember_15fb4f8a-3ce5-479a-91b4-df82973ac91f_terseLabel_en-US" xlink:label="lab_wst_EuroDenominatedRevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-Denominated Revolver [Member]</link:label>
    <link:label id="lab_wst_EuroDenominatedRevolverMember_label_en-US" xlink:label="lab_wst_EuroDenominatedRevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-Denominated Revolver [Member]</link:label>
    <link:label id="lab_wst_EuroDenominatedRevolverMember_documentation_en-US" xlink:label="lab_wst_EuroDenominatedRevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-Denominated Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EuroDenominatedRevolverMember" xlink:href="wst-20191231.xsd#wst_EuroDenominatedRevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_EuroDenominatedRevolverMember" xlink:to="lab_wst_EuroDenominatedRevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_49022d20-5961-4d6d-b988-c35b9049481f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_5487922d-ba37-401d-83db-d652fd5ee62f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued commissions, rebates and royalties</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3b304b2a-0a93-4b79-9c6b-69281c97feec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_154de6d2-fd0c-42b5-8ff8-10f20d2ae7ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_96243ca9-6131-400b-98af-f0d04a15121a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_6bf78661-c67f-4ef7-8e29-5d1af096b42a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_ea348deb-b849-4e74-bb87-8661b0a67239_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f45eafd4-830f-47f3-905c-fb9a3fe9ebbc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_c1545499-e7ee-4d44-8b1e-e1608fc40c68_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_d26c5467-f926-484f-b1f9-db9042ea9959_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net sales</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_b3f0d617-41b8-4503-956a-d9f652eaffb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_f1a714ab-4f49-4837-b50b-838e2f924a64_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased under share repurchase program</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_d5cfae0b-adba-4dd6-afb8-6b428fc9c150_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_995851fc-a26f-4e2d-87e7-2ee6fdd3167a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_870f9e0c-bee7-483f-8161-9deb6401bf6a_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at January 1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_b2011a97-fcca-494b-8a47-c91fb7bb5979_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3b0a22bc-81a7-49f5-b8d2-2bb4b8091d3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_900989b7-9bc3-4de1-8e44-209b8bd88d15_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_506471e8-7258-4f7a-be7f-be3d13f930ab_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_95682176-6fcf-414a-a3e6-797035ac139e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_b2ab6100-73b8-4dec-abea-455295dba096_terseLabel_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo Seiko, Ltd. [Member]</link:label>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_label_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo Seiko, Ltd. (Daikyo) [Member]</link:label>
    <link:label id="lab_wst_DaikyoSeikoLtdDaikyoMember_documentation_en-US" xlink:label="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Daikyo Seiko, Ltd. (Daikyo) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember" xlink:href="wst-20191231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DaikyoSeikoLtdDaikyoMember" xlink:to="lab_wst_DaikyoSeikoLtdDaikyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2a56eafe-b8f8-4e68-8b21-bdec29d02241_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e1d19499-da4c-4beb-ae7d-81185d747f2b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0e61e233-0a32-420b-af3c-e3f08a1985ff_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a9c726c3-01cd-44dc-99c4-b8e4bf1341e0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, recognized inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_cd07b1fe-1b61-4a4b-b0b7-8421c2f51d61_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_098b0477-6a01-4154-b821-510a53e936b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plans [Member]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation, Share-based Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_edeed427-16f7-4555-98db-ce3893f7efa0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_932322ba-4d91-475d-9b0a-0cc2f841ed29_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_84eabc79-906b-40a3-9e15-8d1d5abc7aba_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, excluding current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_a3287896-5864-410e-b3a3-7838074a80f6_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_b1562a1f-af2c-430d-8de6-fc44ca7cef61_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e48e3442-5069-4dd3-8a12-033d39ec0ea7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9d7c4d82-7c1c-4d69-a323-e594ee734888_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_f56f68ae-f1ff-4e60-851b-c7d9d9ca5df4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ProvisionForProductReturns_3d405a2b-58ec-4229-b025-daebdb1648ae_terseLabel_en-US" xlink:label="lab_wst_ProvisionForProductReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for product returns</link:label>
    <link:label id="lab_wst_ProvisionForProductReturns_label_en-US" xlink:label="lab_wst_ProvisionForProductReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Product Returns</link:label>
    <link:label id="lab_wst_ProvisionForProductReturns_documentation_en-US" xlink:label="lab_wst_ProvisionForProductReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Product Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProvisionForProductReturns" xlink:href="wst-20191231.xsd#wst_ProvisionForProductReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ProvisionForProductReturns" xlink:to="lab_wst_ProvisionForProductReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_9c56dd0c-ed1a-4b4f-980b-06272cf1f436_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_YearAfter2019Member_df5f9dc8-9f26-4fb6-a1bf-0df8ed735077_terseLabel_en-US" xlink:label="lab_wst_YearAfter2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2018 [Member]</link:label>
    <link:label id="lab_wst_YearAfter2019Member_label_en-US" xlink:label="lab_wst_YearAfter2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2019 [Member]</link:label>
    <link:label id="lab_wst_YearAfter2019Member_documentation_en-US" xlink:label="lab_wst_YearAfter2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year After 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2019Member" xlink:href="wst-20191231.xsd#wst_YearAfter2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_YearAfter2019Member" xlink:to="lab_wst_YearAfter2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_e1699f9a-b926-4301-8f0a-161bcd7c76e9_terseLabel_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments received in advance</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_label_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) due to Additional Cash Payments</link:label>
    <link:label id="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_documentation_en-US" xlink:label="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) due to Additional Cash Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:href="wst-20191231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:to="lab_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_d8ea10ba-9097-450d-9053-6c7c817d19e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost arising during period, net of tax of $0</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_30d2d325-0322-4f9d-a5f5-cc3f69f0f1f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining term of shares issued at conversion</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_7b36b92d-73ef-4ddf-8e4c-964b95ca1edc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_f6865a09-6095-4d44-9e5f-fca7f9f9ca8a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_af4a758c-b3f1-4a5a-87bd-d7738bee1503_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_9f88c8b7-c4f9-414a-8277-8036996f3ee6_terseLabel_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status</link:label>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]</link:label>
    <link:label id="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_documentation_en-US" xlink:label="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:href="wst-20191231.xsd#wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:to="lab_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_72244997-00e8-47ad-9555-05fd09a9fe0c_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding amount</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_d0383fc8-9e68-41d7-a20e-b07a9100a84e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit supporting the reimbursement of workers' compensation and other claims</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>wst-20191231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b5520f3c-bdfb-4aa1-98ba-ba1f6a92b1c8,g:f267b37f-edf1-4d21-84ed-4e7cdfb1cf2c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="wst-20191231.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:href="wst-20191231.xsd#wst_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6b4c1f16-fdcb-4dba-8d26-b87686732d71" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_DocumentType_6b4c1f16-fdcb-4dba-8d26-b87686732d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_b8f5c1a7-2408-48be-b09f-18474b0b9852" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_DocumentAnnualReport_b8f5c1a7-2408-48be-b09f-18474b0b9852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4b15d3f9-324a-46b8-90a9-0ab986fd0449" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_DocumentPeriodEndDate_4b15d3f9-324a-46b8-90a9-0ab986fd0449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f87c513b-eebd-4a01-bf2d-777f4b2b6b74" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_DocumentTransitionReport_f87c513b-eebd-4a01-bf2d-777f4b2b6b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d679b2dc-acc8-4a6c-81bb-b55bb98dd04e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityFileNumber_d679b2dc-acc8-4a6c-81bb-b55bb98dd04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a6395641-ae73-4350-9ed8-6094ef97580c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityRegistrantName_a6395641-ae73-4350-9ed8-6094ef97580c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_98e74f1a-742d-4486-bbc5-8a6b8632aee7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_98e74f1a-742d-4486-bbc5-8a6b8632aee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_850d263b-453e-4f54-9551-54cfa4e9dde0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityTaxIdentificationNumber_850d263b-453e-4f54-9551-54cfa4e9dde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9a3f68d6-baac-4892-ab45-8d7f2e3fd00f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityAddressAddressLine1_9a3f68d6-baac-4892-ab45-8d7f2e3fd00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d2f7a6e4-4cfe-446c-8d3c-4c7771d479e1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityAddressCityOrTown_d2f7a6e4-4cfe-446c-8d3c-4c7771d479e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_03894692-0a2e-46e8-a7c0-9b71a3e47509" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityAddressStateOrProvince_03894692-0a2e-46e8-a7c0-9b71a3e47509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2cd132cf-0009-48da-ae51-34a2268629f7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityAddressPostalZipCode_2cd132cf-0009-48da-ae51-34a2268629f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5e78788d-21b7-4391-ac21-a0085d5f62aa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_CityAreaCode_5e78788d-21b7-4391-ac21-a0085d5f62aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b8a6f0f4-2227-4f1c-88dc-6d750860766f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_LocalPhoneNumber_b8a6f0f4-2227-4f1c-88dc-6d750860766f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ea4cde27-f675-4784-9c68-0f6f81c3507f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_Security12bTitle_ea4cde27-f675-4784-9c68-0f6f81c3507f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_041dbbee-31c4-473b-a3f2-9e4bbd42572f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_TradingSymbol_041dbbee-31c4-473b-a3f2-9e4bbd42572f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1cfb558a-e5e6-4db7-be81-829f1071441d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_SecurityExchangeName_1cfb558a-e5e6-4db7-be81-829f1071441d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_ae85530f-7bfb-4841-ac5b-4e2e501cf49a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_ae85530f-7bfb-4841-ac5b-4e2e501cf49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_19c7c26d-c7ef-46e0-92a9-f84ce068f8ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityVoluntaryFilers_19c7c26d-c7ef-46e0-92a9-f84ce068f8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ee2fde1b-6215-4bf3-81fb-437eafcce9c0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityCurrentReportingStatus_ee2fde1b-6215-4bf3-81fb-437eafcce9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c80eaaf0-82d0-4ba1-ab7a-84d9dcb7cc39" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityInteractiveDataCurrent_c80eaaf0-82d0-4ba1-ab7a-84d9dcb7cc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6dfac170-5ff2-4f89-bed2-c670af56f674" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityFilerCategory_6dfac170-5ff2-4f89-bed2-c670af56f674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4ccf7ad4-a058-4321-8ece-bfdbfedd0c49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntitySmallBusiness_4ccf7ad4-a058-4321-8ece-bfdbfedd0c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8e9dc768-f73b-4ba0-9d3b-f0dc19732499" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityEmergingGrowthCompany_8e9dc768-f73b-4ba0-9d3b-f0dc19732499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1e90355f-51e2-401b-bdac-baa637846a47" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityShellCompany_1e90355f-51e2-401b-bdac-baa637846a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_3c43e525-403d-4c31-8238-7f6681c13b4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityPublicFloat_3c43e525-403d-4c31-8238-7f6681c13b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_aaad37c1-3b4c-455f-8d5e-f95958dbdfbe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_aaad37c1-3b4c-455f-8d5e-f95958dbdfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_09d559fe-72a7-4622-bf13-4abfc95b2e2c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_AmendmentFlag_09d559fe-72a7-4622-bf13-4abfc95b2e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_88db1696-a73c-429d-a06a-269772197335" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_CurrentFiscalYearEndDate_88db1696-a73c-429d-a06a-269772197335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_70770aa5-222c-46dc-88ef-5dc9e9ae66ce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_70770aa5-222c-46dc-88ef-5dc9e9ae66ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4f841dbf-fb2a-434c-88e1-f8a728135e6a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_DocumentFiscalYearFocus_4f841dbf-fb2a-434c-88e1-f8a728135e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_56891fce-17d1-4d34-a90f-977998d64d30" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6f44aec7-f436-4c74-b618-e82c61ddcbaf" xlink:to="loc_dei_EntityCentralIndexKey_56891fce-17d1-4d34-a90f-977998d64d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_75bd88cc-5e93-4fcf-a9b6-05b756f8662d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_df946562-0b20-4715-8969-d5d479cdc073" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_75bd88cc-5e93-4fcf-a9b6-05b756f8662d" xlink:to="loc_us-gaap_StatementTable_df946562-0b20-4715-8969-d5d479cdc073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_89a658c5-f054-4f5f-9b76-85fae048fe7a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_df946562-0b20-4715-8969-d5d479cdc073" xlink:to="loc_srt_StatementScenarioAxis_89a658c5-f054-4f5f-9b76-85fae048fe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_434c36f9-9d02-49a4-8b53-4476480ad9f0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_89a658c5-f054-4f5f-9b76-85fae048fe7a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_434c36f9-9d02-49a4-8b53-4476480ad9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_df946562-0b20-4715-8969-d5d479cdc073" xlink:to="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ff60c8f2-c870-47b6-95aa-cbeebadc9c45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_Revenues_ff60c8f2-c870-47b6-95aa-cbeebadc9c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_76d0b9a0-c967-4ab9-8f15-7778eb27cba9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_76d0b9a0-c967-4ab9-8f15-7778eb27cba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d93fbfee-555e-4899-ab8c-e623be97b1f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_GrossProfit_d93fbfee-555e-4899-ab8c-e623be97b1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c6b1dade-af74-4757-83ee-3e0c84fd998b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c6b1dade-af74-4757-83ee-3e0c84fd998b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_78c8562b-2389-4878-ab9d-56ce814d0b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_78c8562b-2389-4878-ab9d-56ce814d0b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_e77d573f-8667-4754-a186-9fcd4f826e94" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_wst_OtherIncomeExpense_e77d573f-8667-4754-a186-9fcd4f826e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5641dc9e-b620-4bcd-9dbe-ff0d105ae870" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_OperatingIncomeLoss_5641dc9e-b620-4bcd-9dbe-ff0d105ae870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f2cec27e-002e-4440-8002-d1ac629fc515" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_InterestExpense_f2cec27e-002e-4440-8002-d1ac629fc515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_b32bcf84-0e76-4cb3-b58e-a75d7dc2f3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_InvestmentIncomeNet_b32bcf84-0e76-4cb3-b58e-a75d7dc2f3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f49ca98f-73de-4bdd-8685-5f6a2a4ee5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f49ca98f-73de-4bdd-8685-5f6a2a4ee5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_af087ce5-1743-4591-96a3-7dd9f3b2d24e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_af087ce5-1743-4591-96a3-7dd9f3b2d24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_85276aa3-53c1-46d6-a928-a831830f08fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_85276aa3-53c1-46d6-a928-a831830f08fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f15334cb-623e-404b-8a0f-080dd1c2cc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f15334cb-623e-404b-8a0f-080dd1c2cc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fab8f082-51fd-45eb-aca0-b8caf4bdeba0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_ProfitLoss_fab8f082-51fd-45eb-aca0-b8caf4bdeba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1a59107f-b61a-4158-90ba-2d7a669f0c67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:to="loc_us-gaap_EarningsPerShareBasic_1a59107f-b61a-4158-90ba-2d7a669f0c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7092a72b-dd6a-4fb7-8671-27ad4b9e5716" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ca4156b8-279b-47ed-9074-0a7e2df0b501" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7092a72b-dd6a-4fb7-8671-27ad4b9e5716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:href="wst-20191231.xsd#wst_WeightedAverageSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d4172f6a-efcc-4904-bf96-eb4e5a39fba6" xlink:to="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d61c9970-f76c-4a2b-943c-2d25ca92fbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d61c9970-f76c-4a2b-943c-2d25ca92fbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_953ffde8-f4b8-437a-8082-128c4d873437" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_WeightedAverageSharesOutstandingAbstract_c23a5f07-63eb-41af-94bd-a84eb432618c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_953ffde8-f4b8-437a-8082-128c4d873437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e740e591-e245-4da2-9f4f-b30cc6ec5228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8a123486-3014-4cf2-8614-78eba64b3236" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e740e591-e245-4da2-9f4f-b30cc6ec5228" xlink:to="loc_us-gaap_ProfitLoss_8a123486-3014-4cf2-8614-78eba64b3236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e740e591-e245-4da2-9f4f-b30cc6ec5228" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_53df15f8-92d3-4fb6-8238-9e06b2b05c74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_53df15f8-92d3-4fb6-8238-9e06b2b05c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_2947cc33-6cb8-46d8-80be-638886ac10ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_2947cc33-6cb8-46d8-80be-638886ac10ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_86adbebb-9aeb-41a8-9332-77ac4a75ea7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_86adbebb-9aeb-41a8-9332-77ac4a75ea7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax_11d25c76-5bc4-4794-a454-d73b05a73b61" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax_11d25c76-5bc4-4794-a454-d73b05a73b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_a9d336b3-d305-4427-b151-d6c7b8878e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_a9d336b3-d305-4427-b151-d6c7b8878e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_a3d195ca-15c2-4686-813f-0d49604288e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_a3d195ca-15c2-4686-813f-0d49604288e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_07a12d6c-6969-4812-b52c-a93b9cf2aff7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_07a12d6c-6969-4812-b52c-a93b9cf2aff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e056fa07-8bb5-4374-bdff-eb875cc9261b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e056fa07-8bb5-4374-bdff-eb875cc9261b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_95c24050-7e1f-4d26-a2ac-8405c906a6e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_95c24050-7e1f-4d26-a2ac-8405c906a6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f819383-d8c1-41c1-b5f0-a5ab0a51b50a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d30418c2-94c1-4657-8f33-c38381a456e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f819383-d8c1-41c1-b5f0-a5ab0a51b50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6abdd7d5-8e7d-4b97-8d7f-53960cf64d6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e740e591-e245-4da2-9f4f-b30cc6ec5228" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6abdd7d5-8e7d-4b97-8d7f-53960cf64d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_2a2fd11b-8a89-4dea-ba69-bc9cb41e934f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_2a2fd11b-8a89-4dea-ba69-bc9cb41e934f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_5e1b18e8-8d09-4914-93f4-b7b67864d968" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_5e1b18e8-8d09-4914-93f4-b7b67864d968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_4720adff-2c55-4f7e-b33c-efd176a88ec5" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax_4720adff-2c55-4f7e-b33c-efd176a88ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_d441f824-b569-4cf8-af96-0e70a6d36d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_d441f824-b569-4cf8-af96-0e70a6d36d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_ec06ad38-a779-4f9e-88b6-7660d2e9e5d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_ec06ad38-a779-4f9e-88b6-7660d2e9e5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_fad4cd7f-7ad6-4330-bc49-d153896bdef4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_fad4cd7f-7ad6-4330-bc49-d153896bdef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_fe724653-357f-4908-869d-c4daa3b4fd23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fa3bc1d6-e370-4099-914f-d0585bf983a7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_fe724653-357f-4908-869d-c4daa3b4fd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_111e99f7-96e4-49d8-b417-57e75b16399b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_111e99f7-96e4-49d8-b417-57e75b16399b" xlink:to="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1af52b33-126a-45fd-a528-5e52325cdef6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1af52b33-126a-45fd-a528-5e52325cdef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_960a56e1-4515-4ad1-b860-0a214615dd80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1af52b33-126a-45fd-a528-5e52325cdef6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_960a56e1-4515-4ad1-b860-0a214615dd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2609927c-2da6-497d-830b-ccd376eb8689" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1af52b33-126a-45fd-a528-5e52325cdef6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2609927c-2da6-497d-830b-ccd376eb8689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5e4f2c28-92a8-487a-9e34-7e6cb46147bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1af52b33-126a-45fd-a528-5e52325cdef6" xlink:to="loc_us-gaap_InventoryNet_5e4f2c28-92a8-487a-9e34-7e6cb46147bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_57c6e3bd-a0db-45fd-93be-6a3ad2ea8d47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1af52b33-126a-45fd-a528-5e52325cdef6" xlink:to="loc_us-gaap_OtherAssetsCurrent_57c6e3bd-a0db-45fd-93be-6a3ad2ea8d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_44136d49-006e-434d-ae8e-9bf925b9d84d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1af52b33-126a-45fd-a528-5e52325cdef6" xlink:to="loc_us-gaap_AssetsCurrent_44136d49-006e-434d-ae8e-9bf925b9d84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_65c8808e-1d33-432b-8d9c-15ce89e3bbce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_65c8808e-1d33-432b-8d9c-15ce89e3bbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ea3f55d8-3d21-4196-8ae6-27235f179c62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ea3f55d8-3d21-4196-8ae6-27235f179c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2c23280a-c918-412b-b76e-56b677ad6798" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2c23280a-c918-412b-b76e-56b677ad6798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_26fc59c4-fada-4a0b-89ca-22a3f698dfe1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_26fc59c4-fada-4a0b-89ca-22a3f698dfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_572ead77-256a-41e8-936a-d7dfee9adc1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_572ead77-256a-41e8-936a-d7dfee9adc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0b5ed95-2c91-4a1a-a66d-e622a15c1103" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_Goodwill_c0b5ed95-2c91-4a1a-a66d-e622a15c1103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetNoncurrent_12c618aa-a8be-4f81-bccd-1d7b2f22a52f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_DeferredTaxAssetsNetNoncurrent_12c618aa-a8be-4f81-bccd-1d7b2f22a52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c506370-43ea-4965-8fc4-664b23967e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c506370-43ea-4965-8fc4-664b23967e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f7046579-ecd9-48a5-a063-719ceed5576f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f7046579-ecd9-48a5-a063-719ceed5576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6cfbc18d-b88b-41eb-b85d-33f325e6fd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6cfbc18d-b88b-41eb-b85d-33f325e6fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_95bc0b7b-53f8-4fa1-bb45-556eade4130c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9ac972a2-e522-4c4f-8c8d-b0727427c9cb" xlink:to="loc_us-gaap_Assets_95bc0b7b-53f8-4fa1-bb45-556eade4130c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_111e99f7-96e4-49d8-b417-57e75b16399b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotesPayableAndOtherDebtCurrent_f2ac1350-8e19-4459-a3fa-0f2b2cfe8e33" xlink:href="wst-20191231.xsd#wst_NotesPayableAndOtherDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_wst_NotesPayableAndOtherDebtCurrent_f2ac1350-8e19-4459-a3fa-0f2b2cfe8e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_efb8e836-7175-4847-a97c-439bf64670bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_us-gaap_AccountsPayableCurrent_efb8e836-7175-4847-a97c-439bf64670bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_be11d454-4175-4d4b-8aa1-a1ffeb0f99ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_be11d454-4175-4d4b-8aa1-a1ffeb0f99ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_3ae8f55e-ef7c-4498-adf9-66e5b182ee71" xlink:href="wst-20191231.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_3ae8f55e-ef7c-4498-adf9-66e5b182ee71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_6f687f88-d31d-4295-a13c-dc8275099b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_6f687f88-d31d-4295-a13c-dc8275099b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_509ca34c-5d67-4c99-becd-ba1a0b8e5e35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_509ca34c-5d67-4c99-becd-ba1a0b8e5e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_79812eb9-bbfc-4cc7-9cca-7ac08c4b289f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_79812eb9-bbfc-4cc7-9cca-7ac08c4b289f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_aa51a27f-d37d-4dc0-b0e7-da1f680d0f97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3e4fd913-3eb2-437a-a1c1-5ba0693c4fe5" xlink:to="loc_us-gaap_LiabilitiesCurrent_aa51a27f-d37d-4dc0-b0e7-da1f680d0f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6f5ee3ad-e1d1-4b9b-8c7f-3f83c01d615d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6f5ee3ad-e1d1-4b9b-8c7f-3f83c01d615d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_0607aab3-d079-49cf-87e6-9d36a99fa94c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_0607aab3-d079-49cf-87e6-9d36a99fa94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_eb2b2d96-1a09-47ae-8658-ed8bbbb02903" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_eb2b2d96-1a09-47ae-8658-ed8bbbb02903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b415c173-7382-4bff-b351-5f328f55d815" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b415c173-7382-4bff-b351-5f328f55d815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3d63dcaf-95db-4c4e-b95c-14eeeaed1af7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3d63dcaf-95db-4c4e-b95c-14eeeaed1af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c1fc4176-2f23-4a59-b6d5-082d3486cdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_Liabilities_c1fc4176-2f23-4a59-b6d5-082d3486cdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_58f05fec-189d-4017-bd60-fba5d805ec4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_58f05fec-189d-4017-bd60-fba5d805ec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5f5013a8-f279-4929-ac26-a11acfbf89dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:to="loc_us-gaap_PreferredStockValue_5f5013a8-f279-4929-ac26-a11acfbf89dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5f47b15f-b4d9-4852-aab3-ac238bf2f24b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:to="loc_us-gaap_CommonStockValue_5f47b15f-b4d9-4852-aab3-ac238bf2f24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_d8d6496a-3a6e-4309-a897-59bb5a5460ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:to="loc_us-gaap_AdditionalPaidInCapital_d8d6496a-3a6e-4309-a897-59bb5a5460ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27672a09-7bd3-420b-ab57-d43e042cda93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27672a09-7bd3-420b-ab57-d43e042cda93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d7c21ba1-910f-456a-bb77-c088249ede56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d7c21ba1-910f-456a-bb77-c088249ede56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_4482f4fa-669b-4b4c-8273-c8c98f73745f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:to="loc_us-gaap_TreasuryStockValue_4482f4fa-669b-4b4c-8273-c8c98f73745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_52d521c7-2a93-48a6-b911-97b9ea8a0870" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb42ef06-fefb-468c-9ce9-2c723a442167" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_52d521c7-2a93-48a6-b911-97b9ea8a0870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_80b9002f-22f6-40a3-b0b8-8556566900ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b31a5e5a-7c30-4d1d-97ac-44a0b5cde65b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_80b9002f-22f6-40a3-b0b8-8556566900ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_756be982-9764-486a-ba8b-bbe7f3472347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_756be982-9764-486a-ba8b-bbe7f3472347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_e7e0084a-ee52-48c9-b583-a1add1bfc341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_PreferredStockSharesIssued_e7e0084a-ee52-48c9-b583-a1add1bfc341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c8522e3f-faf3-4101-a98a-63b33c387d83" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c8522e3f-faf3-4101-a98a-63b33c387d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_951a89fb-27a6-42a8-bea0-bd12c8b0b404" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_951a89fb-27a6-42a8-bea0-bd12c8b0b404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e024a4a0-68cd-4175-ba47-36c1707a0961" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e024a4a0-68cd-4175-ba47-36c1707a0961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_94fb2927-e09e-47a0-a3e2-e5fc875b8ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_CommonStockSharesIssued_94fb2927-e09e-47a0-a3e2-e5fc875b8ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_076a88c3-9b86-417e-aa4e-9e2af7d91359" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_076a88c3-9b86-417e-aa4e-9e2af7d91359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_f7f849a9-4630-49a2-91fe-7273f949d2ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3540afb7-2cb8-42eb-8e9b-c92e3ad8c2fc" xlink:to="loc_us-gaap_TreasuryStockShares_f7f849a9-4630-49a2-91fe-7273f949d2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_537ce5a7-9b48-4c5d-b766-4f67d8e5adf6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3f9244b5-f7f0-4e0f-8558-637f09ad9cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_537ce5a7-9b48-4c5d-b766-4f67d8e5adf6" xlink:to="loc_us-gaap_StatementTable_3f9244b5-f7f0-4e0f-8558-637f09ad9cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_40a9c773-e407-4ca1-973a-7ce295e61a96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3f9244b5-f7f0-4e0f-8558-637f09ad9cdc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_40a9c773-e407-4ca1-973a-7ce295e61a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_40a9c773-e407-4ca1-973a-7ce295e61a96" xlink:to="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_638c722c-0bde-479e-b461-0e5c7e2cc00c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_CommonStockMember_638c722c-0bde-479e-b461-0e5c7e2cc00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2890e541-8ac5-4b0d-811c-4b0e0969114d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2890e541-8ac5-4b0d-811c-4b0e0969114d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a7a05aab-18a3-43d0-bedd-e3cbdb01ba0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_TreasuryStockMember_a7a05aab-18a3-43d0-bedd-e3cbdb01ba0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_04e37a60-5b84-4447-a3a6-53ab20d11b68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_RetainedEarningsMember_04e37a60-5b84-4447-a3a6-53ab20d11b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0bf3904-8d60-472c-9498-666049569675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f1b7d6e3-7c37-4f1f-a5e7-96e78b2b4191" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0bf3904-8d60-472c-9498-666049569675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7d24e208-f9db-4c25-8b79-42a09db843dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3f9244b5-f7f0-4e0f-8558-637f09ad9cdc" xlink:to="loc_us-gaap_StatementLineItems_7d24e208-f9db-4c25-8b79-42a09db843dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d24e208-f9db-4c25-8b79-42a09db843dd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40ffa5c6-d473-41e6-aefb-7a1407ba9792" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40ffa5c6-d473-41e6-aefb-7a1407ba9792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_edb94da6-a355-4013-995a-2bdcf19158ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_SharesIssued_edb94da6-a355-4013-995a-2bdcf19158ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_cd34585b-828e-410f-8c76-1f9c3d1d8a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_cd34585b-828e-410f-8c76-1f9c3d1d8a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_93dc2004-8061-418e-b2b0-f88a5714dd64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_ProfitLoss_93dc2004-8061-418e-b2b0-f88a5714dd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1cd46601-98e1-47bf-adba-a0bf4e148a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1cd46601-98e1-47bf-adba-a0bf4e148a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0788b054-9fb4-4c75-a227-9a4e09e85c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0788b054-9fb4-4c75-a227-9a4e09e85c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_3fd22a36-98d4-47db-a560-5a1f6a48ff42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_3fd22a36-98d4-47db-a560-5a1f6a48ff42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6fd46ec0-50a9-4fb8-a462-e9fabd99f7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6fd46ec0-50a9-4fb8-a462-e9fabd99f7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2eab2d4a-b83b-4b24-b30d-3218bd40139f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2eab2d4a-b83b-4b24-b30d-3218bd40139f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dc9c92fc-fa27-4f61-97d5-47337971f045" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dc9c92fc-fa27-4f61-97d5-47337971f045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_30bda3e8-2f47-4378-aa33-420f63385c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_30bda3e8-2f47-4378-aa33-420f63385c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_d19ac3ff-7111-47f9-90d6-9452044b6471" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_DividendsCommonStockCash_d19ac3ff-7111-47f9-90d6-9452044b6471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_f77e33ef-45df-455e-b800-6599579cf8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_f77e33ef-45df-455e-b800-6599579cf8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_5a6a638e-e1e0-4358-b165-2e0384363069" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_5a6a638e-e1e0-4358-b165-2e0384363069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3e65b7e-d1ca-4b48-98a3-a90e6dea6de3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3e65b7e-d1ca-4b48-98a3-a90e6dea6de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8a451cc3-5705-428f-be75-07785fbdae57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_SharesIssued_8a451cc3-5705-428f-be75-07785fbdae57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6e2e145f-5161-4e46-936c-74bb8b91da89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_00353a72-3ce9-412e-b0e0-ed18f14687d0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6e2e145f-5161-4e46-936c-74bb8b91da89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="wst-20191231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e26f3e31-d9ab-4152-9d99-fed3c026f93b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e26f3e31-d9ab-4152-9d99-fed3c026f93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_693b392c-9dec-44db-aba0-628745f9e365" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e26f3e31-d9ab-4152-9d99-fed3c026f93b" xlink:to="loc_us-gaap_ProfitLoss_693b392c-9dec-44db-aba0-628745f9e365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e26f3e31-d9ab-4152-9d99-fed3c026f93b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2e32a2ee-531f-4bf1-9f48-62214c265430" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_Depreciation_2e32a2ee-531f-4bf1-9f48-62214c265430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_11d90989-9d4c-42be-9d73-fc0767e53102" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_AdjustmentForAmortization_11d90989-9d4c-42be-9d73-fc0767e53102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_99d158ef-e665-4c67-bc94-a02d4c9d9aec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_ShareBasedCompensation_99d158ef-e665-4c67-bc94-a02d4c9d9aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_6960c157-10ab-4488-b32b-93dcec1c438e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_6960c157-10ab-4488-b32b-93dcec1c438e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_8ebd592e-b706-433c-aeda-56dac45d763d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_8ebd592e-b706-433c-aeda-56dac45d763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_4e9fec05-1361-450a-a044-264202ac1de0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_4e9fec05-1361-450a-a044-264202ac1de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_8f073bc0-dabb-4cc1-9326-166570c56c27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_8f073bc0-dabb-4cc1-9326-166570c56c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5829f2d7-0149-45d5-9dd5-4fc2225c96a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5829f2d7-0149-45d5-9dd5-4fc2225c96a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9716f2b3-a2d8-4059-8393-4072ae5cf1fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9716f2b3-a2d8-4059-8393-4072ae5cf1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionandOtherPostretirementBenefitExpenseNet_9e03a5dc-c4ff-4e7c-a62c-c4377ddbf8b3" xlink:href="wst-20191231.xsd#wst_PensionandOtherPostretirementBenefitExpenseNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_wst_PensionandOtherPostretirementBenefitExpenseNet_9e03a5dc-c4ff-4e7c-a62c-c4377ddbf8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_57e0d609-fff6-4c6e-b66c-c26c55b56f61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a1dcfe91-9d3a-4365-b094-d2cc149b5d61" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_57e0d609-fff6-4c6e-b66c-c26c55b56f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a085c241-282a-4d40-8627-ceca91cbab4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e26f3e31-d9ab-4152-9d99-fed3c026f93b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a085c241-282a-4d40-8627-ceca91cbab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bbd74fa8-c105-4813-be1d-92543204eaa0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a085c241-282a-4d40-8627-ceca91cbab4b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bbd74fa8-c105-4813-be1d-92543204eaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6bfba7d8-d02f-4536-80ed-2fe90d6d00e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a085c241-282a-4d40-8627-ceca91cbab4b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6bfba7d8-d02f-4536-80ed-2fe90d6d00e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_64c151ae-79c7-4d6c-8e19-7f6dfecdd190" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a085c241-282a-4d40-8627-ceca91cbab4b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_64c151ae-79c7-4d6c-8e19-7f6dfecdd190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_576c4897-42fc-47cc-889f-370f5367b775" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a085c241-282a-4d40-8627-ceca91cbab4b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_576c4897-42fc-47cc-889f-370f5367b775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4d5aa1be-aa0c-4c89-8d3c-cbb0cb6750b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a085c241-282a-4d40-8627-ceca91cbab4b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4d5aa1be-aa0c-4c89-8d3c-cbb0cb6750b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_afe58321-fe39-44ab-85b3-639e26473d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e26f3e31-d9ab-4152-9d99-fed3c026f93b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_afe58321-fe39-44ab-85b3-639e26473d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_768ebbcf-7ac0-4e9c-9951-b66543e184c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_768ebbcf-7ac0-4e9c-9951-b66543e184c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_0e51b43a-5a80-4d50-a5c4-bc0aed1804be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_0e51b43a-5a80-4d50-a5c4-bc0aed1804be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_462f639e-ecc4-4d98-adc4-4edd13472ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_462f639e-ecc4-4d98-adc4-4edd13472ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_bfde806d-dbf0-4252-af9d-2b4acb4abe33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_bfde806d-dbf0-4252-af9d-2b4acb4abe33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d65326c6-1f52-4010-b8bd-fddb1638f079" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d65326c6-1f52-4010-b8bd-fddb1638f079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5d09b50-0464-4e7f-b7a7-445ec3f25f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08356343-81a2-4f1b-af6a-a2811152793f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5d09b50-0464-4e7f-b7a7-445ec3f25f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_67a94c9d-19ec-4fa4-b28c-30070a4f8be4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_67a94c9d-19ec-4fa4-b28c-30070a4f8be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_9fdda3d2-384b-4c44-9795-3218776ed0ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_9fdda3d2-384b-4c44-9795-3218776ed0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_bde44588-b99b-4b60-b3b3-e67d4457f3bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_bde44588-b99b-4b60-b3b3-e67d4457f3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c087e075-7732-4898-a0bc-2adc143eabd7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c087e075-7732-4898-a0bc-2adc143eabd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_af5be436-df8c-4f97-9d6d-3270c74e729c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_af5be436-df8c-4f97-9d6d-3270c74e729c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_dbdff792-1491-4496-aef8-40d36f41e01a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_dbdff792-1491-4496-aef8-40d36f41e01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d6a0eb93-b496-433e-a14b-adafec6fa3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d6a0eb93-b496-433e-a14b-adafec6fa3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b3b846c8-6b91-4f86-816d-861fda1beb60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b3b846c8-6b91-4f86-816d-861fda1beb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_14c6378f-e9f6-47ec-a521-b89551603630" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_14c6378f-e9f6-47ec-a521-b89551603630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f59f3f3a-273a-4da2-a7e6-7c06d79a9171" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f59f3f3a-273a-4da2-a7e6-7c06d79a9171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed80286a-3e30-4380-bba4-21aa5b3a6de1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8440bfa-0ba4-48d3-878c-a07ffe28946a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ed80286a-3e30-4380-bba4-21aa5b3a6de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1f32b12a-b28c-453b-b2eb-3aba9cb1b4b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1f32b12a-b28c-453b-b2eb-3aba9cb1b4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d96165ca-f511-43d9-b7bb-176e3c7bc3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d96165ca-f511-43d9-b7bb-176e3c7bc3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d5d4dd5b-ac9f-46ee-b755-fcb614522aee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d5d4dd5b-ac9f-46ee-b755-fcb614522aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_156e8957-de9a-4b48-870c-b3649bffbb57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_156e8957-de9a-4b48-870c-b3649bffbb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f51f68e7-5767-4f5d-a6f3-77ef88327252" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c2c068c9-5061-48c8-825b-b6321ca8d810" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f51f68e7-5767-4f5d-a6f3-77ef88327252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_7b580f2f-1010-4b99-ba45-a83351ac8a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f51f68e7-5767-4f5d-a6f3-77ef88327252" xlink:to="loc_us-gaap_InterestPaidNet_7b580f2f-1010-4b99-ba45-a83351ac8a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_6f8bbe3d-52ab-4acf-a26e-c8110f2fe8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f51f68e7-5767-4f5d-a6f3-77ef88327252" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_6f8bbe3d-52ab-4acf-a26e-c8110f2fe8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1bbf9ea3-896b-46a1-9bad-13c6e6f58188" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f51f68e7-5767-4f5d-a6f3-77ef88327252" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1bbf9ea3-896b-46a1-9bad-13c6e6f58188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_5416dd88-cf98-453e-8e40-c9e4a6a5bc7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f51f68e7-5767-4f5d-a6f3-77ef88327252" xlink:to="loc_us-gaap_DividendsPayableCurrent_5416dd88-cf98-453e-8e40-c9e4a6a5bc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_4acae80e-cbb5-4fd9-b4c7-2b7fc2834143" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f51f68e7-5767-4f5d-a6f3-77ef88327252" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_4acae80e-cbb5-4fd9-b4c7-2b7fc2834143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b8803418-b1ab-4717-8f9b-c282de9dd317" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c38f4c99-ed7a-4ac6-9b38-615552753be3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b8803418-b1ab-4717-8f9b-c282de9dd317" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c38f4c99-ed7a-4ac6-9b38-615552753be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a3b6a817-24cb-49bf-9c02-809b7eccbbed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a3b6a817-24cb-49bf-9c02-809b7eccbbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_43845b27-832d-4a35-85e9-1a2807371b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_UseOfEstimates_43845b27-832d-4a35-85e9-1a2807371b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4eb36998-4143-4366-94bd-bfcf77074280" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4eb36998-4143-4366-94bd-bfcf77074280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_dba3dbae-9ecb-4e3b-89f6-fa648c0234d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_dba3dbae-9ecb-4e3b-89f6-fa648c0234d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_d06bcc96-b5fa-420c-b61e-9c8b70f300af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_d06bcc96-b5fa-420c-b61e-9c8b70f300af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7348459d-ef45-42e9-88f0-767ad6f159dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7348459d-ef45-42e9-88f0-767ad6f159dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_56b7280a-b00b-4341-ad2c-90855b6c4b81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_56b7280a-b00b-4341-ad2c-90855b6c4b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b1903111-9aa2-4476-bf3a-dfbab67b8244" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b1903111-9aa2-4476-bf3a-dfbab67b8244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2c25a470-5318-4d68-9d38-84f5a7bfd803" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2c25a470-5318-4d68-9d38-84f5a7bfd803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_62346cf8-b5cb-4c51-8a0b-40c5556c7cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_62346cf8-b5cb-4c51-8a0b-40c5556c7cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_53af288d-237d-474a-8d6d-f768c2dae397" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_53af288d-237d-474a-8d6d-f768c2dae397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0b2f52eb-c879-483a-87dc-1d1f2e6c2ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0b2f52eb-c879-483a-87dc-1d1f2e6c2ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b6521f52-016f-4fbc-ace9-cc96d619a02e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b6521f52-016f-4fbc-ace9-cc96d619a02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_b533e907-6e73-4d7d-ae13-bc6e7238fc7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_b533e907-6e73-4d7d-ae13-bc6e7238fc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_855082f6-d735-42e2-b792-f9db83c0503c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_855082f6-d735-42e2-b792-f9db83c0503c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy_c2c66ced-f16e-4d5e-9b05-9ba8f644cb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_EnvironmentalCostsPolicy_c2c66ced-f16e-4d5e-9b05-9ba8f644cb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_fb53b422-27f6-4e62-a049-e201cd82f34e" xlink:href="wst-20191231.xsd#wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock_fb53b422-27f6-4e62-a049-e201cd82f34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_d0dca15e-cec5-4c36-83d0-010165ac0a03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_d0dca15e-cec5-4c36-83d0-010165ac0a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ab6e85fd-eb22-4889-9de1-2685d0fca12d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ab6e85fd-eb22-4889-9de1-2685d0fca12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_e4b01661-d200-4b48-9149-de03d6f89059" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_e4b01661-d200-4b48-9149-de03d6f89059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b025c9d4-c0ba-4fdf-93cb-072ffbe38f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7012422-5777-49d9-ba50-1e6ee52a9d3f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b025c9d4-c0ba-4fdf-93cb-072ffbe38f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_77fa66ae-7fc2-4280-bcef-39a84a853a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_46fcbeb4-fe4c-498f-865a-dd87860128ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_77fa66ae-7fc2-4280-bcef-39a84a853a2d" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_46fcbeb4-fe4c-498f-865a-dd87860128ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0f19a692-9709-4157-81d8-967d18bc3e48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0f19a692-9709-4157-81d8-967d18bc3e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_56ad5607-1782-4d8c-b68b-2b49f18dba5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_56ad5607-1782-4d8c-b68b-2b49f18dba5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e43f639c-f113-472f-8520-979236501bab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e43f639c-f113-472f-8520-979236501bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b4e250ea-1abb-4d16-950e-3f91ea6070bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b4e250ea-1abb-4d16-950e-3f91ea6070bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_127f874d-3073-4131-8054-6c45b6f47e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_127f874d-3073-4131-8054-6c45b6f47e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_679381cb-384a-40dc-a2a3-7a6eda70c32e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_679381cb-384a-40dc-a2a3-7a6eda70c32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_86b0b8ae-df46-4000-b54e-8b66282013dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_86b0b8ae-df46-4000-b54e-8b66282013dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_96273c1a-6251-410c-9da6-50778f86a24b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_96273c1a-6251-410c-9da6-50778f86a24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3dd0fc31-1dfa-48ba-b94b-20ba3b8cafb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3dd0fc31-1dfa-48ba-b94b-20ba3b8cafb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_68de711f-0b08-4aec-b625-945b3ea3eaf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_InventoryNet_68de711f-0b08-4aec-b625-945b3ea3eaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_59de287e-9aad-4bfb-9706-c9638f727a64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_33168e26-20e9-4e46-a77f-3e122199606c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_59de287e-9aad-4bfb-9706-c9638f727a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e72859e2-a01e-4b92-ac63-dee32eb737ca" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_59de287e-9aad-4bfb-9706-c9638f727a64" xlink:to="loc_srt_RangeAxis_e72859e2-a01e-4b92-ac63-dee32eb737ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e72859e2-a01e-4b92-ac63-dee32eb737ca" xlink:to="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_19dc256f-5f1e-423b-8b22-fc08b5b65206" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:to="loc_srt_MinimumMember_19dc256f-5f1e-423b-8b22-fc08b5b65206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0a4f0bcc-cb2b-404c-bff7-95cc1672aca3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fb55c45a-0ec1-4133-a1d8-7957d3323e63" xlink:to="loc_srt_MaximumMember_0a4f0bcc-cb2b-404c-bff7-95cc1672aca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d1d9b02-e577-4c61-9ab4-d861e10efd8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_59de287e-9aad-4bfb-9706-c9638f727a64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d1d9b02-e577-4c61-9ab4-d861e10efd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8222c600-300c-4f5b-97b1-b624cbb8d0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8d1d9b02-e577-4c61-9ab4-d861e10efd8b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8222c600-300c-4f5b-97b1-b624cbb8d0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20191231.xsd#NewAccountingStandards"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ebbdf797-d857-45eb-9521-45b2077519d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_1ccc16fa-63d1-4a73-88d4-036a9cbb3a68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ebbdf797-d857-45eb-9521-45b2077519d7" xlink:to="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_1ccc16fa-63d1-4a73-88d4-036a9cbb3a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_58fedf4d-7434-41d7-a148-b9bd2ce63041" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ebbdf797-d857-45eb-9521-45b2077519d7" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_58fedf4d-7434-41d7-a148-b9bd2ce63041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#NewAccountingStandardsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_fec7d383-0fde-46b9-9d18-0f6d9b6280c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_fec7d383-0fde-46b9-9d18-0f6d9b6280c0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_984d3113-100f-46e3-b4f6-e0b1ef3cd35d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_984d3113-100f-46e3-b4f6-e0b1ef3cd35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_775f0d4c-54e0-4cef-b440-e0b22bf276fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_984d3113-100f-46e3-b4f6-e0b1ef3cd35d" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_775f0d4c-54e0-4cef-b440-e0b22bf276fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1fbfc1db-41b2-476d-b5e6-4a050c78af8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1fbfc1db-41b2-476d-b5e6-4a050c78af8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1fbfc1db-41b2-476d-b5e6-4a050c78af8c" xlink:to="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_58690d32-0f62-4fd9-90d2-5a0510146c37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_58690d32-0f62-4fd9-90d2-5a0510146c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201707Member_57b8fe07-3f74-4a6f-b5be-c96e856d9344" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201707Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:to="loc_us-gaap_AccountingStandardsUpdate201707Member_57b8fe07-3f74-4a6f-b5be-c96e856d9344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_94709381-0ea8-47a6-8a21-24769e5da16e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_a72c3d71-53ea-45b5-8214-cb9e2b9e2147" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_94709381-0ea8-47a6-8a21-24769e5da16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_f79b2575-83e6-4bfd-b90b-9f7bc9f14caa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_212ceb68-deed-43a2-ac15-476c54d33404" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_f79b2575-83e6-4bfd-b90b-9f7bc9f14caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenue" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenue"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevenueAbstract_260ace60-3926-44b8-bec0-d1693db1e0b1" xlink:href="wst-20191231.xsd#wst_RevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_b80b9651-64a0-4419-92a5-d94f83a43764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_RevenueAbstract_260ace60-3926-44b8-bec0-d1693db1e0b1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_b80b9651-64a0-4419-92a5-d94f83a43764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueTables" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenueTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevenueAbstract_bda3f720-b0ba-4c44-ae11-866c27b24383" xlink:href="wst-20191231.xsd#wst_RevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_43b23451-258a-4328-be4c-0043d62dddb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_RevenueAbstract_bda3f720-b0ba-4c44-ae11-866c27b24383" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_43b23451-258a-4328-be4c-0043d62dddb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_4a2a0732-5dd4-4126-afb1-0ea29ab9e0a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_RevenueAbstract_bda3f720-b0ba-4c44-ae11-866c27b24383" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_4a2a0732-5dd4-4126-afb1-0ea29ab9e0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d6c4701f-728c-4ddb-9352-46df9054f927" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_RevenueAbstract_bda3f720-b0ba-4c44-ae11-866c27b24383" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d6c4701f-728c-4ddb-9352-46df9054f927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueAdoptionofASC606Details"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueAdoptionofASC606Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevenueAbstract_c6879179-dd89-4d31-bc33-b23e8113db3f" xlink:href="wst-20191231.xsd#wst_RevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_RevenueAbstract_c6879179-dd89-4d31-bc33-b23e8113db3f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_1304e5cf-42b6-497e-8164-dbda93cfbd29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_1304e5cf-42b6-497e-8164-dbda93cfbd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_5b862059-5bcc-45b7-aa64-960ed022ad85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_1304e5cf-42b6-497e-8164-dbda93cfbd29" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_5b862059-5bcc-45b7-aa64-960ed022ad85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e6cacd17-9afd-4990-8ce0-963e64a8fdab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_5b862059-5bcc-45b7-aa64-960ed022ad85" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_e6cacd17-9afd-4990-8ce0-963e64a8fdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f7c14949-59c1-4e54-882d-8b2c9915a8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f7c14949-59c1-4e54-882d-8b2c9915a8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_95c86afb-bb4a-421c-adfd-920830902e70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_f7c14949-59c1-4e54-882d-8b2c9915a8c1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_95c86afb-bb4a-421c-adfd-920830902e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_66a09fec-218d-41cd-b490-9dd55b216d26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_95c86afb-bb4a-421c-adfd-920830902e70" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_66a09fec-218d-41cd-b490-9dd55b216d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0aa5d8db-15ad-4ee0-be1c-1aadce915008" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ac3c92e6-8a0a-4584-9e40-b27b9d0b18b7" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0aa5d8db-15ad-4ee0-be1c-1aadce915008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8126de79-1aef-4fb7-9449-f650c90c27bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0aa5d8db-15ad-4ee0-be1c-1aadce915008" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8126de79-1aef-4fb7-9449-f650c90c27bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_3f8c8f7b-673c-45ca-9e79-d0284e80a4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_3f8c8f7b-673c-45ca-9e79-d0284e80a4f8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_srt_StatementGeographicalAxis_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7a3621b0-bfe5-4b2b-bc87-cdabf7bf2c8f" xlink:to="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_409b5705-a5ae-4dab-92ea-1dbf66737a9f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:to="loc_srt_AmericasMember_409b5705-a5ae-4dab-92ea-1dbf66737a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_6608f637-764f-45bb-a46a-c962ec942f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:to="loc_us-gaap_EMEAMember_6608f637-764f-45bb-a46a-c962ec942f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_505ed046-bb83-443f-a32c-bb6b4348b5f8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_836904ba-40dd-45be-9db3-7fdb60e252cf" xlink:to="loc_srt_AsiaPacificMember_505ed046-bb83-443f-a32c-bb6b4348b5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_aa250523-1e01-4195-b841-488030321877" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_srt_MajorCustomersAxis_aa250523-1e01-4195-b841-488030321877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_aa250523-1e01-4195-b841-488030321877" xlink:to="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BiologicsCustomersMember_120fe701-b75b-40e6-ad34-e66f88402534" xlink:href="wst-20191231.xsd#wst_BiologicsCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_BiologicsCustomersMember_120fe701-b75b-40e6-ad34-e66f88402534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_GenericsCustomersMember_800ea45c-71a0-400e-a607-c5d49bdf6ec7" xlink:href="wst-20191231.xsd#wst_GenericsCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_GenericsCustomersMember_800ea45c-71a0-400e-a607-c5d49bdf6ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaCustomersMember_a794b2de-b61d-4388-bc8e-bbcb185f1c54" xlink:href="wst-20191231.xsd#wst_PharmaCustomersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_PharmaCustomersMember_a794b2de-b61d-4388-bc8e-bbcb185f1c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedCustomersMember_5b9eb979-3a81-4b1d-a5cf-e8ea4124dfa3" xlink:href="wst-20191231.xsd#wst_ContractManufacturedCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d976828a-a8dc-4b4e-8ef5-1f3ea22f96f0" xlink:to="loc_wst_ContractManufacturedCustomersMember_5b9eb979-3a81-4b1d-a5cf-e8ea4124dfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d8ead353-77fc-41c2-8706-af69beaa9946" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d8ead353-77fc-41c2-8706-af69beaa9946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d8ead353-77fc-41c2-8706-af69beaa9946" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_4488f4ef-2d78-4eba-b4fc-3a3318eb46c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_4488f4ef-2d78-4eba-b4fc-3a3318eb46c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_dd8f2ea7-3dca-4ea6-856e-6a37bb185ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_dd8f2ea7-3dca-4ea6-856e-6a37bb185ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5f783d90-bc39-4594-8723-459bc0942bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ac5ac705-4eec-4593-981b-e0d29e499545" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5f783d90-bc39-4594-8723-459bc0942bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_653e955f-9601-4a5e-87af-de610f9c515c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_653e955f-9601-4a5e-87af-de610f9c515c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762444fc-10ad-408f-9c9f-2ecd97ee9806" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_653e955f-9601-4a5e-87af-de610f9c515c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762444fc-10ad-408f-9c9f-2ecd97ee9806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_33c22451-3935-455f-b38f-be0cf35d0948" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762444fc-10ad-408f-9c9f-2ecd97ee9806" xlink:to="loc_us-gaap_SalesRevenueNetMember_33c22451-3935-455f-b38f-be0cf35d0948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_srt_ProductOrServiceAxis_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_de2a2e8a-51c8-47e8-bd18-9a2b66ae295b" xlink:to="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_4cf93ee6-3782-4762-95c9-03cc4f2e0c57" xlink:href="wst-20191231.xsd#wst_SmartDoseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_SmartDoseMember_4cf93ee6-3782-4762-95c9-03cc4f2e0c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_HighValueComponentsMember_0b9200ff-c80d-48ae-9f81-35ef27731836" xlink:href="wst-20191231.xsd#wst_HighValueComponentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_HighValueComponentsMember_0b9200ff-c80d-48ae-9f81-35ef27731836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StandardPackagingMember_40c6268e-e384-40ad-b69b-2b0aa37a117b" xlink:href="wst-20191231.xsd#wst_StandardPackagingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_StandardPackagingMember_40c6268e-e384-40ad-b69b-2b0aa37a117b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeliveryDevicesMember_68ec1af7-6246-4492-a1ab-f73aa6794cb7" xlink:href="wst-20191231.xsd#wst_DeliveryDevicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_DeliveryDevicesMember_68ec1af7-6246-4492-a1ab-f73aa6794cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_ffe3206b-37d9-40ec-97a1-b8f717a567c6" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2ce8406a-8483-437b-82d0-cb817ad038f7" xlink:to="loc_wst_ContractManufacturedProductsMember_ffe3206b-37d9-40ec-97a1-b8f717a567c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28a5b786-077c-4f58-9d6a-3fd2a3ed7448" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_98adf13e-4f55-4071-8985-9d1d43fec8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:to="loc_us-gaap_ContractWithCustomerLiability_98adf13e-4f55-4071-8985-9d1d43fec8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_441c9e70-e282-4fe7-8d15-805f8a250bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_62bf98ce-5b49-4b13-849e-efb6d37c4bab" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_441c9e70-e282-4fe7-8d15-805f8a250bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueContractsAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractsandLiabilitiesAbstract_7130dd61-031c-49cb-ba4b-976e494c6e3c" xlink:href="wst-20191231.xsd#wst_ContractsandLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ContractsandLiabilitiesAbstract_7130dd61-031c-49cb-ba4b-976e494c6e3c" xlink:to="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9e5410eb-9aa1-46e7-94f3-f9dc33821a53" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:to="loc_srt_ProductOrServiceAxis_9e5410eb-9aa1-46e7-94f3-f9dc33821a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7332aa16-a7cd-4550-b052-c33cab3959ee" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9e5410eb-9aa1-46e7-94f3-f9dc33821a53" xlink:to="loc_srt_ProductsAndServicesDomain_7332aa16-a7cd-4550-b052-c33cab3959ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_159c6c3e-84dc-400f-925a-e14ff10f05d4" xlink:href="wst-20191231.xsd#wst_SmartDoseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7332aa16-a7cd-4550-b052-c33cab3959ee" xlink:to="loc_wst_SmartDoseMember_159c6c3e-84dc-400f-925a-e14ff10f05d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d174d8b5-3f65-424f-8553-8b4c60acd44c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d174d8b5-3f65-424f-8553-8b4c60acd44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ba013ccb-7185-4373-b9ba-4d777da47c12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_d174d8b5-3f65-424f-8553-8b4c60acd44c" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ba013ccb-7185-4373-b9ba-4d777da47c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_18a975b1-6a22-48af-a9f9-e2a1447e176d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_ba013ccb-7185-4373-b9ba-4d777da47c12" xlink:to="loc_us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member_18a975b1-6a22-48af-a9f9-e2a1447e176d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7bf02900-2da8-48ec-9681-ac23b3e51aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7bf02900-2da8-48ec-9681-ac23b3e51aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_76c95c9c-13f8-471b-9a9f-cddf8c386371" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7bf02900-2da8-48ec-9681-ac23b3e51aa1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_76c95c9c-13f8-471b-9a9f-cddf8c386371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_152f1737-bdc4-4c61-9a9f-bcd665cd66c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_76c95c9c-13f8-471b-9a9f-cddf8c386371" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_152f1737-bdc4-4c61-9a9f-bcd665cd66c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ffda5ec8-eafa-4bfb-989f-48935dc147f0" xlink:to="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_b6421f39-4476-4754-8fea-f881645e095f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_b6421f39-4476-4754-8fea-f881645e095f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_9c75eabb-0e6a-430a-9d35-ec22cedefd41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_9c75eabb-0e6a-430a-9d35-ec22cedefd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractwithCustomerAssetIncreaseDecrease_325a4dec-cddd-41e9-bcc5-11327bee2985" xlink:href="wst-20191231.xsd#wst_ContractwithCustomerAssetIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_wst_ContractwithCustomerAssetIncreaseDecrease_325a4dec-cddd-41e9-bcc5-11327bee2985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d91918e5-a8c5-4e08-a0d5-2b4a90c0bbdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d91918e5-a8c5-4e08-a0d5-2b4a90c0bbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_11351418-dd3e-4113-98a5-658e7ae576bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_11351418-dd3e-4113-98a5-658e7ae576bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_550a74b8-a95b-45f7-9f0f-e4df4bf950e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_550a74b8-a95b-45f7-9f0f-e4df4bf950e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_6212ed56-e659-404b-9bbd-8cb73df969d0" xlink:href="wst-20191231.xsd#wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments_6212ed56-e659-404b-9bbd-8cb73df969d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_47286406-d431-4554-a2c6-510746619717" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_47286406-d431-4554-a2c6-510746619717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3b116f59-5914-418f-b99f-639b05c1c006" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3b116f59-5914-418f-b99f-639b05c1c006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bd3f83fc-3347-4b95-88e8-863168813ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bd3f83fc-3347-4b95-88e8-863168813ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInCustomerAdvances_fde61db3-d229-4c23-a058-e4e087da6a25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_IncreaseDecreaseInCustomerAdvances_fde61db3-d229-4c23-a058-e4e087da6a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_07d6473b-4c36-4ffa-b4d3-ec2ee77a002f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba3755c-a48f-4e1b-a4f7-2bff0aaa72a3" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_07d6473b-4c36-4ffa-b4d3-ec2ee77a002f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueSupplyChainFinancingDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_SupplyChainFinancingAbstract_f6c88319-f2ce-409f-a1fa-e52890d47218" xlink:href="wst-20191231.xsd#wst_SupplyChainFinancingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_c0c2d218-d47d-40cd-a3f5-8b5018a34a91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_SupplyChainFinancingAbstract_f6c88319-f2ce-409f-a1fa-e52890d47218" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount_c0c2d218-d47d-40cd-a3f5-8b5018a34a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#RevenueVoluntaryRecallDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_VoluntaryRecallAbstract_e6ab6d4d-a3e8-412a-b9f8-57203d799f53" xlink:href="wst-20191231.xsd#wst_VoluntaryRecallAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProvisionForProductReturns_b9dc9c4e-2c4a-435f-ae4e-922b25dd5203" xlink:href="wst-20191231.xsd#wst_ProvisionForProductReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_VoluntaryRecallAbstract_e6ab6d4d-a3e8-412a-b9f8-57203d799f53" xlink:to="loc_wst_ProvisionForProductReturns_b9dc9c4e-2c4a-435f-ae4e-922b25dd5203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_0d3e6f27-55fd-4869-afb8-aef4a23ac3cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_VoluntaryRecallAbstract_e6ab6d4d-a3e8-412a-b9f8-57203d799f53" xlink:to="loc_us-gaap_InventoryFinishedGoods_0d3e6f27-55fd-4869-afb8-aef4a23ac3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_052fbf45-8b1d-49e3-b9ef-9d23590a72fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_63ca03df-5391-4439-bd35-9532a0d47d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_052fbf45-8b1d-49e3-b9ef-9d23590a72fe" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_63ca03df-5391-4439-bd35-9532a0d47d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b0e8a6f2-689d-48f5-87d9-711b2c5fc0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_977ee29b-c76a-45f1-b2dd-63122109abb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b0e8a6f2-689d-48f5-87d9-711b2c5fc0b2" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_977ee29b-c76a-45f1-b2dd-63122109abb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#NetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_11351790-c911-423f-a4c3-d96a85ef49c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_ProfitLoss_11351790-c911-423f-a4c3-d96a85ef49c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c7387970-2ce3-4b4d-bcd0-f2b15819e968" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c7387970-2ce3-4b4d-bcd0-f2b15819e968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_dc489602-7d23-4bc4-a510-60ecc24bc858" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_dc489602-7d23-4bc4-a510-60ecc24bc858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f0249eee-4df6-4781-8d3a-a3aa107ef5ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f0249eee-4df6-4781-8d3a-a3aa107ef5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f6e43f3e-47a6-408b-97ca-b73372f8e4ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f6e43f3e-47a6-408b-97ca-b73372f8e4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_6965fb6b-4abf-404a-8570-63ffb1bae3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_6965fb6b-4abf-404a-8570-63ffb1bae3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_29ad8150-0c6c-4ac7-8630-7e9035a86676" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_29ad8150-0c6c-4ac7-8630-7e9035a86676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_855487ea-71ba-4b17-b750-6bf8a4329610" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_855487ea-71ba-4b17-b750-6bf8a4329610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7bf61d0c-60dd-4773-bbb3-c16da1df0954" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d478819b-336c-4709-a0c4-6b973ad77339" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7bf61d0c-60dd-4773-bbb3-c16da1df0954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c974dc9b-b4a8-44d7-bf2a-b67739dbdf5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_5f4e686b-ff75-4c13-9baa-4b17b03dc6a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c974dc9b-b4a8-44d7-bf2a-b67739dbdf5c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_5f4e686b-ff75-4c13-9baa-4b17b03dc6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_931976e3-25cd-451c-9f2b-a8066314e1c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0facc1cc-6092-40a8-86d8-385e0693b726" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_931976e3-25cd-451c-9f2b-a8066314e1c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0facc1cc-6092-40a8-86d8-385e0693b726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6c287e8b-ede5-4926-8a21-2e5356995853" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6c287e8b-ede5-4926-8a21-2e5356995853" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_242462bf-2203-49de-9f8c-cea31346c965" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_242462bf-2203-49de-9f8c-cea31346c965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_242462bf-2203-49de-9f8c-cea31346c965" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_a1ebcb33-6c55-4543-80b4-08ae36f8424f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_LandMember_a1ebcb33-6c55-4543-80b4-08ae36f8424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_141212aa-e869-4ff8-b69b-0952eca9ea5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_141212aa-e869-4ff8-b69b-0952eca9ea5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_6aaa4296-7de9-4459-b2ae-b4c3184363a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_6aaa4296-7de9-4459-b2ae-b4c3184363a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ToolsDiesAndMoldsMember_3c979d9f-a350-43f4-a04f-c8fcca721302" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ToolsDiesAndMoldsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_ToolsDiesAndMoldsMember_3c979d9f-a350-43f4-a04f-c8fcca721302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ComputerHardwareAndSoftwareMember_09477af9-12dc-484a-877c-646c398c9718" xlink:href="wst-20191231.xsd#wst_ComputerHardwareAndSoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_wst_ComputerHardwareAndSoftwareMember_09477af9-12dc-484a-877c-646c398c9718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_53e48561-bc9e-43db-93f0-a6dd413f0d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff8a8c67-ffb9-49dc-9599-df2fc9509ff4" xlink:to="loc_us-gaap_ConstructionInProgressMember_53e48561-bc9e-43db-93f0-a6dd413f0d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_45135d39-3bfc-4459-8258-71cb1f739011" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:to="loc_srt_RangeAxis_45135d39-3bfc-4459-8258-71cb1f739011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_45135d39-3bfc-4459-8258-71cb1f739011" xlink:to="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8fff8b53-0036-4594-99d6-699f5b69522f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:to="loc_srt_MinimumMember_8fff8b53-0036-4594-99d6-699f5b69522f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2d2e855a-c46f-448a-b480-4b7eecaf1d2b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c9809d9-39e0-43f0-8748-c2319c75eba0" xlink:to="loc_srt_MaximumMember_2d2e855a-c46f-448a-b480-4b7eecaf1d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6e731b3f-8deb-4086-baca-617fd1a72c64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_98f03a49-7a47-44f7-a4df-058fae29b0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_98f03a49-7a47-44f7-a4df-058fae29b0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6e79a361-7278-4df7-8f3a-8d1547341feb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c76c6712-dd65-4a6f-b5e7-522c06989a85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6e79a361-7278-4df7-8f3a-8d1547341feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#PropertyPlantandEquipmentTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_560e11a1-aaff-4cff-b7c1-52dbdfa9ccc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_560e11a1-aaff-4cff-b7c1-52dbdfa9ccc4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5e09582f-1ad1-463e-a2e3-fc5b592ab992" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:to="loc_us-gaap_RestructuringPlanAxis_5e09582f-1ad1-463e-a2e3-fc5b592ab992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_5e09582f-1ad1-463e-a2e3-fc5b592ab992" xlink:to="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2018RestructuringPlanMember_84a3bcc1-a26c-400f-86ac-26ab36f61894" xlink:href="wst-20191231.xsd#wst_A2018RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:to="loc_wst_A2018RestructuringPlanMember_84a3bcc1-a26c-400f-86ac-26ab36f61894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2016RestructuringPlanMemberMember_621e88d3-c4fa-41ae-8353-778b9b16b97f" xlink:href="wst-20191231.xsd#wst_A2016RestructuringPlanMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_6b696571-7b64-442c-88aa-a457e24ac10e" xlink:to="loc_wst_A2016RestructuringPlanMemberMember_621e88d3-c4fa-41ae-8353-778b9b16b97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7accbf1a-e8eb-4762-8589-8b840f290391" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7accbf1a-e8eb-4762-8589-8b840f290391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7accbf1a-e8eb-4762-8589-8b840f290391" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_d701c5f0-5788-4d72-bcf0-ec8ce4c227ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_d701c5f0-5788-4d72-bcf0-ec8ce4c227ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_85b28b8a-4359-40ce-af14-42133c65594e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_916c53ce-8712-4b2f-924a-35e073999b26" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_85b28b8a-4359-40ce-af14-42133c65594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216036f1-ee6c-442f-b1db-3274fdef6220" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_55a3823c-d605-4d6a-9ad8-db813a23e11e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_Depreciation_55a3823c-d605-4d6a-9ad8-db813a23e11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsGross_6fe5453c-6f69-40f3-bc1d-d4f04beb7e58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasedAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_CapitalLeasedAssetsGross_6fe5453c-6f69-40f3-bc1d-d4f04beb7e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_6f596cd3-8fc8-4769-87b2-66489677776f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_InterestCostsCapitalized_6f596cd3-8fc8-4769-87b2-66489677776f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatentandEquipment_1c378746-3285-48ee-b38f-f3b3b074cec6" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatentandEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_wst_AssetImpairmentChargesPatentandEquipment_1c378746-3285-48ee-b38f-f3b3b074cec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_88693167-e5dc-4d05-a4ce-1d5f7a177a22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_88693167-e5dc-4d05-a4ce-1d5f7a177a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_24dd4ab5-74df-40e5-8bfd-2da13582d1db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_25813086-8d89-4430-874b-80a6f3cc0691" xlink:to="loc_us-gaap_AssetImpairmentCharges_24dd4ab5-74df-40e5-8bfd-2da13582d1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20191231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6a603b6a-a483-4e37-8647-dc21f4253774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_077aec84-468f-44fa-abff-d694215e5a34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6a603b6a-a483-4e37-8647-dc21f4253774" xlink:to="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_077aec84-468f-44fa-abff-d694215e5a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4940c8fc-935e-4c2b-9d5b-abc94c17b294" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_071523f4-1701-46e8-8fed-ef4c7addafea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4940c8fc-935e-4c2b-9d5b-abc94c17b294" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_071523f4-1701-46e8-8fed-ef4c7addafea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_f94f0df3-3d3d-4ca0-9e72-b81d9a035971" xlink:href="wst-20191231.xsd#wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4940c8fc-935e-4c2b-9d5b-abc94c17b294" xlink:to="loc_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock_f94f0df3-3d3d-4ca0-9e72-b81d9a035971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_16e3f1ed-39b7-4b5e-ab99-6f64a2213e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4940c8fc-935e-4c2b-9d5b-abc94c17b294" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_16e3f1ed-39b7-4b5e-ab99-6f64a2213e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1e0d3d19-c69c-466e-a8df-a7f566f3f338" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4940c8fc-935e-4c2b-9d5b-abc94c17b294" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1e0d3d19-c69c-466e-a8df-a7f566f3f338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AdoptionofASC842Details" xlink:type="simple" xlink:href="wst-20191231.xsd#AdoptionofASC842Details"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AdoptionofASC842Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_129b6b23-e0f3-47c3-8b8e-b261ff2c6257" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_129b6b23-e0f3-47c3-8b8e-b261ff2c6257" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9ab01f62-9de2-45a7-8ded-71c0af0aec46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9ab01f62-9de2-45a7-8ded-71c0af0aec46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_d86a5530-d259-4272-86ba-db32fe603f55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9ab01f62-9de2-45a7-8ded-71c0af0aec46" xlink:to="loc_us-gaap_TypeOfAdoptionMember_d86a5530-d259-4272-86ba-db32fe603f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_010d9f87-6d88-4391-bd64-63524514abd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_d86a5530-d259-4272-86ba-db32fe603f55" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_010d9f87-6d88-4391-bd64-63524514abd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_115cf22b-a9fc-4516-afd7-f5401feb0dbe" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:to="loc_srt_RangeAxis_115cf22b-a9fc-4516-afd7-f5401feb0dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_41d40aa9-3bca-469e-9a4b-e55650604731" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_115cf22b-a9fc-4516-afd7-f5401feb0dbe" xlink:to="loc_srt_RangeMember_41d40aa9-3bca-469e-9a4b-e55650604731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6dd6b7f3-1224-4062-a9ef-0a90f0b758bb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_41d40aa9-3bca-469e-9a4b-e55650604731" xlink:to="loc_srt_MaximumMember_6dd6b7f3-1224-4062-a9ef-0a90f0b758bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7227a2c8-08c6-4b93-9b6e-14a31cd5f52f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_291d38b6-b95f-4f62-b7df-92a8dabe87ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_OperatingLeaseLiability_291d38b6-b95f-4f62-b7df-92a8dabe87ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ccb9b5d6-23f0-4b70-b365-fd940433046f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ccb9b5d6-23f0-4b70-b365-fd940433046f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_319579d3-6830-4858-8994-394c58259357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_319579d3-6830-4858-8994-394c58259357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0ece5ec9-c3cc-43ad-9eb5-24f671b87ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0ece5ec9-c3cc-43ad-9eb5-24f671b87ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_38d95611-fd1c-4d8f-bb09-3ee9f8446497" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_us-gaap_FinanceLeaseLiability_38d95611-fd1c-4d8f-bb09-3ee9f8446497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LeaseOperatingLeaseTerminateTerm_6438e20f-1f37-43cd-bd61-280a97d43c6a" xlink:href="wst-20191231.xsd#wst_LeaseOperatingLeaseTerminateTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d89985c8-2efc-435e-9cf6-c17a266fc5cc" xlink:to="loc_wst_LeaseOperatingLeaseTerminateTerm_6438e20f-1f37-43cd-bd61-280a97d43c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseCostDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_307e7b06-b4d8-4faa-94c5-73fb2f711eef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_5b6bb742-7554-4a7d-9c25-c5ebd9521638" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_307e7b06-b4d8-4faa-94c5-73fb2f711eef" xlink:to="loc_us-gaap_OperatingLeaseCost_5b6bb742-7554-4a7d-9c25-c5ebd9521638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_a435f036-69e4-4f39-94b2-48cc87f57951" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_307e7b06-b4d8-4faa-94c5-73fb2f711eef" xlink:to="loc_us-gaap_ShortTermLeaseCost_a435f036-69e4-4f39-94b2-48cc87f57951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_f001e986-117a-4130-b139-448beca4e366" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_307e7b06-b4d8-4faa-94c5-73fb2f711eef" xlink:to="loc_us-gaap_VariableLeaseCost_f001e986-117a-4130-b139-448beca4e366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_67ab6ff3-594d-453f-8cd4-14442e6ef4f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_307e7b06-b4d8-4faa-94c5-73fb2f711eef" xlink:to="loc_us-gaap_LeaseCost_67ab6ff3-594d-453f-8cd4-14442e6ef4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseCashFlowandSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_414255ab-6b33-48d8-8a29-55122916f65f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_94a0a94d-913b-468d-bf78-7d2f530fcf7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_414255ab-6b33-48d8-8a29-55122916f65f" xlink:to="loc_us-gaap_OperatingLeasePayments_94a0a94d-913b-468d-bf78-7d2f530fcf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b4ba424c-6b28-4572-9b27-ea16a47cb4f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_414255ab-6b33-48d8-8a29-55122916f65f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b4ba424c-6b28-4572-9b27-ea16a47cb4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeaseWeightedAverageDetail" xlink:type="simple" xlink:href="wst-20191231.xsd#LeaseWeightedAverageDetail"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/LeaseWeightedAverageDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bde9be95-2401-4521-a728-5f51012385d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d5abcd70-8578-4727-b924-972e51ce32ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bde9be95-2401-4521-a728-5f51012385d9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d5abcd70-8578-4727-b924-972e51ce32ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_34ab208f-8cd2-4755-ab13-878d7403f9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bde9be95-2401-4521-a728-5f51012385d9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_34ab208f-8cd2-4755-ab13-878d7403f9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#MaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b0fb440-ca49-4e79-a693-4b5a70f16cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b0fb440-ca49-4e79-a693-4b5a70f16cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7aa5e2bd-3d4b-4519-825e-6a760f685f50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7aa5e2bd-3d4b-4519-825e-6a760f685f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1217f55e-bfda-406f-8e08-28850e96d44d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1217f55e-bfda-406f-8e08-28850e96d44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f73a7505-a1a2-4096-a91f-a3bd558a8824" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f73a7505-a1a2-4096-a91f-a3bd558a8824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d0c48dd6-c446-4639-8695-eab2ee461305" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d0c48dd6-c446-4639-8695-eab2ee461305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c1839575-7cdd-4475-8910-a0c6c160921c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c1839575-7cdd-4475-8910-a0c6c160921c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1943677-1799-4971-8ba5-170a3b7bd4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b1943677-1799-4971-8ba5-170a3b7bd4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_47cba490-b979-4822-abd7-3ef452feb3b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_47cba490-b979-4822-abd7-3ef452feb3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_fa97086d-a0f2-452f-bab9-4094cb37a247" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeaseLiability_fa97086d-a0f2-452f-bab9-4094cb37a247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_b6bc127f-1da6-49bb-9465-9b62e1130adf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_b6bc127f-1da6-49bb-9465-9b62e1130adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1bf69360-324d-43eb-b996-8ebf1507ebea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1bf69360-324d-43eb-b996-8ebf1507ebea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_94560e59-19dc-4605-a7aa-4cd968b277eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_94560e59-19dc-4605-a7aa-4cd968b277eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_d18f2b7e-d21d-464a-ad27-42e6c62725d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_d18f2b7e-d21d-464a-ad27-42e6c62725d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_5204bf0d-d49f-4420-b951-3e1a04f31044" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_5204bf0d-d49f-4420-b951-3e1a04f31044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1463ea82-26cc-4b6e-9b50-7ce4a01ecbcf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1463ea82-26cc-4b6e-9b50-7ce4a01ecbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_47446cb6-f883-429a-a0a0-82a449375225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_713f4fbe-ba63-4cb1-a333-9f2c7442a2ed" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_47446cb6-f883-429a-a0a0-82a449375225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompanies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_258296f0-e518-4913-a8fe-9008bd560234" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_66836b8f-1504-40ef-92b6-4d152ddaf27a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_258296f0-e518-4913-a8fe-9008bd560234" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_66836b8f-1504-40ef-92b6-4d152ddaf27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_04123a7e-65f8-4a06-a582-98b149ea8de9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_a07b76be-f034-4f26-988a-327218cb39fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_04123a7e-65f8-4a06-a582-98b149ea8de9" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_a07b76be-f034-4f26-988a-327218cb39fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_147bae45-074b-4acc-a1df-0274eb75baac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fe6fde8f-738f-4b6c-a497-aa3cc7955f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_147bae45-074b-4acc-a1df-0274eb75baac" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fe6fde8f-738f-4b6c-a497-aa3cc7955f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86112379-5489-4e92-9f92-10cff8c99fa0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fe6fde8f-738f-4b6c-a497-aa3cc7955f3e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86112379-5489-4e92-9f92-10cff8c99fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_86112379-5489-4e92-9f92-10cff8c99fa0" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_WestCompanyMexicoSADeCVMember_10cb7305-0df4-4b1c-80d1-f8d37362760b" xlink:href="wst-20191231.xsd#wst_WestCompanyMexicoSADeCVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_WestCompanyMexicoSADeCVMember_10cb7305-0df4-4b1c-80d1-f8d37362760b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AluplastSADeCVMember_3e5a3644-6730-4f9d-a617-06d5c92032aa" xlink:href="wst-20191231.xsd#wst_AluplastSADeCVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_AluplastSADeCVMember_3e5a3644-6730-4f9d-a617-06d5c92032aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaTapSADeCVMember_a88d78b8-7982-46bd-bf36-e1e2ebf88991" xlink:href="wst-20191231.xsd#wst_PharmaTapSADeCVMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_PharmaTapSADeCVMember_a88d78b8-7982-46bd-bf36-e1e2ebf88991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PharmaRubberSADeCVMember_0dee225f-97be-4477-a7f0-fbaf0b9bec86" xlink:href="wst-20191231.xsd#wst_PharmaRubberSADeCVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_PharmaRubberSADeCVMember_0dee225f-97be-4477-a7f0-fbaf0b9bec86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_bb51ff57-2d38-42bb-a4d8-96617b5e306d" xlink:href="wst-20191231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_bb51ff57-2d38-42bb-a4d8-96617b5e306d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IWPharmaGroupLLCMember_3cca1c30-163a-49da-ad7a-b3a3bd3680fa" xlink:href="wst-20191231.xsd#wst_IWPharmaGroupLLCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4cc6106b-1844-4599-8ee7-0a6a4fc2e725" xlink:to="loc_wst_IWPharmaGroupLLCMember_3cca1c30-163a-49da-ad7a-b3a3bd3680fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fe6fde8f-738f-4b6c-a497-aa3cc7955f3e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a1977914-e212-44ae-8401-05c93bf85a18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a1977914-e212-44ae-8401-05c93bf85a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_aa1901d3-88b9-42d1-a7b6-479d6ec78893" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_aa1901d3-88b9-42d1-a7b6-479d6ec78893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44653049-32f1-4a74-891c-f8ffe35360b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_16b0ec89-f120-4ebe-9fb1-53f7289bde4d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44653049-32f1-4a74-891c-f8ffe35360b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#AffiliatedCompaniesTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2cb11c8d-c2a2-49d2-8285-f04525c887e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ce889269-6350-4cc0-bee1-4bdf0614a3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2cb11c8d-c2a2-49d2-8285-f04525c887e6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ce889269-6350-4cc0-bee1-4bdf0614a3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1309143b-0ded-4a3d-adc9-545e0ea404b2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ce889269-6350-4cc0-bee1-4bdf0614a3d1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1309143b-0ded-4a3d-adc9-545e0ea404b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_da390cbc-f806-46ec-9d21-0bbed676398f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1309143b-0ded-4a3d-adc9-545e0ea404b2" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_da390cbc-f806-46ec-9d21-0bbed676398f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DaikyoSeikoLtdDaikyoMember_5a9bff39-c0cc-4584-88da-87e8b99dfd51" xlink:href="wst-20191231.xsd#wst_DaikyoSeikoLtdDaikyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_da390cbc-f806-46ec-9d21-0bbed676398f" xlink:to="loc_wst_DaikyoSeikoLtdDaikyoMember_5a9bff39-c0cc-4584-88da-87e8b99dfd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ce889269-6350-4cc0-bee1-4bdf0614a3d1" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_11f08135-e3bd-407d-9cea-faaf566e12e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees_11f08135-e3bd-407d-9cea-faaf566e12e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d58a95ae-c572-4302-b0b2-b176bd49ca40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d58a95ae-c572-4302-b0b2-b176bd49ca40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_f621f683-cea2-41c9-9d61-e11115d1fb72" xlink:href="wst-20191231.xsd#wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect_f621f683-cea2-41c9-9d61-e11115d1fb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_46d50d0c-bbda-4ce7-af09-0a0a252fbf77" xlink:href="wst-20191231.xsd#wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees_46d50d0c-bbda-4ce7-af09-0a0a252fbf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_bd5ceed4-4b3a-4a90-b99c-38b17c57acd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToAffiliateCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_DueToAffiliateCurrentAndNoncurrent_bd5ceed4-4b3a-4a90-b99c-38b17c57acd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SalesToEquityMethodInvestees_69684b46-b81e-49a7-b093-8dd5667c72c7" xlink:href="wst-20191231.xsd#wst_SalesToEquityMethodInvestees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_wst_SalesToEquityMethodInvestees_69684b46-b81e-49a7-b093-8dd5667c72c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromAffiliates_88afebf1-0d08-444b-a495-f396ba2b7890" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueFromAffiliates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_DueFromAffiliates_88afebf1-0d08-444b-a495-f396ba2b7890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_07991da6-cdb2-42f1-8615-8b30ce5e5994" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_EquityMethodInvestments_07991da6-cdb2-42f1-8615-8b30ce5e5994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostMethodInvestments_3f13c9c9-0dce-4d7b-8135-952e12640e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_24d1e780-a9d0-47e5-985f-e1848b61f2f0" xlink:to="loc_us-gaap_CostMethodInvestments_3f13c9c9-0dce-4d7b-8135-952e12640e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f8a0840b-d60f-40d5-8f8b-bf1d0fce90c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2cb11c8d-c2a2-49d2-8285-f04525c887e6" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f8a0840b-d60f-40d5-8f8b-bf1d0fce90c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2a5db47-46d6-4b03-9ab7-360e5b6a6e72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_199af0db-ca4a-4282-a4dd-c919cb430fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2a5db47-46d6-4b03-9ab7-360e5b6a6e72" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_199af0db-ca4a-4282-a4dd-c919cb430fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c502134c-2c8c-4dec-8b58-74ae50a55070" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_410cfc16-c1f1-48a7-a297-134cd2c516ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c502134c-2c8c-4dec-8b58-74ae50a55070" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_410cfc16-c1f1-48a7-a297-134cd2c516ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_df50c17d-7580-459c-9e80-b823fc46ddf5" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c502134c-2c8c-4dec-8b58-74ae50a55070" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock_df50c17d-7580-459c-9e80-b823fc46ddf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9dc8b9b0-c9b3-4c95-9326-0751520a3b61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2ff17722-43e7-4a7b-b20b-cf46addc5311" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9dc8b9b0-c9b3-4c95-9326-0751520a3b61" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2ff17722-43e7-4a7b-b20b-cf46addc5311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab260d2d-3216-46db-be99-202cdad7ddbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2ff17722-43e7-4a7b-b20b-cf46addc5311" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab260d2d-3216-46db-be99-202cdad7ddbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab260d2d-3216-46db-be99-202cdad7ddbe" xlink:to="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_151aefc4-48b8-448f-8659-4ed50ad5adbf" xlink:href="wst-20191231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:to="loc_wst_ProprietaryProductsMember_151aefc4-48b8-448f-8659-4ed50ad5adbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_d2428b8d-c265-454a-854a-c702900eb70d" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3566628d-73fc-427d-bb6c-fb1b3629cc94" xlink:to="loc_wst_ContractManufacturedProductsMember_d2428b8d-c265-454a-854a-c702900eb70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_892c41e5-3ce2-4f98-abd4-bd98c15065ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2ff17722-43e7-4a7b-b20b-cf46addc5311" xlink:to="loc_us-gaap_GoodwillLineItems_892c41e5-3ce2-4f98-abd4-bd98c15065ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_892c41e5-3ce2-4f98-abd4-bd98c15065ef" xlink:to="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b758635d-01d9-44a6-975f-b55f4c163774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:to="loc_us-gaap_Goodwill_b758635d-01d9-44a6-975f-b55f4c163774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8fb93a2d-b272-48ac-b044-9b2c1e85dae4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8fb93a2d-b272-48ac-b044-9b2c1e85dae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_979466ef-2151-4d8e-9e61-1414849fd90e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_979466ef-2151-4d8e-9e61-1414849fd90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2dc0239-4f5f-494c-9d29-50153a0e8088" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7882c87d-003f-4810-b98c-f197c4dcc317" xlink:to="loc_us-gaap_Goodwill_e2dc0239-4f5f-494c-9d29-50153a0e8088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a3c27032-49ce-4b9d-937e-4d999872300c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_6cb02951-5bfa-4c88-898f-687c1633f68e" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a3c27032-49ce-4b9d-937e-4d999872300c" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_6cb02951-5bfa-4c88-898f-687c1633f68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_18da69b5-fcdb-464a-adbd-7996921feeca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_6cb02951-5bfa-4c88-898f-687c1633f68e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_18da69b5-fcdb-464a-adbd-7996921feeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_18da69b5-fcdb-464a-adbd-7996921feeca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PatentsAndLicensingMember_663cb0a0-437c-4335-8ffa-6f156f6d45fc" xlink:href="wst-20191231.xsd#wst_PatentsAndLicensingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_wst_PatentsAndLicensingMember_663cb0a0-437c-4335-8ffa-6f156f6d45fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_6ac8887d-452d-4313-8687-6d151690275a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_6ac8887d-452d-4313-8687-6d151690275a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4fb68892-8888-4c97-8a8d-1d785cc60dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_TrademarksMember_4fb68892-8888-4c97-8a8d-1d785cc60dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6339b88a-47b8-4be2-b9c4-f1181804fa39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6339b88a-47b8-4be2-b9c4-f1181804fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_23f76b29-1f09-4582-9231-ba3be9d475c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d064499-6c01-41b7-a178-d67d49311363" xlink:to="loc_us-gaap_CustomerContractsMember_23f76b29-1f09-4582-9231-ba3be9d475c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:href="wst-20191231.xsd#wst_ScheduleOfIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassTable_6cb02951-5bfa-4c88-898f-687c1633f68e" xlink:to="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_aecfb4b4-d86b-432b-a40a-a88ea49748a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_aecfb4b4-d86b-432b-a40a-a88ea49748a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_afc5f806-b374-4ba8-bc33-d85e5383c200" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_afc5f806-b374-4ba8-bc33-d85e5383c200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914ce17b-f8fd-43d9-8ffb-da030c291b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems_07036fde-1aa4-413d-a86d-fae3f234060a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_914ce17b-f8fd-43d9-8ffb-da030c291b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#GoodwillandIntangibleAssetsTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd97064f-1712-4038-a201-61b576033cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd97064f-1712-4038-a201-61b576033cd5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_16400a1e-42d4-4466-b8b7-401f9b90664a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:to="loc_us-gaap_RestructuringPlanAxis_16400a1e-42d4-4466-b8b7-401f9b90664a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_03860fc9-9819-41f6-9c39-0d7724ab728f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_16400a1e-42d4-4466-b8b7-401f9b90664a" xlink:to="loc_us-gaap_RestructuringPlanDomain_03860fc9-9819-41f6-9c39-0d7724ab728f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2016RestructuringPlanMemberMember_07e18670-cd13-486f-83fa-2fbed7002e4d" xlink:href="wst-20191231.xsd#wst_A2016RestructuringPlanMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_03860fc9-9819-41f6-9c39-0d7724ab728f" xlink:to="loc_wst_A2016RestructuringPlanMemberMember_07e18670-cd13-486f-83fa-2fbed7002e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1b086568-ea86-4632-8fe4-63f36b1d6809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1b086568-ea86-4632-8fe4-63f36b1d6809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_29f7bcec-e8e3-4dad-87ab-dbb662cfb646" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_1b086568-ea86-4632-8fe4-63f36b1d6809" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_29f7bcec-e8e3-4dad-87ab-dbb662cfb646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_b016278b-d514-4857-a265-bb081e0822fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_29f7bcec-e8e3-4dad-87ab-dbb662cfb646" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_b016278b-d514-4857-a265-bb081e0822fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b88fca2a-48d7-4a16-96c3-9b5917acea02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatent_c799abf2-b0c4-4bcf-8181-e33043c659b6" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_wst_AssetImpairmentChargesPatent_c799abf2-b0c4-4bcf-8181-e33043c659b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesTrademark_3d746f7d-2a4d-4e3c-8818-61595fa36d4c" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesTrademark"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_wst_AssetImpairmentChargesTrademark_3d746f7d-2a4d-4e3c-8818-61595fa36d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_6c8f3f5c-b21e-4590-9fa5-d99910200bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_6c8f3f5c-b21e-4590-9fa5-d99910200bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_88e83309-a0b4-46d3-90e3-5625c47ab963" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_88e83309-a0b4-46d3-90e3-5625c47ab963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1eaa510c-9cee-42bc-a1b1-4972a1017729" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1eaa510c-9cee-42bc-a1b1-4972a1017729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_df618263-2023-4137-97a8-4b07cc3fd852" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_df618263-2023-4137-97a8-4b07cc3fd852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7fb92298-fecf-423a-ba03-ff36340ff04a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7fb92298-fecf-423a-ba03-ff36340ff04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50ea0050-a212-48b1-817a-2d5cbb071609" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50ea0050-a212-48b1-817a-2d5cbb071609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ac77d5af-9265-4e92-b2d2-1bec89c58626" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3879f02e-0e80-4ea2-9ec7-22dd14cec022" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ac77d5af-9265-4e92-b2d2-1bec89c58626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_16329b7b-bf39-4715-b36d-b7c1e1dd2dc5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd97064f-1712-4038-a201-61b576033cd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_16329b7b-bf39-4715-b36d-b7c1e1dd2dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f85cb94c-1e21-4be7-a6c0-5401f6f3e085" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd97064f-1712-4038-a201-61b576033cd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_f85cb94c-1e21-4be7-a6c0-5401f6f3e085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_884db8bd-9184-478e-80d4-a496bc45a26c" xlink:href="wst-20191231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_3b2e09ff-aeae-4e20-aeef-bfdd2f9f6601" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_884db8bd-9184-478e-80d4-a496bc45a26c" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_3b2e09ff-aeae-4e20-aeef-bfdd2f9f6601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_9f154471-0918-4003-b315-0898652ef489" xlink:href="wst-20191231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_d1d1652f-b78b-483a-a307-25254e3044b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_9f154471-0918-4003-b315-0898652ef489" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_d1d1652f-b78b-483a-a307-25254e3044b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:href="wst-20191231.xsd#wst_OtherCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_24182deb-3fb5-4091-9b03-5e5dbd772d33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_DeferredRevenueCurrent_24182deb-3fb5-4091-9b03-5e5dbd772d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_f38d6e81-ee6a-4388-857d-0caf96be410c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_DividendsPayableCurrent_f38d6e81-ee6a-4388-857d-0caf96be410c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_ceab539f-b490-4bf0-b632-432e5d2fff48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_ceab539f-b490-4bf0-b632-432e5d2fff48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_10369bea-01e8-4660-b702-e2b86bfcf92d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent_10369bea-01e8-4660-b702-e2b86bfcf92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_35395cdb-5a4f-4ce7-a160-7514621f84d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_35395cdb-5a4f-4ce7-a160-7514621f84d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_f774a688-10d7-4f95-9e56-3e15041df699" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_f774a688-10d7-4f95-9e56-3e15041df699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_c0c80ab2-d942-4977-a750-9a1ef3dcfdc8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_InterestPayableCurrent_c0c80ab2-d942-4977-a750-9a1ef3dcfdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7c255f14-8776-4855-88b3-66c2f0fdba98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_RestructuringReserve_7c255f14-8776-4855-88b3-66c2f0fdba98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_f28f431c-d682-472a-bee3-eab52fef2b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_f28f431c-d682-472a-bee3-eab52fef2b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f177f9cd-8f2f-4823-a807-ac32bb553cea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherCurrentLiabilitiesAbstract_6777364a-8561-4138-8943-f2ac808690de" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f177f9cd-8f2f-4823-a807-ac32bb553cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20191231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dbc2e8d1-34b4-4560-bea9-c32610ed3b04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_232c710b-2baf-4238-8bd8-2d5bed1d27d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dbc2e8d1-34b4-4560-bea9-c32610ed3b04" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_232c710b-2baf-4238-8bd8-2d5bed1d27d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4924bf2c-e288-4a64-9bf7-b69a8b18dbe2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_6c60e2e9-a01c-4c8e-a6ea-fbc3d789c2e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4924bf2c-e288-4a64-9bf7-b69a8b18dbe2" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_6c60e2e9-a01c-4c8e-a6ea-fbc3d789c2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7cf2d25e-900a-4bf6-b17b-09e346a0f4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7cf2d25e-900a-4bf6-b17b-09e346a0f4a1" xlink:to="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_82f61a49-eb08-498e-adae-a00a58db3fb0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:to="loc_srt_RangeAxis_82f61a49-eb08-498e-adae-a00a58db3fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_82f61a49-eb08-498e-adae-a00a58db3fb0" xlink:to="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31d40d68-d7b0-4268-a064-a30ddca78cdb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:to="loc_srt_MinimumMember_31d40d68-d7b0-4268-a064-a30ddca78cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a9eadd5f-a0c4-4553-808c-1afa801006fb" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4897dd33-e655-4f58-9075-ef274dbeefec" xlink:to="loc_srt_MaximumMember_a9eadd5f-a0c4-4553-808c-1afa801006fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_be22783d-d290-46aa-b1dd-b7f6ab732d92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_be22783d-d290-46aa-b1dd-b7f6ab732d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_be22783d-d290-46aa-b1dd-b7f6ab732d92" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2017Member_efb1da26-6cb8-49c6-a590-1e02f68ef872" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_RevolvingCreditFacilityDue2017Member_efb1da26-6cb8-49c6-a590-1e02f68ef872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NotePayableDue2019Member_1385398d-ee1e-427e-82b6-8f2ea5c3f1a3" xlink:href="wst-20191231.xsd#wst_NotePayableDue2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_NotePayableDue2019Member_1385398d-ee1e-427e-82b6-8f2ea5c3f1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Revolvingcreditfacilitydue2020Member_f4d1906a-f05a-4643-bd78-f0bfeb83879c" xlink:href="wst-20191231.xsd#wst_Revolvingcreditfacilitydue2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_Revolvingcreditfacilitydue2020Member_f4d1906a-f05a-4643-bd78-f0bfeb83879c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_527795bf-dc7d-4180-a476-b2813204688b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_us-gaap_SeniorNotesMember_527795bf-dc7d-4180-a476-b2813204688b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Domain_8f8c2a10-d318-48af-8f52-bd7b18258cff" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Domain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_TermLoanDue2024Domain_8f8c2a10-d318-48af-8f52-bd7b18258cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_c76981af-571a-470d-afc3-0815c6aa398b" xlink:href="wst-20191231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_SeniorNotesDue2022Member_c76981af-571a-470d-afc3-0815c6aa398b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_883abb0f-e4f7-44a1-adfb-97e10ba997c9" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_381b736e-d17b-45b4-99bd-365af5e3a086" xlink:to="loc_wst_TermLoanDue2024Member_883abb0f-e4f7-44a1-adfb-97e10ba997c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d1f291d1-e3a6-4227-9331-6033d908ca4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:to="loc_us-gaap_DebtInstrumentAxis_d1f291d1-e3a6-4227-9331-6033d908ca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d1f291d1-e3a6-4227-9331-6033d908ca4b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_722205a6-0445-4d28-8d99-b8a4631fa7bd" xlink:href="wst-20191231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:to="loc_wst_SeniorNotesDue2022Member_722205a6-0445-4d28-8d99-b8a4631fa7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_5d7e3c4d-e389-44af-be0a-527a9583d2d9" xlink:href="wst-20191231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:to="loc_wst_SeniorBNotesDue2024Member_5d7e3c4d-e389-44af-be0a-527a9583d2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_ea5baf96-0503-4f79-9cb3-c426f65d53d8" xlink:href="wst-20191231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3c6f8d8e-f9d0-4b6e-b10e-cb248223052d" xlink:to="loc_wst_SeniorCNotesDue2027Member_ea5baf96-0503-4f79-9cb3-c426f65d53d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b7664cb-d475-40b4-b7b5-11e20846253e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1504959e-0e27-467e-b3ef-6e0eb8572580" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1504959e-0e27-467e-b3ef-6e0eb8572580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_807b490f-eb48-4a75-803a-f592d8ee2277" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_LongTermDebt_807b490f-eb48-4a75-803a-f592d8ee2277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_fcf6f39b-4e26-4818-9e5a-62df14172121" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_fcf6f39b-4e26-4818-9e5a-62df14172121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_30127c77-484f-4c12-9d38-a91dc90e2f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_LongTermLineOfCredit_30127c77-484f-4c12-9d38-a91dc90e2f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_c382075d-0ae8-4c8d-bf16-b0cad9528691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtCurrent_c382075d-0ae8-4c8d-bf16-b0cad9528691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5dcf617e-5cea-4a05-820a-74e59194459f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5dcf617e-5cea-4a05-820a-74e59194459f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1707acf2-fe30-4952-b920-9df1b38fc83f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1707acf2-fe30-4952-b920-9df1b38fc83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_71babc19-5129-4aa0-ad14-b0ab5f0d1735" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_216cc399-6124-4977-a13e-042bd05db0c9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_71babc19-5129-4aa0-ad14-b0ab5f0d1735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DebtTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DebtTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5fa876a5-3a66-4ba6-9df8-e8332ce90f61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5fa876a5-3a66-4ba6-9df8-e8332ce90f61" xlink:to="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_812674dd-5de9-45a4-a917-34afd6fd2c37" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_srt_RangeAxis_812674dd-5de9-45a4-a917-34afd6fd2c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_812674dd-5de9-45a4-a917-34afd6fd2c37" xlink:to="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1537409b-cc2c-4618-9b08-5788eb3364fe" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:to="loc_srt_MinimumMember_1537409b-cc2c-4618-9b08-5788eb3364fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6a88a25c-9a8e-4ecb-8d14-8436bb87a092" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cec199df-dbb3-49b7-a8be-7954f33e2ae9" xlink:to="loc_srt_MaximumMember_6a88a25c-9a8e-4ecb-8d14-8436bb87a092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c594df43-6817-45d8-a07b-d1abb9475382" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c594df43-6817-45d8-a07b-d1abb9475382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_024e91f1-e223-43d9-975a-aa7ad24675ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c594df43-6817-45d8-a07b-d1abb9475382" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_024e91f1-e223-43d9-975a-aa7ad24675ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_497fb106-6099-4338-9cb5-df774229e868" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_CreditFacilityAxis_497fb106-6099-4338-9cb5-df774229e868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_497fb106-6099-4338-9cb5-df774229e868" xlink:to="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_110d0027-7f29-443a-91f5-058c0d130804" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_BaseRateMember_110d0027-7f29-443a-91f5-058c0d130804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_883bc111-b264-4090-89bd-1cc263da83db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_883bc111-b264-4090-89bd-1cc263da83db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_52180ad9-d5d1-4f34-bb1f-d2c1544da31f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_LetterOfCreditMember_52180ad9-d5d1-4f34-bb1f-d2c1544da31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticLineOfCreditMember_735d03df-9d08-42a7-8704-b4274796ad29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticLineOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_DomesticLineOfCreditMember_735d03df-9d08-42a7-8704-b4274796ad29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignLineOfCreditMember_3afe1202-2980-4a5d-83e0-958c7e9c3c9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignLineOfCreditMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_ForeignLineOfCreditMember_3afe1202-2980-4a5d-83e0-958c7e9c3c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_86fe8442-3bdd-4ec4-9423-563db1ae4b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f94cb8f4-f81c-4f74-bc77-557c7060269c" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_86fe8442-3bdd-4ec4-9423-563db1ae4b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0a7a22c6-6607-4976-9406-8f8f617654cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0a7a22c6-6607-4976-9406-8f8f617654cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0a7a22c6-6607-4976-9406-8f8f617654cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Revolvingcreditfacilitydue2020Member_f14b881d-6314-44af-8edb-b836b906ac9e" xlink:href="wst-20191231.xsd#wst_Revolvingcreditfacilitydue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_wst_Revolvingcreditfacilitydue2020Member_f14b881d-6314-44af-8edb-b836b906ac9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6d7d841e-1d8c-424a-83c2-bbe91670c1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_us-gaap_SeniorNotesMember_6d7d841e-1d8c-424a-83c2-bbe91670c1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_971c9e2b-ecbc-47b7-ae64-3e56fee7a43b" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_971c9e2b-ecbc-47b7-ae64-3e56fee7a43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TermLoanDue2024Member_ad7814f7-b057-4020-a206-34ec9f833aa9" xlink:href="wst-20191231.xsd#wst_TermLoanDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_033aa68e-74a1-4113-b030-9232d2e13e2a" xlink:to="loc_wst_TermLoanDue2024Member_ad7814f7-b057-4020-a206-34ec9f833aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_292c7db8-943e-4bdd-844d-1780eda25add" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_DebtInstrumentAxis_292c7db8-943e-4bdd-844d-1780eda25add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_292c7db8-943e-4bdd-844d-1780eda25add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorNotesDue2022Member_fc7abc39-3ca6-497f-9b1e-a809f131456a" xlink:href="wst-20191231.xsd#wst_SeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:to="loc_wst_SeniorNotesDue2022Member_fc7abc39-3ca6-497f-9b1e-a809f131456a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorBNotesDue2024Member_d8ac171f-5950-441d-b84a-e6268e7d5c35" xlink:href="wst-20191231.xsd#wst_SeniorBNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:to="loc_wst_SeniorBNotesDue2024Member_d8ac171f-5950-441d-b84a-e6268e7d5c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SeniorCNotesDue2027Member_92ef2da0-d934-4b2b-9e0f-72013d925455" xlink:href="wst-20191231.xsd#wst_SeniorCNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5c0628d5-354e-4a12-9a51-01349f95fc3b" xlink:to="loc_wst_SeniorCNotesDue2027Member_92ef2da0-d934-4b2b-9e0f-72013d925455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19467b43-5c4c-4cd1-b340-3bba3e87fbb8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9d75ab53-5b64-4f1f-937a-b7dcc1e3fe49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_9d75ab53-5b64-4f1f-937a-b7dcc1e3fe49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LineofCreditFacilityAdditionalBorrowingCapacity_b1978545-a493-4bed-8ba3-a617f60050b1" xlink:href="wst-20191231.xsd#wst_LineofCreditFacilityAdditionalBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_LineofCreditFacilityAdditionalBorrowingCapacity_b1978545-a493-4bed-8ba3-a617f60050b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_e18088c5-9210-4d00-8ac5-e556b4318aa2" xlink:href="wst-20191231.xsd#wst_CreditFacilityIsAvailableForSwingLineLoans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_CreditFacilityIsAvailableForSwingLineLoans_e18088c5-9210-4d00-8ac5-e556b4318aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_f0cce2cf-7fa1-4a34-bfd1-fee71a6b16e1" xlink:href="wst-20191231.xsd#wst_CreditAvailableForIssuanceOfLettersOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_CreditAvailableForIssuanceOfLettersOfCredit_f0cce2cf-7fa1-4a34-bfd1-fee71a6b16e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4d700345-eb44-45cf-8463-8fb41223a3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebt_4d700345-eb44-45cf-8463-8fb41223a3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8e03ab05-3b36-4e05-9313-0c8ff2b9aef6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebtCurrent_8e03ab05-3b36-4e05-9313-0c8ff2b9aef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_04374da6-6ecf-480b-91fe-9f81fc8444f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_04374da6-6ecf-480b-91fe-9f81fc8444f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_40695d2b-07e5-4ad8-82c9-270c3e98d949" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermLineOfCredit_40695d2b-07e5-4ad8-82c9-270c3e98d949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotionalAmountOfNonderivativeInstruments_2463fc6d-1fa8-468c-9a66-27e0092d4abf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotionalAmountOfNonderivativeInstruments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_NotionalAmountOfNonderivativeInstruments_2463fc6d-1fa8-468c-9a66-27e0092d4abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_406bed39-8527-49b9-b16e-ff5106723626" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LineOfCredit_406bed39-8527-49b9-b16e-ff5106723626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9f755acb-b77c-410c-bc7f-9e9cf8f5d71b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9f755acb-b77c-410c-bc7f-9e9cf8f5d71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_99a12ac6-c660-49ff-b242-13eba24e72bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_99a12ac6-c660-49ff-b242-13eba24e72bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_934a4312-6d4b-4195-830d-de00ae17ada9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment_934a4312-6d4b-4195-830d-de00ae17ada9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2235eb35-3a58-4daf-9305-1a00ef4e4415" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2235eb35-3a58-4daf-9305-1a00ef4e4415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_97a96dc6-2383-45e9-89fd-9b29ffc652ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_97a96dc6-2383-45e9-89fd-9b29ffc652ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f55ee5ae-a87e-4ce8-ae66-00ca5e3ef7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f55ee5ae-a87e-4ce8-ae66-00ca5e3ef7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_dbe8fa17-7d16-462f-b02c-6dbaf07789d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentTerm_dbe8fa17-7d16-462f-b02c-6dbaf07789d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_ffb0c416-dcc4-450d-a581-308f35b1a846" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_ffb0c416-dcc4-450d-a581-308f35b1a846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a82a185b-01a0-48df-a3ed-189017969212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a82a185b-01a0-48df-a3ed-189017969212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e840a7ba-d3c6-4c74-a110-5520793a78be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e840a7ba-d3c6-4c74-a110-5520793a78be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c49f4ffc-0aef-4939-9948-1be63a5437f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_c49f4ffc-0aef-4939-9948-1be63a5437f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification_437edb11-3ac8-4be9-87c9-8f333eb11a86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification_437edb11-3ac8-4be9-87c9-8f333eb11a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_ac7ffd46-238a-449a-9478-6b3e0fd78092" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_ac7ffd46-238a-449a-9478-6b3e0fd78092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_79eafca1-aff7-4c29-9d36-238e1997fcb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_InterestExpenseDebt_79eafca1-aff7-4c29-9d36-238e1997fcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_57748f4a-17fe-4b92-9c49-d401cce39378" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_57748f4a-17fe-4b92-9c49-d401cce39378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_88591a59-3e07-4de2-8458-9af299a4cfee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_88591a59-3e07-4de2-8458-9af299a4cfee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8ff37681-175a-4e74-bd84-5651c06fb016" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8ff37681-175a-4e74-bd84-5651c06fb016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5401a9d0-1c78-4e89-b388-5f287b1d2e21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5401a9d0-1c78-4e89-b388-5f287b1d2e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a9aa475a-069a-4681-b0e2-d6881d1595d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a9aa475a-069a-4681-b0e2-d6881d1595d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d9a85014-da05-4b28-8ad3-15c33b68f2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5fc68ee2-e58e-4b68-a403-2784a80592e9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d9a85014-da05-4b28-8ad3-15c33b68f2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RatioOfDebtToEBITDA_6809b513-8c5b-4cf5-be66-b7ba48965e70" xlink:href="wst-20191231.xsd#wst_RatioOfDebtToEBITDA"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bbabb26-01fd-4210-b141-f0c93f3d3e2b" xlink:to="loc_wst_RatioOfDebtToEBITDA_6809b513-8c5b-4cf5-be66-b7ba48965e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_89b6ec6f-730a-40df-8dbb-adc3304cf765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5fa876a5-3a66-4ba6-9df8-e8332ce90f61" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths_89b6ec6f-730a-40df-8dbb-adc3304cf765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b093a929-64e2-4c08-831d-8004f0a03871" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fc31199e-5fd8-48b3-ba10-f85b8007bc45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b093a929-64e2-4c08-831d-8004f0a03871" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fc31199e-5fd8-48b3-ba10-f85b8007bc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_986a2361-52b3-4efc-a5a3-dd87d05b54c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7e5c6e4f-08b0-4f8e-bdcd-d1f6e1591830" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_986a2361-52b3-4efc-a5a3-dd87d05b54c1" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7e5c6e4f-08b0-4f8e-bdcd-d1f6e1591830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_9acbd1c2-ff5b-43a3-9cac-9851bd6f6335" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_986a2361-52b3-4efc-a5a3-dd87d05b54c1" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_9acbd1c2-ff5b-43a3-9cac-9851bd6f6335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dcabd9ec-ab12-46fb-ab9e-3fd3cece34f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_986a2361-52b3-4efc-a5a3-dd87d05b54c1" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dcabd9ec-ab12-46fb-ab9e-3fd3cece34f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15b8beb9-9299-4786-b9f0-506e1477bec3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_15b8beb9-9299-4786-b9f0-506e1477bec3" xlink:to="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_8a6e6772-9f39-4870-be36-4d306971bc81" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_srt_CurrencyAxis_8a6e6772-9f39-4870-be36-4d306971bc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_8a6e6772-9f39-4870-be36-4d306971bc81" xlink:to="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_1b2ddad9-6b84-4268-954d-661a7d9feeb9" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_EUR_1b2ddad9-6b84-4268-954d-661a7d9feeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_cad45503-3fb7-405d-bf2a-99cd6532f720" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_USD_cad45503-3fb7-405d-bf2a-99cd6532f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_a7482d44-db99-4045-a592-277b90b5c15a" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_JPY_a7482d44-db99-4045-a592-277b90b5c15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_798ce367-a6f3-4f20-96d3-0a858ee7218a" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_SGD"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_88889c54-1e86-4a48-9cfc-570ede23df17" xlink:to="loc_currency_SGD_798ce367-a6f3-4f20-96d3-0a858ee7218a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_04dac43a-2a95-412f-9d74-2dfcfdad64e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_PositionAxis_04dac43a-2a95-412f-9d74-2dfcfdad64e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_04dac43a-2a95-412f-9d74-2dfcfdad64e1" xlink:to="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongMember_3b23a227-1977-494a-a9fc-9036e9706243" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:to="loc_us-gaap_LongMember_3b23a227-1977-494a-a9fc-9036e9706243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortMember_f4f1ddeb-daf9-4a51-9456-3b84a113634c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionDomain_9ec126aa-90b4-40c5-9057-7a722d11cec8" xlink:to="loc_us-gaap_ShortMember_f4f1ddeb-daf9-4a51-9456-3b84a113634c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_40b4f0dc-10ab-452e-b7f2-5f209f1a4387" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_40b4f0dc-10ab-452e-b7f2-5f209f1a4387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_40b4f0dc-10ab-452e-b7f2-5f209f1a4387" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6169cf59-6301-4144-8529-15b3b034b9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6169cf59-6301-4144-8529-15b3b034b9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_aaa3712d-27c1-4322-a016-c85651480f69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_TreasuryLockMember_aaa3712d-27c1-4322-a016-c85651480f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardStartInterestRateSwapMember_29115ecc-36a8-40d2-b5b4-b3e1fef19494" xlink:href="wst-20191231.xsd#wst_ForwardStartInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_wst_ForwardStartInterestRateSwapMember_29115ecc-36a8-40d2-b5b4-b3e1fef19494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_922976fd-c7d5-46d8-8ba5-6897d522108c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_ForwardContractsMember_922976fd-c7d5-46d8-8ba5-6897d522108c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtMember_8d7cd253-f914-411e-9648-49c1cb27d377" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_DebtMember_8d7cd253-f914-411e-9648-49c1cb27d377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EuroDenominatedRevolverMember_812209eb-54c0-461e-9c71-a1b4765461ab" xlink:href="wst-20191231.xsd#wst_EuroDenominatedRevolverMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_wst_EuroDenominatedRevolverMember_812209eb-54c0-461e-9c71-a1b4765461ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DebtYenDenominatedMember_a727d2b5-c93a-49fe-93cc-bd99de38a4ef" xlink:href="wst-20191231.xsd#wst_DebtYenDenominatedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_wst_DebtYenDenominatedMember_a727d2b5-c93a-49fe-93cc-bd99de38a4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_7f2dfe2d-ebe0-45da-a413-7cfa2ee2f60d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_CommodityOptionMember_7f2dfe2d-ebe0-45da-a413-7cfa2ee2f60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_389ed045-016d-4336-8f31-aafa2b346841" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_OptionMember_389ed045-016d-4336-8f31-aafa2b346841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_b3fc90d4-f893-411f-ac7e-f8dab4403c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_62342b5b-72f3-4ee8-a60d-d291fe5f31d9" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_b3fc90d4-f893-411f-ac7e-f8dab4403c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9735cb8e-3d42-4b92-837c-19cfd5627548" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_de3661a2-7a34-4793-bbd9-f8e0d4d51bbd" xlink:to="loc_us-gaap_HedgingDesignationDomain_9735cb8e-3d42-4b92-837c-19cfd5627548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aad22edf-89f7-49a4-a889-d5e8f86f5397" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9735cb8e-3d42-4b92-837c-19cfd5627548" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_aad22edf-89f7-49a4-a889-d5e8f86f5397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0f149bcc-4691-473a-91be-f2bd7deeb849" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0f149bcc-4691-473a-91be-f2bd7deeb849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_62fa4852-7a57-485b-a92c-11c446977840" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0f149bcc-4691-473a-91be-f2bd7deeb849" xlink:to="loc_us-gaap_HedgingRelationshipDomain_62fa4852-7a57-485b-a92c-11c446977840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_a60d95cb-0481-4a38-bcc9-97992ec45958" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_62fa4852-7a57-485b-a92c-11c446977840" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_a60d95cb-0481-4a38-bcc9-97992ec45958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_41f463ab-47c4-4b7b-afe4-19ba541d41a1" xlink:to="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_8f63ef6c-6af8-4fb3-b592-05f46fe71c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAveragePriceRiskOptionStrikePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:to="loc_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice_8f63ef6c-6af8-4fb3-b592-05f46fe71c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_3388aa64-a1f1-4fd9-bff9-2a4857631b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNonmonetaryNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:to="loc_us-gaap_DerivativeNonmonetaryNotionalAmount_3388aa64-a1f1-4fd9-bff9-2a4857631b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_adee1b0a-38c5-49ac-92e4-afb68961efe6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fc731841-7754-4998-8eb2-eeefe6b7fefb" xlink:to="loc_us-gaap_DerivativeNotionalAmount_adee1b0a-38c5-49ac-92e4-afb68961efe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0f814100-1e40-4d0b-a6b0-e65097ef5ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0f814100-1e40-4d0b-a6b0-e65097ef5ccc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_99fe0131-5a42-4223-8e1d-0b7c690b7a93" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_srt_CurrencyAxis_99fe0131-5a42-4223-8e1d-0b7c690b7a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_99fe0131-5a42-4223-8e1d-0b7c690b7a93" xlink:to="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_562ddcd5-7846-4ebe-89b8-3c04012f3f90" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_EUR_562ddcd5-7846-4ebe-89b8-3c04012f3f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_SGD_0b253a89-0771-4503-b9c3-72a3f3a79d66" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_SGD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_SGD_0b253a89-0771-4503-b9c3-72a3f3a79d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_8093101b-4734-4c73-a83a-94d687b32616" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_USD_8093101b-4734-4c73-a83a-94d687b32616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_6fa80e35-0477-4c65-91f5-1559a4bd6fd0" xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_db01b4bc-2909-4f7a-adba-c6f54a640bfa" xlink:to="loc_currency_JPY_6fa80e35-0477-4c65-91f5-1559a4bd6fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_713020d8-0f71-4346-a398-1991217993e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_713020d8-0f71-4346-a398-1991217993e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_713020d8-0f71-4346-a398-1991217993e6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_bd82fec4-eae2-42d8-98bd-84722d980f56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_ForwardContractsMember_bd82fec4-eae2-42d8-98bd-84722d980f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionMember_694aa323-ecbf-475d-874f-c147eb834de1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_OptionMember_694aa323-ecbf-475d-874f-c147eb834de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_45dd37b3-f076-41be-bad5-894d2f533f22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_ForeignExchangeContractMember_45dd37b3-f076-41be-bad5-894d2f533f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_dfcfcab2-c88f-4ff5-a69c-b4b25566f729" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_InterestRateSwapMember_dfcfcab2-c88f-4ff5-a69c-b4b25566f729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForwardTreasuryLockMember_0fb99b4c-7679-4e9f-b2ab-833aee303e69" xlink:href="wst-20191231.xsd#wst_ForwardTreasuryLockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_wst_ForwardTreasuryLockMember_0fb99b4c-7679-4e9f-b2ab-833aee303e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ForeignCurrencyDenominatedDebtMember_1a9ebff7-2a31-470b-b6bd-ec942a0760e6" xlink:href="wst-20191231.xsd#wst_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_wst_ForeignCurrencyDenominatedDebtMember_1a9ebff7-2a31-470b-b6bd-ec942a0760e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommodityOptionMember_23183b8f-a04f-4e40-965e-33adcb7836e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommodityOptionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_CommodityOptionMember_23183b8f-a04f-4e40-965e-33adcb7836e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b12e5d70-f21f-40c4-a6ba-1bf746bf94a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_CurrencySwapMember_b12e5d70-f21f-40c4-a6ba-1bf746bf94a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_41a9ae54-19d5-47a9-b7df-182aa3cdaaed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7026b48a-fab7-49c1-b374-c1b7ca7a7182" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_41a9ae54-19d5-47a9-b7df-182aa3cdaaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_33322f7d-5db8-4029-87fd-01b673eea16a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_33322f7d-5db8-4029-87fd-01b673eea16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_33322f7d-5db8-4029-87fd-01b673eea16a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_NetSalesMember_df76cff1-dee2-4d55-b308-51493fdce320" xlink:href="wst-20191231.xsd#wst_NetSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_wst_NetSalesMember_df76cff1-dee2-4d55-b308-51493fdce320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_91c2c4a0-d3f5-42dd-8053-498ca60cf5fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_CostOfSalesMember_91c2c4a0-d3f5-42dd-8053-498ca60cf5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_bc6952e6-7d99-422a-8504-f2d7adc4cdce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_InterestExpenseMember_bc6952e6-7d99-422a-8504-f2d7adc4cdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_82e525d7-5a2e-4de9-b10b-7ebb1c3cc911" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_82e525d7-5a2e-4de9-b10b-7ebb1c3cc911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_54fcf87f-dcbf-40fc-b575-2cc18bbab766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_54fcf87f-dcbf-40fc-b575-2cc18bbab766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_7e8e41e4-bf96-4b61-91de-1f94dcac28f2" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d682d7ad-44f3-47a2-991f-9d063618943f" xlink:to="loc_wst_OtherIncomeExpense_7e8e41e4-bf96-4b61-91de-1f94dcac28f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_41d1b859-ce7f-4251-9f7f-026cc55f709d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_41d1b859-ce7f-4251-9f7f-026cc55f709d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_41d1b859-ce7f-4251-9f7f-026cc55f709d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c6f5aadf-50df-43df-8720-a72c86254039" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_CashFlowHedgingMember_c6f5aadf-50df-43df-8720-a72c86254039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_e5d83d63-4497-49f7-9b70-ea4260057d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_e5d83d63-4497-49f7-9b70-ea4260057d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1222ef41-e99a-4a84-92d9-c94ea7f38cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_NondesignatedMember_1222ef41-e99a-4a84-92d9-c94ea7f38cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_8124945b-e89c-4713-9074-8242c2670f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f639b302-2045-406b-aa57-dac1350b00ec" xlink:to="loc_us-gaap_FairValueHedgingMember_8124945b-e89c-4713-9074-8242c2670f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_346613df-1b70-4e41-8bbd-c7038d525613" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_966d72ba-6dba-4842-aac4-c4a7361500f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_966d72ba-6dba-4842-aac4-c4a7361500f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_9e454a49-a342-45fd-9006-f6d0753a1de5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_9e454a49-a342-45fd-9006-f6d0753a1de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_04cfb798-fe5e-4cef-ba46-a64955b50241" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_04cfb798-fe5e-4cef-ba46-a64955b50241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_73c3470d-d52a-4095-84a6-542ad5e18df3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_73c3470d-d52a-4095-84a6-542ad5e18df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_9fb23f7a-3b56-4599-be80-30cbed1da12d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_9fb23f7a-3b56-4599-be80-30cbed1da12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_93e23c90-08c4-4476-a572-23beccd66c54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_93e23c90-08c4-4476-a572-23beccd66c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_f605a68e-f684-4b29-9a00-91515e47fa90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet_f605a68e-f684-4b29-9a00-91515e47fa90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths_9f481d7f-cf6f-4c2f-9c03-1e98e3149b07" xlink:href="wst-20191231.xsd#wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_060bdf2b-0a5b-48de-b5d5-9bdcb99b191a" xlink:to="loc_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths_9f481d7f-cf6f-4c2f-9c03-1e98e3149b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d0ac9d3a-5162-44ab-a966-0b05bf8ee849" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b7009bf2-293e-4dfc-9b01-db06f87c9dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d0ac9d3a-5162-44ab-a966-0b05bf8ee849" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b7009bf2-293e-4dfc-9b01-db06f87c9dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_98f14a13-a667-4741-ad91-eeed0cdc1136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d4efc124-1717-4b24-8984-8d350c51a475" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_98f14a13-a667-4741-ad91-eeed0cdc1136" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d4efc124-1717-4b24-8984-8d350c51a475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_78916082-4691-49ba-8daa-ace5c40c5e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_98f14a13-a667-4741-ad91-eeed0cdc1136" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_78916082-4691-49ba-8daa-ace5c40c5e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e1f8961d-33d4-44fd-9b1d-dc13173f8816" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e1f8961d-33d4-44fd-9b1d-dc13173f8816" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bf18015-f514-4dc8-848f-faa9369239b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bf18015-f514-4dc8-848f-faa9369239b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7bf18015-f514-4dc8-848f-faa9369239b0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4d713af6-f131-4b96-bc0f-d7f02e3cfa77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4d713af6-f131-4b96-bc0f-d7f02e3cfa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_152d8fab-8cba-4f9c-a880-8eec4e81c36b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_152d8fab-8cba-4f9c-a880-8eec4e81c36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a0a070bb-0486-4825-9d12-d618607e64ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cbb1fe9f-f48b-4fb5-970d-6af16be63689" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a0a070bb-0486-4825-9d12-d618607e64ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0dc59397-beaa-4353-9495-b81f2381c824" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0dc59397-beaa-4353-9495-b81f2381c824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_87bc413e-ff85-40db-abaf-54607b1dd2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0dc59397-beaa-4353-9495-b81f2381c824" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_87bc413e-ff85-40db-abaf-54607b1dd2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_2994c7e6-5de8-4b98-8d9c-653c4d6fda6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_87bc413e-ff85-40db-abaf-54607b1dd2c5" xlink:to="loc_us-gaap_CurrencySwapMember_2994c7e6-5de8-4b98-8d9c-653c4d6fda6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f765762-9b3e-4668-b848-da5fea28621f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_513656f0-c95f-4dce-b790-a62948c8ee87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_513656f0-c95f-4dce-b790-a62948c8ee87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_3cc76752-b456-451b-a741-b6c34a46461d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_3cc76752-b456-451b-a741-b6c34a46461d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_c8240c41-1a14-479b-8784-7cc1177d595a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a7f0d762-67a7-4f97-ad0c-c9e7e0430e03" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_c8240c41-1a14-479b-8784-7cc1177d595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_84b290ac-f075-49a2-8a73-72439bef46f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_84b290ac-f075-49a2-8a73-72439bef46f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a48b358e-5681-47ce-8204-3c57b461aac2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5ab7ac32-60af-47c5-a87a-13479f275f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5ab7ac32-60af-47c5-a87a-13479f275f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_34faae9a-7ada-4f4a-bdea-587f13d412c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_34faae9a-7ada-4f4a-bdea-587f13d412c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_9081bb6e-b1d8-41fd-810a-8ca0471be5ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_9081bb6e-b1d8-41fd-810a-8ca0471be5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_dea036ec-85fb-4b91-aea2-9689c53ab4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_dea036ec-85fb-4b91-aea2-9689c53ab4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_511c33c2-d4fd-42ac-bf1f-b32c94fffc0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_57cc1901-657c-4701-b3e0-7515cd146601" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_511c33c2-d4fd-42ac-bf1f-b32c94fffc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e1f4e7b6-3de7-4694-9771-0cc1da3f8e04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2d225c29-3368-4325-9358-8179344f38eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e1f4e7b6-3de7-4694-9771-0cc1da3f8e04" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2d225c29-3368-4325-9358-8179344f38eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_35bdcd31-2c4d-4e9d-9f80-88a0d5279ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2d225c29-3368-4325-9358-8179344f38eb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_35bdcd31-2c4d-4e9d-9f80-88a0d5279ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6f7f1c28-c688-425c-8ae7-6a8a51ff8d65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2d225c29-3368-4325-9358-8179344f38eb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_6f7f1c28-c688-425c-8ae7-6a8a51ff8d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2896786e-303c-482d-81b8-3ca217aaef5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2d225c29-3368-4325-9358-8179344f38eb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2896786e-303c-482d-81b8-3ca217aaef5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3839d8bd-ed94-4a79-b720-598c1ecfc2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2d225c29-3368-4325-9358-8179344f38eb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3839d8bd-ed94-4a79-b720-598c1ecfc2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#FairValueMeasurementsOtherFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherFinancialInstrumentsAbstract_bb99ed2d-0aed-4e68-8a2e-9e3edad811b8" xlink:href="wst-20191231.xsd#wst_OtherFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_56c9cf30-48be-419e-86c8-87ca3d39c85b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract_bb99ed2d-0aed-4e68-8a2e-9e3edad811b8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_56c9cf30-48be-419e-86c8-87ca3d39c85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_eeee96b1-11e1-461a-96ab-06d45a5e11b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherFinancialInstrumentsAbstract_bb99ed2d-0aed-4e68-8a2e-9e3edad811b8" xlink:to="loc_us-gaap_LongTermDebtFairValue_eeee96b1-11e1-461a-96ab-06d45a5e11b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20191231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8d8c4c7a-d10b-4851-9fd9-e580aeb72ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b65f6938-7674-44ab-8f08-73948e377dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8d8c4c7a-d10b-4851-9fd9-e580aeb72ec9" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b65f6938-7674-44ab-8f08-73948e377dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20191231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9385983c-03ad-45f7-a342-a42d770c8892" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e3a8a687-e6f3-452f-bd86-76064e287dea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9385983c-03ad-45f7-a342-a42d770c8892" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e3a8a687-e6f3-452f-bd86-76064e287dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_3ff75fdb-17d1-439f-abe7-46faf94aa70a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9385983c-03ad-45f7-a342-a42d770c8892" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_3ff75fdb-17d1-439f-abe7-46faf94aa70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ComponentsofAOCIDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ComponentsofAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ComponentsofAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4fd97e22-8003-48d5-a024-56f5af507db7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_db8d4315-a429-456f-bbc9-af8bc3c489b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4fd97e22-8003-48d5-a024-56f5af507db7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_db8d4315-a429-456f-bbc9-af8bc3c489b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0397bc31-5f5f-4ea1-a3f8-141e520b9da1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_db8d4315-a429-456f-bbc9-af8bc3c489b8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0397bc31-5f5f-4ea1-a3f8-141e520b9da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0397bc31-5f5f-4ea1-a3f8-141e520b9da1" xlink:to="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2cd87358-ab64-47f4-8e24-b557424125cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2cd87358-ab64-47f4-8e24-b557424125cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0cdbf850-57b2-4798-9ebc-64d51c6f8ec1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0cdbf850-57b2-4798-9ebc-64d51c6f8ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d061df7c-328d-428c-88bf-7efeaaa6467e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d061df7c-328d-428c-88bf-7efeaaa6467e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b311296-fd04-4670-8306-215df9a8237c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_98a2565f-d701-435a-a1e5-e3ea3be81131" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_6b311296-fd04-4670-8306-215df9a8237c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_db8d4315-a429-456f-bbc9-af8bc3c489b8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dd9f429e-92f9-4b39-af4f-56a0e0dd8dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:to="loc_us-gaap_Revenues_dd9f429e-92f9-4b39-af4f-56a0e0dd8dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9029ba2c-f469-4499-826e-f33b6f3ab49a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d2c40135-fbc9-4606-bfb4-77ccfde84af2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d2c40135-fbc9-4606-bfb4-77ccfde84af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48465e92-ce17-439d-9208-c95e47d2e5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48465e92-ce17-439d-9208-c95e47d2e5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6e07fd8b-f493-4df7-a2ee-e69a849408ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6e07fd8b-f493-4df7-a2ee-e69a849408ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d2256bc-7cd7-4d31-a2ce-59706274af74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d2256bc-7cd7-4d31-a2ce-59706274af74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7033bbc8-7d6c-478c-81e7-d933631ab203" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_abb4d425-048a-4190-ad47-4025244acf58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7033bbc8-7d6c-478c-81e7-d933631ab203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ReclassificationsAOCIDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ReclassificationsAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ReclassificationsAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_601b16a6-61b8-41b5-ab54-05fb9259c1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_601b16a6-61b8-41b5-ab54-05fb9259c1e6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9974eb17-fe8b-4627-8195-c215d207ec72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9974eb17-fe8b-4627-8195-c215d207ec72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fbd162a8-f115-4801-b373-132b5440dc00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_9974eb17-fe8b-4627-8195-c215d207ec72" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fbd162a8-f115-4801-b373-132b5440dc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ea9b115b-750c-4448-a389-9a867d49cd60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_fbd162a8-f115-4801-b373-132b5440dc00" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ea9b115b-750c-4448-a389-9a867d49cd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b526e99c-80f6-4660-8a2f-f5962088a022" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b526e99c-80f6-4660-8a2f-f5962088a022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b526e99c-80f6-4660-8a2f-f5962088a022" xlink:to="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_488cc582-7588-4855-a0b5-3028bc36fda5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_488cc582-7588-4855-a0b5-3028bc36fda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_1a1b9780-811c-4339-b6e7-9ff87c425937" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cb9a0731-498d-447e-adca-41dc47b8221e" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_1a1b9780-811c-4339-b6e7-9ff87c425937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e0864109-c34f-4aed-a1d1-667303770a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e0864109-c34f-4aed-a1d1-667303770a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e0864109-c34f-4aed-a1d1-667303770a5e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f4dd1ae8-025a-4409-b43c-a02d346a0b24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f4dd1ae8-025a-4409-b43c-a02d346a0b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a3f28c76-024f-4696-b7ee-fa09b0cbfc69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:to="loc_us-gaap_InterestRateSwapMember_a3f28c76-024f-4696-b7ee-fa09b0cbfc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_455aab12-6dd2-461f-8c1a-6dedde6c42a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_830129c9-5d2a-4d03-8f7e-c2c02840a703" xlink:to="loc_us-gaap_TreasuryLockMember_455aab12-6dd2-461f-8c1a-6dedde6c42a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3f3205d9-1801-459c-a2b5-f5862ec1f687" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9b3a44d2-042d-4fce-96da-43a2644d565b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_Revenues_9b3a44d2-042d-4fce-96da-43a2644d565b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_46514718-96a1-4553-b7d2-d6fd6ae698b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_46514718-96a1-4553-b7d2-d6fd6ae698b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_18883ff7-ab24-4bac-a59a-fce46ef28c87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_InterestExpense_18883ff7-ab24-4bac-a59a-fce46ef28c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_07043c3d-a032-4b4b-9d7a-08cc091ce5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_07043c3d-a032-4b4b-9d7a-08cc091ce5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4a5391f7-3b80-4b05-b6f3-d74055072b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4a5391f7-3b80-4b05-b6f3-d74055072b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e98ca6b8-f3be-476d-8535-eb7c9a80c70b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e98ca6b8-f3be-476d-8535-eb7c9a80c70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_421a1120-a025-42e6-8a53-263bf3c3af1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_421a1120-a025-42e6-8a53-263bf3c3af1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_27a680e3-309c-48af-9ed5-a5b13102f187" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_27a680e3-309c-48af-9ed5-a5b13102f187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fcbc2ab8-9d3b-4e4c-b29e-56d6d3ffe36a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fcbc2ab8-9d3b-4e4c-b29e-56d6d3ffe36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_86cbf603-b70a-4a2e-97d2-b3361c7d1c07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_95ae38e5-ec4b-4dcb-a11c-50b65f72e990" xlink:to="loc_us-gaap_ProfitLoss_86cbf603-b70a-4a2e-97d2-b3361c7d1c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c25d0030-6a96-4357-9a90-acd95a6de25c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_15eae9b4-1db6-4e17-93de-26793b8184b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c25d0030-6a96-4357-9a90-acd95a6de25c" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_15eae9b4-1db6-4e17-93de-26793b8184b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0ef1632-7652-4727-8531-308bdee3c21f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_e294d4b5-e293-4159-80cd-a04d093a9795" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0ef1632-7652-4727-8531-308bdee3c21f" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_e294d4b5-e293-4159-80cd-a04d093a9795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6b76661b-a312-4d63-ab70-31f4b12196ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0ef1632-7652-4727-8531-308bdee3c21f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6b76661b-a312-4d63-ab70-31f4b12196ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_da5e8db5-7b87-4b5a-840d-5845ad5c8720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0ef1632-7652-4727-8531-308bdee3c21f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_da5e8db5-7b87-4b5a-840d-5845ad5c8720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_321cf329-424d-4fbe-b79b-85e8c1ae4143" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0ef1632-7652-4727-8531-308bdee3c21f" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_321cf329-424d-4fbe-b79b-85e8c1ae4143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_afb31e32-c49e-4263-8bdd-3badb4f3b1ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0ef1632-7652-4727-8531-308bdee3c21f" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_afb31e32-c49e-4263-8bdd-3badb4f3b1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b0bbeda-eb34-4ecc-bdcb-04a9c3f64d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b0bbeda-eb34-4ecc-bdcb-04a9c3f64d8a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d7c291c7-7d25-4fca-b2a2-72f324e34f84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d7c291c7-7d25-4fca-b2a2-72f324e34f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d1350b3e-45f4-483f-8c21-5e598698e189" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d7c291c7-7d25-4fca-b2a2-72f324e34f84" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d1350b3e-45f4-483f-8c21-5e598698e189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_8f51dccb-2cb5-4ec5-aa90-a34ad495e1df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_d1350b3e-45f4-483f-8c21-5e598698e189" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_8f51dccb-2cb5-4ec5-aa90-a34ad495e1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_557adfd3-dda1-4e62-9a7d-622b352567f3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_srt_RangeAxis_557adfd3-dda1-4e62-9a7d-622b352567f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_557adfd3-dda1-4e62-9a7d-622b352567f3" xlink:to="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1e2c1f50-102b-4f7b-a3ab-a683ef4a69ef" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:to="loc_srt_MinimumMember_1e2c1f50-102b-4f7b-a3ab-a683ef4a69ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7f862f53-a60c-45fe-ab1b-537c9a65a4aa" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9b0df2b5-4197-4f3d-98f9-5109459f24b0" xlink:to="loc_srt_MaximumMember_7f862f53-a60c-45fe-ab1b-537c9a65a4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_58fa24fb-9418-4a97-b363-2fbbeb43a068" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_srt_TitleOfIndividualAxis_58fa24fb-9418-4a97-b363-2fbbeb43a068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_85b8f98c-7496-4c95-8e61-97ffa31f7732" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_58fa24fb-9418-4a97-b363-2fbbeb43a068" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_85b8f98c-7496-4c95-8e61-97ffa31f7732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_3618d132-83da-4aa1-83e9-d2f65ed426a0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_85b8f98c-7496-4c95-8e61-97ffa31f7732" xlink:to="loc_srt_DirectorMember_3618d132-83da-4aa1-83e9-d2f65ed426a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a6b53f10-6cef-4760-b3ea-c1d399d12989" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_us-gaap_AwardTypeAxis_a6b53f10-6cef-4760-b3ea-c1d399d12989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a6b53f10-6cef-4760-b3ea-c1d399d12989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a9fde8ea-f162-4513-8dc6-fbcd4df4da66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a9fde8ea-f162-4513-8dc6-fbcd4df4da66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_0e12ff50-2820-4bc1-b4e8-80340501b618" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_0e12ff50-2820-4bc1-b4e8-80340501b618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_9f30221d-a5a0-4bd3-924e-eb2c42407c38" xlink:href="wst-20191231.xsd#wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember_9f30221d-a5a0-4bd3-924e-eb2c42407c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b8dcabe6-30e0-4a20-b037-6a10c207f8c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_PerformanceSharesMember_b8dcabe6-30e0-4a20-b037-6a10c207f8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_fb2e9aac-e7d5-434b-8291-9bf9980ea8f5" xlink:href="wst-20191231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_fb2e9aac-e7d5-434b-8291-9bf9980ea8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a878b8c6-c8c4-4b54-8474-58fc2db0caa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_us-gaap_RestrictedStockMember_a878b8c6-c8c4-4b54-8474-58fc2db0caa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_ea3ecbda-7d3e-498d-a67f-332d07268f70" xlink:href="wst-20191231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_IncentiveStockAwardsMember_ea3ecbda-7d3e-498d-a67f-332d07268f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_4fc13c85-5fcc-417d-a3c5-8b9bf7fc9c0e" xlink:href="wst-20191231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_CashSettledPSUAwardsMember_4fc13c85-5fcc-417d-a3c5-8b9bf7fc9c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_d7a3816c-f805-4b58-9a19-2a6e0eeb7b96" xlink:href="wst-20191231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a3d2a5a-0dc8-45f1-a34b-4d7860ff46be" xlink:to="loc_wst_StockSettledPSUAwardsMember_d7a3816c-f805-4b58-9a19-2a6e0eeb7b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b10e7f45-73ad-4e35-bdfe-953b37f74f00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cf0563d7-1860-4a2c-962f-e9a631f7fed8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cf0563d7-1860-4a2c-962f-e9a631f7fed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementwithIndividualConversionUnit_c4048676-be5c-4b98-abba-98c789c6ee02" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementwithIndividualConversionUnit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredCompensationArrangementwithIndividualConversionUnit_c4048676-be5c-4b98-abba-98c789c6ee02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04733065-4748-4364-8c24-4bfe277b1b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_04733065-4748-4364-8c24-4bfe277b1b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7493e07f-ec55-4f46-a889-4a1ec9a0792c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7493e07f-ec55-4f46-a889-4a1ec9a0792c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1a837683-1313-4fe0-84cf-1863032be5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1a837683-1313-4fe0-84cf-1863032be5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted_f12dcafe-2bed-4e84-af93-90f8b991bc93" xlink:href="wst-20191231.xsd#wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted_f12dcafe-2bed-4e84-af93-90f8b991bc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1187fecf-8fb2-4c78-8643-d77d3d7d2fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1187fecf-8fb2-4c78-8643-d77d3d7d2fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_815d19be-7be6-4fad-924e-d9ba1f0a9942" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_815d19be-7be6-4fad-924e-d9ba1f0a9942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_f1b5b8d0-69fb-4b3a-9273-814884da5abd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_f1b5b8d0-69fb-4b3a-9273-814884da5abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d9090b7e-9c52-47bb-9d1e-62e7d0f7a015" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d9090b7e-9c52-47bb-9d1e-62e7d0f7a015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_4dc4f8a3-20f8-4fcb-ae1d-1159b74395a9" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount_4dc4f8a3-20f8-4fcb-ae1d-1159b74395a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_f736b814-dad8-4f20-b4e7-2e1348ad7d77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_f736b814-dad8-4f20-b4e7-2e1348ad7d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_d8800a85-7649-4815-bd68-23b96154e8ac" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear_d8800a85-7649-4815-bd68-23b96154e8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e9f4c4d1-dc10-4a5a-99f8-8b3c00ee6042" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e9f4c4d1-dc10-4a5a-99f8-8b3c00ee6042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6a6d15c3-2333-40a1-9f3e-f25e41980362" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementWithIndividualNumberOfPlans"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans_6a6d15c3-2333-40a1-9f3e-f25e41980362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_ce074cbe-f1a4-4869-8183-dbcb31e55eab" xlink:href="wst-20191231.xsd#wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance_ce074cbe-f1a4-4869-8183-dbcb31e55eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredStockUnitsPayableinCash_84d0f9be-37b6-429f-be5d-c8f2328bea53" xlink:href="wst-20191231.xsd#wst_DeferredStockUnitsPayableinCash"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_wst_DeferredStockUnitsPayableinCash_84d0f9be-37b6-429f-be5d-c8f2328bea53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ad92b962-957a-4ec1-bf01-a43596f33d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ad92b962-957a-4ec1-bf01-a43596f33d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e9c5b9b-1b64-4d15-b85f-a567fb61af86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d868f52-0470-4f91-b3ba-28a07434c28c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2e9c5b9b-1b64-4d15-b85f-a567fb61af86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a7c9ba0-6986-45a4-b9fc-b6cce9d4ec81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff0d412-1163-4f74-92db-32f8264ca285" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a7c9ba0-6986-45a4-b9fc-b6cce9d4ec81" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff0d412-1163-4f74-92db-32f8264ca285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff0d412-1163-4f74-92db-32f8264ca285" xlink:to="loc_us-gaap_AwardTypeAxis_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8b59cdf5-2d85-42d6-9a8f-0557bbc377c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockOptionAndAppreciationRightsMember_68f68b7d-ba9f-48e9-9c4f-2e51845aaa4c" xlink:href="wst-20191231.xsd#wst_StockOptionAndAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_StockOptionAndAppreciationRightsMember_68f68b7d-ba9f-48e9-9c4f-2e51845aaa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_46793fe0-5b99-44f9-8467-b874809a487a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_us-gaap_PerformanceSharesMember_46793fe0-5b99-44f9-8467-b874809a487a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_c2eca391-41a3-4f61-a0a1-8b9aa668c217" xlink:href="wst-20191231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_CashSettledPSUAwardsMember_c2eca391-41a3-4f61-a0a1-8b9aa668c217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_46d75fa6-4e2c-45aa-8ff0-81f8f10093b7" xlink:href="wst-20191231.xsd#wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember_46d75fa6-4e2c-45aa-8ff0-81f8f10093b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EmployeeStockPurchasePlanEsppMember_74b3a89a-872d-49da-a9d6-3a927047fb6f" xlink:href="wst-20191231.xsd#wst_EmployeeStockPurchasePlanEsppMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_wst_EmployeeStockPurchasePlanEsppMember_74b3a89a-872d-49da-a9d6-3a927047fb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_0f8c5a71-c944-4728-a235-67bb1d6c4a33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8821cb74-0b5f-413c-81ab-33d2fa59572d" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_0f8c5a71-c944-4728-a235-67bb1d6c4a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff0d412-1163-4f74-92db-32f8264ca285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22dc7b93-7d6f-4485-930d-010b5c46d3ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_22dc7b93-7d6f-4485-930d-010b5c46d3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_293f5850-e45d-4efb-88b3-cf71644f204c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afbc2e92-8be2-4571-9d7e-8807c1d94cb5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_293f5850-e45d-4efb-88b3-cf71644f204c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_PlanNameAxis_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_262b0f10-a39d-4c23-82a2-6af524059979" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_03eb3fb8-ecfa-4433-9dad-0b85f0b75c8a" xlink:to="loc_us-gaap_PlanNameDomain_262b0f10-a39d-4c23-82a2-6af524059979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_210137bc-e775-415e-87d0-91e177fb7168" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_AwardDateAxis_210137bc-e775-415e-87d0-91e177fb7168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_130a1363-8a0b-4278-acd1-b0ce241518f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_210137bc-e775-415e-87d0-91e177fb7168" xlink:to="loc_us-gaap_AwardDateDomain_130a1363-8a0b-4278-acd1-b0ce241518f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_21205553-2fdb-4515-90ca-5da94b4d5541" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_AwardTypeAxis_21205553-2fdb-4515-90ca-5da94b4d5541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69f15114-b202-4e4a-86fc-ded02cec3053" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_21205553-2fdb-4515-90ca-5da94b4d5541" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69f15114-b202-4e4a-86fc-ded02cec3053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bd5b57fd-08d0-4cd2-9305-de7bb822dbe0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69f15114-b202-4e4a-86fc-ded02cec3053" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bd5b57fd-08d0-4cd2-9305-de7bb822dbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_61f24652-a3b7-4ad9-a881-e2153ed1ad75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_StatementClassOfStockAxis_61f24652-a3b7-4ad9-a881-e2153ed1ad75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a8048f6b-c03c-4fc1-85fb-a4740adf5f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_61f24652-a3b7-4ad9-a881-e2153ed1ad75" xlink:to="loc_us-gaap_ClassOfStockDomain_a8048f6b-c03c-4fc1-85fb-a4740adf5f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_srt_RangeAxis_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c8b8741-b3d9-4553-b337-39c6362cf3a4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c82c8533-1d86-4dcd-8ee5-3823fb7fd13c" xlink:to="loc_srt_RangeMember_3c8b8741-b3d9-4553-b337-39c6362cf3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_0be2d3f8-726d-4224-8384-c8e3ed625382" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_VestingAxis_0be2d3f8-726d-4224-8384-c8e3ed625382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_fc2f9a2c-7187-4b49-95c4-5dc91ccf8077" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_0be2d3f8-726d-4224-8384-c8e3ed625382" xlink:to="loc_us-gaap_VestingDomain_fc2f9a2c-7187-4b49-95c4-5dc91ccf8077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5b709d62-43c0-46db-a184-823303883f24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec751c6f-61b0-49f9-8b47-ffec6e72310f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ec751c6f-61b0-49f9-8b47-ffec6e72310f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0f6f7ce6-70ca-44b5-8485-46bcc361777c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0f6f7ce6-70ca-44b5-8485-46bcc361777c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2aaa9161-9c17-4f2f-92f2-192c624adf0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2aaa9161-9c17-4f2f-92f2-192c624adf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_47adc052-363a-4988-bf2b-44020740a279" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_47adc052-363a-4988-bf2b-44020740a279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2e99a3c9-d1f4-4fe3-9a3b-f302a4c0435f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9964b80d-62aa-4654-8144-42550ea9c94d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2e99a3c9-d1f4-4fe3-9a3b-f302a4c0435f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8ff2def1-6c66-41c0-becd-99985ae3b349" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8ff2def1-6c66-41c0-becd-99985ae3b349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_26f1354c-39c8-4dad-bc4d-cc81bfefbd94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_26f1354c-39c8-4dad-bc4d-cc81bfefbd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e68a3e02-416d-46e9-8b71-365dafe348b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e68a3e02-416d-46e9-8b71-365dafe348b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_bc99dd7d-cf49-4fa6-bc5d-54a4a2126ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_bc99dd7d-cf49-4fa6-bc5d-54a4a2126ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_35d5db0e-ebb2-4a25-8f95-5fb74f4e5f62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_35d5db0e-ebb2-4a25-8f95-5fb74f4e5f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_5979c574-6ae8-4d79-a401-cddb0ded5276" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_5979c574-6ae8-4d79-a401-cddb0ded5276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c05876f0-c86e-468f-81b9-15bfeecfe03e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c05876f0-c86e-468f-81b9-15bfeecfe03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e1b9201e-f696-4700-9100-7dffb2c661b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e1b9201e-f696-4700-9100-7dffb2c661b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b291f98-6e63-4d66-8bc5-683d55399bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b291f98-6e63-4d66-8bc5-683d55399bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6bab229d-f359-48fa-8b3e-cbbb1bace659" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6bab229d-f359-48fa-8b3e-cbbb1bace659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ba2712cb-66e1-4cf2-80e5-bc7579fe481c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ba2712cb-66e1-4cf2-80e5-bc7579fe481c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_32c46441-887f-44fe-ac23-91b7f07ea18b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_32c46441-887f-44fe-ac23-91b7f07ea18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f3c19bca-2cb7-4752-907a-43eeaf1e8b33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0db626b9-4536-4ca6-84ed-74bdb7fbc04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_f3c19bca-2cb7-4752-907a-43eeaf1e8b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0d8d9b8d-a14e-4a0c-bfea-06113de8d80d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_05e54e5b-7db4-4aae-9d74-8b70c23145d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_05e54e5b-7db4-4aae-9d74-8b70c23145d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1b5c7fb8-66c4-4f68-99fb-3150a0151482" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1b5c7fb8-66c4-4f68-99fb-3150a0151482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a6beb85c-0d4e-402d-af24-7b34c104672e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a6beb85c-0d4e-402d-af24-7b34c104672e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_78b8c367-6cc4-4b9c-842e-8eb3e307d9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_78b8c367-6cc4-4b9c-842e-8eb3e307d9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_42725df7-6034-4199-8743-70628e68943c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_42725df7-6034-4199-8743-70628e68943c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4abe3bce-ba75-4eeb-8214-4095fccf4934" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77f13444-256f-4e50-ba5c-f18175635b2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4abe3bce-ba75-4eeb-8214-4095fccf4934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationStockAppreciationRightsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e114249e-ddef-4897-b527-d33a65e854ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_178a95ba-d8a5-431f-990f-543d24e64243" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e114249e-ddef-4897-b527-d33a65e854ea" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_178a95ba-d8a5-431f-990f-543d24e64243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eb9102de-e22a-46bf-9124-968dfe6cc5df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_178a95ba-d8a5-431f-990f-543d24e64243" xlink:to="loc_us-gaap_AwardTypeAxis_eb9102de-e22a-46bf-9124-968dfe6cc5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a85a78d2-0556-49ee-87ad-8d4c275871d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_eb9102de-e22a-46bf-9124-968dfe6cc5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a85a78d2-0556-49ee-87ad-8d4c275871d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_79d43ded-9e1a-44ba-a37d-b15ab1a077c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a85a78d2-0556-49ee-87ad-8d4c275871d9" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_79d43ded-9e1a-44ba-a37d-b15ab1a077c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_178a95ba-d8a5-431f-990f-543d24e64243" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be2e25d0-9063-4d8c-bec3-617d5ae8f3d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be2e25d0-9063-4d8c-bec3-617d5ae8f3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f183e887-f795-43ac-b5f8-b3136d4498ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f183e887-f795-43ac-b5f8-b3136d4498ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_14f61ad5-ea73-42c8-b24c-10f2395fd764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_14f61ad5-ea73-42c8-b24c-10f2395fd764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_a3cba50f-02ee-4eaa-b0e0-c8ff1f553980" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_a3cba50f-02ee-4eaa-b0e0-c8ff1f553980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2808d3f2-7233-4125-8e51-7f2e3fd021c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2808d3f2-7233-4125-8e51-7f2e3fd021c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d4c116c8-dc06-4cd1-8032-b3f246bea278" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d4c116c8-dc06-4cd1-8032-b3f246bea278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_faf182b0-27e0-4857-9325-8f5a6fa27d6a" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7d96c981-4e8d-4d70-bf31-bb21a9983695" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_faf182b0-27e0-4857-9325-8f5a6fa27d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7f4d488b-8de8-4e16-ba38-57645ac25eb4" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_a114ddcf-a9ea-4714-bf0f-3cc7ae8d7776" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_a114ddcf-a9ea-4714-bf0f-3cc7ae8d7776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_04c718b6-7d2f-40db-a838-b2e03216ebf3" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_04c718b6-7d2f-40db-a838-b2e03216ebf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_44c3c699-0c4d-42ce-a79a-fb05f513c608" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_44c3c699-0c4d-42ce-a79a-fb05f513c608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_89486014-e517-49db-a198-21e3cd52acae" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice_89486014-e517-49db-a198-21e3cd52acae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_b1d6a462-ce47-4fad-8ead-8e87bd46c721" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_b1d6a462-ce47-4fad-8ead-8e87bd46c721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_76dac07d-c852-4f39-a075-15665c73eee9" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_76dac07d-c852-4f39-a075-15665c73eee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledStockAppreciationRIghtsOutstanding_b4a81007-1bb9-44ce-bbab-5139f23be9c7" xlink:href="wst-20191231.xsd#wst_CashSettledStockAppreciationRIghtsOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_CashSettledStockAppreciationRIghtsOutstanding_b4a81007-1bb9-44ce-bbab-5139f23be9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledStockAppreciationRightsOutstanding_7d8da21e-9416-4c3a-864a-f522b2f8f1f8" xlink:href="wst-20191231.xsd#wst_StockSettledStockAppreciationRightsOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward_1e6cda91-60da-4589-94bb-6fe76fddb144" xlink:to="loc_wst_StockSettledStockAppreciationRightsOutstanding_7d8da21e-9416-4c3a-864a-f522b2f8f1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a3d26887-1e94-400a-aeef-338d8436a1fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a3d26887-1e94-400a-aeef-338d8436a1fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_srt_RangeAxis_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3adb8881-4fd3-44ab-a936-c4f53f2b2d9e" xlink:to="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3b2533d8-5949-4376-b34a-b67bd9581881" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:to="loc_srt_MinimumMember_3b2533d8-5949-4376-b34a-b67bd9581881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5e3dc6da-692f-4c5e-a906-7e805195d423" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47554cf0-5a5a-4d69-8dd3-e1bbba11ab97" xlink:to="loc_srt_MaximumMember_5e3dc6da-692f-4c5e-a906-7e805195d423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81f4724c-10ac-441d-9f3d-8d7d399bc102" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_us-gaap_AwardTypeAxis_81f4724c-10ac-441d-9f3d-8d7d399bc102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_81f4724c-10ac-441d-9f3d-8d7d399bc102" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IncentiveStockAwardsMember_84c6670a-93bf-415c-8534-382c96bcf7d8" xlink:href="wst-20191231.xsd#wst_IncentiveStockAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_wst_IncentiveStockAwardsMember_84c6670a-93bf-415c-8534-382c96bcf7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CashSettledPSUAwardsMember_4b4570ab-dbde-4cea-9803-41c9659f763a" xlink:href="wst-20191231.xsd#wst_CashSettledPSUAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_wst_CashSettledPSUAwardsMember_4b4570ab-dbde-4cea-9803-41c9659f763a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_StockSettledPSUAwardsMember_ff08f4d3-bbd4-46c6-9fee-ff05d9edb452" xlink:href="wst-20191231.xsd#wst_StockSettledPSUAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_wst_StockSettledPSUAwardsMember_ff08f4d3-bbd4-46c6-9fee-ff05d9edb452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9b78f123-0f3a-4670-8a9e-277a1b5a3a24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_306a9bc0-def9-441f-a77a-e86037ffae58" xlink:to="loc_us-gaap_RestrictedStockMember_9b78f123-0f3a-4670-8a9e-277a1b5a3a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_af32f328-2fa6-4692-95ca-721ce8d24f84" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_srt_TitleOfIndividualAxis_af32f328-2fa6-4692-95ca-721ce8d24f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2353de8d-ffa1-40b3-9596-dd472bbf2898" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_af32f328-2fa6-4692-95ca-721ce8d24f84" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2353de8d-ffa1-40b3-9596-dd472bbf2898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c7ac6b50-815a-4bc5-9856-e02d8b01e5b5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2353de8d-ffa1-40b3-9596-dd472bbf2898" xlink:to="loc_srt_DirectorMember_c7ac6b50-815a-4bc5-9856-e02d8b01e5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d12f8511-92b6-40c3-8ba0-f110fd91c68f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d12f8511-92b6-40c3-8ba0-f110fd91c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_3cbd6015-b7c2-42b4-80ce-58258ab843ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_d12f8511-92b6-40c3-8ba0-f110fd91c68f" xlink:to="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_3cbd6015-b7c2-42b4-80ce-58258ab843ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4bf887e9-f5e2-49b6-8ec9-2a22a304cf8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_3cbd6015-b7c2-42b4-80ce-58258ab843ba" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_4bf887e9-f5e2-49b6-8ec9-2a22a304cf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ab5347d0-a03e-4d3c-9f3d-c225d1c0e8a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_2c9285d6-d83d-402f-bb1c-4831f5c9d045" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage_2c9285d6-d83d-402f-bb1c-4831f5c9d045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_0c20c0bc-84ac-4ed1-8834-adf656ebae3e" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting_0c20c0bc-84ac-4ed1-8834-adf656ebae3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d6fe4abf-5332-45e9-9676-9f641707cd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_d6fe4abf-5332-45e9-9676-9f641707cd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67ed1daa-d975-4c05-b4fa-6bc8954dda34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67ed1daa-d975-4c05-b4fa-6bc8954dda34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_93595c49-78af-4b95-b532-99588508d04c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_93595c49-78af-4b95-b532-99588508d04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_2816ab59-b704-49ec-884a-533540121cf6" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget_2816ab59-b704-49ec-884a-533540121cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4406a938-3ca1-4a9b-8d85-58ae5e59d957" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4406a938-3ca1-4a9b-8d85-58ae5e59d957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d9ea946a-1470-434d-8f99-c6dc2526a9ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d9ea946a-1470-434d-8f99-c6dc2526a9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1ba4c257-3cb6-4f8c-962f-bf248b4d0183" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f8cca978-536f-4fcb-9911-77b7b03fdf55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1ba4c257-3cb6-4f8c-962f-bf248b4d0183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91509b78-6a04-489a-9731-30b7bab3c7f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c50bf412-8902-4179-b7d7-882571df2b94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c50bf412-8902-4179-b7d7-882571df2b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab9d9540-3ede-4898-b96b-c745a8bc7300" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab9d9540-3ede-4898-b96b-c745a8bc7300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_3ba041dd-8075-4c9d-b2c2-63d59229aab6" xlink:href="wst-20191231.xsd#wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue_3ba041dd-8075-4c9d-b2c2-63d59229aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2e117f3f-650a-4b3b-8156-bc9ff08be4de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2e117f3f-650a-4b3b-8156-bc9ff08be4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_161eb517-1cbc-43f4-bfbc-7a727e99ee6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_161eb517-1cbc-43f4-bfbc-7a727e99ee6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9bbac2fc-cd02-48f1-97e2-fe64d99e492e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d9b9c9be-4256-42bd-9270-afee4c66a9cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9bbac2fc-cd02-48f1-97e2-fe64d99e492e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cb355965-b03f-4b50-bbce-752fec3555f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5ce935ee-0039-4ef2-9cb0-e35231b116d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cb355965-b03f-4b50-bbce-752fec3555f5" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5ce935ee-0039-4ef2-9cb0-e35231b116d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_939e5a6f-661d-4513-94cd-fadef5a076db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_939e5a6f-661d-4513-94cd-fadef5a076db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_fa0b1c3a-c5d8-4b22-8bae-95b4cf7e71c3" xlink:href="wst-20191231.xsd#wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:to="loc_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock_fa0b1c3a-c5d8-4b22-8bae-95b4cf7e71c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_fc4a8be8-f4eb-4cd9-93ec-87384028e8be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_fc4a8be8-f4eb-4cd9-93ec-87384028e8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_dd6e6210-f965-411d-8feb-89ba0de7d51c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_dd6e6210-f965-411d-8feb-89ba0de7d51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_f2319f86-4069-4656-8653-0b1743ff657d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_f2319f86-4069-4656-8653-0b1743ff657d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_53ed12ff-ee65-4fad-ba25-f6f15f303cd7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_53ed12ff-ee65-4fad-ba25-f6f15f303cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ac6f65e9-0dca-4e2e-a92c-40bf0e6cbc80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_efbb57ac-d9ac-4c2c-a7de-430ee776e6d4" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ac6f65e9-0dca-4e2e-a92c-40bf0e6cbc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_192f30de-460d-4f00-92d5-71cac758e39c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_192f30de-460d-4f00-92d5-71cac758e39c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f7581ead-6ebe-479f-874c-13b69b269118" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f7581ead-6ebe-479f-874c-13b69b269118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f7581ead-6ebe-479f-874c-13b69b269118" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d42fdc69-1489-4712-9112-fab4c11c6cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:to="loc_us-gaap_EquitySecuritiesMember_d42fdc69-1489-4712-9112-fab4c11c6cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_9a2e9a0e-aca9-4c05-997f-b26fbdfa7576" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2da0b8c0-cbee-4f2a-b1b4-ba95163635cb" xlink:to="loc_us-gaap_DebtSecuritiesMember_9a2e9a0e-aca9-4c05-997f-b26fbdfa7576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_be666443-fa1d-42c7-a5ba-6f415a9ceadd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_be666443-fa1d-42c7-a5ba-6f415a9ceadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_be666443-fa1d-42c7-a5ba-6f415a9ceadd" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_29e76f09-f606-444e-9fa2-4cef24d611ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_29e76f09-f606-444e-9fa2-4cef24d611ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ba33ee67-7950-47b8-8fe7-666499e64f57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8c309156-5051-49ad-8f0b-b6af46a4c239" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ba33ee67-7950-47b8-8fe7-666499e64f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_28b524e7-7e35-4744-9312-48e44609c607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_28b524e7-7e35-4744-9312-48e44609c607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_28b524e7-7e35-4744-9312-48e44609c607" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_cccd3c3c-c304-4cb6-8c6c-a8b81b7a4b31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:to="loc_us-gaap_ForeignPlanMember_cccd3c3c-c304-4cb6-8c6c-a8b81b7a4b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_476c6a90-8f4c-49b2-8dff-ddeb37b8545b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:to="loc_us-gaap_DomesticPlanMember_476c6a90-8f4c-49b2-8dff-ddeb37b8545b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b9b35893-0ef7-40c2-a3f8-0428d4fc383d" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_94b85689-9daf-4326-9db0-114210ee84f1" xlink:to="loc_country_US_b9b35893-0ef7-40c2-a3f8-0428d4fc383d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eb13e1b3-1913-4460-b6f1-1ec9ca8c6b26" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_a10c80aa-382e-4092-bbbe-e502bee01225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_a10c80aa-382e-4092-bbbe-e502bee01225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fe0e3f52-06d5-4f92-ac09-a71fc0cc8fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fe0e3f52-06d5-4f92-ac09-a71fc0cc8fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0fc89bf2-496a-4083-b589-ae93403265bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_0fc89bf2-496a-4083-b589-ae93403265bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_48ce7bf6-8b70-4cd2-97cf-cfabeed64582" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_48ce7bf6-8b70-4cd2-97cf-cfabeed64582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_056448ac-4ff8-45b5-8e1b-cd6431910bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_056448ac-4ff8-45b5-8e1b-cd6431910bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_d8fb9b09-5bf1-4ac3-8242-260e3c6fee3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_d8fb9b09-5bf1-4ac3-8242-260e3c6fee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_03199d7a-e164-4ba1-8bb0-446ee90c917a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_03199d7a-e164-4ba1-8bb0-446ee90c917a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_98472628-7e99-4fcc-99c5-f90235c23db1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_98472628-7e99-4fcc-99c5-f90235c23db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e3d1c057-8772-4dcf-ac5d-c1fafe9b6ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e3d1c057-8772-4dcf-ac5d-c1fafe9b6ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ed2dfef4-d1a9-4b77-afea-22b95b7e59cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ed2dfef4-d1a9-4b77-afea-22b95b7e59cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_bc18d192-44df-483b-9c4a-4577e8518718" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets_bc18d192-44df-483b-9c4a-4577e8518718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_142a7aa1-6764-4475-b457-61abe015cab4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_142a7aa1-6764-4475-b457-61abe015cab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_4a35b51e-2930-4f80-821c-388c41624fef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_4a35b51e-2930-4f80-821c-388c41624fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_320142c2-4205-4627-a7c4-968c2f0fbe4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_320142c2-4205-4627-a7c4-968c2f0fbe4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_407151bf-99b3-448f-8c2b-28ba3c8b23e2" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost_407151bf-99b3-448f-8c2b-28ba3c8b23e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_a2f55d6e-d98d-4fff-9fcb-41cb04cfe52f" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1d32b010-8228-4670-8eba-bf633999c37b" xlink:to="loc_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost_a2f55d6e-d98d-4fff-9fcb-41cb04cfe52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5fcd15df-70dc-45de-8c1a-33309ca75ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_192f30de-460d-4f00-92d5-71cac758e39c" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5fcd15df-70dc-45de-8c1a-33309ca75ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4aebf8e9-1603-4167-ad93-a334c3964a59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4aebf8e9-1603-4167-ad93-a334c3964a59" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_998600bc-490f-4d52-b916-55f28fdf021a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_998600bc-490f-4d52-b916-55f28fdf021a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_998600bc-490f-4d52-b916-55f28fdf021a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_da94b863-a093-4cdf-96c5-c470ec850fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:to="loc_us-gaap_DomesticPlanMember_da94b863-a093-4cdf-96c5-c470ec850fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_242f3d00-270e-4d13-bd6e-c142c8e04337" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:to="loc_us-gaap_ForeignPlanMember_242f3d00-270e-4d13-bd6e-c142c8e04337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_855ffcdd-038a-4b24-b242-8d5e4480f54d" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_824361b7-535f-4176-85c3-88e136f1278b" xlink:to="loc_country_US_855ffcdd-038a-4b24-b242-8d5e4480f54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ee9afb7d-4562-4864-90be-14a63665a74c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ee9afb7d-4562-4864-90be-14a63665a74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ee9afb7d-4562-4864-90be-14a63665a74c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4f2df76b-bbb1-4692-896e-52fb839a6020" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4f2df76b-bbb1-4692-896e-52fb839a6020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_45cad695-8266-49f7-9f5f-204e03ec9fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_956f69a6-3394-40a5-bca8-e93b51c4de23" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_45cad695-8266-49f7-9f5f-204e03ec9fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f4f65312-c681-40f9-95da-0c7b2ca93a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f4f65312-c681-40f9-95da-0c7b2ca93a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c158b674-6628-4f4a-9340-6fadbcc383ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f4f65312-c681-40f9-95da-0c7b2ca93a4e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c158b674-6628-4f4a-9340-6fadbcc383ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c6e619f4-188f-4f71-910c-0ab6ab129ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c158b674-6628-4f4a-9340-6fadbcc383ba" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_c6e619f4-188f-4f71-910c-0ab6ab129ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_7591a295-e3e0-4af4-b50c-4528964dad5c" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_bc614479-a5df-4f40-805f-72f3c73ecdb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_bc614479-a5df-4f40-805f-72f3c73ecdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6059a1aa-0b9c-4de4-8da9-d67f4568518f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6059a1aa-0b9c-4de4-8da9-d67f4568518f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e02a6ae6-3602-4ce4-b9e8-58ba25adca51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e02a6ae6-3602-4ce4-b9e8-58ba25adca51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6aeb09e8-8f61-4a72-9182-558351822058" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_6aeb09e8-8f61-4a72-9182-558351822058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_a5e45532-b66b-4770-bb09-85c944810cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_a5e45532-b66b-4770-bb09-85c944810cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_838f0961-159f-403d-8051-595ca1acd447" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_838f0961-159f-403d-8051-595ca1acd447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f6f12bc6-18f9-411e-bdb4-3921654cc0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f6f12bc6-18f9-411e-bdb4-3921654cc0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_427e6262-d2c5-4178-8569-df86aa462de7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_9e14f031-8a08-4e1d-a44f-b1ffadda155c" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_427e6262-d2c5-4178-8569-df86aa462de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_2dddb995-2e57-4ef9-8231-d0ba232bee2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_2dddb995-2e57-4ef9-8231-d0ba232bee2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_621b825c-3b27-423c-b36b-aa5e2b632029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_621b825c-3b27-423c-b36b-aa5e2b632029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_afd596ab-deda-4682-8e3d-ff62cc3e37a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_afd596ab-deda-4682-8e3d-ff62cc3e37a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_9d65c980-d465-4277-8ae3-c909370c8534" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_9d65c980-d465-4277-8ae3-c909370c8534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d6c6ecd0-5fdc-4cae-be54-25592252096d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d6c6ecd0-5fdc-4cae-be54-25592252096d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_0c069717-9eaa-4e55-a0d0-ce7226665f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_0c069717-9eaa-4e55-a0d0-ce7226665f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_d8c0504a-033b-4ba6-9728-2bfe2b0d9df3" xlink:href="wst-20191231.xsd#wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges_d8c0504a-033b-4ba6-9728-2bfe2b0d9df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_122aee44-3886-4cf1-a568-216cee0943c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ea420735-1ae1-4d31-b071-878da21e0001" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_122aee44-3886-4cf1-a568-216cee0943c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_cc458de2-0d96-42e5-9212-4b45bd71218a" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_cc458de2-0d96-42e5-9212-4b45bd71218a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_2ed2ce03-d438-4b0a-bf7f-2de95dc44c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_2ed2ce03-d438-4b0a-bf7f-2de95dc44c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_756dfe54-cac5-470a-805b-735d3a56c793" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_756dfe54-cac5-470a-805b-735d3a56c793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0afcb7a6-488b-4331-a803-ea93bf2c3b12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_11a624fe-e4ea-4387-a16b-e223d6475115" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0afcb7a6-488b-4331-a803-ea93bf2c3b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_a3f0c5a8-4fd1-458d-b6bd-c277fc360c80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4aebf8e9-1603-4167-ad93-a334c3964a59" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_a3f0c5a8-4fd1-458d-b6bd-c277fc360c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1a456d8c-663a-4b77-9829-e3822cf9a7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_05fc90ee-4f17-4956-b1a4-52a84d08f07c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1a456d8c-663a-4b77-9829-e3822cf9a7bf" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_05fc90ee-4f17-4956-b1a4-52a84d08f07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3f73372a-7f33-43de-90f6-57b2d011a1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_05fc90ee-4f17-4956-b1a4-52a84d08f07c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3f73372a-7f33-43de-90f6-57b2d011a1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3f73372a-7f33-43de-90f6-57b2d011a1b9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f305cb98-2e2b-41fb-a585-3abb61d3018a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f305cb98-2e2b-41fb-a585-3abb61d3018a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_56d23bb2-9100-4b9d-be63-5445104b064a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cecdf475-d3b6-4778-b761-9e7af93d6f8e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_56d23bb2-9100-4b9d-be63-5445104b064a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_05fc90ee-4f17-4956-b1a4-52a84d08f07c" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_28f4062c-e740-49de-9921-053df4675e89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_28f4062c-e740-49de-9921-053df4675e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_20f66b7a-60ae-4f88-8316-4cfd842b97f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_20f66b7a-60ae-4f88-8316-4cfd842b97f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6a2c8741-fbf5-44e5-a2bb-73090e518da6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6a2c8741-fbf5-44e5-a2bb-73090e518da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d9df2d61-80c3-4e8e-af88-faaa7ec0e757" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_d9df2d61-80c3-4e8e-af88-faaa7ec0e757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_9c539200-1a73-4e60-95ad-8ee752fa9563" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_9c539200-1a73-4e60-95ad-8ee752fa9563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_c18d00b9-7f7a-4243-b6d7-862c9ac4092d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_c18d00b9-7f7a-4243-b6d7-862c9ac4092d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_25f08cc1-b177-4453-8924-06895284a8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_25f08cc1-b177-4453-8924-06895284a8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_2b090181-f0e1-4d0c-8657-be75df2bab0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_2b090181-f0e1-4d0c-8657-be75df2bab0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_b831ce15-ad5c-460a-93b5-27474f24b5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_b831ce15-ad5c-460a-93b5-27474f24b5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d4a3884e-f968-4914-987d-7409a4571eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ec28e4b9-59b2-4ee6-9bdf-8a645278d127" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d4a3884e-f968-4914-987d-7409a4571eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_beb33599-5080-4e09-ae9d-9f29f33c35cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_beb33599-5080-4e09-ae9d-9f29f33c35cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_57411c4c-6bd1-4ca1-ba62-34645511b2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_57411c4c-6bd1-4ca1-ba62-34645511b2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7805ad90-588e-418d-8adf-3d1f63926cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_7805ad90-588e-418d-8adf-3d1f63926cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_ec6df79d-70d9-4acc-9807-9fa6f84b73a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_ec6df79d-70d9-4acc-9807-9fa6f84b73a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3e3c7c8f-6d75-487e-a6a4-b740282250fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_3e3c7c8f-6d75-487e-a6a4-b740282250fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_91556062-4b21-45bc-a43c-ab52956f88de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_91556062-4b21-45bc-a43c-ab52956f88de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7179648e-4fb0-47cd-b9cf-c4af23ae27c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9a83528-595f-4678-ad14-92b15e68bd16" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7179648e-4fb0-47cd-b9cf-c4af23ae27c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c069da62-ee9f-4eee-bdbf-c03d157b4b87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5305c624-1671-49aa-b040-f42856e308b6" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c069da62-ee9f-4eee-bdbf-c03d157b4b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAmountsRecognizedinBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_720718b0-db5c-4167-b431-07407851daa9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_1c84f524-84ea-4e6b-a209-f34bc006666e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_720718b0-db5c-4167-b431-07407851daa9" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_1c84f524-84ea-4e6b-a209-f34bc006666e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_af3cd85d-36fe-41db-af68-aca1b8ea2904" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_1c84f524-84ea-4e6b-a209-f34bc006666e" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_af3cd85d-36fe-41db-af68-aca1b8ea2904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_af3cd85d-36fe-41db-af68-aca1b8ea2904" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e7c62e22-5596-48e0-ae16-acbf30182b81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e7c62e22-5596-48e0-ae16-acbf30182b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0184fee5-4708-4f8f-88ac-43f410ac5e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_86a8462b-49fe-4740-9618-1ba4c09f4017" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0184fee5-4708-4f8f-88ac-43f410ac5e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_1c84f524-84ea-4e6b-a209-f34bc006666e" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_7ce2c01c-e1d0-4dfa-b059-3560e1dd3ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_7ce2c01c-e1d0-4dfa-b059-3560e1dd3ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_83ecf475-ae9c-47ce-b4bb-ec05b0dd1a89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_83ecf475-ae9c-47ce-b4bb-ec05b0dd1a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_10b35957-5818-4fc2-8999-35fc190e4a36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_10b35957-5818-4fc2-8999-35fc190e4a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetsDefinedBenefitPlansNoncurrent_a523794b-4315-45b0-bd22-0b1ccdc8207f" xlink:href="wst-20191231.xsd#wst_AssetsDefinedBenefitPlansNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_827d6cb3-4ebc-4f91-a17e-e0f2e812ad17" xlink:to="loc_wst_AssetsDefinedBenefitPlansNoncurrent_a523794b-4315-45b0-bd22-0b1ccdc8207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b68e310-e625-4533-93e8-16be5e9a3fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_baba6856-f602-4589-a3d3-8dbc73e7dc3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b68e310-e625-4533-93e8-16be5e9a3fcc" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_baba6856-f602-4589-a3d3-8dbc73e7dc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a97490d8-84d4-4a34-9b8e-3baa079b6171" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_baba6856-f602-4589-a3d3-8dbc73e7dc3c" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a97490d8-84d4-4a34-9b8e-3baa079b6171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a97490d8-84d4-4a34-9b8e-3baa079b6171" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_edab0bc4-88b6-4e14-a3df-20d79e510d11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_edab0bc4-88b6-4e14-a3df-20d79e510d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_580f81ac-c1a0-4064-878f-19c7e618378e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_8123663d-fea2-435d-95f7-d5a9eea7ee30" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_580f81ac-c1a0-4064-878f-19c7e618378e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_baba6856-f602-4589-a3d3-8dbc73e7dc3c" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4d5a4258-8485-41de-ab6d-30373b0a4e85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4d5a4258-8485-41de-ab6d-30373b0a4e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_61f37ad2-bb36-4f08-bffb-33c56baa25e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_61f37ad2-bb36-4f08-bffb-33c56baa25e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0dafe1a7-8375-4a75-9f9f-798f1ee9dba4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0dafe1a7-8375-4a75-9f9f-798f1ee9dba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_1c1196cf-0146-49a7-b5fe-b7ac54d549bd" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_41435f0e-7f67-42ff-a2af-7045bfbf5688" xlink:to="loc_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome_1c1196cf-0146-49a7-b5fe-b7ac54d549bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansExpectedBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_522a5787-c131-4729-8268-d8d3eeb6a8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_522a5787-c131-4729-8268-d8d3eeb6a8a3" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_059b4cde-65f3-4512-8d8e-fc2d11c028c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_059b4cde-65f3-4512-8d8e-fc2d11c028c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_059b4cde-65f3-4512-8d8e-fc2d11c028c5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_e63796f8-ff88-4e19-8bff-7ad4b5cd2c80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:to="loc_us-gaap_DomesticPlanMember_e63796f8-ff88-4e19-8bff-7ad4b5cd2c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_54246960-00bc-494e-bb67-373bcddb10b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:to="loc_us-gaap_ForeignPlanMember_54246960-00bc-494e-bb67-373bcddb10b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d64124a6-520d-44e0-9d0a-cfb2a61ae694" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_b93b9446-4778-441b-b3fa-69541d14bf29" xlink:to="loc_country_US_d64124a6-520d-44e0-9d0a-cfb2a61ae694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_1277df5e-4f04-4bdd-99f2-15624f34fb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_1277df5e-4f04-4bdd-99f2-15624f34fb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0bb7c53d-0f95-4824-9243-c75342cc8c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_1277df5e-4f04-4bdd-99f2-15624f34fb9d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0bb7c53d-0f95-4824-9243-c75342cc8c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e2cf48d4-4190-45ea-bd41-d2cf3d08c996" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0bb7c53d-0f95-4824-9243-c75342cc8c1c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e2cf48d4-4190-45ea-bd41-d2cf3d08c996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_c0614638-c7d6-4843-96c3-4eba69ab4e4f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_541e104b-7b59-4272-a073-ec204c24614d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_541e104b-7b59-4272-a073-ec204c24614d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_c9b53bc9-a138-40fe-9e48-fd06967121a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_c9b53bc9-a138-40fe-9e48-fd06967121a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b17fe0fa-5f3b-42f1-8603-0a1e1d1508d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b17fe0fa-5f3b-42f1-8603-0a1e1d1508d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7f19f56b-5ceb-4975-83aa-2473760853f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7f19f56b-5ceb-4975-83aa-2473760853f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ec88de19-37fa-4d91-9aa7-55e6912c8ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_ec88de19-37fa-4d91-9aa7-55e6912c8ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_3ac690ff-8921-4cd1-8ce6-e41f083eee2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_3ac690ff-8921-4cd1-8ce6-e41f083eee2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_654d7b15-c905-4cab-b389-ac87effd9bdc" xlink:href="wst-20191231.xsd#wst_DefinedBenefitPlanExpectedFutureBenefitPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_452816ad-1252-4716-a38f-33deeb2e5a19" xlink:to="loc_wst_DefinedBenefitPlanExpectedFutureBenefitPayments_654d7b15-c905-4cab-b389-ac87effd9bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4e61c8e0-b229-443e-8ec4-7876193828ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83b4c54b-99d0-4268-80d6-ce0bbe92c2df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4e61c8e0-b229-443e-8ec4-7876193828ae" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83b4c54b-99d0-4268-80d6-ce0bbe92c2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e3003d25-64c1-427b-a912-9f733123ebc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83b4c54b-99d0-4268-80d6-ce0bbe92c2df" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e3003d25-64c1-427b-a912-9f733123ebc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e3003d25-64c1-427b-a912-9f733123ebc3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_93252d8d-ddde-4581-b206-987132b689a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_93252d8d-ddde-4581-b206-987132b689a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_71fcaaa8-c8e8-4459-8c2a-66ec92f6c569" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_561633a6-12ee-4106-a275-3368ba9e3a4a" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_71fcaaa8-c8e8-4459-8c2a-66ec92f6c569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_83b4c54b-99d0-4268-80d6-ce0bbe92c2df" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4f87835-230f-47e5-bdaf-1a9a237a9d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_c4f87835-230f-47e5-bdaf-1a9a237a9d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_a6995835-1657-4e58-8d0c-beac4e96ce7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_a6995835-1657-4e58-8d0c-beac4e96ce7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_1918c6a2-0025-4820-8f34-bd580059584c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_47cbb111-b0b6-4b25-ae05-873e57a71fd6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_1918c6a2-0025-4820-8f34-bd580059584c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5fb2cd68-d6e7-4914-b228-63fe09558eed" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a3c79f83-0d69-4c65-98bd-615b0919b059" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a3c79f83-0d69-4c65-98bd-615b0919b059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_df53402b-1532-4868-8575-2cb0bddf0f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_55accbc1-0a23-4a6c-8f39-9643b08cb3a6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_df53402b-1532-4868-8575-2cb0bddf0f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#BenefitPlansAllocationofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4852c0c0-1d28-4365-8189-c108ad7294ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4852c0c0-1d28-4365-8189-c108ad7294ab" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2949812-59d5-436b-88b1-7a68303074c5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:to="loc_srt_RangeAxis_c2949812-59d5-436b-88b1-7a68303074c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c2949812-59d5-436b-88b1-7a68303074c5" xlink:to="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c05ff02-b221-49fc-ae08-c509123fd17b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:to="loc_srt_MinimumMember_0c05ff02-b221-49fc-ae08-c509123fd17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_70d673bf-2180-4528-8381-7980de5c88cd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_393d8d62-88d4-4999-bb25-83f485e310e2" xlink:to="loc_srt_MaximumMember_70d673bf-2180-4528-8381-7980de5c88cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bf97f5ba-3917-4641-b92a-80642802c72b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bf97f5ba-3917-4641-b92a-80642802c72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bf97f5ba-3917-4641-b92a-80642802c72b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_ae3343b3-c993-4a34-ab4a-50e4f5211da0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_ae3343b3-c993-4a34-ab4a-50e4f5211da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_IndexedMutualFundsMember_bcc7c5a7-a729-4ebe-af27-63c238f0447b" xlink:href="wst-20191231.xsd#wst_IndexedMutualFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:to="loc_wst_IndexedMutualFundsMember_bcc7c5a7-a729-4ebe-af27-63c238f0447b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_InternationalMutualFundsMember_e5fa676a-a84f-4ddf-a780-7fce5bf8c5f3" xlink:href="wst-20191231.xsd#wst_InternationalMutualFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_6bf4cd07-9fa5-4c11-a0dd-3be383397c6a" xlink:to="loc_wst_InternationalMutualFundsMember_e5fa676a-a84f-4ddf-a780-7fce5bf8c5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_1505ff85-6d10-4782-962c-1f1a14332960" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_us-gaap_DebtSecuritiesMember_1505ff85-6d10-4782-962c-1f1a14332960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherSecuritiesMember_dd338ad2-016b-48bd-9a50-2860f7820d8c" xlink:href="wst-20191231.xsd#wst_OtherSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_OtherSecuritiesMember_dd338ad2-016b-48bd-9a50-2860f7820d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_MutualFundsMember_0e73a5f9-32b2-4516-b512-251d0155a75a" xlink:href="wst-20191231.xsd#wst_MutualFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_MutualFundsMember_0e73a5f9-32b2-4516-b512-251d0155a75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_BalancedMutualFundMember_07ee6321-09d7-4f70-a1c8-a797bc3a1ddc" xlink:href="wst-20191231.xsd#wst_BalancedMutualFundMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_BalancedMutualFundMember_07ee6321-09d7-4f70-a1c8-a797bc3a1ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionPlanAssetsInTheFairValueHierarchyMember_9d22d10c-2df0-430a-a562-2363f9ec06f5" xlink:href="wst-20191231.xsd#wst_PensionPlanAssetsInTheFairValueHierarchyMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_PensionPlanAssetsInTheFairValueHierarchyMember_9d22d10c-2df0-430a-a562-2363f9ec06f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionplanassetsmeasuredatNAVMember_c876f4c5-3ffc-44c6-88e6-f7ba00894a80" xlink:href="wst-20191231.xsd#wst_PensionplanassetsmeasuredatNAVMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5f85dcec-8b13-475e-9a57-6f982f1ff59d" xlink:to="loc_wst_PensionplanassetsmeasuredatNAVMember_c876f4c5-3ffc-44c6-88e6-f7ba00894a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04ab734f-50e4-4b6e-80d0-530327019ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04ab734f-50e4-4b6e-80d0-530327019ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04ab734f-50e4-4b6e-80d0-530327019ab1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9997b528-7dfc-4e15-b705-249d9556215a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9997b528-7dfc-4e15-b705-249d9556215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a2ebaf4c-e107-4c01-a5c0-1a3dbb287878" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a2ebaf4c-e107-4c01-a5c0-1a3dbb287878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7a1869a6-240d-4eea-ab80-2ad85daf1890" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_23d85f32-107e-4b56-9064-50c75345a191" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7a1869a6-240d-4eea-ab80-2ad85daf1890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6f6b3626-9808-41c4-b84d-e07f19a43315" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription_f4e3ba87-3a49-4c2c-ac30-8de6f184dc0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription_f4e3ba87-3a49-4c2c-ac30-8de6f184dc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_03e86556-cb22-4fc3-a003-f99d16a84256" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_03e86556-cb22-4fc3-a003-f99d16a84256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_c5b0a647-3d25-400a-81fa-2abf46c6ee07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_c5b0a647-3d25-400a-81fa-2abf46c6ee07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0fbe7d8d-0cae-4760-a08f-17c90a46fd51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_526f2c1b-0b09-463c-a7a4-371a0c85211c" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_0fbe7d8d-0cae-4760-a08f-17c90a46fd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpense" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpense"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_bc703cb2-249e-417c-86a2-aee2bf1e6ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_9cf96e51-b8a3-4055-9939-2e3cbb26b0f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_bc703cb2-249e-417c-86a2-aee2bf1e6ee1" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_9cf96e51-b8a3-4055-9939-2e3cbb26b0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseTables" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_d86bf65c-6798-4ac5-8a50-4f1b7ccb23c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock_33a7cfb6-fe8d-4cb2-aae0-1a42ef28e7d0" xlink:href="wst-20191231.xsd#wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d86bf65c-6798-4ac5-8a50-4f1b7ccb23c2" xlink:to="loc_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock_33a7cfb6-fe8d-4cb2-aae0-1a42ef28e7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_49509174-522e-4a11-a01a-dab0d970ea2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d86bf65c-6798-4ac5-8a50-4f1b7ccb23c2" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_49509174-522e-4a11-a01a-dab0d970ea2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_6e479f89-0034-4ed1-bb15-c9bbec156a72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_SeveranceCosts1_6e479f89-0034-4ed1-bb15-c9bbec156a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1d5758af-a9e0-4b38-9f68-5060ddde2023" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_AssetImpairmentCharges_1d5758af-a9e0-4b38-9f68-5060ddde2023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5ac50c08-c8f8-4100-823c-bbed088fbed8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_OtherRestructuringCosts_5ac50c08-c8f8-4100-823c-bbed088fbed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_73de8794-2f62-4fd8-8aaf-c6e0beea8db3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_73de8794-2f62-4fd8-8aaf-c6e0beea8db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_0622ee99-a9cd-4bdf-91f2-24e1a7c16dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_0622ee99-a9cd-4bdf-91f2-24e1a7c16dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_117e3974-b68f-4655-ac29-c0212d4529ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_117e3974-b68f-4655-ac29-c0212d4529ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_fdd4ee2f-f0f9-410b-b8b5-d214f84d1c33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_fdd4ee2f-f0f9-410b-b8b5-d214f84d1c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Developmentandlicensingincome_dc8ccf9a-eb35-4ca4-9329-1ec1ad949e8a" xlink:href="wst-20191231.xsd#wst_Developmentandlicensingincome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_wst_Developmentandlicensingincome_dc8ccf9a-eb35-4ca4-9329-1ec1ad949e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1a61a4c9-357e-4063-a14d-8972f294d9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1a61a4c9-357e-4063-a14d-8972f294d9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_d8abbc86-939b-4ba7-8f4b-13f44e2f0d31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_d8abbc86-939b-4ba7-8f4b-13f44e2f0d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_6f14581d-82a7-4cf8-9313-7b797e17e5eb" xlink:href="wst-20191231.xsd#wst_OtherIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_861c2e2d-c228-48a5-ae2f-d3db53a9ce26" xlink:to="loc_wst_OtherIncomeExpense_6f14581d-82a7-4cf8-9313-7b797e17e5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseRestructuringandRelatedChargesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeAbstract_98797b46-90a5-4967-9751-17a8eb1f2c71" xlink:href="wst-20191231.xsd#wst_OtherExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_98797b46-90a5-4967-9751-17a8eb1f2c71" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3556d519-5556-49e1-9882-03de19b6c403" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:to="loc_srt_RangeAxis_3556d519-5556-49e1-9882-03de19b6c403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3556d519-5556-49e1-9882-03de19b6c403" xlink:to="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c78439a3-b46b-4ed1-b9bf-2b1b734860dc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:to="loc_srt_MinimumMember_c78439a3-b46b-4ed1-b9bf-2b1b734860dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0533a9b9-17a3-47cb-ad25-5164afd99dbd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_57f19685-0401-49bd-bd6c-094a24ef6f76" xlink:to="loc_srt_MaximumMember_0533a9b9-17a3-47cb-ad25-5164afd99dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_1f86c16d-84b7-48f9-b437-306090f660b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:to="loc_us-gaap_RestructuringPlanAxis_1f86c16d-84b7-48f9-b437-306090f660b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_1f86c16d-84b7-48f9-b437-306090f660b4" xlink:to="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2018RestructuringPlanMember_80950b5f-8c2f-429e-b5ab-8d866038d821" xlink:href="wst-20191231.xsd#wst_A2018RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:to="loc_wst_A2018RestructuringPlanMember_80950b5f-8c2f-429e-b5ab-8d866038d821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_A2016RestructuringPlanMemberMember_8a13cff1-83de-4c2e-b134-58dbf1de0725" xlink:href="wst-20191231.xsd#wst_A2016RestructuringPlanMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_f7337d07-4fa2-4f3a-8a8c-3124d8049908" xlink:to="loc_wst_A2016RestructuringPlanMemberMember_8a13cff1-83de-4c2e-b134-58dbf1de0725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_67f363df-b7d3-47f0-bc05-80fac241ad4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_67f363df-b7d3-47f0-bc05-80fac241ad4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_67f363df-b7d3-47f0-bc05-80fac241ad4c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_021af1fc-3aa9-4407-b386-00c2962e7818" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:to="loc_us-gaap_EmployeeSeveranceMember_021af1fc-3aa9-4407-b386-00c2962e7818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetRelatedChargesMember_dd5564d3-0d55-426e-a22a-6669469e4f1c" xlink:href="wst-20191231.xsd#wst_AssetRelatedChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:to="loc_wst_AssetRelatedChargesMember_dd5564d3-0d55-426e-a22a-6669469e4f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_0ed84575-725e-4bc7-9012-8a003f51a8de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_7c8f6914-e238-4a90-9ad9-6459872d123b" xlink:to="loc_us-gaap_OtherRestructuringMember_0ed84575-725e-4bc7-9012-8a003f51a8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4197896e-d4e3-4688-afe7-1b07a7daa0e0" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_df510687-4cf8-4191-a98a-2f0c1c493e02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_df510687-4cf8-4191-a98a-2f0c1c493e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8851ff6b-f6e1-4e39-a21a-3ddff68f00a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8851ff6b-f6e1-4e39-a21a-3ddff68f00a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f9b400c9-fece-4399-9820-257ce9aeaac1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_RestructuringCharges_f9b400c9-fece-4399-9820-257ce9aeaac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_11ebeb7a-d669-4557-9e41-bef11b8572cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_SeveranceCosts1_11ebeb7a-d669-4557-9e41-bef11b8572cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AssetImpairmentChargesPatentandEquipment_05e4074c-37ca-4991-9945-cd7b65b72d4c" xlink:href="wst-20191231.xsd#wst_AssetImpairmentChargesPatentandEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_wst_AssetImpairmentChargesPatentandEquipment_05e4074c-37ca-4991-9945-cd7b65b72d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_0cdbf7cb-df7a-4a32-8c4b-6621db4262a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_OtherRestructuringCosts_0cdbf7cb-df7a-4a32-8c4b-6621db4262a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_070ee35c-fcb9-45e7-aeaf-a9a9455e3fce" xlink:to="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b2d633a8-6d08-41df-b344-a0f523cbb6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_RestructuringReserve_b2d633a8-6d08-41df-b344-a0f523cbb6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2bfec495-351e-47b6-970f-ef108586ace6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2bfec495-351e-47b6-970f-ef108586ace6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_0f2c8cda-71bb-49d3-b412-5ac52692a96b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_PaymentsForRestructuring_0f2c8cda-71bb-49d3-b412-5ac52692a96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_62002afe-64f1-4074-9d26-8087cbbc6982" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_62002afe-64f1-4074-9d26-8087cbbc6982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b5065214-840b-4e01-bb59-568903c2eca1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2f7cd333-1f7e-4f10-9aa8-54dd29718f3a" xlink:to="loc_us-gaap_RestructuringReserve_b5065214-840b-4e01-bb59-568903c2eca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseOtherItemsTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:href="wst-20191231.xsd#wst_OtherExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_b1db7e0a-4bc9-472b-a738-e7bb1505ce49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_b1db7e0a-4bc9-472b-a738-e7bb1505ce49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_38563ec5-dea9-4ea6-97e6-4788501d80ef" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_b1db7e0a-4bc9-472b-a738-e7bb1505ce49" xlink:to="loc_srt_StatementGeographicalAxis_38563ec5-dea9-4ea6-97e6-4788501d80ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1a87f6a2-8176-4f54-8909-8069e7f0ef7d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_38563ec5-dea9-4ea6-97e6-4788501d80ef" xlink:to="loc_srt_SegmentGeographicalDomain_1a87f6a2-8176-4f54-8909-8069e7f0ef7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_VE_7b2126b7-873c-4a9f-a0a4-f9064ebb4a5c" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_VE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1a87f6a2-8176-4f54-8909-8069e7f0ef7d" xlink:to="loc_country_VE_7b2126b7-873c-4a9f-a0a4-f9064ebb4a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_a911fc97-b72d-495a-8da7-a050e01b610f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_b1db7e0a-4bc9-472b-a738-e7bb1505ce49" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_a911fc97-b72d-495a-8da7-a050e01b610f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_55399c18-4bd6-40bf-b295-f73363298857" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateRemeasurement1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_a911fc97-b72d-495a-8da7-a050e01b610f" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateRemeasurement1_55399c18-4bd6-40bf-b295-f73363298857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_68ede2d2-eeee-4456-9b7b-96f75816c0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_68ede2d2-eeee-4456-9b7b-96f75816c0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_0e668c04-84c0-4939-a257-e7ba37d6378f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_0e668c04-84c0-4939-a257-e7ba37d6378f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_14004b1c-1a6b-4957-bb91-4b8a172532af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_14004b1c-1a6b-4957-bb91-4b8a172532af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainBeforeTax_355bba6d-323c-4678-809f-9e23d2f4540a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainBeforeTax_355bba6d-323c-4678-809f-9e23d2f4540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c3eb554a-fca0-4741-b565-ab98c028c650" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c3eb554a-fca0-4741-b565-ab98c028c650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_21083ae5-bc3a-4e5f-9d72-86b2ea1aabff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_OtherExpenseIncomeAbstract_2186ca60-bd59-45fc-bc01-314d6c28fbfb" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_21083ae5-bc3a-4e5f-9d72-86b2ea1aabff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#OtherExpenseDevelopmentandLicensingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_58b08611-8bd2-4668-a469-c0944fc9b494" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentandlicensingincomeTable_e6a09995-a7fd-4565-ae29-16adf2005919" xlink:href="wst-20191231.xsd#wst_DevelopmentandlicensingincomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_58b08611-8bd2-4668-a469-c0944fc9b494" xlink:to="loc_wst_DevelopmentandlicensingincomeTable_e6a09995-a7fd-4565-ae29-16adf2005919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_a3f5e369-479f-44f0-aaf0-7d9c7b0de144" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DevelopmentandlicensingincomeTable_e6a09995-a7fd-4565-ae29-16adf2005919" xlink:to="loc_us-gaap_NatureOfExpenseAxis_a3f5e369-479f-44f0-aaf0-7d9c7b0de144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_a3f5e369-479f-44f0-aaf0-7d9c7b0de144" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_SmartDoseMember_a57a9c4b-a4b7-4a3f-8582-d39eabe83364" xlink:href="wst-20191231.xsd#wst_SmartDoseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:to="loc_wst_SmartDoseMember_a57a9c4b-a4b7-4a3f-8582-d39eabe83364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherMember_ddf200e6-5165-43a5-b578-f2471212723f" xlink:href="wst-20191231.xsd#wst_OtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_6be78a15-4572-444f-a149-4241ce51d4f3" xlink:to="loc_wst_OtherMember_ddf200e6-5165-43a5-b578-f2471212723f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:href="wst-20191231.xsd#wst_DevelopmentandlicensingincomeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DevelopmentandlicensingincomeTable_e6a09995-a7fd-4565-ae29-16adf2005919" xlink:to="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Developmentandlicensingincome_acda4c03-973e-4243-94a3-5113d47c38a4" xlink:href="wst-20191231.xsd#wst_Developmentandlicensingincome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:to="loc_wst_Developmentandlicensingincome_acda4c03-973e-4243-94a3-5113d47c38a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3a592fd0-9036-40f5-bba2-80498c6675ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DevelopmentandlicensingincomeLineItems_8d190387-f344-4e74-afbd-95099654d2e1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3a592fd0-9036-40f5-bba2-80498c6675ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_61bff584-e6e9-4f7b-851c-6677f69e4d42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c22bd15e-5d7a-48c1-9b02-6a86bef129b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_61bff584-e6e9-4f7b-851c-6677f69e4d42" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c22bd15e-5d7a-48c1-9b02-6a86bef129b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3f6ffb8f-7940-4b82-bbe1-2ee47624925f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_fa47e01e-8426-47f9-8f6a-dee3f25071b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f6ffb8f-7940-4b82-bbe1-2ee47624925f" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_fa47e01e-8426-47f9-8f6a-dee3f25071b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_2855e90c-7189-479e-a4f7-7860514c9bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f6ffb8f-7940-4b82-bbe1-2ee47624925f" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_2855e90c-7189-479e-a4f7-7860514c9bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d5f9687e-7722-41b1-8129-5d30db8ec34a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f6ffb8f-7940-4b82-bbe1-2ee47624925f" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d5f9687e-7722-41b1-8129-5d30db8ec34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c0699eaa-b3fd-472e-8f2a-65516d76d1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f6ffb8f-7940-4b82-bbe1-2ee47624925f" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c0699eaa-b3fd-472e-8f2a-65516d76d1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0edabcd9-b573-4683-9d49-6d92ee31fd78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f6ffb8f-7940-4b82-bbe1-2ee47624925f" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0edabcd9-b573-4683-9d49-6d92ee31fd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ae8593b9-7d2a-406b-8b26-9933a325256a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_StatementTable_ae8593b9-7d2a-406b-8b26-9933a325256a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_80c8c491-4e53-4831-a6ff-5e46e6f08c01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ae8593b9-7d2a-406b-8b26-9933a325256a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_80c8c491-4e53-4831-a6ff-5e46e6f08c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_88a31f11-3a09-40a2-8c5a-f6189bf1e3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_80c8c491-4e53-4831-a6ff-5e46e6f08c01" xlink:to="loc_us-gaap_TypeOfAdoptionMember_88a31f11-3a09-40a2-8c5a-f6189bf1e3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_7d6401ca-d621-4698-b934-89edbaa3ef91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_88a31f11-3a09-40a2-8c5a-f6189bf1e3d4" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_7d6401ca-d621-4698-b934-89edbaa3ef91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ae8593b9-7d2a-406b-8b26-9933a325256a" xlink:to="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3d2ee4fb-57c6-435f-9c7f-5ddf5fd59d18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3d2ee4fb-57c6-435f-9c7f-5ddf5fd59d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_281c8a2b-c049-47f9-a98f-b76864c73394" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:to="loc_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations_281c8a2b-c049-47f9-a98f-b76864c73394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_10d8456c-dae3-43fc-a5b6-fc92f5680ac2" xlink:href="wst-20191231.xsd#wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de2f8ad4-9d2a-4377-bd80-fd4d617016ff" xlink:to="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_10d8456c-dae3-43fc-a5b6-fc92f5680ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_66c6a377-7298-42c6-99b2-dbadf919f1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_66c6a377-7298-42c6-99b2-dbadf919f1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3d56a08b-051b-4b15-adf9-b90c24161796" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3d56a08b-051b-4b15-adf9-b90c24161796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2e9f3b6c-1fa1-4a8f-b9fa-9a848641f6b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_2e9f3b6c-1fa1-4a8f-b9fa-9a848641f6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_19b791d5-0c9d-4465-9450-8d5162a282d1" xlink:href="wst-20191231.xsd#wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense_19b791d5-0c9d-4465-9450-8d5162a282d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f8d245ca-39ca-473a-a44e-ebe0f88d2823" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f8d245ca-39ca-473a-a44e-ebe0f88d2823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_09202a11-22ae-44d0-9424-18f90e0ad79c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense_09202a11-22ae-44d0-9424-18f90e0ad79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense_7283a69f-acdf-449a-b2dd-ffea2dcce504" xlink:href="wst-20191231.xsd#wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense_7283a69f-acdf-449a-b2dd-ffea2dcce504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax_b5e69ddb-5754-4fac-b000-521c5fa80718" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax_b5e69ddb-5754-4fac-b000-521c5fa80718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_30e39636-58fa-4577-8282-17aa3e018e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_30e39636-58fa-4577-8282-17aa3e018e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_62797d88-5097-4fa0-8725-59b0616bea7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense_62797d88-5097-4fa0-8725-59b0616bea7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_dc4ec72e-9769-4bba-a1f9-75256f7a0ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate_dc4ec72e-9769-4bba-a1f9-75256f7a0ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_31fc68d1-7570-4440-abc5-319db44fd582" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7994592-5284-4cd6-a50a-a5f17812a08c" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_31fc68d1-7570-4440-abc5-319db44fd582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e1fb7588-4d41-4d88-a361-40eed40330c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9cd010b3-463c-458e-8812-fb9903c41ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e1fb7588-4d41-4d88-a361-40eed40330c8" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9cd010b3-463c-458e-8812-fb9903c41ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_c90cedd5-7def-4309-ada5-6f2893d5fe56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9cd010b3-463c-458e-8812-fb9903c41ba5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_c90cedd5-7def-4309-ada5-6f2893d5fe56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_39897db2-bfeb-4d65-9a00-d35c87f119b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9cd010b3-463c-458e-8812-fb9903c41ba5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_39897db2-bfeb-4d65-9a00-d35c87f119b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_33df4aee-5ccf-4d92-9813-fc489f739856" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9cd010b3-463c-458e-8812-fb9903c41ba5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_33df4aee-5ccf-4d92-9813-fc489f739856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c644be05-5937-49f1-b3b7-409ecda15586" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9cd010b3-463c-458e-8812-fb9903c41ba5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c644be05-5937-49f1-b3b7-409ecda15586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_be06cba8-1c9f-4716-9e37-5efc99bc9c22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9cd010b3-463c-458e-8812-fb9903c41ba5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_be06cba8-1c9f-4716-9e37-5efc99bc9c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_12b46c71-809c-4b8e-8df9-8c9dfd0a5c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_37b7fea9-3ed3-467b-8783-edb0886adf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12b46c71-809c-4b8e-8df9-8c9dfd0a5c9f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_37b7fea9-3ed3-467b-8783-edb0886adf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_03758bcc-80d8-4945-b241-e062cc7d4a23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12b46c71-809c-4b8e-8df9-8c9dfd0a5c9f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_03758bcc-80d8-4945-b241-e062cc7d4a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d1e1aeeb-bbc2-4ea3-8645-849719f3ea0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12b46c71-809c-4b8e-8df9-8c9dfd0a5c9f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d1e1aeeb-bbc2-4ea3-8645-849719f3ea0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b9f7cca3-00b5-4f43-a87c-6c3409c830bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18ee39fa-aa77-4f2c-aef9-599be59c7788" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b9f7cca3-00b5-4f43-a87c-6c3409c830bc" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18ee39fa-aa77-4f2c-aef9-599be59c7788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aefb866d-f0b6-4d67-812a-f5919800c724" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18ee39fa-aa77-4f2c-aef9-599be59c7788" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aefb866d-f0b6-4d67-812a-f5919800c724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f55687b5-f4aa-4516-9363-816ffa3b95e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18ee39fa-aa77-4f2c-aef9-599be59c7788" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f55687b5-f4aa-4516-9363-816ffa3b95e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d118d15d-7c5f-4aab-9e9a-998126593b47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18ee39fa-aa77-4f2c-aef9-599be59c7788" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d118d15d-7c5f-4aab-9e9a-998126593b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3c43f9a9-8340-4f5f-8a67-bb5fe8aba751" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18ee39fa-aa77-4f2c-aef9-599be59c7788" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3c43f9a9-8340-4f5f-8a67-bb5fe8aba751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_beb4116b-4ed0-4784-a55f-d699ba640f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b9f7cca3-00b5-4f43-a87c-6c3409c830bc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_beb4116b-4ed0-4784-a55f-d699ba640f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_87b659f8-3188-4370-ad2f-22e437c26d99" xlink:href="wst-20191231.xsd#wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_beb4116b-4ed0-4784-a55f-d699ba640f3a" xlink:to="loc_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit_87b659f8-3188-4370-ad2f-22e437c26d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_777a9f28-83da-4d8c-81ae-95c760b672e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_beb4116b-4ed0-4784-a55f-d699ba640f3a" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_777a9f28-83da-4d8c-81ae-95c760b672e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2b9272f7-912a-4fcb-b701-0c21dcf57e40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_beb4116b-4ed0-4784-a55f-d699ba640f3a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2b9272f7-912a-4fcb-b701-0c21dcf57e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7dffbbd7-53fa-4650-9b70-489112c4e872" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b9f7cca3-00b5-4f43-a87c-6c3409c830bc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7dffbbd7-53fa-4650-9b70-489112c4e872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_276402f3-a721-436d-9c90-f5dc846b1d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_276402f3-a721-436d-9c90-f5dc846b1d5e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_0e1128d5-1618-456f-9008-b5583cd8bd32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_0e1128d5-1618-456f-9008-b5583cd8bd32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_5d7aa21b-b8e9-4601-9829-e978f98041ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0e1128d5-1618-456f-9008-b5583cd8bd32" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_5d7aa21b-b8e9-4601-9829-e978f98041ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_e6c179be-b70a-4ea5-916c-676f74c834c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_5d7aa21b-b8e9-4601-9829-e978f98041ef" xlink:to="loc_us-gaap_ResearchMember_e6c179be-b70a-4ea5-916c-676f74c834c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodAxis_fd97a704-ad74-4067-9b11-26ec8e085295" xlink:href="wst-20191231.xsd#wst_ExpirationPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:to="loc_wst_ExpirationPeriodAxis_fd97a704-ad74-4067-9b11-26ec8e085295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:href="wst-20191231.xsd#wst_ExpirationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodAxis_fd97a704-ad74-4067-9b11-26ec8e085295" xlink:to="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2019Member_6c76e484-aec0-4667-ae59-46c9435400ff" xlink:href="wst-20191231.xsd#wst_Year2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2019Member_6c76e484-aec0-4667-ae59-46c9435400ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2019Member_9ed5b54a-472d-439d-b175-9a3c26edb145" xlink:href="wst-20191231.xsd#wst_YearAfter2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_YearAfter2019Member_9ed5b54a-472d-439d-b175-9a3c26edb145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2037Member_cccc71c7-c229-4cee-aebc-884b45c1993e" xlink:href="wst-20191231.xsd#wst_Year2037Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2037Member_cccc71c7-c229-4cee-aebc-884b45c1993e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2038Member_3640809e-c7ae-465e-a15f-10a33485d37c" xlink:href="wst-20191231.xsd#wst_Year2038Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2038Member_3640809e-c7ae-465e-a15f-10a33485d37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2039Member_9602b348-865f-450a-9b1b-eb16cb0e9dac" xlink:href="wst-20191231.xsd#wst_Year2039Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2039Member_9602b348-865f-450a-9b1b-eb16cb0e9dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2020Member_cf64c51f-71ca-43ff-9f67-89e780651b5f" xlink:href="wst-20191231.xsd#wst_Year2020Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2020Member_cf64c51f-71ca-43ff-9f67-89e780651b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2022Member_d49df58c-66ff-41b9-8b6d-e01e0d1717e0" xlink:href="wst-20191231.xsd#wst_Year2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2022Member_d49df58c-66ff-41b9-8b6d-e01e0d1717e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Year2023Member_517e8c49-2958-4c20-8a0b-b5f613796eb1" xlink:href="wst-20191231.xsd#wst_Year2023Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_Year2023Member_517e8c49-2958-4c20-8a0b-b5f613796eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_YearAfter2023Member_fc542331-5345-4a23-a9aa-32b79c6445a9" xlink:href="wst-20191231.xsd#wst_YearAfter2023Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_ExpirationPeriodDomain_951dbb8a-ce50-4df1-a0e0-740c01376d1a" xlink:to="loc_wst_YearAfter2023Member_fc542331-5345-4a23-a9aa-32b79c6445a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_890a97bf-7c7d-43ea-8b43-7faa73245eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_890a97bf-7c7d-43ea-8b43-7faa73245eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_890a97bf-7c7d-43ea-8b43-7faa73245eb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_79f9fca5-c209-4d2e-b98f-35a1372fc7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_79f9fca5-c209-4d2e-b98f-35a1372fc7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f8987a24-2c8d-42e3-b9ae-92e1671ad4fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:to="loc_us-gaap_ForeignCountryMember_f8987a24-2c8d-42e3-b9ae-92e1671ad4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_0a8a173d-3190-42fb-a2c9-cf74d608f91e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_c3176b47-c769-4426-ab72-3796d78dc2c0" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_0a8a173d-3190-42fb-a2c9-cf74d608f91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_691b6968-7a63-45ed-889a-a4ef5c039fae" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_ddd8cde7-17f2-4ac7-b53a-976541eb018e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_ddd8cde7-17f2-4ac7-b53a-976541eb018e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_415149ec-65f3-47e9-b094-f9cccc6be78f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_415149ec-65f3-47e9-b094-f9cccc6be78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_b14914be-a47a-4798-8121-462f09b4df9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_b14914be-a47a-4798-8121-462f09b4df9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_a192c24a-ee9a-4ab0-804f-32f10db457fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_a192c24a-ee9a-4ab0-804f-32f10db457fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_dd5d7115-9ec1-40aa-b6b6-7af9d37010a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_a3cb1efd-ff68-46fa-a967-51a5c1d13c1c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_dd5d7115-9ec1-40aa-b6b6-7af9d37010a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_276402f3-a721-436d-9c90-f5dc846b1d5e" xlink:to="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b0b78591-a0b9-4d70-9666-1bc9588720eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b0b78591-a0b9-4d70-9666-1bc9588720eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_88905445-9acb-4929-94af-1bd36ee47098" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_88905445-9acb-4929-94af-1bd36ee47098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_996a2930-f43f-4041-973f-4670bfd4882c" xlink:href="wst-20191231.xsd#wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:to="loc_wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges_996a2930-f43f-4041-973f-4670bfd4882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2b3759c4-5d86-446a-bdf6-07061778a82a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2b3759c4-5d86-446a-bdf6-07061778a82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_fca786f6-2670-4853-9cc1-0705a798a87c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_fca786f6-2670-4853-9cc1-0705a798a87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0f96d2a5-740e-4f07-963d-68d05cfdfc24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0f96d2a5-740e-4f07-963d-68d05cfdfc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_7a948b0b-b41f-4451-936f-056d1c387812" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_b54858b3-9d38-4460-86dc-7d9c8b10304c" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_7a948b0b-b41f-4451-936f-056d1c387812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a84d451-27ed-4f33-b22a-ded1d874b7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_276402f3-a721-436d-9c90-f5dc846b1d5e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a84d451-27ed-4f33-b22a-ded1d874b7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0a992c3f-eacd-413b-848b-0a919ff7567b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a84d451-27ed-4f33-b22a-ded1d874b7d7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0a992c3f-eacd-413b-848b-0a919ff7567b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_fbca618c-d614-4e9d-b9f0-9ba2bae8ab26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a84d451-27ed-4f33-b22a-ded1d874b7d7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_fbca618c-d614-4e9d-b9f0-9ba2bae8ab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_54555ce4-a2f7-4c68-a55d-d85f58abbf2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a84d451-27ed-4f33-b22a-ded1d874b7d7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_54555ce4-a2f7-4c68-a55d-d85f58abbf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_ed29e6a2-0c53-401c-a4e4-84345cb82a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a84d451-27ed-4f33-b22a-ded1d874b7d7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_ed29e6a2-0c53-401c-a4e4-84345cb82a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_609542a5-4aa6-4e7e-aa29-1deb22297169" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_276402f3-a721-436d-9c90-f5dc846b1d5e" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_609542a5-4aa6-4e7e-aa29-1deb22297169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_03d7d8ea-ff59-4631-a4f8-7e397a5356ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_03d7d8ea-ff59-4631-a4f8-7e397a5356ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c711646c-8986-41ea-bc95-04eab383eaed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c711646c-8986-41ea-bc95-04eab383eaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e80f1017-60e0-453a-8446-11260c6c1426" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e80f1017-60e0-453a-8446-11260c6c1426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_27dc8f9b-c7bc-4492-ba18-595e7bbc16f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_27dc8f9b-c7bc-4492-ba18-595e7bbc16f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_530c935a-1893-463a-a75e-e2296275adc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_530c935a-1893-463a-a75e-e2296275adc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_21dd87f0-6270-4528-9ade-49ce28c928bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_21dd87f0-6270-4528-9ade-49ce28c928bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_c501ae17-f480-472c-bcbd-a6518d7dfd45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_c501ae17-f480-472c-bcbd-a6518d7dfd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2ee24e1b-1944-417b-b548-8cfee5ca0dc5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2ee24e1b-1944-417b-b548-8cfee5ca0dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_316def7c-0522-41a7-840d-ba90823a1d61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_316def7c-0522-41a7-840d-ba90823a1d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage_523b6764-ef10-4484-a20b-c542df4219bc" xlink:href="wst-20191231.xsd#wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage_523b6764-ef10-4484-a20b-c542df4219bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_a8df2fb1-2693-43cf-b13b-3e6b9d848cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_a8df2fb1-2693-43cf-b13b-3e6b9d848cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction_75d63cd4-59a1-4e9a-a101-faf10a670b4a" xlink:href="wst-20191231.xsd#wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction_75d63cd4-59a1-4e9a-a101-faf10a670b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_0ad2a002-2e3e-45c7-971b-95bad4ab88f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_0ad2a002-2e3e-45c7-971b-95bad4ab88f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6c4a6844-223a-4045-ad02-6ae94c0d3ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38eb18c1-88a4-4308-8d52-c40df8ed6aa8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6c4a6844-223a-4045-ad02-6ae94c0d3ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20191231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c96b523a-a5d1-44f2-b66e-fa9ed35781b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_152be9d6-1eea-405a-a324-de0aedeeac47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c96b523a-a5d1-44f2-b66e-fa9ed35781b9" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_152be9d6-1eea-405a-a324-de0aedeeac47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#CommitmentsandContingenciesTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96e2daf8-8fd0-46c1-8692-7c48547d95cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96e2daf8-8fd0-46c1-8692-7c48547d95cb" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cccdf710-2b32-46b6-83a4-df68b0ea0906" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cccdf710-2b32-46b6-83a4-df68b0ea0906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cccdf710-2b32-46b6-83a4-df68b0ea0906" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_Revolvingcreditfacilitydue2020Member_4c5f96e6-e9ad-428f-ae0e-127598c0a8ea" xlink:href="wst-20191231.xsd#wst_Revolvingcreditfacilitydue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:to="loc_wst_Revolvingcreditfacilitydue2020Member_4c5f96e6-e9ad-428f-ae0e-127598c0a8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_RevolvingCreditFacilityDue2024Member_ea93e9fe-bd5f-49bc-9a2c-1c1b657b3ef2" xlink:href="wst-20191231.xsd#wst_RevolvingCreditFacilityDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ea1f8efa-97aa-40d8-a53a-294ec8c463fa" xlink:to="loc_wst_RevolvingCreditFacilityDue2024Member_ea93e9fe-bd5f-49bc-9a2c-1c1b657b3ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_672ebed3-1893-4e7a-ac30-5dfd915938ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_us-gaap_CreditFacilityAxis_672ebed3-1893-4e7a-ac30-5dfd915938ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2c9e1ff5-1297-4117-9bdd-6be413542f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_672ebed3-1893-4e7a-ac30-5dfd915938ab" xlink:to="loc_us-gaap_CreditFacilityDomain_2c9e1ff5-1297-4117-9bdd-6be413542f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_87d49cee-a244-4a6e-b1cc-d5bd1b032f06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2c9e1ff5-1297-4117-9bdd-6be413542f0c" xlink:to="loc_us-gaap_LetterOfCreditMember_87d49cee-a244-4a6e-b1cc-d5bd1b032f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_29c7bea2-afc0-4191-990b-c014ad9045c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_f424ffd9-93ce-4aeb-b2d5-bc1dc3b31a5e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_29c7bea2-afc0-4191-990b-c014ad9045c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6ebed752-ecfc-410a-9239-dae5b394378d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_29c7bea2-afc0-4191-990b-c014ad9045c8" xlink:to="loc_us-gaap_ForeignCountryMember_6ebed752-ecfc-410a-9239-dae5b394378d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a12d62e4-1cd7-457b-98e8-4616f4ecb24e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_srt_RangeAxis_a12d62e4-1cd7-457b-98e8-4616f4ecb24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a12d62e4-1cd7-457b-98e8-4616f4ecb24e" xlink:to="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_613f3424-4204-47c1-bfa5-94c280643039" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:to="loc_srt_MinimumMember_613f3424-4204-47c1-bfa5-94c280643039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_caf2c00a-d12e-45c2-ab29-28224b845476" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7c231f16-7cb8-48e2-8ccd-af3e84f220f4" xlink:to="loc_srt_MaximumMember_caf2c00a-d12e-45c2-ab29-28224b845476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_341bdf1a-28e6-441b-8bd5-48ef775a7975" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod_74206acd-d27d-44ad-bc66-57b2df29f4e0" xlink:href="wst-20191231.xsd#wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:to="loc_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod_74206acd-d27d-44ad-bc66-57b2df29f4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_1898417d-125e-4b64-9c88-0dbd2e9853c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_1898417d-125e-4b64-9c88-0dbd2e9853c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_846f5aee-8423-4611-967e-7cafd648c4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_94895cdb-d0be-4fbf-aec7-e68535c43931" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_846f5aee-8423-4611-967e-7cafd648c4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationTable_80b0e2a3-9ef1-4d97-8c8b-c9a73b68dbd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96e2daf8-8fd0-46c1-8692-7c48547d95cb" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationTable_80b0e2a3-9ef1-4d97-8c8b-c9a73b68dbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationTable_80b0e2a3-9ef1-4d97-8c8b-c9a73b68dbd3" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_84cee936-10bf-47b2-8243-ba27ed3de57b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_84cee936-10bf-47b2-8243-ba27ed3de57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_34e0ae0e-7edb-4069-bb90-158fd398eade" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems_b37a7774-3d6d-4a93-8938-ae9f0e7149fd" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_34e0ae0e-7edb-4069-bb90-158fd398eade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_415c68fc-2d48-4425-b936-786afa755731" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96e2daf8-8fd0-46c1-8692-7c48547d95cb" xlink:to="loc_us-gaap_LossContingenciesTable_415c68fc-2d48-4425-b936-786afa755731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_15b9742b-52d2-4e58-92b0-b1c33218b45c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_415c68fc-2d48-4425-b936-786afa755731" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_15b9742b-52d2-4e58-92b0-b1c33218b45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1a7d9542-d935-4134-9ceb-f2f13eb21a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_15b9742b-52d2-4e58-92b0-b1c33218b45c" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1a7d9542-d935-4134-9ceb-f2f13eb21a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceClaimsMember_ad69dc42-cb54-477c-adff-86ca367b031b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InsuranceClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_1a7d9542-d935-4134-9ceb-f2f13eb21a7d" xlink:to="loc_us-gaap_InsuranceClaimsMember_ad69dc42-cb54-477c-adff-86ca367b031b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_415c68fc-2d48-4425-b936-786afa755731" xlink:to="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_42326b5a-93d4-4cc8-b13e-75c0684b69c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_42326b5a-93d4-4cc8-b13e-75c0684b69c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyReceivable_a8f9ca19-a82b-4085-91ee-1735124437e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:to="loc_us-gaap_LossContingencyReceivable_a8f9ca19-a82b-4085-91ee-1735124437e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_56b5e4f1-1532-45dc-9fdc-1aa535bfc802" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6cb841f4-eb5e-45bb-8601-c33921d757b2" xlink:to="loc_us-gaap_LineOfCredit_56b5e4f1-1532-45dc-9fdc-1aa535bfc802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_259e12c3-8737-4b80-a3ca-654b3ae86dec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_22866496-0656-4275-8a3f-1e30ec0af3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_259e12c3-8737-4b80-a3ca-654b3ae86dec" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_22866496-0656-4275-8a3f-1e30ec0af3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cc48d92a-d41c-41f5-a9cd-5ea5ed0826f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_f464839d-0d5f-4d4f-a45e-bdcec8c43be9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cc48d92a-d41c-41f5-a9cd-5ea5ed0826f3" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_f464839d-0d5f-4d4f-a45e-bdcec8c43be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_cedbb642-42fe-405d-8bb0-a14bc1cb59df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cc48d92a-d41c-41f5-a9cd-5ea5ed0826f3" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_cedbb642-42fe-405d-8bb0-a14bc1cb59df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d79d8e21-44e8-4508-a5ec-abb71f057333" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cc48d92a-d41c-41f5-a9cd-5ea5ed0826f3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d79d8e21-44e8-4508-a5ec-abb71f057333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTextualsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationTextualsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTextualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8f9654f9-e225-486d-b557-50ed02fbe039" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_458fb0d1-922a-41b9-a4f9-cc9e9d2c97b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureOfMajorCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8f9654f9-e225-486d-b557-50ed02fbe039" xlink:to="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_458fb0d1-922a-41b9-a4f9-cc9e9d2c97b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_e48bc6ee-4b29-42e3-beb7-2e4e5d48dc5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8f9654f9-e225-486d-b557-50ed02fbe039" xlink:to="loc_us-gaap_NumberOfReportableSegments_e48bc6ee-4b29-42e3-beb7-2e4e5d48dc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSalesbyProductGroupDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_13b512c7-995e-4d02-8b2c-a1a3b8c7049d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fb5371a7-c7a1-4150-b6ee-01c680fa0e53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_13b512c7-995e-4d02-8b2c-a1a3b8c7049d" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fb5371a7-c7a1-4150-b6ee-01c680fa0e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dc72b50c-b8fe-4c45-9b71-32ee6e05aded" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fb5371a7-c7a1-4150-b6ee-01c680fa0e53" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dc72b50c-b8fe-4c45-9b71-32ee6e05aded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dc72b50c-b8fe-4c45-9b71-32ee6e05aded" xlink:to="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_f0ee9242-faea-4297-85d7-d710e6dfc25b" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:to="loc_wst_ContractManufacturedProductsMember_f0ee9242-faea-4297-85d7-d710e6dfc25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_6bb66ce5-fa66-4831-aba2-2b7f2d2090dd" xlink:href="wst-20191231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:to="loc_wst_ProprietaryProductsMember_6bb66ce5-fa66-4831-aba2-2b7f2d2090dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_55a9eda6-6491-48d0-b1ec-db759de40fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f59c3dda-a351-49de-b294-4dc886870a2c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_55a9eda6-6491-48d0-b1ec-db759de40fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_78dbf8c0-8204-4047-a549-0f4ed60e8e42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_fb5371a7-c7a1-4150-b6ee-01c680fa0e53" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_78dbf8c0-8204-4047-a549-0f4ed60e8e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c582fe81-a85c-44e6-994f-26f2c4db1e66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_78dbf8c0-8204-4047-a549-0f4ed60e8e42" xlink:to="loc_us-gaap_Revenues_c582fe81-a85c-44e6-994f-26f2c4db1e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSalesandPPEbyGeographicLocationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_797dc1bc-8a66-4a5d-8d2d-4e202be7c01c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_967108ea-418a-425a-b274-76007bee60cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_797dc1bc-8a66-4a5d-8d2d-4e202be7c01c" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_967108ea-418a-425a-b274-76007bee60cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_51be5e67-d0b9-4f1a-9a1f-9e40907be009" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_967108ea-418a-425a-b274-76007bee60cd" xlink:to="loc_srt_StatementGeographicalAxis_51be5e67-d0b9-4f1a-9a1f-9e40907be009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_51be5e67-d0b9-4f1a-9a1f-9e40907be009" xlink:to="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9c891ac5-c8ca-46f0-8056-a36423d75194" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_US_9c891ac5-c8ca-46f0-8056-a36423d75194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_DE_36464644-f6ab-45eb-934c-b24aa6f90a74" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_DE"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_DE_36464644-f6ab-45eb-934c-b24aa6f90a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_dfd3c2cb-e580-43f6-bc36-a89d97f20adf" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_FR_dfd3c2cb-e580-43f6-bc36-a89d97f20adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherEuropeCountriesMember_66959032-bd37-47b9-9da7-23559246947c" xlink:href="wst-20191231.xsd#wst_OtherEuropeCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_wst_OtherEuropeCountriesMember_66959032-bd37-47b9-9da7-23559246947c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherCountriesMember_57314f87-fa59-4eda-960f-77f0e92f3896" xlink:href="wst-20191231.xsd#wst_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_wst_OtherCountriesMember_57314f87-fa59-4eda-960f-77f0e92f3896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_6e35f6b8-6156-42b2-8d28-3861f65925d7" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_IE"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e559cd80-2135-4dc7-a767-5939f1ded708" xlink:to="loc_country_IE_6e35f6b8-6156-42b2-8d28-3861f65925d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_967108ea-418a-425a-b274-76007bee60cd" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cb5c87d1-b595-4f37-a23f-eb6f9de1b7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:to="loc_us-gaap_Revenues_cb5c87d1-b595-4f37-a23f-eb6f9de1b7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c7ada741-6fd5-45b4-9f17-fa6855de403d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fd3eed4d-c3b9-4d5e-931b-399471b365fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c7ada741-6fd5-45b4-9f17-fa6855de403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_abdb8e6e-bb2c-4414-a292-68fdd0e77352" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f34a0236-068c-4c16-8440-7317695db7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_abdb8e6e-bb2c-4414-a292-68fdd0e77352" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f34a0236-068c-4c16-8440-7317695db7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f34a0236-068c-4c16-8440-7317695db7c8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2c796e38-2ed3-42c3-aadb-1a8b1ba0c682" xlink:to="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ProprietaryProductsMember_0ba47ea6-11cc-4043-9d39-6771fa7b9052" xlink:href="wst-20191231.xsd#wst_ProprietaryProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:to="loc_wst_ProprietaryProductsMember_0ba47ea6-11cc-4043-9d39-6771fa7b9052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_ContractManufacturedProductsMember_817502b2-9c51-4128-b98b-44a11c70e003" xlink:href="wst-20191231.xsd#wst_ContractManufacturedProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:to="loc_wst_ContractManufacturedProductsMember_817502b2-9c51-4128-b98b-44a11c70e003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_CorporateAndEliminationsMember_83347f01-a33b-46d2-af9a-ae4fcb883780" xlink:href="wst-20191231.xsd#wst_CorporateAndEliminationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_876f0f73-313e-4c45-8a7f-e76f96711d7d" xlink:to="loc_wst_CorporateAndEliminationsMember_83347f01-a33b-46d2-af9a-ae4fcb883780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f34a0236-068c-4c16-8440-7317695db7c8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a29f1075-4369-463d-8326-63181046e09a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_Revenues_a29f1075-4369-463d-8326-63181046e09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0c8779c7-4de6-42b3-9c5a-e91092880458" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_OperatingIncomeLoss_0c8779c7-4de6-42b3-9c5a-e91092880458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1065365c-14f1-4ab9-b62d-a7f94c62fd19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_InterestExpense_1065365c-14f1-4ab9-b62d-a7f94c62fd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_d530a23a-69eb-4541-928b-9f364af9ea10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_InvestmentIncomeNet_d530a23a-69eb-4541-928b-9f364af9ea10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8eb51ab5-c423-48f2-8fb3-881abceedefc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8eb51ab5-c423-48f2-8fb3-881abceedefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c54c5f4f-0407-4678-8e7b-b83ef0febf07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c54c5f4f-0407-4678-8e7b-b83ef0febf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b2324999-9560-4506-8263-8e4cebf993b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_Assets_b2324999-9560-4506-8263-8e4cebf993b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49c0d9f8-fba3-4cc0-a727-8027110e15b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49c0d9f8-fba3-4cc0-a727-8027110e15b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3eeeb028-6591-4c19-bc21-9feb7c30966c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d77a38-816d-494f-a139-5aa69a892029" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3eeeb028-6591-4c19-bc21-9feb7c30966c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="simple" xlink:href="wst-20191231.xsd#ScheduleIIValuationandQualifyingAccountsNotes"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_5bb44be5-bd2d-4bb0-83f1-312043f67315" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_0a9264f6-94d5-416a-b969-02fd0a5515e2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_5bb44be5-bd2d-4bb0-83f1-312043f67315" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_0a9264f6-94d5-416a-b969-02fd0a5515e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="wst-20191231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_6c18ae9a-1e95-4ebd-84ee-dfd757bf2590" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f475ab0c-e962-4130-9073-f0f64525e937" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_6c18ae9a-1e95-4ebd-84ee-dfd757bf2590" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f475ab0c-e962-4130-9073-f0f64525e937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f475ab0c-e962-4130-9073-f0f64525e937" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_a1f71cc7-7d0a-49ea-b263-b07dfd1fd739" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_ef81e268-a73f-40b9-8f6c-12a66e761cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_ef81e268-a73f-40b9-8f6c-12a66e761cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_1e80bc03-708b-43f4-a88b-dbe4b1caeaec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_603e805d-3136-47ad-b096-f944ea5e1f09" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_1e80bc03-708b-43f4-a88b-dbe4b1caeaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a1b5c347-f3b0-419f-862e-987f58b93846" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_f475ab0c-e962-4130-9073-f0f64525e937" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a1b5c347-f3b0-419f-862e-987f58b93846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_a1b5c347-f3b0-419f-862e-987f58b93846" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_9df3763e-b083-4d78-b44e-27d3fb153d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_9df3763e-b083-4d78-b44e-27d3fb153d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_45d36738-c736-4c51-afea-b080ba2e0c16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_45d36738-c736-4c51-afea-b080ba2e0c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8ec2812a-f9d9-471f-9f97-ce22e47f66fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_8ec2812a-f9d9-471f-9f97-ce22e47f66fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_f47129f3-355d-4bdf-a5a6-f8ad9befed3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_0ea0183a-2c26-4264-8b83-97c5099efd65" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_f47129f3-355d-4bdf-a5a6-f8ad9befed3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>wst-20191231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 wst-20191231_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KE/C/\=O@K^SGX%N/B=\??BSX<\%
M^';5@D^M>*-9AL;97()5/,F907.#A1EFQP#75U_/?^RS\2Y_^"[O_!RWXDM/
MVD8_[=^%/P(M==U#P/\ #_41OTWR-.O;?3X)I8&^5Y)KFXBNI=P.XHD39C0(
M #]EOA=_P5$_X)X_&6^M=-^'W[87@6YN+^-I--BO=;2R:_0#+-;_ &GR_M
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M/^"5W[5?[.NB^&?$7C3PRFM>!/%_@7Q[+KVEW\;P3SK%-Y^GV4L)*6LZAPK
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MNEM64N54LJ&, G@L.M?._B#_ (.<?BW<?\$^[+_@I-\//^"7NLWOPXM?%/\
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MW D$<U\9?\'#G_!+^V_X*9_L!:SHW@KP\ES\3/A\LOB#X=S1Q S7$R)_I.G
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MOA-X%D\3>*H?&7C&?0K6Y5(H939V#PV%X;F<+<0;MXAC4R@!FVOMG_X)Y?\
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M*ND^+_@UX*^(\7A/7GU/XC2Z9XES(T*I>+IW]FRP)$WVB)D5KHNP<;A&0P4
M_0WX^?M7?LR?LJZ78:Y^TQ\?_!_@"RU2=H--O/&'B"WTZ*ZE4;C&CSNJLP'.
MT'. 3VKL/"?BOPSX[\+:;XX\%>(+/5M&UG3X;[2-5TZY6:WO+69!)%-%(I*N
MCHRLK D$$$=:_'S_ (.F/CMX$_:B_P"""GPZ_:.^&9NCX?\ ''CKPSKFC"_@
M$<Z07.G7TJ+(H)"R*'VL 2 0<$CD_I)_P3*_Y1N?L^?]D/\ "?\ Z9[6@"[\
M8O\ @H7^PE^SQXL/@/X]?M@_#?P7K>W<-*\4^,;.PN&7.-PCFD5B,\9 QFH_
M!G_!1?\ 8!^(GCBV^&7@C]MCX4ZGXDO'1++P]:>/]/:^N6?A5B@\[S)"?15/
M;UK\9?\ @]K:&'XI?LLW$K*@5?$Y=V., 3Z.>3Z#FNT_X.S_ (]?L@_M=?LY
M_"KX(_LM>._#'Q4^-<OQ*BG\/:=\-KR'6]4M],^QW27"$V1D:-))VM,1GEVC
M#*#Y;$ '[F45\:2?MFW/_!*;_@CMX!^/W_!2#6=1N_%OA7X>Z)IWB.Q@E6XU
M+5M=:V1%L@[-MEN2RGS)2VW]W+*6*@FJ_P .O^"LOBW1/VO/A=^QW^V'^SE8
M_#S7?C;X%/B+X;WVB>-&UB!KA4:271[XR6=K]GNT11AD\V)V8(&!(W 'VEN4
M,$+#)&0,\XI:_%;]DK_@IY_P46_:5_X.!?BYX G_ &:=+U6+X6_#O4_#.F?#
M:/XA165OH5J=8TLW.HO=M!(EW=2/'"&5%4;0BJ<1EG^Q?"'_  69N=?_ ."P
MFO\ _!(#6?V9OL/B#1])EU&V\9P>,Q/97</]F1ZA!F$V:21LT<R(XRVQPV/,
M #, ?<E%?#/_  3)_P""T<?_  4?_:,^-7[,EG^S8_@[7O@Q<O::A=3^+Q?6
MNI7*7EQ:,J,MI&T<?F6Y.\J3M8?+D8KP[P'_ ,',_B+XK:W\<?A+\*?^";'C
M3Q;\3/@W<S01^"_"'B3^T?[7%M=3V]Y=&5;-6@MH6A3YA'))(US"B1$L< 'Z
MKT5^9?[97_!P]XM_87^ O[/OQL^./_!/S7[2X^.VC3W#>%)?%C6^J>';R!K<
M36\T$ECF0%+J%XS\KMEE:.,@;NI\$_\ !<[QMIW_  59\-?\$Q?VG_V&=7^&
M=SX_T,:GX#\0W/C:TU*XFB>*XDA%[:VT92U9S:SQ%4GF,<J '<K>8H!^A=%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\^.@_ [QM_P;R_\
M!P!J_P"UI\8_"NJK^S=\7;K5[(?$>PT^6YL]#M]5N$NTM[LQJ3"UO>10H0W+
MPJ9$WD,@_H.J.\L[34+62QO[6.>"9"DT,R!D=2,%2#P01V- '@'B7_@J5^PE
M9:!;WGPR_:-\+_$O7-4BSX;\%?"W7;77];UN0CY8[:TM)';!) :639#$#NED
MC0%A^:W_  7X^#?Q,\&?\%6?V(O^"E?Q#T*?2?AQH/BOPUHWC^^>X6:T\(7,
M>N)=F2[F7]VD3+<R+YV=I^R-TR@;]D/!_P ,?AM\/6G?P!\/=#T,W3;KHZ/I
M,-L9CG.6\M1N.>>:UM0T^PU:QFTS5+*&YMKB,QSV]Q$'21",%64\$$<$&@#\
M5=,^&&N?MH?\'<UK^TC^SWJD6N^ /@YX-MCXS\::)<"XTZ*Z?1+B!+%+F,F.
M29WO8U:(,6"I,2/W;"N,_P""3WQD^$S?\'7G[6OC"3XDZ%'I6I^"?$5MINI2
MZM"L%W+!J>BR2K'(6VN5CMKB0X)PD+L>%)'[J^'O#'AOPCIBZ)X3\/6.EV2,
M62TTZT2")23DD(@ !/TJ]0!_.7_P;V?&CX1^%?V?O^"DD_B;XEZ'I\=WX=DU
M"S>\U2*,7-J8=?C$T6YAYB^9- F5S\T\0ZR*#L_\$9O$OAV]_P"#4_\ ; \*
MVFNVDNJ6%SXMGOM.2X4SP12Z%IXBD>/.Y4<QR!6(PQC< DJ<?T-UX!_P5.^$
M7Q7_ &A/^">_Q:_9_P#@AX);7O%/CKP7>Z#I%F=1M[6..6YB:/SI99W15C3.
MXXW,>@4]@#\,?V;?VT/V9? W_!I-\0/V:_$OQ6T>W^(>KZE?6.B^"+RX\K4M
M3:[UJ)HYK6!]KW4*JLK-+%O1&@D5B&0K7JWQT^+'QZ_X(\?\&Q?P ^&_C3]F
M'P]X@\9^)_$%U(5^(OA*'5+'P;)>W6H:G;3R6ERC1B^6*9%C250$D,NY24*-
M^@/_  0%_84^-'[$W[ ^@_LR?M?_  0T^Q\5^$/$NHZCIVJ_;;#4K9UN[AIE
M:VDBD>2)UX#;D3G;M+<X^\+_ $[3]5M6L=4L8;F%B"T-Q$'4D$$9!XX(!^HH
M _F_E^*'P;T+_@Y"_92^/NA_$#XF^(O">N^!;&5/B#\2]!U>/4?%-[/;:K U
MS!;W4*R^6\\L<4<5M$L"G"PKLVD^S?M9_$CX5R?\'F?P=U#5?'&ABQT3PS#I
M^JW-SJ$2PV>H?V/JIB@D9CM2;S)8 JD[M\B #) K]VIM.T^YNX+^XL89)[;=
M]FG>(%XMPPVTGE<C@XZU-0!^:?\ P=H>)/#ND?\ !%_QOH6JZ]96U[JWB708
M]+L[BZ1);QTU.WD=8D)S(516<A0<*I)X%?-$GPN_X)Q_MN?\$3?V-OV5/VP_
MBG9>$7\1^"KJV\!_%JTU2'R_"GB.SAMU:RNBY$0CG65DDCE>,%X8D!61XG3]
MPZK:CH^D:Q"]MJ^EVUU') \,D=S KJT;XWH0P.5; R.AP,T ?S[?L%_LY_\
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M^%!?:O;ZS ]K;F76=8FBWRABB[XKB"1<GE)HV'# G]\:* "OY]O^"/EGI/\
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MEM*V[$<I>>%=C8.9%&.17[LV=G9Z=:1:?I]K'!!!&(X8(8PJ1H!@*H'  '
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!!J#_OJC_A,?#'_0:@_P"^J -*BJNGZWI.JNT>G7\<S(,L$/05:H ****
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MK&C+"2K*@!%7+"PL6L86:RB),2DDQCGBH/&/_(L7O_7 U<T[_D'P?]<5_D*
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MR.][_P!>47\S6Q6/9?\ ([WO_7E%_,T ;%%%% !1110 4444 %%%% !1110
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M_P#!4;]G&^_9]_:"T/9(F^X\+>*;.)3?^'K_ &X6YMV/4'@21$[9%^4X(5E
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M0 4444 %%%% !1110 4444 %8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,T
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MIEM*RZKKD(/&;JX#1I( '$?FQ-D**_1N@#'\2_\ (7T?_K]/_H)K8K'\2_\
M(7T?_K]/_H)K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH \+_X)[_\ )$]6_P"Q[UG_ -*37NE>%_\ !/?_ )(G
MJW_8]ZS_ .E)KW2@ HHHH **** "BBB@ K-\8_\ (L7O_7 UI5F^,?\ D6+W
M_K@: +FG?\@^#_KBO\A4U0Z=_P @^#_KBO\ (5-0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !6/XE_P"0OH__ %^G_P!!-;%8_B7_ )"^C_\
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_X)[_\D3U;_L>]9_\
M2DU[I7A?_!/?_DB>K?\ 8]ZS_P"E)KW2@ HHHH **** "BBB@ K-\8_\BQ>_
M]<#6E6;XQ_Y%B]_ZX&@"YIW_ "#X/^N*_P A4U0Z=_R#X/\ KBO\A4U !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %8_B7_D+Z/_U^G_T$UL5C
M^)?^0OH__7Z?_030!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S0!L4444 %%%% !1110
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M_@N9\6?'GQ1\.^ ?^"2?[.VOR6GQ"_:9U=]+UK4+;E] \&VX\S6=0?'0-"#
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M% &/XE_Y"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z?_036Q0 4444 %%%% !1110
M4444 %%%% !1110 4444 ?+?_!7O]D#XZ?MC?LH6>@?LP>,-.TCXD> O'NB^
M.O JZUG[!?ZGI5QY\-K<XZ1N<X)^7>L>["Y(^??^"1G[?OP3_:R\8/\ LO\
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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M_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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MG:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\
MWZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I_
M_/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G
M:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY
M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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M^C_]?I_]!- &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S- &Q1110 4444 %%%% !1110
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MBQ>_]<#6E6;XQ_Y%B]_ZX&@"YIW_ "#X/^N*_P A4U0Z=_R#X/\ KBO\A4U
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_B7_D+Z/_U^G_T$
MUL5C^)?^0OH__7Z?_030!L4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S0!L4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X
M'_Y!$O\ U^S?^A4 ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA?1_^OT_^@FMBL?Q+_R%]'_Z_3_Z":V* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /"_^">__)$]6_['O6?_ $I-
M>Z5X7_P3W_Y(GJW_ &/>L_\ I2:]TH **** "BBB@ HHHH *S?&/_(L7O_7
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M-MR53>V,*:\]_P""-?[%?C#]C7]CJUF^-]RU]\7/B=K%SXY^,.KW"CSI]>U
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M@ HHHH *Q[+_ )'>]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K'\#_P#((E_Z_9O_ $*MBL?P/_R"
M)?\ K]F_]"H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M S?&/_(L7O\ UP-7-._Y!\'_ %Q7^0JGXQ_Y%B]_ZX&KFG?\@^#_ *XK_(4
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M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!
ML45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
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M^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
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M)[_\D3U;_L>]9_\ 2DU[I7A?_!/?_DB>K?\ 8]ZS_P"E)KW2@ HHHH ****
M"BBB@ K-\8_\BQ>_]<#6E6;XQ_Y%B]_ZX&@"YIW_ "#X/^N*_P A4U0Z=_R#
MX/\ KBO\A4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_B7
M_D+Z/_U^G_T$UL5C^)?^0OH__7Z?_030!L4444 %%%% !1110 4444 %%%%
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MO@'_ (:'_P"#CC_I'5^S_P#^'=N/_C='_#0__!QQ_P!(ZOV?_P#P[MQ_\;H
M^_J*^ ?^&A_^#CC_ *1U?L__ /AW;C_XW1_PT/\ \'''_2.K]G__ ,.[<?\
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M:CJ_Q5^,%XYATCX._"G3SK&N3SX^Y,D64LP.&;SF5@F65'QBO%/^&7O^"O\
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M/^N*_P A4U0Z=_R#X/\ KBO\A4U !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8_B7_D+Z/_U^G_T$UL5C^)?^0OH__7Z?_030!L4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5CV7_([WO_ %Y1?S-;%8]E
M_P CO>_]>47\S0!L4444 %%%% !1110 45X%^VU_P4Y_8I_X)\Z-!<?M*_&B
MRL-:U *-"\%Z2C7^NZN[':B6UC#NE?<^%#L%C#$!G%?+P\8?\%K/^"IO^C^
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MF_\ 0JV*Q_ __((E_P"OV;_T*@#8HHHH **** "BBB@ HHHH **** "BBB@
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M?(W="L(C# #=N/-?4-%% !1110 4444 %%%% !1110 4444 %8_@?_D$2_\
M7[-_Z%6Q6/X'_P"01+_U^S?^A4 ;%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 9OC'_D6+W_K@:N:=_P @^#_KBO\ (53\8_\ (L7O_7 U
M<T[_ )!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)K8H **** "BBB@ HHHH
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M_P#)$]6_['O6?_2DU[I0 4444 %%%% !1110 5F^,?\ D6+W_K@:TJS?&/\
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MR%4_&/\ R+%[_P!<#5S3O^0?!_UQ7^0H FHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OSW_P""[G_!>'X?_P#!(+P-I/@KP=X2M/&'Q<\763W7
MAWPW>SLEGIUFK&/[?>E"',1D5D2)"K2M'(-Z!"U?H17\D7_!V _CEO\ @MK\
M1U\6B?[ OA_PZ/#'F@[?L/\ 9-L7V9_A^UF[Z<;MW?- %B?_ (.QO^"S5UX_
MA\:W7Q@\(R65O=>=%X8/@&Q%B!_<W!!<E<<?Z_=[YYK]V/\ @A5_P75^'/\
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M6Q6/XE_Y"^C_ /7Z?_030!L4444 %%%% !1110 4444 %%%% !1110 4444
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%%
M&/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_
MP@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__
M  @^D?\ /S>_^!;5F:YX5TZUU'388Y[DB>Y*N6N&) V]O2NKK'\2_P#(7T?_
M *_3_P"@F@ _X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_
M\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"V
MK8HH Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "
MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
MX%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_
M (%M1_P@^D?\_-[_ .!;5L44 <SXE\):98Z#=7<-Q=%HXB0'N6(_$59LO!>E
M2V<4K7-YEHE)Q=-CI5OQC_R+%[_UP-7-._Y!\'_7%?Y"@#-_X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M3O\ D'P?]<5_D*I^,?\ D6+W_K@:N:=_R#X/^N*_R% $U%%% !1110 4444
M%%%% !17#_M%?M*_ 7]DKX4ZE\</VDOBKH_@[PKI29O-7UFY\M"Q!VQ1J,O-
M*V"%BC#.YX52>*^!I_B[_P %)?\ @MF?[*_9D7Q%^S%^S'?96Z^*.JVOD^-_
M'%J>O]DVY_Y!EM(OW;ESO*E74L-\- 'L'[:W_!8KP9\'?BLW[&G[$_PMOOCY
M^T-=*R1_#_PG<+]B\/=!]IUJ^_U5A$A(+(S;^5#>4'5ZY?\ 9[_X(^^-?C/\
M5--_;(_X+'_%*Q^-'Q,LG^T>&/A]:6[)X'\"DX/EV-B_%W,N #<W );:I*LR
M+*?I;]BG]@C]E;_@GS\*E^$?[+7PLM-!LIG$NL:I(3/J.M7.#FYO;I\R7$A)
M8Y8[5R5157"CV.@!$1(T$<:A54850, "EHHH **** "OP!_X/G/^;7?^YV_]
MP%?N_P#$[XJ?#/X*>!M0^)OQ@^(&C>%_#NE0F74M<U_4HK2TMD]7EE957T&3
MR>!7\S7_  =:?\%*_@-_P45UGX*W?[,WA_Q;?^#O!MQXJM;3XBZKX=FL='\2
M7,S:4)H]-DF"O<"W^SH)6*J ;B/&002 ?D/7[_?\&,?_ #=%_P!R3_[GZ_ &
MOW^_X,8_^;HO^Y)_]S] '[_4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!X7_P3W_Y(GJW_ &/>L_\ I2:]TKPO_@GO
M_P D3U;_ +'O6?\ TI->Z4 %%%% !1110 4444 %9OC'_D6+W_K@:TJS?&/_
M "+%[_UP- %S3O\ D'P?]<5_D*FJ'3O^0?!_UQ7^0J:@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "L?Q+_P A?1_^OT_^@FMBL?Q+_P A?1_^
MOT_^@F@#8HHHH **** "BBB@ HHIL\\%K ]S<S)''&A:221@%50,DDGH * '
M5^=W[6?[?'[0W[=GQRUK_@FO_P $A_$$=OJ&DO\ 9/C9^T2(3-I7@&%LJ]E8
M."%N]58!E 0_NCG!#)));X'QI_:Q_:#_ ."SOQ5UK]BW_@F;X]O?"/P.T&_;
M3?C7^TQI@^;4"!^]T3PY)TEE93B2\4E45PRG:4^T?='[)O[)/P!_8A^!>B_L
MY_LU?#^U\.^%]$AQ#;0C=+=3''F7-Q*?FGGD(RTC$D\#@   '/?L(_L#_L\?
M\$[_ ((0?!/]G[P[,BS3F\\2>)-5E\_5?$>HM_K;Z^N" TTSG)[*H.U%50!7
MM-%% !1110 4444 %%%% !6/9?\ ([WO_7E%_,UL5CV7_([WO_7E%_,T ;%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_@?_ )!$O_7[
M-_Z%6Q6/X'_Y!$O_ %^S?^A4 ;%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 9OC'_D6+W_ *X&KFG?\@^#_KBO\A5/QC_R+%[_ -<#5S3O
M^0?!_P!<5_D* )J*** "BBB@ HHK@_VD_P!I_P#9_P#V/_A+J/QS_:7^*VD>
M#O"VEK_I.JZO<;0[D$K%$@R\\K8.V*-6=CPJF@#O*^*_VT_^"Q7A+X3_ !7D
M_8Q_8;^%=Y\??VA;E61? OA:X4:?X<Y"FYUJ_P#]591(2"T9;?\ =#>4'5Z\
MD7XI_P#!2/\ X+;#[#^SZGB7]E[]F&]^6X^(NI6XA\=>.K4_] R Y&E6LB]+
MELNRE60N"\0^S_V+OV#?V5_^"?GPI3X0?LL?"JR\/:?(RRZMJ!)FU#6+@ YN
M+RZ?,EQ(23RQPH.U JX4 'S+^SC_ ,$=O%WQ6^+&G?MG_P#!8?XJV?QM^*EF
M_G^&O!,-NR>"O N2"(M/L'^6YE7 S<3J2Q56*ET$I^^@ H"J  !P!110 444
M4 %%-GG@M8'N;F9(XXT+222, JJ!DDD] !7PI\>_^"Y'PZU/XDWO[,/_  3)
M^#.L?M/?%BW/EWMIX(N$C\-: Q)42:EK3YMXE!!X0OEE*%XVQ0!]P^(O$?A[
MPAH5WXH\6:[9Z7IFGV[3W^HZC=)!!;1*,M))(Y"HH')8D "O@7XC?\%M/$_[
M1WC74?@%_P $8/V<;OX^^*+*<VNK_$J^=]/\!>'9<?>GU%MOVU@/F$-N1YB\
MQR,1BJ/AW_@CW^T?^W/KMG\5O^"W/[3C>.K6*X6[TS]GSX:3W&E>"=)<'<@N
M2K+<:I(AP0\K#:=R[I4-??/PY^&GP[^#_@G3_AM\)_ FC^&?#VDP"'2]#T'3
M8K2TM(QSMCBB5409)/ ZDF@#X8^&7_!$;5?CYXYL/V@O^"R7[1%Y^T+XPLYO
MM.D^ 5B:Q\">').?EMM,7:+L@':9;@?O% WQDC-??&AZ%HGAC1K7PYX:T:UT
M[3[&!8+*PL;=88;>)1A8T1 %10      *M44 8_B7_D+Z/\ ]?I_]!-;%8_B
M7_D+Z/\ ]?I_]!-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'A?_!/?_DB>K?]CWK/_I2:]TKPO_@GO_R1/5O^
MQ[UG_P!*37NE !1110 4444 %%%% !6;XQ_Y%B]_ZX&M*LWQC_R+%[_UP- %
MS3O^0?!_UQ7^0J:H=._Y!\'_ %Q7^0J:@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)H V****
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M^*)O+##=&Z<K7W7\!/V=?@3^RW\-K+X0?LZ_"70?!GAG3Q_HVC^'].2WBW$
M&1]HS)(V,M(Y9V/+$GFNSHH **** "BBB@#'\2_\A?1_^OT_^@FMBL?Q+_R%
M]'_Z_3_Z":V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /"_^">__)$]6_['O6?_ $I->Z5X7_P3W_Y(GJW_ &/>
ML_\ I2:]TH **** "BBB@ HHHH *S?&/_(L7O_7 UI5F^,?^18O?^N!H N:=
M_P @^#_KBO\ (5-4.G?\@^#_ *XK_(5-0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6/XE_Y"^C_]?I_]!-;%8_B7_D+Z/_U^G_T$T ;%%%%
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M0 4444 %%%% !1110 4444 %8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,T
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M_M;:9X\_9O\ &TPQ_P (Y\=/"$^CQN1@,\=[A[8Q9(Q(\D>X$'%?:O@7X@>
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MO\0?A'\*/BUI_P#9/Q5^&/A[Q-:!2HM?$&BP7L>#U&V9&&*^;?BS_P $)?\
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M*)7<XX4U\4ZE_P %5?VT?^"B>H3^ _\ @BU^S66\*-,UO>_M+_&&PFT[PY
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MM? WPTMI/$6K3W _Y8>59!UBD_V9GCK\,_\ @U3_ .":/[/_ /P4<?X[:/\
MM+>)_'4WA?PNWA9KKP/X<\8W&EZ5XA-S_:V#J,=N5DN/*%N1%B1-GGS==_']
M%_[,W[#G['W[&NA_V!^RU^S9X.\#1-$([BXT#0XHKJZ4=//N<&:<^\CL>.M
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M(^)GQ"L/VDO^"MGQXU']I3XB6DGGZ9H6MVXM?!OAQR<^78Z.N(I,9VF2<,)
M QC#<U]R^"_!/@SX;^%+#P)\._"6F:#H>E6ZV^F:-HUA':VMI$.D<4485(U'
MHH K4H AT[3M/T?3X-)TFPAM;6UA6*VMK:()'%&HPJ*JX"J   !P *FHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q+_P A?1_^OT_^@FMBL?Q+
M_P A?1_^OT_^@FMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#PO_@GO_P D3U;_ +'O6?\ TI->Z5X7_P $]_\
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M-/QSGC[+<QX_"@#/@_X.3/\ @B-<0K/'^WKH85AD"3PSK"G\0UF"/QK4M_\
M@X<_X(N7,RP1_P#!0#P>&8X!DM;Y%_$M;@#\:X6^_P"#7[_@D5;@CP!\+O'/
M@\?P#PU\5M;39]//N9>V!^%<UJW_  :\?LDM&R>"_P!MO]J3PZIZ6^G_ !8B
ME@/LT<]G)N'3C/84 >XV?_!?'_@CA?2F&#_@H5\/5(7.9M0DC'YO&!^%:5E_
MP7(_X)!Z@&:#_@HI\*UVD9\_Q1%%^6_&?PKYCN_^#;#Q-I$(M_A__P %/?'J
M(AS$GC+X;^'=?4'GDB>V7=_AD=ZS+W_@@?\ MYZ(ZRZ#_P %#/@?XGCB_P!1
M9^,_V(_"0VCKM,T WL">IP,#ITH ^P;3_@L[_P $EKV 7$/_  4>^#*J2<"7
MX@V,;?\ ?+2 _I6G!_P5Q_X)67*HT/\ P4F^!!\P JI^+.D!N>@P;C(/MUKX
M9O/^"0'_  5%\/SFZTGX5?\ !.+QO( ,2>,OV<GL6EQTW&RA8C/3CI@8K-N?
M^">/_!1;PT9&\5?\$,?^":'C-FSYS^$_"O\ 9[2GN5-]9DJ23D$\CZT ?H7;
M?\%/O^";=[.MM9_M_?!B61L[8XOB=I3,<#/ $_I6C9?\%#OV!]1<QZ?^VM\*
M9V4998?B!IS$#UXFK\SKO]F/X^^';=K7QI_P9_\ [/FOP#_77O@WXF^%+=A@
M]5CFLQ(<G' (.#SWK-O/!'[-FD1B/XL?\&@/BNR\MLO_ ,(;H.BZN?3@V[1E
MN<_H: /U3L_VX/V,]10RZ?\ M7_#F=5.&:'QG9, ?3B6M&W_ &L?V7[N%;FT
M_:'\%2QL/EDC\36K*?H0]?D1>Z]_P0YLY@WQ7_X-J/VC?!S(N&FU3]FZ>.#&
M>H:WO&##KSCL?2LRZ^*/_!H-IUPUQ\5OV--1\#$D>;_PD_PF\4VRQ_58$<#@
M9X'8T ?L[!\?O@?<ND=M\7/#LC2$"-4U>$EB>@&&YS6E:?$SX?7\WV>Q\9:?
M-)C.R*Y5CCZ"OQG\-Z#_ ,&4'CZ/R]+G^&L GXSJ6I>*--(R<=;AXBGUXQUK
MNO#W_!/O_@SI^(T"VV@^*O@1(TA!2#_AHJ^M)V],*VKH_P"&* /UH_X3'PQ_
MT&H/^^J/^$Q\,?\ 0:@_[ZK\V?"?_!!?_@VO\;A#\*O WA6Y\W&3X:^/NL3^
M=G[N=NJOGOC'J:[6'_@V3_X) F)9= ^$GC*SMI%#)'8?%O7O+;/\0S>'.>.<
MT :?_!>O_@K_ &G_  2P_8R_X3WX6+8:I\1_&.I'1O MI>)YD%K+Y9>>_E3C
M>D"8PF?FDEB!^4MC^3SX\_MB?M4_M/\ C^X^*/[0/[0GB[Q9KMQ.9OMVL:Y-
M)Y))SMA3<$@0?PI&JHHX4 <5^MW_  =%?\$5?@W^PW^SU\.?VA_V3=%\8-X=
MM?$EYI/C-->\77VL1V1N8HFL707+N8(]T$\;," S2Q*23MK\2* /U<_X('_\
M'$O[0?['OQ_\._L^?MA?&K4_%/P5\27T>G7-[XLU*2ZF\(22-MCO(;B4EUM5
M8CS822BH6= K*0_[9>._^#DC_@DIX<UA_"?PY^.VM?$W7U^YH/PP\#:GJ\TO
M.!LD2!8&R>.):_D2^$>A:'XH^*OAKPYXG\266C:9?:]:0:EJ^I/MM[&W:91)
M/(<'Y$0LQ !) P 3Q7]6GA'_ (+#^&/B5IP^'O\ P1;_ ."5_C;XMZ<7\NT\
M6P^&H?!7@I#G;O%[>1)O*\DQB)"0  <G@ U)/^"U'[:7Q?\ W?['_P#P1%^,
MVK1RG$&H_&'7M.\$0A3_ ,M2ERTS.N.0!@L.F":\I_:4_;__ ."O7PST)O$'
M[4G[7O[&/[*NC30F2"TNKS4?$WB?&.?*M3^YNB,' B1CUX->K?\ #"?_  6C
M_;14W'[:_P#P4)T+X'>&+HYE^'W[,FBF*_,9Z+)KMZ#/#*!PWE*\;$DC@"O7
M_P!E[_@A[_P3._92UP>//"G[.%AXK\9/()KOQY\2;A_$.L7$_>?SKTNL,A[M
M"D?TY- 'Y+7WQ!_X*1?M^/\ V9^SK^U=^V'\=[2\8AO'&D0Z=\&/!<B'^..3
M9+->Q ?>B58I&'3DUVOP1_X-*T^+WBC_ (67_P %"_VM["SEO$7[=X8^&4UY
MJ5Q)ABP+ZOK;32*_.&$< !YPWK^\0TW3E 5;"  #@"(?X4?V=I__ #XP_P#?
MH4 ?)?['/_!(/_@D]^PH;/4_@'^S-X437K+#1>+?$<)U;5ED'_+1+F[WM 3W
M$/EK["OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_]^A1_9VG_P#/C#_WZ% %/_A,
M?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A
M0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?V=I__/C#
M_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\
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M^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\
M"8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"
MG_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0
MH I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\
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M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
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M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M%[_UP-7-._Y!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\ Z":V* "BBB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_\
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M$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%% !1110 4444 %%%%
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M>_\ 7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%8_@?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A4 ;%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 9OC'_D6+W_K@:N:=_P @^#_KBO\ (53\
M8_\ (L7O_7 U<T[_ )!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** ,?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)K8H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A4 ;%%%% !1110 4444 %%%% !1110
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MQ1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/X'_Y!$O\
MU^S?^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!F^,?\ D6+W_K@:N:=_R#X/^N*_R%4_&/\ R+%[_P!<
M#5S3O^0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#'\2_\ (7T?_K]/_H)K8K'\2_\ (7T?_K]/_H)K8H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_X)[_\
M)$]6_P"Q[UG_ -*37NE>%_\ !/?_ )(GJW_8]ZS_ .E)KW2@ HHHH **** "
MBBB@ K-\8_\ (L7O_7 UI5F^,?\ D6+W_K@: +FG?\@^#_KBO\A4U0Z=_P @
M^#_KBO\ (5-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XE
M_P"0OH__ %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$T ;%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\
M7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_@
M?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A4 ;%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 9OC'_D6+W_K@:N:=_P @^#_KBO\ (53\8_\
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M"G'P)\ :5XD\3>'KNZ^#'Q3^%5H\.B>*;>PA$ES8-!(H:VNH8%,A4!%VIC8
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M:Y^.'_1C/CO_ ,"8* />J*\%_P"&N?CA_P!&,^.__ F"C_AKGXX?]&,^._\
MP)@H ]ZHKP7_ (:Y^.'_ $8SX[_\"8*/^&N?CA_T8SX[_P# F"@#WJBO!?\
MAKGXX?\ 1C/CO_P)@H_X:Y^.'_1C/CO_ ,"8* />JS?&/_(L7O\ UP->+_\
M#7/QP_Z,9\=_^!,%5=9_:H^..K:7/IH_8>\=1^<FW?\ :(#C\* /?M._Y!\'
M_7%?Y"IJ\!MOVM/CC;V\<!_8:\='8@7/VF#G J3_ (:Y^.'_ $8SX[_\"8*
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M1_'+4;RSNA^Q!XZ3[),9"OGP'=QC'M0!]#T5X+_PUS\</^C&?'?_ ($P4?\
M#7/QP_Z,9\=_^!,% 'O5%>"_\-<_'#_HQGQW_P"!,%'_  US\</^C&?'?_@3
M!0![U17@O_#7/QP_Z,9\=_\ @3!1_P -<_'#_HQGQW_X$P4 >]45X+_PUS\<
M/^C&?'?_ ($P4?\ #7/QP_Z,9\=_^!,% 'O5%>"_\-<_'#_HQGQW_P"!,%'_
M  US\</^C&?'?_@3!0![U17@O_#7/QP_Z,9\=_\ @3!1_P -<_'#_HQGQW_X
M$P4 >]45X+_PUS\</^C&?'?_ ($P4?\ #7/QP_Z,9\=_^!,% 'O5%>"_\-<_
M'#_HQGQW_P"!,%'_  US\</^C&?'?_@3!0![U17@O_#7/QP_Z,9\=_\ @3!1
M_P -<_'#_HQGQW_X$P4 >]5CV7_([WO_ %Y1?S->._\ #7/QP_Z,9\=_^!,%
M4H/VH_CE#KD^L_\ #$'CHB:%8_+\^#C'?- 'T/17@O\ PUS\</\ HQGQW_X$
MP4?\-<_'#_HQGQW_ .!,% 'O5%>"_P##7/QP_P"C&?'?_@3!1_PUS\</^C&?
M'?\ X$P4 >]45X+_ ,-<_'#_ *,9\=_^!,%'_#7/QP_Z,9\=_P#@3!0![U17
M@O\ PUS\</\ HQGQW_X$P4?\-<_'#_HQGQW_ .!,% 'O5%>"_P##7/QP_P"C
M&?'?_@3!1_PUS\</^C&?'?\ X$P4 >]45X+_ ,-<_'#_ *,9\=_^!,%'_#7/
MQP_Z,9\=_P#@3!0![U17@O\ PUS\</\ HQGQW_X$P4?\-<_'#_HQGQW_ .!,
M% 'O5%>"_P##7/QP_P"C&?'?_@3!1_PUS\</^C&?'?\ X$P4 >]45X+_ ,-<
M_'#_ *,9\=_^!,%'_#7/QP_Z,9\=_P#@3!0![U6/X'_Y!$O_ %^S?^A5X[_P
MUS\</^C&?'?_ ($P52T+]J/XY:-9M:G]B#QU)NF>3<)X!]XYQ0!]#T5X+_PU
MS\</^C&?'?\ X$P4?\-<_'#_ *,9\=_^!,% 'O5%>"_\-<_'#_HQGQW_ .!,
M%'_#7/QP_P"C&?'?_@3!0![U17@O_#7/QP_Z,9\=_P#@3!1_PUS\</\ HQGQ
MW_X$P4 >]45X+_PUS\</^C&?'?\ X$P4?\-<_'#_ *,9\=_^!,% 'O5%>"_\
M-<_'#_HQGQW_ .!,%'_#7/QP_P"C&?'?_@3!0![U17@O_#7/QP_Z,9\=_P#@
M3!1_PUS\</\ HQGQW_X$P4 >]45X+_PUS\</^C&?'?\ X$P4?\-<_'#_ *,9
M\=_^!,% 'O5%>"_\-<_'#_HQGQW_ .!,%'_#7/QP_P"C&?'?_@3!0![U17@O
M_#7/QP_Z,9\=_P#@3!1_PUS\</\ HQGQW_X$P4 >T>,?^18O?^N!JYIW_(/@
M_P"N*_R%> ZS^U1\<=6TN?31^P]XZC\Y-N_[1 <?A4UM^UI\<;>WC@/[#7CH
M[$"Y^TP<X% 'OU%>"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\ @3!0![U1
M7@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P4 >]45X+_P -<_'#_HQG
MQW_X$P4?\-<_'#_HQGQW_P"!,% 'O5%>"_\ #7/QP_Z,9\=_^!,%'_#7/QP_
MZ,9\=_\ @3!0![U17@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P4 >]
M45X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,% 'O5%>"_\ #7/QP_Z,
M9\=_^!,%'_#7/QP_Z,9\=_\ @3!0![U17@O_  US\</^C&?'?_@3!1_PUS\<
M/^C&?'?_ ($P4 >]45X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,% '
ML7B7_D+Z/_U^G_T$UL5\\:G^U'\<M1O+.Z'[$'CI/LDQD*^? =W&,>U7?^&N
M?CA_T8SX[_\  F"@#WJBO!?^&N?CA_T8SX[_ / F"C_AKGXX?]&,^.__  )@
MH ]ZHKP7_AKGXX?]&,^._P#P)@H_X:Y^.'_1C/CO_P "8* />J*\%_X:Y^.'
M_1C/CO\ \"8*/^&N?CA_T8SX[_\  F"@#WJBO!?^&N?CA_T8SX[_ / F"C_A
MKGXX?]&,^.__  )@H ]ZHKSKX*_&GX@?%#5KW3_&/[/GB'P;%:VZR0W6LRQL
MEPQ;!1=G<#FO1: "BBB@ HHHH **** /A[X\?'?]H_2_B/X/\ ?'S]C+QGKB
MZ5\>]6?PKJOAH:1>V'BO0Y=*UT64*JUW&;:X6":.&2.[6)"(6D,C!SC$_8X^
M"7[5_P#P2<_X)Y/9?#3]CUOB1XCU_P"+6I^)-1^$'A'QG:68\&Z+J=U)+]CL
M9[A?)O&LXEA4PJ8UDDDDV/M4,WWY10!\Q:+\-_B'^V-^TM\+?VH_BS^S_K7P
MUT/X0IJU_P"%=#\8W>GRZWJ.K:A9&Q:66.PN+F"VM8;:2<!3,TLLLJ,4A$"F
M7@?@G\"?C/\ \$Y/VI?VA/$WPT^ /B#XB> ?CAXH3Q[X8M_"=W8QW&F^)IH3
M'J5C=B[N(1%'<2)%/%<C,: RI(5*IYGVW10!\S_\$FOV(/$7[!O[)$7PX^(^
MK6-_X[\6>*=3\8_$:^TMF:UDUO4IO-F2$L 6CB00P!R 7$._"[MH^F*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)U.^@:?3;+6+;[)$EJ]S&C(&@FN$BGQ$S$$2GX:_X*\_LA^.?V)_^#:SXE^
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MEJ,F3YT\5Q;N%=B78*Y)VE$3[TH **** "BBB@ HHHH **** "BBB@ HHHH
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M 9&QA06Q7Q-\7/\ @M!_P5'^!/P@U3X]?%G_ ((&^(]#\*:-8+>:EJ5[\?\
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MJ7[/&C:[!/'HIT"5?$&HZ);WPOK7P_<WIN3%]GCE2.-KA(1++;QK%A&+3-]
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M\T7PMH<UEIFAB]*?VA?_ .D3S2RW=PL<<6=RI%"IC D9FE;,_;?_ &$/BO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<P.4N/!^G^*;:74XB-N0]LKF1<;EZJ/O#U%>KU^7'_!02QM?V O^"]W[./\
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M\2[;7M7^&'BA_#OCNR@M)XFTK4T!+0,98U$F,,-\9=,JR[LJ0/1:^4OV&?\
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MY:P/V>/VZ?"'_!1#]@KXG?$W3_AQ?^%M2\.MXG\(>-?">KW$5RVFZM8P.ES
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M/@7X]TU?B1\)_%]CXIL/#GB.S6V\0Z%L;R[N$Q9S+!)#(Z-)"\D&_P HL=R
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MBCP7X>\4>'KP76BZUI]K*LUI, 0'0ER <$]N]?3=% !7QS_P7K_8^OOVT?\
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M\ ++X51>)]!\5Z_>Q7^I^"+U[X6]MH]S?Q$K-YL"S2)&Q!V1!HXXE5O,I?\
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M&#2[C=\)M7@N/[4T3+/?ZEJ<=FS1QP1+M\R[D $B2/$YE# +M?M+_&3]F?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&UTB.X:\N]1O%@DDB@DGN)&$42NSI#N\P(\AC7['HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^-"ZYJ&J>.-=TTWW]EZ?IEH;AH+.V,B)+=SL"H:0E(E0L8Y"0!Y3_P $F_\
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MQ7\,KVU?9<6^NV&G7TD"Q..4>9#+;AN-OG[OX16E^S]^WA8?\%G_ -D'X ?
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M]L%[O1O!W_!%3QAXR=D\"V-OX/35IY/^/>"_:R\--;/,3\HX25@3T5)3TSD
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M#":3H.BVJPVEN)6EDD( !EFE<EYI6(R\KEG<DDDFNMH **** "BBB@ HHHH
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M;G^&OC[P?<3V6FS)8VUGYMK?6MU'- [K:H9%:.:-N-JHVYV^J:* /E3X(?\
M!-F8?&_XG_M9?MA?$#3/'/Q'^*O@E?!5^OAO19-*TG0?#(W%M,LXWFFG<R.W
MFRW$LA9W5=B1!=I\0_88_P""3/\ P4@_X)W^#;_]E3]G7_@H[X4/P5;6+J\\
M._\ "3_"HW_B/P_#<2&22"UD^V):EB[,V^:.6/S&9_( 8QG]&J* /S+\&?\
M!!W]HS]AWXZ7_P 5/^"27_!0:[^&>A>,(H1\0_!/Q \*1>(;"_ND&&U*% \*
MQSL2S[%6,!G95=(2(5]7_P""DW_!(_XH?\%"OV&M&_8=N_VS/[&L8-3M=4\3
M>,?$'@,ZQJFLW\4DTTDH\N_M(;9))IMPB2,I&JB.,*@55^W:* ,CP)8^.M-\
M*V=C\2?$VEZQK4<0%]J6C:+)I]M.^.62WDN+AHP3V,K?6M>BB@#P;X$?LN?'
MCX6_M7?$W]HOQO\ M >%]?TOXD)I"2>&=.^'=QI\NFKI]K+!$([M]4G#[O,+
MONAY(PNW/'/?L8?\$O/@C^PA\6?CM\:?@3)!!K?QM\9'7I/M>F9@T5/)R+.-
M$D4R0_:Y;RXPIB^6=(L?N5<_35% 'QM_P3Z_X)B?&C]A[]I?X[?M":S^U5X;
M\81?'GQ?_P )'KNB0?"^?33IEVKW3(EO,=6GS$/M."KHS$1C#*234W[+'_!*
M_7/@QXV_:4O?CA\<- ^(7A3]IC7+O4?%/A6U\ 3:3]B6Y@EMI;99SJ5QYL30
M2;#E%;(W!AG ^PZ* /S>^&?_  1R_;J^#7[&GQ$_X)J^"/\ @H9X?OO@EXA\
M*:[HO@YO$/PU:X\2Z-::A;SQKI[7@O!;M;*\[;W-NTI0NL)MLH8O7[G_ ((_
M?##XL_\ !+OPS_P3)_:X^)%WX]T[PGH&G:?H/C+3M*CTF]TJ6PMT@LKJT4-+
MY4L2*5R[2;U=T;*,5K["HH ^3_@E\"?^"N7P>\-6GPGU_P#;4^$OCW2--A6W
MT_QUXO\ A9J(U]H5P%^U16VJQ6]U*%X,H:(N1N<,2:I?MV_\$J?^&P?V1&^!
M>A?M":MH'CV#QYIGC>U^)NH:7%>RW&OV1 BFN+53'&T(C B2%-B1*D> P0J_
MU[10!\)>+/\ @E;^U_\ $S]L/X)_MP_$?_@H/9MXT^&NE:OI>OPZ+\+[:WL+
MFQOH%B>/3HI+B1K67'F%IKA[H%V5EC1$\D^0_L&:1^TE/_P6A_X* :O\!/&?
MA&V@C\3>"H=5T?Q=HUQ-'/(VC3&&XBGMYD:(Q[9 T95A()!\T93+?J3-$L\3
M0N6 =2I*.5.#Z$<@^XYKR'X,?L&_LL_L]_%KQ!\=?A!\/+[2/%OBZ99?%FM_
M\)9JEQ)KDBJZH]Z)[EUNF02/L:4,4W$K@T 4?V)/V+]'_9#T#QAK&K>,3XJ\
M>?$SQE=>*OB/XP?3Q:#4M2FPJQP0;Y#;6D$2I## 9)"BJ279F9C[=110!\\7
MO[!/VS_@JM:?\%-O^%K;?LOP'/PW_P"$)_L+.[.KOJ7V_P"V>?Q]_P KR?)[
M;O,_AJI\1?V(/&_AK]L?4_V[/V2?'OA_PYXQ\6^$H/#OQ$T3Q5HDUYI?B*&V
M;=8WI^SSPRPWEN"T0?+K)"WEE5(61?I*B@#P#]E;_@GM\+OV>_A'\0? ?CJ^
M7QYK?QCU_5-;^,'B'5=/6!?$EYJ"F.>(6X9Q;V:PGR(K8.PCC&"SLSNWC2?\
M$DOB9JO[)VG_ /!-+QC^TM:7_P"SSIE]#%]DC\/31^*+_0(+L74&@S7XNO)6
M)2L<+7,<*R26\8C"(Q:8_<E% %?2-(TKP_I-KH.A:=#9V5C;I;V=I;1A(X(D
M4*B(HX50H  '  KX]_;3_P""8GQJ_:Q_;K^"'[:>@_M5^&O"Z_ F_O[GPWX8
MN?A=/J'V\WHB2X6YN1J\&<QPHJ%(UVDDG=T'V510!\I_%G_@GU\:_B=_P4>^
M%G_!0"+]ISP[I\7PR\*:CH<7@P_#6:8:C'?QE;J5KO\ M53$V[8R 1,$" -O
MR34/@G_@F[\0=#_X*4_$7]OKQC\??#>N:/\ $?X?VW@_5/AZ?AS-#Y6GP%2G
M^F-J;AW;#A\P;6#X"KC)^LJ* /SN_9U_X(^_MC?L<?#3QU^QM^S3^WCHEO\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6821646608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
<td class="nump">$ 1,599.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">1,234.2<span></span>
</td>
<td class="nump">1,172.0<span></span>
</td>
<td class="nump">1,086.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">605.7<span></span>
</td>
<td class="nump">545.4<span></span>
</td>
<td class="nump">512.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">272.7<span></span>
</td>
<td class="nump">262.9<span></span>
</td>
<td class="nump">246.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Other (income) expense</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">296.6<span></span>
</td>
<td class="nump">240.3<span></span>
</td>
<td class="nump">225.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating expense (income)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">291.8<span></span>
</td>
<td class="nump">240.7<span></span>
</td>
<td class="nump">222.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">59.0<span></span>
</td>
<td class="nump">41.4<span></span>
</td>
<td class="nump">80.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net income of affiliated companies</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
<td class="nump">$ 150.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
<td class="nump">$ 2.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 3.21<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
<td class="nump">$ 1.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_WeightedAverageSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">74.0<span></span>
</td>
<td class="nump">73.9<span></span>
</td>
<td class="nump">73.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">75.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_WeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_WeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000105770-20-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000105770-20-000015-xbrl.zip
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MY3\")@_KH#]O],)@'%=ZXH5>:*-QC*MK?Y_(@8Q88[]^D%_:&HLJV9#RMQP
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M@SD:R&=\;KQ1*2^7F\_+4]O#\>YXRVP/9<>:4.09^X0.Z@H9J@_IVYV825S
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M:L1=J,!J#[P]\-N5RI:P*)%)3ISRH2AFU.2K B[P((L9%C/6P(Q, D3U%UA
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M9% PU@4*D9BS(9]GB&V(90Z0%"+KP%>-D@14BBC3+#9='$9DY7 F-,(R<KE
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M&\1YGR#.346%:085E(! D7\NCX'A[ [WLA+U4,O3I+AA"-YH/82P(OA/JXH
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MQL^,XD!Y3G70J[)!B+3"J9J@ZLU'JZG4L=_00[X[6TS].<+R2#^GQIBE.@L
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MQW95*K19\':$*N'"-)'3I[7Z"TIBE53.5IIU!HN!2UL"F1SQJ/Y:L@%DY++
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M%/ >B\EV>72;<)0/;GBSO^Z^+7^OJCN7;,UYY_UE]P=MR\)QVCQ?U9$^81]
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MV"H/58)"]9=1Q2H/;!<]^E/\/:RQJ3]$8RG\@AW7US#P'!DF_IJYP GAEQ\
M59W-7&*HP$L75K!-Q5R* D3UEY,<-!"&3DZ94U['0]?MP&.!Y3Q\/&XW,A1)
M88]E%3UR41UE(0;KI<,]5E&/S54=SIK]17F5E !EB/T1+O4%.\;F;5L_$R1H
MH@'A!&LW#]:5**&(*B[0KU@8TA)!KM2F6(G8FM()ESIFCZH45[[) O,L4Q8(
M3[<BX=L4AMHXKOY25@5%%JO52 P5'I++>4:6LM]^.7I]2K\*R;?D]$<A;NH'
M@F&H-% QP"1WGN&R T$!5NN:XA_.1#<H13=)-+V<Z9Y1L\0V>;]B&VPA0UJE
ML^^&CU1NI['_9H/V=2$K]=?JX^K]$_DKQ6OONK92-GR\,AM%'\F#Q@8XE#M%
MO$Q0OI4M8;#%QW,]\G*T 8[89II#4$ANWW88+H7EG=G(1M6!*)3(T 4.MIJ7
M;"E#>;4.0WE(%8]-.=)+),YB2.\R>7*+I2EKM"JQ]0E7 CY1W#'WF/@NG!A-
MYPZ>!1&@Q9]NL4)Z#2F=,B0#ER/003WBWUD4P%RF,L22@VB-)^,M$RZHU('O
M28=-N73S3^V*^KAN3/*SX<@XA*A6(5V$;30."FW['0@F1B/4TZ\%:JG#["+@
M&UY,JNJRQ60F?DMT]39%!ZW*G:H&MM\U[:LTXVM#O)X;FY:V9!I/EQ*RM97*
M&FOTUUD>E[UY2UX>L_03*]=MVSE:)SK\UBCQS5MV$B6^LH;:UBT[#21?8]U_
MLM4AG!:Y'DRDL4G<A_/+;N>LN8WT^@-\20XMJ;:DVI)J2ZHKO=VWD^J/W<LO
M5^R\\[G3;Y]M%9WVF/ B&<V9'XQ!M,9X.[*5D?W/Y3<4M='VQB[&W/WVRR$<
MR:_<%3^S8/2V'3=+RY_3LBTMM\AED<LBUS9L=RHH-2^:YW\4C8[GYZVMDHW8
MF0 )B <@",FI1&>1*_E NB@N.?GT0GN8+*6VE-I2ZJIL]UK6Q[/V>?-KL]O>
M1O-C0KJM_=$2:TNL+;&N\'83L>ZW6Y^TG?'BLMO_Q)J?VUT@V5M(G#W6#.0_
MOE=1Y]"SC)39W.-D6=-S6K9E34_*FCYVFQ=GK-N\ZIQM992951LL;;:TV=+F
M3=CNU,;3NKSH=YNM/OO<O/CR 7Y\Z78N/EJ#O#U/EEA;8FV)=06V^W:#/#MK
M7GQN=O^'-:GT2F^K*/=:869GPIORX)L]99:$6Q)N27C5MMLBUW-:MD6NBLE'
MGR[/ST"K91\_O__T_&2CCR*86O76DF]+OBWYKN!VWTZ^>T"[FU>7W3:[ZK?K
M[+Q_MEVNH[6H> \6Q6=^L-A'SAXU2\<M'?_1=+PBH3TO!_YP#O^91%/WW?\'
M4$L#!!0    ( !>755#!5Y2U( @  *\6 0 :    97@R,6QI<W1O9G-U8G-I
M9&EA<FEE<RYH=&WMW6U/VS@ !_#W]RF\3GN2:-*6I]%V2*RPTHVQBK*;=F\F
M-S:-16KG'(>N^_3G) T'C$$96<BF_TG'(*E3YV_W%S>/W4>['WK'GX=[Q#?3
M@ P_OCX8]$BM[KJ?5GNNNWN\2_:/WQ^0-:?1),>:RD@8H20-7'?OL$9JOC%A
MVW5GLYDS6W64GKC'1VZRJ#4W4"KB#C.LMMU-IMB?G++MO[J/ZG6RJ[QXRJ4A
MGN;4<$;B2,@)^<1X=$KJ]<6K>BJ<:S'Q#6DU6@WR2>E3<4:S^4:8@&_GR^FZ
MV=]=-WV3[EBQ^7:7B3,BV*N:^-+XTK35<.V$;&IDY@%_5?-YLO3V6LO97 ]-
M9R:8\=O-1N-)IY:^;KM[HJ2QB].V</9KMHSOEF3X5U.G@9C(=EKC9 %)@7S^
MF'JG$ZUBR>J>"I1NZ\GX>6M]?27_GS2<QHM.-N]Q(_VODRR@?D*G(IBWGQV+
M*8_((9^1(S6E\ME*9%NC'G$M3K(71N(;MY6WZY'^.<O6;=,N)Q"2UQ?KVFRE
M:[?WU1=C88-M7EZQ)5;IFCBN+^79AN'ZP9)H+9?$Z./KT6!WL',TV!N1#V_(
M\?X>Z7UX/]PY_'SWE;QK-E.J)T+6Q\H8-6UOA&G(AHX#GI=9O"+@)Z9-8Z/R
M(FF39%/&2C.NDS0#&D:\G?_2N?!^2?GL;R&9?>]VTD^8B,* SMM"IKFD[[OX
M$&QM.2_75]//@;%K9%A>G\5GQ,D^(ZYAW\_<V' :+YL_GG]CX9MGKMHE_W3A
MFV9N.9O-U5^QX%6GV=I8LJR;1IW%;1LQ"JE\55NMW?&3<[75S[@VPJ/!8EK6
MUSHA9<R2FW6LINT,^82L8S6SKIC7^9K:Y*\W*FRWPJ_GY1=].9GT !6NI$17
M35Z[*E&VQ7D;:Q$QX25;6*).2.Y(=>N<1LRXIS1-*MTFMEY<)R^SJS.0=GJX
MF'5E\XEN55ZW&AGEG?[NG>G#3'(=^2)<NB,]E):W(%[-_GVQ5]S2;DNW_^5N
ML^1*U;8_\<B0H4_UE'H\3M>(C+@^$QZ/5HA%Q3GO K^;(A5*><BEC.;!&96"
M/E2>V;>*/R50JI/OLSVU3/>$3;]G(_>$2;=-9!C0R*Y0M&1[(]A;@DT6]M9N
MX/G\AVFV*HM1]@VN0FG:X933>/JXN='H7(WSH2.L:@>\/BU\E.^>Y)-+(6*+
M<[\TC[GGD[Y]94CV8JU"3@[$5"1[S)^S,27)8/D%>NW]<QYH'E#)L/7!UJ?*
M6Q]\<?@]>;G >%];9\@1#05;[,\ Y85FO6LEG]EOX[ <EL-R6%ZXY?WA$=E7
M05+)*!^. VZ,P2L4)=R&V^#ERH%%9^B,G#<.R"XNTSTY =D@&V2#[%]"]BX9
M]<G0<(NV83C26D"D(ULY&BKL'H'9,!MF_Z+S]W8D#>97S]T[..A!<.S?KE*6
M !R PY=K ._9-]'4,^0]E?&)_276MLXP'(;#<!@.PRO>P!<NHG'.1^!D<+""
M_2A%':R,-.4!_(;?\!M^EW$1Y- 6IA-;:_*\YPM)7]A!^M0&.X?I15W>E<0*
MTD$Z2 ?IY9(^D$Q0,M3BC)KS:WQ@>@'C]"18F [383I,+\5TK5CLF8@L3F?&
M+A><'P[,@3DPKW@#WW3C*;*C)UP:(2D9.3O0O("XSQ.%Y_ <GL/S<CV/!,7(
MO+!+8JF840G( 3D@!^3E0AY'1MOUHV1HYKA,J+#1>1XK4 ?J0!VHEXOZ/[C3
M=W'[6<0WA;TL<!R.P_&2'7_-U4131IBC'-PHO9#+][D>8U .S($Y,"\;<TTC
M$21[6"@H+R#L+$]0#LI!.2@OE?*>+3JUX\CT9)81-"_BVJ%%I/ <GL-S>%ZR
MYUK.:!#@PB'<VA:>PW-X7OD&OM'S72JG5)^2G:>/US8[(W!>Q!VWTDC!.3@'
MY^"\7,X7=_LC.]Z_L8A$\@AIG."">RF"=M .VJO>P+?0'IO(\Y,]!:0_'>^3
MGB+O^F#]_K'WN0U<SJ$Z5(?J4+U4U=]H*CV.HZ.%I9T%"LOOG^36EK,%RD$Y
M<%F.\KY=0HCCHC@N6D'+,2X'YN#E#ICOBR1/@9MP%78Y44@%[ML"RD$Y*"^9
M<A4DE?__5)<0I[G@-)<J10G203IX^0G2\[WG.Q =N\XKE"1 !^C0Y2= 3TYL
M >4XI:5"4<)R6 Y>?L+RP0"<@W-P#L[!>;4;>#G.LV>BD4.EC8\'6N!1<Z =
MM(/VBC?PG6@?J1BT@W;0#MI!>^4;>"G:WU(;ZPKIOP/H]T\\#1.<@W-P#LX?
M@O,(8_.BQN:1IARW1(?EL!R6EVOYP- @O;!(.P>PO C+;: X-@K*03DH+Y?R
M=TISBC%Y49>()H<?LDRA.32'YM"\5,T/Z"F?*<5PPUS<,!><@W-P7O4&OI'S
M0Y6<-,T$K@_%]:$52Q*6PW+H<@?+U<GYHRTP.L?H'*)#=(A>]0:^3?0WMK!@
M%* 7-D#/ H7G\!R>P_-2/1_Y5$Y\*LA[SM(Y1_%XS#49:L5BSR1/CG9P:5%1
M3='SA83S<![.P_F2G;<UIZ'2G#Q?G)3^@@P-=P@>?%'<B3!YQA >PD-X"/]
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MAA2500]O8I:9?+4:6-(RX+9A#4OLM9I*P8T*61VV.*-5&DX37#UV*E72*G9
M16X3ZE/)FFK'?"-$N@OD)&1OXP@&>50+[E1)!$Q2:\E%!VX%(Y:\!3TB"UHE
M;_@V)A9$74!_2I]4!W8P+L8[%Q>+.K >%H_.IQO1\?A,_.@@06!-5<K8E\Z4
MDDN.=(@;9N0<$-*F"W B7)0<*ZW\G)G,MF$Y5 .. T1CE*V)KC#Z4-F^- Y5
MM:T0(BXPKR0Q-@T&!&X_H1*$2B-2T$(5AR"+8-\2HP&AJBH4EY<6#\G.Q<-=
MG;B>2EV'9,IHH2P#N593K+/;0I+!FQY1%N+C=L8<D(^.2.DN\O*QJ?W#8S^F
M<,D[:>)-1_;'^TXQ7FQG0C!3G /8$X#+ [P@\*8[!]Z[9![!L0DR/DQI"&]H
MN8?AKTC>S%A,DM260;1"#];T%<9YO$EXOYK!)JCXO0:O@-+]#>$,$8!4>D^N
M,1,[5 JG/GP@%(X+HRUOHR6Y='?\B9-PB!A*0W4*WC>58RZTNB7=' '=DV\]
M84*>'!\[N.D]WMGX^(9-;SBW3A=QU5HF2L[;JSA?YDS&ZU<0J0V&#[LD^+TW
MUMVQEO "RHI">4^TM1*-#1@1MZ0*-H7N^X@#)'['A07_\_YB$;#T>ZU@<@C1
MNDS"H=#;_^]GGY^5#_"4"PW*"@JM %@^DN##C401X-4PCKM]Y8SD+5.(2&$#
MB0CD.QR=+PX$OPJTS18P'@AM2;$R14='=QEV"\ ;L@YAR[]I(K("@W&@+ZXN
M@"),4'"CJ6!;#TU?(CO9W:WF!4A(9I')6L /A<P+!(:?3!JHMF)55^74Z"EQ
M:2_EI/GEQS;)FHI*FSFA=9:;F)[E6B  N$]D.9UO^ 7]6]N>YP+^S\L&KU\=
MG9RZ\+G^Z[Q8_NV4M]CTK;JQ8[9_PIY/<8(+Z?(R5Y2)ZR^4U+QU%!\CH?G3
M(!.;'"2+P%/$>QI;;!?FKU_UO^^='O1;\;K4@\6@,O$6UR">KDYI]>+3O2M1
M>]M[RK$SNO9T.C;>FV+0V[P[M>5F%!-$LHO*\N"UJN8SWN$*M\G._PM02P,$
M%     @ %Y=54))P;"U/!P  N"8  !H   !E>#,Q,F-F;S,P,F-E<G1I9FEC
M871I+FAT;>U:VW+;.!)]WZ_ *+6)4Z6[[7A&]KC*M]1H+DG*T4YFGZ8@HBFB
M#!(, $K1?OT> )0L6?*.$[]8XTU5:)%H-+J)T]T'($Z^NWQ_,?KWARN6N5RQ
M#_\Z_W5XP1JM3N?3_D6G<SFZ9#^-?ON5';2[/38RO+#225UPU>E<O6NP1N9<
M.>AT9K-9>[;?UF;2&5UWO*J#CM+:4ELXT3@]\4]P)2Y._W'R7:O%+G52Y50X
MEACBC@2KK"PF[),@>\-:K5KJ0I=S(R>98_UNO\L^:7,CISRV.^D4G2[TG'3B
M_4DG#'(RUF)^>B+DE$GQ8T/^V?VS!S,Z>!"?6C=7]&,C(Z]]<-!O'QV6[G@F
MA<L&O6[WG\>-('=ZDNK"09U!Y_@SZMC0Y.B+:W$E)\4@6.P5^ Z+]C%/;B9&
M5X5H)5II,S"3\5[_\+"Y^,^Z[>[KX]CVHAO^'7L%K93G4LT'KT8R)\O>T8Q=
MZYP7KYH6L]&R9&0:!:W\#\%X^!%N9]&W(^A1LJ!6[6NO'[R[^N.GX?EPQ/9[
M[?ZZ:TNWGZ;IX44+2K3A'HD#!KO(>#%X=7%U/1J^'5Z<C8;OW]WCUI;9?#HN
M'VR?K6&3G9,IN!'LYS8[E^:&G&NRA(R3Z9RYC+N7+PZ_/]YP:PV>$F^J<(-6
M[WN,6G(A$'(M1:D;[+_!DYR;B2Q:3I>#'\JG ^![7DFOO7#VZ5JY]HY[W?9A
M>*U#EO$I,4-323.D/I=)R\Z*HN**75.IC6.Z8&^UR5FOV_J%Z91](NO8AXR;
MG"=4.9E ]".9J4S(-MFP2-J8_A^>T_3W=W;ZS[G%I&.&\SF[*?1,D9A0,Z+
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M&3<4T ;TR+$BCPJ&(LW'2MK,]_!B.7*WS]_^7DB;*&TK]/-9W6@585<:G9#
M8\OV@#)!@&V$TM67)./%A-@9$N9UI2#1V^>MWN$>12MZAR+>Q5N,Y3FB6NAG
M/JNN1$%$I;?EP0.E:P.E&,C[>3<V(.$9S:,8Z%%_Y_#.=P[OO7;W*+S72[)8
MJ6+V0_G^:V@V/;-(>&4?WL67^#$!9O5(D33HRD!!Z:FK#?D84E0$/7X1<YO)
M5ZN!(<4#;FO6<(N]9ETI?*-$5H<M5BLIPI:"K<96"LF-] [(R&U"?2J\ILIZ
MOA$BW09R$K*WM@2#'*J%[U1R!$Q2*>Z+#MP*1MSR%O2(+&B5O.'7F+P@Z@+Z
MDWA4'=C!N!CO7%PLZL!Z6#PXGVY$Q\,S\8.#!($UE<)CGUM=<%]RN$7<>$;N
M X(;L0 GPD7RL532S3V3V3:L#]6 XP#1&&5KHBN,/E2V+[5#965*A(@-S"M)
MM!'!@,#M)U2 4"E$"EJH]"'H1;!NB=& 4)4EBLMSBX=DY^)A62>NIEQ5(9EZ
MM%":@ES+*>;9;B')X$T/* OQ=CMC#LA'1Z1T&WGY6%?N_K$?4KCX4IK\HB/]
MZW4G&R^6,R&8*;X#V!. ZP=X1N 5.P?>93*/X-@$F=],J0EO:+F#X:](WIZQ
MZ"2IC ?1"CU8TY=KZ_ D\>O5%#9!Q><*O )*]S:$4T0 4ND=N=I,K% I[/KX
M#:&P71AM>1TMR;A=\B>?A$/$D C5*7A?5XXY4_*&5+T%=$>^^8@7\NCXV,%%
M[^'.QL<W+'K#OK58Q%7S-E'ZO+V*\]N<Z?'Z%41J@^'#+@Y^[[2Q2]82'D!9
MGDOGB+96HK'V'TO0(B1L"MWW$ =(_-87%OSUZXM%P-+G2L+D$*)5D81-H=?_
M7\\^/2OOX2EG"I05%%H"L'Y+PF]N))( KYIQ+->5,^(WGD)$"AM(1"#?8>M\
ML2'X5:"MEX!Q0VA+BN4"'2TM,^P6@-=D'<+&?]A$9 4&8T%?;)4#17A!P8VZ
M@FW=-'V.[&1WEYIG("&I029K C\4,B\0&#Z9U%!MQJHNBZE64_*EO>"3^LN/
MJ9,UY:72<T+K+-,Q/?.U0 !P'\ERVM_P&?U;VY[F!/[/$P<O7QP<'=MPW?*)
M?J?\;)SNO ,?J9 (CM]!6]@'+/^DSW4A<UYDDE+V=HGO]Y';_&U BO4.\D:@
M+.PMC0U6#O.7+WIONL?]7C,>G[JW+I0ZGNH:Q(W6*:T>A+IS1*JQO2<?6ZTJ
M1\=C[9S.!]W-LU1;3DIYKDAF463N/6957^.9KG"Z[/2_4$L#!!0    ( !>7
M55#DFKH*^@,  "D/   :    97@S,C%C96\Y,#9C97)T:69I8V%T:2YH=&W=
M5VUOXC@0_GZ_8I;JNJU$7H%M"RP2#?2*KELJ2-7=3RN33,!J8N<<IY3[]3=.
MH-MN>R\ZW>FN11 1SW@\SS,S'KO_;C0-PB]78UCI+(6KZ].+20 -RW%N6H'C
MC,(1G(>?+J!MNQZ$BHF":RX%2QUG?-F QDKKO.LXZ_7:7K=LJ99..'.,J;:3
M2EF@'>NX,>B;$7HBBP<_]-]9%HQD5&8H-$0*F<88RH*+)=S$6-R"96VU IEO
M%%^N-/BN[\*-5+?\CM5RS76*@YV=OE._]YUJD?Y"QIM!/^9WP../#?[5_>J1
M&PX-U*.%WJ3XL;%"8[W;]NVC3JY[:Q[K5==SW1][C4IOT$^DT&1.T>3Z;VWC
MF26-]]IB*5^*;N6Q,6 F[.0+%MTNE2Q%;$4RE:JKEHL#O]-I[G[@VNYAKY;M
MN=6G9PQ8"<MXNNF^#WF&!5SB&F8R8^)]LZ!H6 4JGM2*!?\5R7G"4;VN:VQ'
M9"?E JTM5L^OT(T_GT].)R&T?-M["NUE4!&1C&J'Z@5&_L5I_U<.@_$LG)Q-
M@F$XF5Y2[<SFU\/+$,(I>,=P;<_MP(;Y.*BD7JOCOAWDPSD,1].K<#QZ GL'
M]L3] -.SMP,W/!_#?#@['5Z.Y];T\\7X"PR#D"#2ON3ZSW#^4;+_N>P_)Z']
M,@D3 9$4 B/3 &#-]0KT"F$H1,E2F&$NE0:2G$F5@>=:/X-,X 8+#5<KIC(6
M8:EY1*IS5'<\PJ()$Q'9<&"L[.\=^[[;"V26,[&IWKS>(21258ODY+., 45,
MK6*$$68+5/M[W@>WU_*:% 7OI FL@(2GI/#@VQRC4E'#(A:8B&%\'ZV86"+U
ME2SC16%PT-=HQM2$8(4*R>?'#M6P=OZ0QTT8*Q[!)QM^4HBB"5<*"QZ;5F:6
M"%8<$UJ(%M;\#F&:) 15&2J,U2V^)M"8Y@G]R4M5E(QF:_EXU]BR;':-"AB+
M96[:Y&/UG9*IMJW].5,+)K"PIO<I;F 8:2,Q2=HD.2,@G>/>&\K) ^\00L*]
MS;ZD3-,-96F6IR;F#WF@\)>2*S0'A<(0\HW> W8(E&->YR ^?"#Q6]8\9,R6
M2>^DU:[CD56Y2'R>]$S@WQ*G?LTI%U1]&:N(HL+7C%1C&JTXVA'.N"+&<ZH!
MPVW3B%F: DVCU:G629 3V46SFI5PP41DQLE@7)TDJZHAK3*M0R.IU*LUB^]J
MQOZ'M]G7%YJJ;<88R9J@+I!?J(P:16U_KWW4*ZKGTQWJ54&D<^DK]OTOM8(W
MDXZ-P8BJO.HH<(8+53*UJ5NR7[5D__?/N[FLKY%=A2DSY#R^>7UW)VN\/),M
M"IF6&GL+J;7,NN[SR]O?N8X\>=:7R.HZ._@-4$L#!!0    ( !>755!OB*WR
M!@0  &P/   :    97@S,C)C9F\Y,#9C97)T:69I8V%T:2YH=&W=5VUOXD80
M_MY?,4?47"+A5^"2 (=$#%%HTQ"!T]Q].BWV&%:Q=]WU.H3^^L[:D$LN4=_4
MJDV0L>R=V=EYGIG9\?;?C:9!^/EJ#"N=I7!U?7HQ":!A.<Y-*W"<43B"\_"G
M"VC;K@>A8J+@FDO!4L<97S:@L=(Z[SK.>KVVURU;JJ43SAQCJNVD4A9HQSIN
M#/IFA.[(XL%W_7>6!2,9E1D*#9%"IC&&LN!B"3<Q%K=@65NM0.8;Q9<K#;[K
MNW CU2V_8[5<<YWB8&>G[]3O?:=:I+^0\6;0C_D=\/AC@W]QOWCDAD,#]6BA
M-RE^;*S06.^V??NHD^O>FL=ZU?5<]_M>H](;]!,I-)E3-+E^K&T\LZ3Q7ELL
MY4O1K3PV!LR$G7S!HMNEDJ6(K4BF4G75<G'@=SK-W1]<VSWLU;(]M_KUC $K
M81E/-]WW(<^P@$M<PTQF3+QO%A0-JT#%DUJQX+\B.4\XJM=UC>V([*1<H+7%
MZOD5NO&G\\GI)(26;_M/H;T,*B*24>U0O<#(OSCM_\IA,)Z%D[-), PGTTNJ
MG=G\>G@90C@%[QBN[;D=V# ?!Y74:W7<MX-\.(?A:'H5CD=/8._ GK@?8'KV
M=N"&YV.8#V>GP\OQW)I^NAA_AF$0$D3:E]SGY?-[R?['LO^<A/;+)$P$1%((
MC$P#@#77*] KA*$0)4MAAKE4&DAR)E4&GFO]"#*!&RPT7*V8REB$I>81J<Y1
MW?$(BR9,1&3#@;&ROW?L^VXOD%G.Q*9Z\WJ'D$A5+9*3SS(&%#&UBA%&F"U0
M[>]Y']Q>RVM2%+R3)K "$IZ2PH-O<XQ*10V+6& BAO%]M&)BB=17LHP7A<%!
ME]&,J0G!"A62SX\=JF'M_"&/FW"*2C 5PP\VG')UBUHW:2'!R=6?"19<*2QX
M;'J;63-8<4S@C LF(D[@ITE"2LIP8Y;9 FX"C6F>T$->JJ)D-%O+Q]O(EG:S
MC51(62QSTS<?J^^43/EM[<^96C"!A36]3W$#PT@;B<G:)LD9(>L<]]Y0DAYX
MAQ 2[FTZ)F6:;BAMLSPU2?"0& I_*;E"\^50&$*^TGO #H$BZ74.XL,'$K^F
MT4,*;9GT3EKM.AY9E9S$YTG/!/XM<>K7G')!Y9BQBBC:"30CU9A&*XYVA#.N
MB/&<:L!PVS1BEJ9 TVAURG\2Y$1VT:QF)0]U00;CZM.RJAK2*M,Z-))JOUJS
M^*9F[']XWWU]H:GZ:(R1K GJ OF%RJA1U/;WVD>]HKJ_L&6]*IR-P:L'\)<;
MQ)M)TL9@1+5?]1DXPX4JF=K4G=NO.K?__+/XSQP6<EF?1+L*4\K^.WQ\>/OF
M6-=X>29;%#(M-?864FN9==WGY[^_<Z)Y<J_/H=6)>/ ;4$L#!!0    ( !>7
M55#0F*[O"!X  "*X   :    97@T-&1E<V-R:7!T:6]N;V9R96=I<RYH=&WM
M/6MSX[:UW^^O0#=M8\_0#]F[V8>WF7&\3K/WYN%9.]WIIPY$0A)BBE0(4E[U
MU_<\ ! @*5N^[7;LM3*3Q.(#/ #.^X6W?WCWR]G5WR_.Q:R>Y^+BU^]^?'\F
MGNT=''P\/CLX>'?U3OQP]=./XOG^X4A<5;(PNM9E(?.#@_.?GXEGL[I>O#DX
MN+FYV;\YWB^KZ<'5AP,<ZOE!7I9&[6=U]NS;MW@%_JMD]NW_O/W#WIYX5Z;-
M7!6U2"LE:Y6)QNAB*CYFRER+O3W[U%FY6%5Z.JO%T>'1H?A85M=Z*?E^K>M<
M?>O&>7O O]\>T$?>CLML]>W;3"^%SO[R3/_C\!]'(X#C *[P95.O<O679S.%
MP[]Y>;2H3VYT5L_>C X/_W3RC![Z]NVD+&H8K((W^4\>H#=,K3[5>S+7T^(-
MP8L#X ON_EBFU].J;(IL+RWSLGI33<<[1R]>).Y?<;A_N'O"][XZI'].<("]
MB9SK?/7FZRL]5T;\K&[$AW(NBZ\3 WNQ9U2E)_R@T?]4 #S,@W[>V(G!.+DN
MU)Z=Z&CT F=W_FFFQ[J&;7T>SVQX3BFLL*K<I 869)/7_NMK<;396GP\O[P2
M%S^<?OCI].S\UZOW9Z<_BLOS#W][?W9^F8CW/Y_M?SES?7=^>?;A_<75^U]^
M%K]\#],\^_7#^ZOWYY>]*=YSJW]K3*TGJP>#]\^'YW]J1#D1[U2JYF-5B>-1
M IQE]#H1]4R)M)S/RP) +]-K?.RC,K6XF,EJ+E/5U#J5N;A4U5*GR@!B%.F^
MV/GS5Z^.C@Y/\%'Z<W0BRHI&LW?.ROE"%BM[<U=H(RHUU0:0!;E>D0$8ERI%
MIBI&1SOC7?PRO@\7FPJ8+<S^_%,ZD\54B=.TQMNCU\?/$R&-D,#Z,AAF)_A@
M^+#[ZD88W-G"Q[?U].$WN@:PTDV0X0H6S33SN:Q6;M&GJE 5;#/LSAR6M\C$
MHBJ7VL#N&/=,L*.CER<F1ANC:C$IJWHFQBHO;T16PA2*LA:+IEK =5&7< ??
M6>2J5O0)0 G3C'\#)("["5WZO8%)3#1L[7B5 ,), %N*5.';0R"<5H"=N2(0
M 2]+_)0DE-IIL20)T=*]X?$2O_K=*I<W9NT[?#MQ>(YOU.54P1.5N-$P97S6
M#1R]>09$!$OJI;[_;"*43&<(]LU,PQ^P%-K#3[,/)H]@%4)9T;5N*8H"UDY\
M4+3:L +?E]5<C [W_D],= Y#>D@# L.I>+J!$>?:X):W<-4SC63(7X8_I5C
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M*"9E2C\38#:% IL+5!O$L!L8"K\#NS@O*Q4HDK3E+A04[WAL"CB-#M$)1"I
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M D]FI/JWT1TL&YPO:A,>BV1?6[]I#R62>3 NLQ7\;U;/\V__!5!+ P04
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M@[S.7LX*X;]#6-Y$6$H@F[5MLM3LU<GL&Z^5;X3 7)S1TGKUY&G32-541?_
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M/=IN[!XYHG^LG6^W]]A(<!B]+Z46&7)<("BR?^%33B4F=>?PM':C^G@1_5P
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M!50*IB35G0/"%HS*?\6DU_LXZN-C\&B)G)E6ZF0HA,I"-J019+316"@A&H+
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MOT+1F61BPU8(3+$1C \@4TR)0O)A\9OD+Q8RL^N%+YQ*$:T1#@U$XX+D@%"
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M^/;Y-+Y]<1G??IMM6!0IC765%V1!52QH"#XD'[4@)P*D;/^Y 'WS]6^?_+;
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M30:CM6W37+QY8C-_]2I+-%9(%T5D_*+U0& +^:!-HFC;M%8YNR+[5B+I(+-
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M;4!HG$7(J"B!BR:"4X9=:GZW%A4L<-3XT![UXW!_47B A@(B<%Q5QP)Q6!4
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M+ 7Y7C/;#>LM<6.. 2M$A34B0=0WC^+:&6I3;"R)4]R 4\S_0J9X$+=_[VB
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MD]@E*-A'%%$,"^@00!S!J4B) !7K# &*:9PF<9/BX:M*M^7+)'B/B&,KG=)
M9!'+F!., =U:SC2X)$$FDW6B[?*M:/)XY8,<H=A@\$,THXX92:R15,=,$$M
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M@+WO@3VR /;&4\F/RKTHH2II/BS_G_P[SO^"Y.MJ+_1N/AADA=_D%+W* &.
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M17B81:B+S<7&(#RJ09BY!$=@!=IEHV9O&([>OWW[)GS>.3S>Q(]63YDVWP*
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M*X'Z-0(&4'=R292G-<6.7/8YWXK>C.WV]''E3_5CMM=)C'HE9^>3\;R +&C
MF<KK I<7M]235X3A%_]A-Q\"H,BL5[71JVRHAB;SZFH,7PP -7B%:OH36\KD
M6P7"N+\/2@Q^C80G0QC%SG X@;L.2VG-A]&K?#0H$S<U3:;?U&29RN(=2G^M
M2+8_3&'N 85.]=IL?>"#F8R =*#E"K^@KYP>3=0(C!1.T N"MR*""+ICM8H+
M9[(T@]7Z04,Q@ZCQ71 5!.PT&]:.'R:WLX*KAH?*Y"M8U=_?'^UWVT='J\HA
M]XS_M1NZD>JO$]-_=,%HJZCOE'?KH]-^KD%%P),GJ3+CR<B-2FEPD74%&*\
M"<# VXD)HN)UBS-G0QCQJ3=Q8-:5_0+ZR6/",WA7Z]^@<S(/!C) AJ>CH,(\
M2E39<!#D"1YH71^<K-%55("%<8,B2@-2. ><X+VZR(XFIR4:.7.J/SXS?M35
M* "!'92@(WRJ-2%,ZHM'$^,K/\:+408"<Q5=  $4R,WIUL(8@K<&TPD@%7XH
MQMDX?!'>"09M6'BU7(UNJQPSC.G6P+>\>KAT@*+@O_X-(UC%N>4,;U9#U;\J
M 6=?Z:BH0&>)-F>+-!U4.4$S*4#2W6@V0T^5FG Z*RFP%9UZ-O5_7"Q@VRU
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M2?6H.AQ<#R/(XE[>]R.;ZI.CO9DZ"<C\P@?/U=?H'$A:@/,PK0_:"O4UF9G
M_<'7N1D*V2]&RO7+]!B\KI-9"\]J Q3T=9D&&%^%,IS(G*EA");-Q>1\ ?/
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MW29C<S_!DTW&YN&[0+RS-2\> ?QZ33TG('GPT2;#TK"&"A8#*K2H0G+E1K2
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M_O^/&ER\*%=M->:VCHU<[R7+3'A+!BS+0VJ)+^MURQ+#65U.'O+Y]36OI]<
M$>$BG^"M#VHJSU_ZO4[N^\X/$[-8^)7=.83_S]Z;=[=M)/W"7P7'3V9>^QR*
MX2)JL6;F'$:2$TTLR2,I\>O\,P<DFB1B$.!@D<Q\^EM+=Z,!+J(V$Z3ZGN=F
M9!($&M55U;7^ZL2/54G/3Y$;>WRNIJG R+?^VSD>D:TIDR,^00++03%PNU%T
MI["?7#F A6Y&B&"OPI";NTO5>*WE+S$2+K(:54%PAHOP?MRO&'Z;YK$ESQ@
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M0T<DUB>>X@$B9F=L9.),1ZP"@;O)U%L!)H!3O*I95S:,;2;MEA3&8\TYU>:
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M1"F9@?#NA/[C@O5-'G3B8!4GKQJ;]X$Y5#D,0[$2L EE K1]G.;GN0'UQA7
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MC1  )AX(BG!?1*EP]FN:3]:[__3@]P@SYO=7$E^P= .?#%(V+T"(:M5XE7N
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M C^[SO_ '@*E \SCR==&-OBA40=/=T*S9["D"8\[%V1 <@A8*0EB^,/)JFY
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MD4#CA\UZ2W^(/.9^ QO+=8:N3^C3Q'/@IN"U _\;1:<2@59;T:*3T2AC%9/
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M\"*;B0]K'#Y9A :@RE@92P H],,N3D;B["*V#]ZZ?D!^)?A>,9=0],%]ZF.
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MVUV!V-RM']@2Q)<XAFQQ[?I9>]^RMF7M;63M_9>(:5O6?FTY]]?S_(IE7C?
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M[T(:BR:@=?S=SI,ZM^EM ';6(T9I2;()<UTO2#HA=3K$'MR,/Q%6AL]]5RH
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M1GE$T]U%LKUW^D$YR\=)J#B:H[Q&<#&T=_@M?&:?]'=O!LK'1C"8(81Q31;
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MT+="N<]@W&+]"^82:L>2HF%6@[-X)PK/_$N9\<*O[U[,%C[ 1 > W*0V\I;
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MZP-,0!=>LQ=P_8?A;'P;;DDRUP\X&8\CB?*K8"?E!9JLBQ0:BYACG2X&)=,
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MWO&'P[U/RNG9'OQ\<'QVJNP=[RNG7S]__L0^[WWYKNSOG>W=#S9:AO9V-H9
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M;@#^_\Y[<X&V6.E)@ZT_GB:A;0NA;0W^O82V1T);Z^,;CNEZ/@E5PW-=U?+
M!O:<V%(I_.!0&OF^[F$.[GP5+PEM$MI>.+2MP;^7T/9(:&M]_""@NAZ:NDI-
MWU M-]+40#-ME1+/CL)(IY[CXPFJ^=PG"6W/[=YO]_8]+RH ')<W)PR:P@*B
MTH",#6^B\GA:CW_F>%J3)X;<==QA+GE<[<%-<L[VJJ-$NV(Z9>]OS]6I2Z-
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MWQ15H3>J@EJQID=NJ'JN':I6;)FJKP>&ZKH.K)!M1U2C3]>O_&6KBIX=T-F
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M6V]83CJX&;>..,0(\V(CS!VJB?!H0R6+,HX_BW<\V#%GO9OCW=E&N-(S*<K
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MW4!@!TQHG+L.A0(W?&_ZV>66]*#O?'_0G_33^.FR6++0O9L.CF7'=]YP]KK
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ME$OL#9(;I]ECOAA*71?S]'H2?ZYS>+4E=H$,OP_#9\K7O=TGAV]>2TE=-"*
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MB%S# SH3$.7!Y!VEQ(FM';;TTGQ(0:1@-^;N\Q2\TTDV,L>08CU(:01/T=A
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MN>):<F4IM6O/BTORVB(&1@Q\\AAX"Y9[Q, 'P<">29_FW.0%$X0+"1A(>48
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ME;#&"$)341*J:$$XZ-C$Y(7(4[2]6 '07T1V\AA9C$AW"=*Q0II"%:I2CE.
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MYQS><R]&PS$(PL9S&/Y5?[7#+,K G_17[6W]0W?^^91J+22C8-A86A):L8+
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MNP]_V'FYN__VP@Z]^MW[VY?G:ZLS&7"0D^Q90+ 6QP+X[TZ/X)[Z%CS3BUI
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M7@UL"L.V\V'/HS?P(+ H?1H,((#&%"L,^DY"]*K])$ ,F!F'<-O!*: &W,K
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MT6=XUDT]/A[(TV?UT)]R_]RV6$.(C3(3_K2WE%#M>-I:CHV !.?*N,*'K-J
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M(\S=%LS-%5=N,R58BM4HA@',V93 GS@!;;;4+K?,2&QID%]9[1AA;G5[1Z^
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MFT B-1J/VUKS9L9A[/EH YUGW=)YMF^[D6PMW'KHJ?! ')W-G]4NC.G8]^0
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ML#M+1IU0I:6"2B:RJ#H_(,C-5>>2YKFQJ2"IR1VAL Y$RBHGABE;(#<-I0I
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M:JR-3<8'C$,%_%?.UPOP/Q[PS]96)9\$#H(@KW*!KQ8>N4028LRF:$**A%7
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MWJQ1M;&Y2G98#$%01Y&5 ?PSSC@852PAC$5,T5&-(QA5FMWJF_5S7^>S1 >
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MSQ.8>N[GE\#8 VFNH!BA7CJK.0_$6M!91N@H;2*"L6*</X/FFJU0B)1$9D5
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M8W.=MW9WN.21)F^1%($@G@A#CK*(5+#@&%D%VM)GS+S9HYP;,Y]2418!N$4
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M!X#?PWAM$4B-*'=?M'FLE2?(4L@9VYMY\MYR;L+%4,>NV F">\LC05J3'._
M FD</?P@0B7B+.;I<J[!XMN6FWOUANOWJDURI@"F[D%UC&SS 6YU;/W;?';U
M]*V[=K +^W7B4\O:_:X8#"Y]H^*7L>-1__?)'VI>ANHO$RZ'2F<<#N-OTU^N
M$.!4_\Z;NS?Z+4\#& U@N9S\UNY5$U ]]]QI7<83QW7"XS<9T.3SY?JS2[06
M]8>:+6,C;_[\UHMO_Y N&\SO>/$C$(1?+Y2OE"[\E_]D538)1 Y_?:3V0S^<
MTM?5C"@KF-(EZZ>F<..2%96#18]+LW,?^K!"#38_,]$KHOUZ@/*HVX[=LBGZ
M"D[</K;=ITS0]7%_>S]T6ONK;'OM*VFM-8^;WS[D\A;>^O;YJ'7Z1Q?^CEMK
MJY-K_H5GB=[VYB&,L=5MT:^TN19@3%]Q\_3#\59EGNZ2[;55UOP$8]S\C)L?
M]?&$V O^>R# Y-VQSB0GA$-*R8AXIH/68%Z@2$S%V\TLS5GE],8:@\7?0HN'
M.T_3R>5-&6K_[/4'(U3%<V[6B _$^/_#B7VC_/\/CO?5HN;,Q8+W]\3[DXMX
M_WDGD*"5=P*)D!+BL 3(2B*1@I6C05D*O^0BV2?H_OL@VVA1\:CT GZ 2?QW
M&JA]=$@O'18?#<2GBU@P_)X8?GH!P_>;.YIJYB+1R"1*<K19(<U91#)8 '58
M+FO4T@J[ANC@N4WV10><8I@_^)1N]O/)\*-$J7YF'F]V'F^EA7Y+$:V?LL]^
M=GZ+(KVB2(L"O:<"Q1<5Z-<=R;4+,=<-,LH1M](C;;E#W @+VI2:FD]:W5BY
M\+IVV>+!V%MDMK^:>OMSM)U/R4WUFJ#IH=)"#HYWDF;:80N6N>*YY1,1R'FK
M$%7>)Q(U3CSS]_!E\< $/D_)Y5C6_DJ1Z=HJW5&8ZZ"$0\ZE@'C"&!DF-0HA
M.>^(=%P96/N;O;2?IG1\G&RPNM \YZ[5"V^'>Q\[_:/57OAG?'C8F:2"KI\G
MGI9LL0NBL7ZTX[70A&F*'/<"<9<HTI)'1"QFTE).N*,O+UML=ODO)![/DFY,
M:O?L\/YY8R4YK"2'+8:56I+#7FARV)N2TJRA&U4Q3%7H4-5,_#!3_TKV_6]W
MD.XG"M#-T41SP8[<Z L0E_/,PHKT-E6$9&G0[UXIC'FV?,,W%(/]J?.5$CV]
M,7?P[TGESROP6>M0ZL;:7G=C<Q=O?_IRL+WY9:^UUN1;],/)]K<_]UO=/SO-
MS>9IZS0[*UN70JE]OO%I2VRLP76?OG1:GS[@YNG>_M;FGYVM;I-N=;\>-T^;
M,(;M/7!F+N23M-8^[X2@N63*("$C1=RR!+Z,-2B9P (AEEFKJOS!FT(<B[)9
M%@]'YC^,G#ID D9[=792];]'Z52],&-9,(7_ O3]E^MHN5RN0JR-PPNUZ)G)
M\Q8&AY*<\]*TXB6"LXW)PJ_W/DR6_6-_\'K)KIY4=>*+JO-@AVC+0V(*89-;
M8/KH<PM,B23Q+ GIA1)Q:<7<2(]5-&<Y/KQ T7@+-7)V\>OK,YD&K*K=S206
M75NS/5QB0[A*MF:'MW+@ST-L>IG*-(P'F4_U=GO]VV3LJ_70OTQ'?D9R2UXL
M"#W8P<+)CA2.)FH3DL+F,G0;D#-<()4LB8)P2G-R-YEIGSP5_DD;R2G-P151
MN4C[,R,.C\I\S.<2BK7)&+_ $/^.@QP6/=-1B+YY^?A,=DB47*GD$0N:@+.6
M:0J,EL@G#(L 0D(S8R=;5O**ROFOGV\!4ECX?LS"=ZE)PF*Q\-V!5>^Q&4CR
MN?,-]FC3YCY9HY-RWGQAVW\]WC$A*A?!QC0D-Q/5"K8]211Q2K0&%)8L,RB^
MM//FR7I/"(*OH0NZQ2#Z2>J2<@1=CJ 7P],I1]"/>016SJ$?<%:WP,,H\OD0
M,_G7U>/7$O>>/\^$XL*8\X+.MM\"8\X]&P1=4RITBZ,T/?M>&\<6/'GS*':^
MQR8,8^_U'(=OY^=L?MQK;:[B/)[6I^U.<W_WI-7]V*[ZMG[[FGNK'C>_?;Y<
M6=2!=R+-;Q](,W>,HDV\W?UZLK&V3K>^_9G[MNYM;ZZ>Y&JC[4OT"AMKNSL)
M)Q(D#B@P8L'5BCZW%M*(8P9K*9463E3'X8L7U"]T.C^8SD<XLUZ@201]2![K
M_/;JS+W1\]NGQO=L<V\>]0NLSP?K%Q@7-C:_[B2"B9(A(><S:TY,$3FK&%).
M J8[IB5W .MXF3\!K-]O-RTJ[A2BG(<!;UJ2;UXC>.\-8BSP/1]\SV3:Y%.3
MU>,='9T0P09$N'"(!PQFN8X$.>$D]8IX$M32BEZ^>N[YW%;YHB-/L;T?!KY9
ML;U?(7Q_[(\'!;WG0V]R";W9CL'6,A)SC8'.G)5:@?6M'6(J,FJBBKIJ)/H4
MG)7%^"[&]S7HS8OQ_1K1N_V]V-YSHC>]B-X?3G<L(4EJS!")& -Z2X.,8QJQ
MX#2C+"@>=$;OPE:YH.C]NFWOS=P9LTJC+!;X*\/PU;RJ!<CO!^3L$I"+'4.,
M\TQGLF%J$.="(,<SD*=  E8L84&75C@I=O@3(/F3&-G/:\W>FP&D8.3=,;+
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MEL+*@;UOO,NTX9FG"%L0/6=22HXX:< =)-<=:=[/('B*T$"1AGM( R L3=[
M%M5(.)Y9E;5&.EB)?%1,.?@;B7%I1<ME]H :_ FB D4>YI<'VOR\$R4!)<D(
MPK!#0<\JAT#->OBAF!/&6.QD)0\W1XLN:M)WY^'$2_H6'.FZE<N"'8WFEIG]
MLW28]^/!H#;A6OV>K__QAH7$'[5V=X@7TH*/ATC,I-F@,Y!-%,PRYP()CACP
M+W-'\(<\['J"$]"R\+<M_''S"-"!8T]X0@H@.[/Q"V2I46!*$.>C(V#TQ=QM
MY+8#K1RJ"N.ZJQ 8GA7KMZW#:M?:Z5/$T)<M],P/V[7[_4&.UL'EHZJKT&@
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MNV(^V\/:0??MR3[Y<'(W!I^'_CA/"?L1F[8O9EXN9UV?O^!<JFU01.;2$B9
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M<">\4GKE#;]VCG%3]EGS(*A9904-6IA&/<L35PP6,?I,Q>A__Y>FA/Y<0+"
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M=X.#EUCDJPGX]>(8=H#KQ<P[+[*]!I!W&[AF(_7B_X8P''AD,S5\L^>'[?X
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MOO7>Z0YLZ^>AE8^>6W3_9:]=1-K-]?.>.]JH[L3W%/-3J@R6*H/W2^ 0W).
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MH><%#@L<UF/MZM&XO<#AT\'AE&\)A'VA+2R7H@E4Y<0!#C5)2 42G;;,VJ@
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M*,TD*&U.*\%<),.8-<@GGQ!\ D&)4XJTU\XS$I),YJF4X/MMHKJ"8"DKN;B
M]\2*8 &Z.0'=E$88J;+$1HM (8R(,ZJ0YD0@)ZVF42A-C,D:H:A3UYN"<?7"
MN"72"#/*Y$B0_8PS#=L!LAXC3?:'AL+=:Z$G%F_PLAN9EDELFD%JBI%;(8W7
M4A@> S4N<4R(8#S!#-F[-'*Y04_\D /X8G_P[L=1[/1CD9EFDID^3BN'C$45
M=$@(5D8A[BT#Y= ;1#4E7A.?!*8K:_))&A(LO9FQH-SRH9Q*T4@'J$:MY]B3
M7%02@,Y+@S55.-U!-[Q+T[\">0^#O"DU45I&)0V =B[_2#8B"_H\8J#1>Q)I
M),D^97^_ GN+#'M+I"^.>G/'$<(4.J^%=KCT7L1CVPN-02_:_K!WTLBY],6#
MN)#H,8M!75#"25).,I\X%T%[;C7E7$H94^"S]V(JXM%#Q*//TQJAY#;$$"+R
M++>HDYXCK>"'T4P*S86P6!0K>K&B%V"[MJN L<F"ZI< S;#A5C ,RA]+,D03
MM)S94UB [6' -J7WD:!(KBZ$-/,6<6,U<M1)T !5X%P%ZY6ZOGU  ;8";,NG
M[DV@97X:W]*3>KW\@8N0);_3'=A6P\74[<7&P/YX.8:BTI/WJK@4L(M:J&!8
M2CQ&H4/@A$B?8J \!'H//7!26_6/7K?]=E1N$.9J^RCV1K7;WE2D-ZGA]R/V
M-YN=;J\Y.)G X7HG7+S+N_\-X?!F'!QTX<AW."67V"BY.[.)8KO3.J8VE&OA
M&2B5B2+.DD;6,(^\PXP2)84E;&5-+UHGI[J#[TNSS;\8R)U%135)Z,@]R5T:
M>"+6FHS"UD7AC-,ZW#^KL8!O?<%W2@]V$0#7)H4\M: ':PW@ZT M!@Y,@>LR
MP5QN\;! ];(+[LZK!,_<GE\O7]E":$[VQT13?SGFEI=J1YZ38@0T-#8DOXF=
MF)J#PD=GXJ/^@J/,2Z&2-4APS1%WPB.ML$0^:8]CHLP0LK)&Y\U'E][(5@!N
M00"N1DI( ;J' MV4PA <S6NB$4G"@,( &&>Q9(A)8R- 8.2)/57?[8)V3XAV
MS_'\XE*9E8ARX9?<J:1^SI0G6[/9C'GU6KZZ-@!<'F'CT96IOWI=$"FRB;*(
M%3.)%?O3^I/Q!M9 .:0\=HAC1Y&)02')HB4"<^^L65D3J[HX@6HB<Q1645C%
M K**>GC'"M.X-].8KOK)F>(V:81=2KGJ)T,F,(XT4TD*Q[!5)#NO:'%>+36_
M*,ZKA=)1U]M=>(_3<:>B!(B9FIT8&FYDG6MD4UT^E(O4C#II'G7[@UX<-'NC
MAD9'+1C#O;KH+):E9 HJ[M++OKYVG#([=7[^3Q!LTLH5^&?\R9A?TJGULDTN
M0H+O7[UFMS<I.];PO1B:@]J*$J4DRN/8VVCP1O&H)>.1<YTCS(@25EI!H[$I
MW+_PT\9(;!C[]/X"F6!:L-A.%;F-RVGFZG=O*X(K^M9,^M8[T+4^##;_SCK7
M^E<"^C#!0B"1 BA<EE!D4L2(:66I]S@%H[/S[VJ4PW-;Z>J.C357K H:/E(9
M/,XX"28*IC$G-#@F'==42&NI]-K?WZ)4T/")T/#C&1HRXTA4-"!K"$9<\%QB
M.!K$@R..ZI0LYSGFJS04*VCX8NI&_6)+1Z7GSAI>[CI1ZWXPM+VF;37V+W39
MKJT]L,2)UD:5_*G,-*&MW,"]N.=F%Y!.+JB+3!-GF4+2, ?JHI)($T]14#+I
MQ)C$F&=U\:I_KL2*+G2L:$&\1XI >%)]L6#?@['O7#F4/FJM@D<IY*H&.CED
MN7$(>Q)PL$+$Y')L0BDP56!O#D.L'^H]KEZX]'1=G++%*?L4I/=W' Q:55A-
M:<*SF,#*5D4QN153\A*2]KCM1O&6%!(O4G&AZ]IY2Q8AV/I1:JPNI/)\KR2,
MQ4.06L3BE6I_M;5*DFF/C)=2  4(6%\?$&<!(^>)18$0K(*V(7*90U94G:R2
M/]^L=07?EV:O?#$U5I_6A5.P=G&P]MP#1 67Q%N'8-ES[R3GD>56(( $JZW2
M(3#U5,'2<]BJ!7.7)<'KV=7R^A'10^NK+J1=99E,AS72BDKYP0=R53JMP1@F
MF1?>H12B!*Z*.7)16^0(#B3F!O;29ZYZ58,I9N1B1EY6N'OBF+("<_.!N2GE
M01(-,)>0XCHBC@-'1@: .0[8%QFV\./ZT-GB4%A4A"O5:Q9!-7A@A=4YZIA/
MMF:E;-Z\S2H++6#,3Z$J9?/N*URP:1U*8BFM"A%1$:O8=(\L<$844H UDY8[
M8ZY/7*ZC%Z@8)0O#* RC;@SC.172PB8>P";.=5"7.,64I=S;@R">1$3&!(8H
M-9P%(3ESIIZM/@JO* ZL%^[ JL+^>M&W;+_?3/!&561 (W5[C<%!;!S!S;OA
M5:-3^H7<7D=T?'3\N+L4&JT7(=2C3/Q#)G8)!!R7=!*>R>0D#UC:E'(++26Q
M(,%95GJ./)F PZ?U8$X<M\Y8A#TSB MAD57"(R."UE([X,-Z98W5N^G(P[=6
M_4"KGH;ZPI$*1ZHS1YJIM4GT6D=&+'>:,^J-4Z#J21FQHLX[75J;/ MO.E>^
M/?,T4*80*-L8\0!<RCC,D2:1)^MP;DR3E>^KO*D>O4T*6WHY_N/?!A:6$7Z'
MYO>U_ZM^C*;(]7Y;.YNN\X- L*G;'72Z@[B8P+#W[P'V[7\Z]HL9;@,P[&V\
M@^O_;.]FD-CXU-PZ?,>WVKLGVW"_S?8?!UL;ZP @_QS^>PKC7?]JI2,F6(Z$
M,PKQB".RFEGD4O))DB"B]BN-'^W6ZY;M[/]_*[&#/O^]TIC,V:=N7N.#P>#H
M]6^_'1\?K_YPO=9JM[?_&\68_=:#P[]-SKVT@>Y(ZA?WQYVWU4^V9ZO9B>A@
M])G0BGW^8G]M[!S$?@0J;A]U.SGIH&%[0!8=WQJ&&."/REZ1#P\'9RUCLMEB
M9,)H^K.^,;[;'ZPV_FI%"_?KQ11[C4&WL96IC,";30CQ>>>C>O#KY@ VG+_+
M#(V#J1JY0E>_'J]P^X!?53:F#!AYL6P+I(:!;;;ZJV= ,+7])[ PYF%;PS8\
MU8\^^U%F2[7F/T>5$9!\Q5\)PRM7H.C9)TM=/UDCXN2O1YQES%\NS,5%L8VE
M0*/E5G'BN6/)&*$4=P$'(:7RZEI+PJ7";\V^;W7[PU[<3F]A5\5.OYKB3[%E
M!S'DVN#]OP]@#[Z!;13^LB=5)M .#.%-J^N_/;<H=[H^1NRCUBX%=*9P_S9\
M_O(9GKMYNIV?!^+4YND?[5VX;F_CX-MF\Q)BM_\YW&OOGH+8UMQM@QBW\^E@
M]W23;\'GO9W]T\TO>P=;],]OV^\_GOQ[^NW']L[N5Q8U9AK0&AO+$-=4(BNX
M0%1J&UP2CF,R$K&!9&-8'\ <<2<H$R(H$2+7R5CBO4B4!B>]==2N-"((R$>P
M-H/>$)#Z[P',+ZJFO3&],E=WQQ6.>M/&N+2-1FOW\W%=? ^E1$HL>4=UX$D$
MF 8=B%;&.*&-HRMUVF@WH!(PF<:7V <<!=)N6Q^'E=S3&%?$[[]J?.CXU09L
M&MG8;G>:;MC/WP#I-[_'"ZM1(7'CE\R4<GT2BG^O+LK?5I_)[[\VCGK=[\T0
MS\WM^SV;9W0_\ZY^7N9&]Z@RR+\:?[1'1SW0KD9/J,0L.)13]6#!85=.SCJV
MO="O&J,!]X.;P\3X./D:F%UL'[6Z)S&.S@&:09-O&J$)#QAT>_W5QGIFI^WF
M8 !?9^,_#/!-%VZ1/VQ,3LNX'7MMF,I^=4;^,+HM4,<(W/OY@O.'N_%[QK#:
M^ >&GM^W%_\W'+=MZS>^V]Y)PYV,+H%A#!H;T<>VB[T1\C'R*J^ >94?"$+
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MA72/HNPR-DU"Q.'>N5-ON)%7/VDWGY],[B*COI8J$F$%ET)R+C1 O0F6Z5S
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MQ_^B./ZG*Q*=QEXWV/[!8YMQQS0QA!?X<%86HH#_#.#_\4)'<!>=D]0B)W@
M_=_EW(5@$)8R)F8IX\YE--.4T-^+*;>XNPIZSLL$4-!S0=#SW'( JVBT\ )Y
MT'LR>@JDH\'(V^A3"%$ 313T+.A9T'/N%H2"GHN!GM-=RJ62P1*%N+* GLI%
M9*UF2$@NLAZBJ"KH67<+Q'*'$5Q;3F%2![C!2D&%Y^8<]R^?7%+5ZL08/E_H
MS942,XY%) +6B#L2D)&.H*1$M(PKEFSNS;6J2JI:3>3MI7/9O6!(+35JE@92
MSRT50H+VI!C.-80EXM)1I'GDV>RKDA%&:DI+C9H"J<^]D,L)J:5&S;) ZG3<
MA+%&Z:2092DB;J1"N<D1"EPIP;GRH(>4&C6+:M=8[LB*B5UC7+D_UP%_$KO&
M;":VV7L(+A77J(MMX]TYD12N<0^NL3MMV[#4>8F=0H(G@[B($3F?)$HB)A.B
M5I[1"[U\:F/P7L8>>"_6G_C"H;4N-HX"K0^&UG,;A\92$BXQ4I2!0"XQ05:0
M_Y^]-VUJ*UFZA?_*#NXY-[HC*)V:!_NY1+B/[0YWO$#;C=L-7X@:05A(/!J,
MX=>_65L22,RCD$1U1&/0UIZJLM;*6I65"3^4AR,^@8O,,[3.0C8NT%J@]75"
MZ[QH'05:'PNMDZ$:FGBN24#"IH!X( 99#K_!K(0Z&2/F7F1H-05:7Z9R<ZD_
M5NJ/+?@CE_ICLP&4;^,JTN]&5:3'NRBK/W/YSE)ZK)0>*_U:2H^]NGXMI<=F
M67IL9NUXO["#^6K2?RW$&O'B"!:#7O@S=FO9X$D$8?J, 1IC-VWDI8V=M-I'
M.Y,R\&)+&2<;AW\WUP_^;L*_<-UW>./@ ]W>^O1S\]OV\?KAUY\;-,L37T^W
M_[HH97RB.]\^G6Q\R_]^)NOO/]/UK9W]]8,/8N?@W<G.U@>V<[ /U]S8OU"M
M+3%%4\04.:(QXEI[9$C0R&,16=[$J2Q;61.Z86:1 OUU!V[,02Q<X:'"0W/$
M0P]3SPL/+0H/392X$UKC(!7"7@O@H421\1[(R'%C1+0&>^ AKAMJ%J$@A8<*
M#Q4>*CSTN!* A8<6A(<VIN9#.54-1CAHGDNMYAPFE*-DDA#!T,@365ECND%(
MX:$2R#YGC5@J \Z6%QZ9)?#^!-&[5UF70A)/1A)350.530JK!/.4J#3B"2=D
M'0:2(!K3*+!E%$B"8-;@L]A!NO296EYM\.0K@-!'I@HL$+I($'JN]P0.]AB,
M0B)PC+B/'FD'/Y@2#E/L"5%Q9<W@!IN_K3\%00N"SA&"/C)=8$'0!4+0":6"
M$,NC2QK91,$)Q8$@PW(DNG,89B"$:@X(JGD#SU\8^@(B:(F NF\CEJ*#KUZ.
M&)M (8.G)X.IFH6<!NPQ4TACGQ-:D80L)1)AHX+@%.9/.JVL<=G@=.YDZWG'
ML?E<(2T@^EH$B0*BSPJBYYH$=S0 ;5+DDP 050Q\:\DB LJT&'A4Z6A6UIAH
MF/E+8E5 M(#H'('HW&D2!42?$T0G9 G*LG&%@")W''%OLD 1%<+<6 DX2E1.
MK4IE@Q00G5-98KEC)$H9Q5<O2UQ1N:;0P9/1P51%Q108"YQ[Q+R@B'.<ZXKC
MA*05*5(P!Z?YRIJA#36+>+JE5ZG+.M_RPNC<"1,%1I\91L^E"<(#PUQ91+"*
MB .C(A-E0,YS)JF+TGN]LJ9$@\U"WRTP6F!T/OIN&:2) J//"Z,3XD2>=B3M
M*"+1$<0#!V]4V(!HCD*#64J"3U;6)&Z8 J-S*DXL=\S$?2LLOEQ+SE>[O>!6
MR.5CR(=56BB['1>"#Z=*2VKE%&6*(ZRHSSG"#0+#THA':33S-,(GP(>J@4O8
MR'*L>!;"*(3QY(11TH4M-V&<ZU#.6,TI8RBXX'.(#$':1H.HDR:F:(W0>%[3
MA17"*(11"&,N"*/D]5IJPI@LE2$<,\%@1'PBB N>D#4R(!V=X9)QKY6?U[Q>
M"T@8)1SHH8K;76M_OEQ+SE>[/2D?/D8)7P8^G!/%;:)(5.'#)^/#J8*GG$2?
MG!5(*ZP0MTXB&Z1%E@DO<'(JY(5\P1JDK$ MQT)^(8Q"&,NJN!7">";"F(C\
MH@D< X(1S:LSG)"(M&4:,1F(THPS&05,H$KD5R&,0AB%,.9<<2N$\3R$,:&X
M89A8!"HY"IQSQ+%4R'BB$*$Z*4;!3S"RWL7,>2&,)U+<IJO/CEIU8W (]_*W
M5Z.=?L4[/LST&]SYQ6]IP+H0[?[P;T)KX'O7JSKI3!$;M@ CJU56)%:K_GZL
MCL<E-.VHA&8W'MIF&SJRQJ!L7 /;JEK-%/.E.I=CW"KX9_+0A!A7'=M>]3]3
M+?H$N\M2IWMH^W VF&4O^C=AT#V)MGLEW+G;X<[=>X'AR[B)_GO>0ENQ>T@7
M%/!V_MG'_O#OMOUF!IN'?Q_L'&Z?[KQO-;<//[9VMK[L;Y^N\PWX>V=K[W3]
MV\[^!OWC^^;OGT_^.?T@-K?\;O9N.1,:R6 LXH))<',30R)AQBAUDBFULB8;
MY.+HJG*_]6H#6E0KN9X4K[,2\NJLY-/Q^M:[76\<YC1XY!(5N?!Z0B8FCRC7
M3/MD?3)A94TT\-56L@K(U#N*P'4_8NND<0T0+RE*V[V];MRS_5@UP9::[1X,
MD1^V-:@QN=_I T)?A<P9?O]UD\/Y)%(V$E.C[4U[<!@Z_='Q9USV_31NBK]S
M2YRYG?+UC:^?Z^_W=E6*A";*4)3<(>Z$1%9SC*+CCD?GI,Z^(Z6JH2_YCA68
M=0M^6<WV=+S?]/O+9C=_QUZ&YG;X\#.#2 Q;G?S1!'R_&X^Q8E?G=G7P85>G
M( 5C&"F>JTQ:1Y&EE""'M:/","^%6%DC0C<N1P&,[0JP^PC@.]=9#M6/NBO&
M@+542+X%6)ULLSL!SO#)&)HS',.[@WG7[]^N#X:,ZO#%O9QXMQKT:H^Z^JT%
M;X;^\ON=%CS>\ +U16NSKPX[(;;@=)O/@&OE"Z5.J]4YKF'_HD]O>[W!X>@A
MFNT1KV21N7:]LGCP!N[9;?:^H]2--<E$Z*Y^U1T]W+58 &,6*.OB+CVEC(DX
M):(B]YZYP'5BF$8F59*<WY(S@CW9V/\(75$/XG?G#? %WO(CO.2GT3M^@5<\
M&^/H];GPGTXW#M9W,8%QG3!'FD:)N,$*@;L=400\C]QIID($\FA<C@S]]^H]
MK4-BI7PPDK+$N,B9D#E+PEM#,;B!R=^R%;Y8QZRMP^]BSSFAD2.E%4-<)8P<
ML0(Q+CT/X%ZDX+-UJ*NL8V)V=T<+B81(8[EB3E$>= ".,3#3X^!4T"BXNV67
M;[&0&5O(Z===2:0GPD@43,KXP< _L,8B[XBC3LN >6TAETOJ_'MZ8O<6J+WC
MOU<_.BWHI5:S?[)D_#/V/_\^>\%7;T%X?6M]U\.@]T9[Y"( #2?1(N-A^N)%
M &H(BA"O\O2E<3GUW')14#&0JPS$[UHLA30B;_@7'N:WFB,7;$(Z&<:CIYH(
MF-\2<\7T=OE8J!C)%49R\'67*,\4#&&4)#&(1TJ12=PCH2/5&F:QAH3:2"[7
MU;A$1-ED8,;9#!%^.6G&5N@M*1>]'[UEL2%XZETG8G0!@$8K:[-0S9 UBJ-(
MD\%)^Y"R+X.O]G:7D(B*=9Q9Q^F[7<TD30E<%)TB05R"BV("S)05)X%9Y:UU
MZ5KK6%(6*A9R;B%[NUH+2@#JD8DA(HX-1M8#?EC)6%;H/;;7X\?4(E?UU\6Y
M4'-20:S7)+..N-^$25,WAV1D.='69I8EP>;A$5RY2MW.815'?55-2ZKY$;+!
M-=M#:;$66<^B1CJ]9O[P33?F)_@1WQXW0W__#<'XWV]'RJ>BPTB/JTZSKM=I
M#?KQ[2C,!$^>/WW.1)")SS)Q]V+TR+Q)O9)?:,B)G_O=\[B;O8A<-]KOR"9X
MJS>V=6Q/>BO_F7KYR::\U$+7R^'#GQ<Z<#CF5 B !HXS+@$D/#'>&Z^-QTP+
M2<THP@S.B>%=7GYQ3#BEF 0_.O#@DI,$&^HHC5I%D>C* HCO:9#SL%7]+B!1
MKU&-P:EJ@>'V5D?+6@!MY^/FJ-OL=.N1T6W&MH^K8\7\YGB$!V'R<\<CW(3/
MKS3L@&[ M)%X'ICC"FF19P3*403C("(BA6+@6R6O+8SF:T)3H->N6BYI5%M7
MQ4X-UW#J%9WI5:#Q"M#>L,;[-8LPMZ_7STN2[L<4D:P/OH<V.K/8A8\8?82-
MLHV#3[L4*[!$H1!5QB%.F4':B80<QQX\2HIQSLQ!>4-=WB>P^B"+F7D^XF(Q
M3V@QV[M"2ZTIS$PYH!OB44ADK&# K([ ]!5;%7*P!VZ0*Q;E,]X\Q&AFGGVU
M&,W3&<WI^JY*X-KQD$."G$!<:( 9PS0"U@ &T20$ A,3HAOXLH1Z]<QD%)B0
M/:AV+^;923?ZSEX;W#9PL* CZFE(#OC(<0E'=3^M5NW8SZ28SG/G+E40R,?.
M\+6''@0XH] 6$TD)5J^B_F&8WQ7!?1>BJN%2]PWJ>Z1S,-,HK4N5GK9R;&,)
MR!H/8[%Q\'77,1.9I!YIZBUXM)8@*P*,994(5UIC3FU=+_2RQGT>YW<?"WJD
MLU L:+XLZ/NNM%19;1-*.F7OP8"KZ;!#!CK11!R]C0[F1.2*<)^SB+Y;G8BG
M=1Z*$<V5$9UN[TH1)/'6HZB9 F\":V2P=PC0"5-C:5Z!6UDSY J=\QR&IIV*
M/*F^=0X]"A\-@V[V*?K['7 \>M#](_>B-_\$^8CM)L,PYK%9GKFVY!5;X_KQ
MQL'>KA T*:<D"I$$F$++'*7,/&+<21NML28OVJDKHD<6A!.+T3RQT9Q^VHV2
M."TQ0X:)7.^28603C<A[H5@0EA@'1J,7F@:+W3RUW7S?33PJK"U#(64/W/F4
M<R)J%($>)"&42D;SAL<[,]]B37_K&[]I@DO4]%,38G7UA'BH%;P[.NJ"G0X7
MJ;[DX[W%>NV;9_W#E[23+UGOA.]5O_S?_Z,IQ6__>O>E5_]*WOYZMA+0[U2Q
MU=QKYMW2];:+=GVN;57Q\*C5.8EQZ/'D)8/XOWDKMFVW\S_-MN\.2Q0-A9:;
M%JR\T":$X%GDF'L3'/P'OQ$AN;=<FD=OH'V(KUW_^'LH#0T1YO4M4:V?;+S_
ML(N-<-Q%AK3# G&C(K(>6,EI'FDPG@N5TP1=LT0%KO%H+;<SZ%5@OC^:/C:J
M=RTPE=S$63LZ:G;CRUK(0VCH0W[N^LM#^WB%YK'Y_NLN^ DN$6]0])0B'I1
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M'&'>C!7RCCG$N3'(*O"DH&>X(2X%DR,G"%T%4KG&'.K]9F-[:%1?C^H%S:$
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MU,N294'8I8@)*0C[W A[KG^DX)))+"#I3=YS9"FRA&'D6:Z8QWB40:ZL&=;
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M?IF7V7QYOP+VBQJR=:7L%R3E"3M#M"#<DV2E"D130[W#21AZ=? OOH/H-\-
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MXVP6T0,#"G$X/<ASB.HX GS-,W)E'_Y3KS>(X7T]3(;;&H=V<\:*M:,_G@+
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MPU ZWCCX O?:^YF/K?_^\>"?4P^??=@U448-C(F8=0%QP@PR!B=D ;VH-82
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M4]@^WH19L& 4"Y(3X00P!:PL,MAC)"57A'L8GY:OK,G&Y5R4%RWA#G.2"\9
M'%/>F!25!)MCVI'$B7#66BR,<^J6N4@QAJ<TAI/UXUW#M-$>1R2%8(A+JI%Q
MEJ'DA#.<>IZT7ED3#76K,:BS *9NS)E)@7BN)Y21<E(=V_KWK!AVLBY89V(
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M#(F&>A><TQ%K%>Z9W:00P"P(8//<_5>"2:DT1B88!@1  /L%U2AAC@GS2=M
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M0P)'F(8:ZDM9,!J(0"!$($0@7$Z '(%PK3["F>BX-MYJYS*DQ&H:I8S@.!5
MM7%,<Q*R8XB$2P^*Q^[HM.<NZ@"G&]$+3]VB4[$VP/=F2!0,.G/#KNMU>H/1
MJ/.O=Z[;OP9(F!K7OA2)>S+_RS*_H_^4J4Z8##<?W;^;39 @KABH4E,(,O)B
M]S */KMJ_"@>A/+6B;RSQU:2(+'U>7"8'+Q]"+B^_ A$P.] P)G* 3D*)EP
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M+JSY=D^W?<1KJ/X^/MGO@=,%C"!*Q#(EPJ!$H$1\)A%ZU1*!D[[^24=B0(E
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MO^=F,B2 A1# -'&%:TNE]0&"=19$3!&,M*ZH_DEE&2+C3N)V,:0 I "D *2
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M_BL*Q]R(N1$NNO;%?<,1N''WR\0 8S=N-_[BJ!4.UL)H,89?_V:=(X%8;;"
M(U'3,5C2V>I493U/9E9F%O(Q2,6YY=&D+!?R:FC#.=BL=6Y,X6Y*M SZW1-
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MK''>*XF2-574T:5V712P>RBP,]1;R3#ET7 CA+6"4\IUU%P;$VZHRU[ [M'
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M +736U# ;N&++2(EXC$-CO.8I/$ <TXG:X0D/H8"=D\,=N>++813&A5+2-!
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M NP+ _;@732>.9X8YS)J*ZW&FC$?#1?,FAK8]0S8?R! JP#[3P+[?,5AF6S
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M?N0^/?A/OJ:N[))1<A+;N0C7HHYI55MFPU, X#X27C/[4R^DM%W>"Q 4("A
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M>(.YI($BQ[E P/EYJRJKD61:4FT]\187\BCD4<BCD,<CD(=DF&G'E+,L<4Z
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MZ-J&7 K.K[P#NTFVG()[3T&Z+;BW4-R;";B226ZI\2BD$!&W/"&3A$-4129
MR1?,J(Q[):^[H?+MZIMI2U[CTY=;2P;0-P#UV;R :BQEQN;$1J!4Q!4ER,8@
MD5=:1"4=I]2M;2RG_^7*&R**^77U .YA!=0"<-\&<#-)U%%)D[$:<<D]:. <
M(Q>30H!Y7.HDH\H 1Z^)'B\ UPA)=+5#:*X)(9\+I&F&6?6YQDPN6G:=-G"?
M _B"[??#]O-YX=620&A2"7$;">)<@? :),BR7"81,2&$V[4-+M9)X\P,JQ8\
M^6QMK\\5'!<M]Q9P7 @XSL48!,PL)QI)3DB.+##(Z101T\XX91(Q4:QM,-/
MKE2K!HX-,] ^ ;$XMU^\(!3_,)&*S_Y3YU@^K%[VK<'5XX/CNS$X'GJCW#S]
M1D9HUK@OM*/7 M-)[CRN#276Y11?&<!PPJ>OYFS-46Q)W[HWR^*+\<M<$F%S
MZI:6H'B(B#2G!&&5J#561IBYM8WKTK<66IS@\;9:\S"LF8;WPD^%GYK+3TW(
M)"ZL])VL--/]-(M<.ZR0U2XA[B-&.G&/B $5T$NMB1%58<<G5FEA%;FI4@Y_
M'%IX#?AO:'_>F,S)]N@8[N4W_J?ZLC[%]7_<F)Y>?7_AMQ>W*DN!1LNMXL1S
MQY(Q0BGN @Y"2N75_JLL26*""9J)E!=WZ3M_&,.H$W?2ZY0B+)'/<6JI>6N'
M\6V$.WK8ME6*XVY^BUVX_\^=GO_T1#?NQW\.L3_^NVL_F-'.,6RU\[>?MH_>
MXSWZL;-U_A:N__/ASJNMTX^O7K/MW0,,Q\3>T>O3?\X]@8VZGW10G%J!C& @
M$D8CD%9$(45@)4BI81SY6BL"O)W 0 _[H[@V-\4W"B?7+ZF+Z_#.R_<KVZ#3
M[D9T6/]-:,56FZW^A:G.&0##P]AZO_YNO94B;$O;@=77/^GES-=*9Z\_]%J]
M4;\5)ZLGK]!J4U?YL=.?P07;U;IJN9AZ_3CY"WX +Y%ZN9+:7%YY-5RW;@OX
M9S*4Q[9_T.Y.4$/6H%!MN$N_J(0>.QKV?AI_4<-(]<T8>F"\._9D$%]./ER1
MRJJ_V]T0N\#S<*])NZUVMQK5ZKX_G;;#\!#&'N80U\+ V#PT?J#Q\?7ZV"44
MK@\*LLZDN/GXK2???I"N&\R^\62\3FX[*/&MAV\YN'*/S-8I57<\^2L6Q#N"
MQ9*J%WR+E/#5!_:PGV)_5>R;F6Z_14,M\]KX>=5E7E=R7E6)=/JN(?R*H%A"
MG99GU.F.CET.*_U^97%FX'FS_>MEW?$N&N/F\-=Z2;P;VB'(V?VS"S^>6H$0
M?:+:9&T&ZL&QMT=['SX>;1UY_O&W]WCK>.ML;_<-_/?WSM:K-V=;1[^W]W8_
MT:VS2V:@(] T?]L^A'N>;9\??OJX^]?9WOGOAUM'\-_C]Z=;1W#N\>_PW'OG
M_YR_GJ^WR0).(4F'0DXYY2X29%@BR$M*3$A1P*P"M)&EQ+X^HPB ?Y?(J&>.
MI<&[:#QS/#'.9=166HTU8SX:+I@U%9;J"99>,987+&T(EL[J=.ID9'"$H& ]
M8&F('%D>&+)468RS25V2@J4%2PN6+AI+B6/*&Y.BDH9SIAU)G AGK<7".%?+
MI6J"I:I@:3.Q='LFER:&-4G)(U'EG$8JD LN(*V,)C9Q'"-@*1,%2Q\22TM0
MZGW';UP1JYT-6]T*)6RGE<OC59\'K5Y.UFP-#^&!*V/'0YLVGFD.[D-8+]BW
M<,2X8,R%7[QJPXG]V!VV;:>0Q/U(XLV%WG8Z,J)81*$J#,NE0D8I@X30,4C-
M/+$XY^VJQD6P-!W&FAD?64"Q<6:( HK- ,69%4(FKX50&BEJ"4C.6"/'G$5>
M66()Y0%'NK;!UW4!Q0**SP84;TZN>0B# KLQSZ; XV/ XYQA 23]X".1R'BN
M<JO0@&RD#&%'+*6:8V]%AL=&)>,\063\BNE@$O$( QR_$GKRY']:XD#NNY[>
M1GB10;:<I-9)O]WKMSY/^B6W[*1A<C.B09X:$2[;9))Z_6,[A$M]&;X\C_U>
ML(/#;R'%7PYM]P!^<)].VH4?[\2/?\W;5# EW%&A@!6U09P[AS2/$@G,$HN)
MJYA$!GQ-"?VI<;;WI@-;J8KS7)#S^^TJ!3F? G+.#"\,6T=UI,@J8K+A)2#M
M243,Y71*XQUEMB!G0<[GAYQ/R?A2T/(!T7+.#F.QU))1C1B5&G'G(]**YH@Y
M:J.3&%L2<E'Q![;#K#Q(EA".^P[B9C@:#8:Y?^$@9R;W(USM<Y5@W ?@RAG.
M!UUXN#HQV<5N3.WA@U7A76VK?//C-_[,UJ>]:/O3W\R5G"RX?R?<?S]O7]!2
M4<)#0CP%@KC&!KF@'?*P4DD4Q%EC,N[SXIXL[LD"A(V)V2A N! @G)D+N,+)
M*,M0Y-X@KHA -GB.B%74.Y.(L"D#(2U 6(#PV0#A4S(5%$A<!"3.V01($$P8
MXY"6AN1D9(.,Q@QYK[FQP&U:^^LAL<1F/+9-8+4#$J:Y&E=R.R;=SE^TNG&8
MXQ52';U5_=KW8WA X\!J6XV;;QQX&T_LL%]_WDDW]08N3' G)MB;MQ((+[0!
M;D<F2(^X!Q+(Z8"(!<.L$%RSQ)=E)5AY$W'QHST11+RG</P89H("B8N%Q)F]
MP$6B.;<8J50%9FF Q) $HE%%$J1+*5?J>7#AN*!A0<-FS-VR+04%#!\9#.<L
M!=Q$0[61"#.>O4C!@J1($L*59!A! S"5\;1Y31V?("*6$(+[#F(N"'.Q//G,
M/#"N;IG- W7!\Q(ZL)K6@6H1;';#'ST8[&(B_F;@]_.& 0 G3(B-2"3L$3>,
M(T=Y0$PJF#^*N;$D]](JX0/%:U; L#EV@0*&"P/#F4E R!B"$QKY"+(OQSPB
M[6V.H;5&6>*442S7OV$%# L8%C!LC%V@@.&BP'#.)!!48)Q%B0QS&L P%]Z5
M.*'H023$05+F1(FG:K!)X!E$$.1< MOWARW;#0 BGV.G=Y(3#4J@P!+=8H]A
M"X O?ZFG^.UX"12LOQ_6'\Q; 5Q,CN>&%4#3''&B!'+1*40\ Y17'%B\ZJA]
MM3AP\8457UB!P,>P !0(7  $SH4#I$1]5 EY80/BRBJD4V2(8)RH,-$Q+[.X
M:PH$%@@L$-@(O;] X/=#X)S&[SFQF F! K$6\2 2,DHZ1%*TH'Z#(*BK(-&K
ME6X+!#ZVLK_:_O_77WP<#"X4",B9 X-#VX_(V4$,K1-[5I48*-[_)Z'R?T>:
MV':O&V(8P<]<)[[^<A*[@_@NKX2?\T+XI7><OZEKS_0&P\((]V.$3_-V@60<
M3"^6R 6/<X4!AHQ(#L1C*E4PP@GKUS98*>Y;?&$%)Q_$+E!PLKDX.3,>!*MH
MH@",43N#.#4!.6D4"HI'@HV(2J6U#?G0]M."DP4GFS%W3\!X4.#Q8>%QSK!
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M]P5WK5Q3HNVG-<&'\:!?*415[%Q>_KF8.JS#?GM<R*(-V_&@[5_4\=O +56
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M3I/(HRKN:+,;IE%'VW%86..^K#%3,%C"4?C<>T-98 W.@#6\A 4 ].T\3%/
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MX=12@#W@HER\F=&BDA:(*Q!W'<0EPK47F'A,(X_4&R6YQ)0R3;PB1A:?[R-
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M^I8<REI0;M$H-V>M-"0!F'&&8L"^;EVJL= H%PR1.!+N#* <6]=-"F MX%;
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M]9CIA;8( D;D&=KWJRZ6NJE,X[K&=8WK+TV9!6"=,RI"YE <.1A[(B >"<S
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M N1;>A\GC7PK1+YQ+)GYV&6!"^8>IAQA;OHH]%F$7!X*TPR9Y_@NV'S:Y-/
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M4$-64YDP!NZJ_$N@'-BA0,>:RM-8JK0[:R !NL-CE#D\XE^P3Q6 5HG/.S&
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MYV3S;C[V$S(Q/KFW.C/).#CHE(YY\/9Q;:<GHJ5ABPRSF<Y4XV3?,0-(?#\
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MD8A2'I@NHR1D,$?!5+C#U^&.EPAW_)BH(Q&.W$!($",A13@*+!38+D?8%8[
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MO'7P8U-1&VO47F/47JAR0 -W>X!;W&#,QS42:92)B[C"X$;MA,3?4_D-@"(
MXIE@PRPN8K"Y%P'#33<G5E5O6-:2X:YKU)3.AY?//4ROZ\XSSBGTWWK_RGHM
MASZ\G."1=<*L%J'_P2 OLB%8/T5N<!'% QBL,EK4@)4+VTL3D'[U:Y)*6@JP
M<[B@A9&/)%=^^07\7V5@Q7!?/J1YS&.2R2][Y$H85 B0_'Y<@ 75U>532UH_
MR]29'FWLM-]NV#QCY]%>:EBF>L!+[5FFU9?NH!V +Q@RL(;B@EQDI<6TH_XT
MMB\R(21 =PRNO$^BT+9T(VVUW<@*.P"OQ;5$6(G"'94L(K&RM.ZB<4?!>R*=
M40#U2W!-;^4GF2C2TI<M@+@&_"'_[1@?R."'?,QV'ZC+2,<XZFYWE<^\S?N@
M+D!]J+T<,$XUQK-KJ4$^ OF,C^H=2B4 QQ[D^5!]I3Y]9QR*+(N3Q/AX.V"]
MCG$2BXS!^_;5'A[C_Y'^Y3OC#-1%KQ%#%;P#$TR2W-@GV47:,!T[QL>/.QWC
M\//^'VK(\'?!Y3CAY7^>'*;9!0QAIT=R47T]FL:?:3PH8%1$!F[_?WOGUIPX
MC@7@OZ*:J9J:V6J(96XFF9JJ-$EFIS?=R8:>W7WK$D8$58S-6'8G_/O5D60P
MD-! !VQG3C_0Q#=L^>C3T;DI9N$]-(L^3>]X'T4/<0KW),W5\K]O+Z4%AP7D
M7,K(%_JOO6ZE%]7ZLW (/CY0DW6+JE_=SKFGS0]>[5]62LZGJG6)L3)TT<IP
MD)$7?7TX\I9^$'M[(R]_HHX[$K%,M-D6QD;%5C-H7L%FXY:#[1JZ:OR(]0BJ
M$'W%?!$(->3-#UD>5B^XSR&3AC2<YT=6SM2P:].GMQY$X2YV&TB1V <A-KKS
MD-BEA]_;(_;><R47OC<],U?Z0@WC/T4))[>IN@#HT&OSHP]ID#GO7,77260M
M6KUHHJ1AIF$,?V=74  /U4 R- !7DZ8=]>V1"-1!2E_7/TS-N.&B+?MHMFS%
M]69EC=GN+Z6S96/41$EO^I!1$_3$7I ZE#]Q/P5=E$^F032;&.Q>FC] JW[!
M)F5M#HTL<"+3G%-C4+E4>B_Y6">_JY/#[S-KV-B,.D'*'I&RU749(F61LF6@
M;,-:_2'-8Q*:= ZP'0-/#67_6-ZS&;5N\^"HM7:0W0+5WGIW.CAIVTC:BHH&
MDK94I'5CGBAX F,?63S4H+7Z;%_)1NTF)'?9$>0<#B&?(B4\?#-N-3,5:Y,(
M45MQU'80M145#41MT:CUX+OK6J66SPT$+%-:OVTY@$P+MZO!YZVIL>]Y' *2
M/]3)>Q$_\"39$[ ?TI 3UT1#>,C78_+50[ZB!PP1NR]BV_HK6&?W)>QY>I_*
M) L5;"\@>\&^"@5@]<A<2=C72",WA8"S5TMVZ_-ILA1/T4;X'A.^781O144#
MR5LP>9U<G+;UBW6LX2"=3H,LH,R0EW/YTX^>2SMG8$X0)MR,W :P[',NO1@
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M'7D<"_4#FP9WG%L>=6Z)ZPU753:0M$7KSAWXWC*Z,_7'++SG-1$^^>I&XR@
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MZ3&I;^>DOL9R8RY]#J+A3/TW3B;!;_\'4$L#!!0    ( !>755 98A8R_QP
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M!EV%3\3?KLM$VS__PA_X,&@3\OF7_P=02P,$%     @ %Y=54&UNWO%P.P
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M5H<FH>PU% ?G5?VT=!TJ?Y7\R5<_6J3R9L]]UY7ZBK_YT1P&:"O@@@9";;F
M*&+,& *C1$'@DGO4O&BRI[45NC[%\/LSY%9BM;IAJ@?S'R " L-)^AU<SLW"
M"6:I4,3%C(BR-"3@?$UR .LC#0ERTY!^$Z@^!?;U&%+-#%5;OX[Q(]_+[JQE
M,D2F+=&^+-*> X:1,I#(> :M'2C>J*_W%8@^Q>_U#+^WFNN68UX7R#-F4^F?
M83D5I3T5*UV'42!K@_):XO_;]"._!:5/T70]HQ^H\A:[%H/(19242A)T$*6]
M D9='-<AGI/146"XSEM7&338A$F995NV+8WE$J4"C@:*%$%(IKBCU+0Y%_)D
M=B=VLOL]E03[*+P>CR?C\X_0?2YQ9=D57&%Q/!@PDI*(?Y>,DR?>)TD\^.0I
M RUU$T]W,YP^.2[5"'"XXJN1X 5DP,>GC_[7-?'64&4))@2*82MC'OUK[XEU
M,1!MDH\XS4)P3?)\#P'KDV-3BQA5C?%H&Q.;H2.=/06G2\T4(]*P1)Q+#KUS
MJ4*2/##?I$]X%?1]<JAJD>WX9JWK?&_&$T40B49-+)1.T4Q'?$-L($PJ$0##
M@=RF]OAN2#W=DCB(.Y4,T'JO:@T6I3KQ:"FQIO17D&A!:W,FD)7(#+\T+AUQ
MNVHW>CS"!L9A]*AJCLK)ZX$-1LFD@:" 4(X<E_(?K0GGTDFO&%.B29/$Y>/K
M9N ]!K@Z148X9+120J\@1&H(2S2%'+5K=,'VSNF&XZ:?=[+QK:SBWAJNYW+=
M=^C#<"AOH"54.'0"DU;+\YU)*E#H'.++TZ1&:/N3:GW(+Q]$@6KZ;W"GV/3U
M^"1GG%#]#*9G\S =IN%BHQ#EGL3%=Q'Q_YL,Q[._X<?G'4[FC#D6& 6B5+EE
M6#$@CF:%<0.NTDR!-;$)90Y"W:<(KP*GCF?!>A<X3R;IVW T&G@5I+1EN4YE
M+X6:2((+DOA@O>:.L9R;5&5? .A3_%6!"GOIM47*9RD+3FIKKAE3&;+CZ/A)
MZ="!=YQXC7+&H*/S*5.IFMCZ?EA]BJ(J,*"B#6K>@^K'Y\-2<70!Z>6OJZ,D
MEXPUS@D>M4<I'89WJ -B2^\3R#([*H4RJ4E\O0VX/H5251:,RO9HL?FY1EKC
MO1 636>$S$2:J(F#<JR"*AJ3,S;0)D[&1C1]J@VKP(7#-=ZWXX7"\ECJEXF%
M4AUG,<(*$ET;D[2//C*F96[!EA;'"_<)\%8+P +.LI+)B\299YI %!AIEJV?
M %!>:F/ HH=';9L,^6TL?8KH'X%OM\/!PZQ5]0SX9+R&PB3A%,69WT=53@9$
M2@(SG%"P68(2CK:YEN<FD#[%_ST@S$%VJI?O3&G1>]&/WOMA>CU^[K\,9WXT
M "]XRBP0"*9T#8F1X$HA"8_1AJ1XX+Q-@>)F/'V*\WO G1I6JWA-[LR7C<"7
MOANC@--K36/R, YG R4=T]IY8G2I0T?1B!/2$V&EU([F@*IHP::'H?4I:] #
M8E6V98N^4UMU5Y0J11FS()$!)S)$05RI[J766)Z,=,$U\1QWQ-FGC$4/V-?2
MRM6H^+$#/YUWW]=6[I!I].4"/D"/KEP][8CW^"\EM3&14R5CD]W"VU!V3&^T
M;4O6 T8=:*PCMCZ]UMJR9J/3>P9NW*#SB$U,+]NIGKYZ^9^_O/[XWP<J[?9X
M#5O ;L;<3$6EX^S)V5]?O3G]^Z']7C>/V;A;[F;LE?J_EL-!?OKI?3?Y.L31
M?OK^R[2T?W@U'/MQ+)V4XVSX=5G]PH$F:FTB6=DRD8@2KT5.M%#*"4,S3IHM
M9OWM(58H,8@ :5HZ^R\6Y%4O*A,5IYI1HIE@1 H4/TBZ:.G(5/!>X'+<J+I@
M$YX^9:(:\6=#\<'!EJD8 '[QWQ>;UJ<9WW+ OY87J0PDC9E#2"387)H@)DU\
MJ9-AUD:!4402J4E%W9V(>M6V]4A<J6.>FG5+E]2]..5P'19G-@>'<:7UV1-)
M@R(>;''3RCDN[EIU/WL069^R4(\PT1QNK7HDNF1T.2#S>CJ=H]3+6U\'CE.A
MD,<$9*G&D]$0'[DA0F2>H_'9MDDVW8.I5U=''HLYE4S49.*Y@'.:EV7J:Z>M
M!L"=<]9(XJ4O.Z:6$R>M*6?$I8JEL9=NTR%K.WQ]RAD]PB14RW(MIJ)AT<(X
M3=>V=@9)F,Q$I*0T6B_'-LL=<N!(9C0R3I41ODTE[KVP>I4G.OZ$=*BAFLQ)
M%_A>3;H%M3?);X*'*&DFF@N.#,<5-S G"$0O,F4I9=LDT[@CSCY5UCS"'%7;
MDM7G*@2&4<&\BY_\%&?2]=> ^](M4,=21^B(S(:3 "P0Y@PWH!4UT*;"Y$%H
M.UY$]YN:LRH9K$W(O[X$*U[RZ#(17K@M1;#$+I;@X*D(Z.,IU20U=!>@'>^%
M^TV0IHIQ&KO=9Y]\!]-?QFB U_B-<;FPKC2^+]_^"3F>RMX?C*?+>V7*V>++
MO:,%[4^_E!],!T&'S!+5))8Z*YF\)(XJ(!87[)Q<<*G-X;:F4FV5T*2_W?7S
M<6E2C?EW:&YYR.>ZYD2"($II((])$@D,8QCJ'?&"&LUS$)XW676WAUC+]?@X
M.8G_,Q]V</=E4=+38$ X(EQ6Y9[[C-.4U@2X4%$P#MDTR1IO#W'''8='654.
MI=E=KDAE U;W;2_Q7100O!Y?.S\W3E<'ZP9.6^9]YB0574CO%O7VDFB9I4C:
M)6N;'&3:!^Q3V+MH3KK:1FU'OY_FTY(GG\)T=5^C]*CIH B3Y?8<5]K:65WN
M\_%1<\.]:G-F[B%@.VYJ_#9I=8BQZE7NH^0ORL7-,TC%#7H!$7V7R6B8%JH;
M" M9@V#HNK#2YS\8$I)GI5FTCZYPNTV9V0.XGL+F1FT"U315B^S.K?J S0KP
MD"GZPTHE4]QU](>M5T2SK'#E3MZZ)KUG=\2YXX;';X)?+4W9.KZY[.RSCD]%
M;@(5I>NJ*[?=1^+!!5)V;'AD7MC4A&K;0ZR0YLC#62E/'BC)T/]P*"=(5CKP
M11*D+V?W9;1!2 JT26O4*PA/H"+J4)9LR!_LH_^*'1.N[D<>1*\#ON2.(.BT
M;'"&8GF22L[-:VF -<F"KH/HTW&[(W%@;QM4/$[WC_FR@0O.W.M78P]REE;G
MD E3Y3[@J(HS23W1#E'1&+G@;;IPW87H"10SU>9''>O4.R6_,8LY<$ II$P)
M@W+ BH,B(5KT(%1DVHG(DVVR5FZ&TZ<#<D>B206[5-QHF\ZZ>9S-.Y0/OX#N
M*YS!;#:"]/?A[--DOM ('R3FG,:H@KAR":%T 8A/"%-;+9CC0J<V)=E;XGL"
M14NU6=3"<C7[.]WHW?L!(]CS\?!_(:%^?O;#<7&E7LSAX^3YO)OYX6@1CPPL
ME5E[$$0'A6@A8XBKM"(Y@J>HI&1TD]S\OH"?0J%3?3?H",:M2,5KJ9."[K0K
M^'"!GH]G ^W+(FPDL5Q$#&T5(U9I2UQ*C"N'4S!MDO5Z ->.)4Z_$6+5,U7M
MK!=Z=,\GXR(L?H'_FJ(BNM7!LU5OX4WJ"#0I87#VY:*T:(FZ-#/F@O H&&"<
M*(-JTASE(-1/H1*J>GQ_-#/7:XVYFFA/QV=^!*?YVH;IU6ZI2:5$2P1B.&1\
M:R00&P,E8+/S5L?$<Y,);CMX3Z& JC;7&ABN>F?.RRO)7_Y:0A18K?8#QXQ-
MPGH"$JTN@^3$E1[$U$:J%!@P;?(,#^!Z"B5-#?RP:J:J<D'OZCH/O_$ZCQ6J
M%<;2Q#I[T!!<(M8*BOAR)K;L+&0OHN.:2FMO'%W8>%'O;D_=BBB_D=QU8YM4
M[/IZT7JE;$(MCQJ_!8QATUK#ZD57ELN3%:?=B^%TV=QC48#'K??@K211>$-D
M*C=M!@B$.AM9XI(G+UM,2X=#WXJ0CUUW4WOJ.K+%:S*U='P!C%06?[\>W[[_
M=4"]2]$"(XSGDK[3E#B<:DEBD)-GB5+3Y'SQ-N"V8MMCE^,T8%M=JS7DT\6U
ML@N9A3/!F4Q,IAHAE:M%M7 $<"8VUG'/VR3#[D6U%8,>NQZG/8/VM5-#ZBQ[
MFBW[,J_Z/7L!P5B1B-;.XG(N(@D0%9$T.91=2J.;I.VW ;<5D1Z[\*8]D0ZT
MVA&6MO?^^V*&##I1_"_R.@1=-JAPA@R2$AY N<BY5;9)Z/<@LJV8=*RN^X^^
MINUCKM:STJ7TJTZR)=1(*ENIA2 T*.2V5SAK1L-)9-0XZB6+\DANTET0M^+5
M;RT)W\B"5:N8R_]+T/#5CV#AQ97 (,X@E1^<C-/U;ZQ]\CUTPQ)CW!1Q=:;K
MY:_QDQ^?PP<_@Y<Y0YQAF)',\I*M3!.1$==V&\KI,\Y#<H%+)IH4VQU7S".6
M:LJ$7K4.BG",W\BBO:K-UA,108%7T7G3)%+?MU3S<:L;>\SVFQ-'(PX\QG%)
MB A.>T:\"T7X&(@OMZ8XX_ G0CDFFG@Z^QZ7?-SJRZ?/T4,YT)JCFPY#)U'N
M,BZ)_5R.'&N%J[T,9;-(^YQ3TDD?<Q[=LTO+L2I GSY'#^5 -8XN13S-ZV*?
MCE<ZO*&Y@8G1!&,TL9JC(H+F).CL";-:@C7*"=]D)MT%9)]*4)\03YOQH'%7
M]+-BBN[[))\-S\?#/(SE>/DR=EYTCA\-8YF\KH'9JG/UE@/7:5^]CQ0U6GYO
M]]SF6GP4;3ZV5C^6O$X[G:Z&/Z9&-TET/'V^*+?1C-HI]&+\8VITHTR5FM=?
M['E\+\D?Y6T4B1G"N"X+!J4E22V)L%GSS(SVHDE9V3J(&C>:+\9"YVHX_02I
MW&FZW'=>5=1/!RY);YSGA 9GB 2,6@/^A[B@F36 _E>;#E!;8.M3HF)O;FRZ
MH[RF32JFME? _C[I_OEZO#@W/;T!S"B=$D<DD:>,;DZR)%!)20++(A=*H)O5
ME"QW8^M3QJ ^62K9I#Y9/OAO;]$Q[H9^= .7,M12H))0@-(5MK0X!Y&(-Y2J
MK+V/;=IM/ RM3X%[?:K4L4CC(.4=?+M:V\]F?IQ\E_;Q5.X8J(Y+L@W*&N[<
MYN?L[[[=/UY+W=SOGAV@H@^ ])[#ZJ\]=')C@#I*N ]5?:GWCH\V#M-" ZWB
MG=7P)VFR:$@YR2=GSS75^[\A#PQ853=;H:[/EM6AQ?+D@_5T]Y M6/00\HJZ
M*H>A.A]GTV5I$LYB%^>@#HJ?=QF]J@9WEZ>B,L_F7[Z,OC__Y(=7V?R#=7C?
MH%55MS7ZBAK[VV2$"ZA'IPU0@-'!RKICO*IZV@9S':=HMBRC?P_=HJ7$7H[0
MS3%J.3_W8FLB_MZK_UTC-5)%*Q_@UH,.\8_O&*J12EHF+?^^B%(AG7R%SI_#
MN_GG %TY5S*:XW>7#<!/Y[-I\=!Q1AM0E4KD5\[*E3U5KAEQ3&F2O<XI4$I]
M:-(J>T><AR8H[GC<K>?\Y*?#.$A:2^!.D<Q8Z4UC&?&!6L*=S$)8JP5ODJO8
M"66?TJ$M67<SL]'.E'7+@LNA+C]:W2VR '?]?NZKODBKP_@G75<VEI?-0V+T
M7 @H6\;<$JD0O*<<"#5,&)-CC+;)M7N'0^]3YO68O#RRT1MGY*X=TO?KS?IW
M7U_O'JO. KLEUAI>QYV/VML=>VC$QBIJY9[=^< [?[!H%;Z_$W?@ QNK>0^I
MV](51Y_[40M]WQRZ-8'ODZ2&#M^4JK)]-+3ZQ3KR;T)13[J]9Z]KOUY3TE;S
MTK7LJY5\_Q?@KI'J:&$KG-4(4.X1WE\3MX:H2(0[D56*ER\?,A#<)IT9)=F4
MXE"(Z 6"5R3P))E/3N@VQ0R7" Z-.BZ/GES)1)G-TJ,#:V/P1+(@2 #T+V,,
M*B29K'%- MG;4/H4K>YG\YO^_H'JKMCW>-+-%A?)7^+(66DNJ"#18?0@%\<Z
MP&L2G$B!2>XS;=3S^":4/@6#=<Q^H+JKF?UOOAN6-?(*AO36!:4CX1H"LD^A
M5.76"@J*%8DS9TU.&-]"TJ>"FCI&/TS9C4/U)2@__?1J-/F&KO%BYVJ5B7@]
MSI-NJ:A#U_>M'U!S]=]/JFI^T8W\T?)A^VIP\V 5M;4%VAJ:>>M+%^ZR@SS)
MUQ?!*IOE.PU?1WO[2U3)"[W^T.FK.>*!M\/Q\//\\OKS%W,84'".2D.)U[J<
M8K*2^)0]44QJDT$R:..C;HFOK@=[YV-6[6,&"F3*N/@2)I,H-Q.:TNO=HEZD
M$H%R%VB3O:O=8/;)\VW!L_O]XJI&K.8\;8GQ]?CCM\E_@^^F RN-"I #<@(8
MD8HJU$V2Q!DM8[+":!H>D6M72/OD<?>(;GN:\A$8A^R!)5#/ =#%#"0'AW&%
ME1A7^&P(!A7H8XKH11N'?@^L?7+Y^\6Z_<QY?-Z]FLR[)4YGF:0459)HQD#)
M0"9!:T,,Q"2EM29!DR-@NT/MTU'V7K%N/V,^ NF&7U<OAZ"0< *FA$J+;D!P
MD03G4"TQ^(2> */J<>>Z2ZA]NGRI7Z3;RYC')MW'3]"!SS/H!@C29L\T\0X0
MIE.>>!42X9SR2+6BP!\S?KA"NN.U2[\7RNUIRL;IN).<AZ.AGRWON_/C_?I"
M;!JETL[B0_BJ;+/>?LC>>\QWC]5,(<UVGV\_ZH -Z+L':Z:89NG6348XN$9E
MBT';4:AU74II%/!M.!KY<7I=2F+.A\C95:_IW55UWVAU=+0UWL;*V7L>>GC,
MYHIJ-2_=\\B+'^W_%NXP>',%WBM-8TW>_#I\?^O_,>F>C_PA=8\'/K"YQG>6
MNM*62NFG,H,W&)/<@E1Z*X#-!D %(D0)43+WQ/)$2=32NRRU;)3DN!_6H3'0
M/:,O"DT'+"@!9;,ZL0"EPAQ($-02Y\&F("./,1]9[ 6P/FV25&3.S<"FJGVJ
M1<[WH#J)<?ZYF +2M1O>0Y(B&\,(7;0F48P39Z@CS.%/I /P;1I=[@YUQ_V0
MMDWM'X=:-8S8.&B^S^<Y. S88?#V'ESKL&#]@I6UZH4]U';72'5TM!7.A@K9
M.PRX?[RFRFGE_M_QN/W?N <&;*JD9F_6"PC[G'Y;_%H=B6\CJ"77WF_#VB_7
MD[$5S\O8^Y-Z_;?KR=KT<,-D?%Y*E<MS!DQ9*YS1Z$WD0*3+L92^&L*52C)Z
MZB5O<K7+.HA#/=4RQD7A4 :O.$4_*8?$2"FN)YZA]Y("]]%2 )F:[-ZL8>A3
MU+*WK6_?L[R?CJN%(^N2O)N,XPH+R]G37&Z(<ZR43WA// =!?(A.TD1-TDUV
MB#?#Z5.953735]!\XSAAL3H<'!!L&J7BZM7:Q7\!W? KPOL*J\Y4I2)^.NOF
MR_X+^^CCW@%KJ69[U.VU=(##L\6PQ]!8.R?IWJ=6>/EV&?\HFGS<%W9YL\AT
MDJ\^MO;3%S =GH]+[L9/_PKI_)"PK V.8YBHBHYJF/*5'W9_\Z,YO 4_G7>P
M[Y2[>9PZJMP"8S-5[#VOWC=:0[6TFD4W/NSRFY-<M\'H(4]KJ-Q]Y*T4^BZ?
M=PG@Q7 :1Y,";. "DRHD3YR2AD@=./$Z>,) >Q<E<[G-28X[$1V\?3/I,,H8
M+V.V^/VBY^OB>9L4 ,Q%RZ@DG/-(I.! @L<P0:K,E0,K0YM#9#OB[%-P78=-
MM[9L&AJN6C2^%/VO,$JOQQ^[^70],)0Y1P_9$:4HQIJ4:^*"8OAEN7R"2R5]
MDQ3,/9CZ%)>W84TM@]0KO"YY^+MEE2SZ%*@BV0J!K/6!^* ]41R$-=*SU*:3
MX?VP^G1@J0U/*IJE7FKO:O'?.,$YX:AREECG.)'."N)%8B2+G$Q0(J3 FZ3X
M[H5UJ- _S:?#,4RGSR>? X8VA1!EJA^.S_&5Q7]-AVE1[EZ<KB6.[P/GJ?&)
M:9(L1\,[-+SEP B3U"89!(!KDJS? VN?UNF*_+KY.K6V8K5W[ 5DP-5@48D,
MX^EU2(NRNV$>0EI;-2BS#@Q.!6 L)3)&3H)R@F0NO%'>*>N;.(0[(^W3XMZ0
M:FTM6+'+\0PZ# 7+3;A7:9DUO9Q<>;&#G#.2763"-:XT4HIRM3@7! 35@N'/
M@#6YOWL7D'WR"1K2JYG=ZA4D;@Z,II<OP2:59,&4SCH0DS6^ \EX$C*^"$PC
M_ PZV#8,VP=LGPXN-V1:<SLVWFW<F-1ZOKC^&YV!-_ 51F+C9RIG\G9Y9,-T
MWMZ2-TNH+F*<3?L%E0WPX',::GTW&:N<Q;NJ%U[6V*$?TL$G=$7*.E&J]7=7
MZ\-C5CJ)MQOVHZAK_Y.O6XY\)-6UVBLI#YJ,"Z4G^>3T^>O]7]Z[1JJCH*UP
MUNH(=\L"RSN$BAT6U[A^]+\.&'KV061/8G:92"\9"91:DIT/48OH>6S3-&,+
M<%6RBG<\XR?(Z%E\@+B*A>+"G%=Z4=1&$T+I<A($AD,F$)]2(#EI5(O,F3$X
MMEX>P-RG+$IU[FU,31[!MM4"DIMP7J'.[ITNE_*LRBC?8Y U25>:2UHZ+P6A
MEOEE.9W+/A.J+8947E'&;0MVUA2B5Z>JFO/UT<S?.+ZY]98=MOK>.UR=)7A[
MQ)76X2LF%:,O,[[SX?A\U:(&$2PGK.7GT+XP?3L<3SH,;B_R+"?E%-CZ*.7N
MDMGWMS#[-$GEGO;I;'G]DT..IH0!=LFL8.2K)0E66J)3\A ,9-TJ1W8T&0^=
MB$OO[=-<SM=-\9%GT'T=1IB>349I(&5,*7M+F/&ETUG %USARY6,-5+[Q+)O
MLF5R-Z0=U_2VDV1?B7QSKJUDX>I9[I>_EEP\#$3FD;$0B.4BE$.SEGCT.8C!
M:5OP%+ES3>Y6N(&C5POP4^'6(;:L1JCWW20/9T7,@7;.^Z038=:A+VN$(M[$
M<MV@2M8%QB$VF?"O(!S^=JPLNE+I3S &''H H+E5#"4SY>"0L)YX9QD!EI,U
M(F4;3+NE[!:>7LW$>Q)@PWV3!ZN^XBQYO!D 8DRE]H684"[R<#F1P+0CBD4&
M)N405$-N/8*;]+@;W57IVC^&- ZQSF:3^,_%A:_KN_E[!%=W#%0GK-H&98U,
M[^;G[)T?OW>XEIIIE0F_XVD'G[G:;MRF&FM]QFKS8T]&B[5K6"Y27-R]'&Y^
MHL0;U36[XV-;*OX0#;2SR^*[IU^6*9PX&W[%>;RV$>Y[1DN-;RU;8_6>?/G2
M01PNOO&A. K3DV^^2TW5O>4SFZM_']G;F>/=9.&<0'H/W>+FLG%<OH9-#;+;
M4UN:Y #Y:QAE%1F5JZ/WT>ZU7Z^CIKL1U99W;]]JPR#U96_E1UU[QL'>TWVC
M-=!):T]I_6'K)0WO8+55-8RKCQQV+?1^SZFOT#UE/$(AQ_OR#731QLLMQ/<(
MI8/9<%GXM2["2?K'?!G<+H/DLH^87&+68QS.G=-$BAR(2R&3$)435BF:>9-$
M="N!6A:,;(T+^?'+V"^;9$+ZV0_'Y==/NN%T.#Y_,>_PSR5_KNP@(+EH09*0
M:*E7U9E8&@-)(K$8$V4Z';T(IZ&\O4JE]N+EVJ6ZI2]$K'OX<X.P+U"2,:0U
MD<K4BX"[U99>F7>?=Y"&LWN%TA9" @V$AU*V >7\ ?!$HE:1&P<IL";%,HWE
MZE."]TF]1(_!J^8OR^+57NO,?*7,1:71Z?/76]OAU:2[4R%7T@<939)1$9PP
M')&J7,YD7;D",T9GE?"IS<']OBA@QY->_UK$G@95C_*BWBQ!.U@#%XO[E<Q
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M1P(R2Q<1&7T7)U7!!\2X[>G],7]]%LM8X.)L,2#BF\\>%._T',9#"OC&HP=
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MD#QZ$QP-X.RBGKF]F<Z6DE\L9N-XL:CN_?OIJ^FDGJF0@,^6\92KN+.1YJ6
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M0T4#57D'9SB_7%1?X>)REU0J2:D-\1<4;<-U[%$1LH@\%65R;9G>0C^VHGD
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M;!N(C?BO3!Y$P9BY44Z;+ *7":V3BK8"SE,9D;N1:.6O]UO+\H%0X[^,91E
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M.NQ!_^]A[>8;P%*VXE4,KB@HCL=*Q:XJ.XD%K6VTS#!A[HYI?&H(>.0,. 0
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M9GF4,AV0P_3__N\ABU(6:;1+H:A,B2VYV,IL$M/1^F0&*D8MHF,@T-9YVCI
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M(:^<\;71G")HZP!CXA!8S(*DY*[P)^OM+B7J39R]C55;.?FJ]EYPP;36=2P
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MY:($IPOA7M5"A%1TT4T*GP\%@4=BF(,A8!L[]^CYV_.CHQ/1:2F!)V= I9C
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MAV)V97B21NT/PFZ0?SN[R'C>%G#Q%XN9/> 5+6<:LXN"G>'0QM&;7'CGS^2
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MN_]Y066D)DOW?^CX390&@+\]JR3%@$)987PV0LM0"7-.H1JK7-)J)HS#G%"
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MOK*R"&GY)+$X@,(3V(C'I^\P:8TXK:Z!^0EY??GFD7^-R1,YK22(6-A9K%X
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M2O.WHCA^2Y3^6K 8FXV1.S9L+.*;D#8NT!!08[=2V8IF^L8J([&UZ"7JR?2
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M2CB>XU.)D-2[EG>7?\?AQFZIDV,4U7WG+R8*"$K+R,K)[U13U]#<I6^PW_#
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MQM,#: ID^6PI,7KY&AO@)8#?:/&@^3US__L!>C&!2BXKXP=U5]T1CP/):C-
M8%5N2_;[V9RS/![0G&*L8:P@&PA!@_N;B?[+&]24(\EDVVEMY+'M3V(C\^V-
M5DP<'SY_OFS<+:2OQY,G^I! L5&&/6AQ'D0I80FU8P%PBJ.(*$L@F*[%4)M
M1E.=R&9%'E3/T523TS^L<H@9.Z^/FD?H[R^Z9!>A(ONR+S>!I^\80MAL@'D+
MVNTF7/C*)8K=PDVL:#R'G2^UEL"S0BM>0-WHR$DCB<6US=N2Q,T?W)ZT"_#"
M7?!=*S3_\'BM:8P,T"\8[9,4%O J5[K9"D+2E/<-JOLPM HV,.>"]&7>-35D
M['L\%0F31CH_?4ZUSI;I#PR%)2VD6+;3]Z-#JUJ.K75E*(HEBR=R9ZX\OUZX
M:A(*;;QF/7DY@M0 :HPN?Z/O6C35!0T(#:G4& >O. >2?H=_VJ4=AVMB.J)I
M(8]5[6FIQ5*/,AY'/+&RX &8(N FW3G^%;KI4=&Y1_$3,!@#1A#2/GGYNOTS
M:DJJ]OJ71Y6.3P9RC!\V<[Q^<RG!(6C91)V$%0;)/;CP;!,IDM A=ZNI2#"\
M)<OY^%/7>K*VG[GJ*4N5_$?9F75U MQ;K=U^:M'K5:;&,1*T>]"V"2*-F!48
MN=*?*DHQ9JG7Z%.F+D'L=:['XO3XO1?EN4T:<74<RELOV'Q@Y:.Z]; ?%=#-
MGYE0P2G !A;O3"7H,,Y#LR2Q>A#-@QFB":Q#\3-P$89,_<H[_09)<.!U#['H
MP+L=)9;G]PV8#03!>5'=D-8X"TN]<Z -]"7DS'D3CU>3[ :/-%&^5^>LTS!/
M_8E.&B9DO<-Q4@[A;@Q?R%@<3C9>,W[84+RI_ SU8+1W)H=I]A73ZR4K<,(R
M&X#J'=&5*/I!QBYP!UT[AMP+DS(U&*;NTF0<JD;N?Y;B_E9[?;3Q_<X>"1^?
M@'%;W(38'<\*X?+-$#.^55\IZGUT6^@H0[R4Q;]"@.7@*2=%_!T[J>%)\4I?
M2J)3E\_>"C/0=O<,]K%LVC+2YI[_$CED%\I\UU2X2P"2;%NPA#J,]A@\>#0)
MWXA?2:$?=&&83,?O!R7!#.)S6MJ"U91R<))5OJ<2..0?#*DA2UF?;^<OG[UV
M;<<%/IS[S3V'>U5]A+^ENS&<F/E0$8VF.(;CG%E;>,"G!,B_?F6Z9S*(X;W/
M'7J-_'L#6-LM?</ONI5YVQD:9;QO$=_Y?C)'<?LM*:LWZ=5BA:A&Y'8(MHJ?
M3O\$/TBP,L2Y7)G%F%Z2",RVR+&-^IO2/HE9SUYFL=)=WG/[ U5#QEZE+F@W
M]GJ_ O8!<4.0A(/X>0C:S+%!:!X8L\+4(/Y5(:K9&S3V O=>I)4D3;)T9:8Z
M;KWT\G#3J]"^'ZH8[_O4^&5!:\IP7CJ%S $!S"N6"EA?SX@ [2C5+('&!0=I
MB)4,+^F+@;H]2JJL,=:T]/2IN7E/.:<1-Z$ -\G-&Q=M=WCTI(GMOL#QH\$R
MWI<UBZ!<V,A G4,E8)O) Z/9<(K#2/SXPD);UJ'>F),(:0-,#7'NA?P[^W!]
M<9=/9B>_RF0R'LWZ!BPHAWU%2D"&OZ:VE4%_N5*F&1(R-#0S.0J5'&T*?S-0
M38!O?0?B)DX^*5%/)]E8KM2W^&J[CM11I6P_[7V9L.WE_/F$^*0Q2TG \?]0
M<_ZV4,[80FUG* Q#* ($L8'6Z@&XX-=:NB'2L^/M<DI?K(BI>^FA+?@S3^Q:
MVCOWUNQI??[AQ%V1X9ZJ(_,6RJSK#XV'C>T/3]DIT%T^)_IHZN]3]HG:P6-C
MLM7:VTR)@X0 =SDO[_0M=Y]'ZC$KD+I478^W*J/)#"E*NV?K]/?G88=-75;J
MM54O=ZOR%MKG]FU9],GB.+=9#_D3! VI^[K1E#/HF0R6H#-5]##:%HPH!QMZ
MW0QSR'>(?BV4I%=729[%.I\0[^\?:]?3+2NK7LZ:T%"@64!5LW"\ O)0(+X+
M)AIY2/C]_J6*BL4]<W+9EPK7)L,.?BZ9FM2GB[@-A.X[W93\"4?:ITC;$..S
MW9HIY0N9SBT/,,Y,F,H&H]M2&-M&@NDV4)USWXV<8+HE9O\,.#I0LK/KR<2]
MCCAQ$G>CW>VA;-LRLK=3ZMZS-7MW;(1H94(A[8#T 8_A*5&?5X(7!$Q5OS@N
MNJ$3D9:A55]/?GU3)W.QN^9+T]'&%^[!M[)Q)(O$"[F=2I)Y]%HB63@FO,?H
M_)<[$I3OV44^F:[:^DM'$G>J?LA-!;B9N[X#J(,H2KC_0,Z->"DF&BK3"\!2
MDE=*]6 T<=9 R/#96Y5,#]SM*+!O+.S<)]UB?8%;HR,F%G7I6T898J5]F&V0
M'+Y^"J(;44%<<%O^UT(94^T[].-V2?NZ)3ND[ZCD+;S^:+WWA51JK^P[SJ._
MH2RB"##*:?(-!"1P AQ =6Q_PRR4[2F)[EY4A^QG,K'EB]+^CNVMV0?#S@<P
M%GW+QIST7R]DO;K*<R@!+HSRP\]9T'PIA@QY>RH7+9BJVQ^JA"<I-=0@7+Y@
M^)\]66O5MG_T_4')P?JS<0U1@@]?CNQV'Y,7D$KUT?*JITZ0!@<;P!V## 49
M"A<1FP7W@XG&7!^(5Z?R3";%JX!'MYT<[&[R>A\D7]:RYN918:5;J)GG;7N:
M.W?XJ>WAK!]<$+SP,)-,]>/[\(]-K]/UXB&DXM:GPZ1 B[Z.[(KJ(&SHX\GZ
MLK!5>=_@0)6\#VG3"7-Y!^=:V@_0>]C \8GO[DZ-;W>?>YJ4JBT"55ZYYG)\
MV?Q\7S6X-K%%I)3NYT*L+8>9-S&F7U!;3=7 C)ZKY&LAO@ZI</'U;5Z'K/L-
MF^>"'AN\DMXX48=Q']T=82W58L?YVVZMYD#3$;HKPP9T5F<H^5.B3[Q%1MS-
MV";1NV?Q1_W(Z[OBO?X/4-Y?JS14_8Q/ANNY<-88M[]($,[5V@@*-79XVIG(
M(@W(J;>]IP7.*WMI]XJTW''><3V[U0"(#X00$:>D2EG-@Q:*H&*2'BY-.4UW
MM*=%RJYW&F?<MPW?9F!\9=OYPY>VGW:Z**FX*S]&ZML1M!"6\!NJ[3-#S)"V
MGWD+'@)/O^PEAA(#=WV=ZT))UQO8(+&",=FO%:*"M>Y].+*CS-<G_Z#7'B_9
M7*D\4B2S]R$N.^=^\-;G;0V5<Y[6JJ+">>^Z'M4K+%S=VO71G6O'W:X1 &6*
M?XQ8_@RE]19P [*MEOD42R@20SHBTC RX*5#=_(HT?U&9^@>LU^+IJ(=KD17
M+DYKH_4T=[2TF6]9R1VZU*YL8T/$[$;:4-!]D+I1('Q>MB?$'0G"ROJ!S>HI
MHCUTV'PP-6AO<$GE< ]-J'@RM63_0?,<HST77 19N9'V0D<H4T5;4H@C2M,.
M3>TGE9N;VEWN94K\MDL#N&A+B'[X&%3O+IS?63!0R!(;7YA2R_'I:'*QTO&\
MP#NAX?GA+$=BK"# BD$1/NJF%,&;1AD2IVABS%LL-?#A$.,<P5-0*WQK('6^
MKJDG='U.UB_JA)V^UJYG06"WP+4)KC<HPB.LK*E$$)82!5].68C3):%2'D6Z
MB_*#)Q!!M!^O1(/#?*>BTN[A-<YG8+1253WNG R8N="%QLMK  V?YUC\F_[W
MH9W=M8X"-=J71^E^8/MQ2E&&/EDDR\(RI^]J(@Z>MBP^YVZSNGSDOL+-W)$P
M9[]/VI$967AME+E!40.TMCM:3UN?4QUN1#X_&BQ@.#/\P,5ZGWN;^;NDR9L'
MN?*R$Q/@?'#"'5@S.0<%R2O0P)"6315=V>UP8R?8<(XDXMSC!D_=*9T_S#-P
M*]0_,/4C;CZJ=\Y8)2J&4<7%BWD!H8H=TID8Y\_B'R8TB 0J[7C<,1F)$ENJ
MK9UQ?U\QXC/^-5K/2LTLVLJ3W_<=+_'%BX;Q'QI<W]"L+3X06IY%VD/G6_'=
MM#P&QSBJ!:/,,)@^_KS\R]T>3$/(FQ;GRQ$2US[KW?Y@YO#J#?=70F8XN!W%
MD&JFG9Z$GW7@9+V"B(MOH$$4J0764V)[VUCBU/!$ENK7QH#H1NNSB?.X2+L)
ML3RW]]MUL[WC7G9=<%\?>&QRAE)-C,[^+A3G/L &1%I$_%8G8+Y/WT;&Z*BF
MR T,Y-EZ55?7 Q'P9C:P$DV9H]VGZC2R 4&E<7J?DLBX]H( 50VGK&_OM7+[
M>GCU<=0"T_O,^YU]V\MYWDI;1Z@,,CY!6Z:+V<<XQ(2R\6PXJ(%?3J..GNP<
MC]^Y9"J'G8A$\Z!\1]7N7E+=;]0BHY=Z2\"E7$>UQ*JG'_:Z3UB":6&M>&&@
MT5+^X:Z$AQ4 QQN.TZ'/M(FEVE<7^IWBMSW../TLS;MS\EZSY9,R&84S'[@N
M<5Q+.,[+ \2+0Q]L:+J380Q9?AV.V?=E&F,\KMS9^,;$]]R5X/T5\K8B;X=M
M0LM]=_/GGUALO(HAMAL0Y*W[<E)JH7K$_RN&+UQQD<L-+IT_$\CGF+&B%KXR
M\PB)U;J\,F^FMR W(Q0IU[!X+QU@!: (S7@IEAR(9HET,E.0VXA8I469'W7!
M5<612X>L#JKE+)<<ZG_^^H/3;HS'Z\8VZY=]7".Q@XQM3ZM&%QIFKM-.@$Q"
ME:=W]X_CM2J(F.M'X0&MF9ZNKOK"/CE:K?TMY8IKSEPES$\/.Z92[L44V95:
M4*5S@A^X>FBX9QC/115JFBDGO.A*E@/6C$_P?:/3K\;/X)N+5O@@+7.$-013
MBI=FV+8^IQQJOQ%IK&&"B)+ +4Z_BK(/WVC[=DS*[X;M@1LOL>JEBHV?+^[9
MAEH)I#H3JZ#2CN\V0WXZ2A060'4-])+..#JYBC^9:AT8JY93:U4XWK9LK7F%
MZ)EUO5C2.P_1N?_RY:M1]]WBT<&*6\UELV6W9^ZR2CB[ZUH7< &HT>"B>-.N
M,;$M.3@'EF U_73\"_A6C&PPB[/YC8G HR\L10JVA\SAB0IG.$Z%GMN#&ZT/
MDD?RKKK#M$M(&IZDECVW&;0H'A]('B=R;F*E403<* Y/NPQ&G8NM!<=MG@50
MONQWBQRWT_*,N3AE'/#F!FYM6%5/Q4K@HG/U5>9FSO$)$J;@5/J U--" ]LP
M:>5M;R^UVD4I^Q N#]WKM9]H>5(BHM<C%##OE#?.G\A[^:"?\A9;==4-?0ZP
M"(J$KZP)%->Z**B,[\,F_IC."0TU,2=F[1N(9FFT=SBE:\L+;!?BZ"CNRN8M
MOL^IZB>B:7N9ZZ-M>P44=3I1.1Q@*4N@@ HGFM;4!!:UCU#1)Y^\1<)-'JPI
M"&7)V"3YY$L,I5NE^PPIN%1D#V!]=K>,&-I_0S6W@-J,S1)71FKBE7RE1S.*
MC:L.:M7EHKTH<(?U,@?=DO421G'*@0JGXT-]@S04Q3I3'Y5*R>B/MIL6T<?
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MQL$=9>5$QS2"/%3@\=8R+"E\:7!".D+ 1(C(!N07G3OP*9542;?5O&"4POM
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M/#AU7R%^.GI_+4_?#]^!H_/]BD9)'W9+DCT.]JILIJP@<!6#\!9X;RA7#\N
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M3'JG.X#'HPIQGW^+JWS:$/[+"TX-<A :Q;NYC5*<G:[45UQB P)337HO!-A
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ME75_JJ3L0K1QO/2A^SK\*-O<\.\E.?^1?O;[2S\K4.%20 _O94@-6,@#[O
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M/'$58^M9?]Z4-FTZ&M\T8IMG^<#R_I:$72/.<98/'7;%XPXP33@R82A28GC
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MU%>BK]_TB6_NLR8- [N \*XI)*Z?C4-%UW@Y#YCR ^L/H(R^&?/MSM+MFCQ
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M,)T:2W2]/MD9L3IARS6).ES8%<$S3.U,7=%TK8<:6[\HA]YOR@LN+IRL)O&
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MEIH"=!'%X!:V"'RXM5:>(.\7*^M*5:H2HS\S+KWWS+74)F!$RY_P\A#_)<.
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M(6J#E_;8%XS7ZW-@]Q;'S;-?7]G5Z0L;F:EB042H']6V:ICZM>3PD5C&*#L
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MJ*Q150KVI0^O/^]*?XVI2ZP('?+]FCNHT/WV*W;;JZZ#0N_6?2MX1:'%D:&
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M>K5[9.J]>OJN3Q1:*@$Z8J$""T[F43FR:HCPIBEWG7 >4)P5X7G$X8>LUI-
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MM+Z&\<7]N]5R^%N__QA5EAS'.>8E:$?+ETS9U(B^PT;V]>GO(F*?>);MZT@
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M;J?2?:M"0?YXP8O-);CV5X2:@G2#NSAY[!1!UG0?-*1 EQ#*I5%YTY76EW:
M1UD?&T96B08B/"VG1O@S@Q;?[^:/!Z79&M"'-5C=II1U_D__RD:B]=H:+??E
MFE.08E.NT:5CYL)[LG-U;25LOMP;?X<$G.'@-A+=CV?9+, Z,C(-)?6  (RG
MU%>YRYF85X&!$@<Y%F7JNSK(>*I<U_^35[8S -6R\#^DL=O+V0G: L-D9*>=
M)'FVO7_C/*0$$)+U0?I5.TG;."N!LLW[I*VNC.0?O'#>+44M;_#O)F+YB&KH
MY<@(0D*=[*U>K=>9*ZPG (-P,]]^+U(P0**UZEE+%\7'T#E(K28_[):\M.QA
MT( \"PD[\D;@R:U)<^49:APY?[Q5=."YI19V-S2BD! 0^<!^.D?_VOGQ/%71
MVE<U<CTN]TX)SH5@*ME.O(T2A",7H6J@IQAEIBKK[I !7J9^QJ+I>LOFZNH@
M/4^5;,6@[=L3^\_M3[\ZF^-]D&=ASW*?((,VO"KG2'M PM>9DKTLO?3/'!W0
MJ:G#5'8B9NI3(XG0FGXE^8K2O>7EU7(6KV_Q,5 7[@64K9\U:<LZ#V3%IZ3U
MW748UF\(.4K9GVX7K<U.(3#*,DAC<:8\K4]B\?ZC#SO91<1V( $[8]0-;_G7
MB#F2!.&BF-.S\J5^YN/$"^Y?/74^/*,S<RW1GYR1X'8"#WT0$X=Y]B)^_5S%
M"E+G!&8ZDZX BQT%JAW>6_=&+Y75O=AAFT&X>MPWX^T[U5VM92")-VV*W.NX
M"Z1#.IFD1O].I,CG]ONKD94T6_T6M0B14#7=9I;3KM;@,23Y2Q:HOJ6APJX$
M^X&%D,$>NOABO]6PZ1;.KI'E/3SJ%^Z.)F=DO6I6^<7W.X)G&4*Q[U' 2>0D
MH@W!WRH&?2B6!18[2;+S^Q=D\< -M&W'5MG17^S'=1EARXH_==\_-JK-/]#2
M_3+:]CU?NF4W07R!40T><*3U=^.)*$@X@;?QTW'2V W@+*7H>Y%*9JLBX-]E
M=\#]>_ZAJY'[+16L$W2?Y$8TWX*=-.F ;QOOJN=C\U1PTUUH"@'8PR=DR6&]
M.)Y2U/<SDLO1ME[CSZ]NQ5'"Q.<W;?*XIL.0E")>Z]:O_1ZB3IPP<6C+$KKI
M>^CM,Z0-'A+F<7.!C=R7<)8]1R(($II\:D59*&V$9Y#JC0I+ A3A&ZYY;$0&
M$V[.;A\.%+CT#I6(!R[V=H*MVW'M_JT(XG?LIN&&:1V[@8@^KO-A^Q.9WXWU
ML^QOF5]Z:'%.L:IO*C$\7H2L$K3ZK03>;V<$;0ZA91$+3B7TH !7G:G*7J3R
M(XEG-$IY\@_%3E.1^K.7*UB*N]RT4\5AA=/R<;]'OK42066V"6<SM[!%3+#3
M?G*6O)+$D2SQ(#_.HV0H*.ZV]5&</._PIC\JN,8DURY2_]_S^H WWWK*;BX/
M>']%O,!GKF=I=4<"B>O':MQ"'KPS8JFSLB:@WJ?NJ#58+P$O6$B@MZ)6NZ<(
M4<:1>-S#."0^PP<2O0*]&YH=(5!F(?_<NXVXCEL]. 3CZ:HB)'2.MZ+E:[#.
M)D*H/1_/, (S*(#7<(=241ZN8_\Z@60;,W#!0S_H.-HL^W28CC^QI7\YY'7?
M5 ^C<YGPOY+2Y1]T7+(W.9GC0"'(>-A?H\3&]#LDC4'4]]\\-!)OGV^.=TX-
M<*TX<#5'7MY^[WNS=BD^;*I5CJIBV:62;-U>I;PXY"%WV.['YN%AX03ZSU+Z
MY:R:Z\3.)P?F8I\446=(_D3U8S,4R6M\S5E']$;8I_CG_D$A?%A3+!$/H,LY
MDG64JP@@%>I3$63:]]C\"$FP>VH6IGV]W!Q/)L4*$A7,,H\T3;[M++[%M\K^
M ]KX+<96P;73<,!)5/H&.SCK$8!*Q8IZ>4QM2H*^$4-P)_%*P1*N1T*E^QWN
MQM[YY*D"7_@(DW+&I6(\*"C^ !>5/<RFE'HNXD2]W8I[9N4UY1;QZLIWVX5+
M/Q>!/VG^'*5U4/0$/$R%@V8FA]G6ZEW]TM;=FAP-(,'Z)5-K>BJS0BG_XAC[
M];E'WMAD&")P$(5' $M9H$8!0]<$/Y$,;9Y]AK:R?;D&R\(I8(=F]B0?<35C
M/[93^=Q XQ__@MW_8P^2,DT"W'2(EZ))C5D<:98];-X%P5PF]T_B._;/FSK'
MW&RX^V(\82#4G,>T0S#GN"6F&Z%^4R73?> *L[2C6&@H3IUMU5V\O7&8?. [
M_Z?O0BRE\5Y3_3580MH:C(QO,MWQ$H#3'Y1A3G ?FCCP!\>*D),[7T][^-QC
M:(7OZ-[T2==+N4W>A";=!%R#Q.9YYMT5H\N48Z[!,B'^:8X;TT<\E./"Q'?)
MFNY\]4HUVS=U/J/FH!IS\P+J/&C4!@F#$90%W&:.*9!4\"#0L+)QW':P'F2$
M4%12E(X_+9W;S4]NY#[A=86L0TR/1M7U<R3'*?BVPS*TFQ@;)JU7YRFIW@IR
MU[[_:'? 3N72NY?>SB8<)P%6]E.VK Q$X'H4'Z[=MU4;G3^$#351!$*'IMK=
M;1S'9AR#U?)_Z$01>].7]% EOTX)OL?5)7.V\ER[$UO3ZW$#T,O2!A)G:G.C
MJZ@ZLE.F;Y[(I[R[8_^D_J-B7NZ):S'W^%!GIJ:F)J=Z P,W6$A92^PN/?4T
M==,Z(E>N^/6_?LU5NI]C#M8 =1295-X ?:@NR1R=\MT[JSD6S]K]-O-7]^OM
M92Z7;(E/!0FT+([2^A?_BR#_K#FU?XK0<:C[@YM($/GVR_$/Z7I+R</4HOW#
ME0=0I_6\^:DX\ "25<4MNQI@Q9' 0YOGF7BJILO<@A\-?S/FX,"O;62RR66-
M0Y[E1\T]CW3J\ZW>1R&QXTC ";%>7%HSUP,[3&BP3VQ!/GWX%6,@,-DZ^D7]
M1^*+!@G/R]9\J0*S3ZK[PE)P-3H<Y?4X9OE"QAHL $D4;$=LY.A$4IZ;*#Y
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MF(,_#3F1U6$>L%#_$3;35ES.SU]^',;>- R)&/,L</Z;.$]SGK@*J/O4IJV
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MJ(2W<K=43+/ZAF;!(!@^_;M[0:K^D&[X&(6Z9YFF'/0*6.%(+D*B\V#&AJD
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MT"&'@38822JJ=@T6,H<G1CGC MF'1UQ.0:MCKH_MZLPD.<_UF@3W6B-E@_!
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M[V<P(MB1\+0T'*#A! CT=^#3BI*O:_^J"G-N>O7J9?&G&:*-.JXN-,FDA?[
M)]=O.[^0G.&F-1A#CQV$-B++9G$T ,$.K 2!V=^-4M:L1=M36,DFX1]8.;CJ
MD3#U;'K-BYO "CSWX]*QW'=++OU(X!CI]QY"8R^W>#WYS*\TNVHQ;@(D@QU
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M\(T>O8("8$P.$>1X@N1*H.@!Y]W$_Q^^2;#^:Y"P"4E]R2_"?5O$PC8AC.#
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MRC%G%VBI'G?*_!RI*R/RGF.#SP;F/C0_?_YT2?>^:W-5I)WH1QH43J_8A#1
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M.[S.EEB(]O#FO%Q$O V,"(BJ#F/$7I?UB3L6ES,>+OOOOU_XA2$A8=44AX
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M,)=8#:"X4AM9[XF<E"GF.]Q,>K!3UV<8+,0C>$?4*[$O4]\_R0O]*>#&8E#
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MILS4H?V4<Q2E##.4V_$ANM#1A[_;A^43=MD%7;2_+O0E9EL"W. WGK()X>"
M)E!)='E*0 9K;?"K!^M]'=?B!\7VSKR/@7+5R\G(TG.%Y.FE\WN7C)4QP+I8
M3)"TUP7I6H%8 =<.LP\ P^CV,_R6K9<@Z0(=*V0V!L'.[_/Z8&-]#:5',8F>
M'/]8^D7H&B?Z_-RZK(Q";K[E4W@5IUTC(S":V.I]]/DAG6=4[3&?9XW=587I
MNTQWR3K[)QW=[S#1_(L4<=XP0 FQ*V/UA/V[()'<Q^VY8GKJ1\R$ !I7-92"
M8*9MO0>IX)IA1(&TBA]8(_94_YIB=:KARN_T^W-U \FY]GL+(R_F!Q]4=CP7
M](53#P*;Q$N@ MV$!R=Q%3$V_.+.L.!Y QS%H$=#M9GEMM8]S3MXN_U]Q?/O
M+*.2JL"W/Q_E(/<%W=*.<8TQ#M;7"D0^;2% DSOW1<SOPR"C& ]MCWK/RTC^
M?>3E:!QT-W#GN-"K>N'$:]WET/?U%!B'^P$$FO3GL;277YEU;.Q7AE-"]%J*
MU>5ZQK3-T9B8:E^,\Z=5G?Y6]@]%NE_SKC;TH\96])=7]UPZA^ Q_J"+$'$"
MEEDFC+45>VXHYLC'WV.,5-8:V23]=AWGX8L+B$OMQ@^-7C=;#$=//*IKSGGS
M+?>-A\>!H6T$(_9?=DSE=\NIUK\/5XLCS$<>!(9=,Q0?%0I(G>X/OG[X\#*B
MY65#0YCWT-!NM_Y!KW>G4]:U]VQCYM0E[$#8B$. LP*I1^RTY*TK^B)>P+['
M0&S_WWC^9%[5#T5*2\O#>5>=>S0*L6YQZ)E+=FONS5;IG4>EXO28#[CQ@!)'
M!UAC%=@!PS4OBNDXV(NVX#ITIH]3J)EK:713/F7UQWD1'\KB8LHB9F\S^U#C
MLP*DX[DS7E[#T<6-E!,33G)DM9'=AD\'7/6/VNG(YWU@:B0FP%6WRMLAFZ)6
M MB'."^![5Q'7(\AYCSC+/=,.&&W64<V3:P%;0QO,3O51/OA_>_-*V-D$5?B
MNXY<H;W.["/W#DBT<%UY05ME3>G_@@[?%Y:Y"9'!T9^ >F]62TN&-R-2; Y=
MHT,S_#599Y855:1KJJ9+]_W:L#V%AY:NGZ0>,^ 6!30\F/B=U4N3QFH *O.K
M:SVV(F/-MZ*^T'#&A8\'(J>,^-\EPR4(-TJ(\S!)=-0 )3"TS)#U.Z<F:$69
M::YZHDQWSQ?9G)W:\6 8<.(, 1M<&?2"8.<R]RS/AW\/JPS >W#2-DZLI0UG
MUM?L"!MS:%H!V:IZYL7Y@6:$I$F,K$V&Y)E<S(S;T*!X>>Q?FD#,<J%^.P9$
MY(F7,<*?,%+SLY876IN!HXQ:U;;FX8\/+[:GG6QQ*;^>O%*HIA!T.%A+1!AY
MS.>_6:-1Z(\UUT(P2E/LVH[K.8DUP/5HF8WN\+/L7E,$EO\!OE>%VUV:[#L1
M5N(ZHG"CV\N\ [7SA'!JBVMCW\:_H$=C7=?K7TO3@(Z1@MRT!LILQGX-UT91
M$3TJGP9>"RK5$(JED<3E:^BA=^(]RGG";[#GC4T=4;\(*S<35VA9%WCKL**0
M:<N5]S>_OCCT?O])".\QOXH43A 'K=481^^80K:L,1VNQ8:Q3#AW ,LGH5;P
M_@Y7EWHSOJIG0_%MGW<?# ISG/N<Q1.AE//DH?Q[OTP _;7^UR!FYH(Z7,PO
MMSG*%0F]C<^(UADSJ^')S4>/KQJ1LZ)6S/5;5+D^.T.R->9U,B?U%<^?*7 S
M:S#&/$)\N_R:08,"M:X%]FS'E) :+S>\Q7O!)]T,UG73G)V']V@XA3>$A84%
MH!124IJO'A-!J1WHO7/&3%CHG#0$<E'(#E8$;USCR0\+=I*XES'6K-%DK *6
M["_\$6N#0JE7\_:Y"*0'3<R885>;_JR7:DE:N%O\T>XP24[9G;<D^%$CF(,)
M;T("-R$4/4X]\(G]E1/&;]/EWR>%UR>)1:#F83+'YM_41=BX7BIQ>\Q\3BF\
M-^"Q](&LWVIJS'Q"DS6L"#S)=YO@P1A&6CX=;(M"1KS5U)F/$*6_*:_OA1U]
MHV[S%B()=/]P<ZI#*_78:G<026REI.;:/TS=]3K=UQ/SA8P"_$.)??L_2SO9
M0$]"  (=Y(>*]MVPIK45<ZXYYARH>#4_UC&V0 J;B,CY" +]7NNK#:J/]9_\
M9,CL;,H>]PF[;[$MOEKH>&4$M[5SF%/.?VA("C<1I?+TV<%+#Y52HBYK#;@/
M/Q9;,XDP[5AA+EZ6"&]Z CPI0+6ES,H%'BZ"NY5#WXK!0^$)( 'KH1 HIKQ0
MUC,JKL]D$Q+ KUKF"#PY!"IO$](012.._NS"&5BWKF?^PLU,+.![:G#T+S2*
MW@E$)A9FZ<:R[/,(D_E4L7TU8LG$QF =,^[8..CEM%\U]\"UOR!MQJJB[7M(
M+"I.E$2O13;5KU 7(O20[+1,K-XPCI&MY_3I45&\MW6PUTD[&1*ZL:6#F@HS
MWJ"XQ?MQQ<"Q84C!2#RIR?,.5@[0_.U*HV@V6_MM6Z-7\[2(8[1C]<=4J"-?
MX06+/M-5F>-OKZ\HZMM';G,XZ/EM-F0:0/2V7VZ+F8^P[/..[WJ,J8B*V6F8
MI_=*N/P6Y#/]8J#V!]$2F@"$UTU%I=Q0+VRW4MG!-F2F"CZQ=.!FN_YXI*31
M$\,1F=S/(C^3(IW^2(1(K!Y:/G_AVU_[\#YDA/$TK:Z-Z#.Q[4_OWIZ[<>R.
M2+KTYP4M\\O_PXG!_M]I+^ +&X.C8H+W\!T\>_8PV3NRX585&H6P+.:T[RC6
M8:[D)>[03(27>'S!5)9 5O3K$W#SVM#ILX+T#29(=5)=0;V<#]V$I.?" Q!_
MM6C-H@)EH[.;D(QR**FV#&A@!S+JN^M3*5.#T+NVYA.\(PR\]/3156+=#^(V
M?:,]QX:;8-T0TPNY$.T[2!E<OS/L935?9HT"FJ)D$4@$^Z<6UWCJ4!#S5+#@
MS KN$<Q1_K_P$#?1>=L[%4@@?_D\^Q%ZHB?6>P_)HJ'?D(&P@3;ON;68=^]J
MG9KA+:H=S(&'!LG.#"D8L1T0+/21FC96XN?7U$,])NZ3TUMP,GV/XJN$\::J
M-[;WW3OJ^>Y@J]6S,@,F"= QX2E5<O1!HVLTGTH4*/C] %7M3K57:>TF! (\
M=2P^8R>M$N<2>*GX]#ZMF[,OVK97NA^##S)O(U9BN0[ ,L>97\,3XI[$6'Z,
MC/B-VP$\&3V3M%*U6F:6>ZOU"[0SOS\HHQ@H<E3_)LQM>M0E])](L%*PUXZ?
M O^&QWZ  4$M"(%N@JW@/__I"Q(=RE,ZR['C5W:9HN/H47>PNS&A39]XKD^-
M'J9,I=O*A2M:G'YS[$C)+:4KKCU_\/)"G'@,<P%/7?K+Y62R+5=:N,;84>^O
M W!Y0'KH_<*\PJ<B8O#C[UB-N%?O6ENO?YX];#K[=M?ZB=-:R<<E<U(2X">F
M%BV9E5P0CO:<A=/OTXA._7!@'XXG%]?=2E+N4L.<1ZFNW86)?#4TUW]19]2_
M;;7[J>D1_=U)N_+Z3@Y].)F> K%E\/-)D;-:G*= '5N.'K_6C53'V+*1O=1X
M-:#)B?WZ\3/3D:<2@^D^;U$V8W[VC1/H,DO]^?/"DL\?X2C5G"\L_,HLVY[Q
M=66M'"WJP2;VTS*)L0V 04^[>?^NJ,0AF:.+S$_O5ALH5'MEY<"VV?N&U]K>
MVX!0&D2FVRWX63CZ4\\R0X#*.N3RD6?)-AUV'O^%S+ 59YO9_E/]Q"',?)VZ
M#[)2HFF^^$VV_DA$HV%$<GTJG/X*UD+*@BV0^O# ?C)/;MWA(\_AL6!( R0(
M!]D&\Z(<[UDTUN&3B,<-"I7,20_ZZ-80ZU*R-[?V\V 7]G>4H?#OLQQ/?NVO
M>LIY'HKAYLH0U#"@RAA+MA-'-,=F7RU"<BTX>O*E_S'#L]TC:IQU']\^P^M2
M=6F:><HG<X0%XB /VF[&LN3)3M _XIKU!A%WYLS8)B"LBGAN_!LAVDK0HGQ^
M'R13.W C1J*0/_WGWH%WF4>O,6[;$MFE]'>$[=$T0!<^@!/"'/^$"UM3F$./
MSJ?U(S*Z5#L^1L9(&5[HWE#Y:Y3RN\2G3P07T)#Z9H\#*BN4J"E[Z"J!=?.C
M=S.,Y1#AJ([ES"W]L8EB++YN:VH)U2P*T(J*SBZS5REZ*^XWE"@$4E#1L2Y3
MT("Z>!; =C:B!R>!BQB=*9V/[?X$I#Q]06# %8#9:-2(^/R?AM9QGUFMTYT^
M7ADV8KW&0A'4\^E_?Y# N$-OA375,\/ &=\%XNC0:4^&Z,J#>=+V;V)LV=%^
M#3CPD+TCWG1NPKZ9F#@OIU[E[C=BQ.R3*-8:]DNZ> ;(*X-/#%L'-39GOC^B
M7J3_2=AYYA)DT&4U5/@KE$H2B)]FC$[C_%D;B=&C,X$+H"AEESDW:"Z,^L0R
ML8CK&ZX-V9,'8]&9W[_8:]\-S,[X0SD"X6;GU-*5F+6,34@6K+%PC7F+G48G
MYW2)A:KX=57$UH;!=S<'C[<<M1T<C2V-O1:I?3/55&8F-N#!N0.^I@4_B4PR
MB)#8H%R>A^*:I[+!*5; 6?_  /WM+<3,F/A#_]P12*([>A77*G],6D6?N66%
M[KBU>]!KL3U&Y^P&,1]FL<L56KH%T&&L,W@Y 17.NH)/)X5*'>KQQ$JQE=)M
MSE8#3O-.J5F'XU7=6S[EF=0U3@>H=HHET"R+#SM^C8'$,QD$8']Q<O 85IUW
M :AC00?*M@,![!L7FB=L-7C'V%*?",5F&YFCU2W\Y]>;*=&>F>7=:Z^VL9_W
M[KC:\AW7(LHLI!-F.@:P.P&',$:$ZP!-!JL;[JGH+\S233/<=^-I?)F6^>S'
MQG?+ZBV/.Y$V30</;S^OZ!1L_Y/(4XNC$Z!H'\%.9?;9/BM?YU:!\KC-@7:S
ME[S4V;K?KTT/EYG:?A<_<' ZS_\85Q?CP*YGBH*T83< ]P>J8PR+;57XB6:O
M/=UR8KJYP;^7RC;.ZA]5SUX9(BOO/6!]5>BO%-<".^,O _QARPV2A&(V(3MI
M@.4\LN]!G5,63^ZY;Y]9'M7/88E"HXQ*F/IYGVJ3V,\,C@[*T[K6^CJ'9&:[
M?[F].@E.7ZY/M;#=?3G59#?V;6Q1F;9S4^N\?HS;<?2#[H6]SGN%\!>W8XO_
MFU> _W_3D&*XGNZMW#EUK@+Q/JX2F8Y/+;Y91)+%0&M:6^@N]54R?;<T[Y*O
M5;_5G#=_:)'[]8[V047-6!5N:R9$ ,7:8-^!9&^%M,#%I]":+7L0LH ELO7?
M?DHDJ<HU\J?%5<G@U)G<38A$17! 8E52"5\##-88$CV!UES,1'%/ 4Z<,GX5
M5N['G"Q@39_UIWF'=;I4'VWNVE\F)O+2V\=>'ZHMM;>FZ,J5:66%+.(P_\Q_
ME?P5@Z='91-:2=TF>-IN0UM# 7GN !O?)^5*1D8!U^9)PC\LE(BMDW4!H4T^
MG\,F? <.9S$/OF>_W7F/<#!I+^0%S?>T':P,UE2](L>.G:_FR5LN@)!<OFR!
M$;\)Z7XET-G:FD@6[54QYTW6/??_W);ITND4+_7ON$.$?EQ<4";<_'%0=LDQ
MU5W0NUNTJA,&.C$A?@XNX+6]0 S*/8OKT39?2[]Y.YHR^> )NM*)[9%3IL26
M+G[Z>?2:%M+/U]?PI>[R \<SRI=_<J#:SAV(Y3IY(:"/NP,[!&>='P4TG09&
M$(RO:;C <_PGMBI AVLKD?6>2*>I.$4]!4PV)GR[\DF44Q574D;>K5[0#M,Z
M\/"!6K/$*ISE;S*3)1"7XL:!XS**ILTT,8@KKS<A8K#^U[C^VY%-+[S1N %O
MM];BBJH;B'W-EE;9LQV?.YTO)0_E;2]LVG-.Y)&@:,Q.64.$K4&<'Q6?619H
ML:1K&%G4]"3?T-LC U5$B[J<TW/CMRHN605K!PR@QAP@F)I*+!5&Q/.,UE1X
MJFP]GFS6H'4S;9<O%2TQ2/'$__*RL7[^O><-L>OUJQ+TBRN6QI/H2ZWMA:9V
MCEJB]X$TT&DFL@@#.$ 'UX^<%AWLVM]DJPD0<+7HRG[_?4U-0:WX@5A*03@M
M/%-KW:C9L^Q<^ /IB'GQ?Y8N8<<?)<"M2&$@=FV%;V46T .#IUS2 J);ZD;W
M3_\?*B)(&.8&[MF%KGL<E7,?/B/X]UB^-E/7YT8CY.S;M7=5'B0,Q\@0*P43
MM(;1'*P"*#5[6WGP\]0FY#(M30Y(1H=T3^&@MCJ EGW^SOHHFR,&RBNK5XIN
M:66Z&$6^')4['*9Y&&^D4LE_N%7&G&N)?4N0$>S#];C9H$"E. VLT0U(XC#
M\R8!VB4'V%\H$S-7]=MKG=K9\3%*44P[4TSO55[R:8.F*NO.;KQF-I;\/_T@
M\/^3[=4F!$\9'21!,:IL:2+W"&#BQ%;*,6K^*5 9,^<[U!G6&U\_4'"J_/Z4
M\A?ICT+3IY&034C?5K);,NQ73OW,UNZA]%:85:T4J, $TH<W(54QV-%-"! ;
M"0=F(?%\_ZW"M$[\MDT(@[()>4G(P45$ >=IK!)<K]+6:ROY40Z-$TNUG7GF
M?0%')N?!BYN8_B%_6V>;HE2)4/#QJ: ^)N7 OZLCFS8A G4J7F")!.V[Y[8
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M%T8M[:7;KJ(?R^ZR[X(O7K;@W'BG;OM)]0T-L$:YMGX AY%)R<D*-NKK"UG
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M8B,2>9HUX41%BGI](2?;2BY 'K]]X/L#H_[JJ$)12I6'EX=:P@TXA$1_!E>
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M0)SGZ9S?LH-@PG 4CVC,_O\F %!+ P04    "  7EU50;:UY<MOD 0#]&Q0
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M^K-8ED7[&ZA_ SW4V%3_PX4X/^^]HI=Y"P?)V8F9;Z[XF:V50?E0PF<O@3;
MG>-6KIV_W?6L*U7^ M8Y%[ER/ [ LK=RO]R17&A3EU^M[Q_$JJ@LZ,L\5Z^M
MT&*\>=I=<D.>]*\NOY&<WZ@U<:=^>9-G3%Q+=??]>O6E7+,_U;>;J:L6R/<#
MBE,"99)$$,=1#(GP)/0IECSPPU028D/0XXDZ-_YNQ"*W JPE8)L\U][A/<G_
M%"5XT%H N<Y!09:*)<HU$,OL-J-+ 80R$M9/0A1V]#WB2V#&[O.8VI')O](
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MZ;CG7!V]<&B,TTI'3.;5(>_GK/CSJWK.V_4]R58+3/TD09)#WV=Z?:<A)%%
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MO'_,J9N$&R%PH%&XV7U#=V/TCK V"FH73Q>.CQ EG#,?"A11B'D:0\K]"/)
MLHAP$=$X'E".\L!01LMA^HS=;>7Y.L?-=B=F'U'3;9AA $VU!]-*UZ1+7@ E
MH,OMEZ/:N]U[V1]FXHV7HWKN[[H<OW1@Q?U5F?%LN2FS1_%%L$U>;>S6K17J
MRI,Z+FU3IT9=RS9&Y4;D5?SJ994#NI Q]GP6<\@IYLJGPA$D@?*I:!+[OA?2
MP*-699"<2#4W$Z6KU+9UDVATJJNPLIU6VB6KKE9_TPU!FNS:!^6652'OPX/?
MW4RY&8--/I$C<]ZS.=PI!-X]F\:KY].XC:N[T>=;6J\+4&OFL%6 2Z"==A)P
M(MBTC09<8KG7A\#IPP<&!ZJG5R5MK^7[;$56+"/+FW6151T1:*%L2U8N./*B
M2 H!1>S'RJ.D 4QC9?YQ01D+ L)X:+7A;C+HW"A[*[->QENI02NV\HH:P6V#
M#$TFP(QA7<,Z,H$Z0-0^5M$"(J<AC";C3AO9:('$7L"CS;W#>.EYDV+=M_BR
M*#;WM:FD Y:NR)+I'BZ*$9N+KNDRNZVX4A<WUMSX68FY0 SY7+NH/HU3B#W,
M8!IQY;&*($H2$E,_M&HUZDRRN3%<*QO(E7!V).9NMLR8[E7F8&0Z;'0"C;Q5
M/_8+T-$+5'&7'<VVE^YTNP#;6?S<-XO6Q.D<<9?LZDZX22G8.:8O>=K] $,S
MT=B2%$4F,U;;LAOUY>ATX:J.&+6MFXL[L2J4.=S&E-"E(G!"_"3B&!(:4XC]
M2!&X3T(844'](/*1%UIEK)PES=Q(N]NHKCZI?29Y6[VL*2G\1Z6#=<K;.;-G
M1NB3S<G()/Y2#[#>5.:MX32=FI\!R78.<'6;DW>.0!.G[CG ;C_#S\5#AY[G
M* N=+"\?'I;-Z'6YI*MZ<#76.RD%*ZO:K[4Q7T7?^M*+0]VOD.H6JRP.8<)3
M#R8BIDE$$YYXV"[Z=H@8<R/>1@O04:.MWK53!-2:@)TJ P-X!TV<Z<G2V-,Q
M^N'3*#,QX)#J'"#=GF,-DF3BHZYST-H_#3OK:0/W3MF=X)NEN)9O!2TKAMZ%
ML<4BH5R@!,KZH)Q&,$V)#V,JTY#Z7 0LMMHS[1EL;MSX<;VZA6H@W4N0=MW3
M E0'P]HB:A)&P*^D;#:^+?=-^\ WW"]U!.G8^Z2-F!JU"L_:2APG/- $$Z<;
MHWWC3;LA:J#YWD:HR3WV)7>KXYTW1#OHRA)49F#=H#I7Y'5;[;N^>=I=<E,7
M6[S\1G+^21F4E7?_[A^;K'SZL"K*O"IG6KS[+G*6%5K"3YLJPA^+,$)>G$+B
M\;@N%I]002 -1(Q1P$(1"M,"OE,(/#>2ZPAH7N%VDIGM9[\YSM?8#*IU@914
M^Z<=A4%'8YW9WKVNT1I4:JNOUGH%:\U!K3KHZ'X!.MJK:RO]9_92F!=1GMO+
M,5%)YGF])%8EGJ><L9Z"T9.(,5GYZ2E![1:SGG3<88[/1U$40ES7S1A6MQ]U
M%=PV%_RI$:EXNQ&+B$=)$/D"\H@BB&7D0<H3J3PA'X<"^3).C9H$V X\-UMA
M*S%85K6>EZW,VU+9@&\LSUR-)\',&1H#VI$_Z[7(%V"';B7UQ;9BQ--%R]"*
M?=_V &SM)MFBY=)E,AY[4O?)%I&7KI3U_>?NV;P,IU-\FK'+%7];1]J^V%%(
M8@]SGTE(&4-UL:U$YYSCD")%:^J7>.!VCI4<<R.VST*_'ME2$5H;XEK)#\HU
M:!2H-GR:\ZUMU.O0O1Z[2;/=!AIM*B;<(3H485Q/B4XZ;>=DFBVD07B.L[MD
M)\HK;3P-PNOXGM2PQPTT"=7;U92.8'$<<Y3$,.(!AIB$"*8)CZ!(*2<RCH)8
MV!E]VT?/C?VT9 -K;W3P,K3/!J$PM@5F!("]=;6GJU/[:??T:2VD/:WV;*#]
M*X9&S^;98W7LU?$"VSZNNQ"$.LF@&WUP]>'#JEPWK>.J$S/UC)MUKC_N.EF1
MT#!A <<0Z8A:' <I3#@1,/ 3M;RC,/69T:;QV(+.C2DNMPT2?]#:_0BT?J"K
M8)TN]"Q.Z.H#R)22C?%D&Y$[TAM@QE9SF->1N6^GXO-=ODX?;+L)O@!;A4&C
ML>,TVK%GQ6U,[TBR3ASB.R[B^Q&_(X\WM*.5[MRJ_'BU@DIE@>H=RH=Z+_.K
M>F(5K:3\:!)3SX=>F$J=.(R4KXTIE)@0DE _9D%BU]KJY)AS^TJT(E]4P?]E
MY;%MQ;X 6NQ!\6,F\)OQNF-01Z9H!W@.Z(!EC)#;5EBGAYVX)Y8Q#OO-L<QO
MM>.C*J$A?UI\>+=("4[C6"0PPG$,<8H93+PHA:%$..$X\./ **IU]\BYL<F'
MS^\^7GYZ:T85'63ZF6"8OB,O]%.J&J_B?>UZVE$U%^M%&K?_T.LS[JS/S@,G
M67[["K2KZ\!?[".3_I;=WOU.EANASR;7*VU=-+L824"#1/H)Q)Y:5#@,B.X'
MCJ D4GHLH9%,C&HI]HXRMR6F!865I& GJN6.4#^L_8O1&5@CK\_Q<3(/;W&"
MUT0Q*0-QLPH>.8E'3\3'\7LG"],X*7XWMN+TQ:YZA5=]/>_62_6,HH['^+Q>
M+M^O<QVIL?!HE*2^U!U\XPCB*(AAJLT0&8;JUU2BT+?JP6<Y_MQH]$@/[*X.
M_]I&5/VA]0"-(O:%\*VF*8["$!.?*1]4ALHEI0BF**703Y2Y&,6)X-A;/(J<
MKF<P45TYQINJJSL=AE3HZ2GOGK&209:CWH38)@#H@OU33J:9@SOB!(UM [M?
M1 Y:RQNA-VZ?^7X17KGIO!$^ISO0FSUFZ,=-?0.R^R:A:EV4Q:=U>;G4;P-=
MBJ8[HI?&B<\$@H@F!&)=5)U2CJ#GL91SEE+)K$I$F0PZO\]8)7.3?'@!*K&!
MDAML!1_8B=)H"DP)SBVPH[.: TP'\)@Y2&[)RV#<B1G+'(E]FK*X=VCYNI>\
MI[AQN>'9ZK8YO+@LRSRCF[(*=EE_4EJO5Z5"0#WTMJWENU!67I@$TH=^''/%
M7AZ#B1^%4"0<1R3"21@CFU::;L2RXK<)VFQ^U6,T)H1MD3LGT^1C$<8!3R!F
MQ%?_"7V8,.1#F6(BE7GN(1DM'JK7[4M)\G*ND_52Q/&F[ U1_V2VX99N9@NA
M, P\I&;+C]5L^4F@O*=8P)C'* U(1%#:SM:[%9_W7+4"_O]SILPLA^FQ']FV
M..0:78"M4FT0!NBJI0.;GRL&6LU<5JETB;3;.I9.))NXTJ5+-/=K83I]^KE9
M#8>SQRHAZ^2PHFGO^_0B5I[2V..4A9 C-?,X]25,24(A#23CB/'$-TL'=R?2
MW-R[;I1])3UHQ&^[7]L:1>=/FB%Q3SH58Y/VH?3;77+D13,I%]M)F2C7X5QH
MQTE[&"S5*V5 G(OB\62(LY_L./+M9=N[P/<#X<<((D(]B&D80.63IC 029+$
M >$A#YV$O\V\$V%OS):CL+=A+0?'0'1DLCP1 #=%OT%;U"8)BGO57H.VB!B'
MQ[GM,_AE<W]/\J=KN>LT]#=EYNJ$LKJR:^Q3PA&14"#!E<6(0I@@$L-81^PB
M7\0IL>KT<VK N3%5(Z\V!SO]KUJ1A]7:/0FZH<7G$,JQ[;GS4+2WV RA<6J/
MG1IS6FO+$($]6\KTOC,[T;S9%-E*%,47<5NE+U3AZ1'#*$T\#I,D8A![@2(;
M'U'( YPD7$HBL%5V0.]H<V.:5D;0"CDH"Z ?8-,]0$>PC<TJAD -;R#3!\ H
MG6,.#O@Z+6/Z=#_:*Z;W)OM(Y,OEYF%)BO++Y5MQ]7N;>NY[F-* 09E&:=-\
MD" $HX3'L9>D4L9&<77'!I@;,;0R@B\_7?X$N !7/_W^TX"XVH-@]C.""XA&
M)H%1T3$/.#X7I8EBC0>B915KW =%3YCQP=LFBS#N$[H;7-Q[W3";Z),H.\:6
MX+?*V&K>OY!'))$^@Q%*M?>51C#U4P^&E(9AA#!!V"K@ZOA0<R.]NI[0SE50
ML@K;9 (#@,T,(C>PC4R$!Q#3!Y?N"W><1L.E:=0SVJ1VT6FM7QI%!G<,(XPJ
MZKK.XKY<U<U$WGW7N]U"MW-:KHM-WCD^"C!*DC141E*"=2DS02$1 8)88"$1
M)21"U"Z^W6I\FQ4R371[';3^0ZW CZ 1W8Y2[*; C&5&@W5DXJGQ;(J_Z<WG
M^A>-[& G//ACE,WG0;BYI"@[ 29EK4'8O"2R80\9NB%-"_&/C6+,=X_J/]O*
M!7Y"0I^F%$9>Z$$L>:(L(9'"F$F&)0I%C*WZ$QT99VYFT$Y,4,DYO#S$,6!-
M]YK/AFOT+>8!2 W86.[%P>U^\N&A)MY&[M5W?_>X_W*'A<X4$S4V57.DGXGB
MT+=7TH#B@(>0H4@11X24"T44CZ T8FF8)$$JI)WY<XXX\[.&.A6N=NVY.XHY
MJ$AF.E5F5#05_"/SU>'*8I7]U+IN.U7&-Z)<H#IZ93!3>5Z_^I<E<D85OFR?
MZ3B6Z="*I3) 'HI22 *60$R(!VGJ41@3$88TBM6?K=JNVPP^-U-MBIBFX:PY
M%K(CLV0OJ..SXA#4)HEM>G76&X*,<8R3>U;3S0J_BOQ>=W#;-2/\+-K.'-?R
M)L^4[?- EA]6_RE(_EZ]P@L/44^RA," *P,28^K!1/T(!8I][A&?)*E5N.8@
M*>;&<[[G!Y9EL >!;\9KHT,Z,L$][Z)YT>F4>0%V6NC J:T>NN"#U@1H51S6
MXSX'2:>ENP<),FV5[W.PVBL(?M;#[(,J;M2[>T<*H0W*S^LGLMRU7M$%8^O\
MIE]%>;?F]?F%$,4B(BB1.,;0PV$,L>^'D&(908$]/Y(X\K%GU!IEJ !S8\&M
M#I5)DM=:[!H]W1->91$2*3/=-L6T\>W@^>EGRRE0']L2? 9XH\"V\U-==[LI
M?%,K ;9:C R]>9#(V%,P41#)&%-A%6%R#HX]$2B#'CM9A,HY2G<C6,YZCOW7
MYN_J"3H9BZS40[]G;/TLP"I&V$\1)Y '<0 QHP(F7 3J/YBAQ \EI[[I9Z5W
MI+E]/[[>": %!HW$H!;YXMPPMGZX3W\EG($X\N?@=? SIWIG.$[$Z8[PM*)Q
M(XQZ^+K__LF(V4B-+@.;W3 TF/#;):NJ0.O:!/EZI7YD56AV46>.O4R+1(10
M+\(2HB02$$=I#"DG&/*0T"A@'!&[@W5; >9&S$I^L%, ?"F5C4-R;GD.9CT-
M9KL=8X([,F&_P/6Y\--DJ0Y%SVTXHZ4,$P<Y#D-H/_1QX'.&!@A(D>>ZV>'W
MRZ(09:%^N%+_SLHKDN=/LJZ062P"&0O?QRD,@PA!'$0$)C1FT*->X@<^]G!B
MQ76&X\Z-XG117E:)"5A73MNC?C/034_UG4,Y^@%^+7%5X[B6^:+ZN18;7!E!
M.^"@W@HHMV?R9D-/?/QNA<?^2;O=[<,(ZI?UFG_+ELN/V4I\*,5]L? BWT\]
M14!$T A6]<=U;RS(9) @(E!"B57_U+T1YD8ZK8#@#RTBJ&2T#&'<1]&,6\["
M9F06L8/%FBV.JNZ2%_8'F90!CNKX<JT?OW#8JMZ9.%LOX;<'3DJAVP-Y<;-G
M@(,8X40@2,.00BQ] FFJ(Y?C-$)(ZAYXQ&:E&XTZM]5_R*,"M=B@;J84#TSN
M,IL$,Z)P#NW(Y.$$56M.L4+))<^8#3PI]UAA\9*/[&X>F$]!EOHL^5&L-N*3
M*)OE(.(@Y,*/("*ZT')* T@X#F$BA+(]?.;'Q"Z;XM H<^.@1C[P1JS8W3W)
M_QS(.(<A-6.8LX$:F5$&8&2?0]&'@=,,BH,#39L_T:?K7O9$[\7V1V\Z5L3W
M@J2MFX&",/)Y"FD28(@CYL%4H@1&$6-81B&)8Z-HMOU'SVVE5]%16KP!!T O
M0#M]8C8<BI'7LD,4S,^]AJ,QT4&7!2I6AUF'%>\YO7IQPV3'58<%[9Y/';EB
M8.2M[EVD^X*\+$6-$>>!D-!G7-?Z0AZD,B PI&'JR= /HL1J ^3(.'.CIDK,
MNL.-91#M$1S-[ X'Z(S,5AU@1BWF? ()IX&L1X::-E2U7]^]8-03EP\C@=]%
MH=V<IH=5R$3LLX#!)$J5]\%Y!),@)C#VE.O!D5">B%69OV=/G]N";X0;V!/L
M.7!F:WTP'".O<&,DK-?T08U=KN3G TRZ?@_J]G+5'KYHV%K5!R";*MOP?ZVI
MKI=^+?5^Q*^*&#9Y=89;]_JZY/^UJ6O;U*4AU'U-50CE/ J9E8L 12%#>N<S
M207$J7(]$D*X6O9,QH2Q0$16U:N<238WCNAH .I61(!L=6@.%3=-<K!676<&
MZY00K;T=G[B;7#,N>I4I&YG'#D['!>A.8JT4N.Q,8E,?1]_<5L;YH='M1W=,
MZ!QOERSJ3KA)&=@YIB_9V_T PYC_L]"YYDQG(*UNU3]$_B@^=YHKIRQ)4\8(
M#*3N:IYP70M>,LACK'@]$0Q1*Y?MQ'AS8^EGXH)&WK.Z6Y\"W(QC'<(X^N[R
M&0A:<Z$A+BX9[M20D_*6H?XOV<CTMN&)V&63[*C+ S6>#0^\F$14>8,BC2".
MHQ"F'@]@1 )*N/Z+[]EF6N\/,S=&>9G\6Y>L&N0H'L'5<'?H;+3&WAP:!-2@
M%.CC.+C.<3XPTN1)S,>U/92EW'/U,#;X;94+MKY=9?]=1> U9DRAS)NJY7VA
MZ&>SU)ZMSDR[43907EM"ZMJ;=9%5';T6',O 0V$"$^510NR)!%+L^S!)>("I
M%PI?&*4FNQ1J;DS3"@_XILI+?M!B@R=]%O+0R&S'-TYFSHR=IIZ/D;FLJT[E
M#K8*53YB/4M;E>IDVDJIUJG4MVSU<L=]+E%VR91.Y)J45UTB^9*%G3Y[<+)%
MMM(-%E=UQUOU2%W 1Y\9?-[*MHBCE/K4BQ4+"P2Q3Q$DD6Y\*,(P8E'(8T9L
MRRX:C&NSSJ>IKX@]!'[X\T?PH'X+6$=X^W0+ ]C-&-4YE"-39B,OZ I<%00[
M<9 Z)+G"'!C'J14& T^=6&&.Q8&T"HN;'5<JW!V.DY D7NHG4-&-KRO>8T@8
M83!)PX2%5#%18G72>'K(N1E^G<Y[4Q0H=%:6<(XA"OW%",<,6C"':9+J@W.K
M.3B\TN!H&:C7:CRB#;&/ZZ)XGA")I,?2F"90L#A0I"0#2"F.8!2%F H?$Q*S
ML[)0CX\]-W;2/6O6K;1@J<1UFI':,PG&AM(8T(YO+NUGIFXE!UKTR;)33P,V
M:H9JS_"OFZ5Z&I>3F:H&C["/&?^R>7A8/EW=D6S5E(-?W5[2HLP)*Q>""2^@
M,89Q$#"(6<HA04$"B0C5[U,>Q]QHE_[40'.CJ5I64 D+MM*"/UIY+0*K>_'M
M)R67J(W,0%,!9AZ7[@JXB:+4AP-H%;1N@DI/"'OO[9,%M)LHT0UO-[I^8+;=
M'<G%&U)HS_=>1V94K\EEGJNYK?OC/NTN::KN76K*_K1>73_H:^OR>YVJ_]>;
MLM#9@?HPMA,:D/@HPNH_,$IUV:80$Y@B1<HH\4(2<1'Y(;?*X)M*\MEQ^^7G
MHNVT\716-,=TDV]FO,YR2L?^\&B%(-4:@:[6H*,VH$^@>UVC.JATOP!*>UBK
MWQ8Q[0"@[.@=!*-%KDP^<TZS+B<3?MI,SJGG9"\[='(![+V'UD=Y+]3U9%FU
MA;]<\8_JC5\>"R06 8X#*3!$(@D@YJD/:4@X]+!ZP7R9))(8IZ4.&']NWZ-&
M]&ISL=#RFYO*0] _[7*,C.E4>R&-^!>@4J""MU)A6&"V$^S-O9>1YV BIV:D
MN;#R>,Y LL<1&O+4R?RC,U3NNDWG/&;@ 5];EGR=W^1K)@2O*I0W[6@?ZYRG
M72^T!:8DQ,K]@9QY,<0IB6$:<PQ]D@9!ZDN>QNEB)6Z5X-SPO,]. J,UE]9K
MKBO'>$NNDO0"K(3M 9\E](:G?2/ .='1W[:YP3H'/[3"5]%9/X*V 7:C0*=O
MH\,3P&'0.3T.M!1AVK/!8?CL'10.?,S@ G*;^\U2\\ G4?Y"LI7>RM<#OA5%
M=KO2?[C._]\-66;R20U\18J[]\OU-]T&4A1-;8X@00GV,(5)C#'$2'"84)+"
MQ*=(!DE,U ^6]>7.%FIN1K760!1 N?1:6J#%!;6\PZO.G3]S9J0Y]7R,S*0=
M=8 ^_M4*@1^T2C_6P:Y[,W19UC%$57A%N08WRLG5\19C%+9SAK3CNG?GRS5U
M63QG2!ZHFN?NV<-XN_H<?,P(S9;'^XX+ZC$2Q3#QJ-"A9Q&D?B)@HMN1$Y3*
MU+,J^VDPYMQ8M[:+KC9YM5X[LMMQK0G:9E3J&,.1F;*&KR/N^/UN+0!R27 F
MPT[*7Q8XO*0GFUN')DV1^W5>Z@A:G8SUH2@V1&G5N-X+CCS&8Q[ )*$!Q#[F
M,$5) +TD1(Q)G/C$*N:U?[BY<4Y'6L"5N"!KY 6B%M@VS:D7:S/:<8?@R(S3
M!4]+"EI1V]TXE^E&)IBX323J'7'B%"$3[?>3?XSN&AC!FDDIU(>:B3>B_";$
MJBE$^LLFXWJ4#ZMWZ@)6OA%RG>N-OTNIUO/7]4/&(B]J/!J/QFD2^2F,$9(0
MXR"!-"(^#%(1",I))'TK[G$AU-P8:J<3H+52H*VZVZJE.SS7BJE+M&;5%CG1
MNH%*.:"T&^BY.IEG,]Z;>O;&/DJ:;.+LPVX=(NTT'M>%7-,&ZCI$<B^"U^6S
MSSM2^;J^9/_89+EXLRFRE="[8[_DRHU>!+'D?LRHFE%15>,(81(G%(J \U B
MZ7$[!C\UX-S8N9*R3I35.5.TD7;8Z<E1E.V.2UQ@-]7Y2+D&C;!@)^T%J.1U
M?QIR"IDQCC^.CODJYQVG$#AVP''ROC-VQG1\4B[NE%&:/8KZ:+C:HLM69)G]
M=Q5D<"UO])_7*\5RG]:KYA\WZZ+,19DU1<_4&_8[66ZJ&SZ)\EI^)=\7 I,T
M3I$'?>XCB&.:PC3T!>28)Q$B1'FXVT/>KY;;:V,*/N!L^.L$?'>UR4N2+>U3
M0,>?:8L]O5>?N"EW!)\IVX;,U"<H%Z!-E6\B,)HL^2^B+)=U\*LV2#N3WCU_
MN6@M5?+=\9;B%//C?$-R5*&GW\Z<8@X.;H9.,O! <W@[:B7I_H!-N]J%0#P5
M/@ZA2$D$L1<32#D7$"'$/1QP$B*KTI>F \_-/'YW_[!</PG1\HNM86R*MZ&!
M/ **8QO*M<@5#==T_ESJBK GZH=M"Y]3:]IT[&FM:DM$]JQKV_OM0^Q_40LO
MSUAQM2E*Q:3Y-@PH3** Z# @%A&(HYA!&N, 1H+%7B(C*6-A&D9_9(RYD5$K
M)MC*.:#3T3$\^QG($4HCD\VH )E'KSL :J((]2& 686?GX"B)\3\V)V3A9&?
M$+T;*G[J4GO6JRH>?!95U,_5'<EW070A03R220P1IA1BC'2)IPC!B.M\6"_E
M@AA5_^P=96[,5PD*\UI2P&I1!ZSMX[">IC\G8(U,@#5.C9#@:@2<S%G0"5X3
M\>! W*RH\"0>/61X_-[)Z/"D^%U"/'VQ'26R*J9.^4F_?7F[B*AD-)0^##W=
MS%<0I!@PD1#'/"(D]M*8&UE^W8?.C?!^6V7Z3:R2C@I],'-YK[\PY *\72^7
M)#?T0Y_AUD]Q0]$8F=&& V&\. ]IOG/]BM;W*P3[Z7;]^'-[>>W[M?]ZZ?<]
M>^@DB_20&NV://BW85M(G0TM-72=8OVK*._6O,X7J4Y;JNVJM]ECQL6*%]?Y
MV_]#W;LU-XYCV<)_!0\3,5D10AV0!$E@SI/+F=63)[(R<]*NZIBO'A2X.MDM
M2QY1<J7GUW\ +Q)MZP)0(,WNB.JT+9+8>T%<N.V]=E'N=6#G2BK*DTC!7)M5
M&Z:Q@I0R AGEN<+:_!/%/8XT+K=LHF<6C2Q#L03;I6SM-2^%8NMEL;RK7@NF
M=;$H[$M29;_9/\G62[\]JP =[+:;-5)_C<-3SXXEZL2.IMMJET#'IUF5"&)Z
M:.>7>0/!,\_";7J%0SGD=E@ JT;=* N'XLLMM(!/[D?H;4;)EZ5Y:EL<X8NN
M-?>B>1PGG/ L@4K3"&)!A-UQ2V%NEIMIA!+!E5> S.GFIC8/ZV9KK9:@8W(U
M%ZF,]J/7,W"[46<X$(?>D;L$/V^N<X,E)(^=:7%4CG+S_B7_.-XULC[<:^D>
M>[YP^YTUTC[EYU7%CDK^715WW\V_5X]JS>[4W\RC-^_-/.A75JSM\>FS G,I
MU6E&#86I-+8SSXA!'C$*4XH1,I/2W+#=*"IRP_@W-?:TTF*U%^#KS>^UX)B9
M_;0N@<8G4#D%K%? N@4JO]Y&FVZ@+YX;K4_,Z@F-(P%T[EZ+VS4'TAL#$VAP
MJN3P:J3<OZ<!14HG_DV8A&[>0"[^:ZCK#=N_P33X!C:SWVQD]\B/RX?MIORD
M'M4B:<XU-%4ZBQ&'6636.CA*.2296>9$5$4)RY7=6_:9&9QH:VJC=&4;2'KF
M5YT"U6W4"P35P"/0GO!MW3IKZ PX(^?-_PZ8A.3B4\V-RHL.?K_D*)=;>M0%
M4,MBM?Z\VJCR_5;%*(Z;[S2/.=4ZS2'&C$&L[>D3XCE$".=$L9@1Y1QW=*R1
MJ3%$;2>X I6IP-@*K+$]#I:/PGK^_#T$6$//4H?'R:,"0 "\QE+_[XN;G_C_
M&4!."?\?NW4\T?\SQC\3_#]WK3\=5H7MS!+GKV+SO8URJK:(VDJ<[U7][SQB
M:9['40X%M8=[B4@AP22"FF4X3UG"H]Q9WMBYU:D1YO5W.T&V)W:B<0&P:D,-
M0//'INCM.]E8[R&[Z]X/YPEU$'0'9MC69F"-WD4MSNJ=Y$Y!X7?OA\36G80'
MP7@D5@Z(M1=/>V-V@KC=GS4:DWN[UZ5V_YO#Y[5>/;)B8<4)S:K\ABW4C1+;
M=:7]="7_L:U/+'=)C1'*,5=20LDUL@HI&61<2*ADBHG(TU1JK^)_H0R;VHAA
M(P*J>H"KI1DAVH-?4.Y<V(5U;-@/^\^_H1GXMW?HY^BG*K?FW][%/Z>.9!>\
MD]W6^6_1=0,/1PX)JC>='MQY"?5J#4OCI_G;SK_1TU'[@#Y6UJF7;9-)+NV#
MJ$\.::_G]QL!K(SHU5+:?^QF[J-I;;EIH\#C'+,XP1P*C RKISR"'&,&.<LS
M(=)4">ZEP7RJL:DQ=:77VV^O]"2F;B0:"JFAY^D6I"KUWO[0L72 O5(72$+2
MULGV1J4B%\]?THO3/1?7K_BF[,F/V!AV6M[-52)SAA2#BBAJ<S43R.)**CA/
MI, VGC_I7:CB65-.K\"H%2FJ%^"A,;=W48KG>+I1Q448O4&9B6=&#E))XB ,
M Y6,>-[66]6&..CQB2(0AZ_ON8;<U6NV"]+RUZUYJOJM6!;WV_NVR?=;-==I
MQ%DJ.60TEQ"CC$(>IQ3F(L,YU;'&Q"FCT;/=J<TK;E<;MO!<P#DB[+@^"X_;
MT,NO?8WWRN09J(T&C=5@QR_&[H!K*C^@@BZ9')L>=T7DA\>K!8_G[3V#/U9K
M5=PMKYM,J-LU6Y9,V!U4&P%;2U#:O0PL&$DCE4$D,K.TD3B&))(*IK'*!%$Z
MIV[9A9[M3HV-&K-!:S?H&%YI:'E&B3BB[\94 V Z,%.=A7/6"N@&W?WQ!"IH
M2(ECT^.&E_CA\2K4Q//VGLKDN[(N5Z4MXF*8<1](UVP69!&)4I[D4!(1F145
M)Y Q'D'""8YTFJ211%["X^?;G!I#[4T&K 2-T9WPWKYZX0[HN[%48$P'9JC+
MX?17\78'**A(MT.SXVIPN^/P2F+;X]:>*C1E(['9*.!5JEZ?C6-UF:,Y%YQ*
MBC*8*&R8B,H,$DWL45\:BTPG/-+:2X_F='M38R$G);0#'M6N[OWRU&8YTRFG
M"6H J <FI]K:PVJO=<[&(#!ZBMV$@W,LV9O[U799'2JS!N"U$JN[9540IUC6
M]=@K\C>7&-?84A1L =HLP5FU;2>;/N%-GSQT%!]7U?GHPW/%QX>ZT\3"-%KH
MHAYPEN>[T%]MQZU#SNGNG'G*N H\;BZ]TN)QO.T221 S\=W7_FI3HN8JIS'6
M20K-_PN(JVV^/(^AU$@DE&D:":_E](FVIC8T=(J[=PO9G<\6\P;9;3X:"+J!
MJ;XW:CV5,4[B$5[RXG!S;Z!E<=+OPR(5IV_IN]A=%X]FF'LT3^<+-6<B8EG,
M-4QR:2:1 B%(&+("KY',A3!3R@S[+6R?/7]J'+$W#_Q9&>B]6GT.G^O*M#<H
M@Z]"G?'HL=P\Z'78I>7S)D9>1A[T[_62\?!E?=]?K<P<0AINJ"<:^]W\55E>
ML_7Z2=?)FV:^L;G9\G\HL;E=??CQ4*SK:7621BKEE,$X(@1BA# D4BF8<1JQ
M5&-%E=?QW\4638TC]J=<58"HZ'HP,Q/G#2AK)VPQ(K5SPY=(+NU'5^H9L7<&
M)ZO:EVJRTBY1.V>2MK>NG_>6\0G<['OKP_G>ZD%S@1 .2XR7&C4RE0;"\#7Y
MAGKP!7']SX(\KLWBO)QG..89CA!4-)%FF9:GD*(H@3DF*LXD5HHY[>*=:6=R
MU%KM3S1ZTCV"YP\@F:",F"DL@@EF5DA $\@UB2#+,)4I4CS%:OZHUGPU(I;=
M]H9&<]VU-"RV;D-, +P&'CAJH)Z9""H; \?]'P<A>!C_@:;&C\H_[N_!(/L3
ME_=CU\];>^#R17]3#ZOUQLZN;]1=%;\RIXG*6*8I3&(L#"U@"DDJ,522*4)S
M'DGD%3%_O*FI<6QMJ=U!7N]L!65CK!\OG,#7C1K"H#8P.^P!VYL);LX!YLT0
MY[$(21(G6AN5)\Y[_9(J'.[P8PNIBOF'Y:;8/'U3=U;(E2TWG\WW89YK$6>6
M&5!NU0F1() 2,XF(,C.!2&**DB1SX8AC#4R-&6H;P=Y(8*UTHX2C()XF@A#0
M#/SZ>Z+B_-Z?<_V$Y+VYM7[3S0\O7_"CCQWEM3[G5/LRG[VNI[YIS00U-9A)
M1%/@_)NR9A<+&XVQ4?>?BJ6R_Y;SE$<XXN8-CW@<0TRT66;9L"TNA4AT;I9@
MS&L6X-G^U B@,1_L[)^!Q@/0<0%4MH,_K1OUS[YBH)Z]Y#:7&!#[@1G& W8W
MU/WE+?MA%U1^TM.$<>4A^^'S2KZQYV/\(\4^+J7ZH>1OV\V6+7[=+F6;U8IR
MC#3+5%.B)\(2,BN<)F*.=,:I4LQ)<?E4(U.CM<9.4!L**DM[:( =Q?0T/X5"
M:F 2&AHD]]BM$&"-%+#5#S2OP*ES:)R(ECIZZV@A4N>,[\9%G;WV@AWV>F]_
MITRYCYJ8\UP(K70&*9488DHHI(I1R-($*4FH3(63/)I;<U-CQNO5_?U*VN6-
M8(L%6#V<+G;3!V"//>(@L(VR5=P>+G94Q_?6!MXT/HM*\+WCXRV.OX5\UON#
M.\GG[^I')K=6RVN[?KK9K,0_VX&-ZEQ+1&!$["Y1+!!D-D**IRC3*E6)3B(?
M!CG0QM1HHS415#;V3.PYA*4;65R(T, ,X0N.-RN<<#\D%1QJ9M3W_X2?+U_Z
M4Y?Z+Y[^6[%UC!+:?"E%IN,XT@)&>4PA1C(U[W9,H,I(%*%$:86=<OM>/WIJ
M[[6U#ECS>DS\7X!V?DW4'XJ!7^" *+@O>OJC,=)2QP,5K_7-8<=/K&I>W##:
M6N:PH=T5S)$K_ GHO>*;_U;+]VJYNB^J;,+F^T0E2606Q3#)DLCNWB#($<:0
M)41$L4J(EL(MF.54,S[?OG$B6:REP)@*.K;V>#N/XGJ>K4)@-3!O#0V2.YF%
M &NLE+LE6/%%<5=7KS)/WBZJ8-&J8BQ?K=>KO^RO]ZNE>OHY#..=0^<$]QV]
M=306/&=\EP_/7MOSD,].\CZ6Y5;)]U6HT%>U+E:R*GQ4?KA_6*R>E*HN^FJ^
M)=]9J:KTNKE.28*YM#6$<@4QI@322)C)'.:))@0A&DNOP[Y^=DQMTM<:5Y6M
M+BOC/8_S>O:'X['>\"@/?;Q7K0-K%T#M ZB=F-7U\<H9:!UI%HVM*W5"=<!S
MOLO #'K>U].4<<_]+L/KU?G?A8_K439)?%=RNU!?]$<SE"[O"KY0]>;8+T^_
ML7^LUM<VZ[O.52.9TAQ%".I$<HA%%D.B50IQ)G*=)3A#;N%.GNU.C0];TRT=
M[HUOMGQM3<O*?E YX)<DZ-LAYV>E \$\-"%.!F&/ZDW#(#U60:>0B/L5>?+'
M[53=)X^GC5<*RM_%9]6A>MS>;^)\)<R7;;NP$_%3HO:[,A*"<JR$4E!1F4.L
M,+8;GQBJ/%=)3E&L_";,GNU/;6#HF-\(J8AGA29L-JC?S-FW0WC*61QK.R0K
M K%$%'*6,"@3R@DG.<O39/Y0SRDV;+UY\VYY:<MPG?,+,[\*964;[XKE\I1B
M=9"NH)GB">$2,F1K3Z;8K",C)" CA&!&4LQIU'3%AZ6CB/K@'=%:,D(WJ*4<
MO _<%I #HCKP/*E+. Z5;3[7]8B""I;V!"_D0M'7A%$7B#WQ>;DP[/L8_P7A
M+\5JL;HK1-E6*VOC\U+%(YUE"F8Y3B F-(9<,P8ICB3*6*RIHJZKOV.-3&U$
MW]FYJZ;7)^3Q**3GUV\A@!J8A ;&R'T%%@*KD99;O3#S6E:= ^/$&NKHK:,M
MF,X9WUT=G;VVWU+H]^5>6=$0:B/#5[95&\MO[4'0K\;R6E]Z4V_6F:N_-GJ+
MY9R@#$4R1Y#A.#.DB:R:GDC,+!")3)BY>LJ<MLS"FC4UFMU5)I5;9556&I5#
M\&1#"EKQ2K^I8J#^<YM!CM\K W-ZUZ%*+*=UJ5-%]MOSH]#&K>;@HKIIYUFX
MZ698I$/.0@-9-NKD-"R:+^>L@9\>I(I(6XZWVC\[%(VN,151(B24U%83R2F&
ME)I?D619CD2>X3B^H)K(N?:GQLQM&0S1EL%HRZ-[;F3Y=H,;[PX([L $^ZJ\
M2&O[KEKWP)D#/:$;L.#(61/>LO"(*SYG"I X/Z8?V7U3K4:WJ!8P7[:;+]IA
MZZ Z.[A5/S:_& C^.2><)B@3 E+"$RL!'4&",8$DB@F2.$KRV"OE*8Q94Z/&
MEUZ!U;;:7CNW*??)^Q0@4+>Z<>KXG34PU?;MIV;SM#[L!-8S4+D6,%$C+-8A
MN3F09:-2=E@T7S)YX*?[*Q!=%YNG*S-SOEY)-6<ITCR*!90D41!SA*#Y]C.(
M8LQUPHD4PDF7Y.6#IT:RUC9@C0/6.G>EH6=@G2:^2R 8F+H<O?=2%#KDZ@5*
M0L\>-YJ"T"$GNLI!!S_O'1.QMOGFJ[59E:JR>LUOO[/E3F%?E<W:=4X3H363
M""K$,XBQ4I#H/(5<8TY2'<<B9Y[A$(Y-3^VUK2PWX^K&VMC$0FR,Y:"H3/<^
M]77M ><#WP%P'?ZLUQI=5?"I3&PF+16L^QH<-E;X.E1=GOZ !3[?=6U][*-=
M3U0.G.KZ/J%/KMBC6JP>JE.MI5P4PLY.EG?UFSC/,QKIZAB7ZPABK22D>:9A
MENL$68TSGF3SI;JS4YQ;M\/=DPTZO5&T?J->-3O<V]6QN:J#M;/:B['.PTWC
M2%1"(DQS!+'*(\@12:'!&BE&5"*04^V$,#B/6C=E'(#/'ZD'@VU@PA\+,9^L
MO4#(C73*?OM= ;:KF&=8O2RD6K>)?+OS+5EGW!CR!744'-@NS76  ;EW>-;!
MW_9&N7UX6#P!=K=6=9$\\Y]:5U7X-BOP5['Y;NX7S9%TL+Q !_Q/)@>>NG_$
M#$$'-YZG";K<T&]Z_VFUO#,#S+U-1?R-667Q36&/IAZ:.O9?]%?S[1#% UM\
M7-K\[5L#L)IC+5/$:0:U( SB-+8J>4I JI!(29S05'OI@O8S8VHD'Z,X]IO;
M]X3?;9X_/*@##P'6 6@Z[AY8%V9@[X05 &W=L.2V<\16 :V4&"I?PBT!+L,R
MY'*@IR6C+@TN0^OE,N'"I_7>][ CI^'9&\NZML#-[P_2S,=-MV0H;M5"XR3+
MB8HAI3JVRX<(,LD4S!!A>9236"9>9>V=6IT:[>V-!CNK06TVL'9#%/>4P'+K
M!.==C[#0#K_A<3FJ?;8ZW%$*O,OAT/#8&QSN6!S8V_"XN:?0@\V+_H652MJ#
M%S,KK.;V5^NU^1Y5L_)?GO:7?*W9\LK6ZOI2ZUA^V6Y*:YQ56EXM[#Z,_7">
MY3+)"<)0*ZTA3I29W"5FKH=R&LDTE23+O/9QAS%S:BQ8"Q,T)H,KL2D>[?'%
MG]9DT-CLJP,_3/^Z\>7;]]K !%M9#[DU'W1=!!T?;>IO][K&3U Y.FM[V_RP
M=]:UQ_VU*0;MD*#2%<-8.JZRQ:!HOQ*^&+8U_UWSZ]7Z8;4VP]754GY8%)4\
MD6VHF7(QC'.SV,VAM"']6*$<TBQ7,$D)SM*48B:)ZS[NZ::F1O,[:ZMML*Z]
M/;)^SJ!\?C,W''9#'^6/")O[CFXX^$;:TMW#^%TQ^3];MC;?>5!4]69L866V
MJ,81>_2\VM6LJR OEM7;41=2L>6$2B9J_-^IG^]^?O[YPWIE0]5_^GE?7Z6)
M'=/5/O%FM6&+(Q7R_KW9<R[KSZL"'F:$O*\$:&L1K>;QAHPJ38 98(U<N/E#
M>[,]YS4WKY^:X_.RN%M6P4?&/.NO?4ZQ-%?=UY;).HA4F5'9N&Z-M!O>JT4A
M*SCJQP;:B';[VIS8B3[S@-&VHMT<Z>Y%.][A/^!\M9O:JZ75<ZK%/3XN;[^K
M78SP?Q9J;9[W_:EYQR.2<:U0 E,FJ=V %I!AJF%JEBLTRFB"I7(=@/R:GMJ
MU%A?*:&U@C4?E\ >_G1BZ'=.]*!;SZXY/VH-!_C H]CDL'8?ZH;#?*2A+SCV
M7I3?#[X30X#G T<;$OHYVATB>CXA3,J'S:5SB$I^EFZWTTLQ PA*DUR;WJ*I
M'5022&@F($UI'D<XU2E//(*!AK!QHO%#5\VL;;USU<RYJKS8JR_7'R]+][BH
M2]WVND;OH3=*_:A[Q"GQ8_8BHWD8^9PA@!\R#^0B^]XT&R0$LN=R0H*TT6\<
M>*^T,D^UJ=/UH//EH0IU6M[9?+-KMEX_Z7I3K+S9U,N73^;;N9CKF/(<90@F
M,3&<3Q&##,4("I1Q)6@BS$OF<]C1UY"I+2MV9E=+=""ZAL] N6FW<NP[OO C
M^-Y]Y4;F8_3 P,3=NE#)2+2UU/8]8OT U\][Y&;7(Y].]H@W15\*9T@Z[FW+
MJ-1[*6(O:?;BY_6CU&M6?C>/LO]\^)]M\<@6=GOOZVI1B*=]5BWB*%:**)A3
M,UW&BBO(9$8@UE;X)TLX%MB'/YU:G1I96FNK=Z_ZH6.W'S&Z(>[&@L%Q'/J
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M;?TTE-IX6<6$5WXZJ/KOW .U:V;JJ=:B,-<'%<X;OBL"B^X-:/#8@GW#8W]
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MD"JI!)6(LMB+2GO8,#42;5VPR\7GVD+[X@2>:\8^/>-X,C(LWD.??1R%NG'
M'GQ8%^P%E5)UG8(S#'E>@&70(XP>9HQ[2-$?IU?'$!<\RC][Y_-JH\JO[*FJ
MU[N450C1>\4W-5-OYDQQE<<ZA2DG$N(TBB%16D+$:!P)8E:IRNDXP:&MJ9%>
M92YXJ.VMYBZK*L!*U.8":4QWSU8Y!_1I;@L,W\ <5B/WM8-<'9IFK9TU<\.
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MAV1@]O9 PYM+#SL=DN9>M# J QWV[B4Y'+FJWWO[395F\2V^-\$/6-.4,Y[
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M=RH,Y=7JU,;NO=%@9S6HS0;6;HAH3Y$FMTYP6T($AW;@ 38(JMZK#2^40BY
MW!H>=4WBA<7+98K?S?TXZNO:)F9NGBPM;JZ6T@JO/K0%2AN!XS22.,><V>0)
M#C'#!%)I>B!*2"9Y1JA*O;*I'-J<&C^U)L^J:<BF.H?:F=W(&O<3HG;I #=V
M"@SKP-P4!%%O;O+ *"0SN30[*B]YX/"2E7QN[:NYS#<?E^5F7:U$?C7?GZM[
M2X3S).(TS6@,-;+'0"B)(65I!DFLXHPBA)CT2KX_UM#4V,?:"8J=H3.@S76
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M*76"!<$I)E!$5K=8Q1(R&2&8,QP3)9$D?B7O+K0W-[+HS07/[ 76X(%: )<
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M]<3(#-?Z =J*G3M/NN*==Z#OI-X;L.?.?K'E@$+.(9 -JM5\E4'3RC&'P.Y
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M")'>F;UD[KEM?YN7;:+4N;_32^>5JC>+CCZ3"7A;^R9+-)Q%-^SG,<[#(/\
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MKO0Z0ZTS]F\=2QI_0.>0IZ33%1WF-J^?J!M&#IY\>@#\U'GS<W<$ (QR[C$
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MHBR*($L3$QOE*$D3K+%._+:575J=VY?>VPEVAGKN*SMA[;C''!K!L2.H0_#
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MI7M,)ZR:_A3/^M/$L*O'5EV@.OP,[9K&0]F4#63FHVSN797-(W7S,;8?9B$
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M9YJ+]TO-5/F:+JH4P?,H1%0$8:JM(Z3W<TQDD/&$0JG""&N#208XZI'+WEH
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MBL,$LHPP&# :QCR(F41.-Q=7@#I*Z9,=I+Q/#I;7Z%GNROICXGOGM(.C$FW
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M@+">YRR2QEDV"B!1YL0C"(- DC1CV&G?<0,=IL8O1RXQQ59RD_)P*SI8Y.K
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MT%$ 7-]VW$/WW^J]W_KE3HC"[ _UCY^*;ZN_EG--;HDD!$%,6 :1C%-(@CB
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M+!:KO[3U*^><,JK-?P0YPUROSC&'+$L"F$9<)5&D_U$&/2YT+;J>Z'WN3E!
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M_?NRD'11Q7LLGV6=7?M7FB^-']$V^B(C8423% H6(CV;(P%ID"HH,I(0*J)
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MZR3+ I5A$KB5;S_5R]36AT;(.L6=8TSS213MS-^KL?',XP>PM.JH#QC>W(7
MH"'.)SL:-\RY2]>C4.?.A_L6+2^E?NGQ;BG>R&>Y6#V9Q:@I9UJ[T\U5QF.,
MJ( ":0Y 49Q!%J8(9@1+B5"D$'*J(V+1Y]3(8"MRY<O2$MJUGOAEL.U88F (
M/7/&.?2V97/'\:=UP&S8FM^7NQVYL+<U#L?5N^U?==_,?J,_[C?K4G\D_[EB
MY1U?KY3&-*N\B)X6<BWW=?1:%_8[)OQ<K)[S4EO1=+%S/&I$FX<)"U"0(1B&
M$=,63$8@$PQ#R1".,X&%2*R];_V).376:XE:117Q1UH\Z-EJ7%L,!-5\-B
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MB"131)5D 0R12B$*6 II%D10):9$89R$F#D%(%OW/#6*:PD.3H4#U'$ VZB
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M^#GNC> F-+O4HI=FO9);@=T6+<LAL%MJ!D1TG 7BURK._<,VSOU-7CZMFB5
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MA(8I3Q#$(0X,/>J?(D5@&F<!$TDF16;M"'VFCZEQXTY,4,OI[-W2A>=E2AP
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MFIZ/4;4[;9K"6(VQ7WIE5_]4:_ES<Q9UVJZF2B_QYCAK0<LR5SEOW%5VVLX
MJ_0U<6,#UP#T."2#5P_T(>OX=0<](GZR8J'/_OHM,-\*2?6"]?)!KU7;2A$Q
MU2N!DC",%88H33"D(HRA#%4:$94&"#NE,CON8FH6M]XA&9<8L)44&%%=X^4[
M$+6CY>MP\DRH!]!X2%)V7ODAJ>M$+Z.2SGDM7]-%QY-7NA2\RY=YJ>W97U<K
M85([?U)?9"D+D_DW([%,PTR;@IE)+))28KP+]/3/B&0$"\I3IT!8BSXG1P6-
MI.#!B-K3UZ #8D>W@V& &\\#80=?)7"5NMULF[=">W!#N(R0%X^$CFYOXYQP
M&8>S?@H6KP[EU%E>MG&J6.C=_OG#KFHP#9. L#B&BO$JPVI@BB\+R'"<D "I
M6#!YG;]G?^&FQF*G]C9U]%:],3I4\-5CUQ1['G"\[9CR5J/HF5*O&L#7V02\
M5:@>'GJ_SJE7R'=CO]7KD;WLTCI '[?)C7L8J?!KH7?4_Q]W[]H<-XZE#?X5
M1.S&NZX(H8<$P MF/LFW&KWALKVVJSMZZT,&KC+?3F5JDDR5/;]^ 5XR4WD%
MF"#%FHB9:EDBB7,>D \.#LYEIAA/-8LSB!BS]7#SW!BU*H7:F+84)WF*B1RS
M%.X1&:>V:+1)>^,6MSTV=V[,_\(S,O1)5,#2M8>I<;6V$\A\NSP5D\AA.R/F
M7R,;[3+.H4O/GAOJVG)>[[16HMIX4+^Q'S:6X8NR*-8%((P SU>J69)0G692
M0$:(#37@$M*($6A#!"66.<'*;SFX0IBI\?[N^?9&&[!3':^.*'JN4=\B8#VF
MSG$U&&E"AJ;]'G,Q4OFP_K@.4U*LASPO5&:L/W*G2X]=\<Q^]&N=1)6R7;/D
MW:(R[VQA'EZGO77]M+2:Q1+EB5(*)CJ3D* TA53&$@J>Y)%6<8:T5TZNRZ!3
MH],C#?MT_3WK6AEH^_?5A<Q:=9HT74]7L]-LN#%G:(P'9LA&7%C+"[8"-^FW
M-]NN?3I@KJT/1"')SFG<44G-!XE]\O*ZMZ?#>1. ]4GOVJU?U-Q^D74WTP.S
M=:<(*<UM"QV"8*IM>FT:8V,PYK:Z@([2.*>29=RM;4$@B7P^O''Z&]0UO.'K
M@XVIIZ?XRHER= Z/!_Z([H#--G_'$S!,Z;5 ^ 5UZEXITKA^W##X';AN SW6
M/TOOFUH]?%BRQ=NU0A$B;47X-%4H141#9G?8Q#9MII@(F))(8<81P]RI).W)
M$:9FXEDA@942&#&!E=.SR/YI+,\36Q"$AHX4&@X<]]2QJT$:*?_K&%A!6XV<
M!>), M;Q^T;+HCHK]FXJU/D+>X<MJ-5*R39Q:K/#?O?#4JUJ#\1F*:6,IUD.
MLSBS/D6;89PS#G66*($%(0H+SX $AV&GQH5U^>-%_9DPSP*/CC@[!P($1F_X
M(_Y:X$TJYXZ7KQ4:O&K%_B7HJ;T'3H'/XUU&'ONDW0.-(V?H/G>'"J*Z%69M
M6M>VWJFH\H^J^M4086FCRU6Y31!A*-*(4 894V:#R[+4&&U:P)SS*$EBS9)(
M>51%&$)&IT]T_*H(-I*1V=)NJX+-@3&_2_#JWHA_^M,<?C:=F7'<R7G)4GP[
MJ@&'Y'JKX^8?0R3V# '^L$%25\CWPD%2UR-[.4@JP!C]E@&[J_^DO[*Y*O=+
MV<52YR*3&<Q)B@VI,PKS-%%02R&S6+$HTUZ'VZ>'FIKQ^?5[\?AHTZ]M9.1_
MFO_,[3]J!X@?+9]!UXUDPV V,&5:(>U)5!WH76/V5:V>"J&&+1EX&9N0C'9F
MM%'YZ;+6^VSC<,>UH3-?U)-:K%7YWHC[[D>]<YN_69>5H:V5C?_\L%S<UR<T
M337;US]_5<O[%7O\7@AFP%)L+P1TEF&5ZHQ$,)?2< _.&*215%"06$HB.%6T
M9^^\T*).CKMV0CWJ.:\_2&MF?EXM']6J^MD4%J[JW]MRW8]M_O%/L*LJJ'7M
M&Y 3_(5PH\MI3//0AS8[,]RJ"2Q/@$Y/L%&TGF.K:GNPW163/CK7(P7\##4S
MPX0#!9?VA8*%AD+]="C18"->YWT]$7?ZCZ+Z?K>0Q5,AUVQ^>,SU^N<W,Z[M
MS7CD,3^*<J9R@I @$F;F?\R*11#,J8PA4PF3*8ZH9E[I[0/+.[5ERTK;M#)M
MW9?/HM/_L"+[9XT-.N%^_N,)3./ RU+3^:,-X=A1T2PW6PVW_7YOP%53WMM!
M/?!$#.'9'DKD%W&)#XS_*5_ZT,-.K8?=^^5*JZ*R,7%-KL0,YYF*A3!O&;=!
M:%$602.335U@E#&4BC3%T^A2=R#[U!:K\=J/;:#8IEE-I=O=X1NF";<9D A*
MC8T)%,O<Z,Y2*.(D23&+4$9]:F-/]45[D=+9C9S3G7O'_?G$IO(ODW0Y %U,
MJ!'AR<F;1)IF#_'_&NF;_>=EO':!IT7H:7$5]XNZ_N*B:JI4WRU^7VSK;GYC
M/]I3N?*N_*)8N5PP/O_Y>5F6=5K!@RW(^DDWMYAANS.\6<PR$B41AS(U_R$Q
M2\S.7VM(J48BUJF.8S_K:A@YIV9);;.:C'&]%C4K&NHR+P&8%XP7<\MZMM_+
M>D=Y4+$?@+?J>RZ) TV_X_+W\I,Z]%*WU;!M%F"G<U?).A"M4Q,4ML=/IRCH
M-+T!C:[6.[#5MKLKX(HV['P$7;T&$G7<E6I8O ]6I8&'Z[<"?535&U9^_[Q:
M/A7VH3]_+^WJ]KY8L(6HJWY7Q5-1%;9P8D851C*%*5$$$H1BR*,\AT3$6* ,
MBRPG/M6TW8?V6B=&J(]MSR^%$=TFO];&K>YDMM%SK=!^2X''/+BQ^S#H#DS8
M%E@K->C$MAN15[\W*/\"-L*#V\LP>_.O/V(A*=5C]%%9TA^5?>+K\03_I"T[
MPE=557-CT7_]O;;FR[8P<19GB8A2"E5J:RH2SB'7.H,XBV5&!4]TXG06=GZ8
MJ=FR5E)8-J("(RM@M;">]9XO0'N>BL(!-G3(V!A8N>=UA<%LI.2NWMAY97A=
MAN1,FM>9FT?+];JLP&["E\/5UP;)?57W]NWXHAZ7J\JP\-W";&P?ZI?E]<_V
MCW7(PXS*/(_B1$",A8 DI2FT5;)AQ!3*.8L(54F_Z#=G&:9&KL_"VAHYP48+
ML*-&'=S47=%$-'D&#O29,=_PM$'F8<2XLW!3<$4DF3>(PX2(N8OQ0K%?WCB=
M#NKR?Y2_85G'@]T]/+)B91]GMNZK>U5^6S&I'MCJ7[,(1UPH$D,IL=D58Z0-
M.RILML8RRA05*(F<JD$YC#4U%JS%!<5&7B :@6]L,]U&9'?+Z1+.ETW-@.@-
MS%T-<%M1P9L.N&_A@7.W.P,".)+QN77,_KFR!;/D\L^%_=?F_=MK8F8]^463
M'%<:V>K#H+^%L5 =P3MCIEYZPFBVJJ,JNP:KZRW7]6^JRS+=BO]:%RLE;Y_4
MBMTKFT_R6:WJ [U9)'B>QA+!-).VJU-DR!@91L8IXAIEF>38*TG,=>"I,7,M
M5 D>S?.^UP?XZX5!&Y3VU^:3Z'X/'E<VR/GA!K!&)R!L\M1C=VF_GE 79\G-
M/!T"^X%Y?=,_JI89=$+?@%;L.FG/1D(TP17A&TNY8C5$NZF+8[]($RI71$ZU
MIG*^OQ^S-1$'OZGJ^U+:5C5-W[M/?RX,27PO'LTHPJZB]VHF$988$PRC-+=5
M^R(";3D#&,<)S3/!4Y(1'VIS'GEJW+81T9875>;)IX]@KX3<C:<& 7)@HFH#
MN!JAP5;J&[!%=RMX.)[RQBHD4;D//BI3>6.R3U7^#^C9IMG8!<QNLS\8:E0?
MNH"8&<<X4T084TMP#DG",*19FD*5,(:R1.@,>_6L.C'.U'BH:9(\MS)NHH.\
MCWU/8>I&/0&0&IAH-A*"6L0;L!$R8%OA\R@$[0I\8JAQF_J>U_>@)^^%R_U=
M8E_4TW+^9)[XQMA$1?6>B?J)=76Z..L:["*NC,62PL1P@_6+Y3!7>08EXDFN
MJ=)I[I0S[SK@U.AA(S-HA :=U&T1Q#CK<;SHA/QE3UEH/ <FD2V4HH%2MP+?
M #DPEN[.L]"8CN1!.XEM#>UR 4K;;4$"R2H5R%/F@]09=YG38T;SF?DHM>LX
M\[K/GZJ-\5<?B1CY_VX,0S-.XQKZM/I]453E6YMJJ!9UX/L3F]N0]_;%3QGB
MA",!L404$J$P9)132 GA5&<Q(=3)J+M&B*E1^HX>\*E1!+2>MN4*U+J 3AFP
MHTT/<NH];Y?)?XS9&'A!^"M,A/O*,<:$C+2:##<Q7BO,M8B>675Z/WJTE>A:
MY7=7IZN?=764TM%4KL8I^_BX4J)I O6EN/]>E76<5!M-^G.O8A-+4LE%A"#A
M1$,B208IDC%,",Y2H0G)_.I8AQ=Q:JO=LP";YCQC1QW0Z--DA';AV*<W]6--
MLYO?Y&4G;^#%\4(7E9N3DWFSF<:1:F^%!G^@@*I04KY4O%5@E,^$8X4>J6\1
MV8>'HO:!V\)>ML2/6;?40A2JW#:5N>5E7?EG%G&F&&,Y3+!BD,0T@91KL^5A
M(L4B4R3%7I6RO$:?&N?O"%\7ZWLF/MC*#_[H-/",9O6;&S<V'PSQ@8DZ)-@]
MRM7V "UL!5L? 48N:ML#F\,ZMWT>TK>:(*^V50O>L-7JI\VKJH/C9K&0BE"-
MH*B+UR:$0IHGQ,R'IEDJ543]*BV=&VQJ?%87&ZUL^R%II+X!]V=;POMCZT90
MH1 ;F(^V8+VMP?KU+%@]2MY=1B%LO;HSXXU<;.ZRYH>5XASNZ1ES]/ X7_Y4
MJBV+?MQJ^[BL(PF4;)*/ZL/NW;_;&*B/R^J?JOJRB;!M2J*\7Z[:7]GKXIEF
MD<!:I9 ):@PL*6+(.9<PR9'.B+&OD$1>@4NCBC\U1ON'LM:SV=IU$9N/M=1U
M59+55F[/D*AQWP@WUISN/+_T!GZC=%>/JPXK-6J"G\HF076*WK1%M^J7XXO#
MR^$?S_4B<Q0T*&Q<#<:-+'N1V3D(3WL9*?JMC7<+80-_U5O5_._=PD;4+<Q7
M8"MO:(Q2%E$%8Q$I2!!%D!&;7B!QIJF(;5GM'B4ESP[J1$SC%X'L9+99-<56
M6K]UYSS:;LO$]>"-P^H;P%YUDOYBL;MSP,Z;EITP"<FBYP<<E?2<=-_G*+>;
M^E&*[9#U;/O_H5BHNTH]E#-)\SPBN8*IQIDQC:/<UC]&,!*),@S#99I'/J;Q
MZ:&F9L9:2?<<7G]884$MK:=3\0S";AP2!K?!M^?](/-FC\MHA*2.,Z.-RAN7
MM=XG#8<[0KCSMB]SPD7$119!I%,)"4X2:/Y)8"98)@EG*-9>='%BG*EQA15S
MI];P%41Q"EBL>)PKF4":YM9%:G]BB,%<I4F2)S1%23XS^VV^'!':W?$&9!6+
MY5(?!"F'![F/KW2*/-SK=;S26SHH Y\:Z@5]I!>Y]]+E@4RUUS\_LFJ]4I_T
M]M<_ZWX[F$F9"T(@Y<10!M4V_4EAF*8H1BEE6&"O4Q7WH:=&SWMVR4_0R-VK
M2Y+'!/2T[(+ .JZEYXKH]8;>17 &-?Q.C_ZRAN!%5"X:AI>?T+=ASW)5?5.K
MASJUR_K(9H:5$H0R!8E*S)82"0Y9@C&42.$T(XA*OPH8AT-,C7]J"9MSRR89
MT]:P\&U-<H"C&[U<A\[@YP@;8-KDRS?GD.G1@>.4\F$;91R,,G(_BU-:'K:=
M.'EEO\^[:47YGA6KO[/Y6FW#1F8TXSHA-(99F@EK?5#(B490YI1H\W]2^)7B
M/CF2U\<^0N7M)NF:U>("9K/5BA5XLC+[??&GH77[\(, -O#WW[77M5*"6LR=
MH+)P-' 1BI!L<'JP44GAHL[[W'#YAGX4\;Y8%)6J&]?>+2HS^W6O@'JPVP=;
M%/&_Z^.S=S_L29KZIV*K]^;:6<013S#)(:5);JP$HB&3(H,,4[.!H2S*9.QC
M)?038VJ6Q+;]"ULL;'M0MB,[4(WP-P!%B/BQ3<]9<J.BX;$?F*<:!=J>X%L5
M-NW!=[4 [[I9L(H JTDX)KL.R9 TUU.243GP.K3V"?+*IP7/%)C%J8XUSA@D
MF<T:LZ4$>9:GD%.,A4RBB,4T4%[ U'AP/S!=/#MT>O5Q62D0I[\$B_R_/LY_
M0FQV-JI_E/C](0CIW'!3B<T_12TNM_3TOW0U9#_I.LOI^W)N;BZ;@ER;+)8X
M0Q*A)($1(<1LUI((,BU3**1.91++%,=^J:<NHTZ-4S9";]))6['_GZZ;:-^4
M(K=)</3GA(9V:!=/"%3]'3\^* 7U!3D-/*Y[R >+ X^1U\T];1R;Q?%FO5I9
MG_-=6S'SBQG7$J%]?M<E2;(<,:)@KE-L8Y&,O<.(F0))J(HYBXE?@KSCN%/C
MJ5ILT,D-.L&!E1QTHGO6$?&="D=S*#S 0YM&8;#UMY7\D IJ-SD./:X-Y8?'
M@3WE>7O/:J.V];(- 5^I[V;+9S9[=W7A?GNX]MG^8KDPUEQ]U>>E84I5%:NF
MN7/3%_.S>?7*G9_OS).63ZII"?+CG=;*6 59S+&,,#$SEU!(DAQ!IM(,9BF2
M6J(\2C#W*ETZ@M!38\S/JV*Y F43W=]5D6.KHK3%?^1Z9?^G25*ZL:V2/>NC
MCO$6N/'MU.9V8+*N%0'/] 6O&HU_ 5;G&_#6J++8=D(&5JL;T+P/;;9'DYKT
MJHDN^^7&MEL.6/AUQ!D)6D5V#+G'+4D[XDP<U+<=<^R>-GB]6%;OE;F%S>U3
M&S=FUZ^=190BC2E,E-:VPUX.&;>]2U(>,:T3)*C7,G1AO*FM(*V<GL;T!4P=
MC>AP2 UM/#>2@E;4NG%]*RQXU8I[VB7K;S.[ 1/45KXPY+@VLIO^![:QXVW]
M>.2+*I6YZ;OAL[?J2<V7CY:EVB%FB4R8Y(I"H979P6L:PUQF&$J:,X(40B3Q
M.M0].]K4.*03MO:YRZVX?J1R'F W2@D&V\"$\@RQ'4D[5@G')4Z(A&22\P..
MRB-.NN^SB-M-_3BD-8EJJZ<UX%MR:KU/2B(IJ4B-]4&-,8+C&/(H3F&D$YR;
M?3&CQ"NR_=* 4V.25MYZ-]/3T7<18S<F"8G<P&3B!YHW@[@B$9)$+HXY*H^X
M(K!/)<[W7=L3R/H$;94BO5S5)1P^;-,6J<*QX )&*%:0V"9!'",.L5"Q2&4>
MY1GVRZYS&-7GVQ@GTVZG%4[M!M\5^XIT.Y<9<'1PA45U:/_4U7!>T6CH(D##
M-!TZ/>P+-2"ZB,/I9D27;_7O=F'#PBR(G27#&<6"YU#++(&$IA+2-,D@RSDF
M211G(M&N/2R>/WIJ-DL=#&G$RWMT.-@#[3Q77 ?%P)30H4"O1\&]>T-_-$;J
MR>"!BE>3A>.*GVF=L'?#: T1C@NZV^;@Q!4AVB26[]<V\^^W8E$\K!_:<F[E
MV[6Z6WPS6-61K.4LTC'!C&!H@^\AX8K /$X4%$@QJ?((4>+5W+6'#%.C-&2L
MQ6MZ*;H![VL9#0+G>)92+?X-:!0 K09=D4%[HK>N"WK5:M01]@$C5J\ <;@6
MCFYBO&![1R^<SK=^]'M4SPH*JBR5.M%R\O>%+$IA*]@J^>Z',)>V9923""58
M80X1B@@D"48VS%[!E&=49XK@S*W9V%523(T K1+_#HJ'Q[7-2)JWQ?;Z=+SN
M-RENU#@XU .38R/_#3C=J/8&[*H!&CU HTC 6@S7X!BT+$,O0<:MT' -5@?%
M&JYZF!]+2E7,OJV8M'VT?C[PY7P649Y&$@D88<(AT2J#7'(%M1!9&AFK3RFG
MDEX'3YX:F[7"@48Z-_XZA.L\)UT%PL \XZB_,V^<U'7+!65'!J42?[M?/OV;
MN:?A ?/#_N=_^+Q1/NF3:G2?Z>D+^A;XW<:KOE6KXLE\]4^;#[Y0Y6VUR=*>
M,8YTHJ2 .<\B2)CBD*,\@DC$48)SS6CLY$#J,_C4/N!-M/;*1FN7?[+'.B_0
MQOMZ5_WUF (W*V0H8 <FA><1\%O!P8[D-[;,Q;:$0\@BP?Z8A:T9[#'^R"6$
M_9$YK"C<XQG^'N_CU=1WN@6\_KF]I-WRU276FQRC;0F]L@Z0_/:=+3X]VD>4
MM_+_K,LV:Y(OG]1K-5_^^8VM[E4UXTK%B"4*1HH+2(39JM$H22#A&F5QG,LT
M4AYUT%],$2<J&+^V^H[$@%F1_^T5MT+_ JI:;'>O]LN\'I>/$*8[V^.W^-A%
M8+?/!^ _P=%6($W/CS:_<P<*T(3L5P8,T*)Q W;?I1H0&RQ:OTO?_A+ODOM!
MS.3?J9'.>_X"[Y;7.=.+SNN9XZR7D6NT4[,7A7WW<.YE!>F9\,$>BXK-ZXA-
M65BO>WFW$#8V7+Y>MXUL/K-"SG+%S;:295!EF$*2<05SE!$H&55")C+CR"O8
MTG7@J>TN;X58K0T1B4;^IMA6JX!G7H@K]&X[RR$ '=BX:$4&NS*#3FC U]M6
M85;P@"DCGE %S1UQ'7O<)!)/1 ZR27SO]W='OVV-DJ:9UKN%?&MV.;,4QSJG
M D,M;%-LDB!(>8Y@C#,NXS37B4A=W=)'1Y@:_W1"=AWSWMF<"".GNZ/Z.)"7
M'=97PS,PFW@CX^7"/JO]%:[LX\\=S:5]5JU=U_;Y"T,$(,FFB-Z'33!P%F.1
MYDD,A;!EPB-*(<5Y#".AD#(??4J15\/[\\--[4/?.^>5;97)( '81^%V,S/"
M@3@P'5R%WY4Q0Z=@&2X\Z&#$%XP$.J7]^:"?DW?UK9C9'/G\HZB^OS&;I^6#
M6FU.RV=Q0@3-.88BQ1(2QA.8\R2%4F@9122C./+*0#T[VM2895/ Z$\C+1"M
MN#=@W@GL6R_S'-*"1U+B+((,Q2DDW.;Z(L6A1EF4$((%(7GG@6_6EJ\56U5C
MP?[<9[XOP(#&BM*JWN44=0D(6Z)$U#&] ,<W=8!\R$E0'"&4I@QBS@0D" N8
MF]75V,LI2Z3@:9;(YY-@%OB7G()N^!>< !IR J0F.K(1TTFJ.21YPJ&9"01Q
M9'ZF.,-F]^*761:,<<;)*=N#.R2VCNZ14'@-[1-Y1LYO-N3\X2(Y]ZC,ZP!)
MV-J\YP8<N3JO@^Z']7E=;NK;2G,WY=5FP;8_?N+SXKXY5,HR2900#!*%$T/>
M(H6,J!R*+$UT0HE,&>N]ECH(,.D5]34S_Q2>S.*">BICFFA$H9+86#",I9!&
MAL732)DM*,U(PG#/Q7-(S(=?0@=#W(W10X$W5C/.8R7HNG]M10[9F-,9G[!-
M.B\/.W+#3F<<#IMWNM_:LS"[NK=>M2_JT;:.6-S?+?1R]5 _><<11HV9GB,"
MN:;&:,\I@C0E$;1G<IDQWJ44B5===H=!I[9I;64&&Z'!CM17.,6<)L"-D$+#
M.C C!4#4OR"[!T1!Z[&[C#MN.78/) ZJL?O<V[<0Y,-Z7D>"-G4E/^F/ZL];
M46>8F!$_K\P^KGB<J[M%8VU\TK=R60<KS#CC3!*2P42*')(DP9!1*:"66))(
MYBQ'GE54^@LSO8UPHX'M@O"PE(4NC$FP4M5J63Z:7]N(:O;X."]$\Q&:JQ;J
M3\ VJH*R8@O)5J</PT//IN/N>I09&GKKO5$";&?)Z &VBH"-)C;[N#UH-%=U
MVH0L:WDMHF$K7O:69N1BF->B=E@G\^HG]G4(=+'X.X%AO[)B80O2O/[YGTK>
MF_&_J'E-%>7WXO'USZ:>\*99QX=EPR.O?QY[V)>B_-<WQN=J1F0J190A*)&9
M?<(Y,8P=:6-DZERQ&.=$>)V&C"?ZU*S4G<R8'=5O@%4>O++J_V(C6EL$P"X$
M-_8/#0I@VRVGPZ'^Z]&G PL&^*.&P]/V'?$5<]W23_'%&=PS</F=N32]/9P#
M8R,=UL<PFO0CNRK&GI5#C\?H$O3()6-S57Y;-F'3OZGJ^U+>+9Y462E5SB2+
M8\5Y#AE2"I(\RB!+!((9982I+(TSMZJPEP::VM)3RPJJ)6!:%_/"3(9C//)%
M1,]S=TB<AO9X=!"U:2.-I& C:B"\/#*! N$V5L).7_S\TF@<0#F7[7+N]O&2
M4AR4>)8[XG)]_][!RT7=MJ_)5*>*2H20@)FF$20)P;:"=@XEM6^ ,?EU[-?$
M8V^ J3%C(Q\HK8 WX)&MP),5$_S??T.);?@$2IN5\Q\@CJ*_1>"AF,^M[Z7^
M90G8VLS%JOAO)?^C^U51EFLE_QUDR=_PYG);F_[9+XSQ5M<RM'^P\3R;VY?K
MJO;BF'74/(/\+7[^C-U?[#_#OY'QLXEWC93H/YV#!T?4,_FUF<E:NAMP5T]'
MV(;%Q_0/W:7XV1BCMR8^IN&Q?L1'K_,WV;KXGQ.9<3;8Y<Y\$D^%7+/YFZ6A
MOI6M!O[[HJAF(LV$SC6'N=#6HLNDM>T8Q,;,TY@H2;BS17>%'%.CM4U(E=C-
MG14;F<':".UNTEPS0Y<MQ)%P'_X0OX'\9+IR';6UU>0&;'4!OX\V'^X6Z$CS
M,I*!^N;YRV\]\[*;LGKYKW\=R$X- -T9,_::IX]FY0: 8-<(#O&XOC9R:5M;
M6R.\K:NM8QIIQ#,H$(DAR7 &<XD89"RF4A&*4^95Z?-@A*DM)W7_2_/!_+I<
MRK*V.-O.F"7XNIS+OIVD#X!U-4*O@&MP*[1!JMD.#] %^I3N82W0_4%&-D%/
MZ'AH@YZZL'><;<TQ[XN%#5ZTCR\__;FH]V8?5+TKVZ$<N[?87+:MPC 3.B4\
M36.8D5A @LT6FA*10,JYE"S*9!9Y54,((M74&.6MXE6]6;:R&L.T]*V_%V:N
M7(^>1IZ!L4S55J&ZOW%Y XQ.L%8*M%KMFJ_-9GKW\JUN00-3PT$=.'0U@&!C
M![>&P_)(^&O A_<,D.U;5&=3M/#6R/70U-&Q]2E$I>1;:T,:!6S-PQG+B=8B
MTS 7TG!YGE/(N":VO#%*$4ZXCKS2S >7>'(\W\H&?A9J[AF9-OSTNM'_I"9M
MZ&.PZ^NN;<N\@AV];T"G.=B\$U^"5. 8?9J"!A\/+O2XD<MCS<%!V/-H U]7
ML;MM?]ON=R.2,)XR!DDB,"24II"G&L.<QXIJD>,HZE6:^]DH4UL2-O6BN\;O
M_;P'QQ%U8_2K<1J8A?TAZETX^R@$0U3(?C[0BY3"/JKKJ9K7QR_N]_5_8S_>
MK(WANY#_>\G+6QLI;-#*OAEV*@M+.>:"]\O5K1!-1+$QJY<K5=POWK'5PEC2
M91-&9:[JNKA'5&91GDO(J4@@T4D.<XQS&,=$,!YI%&.GVF:#23@UUMEJPN;
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M[+17"I?KP%/CC\_F0=]M TICXQ5U &WMMBH6V[#X)F"*+0K?@MW.D^'H<AP
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M<?8?0.PJXDN$U\Z?*SV.,1UCD>:Q3GK=O[8*->6C-BK9SN-UPL^.5B'9-!#
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M5J!7+S6?B7%CJ('@'IBP@B(=LNS'*<Q&JO5Q,/Q4"GR<PL6CJL?)1_1TT]B
M[_*3_F V#TIM@Q5LFY>ZR\N,QX2F1".H(T4A2:T%9>PF*+"B6@FNXTA[U16]
M-.+4^*P1V.ZL&I%W(G(\_307L79TU(1$<&A/S6GPP!^#]!)R1B>H\^;BH.-Z
M;UPQ.'#?.-_8L[)&\51(M9#=052WC^!"Q2J+":1IFME\D A2;7/54JFX^9U&
MN9?Y=&*<J5'+1DP@E9BSE6WRN%A6X-%LCSU+7IP -DE4@DC*H)*V;Z^,..18
M*R@UEIC$E"54S9[4BB]'A'9WO#' ;:-$PB#JQM$!4!J8F;?PM"(.L)6]@$+0
MJAPGAAJWUL9Y?0\J:%RXO&<V\*9/I,U95HMR/RC@]<_#5I*VT>R'8J'N*O50
MSBA%B",J#,A"04,3&G(E,<RIUBDWI*%2KSJ7UXLT->;>[=VZJ]-NF(W=@!WM
M\6HU W]8W4"MG&^R\?43[$9BXT[;P'PWTHSYYS(' SEHIO/U4HV;!QT,Q8,L
MZ7!/[LGG%:OJ@9H35"O%<F%CNVK_5DYD3K%44+ 40:*2!!KRSB&/5"XS%!/&
MO;;G9T>;&@NWB<);(7NY$\\#[$B5H6 ;F 6]$?/G,Q<D@E+5V0''92$7W0\(
MQNFF?MS1=C:[W70V^U1W-ML66'^KM#)&IS07=J$;/]^NU;?E-\-O97U::TM9
M<<P$BVD,J9#4;".)ACEF.8S26!O>B9% 7B&=@>2:&A]]47(M:J/"]AC<2&K+
M405I)AIZ6MVX[04F:V 6/#H5MO38MBE+IU,];1NM@%PK4"WWYC8<>0:&.B3-
MAA)M5$(.C.<^=8=^O'_666UIVJ#=LJY2]NT[6]1!=TU)Y$T,WNWCXTJ)HC9=
MOQ3WW[?%-N(\Q\9&A)'B"22,"=LB.H)QAKA&A"09=>X3?:4L4R/S9M-7ZP.:
MNH65T0C4.K1%Q!L":7ZSJQ9H]/(LU1%B/L\S^LBS-#"+_R4GR#TW;<2)&BDW
M;8P)\TI/"P3QF?2T:T<8+3TM$!2[Z6FA'MEOZ[.MQ5F/_KP,9UM<MCQV"!\G
M>4Z25$(<Y1B2+,\A9WD$E="Y4MAL>&+A=V365Y3IG:GM%N7U+%K7>S[<-BEC
M8#SP>M:J4#-@0X_/M0"=&L,'45R+9LB-1V]91MUI7(O8_M;BZN?U8\W]<+./
MJGKWH^W"]^MR*?\LYO.90$C&4A*82VV#ZC&!E*78_ ?I6,<Q8:F7S]EET*GM
M#G;"+5G;<,T[M-X);#?Z"PWAP%1WI%V=[8K[:B,SZ(3^)1RI^6 4DL"<QAV5
MK'R0V"<FKWO]'1I-Y%D=AV9[A+Z?+_^TAN+Z\;$I_\_F=PN]7#VPQG=BQ-A:
M"IF9@)@B#F-.%204&\LMCS*8:"ZX3 D6RJE=QY5R3(VJYK4J-V!>^S;K#L-6
MG6:GM:,0*+8:N6^(KYFPR]Z*D:9A8+KK,P-MU73@8M\%G11W#\5(DS.2=V+H
M2?+R3 2 ]HQ7XIJGC^:1" #!KC<BQ.-Z%L&O.U9OVH9\8S]L'^LORF)0S!O'
MQVWU7MGZ/7-[&KPV[\7/9Q?/A!*QIHFP3@EI#V!3F'.:&U,#&WN;4T0RKP/8
M #)-;9G[_6]?_P9T(S$0R]7C<F6D!!7[ >P/GB7V \R9F^4^\DP,'5_2:=.U
M=;+'IU9&\%RC&\ JT"H%-EKMWW1CBY&)H"') >$.VB0@@%CC-A0(A^-!\X&
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M&8I1HKB0$,L40R*2!+(DE1#I.$$1(RG)DO[M#O:'FQIK[?<[F&_;1UW3Y^
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M:@IVGS^MDN 1SP[T X]=TT>87=#MC9__\4W[$_N'.T;_QS?_!U!+ P04
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MM^V[5D)\.B\)QI?/_XB?'>D@(\M,DXSDX2K#=6@3UR18HZTV@B?#;M)<U+)
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M'"E>Q28]3-:P73MZ1$V/TF_BT/,-JF'Z:1PF<,G.J^_KHM[+%<*BHKI+UA&
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M-0"\#_!E[86<Y)N,.'0KO$B<""M+29&4Q!FGNIDJQFA(%*H4]]Y+49.G-K6
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MFR^Z;H-?0A#:E? 8HXDR.@BW:QD2"3EF8ZB1R-OAKB!WL475SL9JV:+>]=(
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MS)G13%7:I@#J&5SF/$E)#USF/$5B#00W.[;N3\S(9(,B(FL,X;C,Q"J%CGS
M[97ZF*2LDBE7<<A'M8"HAUWH@-IZEIA<K^'@*1,1W3W#K"K'K8($5QID)&-,
M\M)$QMM 90MY=X< 4U]3.YZBV080W,L$!V:],RHPHCWGY2XX$^^R(\ ]D](
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MYX]A?AF\')V5?SJ*-/+$RWFG-*6]9$S$BXP[?U"462^D=W62T.KQ-%RE9V]
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M8%-/EQB!?X OY_/X&;<)]+$_S?W93<_GZ'SY>38O]]P?9R_@ZL-II)U6.>A
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M.,XG)!LW63\"#3^QT0QJ@]Y=Q,'TN@_^?%!WT9 X]Q%,E%>L\B> ESJ#BB*
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M@G:U,#9#X+$6ZG<UO+[?/\W+>=F\[M.O#D\4]WK\0"OFX4-JLX9:+HLJ(4-
M0^%:#(1*28&;+R):I02*G/I?0Y]DB;C)8EY?YM])B1^_YXMO^;?Y;/69$IO
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M/WWQI7Z:U",[RO 9!$\IOG)" (9D0>:BM"@YR'#Z%7B;M#MAT)T[!@>Q50>
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MT@EQS]>.$U^=8H.BM0TZ<%M/S,A_+.KA&.98@@H*DC.40$M1>7,89='.Y=H
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MH,ZI%%Q(X+E3Y$Y=!L>2 E3>A*@T"K/+@>(SKSG6BZX??^^YFSKURB R\Z4
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MK)VN$TK>IBQA@S#CQCK#@^A8?7> &5)#7JZF\>V]<JV;:U-2)R93 9\JY:5
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M67:I ,J<@#O/N/7&"R[:8^OH)EK\K+;\&]FG R^VI0U==HJA#0A)4ABHHE6
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M12ST'1,F1JV+9;[)%F1#8KH3'-)WO95T B1T@/?M'%O%2$]YK2#H*4I9F F
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M'6*63A$FKX>"#)EE(0!3SH!R@E24N(!DN#/,9J/:D(P](=.X);_C(NP0LW2
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MUH-OOU% 79W_6@\;^5C*L3C-0-LH*HF) X\Q@5%9\V2*P]1D?]QUH3VDGNW
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M[0"[ U3Q0HD4OWA!T0K6 5@DN\\6P3EF$\]>I=C7H[W?=^*;;9?J='%A>60
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M+8-/*)H<0K;UWC]A/3!9)*S07O.9054;4!(A3"I0F,G[NYKK&R,FKDVP3=R
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M%"2D:,!)\HAS,2XR#,RS)EEZ^XB9%ESCJWPYLOP[Q-!NDA &3D%3J;,Q0G4
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MXBR4H,D;PDS>D&$%K"T,O2C2>3,4!\<@8/11) T1<(KL.M@#WKV=&92ZF.C
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M.MCYK](^9E%(H;SWX+5AM=4TA>G"D!5 E8AD[V6;N8]7KQ\$/_MBX7>$C#M
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M?X55GC$,C#L90"11LPZ- A>=!&^39MYCR6;(@>?!YN\(6ON//XY$SO*\:NP
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M 5!+ 0(4 Q0    ( !>755 'P&E\S$8  'U6 P :              "  0
M  !E>#$P,F9I<G-T86UE;F1M96YT86YD+FAT;5!+ 0(4 Q0    ( !>755#!
M5Y2U( @  *\6 0 :              "  01'  !E>#(Q;&ES=&]F<W5B<VED
M:6%R:65S+FAT;5!+ 0(4 Q0    ( !>755 D9J%P<0,  #@,   3
M      "  5Q/  !E>#(S8V]N<V5N=#(P,3DN:'1M4$L! A0#%     @ %Y=5
M4$IYSVY-!P  J"8  !H              ( !_E(  &5X,S$Q8V5O,S R8V5R
M=&EF:6-A=&DN:'1M4$L! A0#%     @ %Y=54))P;"U/!P  N"8  !H
M         ( !@UH  &5X,S$R8V9O,S R8V5R=&EF:6-A=&DN:'1M4$L! A0#
M%     @ %Y=54.2:N@KZ P  *0\  !H              ( !"F(  &5X,S(Q
M8V5O.3 V8V5R=&EF:6-A=&DN:'1M4$L! A0#%     @ %Y=54&^(K?(&!
M; \  !H              ( !/&8  &5X,S(R8V9O.3 V8V5R=&EF:6-A=&DN
M:'1M4$L! A0#%     @ %Y=54-"8KN\('@  (K@  !H              ( !
M>FH  &5X-#1D97-C<FEP=&EO;F]F<F5G:7,N:'1M4$L! A0#%     @ %Y=5
M4-!LC'4UF@0 'N=" !               ( !NH@  '=S="TR,#$Y,3(S,2YH
M=&U02P$"% ,4    "  7EU50&6(6,O\<  "520$ $               @ $=
M(P4 =W-T+3(P,3DQ,C,Q+GAS9%!+ 0(4 Q0    ( !>755!M;M[Q<#L  !J)
M @ 4              "  4I !0!W<W0M,C Q.3$R,S%?8V%L+GAM;%!+ 0(4
M Q0    ( !>755  *->8[M@  !=!"0 4              "  >Q[!0!W<W0M
M,C Q.3$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( !>755#Y4I!7R L! $&0 0 3
M              "  0Q5!@!W<W0M,C Q.3$R,S%?9S$N:G!G4$L! A0#%
M  @ %Y=54&VM>7+;Y $ _1L4 !0              ( !!6$' '=S="TR,#$Y
M,3(S,5]L86(N>&UL4$L! A0#%     @ %Y=54+Q*V>Q#*0$ W/ - !0
M         ( !$D8) '=S="TR,#$Y,3(S,5]P<F4N>&UL4$L%!@     /  \
*_@,  (=O"@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838169360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100.0<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">74.1<span></span>
</td>
<td class="nump">74.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837866496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $15.6 million for 2019, $6.5 million for 2018 and $5.7 million for 2017. The increase in 401(k) plan contributions in 2019 was in response to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting).<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Pension and Other Retirement Benefits</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:43.032%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.498%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service credit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss (gain) arising during period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service credit arising during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service credit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total recognized in OCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total recognized in net periodic benefit cost and OCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit cost by geographic location is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.711%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.082%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.498%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. plans</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded a $3.5&#160;million pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we contributed $2.6&#160;million to our U.S. qualified defined benefit pension plan.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in benefit obligation:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit obligation, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(267.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(288.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Participants&#8217; contributions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actuarial (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amendments/transfers in</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefits/expenses paid</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit obligation, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(287.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(267.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actual return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employer contribution</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Participants&#8217; contributions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefits/expenses paid</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Funded status at end of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">International pension plan assets, at fair value, included in the preceding table were $39.4 million and $33.4 million at December&#160;31, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amounts recognized in the balance sheet were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Noncurrent assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Noncurrent liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net actuarial loss (gain)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service cost (credit)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The net actuarial loss and prior service credit for the defined benefit pension plans that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year are $1.8 million and $0.1 million, respectively. The net actuarial gain and prior service credit for the other retirement benefits plan that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year is $1.6 million and $0.7 million. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accumulated benefit obligation for all defined benefit pension plans was $283.9 million and $263.0 million at December&#160;31, 2019 and 2018, respectively, including $73.9 million and $64.0 million, respectively, for international pension plans.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, our U.S. qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2019, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All of the defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets as of December&#160;31, 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.955%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.147%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.147%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.149%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Domestic </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2025 to 2029</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">158.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2020, we expect to contribute $0.7 million to pension plans, none of which is for international plans. In addition, we expect to contribute $0.7 million for other retirement benefits in 2020. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:29.570%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.740%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.90&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of compensation increase</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.41&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.01&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term rate of return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.54&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.823%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of compensation increase</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.49&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.01&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The discount rate used to determine the benefit obligations for U.S. pension plans was 3.35% and 4.30% as of December 31, 2019 and 2018, respectively.  The weighted average discount rate used to determine the benefit obligations for all international plans was 1.28% and 2.19% as of December 31, 2019 and 2018, respectively. The rate of compensation increase for U.S. plans was 4.25% for 2018, while the weighted average rate for all international plans was 2.49% for 2019 and 2.60% for 2018. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans, which accounts for 83.86% of global plan assets, was 5.60% for 2019, 7.00% for 2018 and 7.00% for 2017. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The assumed healthcare cost trend rate used to determine benefit obligations was 6.25% for all participants in 2019, decreasing to 5.00% by 2024. A change in the assumed healthcare cost trend rate by one percentage point would have an immaterial impact in the postretirement obligation. The assumed healthcare cost trend rate used to determine net periodic benefit cost was 6.25% for all participants in 2019, decreasing to 5.00% by 2024. The effect of a one percentage point increase or decrease in the rate would have an immaterial impact in the aggregate service and interest cost components.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our U.S. pension plan is managed as a balanced portfolio comprised of two components: equity and fixed income debt securities. Equity investments are used to maximize the long-term real growth of fund assets, while fixed income investments are used to generate current income, provide for a more stable periodic return and provide some protection against a prolonged decline in the market value of equity investments. Temporary funds may be held as cash. We maintain a long-term strategic asset allocation policy which provides guidelines for ensuring that the fund&#8217;s investments are managed with the short-term and long-term financial goals of the fund, while allowing the flexibility to react to unexpected changes in capital markets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended December 31, 2018, in anticipation of benefit accruals under our U.S. qualified and non-qualified defined benefit pension plans ceasing effective January 1, 2019, except for interest crediting, we changed the U.S. target asset allocations from 65% equity securities and 35% debt securities to 30% equity securities and 70% debt securities.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following are the U.S. target asset allocations and acceptable allocation ranges:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Target allocation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allocation range</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27% - 33%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67% - 73%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0% - 3%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.070%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.980%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.824%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets in the fair value hierarchy</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets measured at NAV</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">204.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets at fair value</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.230%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.824%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets in the fair value hierarchy</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets measured at NAV</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">181.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets at fair value</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837834640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and integrated solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,398.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,308.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,236.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">362.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intersegment sales elimination</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We do not have any customers accounting for greater than 10% of consolidated net sales.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents net sales and property, plant and equipment, net, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:23.801%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.704%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Sales</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, Plant and Equipment, Net</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">814.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">766.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">734.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">337.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">315.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">95.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">165.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">145.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">142.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other European countries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">230.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">201.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">201.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">194.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">839.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">822.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">855.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.980%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.908%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate/ Elimination/ Unallocated Items</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,398.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(66.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating expense (income)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">291.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,480.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">386.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">474.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,341.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,308.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">266.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">266.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,342.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">301.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">335.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,978.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,236.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">362.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(66.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">225.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(69.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,321.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">286.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6832616576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Sales by Significant Product Group</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents information about our reportable segments, reconciled to consolidated totals:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,398.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,308.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,236.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">362.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intersegment sales elimination</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Sales and Net Property, Plant and Equipment, by Geographical Areas</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents net sales and property, plant and equipment, net, by the country in which the legal subsidiary is domiciled and assets are located:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:23.801%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.704%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Sales</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, Plant and Equipment, Net</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">814.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">766.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">734.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">337.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">315.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Germany</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">95.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ireland</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">165.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">France</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">145.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">142.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other European countries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">230.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">201.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">201.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">194.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">839.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">822.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">855.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables provide summarized financial information for our segments:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.980%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.908%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate/ Elimination/ Unallocated Items</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consolidated</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,398.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,839.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(66.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating expense (income)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">291.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,480.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">386.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">474.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,341.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,308.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,717.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">266.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">266.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,342.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">301.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">335.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,978.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,236.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">362.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,599.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating profit</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(66.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">225.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other nonoperating income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(69.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,321.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">286.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8721-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6736053120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Allocation of Share-based Compensation Costs by Plan</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock option and appreciation rights</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, stock-settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, cash-settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, dividend equivalents</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stock-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in outstanding options:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions, except per share data)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercisable, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.09&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.42&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.95&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60.92&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67.02&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercisable, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.44&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of Stock Appreciation Rights Award Activity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in outstanding SARs:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">116,087&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,364&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,790)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,629)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(67,511)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(400)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(400)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35,993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs exercisable, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,781&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,285&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.13&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.08&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs exercisable, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.73&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Performance-based Share Activity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296,037&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">341,944&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378,062&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84,309&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102,307&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92,045&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50,556)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,284)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11,369)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(48,964)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(121,984)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(116,684)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16,204)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23,946)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(110)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">264,622&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296,037&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">341,944&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.01&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.85&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50.06&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69.09&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68.65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66.03&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Nonvested Performance-based Units Activity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">806&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">560&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">598&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(206)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(107)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(211)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(910)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(970)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,981&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56.95&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.53&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66.61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">86.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837439424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Textuals) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod', window );">Contingent consideration, payable period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Contingent consideration, estimated outcome, low</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, estimated outcome, high</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems', window );"><strong>Unrecorded Unconditional Purchase Obligation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment</a></td>
<td class="nump">249.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">Outstanding uncondintional contractual commitments due to be paid in 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember', window );">Insurance Claims [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for insurance obligations</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyReceivable', window );">Amount reimbursable by the insurance company</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving credit facility, due 2024 [Domain] | Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letters of credit supporting the reimbursement of workers' compensation and other claims</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118943654&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77896938&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77896938&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration Arrangements, Range of Outcomes, Payable Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818135040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments (Textuals) (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>JPY (&#165;) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>SGD ($) </div>
<div>bbl </div>
<div>$ / bbl</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>SGD ($)</div>
</th>
<th class="th">
<div>Nov. 22, 2017 </div>
<div>bbl</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember', window );">Commodity Call Options Held [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice', window );">Derivative, Average Price Risk Option Strike Price | $ / bbl</a></td>
<td class="nump">70.71<span></span>
</td>
<td class="nump">70.71<span></span>
</td>
<td class="nump">70.71<span></span>
</td>
<td class="nump">70.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNonmonetaryNotionalAmount', window );">Derivative, Nonmonetary Notional Amount | bbl</a></td>
<td class="nump">135,967<span></span>
</td>
<td class="nump">135,967<span></span>
</td>
<td class="nump">135,967<span></span>
</td>
<td class="nump">135,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars | Cross Currency Interest Rate Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars | Cross Currency Interest Rate Contract [Member] | Net Investment Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars | Long [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">United States of America, Dollars | Short [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">&#8364; 33.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Cross Currency Interest Rate Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 9,800.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Long [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 6,550.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Short [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore, Dollars | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore, Dollars | Long [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SGD', window );">Singapore, Dollars | Short [Member] | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">&#8364; 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAveragePriceRiskOptionStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average strike price on the group of price risk option contracts such as put options or call options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAveragePriceRiskOptionStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNonmonetaryNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal number of units used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNonmonetaryNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_LongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_LongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PositionAxis=us-gaap_ShortMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PositionAxis=us-gaap_ShortMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SGD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SGD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820081712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense Other Items (Textuals) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Feb. 17, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax', window );">Venezuela currency devaluation</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Venezuela deconsolidation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">$ (11.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainBeforeTax', window );">Foreign Currency Transaction Gain</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign Currency Transaction (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Gain (Loss) on Sale of Assets and Asset Impairment Charges</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_VE', window );">VENEZUELA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1', window );">Foreign currency exchange rate, remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateRemeasurement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateRemeasurement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfInvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfInvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_VE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_VE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844785184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Nov. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase in investment in affiliated companies in cash</a></td>
<td class="nump">$ 85.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Purchase of investment in affiliated companies</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember', window );">The West Company Mexico, S.A. de C.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember', window );">Aluplast S.A. de C.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember', window );">Pharma Tap S.A de C.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember', window );">Pharma Rubber S.A. de C.V. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember', window );">Daikyo Seiko, Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_IWPharmaGroupLLCMember', window );">I&amp;W Pharma Group LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_WestCompanyMexicoSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_AluplastSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaTapSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_PharmaRubberSADeCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_IWPharmaGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_IWPharmaGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845293360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Textuals) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation gains (losses)</a></td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2020</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2021</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2022</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business acquisition, recognized goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business acquisition, recognized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6835228736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Income Before Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="nump">$ 161.2<span></span>
</td>
<td class="nump">$ 132.9<span></span>
</td>
<td class="nump">$ 96.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International operations</a></td>
<td class="nump">130.6<span></span>
</td>
<td class="nump">107.8<span></span>
</td>
<td class="nump">125.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">$ 291.8<span></span>
</td>
<td class="nump">$ 240.7<span></span>
</td>
<td class="nump">$ 222.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843960032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income, as reported, for basic net income per share</a></td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
<td class="nump">$ 150.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="nump">74,000,000.0<span></span>
</td>
<td class="nump">73,900,000<span></span>
</td>
<td class="nump">73,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Assumed stock options exercised and awards vested, based on the treasury stock method (in shares)</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares assuming dilution (in shares)</a></td>
<td class="nump">75,400,000<span></span>
</td>
<td class="nump">75,400,000<span></span>
</td>
<td class="nump">75,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive options excluded from computation of diluted net income per share (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Share repurchase program, number of shares authorized</a></td>
<td class="nump">848,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="nump">$ 83.1<span></span>
</td>
<td class="nump">$ 70.8<span></span>
</td>
<td class="nump">$ 74.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Shares purchased under share repurchase program, average cost per share</a></td>
<td class="nump">$ 103.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1500-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7004266032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="nump">$ 14.5<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844587184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans (Amounts Recognized in Balance Sheet) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">$ (2.2)<span></span>
</td>
<td class="num">$ (2.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(52.5)<span></span>
</td>
<td class="num">(56.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(46.6)<span></span>
</td>
<td class="num">(50.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Total liabilities</a></td>
<td class="num">(43.8)<span></span>
</td>
<td class="num">(52.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AssetsDefinedBenefitPlansNoncurrent', window );">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansAssetsNoncurrent</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(5.9)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Total liabilities</a></td>
<td class="num">$ (6.6)<span></span>
</td>
<td class="num">$ (6.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AssetsDefinedBenefitPlansNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AssetsDefinedBenefitPlansNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6841754864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Components of AOCI) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
<td class="nump">$ 1,599.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(154.2)<span></span>
</td>
<td class="num">(117.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="num">(37.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(36.9)<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(149.6)<span></span>
</td>
<td class="num">(154.2)<span></span>
</td>
<td class="num">(117.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Losses on Cash Flow Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gains on Investment Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Pension and Other Postretirement Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(40.4)<span></span>
</td>
<td class="num">(39.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(40.3)<span></span>
</td>
<td class="num">(40.4)<span></span>
</td>
<td class="num">(39.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(113.8)<span></span>
</td>
<td class="num">(74.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="num">(39.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="num">(39.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">$ (108.9)<span></span>
</td>
<td class="num">$ (113.8)<span></span>
</td>
<td class="num">$ (74.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6923909392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Segment Financial Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
<td class="nump">$ 1,599.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">296.6<span></span>
</td>
<td class="nump">240.3<span></span>
</td>
<td class="nump">225.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating expense (income)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">291.8<span></span>
</td>
<td class="nump">240.7<span></span>
</td>
<td class="nump">222.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">2,341.4<span></span>
</td>
<td class="nump">1,978.9<span></span>
</td>
<td class="nump">1,862.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(126.4)<span></span>
</td>
<td class="num">(104.7)<span></span>
</td>
<td class="num">(130.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">103.4<span></span>
</td>
<td class="nump">104.4<span></span>
</td>
<td class="nump">96.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">1,398.6<span></span>
</td>
<td class="nump">1,308.6<span></span>
</td>
<td class="nump">1,236.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">313.6<span></span>
</td>
<td class="nump">266.4<span></span>
</td>
<td class="nump">243.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating expense (income)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">313.6<span></span>
</td>
<td class="nump">266.4<span></span>
</td>
<td class="nump">243.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">1,480.6<span></span>
</td>
<td class="nump">1,342.3<span></span>
</td>
<td class="nump">1,321.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(91.2)<span></span>
</td>
<td class="num">(77.0)<span></span>
</td>
<td class="num">(107.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">82.2<span></span>
</td>
<td class="nump">83.9<span></span>
</td>
<td class="nump">77.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">441.5<span></span>
</td>
<td class="nump">409.1<span></span>
</td>
<td class="nump">362.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">49.1<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">48.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating expense (income)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">49.1<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">48.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">386.0<span></span>
</td>
<td class="nump">301.4<span></span>
</td>
<td class="nump">286.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(37.2)<span></span>
</td>
<td class="num">(20.7)<span></span>
</td>
<td class="num">(18.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">17.2<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_CorporateAndEliminationsMember', window );">Corporate and Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="num">(66.1)<span></span>
</td>
<td class="num">(70.4)<span></span>
</td>
<td class="num">(66.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other nonoperating expense (income)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="num">(70.9)<span></span>
</td>
<td class="num">(70.0)<span></span>
</td>
<td class="num">(69.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">474.8<span></span>
</td>
<td class="nump">335.2<span></span>
</td>
<td class="nump">255.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_CorporateAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_CorporateAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825780368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Effects of Derivative Instruments Designated as Hedges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (Loss) on Derivative Instruments, Net, Pretax</a></td>
<td class="num">(6.9)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings within Twelve Months</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember', window );">Net Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (Loss) on Derivative Instruments, Net, Pretax</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Goods and Services Sold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (Loss) on Derivative Instruments, Net, Pretax</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (Loss) on Derivative Instruments, Net, Pretax</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Foreign Exchange (Gains) Losses and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (Loss) on Derivative Instruments, Net, Pretax</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Hedge Contracts [Member] | Net Sales [Member] | Cash Flow Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Hedge Contracts [Member] | Cost of Goods and Services Sold [Member] | Cash Flow Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Hedge Contracts [Member] | Foreign Exchange (Gains) Losses and Other [Member] | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (Loss) on Derivative Instruments, Net, Pretax</a></td>
<td class="num">(6.9)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardTreasuryLockMember', window );">Forward Treasury Lock [Member] | Interest Expense [Member] | Cash Flow Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency - Denominated Debt [Member] | Foreign Exchange (Gains) Losses and Other [Member] | Net Investment Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember', window );">Commodity Call Options [Member] | Cost of Goods and Services Sold [Member] | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Foreign Exchange (Gains) Losses and Other [Member] | Net Investment Hedges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in OCI</a></td>
<td class="num">$ (1.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1),(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109977999&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings within the next 12 months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=wst_NetSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardTreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=wst_ForwardTreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=wst_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=wst_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845203120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Nonvested Performance-based Award Activity) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Non-Employee Directors [Member] | Deferred Compensation Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">14,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level</a></td>
<td class="nump">$ 121.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember', window );">Incentive Stock Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level</a></td>
<td class="nump">$ 106.14<span></span>
</td>
<td class="nump">$ 93.00<span></span>
</td>
<td class="nump">$ 86.93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember', window );">Cash-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning</a></td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">2,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">806<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget', window );">Adjustments above/(below) target</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and converted</a></td>
<td class="num">(211)<span></span>
</td>
<td class="num">(910)<span></span>
</td>
<td class="num">(970)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending</a></td>
<td class="nump">1,981<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning (in USD per share)</a></td>
<td class="nump">$ 79.48<span></span>
</td>
<td class="nump">$ 92.25<span></span>
</td>
<td class="nump">$ 25.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level</a></td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">89.64<span></span>
</td>
<td class="nump">83.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue', window );">Adjustments above/(below) target</a></td>
<td class="nump">56.95<span></span>
</td>
<td class="nump">41.53<span></span>
</td>
<td class="nump">66.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and converted</a></td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">93.00<span></span>
</td>
<td class="nump">86.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending (in USD per share)</a></td>
<td class="nump">$ 150.33<span></span>
</td>
<td class="nump">$ 79.48<span></span>
</td>
<td class="nump">$ 92.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting', window );">Number of shares to be issued upon conversion</a></td>
<td class="nump">84,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Average remaining term of shares issued at conversion</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning</a></td>
<td class="nump">296,037<span></span>
</td>
<td class="nump">341,944<span></span>
</td>
<td class="nump">378,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">84,309<span></span>
</td>
<td class="nump">102,307<span></span>
</td>
<td class="nump">92,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget', window );">Adjustments above/(below) target</a></td>
<td class="nump">50,556<span></span>
</td>
<td class="nump">2,284<span></span>
</td>
<td class="nump">11,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and converted</a></td>
<td class="num">(48,964)<span></span>
</td>
<td class="num">(121,984)<span></span>
</td>
<td class="num">(116,684)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(16,204)<span></span>
</td>
<td class="num">(23,946)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending</a></td>
<td class="nump">264,622<span></span>
</td>
<td class="nump">296,037<span></span>
</td>
<td class="nump">341,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning (in USD per share)</a></td>
<td class="nump">$ 76.84<span></span>
</td>
<td class="nump">$ 64.38<span></span>
</td>
<td class="nump">$ 54.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level</a></td>
<td class="nump">103.40<span></span>
</td>
<td class="nump">90.45<span></span>
</td>
<td class="nump">84.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue', window );">Adjustments above/(below) target</a></td>
<td class="nump">83.89<span></span>
</td>
<td class="nump">33.86<span></span>
</td>
<td class="nump">42.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and converted</a></td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">93.00<span></span>
</td>
<td class="nump">50.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">69.09<span></span>
</td>
<td class="nump">68.65<span></span>
</td>
<td class="nump">73.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending (in USD per share)</a></td>
<td class="nump">$ 66.03<span></span>
</td>
<td class="nump">$ 76.84<span></span>
</td>
<td class="nump">$ 64.38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-vested PSU Awards [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">13,308<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted at target level</a></td>
<td class="nump">$ 116.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Cash-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Stock-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Cash-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Stock-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage', window );">Actual payout range</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Actual Payout, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844635136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Stock Options Activity) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life of options outstanding</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life of options exercisable</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of total options outstanding</a></td>
<td class="nump">$ 227.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value of total options vested</a></td>
<td class="nump">$ 158.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted</a></td>
<td class="nump">$ 24.72<span></span>
</td>
<td class="nump">$ 20.16<span></span>
</td>
<td class="nump">$ 18.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 46.9<span></span>
</td>
<td class="nump">$ 61.3<span></span>
</td>
<td class="nump">$ 91.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Grant date fair value of options vested</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 6.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Stock Options, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning (in USD per share)</a></td>
<td class="nump">$ 58.93<span></span>
</td>
<td class="nump">$ 48.76<span></span>
</td>
<td class="nump">$ 38.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in USD per share)</a></td>
<td class="nump">103.40<span></span>
</td>
<td class="nump">90.36<span></span>
</td>
<td class="nump">84.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in USD per share)</a></td>
<td class="nump">46.42<span></span>
</td>
<td class="nump">35.95<span></span>
</td>
<td class="nump">26.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in USD per share)</a></td>
<td class="nump">92.71<span></span>
</td>
<td class="nump">75.32<span></span>
</td>
<td class="nump">60.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, ending (in USD per share)</a></td>
<td class="nump">67.02<span></span>
</td>
<td class="nump">58.93<span></span>
</td>
<td class="nump">48.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable (in USD per share)</a></td>
<td class="nump">$ 53.12<span></span>
</td>
<td class="nump">$ 45.32<span></span>
</td>
<td class="nump">$ 35.44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Stock volatility</a></td>
<td class="nump">22.50%<span></span>
</td>
<td class="nump">19.80%<span></span>
</td>
<td class="nump">19.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6841638480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Allocation of Plan Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 244.1<span></span>
</td>
<td class="nump">$ 214.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_InternationalMutualFundsMember', window );">International Mutual Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 15.5<span></span>
</td>
<td class="nump">$ 17.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_InternationalMutualFundsMember', window );">International Mutual Funds [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">$ 17.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_InternationalMutualFundsMember', window );">International Mutual Funds [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_InternationalMutualFundsMember', window );">International Mutual Funds [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherSecuritiesMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Weighted average asset allocations</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_MutualFundsMember', window );">Mutual Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 21.7<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_MutualFundsMember', window );">Mutual Funds [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_MutualFundsMember', window );">Mutual Funds [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_MutualFundsMember', window );">Mutual Funds [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionPlanAssetsInTheFairValueHierarchyMember', window );">Pension Plan Assets In The Fair Value Hierarchy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">39.4<span></span>
</td>
<td class="nump">33.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionPlanAssetsInTheFairValueHierarchyMember', window );">Pension Plan Assets In The Fair Value Hierarchy [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">33.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionPlanAssetsInTheFairValueHierarchyMember', window );">Pension Plan Assets In The Fair Value Hierarchy [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">32.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionplanassetsmeasuredatNAVMember', window );">Pension plan assets measured at NAV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 204.7<span></span>
</td>
<td class="nump">$ 181.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription', window );">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</a></td>
<td class="text">0.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription', window );">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</a></td>
<td class="text">0.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription', window );">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</a></td>
<td class="text">&#8212;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription', window );">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</a></td>
<td class="text">0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription', window );">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</a></td>
<td class="text">0.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription', window );">Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description</a></td>
<td class="text">0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of investment policy and strategy for defined benefit plan asset. Includes, but is not limited to, investment allocation decision and factor pertinent to understanding investment policy and strategy for plan asset. Factor includes, but is not limited to, investment goal, risk management practice, permitted and prohibited investment including use of derivative, diversification, and relationship between plan asset and obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_InternationalMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_InternationalMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_OtherSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_MutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_MutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionPlanAssetsInTheFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionPlanAssetsInTheFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionplanassetsmeasuredatNAVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=wst_PensionplanassetsmeasuredatNAVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838020272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2019, the total amount of these forward exchange contracts was SGD 601.5 million and $13.4 million. As of December&#160;31, 2018, the total amount of these forward exchange contracts was &#8364;10.0 million, SGD 601.5 million and $13.4 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:52.487%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.906%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sell</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Euro</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Yen</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,550.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SGD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2019, we entered into the cross-currency swap for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#165;9.8&#160;billion ($90&#160;million) and the swap termination date is December 31, 2024. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;">Commodity Price Risk</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From November 2017 through October 2019, we purchased several series of call options for a total of 352,682 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we had outstanding contracts to purchase 135,967 barrels of crude oil from January 2020 to June 2021 at a weighted-average strike price of $70.71 per barrel.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Effects of Derivative Instruments on Financial Position and Results of Operations</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please refer to Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:16.269%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.328%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain Recognized in Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December 31, 2019 and 2018 were $8.7&#160;million and $3.7&#160;million, respectively. We expect to recognize $5.6&#160;million in earnings, pre-tax, for forward point components in 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.587%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.306%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.466%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.105%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.105%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.239%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Hedges:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash Flow Hedges:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward treasury locks</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Investment Hedges:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency-denominated debt</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross-currency swap</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:57.455%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.873%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:16.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.168%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Loss (Gain) Recognized in Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commodity call options</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019 and 2018, there was no material ineffectiveness related to our hedges.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6608640464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text">Revenue<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adoption of ASC 606</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2018, we adopted ASC 606, on a modified retrospective basis, applied to those contracts which were not completed as of January 1, 2018. As a result of our adoption, we recorded a cumulative-effect adjustment of $11.4&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2018, to reflect a change in the timing of revenue recognition under ASC 606, from point in time to over time, on our Contract-Manufactured Products product sales, certain Proprietary Products product sales, development and tooling agreements, as well as an acceleration on a portion of the remaining unearned income from a nonrefundable customer payment.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards in effect for those periods.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. As of December&#160;31, 2019, there was $5.6 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $4.7 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by market group:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:67.292%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.951%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.954%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Biologics</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Generics</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by product category: </span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:67.292%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.951%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.954%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High-Value Components</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Standard Packaging</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delivery Devices</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:67.292%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.951%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.954%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Americas</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe, Middle East, Africa</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia Pacific</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contract Assets and Liabilities</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contract assets and liabilities result from transactions with revenue recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet in other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:83.048%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.952%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract assets, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract assets, December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in contract assets - increase (decrease)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income, December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in deferred income - (increase) decrease</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The increase in deferred income during 2019 was primarily due to additional cash payments of $114.4&#160;million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $110.4 million, including $20.8 million of revenue that was included in deferred income at the beginning of the year, and $2.5&#160;million in other adjustments. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Supply Chain Financing</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of December&#160;31, 2019 and 2018, we derecognized accounts receivable of $10.1 million and $5.7&#160;million, respectively,  under these agreements. Discount fees related to the sale of such accounts receivable on our consolidated income statements for 2019 and 2018 were not material.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Voluntary Recall</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 24, 2019, we issued a voluntary recall of our Vial2Bag product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During 2019, we recorded a net provision of $5.4&#160;million for inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837942272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Affiliated Companies</a></td>
<td class="text">Affiliated Companies<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the following affiliated companies were accounted for under the equity method:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:55.371%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:19.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:19.315%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ownership interest</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aluplast S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">I&amp;W Pharma Group LLC</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Daikyo</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On November 1, 2019, in connection with the amendment of certain commercial agreements with Daikyo, we increased our ownership interest from 25% to 49% in Daikyo in exchange for $85.1&#160;million in cash and $4.9&#160;million in shares of our treasury stock to certain stockholders of Daikyo. We believe that the increase in ownership interest will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unremitted income of affiliated companies included in consolidated retained earnings amounted to $82.4 million, $75.8 million and $69.9 million at December&#160;31, 2019, 2018 and 2017, respectively. Dividends received from affiliated companies were $2.2 million in 2019, $1.7 million in 2018 and $2.2 million in 2017.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our equity in net unrealized gains of Daikyo&#8217;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $0.4 million, $0.4 million and $0.5 million at December&#160;31, 2019, 2018 and 2017, respectively. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our purchases from, and royalty payments made to, affiliates totaled $115.1 million, $86.3 million and $86.7 million, respectively, in 2019, 2018 and 2017, of which $20.8 million and $12.9 million was due and payable as of December&#160;31, 2019 and 2018, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $9.2 million, $9.6 million and $8.1 million, respectively, in 2019, 2018 and 2017, of which $1.9 million and $1.6 million was receivable as of December&#160;31, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019 and 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $179.3 million and $77.8 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $13.4 million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.3A-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355119-122828<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6606585920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill recorded due to acquisition</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock', window );">Schedule of Intangible Assets by Major Class</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:24.121%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.461%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.461%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and licensing</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technology</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(48.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Intangible Assets by Major Class [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838039712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconcilliation of Basic to Diluted Net Income Per Share</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:61.942%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.060%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common shares outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares assuming dilution</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6836358704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Voluntary Recall (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_VoluntaryRecallAbstract', window );"><strong>Voluntary Recall [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ProvisionForProductReturns', window );">Provision for product returns</a></td>
<td class="nump">$ 11.3<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ProvisionForProductReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for Product Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ProvisionForProductReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_VoluntaryRecallAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voluntary Recall [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_VoluntaryRecallAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6825698576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Adoption of ASC 842 (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 72.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">70.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LeaseOperatingLeaseTerminateTerm', window );">Lease, operating lease, terminate term</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating leases, option to extend</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LeaseOperatingLeaseTerminateTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>lease, operating lease, terminate term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LeaseOperatingLeaseTerminateTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845378816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Stock Appreciation Rights Award Activity) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward', window );"><strong>SARs, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CashSettledStockAppreciationRIghtsOutstanding', window );">Cash-settled SARs, outstanding</a></td>
<td class="nump">23,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_StockSettledStockAppreciationRightsOutstanding', window );">Stock-settled SARs, outstanding</a></td>
<td class="nump">12,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>SARs Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning</a></td>
<td class="nump">39,819<span></span>
</td>
<td class="nump">51,368<span></span>
</td>
<td class="nump">116,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted</a></td>
<td class="nump">3,364<span></span>
</td>
<td class="nump">3,480<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised</a></td>
<td class="num">(6,790)<span></span>
</td>
<td class="num">(14,629)<span></span>
</td>
<td class="num">(67,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited</a></td>
<td class="num">(400)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, ending</a></td>
<td class="nump">35,993<span></span>
</td>
<td class="nump">39,819<span></span>
</td>
<td class="nump">51,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Exercisable</a></td>
<td class="nump">27,781<span></span>
</td>
<td class="nump">30,285<span></span>
</td>
<td class="nump">39,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward', window );"><strong>SARs, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Oustanding, beginning (in USD per share)</a></td>
<td class="nump">$ 46.48<span></span>
</td>
<td class="nump">$ 38.55<span></span>
</td>
<td class="nump">$ 31.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in USD per share)</a></td>
<td class="nump">102.51<span></span>
</td>
<td class="nump">89.64<span></span>
</td>
<td class="nump">83.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in USD per share)</a></td>
<td class="nump">42.08<span></span>
</td>
<td class="nump">28.45<span></span>
</td>
<td class="nump">27.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in USD per share)</a></td>
<td class="nump">63.43<span></span>
</td>
<td class="nump">63.43<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Oustanding, ending (in USD per share)</a></td>
<td class="nump">52.36<span></span>
</td>
<td class="nump">46.48<span></span>
</td>
<td class="nump">38.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice', window );">Exercisable (in USD per share)</a></td>
<td class="nump">$ 40.73<span></span>
</td>
<td class="nump">$ 36.91<span></span>
</td>
<td class="nump">$ 30.77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CashSettledStockAppreciationRIghtsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of cash-settled stock appreciation rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CashSettledStockAppreciationRIghtsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_StockSettledStockAppreciationRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock-settled stock appreciation rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_StockSettledStockAppreciationRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6847110640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and post-employment benefits</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other charges</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Total restructuring and related charges</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax', window );">Venezuela currency devaluation</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Venezuela deconsolidation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_Developmentandlicensingincome', window );">Development and licensing income</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(10.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other items</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherIncomeExpense', window );">Total other expense</a></td>
<td class="num">$ (2.5)<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_Developmentandlicensingincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_Developmentandlicensingincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838165904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Amounts Recognized in Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">$ 69.4<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">70.2<span></span>
</td>
<td class="nump">73.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome', window );">Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(11.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome', window );">Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="num">$ (1.2)<span></span>
</td>
<td class="num">$ (0.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844636304">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>(Reclassifications AOCI) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
<td class="nump">$ 1,599.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,234.2)<span></span>
</td>
<td class="num">(1,172.0)<span></span>
</td>
<td class="num">(1,086.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8.5)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
<td class="num">(7.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Pension settlement charge</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">291.8<span></span>
</td>
<td class="nump">240.7<span></span>
</td>
<td class="nump">222.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(59.0)<span></span>
</td>
<td class="num">(41.4)<span></span>
</td>
<td class="num">(80.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">241.7<span></span>
</td>
<td class="nump">206.9<span></span>
</td>
<td class="nump">$ 150.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.8<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Losses on Cash Flow Hedges [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.4<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2.6)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.8<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Losses on Cash Flow Hedges [Member] | Foreign Currency Contract [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.0<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Losses on Cash Flow Hedges [Member] | Interest Rate Swap Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Losses on Cash Flow Hedges [Member] | Forward Treasury Locks [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Defined Benefit Pension and Other Postretirement Plans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification out of Accumulated Other Comprehensive Loss [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service credit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (loss) gain</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2.0)<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>wst-20191231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:wst="http://www.westpharma.com/20191231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wst-20191231.xsd" xlink:type="simple"/>
    <context id="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f56fa522aba4347a769ceb8b2131331_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i1ecebe1ac085442a9fcafcfcb6dea5b9_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i710deda8952743be8f828089af9cd00d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieecec5a0e59d4a618aff5d091e295a63_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i93edb6fbbea140fbb4c158d60be85402_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="iac89a5ed6468416b954a6d59e93629c9_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="ib69c911484784ff7a59966d8a7af0ed0_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i5f31229f62de404da8827c5ece21e752_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i18dd631cd0f04e0ba55e512d49411755_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i68b43b173ce141aebdc6cada18dd16ec_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i28ac7a64b1174ffdbf7756a30346e4c6_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i63ad3b3b7bf848afa7195c490bcbc124_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i4575754faab44617861e28e31c5333e6_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i22926bbe0d8140baae5202df1227e9e9_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ia2bb2237e0bf456cbd5e22b740b8ee66_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i345008dff47d4290a0527300056fd7e4_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i112779a33c9549a2a1e6ad79daa2521c_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i6e529adeb51c4013a1e2867fc2c654a8_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7a9668a28ec340d18d524b415f8ae63c_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="if2a7c56a3d9349b585ddce443188576b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="iaabf64c6efeb4ff68ff50ae560a0e2a1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i2593d47d63744a01ad1ef0a31243b137_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie83aebbd70244c51b7c3c99d188dfa54_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i98bb331ce4d3451dbc548acf205baab6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia2125fc186e24ff583ffd6d2cbfeeabf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i34ea6f372d13421d9d8f0f909df6b05f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9fd4b9307ef443f8b750812dd815616b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie1c0bfc76dab4660a6dee12ff3e6f75a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5dbdcdd33a9544e0b1ff9915c052d4b4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic8619d0eee6a4571ae753f283f316223_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ife6de079702a446a909c0761fb4355a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id147ab88ff2d492590eb6168cdcfbc21_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib1cf95202daf4d82a61721c34a7388af_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i33c93a4501344846964d319fe27f7071_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a596f80b14841c4a875b755bfc6bdd8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i29ada30e40a84d7f9ccb23e70b3c3f64_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i449c08ea3f444ab2a681565eeb8cd351_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic5e2483f32b14044bd9f5d96ac49cac9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e7523417a4c4eb7954baff026cc2dc7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6dc1473063042a993f976b7cad5d115_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icbcb7101f4b347c386f48f408e3ef92f_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i8d77cb69d6a14565b31edce03b6c02c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ae050fec07a41a1ad0d8ace81bbadbd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i233817b047df4ab4a84d4b14575f9f25_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="i2a2868b8c8554bf08566aa6693065131_I20130630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-06-30</instant>
        </period>
    </context>
    <context id="i206cd48a54414476aa718a6e0111302f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3cfed53a74b468cb29ff189c2377269_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i94338860cdfc4c5c8a8a280138f4eec0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:BiologicsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i17b4a6ef0fda43fc8f9f9d4f83f071a9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9deaff27fd544743b1c994ebf17f9064_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:GenericsCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if213b8734da249fd94de624effacc125_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4fea264d5e3a41b6b564f9b5e494a691_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:PharmaCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3f203ca7692647f9ad837576643bf7b8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibeb2cefdf0cf432eb6f5b7d915d85fc5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wst:ContractManufacturedCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if87ccca3baba4a5395c1b9dc357f28b1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9c242a3de0ae43649e6e851b01494740_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:HighValueComponentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i18bdeec0a55048dda5a14c6fef41b7a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9dfa01f2e8de483cb3ee9d49bc79dc3e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:StandardPackagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iac8f1d1fb3f74df2a85e394a8eb7560e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i282d10e015594727b9481e65e9dc6cc3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:DeliveryDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id8848d2f515c4077b4f7260b808d43f9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8472c3bc9a9d4f95b15a5c727249f384_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id71e4d3f80ab475b8388901e312bddb1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc5498ad1a414e15bf91e6c05c11a237_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8c247c9265104fd983758887d598a274_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i14a6633405de48c18ad9dd4624d66563_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifbec786ebf7d48a3b104bb1d4b9fcd56_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie1d3206f6ead449095a75f97c9ea7d4a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i46836a3158d542afb32cd1e654a0c77d_D20190101-20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-01</endDate>
        </period>
    </context>
    <context id="i4ecf186e93644ab891c8d431739b0932_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0bb40d435fa14466b3b81d438b389a9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f3de1c6f6fe45f6b458941cbcce9c89_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i072cba6507a54b579148c043620aac02_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8bad24d1776a40448ef8b8ec4302b349_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic9a6eb4dd6a7413aa8ceaa3c09928e24_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80e9aba82fbc4331be3320b17f956428_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i28f45a82c6a848438e8a0997d7c86692_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i444fecb15f1e48779e2506de06cd3906_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i65529b8816d44f1e8f82c472ecfd4c41_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic95407f4963a4c28b32add928e5039ed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icd7312c6ba844d1aa28e958e6af15331_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic729fd36e94941198d96cc6d4ce68a25_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibfb480f0f96a47448a5795388ca43da9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i70792108505c44a39433fc64251bb816_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2dafa88e942442b4b0e84b4bbaa57641_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i35452878f20d488ca8c0c5945f7c5a56_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie4538d252d0f4c568c400e1ed7914057_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i63edb0c1b14e4ce8928a6297cfb75091_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ToolsDiesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i33000cbc9d234e3199e997271c9fa20a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i231518ba36c64c4092eb780bf33ded51_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wst:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7d7f3d86824a4066a23c46e16851c996_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i317d53aa6f2d4db580df360452af00b7_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i89cf005616044c5e8e5067ff128a6379_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:WestCompanyMexicoSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1e7eb7b421641b6b38d74b93995f136_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:AluplastSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i649d27b290864823b58120ef0a909e69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaTapSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8604ed7fa7ef45dfa5249a8547428da8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:PharmaRubberSADeCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff6398961be24db984f094bedc419067_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:IWPharmaGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e7adf4b261e42b0ba535696463b6408_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34154b71394444eea4aac71d4bd6a886_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib03c963f83384e04af745078ed7c6c28_I20191101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-01</instant>
        </period>
    </context>
    <context id="i135f442ad6834fb6b1c797458a39a2ee_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wst:DaikyoSeikoLtdDaikyoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i10b2bd972c5247c89ad526ba8664ceea_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i9b16d7361925410886eeb15e971ce722_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic2afcfd5d059438e8bc7bc4552794714_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i529afefe3a5146a8ae99168ace63b1f5_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if22f0c39a4254fd9831626f40147da4c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic2831b7068f5415993b76a543c279df1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i745e6936945c4146b553af9a8d7a2d88_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wst:PatentsAndLicensingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i90dd87315fb54344b4f25c4ac0d5be42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id025bdb034db45568a0aa20c7a5a88e0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6bb357a5970a432e8774216e7e63f9a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i370687821342468aa0b202a3b92a0f3a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i930683f0ef754186a359e86df7c8ec95_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie38e99e04c054de492c86997ca5d77b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib9a4a99992a34bbfbd4970a826236a2a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie0002a699af14295b2302af2a16bab97_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:NotePayableDue2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ife1cf0309fce4ebd9ef5c548ba5929a5_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:Revolvingcreditfacilitydue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6676f9d8fa624212a28167a0b290deb2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Domain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia9eb640c923f4733a19388100c5bbed7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91c99566b2144913acb7f361f5c22294_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i88b05261cd00424e9002e44c4d03c23e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7b22bd295c93485fb2d2ff977a010756_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i303951a1d742421f9ca04aef7b201e68_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib25bd41fa2f6434989c8b30e7094cd66_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:DomesticLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i42fb76fda75b4b14a4664b19c1e784dc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ForeignLineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24ec845a2a624436a8201d02881d6167_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i28d2da44a3ca41a68e529adf0d248f25_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i984913c14dbf4de19cd8e36ccae92f15_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib9d7d55f956d49e2be8ad5e98d032270_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife43bfe94fc749d880537b4733fda5a9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i78e7486b947f4f99a466314587751bc2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56b5019b842b48aa8fa6565a51c3f1cd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie079f1f282e8458c9a8cdce88d50af68_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaf55a0f044ed4e1a852eca470f62e0d8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie6121497184640d09c106918c72a6948_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i04ab47ee62a5494f909f92a95cc7c70c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:RevolvingCreditFacilityDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id2b82a1b8c6a41898a7270bcd13e5504_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id4fca98c38414a20b353c860de269825_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieb4ecdaaaca7414f9a37335a909966d2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">wst:TermLoanDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8bdb4a99fe0e4bd7a545168d11cbeb80_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i73656a3ae59a40a38eba7861eb07cd4a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i39f68633b1e54492a14344435d453361_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1fb56017b0b444b684e46fe8935ceb60_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i74d6333665a945df9a67c0096b0b8f50_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i342543b0c2f347e9b92ff37b1a7384ad_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia7b648773fa64e1a87127b924772b46e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i830343e85a824475b975c25156e43753_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorNotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifde5cb3bbd874edd8d0787db92019d6f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorBNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i11599bc1fbc343258d69e5c0fd059879_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wst:SeniorCNotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3aeebc15e0d840ad96d6c9b1d2194147_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f67399f84d54d7d9030ffcf5f5c6ac4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9eb6fafaba61400aa82fd9842455a69a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iffd10e01ebd64b78a96cb615682a5c6e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if06d9d35bbb0409183e672452771280d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i823dde1ddb5c418a9c33b324e0c85370_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iad4d547d2e35453f98a85f299454f00a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieafbd5812ce143ef926bb1c0787dfbc6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0350a757f15d45c69e08b7eb2c4328de_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie91724d6f39f459f886db959578117c7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:LongMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i41f0ad8b423640e7ab03461e54ef5610_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SGD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PositionAxis">us-gaap:ShortMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5b88e6dc60f545a3bf0b56c374eb3e15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ida576a4da2ec47b5b4725b7e5768d696_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5e9aa415d9a4ae0894a28edad8214aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib8c160a1ee5b40b5815b9d3cfcebe527_I20171122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="i2d648861366e4cdba756d7642ed7befe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iffca62c03c8741448a75a7f9e1f891ef_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie04ce0467d524a8b80a1b327747a40f3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1b51d389a3a949c1a96cb422c48a5fe8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6516bd8d8ea049f183846349a305264f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iab7e1e117b2f4ca4b60537b7871e437a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i88d7a3c0aeba474fab1d76fe62b33c49_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8b1d512dc5f74c76b6f5691e47874f8c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardTreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0cea4779b5e94dd0a2b87c75a76cf6ff_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForwardTreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i83d0a9a392814a039ab15f60e9215923_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f8b7ccbfafd42afab343384ad715db3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3e81e564ed5e4b758e644f7a48f8ab95_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifad6e6da551a403b9f68328ad4a2647e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">wst:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifb86356e282f48e09566b38bfd145856_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4786eb20ae494021a5b1565f7a6b78cb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7230a373ea8c425db7fc49d912890ad7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3a0f779ffd67404fadb2c88b38a8fdc2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5444a6541e6a4839bba8118e13149c48_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">wst:NetSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifc4590db188d460db03346773c2dfbe4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i06546c728f1b443790dab4e6acbc50dd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifcb34bb0d2724fb1baccf7a4fa927eef_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5398fe0e5da44d5c9cda165e14f5d41d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i938788ff937e43d487f7bb5a02deca1f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i72df90269a054543b29d4dd406291594_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9c77ba79e344403eb264810bc01f9141_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icefa72050c4e4056afec90fa88e94c46_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i56943e3e899240ba88693a4605ca6bff_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i241e5f10a4ee4e61ae7e0c26389d98fd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icff6c5eae2bf4042940d49d48243f475_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if5dac4480e07412789c6a00d0537966a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i49fc1eac9a9a44988c05ab15c2b63dfc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1d4ee3958e024ea9be2a4c855879a06a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i328f95c25c924ece85bbcd0f93f45e60_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i30b7e14d051044b6b066bd549c53bd4b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i54c1d0f284e747c89538b5a73987ad3d_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i9d70b978d8424d62a3d315bd9abaa763_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="icd5b5ea0ff6242348184786c3aa961a1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i61530ee5d64a43f0808f912144af8669_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i20cc775951344c239b53db6971de8efc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0d3c7ebb49d2493aae018dd123c22d48_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i53303cfc86bc4dff961279511a95e263_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5c9924dfc84f437e82ad7ec265e9ce95_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i226a4aed358e47e7960939567dde9022_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i61e147e1374f4056b910aed673effca0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3de8a9a6e8a94858b2a73224b4e7f5fa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if438f100318e4fa3a354238bdb515b75_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4cec6a2db0f04eb8ace95c800f171e3f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if2e238f2cc9d40cb97384f851a4ea42e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6f47dbaaaf6d430698b26cb6d8506727_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iee4a569c86594ed29bf4011534feefa3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7fe96b1532ac40c18a9abf4c6908270f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i52141f7b63cf445d8c4a8244666efd47_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3d9afa908f244094a5308013f6de9d86_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iebf8f5c36fb64d06aff88d876051dba3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9ec88e31a4b8432c9b702366e072bcb8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i09ac587c6b034ba186fc3c9de00c5b88_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i907bb151930c472cb4617e8718b30e96_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia7b4b4807f6a4884893b217405bc6fea_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6b919d55672f4707aaf1d62ddfc9503d_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockOptionAndAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i867e15a5465644589509da385c3661da_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6f53f5cc02db4483948008576a947179_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ied22694c54d942dbbe6f33ff6b1dcfa0_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i257536d153674569b8fd3a765b5ea232_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i7bc4c67901ce44cc8ef5352dc9cb7c54_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i567d1eac07af4457b1dd2b7b2b50501d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idf6f7b5a95fd4d168630008ee5f37653_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:PerformanceVestingSharesOrUnitsDividendEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6077149f426d4ae8a0b5fd6b074a7a43_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i9df6a38179044003b818ff0f67bc84c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d97e40c7db14ee0809a960d3d36fb39_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic2bf2b4179734ec29b0e706a4dd04b3c_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie1169a473b724d8d93c956648282e54b_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa59b208a4dc470ead37d30735e6af30_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia961f06db9c748b8981269960022f06a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i93f7c7e71c7f49ec88d39755fd192a57_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ib0f756b7f10140c7a667c59d6aed2b9d_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i335850f837034b4f92801e3e27dcb7c9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if59d999a99954d12bc5b0af492454ea2_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ice189043bdb14f77817f481da434b9f6_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i7986a8931ce14e87a14397225a1db358_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2930b7a825204376adcd1aaccfb3a4e3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4e8c24828a0f4b248dd1d741a061b3ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:StockSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id624f0b918514c1fa67d18292cb0f592_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3248006f27a44046a786ecae30f2c7b9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="if424c5cbb6af4281b20e4f9016d91f87_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="iba2d66afdb1b460b9bc719352ac92b1b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90a36423c0a44b9986aa0cbeabb16721_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:EmployeeStockPurchasePlanEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia14da4b7cdb047cd878899fb992151cf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if56b24e99d71498ab539bcd0ec6f2c84_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i680ad925db4e48d78b3237fca4762bf7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8169a62ce26b42908772007e3660188a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:IncentiveStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i3b7feba544854c48a311d6c134d52a58_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id9e1503f92494d249bddbebe72901fbf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wst:CashSettledPSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if87f6788dfb44067a1387bf33301a378_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ibcf3086a15804eef96196b34fe5f6a29_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3372ec3c59ed4ec6845462cf9a97844d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if02e282f48e34ea9924bc5e936dee280_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="iec2956a56fea4665ac7855ee4d00856a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i691d61af8bdb48d58e96be31e865a8f0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i05084a034d864aaab4d454ef2374f73d_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ia045884eabdd4675b086f7cbe1088331_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i482e7650de754ebd863450ff98ddd102_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3bc0be5f11db4f4b96289239a9c31f9b_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i437e493b76d849dab6516dfc8137e7a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic213450143c643fcabdf167b9544dd56_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2c070b0619d84059924fa1fee46ec2a9_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i6298ee303c464f0bbd0097078dcab7e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i81168432177b4e14899b98a50ad8eb27_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib0f2d011f88041df81ed72918d912b28_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7a63732b565e43618a5fad775146f15b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8d13573002854b4794e6d272dc9f023d_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ief24d588abd841029d2aa9c0845ad0d7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i026dfb891cba455ab72f03d27baf78a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc6ad07586d04905b438308adf2938bc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icf432c4ed1ca4ca8826cfc7b51ce110f_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="iad1e003ca731453b8c13de225178286f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i71005f2a08e3495aa5b8b71712dd46e7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icef51169ca6c490e91fd071db31d7686_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2ff94b3c95ef4cdf82dcbfbe15cce239_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iae5ec6c92f2841c58c748c66b981c526_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibfe9d51b887b49898618b0e671ee0909_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib2a035cec19e4b06b8a0a0f2b1507211_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i059f6519363e4795ac9e2b62228928ea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic6b75ff5856344798be8d09feba9d76c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib6b6fc1c55ae4f2c8edcfa03284c2531_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i872e47c6d50b462c8e589892b0d54db5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3c0ee7d7ac4d4a6dbfcb60f511f35cc1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if7f540d9be17469abb37970c9409c4b0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if92ca63024e94955aa542248e84899d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i83e89bb3731949e9b811eea8345a785d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1671a272484847b0a73c5e28afdbbc6e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa3a175482f741ac9a27d320bfda7d20_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3c5104f4fc949a7b5a23bb9ae7a2280_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d9ab3e1be7b43a6a9aed789c9de3fe0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0443f666d5124baa94d26af15d452b44_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionplanassetsmeasuredatNAVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7973d3e744414be78965041980c27ae2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id865d211c82f481ba1e8e730281c3396_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2590f85ac39247ee8575a025ddfafb6e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id85ff1c02db44ef69cddfb8fa9561ced_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:InternationalMutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic2cfb2df0ba2490e8bc77e8e71719012_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i049d668d485c4a138de851c7ad4dd119_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia16d87c6eeea4a8a9a6aeceadbe8a2e9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ide50b00aea9546c98b500e0e9ab6663d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionPlanAssetsInTheFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1c5adfefdd0a41bc979246bd31ec015f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:PensionplanassetsmeasuredatNAVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i551f76dde6ca4da6bd01b58607183318_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibef8133166a844e388b00a88119d4a66_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0a698e5c8f8b445582c108fd424dc99f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id309afa6d90f4b3ca6e334c040f495a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i20418919ecf14b199ebd3c21c8ead300_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3b4e26d82c6947d6ac866551afe0974e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">wst:OtherSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9313d976ef2b4f7b845722c3a2d91a03_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0e49cb2c7f3a4e50aac7c89a7a0d7753_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i617f29de38554e598979b53825165b3f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8e0171741848480aabaad6cf352a5967_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5c3b94bf9830453eb8c83e9fe89297ed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iff067a80b3c0472aafbb0d3d5e4c92ad_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i63038b37ba3f4411817f0419317cd970_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a770acf6d014af1b07375d85b007733_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie0e8452d0cd54d09bd29f966f85d7796_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wst:AssetRelatedChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic58d406b08ad4b8ea3459ce6ee377143_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09af60c60dee44a093e76f37f68e79e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2018RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i508d135f28ec440fa57fc415a1e8cc42_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2016RestructuringPlanMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i67268793d14a4d86b86841792ac25b2a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">wst:A2016RestructuringPlanMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9a2c29927a97445985c175fb950377a6_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i17de35ea5588457687be31c78183d563_I20160217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:VE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-02-17</instant>
        </period>
    </context>
    <context id="i1e11b27427cd46d590025400238fdb38_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib48ea9474bfe4c5d806349adbf636277_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6760c6eadf5e4027ab3c48a8a4c417ad_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:SmartDoseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ica512f947d5545b0a280adcd3765b3af_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">wst:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia0a47ab88878443fa4e6adac51e1e3c3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iafeae8bf38a74e0390f625e332ddc2d6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i77e352a3c93e42ae8d803009dcc77900_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i29b000bedbc74b059850aa72d8e23d8a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i57428a739d8c47e29c71f898beabc22b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d6aec77c75b4f37a744be6b762f91c7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i49459769fb524550871915ef2336f3bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i315770c7cae047a4a1c795627dca7961_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d27b8c83d9e4aed8e3bf7c54c872328_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6c33648dc8604a2e97bec4df1cd23f1f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:Year2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6eefab0034b46c0afd45df41bf8245f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wst:ExpirationPeriodAxis">wst:YearAfter2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia4a3ac6bafdc43978ec3c7db0603a567_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ProprietaryProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:ContractManufacturedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i078c4378a1b84554a97a59aedf1dfea7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iec0e5799d11f4ece904985f859626f83_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib2ea62dcc46049b7b44a7e372ea6a995_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ic7f8ebed49c04cffb17e7209463597e7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4e4f0863e8134660bc06abb0a0554e60_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i11483b8c07b24a0285c429890af29b9b_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="id465de2bff9a44b58c23173587870451_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7d5c2cd9d804dc19f76970e86ae5660_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i30dc74ba8e0b46938ade75bfad703ec4_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i9f4a7e1e4f344e59acb8e316afa24ca7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i02b772a610de4ee59ff680dfeb546f55_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibdf9bc802dfc4329a0be62772f1a8f6b_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i2f86ebc34b44436088bdd5978d8e3e07_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fc499a8a70a4e75bdc070421802e388_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie056e2b910a94d86a17d8e9f6a20dc06_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i476449ab4421489bb9b91517a6fc7efe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i85b512abe143458ebeb74749610bb670_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibe71ee072f1e4070b5fe8ef25b5b4c68_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ief76596d19a14b5699a2fde2cb8e562b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7ef689740fa64b5883e5e5174f62fe1d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i048c1c583b8248d7a9ab445c65149f1e_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i903f49cdebbd412fb6eb73679c880d2e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i29c04b723e3b410593ed485b6a229bfc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i917cb1338bde49fd8e568f601fd1e22a_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ib6dd3862267a4178a471745a2b35ad9e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id92da6f6ed734f7aa39fcd3fd2e821c3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id9a7d300fbe84c79a997b01a28de9fb5_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ibbc09f1765984af1a548e59801303ef6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i53739c8ad7af43158f8713882ca97f50_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibe7421492df04bb4bddbdcbf7176b677_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ib228924631aa44288381badfd1e2059e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i29700e0161cf4255a1c0d184517c3f32_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i319915b8ecd44b91bcc26caf2f45657e_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherEuropeCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ic9b2e0330857436684b723ea8478ec77_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibcb96f50eb494612ba0edad271cb1096_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iafe47744d2e84db7a253c53f75362e62_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i8b9f65fe26504bfe928b879458ca9505_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if148c501c02e4e2c97646022381c7196_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib47295db1ad64e7c8b1a5e5f348d4c2b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wst:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9a1c2431d80b42aead2763d611b9d0e5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i509b63e47a3144be9248957ca04eda93_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iad3960c7889746f797e090bc457710a9_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i1350bd4286de44cfbac587447b6169de_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wst:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i63c8f0dd6fd44e0192bbca698c80730d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id6ac79d82bd448c79b4fdc95685aab8b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iafcda053ab8e47e38f791920cd9cf950_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09e8d9cf8ecf49a8bb93848beaa81037_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iee5aa6955d81437b952a802f4ada2d98_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2ee0f05c56c248109cf70bf6a1dfcf1d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iabc48380a0f84fafbbd805cba9caddec_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6b41e0d9c7ef435a9edc553f82a3fba8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i48adb9af41f141dbba997f45f6e7b647_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i61105e0ada8748f28fbbec27f4b1f63c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib8e071d9eab748839372112a8d75b384_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="ic7003c1f4ab54e5c92dc94b3582d241f_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="id0bb2326a07b4350912a6c72afbe1a89_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i935b128fab324f209cb4528dec5e49f2_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="sgd">
        <measure>iso4217:SGD</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="bbl">
        <measure>utr:bbl</measure>
    </unit>
    <unit id="usdPerBbl">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>wst:bbl</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="plan">
        <measure>wst:plan</measure>
    </unit>
    <unit id="segment">
        <measure>wst:segment</measure>
    </unit>
    <dei:EntityRegistrantName
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8zLTEtMS0xLTA_37596e15-32a8-47ef-ae13-037ef6b13199">WEST PHARMACEUTICAL SERVICES, INC.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl80LTEtMS0xLTA_01928443-d96e-40d3-81e0-a289f7cce8b0">0000105770</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl81LTEtMS0xLTA_114e6d36-d13b-41d8-8328-00adf7531682">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl84LTItMS0xLTEwOTI4_450b1b14-ddac-4b9a-9606-cbc2dc6e8088">2019-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl85LTEtMS0xLTA_36f648e9-9e30-47cc-8817-d7ab3c6a8f0e">2019</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8xMC0xLTEtMS0w_c16aeb1e-73f4-4641-aefe-83b6f7677eba">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8xMS0xLTEtMS0w_be04e75b-5cb9-4cc9-ac9f-1fb67570ad66">false</dei:AmendmentFlag>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1ecebe1ac085442a9fcafcfcb6dea5b9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8xNS0yLTEtMS0w_edd0e3f4-b596-471e-99fa-49bf21029e64"
      unitRef="shares">73837449</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityPublicFloat
      contextRef="i8f56fa522aba4347a769ceb8b2131331_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180L2ZyYWc6MGM5ODkwZTQzZWI4NDlkMDk5MWZmNTUwYjE2ZjgxYTcvdGFibGU6ZDBlOTkwNDBjNzFhNGY5MTkzZjZmY2Q4MjQwMDBkZmYvdGFibGVyYW5nZTpkMGU5OTA0MGM3MWE0ZjkxOTNmNmZjZDgyNDAwMGRmZl8yMS0zLTEtMS0w_78b9a4e4-e8d9-4597-be29-c1ef5e5d0030"
      unitRef="usd">9218126218</dei:EntityPublicFloat>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMi0xLTEtMS0w_236aeb8d-8a39-4706-8b34-e96d3762af65"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMi0yLTEtMS0w_3ab20adb-7a05-4297-9799-c8ada719253f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMi0zLTEtMS0w_dc760296-bad6-4eae-931f-f317a290f471"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMy0xLTEtMS0w_33787d4c-efa8-4dff-b1f7-95659bf757de"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMy0yLTEtMS0w_0f2e0dc6-e4d5-4ae0-ac3e-7b1dc343c07b"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfMy0zLTEtMS0w_b735b1ff-41ad-4717-91be-0a6d40ac0dd3"
      unitRef="usd">1300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNC0xLTEtMS0w_1d1fed4d-799f-40e9-8f84-211b0ce9e964"
      unitRef="usd">800000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNC0yLTEtMS0w_525d983e-1111-4d2b-a219-5bc0fd888fda"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNC0zLTEtMS0w_cbfedf8b-8583-4f6c-aafc-a14b4d1e815a"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNS0xLTEtMS0w_0ebabdc3-35dd-477c-8323-fc2d1de20b1a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNS0yLTEtMS0w_4637c023-477e-4027-946c-53f53b9446f0"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNS0zLTEtMS0w_89331ab2-79d1-4d3c-bb7f-88baf24299db"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNi0xLTEtMS0w_7d96e327-c6bd-4d98-ac5f-09b5804ab610"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNi0yLTEtMS0w_c9768323-0f9a-47c0-9479-705eaec48147"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNi0zLTEtMS0w_17c23cef-80a2-485c-8bcc-099e26b2292c"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNy0xLTEtMS0w_f2896b85-ce66-4cb6-82c7-2a78def150c7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNy0yLTEtMS0w_dfb947a8-669d-451d-80ae-f0eeddf5c051"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfNy0zLTEtMS0w_829672eb-e81a-40c6-8125-ad52560d65a2"
      unitRef="usd">-2500000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfOC0xLTEtMS0w_8d690bce-6172-4c4a-bccf-c9a0720a577e"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfOC0yLTEtMS0w_236b9042-5f5c-4975-96e0-e33cc73717ee"
      unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182NC9mcmFnOmY2NDBjZjkxYmZkNDRmOTI5ODM3Yjk0YmEzNzdmMjM0L3RhYmxlOjA2YWMxNjAwMTRlNzQyODE4ODg0MDcwNzY4ZmIyNGM5L3RhYmxlcmFuZ2U6MDZhYzE2MDAxNGU3NDI4MTg4ODQwNzA3NjhmYjI0YzlfOC0zLTEtMS0w_7bffd9ec-b485-4c62-9f91-a4c39e8d02c9"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMi0xLTEtMS0w_c18810c9-c524-4087-bd46-33c878cb66e5"
      unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMi0yLTEtMS0w_b624cd06-c9c7-4d15-b872-c18a4eeb409f"
      unitRef="shares">3000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMy0xLTEtMS0w_98da3c9f-748a-440b-8aa8-207f693f1d34"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfMy0yLTEtMS0w_aa540c3f-b538-40d3-82c6-444565d37dca"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNC0xLTEtMS0w_fd69efae-75b1-4b49-b069-5dfc16a5f4bb"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNC0yLTEtMS0w_3092d46f-b621-475b-bdf7-13c317a67c54"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNS0xLTEtMS0w_eb7fd6b5-2d5c-4c9a-b728-6ade6dd4fb35"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNS0yLTEtMS0w_f876bd49-b78c-4595-8f62-5faf1d2774a0"
      unitRef="usdPerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNi0xLTEtMS0w_bf932e19-5c5e-490c-931f-548a6d790c32"
      unitRef="shares">100000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNi0yLTEtMS0w_71ff901f-2c37-476b-b5af-8da49b78c98e"
      unitRef="shares">100000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNy0xLTEtMS0w_ef778bf7-7c0b-4876-b23e-6fbcfc5e309a"
      unitRef="shares">75300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfNy0yLTEtMS0w_cfc5bbf5-41eb-4db4-818c-876c73bc87f0"
      unitRef="shares">75300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOC0xLTEtMS0w_a8b1ad92-7df8-45df-87b8-82aa8d2abdaa"
      unitRef="shares">74100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOC0yLTEtMS0w_32eb0dd8-283e-49ab-975a-3cab46cdd65b"
      unitRef="shares">74100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TreasuryStockShares
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOS0xLTEtMS0w_eed10ac7-4ba9-47cc-b7d3-938a301f05e0"
      unitRef="shares">1200000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183MC9mcmFnOjNhOGRlNTAxMzJlZTQ0NWU5NGU5MGM5MTEwNjFkMDZjL3RhYmxlOjc0MDdhOWUyODkwNjQzNDA5YzRlZjQxMTgxZGM5NjI2L3RhYmxlcmFuZ2U6NzQwN2E5ZTI4OTA2NDM0MDljNGVmNDExODFkYzk2MjZfOS0yLTEtMS0w_ab31ece4-fa83-4db7-ac69-9ea9d414a39e"
      unitRef="shares">1200000</us-gaap:TreasuryStockShares>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjU3L2ZyYWc6M2U3ZWE0MjhmY2E1NGMwNWFlZGExNThlNWNmNDE0NTMvdGFibGU6NzczNjQ3ZDVhM2UzNGNkMzliOGY0YTA4MTI4YmU4YzcvdGFibGVyYW5nZTo3NzM2NDdkNWEzZTM0Y2QzOWI4ZjRhMDgxMjhiZThjN18xLTEtMS0xLTk4MDg_c5f954ca-fe7d-41e1-b80d-2ee2806ab583"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjU3L2ZyYWc6M2U3ZWE0MjhmY2E1NGMwNWFlZGExNThlNWNmNDE0NTMvdGFibGU6NzczNjQ3ZDVhM2UzNGNkMzliOGY0YTA4MTI4YmU4YzcvdGFibGVyYW5nZTo3NzM2NDdkNWEzZTM0Y2QzOWI4ZjRhMDgxMjhiZThjN18xLTItMS0xLTk4MTE_9ddc69a8-3d67-4781-ae5b-a243d03acc26"
      unitRef="usdPerShare">0.58</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjU3L2ZyYWc6M2U3ZWE0MjhmY2E1NGMwNWFlZGExNThlNWNmNDE0NTMvdGFibGU6NzczNjQ3ZDVhM2UzNGNkMzliOGY0YTA4MTI4YmU4YzcvdGFibGVyYW5nZTo3NzM2NDdkNWEzZTM0Y2QzOWI4ZjRhMDgxMjhiZThjN18xLTMtMS0xLTk4MTE_97154482-fde3-4041-8848-3009ace4687c"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="ibfb480f0f96a47448a5795388ca43da9_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzItMS0xLTEtMA_9868b72c-5b00-453a-aedd-4b371624675e">15</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i70792108505c44a39433fc64251bb816_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzMtMS0xLTEtMA_50df2b46-23c5-4e47-8981-252024c9bdb8">35</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i2dafa88e942442b4b0e84b4bbaa57641_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzYtMS0xLTEtMA_e0a3dcda-b298-4d60-830a-e670abdf659e">5</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i35452878f20d488ca8c0c5945f7c5a56_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzctMS0xLTEtMA_640c6db9-7d08-4f52-9931-0c9da70fb442">12</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="ie4538d252d0f4c568c400e1ed7914057_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzEwLTEtMS0xLTA_d2d240c0-5c5f-487e-9e80-d6a86c150c55">4</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i63edb0c1b14e4ce8928a6297cfb75091_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzExLTEtMS0xLTA_a4dbeaaa-25b7-47ba-816a-3b34d3b7c6d2">7</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i33000cbc9d234e3199e997271c9fa20a_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzE0LTEtMS0xLTA_794b04a6-8a67-4bd1-b312-d37711085217">3</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="i231518ba36c64c4092eb780bf33ded51_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZToyYTcwNTNjYzI2Mjk0ZDM4YjA5ZmMyNDViY2YzZmM1OS90YWJsZXJhbmdlOjJhNzA1M2NjMjYyOTRkMzhiMDlmYzI0NWJjZjNmYzU5XzE1LTEtMS0xLTA_16dea48c-700a-481a-858b-954876c50794">10</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:CapitalLeasedAssetsGross
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDAvZnJhZzo1NzdiZGQ3YTc0NWU0Yzk4OTgyMDE1Yzc4ZWFlMmM3ZC90YWJsZTo3MzBjNjJmOWU3MmU0YzM4ODk4ZGJhZDBlYjcyNjNkNi90YWJsZXJhbmdlOjczMGM2MmY5ZTcyZTRjMzg4OThkYmFkMGViNzI2M2Q2XzEtMS0xLTEtMA_1ac7aa87-33bd-44e2-a80a-1ae14b531d5b"
      unitRef="usd">0</us-gaap:CapitalLeasedAssetsGross>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i7d7f3d86824a4066a23c46e16851c996_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5MzQz_3df9f4a3-52e4-45a8-8ae6-d4e15b74807d">P5Y0M0D</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:CostMethodInvestments
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDYvZnJhZzowNjEzNTFiMjg2OTk0ZmIzYWMyZGIzNmUyYThiMjViZi90YWJsZTpmYWNiMjg1ODcwZDM0YmM0OGU2OTdkM2NiMWQ5YWQwZC90YWJsZXJhbmdlOmZhY2IyODU4NzBkMzRiYzQ4ZTY5N2QzY2IxZDlhZDBkXzItMS0xLTEtMA_12b14206-5c40-4bf8-bd5b-4f9fcf9d614e"
      unitRef="usd">13400000</us-gaap:CostMethodInvestments>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzUtMS0xLTEtMTE5NjM_220a4eee-0ef1-41a6-a098-538f91ce8b2e"
      unitRef="number">0.0278</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i830343e85a824475b975c25156e43753_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzUtMS0xLTEtMA_2ef602db-f703-45a7-bddc-e5ae10510a12"
      unitRef="number">0.0367</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifde5cb3bbd874edd8d0787db92019d6f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzYtMS0xLTEtMA_1f09d08d-0a0b-48bc-b928-4c00b129d53d"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i11599bc1fbc343258d69e5c0fd059879_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzctMS0xLTEtMA_1931cb79-3e81-4cdc-8301-339a81390e50"
      unitRef="number">0.0402</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTgvZnJhZzoyZmU4N2Y2ZDc2NGI0NTI3YjA2NGNiZWZkMjc1Mjc4Ni90YWJsZTpkZGU3NzU2NDhjYzg0OWNmYmU3ZmM3NDkxOWNlZjAwMC90YWJsZXJhbmdlOmRkZTc3NTY0OGNjODQ5Y2ZiZTdmYzc0OTE5Y2VmMDAwXzktMS0xLTEtMTAzNzc_528f9a6e-895f-4817-a690-486e55f17f95"
      unitRef="usd">2300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMjY1L2ZyYWc6ODk2Y2RiMTZhZWQ1NGU3NGFiMjc5MzI1YzgzNDQ1ODUvdGFibGU6ZmQ1MzU1MTBlNzY5NGY0N2IyOGEwZGMxNWYyZTRhMjEvdGFibGVyYW5nZTpmZDUzNTUxMGU3Njk0ZjQ3YjI4YTBkYzE1ZjJlNGEyMV8xLTEtMS0xLTEwNzAy_313a1867-32e5-4c91-93eb-a83f04ba338f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU1MjU_5649237d-81f3-42ad-be9c-00e04ab34944">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzEtMS0xLTEtMA_1f69504e-9722-46d1-9921-a3b81f5bb574">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzEtMi0xLTEtMA_a8160fbd-d2e0-4a5d-af8e-fa8b5ed5596e">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="i3b7feba544854c48a311d6c134d52a58_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzQtMS0xLTEtMA_721eeab5-88cc-4639-a7da-42cbed405dd1"
      unitRef="number">0</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="id9e1503f92494d249bddbebe72901fbf_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzMvZnJhZzpkZTA1MDhmZGY2MTU0MzUwODkxMjU1NzM3YWYyNDdkZS90YWJsZTpiOWNmZTI1YzI4MTg0OWRlYTJjYzZiNDMyNjg4MDAzOS90YWJsZXJhbmdlOmI5Y2ZlMjVjMjgxODQ5ZGVhMmNjNmI0MzI2ODgwMDM5XzQtMi0xLTEtMA_ade047f6-2741-47c4-ae57-4f61a8555a00"
      unitRef="number">2</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription
      contextRef="i551f76dde6ca4da6bd01b58607183318_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzEtMS0xLTEtMA_5b871705-2aaf-47ec-b746-606f418e3588">0.27</us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription>
    <us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription
      contextRef="ibef8133166a844e388b00a88119d4a66_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzEtMi0xLTEtMA_26d66bf9-9d0d-4343-8499-745e250fbd74">0.33</us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription>
    <us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription
      contextRef="i0a698e5c8f8b445582c108fd424dc99f_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzItMS0xLTEtMA_88517aba-68ed-47f1-b7c0-cb6c07005935">0.67</us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription>
    <us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription
      contextRef="id309afa6d90f4b3ca6e334c040f495a5_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzItMi0xLTEtMA_03b21684-4f35-4048-8e24-7b6234446ead">0.73</us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription>
    <us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription
      contextRef="i20418919ecf14b199ebd3c21c8ead300_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzMtMS0xLTEtMA_ef0c26b6-5e00-4559-92be-a9ec065e6ca2">&#x2014;</us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription>
    <us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription
      contextRef="i3b4e26d82c6947d6ac866551afe0974e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTozMDA0ZDVkNmZiMDE0ZDNjYWJhZTYyODhkMzlhZDQ5OC90YWJsZXJhbmdlOjMwMDRkNWQ2ZmIwMTRkM2NhYmFlNjI4OGQzOWFkNDk4XzMtMi0xLTEtMA_ae2d9c45-106a-4ca4-aaa0-67733c3b19cb">0.03</us-gaap:DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i9313d976ef2b4f7b845722c3a2d91a03_I20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzkvZnJhZzoyOWNiYTA5M2FmYTY0Mjg2YTUyNDFhMzI1OWFiZGE1MC90YWJsZTplZDQzNzMzMThhMWU0NDk5YmYwODI2Y2M2MTU3ZmE4Yi90YWJsZXJhbmdlOmVkNDM3MzMxOGExZTQ0OTliZjA4MjZjYzYxNTdmYThiXzEtMS0xLTEtMA_e46706e2-6726-4e17-a96a-bbc8fe62148a"
      unitRef="number">0.0425</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <wst:Developmentandlicensingincome
      contextRef="ib48ea9474bfe4c5d806349adbf636277_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDUvZnJhZzphNGEzZmFlZDY1YWQ0YjZmYmM1MjEzOTgxM2IyZDJkZC90YWJsZTpmOGY2MTY5MmNjY2E0OGQ4YWFmMDE0OTE5NjQxM2ZlNy90YWJsZXJhbmdlOmY4ZjYxNjkyY2NjYTQ4ZDhhYWYwMTQ5MTk2NDEzZmU3XzEtMS0xLTEtMA_0d07c737-e6c6-4c6f-8dba-fc16c2b95f74"
      unitRef="usd">900000</wst:Developmentandlicensingincome>
    <wst:Developmentandlicensingincome
      contextRef="i6760c6eadf5e4027ab3c48a8a4c417ad_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDUvZnJhZzphNGEzZmFlZDY1YWQ0YjZmYmM1MjEzOTgxM2IyZDJkZC90YWJsZTpmOGY2MTY5MmNjY2E0OGQ4YWFmMDE0OTE5NjQxM2ZlNy90YWJsZXJhbmdlOmY4ZjYxNjkyY2NjYTQ4ZDhhYWYwMTQ5MTk2NDEzZmU3XzEtMi0xLTEtMA_947e5923-1427-492a-bfc7-bd81000ef4f1"
      unitRef="usd">1500000</wst:Developmentandlicensingincome>
    <wst:ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzExOTk_3f334523-3b30-4be6-b24a-5b3930387693">P5Y</wst:ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod>
    <dei:DocumentType
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NTUzN2IyYTQ2ZGUzNDU1ZjlhOTI3Mzg1YzE0ZGYyMjcvdGFibGVyYW5nZTo1NTM3YjJhNDZkZTM0NTVmOWE5MjczODVjMTRkZjIyN18wLTAtMS0xLTE5Ni90ZXh0cmVnaW9uOmQwY2I4OWRmZjExNjQ1NmNiZjQxZGZjZTFmYzQ3YWQyXzEwOTk1MTE2Mjc3OTM_d699d2a0-35cf-4d98-ad7d-f0b409efd2a8">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NzE4MzkwNjdlYTU3NDRkMmEzNTA1NDU0NDc4YTA1MzEvdGFibGVyYW5nZTo3MTgzOTA2N2VhNTc0NGQyYTM1MDU0NTQ0NzhhMDUzMV8wLTAtMS0xLTE5OQ_825288f5-8547-4e0d-8528-512a2af94f89">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjM0NTA5_450b1b14-ddac-4b9a-9606-cbc2dc6e8088">2019-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6YmFkZTEzMWNmNjFlNGZjN2FjYWNmYWVmNTczZDFlMDEvdGFibGVyYW5nZTpiYWRlMTMxY2Y2MWU0ZmM3YWNhY2ZhZWY1NzNkMWUwMV8wLTAtMS0xLTIwMg_9548a4a6-45a5-4ecb-a6a8-6c39fa5062ee">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTU3_b0b18d63-3839-4586-a7c6-aa83d01906a8">1-8036</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6ZWQ2OGFhY2Q5YTE3NDYxMzg2NzdmOGM5YmQxZWZjZjkvdGFibGVyYW5nZTplZDY4YWFjZDlhMTc0NjEzODY3N2Y4YzliZDFlZmNmOV8wLTAtMS0xLTIxNi90ZXh0cmVnaW9uOmIxY2M3YWQxMmI5YTQyZTFiZjFhM2Q1N2QzYzg3NzU2XzEwOTk1MTE2Mjc5MDU_37596e15-32a8-47ef-ae13-037ef6b13199">WEST PHARMACEUTICAL SERVICES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8wLTAtMS0xLTI2Mw_53c08fb5-12f3-473b-9b71-34518f19329a">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8wLTEtMS0xLTI2Ng_b75bed8c-f6ef-4df7-9e74-e4f2d1ef876f">23-1210010</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTAtMS0xLTE3NC90ZXh0cmVnaW9uOmNkODY0Y2I5MDU0MjRjMGNiYzlmNDJjYzY3ZDVjMzcyXzEwOTk1MTE2Mjc4Mzk_1f119f99-c0cb-45ad-aa9f-ed3186ef00c8">530 Herman O. West Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTAtMS0xLTE3NC90ZXh0cmVnaW9uOmNkODY0Y2I5MDU0MjRjMGNiYzlmNDJjYzY3ZDVjMzcyXzEwOTk1MTE2Mjc4NzA_4659685c-bbaa-4174-8a09-4c1ba0fa1ca3">Exton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTAtMS0xLTE3NC90ZXh0cmVnaW9uOmNkODY0Y2I5MDU0MjRjMGNiYzlmNDJjYzY3ZDVjMzcyXzEwOTk1MTE2Mjc4NzQ_ffa85ced-4010-4552-9f90-1a1e0d8199f4">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWFkMDMzMTAyNDBhNDVhNGE1OTJjZDE4YWRhNWE4OTgvdGFibGVyYW5nZTo1YWQwMzMxMDI0MGE0NWE0YTU5MmNkMThhZGE1YTg5OF8zLTEtMS0xLTI2OA_52ee64c6-c26d-4df2-9b1e-c3ce9afb1859">19341-0645</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTA0_7e93ccc5-a936-4269-943a-158489fa556e">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTA5_d49982ba-f60c-4e82-b854-4b2bc9c934ff">594-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWM5Y2I3YzUwNTlhNGY2YzhiMWQ5YTM1MGY5NTNiNWQvdGFibGVyYW5nZTo1YzljYjdjNTA1OWE0ZjZjOGIxZDlhMzUwZjk1M2I1ZF8xLTAtMS0xLTI3Mg_2a03776c-eb50-4f37-8a77-9d15c479f8f3">Common Stock, par value $.25 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWM5Y2I3YzUwNTlhNGY2YzhiMWQ5YTM1MGY5NTNiNWQvdGFibGVyYW5nZTo1YzljYjdjNTA1OWE0ZjZjOGIxZDlhMzUwZjk1M2I1ZF8xLTEtMS0xLTI3NQ_d7595ef5-a1ad-486a-b7ba-9c2a6deedaa1">WST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6NWM5Y2I3YzUwNTlhNGY2YzhiMWQ5YTM1MGY5NTNiNWQvdGFibGVyYW5nZTo1YzljYjdjNTA1OWE0ZjZjOGIxZDlhMzUwZjk1M2I1ZF8xLTItMS0xLTI4MA_9a8e8214-d8f8-43b1-9f1b-5c8ca8fea52e">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc1_46bc29c2-a7a3-4f2f-ad53-8c86bdd0972b">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc5_df455388-3caf-44da-82d7-aa6bc122a56f">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc2_9489b403-032c-489b-b66c-4b24942ea16b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc3_2b0e2bb9-f2e2-4f62-b0fe-17ea86903729">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6MTFjNTJhMDgzNTMyNDBiMjk5OWMyMDZmZWYyMDc0OWMvdGFibGVyYW5nZToxMWM1MmEwODM1MzI0MGIyOTk5YzIwNmZlZjIwNzQ5Y18wLTAtMS0xLTI5MQ_6957b5a8-4724-4331-8f19-d2452be269c5">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6MTFjNTJhMDgzNTMyNDBiMjk5OWMyMDZmZWYyMDc0OWMvdGFibGVyYW5nZToxMWM1MmEwODM1MzI0MGIyOTk5YzIwNmZlZjIwNzQ5Y18xLTQtMS0xLTI5NA_faa0e977-2513-43ee-9bcb-52df9656354e">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGFibGU6MTFjNTJhMDgzNTMyNDBiMjk5OWMyMDZmZWYyMDc0OWMvdGFibGVyYW5nZToxMWM1MmEwODM1MzI0MGIyOTk5YzIwNmZlZjIwNzQ5Y18yLTQtMS0xLTI5Ng_8f49f925-c57a-4772-b36b-b78e9d643b0a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8xMDk5NTExNjMwNTc4_412c576b-3f54-48c3-a1b4-4727d41c5283">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i8f56fa522aba4347a769ceb8b2131331_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8yNTE4_78b9a4e4-e8d9-4597-be29-c1ef5e5d0030"
      unitRef="usd">9218126218</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1ecebe1ac085442a9fcafcfcb6dea5b9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xL2ZyYWc6ZjcxZDliZWNjMmVmNDc4Yjk0YWU4Mjk0NDc2ZTYwYTAvdGV4dHJlZ2lvbjpmNzFkOWJlY2MyZWY0NzhiOTRhZTgyOTQ0NzZlNjBhMF8yNjE0_edd0e3f4-b596-471e-99fa-49bf21029e64"
      unitRef="shares">73837449</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180My9mcmFnOjdjNWMxZmM5ZTE5ODRlNTA4YmU0ZTdkOWJlZTQ4ZDllL3RleHRyZWdpb246N2M1YzFmYzllMTk4NGU1MDhiZTRlN2Q5YmVlNDhkOWVfMzc0Nw_f8210b56-772b-4426-bf39-e0569cee3338"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN180Ni9mcmFnOmM3NDE0YTczMTJmMTRkZjg4MWFmYzAxYjE0MTBhMjRkL3RleHRyZWdpb246Yzc0MTRhNzMxMmYxNGRmODgxYWZjMDFiMTQxMGEyNGRfMTcwMTI_f8210b56-772b-4426-bf39-e0569cee3338"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:Revenues
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMS0yLTEtMS0w_56c61f3d-9087-475a-9d56-a0fe8b5f36fa"
      unitRef="usd">1839900000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMi0yLTEtMS0w_acb286bf-135b-41b3-a485-557730243c0d"
      unitRef="usd">1234200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMi00LTEtMS0w_a3134226-00ef-402e-8671-7cbc498b8612"
      unitRef="usd">1172000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMi02LTEtMS0w_179847e6-5989-4afd-8024-b25b3f8e9062"
      unitRef="usd">1086200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMy0yLTEtMS0w_cd77a5a9-2b25-4609-8123-9e032186c922"
      unitRef="usd">605700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMy00LTEtMS0w_d4940563-3906-4576-8d10-7af9d293469b"
      unitRef="usd">545400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMy02LTEtMS0w_71555182-593c-4c81-a408-90bb17137a06"
      unitRef="usd">512900000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNC0yLTEtMS0w_e3d30e9e-3297-49b3-be88-e7b693fd67c5"
      unitRef="usd">38900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNC00LTEtMS0w_a7caaf17-9961-42c6-a177-219560e784b4"
      unitRef="usd">40300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNC02LTEtMS0w_2f59efdb-cbb8-4c21-8460-07f9655342a1"
      unitRef="usd">39100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNS0yLTEtMS0w_f37a2384-5153-4537-b30f-aee58cadff3b"
      unitRef="usd">272700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNS00LTEtMS0w_116d8158-2506-488b-a049-20e6a499db57"
      unitRef="usd">262900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNS02LTEtMS0w_7aaec093-3182-4c17-baf2-0e882250e69d"
      unitRef="usd">246000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <wst:OtherIncomeExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNi0yLTEtMS0w_78ce33bc-680d-497b-a784-c74c748a749d"
      unitRef="usd">2500000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNi00LTEtMS0w_82dafc0a-6e0a-44c7-ad20-7d2d40e5050e"
      unitRef="usd">-1900000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNi02LTEtMS0w_7d04ccda-a475-4a28-a06f-6091163fde15"
      unitRef="usd">-2000000.0</wst:OtherIncomeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNy0yLTEtMS0w_40eebd30-5487-47b1-9da9-06bd167dc3f5"
      unitRef="usd">296600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNy00LTEtMS0w_66f009ec-f26d-4ff5-97db-beb948f36f64"
      unitRef="usd">240300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfNy02LTEtMS0w_20054cd5-77ef-46b2-a70f-cbc0dc3c6274"
      unitRef="usd">225800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOC0yLTEtMS0w_88247766-e004-48ce-8f1a-6c5090bd5a51"
      unitRef="usd">8500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOC00LTEtMS0w_5108c44b-7f86-4fee-9859-e8a714180028"
      unitRef="usd">8400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOC02LTEtMS0w_aadf4505-2456-4613-a3e6-92a079c5d73c"
      unitRef="usd">7800000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOS0yLTEtMS0w_708ea232-1c6f-448a-9a43-16733187b766"
      unitRef="usd">3800000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOS00LTEtMS0w_263789ac-2877-48e6-86f4-e2636eed9918"
      unitRef="usd">2100000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfOS02LTEtMS0w_bbe11c31-e392-47d0-b035-ea85dcd1e869"
      unitRef="usd">1300000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTAtMi0xLTEtMA_871e7edb-4934-4d6f-8734-d5fbaf1adb21"
      unitRef="usd">-100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTAtNC0xLTEtMA_65da68f6-b3f1-4f02-993f-4929ba3d8043"
      unitRef="usd">6700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTAtNi0xLTEtMA_1f662d87-90d4-4803-9c3e-9ca07f03161a"
      unitRef="usd">3100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTEtMi0xLTEtMA_af03d508-869d-4828-ba67-455030f59f3d"
      unitRef="usd">291800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTEtNC0xLTEtMA_eab5584c-a8e0-49ad-8ae2-9004e877363c"
      unitRef="usd">240700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTEtNi0xLTEtMA_61c3f5cf-c443-4bab-8003-b73589de57a0"
      unitRef="usd">222400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTItMi0xLTEtMA_5d9d24ce-9699-4867-a3ab-1954497d7104"
      unitRef="usd">59000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTItNC0xLTEtMA_017d040c-5bea-4992-bc40-ff0f92ca7526"
      unitRef="usd">41400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTItNi0xLTEtMA_d012ce75-ec98-486e-9848-8404ff224311"
      unitRef="usd">80900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTMtMi0xLTEtMA_197d6001-3bfc-411a-b525-c730bc01eb50"
      unitRef="usd">8900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTMtNC0xLTEtMA_692d22a3-83a0-4f67-9545-a7ae85e4571e"
      unitRef="usd">7600000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTMtNi0xLTEtMA_dd50a2a7-0ac7-48db-879d-4e2e1a03d702"
      unitRef="usd">9200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTQtMi0xLTEtMA_7e166ac3-7b96-4a4b-b587-62af52768db6"
      unitRef="usd">241700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTQtNC0xLTEtMA_013312ed-4d24-4caa-8a3f-8d28f8055e87"
      unitRef="usd">206900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTQtNi0xLTEtMA_a1dcfb73-4359-42ea-95fb-5aba15c63179"
      unitRef="usd">150700000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTctMi0xLTEtMA_315054ec-f00c-49bc-92f2-5a2c0ab15eeb"
      unitRef="usdPerShare">3.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTctNC0xLTEtMA_de0da35b-e97b-44e5-af30-a845e04eec55"
      unitRef="usdPerShare">2.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTctNi0xLTEtMA_e45d508c-0aa7-4dd5-a50a-ee127dbffa5f"
      unitRef="usdPerShare">2.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTgtMi0xLTEtMA_f5ebeb37-1ca2-45aa-b5e0-1e9de0281831"
      unitRef="usdPerShare">3.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTgtNC0xLTEtMA_f8210b56-772b-4426-bf39-e0569cee3338"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMTgtNi0xLTEtMA_af9386f8-c891-4d0b-a616-fb015f5a52f6"
      unitRef="usdPerShare">1.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjEtMi0xLTEtMA_0d61fbe5-c372-4879-bef0-c6e4828f9f58"
      unitRef="shares">74000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjEtNC0xLTEtMA_2b1bba6c-8e73-462f-8bc7-723d193602bd"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjEtNi0xLTEtMA_1140bcf4-8a3b-4d64-9cb8-a2cc687443b6"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjItMi0xLTEtMA_3102190d-8742-427b-b412-3e9fa019df56"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjItNC0xLTEtMA_a57c73fe-cf01-4530-b3b2-67f0a9f56de7"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN181OC9mcmFnOmY1YWY1OGU5MDg4YjQxNDJiZWU0YjE3NzUyZDBhMGZiL3RhYmxlOjAxN2UyMmI0NTY1OTRjYWE4Njk5YmQ0ZDk0ODlkMWQ5L3RhYmxlcmFuZ2U6MDE3ZTIyYjQ1NjU5NGNhYTg2OTliZDRkOTQ4OWQxZDlfMjItNi0xLTEtMA_ad1bea1e-9213-46c4-8880-75d5ad2e8432"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMS0xLTEtMS0w_630dae50-57b3-4c26-ab71-5c19cf9ef472"
      unitRef="usd">241700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMS0zLTEtMS0w_07a81b4e-2a6e-43dc-abda-f8560cc7c00b"
      unitRef="usd">206900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMS01LTEtMS0w_e4f01d7c-875c-4f43-91b2-77638b55de0e"
      unitRef="usd">150700000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMy0xLTEtMS0w_dc5bbe3b-170b-48a1-bc69-c1aa40e9c89f"
      unitRef="usd">4900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMy0zLTEtMS0w_0a8eb58e-feaa-4f5d-8f4d-07de3a85db2d"
      unitRef="usd">-39200000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMy01LTEtMS0w_d8075d63-7a44-43a7-a658-c6ed30661cbf"
      unitRef="usd">68800000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNS0xLTEtMS0w_c139c86d-7fe7-4822-89e8-eb8316f04749"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNS0zLTEtMS0w_edcb2751-beb8-4b51-9c37-ef8a33fbebce"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNS01LTEtMS0w_c563c42c-c8c7-4fbf-98f9-873904d7ff35"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNi0xLTEtMS0w_81a63a9b-64f1-47ad-bbd2-5738789b134c"
      unitRef="usd">-1900000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNi0zLTEtMS0w_946cb833-afb6-4ccb-a1b1-273654c7242a"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNi01LTEtMS0w_015217d8-e990-4013-8819-7a014ca45205"
      unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNy0xLTEtMS0w_084fff51-0845-4d9e-bd49-579c92c3610b"
      unitRef="usd">-2700000</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNy0zLTEtMS0w_c5ed380e-8415-4608-806f-5d88dd1f0f26"
      unitRef="usd">0</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax>
    <wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfNy01LTEtMS0w_93a3f503-89c4-4b83-8f92-25d10fa454b8"
      unitRef="usd">0</wst:OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOC0xLTEtMS0w_ef954d40-7936-43cf-972f-cefc386265eb"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOC0zLTEtMS0w_b67b53cc-c50a-4ff8-976e-bf60825432a9"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOC01LTEtMS0w_14482154-6bda-49c7-8a40-b29dd7d09193"
      unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOS0xLTEtMS0w_63fb42d3-578d-4d66-9220-188d04580925"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOS0zLTEtMS0w_34c3218c-c251-4bc0-98fb-dd9117d1f23c"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfOS01LTEtMS0w_dab44749-0bb2-45e8-9aec-7d8a3b07e2ec"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTEtMS0xLTEtMA_49f0152e-1e92-4fbf-8048-2a846839792d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTEtMy0xLTEtMA_ff594325-90ef-4846-ab29-4006df1b66a9"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTEtNS0xLTEtMA_c524b0fe-4b3b-4875-a79a-c98bccf1ba9d"
      unitRef="usd">-4700000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTItMS0xLTEtMA_8faaa371-4783-4bd7-87f7-b23e408474ca"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTItMy0xLTEtMA_ffe595dd-8d0d-4ec3-873b-457050f9a0e3"
      unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTItNS0xLTEtMA_e2e6a1b2-1d7a-4566-8b63-5c1f468c4427"
      unitRef="usd">-1000000.0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTMtMS0xLTEtMA_69786a86-9f00-4646-ab9b-6a706d974f2c"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTMtMy0xLTEtMA_241fba10-2b3a-4f3e-97b0-ff7eaeed47ad"
      unitRef="usd">-36900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTMtNS0xLTEtMA_f6e47f09-aa4a-48bd-86c1-447fe4b1317b"
      unitRef="usd">69500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTQtMS0xLTEtMA_b682766c-2cc0-49c2-8c1e-7485907c7760"
      unitRef="usd">246300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTQtMy0xLTEtMA_d33f48ab-ffcd-444c-864d-b8be4a271b19"
      unitRef="usd">170000000.0</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182MS9mcmFnOjc0ZDIzZDUzZWE4YjQyNjY4MjAyZmE5MWE3ZmQ4Y2Q1L3RhYmxlOjAyOWE3OTkyNTI3MzRkYzViNjdjMWNkYTZhYzRmYzZjL3RhYmxlcmFuZ2U6MDI5YTc5OTI1MjczNGRjNWI2N2MxY2RhNmFjNGZjNmNfMTQtNS0xLTEtMA_f5d95bf2-c11c-4736-ab67-76123f94c6b4"
      unitRef="usd">220200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMy0xLTEtMS0w_5cc5d622-b530-4746-8ac5-f3269aca00f4"
      unitRef="usd">439100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMy0zLTEtMS0w_46733361-7a9e-4b59-b242-c5bea0f42c92"
      unitRef="usd">337400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNC0xLTEtMS0w_10c49013-abab-4e09-845e-a2fc3c6ba5a9"
      unitRef="usd">319300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNC0zLTEtMS0w_04843306-fba9-4b6a-8572-1ae5e478ec86"
      unitRef="usd">288200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNS0xLTEtMS0w_8e6f81df-f7cf-4181-a1cf-3457b455562a"
      unitRef="usd">235700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNS0zLTEtMS0w_0a40856a-c03e-4ee7-a9e9-26c802cdc2ff"
      unitRef="usd">214500000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNi0xLTEtMS0w_68a9f9c4-9d25-40c8-85eb-a8b1c255c442"
      unitRef="usd">64600000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNi0zLTEtMS0w_693afb72-124e-43f2-bd1c-261e547f3195"
      unitRef="usd">54300000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNy0xLTEtMS0w_7e461640-3886-4683-9208-675a20f238e1"
      unitRef="usd">1058700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNy0zLTEtMS0w_c0d31fb2-ad62-47e6-90df-a3aa3c72ecf1"
      unitRef="usd">894400000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOC0xLTEtMS0w_5d070695-b871-448c-ba41-03bedacb5762"
      unitRef="usd">1820100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOC0zLTEtMS0w_f88ad533-ea84-4da5-b57f-5844b2bce690"
      unitRef="usd">1752700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOS0xLTEtMS0w_b3ff9ef2-efad-4cf9-b3eb-28fdc742c9df"
      unitRef="usd">980800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfOS0zLTEtMS0w_2410f6ba-87a6-4687-ac8d-a6408b8ec5b4"
      unitRef="usd">930700000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTAtMS0xLTEtMA_5b254dec-7295-4e3d-b472-84cf48310f33"
      unitRef="usd">839300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTAtMy0xLTEtMA_8450a920-5296-4513-bd7c-f6afa0e61c28"
      unitRef="usd">822000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMS0xLTEtMjI0MQ_57499681-3e58-463b-a647-b502cdf53feb"
      unitRef="usd">70100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMy0xLTEtMjI0MQ_4e8afec3-83e1-484b-b158-3952e4ad3d48"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMS0xLTEtMA_52b42f24-652f-48e0-9b0b-7d5c5d598cb9"
      unitRef="usd">192700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTEtMy0xLTEtMA_ed8a8e85-01e0-470c-b374-fb49fc6d6e83"
      unitRef="usd">91200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTItMS0xLTEtMA_565827a8-cbfc-4d6e-ae37-95d20bd3b9c4"
      unitRef="usd">107800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTItMy0xLTEtMA_e10edf07-297e-49e2-a723-6252d6046ef8"
      unitRef="usd">105800000</us-gaap:Goodwill>
    <us-gaap:DeferredTaxAssetsNetNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTMtMS0xLTEtMA_4b173a27-706b-4f7b-a39a-bb640394be0d"
      unitRef="usd">14000000.0</us-gaap:DeferredTaxAssetsNetNoncurrent>
    <us-gaap:DeferredTaxAssetsNetNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTMtMy0xLTEtMA_bf9eaa1d-8124-4ebe-a4db-8267eeab4ae7"
      unitRef="usd">24700000</us-gaap:DeferredTaxAssetsNetNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTQtMS0xLTEtMA_f638759a-6e03-4c2d-8cb2-2baa15ca5f85"
      unitRef="usd">29800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTQtMy0xLTEtMA_91e4b503-5602-4616-ab54-f917d3c324f1"
      unitRef="usd">20300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMS0xLTEtNzg5NQ_3d92312a-336e-4d91-89b0-b1d75fe10112"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMy0xLTEtNzg5NQ_5fd611f1-9c6f-4432-96f2-33b38ec902e9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTUtMS0xLTEtMA_95e111e3-fa85-4fb3-8e84-968dae00a8e1"
      unitRef="usd">24700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTUtMy0xLTEtMA_4ba9e4f7-497c-42e3-9db5-bfc3fbd64f9c"
      unitRef="usd">20500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMS0xLTEtMA_d39dd829-b533-4111-8b47-8dcb007ca476"
      unitRef="usd">2341400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMTYtMy0xLTEtMA_28e67e73-e285-48c6-9e07-6cafa73d2cec"
      unitRef="usd">1978900000</us-gaap:Assets>
    <wst:NotesPayableAndOtherDebtCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjAtMS0xLTEtMA_0793cdfe-08f2-42f5-a925-1251071f6f57"
      unitRef="usd">2300000</wst:NotesPayableAndOtherDebtCurrent>
    <wst:NotesPayableAndOtherDebtCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjAtMy0xLTEtMA_84ec082c-79c6-4d52-908a-deb965e56e11"
      unitRef="usd">100000</wst:NotesPayableAndOtherDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjEtMS0xLTEtMA_d6882556-ed40-4d1c-bfd9-8ca1c8950a48"
      unitRef="usd">156800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjEtMy0xLTEtMA_caee27dc-cf9c-40b8-8a46-9757dc06fadd"
      unitRef="usd">130400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjItMS0xLTEtMA_a712cea0-0275-499b-991b-b3f806f307b3"
      unitRef="usd">2200000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjItMy0xLTEtMA_ab2958d8-342b-4ac2-9fd5-a0adcb8371bb"
      unitRef="usd">2300000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <wst:AccruedSalariesWagesAndBenefitsCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjMtMS0xLTEtMA_36fd792f-9fc1-49d6-b70d-1f6acd8db21b"
      unitRef="usd">73000000.0</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <wst:AccruedSalariesWagesAndBenefitsCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjMtMy0xLTEtMA_d9db981f-33d6-48e3-87a1-88b60d122090"
      unitRef="usd">64500000</wst:AccruedSalariesWagesAndBenefitsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjQtMS0xLTEtMA_a6ad9517-69ef-45f1-8800-0f5537cf3e6b"
      unitRef="usd">6400000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjQtMy0xLTEtMA_a4be8b74-7712-4a7b-89ca-d5046b2fa6ef"
      unitRef="usd">9800000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMS0xLTEtMjI0Ng_551ad84c-52f2-4401-ae93-9d8d336c173f"
      unitRef="usd">9600000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMy0xLTEtMjI0Ng_b762f923-19be-4e86-885d-1b2d77a66fc3"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjUtMS0xLTEtMA_9801dd14-5e2d-483d-a904-357c45c1c089"
      unitRef="usd">91300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjUtMy0xLTEtMA_43eaa3c5-e14e-4f61-b837-7a29380cc7b3"
      unitRef="usd">76600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMS0xLTEtMA_7aeccf2d-7335-43cb-a175-582362d24931"
      unitRef="usd">341600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjYtMy0xLTEtMA_841f7c51-3517-44d3-8bd0-1d2bd227e451"
      unitRef="usd">283700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjctMS0xLTEtMA_01a6e307-a1e7-4e6a-bdc0-ebfc29c56ec2"
      unitRef="usd">255000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjctMy0xLTEtMA_79dad11e-dc8a-4bbc-baa5-4a94dad0b214"
      unitRef="usd">196000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjgtMS0xLTEtMA_24e82301-cf57-48ad-b5da-41164cbb354c"
      unitRef="usd">15500000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjgtMy0xLTEtMA_e041a2aa-85af-4a51-af00-0f95b6642c22"
      unitRef="usd">13100000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjktMS0xLTEtMA_1f6b297f-99ca-4afb-bdad-0c513dfd8103"
      unitRef="usd">52500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMjktMy0xLTEtMA_32eee9af-6469-4d1b-923a-bc40a86ab8e2"
      unitRef="usd">56200000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzItMS0xLTEtMjI1MQ_cf3b6288-b940-47c3-b0d8-7b5707fa4e63"
      unitRef="usd">62400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzItMy0xLTEtMjI1MQ_5c12ce9b-39bd-47dc-9d6d-a2d15885a344"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzAtMS0xLTEtMA_78495612-26c4-41c8-86d8-0f7d9bc5b592"
      unitRef="usd">41200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzAtMy0xLTEtMA_a1a962a1-e785-426a-9dbb-1ce37d8532d0"
      unitRef="usd">33600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzEtMS0xLTEtMA_3ae5f39b-7ea0-4f07-a28d-1ef6278b2b97"
      unitRef="usd">768200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzEtMy0xLTEtMA_12c54b61-a63d-42cc-a905-a7f280889232"
      unitRef="usd">582600000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzMtMS0xLTEtMA_aff6ea24-6dc4-40ca-b964-1e083851414d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzMtMy0xLTEtMA_62e3d9c0-ce7d-4b52-9adb-0fdb86a82822"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzYtMS0xLTEtMA_8efdf3b9-b8ba-49dd-a889-c1126c86833d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzYtMy0xLTEtMA_ebc0cf84-d25e-4946-81a4-b103c91027cf"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzctMS0xLTEtMA_81b5a892-33cd-47f8-a9ab-79fbac1844c8"
      unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzctMy0xLTEtMA_10ddf62b-decb-48e1-975f-f419b52d1ea1"
      unitRef="usd">18800000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzgtMS0xLTEtMA_3a51287a-8199-4d9e-bd5b-67cbe49e01f8"
      unitRef="usd">272700000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzgtMy0xLTEtMA_7e943e57-cca3-4a3f-8da3-45a2100ecc90"
      unitRef="usd">282000000.0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzktMS0xLTEtMA_e5426fc2-7e82-4343-bfff-a697b308ae85"
      unitRef="usd">1549400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfMzktMy0xLTEtMA_622e0d5d-fca9-4099-a62a-33a9303a5a17"
      unitRef="usd">1353400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDAtMS0xLTEtMA_36950e43-ccee-4493-8d92-317fed0df87d"
      unitRef="usd">-149600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDAtMy0xLTEtMA_70577095-741b-4b67-9834-4cebdeb796e0"
      unitRef="usd">-154200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDEtMS0xLTEtMA_da5fa51f-af3a-43be-9fe2-9370474cc960"
      unitRef="usd">118100000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDEtMy0xLTEtMA_7320bcdc-cd79-4449-8f44-f386820577ab"
      unitRef="usd">103700000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDItMS0xLTEtMA_02ea0a4c-4736-44a9-9c38-810380de4cb9"
      unitRef="usd">1573200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDItMy0xLTEtMA_d9426690-c84d-440e-9117-7d4843ceb018"
      unitRef="usd">1396300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDMtMS0xLTEtMA_a80b38a3-23ff-440d-a01e-76e717bcc2cf"
      unitRef="usd">2341400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN182Ny9mcmFnOmVlZjI1MzM0Y2VmYzRkNGM4ZmEzNWIyZDBkMzI3ZjlmL3RhYmxlOjdjMTAwNzY2OTlmYTQ1ODU5OGJjNTg1OTcwMDRkMDJlL3RhYmxlcmFuZ2U6N2MxMDA3NjY5OWZhNDU4NTk4YmM1ODU5NzAwNGQwMmVfNDMtMy0xLTEtMA_775d59ad-2908-4324-8f7d-288c50dc09dc"
      unitRef="usd">1978900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i93edb6fbbea140fbb4c158d60be85402_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xLTEtMS0w_1a87c10b-fd50-4ef2-aea6-07a87bde6430"
      unitRef="shares">73700000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93edb6fbbea140fbb4c158d60be85402_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0zLTEtMS0w_23361287-b571-4074-9c6c-45960f94506b"
      unitRef="usd">18400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac89a5ed6468416b954a6d59e93629c9_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS01LTEtMS0w_8267ac68-da90-48eb-b486-fa77630619a0"
      unitRef="usd">260400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ib69c911484784ff7a59966d8a7af0ed0_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS03LTEtMS0w_fe4258b7-cddf-4e3f-bb69-d7a13442ebe2"
      unitRef="shares">600000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib69c911484784ff7a59966d8a7af0ed0_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS05LTEtMS0w_9a351a65-8c26-4bb4-918a-6a030d33489f"
      unitRef="usd">-46100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f31229f62de404da8827c5ece21e752_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xMS0xLTEtMA_aa893f95-43e6-44a1-bf5c-0a3dc3b779ad"
      unitRef="usd">1071600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i18dd631cd0f04e0ba55e512d49411755_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xMy0xLTEtMA_64899fee-1973-4ed9-a5a1-81d214810099"
      unitRef="usd">-186800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMS0xNS0xLTEtMA_de8f0023-848b-4bfb-b5ee-005768e2430d"
      unitRef="usd">1117500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i28ac7a64b1174ffdbf7756a30346e4c6_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMi0xMS0xLTEtMA_fe5f05d1-9aaa-485f-8860-49b187c35bc4"
      unitRef="usd">-4100000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMi0xNS0xLTEtMA_f0ae5603-b881-4f75-9f90-cefd81570427"
      unitRef="usd">-4100000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:ProfitLoss
      contextRef="i4575754faab44617861e28e31c5333e6_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMy0xMS0xLTEtMA_66b856c8-147d-4558-97cb-97c8f3517e37"
      unitRef="usd">150700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMy0xNS0xLTEtMA_91e0cdbb-c468-470f-9685-9289a67d8dfa"
      unitRef="usd">150700000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i22926bbe0d8140baae5202df1227e9e9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC0xLTEtMS0w_cb4f04f3-896b-45cc-b6a8-77a1837a6899"
      unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i22926bbe0d8140baae5202df1227e9e9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC0zLTEtMS0w_b91e89f6-3466-44fc-890c-7145e29020b0"
      unitRef="usd">400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia2bb2237e0bf456cbd5e22b740b8ee66_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC01LTEtMS0w_1a50057e-86e7-4960-93f1-18340569504a"
      unitRef="usd">44100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC03LTEtMS0w_0cca6c8c-35cb-4858-8522-566dee9e54b3"
      unitRef="shares">-100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC05LTEtMS0w_7832099d-3a7e-4e4d-b4f5-a50921185494"
      unitRef="usd">11400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNC0xNS0xLTEtMA_d09a9a32-c1a0-477e-a07f-fce178ab667d"
      unitRef="usd">55900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNS03LTEtMS0w_1d232ea7-2717-47f9-8d24-099f1cb29de3"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i345008dff47d4290a0527300056fd7e4_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNS05LTEtMS0w_c95d9459-366b-4ee5-8db1-c9b8204fb4e9"
      unitRef="usd">74400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNS0xNS0xLTEtMA_1cd0c535-97c5-4b9e-97a7-3385f095e55f"
      unitRef="usd">74400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStockCash
      contextRef="i4575754faab44617861e28e31c5333e6_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNy0xMS0xLTEtMA_163aed75-6eb6-4181-86b7-82bbcf91288a"
      unitRef="usd">40000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfNy0xNS0xLTEtMA_1c5aca11-88c8-486c-ae31-27ea41230911"
      unitRef="usd">40000000.0</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ia2bb2237e0bf456cbd5e22b740b8ee66_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOC01LTEtMS0w_b7f3161d-1a9b-43df-84e6-f8c43d0b2326"
      unitRef="usd">-4800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOC0xNS0xLTEtMA_96594e83-9be0-4d1f-9a79-98bf16e4c997"
      unitRef="usd">-4800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i112779a33c9549a2a1e6ad79daa2521c_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOS0xMy0xLTEtMA_598d4c63-98df-4833-b6ae-cb7b0d06127b"
      unitRef="usd">69500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfOS0xNS0xLTEtMA_c17c96d8-718c-4539-ac52-fbf8b26fbf2d"
      unitRef="usd">69500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i6e529adeb51c4013a1e2867fc2c654a8_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMS0xLTEtMA_a7582dd3-70f6-4671-8f1f-64a6d2923de9"
      unitRef="shares">75200000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e529adeb51c4013a1e2867fc2c654a8_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMy0xLTEtMA_ce0fe200-f9d6-4c8f-8ee6-73ed0b23aac2"
      unitRef="usd">18800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a9668a28ec340d18d524b415f8ae63c_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtNS0xLTEtMA_e31152f1-16c4-4ff6-b62a-70cb52514196"
      unitRef="usd">309300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="if2a7c56a3d9349b585ddce443188576b_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtNy0xLTEtMA_c9304863-0ee6-436f-9755-9d66706bbff9"
      unitRef="shares">1300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2a7c56a3d9349b585ddce443188576b_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtOS0xLTEtMA_7883cbc8-8f08-4d63-87f3-ff97fd592c60"
      unitRef="usd">-109100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28ac7a64b1174ffdbf7756a30346e4c6_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMTEtMS0xLTA_b7ebbb2a-d657-42da-a0e7-db2d99e3a248"
      unitRef="usd">1178200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaabf64c6efeb4ff68ff50ae560a0e2a1_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMTMtMS0xLTA_f43e604f-f03b-436b-98c7-02b775a2b7a6"
      unitRef="usd">-117300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTAtMTUtMS0xLTA_b02fe1de-3ba0-48ce-b4d6-affc3fff498b"
      unitRef="usd">1279900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="i2593d47d63744a01ad1ef0a31243b137_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTEtMTEtMS0xLTA_3305c04b-126e-40c3-9421-90112546dd9f"
      unitRef="usd">11400000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTEtMTUtMS0xLTA_7aa70283-f2c4-43df-8e56-2a9b1d4d94a2"
      unitRef="usd">11400000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
    <us-gaap:ProfitLoss
      contextRef="ie83aebbd70244c51b7c3c99d188dfa54_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTItMTEtMS0xLTA_2e2161b9-2c60-4b93-aaa0-1b39e415688e"
      unitRef="usd">206900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTItMTUtMS0xLTA_7ef9555e-bba7-4c1e-95b3-b8d6616cf6e3"
      unitRef="usd">206900000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i98bb331ce4d3451dbc548acf205baab6_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtMS0xLTEtMA_c03a5002-1a75-4c19-8c36-71639ebb87e3"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i98bb331ce4d3451dbc548acf205baab6_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtMy0xLTEtMA_895a60c7-6743-4c5c-b6d3-353e8cc6b8a0"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia2125fc186e24ff583ffd6d2cbfeeabf_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtNS0xLTEtMA_8dd196df-08ae-4f5e-b7f0-496deba110a4"
      unitRef="usd">-27300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtNy0xLTEtMA_2b864f91-4699-4b11-8a1e-b6d38e971fc2"
      unitRef="shares">-900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtOS0xLTEtMA_c81b1253-5302-48cb-848e-4e86969330a6"
      unitRef="usd">76200000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTMtMTUtMS0xLTA_e207b638-3e6e-431f-b771-50729812437b"
      unitRef="usd">48900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTUtNy0xLTEtMA_4a0f7c2c-2d4a-4147-ad23-94e3c2f2e7f5"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i85fdced1243843ed89c0d834a32591c7_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTUtOS0xLTEtMA_3f83495f-f3f0-41f9-99b0-ef727f76943c"
      unitRef="usd">70800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTUtMTUtMS0xLTA_f4590c68-cc2a-46f5-8f99-6de853d4234b"
      unitRef="usd">70800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie83aebbd70244c51b7c3c99d188dfa54_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTctMTEtMS0xLTA_0d31a3c3-bad1-4b32-86b6-99a3539bf808"
      unitRef="usd">43100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTctMTUtMS0xLTA_364bdfba-d7fd-4079-8a03-327c0e94fadf"
      unitRef="usd">43100000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i34ea6f372d13421d9d8f0f909df6b05f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTktMTMtMS0xLTA_0273f577-6111-493c-b3ec-ab4856ef19df"
      unitRef="usd">-36900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMTktMTUtMS0xLTA_86a4b9cf-96c6-4fcf-a373-ed2cfc10a00c"
      unitRef="usd">-36900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i9fd4b9307ef443f8b750812dd815616b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMS0xLTEtMA_679c0a67-7ee2-4349-9e49-ec7cdb303275"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fd4b9307ef443f8b750812dd815616b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMy0xLTEtMA_13136dcb-7749-45e3-be8b-61e21806216f"
      unitRef="usd">18800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie1c0bfc76dab4660a6dee12ff3e6f75a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtNS0xLTEtMA_04d34b1e-4fc2-4a98-ab1e-c02c8231a23b"
      unitRef="usd">282000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i5dbdcdd33a9544e0b1ff9915c052d4b4_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtNy0xLTEtMA_bd6797a7-7e80-40da-b44e-6ec278bed95b"
      unitRef="shares">1200000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dbdcdd33a9544e0b1ff9915c052d4b4_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtOS0xLTEtMA_742612fd-9688-42c1-af81-f7185d76a9a3"
      unitRef="usd">-103700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2593d47d63744a01ad1ef0a31243b137_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMTEtMS0xLTA_df69bfd0-95b5-40a0-a9c9-019dc4a68cb4"
      unitRef="usd">1353400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8619d0eee6a4571ae753f283f316223_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMTMtMS0xLTA_08086913-d3cf-4a26-af92-2f97153135eb"
      unitRef="usd">-154200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjAtMTUtMS0xLTA_e1c8f84b-8814-4240-b5ce-0fbb09caf810"
      unitRef="usd">1396300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ife6de079702a446a909c0761fb4355a4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjItMTEtMS0xLTA_67db4e41-6260-4cd3-b894-5f946b816287"
      unitRef="usd">241700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjItMTUtMS0xLTA_9c84f994-38dd-40d4-9c9f-a78af8f335d2"
      unitRef="usd">241700000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id147ab88ff2d492590eb6168cdcfbc21_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtMy0xLTEtMA_39e97c82-c162-4f30-bccc-cddb57b78601"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib1cf95202daf4d82a61721c34a7388af_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtNS0xLTEtMA_b6897663-82d9-489d-85d1-7a0a718921d2"
      unitRef="usd">-11100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtNy0xLTEtMA_af743212-bbba-44a3-ac6e-778ed0180c3b"
      unitRef="shares">-800000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtOS0xLTEtMA_77fb5aec-b0ba-4143-92de-db1f02fdd04c"
      unitRef="usd">65600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjMtMTUtMS0xLTA_42f03a10-fe24-4938-a86f-049ab3fc404b"
      unitRef="usd">54500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjUtNy0xLTEtMA_1705fa64-7285-42cd-8503-60d7cfbb3e82"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjUtOS0xLTEtMA_ab9ca0bc-3986-408e-83ac-fc10e4306236"
      unitRef="usd">83100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjUtMTUtMS0xLTA_4af88bef-201b-4c8f-ba24-811914402287"
      unitRef="usd">83100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="id147ab88ff2d492590eb6168cdcfbc21_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtMS0xLTEtMA_3800910e-fd1f-4c53-af7f-548e44c91ea1"
      unitRef="shares">0</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ib1cf95202daf4d82a61721c34a7388af_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtNS0xLTEtMA_19eed388-3713-4360-8e07-f9301e59e9dd"
      unitRef="usd">1800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i33c93a4501344846964d319fe27f7071_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtOS0xLTEtMA_e51fcf61-455f-43af-8bde-bb1245be675d"
      unitRef="usd">3100000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjYtMTUtMS0xLTA_18791fc6-8f81-4cad-aa11-7b8e032d5792"
      unitRef="usd">4900000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:DividendsCommonStockCash
      contextRef="ife6de079702a446a909c0761fb4355a4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjctMTEtMS0xLTA_0e83bbed-c306-471c-ae0d-10a521eb01ca"
      unitRef="usd">45700000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjctMTUtMS0xLTA_5c160eda-d62d-40fc-9f75-4bb12936155d"
      unitRef="usd">45700000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8a596f80b14841c4a875b755bfc6bdd8_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjktMTMtMS0xLTA_274d1948-4654-4c8c-a5c0-a6f5037536f6"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMjktMTUtMS0xLTA_5104d2ad-e22a-453d-845d-d4077e59de60"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i29ada30e40a84d7f9ccb23e70b3c3f64_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMS0xLTEtMA_1368f481-4648-41b0-9307-c222b7b8c2df"
      unitRef="shares">75300000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29ada30e40a84d7f9ccb23e70b3c3f64_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMy0xLTEtMA_12bfc45b-7848-43ff-bb0d-664ceb25c79a"
      unitRef="usd">18800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i449c08ea3f444ab2a681565eeb8cd351_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtNS0xLTEtMA_c35382fc-da72-49c2-8ef5-42c0cf642271"
      unitRef="usd">272700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ic5e2483f32b14044bd9f5d96ac49cac9_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtNy0xLTEtMA_9cc92d62-a135-44fa-969c-eb813ed1e975"
      unitRef="shares">1200000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5e2483f32b14044bd9f5d96ac49cac9_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtOS0xLTEtMA_ab10e23e-118b-4f0b-814a-e2d014af8864"
      unitRef="usd">-118100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e7523417a4c4eb7954baff026cc2dc7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMTEtMS0xLTA_b092a5fc-3a25-43c6-a2e3-d9d18ee873e3"
      unitRef="usd">1549400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6dc1473063042a993f976b7cad5d115_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMTMtMS0xLTA_b13065ba-c859-4598-8e1d-4124f5cc41ed"
      unitRef="usd">-149600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183My9mcmFnOjljNDc2YzU1ZjM2YjRkMjE5MjA1ZGU0YWIzNWRlN2YyL3RhYmxlOjFlZmM2M2JjYmI1NDRkOWE5OTYxN2E3OTE0M2ZmMDljL3RhYmxlcmFuZ2U6MWVmYzYzYmNiYjU0NGQ5YTk5NjE3YTc5MTQzZmYwOWNfMzAtMTUtMS0xLTA_b2fd4168-a55c-440f-b08a-36a12153720c"
      unitRef="usd">1573200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMi0xLTEtMS0w_3c895fea-4ca7-4215-901c-8ffa096ff676"
      unitRef="usd">241700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMi0zLTEtMS0w_de18469c-0ffa-4e55-bb38-6e36c1d56350"
      unitRef="usd">206900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMi01LTEtMS0w_23392cd3-ce3a-46f3-b000-d56c12e2b016"
      unitRef="usd">150700000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNC0xLTEtMS0w_dc719e13-9846-4259-9771-ee0eacec7646"
      unitRef="usd">100000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNC0zLTEtMS0w_53d212de-440e-44e1-8971-cf4cb2fd65b2"
      unitRef="usd">101700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNC01LTEtMS0w_b4e74a73-ffa0-4347-8307-ff4e45c3f483"
      unitRef="usd">94300000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNS0xLTEtMS0w_da9bb333-fcc9-4b10-96cb-71b089b42e78"
      unitRef="usd">3400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNS0zLTEtMS0w_a597816c-b147-4987-8a03-c9b06b2fc41a"
      unitRef="usd">2700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNS01LTEtMS0w_f96dd2f7-430d-430e-84f6-41fbe80aeca5"
      unitRef="usd">2400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNi0xLTEtMS0w_f4aabac2-6ad6-41de-8269-f284a3461e83"
      unitRef="usd">24400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNi0zLTEtMS0w_94ed56ba-b87c-4810-a173-5807e3f0d11d"
      unitRef="usd">15100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNi01LTEtMS0w_be02d5e3-978e-429c-b9bd-4d4e9dc10bfc"
      unitRef="usd">16100000</us-gaap:ShareBasedCompensation>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNy0xLTEtMS0w_64f5eae6-b735-4208-ac0e-ad943b3dcddb"
      unitRef="usd">2300000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNy0zLTEtMS0w_ed07f056-af1e-44bb-8a8e-b2b744fea65b"
      unitRef="usd">2200000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNy01LTEtMS0w_c2880dab-bb0c-4951-9db4-6e54ffcf3427"
      unitRef="usd">700000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOC0xLTEtMS0w_13fa0d68-8eda-401d-acb8-f0ba13704e8f"
      unitRef="usd">-3500000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOC0zLTEtMS0w_50efae7d-0454-4160-bb5a-3f15859d75b0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOC01LTEtMS0w_e7e3b0dc-7d28-46f8-9956-ce3e5c069122"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOS0xLTEtMS0w_8ce006c6-89bd-4c4e-aab4-eb9c40de00ac"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOS0zLTEtMS0w_ab1785d9-c9f8-43d3-8586-9222d92816c2"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfOS01LTEtMS0w_02936386-3a2e-45c3-a23f-eb5984a93c90"
      unitRef="usd">-11100000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTAtMS0xLTEtMA_f2c1b1cd-3dc6-42fc-8965-3320bf4cf435"
      unitRef="usd">500000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTAtMy0xLTEtMA_89dc2c33-0b77-4512-a796-02e2937327f2"
      unitRef="usd">600000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTAtNS0xLTEtMA_056261b3-2d35-441b-b4ec-f8b12ad8a43c"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTEtMS0xLTEtMA_f9450ede-ba91-4927-942a-588ee1fbb7db"
      unitRef="usd">-800000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTEtMy0xLTEtMA_7b79a4b8-86f2-4415-b2d9-3e4b5770f6fb"
      unitRef="usd">-1800000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTEtNS0xLTEtMA_fd5323b4-debe-40ff-8329-81a0400bb543"
      unitRef="usd">-1600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTItMS0xLTEtMA_2cfc91b9-4131-44d7-849b-9835d7957751"
      unitRef="usd">15300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTItMy0xLTEtMA_746db006-420c-48c9-9850-29f039ee9ad0"
      unitRef="usd">900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTItNS0xLTEtMA_6d7895ea-ae62-40ea-b530-50c6fecbdab4"
      unitRef="usd">41700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <wst:PensionandOtherPostretirementBenefitExpenseNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTMtMS0xLTEtMA_7baf46d8-7446-4afa-95cd-1504992ca063"
      unitRef="usd">-2600000</wst:PensionandOtherPostretirementBenefitExpenseNet>
    <wst:PensionandOtherPostretirementBenefitExpenseNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTMtMy0xLTEtMA_e3a2c787-08aa-4dc5-8484-8958e0acb160"
      unitRef="usd">-7900000</wst:PensionandOtherPostretirementBenefitExpenseNet>
    <wst:PensionandOtherPostretirementBenefitExpenseNet
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTMtNS0xLTEtMA_2a7a8619-ed37-46f9-ac38-2448e220228e"
      unitRef="usd">-6900000</wst:PensionandOtherPostretirementBenefitExpenseNet>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTQtMS0xLTEtMA_6efd92d0-1ad6-4d19-859b-c6a42b9085ff"
      unitRef="usd">6700000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTQtMy0xLTEtMA_e9fe3215-cd1c-41de-9591-d1dd66e722bf"
      unitRef="usd">5900000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTQtNS0xLTEtMA_27610b37-adb9-491d-8a94-f0f42d9027b8"
      unitRef="usd">7000000.0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTYtMS0xLTEtMA_671851ca-4a9a-4b07-b36d-073516afe52a"
      unitRef="usd">33300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTYtMy0xLTEtMA_25e3a836-50e6-4464-9bb1-e33961a30148"
      unitRef="usd">43800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTYtNS0xLTEtMA_61e7b5ad-e183-44dc-b335-212cc5a685e8"
      unitRef="usd">39700000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTctMS0xLTEtMA_74382795-a48c-430c-84fc-d050a3f78e98"
      unitRef="usd">18600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTctMy0xLTEtMA_96ee05a0-a0bb-43d1-bdd1-eb07276bbb74"
      unitRef="usd">7000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTctNS0xLTEtMA_76049bcc-7325-468b-a3b4-831079afcb74"
      unitRef="usd">3600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTgtMS0xLTEtMA_b47769de-b07b-4639-90e8-8f781234ba4e"
      unitRef="usd">-2600000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTgtMy0xLTEtMA_360c817b-38e2-41b0-a9ae-e8e28c79b6f2"
      unitRef="usd">6200000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTgtNS0xLTEtMA_4535c323-8e7c-47de-baa4-f937ca7c22a0"
      unitRef="usd">-300000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTktMS0xLTEtMA_89a35c39-7287-4454-9a09-e61039302118"
      unitRef="usd">25300000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTktMy0xLTEtMA_361571eb-19e0-439a-a0cd-4f8ac5d8193c"
      unitRef="usd">400000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMTktNS0xLTEtMA_23dfc7f8-be8d-4728-b590-24fafa4c8b6f"
      unitRef="usd">12600000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjAtMS0xLTEtMA_6f3da0c3-3c2a-4faf-aa01-65585b37cf98"
      unitRef="usd">-9600000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjAtMy0xLTEtMA_d8ffe0f9-54d0-4208-82f8-044b795c9359"
      unitRef="usd">-28300000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjAtNS0xLTEtMA_dd6b696c-f952-4005-b296-2f9c4873f0fa"
      unitRef="usd">11000000.0</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjEtMS0xLTEtMA_47f2551f-1255-444b-8778-a5bf53b75566"
      unitRef="usd">367200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjEtMy0xLTEtMA_3eb93533-3498-4cd7-a59c-7baafa33d9d5"
      unitRef="usd">288600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjEtNS0xLTEtMA_edbb6aa8-b5b5-4f10-a850-9032fa7cc507"
      unitRef="usd">263300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjMtMS0xLTEtMA_21747297-ef78-456d-8bf6-b2cb29525aba"
      unitRef="usd">126400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjMtMy0xLTEtMA_0fb2d122-f62d-488d-b4f7-4854bbdfe679"
      unitRef="usd">104700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjMtNS0xLTEtMA_f103c8c1-8585-4ec1-a9da-ba70ca2ac9c5"
      unitRef="usd">130800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjQtMS0xLTEtMA_918405f7-6c44-4036-9b6b-6db839c98f03"
      unitRef="usd">85100000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjQtMy0xLTEtMA_24c90445-dfa8-47e9-ae4c-9e94392b11e0"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjQtNS0xLTEtMA_7c14adb3-2640-4778-a80e-c121f3772922"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjUtMS0xLTEtMA_2eeb67f4-c1fe-4957-849a-3525ddd43eab"
      unitRef="usd">18900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjUtMy0xLTEtMA_c91a340d-17c4-40f3-a1ea-0f92627bbb1a"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjUtNS0xLTEtMA_b41231d1-3033-48f5-b6f9-09999abb877f"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjgtMS0xLTEtMA_e5cb68bf-26b2-42c9-b736-25bac975dcbf"
      unitRef="usd">0</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjgtMy0xLTEtMA_ac3780d7-5793-49bc-8ef4-55644d4dfa6d"
      unitRef="usd">0</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjgtNS0xLTEtMA_d20b6725-0a8d-49a7-b4a0-c3beddbf4c53"
      unitRef="usd">6000000.0</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjktMS0xLTEtMA_0e3780ef-9cda-4f17-be79-a1fd68c9bf22"
      unitRef="usd">-2400000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjktMy0xLTEtMA_47db92d7-1f6f-4e26-bbd8-52b8ca8be44e"
      unitRef="usd">-3900000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMjktNS0xLTEtMA_028d2369-89af-4481-8bec-091ace22de2b"
      unitRef="usd">-3200000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzAtMS0xLTEtMA_d1e7bcb3-336b-4f8d-b9a7-3eaf4ee05461"
      unitRef="usd">-228000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzAtMy0xLTEtMA_cf85351f-7df3-4a25-9b9b-db4bbdf0e083"
      unitRef="usd">-100800000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzAtNS0xLTEtMA_462f9331-df73-4abd-b37f-4f7400a9e953"
      unitRef="usd">-133600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzItMS0xLTEtMA_1fa19243-9764-451f-af6c-53c47d609ccf"
      unitRef="usd">108500000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzItMy0xLTEtMA_1edd0966-8ffd-4fc7-aeef-62b40ddc9200"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzItNS0xLTEtMA_1e902061-75de-4a88-b75d-283f4402ab2b"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzMtMS0xLTEtMA_5dbb36ad-5152-4dd4-9677-a7aef424ab88"
      unitRef="usd">136300000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzMtMy0xLTEtMA_c74d3e5f-117d-4136-b922-1aa99420e359"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzMtNS0xLTEtMA_1cb39708-c02a-479a-acd2-81918ad4bd92"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMS0xLTEtNjI0Ng_8d36be0c-9135-43db-bd6b-6e0be01998c6"
      unitRef="usd">90000000.0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMy0xLTEtNjI0Ng_de1dfb95-3775-472b-beb0-ab06910505e2"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtNS0xLTEtNjI0Ng_418e7f99-d5cb-4586-b1cb-f01c1cab0a75"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMS0xLTEtMA_d9dec62e-e36e-4e59-a8fd-148f12d460ee"
      unitRef="usd">100000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtMy0xLTEtMA_fb648155-fb24-4435-88ae-641dbfa60764"
      unitRef="usd">100000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzQtNS0xLTEtMA_b59fd916-5904-4da7-96e5-a7df6c61f1a4"
      unitRef="usd">34900000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzUtMS0xLTEtMA_01570fa0-8603-477e-a329-9920800a9142"
      unitRef="usd">1200000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzUtMy0xLTEtMA_b9d7e481-e100-41d5-abbe-b977dbdd5b9d"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzUtNS0xLTEtMA_609cee66-46f9-499b-9bd1-fe7b3242fdd9"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzYtMS0xLTEtMA_911538df-d101-488b-878e-9c7f3973735c"
      unitRef="usd">45100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzYtMy0xLTEtMA_0d616981-f23d-4058-8caa-81ed8d39f8f1"
      unitRef="usd">42100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzYtNS0xLTEtMA_edb7e16a-478d-4242-a37e-bf00b72a85ba"
      unitRef="usd">39100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzctMS0xLTEtMA_5a695b21-0ecb-4e6d-8ca2-3276539b9df0"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzctMy0xLTEtMA_afc1db44-6105-43d1-988d-ff1c51ae87cb"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzctNS0xLTEtMA_bdf29df8-17fd-4525-9423-9c813cb1b9af"
      unitRef="usd">-700000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzgtMS0xLTEtMA_bf489a5e-a42a-4ea6-9d66-3d712667a188"
      unitRef="usd">25100000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzgtMy0xLTEtMA_641c530c-5506-4d3a-881e-e587d7f4d9c8"
      unitRef="usd">27400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzgtNS0xLTEtMA_6cfea85a-7396-4a9c-9d56-672450923d1f"
      unitRef="usd">35700000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzktMS0xLTEtMA_5db5ffb8-da87-4dfe-966d-e0a16d2d3dba"
      unitRef="usd">5400000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzktMy0xLTEtMA_341d286b-0e09-4810-bd18-86ad5ed808da"
      unitRef="usd">4900000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfMzktNS0xLTEtMA_a663d8b2-ca04-410e-8529-a5a5503d595d"
      unitRef="usd">4400000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDItMS0xLTEtMA_b5f68074-2010-4a54-975f-6de5cbac81b4"
      unitRef="usd">83100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDItMy0xLTEtMA_889b2dc5-fd1b-4bdd-af54-6ae8419ff681"
      unitRef="usd">70800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDItNS0xLTEtMA_d0210e3e-8cfd-4ba7-9a3f-d57fd67a535f"
      unitRef="usd">74400000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDMtMS0xLTEtMA_2b7eed5a-96da-4d18-9ade-4cd1753436da"
      unitRef="usd">-36800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDMtMy0xLTEtMA_ff52e281-8149-4c37-846c-323afd5654f3"
      unitRef="usd">-80700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDMtNS0xLTEtMA_9902d580-0424-4eba-930a-5c6b89a11f1b"
      unitRef="usd">-109000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDQtMS0xLTEtMA_0c418228-dd2a-4331-8db6-b099e0559852"
      unitRef="usd">-700000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDQtMy0xLTEtMA_31044a96-94ab-4059-8add-66623c382ce9"
      unitRef="usd">-5600000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDQtNS0xLTEtMA_5884f02d-56bc-46e8-8c0a-41e621800fa1"
      unitRef="usd">12200000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDUtMS0xLTEtMA_217a4f28-6a8f-4574-91bf-4296c0500481"
      unitRef="usd">101700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDUtMy0xLTEtMA_98f199e5-f623-4721-a7b4-f06a396e6b6e"
      unitRef="usd">101500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDUtNS0xLTEtMA_6826c9f6-a870-4aeb-92a1-95f168046b5a"
      unitRef="usd">32900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDYtMS0xLTEtMA_12b9edd9-4095-4b43-8b6e-d23920e8a663"
      unitRef="usd">337400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDYtMy0xLTEtMA_2e5fdf43-8005-44fd-9f5a-1c99ecdc6d12"
      unitRef="usd">235900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDYtNS0xLTEtMA_8143aa0e-deb0-4fb1-a3e6-35715490f534"
      unitRef="usd">203000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDctMS0xLTEtMA_bb2f6a77-14d9-41dd-bd35-a75a6e19c2f0"
      unitRef="usd">439100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDctMy0xLTEtMA_13144556-227d-4262-9623-c0e9d61bd86f"
      unitRef="usd">337400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNDctNS0xLTEtMA_078f4720-9e77-4a03-8873-2e2ca53e151d"
      unitRef="usd">235900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTAtMS0xLTEtMA_abc00c51-d709-4d3b-a06b-ce98cf72833a"
      unitRef="usd">8600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTAtMy0xLTEtMA_d309114c-544b-498f-b856-29ab3ad0a237"
      unitRef="usd">8400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTAtNS0xLTEtMA_d6e2340d-0dd9-47ff-8c70-b2044a9e24df"
      unitRef="usd">8000000.0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTEtMS0xLTEtMA_3ded77e8-84ae-44e5-babb-6c5345dd4ee7"
      unitRef="usd">47500000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTEtMy0xLTEtMA_8aab1205-1e1c-4bbc-b80b-8cb60f53f100"
      unitRef="usd">42000000.0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTEtNS0xLTEtMA_d68649d7-5b9c-4ca5-96cf-0bac2e79a568"
      unitRef="usd">31000000.0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTItMS0xLTEtMA_346a3f00-d06c-4e5e-8152-10f2f9a514fa"
      unitRef="usd">17000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTItMy0xLTEtMA_e534e869-15b0-4556-b865-532b9efd1e16"
      unitRef="usd">15000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTItNS0xLTEtMA_500d0fe8-5734-48ab-a795-1e049a9e0e7b"
      unitRef="usd">20100000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMS0xLTEtMA_a6998059-86fe-471e-8d0e-a0b584b0a6df"
      unitRef="usd">11800000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMy0xLTEtMA_e74256c6-f6ce-43af-aad9-83273d4e5d6a"
      unitRef="usd">11300000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtNS0xLTEtMA_6cce7a5d-6161-4ff3-979c-0d0bc5148483"
      unitRef="usd">10400000</us-gaap:DividendsPayableCurrent>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMS0xLTEtODQ4MQ_0cc9a64e-4e45-4763-bacf-22c3e7094151"
      unitRef="usd">4900000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtMy0xLTEtODQ4MQ_d12ab61e-610b-4a54-967b-7275c7ad1970"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN183Ni9mcmFnOjZlYmMyM2Q2ZmJiZTRkM2FhYjk2ZDcyYjYwMDQwOTVkL3RhYmxlOmNkNzY1NjJjYzFhYzRlNDVhNzBlOGE1ZDVmN2FjOGM0L3RhYmxlcmFuZ2U6Y2Q3NjU2MmNjMWFjNGU0NWE3MGU4YTVkNWY3YWM4YzRfNTMtNS0xLTEtODQ4MQ_64875146-ebae-440e-9d91-c8e35f9595ff"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzODU_3cb4856b-482b-472c-975b-d9ffc8f17f85">Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Principles of Consolidation:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 16, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Other (Income) Expense&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for further discussion. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Cash and Cash Equivalents:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  Cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with maturities of three months or less at the time of purchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Accounts Receivable:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Our accounts receivable balance was net of an allowance for doubtful accounts of $0.5 million and $2.0 million at December&#160;31, 2019 and 2018, respectively. We record the allowance based on a specific identification methodology.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Inventories:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. The following is a summary of inventories at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.404%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.975%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.605%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.816%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;235.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other (income) expense. Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Leases: &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2019. Please refer to Note 6, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other (income) expense for the difference between the asset&#x2019;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Impairment of Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#x2019;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our 2017, 2018, and 2019 annual impairment tests. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment tests in 2017, 2018, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 5 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Employee Benefits:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Benefit Plans&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for a more detailed discussion of our pension and other retirement plans. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#x2019;s gain or loss is initially reported as a component of other comprehensive income (&#x201c;OCI&#x201d;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#x2019;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience. Please refer to Note 3, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Revenue&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Research and Development&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Environmental Remediation and Compliance Costs&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Litigation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Income Taxes:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other (income) expense. The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for a more detailed discussion of our stock-based compensation plans.&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Net Income Per Share&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.&lt;/span&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0MDU_ade5f825-a3a4-4365-8647-11c44def6d3e">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Principles of Consolidation:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 16, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Other (Income) Expense&lt;/span&gt;, for further discussion.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjE3MA_632d6723-8d20-41b1-b692-ebd849879a11"
      unitRef="usd">18900000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjE4NQ_ff106e9d-82b7-4be9-adaf-9d7878e00207"
      unitRef="usd">4500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjE5OQ_93b74281-7700-40a8-bfdc-ed9294f003d9"
      unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjIxMw_81b8ff2c-b7c9-43cd-93d7-ddd986d5f2e2"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMzg0ODI5MDcxNjIyNw_b57e5918-a197-4112-92d3-f05e61470d81"
      unitRef="usd">11200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:UseOfEstimates
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNDg_81764d37-5909-483b-a80c-b5dc4bb25d09">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0OTI_958dc590-ab54-444f-8b73-ef2af6bdb066">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Cash and Cash Equivalents:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  Cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with maturities of three months or less at the time of purchase.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NzQ_52fb9378-c759-4a95-8be1-83aa6d4d47fd">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Accounts Receivable:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Our accounts receivable balance was net of an allowance for doubtful accounts of $0.5 million and $2.0 million at December&#160;31, 2019 and 2018, respectively. We record the allowance based on a specific identification methodology.&lt;/span&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTExMA_e8946901-a823-4eab-8aef-5270d5666303"
      unitRef="usd">500000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTExNw_10fcb8ed-1421-466a-a783-c8f5fb94142a"
      unitRef="usd">2000000.0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzOTI_e0f2e7fe-2e7d-4d87-96df-8f36ff0aa6ef">Inventories: Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NjA_91a564ad-fa08-4e35-99ce-4c222e56a033">The following is a summary of inventories at December 31:&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.404%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.975%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.605%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.816%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;235.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMS0xLTEtMS0w_0204e91f-67a3-4ab2-bfea-9ab3e02b811a"
      unitRef="usd">100900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMS0zLTEtMS0w_30ddb22f-a6cc-4c14-8801-784615332c76"
      unitRef="usd">90400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMi0xLTEtMS0w_37303f0f-cd0a-4740-b477-f46fd745b9ea"
      unitRef="usd">37400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMi0zLTEtMS0w_8e1b9607-59d6-47e0-8e18-db25cf2e6da1"
      unitRef="usd">42200000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMy0xLTEtMS0w_51e12e50-b765-4956-a7cb-ea8f4bf57710"
      unitRef="usd">97400000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfMy0zLTEtMS0w_22908ae9-8709-4fb6-8894-20137fa398cf"
      unitRef="usd">81900000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfNC0xLTEtMS0w_7273bcac-2aa6-471a-a9e4-77043f2a161b"
      unitRef="usd">235700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RhYmxlOjc4OGE3Y2I5MTBkZDQ2ZjQ4OTRmMTk1ODczNDBlODA4L3RhYmxlcmFuZ2U6Nzg4YTdjYjkxMGRkNDZmNDg5NGYxOTU4NzM0MGU4MDhfNC0zLTEtMS0w_64f824ce-7379-4f89-b0ef-7420eef00a28"
      unitRef="usd">214500000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTA5OTUxMTY1MDEyNg_d35da491-6b99-470d-b5b4-117ba72d6f3d">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other (income) expense. Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTA5OTUxMTY1MDEyNw_cd052648-f6f8-4686-86dc-4060aa4692c6">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Leases: &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2019. Please refer to Note 6, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional information.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNjc_d5115c8b-4a2e-4264-aeb2-3d00e7d4e8b8">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other (income) expense for the difference between the asset&#x2019;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.&lt;/span&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTA5OTUxMTY1MDEyOA_7924a8e1-fdc7-4b6b-a3a2-e6c3a7162fa4">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Impairment of Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#x2019;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our 2017, 2018, and 2019 annual impairment tests. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment tests in 2017, 2018, and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 5 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8d77cb69d6a14565b31edce03b6c02c8_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfNTYzMQ_5747060e-7b97-4c4b-96ea-2be8d3bb6810">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8ae050fec07a41a1ad0d8ace81bbadbd_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfNTYzNw_0ca7b1f0-9d0c-424e-872b-489c896b6215">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNzQ_be29edd5-c322-4ddb-95a2-876483f666e3">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Employee Benefits:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Benefit Plans&lt;/span&gt;, for a more detailed discussion of our pension and other retirement plans.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NDY_f0e2267a-4661-467e-8a0c-facf3144dee9">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#x2019;s gain or loss is initially reported as a component of other comprehensive income (&#x201c;OCI&#x201d;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#x2019;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.&lt;/span&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NDc_108f6960-ee27-47fb-a085-0b59ada0f048">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0NTM_f48fa3ed-4763-404a-8cbf-76759a8ceed1">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience. Please refer to Note 3, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Revenue&lt;/span&gt;, for additional information.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNjQ_f618950f-8048-4f08-ba50-05be36e38fbb">Shipping and Handling Costs: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzOTc_8196e56c-cafb-4ea3-bb45-c476e0e23c65">Research and Development: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are expensed as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EnvironmentalCostsPolicy
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0MTc_bed3d50a-a8b1-4ed1-bf2f-156fd3931f0d">Environmental Remediation and Compliance Costs: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.</us-gaap:EnvironmentalCostsPolicy>
    <wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTM0ODQ_c245bd81-f394-4b92-a509-6ddccd7c3197">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Litigation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.&lt;/span&gt;</wst:LegalMattersContingenciesAndLegalCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzODg_fa3139fa-ace3-4666-a7e2-6041a904ffc9">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Income Taxes:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other (income) expense. The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzNjU_f0409d84-ddb5-4907-97ed-60bb5cefbb62">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for a more detailed discussion of our stock-based compensation plans.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184Mi9mcmFnOjY1ZjgyNWQzMmVjNTQzZmFhMTAwNzY1M2E3YWUyODAyL3RleHRyZWdpb246NjVmODI1ZDMyZWM1NDNmYWExMDA3NjUzYTdhZTI4MDJfMTMzODk_bc47c7c4-1094-4cb0-9bfe-e435772a8ac3">&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Net Income Per Share&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN184NS9mcmFnOmJkN2RiMDAzOTNjMDQ3ZTRhZTQyOTU1NDFjMzc0MGY0L3RleHRyZWdpb246YmQ3ZGIwMDM5M2MwNDdlNGFlNDI5NTU0MWMzNzQwZjRfMTY0OTI2NzQ2MzY0Mg_b6433339-e416-44f5-81f7-2fe2f9246769">New Accounting Standards&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Recently Adopted Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2019, the FASB issued guidance which clarifies or improves a variety of ASC disclosure and presentation requirements by aligning them with the SEC&#x2019;s regulations, thereby eliminating redundancies and making the codification easier to apply. This guidance was effective upon issuance. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2018, the FASB issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2018, the FASB issued guidance to address a specific consequence of the&#160;2017 Tax Act by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act&#x2019;s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act&#x2019;s reduction of the U.S. federal corporate income tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2016, the FASB issued guidance on the accounting for leases, ASC 842. This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Standards Issued Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 (&#x201c;ASC 740&#x201d;) and by clarifying and amending existing ASC 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under current guidance, an entity reflects credit losses on financial assets measured on an amortized cost basis only when it is probable that losses have been incurred, generally considering only past events and current conditions in determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements, primarily as we have not historically had a material amount of accounts receivable write-offs.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODg4Mw_15ae0aa0-3d1b-4045-aae4-fe2ab73f2412">Revenue&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Adoption of ASC 606&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On January 1, 2018, we adopted ASC 606, on a modified retrospective basis, applied to those contracts which were not completed as of January 1, 2018. As a result of our adoption, we recorded a cumulative-effect adjustment of $11.4&#160;million within retained earnings in our consolidated balance sheet as of January 1, 2018, to reflect a change in the timing of revenue recognition under ASC 606, from point in time to over time, on our Contract-Manufactured Products product sales, certain Proprietary Products product sales, development and tooling agreements, as well as an acceleration on a portion of the remaining unearned income from a nonrefundable customer payment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported under the accounting standards in effect for those periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We recognize the majority of our revenue, primarily relating to Proprietary Products product sales, at a point in time, following the transfer of control of our products to our customers, which typically occurs upon shipment or delivery, depending on the terms of the related agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We recognize revenue relating to our Contract-Manufactured Products product sales and certain Proprietary Products product sales over time, as our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We recognize revenue relating to our development and tooling agreements over time, as our performance creates or enhances an asset that the customer controls as the asset is created or enhanced.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For revenue recognized over time, revenue is recognized by applying a method of measuring progress toward complete satisfaction of the related performance obligation. When selecting the method for measuring progress, we select the method that best depicts the transfer of control of goods or services promised to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Revenue for our Contract-Manufactured Products product sales, certain Proprietary Products product sales, and our development and tooling agreements is recorded under an input method, which recognizes revenue on the basis of our efforts or inputs to the satisfaction of a performance obligation (for example, resources consumed, labor hours expended, costs incurred, time elapsed, or machine hours used) relative to the total expected inputs to the satisfaction of that performance obligation. The input method that we use is based on costs incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The majority of the performance obligations within our contracts are satisfied within one year or less. Performance obligations satisfied beyond one year include those relating to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. As of December&#160;31, 2019, there was $5.6 million of unearned income related to this payment, of which $0.9 million was included in other current liabilities and $4.7 million was included in other long-term liabilities. The unearned income is being recognized as income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our revenue can be generated from contracts with multiple performance obligations. When a sales agreement involves multiple performance obligations, each obligation is separately identified and the transaction price is allocated based on the amount of consideration we expect to be entitled in exchange for transferring the promised good or service to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.954%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.954%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;High-Value Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Standard Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.954%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Contract assets and liabilities result from transactions with revenue recorded over time. If the measure of remaining rights exceeds the measure of the remaining performance obligations, we record a contract asset. Contract assets are recorded on the consolidated balance sheet in accounts receivable, net, and other assets (current and noncurrent portions, respectively). Contract assets included in accounts receivable, net, relate to the unbilled amounts of our product sales for which we have recognized revenue over time. Contract assets included in other assets represent the remaining performance obligations of our development and tooling agreements. Conversely, if the measure of the remaining performance obligations exceeds the measure of the remaining rights, we record a contract liability. Contract liabilities are recorded on the consolidated balance sheet in other liabilities (current and noncurrent portions, respectively) and represent cash payments received in advance of our performance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.048%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.952%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract assets, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract assets, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in contract assets - increase (decrease)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(33.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in deferred income - (increase) decrease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The increase in deferred income during 2019 was primarily due to additional cash payments of $114.4&#160;million received in advance of satisfying future performance obligations, partially offset by the recognition of revenue of $110.4 million, including $20.8 million of revenue that was included in deferred income at the beginning of the year, and $2.5&#160;million in other adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have elected to disregard the effects of a significant financing component, as we expect, at the inception of our contracts, that the period between when we transfer a promised good or service to the customer and when the customer pays for that good or service will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition, we have elected to omit the disclosure of the majority of our remaining performance obligations, which are satisfied within one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Supply Chain Financing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have entered into supply chain financing agreements with certain banks, pursuant to which we offer for sale certain accounts receivable to such banks from time to time, subject to the terms of the applicable agreements. These transactions result in a reduction in accounts receivable, as the agreements transfer effective control over, and credit risk related to, the receivables to the banks. These agreements do not allow for recourse in the event of uncollectibility, and we do not retain any interest in the underlying accounts receivable once sold. As of December&#160;31, 2019 and 2018, we derecognized accounts receivable of $10.1 million and $5.7&#160;million, respectively,  under these agreements. Discount fees related to the sale of such accounts receivable on our consolidated income statements for 2019 and 2018 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Voluntary Recall&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On January 24, 2019, we issued a voluntary recall of our Vial2Bag product line due to reports of potential unpredictable or variable dosing under certain conditions. Our fourth quarter 2018 results included an $11.3 million provision for product returns, recorded as a reduction of sales, partially offset by a reduction in cost of goods sold reflecting our inventory balance for these devices at December 31, 2018. During 2019, we recorded a net provision of $5.4&#160;million for inventory returns from our customers and related in-house inventory, partially offset by a reduction in our provision for product returns. We continue to work to get the products back on the market.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i233817b047df4ab4a84d4b14575f9f25_I20180101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfMzg0ODI5MDcxMzEzOQ_e59ac37d-4ebe-4356-b3b6-f2929a708ae1"
      unitRef="usd">11400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i2a2868b8c8554bf08566aa6693065131_I20130630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfMzg4MQ_f73b269c-6e13-4205-a3c5-9f95507a210f"
      unitRef="usd">20000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i206cd48a54414476aa718a6e0111302f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDAzMQ_d4a87874-b352-4270-9392-4875f1eeaee7"
      unitRef="usd">5600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i206cd48a54414476aa718a6e0111302f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDA4Nw_728fc4da-795c-4f3b-878d-77c21d0dd59e"
      unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i206cd48a54414476aa718a6e0111302f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDEzNg_b52f1bbb-21ec-435d-a952-4843e7b77801"
      unitRef="usd">4700000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODg3OQ_026c91af-fae7-451a-a2ac-2a6f874293a2">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the approximate percentage of our net sales by market group:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.954%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Generics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the approximate percentage of our net sales by product category: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.954%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;High-Value Components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Standard Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Delivery Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the approximate percentage of our net sales by geographic location: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.954%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib3cfed53a74b468cb29ff189c2377269_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMS0xLTEtMS0w_24957fc3-808c-4d7b-b574-45bec3ba48ae"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i94338860cdfc4c5c8a8a280138f4eec0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMS0zLTEtMS0w_4a705cec-e123-4c64-afa2-a827cc35b489"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i17b4a6ef0fda43fc8f9f9d4f83f071a9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMi0xLTEtMS0w_fcf86948-d5c7-4b6b-a4ac-4fdbf339916b"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9deaff27fd544743b1c994ebf17f9064_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMi0zLTEtMS0w_8d63c7ce-44fe-4deb-b180-40a8053e7557"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if213b8734da249fd94de624effacc125_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMy0xLTEtMS0w_39f947d5-c65a-499f-96c9-d21603dd5ee7"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4fea264d5e3a41b6b564f9b5e494a691_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfMy0zLTEtMS0w_5422de09-0d2f-4812-aa72-d6be314a444b"
      unitRef="number">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3f203ca7692647f9ad837576643bf7b8_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNC0xLTEtMS0w_043180f0-ff81-431a-9d2a-f97f0b57bdd5"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibeb2cefdf0cf432eb6f5b7d915d85fc5_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNC0zLTEtMS0w_dcce5b59-1472-4a32-9536-70449b215734"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNS0xLTEtMS0w_2d1eab4f-6767-4f98-8ac9-efabd920b324"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjU0NDdjNzVkNjM5YTQ0YzNhYWU0YTgxMmQ1OWRhYjJlL3RhYmxlcmFuZ2U6NTQ0N2M3NWQ2MzlhNDRjM2FhZTRhODEyZDU5ZGFiMmVfNS0zLTEtMS0w_dc17d7dc-6540-4e44-859a-c99e8c7f57d7"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if87ccca3baba4a5395c1b9dc357f28b1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMS0xLTEtMS0w_b73aeb75-8b39-4d87-a2af-974ee9ccba85"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9c242a3de0ae43649e6e851b01494740_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMS0zLTEtMS0w_685aa894-7cb9-4a88-a76a-c04adf6f012d"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i18bdeec0a55048dda5a14c6fef41b7a5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMi0xLTEtMS0w_6689cca9-c936-4d72-bdd9-cec598e2d38b"
      unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9dfa01f2e8de483cb3ee9d49bc79dc3e_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMi0zLTEtMS0w_98ed6413-3f02-4c26-a067-d6fb3f9c2af6"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iac8f1d1fb3f74df2a85e394a8eb7560e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMy0xLTEtMS0w_93c84056-4510-4926-b617-503b7f2752c8"
      unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i282d10e015594727b9481e65e9dc6cc3_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfMy0zLTEtMS0w_a45c5198-6653-4e10-933b-a4c681fd40b2"
      unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id8848d2f515c4077b4f7260b808d43f9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNC0xLTEtMS0w_087e73c6-7e61-4110-b2d9-6d33b1f340cd"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8472c3bc9a9d4f95b15a5c727249f384_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNC0zLTEtMS0w_167f3d7a-ea4e-4438-9d4f-adb36c6c4993"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNS0xLTEtMS0w_453d8c8d-2140-4067-9e7e-91405a38f668"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjBlYTNmOTcyODBjYTQ5OGNiM2FhMDhhNDRmNWE2Zjc3L3RhYmxlcmFuZ2U6MGVhM2Y5NzI4MGNhNDk4Y2IzYWEwOGE0NGY1YTZmNzdfNS0zLTEtMS0w_e0dd4c87-8f20-4410-b0ff-4f6dd9d7b788"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id71e4d3f80ab475b8388901e312bddb1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMS0xLTEtMS0w_38729dd2-02a8-4d0b-bd71-e18c90870c1f"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icc5498ad1a414e15bf91e6c05c11a237_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMS0zLTEtMS0w_12cf6364-0c47-4b70-aec4-93d17a29073f"
      unitRef="number">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8c247c9265104fd983758887d598a274_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMi0xLTEtMS0w_11f15b35-2241-4285-b9fe-89d04b111e4a"
      unitRef="number">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i14a6633405de48c18ad9dd4624d66563_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMi0zLTEtMS0w_106c12ea-c133-4e12-9a55-5f18b4b2e78d"
      unitRef="number">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifbec786ebf7d48a3b104bb1d4b9fcd56_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMy0xLTEtMS0w_076c163d-f405-45be-bcef-4f2c5eab6c99"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie1d3206f6ead449095a75f97c9ea7d4a_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfMy0zLTEtMS0w_6a809022-e69f-4c74-8d76-b5b66c73e2cb"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfNC0xLTEtMS0w_ce83afdc-4cdb-4c28-8848-12e6448e811d"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOmJiMzhkZTkxNTVkYzQyNzk4YmFhOWYxYTYzZGIxZjZiL3RhYmxlcmFuZ2U6YmIzOGRlOTE1NWRjNDI3OThiYWE5ZjFhNjNkYjFmNmJfNC0zLTEtMS0w_476b62cd-ec90-433c-aa12-fab2b96a2712"
      unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODg4MQ_cd38ba6d-396b-46e7-ad92-a9f7cbe0f012">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.048%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.952%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract assets, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract assets, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in contract assets - increase (decrease)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(33.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in deferred income - (increase) decrease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfMS0xLTEtMS0w_29379038-65d3-47a7-b01c-c6f14344ecc5"
      unitRef="usd">9100000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfMi0xLTEtMS0w_fcf50d51-c747-485c-bf1f-33afe9dfe135"
      unitRef="usd">9800000</us-gaap:ContractWithCustomerAssetNet>
    <wst:ContractwithCustomerAssetIncreaseDecrease
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfMy0xLTEtMS0w_413e699c-ed8b-4bee-9c2d-0728a13083cb"
      unitRef="usd">700000</wst:ContractwithCustomerAssetIncreaseDecrease>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfNS0xLTEtMS0w_ee102ca0-dda4-477e-a75e-e853c455b033"
      unitRef="usd">33400000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfNi0xLTEtMS0w_6b457cf7-8e10-43ef-9146-f801956df7c0"
      unitRef="usd">34900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RhYmxlOjNiYzJkNDllNWJhYjRhMDg4NTlhNWJmODY0ZTljYWU3L3RhYmxlcmFuZ2U6M2JjMmQ0OWU1YmFiNGEwODg1OWE1YmY4NjRlOWNhZTdfNy0xLTEtMS0w_d2a8170b-95a6-47ef-86a7-c187440bcac1"
      unitRef="usd">-1500000</us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized>
    <wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDM5ODA0NjUyMzk0NQ_79e3d26c-2197-4d91-a75d-af8b6b0d15f3"
      unitRef="usd">-114400000</wst:ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNjY5Mg_55babc0e-e7af-49ba-9b93-62bf9bc7d528"
      unitRef="usd">110400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i46836a3158d542afb32cd1e654a0c77d_D20190101-20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNjcwNg_d494862b-1504-4e76-95ca-8585ecd744f5"
      unitRef="usd">20800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfMzg0ODI5MDcwOTg4Nw_23dd36bb-b9c0-41b7-a21a-57ddca1ec224"
      unitRef="usd">2500000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODExNA_19634fff-21ae-4968-8387-f3dceeb1392f"
      unitRef="usd">10100000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDk0NzgwMjMzNjM4NQ_56fa0d5a-9e37-46c9-8334-d86bd79a8b35"
      unitRef="usd">5700000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount>
    <wst:ProvisionForProductReturns
      contextRef="i4ecf186e93644ab891c8d431739b0932_D20181001-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfODUwNA_b33bbd1e-0265-41a8-8132-772b7681a0f2"
      unitRef="usd">11300000</wst:ProvisionForProductReturns>
    <wst:ProvisionForProductReturns
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185MS9mcmFnOjFiMzA0YjFiMTNkYTQzNjM5NzliN2VlODRmYjJiOWVmL3RleHRyZWdpb246MWIzMDRiMWIxM2RhNDM2Mzk3OWI3ZWU4NGZiMmI5ZWZfNDk0NzgwMjMzNjI4Ng_171d798e-a981-4dd4-860b-6bd60793583c"
      unitRef="usd">5400000</wst:ProvisionForProductReturns>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMTA2NQ_ee6db0ac-6332-4e17-9aeb-d1f90006b4d3">&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Note 4:&#160;&#160;Net Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:61.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.060%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;241.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-indent:-9pt;padding-left:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, 2018 and 2017, there were 0.1 million, 0.4 million, and 0.4 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. During 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of our common stock from time to time on the open market or in privately-negotiated &lt;/span&gt;&lt;/div&gt;transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2020.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMTA3MQ_8bbe7e44-8531-4032-a950-73ac1f580053">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:61.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.060%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;241.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-indent:-9pt;padding-left:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Dilutive effect of equity awards, based on the treasury stock method&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average shares assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMS0xLTEtMS0w_f7de0149-91f0-456d-9519-4d1f9f4ede00"
      unitRef="usd">241700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMS0zLTEtMS0w_76c77c4f-2242-44a1-b956-39805a3907e7"
      unitRef="usd">206900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMS01LTEtMS0w_5f0554e6-4bdd-409e-a90c-90a36fc8647c"
      unitRef="usd">150700000</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMi0xLTEtMS0w_d0c12105-9da4-4867-9a6f-107944eb904f"
      unitRef="shares">74000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMi0zLTEtMS0w_9e120079-41af-4f0b-bdac-31454a7e3c70"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMi01LTEtMS0w_7109ac0b-1314-4336-9e79-2a5b80494547"
      unitRef="shares">73900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMy0xLTEtMS0w_6f709f1d-5708-4eec-bd99-f2f1411964b5"
      unitRef="shares">1400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMy0zLTEtMS0w_4d0336a6-1d98-411f-9f4b-02f13b548cc5"
      unitRef="shares">1500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfMy01LTEtMS0w_7558a52b-e77d-4917-b389-ba8a94646fd2"
      unitRef="shares">1900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfNS0xLTEtMS0w_134ab346-ea98-4c00-9781-6bf1e6661ae2"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfNS0zLTEtMS0w_b00e1cf7-551b-48d4-965a-64a77cc203e2"
      unitRef="shares">75400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RhYmxlOmJjODA5OTk0ZjU2NjRkZDA5NWJlNjljODdjNWJjN2Q3L3RhYmxlcmFuZ2U6YmM4MDk5OTRmNTY2NGRkMDk1YmU2OWM4N2M1YmM3ZDdfNS01LTEtMS0w_cb9fd29d-c869-4f8c-8f47-dfef00b69d70"
      unitRef="shares">75800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMjE2_983e919f-45fb-47b4-9770-239cd756d2b6"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMjIw_ade0bf8d-62fb-4044-a0a7-475a92fb9de3"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMjI4_0be090ee-10d4-49eb-b95d-9ab18537c6a0"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfNTEx_b7436178-f615-4d87-964a-dbec5f284f11"
      unitRef="shares">800000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfODQ0_a5175a3c-7ce3-4af5-8618-941f3fa0fa3f"
      unitRef="shares">800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfOTA1_3edd52b2-a6df-4434-b93f-005efeb280e0"
      unitRef="usd">83100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfOTMy_a0633744-b610-4ff1-8807-517964ac86da"
      unitRef="usdPerShare">103.89</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185NC9mcmFnOjVhZWMzMjgyZWM2OTQzNGRiODk0YTZiM2RkMDdhOWZmL3RleHRyZWdpb246NWFlYzMyODJlYzY5NDM0ZGI4OTRhNmIzZGQwN2E5ZmZfMzg0ODI5MDY5OTI3NQ_a578d7d7-7f1d-4b0f-8ec5-84b840fb1dea"
      unitRef="shares">848000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTAxOA_b9e72b93-1cec-4a34-b834-610e25937f7e">Property, Plant and Equipment&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A summary of gross property, plant and equipment at December 31 is presented in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:55.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.307%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.701%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected useful lives (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15-35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;572.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;569.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5-12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;817.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;806.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Molds and dies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4-7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;115.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,820.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,752.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Depreciation expense for the years ended December&#160;31, 2019, 2018 and 2017 was $100.0 million, $101.7 million and $94.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;There were no capitalized leases included in buildings and improvements and machinery and equipment at December&#160;31, 2019 and 2018. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2019, 2018 and 2017 was $1.0 million, $0.9 million and $2.7 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019 and 2018, as part of our 2018 restructuring plan, we recorded within other (income) expense $0.3 million and $2.2 million, respectively, for non-cash asset write-downs associated with the discontinued use of certain equipment. During 2019 and 2018, as part of our restructuring plans, we recorded within other (income) expense $1.9&#160;million and $1.1&#160;million, respectively, for gains on the sale of fixed assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTAyMQ_b0823f6d-3574-4232-b34b-ff65e4602ec3">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A summary of gross property, plant and equipment at December 31 is presented in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:55.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.307%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.701%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected useful lives (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15-35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;572.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;569.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5-12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;817.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;806.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Molds and dies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4-7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;123.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;115.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;155.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,820.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,752.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0bb40d435fa14466b3b81d438b389a9f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMS0zLTEtMS0w_823bab4c-dc09-4f00-9821-5d6bd21354d8"
      unitRef="usd">22100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9f3de1c6f6fe45f6b458941cbcce9c89_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMS01LTEtMS0w_1b97ebc7-d1cb-4b12-9fce-452c0371da5c"
      unitRef="usd">20900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i072cba6507a54b579148c043620aac02_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMi0zLTEtMS0w_b0d1a004-648b-4300-a187-26d4d6eb445b"
      unitRef="usd">572900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8bad24d1776a40448ef8b8ec4302b349_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMi01LTEtMS0w_8be3b63c-210f-4db7-a8f0-6401cbe90aea"
      unitRef="usd">569100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic9a6eb4dd6a7413aa8ceaa3c09928e24_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMy0zLTEtMS0w_21fa3c77-c5e2-48ba-bd89-a6ec3edb2891"
      unitRef="usd">817000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i80e9aba82fbc4331be3320b17f956428_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfMy01LTEtMS0w_5c2ad04f-b3dd-4314-a570-ccd2c2b34ef1"
      unitRef="usd">806700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i28f45a82c6a848438e8a0997d7c86692_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNC0zLTEtMS0w_9a019ec1-fa18-4099-b785-0f1a125bafdd"
      unitRef="usd">123800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i444fecb15f1e48779e2506de06cd3906_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNC01LTEtMS0w_2d706307-9704-42f6-9a2b-3ded47b8fc15"
      unitRef="usd">115800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i65529b8816d44f1e8f82c472ecfd4c41_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNS0zLTEtMS0w_97b94e2e-74fe-4ab6-ae7f-b8c51867fe9e"
      unitRef="usd">155600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic95407f4963a4c28b32add928e5039ed_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNS01LTEtMS0w_82309e4a-88b1-4721-865a-7693915de61a"
      unitRef="usd">151100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icd7312c6ba844d1aa28e958e6af15331_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNi0zLTEtMS0w_e21e3a5d-feeb-403f-9b83-523b808d9b2a"
      unitRef="usd">128700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic729fd36e94941198d96cc6d4ce68a25_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNi01LTEtMS0w_8bb2510b-8f5e-4e4a-bb35-5e115a628a28"
      unitRef="usd">89100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNy0zLTEtMS0w_69825b8a-2db0-44b4-8c92-fda1ef10eed3"
      unitRef="usd">1820100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RhYmxlOmY3NDAwNjk4OWJlMjQ5NzlhM2IyM2VjMGNiZGZhMTUxL3RhYmxlcmFuZ2U6Zjc0MDA2OTg5YmUyNDk3OWEzYjIzZWMwY2JkZmExNTFfNy01LTEtMS0w_e0e9e15b-23a6-4925-b5ea-45736863f9a3"
      unitRef="usd">1752700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:Depreciation
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjA3_b567debb-b6e3-4583-affe-84ce2f9158f8"
      unitRef="usd">100000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjEx_d0d68e3f-7323-4cfa-8e2f-4534ba7de978"
      unitRef="usd">101700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjE4_f8ecd50c-c6bc-41da-9cce-05e91a0867d3"
      unitRef="usd">94300000</us-gaap:Depreciation>
    <us-gaap:CapitalLeasedAssetsGross
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMjQ4_794d4beb-f44e-4798-a1e0-66e02b895096"
      unitRef="usd">0</us-gaap:CapitalLeasedAssetsGross>
    <us-gaap:InterestCostsCapitalized
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNjM3_505f1752-3d35-4d61-a680-f585995dcc30"
      unitRef="usd">1000000.0</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNjQx_9723dc61-050c-4bb7-afea-3c02e1177c58"
      unitRef="usd">900000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNjQ4_b525f258-3919-4eb7-8c27-20460fd7243a"
      unitRef="usd">2700000</us-gaap:InterestCostsCapitalized>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTA5OTUxMTYyOTI4Ng_464e2fca-65d1-4f13-b23e-7da10da7f58c"
      unitRef="usd">300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfMTA5OTUxMTYyOTMwMg_9bd2a908-709a-4120-b792-e090bf1aefca"
      unitRef="usd">2200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNDk0NzgwMjMyNzMxMw_c797fc17-1636-4399-8a92-f90dad128d9f"
      unitRef="usd">1900000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN185Ny9mcmFnOmE4MTFmNTM5YjBhYjRmMjc4N2U5MmNiNWU0YjhkNDIyL3RleHRyZWdpb246YTgxMWY1MzliMGFiNGYyNzg3ZTkyY2I1ZTRiOGQ0MjJfNDk0NzgwMjMyNzMyNw_933077c7-1c43-434b-8dfa-2c3a31b1eb34"
      unitRef="usd">1100000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xNjQ5MjY3NDUzMjI4_94480ea9-eb06-4433-b3b8-2f1e18ce7476">Leases&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Adoption of ASC 842&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of December&#160;31, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5MzQz_3df9f4a3-52e4-45a8-8ae6-d4e15b74807d"&gt;five&lt;/span&gt; years, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $71.0&#160;million and operating lease liabilities of $73.1&#160;million for operating leases where we are the lessee in our consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Lease expense for 2018 and 2017 was $14.5&#160;million and $13.3&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, the weighted average remaining lease term for operating leases was 11.7 years and the weighted average discount rate was 3.76%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Maturities of lease liabilities as of December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Maturities of future minimum rental payments under non-cancelable operating leases as of December&#160;31, 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have elected to adopt the leasing package of practical expedients, which allows us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <wst:LeaseOperatingLeaseTerminateTerm
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8zODQ4MjkwNzA4OTAx_5a819785-b212-4311-bc6a-c5ee4b2cd46e"
      unitRef="number">1</wst:LeaseOperatingLeaseTerminateTerm>
    <us-gaap:FinanceLeaseLiability
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NTE5_f6196daa-5591-4200-a411-8a18ef62190d"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i317d53aa6f2d4db580df360452af00b7_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5MzU5_8d912966-2888-493c-9677-a5c8e5730acf"
      unitRef="usd">71000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i317d53aa6f2d4db580df360452af00b7_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5Mzc1_f24a9f64-4c34-4ba5-b913-6c85925fbe56"
      unitRef="usd">73100000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5Mzg5_d54ca4e1-8814-4c05-80ec-80157f1ba04f">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF8xLTEtMS0xLTk5MTE_ab9fb55b-776e-4b35-8904-e19d4ce63a24"
      unitRef="usd">12900000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF8yLTEtMS0xLTk5MTQ_d1d87cb5-5dff-4231-a616-72ea2d7a272e"
      unitRef="usd">800000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF8zLTEtMS0xLTk5MjM_8283be18-9f21-4c07-843e-6dadff577a97"
      unitRef="usd">3300000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZjFjZjdlNjA3ZDU1NDMxMWExMTY4NWQwNzBmZDU0NDAvdGFibGVyYW5nZTpmMWNmN2U2MDdkNTU0MzExYTExNjg1ZDA3MGZkNTQ0MF80LTEtMS0xLTk5MjU_648bdea8-8324-4a6c-8a4b-495ac07298f8"
      unitRef="usd">17000000.0</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5Mzkx_f838b0ae-6740-4415-bca7-27ccf1e80f4f"
      unitRef="usd">14500000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDA2_7048d75b-bbfd-4f00-9368-ddfbcb16b479"
      unitRef="usd">13300000</us-gaap:LeaseCost>
    <wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDIw_c8581382-b4c5-4bf2-864e-1a036a2414b2">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Supplemental information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ODhmOTg0ZGRkZTRhNDM4Y2EyZWJjNmJlMTMzNzQ2YTYvdGFibGVyYW5nZTo4OGY5ODRkZGRlNGE0MzhjYTJlYmM2YmUxMzM3NDZhNl8yLTEtMS0xLTk5NDQ_dd846379-56e2-4a3f-86a9-f9d3d11a3aa7"
      unitRef="usd">12500000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ODhmOTg0ZGRkZTRhNDM4Y2EyZWJjNmJlMTMzNzQ2YTYvdGFibGVyYW5nZTo4OGY5ODRkZGRlNGE0MzhjYTJlYmM2YmUxMzM3NDZhNl80LTEtMS0xLTk5NDk_18a4df37-09bc-4cec-9cc6-61c3f56c575e"
      unitRef="usd">9100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDIy_65b2f2af-65a4-4cad-b945-7fa1e514222e">P11Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDQ1_1e6477fc-3d81-4a05-8986-cf0d00fa12cf"
      unitRef="number">0.0376</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDUx_9de7bebc-910c-4875-81f2-4218880863a0">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Maturities of lease liabilities as of December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: imputed lease interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF8yLTEtMS0xLTk5ODg_f0f1d60d-d31a-48ec-a418-4038f86785b5"
      unitRef="usd">12100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF8zLTEtMS0xLTk5OTU_f10176df-bcff-4efe-ba73-7b6678b3864b"
      unitRef="usd">10400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF80LTEtMS0xLTEwMDAx_8eb55dad-145b-4d0c-a8e1-b5b62c71c1d7"
      unitRef="usd">8600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF81LTEtMS0xLTEwMDA3_90aa31e9-568f-4287-ba8b-37e329e7e856"
      unitRef="usd">7800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF82LTEtMS0xLTEwMDEz_a11f6803-1e00-4269-9b38-3db8323d74d8"
      unitRef="usd">7300000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF83LTEtMS0xLTEwMDE5_919bc387-8429-4455-b438-3fd1d073f052"
      unitRef="usd">41800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF84LTEtMS0xLTEwMDI0_50213b57-2695-4900-8e71-49b48be470fd"
      unitRef="usd">88000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF85LTEtMS0xLTEwMDI4_6064f224-2b1f-4b9e-ac86-c8bd6230dbef"
      unitRef="usd">16000000.0</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6ZWFkNTFhNTA0ODNjNGZlMjgyNmFiYjBhYWUwMjMxMWQvdGFibGVyYW5nZTplYWQ1MWE1MDQ4M2M0ZmUyODI2YWJiMGFhZTAyMzExZF8xMC0xLTEtMS0xMDAzMw_d09c41ca-5210-468a-b774-e6b93903a2da"
      unitRef="usd">72000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NDUy_68ba25a8-5f70-4393-913c-e6d8c7397c88">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Maturities of future minimum rental payments under non-cancelable operating leases as of December&#160;31, 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl8yLTEtMS0xLTEwMDQy_6abf93c3-b82d-46a1-b521-113526ab3c02"
      unitRef="usd">13000000.0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl8zLTEtMS0xLTEwMDQ4_22d6b117-44a1-46f4-96ff-d7b4a63c8f18"
      unitRef="usd">10500000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl80LTEtMS0xLTEwMDUy_1ee67179-5206-401f-b7e1-dd4e489a237b"
      unitRef="usd">7800000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl81LTEtMS0xLTEwMDU2_186d6106-3e25-491d-88a9-42dc4ca228c5"
      unitRef="usd">6900000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl82LTEtMS0xLTEwMDU4_695c66f1-3e68-4d8a-a51a-80710a9f6817"
      unitRef="usd">5500000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl83LTEtMS0xLTEwMDY0_04bed17a-3466-498c-989a-000d4129fdc2"
      unitRef="usd">37800000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGFibGU6M2I0OTVjNzBlNTVmNDcwMzk1ZGY0MmM5YzAwNWFlZGYvdGFibGVyYW5nZTozYjQ5NWM3MGU1NWY0NzAzOTVkZjQyYzljMDA1YWVkZl84LTEtMS0xLTEwMDY5_b294cf16-b9f2-4ef1-8ab6-c486b342c7d5"
      unitRef="usd">81500000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i7d7f3d86824a4066a23c46e16851c996_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5NTAy_10310327-4fda-4ba2-a359-6cb630851354">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzE2NzQ_5f03fc38-66b8-43eb-a21a-4c56364e6a19">Affiliated Companies&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, the following affiliated companies were accounted for under the equity method:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:55.371%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.315%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The West Company Mexico, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aluplast S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharma Tap S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharma Rubber S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;I&amp;amp;W Pharma Group LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Daikyo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On November 1, 2019, in connection with the amendment of certain commercial agreements with Daikyo, we increased our ownership interest from 25% to 49% in Daikyo in exchange for $85.1&#160;million in cash and $4.9&#160;million in shares of our treasury stock to certain stockholders of Daikyo. We believe that the increase in ownership interest will not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Unremitted income of affiliated companies included in consolidated retained earnings amounted to $82.4 million, $75.8 million and $69.9 million at December&#160;31, 2019, 2018 and 2017, respectively. Dividends received from affiliated companies were $2.2 million in 2019, $1.7 million in 2018 and $2.2 million in 2017.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our equity in net unrealized gains of Daikyo&#x2019;s investment securities and derivative instruments, as well as pension adjustments, included in accumulated other comprehensive loss was $0.4 million, $0.4 million and $0.5 million at December&#160;31, 2019, 2018 and 2017, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our purchases from, and royalty payments made to, affiliates totaled $115.1 million, $86.3 million and $86.7 million, respectively, in 2019, 2018 and 2017, of which $20.8 million and $12.9 million was due and payable as of December&#160;31, 2019 and 2018, respectively. The majority of these transactions related to a distributorship agreement with Daikyo that allows us to purchase and re-sell Daikyo products. Sales to affiliates were $9.2 million, $9.6 million and $8.1 million, respectively, in 2019, 2018 and 2017, of which $1.9 million and $1.6 million was receivable as of December&#160;31, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019 and 2018, the aggregate carrying amount of our investment in affiliated companies that are accounted for under the equity method was $179.3 million and $77.8 million, respectively, and the aggregate carrying amount of our investment in affiliated companies that are not accounted for under the equity method was $13.4 million at both period-ends. We have elected to record these investments, for which fair value was not readily determinable, at cost, less impairment, adjusted for subsequent observable price changes. We test these investments for impairment whenever circumstances indicate that the carrying value of the investments may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzE2Nzg_2cd9aa8f-7f79-40f1-a135-d93b422020db">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, the following affiliated companies were accounted for under the equity method:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:55.371%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.315%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The West Company Mexico, S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Aluplast S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharma Tap S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharma Rubber S.A. de C.V.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mexico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;I&amp;amp;W Pharma Group LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Daikyo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i89cf005616044c5e8e5067ff128a6379_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzEtMi0xLTEtMA_2561d5b4-d888-4ac2-b662-21aa13953870"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie1e7eb7b421641b6b38d74b93995f136_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzItMi0xLTEtMA_880ccbef-68e7-4916-af85-801a5e63730e"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i649d27b290864823b58120ef0a909e69_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzMtMi0xLTEtMA_500f66a0-ac77-4d5e-9a68-27851b335a33"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i8604ed7fa7ef45dfa5249a8547428da8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzQtMi0xLTEtMA_f0e69855-37f1-4ca9-bf31-784dcc820c79"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iff6398961be24db984f094bedc419067_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzUtMi0xLTEtMTA2MDk_20e6f53c-59db-4c9c-98d0-46735605a3f4"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4e7adf4b261e42b0ba535696463b6408_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90YWJsZTpkZDNhZTQ0OTlhMDY0M2ZkYWJmMTJkYzY0NjUxZmU5OS90YWJsZXJhbmdlOmRkM2FlNDQ5OWEwNjQzZmRhYmYxMmRjNjQ2NTFmZTk5XzUtMi0xLTEtMA_7920e1fa-f6fe-4f36-9d69-c2e314cba0e1"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i34154b71394444eea4aac71d4bd6a886_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzM4NDgyOTA3MDUwNjg_38aa05be-125b-4dec-93b5-34c0078fbf61"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib03c963f83384e04af745078ed7c6c28_I20191101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEwOTk1MTE2MzU2MjM_487bd870-3adf-4a46-8d4d-11eb3566ad94"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEwOTk1MTE2MzU1OTQ_ab1dba1a-d113-46d0-abc0-a6a9520bbff3"
      unitRef="usd">85100000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEwOTk1MTE2MzU2MDk_2311a5c8-f29c-404d-81ac-8e80c8b9489d"
      unitRef="usd">4900000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzIyMQ_ab7a3cc4-92b8-4f7b-825e-d2ae953d9895"
      unitRef="usd">82400000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzIyNQ_1af935b6-be57-4086-8d90-f4607c23539b"
      unitRef="usd">75800000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzIzMg_a3b1e5b7-62ff-4452-825f-ebd4a7c19f39"
      unitRef="usd">69900000</us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzMxNw_1514fdae-0688-40b0-88bc-5b2a5ebbd69c"
      unitRef="usd">2200000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzMyNw_5dbbd8a5-5f37-4301-af6f-b4712909af77"
      unitRef="usd">1700000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzM0MA_1746b86f-5907-4313-a3bd-334e2a3d2b38"
      unitRef="usd">2200000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="i4e7adf4b261e42b0ba535696463b6408_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzUzMw_4a0caa06-8a24-476f-abde-321d9865c17d"
      unitRef="usd">-400000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="i34154b71394444eea4aac71d4bd6a886_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzUzNw_3c281d57-d53b-4aa7-9e53-7b70250b89ba"
      unitRef="usd">-400000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect
      contextRef="i135f442ad6834fb6b1c797458a39a2ee_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzU0NA_d1ec2ba8-0d3a-4522-b086-4aee9aa5e00c"
      unitRef="usd">-500000</wst:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzY1MA_1ec207b3-a9cb-4fd2-b60a-fab9fffb1b69"
      unitRef="usd">115100000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzY1NA_2fc9c4b8-5b4a-4c88-8da6-ce737bb4a1ee"
      unitRef="usd">86300000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzY2MQ_e6116031-0083-4a7b-a5ec-a573b599a0b6"
      unitRef="usd">86700000</wst:PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees>
    <us-gaap:DueToAffiliateCurrentAndNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzcwNg_1c56a54b-1e79-4fb1-af26-4bbd1db19abd"
      unitRef="usd">20800000</us-gaap:DueToAffiliateCurrentAndNoncurrent>
    <us-gaap:DueToAffiliateCurrentAndNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzcxMw_e640c14f-71f4-43e5-a297-a91bceb12eae"
      unitRef="usd">12900000</us-gaap:DueToAffiliateCurrentAndNoncurrent>
    <wst:SalesToEquityMethodInvestees
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzkzNA_c60721f7-5a33-4396-a459-5d4d5636c74b"
      unitRef="usd">9200000</wst:SalesToEquityMethodInvestees>
    <wst:SalesToEquityMethodInvestees
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzkzOA_df499ae5-b151-4cd2-8059-156584980901"
      unitRef="usd">9600000</wst:SalesToEquityMethodInvestees>
    <wst:SalesToEquityMethodInvestees
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3Xzk0NQ_80504f53-3da6-47bd-979d-d12c73cb4431"
      unitRef="usd">8100000</wst:SalesToEquityMethodInvestees>
    <us-gaap:DueFromAffiliates
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3Xzk5MA_84159e54-6d41-418e-9211-64eccb339e26"
      unitRef="usd">1900000</us-gaap:DueFromAffiliates>
    <us-gaap:DueFromAffiliates
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3Xzk5Nw_6a14872d-0e59-4b13-a73d-ba898b5044a0"
      unitRef="usd">1600000</us-gaap:DueFromAffiliates>
    <us-gaap:EquityMethodInvestments
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzExODQ_371a0612-28ea-4563-8e7a-cd4c33d32ac8"
      unitRef="usd">179300000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzExOTE_8db68614-2318-4346-b2d3-69452d0ce68c"
      unitRef="usd">77800000</us-gaap:EquityMethodInvestments>
    <us-gaap:CostMethodInvestments
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDMvZnJhZzo1NmQ2ZTRmNTBjMzc0OTBlOTVlNjBlNjZkMDlkNDM4Ny90ZXh0cmVnaW9uOjU2ZDZlNGY1MGMzNzQ5MGU5NWU2MGU2NmQwOWQ0Mzg3XzEzNTA_6b33270d-d24e-4ca6-9a33-f0864e8b2f59"
      unitRef="usd">13400000</us-gaap:CostMethodInvestments>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzk2MQ_874e8695-3ba2-4b3c-848f-e3cd9fd71c8c">Goodwill and Intangible Assets&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The changes in the carrying amount of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill recorded due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded goodwill of $2.6&#160;million. The goodwill was recorded within our Proprietary Products reportable segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, we had no accumulated goodwill impairment losses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Intangible assets and accumulated amortization as of December 31 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.121%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.461%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.461%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.741%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(48.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded a customer relationships intangible asset of $11.2&#160;million, which is being amortized over ten years. &lt;/span&gt;&lt;/div&gt;The cost basis of intangible assets includes a foreign currency translation loss of $0.3 million and a foreign currency translation loss of $0.3 million for the years ended December&#160;31, 2019 and 2018, respectively. Amortization expense for the years ended December&#160;31, 2019, 2018 and 2017 was $3.4 million, $2.7 million and $2.4 million, respectively. Estimated annual amortization expense for the next five years is as follows: 2020 - $4.0 million, 2021 - $3.5 million, 2022 - $3.5 million, 2023 - $2.9 million and 2024 - $2.6 million.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzk1Mw_a2b12c68-e1f5-470c-b0f2-32cb90d854fa">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The changes in the carrying amount of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill recorded due to acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i10b2bd972c5247c89ad526ba8664ceea_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzEtMS0xLTEtMA_159ad944-a73c-49c3-9cba-169346be3658"
      unitRef="usd">77600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9b16d7361925410886eeb15e971ce722_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzEtMy0xLTEtMA_82bcc04b-6eeb-4baa-8588-1211ada81b1e"
      unitRef="usd">30100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzEtNS0xLTEtMA_f5e1c641-fd94-4253-bd4d-f70a29365bb0"
      unitRef="usd">107700000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzMtMS0xLTEtMA_1efafbff-fe00-4b8c-8a51-8e48cdeb007b"
      unitRef="usd">-1600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzMtMy0xLTEtMA_4f188b58-f3ac-4515-a1b6-2abef3f73e60"
      unitRef="usd">-300000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzMtNS0xLTEtMA_26613f3c-9402-4bdf-b482-5d986f6ad86f"
      unitRef="usd">-1900000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ic2afcfd5d059438e8bc7bc4552794714_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzQtMS0xLTEtMA_d5ae1d7c-67cc-41ab-a117-babfa8c4fed2"
      unitRef="usd">76000000.0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i529afefe3a5146a8ae99168ace63b1f5_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzQtMy0xLTEtMA_4b3ad35d-54ad-47a8-a72f-c1b545ef02a3"
      unitRef="usd">29800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzQtNS0xLTEtMA_8124b9b5-bf76-4e16-8b16-ba3b6b0164bd"
      unitRef="usd">105800000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzUtMS0xLTEtMA_0481c20f-0664-4c70-98c2-f29c577d6be5"
      unitRef="usd">2600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzUtMy0xLTEtMA_b9a71497-13ce-448d-8c81-a9d732aa6fe9"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzUtNS0xLTEtMA_3b6cb02e-cac7-4802-ac26-1237d355e779"
      unitRef="usd">2600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzYtMS0xLTEtMA_a46ab0e1-7bad-4e10-b72e-5e7451871b17"
      unitRef="usd">-500000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzYtMy0xLTEtMA_325b8083-f49c-4cde-a97a-eb0237992af0"
      unitRef="usd">-100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzYtNS0xLTEtMA_31ee2a7c-1f84-4bb0-969f-8b07edb63fa3"
      unitRef="usd">-600000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="if22f0c39a4254fd9831626f40147da4c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzctMS0xLTEtMA_8fa91e16-b950-4bbb-bcee-dbcd99258f53"
      unitRef="usd">78100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic2831b7068f5415993b76a543c279df1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzctMy0xLTEtMA_dd71895c-e5fd-48f5-af63-9ab59bd8777a"
      unitRef="usd">29700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTphNjQ3NmY1ZmIyY2Y0YWQ5YWY0MzUyMzY2YjExMGQwMy90YWJsZXJhbmdlOmE2NDc2ZjVmYjJjZjRhZDlhZjQzNTIzNjZiMTEwZDAzXzctNS0xLTEtMA_d5d9781c-5751-4ad3-90b6-936366ca73ee"
      unitRef="usd">107800000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzEwOTk1MTE2MzA3NDA_ecafaa34-2763-406f-84e2-1bcd6a28e40f"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzk1NQ_2807703b-b7a5-46b8-910f-b07db38ee078">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Intangible assets and accumulated amortization as of December 31 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.121%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.461%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.461%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.741%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and licensing&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(48.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i745e6936945c4146b553af9a8d7a2d88_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItMS0xLTEtMA_5a5f5875-6421-4cd5-ab9c-9ea8884c270e"
      unitRef="usd">21500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i745e6936945c4146b553af9a8d7a2d88_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItMy0xLTEtMA_7b29ece8-c387-44de-ae06-c49beac25e19"
      unitRef="usd">16000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i745e6936945c4146b553af9a8d7a2d88_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItNS0xLTEtMA_654c5453-bb7b-4dd5-b03f-640247793236"
      unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItNy0xLTEtMA_2aa4cf23-a85c-4ca5-812d-d0eeed202aca"
      unitRef="usd">19600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItOS0xLTEtMA_5133fa82-e89a-4119-bb57-f5b61d349cf6"
      unitRef="usd">15100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i51f1f58ebfa54bc1b2a6f2d25594b38e_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzItMTEtMS0xLTA_563f5503-56c2-4e6c-9843-d32925f525a7"
      unitRef="usd">4500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i90dd87315fb54344b4f25c4ac0d5be42_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtMS0xLTEtMA_025ee948-51ce-47a0-8591-e7366298480d"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i90dd87315fb54344b4f25c4ac0d5be42_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtMy0xLTEtMA_e91966f5-86c3-4ffc-a0a6-9da33819e91f"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i90dd87315fb54344b4f25c4ac0d5be42_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtNS0xLTEtMA_8bc78c29-ea4d-41b8-a896-12791c35c50f"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id025bdb034db45568a0aa20c7a5a88e0_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtNy0xLTEtMA_fd700507-587f-4592-ac81-8a78c8b45b3b"
      unitRef="usd">3300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id025bdb034db45568a0aa20c7a5a88e0_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtOS0xLTEtMA_346fe9be-0d7f-49ea-9a22-14b4af36197f"
      unitRef="usd">1200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id025bdb034db45568a0aa20c7a5a88e0_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzMtMTEtMS0xLTA_4ed87045-3e3f-4740-8073-0f4c8159a4ad"
      unitRef="usd">2100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6bb357a5970a432e8774216e7e63f9a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtMS0xLTEtMA_dff30abc-5e06-49f0-941f-125823671c7f"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6bb357a5970a432e8774216e7e63f9a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtMy0xLTEtMA_102379ef-6348-410a-b670-9b5d3df04b8a"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6bb357a5970a432e8774216e7e63f9a8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtNS0xLTEtMA_840cec84-fa0e-48bb-9e39-4886eee1f1f3"
      unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i370687821342468aa0b202a3b92a0f3a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtNy0xLTEtMA_fbb5f9cb-7e82-4b4c-903e-46c2a2aba4bf"
      unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i370687821342468aa0b202a3b92a0f3a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtOS0xLTEtMA_a632992d-686b-4f3f-b385-667e9f3668fa"
      unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i370687821342468aa0b202a3b92a0f3a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzQtMTEtMS0xLTA_948c4fc0-74d7-49d6-b8cd-c5decad14f91"
      unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtMS0xLTEtMA_bcd6569b-79d0-46ac-a4ee-204f51fda090"
      unitRef="usd">40300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtMy0xLTEtMA_5c7231c7-64c5-461a-9675-2f93a2e9ee32"
      unitRef="usd">21600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i94d8ee3ce7394ca9bfd726a328f9a679_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtNS0xLTEtMA_a4d933a7-e928-48e4-9a30-23f0cb649538"
      unitRef="usd">18700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i930683f0ef754186a359e86df7c8ec95_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtNy0xLTEtMA_cc47eb27-06c0-4c6e-8517-5e9a1a020025"
      unitRef="usd">29300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i930683f0ef754186a359e86df7c8ec95_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtOS0xLTEtMA_fc1f954f-bfc4-4dcb-97f7-a085067be608"
      unitRef="usd">20000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i930683f0ef754186a359e86df7c8ec95_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzUtMTEtMS0xLTA_71b65269-1a48-46d5-82f1-75c5505ab7fb"
      unitRef="usd">9300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie38e99e04c054de492c86997ca5d77b1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtMS0xLTEtMA_992125b0-37ca-499d-9f2c-502908956018"
      unitRef="usd">11000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie38e99e04c054de492c86997ca5d77b1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtMy0xLTEtMA_8d4c9490-7c63-46b4-ada9-9dbbe38358e4"
      unitRef="usd">7400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie38e99e04c054de492c86997ca5d77b1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtNS0xLTEtMA_5828d8fc-2dc8-45ba-aa19-3c399741f0bd"
      unitRef="usd">3600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib9a4a99992a34bbfbd4970a826236a2a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtNy0xLTEtMA_4ff215d8-3dd3-4632-96bc-938eecbcced0"
      unitRef="usd">11000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib9a4a99992a34bbfbd4970a826236a2a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtOS0xLTEtMA_216b4048-dc5a-41bb-8f00-7f086aa78091"
      unitRef="usd">6800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib9a4a99992a34bbfbd4970a826236a2a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzYtMTEtMS0xLTA_db2d1598-134c-47b4-a975-45599e7f30a8"
      unitRef="usd">4200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctMS0xLTEtMA_6a234a2d-1354-44a5-9075-c75d73eaa6ef"
      unitRef="usd">78100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctMy0xLTEtMA_84ff1b3e-6dd0-4a79-bf5b-3253f8970131"
      unitRef="usd">48300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctNS0xLTEtMA_8cdd5724-7182-455a-8221-3237a04e80c5"
      unitRef="usd">29800000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctNy0xLTEtMA_6c93cc9b-c845-4d4e-a7bc-5fcaea0fd547"
      unitRef="usd">65200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctOS0xLTEtMA_ea922a5f-a076-4a8a-b580-15ac7b7c19e5"
      unitRef="usd">44900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90YWJsZTo5ZDYxMmYzMmNlYjg0NTlkYTQxZDkzYWU5MjQ1NTk1My90YWJsZXJhbmdlOjlkNjEyZjMyY2ViODQ1OWRhNDFkOTNhZTkyNDU1OTUzXzctMTEtMS0xLTA_9d01c814-1a82-4e08-9583-ff62f979059a"
      unitRef="usd">20300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="icbcb7101f4b347c386f48f408e3ef92f_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzEwOTk1MTE2MzA3MjI_4763a09a-ceaa-4f64-91f9-e92ed9cc247c"
      unitRef="usd">11200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzM2Mg_4c57f8dc-8cd7-4a50-a2e5-d9fb04a4f0a4"
      unitRef="usd">-300000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzQwNg_afb38810-edad-4a26-978c-0eadbe29a6d9"
      unitRef="usd">-300000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzUxMw_9c2933b5-9f6e-4773-9343-85ad6253cc83"
      unitRef="usd">3400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzUxNw_7e9c0cce-2e73-4c18-a604-312ebd8d34d7"
      unitRef="usd">2700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzUyNA_22a8129d-6693-42b6-92b1-60baca0c4847"
      unitRef="usd">2400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzYyNA_b6d3ff8d-aacc-4326-8a24-249e333cecb0"
      unitRef="usd">4000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzYzMw_26ce8aff-c65e-4ca3-ab6c-538dcbe562c6"
      unitRef="usd">3500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzY0Mg_1aed4256-3498-4581-9ce9-c44e62e02e75"
      unitRef="usd">3500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzY1MQ_e46b5ba2-ffcb-40f4-b090-ec97b02b3689"
      unitRef="usd">2900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMDkvZnJhZzo1ZjMwMmY2MjBjNTQ0NmJiYWIyNGQ5YTgyMjBiOWI3ZC90ZXh0cmVnaW9uOjVmMzAyZjYyMGM1NDQ2YmJhYjI0ZDlhODIyMGI5YjdkXzY2Mw_242c0be5-5cdb-40d2-9e2b-04dcb1b1b6fb"
      unitRef="usd">2600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90ZXh0cmVnaW9uOjZlMTRjYjJiMmVlNTQ0N2FhZWFmYjE2YTE1NTM3YmFjXzIwMg_224b47f3-95d7-412a-a87e-47c089f2e1ac">Other Current Liabilities&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Other current liabilities as of December 31 included the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued commissions, rebates and royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued retirement plans (excluding pension)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued taxes other than income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restructuring obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90ZXh0cmVnaW9uOjZlMTRjYjJiMmVlNTQ0N2FhZWFmYjE2YTE1NTM3YmFjXzIwNQ_d4ddb900-ff52-4673-a3e1-f2270bba01d0">&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued commissions, rebates and royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued retirement plans (excluding pension)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued taxes other than income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restructuring obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzEtMS0xLTEtMA_ac25f32a-c9fb-42ea-88ec-44e52f89bd64"
      unitRef="usd">27500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzEtMy0xLTEtMA_3bb0c417-7204-401e-af5b-4916db344040"
      unitRef="usd">25500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzItMS0xLTEtNzM1Mg_7ced1359-2377-43e1-b2b6-a28b0c9c25c0"
      unitRef="usd">11800000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzItMy0xLTEtNzM1OA_749b2b9e-2d40-4e7b-a542-47a2cb303226"
      unitRef="usd">11300000</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzMtMS0xLTEtNzM1Mg_e8eed48d-9393-4cd0-bd3a-e68b8c7628e8"
      unitRef="usd">9700000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzMtMy0xLTEtNzM1OA_fc40f9d6-9535-42af-b798-819c5107ea44"
      unitRef="usd">5700000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMS0xLTEtNzM1Mg_dd211bd2-6ecb-40e5-9ed6-66630f1afc4e"
      unitRef="usd">7900000</us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent>
    <us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMy0xLTEtNzM1OA_8f6490ae-fd2e-4890-959d-4fb957d98766"
      unitRef="usd">2300000</us-gaap:OtherPostretirementBenefitsPayableCurrentAndNoncurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMS0xLTEtODMyMw_ac486d73-bb51-4af2-ad13-1eedca248e5c"
      unitRef="usd">6500000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMy0xLTEtODMyNQ_2b3ed93e-91d3-4d63-a4ff-079c79990f4a"
      unitRef="usd">5500000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMS0xLTEtNzM1Mg_34e871d8-97d8-4428-b27e-f7263044a5ad"
      unitRef="usd">5900000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzUtMy0xLTEtNzM1OA_318c403f-acd9-4f29-8fa8-295447699917"
      unitRef="usd">4900000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMS0xLTEtNzM1Mg_fdcbc05d-1d17-4eff-9441-f6d34967bed5"
      unitRef="usd">3300000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMy0xLTEtNzM1OA_b41c01f7-8b34-4947-9a7c-95d44b3210b4"
      unitRef="usd">3400000</us-gaap:InterestPayableCurrent>
    <us-gaap:RestructuringReserve
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzctMS0xLTEtNzM1Mg_208f9087-531e-4851-9b42-b031ec913788"
      unitRef="usd">1500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzctMy0xLTEtNzM1OA_f3794338-e1e0-40ca-8f3d-fd4017eaa18f"
      unitRef="usd">3300000</us-gaap:RestructuringReserve>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMS0xLTEtMA_91a56d36-04ff-4291-a69e-f6c256248a39"
      unitRef="usd">17200000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzQtMy0xLTEtMA_31e79f9e-fa97-4e68-91f9-44b564ee5ddf"
      unitRef="usd">14700000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMS0xLTEtMA_04d1dbcf-1f54-450f-a025-95ad31f693b1"
      unitRef="usd">91300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTIvZnJhZzo2ZTE0Y2IyYjJlZTU0NDdhYWVhZmIxNmExNTUzN2JhYy90YWJsZTpjNDBhNzM4ZTkzZDE0NDZlODFlMDZiM2ZjMjFhNGYyZS90YWJsZXJhbmdlOmM0MGE3MzhlOTNkMTQ0NmU4MWUwNmIzZmMyMWE0ZjJlXzYtMy0xLTEtMA_d688edfb-a773-48fc-80e9-bef2d45b3bb2"
      unitRef="usd">76600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzM1NDE_7f573999-dbe0-4581-bdd8-b9225fc3674e">Debt&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.711%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Note payable, due December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Facility, due October 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Term Loan, due December 31, 2024 (2.78%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series A notes, due July 5, 2022 (3.67%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series C notes, due July 5, 2027 (4.02%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;258.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Credit Agreement - Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains the Credit Facility of $300.0&#160;million, with sublimits of up to $30.0&#160;million for swing line loans for domestic borrowers in USD and a $20.0&#160;million swing line loan for our German Holding Company and up to $30.0&#160;million for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of $350.0&#160;million and earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily LIBOR, plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December 31, 2019 and 2018, total unamortized debt issuance costs of $1.1&#160;million and $0.6&#160;million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December 31, 2019, we had no outstanding borrowings under the Credit Facility, as we repaid the outstanding long-term borrowings denominated in Euro and Yen in November and December 2019, respectively. There was no material gain or loss on the repayment under the Credit Facility. At December 31, 2019, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.5 million, was $297.5 million. Please refer to Note 11, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for a discussion of the foreign currency hedges that had been associated with this facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Credit Agreement Amendment - Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#x201c;First Amendment&#x201d;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $90.0&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month LIBOR plus 87.5 basis points. As of December 31, 2019, there were unamortized debt issuance costs remaining of $0.2&#160;million, which are being amortized as additional interest expense over the term of the Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;At December 31, 2019, we had $90.0&#160;million in borrowings under the Term Loan, of which $2.3&#160;million was classified as current and $87.7&#160;million was classified as long-term. Please refer to Note 11, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;, for a discussion of the foreign currency hedge associated with the Term Loan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In 2012, we concluded a private placement issuance of $168.0 million in senior unsecured notes. The total amount of the private placement issuance was divided into three tranches - $42.0 million 3.67% Series A Notes due July 5, 2022, $53.0 million 3.82% Series B Notes due July 5, 2024, and $73.0 million 4.02% Series C Notes due July 5, 2027 (the &#x201c;Notes&#x201d;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes is 3.87%. As of December&#160;31, 2019 and 2018, there were unamortized debt issuance costs remaining of $0.5 million and $0.6 million, respectively, which are being amortized as additional interest expense over the term of the Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Covenants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2019, we were in compliance with all of our debt covenants, and we expect to continue to be in compliance with the terms of these agreements throughout 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Interest costs incurred during 2019, 2018 and 2017 were $9.4 million, $9.3 million and $10.5 million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;$2.3&#160;million in 2020 and 2021, 2022 - $44.3&#160;million, 2023 - $2.3&#160;million, 2024 - $133.8&#160;million, and thereafter - $73.0 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzM1NDY_cc6a77f8-0faa-4506-8f44-96bc4a540fec">&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.711%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Note payable, due December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Facility, due October 15, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Term Loan, due December 31, 2024 (2.78%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series A notes, due July 5, 2022 (3.67%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series B notes, due July 5, 2024 (3.82%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Series C notes, due July 5, 2027 (4.02%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;258.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;257.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie0002a699af14295b2302af2a16bab97_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzUtMy0xLTEtMA_15519acd-86e5-43d9-bdb8-cd0648796352"
      unitRef="usd">100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ife1cf0309fce4ebd9ef5c548ba5929a5_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzYtMy0xLTEtMA_ed25d306-7a04-45e4-9ae9-9f513a69a53b"
      unitRef="usd">28600000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt
      contextRef="i6676f9d8fa624212a28167a0b290deb2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzgtMS0xLTEtMTI4OQ_d568276a-ed74-4a0a-a5ce-32b5a251d2b2"
      unitRef="usd">90000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia9eb640c923f4733a19388100c5bbed7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzgtMS0xLTEtMA_d241fad2-c023-41e8-8b2a-d2d936cae2f2"
      unitRef="usd">42000000.0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i91c99566b2144913acb7f361f5c22294_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzgtMy0xLTEtMA_a835057d-b52d-41d2-b059-fc1d35fd24c8"
      unitRef="usd">42000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt
      contextRef="i88b05261cd00424e9002e44c4d03c23e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzktMS0xLTEtMA_be941942-b3fc-4ddc-9712-c16dcc17abb3"
      unitRef="usd">53000000.0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7b22bd295c93485fb2d2ff977a010756_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzktMy0xLTEtMA_41a5e76a-3674-4c29-86c4-b3d534ec7261"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt
      contextRef="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEwLTEtMS0xLTA_ffd78425-4e8b-465e-b4aa-22a7d6dd6976"
      unitRef="usd">73000000.0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i303951a1d742421f9ca04aef7b201e68_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEwLTMtMS0xLTA_bfc63e8b-6df7-4b51-9bd8-48444c1cc119"
      unitRef="usd">73000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEyLTEtMS0xLTA_8227d11d-26f1-4f6b-8f2f-faecbea6e6e7"
      unitRef="usd">700000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzEyLTMtMS0xLTA_bb7a5e84-1141-474c-8ecb-9c760fdeee47"
      unitRef="usd">600000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzE1LTEtMS0xLTA_bb805765-f325-438b-91e6-fda28cd03e56"
      unitRef="usd">255000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90YWJsZTo0OTI0MDk4MmUyOWQ0OWE0YmY5ZWNkZDRmMjkzYjAyNS90YWJsZXJhbmdlOjQ5MjQwOTgyZTI5ZDQ5YTRiZjllY2RkNGYyOTNiMDI1XzE1LTMtMS0xLTA_1a3d0ea0-b10c-43ab-b692-4b02705cc57f"
      unitRef="usd">196000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwMTI_a40b5439-ffde-4945-8052-12460f56b881"
      unitRef="usd">300000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <wst:CreditFacilityIsAvailableForSwingLineLoans
      contextRef="ib25bd41fa2f6434989c8b30e7094cd66_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwMjc_9d72fb91-4fd5-4f50-b8df-53f70c066147"
      unitRef="usd">30000000.0</wst:CreditFacilityIsAvailableForSwingLineLoans>
    <wst:CreditFacilityIsAvailableForSwingLineLoans
      contextRef="i42fb76fda75b4b14a4664b19c1e784dc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwNDI_7eb8e014-6cc7-4c2b-8c64-68455c5f81cc"
      unitRef="usd">20000000.0</wst:CreditFacilityIsAvailableForSwingLineLoans>
    <wst:CreditAvailableForIssuanceOfLettersOfCredit
      contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwNTc_2b328650-960b-444e-996f-615af8bc1989"
      unitRef="usd">30000000.0</wst:CreditAvailableForIssuanceOfLettersOfCredit>
    <wst:LineofCreditFacilityAdditionalBorrowingCapacity
      contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwNzI_a09ec0e3-3d09-4321-8e83-391060c7d385"
      unitRef="usd">350000000.0</wst:LineofCreditFacilityAdditionalBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i24ec845a2a624436a8201d02881d6167_D20190101-20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwODg_60862198-72b7-4f78-a13f-9935be44fd0c"
      unitRef="number">0.50</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i28d2da44a3ca41a68e529adf0d248f25_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIwOTY_ab614191-0f62-497b-bfe7-62c8fe5e4403"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i984913c14dbf4de19cd8e36ccae92f15_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMDM_ac8fd147-ede5-458b-89ed-0c8e91736679"
      unitRef="number">0</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib9d7d55f956d49e2be8ad5e98d032270_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMDY_d6a30319-97a2-47ee-8284-b875d22101b8"
      unitRef="number">37.5</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ife43bfe94fc749d880537b4733fda5a9_D20190101-20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMTI_c686d509-01d2-4ce0-9524-4b86e68f3877"
      unitRef="number">87.5</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i78e7486b947f4f99a466314587751bc2_D20190101-20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMTg_9ce2c187-4738-4d14-a6a4-0a672b207352"
      unitRef="number">137.5</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <wst:RatioOfDebtToEBITDA
      contextRef="i56b5019b842b48aa8fa6565a51c3f1cd_D20190101-20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMjU_970e9a06-d77c-4e1b-beac-37d1fa4e6f76"
      unitRef="number">3.5</wst:RatioOfDebtToEBITDA>
    <wst:RatioOfDebtToEBITDA
      contextRef="ie079f1f282e8458c9a8cdce88d50af68_D20190101-20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMzA_2ca5f829-3207-4629-bff4-e6f9e75b9fb5"
      unitRef="number">4.0</wst:RatioOfDebtToEBITDA>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="iaf55a0f044ed4e1a852eca470f62e0d8_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxMzU_1575df8f-b93a-49b2-93e5-8fc4fbcba9d0"
      unitRef="usd">1100000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="ie6121497184640d09c106918c72a6948_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxNDk_6de14bd3-eb9b-4ad4-a2dd-aad0b573b571"
      unitRef="usd">600000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:LongTermLineOfCredit
      contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIzMDc_77eeecbd-4da7-4434-867b-0b70b567024f"
      unitRef="usd">0</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIzMjI_8c1a11b6-fc48-400d-85d2-3cc9e65dd3f6"
      unitRef="usd">0</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i04ab47ee62a5494f909f92a95cc7c70c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzEwOTk1MTE2NDM3MzY_917ace18-9c09-4ddc-9c47-ed86cd39166f"
      unitRef="usd">2500000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i45a17cab0f674ab9ad6b6eb351d70d06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzEwOTk1MTE2NDM3NDI_955de4a6-e195-4409-b9d1-a5d0a180033a"
      unitRef="usd">297500000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxNjM_8117d9e2-658b-44df-85e6-0d89a6a89516"
      unitRef="usd">90000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id4fca98c38414a20b353c860de269825_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxNzg_2ffad452-7964-4a28-901b-22f3487935fa"
      unitRef="number">0.875</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment
      contextRef="ieb4ecdaaaca7414f9a37335a909966d2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIxODQ_7c4c35e2-8798-4574-9c0d-2fd17cedf963"
      unitRef="usd">200000</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyMDQ_7cc0d1a3-39c7-4fa7-aa41-901cf9f21bf7"
      unitRef="usd">90000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyMTk_347d5c12-fddd-4c46-bd09-1874c72d51eb"
      unitRef="usd">2300000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id2b82a1b8c6a41898a7270bcd13e5504_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyMzM_43c2c86b-c482-4c41-ae19-f7636ab17a48"
      unitRef="usd">87700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8bdb4a99fe0e4bd7a545168d11cbeb80_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzIyNzI_8c6f0183-86a0-4603-96f9-72b25ef7c1f9"
      unitRef="usd">168000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i73656a3ae59a40a38eba7861eb07cd4a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzIzODc_e22aaaf6-a65a-45ba-911f-cb49ab85bf82"
      unitRef="usd">42000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73656a3ae59a40a38eba7861eb07cd4a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzIzOTA_b677b073-15a2-4889-9467-175d293cd6df"
      unitRef="number">0.0367</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i39f68633b1e54492a14344435d453361_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0MTI_d8f249c1-ed12-4eea-99dd-7e4df2109921">2022-07-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i88b05261cd00424e9002e44c4d03c23e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0MTY_a2a9b4a2-a208-421c-a9b3-b4a3a5b662e1"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i88b05261cd00424e9002e44c4d03c23e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0MTk_2e6ee604-a104-42a9-b729-988bc663366b"
      unitRef="number">0.0382</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i1fb56017b0b444b684e46fe8935ceb60_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NDE_038cfac0-eb7f-40af-b0ee-f35427314b06">2024-07-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NDk_cb28cac6-8770-4e7d-9c54-897e15912917"
      unitRef="usd">73000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8fcb93dd14fc4367a6ad1eae6c442124_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NTI_27f7ab50-d3b3-4c69-bae9-3eac895e6b17"
      unitRef="number">0.0402</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i74d6333665a945df9a67c0096b0b8f50_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI0NzQ_701a3a03-283d-400b-9feb-07d0c251ab1d">2027-07-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i8bdb4a99fe0e4bd7a545168d11cbeb80_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI2MjI_70c9ac38-99c0-48d2-8c27-05f5a25e88cd"
      unitRef="number">0.0387</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification
      contextRef="i342543b0c2f347e9b92ff37b1a7384ad_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI2OTk_37365b5f-2ee8-451e-a637-09931cceeaf9">0.5 million</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification>
    <us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification
      contextRef="ia7b648773fa64e1a87127b924772b46e_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzI3MDY_96d4ce90-1a0d-4331-86dd-63dfb74b2d14">0.6 million</us-gaap:DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification>
    <us-gaap:InterestExpenseDebt
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzMzMjM_3e23c11b-f2fe-4c0f-8947-70eddf2586e0"
      unitRef="usd">9400000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzMzMjc_1792df5e-d65d-490b-9de4-784274aeb1cb"
      unitRef="usd">9300000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzMzMzQ_a8906ec6-6466-4140-b790-d8346fbb3cc6"
      unitRef="usd">10500000</us-gaap:InterestExpenseDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyNDg_53f48b2e-022a-42d8-b46f-ea6f593779bb"
      unitRef="usd">2300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyNjI_d7bb71af-9376-44ca-9a0d-920d53f5c9f9"
      unitRef="usd">44300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyNzc_8afbdd37-e301-40c0-9319-85b06c0708b0"
      unitRef="usd">2300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzE2NDkyNjc0NjIyOTE_8bb375d2-a510-445a-9b79-cb2f1d7426a4"
      unitRef="usd">133800000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMTUvZnJhZzozODU3NThkOTViMDM0YTBkOGZlZWU3N2M4MmUyNzhiZi90ZXh0cmVnaW9uOjM4NTc1OGQ5NWIwMzRhMGQ4ZmVlZTc3YzgyZTI3OGJmXzM1Mjk_ba8ebaa8-3786-4172-8b08-1f5a84849e4e"
      unitRef="usd">73000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM3MDQ_032c506a-a5f7-4e25-aef0-24d5c6a2d193">Derivative Financial Instruments&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our ongoing business operations expose us to various risks, such as fluctuating interest rates, foreign currency exchange rates and increasing commodity prices. To manage these market risks, we periodically enter into derivative financial instruments, such as interest rate swaps, options and foreign exchange contracts for periods consistent with, and for notional amounts equal to or less than, the related underlying exposures. We do not purchase or hold any derivative financial instruments for investment or trading purposes. All derivatives are recorded in our consolidated balance sheet at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Foreign Currency Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have entered into forward exchange contracts, designated as fair value hedges, to manage our exposure to fluctuating foreign exchange rates on cross-currency intercompany loans. As of December&#160;31, 2019, the total amount of these forward exchange contracts was SGD 601.5 million and $13.4 million. As of December&#160;31, 2018, the total amount of these forward exchange contracts was &#x20ac;10.0 million, SGD 601.5 million and $13.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition, we have entered into several foreign currency contracts, designated as cash flow hedges, for periods of up to eighteen months, intended to hedge the currency risk associated with a portion of our forecasted transactions denominated in foreign currencies. As of December&#160;31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:52.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.906%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,550.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In November and December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Euro and Yen, we de-designated these borrowings as hedges of our net investments in certain European subsidiaries and Daikyo. The amounts recorded as cumulative translation adjustments within accumulated other comprehensive loss related to these borrowings (prior to de-designation) will remain in accumulated other comprehensive loss indefinitely, unless certain future events occur, such as the disposition of the operations for which the net investment hedges relate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, in conjunction with the repayment of the outstanding long-term borrowings under our Credit Facility denominated in Yen, we entered into a forward exchange contract, designated as a cash flow hedge, to manage our exposure to fluctuating foreign exchange rates. This forward exchange contract matured on December 30, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In December 2019, we entered into the cross-currency swap for $90&#160;million, which we designated as a hedge of our net investment in Daikyo. The notional amount of the cross-currency swap is &#xa5;9.8&#160;billion ($90&#160;million) and the swap termination date is December 31, 2024. Under the cross-currency swap, we receive floating interest rate payments based on three-month USD LIBOR plus a margin, in return for paying floating interest rate payments based on three-month Yen LIBOR plus a margin.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;"&gt;Commodity Price Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Many of our proprietary products are made from synthetic elastomers, which are derived from the petroleum refining process. We purchase the majority of our elastomers via long-term supply contracts, some of which contain clauses that provide for surcharges related to fluctuations in crude oil prices. The following economic hedges did not qualify for hedge accounting treatment since they did not meet the highly effective requirement at inception.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;From November 2017 through October 2019, we purchased several series of call options for a total of 352,682 barrels of crude oil to mitigate our exposure to such oil-based surcharges and protect operating cash flows with regards to a portion of our forecasted elastomer purchases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, we had outstanding contracts to purchase 135,967 barrels of crude oil from January 2020 to June 2021 at a weighted-average strike price of $70.71 per barrel.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Effects of Derivative Instruments on Financial Position and Results of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Please refer to Note 12, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for the balance sheet location and fair values of our derivative instruments as of December&#160;31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:30.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.269%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.429%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.328%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of Gain Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We recognize in earnings the initial value of forward point components on a straight-line basis over the life of the fair value hedge. The amounts recognized in earnings, pre-tax, for forward point components for the years ended December 31, 2019 and 2018 were $8.7&#160;million and $3.7&#160;million, respectively. We expect to recognize $5.6&#160;million in earnings, pre-tax, for forward point components in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:30.587%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.306%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.466%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.105%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.105%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.239%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of Gain (Loss) Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:57.455%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.873%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:30.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.429%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.429%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.168%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of Loss (Gain) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019 and 2018, there was no material ineffectiveness related to our hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3aeebc15e0d840ad96d6c9b1d2194147_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE0OTM_1c30abed-c3fa-40ed-ac90-b39b583e1f10"
      unitRef="sgd">601500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8f67399f84d54d7d9030ffcf5f5c6ac4_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE1MDA_d39010e6-93d1-44a0-9213-f68d0daeba9a"
      unitRef="usd">13400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9eb6fafaba61400aa82fd9842455a69a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE1ODY_9034306e-15d3-4805-9182-212a4752b5bb"
      unitRef="eur">10000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iffd10e01ebd64b78a96cb615682a5c6e_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE1OTQ_c728419b-ac57-4312-af9e-6df2d3276cd5"
      unitRef="sgd">601500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if06d9d35bbb0409183e672452771280d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2MDE_7de3b27b-aa54-4996-afb9-508abc1138e2"
      unitRef="usd">13400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM3Mjk_355c7fb9-4ae4-43a9-80c6-6fa0e40a2686">As of December&#160;31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:52.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.906%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Euro&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Yen&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,550.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SGD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i823dde1ddb5c418a9c33b324e0c85370_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzItMS0xLTEtMA_5a0a1f8c-237b-433a-85b9-a388fe9eeffb"
      unitRef="usd">38400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iad4d547d2e35453f98a85f299454f00a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzItMy0xLTEtMA_bf2b311b-86fd-4d82-b998-e11be13e0127"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iad4d547d2e35453f98a85f299454f00a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzItNC0xLTEtMA_763ad8a1-3fcb-4cfb-831e-895c34792e06"
      unitRef="eur">33600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieafbd5812ce143ef926bb1c0787dfbc6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzMtMS0xLTEtMA_4678b5c2-1821-4ecb-b9d1-650f0de9d43e"
      unitRef="jpy">6550400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0350a757f15d45c69e08b7eb2c4328de_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzMtMy0xLTEtMA_9d8de139-b290-4cfa-98a4-98d013dcca5d"
      unitRef="usd">37800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0350a757f15d45c69e08b7eb2c4328de_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzMtNC0xLTEtMA_9667ba8f-8e0f-4fe5-8599-afccbe8e286a"
      unitRef="eur">20600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie91724d6f39f459f886db959578117c7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzQtMS0xLTEtMA_e3d195a2-2d89-4d8e-a551-1e922bff9b0d"
      unitRef="sgd">29400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i41f0ad8b423640e7ab03461e54ef5610_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzQtMy0xLTEtMA_2ce9d53b-bebe-4361-a42b-f669cb64c119"
      unitRef="usd">16500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i41f0ad8b423640e7ab03461e54ef5610_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpkMjcyZjJhNDEyNzU0Y2EzYmE4ZWZhN2I2OGI3OWE1My90YWJsZXJhbmdlOmQyNzJmMmE0MTI3NTRjYTNiYThlZmE3YjY4Yjc5YTUzXzQtNC0xLTEtMA_ba01b575-fa80-463f-8eb3-1333f4e14acf"
      unitRef="eur">4600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5b88e6dc60f545a3bf0b56c374eb3e15_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyNzU_ed1009b7-705c-49a3-9803-5b504b17ede4"
      unitRef="usd">90000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ida576a4da2ec47b5b4725b7e5768d696_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyMjQ_dc3ee007-0528-4637-b37d-634b55b33eb9"
      unitRef="jpy">9800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia5e9aa415d9a4ae0894a28edad8214aa_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyMzg_58c35b6c-9f8f-41d2-8c5c-fb71060cbf93"
      unitRef="usd">90000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNonmonetaryNotionalAmount
      contextRef="ib8c160a1ee5b40b5815b9d3cfcebe527_I20171122"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzMyODQ_114820d9-9b94-48b5-ad68-9e0ee25c074d"
      unitRef="bbl">352682</us-gaap:DerivativeNonmonetaryNotionalAmount>
    <us-gaap:DerivativeNonmonetaryNotionalAmount
      contextRef="i2d648861366e4cdba756d7642ed7befe_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzM5OTM_d9c53c1a-f21d-4722-9ab4-bbd7167da3e3"
      unitRef="bbl">135967</us-gaap:DerivativeNonmonetaryNotionalAmount>
    <us-gaap:DerivativeAveragePriceRiskOptionStrikePrice
      contextRef="i2d648861366e4cdba756d7642ed7befe_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzQwODg_65c52eac-f12f-47dc-a0c0-88b7f3de76a2"
      unitRef="usdPerBbl">70.71</us-gaap:DerivativeAveragePriceRiskOptionStrikePrice>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0NTg_46b2b432-9698-40bd-8321-746dbcfe4395">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:30.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.269%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.429%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.328%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of Gain Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:30.587%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.306%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.466%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.105%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.105%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.598%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.239%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of Gain (Loss) Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of (Gain) Loss Reclassified from Accumulated OCI into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash Flow Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Investment Hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:57.455%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.873%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzMtMS0xLTEtMTU5OQ_90d17fa8-a8cf-44cd-aabd-85958a6aea7d"
      unitRef="usd">-6900000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="iffca62c03c8741448a75a7f9e1f891ef_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzMtMy0xLTEtMTU5OQ_5ea89a94-381b-4118-a9fe-6ff28d2a9630"
      unitRef="usd">-6300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzQtMS0xLTEtMTU5MA_e7da8bbb-6ec8-4dbc-b25e-377277d04def"
      unitRef="usd">-6900000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie04ce0467d524a8b80a1b327747a40f3_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpiNjNmOWYyNGVjMGY0ZWE4OWQ2ZWRkYjkxMWZkMzFlYS90YWJsZXJhbmdlOmI2M2Y5ZjI0ZWMwZjRlYTg5ZDZlZGRiOTExZmQzMWVhXzQtMy0xLTEtMTU5MA_bf4e17e0-3e56-4001-a880-2ad7f1cbc394"
      unitRef="usd">-6300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyOTA_9d61ece6-abe3-40e4-903d-6edb92dd59ec"
      unitRef="usd">8700000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ie04ce0467d524a8b80a1b327747a40f3_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0MTY_938cdfad-50f8-43b8-a95a-0e79c6df2994"
      unitRef="usd">3700000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <wst:DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths
      contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0MzA_f5e6d2ce-c53f-4392-acb0-59e2c35f7e30"
      unitRef="usd">5600000</wst:DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtMS0xLTEtMTU2Nw_977c0cbf-6ec5-4015-aaa1-8a58d4b5c778"
      unitRef="usd">4800000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i2438be2f494d4c3ab76ac2c994658437_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtNS0xLTEtMTU2Nw_1bbe5c8c-9fb1-467e-a2e3-764ca1415cf9"
      unitRef="usd">-4600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtMS0xLTEtMTU1Mg_794ead37-01e9-4310-a891-4a746f29da92"
      unitRef="usd">4800000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ia98f1a7f56184467b66a1efa6e53f78f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtNS0xLTEtMTU1Mg_24846cda-7d9e-48fc-88fe-04944a274695"
      unitRef="usd">-4600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i1b51d389a3a949c1a96cb422c48a5fe8_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtMS0xLTEtMA_b125ca8e-4e7a-49ec-ac8e-ff2dad7d0a9b"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i6516bd8d8ea049f183846349a305264f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtMy0xLTEtMA_a8aedff1-3f53-4f76-99cc-d254f66ba8fe"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i1b51d389a3a949c1a96cb422c48a5fe8_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtNS0xLTEtMA_34de6f85-0619-4e59-a5e8-2c0d4a71e90e"
      unitRef="usd">-900000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i6516bd8d8ea049f183846349a305264f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzMtNy0xLTEtMA_80d71a24-9256-4941-a345-04ac92b2da15"
      unitRef="usd">600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="iab7e1e117b2f4ca4b60537b7871e437a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtMS0xLTEtMA_13bbaf49-6f2a-4f90-a6c0-9e475e474d7d"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i88d7a3c0aeba474fab1d76fe62b33c49_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtMy0xLTEtMA_6efefbbe-22ab-4591-a960-cee054e8582d"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="iab7e1e117b2f4ca4b60537b7871e437a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtNS0xLTEtMA_6ddef50c-bedf-41c9-8be5-b9337980e4fb"
      unitRef="usd">-600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i88d7a3c0aeba474fab1d76fe62b33c49_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzQtNy0xLTEtMA_ffa79441-10f7-4dba-8e18-8b8d870a3188"
      unitRef="usd">300000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i8b1d512dc5f74c76b6f5691e47874f8c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtMS0xLTEtMA_75444b03-ed63-44c0-8c5e-18363796cc01"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i0cea4779b5e94dd0a2b87c75a76cf6ff_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtMy0xLTEtMA_45ca6772-33aa-4784-8227-7d8b0829bc7e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i8b1d512dc5f74c76b6f5691e47874f8c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtNS0xLTEtMA_3fe419d1-ebb5-43a9-a427-0c9705c99daa"
      unitRef="usd">300000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i0cea4779b5e94dd0a2b87c75a76cf6ff_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzYtNy0xLTEtMA_f656de71-ab56-48aa-9969-e720add3361c"
      unitRef="usd">300000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i83d0a9a392814a039ab15f60e9215923_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctMS0xLTEtMA_b88680a3-3857-48b9-ae75-212d3a6274b5"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i8f8b7ccbfafd42afab343384ad715db3_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctMy0xLTEtMA_25745918-2f48-47ee-9d7d-c8618bf41a04"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i83d0a9a392814a039ab15f60e9215923_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctNS0xLTEtMA_62852698-52bd-4352-b00d-af5171783dca"
      unitRef="usd">-1200000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i8f8b7ccbfafd42afab343384ad715db3_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzctNy0xLTEtMA_214c63f8-3b0f-4c30-bff5-2accea90ab08"
      unitRef="usd">1200000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i3e81e564ed5e4b758e644f7a48f8ab95_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktMS0xLTEtMA_8191fe74-8fbf-4738-9ba7-9030ac9c4899"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ifad6e6da551a403b9f68328ad4a2647e_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktMy0xLTEtMA_07f44b7d-0a49-4fc1-a549-d41d7eea9e60"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i3e81e564ed5e4b758e644f7a48f8ab95_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktNS0xLTEtMA_632218bd-490f-49e9-a4fd-d346b6a7fbe0"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ifad6e6da551a403b9f68328ad4a2647e_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzktNy0xLTEtMA_54b4b712-aba6-4a39-810a-03eb70b74353"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ifb86356e282f48e09566b38bfd145856_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEzLTEtMS0xLTEwNjE4_0f0d7c2c-ca9f-49b6-b2d9-4ae56a09d2c0"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i4786eb20ae494021a5b1565f7a6b78cb_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTEtMS0xLTA_f24b5373-2399-49c5-af08-164acbb6cfa2"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i7230a373ea8c425db7fc49d912890ad7_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTMtMS0xLTA_0ba407cf-b122-477f-a49b-15fac8c337b1"
      unitRef="usd">800000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i4786eb20ae494021a5b1565f7a6b78cb_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTUtMS0xLTA_e49140c9-7ab5-44ca-b2f7-a9d34c5a7589"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i7230a373ea8c425db7fc49d912890ad7_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTo3NzM5NDRhMmI4N2U0MDJmYTk0YTcwNGU2ODI5Zjg3Ny90YWJsZXJhbmdlOjc3Mzk0NGEyYjg3ZTQwMmZhOTRhNzA0ZTY4MjlmODc3XzEwLTctMS0xLTA_c58dd9cf-b54d-4d12-a3ed-1fb1ed0f15e9"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i3a0f779ffd67404fadb2c88b38a8fdc2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzEtMS0xLTEtMTA2NDM_0e1a0779-d6ff-43b8-be17-766dd73178d7"
      unitRef="usd">-900000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i5444a6541e6a4839bba8118e13149c48_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzEtMy0xLTEtMTA2NDY_13aba5da-02e3-4371-815f-5723289c4c2e"
      unitRef="usd">600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ifc4590db188d460db03346773c2dfbe4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzItMS0xLTEtMTA2NDg_906ada70-443f-4d91-904f-37f1b845af17"
      unitRef="usd">-600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i06546c728f1b443790dab4e6acbc50dd_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzItMy0xLTEtMTA2NTA_7770ce5d-722c-44fe-ba8f-3667f92989f5"
      unitRef="usd">300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ifcb34bb0d2724fb1baccf7a4fa927eef_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzMtMS0xLTEtMTA2NTI_c998dad9-64c8-45a4-a5b4-7a49d84be0bc"
      unitRef="usd">-4600000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i5398fe0e5da44d5c9cda165e14f5d41d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzMtMy0xLTEtMTA2NTQ_dcdeba6f-c2ca-4b63-8f31-f25c10144bae"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i938788ff937e43d487f7bb5a02deca1f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzQtMS0xLTEtMTA2NTY_eb74c345-e111-47f8-b6b3-ed0b993748e4"
      unitRef="usd">300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i72df90269a054543b29d4dd406291594_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTpjN2YyZDVhZDY3OTY0NDZjYTk5ZjRiN2FiNzFiZjA2Mi90YWJsZXJhbmdlOmM3ZjJkNWFkNjc5NjQ0NmNhOTlmNGI3YWI3MWJmMDYyXzQtMy0xLTEtMTA2NTg_6d8c15a0-ae84-4f30-ab04-129ab4814419"
      unitRef="usd">300000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzE2NDkyNjc0NjcyODc_67ce2a44-3bba-4d3c-abc3-279a955c9298">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:30.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.429%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.429%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.168%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount of Loss (Gain) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i9c77ba79e344403eb264810bc01f9141_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzItMS0xLTEtNDgzNA_84812f97-3b64-4e41-8ccb-f51e963b121c"
      unitRef="usd">400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="icefa72050c4e4056afec90fa88e94c46_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzItMy0xLTEtMTA0OTk_43b26923-4da8-4a3b-a3c3-40b3f9e2f9a2"
      unitRef="usd">-100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i56943e3e899240ba88693a4605ca6bff_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzMtMS0xLTEtMTYzNw_8cbd98dd-bc28-4c3c-b69c-ee94fdd4661e"
      unitRef="usd">400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i241e5f10a4ee4e61ae7e0c26389d98fd_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90YWJsZTplOTg1N2I1NzQ2NDk0YjdkOGIzMzE3NjAwN2FhMjAyZC90YWJsZXJhbmdlOmU5ODU3YjU3NDY0OTRiN2Q4YjMzMTc2MDA3YWEyMDJkXzMtMy0xLTEtMTYzNw_797b3137-753f-4a40-a129-9deb61c59b9a"
      unitRef="usd">-100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjEvZnJhZzo2OTJkNDMzODYyYzk0YmI1YmQzMDllNGVjODhkZGE1Yy90ZXh0cmVnaW9uOjY5MmQ0MzM4NjJjOTRiYjViZDMwOWU0ZWM4OGRkYTVjXzEwOTk1MTE2NTM0NDY_cb0b843e-06cf-4516-826a-2e8dd324adc3"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2ODI_b63d934b-8e15-4711-898c-e7d3698a8eeb">Fair Value Measurements&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;: Unobservable inputs that reflect the reporting entity&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#x2019; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term liabilities, is valued using a market approach. Please refer to Note 11, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for further discussion of our derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Level 3 Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of the contingent consideration liability related to the SmartDose technology platform (the "SmartDose contingent consideration") was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;obligation are recorded as income or expense within other (income) expense in our consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides a summary of changes in our Level 3 fair value measurements:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Decrease in fair value recorded in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increase in fair value recorded in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Other Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2019, the estimated fair value of long-term debt was $263.3 million compared to a carrying amount of $255.0 million. At December&#160;31, 2018, the estimated fair value of long-term debt was $192.6 million and the carrying amount was $196.0 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2Nzc_e8471896-74fb-4ba1-a27e-6f91ad6b5b6b">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables present the assets and liabilities recorded at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Commodity call options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross-currency swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;br/&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzQtMS0xLTEtMA_42a7fbcb-eaa1-442b-8a4a-9dee00963173"
      unitRef="usd">11300000</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzQtMy0xLTEtMA_cf5b9d7a-b59f-4622-a3c1-5aac9380cf06"
      unitRef="usd">11300000</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzUtMS0xLTEtMA_d7e88487-09e8-4eff-965c-de2c1b3819c7"
      unitRef="usd">7700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzUtNS0xLTEtMA_6d84cf68-9d67-4404-990c-b34819421e54"
      unitRef="usd">7700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtMS0xLTEtMTY3OQ_abf30767-141c-4009-a6ca-6f7999bf9efb"
      unitRef="usd">100000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtNS0xLTEtMTY4Nw_8b947695-bf04-4e39-98f6-a81ea58225b8"
      unitRef="usd">100000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtMS0xLTEtMA_b67e8bae-307c-478c-8325-2db24c1e7064"
      unitRef="usd">19100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtMy0xLTEtMA_bf1df221-1e74-4b78-8621-e1bb6fe44ec6"
      unitRef="usd">11300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzYtNS0xLTEtMA_5221a1e8-1f9f-4f51-9ee3-939435d11534"
      unitRef="usd">7800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzgtMS0xLTEtMA_715ee649-aa92-4bc4-9728-70bf70213822"
      unitRef="usd">3300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if5dac4480e07412789c6a00d0537966a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzgtNy0xLTEtMA_101a1bc2-44c9-4fd8-8fd9-5e9b2025834c"
      unitRef="usd">3300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzktMS0xLTEtMA_7e796fbf-81b0-45af-a716-0d5045cc35ac"
      unitRef="usd">12800000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzktMy0xLTEtMA_2abf6fc0-16c9-44c2-a0da-1900ba4bf693"
      unitRef="usd">12800000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i49fc1eac9a9a44988c05ab15c2b63dfc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzExLTEtMS0xLTExMzM3_4f16def1-bb35-4820-ba9a-58fb373e93a2"
      unitRef="usd">1400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1d4ee3958e024ea9be2a4c855879a06a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEwLTUtMS0xLTA_8b1b396e-b916-4007-8480-e2f940af1b6a"
      unitRef="usd">1400000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzExLTEtMS0xLTA_d15bdf3e-3de0-4479-8843-892691491a36"
      unitRef="usd">300000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzExLTUtMS0xLTA_2655395e-c973-4118-94f6-a8f61104f011"
      unitRef="usd">300000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTEtMS0xLTA_314f262f-0e83-4093-9409-90762a82302b"
      unitRef="usd">17800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i53eb0cd19a5d4173ba1b69d6924a17a5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTMtMS0xLTA_f1c3377e-e5bd-4020-8f10-46926e63be2e"
      unitRef="usd">12800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icff6c5eae2bf4042940d49d48243f475_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTUtMS0xLTA_fd491452-0dd0-4364-9b28-77be4cd706a9"
      unitRef="usd">1700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if5dac4480e07412789c6a00d0537966a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo5NGUwM2ViMzVkM2U0NjMwYmEwYWY4ZTkwOGNlZDVmMy90YWJsZXJhbmdlOjk0ZTAzZWIzNWQzZTQ2MzBiYTBhZjhlOTA4Y2VkNWYzXzEyLTctMS0xLTA_684592e6-2898-4e5e-9330-dc815f7c2a1d"
      unitRef="usd">3300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzQtMS0xLTEtMA_a600f498-3845-4e0b-82e8-4d108a057c44"
      unitRef="usd">8700000</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzQtMy0xLTEtMA_2f51ba68-2d35-458c-b9f9-75da07908ab3"
      unitRef="usd">8700000</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzUtMS0xLTEtMA_81a5886e-d1f2-41fd-881e-8ffb81e999f0"
      unitRef="usd">6500000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzUtNS0xLTEtMA_60bbddd3-a745-4a98-897c-2438ae0518b8"
      unitRef="usd">6500000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzYtMS0xLTEtMA_006e4b2d-5f18-4106-bab8-c3ad7cea5483"
      unitRef="usd">15200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzYtMy0xLTEtMA_ef35d77a-f2d4-48e7-8a27-10cd33338130"
      unitRef="usd">8700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzYtNS0xLTEtMA_8bb3270d-7eed-4258-954b-c17eaf2ede2a"
      unitRef="usd">6500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzgtMS0xLTEtMA_f4ee4068-dcd4-4418-afbf-b006290da113"
      unitRef="usd">1700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i30b7e14d051044b6b066bd549c53bd4b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzgtNy0xLTEtMA_e357c02e-0537-4e5f-bd9c-0d2324346b97"
      unitRef="usd">1700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzktMS0xLTEtMA_c5c737ba-d6e1-465f-a82f-5493424e2c8c"
      unitRef="usd">9800000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzktMy0xLTEtMA_7eaf053d-c871-4e3e-a7ec-ad4f8b798e34"
      unitRef="usd">9800000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzExLTEtMS0xLTA_11e85d33-f11d-43d0-95b0-c49ef2574439"
      unitRef="usd">200000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzExLTUtMS0xLTA_4306032e-5122-4655-9541-2be36d00ee5d"
      unitRef="usd">200000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTEtMS0xLTA_7cacc8ab-e956-4535-8f93-6166a18bf320"
      unitRef="usd">11700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i328f95c25c924ece85bbcd0f93f45e60_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTMtMS0xLTA_fb8d26ee-0912-4076-90bc-16eca0977ad8"
      unitRef="usd">9800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTUtMS0xLTA_f5793629-861a-4a8c-b0f8-34ec3c0b3565"
      unitRef="usd">200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i30b7e14d051044b6b066bd549c53bd4b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTphODA1OThmZmY4YTk0NmJiYTQ5Y2VmODhmNWNhMDcyMS90YWJsZXJhbmdlOmE4MDU5OGZmZjhhOTQ2YmJhNDljZWY4OGY1Y2EwNzIxXzEyLTctMS0xLTA_21618da6-a91d-45f5-a6e9-992d21069874"
      unitRef="usd">1700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2OTU_4b8afd70-99f1-48a0-9eff-d646b3f52f2a">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table provides a summary of changes in our Level 3 fair value measurements:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:83.096%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.904%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Decrease in fair value recorded in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increase in fair value recorded in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzEtMS0xLTEtMA_8045479d-972f-484c-8c29-119f47a24788"
      unitRef="usd">4900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzItMS0xLTEtMA_3ff21b17-fcd1-4444-93d2-fd352ca248f4"
      unitRef="usd">-2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzMtMS0xLTEtMA_01a53986-8763-4257-87b2-4393b99c3218"
      unitRef="usd">600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzQtMS0xLTEtMA_dcbc5a84-ead0-4dbe-bce9-3898f0378fc5"
      unitRef="usd">1700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzUtMS0xLTEtMA_3c3d5828-3d5b-4ab1-afc3-4f6695d214f4"
      unitRef="usd">2100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzYtMS0xLTEtMA_5a5afcee-4049-4fc5-927f-da783905eb23"
      unitRef="usd">500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90YWJsZTo3MTEyODQwMWQ3ZGQ0ZTRlOTQ3ZGViYTI0N2RmMWIxMC90YWJsZXJhbmdlOjcxMTI4NDAxZDdkZDRlNGU5NDdkZWJhMjQ3ZGYxYjEwXzctMS0xLTEtMA_109ffb2b-3bc2-466f-86f9-27e66c1a2098"
      unitRef="usd">3300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM1NDg_c08b9dae-88fe-4f76-85b7-4da0b08b8ae0"
      unitRef="usd">263300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM1ODQ_538d15f7-886e-46bf-8f91-34d82ea27aaf"
      unitRef="usd">255000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtFairValue
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2NDI_966660fd-0e03-40be-b1bc-63a3a0f6b312"
      unitRef="usd">192600000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjQvZnJhZzoxMjM0ZDA2Y2Y2MmI0ZmRkOWFlZmQ4MTEwM2RhODZjNi90ZXh0cmVnaW9uOjEyMzRkMDZjZjYyYjRmZGQ5YWVmZDgxMTAzZGE4NmM2XzM2NzM_f1a63bf4-28f6-49d7-844c-1e7fbb46e95e"
      unitRef="usd">196000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ2Mg_db1af4a0-9a4b-4285-acef-df595bd8a006">Accumulated Other Comprehensive Loss&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.025%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.750%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.378%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.419%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Losses) gains on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Defined benefit pension and other postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(74.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(117.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(113.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(154.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(108.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(149.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.987%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.136%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gains (losses) on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other expense&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Benefit Plans&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ3Mg_c47ec4c7-9e91-4874-a6d6-498fa31438da">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.025%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.750%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.378%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.419%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Losses) gains on derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Defined benefit pension and other postretirement plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(74.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(117.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(113.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(154.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amounts reclassified out&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(108.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(149.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i54c1d0f284e747c89538b5a73987ad3d_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtMS0xLTEtMA_657e0fd6-c33c-4fb8-8362-0fae0ff1eb18"
      unitRef="usd">-4200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9d70b978d8424d62a3d315bd9abaa763_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtMy0xLTEtMA_ed5a24bb-8c59-41bf-8968-0c1ae25c467b"
      unitRef="usd">500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icd5b5ea0ff6242348184786c3aa961a1_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtNS0xLTEtMA_51a17dee-4d20-4476-bfea-aa0c5afe2cc4"
      unitRef="usd">-39000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i61530ee5d64a43f0808f912144af8669_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtNy0xLTEtMA_e169f64e-6544-41fe-87a6-03ceea3a530f"
      unitRef="usd">-74600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzEtOS0xLTEtMA_6022c937-9116-49f4-984f-0efb26937299"
      unitRef="usd">-117300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItMS0xLTEtMA_c395c110-1bd5-42ae-8625-d2c568a04430"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItMy0xLTEtMA_7b5d942e-957b-434e-b1c7-fa4f763d69a2"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i20cc775951344c239b53db6971de8efc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItNS0xLTEtMA_610bbb2a-6505-43ba-927d-54ceca23d76d"
      unitRef="usd">-1000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItNy0xLTEtMA_7dd81524-678f-4e2b-a612-0b55d1c341f6"
      unitRef="usd">-39200000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzItOS0xLTEtMA_0cc58a01-72fb-4f4b-a81f-7d1eb8a3aae7"
      unitRef="usd">-37700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtMS0xLTEtMA_ca51b5ad-767b-4505-ad87-2257468dacc4"
      unitRef="usd">-1200000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtMy0xLTEtMA_c7101e0d-29d5-4e3f-b875-a4d3d95798c8"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i20cc775951344c239b53db6971de8efc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtNS0xLTEtMA_ea291d41-f746-45ed-9bdd-d60c447ab2e9"
      unitRef="usd">400000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtNy0xLTEtMA_85cc130b-7014-40cb-abbb-084bcedf0f7f"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzMtOS0xLTEtMA_9af03166-703a-40d6-b134-642f5a574eaf"
      unitRef="usd">-800000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ecf40fcadb94bfd9de7ca5306ab1005_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtMS0xLTEtMA_bf01411b-c6a2-4eb1-9452-72b641c2f4e8"
      unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i451d0f7798744167844ad741ed7f0cab_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtMy0xLTEtMA_74cd3f48-fb9f-464a-9df9-d24b037154b6"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i20cc775951344c239b53db6971de8efc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtNS0xLTEtMA_58025b5e-799f-454b-b055-3cb571fe264e"
      unitRef="usd">-1400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ideb7093498c44542a51fd9a4af9c21f5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtNy0xLTEtMA_69783bd2-f4d1-4ada-ad2f-1707ca4e3cd1"
      unitRef="usd">-39200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzQtOS0xLTEtMA_00f47f83-7298-4e4d-a481-b22fa8083751"
      unitRef="usd">-36900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0d3c7ebb49d2493aae018dd123c22d48_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtMS0xLTEtMA_8fb2d078-c74c-401e-806d-c806cc85ed96"
      unitRef="usd">-400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i53303cfc86bc4dff961279511a95e263_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtMy0xLTEtMA_95001cd9-1cd6-4552-8030-2bd21ac3eada"
      unitRef="usd">400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5c9924dfc84f437e82ad7ec265e9ce95_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtNS0xLTEtMA_6bbc7510-2b58-45d0-9cbd-3796b669825b"
      unitRef="usd">-40400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i226a4aed358e47e7960939567dde9022_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtNy0xLTEtMA_ad01551e-7068-49b0-acfd-08a95e7beea3"
      unitRef="usd">-113800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzUtOS0xLTEtMA_7fae33ce-8b46-49fb-b9dc-27750b08814a"
      unitRef="usd">-154200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtMS0xLTEtMA_5bec7570-b996-4507-9f5f-cb49b945e891"
      unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtMy0xLTEtMA_5b2c8af0-2c04-409b-a756-e72b1ddc32b4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtNS0xLTEtMA_67386bc1-49ec-4ffd-ab44-933eb82edb88"
      unitRef="usd">-1900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtNy0xLTEtMA_adcc390b-7c3a-4407-8b0b-d091e9525755"
      unitRef="usd">4900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzYtOS0xLTEtMA_a043402d-b5e9-4dc6-aaf9-cadd2cf30af5"
      unitRef="usd">8400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctMS0xLTEtMA_48ea6b3a-55a7-489e-8057-30f24183450a"
      unitRef="usd">5800000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctMy0xLTEtMA_517c4be5-a306-4c74-9775-ebcf775c35cd"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctNS0xLTEtMA_34562731-3ca7-46b9-8f2d-aa828eb0d7b3"
      unitRef="usd">-2000000.0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctNy0xLTEtMA_3144883e-8878-4846-b24d-ae15553daeed"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzctOS0xLTEtMA_6bc4fe8d-d77f-469c-956d-efec81f979cc"
      unitRef="usd">3800000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i06894bda72b24334a7078b4940ec07dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtMS0xLTEtMA_d6e81488-d827-4abf-b712-91a2926a7cd7"
      unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9ba97fd16f504daebbdc5b16c4a91608_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtMy0xLTEtMA_81ae05d8-806d-40b6-8f04-cd35cf627ea6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icc22d0613b744b0cb1b9a5752cfec663_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtNS0xLTEtMA_149f2428-6676-41ab-8bca-1f5013c1f5fc"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia3493958373f4f7c8f2f16447c55277f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtNy0xLTEtMA_0caffcbb-623f-4752-a75d-19b04ec740fb"
      unitRef="usd">4900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzgtOS0xLTEtMA_4dfb3ed4-b0f1-4fe3-9d06-df782bac784f"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i61e147e1374f4056b910aed673effca0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktMS0xLTEtMA_5f73fd52-8a4c-4ecb-bec8-35f91b73d874"
      unitRef="usd">-800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3de8a9a6e8a94858b2a73224b4e7f5fa_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktMy0xLTEtMA_a6f16a62-49fc-47cf-833b-d3cc98b2977a"
      unitRef="usd">400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if438f100318e4fa3a354238bdb515b75_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktNS0xLTEtMA_095c1d9e-d9cd-4e62-8f77-a887b2a585a7"
      unitRef="usd">-40300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4cec6a2db0f04eb8ace95c800f171e3f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktNy0xLTEtMA_5e11250e-87d0-446a-94d9-b305e1300547"
      unitRef="usd">-108900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTo5MGJjNTE0OTgzOTM0ZjIzYTZiNWEzZWEyZDlkYTkwMy90YWJsZXJhbmdlOjkwYmM1MTQ5ODM5MzRmMjNhNmI1YTNlYTJkOWRhOTAzXzktOS0xLTEtMA_648d6b2f-b506-44dc-b2f0-73fb26240b6c"
      unitRef="usd">-149600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ2Nw_ca5d1085-1ac1-440e-a4af-f37177ec0d35">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.987%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.136%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Detail of components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location on Statement of Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gains (losses) on derivatives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of goods and services sold&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other expense&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward treasury locks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of defined benefit pension and other postretirement plans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total reclassifications for the period, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Benefit Plans&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:Revenues
      contextRef="if2e238f2cc9d40cb97384f851a4ea42e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzItMi0xLTEtMA_b34d9f97-6763-4609-83f2-70e919dc3f48"
      unitRef="usd">1000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f47dbaaaf6d430698b26cb6d8506727_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzItNC0xLTEtMA_7f2a450c-d0a5-4f9e-9e88-73f1023e0752"
      unitRef="usd">-700000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if2e238f2cc9d40cb97384f851a4ea42e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzMtMi0xLTEtMA_45f933a9-cfcf-45fe-9422-8c8bc31df6f9"
      unitRef="usd">-1000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6f47dbaaaf6d430698b26cb6d8506727_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzMtNC0xLTEtMA_e27a1aea-0a5e-4327-8415-b6a82e578199"
      unitRef="usd">500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestExpense
      contextRef="iee4a569c86594ed29bf4011534feefa3_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzQtMi0xLTEtMA_33e7d8df-0117-4ca3-94c9-2821c81cf502"
      unitRef="usd">-6900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7fe96b1532ac40c18a9abf4c6908270f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzQtNC0xLTEtMA_6a3262d7-4bd7-4fae-ab26-3cb6c1e2e1fa"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i52141f7b63cf445d8c4a8244666efd47_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzUtMi0xLTEtMA_64adedde-c33f-46c4-87c4-983658455a05"
      unitRef="usd">500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3d9afa908f244094a5308013f6de9d86_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzUtNC0xLTEtMA_1d711a33-83ca-49a8-b2b6-4f7d447dac77"
      unitRef="usd">400000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzYtMi0xLTEtMA_892485c3-98f2-43f8-a93c-cb0321765a13"
      unitRef="usd">8400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzYtNC0xLTEtMA_be43faf7-c2aa-4888-ab33-f4e224d353b7"
      unitRef="usd">-1600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzctMi0xLTEtMA_6c657fa9-5484-4b5c-8706-cf8c0ef23911"
      unitRef="usd">2600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzctNC0xLTEtMA_db2b88d8-1f59-4806-a063-369ae57fe4f3"
      unitRef="usd">-400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="id0be857d93ff4ee58dd4116cfed24dd2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzgtMi0xLTEtMA_9c96cf7b-7c0b-40b2-9ed7-63ea1504cba9"
      unitRef="usd">5800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9f58e4c14cec4f1aa9d0beabe5b9b88d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzgtNC0xLTEtMA_74374af8-0bff-4f93-9d34-837f65b30a71"
      unitRef="usd">-1200000</us-gaap:ProfitLoss>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTItMS0xLTA_158e1055-5fdf-4a12-9fe0-387a2cc0fd98"
      unitRef="usd">-600000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTQtMS0xLTA_39b1e72d-a910-4547-84e9-4db1b28ffa44"
      unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTItMS0xLTA_1381ba37-693b-4a76-81c2-d76f8f336004"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTQtMS0xLTA_6ce887dc-fdf2-48fb-a49b-0c1d0da55efb"
      unitRef="usd">-1400000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE1LTItMS0xLTA_c66574e5-20cd-43d0-bc1a-d1107d8ade46"
      unitRef="usd">-2700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE1LTQtMS0xLTA_25461cab-041f-46bc-a4a5-160a8a78dd37"
      unitRef="usd">600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE2LTItMS0xLTA_9363c5cb-fde6-4604-be8a-b10d1e3e7d6c"
      unitRef="usd">-700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE2LTQtMS0xLTA_2618c5cf-748e-40d4-96da-b45cbe30abe3"
      unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i2dc974e8634e4484888175a6a52e9afd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE3LTItMS0xLTA_6066a7de-25e2-48fc-a160-dfd6346a4b99"
      unitRef="usd">-2000000.0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie4341d9e5380412db36b48256aa26c8c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE3LTQtMS0xLTA_bf42023f-3691-4f5e-99d3-22943d5643b9"
      unitRef="usd">400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iebf8f5c36fb64d06aff88d876051dba3_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE4LTItMS0xLTA_41b4ab9a-0c39-455a-a75c-95d8868b1608"
      unitRef="usd">3800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9ec88e31a4b8432c9b702366e072bcb8_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzE4LTQtMS0xLTA_c3c2d237-2940-4d9a-9b04-81e4fab08e4c"
      unitRef="usd">-800000</us-gaap:ProfitLoss>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxOTY_3e803897-09a3-4826-a545-268adbf5b401">Stock-Based Compensation&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#x201c;2016 Plan&#x201d;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2019, there were 3,119,314 shares remaining in the 2016 Plan for future grants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Stock options and stock appreciation rights reduce the number of shares available by one share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to 2.5 times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock option and appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Performance share units, stock-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Performance share units, cash-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Performance share units, dividend equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation plans and restricted share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2019 was approximately $21.2 million, which is expected to be recognized over a weighted average period of 1.6 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Stock options granted to employees vest in equal increments. All awards expire 10 years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in outstanding options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;67.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, the weighted average remaining contractual life of options outstanding and of options exercisable was 6.1 years and 5.0 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, the aggregate intrinsic value of total options outstanding was $227.8 million, of which $158.6 million represented vested options.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2019, 2018 and 2017: a risk-free interest rate of 2.3%, 2.7%, and 2.0%, respectively; stock volatility of 22.5%, 19.8%, and 19.9%, respectively; and dividend yields of 0.7%, 0.7%, and 0.7%, respectively. Stock volatility is estimated based on historical data and the impact from expected &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;future trends. Expected lives, which are based on prior experience, averaged 6 years for 2019, 2018 and 2017. The weighted average grant date fair value of options granted in 2019, 2018 and 2017 was $24.72, $20.16 and $18.08, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For the years ended December 31, 2019, 2018 and 2017, the intrinsic value of options exercised was $46.9 million, $61.3 million and $91.7 million, respectively. The grant date fair value of options vested during those same periods was $7.5 million, $8.3 million and $6.7 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Stock Appreciation Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Stock appreciation rights (&#x201c;SARs&#x201d;) granted to eligible international employees vest in equal annual increments over 4 years of continuous service. All awards expire 10 years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2019, SARs outstanding were 35,993, of which 23,833 were cash-settled and 12,160 were stock-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#x2019;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in outstanding SARs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;116,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(67,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Performance Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition to stock options and SAR awards, we grant performance share unit (&#x201c;PSU&#x201d;) awards to eligible employees. These awards are earned based on the Company&#x2019;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in our outstanding stock-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;341,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;378,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(48,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(121,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(116,684)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;264,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;341,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;54.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Shares earned under PSU awards may vary from 0% to 200% of an employee&#x2019;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2019, 2018 and 2017 was $103.40, $90.45 and $84.01, respectively. Including forfeiture and below-target achievement expectations, we expect that the stock-settled PSU awards will convert to 84,670 shares to be issued over an average remaining term of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU1MjU_5649237d-81f3-42ad-be9c-00e04ab34944"&gt;one&lt;/span&gt; year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in our outstanding cash-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(970)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;86.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We also offer an Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which provides for the sale of our common stock to eligible employees at 85% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to 25% of the employee&#x2019;s base salary, not to exceed $25,000 in any one calendar year. In addition, employees may not buy more than 2,000 shares during any offering period (8,000 shares per year). Purchases under the ESPP were 51,391 shares, 55,669 shares and 56,218 shares for the years 2019, 2018 and 2017, respectively. At December&#160;31, 2019, there were approximately 3.8 million shares available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Deferred Compensation Plans and Restricted Share Awards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of one share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2019, we granted 14,579 deferred stock awards, with a grant date fair value of $121.40. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. As of December&#160;31, 2019, the two deferred compensation plans held a total of 366,159 deferred stock units, including 6,274 units to be paid in cash.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition, during 2019, we granted 13,308 restricted share awards at a weighted grant-date fair value of $116.39 per share to employees under the 2016 Plan. During 2018, we granted 15,942 restricted share awards at a weighted grant-date fair value of $96.77 per share to employees under the 2016 Plan. There were no grants of restricted share awards in 2017. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Annual Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Under our annual incentive plan, participants are paid bonuses on the attainment of certain financial goals, which they can elect to receive in either cash or shares of our common stock. If the employee elects payment in shares, they are also given a restricted incentive stock award equal to one share for each four bonus shares issued. The incentive stock awards vest at the end of four years provided that the participant has not made a disqualifying disposition of their bonus shares. Incentive stock award grants were 1,300 shares, 1,500 shares and 1,800 shares in 2019, 2018 and 2017, respectively. There were no incentive stock forfeitures in 2019. Incentive stock forfeitures of 200 shares and 800 shares occurred in 2018 and 2017, respectively. Compensation expense is recognized over the vesting period based on the fair market value of common stock on the award date: $106.14 per share granted in 2019, $93.00 per share granted in 2018 and $86.93 per share granted in 2017.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzQ1MQ_fc743844-282b-4217-9673-23f25bb95ef1"
      unitRef="shares">3119314</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <wst:ReductioninNumberofSharesAvailableforGrantForEachAwardGranted
      contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU5Mw_f9c6d23c-0b1f-4bac-b593-25ff14fc8479"
      unitRef="shares">1</wst:ReductioninNumberofSharesAvailableforGrantForEachAwardGranted>
    <wst:ReductioninNumberofSharesAvailableforGrantForEachAwardGranted
      contextRef="i09ac587c6b034ba186fc3c9de00c5b88_D20190101-20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc0NA_03d3b278-0403-4a8e-8a16-b3558e107ef8"
      unitRef="shares">2.5</wst:ReductioninNumberofSharesAvailableforGrantForEachAwardGranted>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMjg_e23fb6ce-a263-4b76-899e-7a794cd1e259">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock option and appreciation rights&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Performance share units, stock-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Performance share units, cash-settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Performance share units, dividend equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred compensation plans and restricted share awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i907bb151930c472cb4617e8718b30e96_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzEtMS0xLTEtMA_9ef28373-8611-4095-b61b-57ddbe121e65"
      unitRef="usd">9100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia7b4b4807f6a4884893b217405bc6fea_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzEtMy0xLTEtMA_b03f9d76-263d-4325-b41b-2d5a39ef9de5"
      unitRef="usd">8600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6b919d55672f4707aaf1d62ddfc9503d_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzEtNS0xLTEtMA_38174cc5-406d-4332-a314-aaf4f8cdf80f"
      unitRef="usd">7800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i867e15a5465644589509da385c3661da_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzItMS0xLTEtMA_32782d80-388a-4bff-9b1e-16e6149cf519"
      unitRef="usd">9500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6f53f5cc02db4483948008576a947179_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzItMy0xLTEtMA_c6579dec-cb1b-4a6d-89dd-2bca0b30efc4"
      unitRef="usd">2500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ied22694c54d942dbbe6f33ff6b1dcfa0_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzItNS0xLTEtMA_87af2e9b-7eb0-4ce3-aa9e-673fe5edd676"
      unitRef="usd">4100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzMtMS0xLTEtMA_5033af42-c203-4570-b328-151c89ec9910"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzMtMy0xLTEtMA_46c2515f-3657-4872-bbdc-e85c8737de9b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzMtNS0xLTEtMA_9f51ea2b-132e-4d50-ad0e-6e5d26d060b9"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7bc4c67901ce44cc8ef5352dc9cb7c54_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzQtMS0xLTEtMA_90309627-9368-497b-8fc8-e16387e5c7f2"
      unitRef="usd">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i567d1eac07af4457b1dd2b7b2b50501d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzQtMy0xLTEtMA_e6f37a40-320c-4000-90c4-cf39118f4ee4"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idf6f7b5a95fd4d168630008ee5f37653_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzQtNS0xLTEtMA_0fc4ff61-1f44-4b2c-aaf3-bf10ec8d5f01"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzUtMS0xLTEtMA_5f8b2796-ae9f-4c23-b773-4bed6af25b56"
      unitRef="usd">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzUtMy0xLTEtMA_a76ffd5a-f28d-4a28-b208-05138dcf2087"
      unitRef="usd">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6077149f426d4ae8a0b5fd6b074a7a43_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzUtNS0xLTEtMA_d0a78f76-db8b-44d1-85d8-61c8dde7036b"
      unitRef="usd">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9df6a38179044003b818ff0f67bc84c1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzYtMS0xLTEtMA_78460ff7-d242-41af-bffc-9a721dcb65d9"
      unitRef="usd">4600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5d97e40c7db14ee0809a960d3d36fb39_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzYtMy0xLTEtMA_a5df1573-f0d7-45a9-b13f-6eeee951abd9"
      unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic2bf2b4179734ec29b0e706a4dd04b3c_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzYtNS0xLTEtMA_c8899587-aa1b-4dec-8e0e-4bf72e939978"
      unitRef="usd">3200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzctMS0xLTEtMA_165382f1-8857-4367-b5ac-cd50f1a4d309"
      unitRef="usd">24400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzctMy0xLTEtMA_b88227eb-c27c-4a4e-b4cf-245147a25047"
      unitRef="usd">15100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTphNjg4MDdmYTkwODk0YWJjYWY2YzZhNDRiZmJhNDBhMC90YWJsZXJhbmdlOmE2ODgwN2ZhOTA4OTRhYmNhZjZjNmE0NGJmYmE0MGEwXzctNS0xLTEtMA_4a96b748-7882-425f-a75c-c78846126941"
      unitRef="usd">16100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE0OTc_ffbe1204-28f2-4a3c-b63c-9ef45c1b7237"
      unitRef="usd">21200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE1NzA_7ac9ec5c-e81a-499b-b86c-ea39768a798d">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE2NzY_3eb4ab3f-289b-4565-b8c8-ce5b195aff73">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxOTE_df97f676-8676-4b06-82eb-8f072915fd28">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in outstanding options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;67.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzEtMS0xLTEtMA_72e49cc8-a945-422c-9d93-5849d9133a36"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzEtMy0xLTEtMA_90e4c761-d9df-47d3-b9ba-711f37ab5d2e"
      unitRef="shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzEtNS0xLTEtMA_c2a1797f-38e2-40c2-96c7-86c5e5449a07"
      unitRef="shares">4500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzItMS0xLTEtMA_d7f7eb6c-94df-41b2-9fe5-678bc2f89326"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzItMy0xLTEtMA_3eebc4d5-b510-4004-b7f9-b89f60446191"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzItNS0xLTEtMA_eb1e804a-d358-4d9d-8e41-1af39de6955e"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzMtMS0xLTEtMA_221aa90e-458e-4bb4-b89f-1dd30df19851"
      unitRef="shares">600000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzMtMy0xLTEtMA_c2b85bc8-895f-4ecf-9c8e-28ff3de78a89"
      unitRef="shares">1000000.0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzMtNS0xLTEtMA_340f5b5b-a15e-4283-9287-977d8f1481f8"
      unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzQtMS0xLTEtMA_5bebb62a-b54d-45bc-9dd9-066ef3a234bb"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzQtMy0xLTEtMA_231985c5-c443-45b5-8e90-caecfdde5e9c"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzQtNS0xLTEtMA_d676da17-47a3-47be-aa83-56454a74727c"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzUtMS0xLTEtMA_1ff39b3e-5d08-4b1d-96b1-f75ea3473fa9"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzUtMy0xLTEtMA_56010730-2896-46b2-84e4-b547f9596822"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzUtNS0xLTEtMA_39a978f7-a3fe-4967-8846-d4775447c808"
      unitRef="shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzYtMS0xLTEtMA_a2bc60b7-54f9-45ee-bcf6-f5ef9de87c32"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzYtMy0xLTEtMA_80661460-723e-4601-a511-a7c066cfeef4"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4NGMyOTkwNTY4ODY0NTRmOGQ5YTVjMzJlYzc1Mzc2Zi90YWJsZXJhbmdlOjg0YzI5OTA1Njg4NjQ1NGY4ZDlhNWMzMmVjNzUzNzZmXzYtNS0xLTEtMA_d81c481d-5afd-4d19-a4fd-3be2b6ee04c5"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzEtMS0xLTEtMA_f372fe02-b180-488c-91d8-c05e3be9c7a3"
      unitRef="usdPerShare">58.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzEtMy0xLTEtMA_95880d67-0c85-48f2-9ccc-9b4995ea90c3"
      unitRef="usdPerShare">48.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzEtNS0xLTEtMA_f37a8080-0d84-47d5-8e24-f9f55d92e4f1"
      unitRef="usdPerShare">38.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzItMS0xLTEtMA_7af707f5-4e78-4f0f-ab04-f1802e50a321"
      unitRef="usdPerShare">103.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzItMy0xLTEtMA_d4400d97-5d40-4cec-8bec-375b020c117e"
      unitRef="usdPerShare">90.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzItNS0xLTEtMA_11a4ebf8-af28-40d1-9319-abb0bd01284e"
      unitRef="usdPerShare">84.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzMtMS0xLTEtMA_42d0c037-80c6-461f-a216-097d5428018f"
      unitRef="usdPerShare">46.42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzMtMy0xLTEtMA_4b2d4b32-cf56-4738-a63e-190a074b78e9"
      unitRef="usdPerShare">35.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzMtNS0xLTEtMA_230000dd-e4b4-4c98-afe7-049a60a01722"
      unitRef="usdPerShare">26.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzQtMS0xLTEtMA_fd33d44c-3c52-4408-890f-6a5fe2c4bb84"
      unitRef="usdPerShare">92.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzQtMy0xLTEtMA_14d3047a-107e-43fd-9e6d-bc4362be6cc8"
      unitRef="usdPerShare">75.32</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzQtNS0xLTEtMA_774bf8b2-1eb1-4d48-85ad-25d40fd2fd48"
      unitRef="usdPerShare">60.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzUtMS0xLTEtMA_87b72374-072c-4609-bac8-4e6983c2e609"
      unitRef="usdPerShare">67.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzUtMy0xLTEtMA_b9a84233-dbdc-4731-8ae9-2b69efea9580"
      unitRef="usdPerShare">58.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzUtNS0xLTEtMA_d5b39d90-1cf1-454f-a96d-8eb94634c87c"
      unitRef="usdPerShare">48.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzYtMS0xLTEtMA_41ecfba5-8707-4ab6-ad6a-a35c50fb7dc8"
      unitRef="usdPerShare">53.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzYtMy0xLTEtMA_12fda810-2609-411e-8a38-36d1783436e5"
      unitRef="usdPerShare">45.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNmViMjViNmVkNTA0NjE2YTIxOWYwMmUxN2Y4ZDUzYS90YWJsZXJhbmdlOjI2ZWIyNWI2ZWQ1MDQ2MTZhMjE5ZjAyZTE3ZjhkNTNhXzYtNS0xLTEtMA_0707d264-d444-4067-9c17-128f732ff596"
      unitRef="usdPerShare">35.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzE5OTc_26094358-6d9a-4536-8af3-5f03322b6377">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIwMTA_c9b042dc-bf25-4d1f-9efc-24838cfacf9d">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIxMDg_7fe12f23-e64b-4b56-a840-eb4b4ebb6896"
      unitRef="usd">227800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIxMjE_8fd65330-7480-4ab2-a221-b08b2593c655"
      unitRef="usd">158600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIzNjM_01ab2f04-82e6-4907-a74e-e743e4b837de"
      unitRef="number">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIzNjc_0c4412e4-7873-47f0-b1a5-346c4d4b4fdc"
      unitRef="number">0.027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzIzNzU_616c1596-d9f6-4931-ba9a-cb1b2b86d04c"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0MTM_c116c98c-bee4-41ea-9c40-c5da92d711c7"
      unitRef="number">0.225</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0MTc_a065695d-255c-4b84-bdaf-8f934ec28156"
      unitRef="number">0.198</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0MjU_17c37cff-f619-4e22-9f4c-58e28833091d"
      unitRef="number">0.199</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i17799e0ff17e4cc3bd48f302e367f644_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0NjY_b5eebd5d-87aa-4d13-a974-e2f90f8cdf4c"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6077cd9623f34511a443f5ca9208cffc_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0NzA_8362ffe4-8fe1-4640-9d4e-741d3a7caabf"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI0Nzg_88521cc3-9ede-4090-ac74-a63312f2c0ac"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie1169a473b724d8d93c956648282e54b_D20170101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI2NTc_1c4d3b47-8519-47b2-89ce-16573180fc8a">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI3NjI_20718057-279b-4239-8b5f-b40c7ca20080"
      unitRef="usdPerShare">24.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI3NjY_58688213-44d3-4e56-9a53-fab15ee0a7d6"
      unitRef="usdPerShare">20.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI3NzM_7f4db4d0-ebb5-4589-8938-41c3fd81dd1c"
      unitRef="usdPerShare">18.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI5NjU_b39e362c-82ca-47a1-a5d9-87f14788042a"
      unitRef="usd">46900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI5Njk_6a27a8af-f8f3-4e9f-bb0b-98019e0ecaeb"
      unitRef="usd">61300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzI5NzY_65d61cac-e837-4508-90cb-39e029a2f619"
      unitRef="usd">91700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMwNjg_552f7b76-de1d-4262-a23c-34b6aea9a94c"
      unitRef="usd">7500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMwNzI_e61b8603-9354-4c30-af2e-cc573d5a19bc"
      unitRef="usd">8300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMwNzk_f4e708a3-dfca-4bcf-8eb8-e01961122632"
      unitRef="usd">6700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMyNDE_095b4be3-8b05-497e-ac03-b84e2d9c4575">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzMyODU_944bf1c9-ec22-4d75-9dfc-c76f14e5d2b3">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM0ODE_b9e0bf40-dae2-4c92-9380-ab71662d2d40"
      unitRef="shares">35993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <wst:CashSettledStockAppreciationRIghtsOutstanding
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM0OTQ_f90af6ce-e870-4ac2-9f78-9af6e83bb850"
      unitRef="shares">23833</wst:CashSettledStockAppreciationRIghtsOutstanding>
    <wst:StockSettledStockAppreciationRightsOutstanding
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM1MTk_80e05907-cb3b-4499-a7e3-743491bfd980"
      unitRef="shares">12160</wst:StockSettledStockAppreciationRightsOutstanding>
    <us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMjM_e1414b51-ab18-45d8-a0fe-094489011e86">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in outstanding SARs:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;116,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(67,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs outstanding, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;52.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;SARs exercisable, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ia961f06db9c748b8981269960022f06a_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzEtMS0xLTEtMA_4a1adbe0-2bf5-49bd-bdce-8f01526ea776"
      unitRef="shares">39819</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzEtMy0xLTEtMA_0a72ea5c-a003-4e1c-b0bc-c4aea8af4690"
      unitRef="shares">51368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ib0f756b7f10140c7a667c59d6aed2b9d_I20161231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzEtNS0xLTEtMA_72e67c3c-f2ff-4687-84b1-ce8e2abda25b"
      unitRef="shares">116087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzItMS0xLTEtMA_ad4ccded-53ef-43c8-a5be-9445ce87c340"
      unitRef="shares">3364</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzItMy0xLTEtMA_96c20b32-d0f4-44d0-9af2-5e1985f75fe0"
      unitRef="shares">3480</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzItNS0xLTEtMA_5451d1ca-443d-4c25-aebc-3de899aeadc2"
      unitRef="shares">2792</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzMtMS0xLTEtMA_b1da9434-f2b8-4c1d-9720-a5ba369948b2"
      unitRef="shares">6790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzMtMy0xLTEtMA_79c63807-f977-461d-97cf-6b1f535061bb"
      unitRef="shares">14629</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzMtNS0xLTEtMA_ee7622cd-ffe1-4e50-9bf0-0a8b95bd7123"
      unitRef="shares">67511</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzQtMS0xLTEtMA_882add3b-0587-47e9-9bb4-e59854654736"
      unitRef="shares">400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzQtMy0xLTEtMA_3aab3d85-334c-4475-a545-28e46148e183"
      unitRef="shares">400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzQtNS0xLTEtMA_b802ee9e-a15f-4d93-abae-37bc522be411"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzUtMS0xLTEtMA_901b95c2-2e45-4eab-bc59-adc05619e440"
      unitRef="shares">35993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ia961f06db9c748b8981269960022f06a_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzUtMy0xLTEtMA_f82d5c34-2d63-4ba9-a590-050742556cba"
      unitRef="shares">39819</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzUtNS0xLTEtMA_0f8ae15f-ce52-4627-a172-a6a085e9dafc"
      unitRef="shares">51368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzYtMS0xLTEtMA_3b1762b7-d5e0-4333-8565-639d2cb275e1"
      unitRef="shares">27781</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="ia961f06db9c748b8981269960022f06a_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzYtMy0xLTEtMA_9385d115-ed5f-4c21-b7a2-bddffc23494c"
      unitRef="shares">30285</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTplMDU4MGFlYjA3NTc0OGI0YjhjYjY5YzFhMzU4NzEwMy90YWJsZXJhbmdlOmUwNTgwYWViMDc1NzQ4YjRiOGNiNjljMWEzNTg3MTAzXzYtNS0xLTEtMA_89f66225-f79f-4853-924d-ec269e81f4df"
      unitRef="shares">39769</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="ia961f06db9c748b8981269960022f06a_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzItMS0xLTEtMA_e3cb9a00-c16a-4065-84af-ad40c817f83d"
      unitRef="usdPerShare">46.48</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzItMy0xLTEtMA_6cfbc909-b19d-43d4-ad14-d09beec9ccb8"
      unitRef="usdPerShare">38.55</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="ib0f756b7f10140c7a667c59d6aed2b9d_I20161231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzItNS0xLTEtMA_75915e5a-8f42-4578-89a2-5ed39a253308"
      unitRef="usdPerShare">31.13</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzMtMS0xLTEtMA_8e0cd1bf-2d32-46bc-bdc5-8cb6d329d475"
      unitRef="usdPerShare">102.51</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzMtMy0xLTEtMA_c0ef48b4-160e-4f2a-978a-313b6a1b15a4"
      unitRef="usdPerShare">89.64</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzMtNS0xLTEtMA_78d20735-3ea5-4c34-a3cf-15268447e5c0"
      unitRef="usdPerShare">83.47</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzQtMS0xLTEtMA_eef6110e-4c39-411e-801b-c2522237fbfd"
      unitRef="usdPerShare">42.08</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzQtMy0xLTEtMA_59b30006-cda7-433f-a5c6-817757738a2a"
      unitRef="usdPerShare">28.45</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzQtNS0xLTEtMA_b611e1f5-f0d6-43a8-844a-f57b8be8637b"
      unitRef="usdPerShare">27.65</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ic589dddc3e404c9dbbbb4041564ca469_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzUtMS0xLTEtMA_4f28c712-e4f8-4c03-8780-4ae0c2578468"
      unitRef="usdPerShare">63.43</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="iab0f4aa3d6c149829db5ca214d4afbc6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzUtMy0xLTEtMA_25b9ce2a-9d05-47c0-9a49-1a4ba192bf60"
      unitRef="usdPerShare">63.43</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i079bed0714544db1b4205d19b50b90a5_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzUtNS0xLTEtMA_c7129fc4-42b4-402d-832d-3ac00d55abe4"
      unitRef="usdPerShare">0</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzYtMS0xLTEtMA_7ccd5646-05bc-49a2-b09d-17fa04a42b36"
      unitRef="usdPerShare">52.36</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="ia961f06db9c748b8981269960022f06a_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzYtMy0xLTEtMA_24bcd81e-60b2-4900-8df9-1e37a3886e42"
      unitRef="usdPerShare">46.48</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzYtNS0xLTEtMA_fa37729c-c693-4b05-ae34-1bea66e517c7"
      unitRef="usdPerShare">38.55</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="iaa59b208a4dc470ead37d30735e6af30_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzctMS0xLTEtMA_9d6b3abb-9533-4831-8693-7416b2533f60"
      unitRef="usdPerShare">40.73</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="ia961f06db9c748b8981269960022f06a_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzctMy0xLTEtMA_0ac8701d-05b8-4013-a65c-4d33bae87ebf"
      unitRef="usdPerShare">36.91</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="i93f7c7e71c7f49ec88d39755fd192a57_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTozOWU0NjhiYjhkMGE0ZDI4YTUxMDNkYzA2NDcxOTViMi90YWJsZXJhbmdlOjM5ZTQ2OGJiOGQwYTRkMjhhNTEwM2RjMDY0NzE5NWIyXzctNS0xLTEtMA_fcc77b7c-721a-45df-bb1e-8374a300a242"
      unitRef="usdPerShare">30.77</wst:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMTc_47ec3c8b-c9fb-4683-819e-eae5fca2da3e">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in our outstanding stock-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;341,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;378,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(48,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(121,984)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(116,684)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;264,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;296,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;341,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;54.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;103.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested stock-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEtMS0xLTEtMA_fdd66d6c-fc5c-4fb5-b1f9-874a89c0a01f"
      unitRef="shares">296037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEtMy0xLTEtMA_197b2532-f992-4195-af53-46aae68557e3"
      unitRef="shares">341944</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ice189043bdb14f77817f481da434b9f6_I20161231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEtNS0xLTEtMA_420e8792-5a85-4040-aca5-0fe0f7aea297"
      unitRef="shares">378062</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzItMS0xLTEtMA_8887a3be-ab75-4057-bcb4-abb881ce9225"
      unitRef="shares">84309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzItMy0xLTEtMA_b95c5793-5011-4a83-8729-3a3c8b33f861"
      unitRef="shares">102307</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzItNS0xLTEtMA_706a4c66-b8f7-4b0e-87c6-1a4fc49a1758"
      unitRef="shares">92045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzMtMS0xLTEtMA_c75205e0-00da-4d01-adee-ba83d75386da"
      unitRef="shares">-50556</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzMtMy0xLTEtMA_d6ba4f35-c28b-4aa9-a4f4-a0c3ee85447d"
      unitRef="shares">-2284</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzMtNS0xLTEtMA_ebb7429c-3df4-4827-bcb4-ab4d0bdc5cfb"
      unitRef="shares">-11369</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzQtMS0xLTEtMA_09e42e6a-5268-435b-b7ce-e5ae366b6be1"
      unitRef="shares">48964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzQtMy0xLTEtMA_8f7f2582-f263-4dd4-b39d-c3aa83d34baf"
      unitRef="shares">121984</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzQtNS0xLTEtMA_75fcb7cf-6898-47f6-8b69-48d2c23b7e07"
      unitRef="shares">116684</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzUtMS0xLTEtMA_5c9910a2-cc7d-4559-bf89-3c21100cc6d2"
      unitRef="shares">16204</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzUtMy0xLTEtMA_f268dbc3-6841-415d-8564-693a47a069b9"
      unitRef="shares">23946</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzUtNS0xLTEtMA_4a696b37-85d9-486a-a989-e7b0fee2d843"
      unitRef="shares">110</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7986a8931ce14e87a14397225a1db358_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzYtMS0xLTEtMA_6365836f-64a8-4e94-8e16-2fe99f68f267"
      unitRef="shares">264622</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzYtMy0xLTEtMA_1c339440-8cb5-4d83-8bec-9abeac43ae09"
      unitRef="shares">296037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzYtNS0xLTEtMA_0fab9599-bf44-40f0-bf5b-89a2e606fee1"
      unitRef="shares">341944</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzktMS0xLTEtMA_1406d244-3d49-47f5-a174-905ca6738869"
      unitRef="usdPerShare">76.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzktMy0xLTEtMA_421d87d2-457b-4079-a963-1bdbffa5878c"
      unitRef="usdPerShare">64.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ice189043bdb14f77817f481da434b9f6_I20161231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzktNS0xLTEtMA_ae64c7f2-3ea9-422b-8455-10009f30fee6"
      unitRef="usdPerShare">54.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEwLTEtMS0xLTA_a774e748-c6b8-43f8-aa3d-bc8f6a6981a3"
      unitRef="usdPerShare">103.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEwLTMtMS0xLTA_4c110963-601a-4a7a-9fa5-26e2382db8d8"
      unitRef="usdPerShare">90.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEwLTUtMS0xLTA_da160ea8-720c-4886-9da8-611925479b06"
      unitRef="usdPerShare">84.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzExLTEtMS0xLTA_28e3a356-cd5d-402f-8aaf-24cb546333f7"
      unitRef="usdPerShare">83.89</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzExLTMtMS0xLTA_22df9040-c070-4531-9eaa-4bbf124d6e85"
      unitRef="usdPerShare">33.86</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzExLTUtMS0xLTA_b8e160e5-338b-4951-aa4b-481b5ebc4191"
      unitRef="usdPerShare">42.85</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEyLTEtMS0xLTA_418e9388-b92d-4c98-b39f-52a2a086de87"
      unitRef="usdPerShare">102.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEyLTMtMS0xLTA_fdbf9f3d-6c92-45a2-a130-c38b6934e6d6"
      unitRef="usdPerShare">93.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEyLTUtMS0xLTA_6c983f8e-3497-46e7-8909-536c5394a2e7"
      unitRef="usdPerShare">50.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEzLTEtMS0xLTA_b239a1d1-e554-46ff-97a1-3c7eef6c3215"
      unitRef="usdPerShare">69.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEzLTMtMS0xLTA_6cc21106-8026-4d29-8c83-bd3994cb35f4"
      unitRef="usdPerShare">68.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzEzLTUtMS0xLTA_d0d7b353-3d4e-413b-adfe-bb2212fd2ec6"
      unitRef="usdPerShare">73.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i7986a8931ce14e87a14397225a1db358_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzE0LTEtMS0xLTA_4bfae260-41b8-427f-9144-f8e644adf95a"
      unitRef="usdPerShare">66.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i335850f837034b4f92801e3e27dcb7c9_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzE0LTMtMS0xLTA_498e7e1f-1cef-4546-8d40-832b8f1c68c6"
      unitRef="usdPerShare">76.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if59d999a99954d12bc5b0af492454ea2_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZToyNDJiN2YwOTM4NDM0ZWZkYjY2OTc1Mjg1NDlmOGRlYy90YWJsZXJhbmdlOjI0MmI3ZjA5Mzg0MzRlZmRiNjY5NzUyODU0OWY4ZGVjXzE0LTUtMS0xLTA_984cede5-3d48-413b-b628-0931aef8504c"
      unitRef="usdPerShare">64.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="i2930b7a825204376adcd1aaccfb3a4e3_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzQ5MzU_41ae99b7-986d-4c84-b868-acfe08f25334"
      unitRef="number">0</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage
      contextRef="i4e8c24828a0f4b248dd1d741a061b3ae_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzQ5NDE_db8a1955-14c0-4589-bf35-cb1239f81ddf"
      unitRef="number">2</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i932f41a6f6654f37a96800a18e76b8f5_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzUzMTU_5d195945-9306-4b20-a8ac-949f7c9e3fe6"
      unitRef="usdPerShare">103.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibefea4b05e3247b8847f23aa2c4ecce2_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzUzMTk_86bcd621-79f9-4b59-95df-2684e9d2aec4"
      unitRef="usdPerShare">90.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id2fa0b3a37f14b4a8a9affe63e07a8b1_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzUzMjY_7ece278e-87a1-423a-8d2d-99e2b6672039"
      unitRef="usdPerShare">84.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting
      contextRef="i7986a8931ce14e87a14397225a1db358_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU0Njg_f5214f74-3d4a-442c-b386-128d60e3e752"
      unitRef="shares">84670</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkyMjY_420df7cc-2dc4-4a6e-993a-eafca167950d">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes changes in our outstanding cash-settled PSU awards:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(970)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted at target level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments above/(below) target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested and converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;93.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;86.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-vested cash-settled PSU awards, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzEtMS0xLTEtMA_bc195cee-a56a-4c74-bac4-648a23bf9646"
      unitRef="shares">1592</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzEtMy0xLTEtMA_b74de860-7410-4865-9fe3-c8bee9a23f12"
      unitRef="shares">1972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if424c5cbb6af4281b20e4f9016d91f87_I20161231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzEtNS0xLTEtMA_3536348f-8bd3-4460-9bac-31f334c0887c"
      unitRef="shares">2451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzItMS0xLTEtMA_5f278996-42c3-4f62-8d14-6862a5cb0d89"
      unitRef="shares">806</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzItMy0xLTEtMA_3977d772-aad1-4118-8b32-c485fda394aa"
      unitRef="shares">560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzItNS0xLTEtMA_33d16f1d-6d21-46dc-8481-e8b7c2fcec22"
      unitRef="shares">598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzMtMS0xLTEtMA_abe82727-e551-42a8-aa18-d28aed5f8984"
      unitRef="shares">-206</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzMtMy0xLTEtMA_7a8d7aa7-fccc-4665-aa19-05ce3068bc5f"
      unitRef="shares">-30</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzMtNS0xLTEtMA_170b334d-e649-4094-a44f-56589eaa1d60"
      unitRef="shares">-107</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzQtMS0xLTEtMA_a8f66a03-006b-4f74-afff-0a0e638bdbf7"
      unitRef="shares">211</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzQtMy0xLTEtMA_aba9a939-c08b-4e46-87c1-297c57d6985b"
      unitRef="shares">910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzQtNS0xLTEtMA_3deebc37-899d-4c98-bcd1-172b4e59c6c0"
      unitRef="shares">970</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzUtMS0xLTEtMA_20252c7f-4a57-457d-8bda-0d811d4194d5"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzUtMy0xLTEtMA_2f5dd7b4-3286-4a43-b753-64365c2c114a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzUtNS0xLTEtMA_888959d4-4c06-43d8-870c-9b26a38132c0"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iba2d66afdb1b460b9bc719352ac92b1b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzYtMS0xLTEtMA_ed65ecf5-efe0-4398-b891-f13c938b1ccc"
      unitRef="shares">1981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzYtMy0xLTEtMA_53749193-b955-40c3-a846-6bfc58fcd6de"
      unitRef="shares">1592</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo4OTNlZDcyNzBiMTA0MmRmOTIxZWFiMTk0NjcxYTY4MC90YWJsZXJhbmdlOjg5M2VkNzI3MGIxMDQyZGY5MjFlYWIxOTQ2NzFhNjgwXzYtNS0xLTEtMA_b49a0ba7-e21f-4d8e-9487-1fcc6218ec91"
      unitRef="shares">1972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzEtMS0xLTEtMA_27d6c4e3-8a4d-48ab-a4e7-a2b32ddf38ce"
      unitRef="usdPerShare">79.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzEtMy0xLTEtMA_90a8036e-cb8d-48ed-b743-a321edb5633f"
      unitRef="usdPerShare">92.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if424c5cbb6af4281b20e4f9016d91f87_I20161231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzEtNS0xLTEtMA_15dfe7f6-ddf5-4457-9b93-6efcee67c216"
      unitRef="usdPerShare">25.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzItMS0xLTEtMA_16dc931a-ba98-4765-8847-9dce886129f7"
      unitRef="usdPerShare">102.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzItMy0xLTEtMA_db1530ab-aecf-4f7a-9e48-b5f3069537f7"
      unitRef="usdPerShare">89.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzItNS0xLTEtMA_04a82f15-e297-4b25-885d-87eb8afb5b7b"
      unitRef="usdPerShare">83.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzMtMS0xLTEtMA_2ee815f2-5bed-4cac-ad29-e11392b91ba7"
      unitRef="usdPerShare">56.95</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzMtMy0xLTEtMA_bae2095f-7c5e-4bb5-8344-3d3edbc4cf7e"
      unitRef="usdPerShare">41.53</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzMtNS0xLTEtMA_2c5336d5-a764-4cfa-b8af-ff112a311cd6"
      unitRef="usdPerShare">66.61</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzQtMS0xLTEtMA_14bfeed9-46bd-47e8-88bd-fa9be9f1bd96"
      unitRef="usdPerShare">102.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzQtMy0xLTEtMA_3fbc74b7-b517-4f82-9b79-9cc47482093e"
      unitRef="usdPerShare">93.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzQtNS0xLTEtMA_8a0bfe58-fa21-499e-8296-671db6ceed21"
      unitRef="usdPerShare">86.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ifcea11af58fe43f3b4e304a7b9c64c6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzUtMS0xLTEtMA_9449fb0c-ddea-4f97-84b6-30c3499e9d45"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ib4237a57fd5d4581b6c19f825e2abd4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzUtMy0xLTEtMA_d869adf6-8579-442d-8c20-9c22072a2862"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i257536d153674569b8fd3a765b5ea232_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzUtNS0xLTEtMA_65ad5a65-fc32-4832-8866-bd6cf1a1d2b3"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iba2d66afdb1b460b9bc719352ac92b1b_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzYtMS0xLTEtMA_60b5bc54-1c8b-4141-b5bc-5efc24be7324"
      unitRef="usdPerShare">150.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id624f0b918514c1fa67d18292cb0f592_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzYtMy0xLTEtMA_830c9bde-ad5a-46a7-a6fb-6f57d305daf9"
      unitRef="usdPerShare">79.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3248006f27a44046a786ecae30f2c7b9_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90YWJsZTo5MzBjZTY3MDkyZjg0YTFhYWMzYjQ4ZmQ0ZGU2MjZkNC90YWJsZXJhbmdlOjkzMGNlNjcwOTJmODRhMWFhYzNiNDhmZDRkZTYyNmQ0XzYtNS0xLTEtMA_05e4bb3c-fbd1-4735-9539-da308399f029"
      unitRef="usdPerShare">92.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYwOTk_7a89b2eb-752d-4bb7-9d5f-91cb63c4cd15"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i90a36423c0a44b9986aa0cbeabb16721_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYyMjM_944b9822-2052-400c-98b1-fb62137199ea"
      unitRef="number">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount
      contextRef="i90a36423c0a44b9986aa0cbeabb16721_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYyNzE_f7957a16-447d-4bae-a900-85dae9980fe2"
      unitRef="usd">25000</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYzNDU_de3dc4bb-6ad8-4e02-a86c-6ea00a3ebeb2"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear
      contextRef="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzYzODM_c58ea93d-5c82-4af0-8e3d-f843201e9b4a"
      unitRef="shares">8000</wst:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i3d3897c4bcfd419cb560d257c307f63d_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY0MzQ_d629de68-579e-4d3c-a4ef-81b5e0a45cc7"
      unitRef="shares">51391</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idfc8369f68e143cc8c2dd873a40d85a9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY0NDU_3aa3a1c7-c503-4776-b913-0071a5722404"
      unitRef="shares">55669</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6077149f426d4ae8a0b5fd6b074a7a43_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY0NTk_98fbe147-efd9-4e6b-a1bb-7f0d22921f0d"
      unitRef="shares">56218</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i90a36423c0a44b9986aa0cbeabb16721_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY1NDQ_e17fe3e5-84ad-49aa-9251-e1e004654e0b"
      unitRef="shares">3800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <wst:DeferredCompensationArrangementwithIndividualConversionUnit
      contextRef="ia14da4b7cdb047cd878899fb992151cf_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzY5OTU_81aad15d-b8cd-45f7-bc9a-8996091689a7"
      unitRef="shares">1</wst:DeferredCompensationArrangementwithIndividualConversionUnit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc0MjA_7f12c10c-d637-4db8-9288-ff4fa9108dc7"
      unitRef="shares">14579</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc0Nzg_a28200b6-1448-4d1b-bada-f0aa8b3b3530"
      unitRef="usdPerShare">121.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wst:DeferredCompensationArrangementWithIndividualNumberOfPlans
      contextRef="if56b24e99d71498ab539bcd0ec6f2c84_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc2NDQ_2a9d63cd-6fb1-4795-94d1-28ec38020290"
      unitRef="plan">2</wst:DeferredCompensationArrangementWithIndividualNumberOfPlans>
    <wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance
      contextRef="if56b24e99d71498ab539bcd0ec6f2c84_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc2OTE_cc011361-83e4-4d1f-9f41-64beadf76453"
      unitRef="shares">366159</wst:DeferredCompensationArrangementWithIndividualShareEquivalentsBalance>
    <wst:DeferredStockUnitsPayableinCash
      contextRef="if56b24e99d71498ab539bcd0ec6f2c84_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc3MjY_7714182d-9dce-4f13-9ac4-0efc94e86b1d"
      unitRef="shares">6274</wst:DeferredStockUnitsPayableinCash>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i680ad925db4e48d78b3237fca4762bf7_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzM4NDgyOTA3MDcxMzU_aa934b64-0217-4a1f-8996-9ecff454ebc6"
      unitRef="shares">13308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i680ad925db4e48d78b3237fca4762bf7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc4NTc_19af4801-4a8e-4db6-a348-581b8d22303c"
      unitRef="usdPerShare">116.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8169a62ce26b42908772007e3660188a_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzc5Mjg_d9313f3a-99cc-45fb-8379-8f62d5a20423"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg2NzQ_7d1105b4-5ff7-4238-90a7-58f3b618c1aa">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg4MDU_2af9e235-a351-47ab-b55c-6dccf3206633"
      unitRef="shares">1300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg4MTY_e580bcb0-57b4-4c34-a20f-fb48fca8b85d"
      unitRef="shares">1500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg4MzA_4ef72a5b-9edb-4306-b1f1-16bfacc4b42f"
      unitRef="shares">1800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzEwOTk1MTE2Mzc4NjM_cbae5d64-5922-45ba-b1a7-5a7333711e4c"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg5MTQ_f4e37c1c-1efe-4c42-9b97-b532bc5883a6"
      unitRef="shares">200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzg5Mjg_dc331344-e7b8-4cd8-9ca6-507082394dcc"
      unitRef="shares">800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib2bf144b45894112bfc96d5727c9b9eb_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxMDQ_cc863306-363c-4083-a782-e758ea50bea0"
      unitRef="usdPerShare">106.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iac0ce33bcdc3479e87a0a56657d30851_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxMzI_103a41a2-f325-4cfd-9e3c-3da0e50e29bc"
      unitRef="usdPerShare">93.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7a3a785bbd274f089ae8cf3666f712bf_D20170101-20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzkxNjM_7b2b62a8-0708-4388-81da-1004272cf041"
      unitRef="usdPerShare">86.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNjE_9e6e833b-3abd-4139-990f-a1702a911507">Benefit Plans Certain of our U.S. and international subsidiaries sponsor defined benefit pension plans. In addition, we provide minimal death benefits for certain U.S. retirees and pay a portion of healthcare costs for retired U.S. salaried employees and their dependents. Benefits for participants are coordinated with Medicare when possible. We also sponsor a defined contribution plan for certain salaried and hourly U.S. employees. Our 401(k) plan contributions were $15.6 million for 2019, $6.5 million for 2018 and $5.7 million for 2017. The increase in 401(k) plan contributions in 2019 was in response to the cessation of our U.S. qualified and non-qualified defined benefit pension plans as of January 1, 2019 (except for interest crediting).&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Pension and Other Retirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of net periodic benefit cost and other amounts recognized in OCI were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:43.032%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.498%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss (gain) arising during period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prior service credit arising during period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net periodic benefit cost by geographic location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.711%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.082%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.333%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.498%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, we recorded a $3.5&#160;million pension settlement charge within other nonoperating expense (income), as we determined that normal-course lump-sum payments for each of our U.S. qualified and non-qualified defined benefit pension plans exceeded the threshold for settlement accounting under U.S. GAAP for the year. Effective January 1, 2019, except for interest crediting, benefit accruals under these defined benefit pension plans ceased.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, we contributed $2.6&#160;million to our U.S. qualified defined benefit pension plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit obligation, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(288.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amendments/transfers in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefits/expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit obligation, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(287.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value of assets, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Actual return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefits/expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value of assets, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;International pension plan assets, at fair value, included in the preceding table were $39.4 million and $33.4 million at December&#160;31, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amounts recognized in the balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(46.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The amounts in accumulated other comprehensive loss, pre-tax, consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The net actuarial loss and prior service credit for the defined benefit pension plans that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year are $1.8 million and $0.1 million, respectively. The net actuarial gain and prior service credit for the other retirement benefits plan that will be amortized from accumulated other comprehensive loss into net periodic benefit cost over the next fiscal year is $1.6 million and $0.7 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The accumulated benefit obligation for all defined benefit pension plans was $283.9 million and $263.0 million at December&#160;31, 2019 and 2018, respectively, including $73.9 million and $64.0 million, respectively, for international pension plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, our U.S. qualified defined benefit pension plan had plan assets in excess of its obligations. As of December&#160;31, 2019, our other defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;All of the defined benefit pension plans had projected benefit obligations and accumulated benefit obligations in excess of plan assets as of December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:44.955%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.147%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.147%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.149%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2025 to 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;158.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In 2020, we expect to contribute $0.7 million to pension plans, none of which is for international plans. In addition, we expect to contribute $0.7 million for other retirement benefits in 2020. We periodically consider additional, voluntary contributions depending on the investment returns generated by pension plan assets, changes in benefit obligation projections and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Weighted average assumptions used to determine net periodic benefit cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:29.570%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.740%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Weighted average assumptions used to determine the benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:44.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.823%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The discount rate used to determine the benefit obligations for U.S. pension plans was 3.35% and 4.30% as of December 31, 2019 and 2018, respectively.  The weighted average discount rate used to determine the benefit obligations for all international plans was 1.28% and 2.19% as of December 31, 2019 and 2018, respectively. The rate of compensation increase for U.S. plans was 4.25% for 2018, while the weighted average rate for all international plans was 2.49% for 2019 and 2.60% for 2018. Other retirement benefits were only available to U.S. employees. The expected long-term rate of return for U.S. plans, which accounts for 83.86% of global plan assets, was 5.60% for 2019, 7.00% for 2018 and 7.00% for 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The assumed healthcare cost trend rate used to determine benefit obligations was 6.25% for all participants in 2019, decreasing to 5.00% by 2024. A change in the assumed healthcare cost trend rate by one percentage point would have an immaterial impact in the postretirement obligation. The assumed healthcare cost trend rate used to determine net periodic benefit cost was 6.25% for all participants in 2019, decreasing to 5.00% by 2024. The effect of a one percentage point increase or decrease in the rate would have an immaterial impact in the aggregate service and interest cost components.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our U.S. pension plan is managed as a balanced portfolio comprised of two components: equity and fixed income debt securities. Equity investments are used to maximize the long-term real growth of fund assets, while fixed income investments are used to generate current income, provide for a more stable periodic return and provide some protection against a prolonged decline in the market value of equity investments. Temporary funds may be held as cash. We maintain a long-term strategic asset allocation policy which provides guidelines for ensuring that the fund&#x2019;s investments are managed with the short-term and long-term financial goals of the fund, while allowing the flexibility to react to unexpected changes in capital markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Diversification across and within asset classes is the primary means by which we mitigate risk. We maintain guidelines for all asset and sub-asset categories in order to avoid excessive investment concentrations. Fund assets are monitored on a regular basis. If at any time the fund asset allocation is not within the acceptable allocation range, funds will be reallocated. We also review the fund on a regular basis to ensure that the investment returns received are consistent with the short-term and long-term goals of the fund and with comparable market returns. We are prohibited from pledging fund securities and from investing pension fund assets in our own stock, securities on margin or derivative securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the three months ended December 31, 2018, in anticipation of benefit accruals under our U.S. qualified and non-qualified defined benefit pension plans ceasing effective January 1, 2019, except for interest crediting, we changed the U.S. target asset allocations from 65% equity securities and 35% debt securities to 30% equity securities and 70% debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following are the U.S. target asset allocations and acceptable allocation ranges:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Target allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allocation range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27% - 33%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;67% - 73%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0% - 3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#x201c;NAV&#x201d;) have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.070%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.824%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;204.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.230%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.824%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzU5OA_9413e721-32ae-4b96-b057-2a949994447a"
      unitRef="usd">15600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzYwOQ_c5320517-c5de-407a-90c0-664714c667a4"
      unitRef="usd">6500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzYyMw_93898c0e-6553-4628-9ba3-fb5b942c4f88"
      unitRef="usd">5700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNjQ_2706e5eb-3e3e-46b0-8326-64c239244ef0">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of net periodic benefit cost and other amounts recognized in OCI were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:43.032%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.498%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss (gain) arising during period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prior service credit arising during period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net periodic benefit cost by geographic location is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.711%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.082%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.333%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.493%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.498%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. plans&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtMS0xLTEtMA_ddc43a27-0c80-43eb-aa40-7849ebcc46b5"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtMy0xLTEtMA_674a5e98-e2e9-4895-8f5e-14c60895d2f8"
      unitRef="usd">10800000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtNS0xLTEtMA_d278d62b-2d09-4f72-abd1-66e91f3d3bc2"
      unitRef="usd">10400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtNy0xLTEtMA_2f943e18-e9ba-410a-b7f9-9b2c5a904a83"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtOS0xLTEtMA_75366780-9d93-4119-9528-f04013cf8ad2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzMtMTEtMS0xLTA_4cb697d3-3740-4709-abc9-65efd213a17a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtMS0xLTEtMA_fd1ba9b7-8280-4029-9918-0e2e8046af3b"
      unitRef="usd">9200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtMy0xLTEtMA_a9211ed4-f10c-47c6-9a63-1368c0ccf443"
      unitRef="usd">9400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtNS0xLTEtMA_f65d19bf-fd90-4384-bb38-ae1fe85a56ff"
      unitRef="usd">9800000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtNy0xLTEtMA_d4ea4c84-81e6-49aa-8e34-cd3b58831e17"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtOS0xLTEtMA_6e709c13-7eee-48d6-b482-ff0335ddc55e"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzQtMTEtMS0xLTA_80dc0242-e5b5-4eb1-b8a9-96e6d38e8189"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtMS0xLTEtMA_9300f93e-7c7f-4028-a6e6-a78adc025062"
      unitRef="usd">12000000.0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtMy0xLTEtMA_86f9b88d-2db9-4a46-a3ee-02a487989a64"
      unitRef="usd">15700000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtNS0xLTEtMA_c78d7cba-f52f-4eef-b9db-bbf117e581be"
      unitRef="usd">13500000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtNy0xLTEtMA_5d2fb151-4a35-470c-9a2b-b0155671038a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtOS0xLTEtMA_2cf3a5ca-90ff-429f-af2b-26da60d57239"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzUtMTEtMS0xLTA_93219eb3-ac24-4175-ab6c-2a7e942bbc0b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtMS0xLTEtMA_7b4da0af-6216-4435-99ef-9c710b4e6e57"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtMy0xLTEtMA_916d2c29-abe7-4737-8b76-474d5549ce93"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtNS0xLTEtMA_622224aa-f0d1-415b-b9d2-82e914d3e709"
      unitRef="usd">-1300000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtNy0xLTEtMA_679e1284-da03-4cc7-bb71-08464f388a4d"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtOS0xLTEtMA_1514b0a1-62a8-4bce-a027-db7cef421c04"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzYtMTEtMS0xLTA_78b97aaf-ee25-475d-a314-178a2730cfa2"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtMS0xLTEtMA_0a801571-c5d3-4b21-bfae-a063c46b9a4f"
      unitRef="usd">-2100000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtMy0xLTEtMA_8fd424ac-756e-4501-99ed-ccfced40c8ed"
      unitRef="usd">-3800000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtNS0xLTEtMA_1064ea27-d577-43b3-abf7-2285cb6a2892"
      unitRef="usd">-4900000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtNy0xLTEtMA_c96940e5-ebba-43e2-9007-cfa506746945"
      unitRef="usd">2300000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtOS0xLTEtMA_0661adf7-8846-4da2-968e-5008b5080f1f"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzgtMTEtMS0xLTA_b264107d-c824-476d-9faf-c99317fd74ab"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEwLTEtMS0xLTA_604c46b7-d43e-47b2-97b2-782ed4325fa5"
      unitRef="usd">3500000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTEtMS0xLTA_91ac93d7-f25d-4dc0-be51-9c746d981109"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTMtMS0xLTA_5d493e2b-8c1b-41df-9124-ab92299df2c3"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTUtMS0xLTA_6a482336-c87f-4ae6-95d7-6a316881ceb0"
      unitRef="usd">10300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTctMS0xLTA_89bb05c7-5c7f-431d-8f30-6f3278e913b9"
      unitRef="usd">-2800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTktMS0xLTA_9a5c7bd1-62b0-4657-bff0-eedeae4d25cf"
      unitRef="usd">-2900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzExLTExLTEtMS0w_4e1cbbad-7d40-40ce-b977-e83d925ae4fa"
      unitRef="usd">-3000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTEtMS0xLTA_a940122f-02d3-4ddc-b81a-4ae405ca27d6"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTMtMS0xLTA_e5a407c4-40bf-462f-bfe8-f7d9a8a6a3bf"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTUtMS0xLTA_58791d51-9de2-45bc-8b1d-098fe7ba7d5d"
      unitRef="usd">9000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTctMS0xLTA_6b10b20e-e514-48a2-8d29-378f96873ede"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTktMS0xLTA_4651efa0-993c-4312-b53c-c0d52c746386"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzEzLTExLTEtMS0w_2fdbe748-2c81-439e-bff0-b4670a5005cf"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTEtMS0xLTA_0b17e39d-829b-41b7-9477-07de91c6e495"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTMtMS0xLTA_35e7adf1-6bbb-44c6-a4c2-67ebeadf0911"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTUtMS0xLTA_0d69a512-358f-4847-9b37-3df58b28926c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTctMS0xLTA_0c0ccf1c-a083-4bad-8471-225fe057a860"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTktMS0xLTA_f34c3219-429f-44e8-9379-597bfe990830"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE0LTExLTEtMS0w_55fa89e1-8f6d-4d8f-bbad-50455409713b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTEtMS0xLTA_ace16995-17b5-415f-924d-0dc2ec6fe2dc"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTMtMS0xLTA_a80b08cd-a100-48b1-b2d3-fb8b816db365"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTUtMS0xLTA_9b045f67-ad1e-4d35-a69a-9ab13f555dd2"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTctMS0xLTA_94e3b670-3c29-4bbc-8b18-2b7c269acf0d"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTktMS0xLTA_44ff6bc3-ee27-46f7-9742-66c59ed0d5af"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE1LTExLTEtMS0w_c761a340-17d3-496f-b6a5-1053268a67fc"
      unitRef="usd">-700000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTEtMS0xLTA_718db9dc-77e9-4a6e-b9ee-9b9ab61968e2"
      unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTMtMS0xLTA_a5615df5-0450-4810-981f-cec43add2367"
      unitRef="usd">-3800000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTUtMS0xLTA_2a7e8c00-e63f-41c0-aa13-aa744e3d5ecb"
      unitRef="usd">-4900000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTctMS0xLTA_44f67b8d-9aba-402b-a9f0-76b85831ef8f"
      unitRef="usd">2300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTktMS0xLTA_1564c97c-ea2e-4420-8e9d-79c0f0219121"
      unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE3LTExLTEtMS0w_737f5a42-2bd2-410d-b01b-b3b479da9968"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzE5LTEtMS0xLTA_1795f524-b4f3-40e0-a94c-b109cf921ed7"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTEtMS0xLTA_06281319-6767-4e43-a509-94fa33415b97"
      unitRef="usd">-600000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTMtMS0xLTA_6471bfed-c54a-4f10-b3df-038cbb85bbbf"
      unitRef="usd">1200000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTUtMS0xLTA_41155e6f-54d2-4b8b-8a7e-5f3240c917a8"
      unitRef="usd">-2600000</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTctMS0xLTA_ce8b2dfb-20f1-484a-b58e-a24740b3204e"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTktMS0xLTA_c239e3cd-bba0-458a-82e7-0be4cbb5de8a"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIwLTExLTEtMS0w_637f927d-1abc-4b62-9769-eba7c2350dbb"
      unitRef="usd">0</wst:OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTEtMS0xLTA_24df26ee-a0e5-4815-9e06-036297e200dc"
      unitRef="usd">-3600000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTMtMS0xLTA_586b6cb6-8983-4bad-8c53-3ce930348c8c"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTUtMS0xLTA_d47915b1-e472-4eea-ba0e-615c2f42772a"
      unitRef="usd">-10000000.0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTctMS0xLTA_d99b513a-7fc9-4c4a-99f9-c83d1e4794c7"
      unitRef="usd">3100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTktMS0xLTA_e6f2df1d-3ffc-4473-8e7e-1b023666e59c"
      unitRef="usd">1700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIxLTExLTEtMS0w_a37ae895-8ba3-4ff4-8568-131506aa11f5"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTEtMS0xLTA_439f9ba2-c340-487c-8203-61cbe30678f9"
      unitRef="usd">700000</wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome>
    <wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTMtMS0xLTA_86edbf60-ec80-4340-813d-ae27c7a663cb"
      unitRef="usd">7100000</wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome>
    <wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTUtMS0xLTA_50454445-ca98-4f3b-99e3-933a3fc4f6a5"
      unitRef="usd">300000</wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome>
    <wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTctMS0xLTA_35d77d40-77a1-488d-9b1c-7b5a8b49bb9a"
      unitRef="usd">300000</wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome>
    <wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTktMS0xLTA_01318cc5-1d68-4034-8fa7-0fab1a20fa1f"
      unitRef="usd">-1200000</wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome>
    <wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3ZTMyMDY5OTY3YmQ0ZTdhYTcyNDMxY2FhNTRmNDc3Yi90YWJsZXJhbmdlOjdlMzIwNjk5NjdiZDRlN2FhNzI0MzFjYWE1NGY0NzdiXzIyLTExLTEtMS0w_4bad959f-86d5-4c8c-83ec-122b6ad23ec9"
      unitRef="usd">-800000</wst:DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ibcf3086a15804eef96196b34fe5f6a29_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItMS0xLTEtMA_ba6f8c5e-a8c3-46a5-b5fe-41b3bd6e3ad4"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3372ec3c59ed4ec6845462cf9a97844d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItMy0xLTEtMA_cd1c4e31-90e8-4f2b-9744-b0ecfef8db99"
      unitRef="usd">4800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if02e282f48e34ea9924bc5e936dee280_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItNS0xLTEtMA_b4e77bc3-3c16-4e38-9c60-5a360b1e984b"
      unitRef="usd">7300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iec2956a56fea4665ac7855ee4d00856a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItNy0xLTEtMA_5b0c7a99-f0f2-4821-b6da-2276d6ba3998"
      unitRef="usd">-2800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i691d61af8bdb48d58e96be31e865a8f0_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItOS0xLTEtMA_32ae29ea-f6e5-40a1-82d1-547a24459287"
      unitRef="usd">-2900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i05084a034d864aaab4d454ef2374f73d_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzItMTEtMS0xLTA_63c8dd25-44aa-4d9b-9f4e-db65b7de24cc"
      unitRef="usd">-3000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia045884eabdd4675b086f7cbe1088331_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtMS0xLTEtMA_6510dff1-6759-4817-9b2f-01e10c5a8d01"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i482e7650de754ebd863450ff98ddd102_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtMy0xLTEtMA_1d9ff695-ee7f-49f6-8d96-1b8d8489d0f4"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3bc0be5f11db4f4b96289239a9c31f9b_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtNS0xLTEtMA_472caeca-00ff-48ec-b7e9-c7ef861f85e7"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i437e493b76d849dab6516dfc8137e7a5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtNy0xLTEtMA_c77729e1-43f2-4ab9-be04-2685fc053dd1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic213450143c643fcabdf167b9544dd56_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtOS0xLTEtMA_eef57264-2518-4f28-bbf4-a93e274a8429"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2c070b0619d84059924fa1fee46ec2a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzMtMTEtMS0xLTA_a78d42a7-81c3-4ef7-9912-4618c3a01540"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtMS0xLTEtMA_71d9f4d5-6d1f-4116-979c-4925ee7c8a59"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtMy0xLTEtMA_24c1486c-9592-455e-a12d-83d682080663"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtNS0xLTEtMA_7c2bd00e-a800-40b8-b711-d88133b2ab3d"
      unitRef="usd">10300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtNy0xLTEtMA_bc3f5d7a-1f95-4405-93f2-cd6f69915845"
      unitRef="usd">-2800000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtOS0xLTEtMA_a131492e-30cd-4180-9b68-3a7026ddf094"
      unitRef="usd">-2900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxNDU4ODcwYjY1NGM0OWEzOGI3NTdjODMyZjQ4MGM4OC90YWJsZXJhbmdlOjE0NTg4NzBiNjU0YzQ5YTM4Yjc1N2M4MzJmNDgwYzg4XzQtMTEtMS0xLTA_98e2d11b-8add-4fe7-9e3a-7fed056471bc"
      unitRef="usd">-3000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i6298ee303c464f0bbd0097078dcab7e1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NDgyOTA3MDYxMzY_bf1fb8c8-d76c-41b8-884a-ab24e7256aad"
      unitRef="usd">3500000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NDgyOTA3MDYxMTc_d8b6d5db-7788-4bef-89d1-7b9ec385342f"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNDY_f3f52b76-0e08-4915-a5c8-b7b6405b14b3">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit obligation, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(288.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Actuarial (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amendments/transfers in&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefits/expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit obligation, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(287.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(267.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value of assets, January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Actual return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefits/expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Settlement effects&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value of assets, December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtMS0xLTEtMA_a40d812d-d63a-47fd-b3af-5e884eb3c2b4"
      unitRef="usd">267000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib0f2d011f88041df81ed72918d912b28_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtMy0xLTEtMA_3c918482-2877-49cf-86a6-95ba44a2ddc6"
      unitRef="usd">288000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtNS0xLTEtMA_95892df2-534d-4db6-89d0-f2d545c3f2fa"
      unitRef="usd">6000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8d13573002854b4794e6d272dc9f023d_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzMtNy0xLTEtMA_5325666c-eb09-4d6e-9ee1-a48a871fed84"
      unitRef="usd">7100000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtMS0xLTEtMA_cdc209f9-bada-406d-b3c1-9ee0f4619646"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtMy0xLTEtMA_422719f0-af68-439f-bac1-998a7c320501"
      unitRef="usd">10800000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtNS0xLTEtMA_9c502e1f-f234-427b-be2c-2c4f7e065ca8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzQtNy0xLTEtMA_8ee8b724-5bcc-4e64-ba54-9dac394d3663"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtMS0xLTEtMA_c000e25b-3fff-4b1a-b161-a922743268cf"
      unitRef="usd">9200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtMy0xLTEtMA_31dc6b89-8fff-44c9-a888-ad4e6e7f23b6"
      unitRef="usd">9400000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtNS0xLTEtMA_712b053e-5f20-4b4a-88fe-0c4efa117850"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzUtNy0xLTEtMA_fe0dc577-a494-4699-8a06-a6838f1ded56"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtMS0xLTEtMA_9917ca6a-7757-48fa-a10c-13e6082d1e75"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtMy0xLTEtMA_90cdbe6d-5eed-444c-846c-678483e837cd"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtNS0xLTEtMA_68bee6e8-32c9-49fc-ab36-11a2a15aaa01"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzYtNy0xLTEtMA_bdbcfc59-c78d-4a62-85c7-7f1d801b23ac"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctMS0xLTEtMA_e4adde59-cdea-4a5f-86bd-03f94057bd1f"
      unitRef="usd">-30800000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctMy0xLTEtMA_5a903278-da51-4a04-acd7-eae9360159e6"
      unitRef="usd">20400000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctNS0xLTEtMA_a646cb2d-e084-43f4-9d89-c4c42f6d655b"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzctNy0xLTEtMA_6674b461-5451-45d6-a708-7bc6757f5b5b"
      unitRef="usd">1400000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtMS0xLTEtMA_4b9e270f-c55b-4fee-9677-786bc31c594b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtMy0xLTEtMA_1d3543dd-aa09-4cea-b176-e14694bd6b9f"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtNS0xLTEtMA_10706ab2-0f67-4e36-bcad-3d2588838354"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzgtNy0xLTEtMA_d0e2e885-bba7-4bd4-9d12-79e5926e9c90"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktMS0xLTEtMA_afd98e36-f5f3-46b0-b594-5d2f9c136316"
      unitRef="usd">6800000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktMy0xLTEtMA_70611554-9c54-4239-bb08-e0361cd4fac7"
      unitRef="usd">18000000.0</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktNS0xLTEtMA_5111bd33-8454-4c1b-9505-4d07b4bd21e4"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzktNy0xLTEtMA_286cd207-cf34-4927-a3f1-1025ad6216fe"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTEtMS0xLTA_b800ddac-3bd3-4f78-aab2-ec4b1bef9b2c"
      unitRef="usd">-1000000.0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTMtMS0xLTA_f8d27ae6-35f3-4a7d-9531-eff2702aff77"
      unitRef="usd">3700000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTUtMS0xLTA_5a56bf56-a8de-4e57-8170-77268ef1877d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEyLTctMS0xLTA_811dc77a-aa53-4eb9-a94a-5c32a80cbecd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTEtMS0xLTA_43ab5b66-482b-469f-a15c-60f63131bd17"
      unitRef="usd">287900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTMtMS0xLTA_49f808b3-2c83-4781-879a-6552ba91faee"
      unitRef="usd">267000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTUtMS0xLTA_6a717cfb-53b2-4d6b-9ede-eef12f80cabb"
      unitRef="usd">6600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzEzLTctMS0xLTA_293085ff-44ab-44a8-ab76-b26d005a6a20"
      unitRef="usd">6000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTEtMS0xLTA_0254ac8f-2976-4ab8-84a2-5665465d65d7"
      unitRef="usd">214500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib0f2d011f88041df81ed72918d912b28_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTMtMS0xLTA_bea8703b-d44e-4e04-8409-800afaf46add"
      unitRef="usd">239500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8d13573002854b4794e6d272dc9f023d_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTUtMS0xLTA_379159bc-c9a9-4ded-859a-29e6f5cd23a5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8d13573002854b4794e6d272dc9f023d_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE2LTctMS0xLTA_93f23ab6-9cbc-431b-aaa5-865dfe8c76af"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTEtMS0xLTA_c092ca53-58d4-40ba-ad5f-ec99e1f5196d"
      unitRef="usd">41300000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTMtMS0xLTA_c85096dc-9371-4c9b-bac5-0fc391b85bb0"
      unitRef="usd">-8300000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTUtMS0xLTA_c675b094-33b2-49ab-9c38-2d99cb47a37b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE3LTctMS0xLTA_13c39f6e-7ab7-4f3f-a322-af930becf1a2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTEtMS0xLTA_417a8a86-5ca8-41a1-830f-ec5200170f0b"
      unitRef="usd">8000000.0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTMtMS0xLTA_4ad4c9d7-5f91-4a65-b58a-34b112cbe82e"
      unitRef="usd">2700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTUtMS0xLTA_04c9f87b-355e-4eed-9022-e8a0665bb8d6"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE4LTctMS0xLTA_00db019f-222a-4b2e-a20e-474089a4dab5"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTEtMS0xLTA_1f62d8a7-669c-4156-bdf6-21dcd157d03b"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTMtMS0xLTA_5be06997-59bd-4668-8117-42e8bc0dd5fc"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTUtMS0xLTA_f54dbe75-77f4-4d9d-84e6-fd4526f930eb"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzE5LTctMS0xLTA_477fb118-537f-4571-aed7-f05aeb625c51"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTEtMS0xLTA_31689d4a-6361-4f4d-8173-36fa2a1928d1"
      unitRef="usd">6300000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTMtMS0xLTA_9ab1f015-0174-4549-b519-b6d98977d4cd"
      unitRef="usd">18000000.0</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTUtMS0xLTA_030f9d3f-19e1-4df0-8f26-0fcac46cdda0"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIwLTctMS0xLTA_7b73720c-99c5-4c12-aa57-0c8a5c97b3be"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTEtMS0xLTA_650655d3-06be-475d-8b14-9bdf9834b8ff"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTMtMS0xLTA_0630708a-4687-45d9-80dd-3979b4ca899c"
      unitRef="usd">-2000000.0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTUtMS0xLTA_717a5278-bdec-4bf7-8536-e4d369e8359f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIyLTctMS0xLTA_a90de3b6-83c1-47d9-95d6-2b74d283e1ae"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTEtMS0xLTA_d349dd35-4643-4afb-bbbb-d58ff3ae62b4"
      unitRef="usd">244100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTMtMS0xLTA_fab25878-e735-49f8-8209-d45a50a8fbf9"
      unitRef="usd">214500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTUtMS0xLTA_4a59f901-b1fd-467e-b7e9-0b29ce1879ad"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzIzLTctMS0xLTA_7fac5f42-f3c4-4353-b879-0b9dcd89b944"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTEtMS0xLTA_d20abe7c-0501-4302-adad-6a5edfcbc3c5"
      unitRef="usd">-43800000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTMtMS0xLTA_3446c812-b288-4748-9f22-02f5e8ae9f93"
      unitRef="usd">-52500000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTUtMS0xLTA_17720fd7-ac66-4ad0-8d19-20b2d05a000b"
      unitRef="usd">-6600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozMTkyYTQ2NDMxYTU0YmIyODk0NDZlOGNkNDI4YmJjMy90YWJsZXJhbmdlOjMxOTJhNDY0MzFhNTRiYjI4OTQ0NmU4Y2Q0MjhiYmMzXzI1LTctMS0xLTA_1c561513-189d-4e70-9b13-dd5d0f330cc0"
      unitRef="usd">-6000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzE3MjM_d4827015-993f-4052-b9cc-ada8cd4027bb"
      unitRef="usd">39400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzE3MzA_d0f92dca-39b2-4224-9368-c117b2f615a5"
      unitRef="usd">33400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwMzQ_fc335e7b-e189-4f91-b735-109ffb53f313">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amounts recognized in the balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(46.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(52.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <wst:AssetsDefinedBenefitPlansNoncurrent
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItMS0xLTEtNzkwMQ_6be8242e-9b6d-4478-8235-1982413d12f6"
      unitRef="usd">4300000</wst:AssetsDefinedBenefitPlansNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItMS0xLTEtMA_43b26b0f-0b02-4ef0-98be-cafc64c323e7"
      unitRef="usd">1500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItMy0xLTEtMA_1ed26a84-6f5a-4f80-ba9f-64115ff31e0e"
      unitRef="usd">1600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItNS0xLTEtMA_10892aa8-82d0-4f73-b2bc-140a391e8ad4"
      unitRef="usd">700000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzItNy0xLTEtMA_b57ac3e0-a66b-4ccc-9ac8-c56864dc7b58"
      unitRef="usd">700000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtMS0xLTEtMA_212e83a5-af26-4260-9f4e-d3c41ad4f81e"
      unitRef="usd">46600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtMy0xLTEtMA_960ebf94-1302-46a2-a55d-84cf906e2d54"
      unitRef="usd">50900000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtNS0xLTEtMA_6d478aba-08e6-42ae-bf47-77df1547faf7"
      unitRef="usd">5900000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzMtNy0xLTEtMA_b9e0606b-2454-4bb8-8989-f4a7b33f9fc9"
      unitRef="usd">5300000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtMS0xLTEtMA_2636a2f9-ab81-4396-a8ce-9b965380c17b"
      unitRef="usd">43800000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtMy0xLTEtMA_e15e0b7d-4eb6-4ddf-9e5f-7d78eb390ba5"
      unitRef="usd">52500000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtNS0xLTEtMA_4f5044d9-cb32-498e-99b2-6b8322614c1c"
      unitRef="usd">6600000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplMDcyMTMyZmY5YTM0N2ViOTQ1YzE0ZDQwY2IyYThkOC90YWJsZXJhbmdlOmUwNzIxMzJmZjlhMzQ3ZWI5NDVjMTRkNDBjYjJhOGQ4XzQtNy0xLTEtMA_ba895559-2a71-4e9e-b5d7-c760a093f2a5"
      unitRef="usd">6000000.0</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwMTk_22c32aee-8873-4a63-9802-25ec385784ae">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The amounts in accumulated other comprehensive loss, pre-tax, consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.826%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.942%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.945%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net actuarial loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItMS0xLTEtMA_47f655af-5f80-4536-a607-422ee1d0f3fb"
      unitRef="usd">-69400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItMy0xLTEtMA_98c93583-fcf8-4d59-8ce0-61908ccaff11"
      unitRef="usd">-73000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItNS0xLTEtMA_0e9c3d79-4de7-44e3-93a7-a6c04cfc4362"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzItNy0xLTEtMA_b7c57762-80a4-412d-bb25-8976dd496e9a"
      unitRef="usd">9400000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtMS0xLTEtMA_4619cc4f-7ea2-4afd-bf03-19f1c01f17bf"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtMy0xLTEtMA_dfec4f28-8999-48ea-b10a-203f6aeec7a9"
      unitRef="usd">900000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtNS0xLTEtMA_e33f3892-04c4-41ea-b3c4-011524fbc582"
      unitRef="usd">-1000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzQtNy0xLTEtMA_214d25d9-6ce2-4d58-ba62-bc3d6f599a31"
      unitRef="usd">-1700000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtMS0xLTEtMA_fad46037-83e3-41b3-85ae-59a40383776a"
      unitRef="usd">70200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtMy0xLTEtMA_c22330fe-befc-4795-9892-97332587a7de"
      unitRef="usd">73900000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtNS0xLTEtMA_c1dc7abd-ab89-4f40-a6c0-633debef2620"
      unitRef="usd">-8000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTphMmNiNDczYTQ2ZWE0ZmRkOTNmZTIwMzU1MTMyZmFlYi90YWJsZXJhbmdlOmEyY2I0NzNhNDZlYTRmZGQ5M2ZlMjAzNTUxMzJmYWViXzUtNy0xLTEtMA_4b940acd-583e-46d1-b936-b4141d9bafcf"
      unitRef="usd">-11100000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIxMTM_783202dc-424f-4133-b1c6-43b0f60dbdb9"
      unitRef="usd">1800000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIxMjA_d033df02-7bc5-4887-85c1-b01f971ef1f1"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIzNTA_8e2a0882-f6d5-41a6-ae7d-14914ba6c157"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzIzNTc_e7f996ed-c988-4b45-8342-c8d9217036bf"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0NDA_d79ad76b-d999-4495-8412-61091639fffb"
      unitRef="usd">283900000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0NDc_ff06383e-c20d-4a54-8291-685804f5528b"
      unitRef="usd">263000000.0</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0ODg_aa98b2a9-6da2-4f26-9777-19a43b036660"
      unitRef="usd">73900000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI0OTU_df194a12-53a0-47f7-9f79-d276bf262a54"
      unitRef="usd">64000000.0</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNTc_0c8b60a5-8ccc-4a55-a260-96da87a60c97">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:44.955%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.147%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.147%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.149%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Domestic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2025 to 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;73.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;158.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzEtMS0xLTEtMA_85e9adf8-f667-4d74-b7b9-caf990f814c0"
      unitRef="usd">21000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzEtMy0xLTEtMA_a67a5e82-061d-4498-b344-522de2f13cb5"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzEtNS0xLTEtMA_1aefad2f-4ec7-401c-9f36-cc6a194de6cb"
      unitRef="usd">22300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzItMS0xLTEtMA_7590f655-3a26-44f6-963f-cf0dea4e14d7"
      unitRef="usd">13500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzItMy0xLTEtMA_d0547ff4-797c-4d75-9acd-e31596a9e612"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzItNS0xLTEtMA_8b9412e4-1ae0-4475-a0fb-ed7a0b834967"
      unitRef="usd">14800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzMtMS0xLTEtMA_36ad0269-fca0-41bc-8466-73b1c8c09c90"
      unitRef="usd">15000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzMtMy0xLTEtMA_1a400bc8-2cd2-4457-bdd1-4adfc95a725e"
      unitRef="usd">2000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzMtNS0xLTEtMA_b351d187-6df9-4d07-bfb8-7cc312709e2f"
      unitRef="usd">17000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzQtMS0xLTEtMA_b62fca68-9b41-4e98-8a2b-2e73e33e6d84"
      unitRef="usd">13700000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzQtMy0xLTEtMA_df0f7293-00bc-46b3-9f1d-ca0c7cbeb0c0"
      unitRef="usd">1500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzQtNS0xLTEtMA_8eefb399-0251-40fc-93d4-bc8943119061"
      unitRef="usd">15200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzUtMS0xLTEtMA_576c5378-e9f8-4214-90c9-602485d8043f"
      unitRef="usd">13500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzUtMy0xLTEtMA_52f867bf-2853-4f23-ae59-2dc2fabcab61"
      unitRef="usd">1900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzUtNS0xLTEtMA_78949892-f5b2-4deb-868b-747752a18699"
      unitRef="usd">15400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzYtMS0xLTEtMA_f612112b-a945-4647-85ff-01c2d54c3431"
      unitRef="usd">60500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzYtMy0xLTEtMA_a5b6f6e0-5b0e-4f36-b89f-9702172de29f"
      unitRef="usd">13300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzYtNS0xLTEtMA_91021317-56e4-40f8-92f7-dbbd528990e6"
      unitRef="usd">73800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzctMS0xLTEtMA_7f2a5186-c7f3-40a1-b1a3-73bd64e80657"
      unitRef="usd">137200000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzctMy0xLTEtMA_364cc3c2-29d0-426a-aa37-9b01e475b5bf"
      unitRef="usd">21300000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <wst:DefinedBenefitPlanExpectedFutureBenefitPayments
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo2NGU2OGJmYWM4MzE0ZWY2Yjg0NzFmZGJlMjRmNTZlNC90YWJsZXJhbmdlOjY0ZTY4YmZhYzgzMTRlZjZiODQ3MWZkYmUyNGY1NmU0XzctNS0xLTEtMA_a5598d1b-2e6c-49a2-9d9a-eb851ab98e0a"
      unitRef="usd">158500000</wst:DefinedBenefitPlanExpectedFutureBenefitPayments>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI4ODM_bed383b8-2734-4c59-b1af-b00afd562315"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzI5ODE_bb0b7e2f-e0ea-4d3a-b6b0-c487de764b65"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNTg_a1623fa0-5156-4c7e-8af1-1e8ade029372">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Weighted average assumptions used to determine net periodic benefit cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:29.570%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.740%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term rate of return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Weighted average assumptions used to determine the benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:44.314%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.823%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItMS0xLTEtMA_ea157cae-7db5-405b-b37e-e292d8ce2ccb"
      unitRef="number">0.0270</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItMy0xLTEtMA_1621b55d-b2f0-4e55-87f4-6ac3d120998e"
      unitRef="number">0.0291</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItNS0xLTEtMA_f22dd13f-5ef7-4fa1-84c0-643032ed30c6"
      unitRef="number">0.0348</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="if7ef8712cf244a80894ea40c3a659407_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItNy0xLTEtMA_2b77d21a-a0f0-4c8a-9963-0d0d1afd1702"
      unitRef="number">0.0420</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i819b6745558c4ceb91e92cbdbb8e087d_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItOS0xLTEtMA_0b74f582-1ae1-473d-9a62-1d0d0839f08a"
      unitRef="number">0.0345</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i554025ca5f6c42a58db7c706e4cfee6a_D20170101-20171231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzItMTEtMS0xLTA_71fe43aa-cd0e-4f9c-af0b-51883937d835"
      unitRef="number">0.0390</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzMtMS0xLTEtMA_e7b136ef-816e-4840-a7a7-0c93a5268ad0"
      unitRef="number">0.0241</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzMtMy0xLTEtMA_78939a2e-0a5a-48bf-8a27-4395bb568a43"
      unitRef="number">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzMtNS0xLTEtMA_d7e39d92-edb1-4b80-b27c-77941fc95abf"
      unitRef="number">0.0401</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzQtMS0xLTEtMA_770cd75d-b9a6-4359-8695-43f61b528b72"
      unitRef="number">0.0554</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="if87f6788dfb44067a1387bf33301a378_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzQtMy0xLTEtMA_4ab6b23e-0411-40b5-a665-88948fa66b6c"
      unitRef="number">0.0671</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i0650a6b7d13d4ae3adf820c1ee862f50_D20170101-20171231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToxY2FhMGNjMDFjMzQ0Y2M0YjEzYjFkODM0OGFkMTFjMS90YWJsZXJhbmdlOjFjYWEwY2MwMWMzNDRjYzRiMTNiMWQ4MzQ4YWQxMWMxXzQtNS0xLTEtMA_73844a68-f4e1-4085-88f1-c9d5294d3cad"
      unitRef="number">0.0647</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItMS0xLTEtMA_a68f5ba1-9fe6-4681-93d0-2f5a280479c2"
      unitRef="number">0.0279</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItMy0xLTEtMA_1195989f-371c-4973-a7b9-29a4a2889742"
      unitRef="number">0.0376</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ie8593cb58e5d4b73ba7e5bef3e3496a1_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItNS0xLTEtMA_f1d12619-cd44-414b-a4c3-0432d25acc5e"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i7a63732b565e43618a5fad775146f15b_I20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzItNy0xLTEtMA_4f910e70-9573-45de-b55d-e1b9ec4cbb46"
      unitRef="number">0.0420</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i7e79bcd26cba4c48bace4d172cddc5f3_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzMtMS0xLTEtMA_014f77a6-9b20-445f-b885-7f1cd2b6af95"
      unitRef="number">0.0249</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i81168432177b4e14899b98a50ad8eb27_I20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZToyNzBlNThhMzViOWM0MTVlYmY5ZTBhNTg3NmFhN2JjOC90YWJsZXJhbmdlOjI3MGU1OGEzNWI5YzQxNWViZjllMGE1ODc2YWE3YmM4XzMtMy0xLTEtMA_1cee9bdb-f84b-430b-ab34-1feaf265cd1c"
      unitRef="number">0.0401</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM0ODc_7ed072c3-52fb-4e58-b96d-4f70df3d8ca4"
      unitRef="number">0.0335</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM2NTE_c9bcd193-7c6b-4716-9351-18568db29740"
      unitRef="number">0.0128</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM2NTg_1ca154ef-2fa1-414a-9166-2be504e72c9c"
      unitRef="number">0.0219</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i5312aa8d6f5f4cbe86ebaa13b7e9a77f_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM3NTg_f3121b53-2445-4cae-be9b-59d36c899c07"
      unitRef="number">0.0425</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i83bef4125c5f4b4a8b87f6ce2f1c9c60_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NDA_4593e754-f9ee-4d3c-a9f7-32306033e349"
      unitRef="number">0.0249</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="ief24d588abd841029d2aa9c0845ad0d7_I20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzM4NTQ_e33e277e-200b-4c72-bfd0-ced6744a4e9f"
      unitRef="number">0.0260</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <wst:DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets
      contextRef="i026dfb891cba455ab72f03d27baf78a4_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwMDM_8752db2e-b788-4c49-bb26-d086a7d968a0"
      unitRef="number">0.8386</wst:DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i026dfb891cba455ab72f03d27baf78a4_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwMzM_0edd44b5-9a8e-4a15-986b-fcb82bce1c44"
      unitRef="number">0.0560</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="icc6ad07586d04905b438308adf2938bc_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwNDQ_3d07c4f6-bdce-495a-af49-9a7351750e7d"
      unitRef="number">0.0700</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="icf432c4ed1ca4ca8826cfc7b51ce110f_D20170101-20171231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQwNTg_5c8bce52-b65b-4c8e-8bf7-6bced2b73a74"
      unitRef="number">0.0700</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQxNTI_871781cf-0d1b-4dad-b3f5-4cb0ac366817"
      unitRef="number">0.0625</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQxOTc_4d227384-4a07-4447-aa91-2e4e7792a29a"
      unitRef="number">0.0500</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQ0Mzc_829ff318-ae18-4a43-9d26-622e82922857"
      unitRef="number">0.0625</wst:DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost>
    <wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzQ0ODI_c8c445fe-f94a-40c4-8f46-81a9e53b80f8"
      unitRef="number">0.0500</wst:DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzcwNjU_28d71652-c4c0-4a27-9f7d-961bbd117452">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following are the U.S. target asset allocations and acceptable allocation ranges:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Target allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allocation range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27% - 33%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;67% - 73%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;%&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0% - 3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#x201c;NAV&#x201d;) have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.070%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.824%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;204.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.230%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.820%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.824%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets in the fair value hierarchy&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension plan assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;214.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="iad1e003ca731453b8c13de225178286f_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzEtMS0xLTEtMA_22f1cfb3-22ba-4ca4-a65a-99650d4d869b"
      unitRef="number">0.33</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i71005f2a08e3495aa5b8b71712dd46e7_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzEtMy0xLTEtMA_4af8d027-bb3b-46c8-8760-adee95b373cd"
      unitRef="number">0.23</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="icef51169ca6c490e91fd071db31d7686_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzItMS0xLTEtMA_98b8fbf3-d74c-42f1-94ac-8388d7f1ec08"
      unitRef="number">0.65</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i2ff94b3c95ef4cdf82dcbfbe15cce239_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzItMy0xLTEtMA_e5f47e16-6321-4835-887b-6a2882581f9b"
      unitRef="number">0.74</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="iae5ec6c92f2841c58c748c66b981c526_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzMtMS0xLTEtMA_86f62a0b-beec-46b8-b0b1-b6a28ca99842"
      unitRef="number">0.02</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ibfe9d51b887b49898618b0e671ee0909_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzMtMy0xLTEtMA_eda1a2c8-f720-4091-a8c5-1e0c99b836f2"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzQtMS0xLTEtMA_de6110d3-0389-44e9-b1c1-1be6c87fe362"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTplYzM1NGJjMzYxODk0Mjg2OGY2Y2UzZmViMmI4ZGIzOC90YWJsZXJhbmdlOmVjMzU0YmMzNjE4OTQyODY4ZjZjZTNmZWIyYjhkYjM4XzQtMy0xLTEtMA_aaf26544-e1c2-42ec-8372-946e5b653854"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i71005f2a08e3495aa5b8b71712dd46e7_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1MDE_3ba10ec2-f950-423a-9c8f-3ab160d53316"
      unitRef="number">0.65</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i2ff94b3c95ef4cdf82dcbfbe15cce239_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1MjY_4239b90d-9dc6-4197-873a-b8bc9d6ceed6"
      unitRef="number">0.35</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="iad1e003ca731453b8c13de225178286f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1NDg_45030913-cf59-4afe-bb61-78ad37e62a34"
      unitRef="number">0.30</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="icef51169ca6c490e91fd071db31d7686_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90ZXh0cmVnaW9uOmY5ZTRlNGM2ZjNjNDQ0ZDVhMzAwNjRiMDgxNGM2MGFjXzY1NzM_fb278048-adf0-4a38-b89f-ab2b305d91f2"
      unitRef="number">0.70</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="iad1e003ca731453b8c13de225178286f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTpjZTNhODZjYWJkNGE0MjcwYjc0NTgxMzQ5Yjc2Yzc2OS90YWJsZXJhbmdlOmNlM2E4NmNhYmQ0YTQyNzBiNzQ1ODEzNDliNzZjNzY5XzEtMS0xLTEtMA_904bb64b-99f5-48e0-b0ac-5e779f623ac9"
      unitRef="number">0.30</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="icef51169ca6c490e91fd071db31d7686_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTpjZTNhODZjYWJkNGE0MjcwYjc0NTgxMzQ5Yjc2Yzc2OS90YWJsZXJhbmdlOmNlM2E4NmNhYmQ0YTQyNzBiNzQ1ODEzNDliNzZjNzY5XzItMS0xLTEtMA_4df82120-0040-4ac4-bf69-2e8be59f5df7"
      unitRef="number">0.70</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="iae5ec6c92f2841c58c748c66b981c526_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTpjZTNhODZjYWJkNGE0MjcwYjc0NTgxMzQ5Yjc2Yzc2OS90YWJsZXJhbmdlOmNlM2E4NmNhYmQ0YTQyNzBiNzQ1ODEzNDliNzZjNzY5XzMtMS0xLTEtMA_4af35454-d399-406d-8fdc-ff059c86b564"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib2a035cec19e4b06b8a0a0f2b1507211_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzMtMS0xLTEtMA_c2cfa95b-54e3-4083-83c6-d7a61b356a7e"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i059f6519363e4795ac9e2b62228928ea_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzMtMy0xLTEtMA_7b66b033-87d8-49ad-835d-d834c0dd574f"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic6b75ff5856344798be8d09feba9d76c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtMS0xLTEtMA_01c5d949-cd5d-41ea-aaf5-301d29334fc0"
      unitRef="usd">15500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib6b6fc1c55ae4f2c8edcfa03284c2531_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtMy0xLTEtMA_669d5458-6286-4a91-9d35-cfa7b5e41dbe"
      unitRef="usd">1300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i872e47c6d50b462c8e589892b0d54db5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtNS0xLTEtMA_c4ec0492-0f32-48cb-b921-52e9546c90f8"
      unitRef="usd">14200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3c0ee7d7ac4d4a6dbfcb60f511f35cc1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzYtNy0xLTEtMA_7725f551-6f1e-47c6-8a2f-8b42bf49e3a6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if7f540d9be17469abb37970c9409c4b0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtMS0xLTEtMA_fd6800d9-0bdc-40f3-b951-ff8beed080c9"
      unitRef="usd">21700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if92ca63024e94955aa542248e84899d6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtMy0xLTEtMA_a63cd9b7-4fb6-44d2-8175-14fb9dfa5a07"
      unitRef="usd">3800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i83e89bb3731949e9b811eea8345a785d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtNS0xLTEtMA_c3722eef-2f8d-42fa-b273-4bdf31c60660"
      unitRef="usd">17900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1671a272484847b0a73c5e28afdbbc6e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzgtNy0xLTEtMA_9a6e0e29-4835-4652-8d11-4e61b066971f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifa3a175482f741ac9a27d320bfda7d20_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzExLTEtMS0xLTA_adeb8b17-dda6-4262-af2e-1137514ab789"
      unitRef="usd">39400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib3c5104f4fc949a7b5a23bb9ae7a2280_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzExLTMtMS0xLTA_af6f8d1c-dd74-4b00-bc0e-50d98d4d7baf"
      unitRef="usd">7300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2d9ab3e1be7b43a6a9aed789c9de3fe0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzExLTUtMS0xLTA_c5379d17-0c82-43f9-9ec9-5cb349fbec63"
      unitRef="usd">32100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0443f666d5124baa94d26af15d452b44_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzEyLTEtMS0xLTA_af4a0439-d237-4aca-9427-f4285929a44e"
      unitRef="usd">204700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTo3MzQ5NzNjZjA5YTA0MzVmOTdkZDVmNWUxM2E4MWRiOC90YWJsZXJhbmdlOjczNDk3M2NmMDlhMDQzNWY5N2RkNWY1ZTEzYTgxZGI4XzEzLTEtMS0xLTA_217c6c44-db17-415d-ba88-27f9aeb23b09"
      unitRef="usd">244100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7973d3e744414be78965041980c27ae2_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzMtMS0xLTEtMA_171f7c5a-6426-469e-883b-6048f132208c"
      unitRef="usd">1700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id865d211c82f481ba1e8e730281c3396_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzMtMy0xLTEtMA_392b70b2-9235-4369-a174-b501b5ea6079"
      unitRef="usd">1700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2590f85ac39247ee8575a025ddfafb6e_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzYtMS0xLTEtMA_5f7b5b37-3e3c-4856-99d2-ef7a8b420d8a"
      unitRef="usd">17700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id85ff1c02db44ef69cddfb8fa9561ced_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzYtMy0xLTEtMA_1422e73f-52d1-41a5-bd42-74b9d9b206bc"
      unitRef="usd">17700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic2cfb2df0ba2490e8bc77e8e71719012_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzgtMS0xLTEtMA_91bdf293-b530-4d5e-8b2a-1f11796f96e9"
      unitRef="usd">13900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i049d668d485c4a138de851c7ad4dd119_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzgtMy0xLTEtMA_734ca602-1212-4c18-984f-1989144ab6ad"
      unitRef="usd">13900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia16d87c6eeea4a8a9a6aeceadbe8a2e9_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzExLTEtMS0xLTA_16b7e856-d639-43ac-acd4-28fe85b96891"
      unitRef="usd">33300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ide50b00aea9546c98b500e0e9ab6663d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzExLTMtMS0xLTA_0fffc0d8-f849-4187-bf7c-67d960c8e8d2"
      unitRef="usd">33300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i14c00763c08f4f1b95c5b66e3cf7413f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzExLTUtMS0xLTA_613346f3-097f-4bba-be77-aeb5b881fe46"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1c5adfefdd0a41bc979246bd31ec015f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzEyLTEtMS0xLTA_ec768a62-4f5e-4746-b6df-278bf0b52868"
      unitRef="usd">181200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzYvZnJhZzpmOWU0ZTRjNmYzYzQ0NGQ1YTMwMDY0YjA4MTRjNjBhYy90YWJsZTozNWNiMGZlZThkY2E0NWNhOGE5ODFmOWUzMWI0NDNiZi90YWJsZXJhbmdlOjM1Y2IwZmVlOGRjYTQ1Y2E4YTk4MWY5ZTMxYjQ0M2JmXzEzLTEtMS0xLTA_05cc541a-d9d8-42db-9079-dfaa92768f9b"
      unitRef="usd">214500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NTE_8c576dcc-d402-465b-b59d-c325bbb23f6e">Other (Income) Expense &lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Other (income) expense consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restructuring and related charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance and post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Argentina currency devaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax recovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Venezuela deconsolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Development and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Restructuring and Related Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes were expected to be implemented over a period of up to twenty-four months from the date of the approval. The plan was expected to require restructuring and related charges of approximately $16.0 million. Since its approval, we recorded $13.7&#160;million in restructuring and related charges associated with this plan. The plan is now considered complete.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, we recorded $4.9 million in restructuring and related charges associated with this plan, consisting of $2.6 million for severance charges, $0.3 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $2.0 million for other non-cash charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2018, we recorded $8.8&#160;million in restructuring and related charges associated with this plan, consisting of $3.1&#160;million for severance charges, $2.2&#160;million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $3.5&#160;million for other non-cash charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.908%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance    and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-cash asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-cash asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. During 2018, we recorded $0.3 million in additional charges related to this restructuring plan. Our remaining restructuring obligations related to our 2016 restructuring plan as of December 31, 2019 were $0.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Other Items&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, we recorded a charge of $1.0&#160;million as a result of the continued devaluation of Argentina&#x2019;s currency. During 2018, we recorded a charge of $1.1 million related to the classification of Argentina&#x2019;s economy as highly inflationary under U.S. GAAP as of July 1, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, we recognized a tax recovery of $4.7&#160;million related to previously-paid international excise taxes, following a favorable court ruling.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On February 17, 2016, the Venezuelan government announced a devaluation of the Bolivar, from the previously-prevailing official exchange rate of 6.3 Bolivars to USD to 10.0 Bolivars to USD, and streamlined the previous three-tiered currency exchange mechanism into a dual currency exchange mechanism. In 2017, as a result of the continued deterioration of conditions in Venezuela as well as our continued reduced access to USD settlement controlled by the Venezuelan government, we recorded a charge of $11.1 million related to the deconsolidation of our Venezuelan subsidiary, following our determination that we no longer met the U.S. GAAP criteria for control of that subsidiary. This charge included the derecognition of the carrying amounts of our Venezuelan subsidiary&#x2019;s assets and liabilities, as well as the write-off of our investment in our Venezuelan subsidiary, related unrealized translation adjustments and the elimination of intercompany accounts. As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, 2018 and 2017, we recorded development income of $0.9 million, $0.9 million and $1.5 million, respectively, related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Revenue&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional information. In addition, during 2017, we recorded income of $9.1 million attributable to the reimbursement of certain costs related to a technology that we subsequently licensed to a third party. The license of technology to the third party may result in additional income in the future, contingent on commercialization of the related product. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 12, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional details.   &lt;/span&gt;&lt;/div&gt;Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items primarily changed in 2019 as a result of foreign exchange transaction gains of $5.6 million in 2019 and a $1.9&#160;million gain on the sale of fixed assets as a result of our restructuring plan, as compared to foreign exchange transaction gains of $5.5 million in 2018 and a $1.1 million gain on the sale of fixed assets as a result of our restructuring plans.</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NDk_6fe1c1c1-cc0e-4d55-8d12-6aad9109aa38">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Other (income) expense consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restructuring and related charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance and post-employment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total restructuring and related charges&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Argentina currency devaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax recovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Venezuela deconsolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Development and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzItMS0xLTEtMA_875b4bed-877c-4610-a04a-c07c7e8d9d32"
      unitRef="usd">2600000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzItMy0xLTEtMA_736fad03-4358-4c80-aaed-6066b26d6207"
      unitRef="usd">3100000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzItNS0xLTEtMA_22a02831-25f5-4524-a0ab-4145fe16cd4e"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzMtMS0xLTEtMA_464e2fca-65d1-4f13-b23e-7da10da7f58c"
      unitRef="usd">300000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzMtMy0xLTEtMA_9bd2a908-709a-4120-b792-e090bf1aefca"
      unitRef="usd">2200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzMtNS0xLTEtMA_2293e62d-b64c-4a52-9a63-65b1168e2b71"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherRestructuringCosts
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzQtMS0xLTEtMA_a29b2d29-263d-487c-ac5a-384d146c73c0"
      unitRef="usd">2000000.0</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzQtMy0xLTEtMA_764feb47-6c80-4da7-95fd-3270cdda9a1b"
      unitRef="usd">3800000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzQtNS0xLTEtMA_9bc0c45f-ecd9-4c14-9e72-4932749e6ea7"
      unitRef="usd">0</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzUtMS0xLTEtMA_1483ac72-4d32-4cd5-8fa4-f3f7f6dd24cd"
      unitRef="usd">4900000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzUtMy0xLTEtMA_778567c8-5920-4424-9790-17bff71f15e4"
      unitRef="usd">9100000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzUtNS0xLTEtMA_5e1c1b9d-340a-456a-96e5-c66dd41e23a2"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzctMS0xLTEtMA_7e09f33f-9bff-4540-a5ba-e85bea7630ac"
      unitRef="usd">1000000.0</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzctMy0xLTEtMA_7a9323e2-b2fc-4ad8-80e7-46f3bf8a29e6"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzctNS0xLTEtMA_bc11505a-5987-4b0d-bcea-956f59fcdaad"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzgtMS0xLTEtMA_dbaeed01-3937-433b-98ba-d3495a72775b"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzgtMy0xLTEtMA_1ad34e09-a2d8-4b3a-8fe9-658f28b50c12"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzgtNS0xLTEtMA_4b420556-3c5f-4528-be6a-c76eddc22497"
      unitRef="usd">-11100000</us-gaap:DeconsolidationGainOrLossAmount>
    <wst:Developmentandlicensingincome
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEwLTEtMS0xLTA_0592e19d-b84d-48e5-ae50-d334ad1177cc"
      unitRef="usd">900000</wst:Developmentandlicensingincome>
    <wst:Developmentandlicensingincome
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEwLTMtMS0xLTA_6f77df2a-24bf-449b-a797-8617c047c724"
      unitRef="usd">900000</wst:Developmentandlicensingincome>
    <wst:Developmentandlicensingincome
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEwLTUtMS0xLTA_5c0162ca-acee-418b-af73-2cafd707be00"
      unitRef="usd">10600000</wst:Developmentandlicensingincome>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzExLTEtMS0xLTA_1898ae51-9ece-46ce-a91b-24e41a05e787"
      unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzExLTMtMS0xLTA_afdfcc01-4463-41d8-9ea6-8e5d950b02f9"
      unitRef="usd">-2600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzExLTUtMS0xLTA_8377b951-268d-41d7-a338-4b89b62fa313"
      unitRef="usd">-2400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEyLTEtMS0xLTA_cb66da2a-2eda-45c5-9cef-3eb0c05e412b"
      unitRef="usd">4900000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEyLTMtMS0xLTA_cd8a82c2-e9b1-4bfe-87d1-c4f3b58c6a80"
      unitRef="usd">4800000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEyLTUtMS0xLTA_70b1cb4e-d71d-4483-9328-04076690c9fc"
      unitRef="usd">-3900000</us-gaap:OtherOperatingIncomeExpenseNet>
    <wst:OtherIncomeExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEzLTEtMS0xLTA_c6eeeea7-e4b3-40f9-bf17-026e4a62fab1"
      unitRef="usd">2500000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEzLTMtMS0xLTA_7333dffb-ae10-40e8-89bc-bab84f623728"
      unitRef="usd">-1900000</wst:OtherIncomeExpense>
    <wst:OtherIncomeExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo3YmY0MDk4NjZjNTA0MjA4YTVjOWM3MWUzMTA5N2EyOC90YWJsZXJhbmdlOjdiZjQwOTg2NmM1MDQyMDhhNWM5YzcxZTMxMDk3YTI4XzEzLTUtMS0xLTA_29eedb81-f4b7-4ba7-93b1-9c2002654941"
      unitRef="usd">-2000000.0</wst:OtherIncomeExpense>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i0e49cb2c7f3a4e50aac7c89a7a0d7753_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzQwMA_2b2f75b4-0cda-4dfd-bd2f-7cb75e6146f3"
      unitRef="usd">16000000.0</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzQ4MA_11cf3e5b-adb0-47c1-989a-e2084d72ff12"
      unitRef="usd">4900000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzU2MQ_7316c62a-3da8-4487-83b9-ccc52a44df15"
      unitRef="usd">2600000</us-gaap:SeveranceCosts1>
    <wst:AssetImpairmentChargesPatentandEquipment
      contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzU4Nw_3925967a-df71-4441-aaa2-b5e0b4160fa7"
      unitRef="usd">300000</wst:AssetImpairmentChargesPatentandEquipment>
    <us-gaap:OtherRestructuringCosts
      contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzY4NA_c9c65c98-4b7d-4b10-928e-be2724e887db"
      unitRef="usd">2000000.0</us-gaap:OtherRestructuringCosts>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NDM_a13933ac-2717-4a23-955e-ed328dcff280">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.908%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance    and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-cash asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-cash asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i8e0171741848480aabaad6cf352a5967_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtMS0xLTEtMA_32b5eac8-a2da-4ffb-a21e-5741374c6735"
      unitRef="usd">2300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i5c3b94bf9830453eb8c83e9fe89297ed_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtMy0xLTEtMA_a529c5e4-5cfd-43a7-b325-9a7f23e1ccb1"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iff067a80b3c0472aafbb0d3d5e4c92ad_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtNS0xLTEtMA_c90462d2-b445-4bf1-9ca8-638628ac1ca0"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i63038b37ba3f4411817f0419317cd970_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzUtNy0xLTEtMA_078c7581-441f-4310-8f96-c46debeb501e"
      unitRef="usd">2300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtMS0xLTEtMA_eb3a7c9f-79f8-4eea-bf4e-26b59de5f862"
      unitRef="usd">2600000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtMy0xLTEtMA_3776807c-eeb7-4063-b5fb-ab80c4a55043"
      unitRef="usd">300000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtNS0xLTEtMA_69ad6fad-7899-4280-ac59-1d088ef74e26"
      unitRef="usd">2000000.0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzYtNy0xLTEtMA_33939694-604f-45a9-9935-4afaceba180b"
      unitRef="usd">4900000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctMS0xLTEtMA_80a8ef22-85d0-4866-91fd-9721b7b48646"
      unitRef="usd">3500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctMy0xLTEtMA_2c67ddbe-783a-464e-91f8-b0ca64e87cd2"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctNS0xLTEtMA_3402df23-fe01-4c2b-9a4e-f2518083c3b9"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzctNy0xLTEtMA_af07d00e-ee84-4449-a705-003d0957ae52"
      unitRef="usd">3500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ia67aaad7c305484ead3aad36641a681f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtMS0xLTEtMA_7d8066fe-6892-4e6b-816d-965014301ba0"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i817ffe0b727e49b5b6a18e31f2cf6d3e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtMy0xLTEtMA_2c03b315-d309-4109-99f8-5f6a2889fb0e"
      unitRef="usd">300000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i5a8e9dd3a030429cb2c11f8fad54fb70_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtNS0xLTEtMA_28e671f2-98aa-4d55-bc45-52014b406ae3"
      unitRef="usd">2000000.0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i617f29de38554e598979b53825165b3f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzgtNy0xLTEtMA_98517233-03b3-4bf9-9f74-a13b70ad7b55"
      unitRef="usd">2300000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="i8a770acf6d014af1b07375d85b007733_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktMS0xLTEtMA_375c24e5-bcd9-4bb7-9cf6-53876bd00acb"
      unitRef="usd">1400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie0e8452d0cd54d09bd29f966f85d7796_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktMy0xLTEtMA_22360fa6-96da-41c2-8fdd-d41f9816cfa8"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic58d406b08ad4b8ea3459ce6ee377143_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktNS0xLTEtMA_f4ab4b11-2ac5-42c3-87bb-d1199e9d43d0"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i09af60c60dee44a093e76f37f68e79e4_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90YWJsZTo1M2YxNzU4ZWMyMjk0NmFmODhlODVmZTQ4YWQ4YjUzYy90YWJsZXJhbmdlOjUzZjE3NThlYzIyOTQ2YWY4OGU4NWZlNDhhZDhiNTNjXzktNy0xLTEtMA_82f95535-ec80-4cd6-8e62-6393cdbd3291"
      unitRef="usd">1400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i508d135f28ec440fa57fc415a1e8cc42_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzExNjU_bbfc0e49-5230-4404-b182-883783c4f6a9"
      unitRef="usd">300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="i67268793d14a4d86b86841792ac25b2a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzEzMzQ_3cb0a917-6bd6-4f8f-b5c7-04e739020e23"
      unitRef="usd">100000</us-gaap:RestructuringReserve>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM4NDgyOTA3MDIzMjk_24039d91-2e78-44a1-9061-9d6b31d47f8d"
      unitRef="usd">1000000.0</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzEzODk_74201a86-9d10-4a38-856f-9023ed301b93"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyExchangeRateRemeasurement1
      contextRef="i9a2c29927a97445985c175fb950377a6_I20161231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzE2NTA_9a001709-9072-4407-a3a8-bcfe14fdfe11"
      unitRef="number">6.3</us-gaap:ForeignCurrencyExchangeRateRemeasurement1>
    <us-gaap:ForeignCurrencyExchangeRateRemeasurement1
      contextRef="i17de35ea5588457687be31c78183d563_I20160217"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzE2NzI_e236d4a8-afed-400a-aef5-9c8eaf9ccd9b"
      unitRef="number">10.0</us-gaap:ForeignCurrencyExchangeRateRemeasurement1>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzIwNTY_9fa18103-6968-4833-96b7-bc8a7449d08d"
      unitRef="usd">-11100000</us-gaap:DeconsolidationGainOrLossAmount>
    <wst:Developmentandlicensingincome
      contextRef="i1e11b27427cd46d590025400238fdb38_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI2NzE_72bce79b-40b7-4d9a-9e2d-fe46212a6a7e"
      unitRef="usd">900000</wst:Developmentandlicensingincome>
    <wst:Developmentandlicensingincome
      contextRef="ib48ea9474bfe4c5d806349adbf636277_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI2NzU_0d07c737-e6c6-4c6f-8dba-fc16c2b95f74"
      unitRef="usd">900000</wst:Developmentandlicensingincome>
    <wst:Developmentandlicensingincome
      contextRef="i6760c6eadf5e4027ab3c48a8a4c417ad_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI2ODI_947e5923-1427-492a-bfc7-bd81000ef4f1"
      unitRef="usd">1500000</wst:Developmentandlicensingincome>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i2a2868b8c8554bf08566aa6693065131_I20130630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI3NDc_b45ea467-95d9-4ed7-91ba-29ee9675442e"
      unitRef="usd">20000000.0</us-gaap:ContractWithCustomerLiability>
    <wst:Developmentandlicensingincome
      contextRef="ica512f947d5545b0a280adcd3765b3af_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzI5ODQ_f0ff6ab1-0994-4bf3-80bb-278c0da83f9e"
      unitRef="usd">9100000</wst:Developmentandlicensingincome>
    <us-gaap:ForeignCurrencyTransactionGainBeforeTax
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM2Nzg_a597c5b1-d5ca-4dae-8db5-123f686fbef8"
      unitRef="usd">5600000</us-gaap:ForeignCurrencyTransactionGainBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM3NDQ_1053260e-7e79-4953-ac9e-05dc5276eab9"
      unitRef="usd">-5500000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDIvZnJhZzo4ZTU0YzgwZjJlNmU0YWFlYjBmOTI3ZGMzMmE4OTQ4Yy90ZXh0cmVnaW9uOjhlNTRjODBmMmU2ZTRhYWViMGY5MjdkYzMyYTg5NDhjXzM3NjI_b7165203-d31f-4078-8b46-76e918111a3c"
      unitRef="usd">1100000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODc_518dc7b6-d6d2-4efd-a0b9-e1beb8f79bdd">Income TaxesAs a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. During 2019, the statute of limitations for the 2015 U.S. federal tax year lapsed, leaving tax years 2016 through 2019 open to examination. For U.S. state and local jurisdictions, tax years 2015 through 2019 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2012 through 2019.&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increase due to current year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increase due to prior year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reduction for expiration of statute of limitations/audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition, we had balances in accrued liabilities for interest and penalties of $0.2 million at both December&#160;31, 2019 and 2018. As of December&#160;31, 2019, we had $5.0 million of total gross unrecognized tax benefits, which, if recognized, would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $0.5 million during the next twelve months, which would favorably impact our effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of income before income taxes are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The related provision for income taxes consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Federal and state&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The significant components of our deferred tax assets and liabilities at December 31 are&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension and deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net deferred tax (liability) asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.365%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.227%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. federal corporate tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax on international operations other than U.S. tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reversal of prior valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments to reserves for unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. tax on international earnings, net of foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;State income taxes, net of federal tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Excess tax benefits on share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Impact of 2017 Tax Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Venezuela deconsolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other business credits and Section 199 Deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2019, we recorded a tax benefit of $0.3&#160;million due to the impact of federal law changes enacted during the year, as well as a tax benefit of $10.3&#160;million associated with stock-based compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2018, we recorded a net tax benefit of $2.5 million for the estimated impact of the 2017 Tax Act and a tax benefit of $14.3 million associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During 2017, we recorded a discrete tax charge of $48.8 million related to the 2017 Tax Act and the impact of changes in enacted international tax rates on previously-recorded deferred tax asset and liability balances, as well as a tax benefit of $33.1 million associated with stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The 2017 Tax Act, which was signed into law on December 22, 2017, has resulted in significant changes to the U.S. corporate income tax system. These changes include, but are not limited to, a federal statutory rate reduction from 35.0% to 21.0% effective for tax years beginning after December 31, 2017. Changes in tax rates and tax laws are accounted for in the period of enactment. As a result, during the year ended December 31, 2017, we recorded a discrete charge based upon our understanding of the 2017 Tax Act and the guidance available as of the date of that filing. A significant portion of the discrete tax liability was attributable to a one-time mandatory deemed repatriation tax of post-1986 undistributed foreign subsidiary earnings and profits (the &#x201c;Transition Toll Tax&#x201d;) of $27.9 million. Additionally, due to the reduction of the federal statutory rate, we revalued our deferred assets and liabilities and recorded a provisional $11.4 million federal tax expense, net of state tax impact, during the year ended December 31, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Tax Act. We recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in our consolidated financial statements for the year ended December 31, 2017. As of December 31, 2018, we finalized our calculations and tax positions used in our analysis of the impact of the 2017 Tax Act in consideration of proposed regulations and other guidance issued during 2018. As a result, we recorded a $7.5 million tax benefit related to a reduction of the Transition Toll Tax and an incremental tax expense of $4.0 million related to other adjustments. The final measurement reduced the Transition Toll Tax expense to $20.4 million from $27.9 million. The net impact of these adjustments resulted in a benefit of 1.45% to the 2018 effective tax rate. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The 2017 Tax Act created a provision known as global intangible low-tax income (&#x201c;GILTI&#x201d;) that imposes a U.S. tax on certain earnings of controlled foreign subsidiaries. We made an accounting policy election to reflect GILTI taxes, if any, as a current income tax expense in the period incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, we have fully utilized all of our U.S. federal net operating loss carryforwards. State operating loss carryforwards of $226.9 million created a deferred tax asset of $15.5 million, while foreign operating loss carryforwards of $49.4 million created a deferred tax asset of $6.4 million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been fully reserved. State loss carryforwards expire as follows: $15.4 million in 2020 and $211.5 million thereafter. Foreign loss carryforwards will begin to expire in 2027, while $48.7 million of the total $49.4 million will not expire.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December&#160;31, 2019, we have utilized all available foreign tax credit carryforwards against the Transition Toll Tax. During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. The $2.0 million of state research and development credits expire as follows: $0.5 million expire in 2023, $0.5 million expire in 2024, and $1.0 million expire after 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $214.2 million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1Nzg_874e11d9-d9e7-4f78-b11c-c53678861278">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increase due to current year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Increase due to prior year position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reduction for expiration of statute of limitations/audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzEtMS0xLTEtMA_19a5fc86-26b8-4f10-a41c-3a060abd277e"
      unitRef="usd">3900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzEtMy0xLTEtMA_e6f1b78e-9ab7-4079-a3a8-586b650f387f"
      unitRef="usd">3200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzItMS0xLTEtMA_b41d7152-c67a-4fbf-baef-96d73cfaffca"
      unitRef="usd">1600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzItMy0xLTEtMA_a40a71b6-1ff0-4a59-ad2f-f505da88f4a1"
      unitRef="usd">800000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzMtMS0xLTEtMA_77f61432-d7ae-49b6-a7f4-f295a3f22133"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzMtMy0xLTEtMA_19fe271a-06fd-4152-b29e-a3a397ab42f1"
      unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzQtMS0xLTEtMA_879abeb3-182c-45c4-a27c-8b141c610a11"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzQtMy0xLTEtMA_c9e90baa-60e9-4ce5-b46e-442b6ca4b6d6"
      unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzUtMS0xLTEtMA_4186fafa-996e-4512-b77f-03e07bea91c8"
      unitRef="usd">5000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxZTM1NDg2NmUzMjI0MDMwODZmYWFhNGQzMjJjMWRkMi90YWJsZXJhbmdlOjFlMzU0ODY2ZTMyMjQwMzA4NmZhYWE0ZDMyMmMxZGQyXzUtMy0xLTEtMA_f26431a6-115a-48e8-8044-7293709300a0"
      unitRef="usd">3900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzcwNw_5ee46983-94a8-4e30-a3df-6975f4c7d029"
      unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc2Mg_2a5659dd-9bbb-4e68-8581-834ee5483b92"
      unitRef="usd">5000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzEwNTg_2a05ecce-063c-4eec-925b-7db3a34f53d1"
      unitRef="usd">500000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODA_88e4ceb5-cd07-4bd6-b96a-8b98ecc92e63">&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The components of income before income taxes are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;161.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzEtMS0xLTEtMA_4786ccd2-87b1-4b47-8a75-dfc152d9b9d8"
      unitRef="usd">161200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzEtMy0xLTEtMA_e24cf7ef-55b1-49b3-b70c-743e26735c75"
      unitRef="usd">132900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzEtNS0xLTEtMA_e094ecb1-9996-4e4d-8d55-e2e36c365673"
      unitRef="usd">96500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzItMS0xLTEtMA_fef0780b-dfc1-4b60-a5b6-46d589eab104"
      unitRef="usd">130600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzItMy0xLTEtMA_c3881f49-bea5-45a9-b626-3db2fc042c6b"
      unitRef="usd">107800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzItNS0xLTEtMA_ad4b4099-778c-4c85-b253-68681220dadc"
      unitRef="usd">125900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzMtMS0xLTEtMA_60fd26ea-dd41-4167-9822-c0d9fc0a5c8f"
      unitRef="usd">291800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzMtMy0xLTEtMA_645b3188-5670-4f7d-a514-8750afd3d35d"
      unitRef="usd">240700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTo1NDFjYmE4NDk2ZTI0ZjAyYmM3Mzc5ZGU0NjBjOGE0NC90YWJsZXJhbmdlOjU0MWNiYTg0OTZlMjRmMDJiYzczNzlkZTQ2MGM4YTQ0XzMtNS0xLTEtMA_8c3028d5-fc9d-44ab-8068-752edd50faf2"
      unitRef="usd">222400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODQ_0f305864-03be-447b-a864-d2de7f107b1a">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The related provision for income taxes consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Federal and state&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzItMS0xLTEtMA_0794312d-feb5-48be-af60-09f225b399b3"
      unitRef="usd">10800000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzItMy0xLTEtMA_21182017-4160-4fab-a633-0d74404dee55"
      unitRef="usd">2100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzItNS0xLTEtMA_373cdc25-56d2-48f7-90fa-b0b5570d4234"
      unitRef="usd">2100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzMtMS0xLTEtMA_d6707815-e7c3-489d-a516-f2f82ce18acc"
      unitRef="usd">2400000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzMtMy0xLTEtMA_9c4d5257-0a42-4149-8aa1-d8f51b5db771"
      unitRef="usd">3300000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzMtNS0xLTEtMA_9fb32e2b-61c5-493d-88d1-715f8d2f8dcb"
      unitRef="usd">100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzQtMS0xLTEtMA_5e71e52b-0a91-4693-b573-735302cb2242"
      unitRef="usd">30500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzQtMy0xLTEtMA_4defc10c-c65f-4c7c-98c2-c5c4b422ec64"
      unitRef="usd">35100000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzQtNS0xLTEtMA_2f135024-3cae-4c74-8a3f-63f47195cf33"
      unitRef="usd">37000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzUtMS0xLTEtMA_e44cc86c-993d-444a-973d-6cb6ca353a63"
      unitRef="usd">43700000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzUtMy0xLTEtMA_d863b90d-5791-4d77-99c4-99b0ac5b75b0"
      unitRef="usd">40500000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzUtNS0xLTEtMA_5280f598-158a-40c7-a054-7bbc4f6bf893"
      unitRef="usd">39200000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzctMS0xLTEtMA_7b82f2fb-d7e7-4637-976d-8c2fda4ecdfc"
      unitRef="usd">10300000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzctMy0xLTEtMA_9940e69c-d1af-40a5-aa30-2a0634489948"
      unitRef="usd">1400000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzctNS0xLTEtMA_0f31ab0e-f00e-4e7e-9a20-17c83b4f2e05"
      unitRef="usd">41800000</wst:DeferredFederalStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzgtMS0xLTEtMA_f6b98b50-8a58-43f2-9312-3bbe36d7c78d"
      unitRef="usd">5000000.0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzgtMy0xLTEtMA_dd590d50-5f72-4d1b-b813-4b213a5b341a"
      unitRef="usd">-500000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzgtNS0xLTEtMA_031ee769-67c7-453b-9b59-6a0c196460c2"
      unitRef="usd">-100000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzktMS0xLTEtMA_703728e3-f76a-4185-afa3-ca48ea5b7463"
      unitRef="usd">15300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzktMy0xLTEtMA_2391b5e1-6959-4d0f-b53a-0785c9d4cc9f"
      unitRef="usd">900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzktNS0xLTEtMA_e294813f-5dc1-4e87-beaf-b9ba4b0dbc48"
      unitRef="usd">41700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzEwLTEtMS0xLTA_209c2e16-b903-4448-ba91-d8c81f215a82"
      unitRef="usd">59000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzEwLTMtMS0xLTA_5495207d-3d1d-4f9a-9f04-be88b101fe42"
      unitRef="usd">41400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZToxYTZlZjg4NDk2Mzk0YjQ1ODg1Nzk0YmIyNmU3NmFmYi90YWJsZXJhbmdlOjFhNmVmODg0OTYzOTRiNDU4ODU3OTRiYjI2ZTc2YWZiXzEwLTUtMS0xLTA_0da13680-1437-481a-8b1e-a4baaec89acc"
      unitRef="usd">80900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1ODk_fd53de44-988f-4b89-87ac-9210dd7fd1b3">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The significant components of our deferred tax assets and liabilities at December 31 are&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:67.391%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.905%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pension and deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net deferred tax (liability) asset&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzItMS0xLTEtMA_31db1c0c-3822-426b-a2ce-4d0dc58bd1d8"
      unitRef="usd">21900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzItMy0xLTEtMA_95ae4a6a-aa2a-46ac-914f-a72f3fdd7a13"
      unitRef="usd">18400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzMtMS0xLTEtMA_f32d87d0-7bd6-4760-9bab-394ce403e267"
      unitRef="usd">2800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzMtMy0xLTEtMA_c02fa2fe-f1f1-4343-8bcf-4353befd4360"
      unitRef="usd">10500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzUtMS0xLTEtMA_9e78744a-744d-4847-8271-803404abe241"
      unitRef="usd">25600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzUtMy0xLTEtMA_dd79b1d4-3deb-43d2-896a-41cd92d0747a"
      unitRef="usd">27200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzYtMS0xLTEtMA_28cdd020-7c37-456c-9fa7-7c38eae9b3a9"
      unitRef="usd">9200000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzYtMy0xLTEtMA_f1fe2b7e-afd4-41d1-9fa5-bebfee9149b4"
      unitRef="usd">11400000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzctMS0xLTEtMA_e193d016-2d02-48db-95a4-82f0f41773d9"
      unitRef="usd">15900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzctMy0xLTEtMA_2b71c7b2-9251-4a97-80c5-044b110a31b0"
      unitRef="usd">16000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzgtMS0xLTEtMA_c5d77167-f014-4bea-a6c8-6a645cf9167c"
      unitRef="usd">43600000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzgtMy0xLTEtMA_a5f0eec4-b677-4816-b040-8348af05bca9"
      unitRef="usd">51500000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEwLTEtMS0xLTA_469036b6-10d6-4146-b562-f1db646d59db"
      unitRef="usd">37900000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEwLTMtMS0xLTA_c5ae723e-8b7a-4e56-bd06-416027a37330"
      unitRef="usd">31300000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzExLTEtMS0xLTA_d81b6c31-7b7b-403c-9756-3e5dda204552"
      unitRef="usd">6300000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzExLTMtMS0xLTA_6364a29c-dfde-4a4f-9f5b-27e351465397"
      unitRef="usd">6600000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEyLTEtMS0xLTA_9a239a37-491e-4721-aed6-c785e76b422b"
      unitRef="usd">900000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEyLTMtMS0xLTA_b262f9a8-464c-4040-bef7-a37468f6e72b"
      unitRef="usd">2000000.0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEzLTEtMS0xLTA_a1d12f7f-4ae1-4471-ad67-446f5e01114a"
      unitRef="usd">45100000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzEzLTMtMS0xLTA_cd03a418-6411-4169-b8fe-38b9b79f19e5"
      unitRef="usd">39900000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzE0LTEtMS0xLTA_464615a7-4886-445e-8421-07f2a9a6e808"
      unitRef="usd">-1500000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTplYWFiMmEzZjkxMjI0MWU2OThhMTZmODJlOWZlNzZiMS90YWJsZXJhbmdlOmVhYWIyYTNmOTEyMjQxZTY5OGExNmY4MmU5ZmU3NmIxXzE0LTMtMS0xLTA_83e48b07-a8bf-4ce0-8f4c-19b8fc688195"
      unitRef="usd">11600000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzc1OTE_f8d742a5-9536-4e95-8717-71255668ffe4">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.365%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.227%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. federal corporate tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax on international operations other than U.S. tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reversal of prior valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Adjustments to reserves for unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. tax on international earnings, net of foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;State income taxes, net of federal tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Excess tax benefits on share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Impact of 2017 Tax Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Tax on undistributed earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Venezuela deconsolidation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other business credits and Section 199 Deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEtMS0xLTEtMA_3d0fdf6b-d756-4be1-93f1-c6219dfe57c7"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEtMy0xLTEtMA_8f96db11-dac6-4de4-a4d3-a27a00c68861"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEtNS0xLTEtMA_f3081ffc-591e-4e25-bdbd-87981af40ee1"
      unitRef="number">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzItMS0xLTEtMA_e8e3173e-d0d6-4467-9779-558ed683c1a0"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzItMy0xLTEtMA_6fc85578-72a1-4e08-b3ba-c7a1a124d0e2"
      unitRef="number">0.048</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzItNS0xLTEtMA_667dce16-9c47-4a9d-ae23-0b1a22840ca5"
      unitRef="number">-0.045</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzQtMS0xLTEtMA_0214b257-ae89-44bb-84e6-503f3ef47ef5"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzQtMy0xLTEtMA_30ab28e2-a719-4e0d-8c1e-3bfc689cb23a"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzQtNS0xLTEtMA_a0686328-3268-4bce-8724-a42aeb600a1d"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzUtMS0xLTEtMA_867214df-4fd1-4809-bd8b-cadd1e51ba99"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzUtMy0xLTEtMA_470f97a3-e4c9-4715-adc4-1a72cb9f15af"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzUtNS0xLTEtMA_1d53599b-8691-4be9-9803-cc849a94588c"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzYtMS0xLTEtMA_5c589b37-9d6c-4c03-81ff-3d93a55483f4"
      unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzYtMy0xLTEtMA_be1844a0-7f89-4483-8df5-2e7e1d6bffc7"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzYtNS0xLTEtMA_49e92896-0341-48da-9d1f-0483f4ec4b9f"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzctMS0xLTEtMA_160011ae-5f0c-4934-b24d-3671902049a1"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzctMy0xLTEtMA_56eddb58-ce1f-404e-8ca4-a4a97a1b7973"
      unitRef="number">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzctNS0xLTEtMA_d7d343e6-93b8-40d3-a60f-ec9a10d623b5"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzgtMS0xLTEtMA_befb4756-aaa4-4175-beb7-1c33b5748b18"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzgtMy0xLTEtMA_bff2ce7f-c5ad-47a7-8fe3-100f259eb3c6"
      unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzgtNS0xLTEtMA_c41a0355-d1aa-4d5f-976b-1feafffb5784"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzktMS0xLTEtMA_f9b4b306-bdc0-4fd3-95fb-47267d95b5ac"
      unitRef="number">-0.035</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzktMy0xLTEtMA_da72f2fb-e8b9-429d-b697-d74e1095e77f"
      unitRef="number">-0.060</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzktNS0xLTEtMA_21c81a0c-0e3e-4a6d-a0b6-4ca417ea81b5"
      unitRef="number">0.141</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEwLTEtMS0xLTA_91295d93-32c5-4f91-ae44-5fd7f3b2a57d"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEwLTMtMS0xLTA_c2ece6b2-b634-4d0c-89c1-989fbc1aedb2"
      unitRef="number">-0.029</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEwLTUtMS0xLTA_1bc740bb-ca49-4a44-bf63-4127b53b6a86"
      unitRef="number">0.159</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzExLTEtMS0xLTA_a75e2513-6dfd-4b6e-8b62-2a8e555191bf"
      unitRef="number">-0.002</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzExLTMtMS0xLTA_1982b5cb-a9c4-4344-934f-bc43727a61d4"
      unitRef="number">-0.013</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage>
    <wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzExLTUtMS0xLTA_cd38eea7-52e9-4df6-9f59-feffc2867492"
      unitRef="number">0.044</wst:EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEyLTEtMS0xLTA_c9336990-b4d9-4489-b40e-b95583611acd"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEyLTMtMS0xLTA_16642bb2-cf5a-440f-ad06-74fcd3b697fe"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEyLTUtMS0xLTA_9f85f9bb-9018-4b42-abab-c4a7462da143"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEzLTEtMS0xLTA_cad54187-0767-4415-a19a-ddc78f2b6440"
      unitRef="number">0</wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction>
    <wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEzLTMtMS0xLTA_71c1941a-311f-4173-8187-1bd0cf445cb0"
      unitRef="number">0</wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction>
    <wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzEzLTUtMS0xLTA_beda39e2-3779-4224-aec2-3294613f9ca9"
      unitRef="number">-0.006</wst:EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE2LTEtMS0xLTA_c07071ac-dcd1-4d5a-998e-e340efe8b208"
      unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE2LTMtMS0xLTA_2838d9a0-4424-4c0d-8d2d-1d3875c825ea"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE2LTUtMS0xLTA_980f827e-4036-4af8-a625-afbc2f88ffd0"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE3LTEtMS0xLTA_9f439049-3c51-4489-aaf7-e0da1e6aaa7c"
      unitRef="number">0.202</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE3LTMtMS0xLTA_5bffa510-5f56-42ed-a305-e1ce36b1f8aa"
      unitRef="number">0.172</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90YWJsZTozMGRjYWZjMjc4ZGU0MmMyYTI0MmJlMDIyMjJiYTk2My90YWJsZXJhbmdlOjMwZGNhZmMyNzhkZTQyYzJhMjQyYmUwMjIyMmJhOTYzXzE3LTUtMS0xLTA_902dd60b-d727-486e-a9d1-207d3a71fe3c"
      unitRef="number">0.364</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzM4NDgyOTA3MDYxMjI_7506801f-9297-49b6-a775-acadfef3d6dc"
      unitRef="usd">-300000</us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia0a47ab88878443fa4e6adac51e1e3c3_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzM4NDgyOTA3MDYxMzY_b6ee0136-e782-4f97-b4d9-b5c6ee7f76e2"
      unitRef="usd">-10300000</us-gaap:IncomeTaxExpenseBenefit>
    <wst:TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzE2ODQ_039f9441-49c1-4f60-9ee5-bdd3ea14fce2"
      unitRef="usd">-2500000</wst:TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iafeae8bf38a74e0390f625e332ddc2d6_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzE3NzE_d7a89978-cd2e-4391-86f8-ea6ef87a8c8b"
      unitRef="usd">-14300000</us-gaap:IncomeTaxExpenseBenefit>
    <wst:TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzE5Mzc_224285a2-57b5-4df1-b359-cdd533ffc380"
      unitRef="usd">48800000</wst:TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i77e352a3c93e42ae8d803009dcc77900_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzIxMjM_688723bc-1d69-43e0-bde6-3561bb7b746b"
      unitRef="usd">-33100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzI0NjU_22f4b76d-8846-44f6-aa7b-3931ec64b16f"
      unitRef="number">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzI0NzE_b7058c57-26d7-46f2-81a5-d025e44dafe7"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzMwMTk_f8d79002-2ffc-4f4c-9030-e5ba8410e01e"
      unitRef="usd">27900000</us-gaap:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense>
    <wst:TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzMxNjQ_e8db94c9-fa2e-4fdf-9ebc-bf24989436ff"
      unitRef="usd">11400000</wst:TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQwODM_7130ef9d-4ce5-4d77-b837-60bc45f7e4f0"
      unitRef="usd">7500000</us-gaap:TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax>
    <us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQxODI_7d48250c-327b-4a36-a034-a3ad5a624eba"
      unitRef="usd">4000000.0</us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit>
    <us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQyODA_7ef53a2a-dd6d-45c3-a7a5-b9e0b713233c"
      unitRef="usd">20400000</us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQyODg_da1f7a49-1a6f-4781-832f-61023724c23f"
      unitRef="usd">27900000</us-gaap:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzQzNTM_71e3e489-ca43-47f4-a495-3f91bb1a892b"
      unitRef="number">-0.0145</us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i29b000bedbc74b059850aa72d8e23d8a_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUxNTc_a6b31016-bf5a-4a79-803d-2d5996ac7ff4"
      unitRef="usd">226900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUxOTI_531a0400-b8fa-4c67-95fe-af9779ce0c19"
      unitRef="usd">15500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i57428a739d8c47e29c71f898beabc22b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUyNDI_13acd4ec-ea0e-4e35-ab5e-283c6d8d361a"
      unitRef="usd">49400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzUyNzc_58cd31b4-fda9-4979-8efb-25b8d17a14fc"
      unitRef="usd">6400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i0d6aec77c75b4f37a744be6b762f91c7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU0OTk_e0da2ba5-4956-4252-ad04-1e428dbddc67"
      unitRef="usd">15400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i49459769fb524550871915ef2336f3bb_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU1MTI_9d44910e-94cd-4fa1-b007-6a24a99f1581"
      unitRef="usd">211500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i57428a739d8c47e29c71f898beabc22b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU1OTA_56a1c588-b803-4909-839b-352fa67ee20b"
      unitRef="usd">48700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i57428a739d8c47e29c71f898beabc22b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU2MDY_13acd4ec-ea0e-4e35-ab5e-283c6d8d361a"
      unitRef="usd">49400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i315770c7cae047a4a1c795627dca7961_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzU5NzU_b71fef6f-f2f0-4d4c-bdb8-1b60e671b4f4"
      unitRef="usd">2000000.0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i2d27b8c83d9e4aed8e3bf7c54c872328_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzYwMzk_d0a4a769-bdfd-4271-b490-8ba23e7c4d48"
      unitRef="usd">500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i6c33648dc8604a2e97bec4df1cd23f1f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzYwNTY_0d710319-22d6-46f1-afd5-862bb6770ebd"
      unitRef="usd">500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ia6eefab0034b46c0afd45df41bf8245f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzYwNzc_6299e8b5-400d-4704-b928-5885c9dc8cd0"
      unitRef="usd">1000000.0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNDgvZnJhZzpjZmM0ZDY1NGNmZTM0YjAwYTgzMGQxNzU4NDY1OWIxMC90ZXh0cmVnaW9uOmNmYzRkNjU0Y2ZlMzRiMDBhODMwZDE3NTg0NjU5YjEwXzcwMTY_518a1ddc-acdc-45d8-a1a5-285dd6ebee38"
      unitRef="usd">214200000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEyNDA_06a47781-b637-40b1-ba4c-56481b030d7a">Commitments and Contingencies&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, we were obligated under various operating lease agreements. Please refer to Note 6, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements.  Please refer to Note 15, &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Benefit Plans&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At December&#160;31, 2019, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $249.1 million, of which $61.3 million is due to be paid in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have letters of credit totaling $2.5 million supporting the reimbursement of workers&#x2019; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.2 million at December&#160;31, 2019, of which $0.9 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our SmartDose contingent consideration is payable to the selling shareholders based upon a percentage of product sales over the life of the underlying product patent, with no cap on total payments. Given the length of the earnout period and the uncertainty in forecasted product sales, we do not believe it is meaningful to estimate the upper end of the range over the entire period. However, our estimated probable range which could become payable over the next &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzExOTk_3f334523-3b30-4be6-b24a-5b3930387693"&gt;five&lt;/span&gt; years is between zero and $3.7 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEwOTk1MTE2Mjk2Njk_4cd95390-b6b2-43f5-b216-ab9ca78e45b0"
      unitRef="usd">249100000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEwOTk1MTE2Mjk2NzM_b6e086b0-fa5e-4731-a6a7-4d3c33023a71"
      unitRef="usd">61300000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <us-gaap:LineOfCredit
      contextRef="i04ab47ee62a5494f909f92a95cc7c70c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzQ2Ng_917ace18-9c09-4ddc-9c47-ed86cd39166f"
      unitRef="usd">2500000</us-gaap:LineOfCredit>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia4a3ac6bafdc43978ec3c7db0603a567_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzYyNA_b5ee57e9-c1a1-41f9-bda8-c35dc6fae796"
      unitRef="usd">3200000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyReceivable
      contextRef="ia4a3ac6bafdc43978ec3c7db0603a567_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzY0Mw_4feaafd6-1482-438a-b686-2ba58e39dda5"
      unitRef="usd">900000</us-gaap:LossContingencyReceivable>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEyMTk_0978cd46-8eb1-455f-88d3-7495c11c7bd5"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzEyMjY_d9a83a61-f000-47d9-b6e9-2640de1008da"
      unitRef="usd">3700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzE5ODk_a6c5a025-9f80-4fbf-8dbf-05d62fbbe1e1">Segment Information&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services and integrated solutions, primarily to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,236.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;362.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intersegment sales elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,599.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The intersegment sales elimination, which is required for the presentation of consolidated net sales, represents the elimination of components sold between our segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We do not have any customers accounting for greater than 10% of consolidated net sales.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents net sales and property, plant and equipment, net, by the country in which the legal subsidiary is domiciled and assets are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:23.801%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.704%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property, Plant and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;814.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;766.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;734.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;337.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;315.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;235.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;95.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;99.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;108.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;165.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other European countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;201.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;201.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;194.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;134.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,599.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;839.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;822.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;855.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables provide summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.908%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate/ Elimination/ Unallocated Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;296.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other nonoperating expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,480.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;386.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;474.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,341.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other nonoperating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,342.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;301.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;335.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,978.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,236.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;362.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,599.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(66.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;225.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other nonoperating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(69.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,321.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;286.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzc5_cababdff-312c-4c8c-a61c-8a040585158b"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzIwMDI_7acf8b5c-b61d-4f27-a804-1da53de11e19">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents information about our reportable segments, reconciled to consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.685%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.907%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,236.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;362.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intersegment sales elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,599.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzItMS0xLTEtMA_a3f2aa48-606f-403d-91ea-74053d0a459d"
      unitRef="usd">1398600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzItMy0xLTEtMA_690e7f34-bf32-4e6d-90ab-2fe3acf7202b"
      unitRef="usd">1308600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzItNS0xLTEtMA_c1f35164-1828-4a6d-a68c-1e3557a1f5cc"
      unitRef="usd">1236900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzMtMS0xLTEtMA_383c33b8-22ae-4274-98d6-d4f4dad3e3b0"
      unitRef="usd">441500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzMtMy0xLTEtMA_27bb0d19-bba9-44fc-b67a-1672a97a3fac"
      unitRef="usd">409100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzMtNS0xLTEtMA_3873e713-3e28-431b-99f5-0220924e6732"
      unitRef="usd">362500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i078c4378a1b84554a97a59aedf1dfea7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzQtMS0xLTEtMA_f6d3fd67-3d15-4e8d-a7c2-847842f0f3ad"
      unitRef="usd">-200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec0e5799d11f4ece904985f859626f83_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzQtMy0xLTEtMA_060e837e-0677-4ec6-b000-2f47e6aded56"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib2ea62dcc46049b7b44a7e372ea6a995_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzQtNS0xLTEtMA_420762c3-beb9-4ef3-88b7-c405fc4321f6"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzUtMS0xLTEtMA_5fea618a-6fe7-4871-92b2-2495c84d0ccf"
      unitRef="usd">1839900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzUtMy0xLTEtMA_1254adb2-46bd-4052-9682-88f4c80f8228"
      unitRef="usd">1717400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1Y2RhMmE0MWQ5Njg0ZDYxOWJlNTQxZTc1YzFjZGQxMy90YWJsZXJhbmdlOjVjZGEyYTQxZDk2ODRkNjE5YmU1NDFlNzVjMWNkZDEzXzUtNS0xLTEtMA_fcabb45d-ea77-42a9-8312-6652a38e2017"
      unitRef="usd">1599100000</us-gaap:Revenues>
    <us-gaap:SegmentReportingDisclosureOfMajorCustomers
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzE3MTE_c55c4211-1f9d-45e8-bbf2-709facda50d0">10</us-gaap:SegmentReportingDisclosureOfMajorCustomers>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzE5OTk_8d8cabee-e6cb-4d41-b609-8668a032392a">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table presents net sales and property, plant and equipment, net, by the country in which the legal subsidiary is domiciled and assets are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:23.801%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.698%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.704%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property, Plant and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;814.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;766.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;734.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;337.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;315.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;235.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;95.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;99.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;108.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;165.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;142.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other European countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;201.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;201.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;194.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;134.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,599.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;839.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;822.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;855.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="ic7f8ebed49c04cffb17e7209463597e7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItMS0xLTEtMA_f936fca0-36b9-43de-95a0-eaebc467f97f"
      unitRef="usd">814700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e4f0863e8134660bc06abb0a0554e60_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItMy0xLTEtMA_2894458f-4ba8-46b7-a2a8-fede9d52d23d"
      unitRef="usd">766100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i11483b8c07b24a0285c429890af29b9b_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItNS0xLTEtMA_40ae6ceb-5e46-4659-9656-c8d2ff4d9bff"
      unitRef="usd">734600000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id465de2bff9a44b58c23173587870451_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItNy0xLTEtMA_3f0e5cfc-b7a6-4439-9c6d-c701bc587d05"
      unitRef="usd">337100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie7d5c2cd9d804dc19f76970e86ae5660_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItOS0xLTEtMA_a20ae904-1d9e-41db-8a02-ab09af69110b"
      unitRef="usd">315300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i30dc74ba8e0b46938ade75bfad703ec4_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzItMTEtMS0xLTA_d3d4f5ab-4421-4db4-a55d-ab9713b677e2"
      unitRef="usd">323800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i9f4a7e1e4f344e59acb8e316afa24ca7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtMS0xLTEtMA_b4b5236b-aed1-4e5e-991d-bed6786e8002"
      unitRef="usd">236300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02b772a610de4ee59ff680dfeb546f55_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtMy0xLTEtMA_9cd667c8-9ae3-40a0-b98f-de07ba703442"
      unitRef="usd">235900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdf9bc802dfc4329a0be62772f1a8f6b_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtNS0xLTEtMA_85ec246f-d7ed-41b3-ba3c-8432f1a41cb4"
      unitRef="usd">226400000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2f86ebc34b44436088bdd5978d8e3e07_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtNy0xLTEtMA_8ab12592-b394-4e0e-a9e1-fb41835359dd"
      unitRef="usd">95400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2fc499a8a70a4e75bdc070421802e388_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtOS0xLTEtMA_8730ff25-50c0-43a6-9acc-6425bca1b32b"
      unitRef="usd">99300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie056e2b910a94d86a17d8e9f6a20dc06_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzMtMTEtMS0xLTA_3c5a8d7f-1d7b-484b-b354-05f848285863"
      unitRef="usd">108800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i476449ab4421489bb9b91517a6fc7efe_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtMS0xLTEtMA_915e3a1e-f824-4d4f-91f5-73860bf8888a"
      unitRef="usd">173800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85b512abe143458ebeb74749610bb670_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtMy0xLTEtMA_bf3b1952-a856-4393-979f-4099b5b17d97"
      unitRef="usd">138100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe71ee072f1e4070b5fe8ef25b5b4c68_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtNS0xLTEtMA_d8cc9888-bd83-43fc-aff9-98246544829a"
      unitRef="usd">100500000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ief76596d19a14b5699a2fde2cb8e562b_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtNy0xLTEtMA_e75262ea-ab5b-4b9b-b108-d0575ad93bf1"
      unitRef="usd">162000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7ef689740fa64b5883e5e5174f62fe1d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtOS0xLTEtMA_26598d62-c8bf-4b3f-9b39-b190d5cc4d69"
      unitRef="usd">165400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i048c1c583b8248d7a9ab445c65149f1e_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzQtMTEtMS0xLTA_c349ab71-977e-4109-83ad-dce46601207d"
      unitRef="usd">173200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i903f49cdebbd412fb6eb73679c880d2e_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMS0xLTEtODg2NA_0855c538-2e25-4ed5-bfa5-ac4e0a4254b0"
      unitRef="usd">150600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i29c04b723e3b410593ed485b6a229bfc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMy0xLTEtODg2NA_bdd5ea6e-5764-43a8-8eaa-c7b9a61fe466"
      unitRef="usd">145000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i917cb1338bde49fd8e568f601fd1e22a_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNS0xLTEtODg2NA_1825e40e-ef11-40ea-9848-37909e0b9602"
      unitRef="usd">142600000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib6dd3862267a4178a471745a2b35ad9e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNy0xLTEtODg2OA_fcb0d708-9985-42be-b771-dc3e84b6af72"
      unitRef="usd">53300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id92da6f6ed734f7aa39fcd3fd2e821c3_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtOS0xLTEtODg2OA_d945740a-b4bd-4b9f-9b06-c87400a5ce03"
      unitRef="usd">50100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id9a7d300fbe84c79a997b01a28de9fb5_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMTEtMS0xLTg4Njg_e5812013-7ba2-4c0b-8320-fc9b8df144e4"
      unitRef="usd">51600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="ibbc09f1765984af1a548e59801303ef6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMS0xLTEtMA_cbc4aa36-8c36-4158-8303-1fe0311530e6"
      unitRef="usd">251100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53739c8ad7af43158f8713882ca97f50_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMy0xLTEtMA_bc72a35c-2b25-4e55-885c-4412117174d7"
      unitRef="usd">230500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe7421492df04bb4bddbdcbf7176b677_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNS0xLTEtMA_3096abcf-9c07-4134-8e73-fe74a585fe18"
      unitRef="usd">201000000.0</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib228924631aa44288381badfd1e2059e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtNy0xLTEtMA_f296c8f6-840d-4ae1-b9db-8d3c79cb2ee6"
      unitRef="usd">59100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i29700e0161cf4255a1c0d184517c3f32_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtOS0xLTEtMA_62eabea1-5b13-4e15-a249-85b187eaf1c6"
      unitRef="usd">59500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i319915b8ecd44b91bcc26caf2f45657e_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzUtMTEtMS0xLTA_32c7b716-9e20-434a-892a-b495250ebc19"
      unitRef="usd">63200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="ic9b2e0330857436684b723ea8478ec77_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtMS0xLTEtMA_b42b7f3b-0edb-4c91-a9e9-8c180325807a"
      unitRef="usd">213400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibcb96f50eb494612ba0edad271cb1096_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtMy0xLTEtMA_82072016-13de-4a21-a3c6-ebd77d7a7ba2"
      unitRef="usd">201800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iafe47744d2e84db7a253c53f75362e62_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtNS0xLTEtMA_cf88004a-7a75-4e81-9617-a33a3eef0d8d"
      unitRef="usd">194000000.0</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i8b9f65fe26504bfe928b879458ca9505_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtNy0xLTEtMA_2f9cd854-7016-421e-bae8-942a27a74db9"
      unitRef="usd">132400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if148c501c02e4e2c97646022381c7196_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtOS0xLTEtMA_b61f65a0-5a18-4cdf-b837-afde2c7efbf7"
      unitRef="usd">132400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib47295db1ad64e7c8b1a5e5f348d4c2b_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzYtMTEtMS0xLTA_a374f4be-0180-456d-8e0c-ad0bab65ca0d"
      unitRef="usd">134400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctMS0xLTEtMA_b1e82a54-c9c6-4c9a-87ef-3806f55dcbd3"
      unitRef="usd">1839900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctMy0xLTEtMA_9eb513ad-17be-43cb-bc22-68b56120ae77"
      unitRef="usd">1717400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctNS0xLTEtMA_f8dc49f8-0635-4b50-84c5-7d012664a9bc"
      unitRef="usd">1599100000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctNy0xLTEtMA_c51d3d9b-5a93-4136-8a84-e4508e533f97"
      unitRef="usd">839300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctOS0xLTEtMA_0e08f0d3-e48f-48c0-9d86-f80e86512d64"
      unitRef="usd">822000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZTo1NDM5MDM1NzZhODQ0YWY1ODgwN2M1YzRmYzE2NTFhNy90YWJsZXJhbmdlOjU0MzkwMzU3NmE4NDRhZjU4ODA3YzVjNGZjMTY1MWE3XzctMTEtMS0xLTA_9a1f6b66-961a-474f-ab02-6230e9010975"
      unitRef="usd">855000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90ZXh0cmVnaW9uOmYwNjliYzFlMDhlZTRlNGRhMGVkMTY3MDExNWYzNWVlXzIwMDk_cb4e0dbd-7e47-427b-bb15-67908ae6d081">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following tables provide summarized financial information for our segments:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.980%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.903%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.908%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Proprietary Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contract-Manufactured Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate/ Elimination/ Unallocated Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,398.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,839.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;296.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other nonoperating expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;291.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,480.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;386.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;474.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,341.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,308.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,717.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other nonoperating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;240.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,342.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;301.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;335.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,978.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,236.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;362.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,599.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating profit&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(66.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;225.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other nonoperating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(69.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,321.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;286.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItMS0xLTEtMA_5e9481da-bd1b-44a1-9a6b-0968a9ba9cdf"
      unitRef="usd">1398600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItMy0xLTEtMA_f3517c6b-ae69-43a5-9954-4071d799188a"
      unitRef="usd">441500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItNS0xLTEtMA_a0cc80fd-9824-4755-806a-c2eda2896768"
      unitRef="usd">-200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzItNy0xLTEtMA_08b41de4-6f19-42f8-a009-b5ea64a95d06"
      unitRef="usd">1839900000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtMS0xLTEtMA_544fc080-d606-416e-83b6-51dae2dd57d9"
      unitRef="usd">313600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtMy0xLTEtMA_893f9676-6f68-414c-9add-7e27b7a7f3c5"
      unitRef="usd">49100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtNS0xLTEtMA_a1505e39-d7ac-448d-84db-be0ed89f6e78"
      unitRef="usd">-66100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMtNy0xLTEtMA_d31db43d-1258-4ef1-8d68-cfcd73632bdb"
      unitRef="usd">296600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtMS0xLTEtMA_967958ba-f8f7-43d5-972f-97f9803e64f4"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtMy0xLTEtMA_7ad7cd51-986b-4282-9db7-5b31ecb8d07e"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtNS0xLTEtMA_2a4f3111-ca8b-46cb-807f-0d7a3bf5d242"
      unitRef="usd">8500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzQtNy0xLTEtMA_f4d8c29b-0273-4c77-9d6c-fe00766bb95c"
      unitRef="usd">8500000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtMS0xLTEtMA_20475c29-44c0-4572-8b74-fa6de4559e86"
      unitRef="usd">0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtMy0xLTEtMA_c432e4b6-356c-47bf-8cc1-861db0624ce1"
      unitRef="usd">0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtNS0xLTEtMA_91fb0643-ed0c-48c0-8058-da2860e14b91"
      unitRef="usd">3800000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzUtNy0xLTEtMA_98ab21a2-4993-41ca-99db-2ddfdf3bbf3d"
      unitRef="usd">3800000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtMS0xLTEtMA_8841c043-0d77-4c98-a1ff-c6555b31995f"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtMy0xLTEtMA_f89c268a-2128-4cbe-8364-263b57390ef5"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtNS0xLTEtMA_fae760a1-238d-4c17-9587-986b8394e5fd"
      unitRef="usd">-100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzYtNy0xLTEtMA_46f88898-6073-4469-b7e7-dfb754fd3c2e"
      unitRef="usd">-100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctMS0xLTEtMA_02aac925-decb-4831-bc84-9d357f6a30af"
      unitRef="usd">313600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctMy0xLTEtMA_bdb163a5-7478-41ec-ba2d-c771167352ea"
      unitRef="usd">49100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctNS0xLTEtMA_5cde523c-4bda-4b89-9885-fd477a0657c0"
      unitRef="usd">-70900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzctNy0xLTEtMA_893d97b3-e46c-4707-92ca-b9a63be43464"
      unitRef="usd">291800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:Assets
      contextRef="if22f0c39a4254fd9831626f40147da4c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtMS0xLTEtMA_7b2bd9bd-66ae-410a-a2dd-dd1bbba2d3e9"
      unitRef="usd">1480600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic2831b7068f5415993b76a543c279df1_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtMy0xLTEtMA_2a34ba0f-9a86-445a-b736-12945c98cf7b"
      unitRef="usd">386000000.0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9a1c2431d80b42aead2763d611b9d0e5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtNS0xLTEtMA_0cc32862-499b-48a2-8b50-beee87ad936e"
      unitRef="usd">474800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzgtNy0xLTEtMA_ffeb3309-5f66-4136-b34f-7d332339c59d"
      unitRef="usd">2341400000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktMS0xLTEtMA_b533c28a-b7fb-4474-9bba-c21650c2edf9"
      unitRef="usd">91200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktMy0xLTEtMA_3fd40fa8-be9b-4e1e-98cb-73166e17336d"
      unitRef="usd">37200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktNS0xLTEtMA_027f924b-0350-4627-ae69-7908ae7349d2"
      unitRef="usd">-2000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzktNy0xLTEtMA_c52ba3cf-d4c1-46ec-8ee6-871774e38191"
      unitRef="usd">126400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaeb2de31d87743ea831b83646bc24e6b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTEtMS0xLTA_a1e36da5-10a2-4c01-afe6-51f6f2d32ba2"
      unitRef="usd">82200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7d56ca93af3b4ee886361b2565b9b7dd_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTMtMS0xLTA_509dc088-0d66-4016-83c5-9f7b133e8c4c"
      unitRef="usd">17900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6b1e787c56f94c5090c5dbd9e7dfd997_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTUtMS0xLTA_d400bd9e-2255-4a1c-b85f-66de6bbc8e8b"
      unitRef="usd">3300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEwLTctMS0xLTA_aad1f39c-a7cf-4130-9cfb-9b832c6ca09b"
      unitRef="usd">103400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:Revenues
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTEtMS0xLTA_406c71bd-e7fc-4272-9196-9098fda90081"
      unitRef="usd">1308600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTMtMS0xLTA_ce54aadc-dd9c-46b8-af2d-236531bcbbba"
      unitRef="usd">409100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTUtMS0xLTA_7632dcce-3f6d-496d-81c8-56c0692e88ca"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzEzLTctMS0xLTA_a4bc5cb0-7527-42b8-a09f-6c77bf7f80f0"
      unitRef="usd">1717400000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTEtMS0xLTA_c2065ec6-98e7-4ff9-a8b1-a68750ce8b5d"
      unitRef="usd">266400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTMtMS0xLTA_d65d564b-96e4-42db-8a40-3a6ae7590d20"
      unitRef="usd">44300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTUtMS0xLTA_907cc4ed-c94e-4792-80e2-e8b5844461a0"
      unitRef="usd">-70400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE0LTctMS0xLTA_9c39957b-2380-4a26-8714-6cb962f41f06"
      unitRef="usd">240300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTEtMS0xLTA_a893545b-1d0c-4990-bf0e-dbee7637c704"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTMtMS0xLTA_e9cc6e85-cb77-47df-bb2e-4a13cd9565cd"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTUtMS0xLTA_b4a3e25e-15b3-46d2-965a-8dffd1f3f266"
      unitRef="usd">8400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE1LTctMS0xLTA_3c8d844b-bd9e-4cf6-908a-5c0a86a5cb08"
      unitRef="usd">8400000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTEtMS0xLTA_685a8610-eb2a-43cc-8eba-4a2a842f4126"
      unitRef="usd">0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTMtMS0xLTA_3b850ced-ed54-4c32-a414-7668beb14e8f"
      unitRef="usd">0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTUtMS0xLTA_ba4894ed-4688-4201-ac3e-36e9a8a94b04"
      unitRef="usd">2100000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE2LTctMS0xLTA_bb312602-3595-46ba-a24a-9d4458b5752a"
      unitRef="usd">2100000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTEtMS0xLTA_a8b3b7cc-b0fb-410f-af5e-6beefbc03149"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTMtMS0xLTA_c3351bc0-3c4c-4406-a984-20086da3404d"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTUtMS0xLTA_a1e9cbfb-afa5-427e-b489-f7025e1ca7ec"
      unitRef="usd">6700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE3LTctMS0xLTA_f9cab5c3-ec73-44aa-9594-676c3bd32599"
      unitRef="usd">6700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTEtMS0xLTA_74a5fcb3-7490-4287-8a30-e109507dd9f7"
      unitRef="usd">266400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTMtMS0xLTA_73ecf48b-5bf5-4975-beb7-7e0ab245a09a"
      unitRef="usd">44300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTUtMS0xLTA_e0d6f351-a7b5-4f7d-9fcd-2707e485c24d"
      unitRef="usd">-70000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE4LTctMS0xLTA_3946b44d-01ed-463c-9ddf-d6f69912504f"
      unitRef="usd">240700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:Assets
      contextRef="ic2afcfd5d059438e8bc7bc4552794714_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTEtMS0xLTA_7e7fd325-2932-40c4-9b28-82bba6248599"
      unitRef="usd">1342300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i529afefe3a5146a8ae99168ace63b1f5_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTMtMS0xLTA_dcfe813f-8b1f-47e6-8963-e79d51ba4220"
      unitRef="usd">301400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i509b63e47a3144be9248957ca04eda93_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTUtMS0xLTA_bb084e6f-d845-46c1-9bba-9f041da1f059"
      unitRef="usd">335200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzE5LTctMS0xLTA_ebf13f64-3574-42bd-8446-60a5623a35cd"
      unitRef="usd">1978900000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTEtMS0xLTA_d30b3e4c-3028-4a9f-ba6a-6a242a5bd517"
      unitRef="usd">77000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTMtMS0xLTA_06445584-2146-440a-8b88-dbc65aab04b1"
      unitRef="usd">20700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTUtMS0xLTA_c745c858-44bd-4d07-97cf-5d9e009c6375"
      unitRef="usd">7000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIwLTctMS0xLTA_44b5263a-18f4-4237-aa09-ca45a99c6485"
      unitRef="usd">104700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5dffeb44c0414317940f4a8818786e90_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTEtMS0xLTA_87dad0eb-fce1-4087-9339-4adf8c9cf88e"
      unitRef="usd">83900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibdaea28ddad549819a14a90f2ca68ef4_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTMtMS0xLTA_fb6a1f31-83f3-438d-9d07-3205a65b2cc9"
      unitRef="usd">17200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2662243b3ebf4c23898d53cb10740fdc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTUtMS0xLTA_6997ac95-ddb0-4ff8-8a1d-a40c420673ea"
      unitRef="usd">3300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzIxLTctMS0xLTA_a5405084-ed51-4733-85cc-37c4465420c2"
      unitRef="usd">104400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:Revenues
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTEtMS0xLTA_4138456f-edca-45d6-bcc3-06f262aaba26"
      unitRef="usd">1236900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTMtMS0xLTA_36eafd30-076c-4d77-9746-5ee98a80525e"
      unitRef="usd">362500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTUtMS0xLTA_98923c6a-dfd3-45b5-ba83-09c2c48cc8c4"
      unitRef="usd">-300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI0LTctMS0xLTA_0661c876-f61f-4c5b-a553-c8a17113c841"
      unitRef="usd">1599100000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTEtMS0xLTA_6cce2df5-19c7-4ced-a2b7-79b0992d6590"
      unitRef="usd">243800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTMtMS0xLTA_488b109d-9d1d-417d-9daf-03f099ccc954"
      unitRef="usd">48300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTUtMS0xLTA_4f0e9b53-96c4-43e4-a485-069dd4661a33"
      unitRef="usd">-66300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI1LTctMS0xLTA_78e8cbe0-8231-4920-804e-ae8009a79a0b"
      unitRef="usd">225800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTEtMS0xLTA_268d8939-b23e-402c-a158-9d8b50eb9dbb"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTMtMS0xLTA_d19030d7-be2b-4508-b5db-0aae845062b9"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTUtMS0xLTA_8d345aac-2768-4d79-af56-6244b04c7d3e"
      unitRef="usd">7800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI2LTctMS0xLTA_72936c96-265e-4f97-8cd4-ccbc65ff9834"
      unitRef="usd">7800000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTEtMS0xLTA_80b73294-4dc7-41dc-aa8a-4136660ce872"
      unitRef="usd">0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTMtMS0xLTA_d20f1aba-d582-48ce-8b7c-53d2169280d5"
      unitRef="usd">0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTUtMS0xLTA_906a2120-51cd-425e-807b-7b1dfe5eeebf"
      unitRef="usd">1300000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI3LTctMS0xLTA_99201847-be02-407f-8403-7622c13ee4e4"
      unitRef="usd">1300000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTEtMS0xLTA_6f604e1d-1cca-48c1-9df6-314ecff3f4ec"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTMtMS0xLTA_1a6a5ffe-ef9e-4c0e-875d-14b15db191f7"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTUtMS0xLTA_0e7a683a-8132-4df2-aecb-dec88e1e030b"
      unitRef="usd">3100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI4LTctMS0xLTA_462f287b-c280-4865-bf59-a31dce079f0e"
      unitRef="usd">3100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTEtMS0xLTA_80519bdb-5fa5-4793-98bb-1bead5dba429"
      unitRef="usd">243800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTMtMS0xLTA_26bf1261-1741-4a11-a81f-9f05c61215a3"
      unitRef="usd">48300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTUtMS0xLTA_fe98bb7a-5a03-4432-bc2f-0b77e9e4c41f"
      unitRef="usd">-69700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzI5LTctMS0xLTA_d676c6fa-3428-40d8-abdd-6045d9007a40"
      unitRef="usd">222400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:Assets
      contextRef="i10b2bd972c5247c89ad526ba8664ceea_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTEtMS0xLTA_6fa36d7a-1443-4b41-b54e-c2342e6f6cd1"
      unitRef="usd">1321300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9b16d7361925410886eeb15e971ce722_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTMtMS0xLTA_5378e85b-7f50-4375-abec-31ba56a8c2e5"
      unitRef="usd">286400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1350bd4286de44cfbac587447b6169de_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTUtMS0xLTA_1219de57-7774-4453-9bd7-0c4cde9e40ce"
      unitRef="usd">255100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMwLTctMS0xLTA_49fa7636-5e06-4745-8435-4eac938148f9"
      unitRef="usd">1862800000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTEtMS0xLTA_5f87344a-41de-43b4-aecb-a76dbcc13b32"
      unitRef="usd">107200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTMtMS0xLTA_e1b4b294-3422-4994-be80-654dedc173cc"
      unitRef="usd">18600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTUtMS0xLTA_aaabb261-2f28-4942-9124-6987d4b71d2c"
      unitRef="usd">5000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMxLTctMS0xLTA_0ee52c76-ddfe-441e-8f4b-dc47d3c30598"
      unitRef="usd">130800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i666fb3bb373b40c4b1ec57649cc76bc7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTEtMS0xLTA_a0ca18d5-6577-4b4f-a7c7-7b2472da9552"
      unitRef="usd">77100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i89f46ce9af78473da9570ac6171d26f5_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTMtMS0xLTA_6cf29657-688b-412c-9d41-c1dc64c9d079"
      unitRef="usd">16400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iad3960c7889746f797e090bc457710a9_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTUtMS0xLTA_7f35deeb-3ec8-4f8b-9713-4158e59b4b8c"
      unitRef="usd">3200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTQvZnJhZzpmMDY5YmMxZTA4ZWU0ZTRkYTBlZDE2NzAxMTVmMzVlZS90YWJsZToxZmZjYTA0MWU3YTM0ZjkyYTBlMTk1NDY5MWY5NGU0My90YWJsZXJhbmdlOjFmZmNhMDQxZTdhMzRmOTJhMGUxOTU0NjkxZjk0ZTQzXzMyLTctMS0xLTA_eeab6535-0273-4f86-be87-a166125a2262"
      unitRef="usd">96700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GrossProfit
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzMtOS0xLTEtMA_cd77a5a9-2b25-4609-8123-9e032186c922"
      unitRef="usd">605700000</us-gaap:GrossProfit>
    <us-gaap:ProfitLoss
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzQtOS0xLTEtMA_7e166ac3-7b96-4a4b-b587-62af52768db6"
      unitRef="usd">241700000</us-gaap:ProfitLoss>
    <us-gaap:GrossProfit
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzExLTktMS0xLTA_d4940563-3906-4576-8d10-7af9d293469b"
      unitRef="usd">545400000</us-gaap:GrossProfit>
    <us-gaap:ProfitLoss
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzEyLTktMS0xLTA_013312ed-4d24-4caa-8a3f-8d28f8055e87"
      unitRef="usd">206900000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzE0LTktMS0xLTA_de0da35b-e97b-44e5-af30-a845e04eec55"
      unitRef="usdPerShare">2.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNjMvZnJhZzo4ZmE1NmYyZTM0YTg0YWExYTM4MzQwMTUwN2Q4YjE4NS90YWJsZTpmNDg3MTQ0OGU3Y2Q0MmIyYmM0NTcxYjdjZTFmZjJkOS90YWJsZXJhbmdlOmY0ODcxNDQ4ZTdjZDQyYjJiYzQ1NzFiN2NlMWZmMmQ5XzE1LTktMS0xLTA_f8210b56-772b-4426-bf39-e0569cee3338"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareDiluted>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzQ_fd2a536d-a943-41e0-a4df-a7f259c2c2b3">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Schedule II - Valuation and Qualifying Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:96.153%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;($ in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;beginning of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Charged&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;to costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deductions (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;end of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;For the year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;For the year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;For the year ended December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allowances deducted from assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Deferred tax asset valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total allowances deducted from assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;__________________________&lt;/span&gt;&lt;/div&gt;(1)Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i63c8f0dd6fd44e0192bbca698c80730d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMS0xLTEtMA_a21f777c-4c10-42b6-90cb-a9d6b552ba82"
      unitRef="usd">16000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id6ac79d82bd448c79b4fdc95685aab8b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMi0xLTEtMA_dd2c6814-54bb-4b53-9d70-8923f2ccbd79"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id6ac79d82bd448c79b4fdc95685aab8b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMy0xLTEtMA_38657aef-b525-480d-ae9a-9bf7c414bf14"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iafcda053ab8e47e38f791920cd9cf950_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtNC0xLTEtMA_2ea91aa9-619d-4161-8c8d-30521ccc78db"
      unitRef="usd">15900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i09e8d9cf8ecf49a8bb93848beaa81037_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMS0xLTEtMA_6c98d1c4-e4fc-4476-8a89-eb1e08973370"
      unitRef="usd">2000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iee5aa6955d81437b952a802f4ada2d98_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMi0xLTEtMA_ed4c9d1e-1c51-4d63-9800-ef91e83c5c63"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iee5aa6955d81437b952a802f4ada2d98_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMy0xLTEtMA_8bbf7b11-8cee-4068-a724-6a2935eb53d1"
      unitRef="usd">1600000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2ee0f05c56c248109cf70bf6a1dfcf1d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtNC0xLTEtMA_a8be44b8-664d-4bc6-8002-48617151b29a"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMS0xLTEtMA_0c1b4d81-9d7a-4efa-89e5-9e61bbec7274"
      unitRef="usd">18000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMi0xLTEtMA_2f2b0c0b-5a64-4fd6-bfd2-adcac0f72115"
      unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMy0xLTEtMA_80119c0b-b71e-4a84-8eb1-c0fb0bd36c76"
      unitRef="usd">1700000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i710deda8952743be8f828089af9cd00d_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtNC0xLTEtMA_4065f5d2-c9eb-446a-b4e3-8f0756511108"
      unitRef="usd">16400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iabc48380a0f84fafbbd805cba9caddec_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMS0xLTEtMA_0e3aa81a-ca9b-4f81-825d-45e3e4418402"
      unitRef="usd">20900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6b41e0d9c7ef435a9edc553f82a3fba8_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMi0xLTEtMA_be71ba87-e6e9-4010-9ad1-739522749d9e"
      unitRef="usd">-3000000.0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6b41e0d9c7ef435a9edc553f82a3fba8_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMy0xLTEtMA_d28125c4-92ec-47d3-8406-117689e3d175"
      unitRef="usd">1900000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i63c8f0dd6fd44e0192bbca698c80730d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktNC0xLTEtMA_ee58b25c-94f0-4d37-bc02-139f74106e87"
      unitRef="usd">16000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i48adb9af41f141dbba997f45f6e7b647_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTEtMS0xLTA_1ad1470a-b8d4-406d-a69e-16e36f1905a5"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i61105e0ada8748f28fbbec27f4b1f63c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTItMS0xLTA_69c2dda4-0528-45c5-964a-7061da5e8a4e"
      unitRef="usd">700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i61105e0ada8748f28fbbec27f4b1f63c_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTMtMS0xLTA_1007089b-9d27-441e-bd00-216b4604dd58"
      unitRef="usd">-800000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i09e8d9cf8ecf49a8bb93848beaa81037_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTQtMS0xLTA_4c003ab6-d9e8-4362-8237-cc65dda80034"
      unitRef="usd">2000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTEtMS0xLTA_7e94eea1-9abe-41f1-ab77-441d1802a22d"
      unitRef="usd">21400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTItMS0xLTA_f6a274cf-7b32-48e3-a784-c78f7a92c217"
      unitRef="usd">-2300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="idcbe9c3b4f3446e8a6a80833ce9453a9_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTMtMS0xLTA_b6229983-91ed-4fba-917e-f767735942c0"
      unitRef="usd">1100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ieecec5a0e59d4a618aff5d091e295a63_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTQtMS0xLTA_ab66eac3-0fc3-4deb-9110-f62db6ca5782"
      unitRef="usd">18000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib8e071d9eab748839372112a8d75b384_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTEtMS0xLTA_89295f54-ba5d-4c99-a58d-62c8346c7d79"
      unitRef="usd">18700000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ic7003c1f4ab54e5c92dc94b3582d241f_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTItMS0xLTA_868c1a3b-83e8-42ce-b0bf-35f2a3b11eb1"
      unitRef="usd">2500000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic7003c1f4ab54e5c92dc94b3582d241f_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTMtMS0xLTA_c8b5599a-24dd-434b-9e3b-f259fbca00b5"
      unitRef="usd">300000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iabc48380a0f84fafbbd805cba9caddec_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTQtMS0xLTA_92e1f9ea-c465-4278-a046-bcdc34603581"
      unitRef="usd">20900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id0bb2326a07b4350912a6c72afbe1a89_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTEtMS0xLTA_b8911633-67b4-4a98-9d5a-0c74fecf7da9"
      unitRef="usd">400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i935b128fab324f209cb4528dec5e49f2_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTItMS0xLTA_06e88b3b-375b-4043-a0f2-5f6327bbc4ac"
      unitRef="usd">-200000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i935b128fab324f209cb4528dec5e49f2_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTMtMS0xLTA_08aeb46f-574a-49bf-9d28-ed099cac5446"
      unitRef="usd">-300000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i48adb9af41f141dbba997f45f6e7b647_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTQtMS0xLTA_259d45e7-a57c-49ef-98a1-ff6fa0229ee9"
      unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i68b43b173ce141aebdc6cada18dd16ec_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTEtMS0xLTA_241f4f76-d056-4751-a0f7-ab89e23214a1"
      unitRef="usd">19100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTItMS0xLTA_f2c12642-977f-4596-9caa-bbc83097bf17"
      unitRef="usd">2300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i1b37c99fe7694438b1f415baaa059bb7_D20170101-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTMtMS0xLTA_40b54a96-0396-4421-b1ce-2b3cd96225a7"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i63ad3b3b7bf848afa7195c490bcbc124_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTQtMS0xLTA_10b0297b-b2d7-4dd8-9e38-1c41e34f1e1c"
      unitRef="usd">21400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMy0xLTEtMA_d28125c4-92ec-47d3-8406-117689e3d175"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMy0xLTEtMA_d28125c4-92ec-47d3-8406-117689e3d175"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTMtMS0xLTA_c8b5599a-24dd-434b-9e3b-f259fbca00b5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTMtMS0xLTA_c8b5599a-24dd-434b-9e3b-f259fbca00b5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTMtMS0xLTA_1007089b-9d27-441e-bd00-216b4604dd58"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTMtMS0xLTA_1007089b-9d27-441e-bd00-216b4604dd58"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTMtMS0xLTA_b6229983-91ed-4fba-917e-f767735942c0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTMtMS0xLTA_b6229983-91ed-4fba-917e-f767735942c0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMy0xLTEtMA_38657aef-b525-480d-ae9a-9bf7c414bf14"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMy0xLTEtMA_38657aef-b525-480d-ae9a-9bf7c414bf14"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMy0xLTEtMA_8bbf7b11-8cee-4068-a724-6a2935eb53d1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMy0xLTEtMA_8bbf7b11-8cee-4068-a724-6a2935eb53d1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTMtMS0xLTA_08aeb46f-574a-49bf-9d28-ed099cac5446"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTMtMS0xLTA_08aeb46f-574a-49bf-9d28-ed099cac5446"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTMtMS0xLTA_40b54a96-0396-4421-b1ce-2b3cd96225a7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTMtMS0xLTA_40b54a96-0396-4421-b1ce-2b3cd96225a7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMy0xLTEtMA_80119c0b-b71e-4a84-8eb1-c0fb0bd36c76"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMy0xLTEtMA_80119c0b-b71e-4a84-8eb1-c0fb0bd36c76"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzktMy0xLTEtMA_d28125c4-92ec-47d3-8406-117689e3d175"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE1LTMtMS0xLTA_c8b5599a-24dd-434b-9e3b-f259fbca00b5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzEwLTMtMS0xLTA_1007089b-9d27-441e-bd00-216b4604dd58"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzExLTMtMS0xLTA_b6229983-91ed-4fba-917e-f767735942c0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzMtMy0xLTEtMA_38657aef-b525-480d-ae9a-9bf7c414bf14"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzQtMy0xLTEtMA_8bbf7b11-8cee-4068-a724-6a2935eb53d1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE2LTMtMS0xLTA_08aeb46f-574a-49bf-9d28-ed099cac5446"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzE3LTMtMS0xLTA_40b54a96-0396-4421-b1ce-2b3cd96225a7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90YWJsZTozNWQ3ZjFlYzU4YWQ0NDNmOTg1YmI2ZDAzMGRjYTA3OS90YWJsZXJhbmdlOjM1ZDdmMWVjNThhZDQ0M2Y5ODViYjZkMDMwZGNhMDc5XzUtMy0xLTEtMA_80119c0b-b71e-4a84-8eb1-c0fb0bd36c76"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xOTYvZnJhZzo5MTg0NjVmMjU5OTE0MDJkOTg0NmQ4ZWVhOWQxNDc3ZC90ZXh0cmVnaW9uOjkxODQ2NWYyNTk5MTQwMmQ5ODQ2ZDhlZWE5ZDE0NzdkXzEzMzc_6085fcb7-3a3e-43de-9452-1c54b19bb439"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTQtMS0xLTA_6ce887dc-fdf2-48fb-a49b-0c1d0da55efb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTQtMS0xLTA_6ce887dc-fdf2-48fb-a49b-0c1d0da55efb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTItMS0xLTA_1381ba37-693b-4a76-81c2-d76f8f336004"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTItMS0xLTA_1381ba37-693b-4a76-81c2-d76f8f336004"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTQtMS0xLTA_39b1e72d-a910-4547-84e9-4db1b28ffa44"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTQtMS0xLTA_39b1e72d-a910-4547-84e9-4db1b28ffa44"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTItMS0xLTA_158e1055-5fdf-4a12-9fe0-387a2cc0fd98"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTItMS0xLTA_158e1055-5fdf-4a12-9fe0-387a2cc0fd98"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </xhtml:span><xhtml:span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</xhtml:span><xhtml:span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTQtMS0xLTA_6ce887dc-fdf2-48fb-a49b-0c1d0da55efb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzEyLTItMS0xLTA_1381ba37-693b-4a76-81c2-d76f8f336004"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTQtMS0xLTA_39b1e72d-a910-4547-84e9-4db1b28ffa44"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90YWJsZTpiY2U0NjFkN2Y0MjY0N2MyYjFlZjZjNTg3ZDlhM2JlOC90YWJsZXJhbmdlOmJjZTQ2MWQ3ZjQyNjQ3YzJiMWVmNmM1ODdkOWEzYmU4XzExLTItMS0xLTA_158e1055-5fdf-4a12-9fe0-387a2cc0fd98"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMjcvZnJhZzoxZGQxMWRiZmIxZDQ0YjYxODZmMjlkYjJhYTQwNDY1Yy90ZXh0cmVnaW9uOjFkZDExZGJmYjFkNDRiNjE4NmYyOWRiMmFhNDA0NjVjXzQ1NA_a6b19da4-5b97-4e0e-a83a-bffcf61d5e8c"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6925175264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Sales and PPE by Geographic Location) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
<td class="nump">$ 1,599.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">839.3<span></span>
</td>
<td class="nump">822.0<span></span>
</td>
<td class="nump">855.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">814.7<span></span>
</td>
<td class="nump">766.1<span></span>
</td>
<td class="nump">734.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">337.1<span></span>
</td>
<td class="nump">315.3<span></span>
</td>
<td class="nump">323.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">236.3<span></span>
</td>
<td class="nump">235.9<span></span>
</td>
<td class="nump">226.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">95.4<span></span>
</td>
<td class="nump">99.3<span></span>
</td>
<td class="nump">108.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">150.6<span></span>
</td>
<td class="nump">145.0<span></span>
</td>
<td class="nump">142.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">53.3<span></span>
</td>
<td class="nump">50.1<span></span>
</td>
<td class="nump">51.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember', window );">Other European countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">251.1<span></span>
</td>
<td class="nump">230.5<span></span>
</td>
<td class="nump">201.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">59.1<span></span>
</td>
<td class="nump">59.5<span></span>
</td>
<td class="nump">63.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=wst_OtherCountriesMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">213.4<span></span>
</td>
<td class="nump">201.8<span></span>
</td>
<td class="nump">194.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">132.4<span></span>
</td>
<td class="nump">132.4<span></span>
</td>
<td class="nump">134.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">IRELAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">173.8<span></span>
</td>
<td class="nump">138.1<span></span>
</td>
<td class="nump">100.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 162.0<span></span>
</td>
<td class="nump">$ 165.4<span></span>
</td>
<td class="nump">$ 173.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=wst_OtherEuropeCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=wst_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=wst_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845058064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Fair Value of Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Deferred compensation assets</a></td>
<td class="nump">$ 11.3<span></span>
</td>
<td class="nump">$ 8.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Commodity call options</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">19.1<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">17.8<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Deferred compensation assets</a></td>
<td class="nump">11.3<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">11.3<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Commodity call options</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets at fair value</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency contracts</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities at fair value</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845792560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Textuals) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 244.1<span></span>
</td>
<td class="nump">$ 214.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Pension curtailment gain</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">401 (k) plan contributions</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">283.9<span></span>
</td>
<td class="nump">263.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contribution to the plan</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Assumed healthcare cost trend rate, benefit obligation</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Ultimate healthcare cost trend rate, benefit obligation</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost', window );">Assumed healthcare cost trend rate, net periodic benefit cost</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost', window );">Ultimate healthcare cost trend rate, net periodic benefit cost</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan, Plan Assets, Contributions by Employer</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">39.4<span></span>
</td>
<td class="nump">33.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">$ 73.9<span></span>
</td>
<td class="nump">$ 64.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.28%<span></span>
</td>
<td class="nump">2.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.49%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets', window );">Percentage of global plan assets</a></td>
<td class="nump">83.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Long-term rate of return on assets</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 244.1<span></span>
</td>
<td class="nump">$ 214.5<span></span>
</td>
<td class="nump">$ 239.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear', window );">Actuarial net loss that will be amortized from accumulated other comprehensive loss</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear', window );">Prior service credit that will be amortized from accumulated other comprehensive loss</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.79%<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.49%<span></span>
</td>
<td class="nump">4.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Long-term rate of return on assets</a></td>
<td class="nump">5.54%<span></span>
</td>
<td class="nump">6.71%<span></span>
</td>
<td class="nump">6.47%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan, Plan Assets, Contributions by Employer</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear', window );">Actuarial net loss that will be amortized from accumulated other comprehensive loss</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear', window );">Prior service credit that will be amortized from accumulated other comprehensive loss</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contribution to the plan</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined Benefit Plan, Plan Assets, Contributions by Employer</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target allocation</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (s)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (s)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions expected to be received by defined benefit plan from employer in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ultimate trend rate for health care cost for defined benefit postretirement plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6834706880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements and Changes in Accounting Principles</a></td>
<td class="text">New Accounting Standards<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Standards</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, the FASB issued guidance which clarifies or improves a variety of ASC disclosure and presentation requirements by aligning them with the SEC&#8217;s regulations, thereby eliminating redundancies and making the codification easier to apply. This guidance was effective upon issuance. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, the FASB issued guidance which expands the scope of accounting for share-based payment arrangements to include share-based payment transactions for acquiring goods and services from nonemployees. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, the FASB issued guidance to address a specific consequence of the&#160;2017 Tax Act by allowing a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the 2017 Tax Act&#8217;s reduction of the U.S. federal corporate income tax rate. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis, but elected to not reclassify from accumulated other comprehensive income (loss) to retained earnings the stranded tax effects resulting from the 2017 Tax Act&#8217;s reduction of the U.S. federal corporate income tax rate.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2017, the FASB issued guidance which expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, on a prospective basis. The adoption did not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2016, the FASB issued guidance on the accounting for leases, ASC 842. This guidance requires lessees to recognize lease assets and lease liabilities on the balance sheet and to expand disclosures about leasing arrangements, both qualitative and quantitative. In terms of transition, the guidance requires adoption based upon a modified retrospective approach. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption was permitted. We adopted this guidance as of January 1, 2019, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. Please refer to Note 6, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Leases</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Standards Issued Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 (&#8220;ASC 740&#8221;) and by clarifying and amending existing ASC 740 guidance. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. Early adoption is permitted. We are currently evaluating our adoption timing and the impact that this guidance may have on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, the FASB issued guidance which clarifies and improves areas of guidance related to the new credit losses, hedging, and recognition and measurement standards. This guidance is effective for the same fiscal years in which the original standards are effective or, if already implemented, annual periods beginning after the issuance of </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">this guidance. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by this update. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance which modifies the disclosure requirements for defined benefit pension plans and other postretirement plans. The guidance removes disclosures that no longer are considered cost beneficial, clarifies the specific requirements of disclosures, and adds disclosure requirements identified as relevant. This guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance which modifies the disclosure requirements on fair value measurements by removing, modifying, or adding certain disclosures. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In June 2016, the FASB issued guidance which provides financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments held by a reporting entity, including accounts receivable, at each reporting date. Under current guidance, an entity reflects credit losses on financial assets measured on an amortized cost basis only when it is probable that losses have been incurred, generally considering only past events and current conditions in determining incurred loss. The new guidance requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset, based not only on historical experience and current conditions, but also on reasonable and supportable forecasts. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Early adoption is permitted. We believe that the adoption of this guidance will not have a material impact on our financial statements, primarily as we have not historically had a material amount of accounts receivable write-offs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6604344544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Leases of Lessee Disclosure</a></td>
<td class="text">Leases<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adoption of ASC 842</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 1, 2019, we adopted ASC 842, using the modified retrospective approach that allows companies to apply ASC 842 as of the effective date and on a prospective basis. As a result, we were not required to adjust our comparative period financial information for effects of ASC 842 or present the new required lease disclosures for periods prior to the date of adoption. As of December&#160;31, 2019, we had operating leases primarily related to land, buildings, and machinery and equipment, with lease terms through 2047. Certain of our operating leases include options to extend the lease term for up to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18yMTk2L2ZyYWc6NTExMDAyNTJkNmE3NDViMTk1YTNkYmYyMTc0YjYxNDYvdGV4dHJlZ2lvbjo1MTEwMDI1MmQ2YTc0NWIxOTVhM2RiZjIxNzRiNjE0Nl8xMDk5NTExNjM5MzQz_3df9f4a3-52e4-45a8-8ae6-d4e15b74807d">five</span> years, and certain of our operating leases include options to terminate the leases within one year. We had no finance leases as of December&#160;31, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $71.0&#160;million and operating lease liabilities of $73.1&#160;million for operating leases where we are the lessee in our consolidated balance sheet as of January 1, 2019. The operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The operating lease liabilities are initially measured at the present value of the unpaid lease payments at the lease commencement date.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Judgments used in applying ASC 842 include determining: i) whether a contract is, or contains, a lease; ii) the discount rate to be used to discount the unpaid lease payments to present value; iii) the lease term; and iv) the lease payments. We determine if a contract is, or contains, a lease at contract inception. A lease exists when a contract conveys to the customer the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The definition of a lease embodies two conditions: 1) there is an identified asset in the contract that is land or a depreciable asset (i.e., property, plant, and equipment); and 2) the customer has the right to control the use of the identified asset. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As all of our operating leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Our incremental borrowing rate for a lease is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. The lease term for all of our operating leases includes the noncancellable period of the lease plus any additional periods covered by either a lessee option to extend (or not to terminate) the lease that the lessee is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Lease payments included in the measurement of the operating lease right-of-use assets and lease liabilities are comprised of fixed payments (including in-substance fixed payments), variable payments that depend on an index or rate, and the exercise price of a lessee option to purchase the underlying asset if the lessee is reasonably certain to exercise.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of lease expense were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term lease cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Variable lease cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Lease expense for 2018 and 2017 was $14.5&#160;million and $13.3&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Supplemental information related to leases was as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating cash flows from operating leases</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the weighted average remaining lease term for operating leases was 11.7 years and the weighted average discount rate was 3.76%.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Maturities of lease liabilities as of December&#160;31, 2019 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed lease interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Maturities of future minimum rental payments under non-cancelable operating leases as of December&#160;31, 2018 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Practical Expedients and Exemptions</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have elected to adopt the leasing package of practical expedients, which allows us to not retroactively reassess: i) any expired or existing contracts containing leases under the new definition of a lease; ii) the lease classification for any expired or existing leases; and iii) initial direct costs for any expired or existing leases. We have also elected to adopt practical expedients around land easements, the combination of lease and non-lease components, and the portfolio approach relating to discount rates. These practical expedients were applied consistently to all leases. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have elected not to recognize operating lease right-of-use assets and operating lease liabilities for all short-term leases (leases with an initial lease term of 12 months or less). We recognize the lease payments associated with our short-term leases as an expense over the lease term.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6652415440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2019. </span></div><div style="text-align:justify;"><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.711%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Note payable, due December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Facility, due October 15, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Term Loan, due December 31, 2024 (2.78%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A notes, due July 5, 2022 (3.67%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B notes, due July 5, 2024 (3.82%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series C notes, due July 5, 2027 (4.02%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">258.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: unamortized debt issuance costs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">257.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current portion of long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Credit Agreement - Credit Facility </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, we entered into the Credit Agreement that replaced our prior revolving credit facility, which was scheduled to expire in October 2020. The Credit Agreement, which expires in March 2024, contains the Credit Facility of $300.0&#160;million, with sublimits of up to $30.0&#160;million for swing line loans for domestic borrowers in USD and a $20.0&#160;million swing line loan for our German Holding Company and up to $30.0&#160;million for the issuance of standby letters of credit, which Credit Facility may be increased from time-to-time by the greater of $350.0&#160;million and earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) for the preceding twelve month period in the aggregate through an increase in the Credit Facility, subject to the satisfaction of certain conditions. Borrowings under the Credit Facility bear interest at either the base rate (the per annum interest rate of the highest of the Prime Rate, the Federal Funds Rate plus 50 basis points or the daily LIBOR, plus 1.00%) or at the applicable LIBOR rate, plus a tiered margin based on the ratio of our net consolidated debt to our modified EBITDA, ranging from 0 to 37.5 basis points for base rate loans and 87.5 to 137.5 basis points for LIBOR rate loans. The Credit </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Agreement contains financial covenants providing that we shall not permit the ratio of our net consolidated debt to our modified EBITDA to be greater than 3.5 to 1; provided that, no more than three times during the term of the Credit Agreement, upon the occurrence of a qualified acquisition for each of our four fiscal quarters immediately following such qualified acquisition, the ratio shall be increased to 4.0 to 1. The Credit Agreement also contains customary limitations on liens securing our indebtedness, fundamental changes (mergers, consolidations, liquidations and dissolutions), asset sales, distributions and acquisitions. As of December 31, 2019 and 2018, total unamortized debt issuance costs of $1.1&#160;million and $0.6&#160;million, respectively, were recorded in other noncurrent assets and are being amortized as additional interest expense over the term of the Credit Facility. A portion of these costs relate to our prior revolving credit facility.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December 31, 2019, we had no outstanding borrowings under the Credit Facility, as we repaid the outstanding long-term borrowings denominated in Euro and Yen in November and December 2019, respectively. There was no material gain or loss on the repayment under the Credit Facility. At December 31, 2019, the borrowing capacity available under the Credit Facility, including outstanding letters of credit of $2.5 million, was $297.5 million. Please refer to Note 11, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Derivative Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for a discussion of the foreign currency hedges that had been associated with this facility.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Credit Agreement Amendment - Term Loan</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2019, we entered into a First Amendment and Incremental Facility Amendment (the &#8220;First Amendment&#8221;) to the Credit Agreement. Pursuant to the First Amendment and the Credit Agreement, we established the Term Loan in the amount of $90.0&#160;million, which is due on December 31, 2024. Borrowings under the Term Loan bear interest at the three-month LIBOR plus 87.5 basis points. As of December 31, 2019, there were unamortized debt issuance costs remaining of $0.2&#160;million, which are being amortized as additional interest expense over the term of the Term Loan.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">At December 31, 2019, we had $90.0&#160;million in borrowings under the Term Loan, of which $2.3&#160;million was classified as current and $87.7&#160;million was classified as long-term. Please refer to Note 11, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Derivative Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, for a discussion of the foreign currency hedge associated with the Term Loan.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Private Placement</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2012, we concluded a private placement issuance of $168.0 million in senior unsecured notes. The total amount of the private placement issuance was divided into three tranches - $42.0 million 3.67% Series A Notes due July 5, 2022, $53.0 million 3.82% Series B Notes due July 5, 2024, and $73.0 million 4.02% Series C Notes due July 5, 2027 (the &#8220;Notes&#8221;). The Notes rank pari passu with our other senior unsecured debt. The weighted average of the coupon interest rates on the Notes is 3.87%. As of December&#160;31, 2019 and 2018, there were unamortized debt issuance costs remaining of $0.5 million and $0.6 million, respectively, which are being amortized as additional interest expense over the term of the Notes.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Covenants</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and to not exceed established leverage ratios. In addition, the agreements contain other customary covenants, none of which we consider restrictive to our operations. At December&#160;31, 2019, we were in compliance with all of our debt covenants, and we expect to continue to be in compliance with the terms of these agreements throughout 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest costs incurred during 2019, 2018 and 2017 were $9.4 million, $9.3 million and $10.5 million, respectively. The aggregate annual maturities of long-term debt, excluding unamortized debt issuance costs, were as follows: </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">$2.3&#160;million in 2020 and 2021, 2022 - $44.3&#160;million, 2023 - $2.3&#160;million, 2024 - $133.8&#160;million, and thereafter - $73.0 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838223712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other current liabilities</a></td>
<td class="text"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued taxes other than income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued professional services</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring obligations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other current liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6719863216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property, Plant and Equipment</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:55.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.307%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.701%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected useful lives (years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Land</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Buildings and improvements</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15-35</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">572.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">569.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Machinery and equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5-12</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">817.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">806.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Molds and dies</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4-7</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer hardware and software</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3-10</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">155.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">151.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,820.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,752.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7003246656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
<td class="nump">$ 150.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="num">(39.2)<span></span>
</td>
<td class="nump">68.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Prior service cost arising during period, net of tax of $0</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Net actuarial (loss) gain arising during period, net of tax of $(0.3), $(0.2) and $1.3</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax', window );">Settlement effects arising during period, net of tax of $0.8</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Less: amortization of actuarial (gain) loss, net of tax of $0, $0.3 and $0.5</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax', window );">Less: amortization of prior service credit, net of tax of $(0.1), $(0.5) and $(0.5)</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net loss on investment securities, net of tax of $0, $(0.1) and $(2.5)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net (loss) gain on derivatives, net of tax of $(0.2), $1.5 and $(0.1)</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="num">(36.9)<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">$ 246.3<span></span>
</td>
<td class="nump">$ 170.0<span></span>
</td>
<td class="nump">$ 220.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820025728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Capital in Excess of Par Value [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2016</a></td>
<td class="nump">$ 1,117,500<span></span>
</td>
<td class="nump">$ 18,400<span></span>
</td>
<td class="nump">$ 260,400<span></span>
</td>
<td class="num">$ (46,100)<span></span>
</td>
<td class="nump">$ 1,071,600<span></span>
</td>
<td class="num">$ (186,800)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">150,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">55,900<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">44,100<span></span>
</td>
<td class="nump">$ 11,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">(74,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (74,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">$ (40,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other adjustments to capital in excess of par value</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">69,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,500<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2017</a></td>
<td class="nump">1,279,900<span></span>
</td>
<td class="nump">$ 18,800<span></span>
</td>
<td class="nump">309,300<span></span>
</td>
<td class="num">$ (109,100)<span></span>
</td>
<td class="nump">1,178,200<span></span>
</td>
<td class="num">(117,300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Effect of modified retrospective application of new accounting standard</a></td>
<td class="num">(4,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">206,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">48,900<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(27,300)<span></span>
</td>
<td class="nump">$ 76,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">(70,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (70,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">$ (43,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">$ (36,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,900)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">1,396,300<span></span>
</td>
<td class="nump">$ 18,800<span></span>
</td>
<td class="nump">282,000<span></span>
</td>
<td class="num">$ (103,700)<span></span>
</td>
<td class="nump">1,353,400<span></span>
</td>
<td class="num">(154,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Effect of modified retrospective application of new accounting standard</a></td>
<td class="nump">11,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">241,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Activity related to stock-based compensation</a></td>
<td class="nump">$ 54,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(11,100)<span></span>
</td>
<td class="nump">$ 65,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares purchased under share repurchase program (in shares)</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares purchased under share repurchase program</a></td>
<td class="num">$ (83,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (83,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for employee tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Purchase of investment in affiliated companies</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">$ (45,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,573,200<span></span>
</td>
<td class="nump">$ 18,800<span></span>
</td>
<td class="nump">$ 272,700<span></span>
</td>
<td class="num">$ (118,100)<span></span>
</td>
<td class="nump">$ 1,549,400<span></span>
</td>
<td class="num">$ (149,600)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6648580160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The West Pharmaceutical Services, Inc. 2016 Omnibus Incentive Compensation Plan (the &#8220;2016 Plan&#8221;) provides for the granting of stock options, stock appreciation rights, restricted stock awards and performance awards to employees and non-employee directors. A committee of the Board of Directors determines the terms and conditions of awards to be granted. Vesting requirements vary by award. At December&#160;31, 2019, there were 3,119,314 shares remaining in the 2016 Plan for future grants.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock options and stock appreciation rights reduce the number of shares available by one share for each award granted. All other awards under the 2016 Plan will reduce the total number of shares available for grant by an amount equal to 2.5 times the number of shares awarded. If awards made under previous plans would entitle a plan participant to an amount of West stock in excess of the target amount, the additional shares (up to a maximum threshold amount) will be distributed under the 2016 Plan.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our stock-based compensation expense recorded within selling, general and administrative expenses for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock option and appreciation rights</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, stock-settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, cash-settled</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Performance share units, dividend equivalents</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee stock purchase plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation plans and restricted share awards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stock-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amount of unrecognized compensation expense for all non-vested awards as of December&#160;31, 2019 was approximately $21.2 million, which is expected to be recognized over a weighted average period of 1.6 years. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock options granted to employees vest in equal increments. All awards expire 10 years from the date of grant. Upon the exercise of stock options, shares are issued in exchange for the exercise price of the options. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in outstanding options:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions, except per share data)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercisable, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.09&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.42&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.95&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60.92&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options outstanding, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67.02&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercisable, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.44&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the weighted average remaining contractual life of options outstanding and of options exercisable was 6.1 years and 5.0 years, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, the aggregate intrinsic value of total options outstanding was $227.8 million, of which $158.6 million represented vested options.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the options was estimated on the date of grant using a Black-Scholes option valuation model that used the following weighted average assumptions in 2019, 2018 and 2017: a risk-free interest rate of 2.3%, 2.7%, and 2.0%, respectively; stock volatility of 22.5%, 19.8%, and 19.9%, respectively; and dividend yields of 0.7%, 0.7%, and 0.7%, respectively. Stock volatility is estimated based on historical data and the impact from expected </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">future trends. Expected lives, which are based on prior experience, averaged 6 years for 2019, 2018 and 2017. The weighted average grant date fair value of options granted in 2019, 2018 and 2017 was $24.72, $20.16 and $18.08, respectively. Stock option expense is recognized over the vesting period, net of forfeitures.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the years ended December 31, 2019, 2018 and 2017, the intrinsic value of options exercised was $46.9 million, $61.3 million and $91.7 million, respectively. The grant date fair value of options vested during those same periods was $7.5 million, $8.3 million and $6.7 million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Appreciation Rights</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock appreciation rights (&#8220;SARs&#8221;) granted to eligible international employees vest in equal annual increments over 4 years of continuous service. All awards expire 10 years from the date of grant. The fair value of each cash-settled SAR is adjusted at the end of each reporting period, with the resulting change reflected in expense. As of December&#160;31, 2019, SARs outstanding were 35,993, of which 23,833 were cash-settled and 12,160 were stock-settled. Upon exercise of a cash-settled SAR, the employee receives cash for the difference between the grant date price and the fair market value of the Company&#8217;s stock on the date of exercise. As a result of the cash settlement feature, cash-settled SARs are recorded within other long-term liabilities. Upon exercise of a stock-settled SAR, shares are issued in exchange for the exercise price of the stock-settled SAR. As a result of the stock settlement feature, stock-settled SARs are recorded within equity.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in outstanding SARs:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">116,087&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,364&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,790)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,629)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(67,511)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(400)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(400)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35,993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs exercisable, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,781&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,285&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Exercise Price</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.13&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.08&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63.43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs outstanding, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SARs exercisable, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.73&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Performance Awards</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to stock options and SAR awards, we grant performance share unit (&#8220;PSU&#8221;) awards to eligible employees. These awards are earned based on the Company&#8217;s performance against pre-established targets, including annual growth rate of revenue and return on invested capital, over a specified performance period. Depending on the achievement of the targets, recipients of stock-settled PSU awards are entitled to receive a certain number of shares of common stock, whereas recipients of cash-settled PSU awards are entitled to receive a payment in cash per unit based on the fair market value of a share of our common stock at the end of the performance period.  </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in our outstanding stock-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296,037&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">341,944&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378,062&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84,309&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102,307&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92,045&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50,556)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,284)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11,369)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(48,964)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(121,984)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(116,684)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16,204)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23,946)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(110)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">264,622&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">296,037&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">341,944&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.01&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.85&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50.06&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69.09&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68.65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested stock-settled PSU awards, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66.03&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Shares earned under PSU awards may vary from 0% to 200% of an employee&#8217;s targeted award. The fair value of stock-settled PSU awards is based on the market price of our stock at the grant date and is recognized as expense over the performance period, adjusted for estimated target outcomes and net of forfeitures. The weighted average grant date fair value of stock-settled PSU awards granted during the years 2019, 2018 and 2017 was $103.40, $90.45 and $84.01, respectively. Including forfeiture and below-target achievement expectations, we expect that the stock-settled PSU awards will convert to 84,670 shares to be issued over an average remaining term of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xMzAvZnJhZzplY2ZmM2Q5YmJhZWU0YWMzODQ5YmU4MzFmYTdiZDhkMi90ZXh0cmVnaW9uOmVjZmYzZDliYmFlZTRhYzM4NDliZTgzMWZhN2JkOGQyXzU1MjU_5649237d-81f3-42ad-be9c-00e04ab34944">one</span> year.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of cash-settled PSU awards is also based on the market price of our stock at the grant date. These awards are revalued at the end of each quarter based on changes in our stock price. As a result of the cash settlement feature, cash-settled PSU awards are recorded within other long-term liabilities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes changes in our outstanding cash-settled PSU awards:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, January 1</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">806&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">560&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">598&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(206)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(107)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(211)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(910)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(970)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, December 31</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,981&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted at target level</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments above/(below) target</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56.95&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.53&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66.61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested and converted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102.51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">86.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-vested cash-settled PSU awards, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We also offer an Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which provides for the sale of our common stock to eligible employees at 85% of the current market price on the last trading day of each quarterly offering period. Payroll deductions are limited to 25% of the employee&#8217;s base salary, not to exceed $25,000 in any one calendar year. In addition, employees may not buy more than 2,000 shares during any offering period (8,000 shares per year). Purchases under the ESPP were 51,391 shares, 55,669 shares and 56,218 shares for the years 2019, 2018 and 2017, respectively. At December&#160;31, 2019, there were approximately 3.8 million shares available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Deferred Compensation Plans and Restricted Share Awards</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our deferred compensation plans include a Non-Qualified Deferred Compensation Plan for Non-Employee Directors, under which non-employee directors may defer all or part of their annual cash retainers. The deferred fees may be credited to a stock-equivalent account. Amounts credited to this account are converted into deferred stock units based on the fair market value of one share of our common stock on the last day of the quarter. For deferred stock units ultimately paid in cash, a liability is calculated at an amount determined by multiplying the number of units by the fair market value of our common stock at the end of each reporting period. In addition, deferred stock awards are granted on the date of our annual meeting, and are distributed in shares of common stock. In 2019, we granted 14,579 deferred stock awards, with a grant date fair value of $121.40. Similarly, a non-qualified deferred compensation plan for eligible employees provides for the conversion of compensation into deferred stock units. As of December&#160;31, 2019, the two deferred compensation plans held a total of 366,159 deferred stock units, including 6,274 units to be paid in cash.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, during 2019, we granted 13,308 restricted share awards at a weighted grant-date fair value of $116.39 per share to employees under the 2016 Plan. During 2018, we granted 15,942 restricted share awards at a weighted grant-date fair value of $96.77 per share to employees under the 2016 Plan. There were no grants of restricted share awards in 2017. The fair value of these awards is based on the market price of our stock at the grant date and is recognized as expense over the vesting period.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Annual Incentive Plan</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under our annual incentive plan, participants are paid bonuses on the attainment of certain financial goals, which they can elect to receive in either cash or shares of our common stock. If the employee elects payment in shares, they are also given a restricted incentive stock award equal to one share for each four bonus shares issued. The incentive stock awards vest at the end of four years provided that the participant has not made a disqualifying disposition of their bonus shares. Incentive stock award grants were 1,300 shares, 1,500 shares and 1,800 shares in 2019, 2018 and 2017, respectively. There were no incentive stock forfeitures in 2019. Incentive stock forfeitures of 200 shares and 800 shares occurred in 2018 and 2017, respectively. Compensation expense is recognized over the vesting period based on the fair market value of common stock on the award date: $106.14 per share granted in 2019, $93.00 per share granted in 2018 and $86.93 per share granted in 2017.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837978448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, we were obligated under various operating lease agreements. Please refer to Note 6, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Leases</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, we were obligated under various defined benefit pension plans in the U.S. and other countries that cover employees who meet eligibility requirements.  Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, our outstanding unconditional contractual commitments, including for the purchase of raw materials and finished goods, amounted to $249.1 million, of which $61.3 million is due to be paid in 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have letters of credit totaling $2.5 million supporting the reimbursement of workers&#8217; compensation and other claims paid on our behalf by insurance carriers. Our accrual for insurance obligations was $3.2 million at December&#160;31, 2019, of which $0.9 million is in excess of our deductible and, therefore, is reimbursable by the insurance company.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our SmartDose contingent consideration is payable to the selling shareholders based upon a percentage of product sales over the life of the underlying product patent, with no cap on total payments. Given the length of the earnout period and the uncertainty in forecasted product sales, we do not believe it is meaningful to estimate the upper end of the range over the entire period. However, our estimated probable range which could become payable over the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0YWYxYWQ0NTY5ZDQ5YWE5N2ViODNjY2Q1N2IwNmQ3L3NlYzowNGFmMWFkNDU2OWQ0OWFhOTdlYjgzY2NkNTdiMDZkN18xNTEvZnJhZzo2MWY3M2NlNjZlYzY0ZjQ4OTZhMTE5NTc1ZjMwNTI2Ni90ZXh0cmVnaW9uOjYxZjczY2U2NmVjNjRmNDg5NmExMTk1NzVmMzA1MjY2XzExOTk_3f334523-3b30-4be6-b24a-5b3930387693">five</span> years is between zero and $3.7 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>65
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "wst-20191231.htm": {
   "axisCustom": 1,
   "axisStandard": 37,
   "contextCount": 460,
   "dts": {
    "calculationLink": {
     "local": [
      "wst-20191231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wst-20191231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "wst-20191231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "wst-20191231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wst-20191231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "wst-20191231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 992,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 64,
    "http://www.westpharma.com/20191231": 8,
    "http://xbrl.sec.gov/dei/2019-01-31": 9,
    "total": 81
   },
   "keyCustom": 57,
   "keyStandard": 596,
   "memberCustom": 53,
   "memberStandard": 92,
   "nsprefix": "wst",
   "nsuri": "http://www.westpharma.com/20191231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.westpharma.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105102 - Disclosure - New Accounting Standards",
     "role": "http://www.westpharma.com/role/NewAccountingStandards",
     "shortName": "New Accounting Standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureOfMajorCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2492455 - Disclosure - Segment Information (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationTextualsDetails",
     "shortName": "Segment Information (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureOfMajorCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2493456 - Disclosure - Segment Information (Sales by Product Group) (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
     "shortName": "Segment Information (Sales by Product Group) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i078c4378a1b84554a97a59aedf1dfea7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2494457 - Disclosure - Segment Information (Sales and PPE by Geographic Location) (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails",
     "shortName": "Segment Information (Sales and PPE by Geographic Location) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i63ad3b3b7bf848afa7195c490bcbc124_I20171231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2495458 - Disclosure - Segment Information (Segment Financial Information) (Details)",
     "role": "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails",
     "shortName": "Segment Information (Segment Financial Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i63ad3b3b7bf848afa7195c490bcbc124_I20171231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ieecec5a0e59d4a618aff5d091e295a63_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2497459 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)",
     "role": "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i68b43b173ce141aebdc6cada18dd16ec_I20161231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - Revenue Revenue",
     "role": "http://www.westpharma.com/role/RevenueRevenue",
     "shortName": "Revenue Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - Net Income Per Share",
     "role": "http://www.westpharma.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - Property, Plant and Equipment",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Leases",
     "role": "http://www.westpharma.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128107 - Disclosure - Affiliated Companies",
     "role": "http://www.westpharma.com/role/AffiliatedCompanies",
     "shortName": "Affiliated Companies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132108 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - Other Current Liabilities",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilities",
     "shortName": "Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140110 - Disclosure - Debt",
     "role": "http://www.westpharma.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144111 - Disclosure - Derivative Financial Instruments",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - Fair Value Measurements",
     "role": "http://www.westpharma.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153113 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157114 - Disclosure - Stock-Based Compensation",
     "role": "http://www.westpharma.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164115 - Disclosure - Benefit Plans",
     "role": "http://www.westpharma.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2174116 - Disclosure - Other Expense",
     "role": "http://www.westpharma.com/role/OtherExpense",
     "shortName": "Other Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2180117 - Disclosure - Income Taxes",
     "role": "http://www.westpharma.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2188118 - Disclosure - Commitments and Contingencies",
     "role": "http://www.westpharma.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2190119 - Disclosure - Segment Information",
     "role": "http://www.westpharma.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2196120 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Notes)",
     "role": "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - Revenue Revenue (Tables)",
     "role": "http://www.westpharma.com/role/RevenueRevenueTables",
     "shortName": "Revenue Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Net Income Per Share (Tables)",
     "role": "http://www.westpharma.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - Property, Plant and Equipment (Tables)",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Leases (Tables)",
     "role": "http://www.westpharma.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - Affiliated Companies (Tables)",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesTables",
     "shortName": "Affiliated Companies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338308 - Disclosure - Other Current Liabilities (Tables)",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341309 - Disclosure - Debt (Tables)",
     "role": "http://www.westpharma.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345310 - Disclosure - Derivative Financial Instruments (Tables)",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349311 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354312 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358313 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365314 - Disclosure - Benefit Plans (Tables)",
     "role": "http://www.westpharma.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2375315 - Disclosure - Other Expense (Tables)",
     "role": "http://www.westpharma.com/role/OtherExpenseTables",
     "shortName": "Other Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2381316 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.westpharma.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2391317 - Disclosure - Segment Information (Tables)",
     "role": "http://www.westpharma.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "icbcb7101f4b347c386f48f408e3ef92f_I20190401",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "role": "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "icbcb7101f4b347c386f48f408e3ef92f_I20190401",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Revenue Adoption of ASC 606 (Details)",
     "role": "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
     "shortName": "Revenue Adoption of ASC 606 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i233817b047df4ab4a84d4b14575f9f25_I20180101",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Revenue Revenue Recognition (Details)",
     "role": "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
     "shortName": "Revenue Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ieecec5a0e59d4a618aff5d091e295a63_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Revenue Contracts Assets and Liabilities (Details)",
     "role": "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
     "shortName": "Revenue Contracts Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Revenue Supply Chain Financing (Details)",
     "role": "http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails",
     "shortName": "Revenue Supply Chain Financing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i4ecf186e93644ab891c8d431739b0932_D20181001-20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "wst:ProvisionForProductReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Revenue Voluntary Recall (Details)",
     "role": "http://www.westpharma.com/role/RevenueVoluntaryRecallDetails",
     "shortName": "Revenue Voluntary Recall (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i4ecf186e93644ab891c8d431739b0932_D20181001-20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "wst:ProvisionForProductReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Net Income Per Share (Details)",
     "role": "http://www.westpharma.com/role/NetIncomePerShareDetails",
     "shortName": "Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Property, Plant and Equipment (Property, Plant and Equipment, Gross) (Details)",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
     "shortName": "Property, Plant and Equipment (Property, Plant and Equipment, Gross) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i0bb40d435fa14466b3b81d438b389a9f_I20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Property, Plant and Equipment (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails",
     "shortName": "Property, Plant and Equipment (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CapitalLeasedAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Adoption of ASC 842 (Details)",
     "role": "http://www.westpharma.com/role/AdoptionofASC842Details",
     "shortName": "Adoption of ASC 842 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Lease Cost (Details)",
     "role": "http://www.westpharma.com/role/LeaseCostDetails",
     "shortName": "Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Lease Cash Flow and Supplemental Information (Details)",
     "role": "http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails",
     "shortName": "Lease Cash Flow and Supplemental Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - Lease Weighted Average (Detail)",
     "role": "http://www.westpharma.com/role/LeaseWeightedAverageDetail",
     "shortName": "Lease Weighted Average (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - Maturities of Operating Lease Liabilities (Details)",
     "role": "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Affiliated Companies (Details)",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
     "shortName": "Affiliated Companies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i89cf005616044c5e8e5067ff128a6379_I20191231",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Affiliated Companies (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails",
     "shortName": "Affiliated Companies (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ieecec5a0e59d4a618aff5d091e295a63_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Goodwill and Intangible Assets (Goodwill) (Details)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i63ad3b3b7bf848afa7195c490bcbc124_I20171231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Goodwill and Intangible Assets (Intangible Assets by Major Class) (Details)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails",
     "shortName": "Goodwill and Intangible Assets (Intangible Assets by Major Class) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Goodwill and Intangible Assets (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
     "shortName": "Goodwill and Intangible Assets (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Other Current Liabilities (Details)",
     "role": "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails",
     "shortName": "Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Debt (Details)",
     "role": "http://www.westpharma.com/role/DebtDetails",
     "shortName": "Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443423 - Disclosure - Debt (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/DebtTextualsDetails",
     "shortName": "Debt (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i2d648861366e4cdba756d7642ed7befe_I20191231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeAveragePriceRiskOptionStrikePrice",
      "reportCount": 1,
      "unitRef": "usdPerBbl",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446424 - Disclosure - Derivative Financial Instruments (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails",
     "shortName": "Derivative Financial Instruments (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ib8c160a1ee5b40b5815b9d3cfcebe527_I20171122",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DerivativeNonmonetaryNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "bbl",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i68b43b173ce141aebdc6cada18dd16ec_I20161231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENT OF EQUITY",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i68b43b173ce141aebdc6cada18dd16ec_I20161231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447425 - Disclosure - Derivative Financial Instruments (Effects of Derivative Instruments Designated as Hedges) (Details)",
     "role": "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
     "shortName": "Derivative Financial Instruments (Effects of Derivative Instruments Designated as Hedges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450426 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities) (Details)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurements (Fair Value of Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ieecec5a0e59d4a618aff5d091e295a63_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451427 - Disclosure - Fair Value Measurements (Changes in Level 3 Fair Value Measurements) (Details)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Changes in Level 3 Fair Value Measurements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i63ad3b3b7bf848afa7195c490bcbc124_I20171231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452428 - Disclosure - Fair Value Measurements Other Financial Instruments (Details)",
     "role": "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements Other Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455429 - Disclosure - (Components of AOCI) (Details)",
     "role": "http://www.westpharma.com/role/ComponentsofAOCIDetails",
     "shortName": "(Components of AOCI) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456430 - Disclosure - (Reclassifications AOCI) (Details)",
     "role": "http://www.westpharma.com/role/ReclassificationsAOCIDetails",
     "shortName": "(Reclassifications AOCI) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "iebf8f5c36fb64d06aff88d876051dba3_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459431 - Disclosure - Stock-Based Compensation (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails",
     "shortName": "Stock-Based Compensation (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460432 - Disclosure - Stock-Based Compensation (Allocation of Share-based Compensation Costs) (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
     "shortName": "Stock-Based Compensation (Allocation of Share-based Compensation Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461433 - Disclosure - Stock-Based Compensation (Stock Options Activity) (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
     "shortName": "Stock-Based Compensation (Stock Options Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "wst:CashSettledStockAppreciationRIghtsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462434 - Disclosure - Stock-Based Compensation (Stock Appreciation Rights Award Activity) (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
     "shortName": "Stock-Based Compensation (Stock Appreciation Rights Award Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "wst:CashSettledStockAppreciationRIghtsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463435 - Disclosure - Stock-Based Compensation (Nonvested Performance-based Award Activity) (Details)",
     "role": "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
     "shortName": "Stock-Based Compensation (Nonvested Performance-based Award Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i5adbbbefb7884a4ea88745c06aca7389_D20190101-20191231",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466436 - Disclosure - Benefit Plans (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansTextualsDetails",
     "shortName": "Benefit Plans (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467437 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Benefit Plans (Components of Net Periodic Benefit Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ieecec5a0e59d4a618aff5d091e295a63_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468438 - Disclosure - Benefit Plans (Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
     "shortName": "Benefit Plans (Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469439 - Disclosure - Benefit Plans (Amounts Recognized in Balance Sheet) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
     "shortName": "Benefit Plans (Amounts Recognized in Balance Sheet) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i7e79bcd26cba4c48bace4d172cddc5f3_I20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i7e79bcd26cba4c48bace4d172cddc5f3_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470440 - Disclosure - Benefit Plans (Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
     "shortName": "Benefit Plans (Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i7e79bcd26cba4c48bace4d172cddc5f3_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471441 - Disclosure - Benefit Plans (Expected Benefit Payments) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
     "shortName": "Benefit Plans (Expected Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472442 - Disclosure - Benefit Plans (Assumptions Used) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
     "shortName": "Benefit Plans (Assumptions Used) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i53a206c33aec4f1e911dfdcf66f06346_D20190101-20191231",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473443 - Disclosure - Benefit Plans (Allocation of Plan Assets) (Details)",
     "role": "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
     "shortName": "Benefit Plans (Allocation of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476444 - Disclosure - Other Expense (Details)",
     "role": "http://www.westpharma.com/role/OtherExpenseDetails",
     "shortName": "Other Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477445 - Disclosure - Other Expense Restructuring and Related Charges (Details)",
     "role": "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
     "shortName": "Other Expense Restructuring and Related Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ia67aaad7c305484ead3aad36641a681f_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RestructuringAndRelatedCostIncurredCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyTransactionLossBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478446 - Disclosure - Other Expense Other Items (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails",
     "shortName": "Other Expense Other Items (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ForeignCurrencyTransactionGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "wst:ScheduleofOtherIncomeandExpensebyComponentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "wst:Developmentandlicensingincome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479447 - Disclosure - Other Expense Development and Licensing Income (Details)",
     "role": "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails",
     "shortName": "Other Expense Development and Licensing Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i1e11b27427cd46d590025400238fdb38_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "wst:Developmentandlicensingincome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482448 - Disclosure - Income Taxes (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
     "shortName": "Income Taxes (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "ieecec5a0e59d4a618aff5d091e295a63_I20181231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483449 - Disclosure - Income Taxes (Unrecognized Tax Benefits) (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes (Unrecognized Tax Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2484450 - Disclosure - Income Taxes (Income Before Income Taxes) (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes (Income Before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2485451 - Disclosure - Income Taxes (Components of Income Tax Expense) (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes (Components of Income Tax Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2486452 - Disclosure - Income Taxes (Deferred Tax Assets and Liabilities) (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2487453 - Disclosure - Income Taxes (Effective Income Tax Reconciliation) (Details)",
     "role": "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails",
     "shortName": "Income Taxes (Effective Income Tax Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i3fd2ea4a741c4b3f995774bd0d5667c7_D20190101-20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2489454 - Disclosure - Commitments and Contingencies (Textuals) (Details)",
     "role": "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
     "shortName": "Commitments and Contingencies (Textuals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "wst-20191231.htm",
      "contextRef": "i710deda8952743be8f828089af9cd00d_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 150,
   "tag": {
    "country_DE": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "GERMANY",
        "terseLabel": "Germany [Member]"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France [Member]"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "IRELAND"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States [Member]"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_VE": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "VENEZUELA",
        "terseLabel": "VENEZUELA"
       }
      }
     },
     "localname": "VE",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_SGD": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Singapore, Dollars",
        "terseLabel": "Singapore, Dollars"
       }
      }
     },
     "localname": "SGD",
     "nsuri": "http://xbrl.sec.gov/currency/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Continents of North and South America.",
        "label": "Americas [Member]",
        "terseLabel": "Americas [Member]"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Non-Employee Directors [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Equity Method Investee, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r197",
      "r309",
      "r314",
      "r642"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r195",
      "r309",
      "r312",
      "r639",
      "r640"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of investment, including named security. Excludes consolidated entity.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Equity Method Investee, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r661"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule of Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]",
        "verboseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r196",
      "r309",
      "r313",
      "r641",
      "r649",
      "r651",
      "r659",
      "r660"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r275",
      "r598"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r199",
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual with Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r145",
      "r661"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.",
        "label": "Accounting Changes and Error Corrections [Text Block]",
        "verboseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201609Member": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.",
        "label": "Accounting Standards Update 2016-09 [Member]",
        "terseLabel": "Accounting Standards Update 2016-09 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201609Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201707Member": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2017-07 Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost.",
        "label": "Accounting Standards Update 2017-07 [Member]",
        "terseLabel": "Accounting Standards Update 2017-07 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201707Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r3",
      "r26",
      "r200",
      "r201",
      "r310"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r8",
      "r48",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrual for Taxes Other than Income Taxes, Current",
        "terseLabel": "Accrued taxes other than income"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r18",
      "r608",
      "r628"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r18",
      "r20",
      "r610",
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued Sales Commission",
        "terseLabel": "Accrued commissions, rebates and royalties"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r70",
      "r77",
      "r80",
      "r356",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Pension and Other Postretirement Plans [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r42",
      "r246"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r65",
      "r77",
      "r80",
      "r503"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Losses on Cash Flow Hedges [Member]"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r77",
      "r80"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized Gains on Investment Securities [Member]"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r74",
      "r76",
      "r77"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r73",
      "r77",
      "r80",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r64",
      "r77",
      "r80",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in Excess of Par Value [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r121",
      "r236"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by new accounting pronouncement.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares repurchased for employee tax withholdings",
        "terseLabel": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "negatedTerseLabel": "Other adjustments to capital in excess of par value"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r386",
      "r419",
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for Doubtful Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r30",
      "r206",
      "r215"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r121",
      "r228",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive options excluded from computation of diluted net income per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r121",
      "r243"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset-related charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r187",
      "r606",
      "r626"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Segment assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r62"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Noncurrent",
        "terseLabel": "Deferred compensation assets"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r388",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r388",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate [Member]"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business acquisition, transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r120",
      "r496"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 6.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, estimated outcome, high"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "auth_ref": [
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "terseLabel": "Contingent consideration, estimated outcome, low"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r491",
      "r492",
      "r494"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business acquisition, recognized intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r487",
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business acquisition, recognized inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r487",
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business acquisition, recognized property, plant, and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business acquisition, recognized goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasedAssetsGross": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Capital Leased Assets, Gross",
        "terseLabel": "Capitalized leases"
       }
      }
     },
     "localname": "CapitalLeasedAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r38",
      "r123"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash, including cash equivalents at end of period",
        "periodStartLabel": "Cash, including cash equivalents at beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash [Member]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r124",
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r117",
      "r561"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDivestedFromDeconsolidation": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.",
        "label": "Cash Divested from Deconsolidation",
        "negatedTerseLabel": "Cash related to deconsolidated Venezuelan subsidiary"
       }
      }
     },
     "localname": "CashDivestedFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedges [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r55",
      "r274",
      "r616",
      "r634"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r273",
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommodityOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Option contract in which the underlying asset is a commodity.",
        "label": "Commodity Option [Member]",
        "terseLabel": "Commodity Call Options [Member]"
       }
      }
     },
     "localname": "CommodityOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million in 2019 and 2018; shares outstanding: 74.1 million and 74.1 million in 2019 and 2018"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r83",
      "r85",
      "r499",
      "r508"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r556",
      "r557"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r556",
      "r557",
      "r645"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r556",
      "r557",
      "r645"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r175",
      "r176",
      "r556",
      "r557"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of net sales"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r556",
      "r557"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r500",
      "r509",
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of contract balances and changes in contract balances.",
        "label": "Contract with Customer, Asset and Liability [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r304",
      "r306",
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Contract assets, December 31, 2019",
        "periodStartLabel": "Contract assets, December 31, 2018"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r304",
      "r305",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "negatedPeriodEndLabel": "Deferred income, December 31, 2019",
        "negatedPeriodStartLabel": "Deferred income, December 31, 2018",
        "terseLabel": "Contract with customer, liability",
        "verboseLabel": "Deferred income"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.",
        "label": "Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized",
        "terseLabel": "Change in deferred income - (increase) decrease"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r304",
      "r305",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred income, current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r304",
      "r305",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred income, noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was included in the deferred income balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostMethodInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.",
        "label": "Cost Method Investments",
        "verboseLabel": "Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method"
       }
      }
     },
     "localname": "CostMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      },
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedTerseLabel": "Cost of goods and services sold",
        "terseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Goods and Services Sold [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r342",
      "r533"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Cumulative Effect of New Accounting Principle in Period of Adoption",
        "verboseLabel": "Effect of modified retrospective application of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r473",
      "r479"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r476"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r473",
      "r479"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Current income tax provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r473",
      "r479"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer Contracts [Member]"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r16",
      "r18",
      "r19",
      "r607",
      "r612",
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r291",
      "r612",
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.",
        "label": "Debt Instrument, Description of Variable Rate Basis",
        "terseLabel": "Debt Instrument, Description of Variable Rate Basis",
        "verboseLabel": "Variable rate basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r568",
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r51",
      "r293",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Annual effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r52",
      "r550"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "verboseLabel": "Debt instrument, maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r134",
      "r297",
      "r298",
      "r299",
      "r300",
      "r567",
      "r568",
      "r570",
      "r620"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual obligation to pay money on demand or on fixed or determinable dates.",
        "label": "Debt [Member]",
        "terseLabel": "Euro Note B [Member]"
       }
      }
     },
     "localname": "DebtMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities [Member]"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeconsolidationGainOrLossAmount": {
     "auth_ref": [
      "r505"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 3.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.",
        "label": "Deconsolidation, Gain (Loss), Amount",
        "negatedTerseLabel": "Venezuela deconsolidation",
        "terseLabel": "Venezuela deconsolidation"
       }
      }
     },
     "localname": "DeconsolidationGainOrLossAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.",
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]",
        "terseLabel": "Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.",
        "label": "Deferred Compensation, Share-based Payments [Member]",
        "terseLabel": "Deferred Compensation Plans [Member]"
       }
      }
     },
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r43",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs, net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.",
        "label": "Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Adjustment",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "If not separately presented, identifies the caption on the statement of financial position in which the unamortized balance of recognized deferred issuance costs related to an own-share lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, is included.",
        "label": "Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net, Classification",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r475",
      "r479"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r132",
      "r475",
      "r479"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Deferred income tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r21",
      "r22",
      "r463",
      "r609",
      "r622"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r467"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax (liability) asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetNoncurrent": {
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r464"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as noncurrent.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance, Noncurrent",
        "verboseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r439",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "auth_ref": [
      "r439",
      "r471",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "terseLabel": "Operating loss carryforwards, foreign"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r439",
      "r471",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Operating loss carryforwards, state and local"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r440",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r469",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r439",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Pension and deferred compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNoncurrent": {
     "auth_ref": [
      "r446",
      "r448",
      "r449"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.",
        "label": "Deferred Tax Liabilities, Net, Noncurrent",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r440",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r440",
      "r471",
      "r472"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Accelerated depreciation"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "terseLabel": "Tax on undistributed earnings of subsidiaries"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r71",
      "r77"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r77",
      "r356"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Net actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r77",
      "r356"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r334",
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r329"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial (loss) gain",
        "verboseLabel": "Actuarial (loss) gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r351",
      "r372",
      "r377"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Amortization of actuarial loss (gain)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r352",
      "r373",
      "r377"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "negatedTerseLabel": "Prior service credit",
        "terseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation": {
     "auth_ref": [
      "r353",
      "r374"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transition asset (obligation) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Transition Asset (Obligation)",
        "negatedLabel": "Amortization of transition obligation",
        "terseLabel": "Transition obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfTransitionAssetObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]",
        "terseLabel": "Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r15",
      "r322",
      "r323",
      "r339",
      "r605",
      "r625"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Long-term rate of return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r324"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedPeriodEndLabel": "Balance",
        "negatedPeriodStartLabel": "Balance"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r331",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Benefits/expenses paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "negatedTerseLabel": "Participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r342",
      "r343",
      "r362",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in Fair Value of Plan Assets [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r336",
      "r342",
      "r343",
      "r376",
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "negatedTerseLabel": "Employer contribution",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanCurtailments": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment",
        "verboseLabel": "Curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year",
        "terseLabel": "Actuarial net loss that will be amortized from accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year",
        "terseLabel": "Prior service credit that will be amortized from accumulated other comprehensive loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 6.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter",
        "terseLabel": "2025 to 2029"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 1.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in next fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 5.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in fifth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 4.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in fourth fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 3.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in third fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": 2.0,
       "parentTag": "wst_DefinedBenefitPlanExpectedFutureBenefitPayments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of benefits for defined benefit plan expected to be paid in second fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contributions expected to be received by defined benefit plan from employer in next fiscal year following latest fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Expected contribution to the plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r350",
      "r371",
      "r377"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r333",
      "r342",
      "r343",
      "r377"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r322",
      "r339"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year",
        "terseLabel": "Assumed healthcare cost trend rate, benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r327",
      "r349",
      "r370",
      "r377"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedTerseLabel": "Interest cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription": {
     "auth_ref": [
      "r341",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of investment policy and strategy for defined benefit plan asset. Includes, but is not limited to, investment allocation decision and factor pertinent to understanding investment policy and strategy for plan asset. Factor includes, but is not limited to, investment goal, risk management practice, permitted and prohibited investment including use of derivative, diversification, and relationship between plan asset and obligation.",
        "label": "Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Investment Policy and Strategy, Description"
       }
      }
     },
     "localname": "DefinedBenefitPlanInvestmentPoliciesAndStrategiesNarrativeDescription",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r347",
      "r368",
      "r377"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "negatedTerseLabel": "Amendments/transfers in"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r338",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits/expenses paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r341",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target allocation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r354",
      "r375"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "negatedLabel": "Pension curtailment gain",
        "negatedTerseLabel": "Pension settlement charge",
        "verboseLabel": "Curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r354",
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r325",
      "r348",
      "r369",
      "r377"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "negatedTerseLabel": "Service cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Ultimate healthcare cost trend rate, benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Weighted average asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Weighted average assumptions used in benefit obligations:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Weighted average assumptions used in net periodic benefit cost:"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r364",
      "r365",
      "r366",
      "r367",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "verboseLabel": "401 (k) plan contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r121",
      "r244"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r121",
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAveragePriceRiskOptionStrikePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average strike price on the group of price risk option contracts such as put options or call options.",
        "label": "Derivative, Average Price Risk Option Strike Price",
        "terseLabel": "Derivative, Average Price Risk Option Strike Price"
       }
      }
     },
     "localname": "DerivativeAveragePriceRiskOptionStrikePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": {
     "auth_ref": [
      "r526",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings",
        "terseLabel": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings"
       }
      }
     },
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r522",
      "r523",
      "r528",
      "r535"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "verboseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r520",
      "r522",
      "r528"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r520",
      "r522",
      "r528",
      "r535",
      "r536",
      "r540",
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r525",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Amount of (Gain) Loss Reclassified from Accumulated OCI into Income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": {
     "auth_ref": [
      "r526",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.",
        "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net",
        "terseLabel": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r527",
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNonmonetaryNotionalAmount": {
     "auth_ref": [
      "r514",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal number of units used to calculate payment on derivative.",
        "label": "Derivative, Nonmonetary Notional Amount",
        "terseLabel": "Derivative, Nonmonetary Notional Amount"
       }
      }
     },
     "localname": "DerivativeNonmonetaryNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r514",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r140",
      "r513",
      "r515",
      "r516",
      "r520",
      "r521",
      "r524",
      "r528",
      "r537",
      "r539",
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r141",
      "r513",
      "r515",
      "r520",
      "r521",
      "r538"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.",
        "label": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]",
        "terseLabel": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]"
       }
      }
     },
     "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r8",
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends declared, not paid",
        "verboseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.",
        "label": "Domestic Line of Credit [Member]",
        "terseLabel": "Domestic Line of Credit [Member]"
       }
      }
     },
     "localname": "DomesticLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan [Member]"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromAffiliates": {
     "auth_ref": [
      "r139",
      "r592",
      "r593",
      "r594",
      "r636"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Due from Affiliates",
        "terseLabel": "Amount receivable from affiliates"
       }
      }
     },
     "localname": "DueFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrentAndNoncurrent": {
     "auth_ref": [
      "r139",
      "r592",
      "r595",
      "r615",
      "r635",
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Due to Affiliate",
        "terseLabel": "Amount due and payable to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r92",
      "r148",
      "r153",
      "r155",
      "r156",
      "r157",
      "r161",
      "r618",
      "r638"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r92",
      "r148",
      "r153",
      "r155",
      "r156",
      "r157",
      "r161",
      "r618",
      "r638"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r158",
      "r159",
      "r160"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r137",
      "r451",
      "r452"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Reversal of prior valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Impact of 2017 Tax Act"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent",
        "terseLabel": "Venezuela deconsolidation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Tax on international operations other than U.S. tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Excess tax benefits on share-based payments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Adjustments to reserves for unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "terseLabel": "U.S. tax on international earnings, net of foreign tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax effect"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r451",
      "r452",
      "r478"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "U.S. research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unrecognized compensation expense for all nonvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Severance and benefits [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalCostsPolicy": {
     "auth_ref": [
      "r129",
      "r252",
      "r253",
      "r254",
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.",
        "label": "Environmental Costs, Policy [Policy Text Block]",
        "terseLabel": "Environmental Remediation and Compliance Costs"
       }
      }
     },
     "localname": "EnvironmentalCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.",
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]",
        "terseLabel": "Type of Deferred Compensation, All Types [Domain]"
       }
      }
     },
     "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/ComponentsofAOCIDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r91",
      "r116",
      "r121",
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends received from affiliated companies"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r39",
      "r188",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r214",
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Affiliated Companies"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompanies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r12",
      "r17",
      "r209",
      "r614",
      "r624",
      "r648"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r547",
      "r548",
      "r549",
      "r555"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r342",
      "r343",
      "r377",
      "r548",
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r342",
      "r343",
      "r377",
      "r548",
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r342",
      "r343",
      "r377",
      "r548",
      "r601"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r342",
      "r343",
      "r377",
      "r548",
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Level 3 Fair Value Measurements [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r551",
      "r555"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Changes in Level 3 Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Increase (reduction) in fair value recorded in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r578",
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
        "terseLabel": "Estimated annual amortization expense, 2020"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r229",
      "r231",
      "r235",
      "r239",
      "r604"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation gains (losses)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r235",
      "r604"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-lived intangible assets, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r229",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign currency contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign currency contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.",
        "label": "Foreign Currency Exchange Rate, Remeasurement",
        "terseLabel": "Foreign currency exchange rate, remeasurement"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateRemeasurement1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignCurrencyGainLossMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing foreign currency gain (loss).",
        "label": "Foreign Currency Gain (Loss) [Member]",
        "terseLabel": "Foreign Exchange (Gains) Losses and Other [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainBeforeTax": {
     "auth_ref": [
      "r558",
      "r559",
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain, before Tax",
        "terseLabel": "Foreign Currency Transaction Gain"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r558",
      "r559",
      "r560"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 4.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Argentina currency devaluation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r122",
      "r558",
      "r559",
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "terseLabel": "Foreign Currency Transaction (Loss)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionLossBeforeTax": {
     "auth_ref": [
      "r558",
      "r559",
      "r560"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 2.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.",
        "label": "Foreign Currency Transaction Loss, before Tax",
        "terseLabel": "Venezuela currency devaluation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r560",
      "r563"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r342",
      "r532"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Currency Hedge Contracts [Member]",
        "verboseLabel": "Foreign Currency Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward [Member]"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.",
        "label": "Foreign Line of Credit [Member]",
        "terseLabel": "Foreign Line of Credit [Member]"
       }
      }
     },
     "localname": "ForeignLineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan [Member]"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts [Member]"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Gain (Loss) on Derivative Instruments, Net, Pretax"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "terseLabel": "Gain (Loss) on Disposition of Assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnOilAndGasHedgingActivity": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gain (loss) incurred in hedging activities.",
        "label": "Gain (Loss) on Hedging Activity",
        "terseLabel": "Gain (Loss) on Hedging Activity"
       }
      }
     },
     "localname": "GainLossOnOilAndGasHedgingActivity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on sales of equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "terseLabel": "Gain (Loss) on Sale of Assets and Asset Impairment Charges"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk [Member]"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r221",
      "r222"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill recorded due to acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r225",
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r520",
      "r536"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r241",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-Process Research and Development (IPR&amp;D) [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails",
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r91",
      "r121",
      "r185",
      "r210",
      "r617",
      "r637"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net income of affiliated companies"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedTerseLabel": "Equity in undistributed earnings of affiliates, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r186",
      "r483"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Tax expense",
        "terseLabel": "Income tax expense",
        "totalLabel": "Income tax expense",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r129",
      "r444",
      "r445",
      "r461",
      "r462",
      "r468",
      "r484",
      "r650"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Increase in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Other increase (decrease) in deferred income"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInCustomerAdvances": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.",
        "label": "Increase (Decrease) in Customer Advances",
        "terseLabel": "Customer advance cash payments"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerAdvances",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets/liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedTerseLabel": "Decrease (increase) in other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Changes in other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "verboseLabel": "Changes in the Components of Accumulated Other Comprehensive Loss, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r154",
      "r159"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Assumed stock options exercised and awards vested, based on the treasury stock method (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r230",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r230",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Axis]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Domain]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceClaimsMember": {
     "auth_ref": [
      "r279",
      "r643"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A demand for payment of a policy benefit because of the occurrence of an insured event, such as the death or disability of the insured; the maturity of an endowment; the incurrence of hospital or medical bills; the destruction or damage of property and related deaths or injuries; defects in, liens on, or challenges to the title to real estate; or the occurrence of a surety loss; and the costs to process claims.",
        "label": "Insurance Claims [Member]",
        "terseLabel": "Insurance Claims [Member]"
       }
      }
     },
     "localname": "InsuranceClaimsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r227",
      "r233"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Capitalized interest"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r89",
      "r183",
      "r565",
      "r569",
      "r619"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      },
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r98",
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r112",
      "r118",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid, net of amounts capitalized"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeLiabilitiesAtFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.",
        "label": "Interest Rate Derivative Liabilities, at Fair Value",
        "terseLabel": "Interest rate swap contracts"
       }
      }
     },
     "localname": "InterestRateDerivativeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap Contracts [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS) [Member]"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination [Member]"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Inventory balance for recalled product"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueVoluntaryRecallDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r32",
      "r220"
     ],
     "calculation": {
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r2",
      "r59",
      "r217"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r60",
      "r129",
      "r165",
      "r218",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r220"
     ],
     "calculation": {
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r33",
      "r220"
     ],
     "calculation": {
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in affiliated companies"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r589",
      "r591"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
        "label": "Leases of Lessee Disclosure [Text Block]",
        "terseLabel": "Leases of Lessee Disclosure"
       }
      }
     },
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "terseLabel": "Operating lease liability payments due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed lease interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating leases, option to extend"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit [Member]"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r613",
      "r632"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r19",
      "r612",
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Letters of credit supporting the reimbursement of workers' compensation and other claims",
        "verboseLabel": "Outstanding amount"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, unused commitment level"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates an ownership position in, or purchase of, a security.",
        "label": "Long [Member]",
        "terseLabel": "Long [Member]"
       }
      }
     },
     "localname": "LongMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r19",
      "r292",
      "r612",
      "r630"
     ],
     "calculation": {
      "http://www.westpharma.com/role/DebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Aggregate annual maturities of long-term debt [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Long-term debt, current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term Debt, Fair Value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r143",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months",
        "terseLabel": "Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r143",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r143",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r143",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r143",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r143",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/DebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt, excluding current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails",
      "http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r53",
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit, Noncurrent",
        "terseLabel": "Line of credit, noncurrent"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r53",
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average of the coupon interest rate"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrual for insurance obligations"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyReceivable": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.",
        "label": "Loss Contingency, Receivable",
        "terseLabel": "Amount reimbursable by the insurance company"
       }
      }
     },
     "localname": "LossContingencyReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r117",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedges [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPrinciplesEarlyAdoptionMember": {
     "auth_ref": [
      "r147",
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents a group of guidance that has been adopted early.",
        "label": "New Accounting Principles, Early Adoption [Domain]",
        "terseLabel": "New Accounting Principles, Early Adoption [Domain]"
       }
      }
     },
     "localname": "NewAccountingPrinciplesEarlyAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementEarlyAdoptionAxis": {
     "auth_ref": [
      "r147",
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The financial statement line items and the effect of the guidance on financial statement line items by guidance implemented if the entity elects earlier application.",
        "label": "New Accounting Pronouncement, Early Adoption [Axis]",
        "terseLabel": "New Accounting Pronouncement, Early Adoption [Axis]"
       }
      }
     },
     "localname": "NewAccountingPronouncementEarlyAdoptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NewAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r147",
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotionalAmountOfNonderivativeInstruments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on a nonderivative instrument.",
        "label": "Notional Amount of Nonderivative Instruments",
        "terseLabel": "Notional amount, nonderivative instruments"
       }
      }
     },
     "localname": "NotionalAmountOfNonderivativeInstruments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTextualsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating profit",
        "totalLabel": "Operating profit"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r582",
      "r591"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r578"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r578"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r579",
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r577"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r588",
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate for operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseWeightedAverageDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r587",
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term for operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseWeightedAverageDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "verboseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionMember": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).",
        "label": "Options Held [Member]",
        "terseLabel": "Commodity Call Options [Member]",
        "verboseLabel": "Commodity Call Options Held [Member]"
       }
      }
     },
     "localname": "OptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Commodity call options"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r72",
      "r74",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service credit arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r72",
      "r74",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "negatedTerseLabel": "Prior service cost arising during period, net of tax of $0"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r69",
      "r74",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Net actuarial (loss) gain arising during period, net of tax of $(0.3), $(0.2) and $1.3"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "terseLabel": "Net actuarial gain (loss) arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedTerseLabel": "Amortization of prior service credit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Less: amortization of prior service credit, net of tax of $(0.1), $(0.5) and $(0.5)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Less: amortization of prior service credit, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r66",
      "r67",
      "r74"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax",
        "terseLabel": "Net loss on investment securities, net of tax of $0, $(0.1) and $(2.5)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r66",
      "r67",
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax",
        "terseLabel": "Net gain (loss) on investment securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r77",
      "r87"
     ],
     "calculation": {
      "http://www.westpharma.com/role/ComponentsofAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive (loss) income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "terseLabel": "Net (loss) gain on derivatives, net of tax of $(0.2), $1.5 and $(0.1)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax": {
     "auth_ref": [
      "r65",
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax",
        "terseLabel": "Net gain (loss) on derivatives, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "negatedTerseLabel": "Curtailment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r63",
      "r562"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r87",
      "r296"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/ComponentsofAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss), net of tax",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r71",
      "r74"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "totalLabel": "Total recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": {
     "auth_ref": [
      "r75",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax",
        "terseLabel": "Prior service credit arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r69",
      "r74",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "negatedTerseLabel": "Net loss (gain) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Amortization of actuarial (loss) gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Less: amortization of actuarial (gain) loss, net of tax of $0, $0.3 and $0.5"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "negatedTerseLabel": "Less: amortization of actuarial loss, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Amortization of transition obligation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r355"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Less: amortization of transition obligation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r65",
      "r74",
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Amount of Gain (Loss) Recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r318",
      "r437"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "verboseLabel": "Other (Income) Expense"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r450",
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "Other Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "Other Income Tax Expense (Benefit), Continuing Operations"
       }
      }
     },
     "localname": "OtherIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r48"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other nonoperating expense (income)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other Operating Income (Expense)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 7.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other items"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r321",
      "r364",
      "r365",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r611",
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability for retirement benefits, classified as other.",
        "label": "Liability, Other Retirement Benefits",
        "terseLabel": "Accrued retirement plans (excluding pension)"
       }
      }
     },
     "localname": "OtherPostretirementBenefitsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r121",
      "r256",
      "r262",
      "r268"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other charges",
        "verboseLabel": "Other restructuring charges"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other charges [Member]"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Given",
        "terseLabel": "Purchase of investment in affiliated companies, treasury stock"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "negatedTerseLabel": "Contingent consideration payments in excess of acquisition-date liability"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r101",
      "r104",
      "r142"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Shares repurchased under share repurchase program"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r114",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividend payments"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r102",
      "r493"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Acquisition of business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Purchase of investment in affiliated companies",
        "terseLabel": "Purchase in investment in affiliated companies in cash"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "verboseLabel": "Payments to Acquire Property, Plant, and Equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]",
        "verboseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r18",
      "r322",
      "r323",
      "r339"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities",
        "verboseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r322",
      "r339",
      "r611",
      "r629"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Liability, Defined Benefit Plan",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r20",
      "r322",
      "r323",
      "r339"
     ],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities",
        "verboseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r129",
      "r364",
      "r379",
      "r380",
      "r382",
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r320",
      "r364",
      "r365",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance-Vesting Shares [Member]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r388",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding in 2019 and 2018"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.",
        "label": "Proceeds from Issuance of Other Long-term Debt",
        "terseLabel": "Issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r105",
      "r422"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from stock-based compensation awards"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Borrowings under revolving credit agreements"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Employee stock purchase plan contributions"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r107",
      "r111",
      "r142"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Contingent consideration payments up to amount of acquisition-date liability"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk [Member]"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r81",
      "r84",
      "r115",
      "r187",
      "r194",
      "r499",
      "r501",
      "r502",
      "r507",
      "r508"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income, as reported, for basic net income per share"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r42",
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r129",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r41",
      "r245"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r247",
      "r633"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r40",
      "r129",
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r13",
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r13",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r77",
      "r80",
      "r87"
     ],
     "calculation": {
      "http://www.westpharma.com/role/ComponentsofAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ComponentsofAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r190",
      "r192"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r109",
      "r135"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayments of Lines of Credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayments of Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r438",
      "r652"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r129",
      "r438"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward [Member]"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r257",
      "r259",
      "r266",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and Related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r257",
      "r259",
      "r266",
      "r269"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 1.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Charges",
        "totalLabel": "Total restructuring and related charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r121",
      "r256",
      "r262",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r258",
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance, December 31, 2018",
        "periodStartLabel": "Balance, December 31, 2017",
        "terseLabel": "Restructuring obligations"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r256",
      "r263"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedLabel": "Non-cash asset write-downs",
        "terseLabel": "Non-cash restructuring charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r301",
      "r631"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees": {
     "auth_ref": [
      "r596"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consolidated retained earnings that represent undistributed (not yet received) earnings from 50% or less owned persons accounted for by the equity method (equity method investees).",
        "label": "Retained Earnings, Undistributed Earnings from Equity Method Investees",
        "terseLabel": "Unremitted income of affiliated companies"
       }
      }
     },
     "localname": "RetainedEarningsUndistributedEarningsFromEquityMethodInvestees",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r365",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r365",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r320",
      "r321",
      "r364",
      "r365",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r320",
      "r321",
      "r364",
      "r365",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails",
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails",
      "http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue Recognition and Deferred Revenue [Abstract]",
        "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAndDeferredRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r90",
      "r181",
      "r182",
      "r193"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net sales",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/ComponentsofAOCIDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r586",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Allocation of Share-based Compensation Costs by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Long-term Debt Obligations , Net of Current Maturities"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r364",
      "r365",
      "r366",
      "r367",
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails",
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r522",
      "r528",
      "r536"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and earnings"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r140",
      "r513",
      "r515",
      "r516",
      "r520",
      "r521",
      "r524",
      "r528",
      "r537",
      "r539"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Outstanding Foreign Currency Contracts"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconcilliation of Basic to Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of Sales by Significant Product Group"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r229",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r225",
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r225",
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r10",
      "r35",
      "r36",
      "r37"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Summary of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r147",
      "r149",
      "r163",
      "r164",
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]",
        "terseLabel": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-based Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-based Share Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r527",
      "r529"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r42",
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r260",
      "r261",
      "r265"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r258",
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Obligations"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r93",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Sales and Net Property, Plant and Equipment, by Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r88",
      "r90",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r180",
      "r187",
      "r189",
      "r191",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r180",
      "r187",
      "r189",
      "r191",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r388",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Appreciation Rights Award Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r394",
      "r407",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r460",
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureOfMajorCustomers": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of the extent of enterprise reliance on its major customers. For example, includes revenues from transactions with a single external customer amounting to 10 percent or more of the entity's revenues, the total amount of revenues from each such customer, and the identity of the segment or segments reporting the revenues. A group of entities that the entity knows to be under common control generally will be considered a single customer for inclusion in this item. The federal government, a state government, a local government (for example, a county or municipality), or a foreign government each will generally be considered as a single customer for inclusion in this item.",
        "label": "Segment Reporting, Disclosure of Major Customers",
        "terseLabel": "Disclosure of major customers"
       }
      }
     },
     "localname": "SegmentReportingDisclosureOfMajorCustomers",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Items [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r96",
      "r216"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r121",
      "r256",
      "r262",
      "r268"
     ],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringAndRelatedCostIncurredCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance charges",
        "verboseLabel": "Severance and post-employment benefits"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted at target level",
        "verboseLabel": "Granted at target level"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted at target level"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending",
        "periodStartLabel": "Outstanding, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Non-vested PSU Awards [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, ending (in USD per share)",
        "periodStartLabel": "Outstanding, beginning (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Non-vested PSU Awards, Weighted Average Grant Date Fair Value [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Average remaining term of shares issued at conversion"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested and converted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested and converted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Stock volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Limitation on payroll deductions of employee's base salary, percent"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of non-option equity instruments exercised by participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised",
        "negatedTerseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "negatedTerseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r395",
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending",
        "periodStartLabel": "Outstanding, beginning",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "SARs Activity [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant/issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Options exercisable (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of total options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r396",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, ending",
        "periodStartLabel": "Options outstanding, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options Activity [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, ending (in USD per share)",
        "periodStartLabel": "Options outstanding, beginning (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Stock Options, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of total options vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r385",
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r129",
      "r388",
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Awards, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r413",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Grant date fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of current market price for sales to eligible employees"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Shares repurchased for employee tax withholdings (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates the sale of a borrowed security or written option.",
        "label": "Short [Member]",
        "terseLabel": "Short [Member]"
       }
      }
     },
     "localname": "ShortMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r583",
      "r591"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Estimated reduction in the liability for unrecognized tax benefits"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r187",
      "r225",
      "r249",
      "r259",
      "r269",
      "r639"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r57",
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/ComponentsofAOCIDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs) [Member]"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r24",
      "r25",
      "r296",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Purchases of shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r296",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares issued under stock plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r296",
      "r301",
      "r400"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r57",
      "r296",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Purchase of investment in affiliated companies"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r301",
      "r387",
      "r408"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Activity related to stock-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Share repurchase program, number of shares authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r497",
      "r498",
      "r506"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary of Investment Holdings [Line Items]",
        "terseLabel": "Summary of Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsTable": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The summary of investment holding table is used for any listing of investment in a summary form. Table lists the 50 largest investments and any other investment the value of which exceeded one percent of net asset value of the registrant as of the close of the period.",
        "label": "Summary of Investment Holdings [Table]",
        "terseLabel": "Summary of Investment Holdings [Table]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax": {
     "auth_ref": [
      "r471"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in deferred tax liability previously recognized attributable to taxable temporary differences from undistributed earnings of foreign subsidiary and other recognized entity now subject to transition tax.",
        "label": "Tax Cuts and Jobs Act, Decrease in Deferred Tax Liability due to Transition Tax",
        "terseLabel": "Reduction in Transition Tax, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense": {
     "auth_ref": [
      "r480"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of reasonable estimate for income tax expense for which accounting for tax effect from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated is incomplete pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense",
        "terseLabel": "Provisional Transition Tax, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)",
        "terseLabel": "Measurement period adjustment, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of increase (decrease) in effective tax rate for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Increase (Decrease) in Effective Tax Rate",
        "negatedTerseLabel": "Net impact to the 2018 effective tax rate, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense": {
     "auth_ref": [
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Income Tax Expense",
        "terseLabel": "Transitional Tax, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ToolsDiesAndMoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale.",
        "label": "Tools, Dies and Molds [Member]",
        "terseLabel": "Molds and Dies [Member]"
       }
      }
     },
     "localname": "ToolsDiesAndMoldsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount": {
     "auth_ref": [
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount",
        "terseLabel": "Transfer of accounts receivable under supply chain financing agreements"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period.",
        "label": "Treasury Lock [Member]",
        "terseLabel": "Forward Treasury Locks [Member]"
       }
      }
     },
     "localname": "TreasuryLockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails",
      "http://www.westpharma.com/role/ReclassificationsAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Shares purchased under share repurchase program, average cost per share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r56",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r56",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, at cost (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r25",
      "r296",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Shares purchased under share repurchase program (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r56",
      "r302",
      "r303"
     ],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost (1.2 million and 1.2 million shares in 2019 and 2018)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r296",
      "r301",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Shares purchased under share repurchase program",
        "terseLabel": "Shares purchased under share repurchase program"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
        "label": "Type of Adoption [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details",
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
      "http://www.westpharma.com/role/NewAccountingStandardsDetails",
      "http://www.westpharma.com/role/RevenueAdoptionofASC606Details",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized debt issuance expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r441",
      "r485",
      "r621",
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r443",
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1",
        "terseLabel": "Total gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails",
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued liabilities for interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase due to current year position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase due to prior year position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Reduction for expiration of statute of limitations/audits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": {
     "auth_ref": [
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months",
        "terseLabel": "Outstanding uncondintional contractual commitments due to be paid in 2020"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": {
     "auth_ref": [
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).",
        "label": "Unrecorded Unconditional Purchase Obligation",
        "terseLabel": "Outstanding unconditional contractual commitments for the purchase of raw materials, utilities and equipment"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Unrecorded Unconditional Purchase Obligation [Line Items]",
        "terseLabel": "Unrecorded Unconditional Purchase Obligation [Line Items]"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationTable": {
     "auth_ref": [
      "r270",
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes each unrecorded unconditional purchase obligation arrangement to purchase goods and services that extend over multiple periods, any assets pledged to secure payment, and the fixed or determinable amount of payments due in each of the next five years and thereafter.",
        "label": "Unrecorded Unconditional Purchase Obligation [Table]",
        "terseLabel": "Unrecorded Unconditional Purchase Obligation [Table]"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r171",
      "r177",
      "r178",
      "r179"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred Tax Asset Valuation Allowance [Member]"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r584",
      "r591"
     ],
     "calculation": {
      "http://www.westpharma.com/role/LeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/LeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r152",
      "r157"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares assuming dilution (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r151",
      "r157"
     ],
     "calculation": {
      "http://www.westpharma.com/role/NetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_A2016RestructuringPlanMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2016 Restructuring Plan [Member] [Member]",
        "label": "2016 Restructuring Plan [Member] [Member]",
        "terseLabel": "2016 Restructuring Plan [Member] [Member]"
       }
      }
     },
     "localname": "A2016RestructuringPlanMemberMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails",
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_A2018RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2018 Restructuring Plan [Member]",
        "label": "2018 Restructuring Plan [Member]",
        "terseLabel": "2018 Restructuring Plan [Member]"
       }
      }
     },
     "localname": "A2018RestructuringPlanMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_AccruedSalariesWagesAndBenefitsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Salaries, Wages, and Benefits, Current",
        "label": "Accrued Salaries, Wages, and Benefits, Current",
        "terseLabel": "Accrued Salaries, Wages, and Benefits, Current"
       }
      }
     },
     "localname": "AccruedSalariesWagesAndBenefitsCurrent",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect",
        "label": "Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect",
        "terseLabel": "Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AluplastSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aluplast S.A. de C.V. [Member]",
        "label": "Aluplast S.A. de C.V. [Member]",
        "terseLabel": "Aluplast S.A. de C.V. [Member]"
       }
      }
     },
     "localname": "AluplastSADeCVMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_AssetImpairmentChargesPatent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of patent recognized in the income statement",
        "label": "Asset Impairment Charges, Patent",
        "terseLabel": "Asset impairment charges, patent"
       }
      }
     },
     "localname": "AssetImpairmentChargesPatent",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AssetImpairmentChargesPatentandEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of a patent and certain equipment, recognized in the income statement.",
        "label": "Asset Impairment Charges, Patent and Equipment",
        "verboseLabel": "Asset impairment charges, patent and equipment"
       }
      }
     },
     "localname": "AssetImpairmentChargesPatentandEquipment",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails",
      "http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AssetImpairmentChargesTrademark": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of trademark recognized in the income statement.",
        "label": "Asset Impairment Charges, Trademark",
        "terseLabel": "Asset impairment charges, trademark"
       }
      }
     },
     "localname": "AssetImpairmentChargesTrademark",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AssetRelatedChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset-Related Charges [Member]",
        "label": "Asset-Related Charges [Member]",
        "terseLabel": "Asset-related charges [Member]"
       }
      }
     },
     "localname": "AssetRelatedChargesMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_AssetsDefinedBenefitPlansNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent",
        "label": "Assets, Defined Benefit Plans, Noncurrent",
        "terseLabel": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansAssetsNoncurrent"
       }
      }
     },
     "localname": "AssetsDefinedBenefitPlansNoncurrent",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award Types Other than Stock Options and Stock Appreciation Rights [Member]",
        "label": "Award Types Other than Stock Options and Stock Appreciation Rights [Member]",
        "terseLabel": "Award Types Other than Stock Options and Stock Appreciation Rights [Member]"
       }
      }
     },
     "localname": "AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_BalancedMutualFundMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Balanced Mutual Fund [Member]",
        "label": "Balanced Mutual Fund [Member]",
        "terseLabel": "Balanced Mutual Fund [Member]"
       }
      }
     },
     "localname": "BalancedMutualFundMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_BiologicsCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Biologics Customers [Member]",
        "label": "Biologics Customers [Member]",
        "terseLabel": "Biologics Customers [Member]"
       }
      }
     },
     "localname": "BiologicsCustomersMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_CashSettledPSUAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash-settled PSU awards [Member]",
        "label": "Cash-settled PSU awards [Member]",
        "terseLabel": "Cash-settled PSU awards [Member]"
       }
      }
     },
     "localname": "CashSettledPSUAwardsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_CashSettledStockAppreciationRIghtsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of cash-settled stock appreciation rights outstanding.",
        "label": "Cash-Settled Stock Appreciation RIghts, Outstanding",
        "terseLabel": "Cash-settled SARs, outstanding"
       }
      }
     },
     "localname": "CashSettledStockAppreciationRIghtsOutstanding",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ComputerHardwareAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Computer Hardware and Software [Member]",
        "label": "Computer Hardware and Software [Member]",
        "terseLabel": "Computer Hardware and Software [Member]"
       }
      }
     },
     "localname": "ComputerHardwareAndSoftwareMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Consideration Arrangements, Range of Outcomes, Payable Period",
        "label": "Contingent Consideration Arrangements, Range of Outcomes, Payable Period",
        "terseLabel": "Contingent consideration, payable period"
       }
      }
     },
     "localname": "ContingentConsiderationArrangementsRangeofOutcomesPayablePeriod",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "wst_ContractManufacturedCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract-Manufactured Customers [Member]",
        "label": "Contract-Manufactured Customers [Member]",
        "terseLabel": "Contract-Manufactured Customers [Member]"
       }
      }
     },
     "localname": "ContractManufacturedCustomersMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContractManufacturedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract Manufactured Products [Member]",
        "label": "Contract Manufactured Products [Member]",
        "terseLabel": "Contract Manufactured Products [Member]",
        "verboseLabel": "Contract-Manufactured Products [Member]"
       }
      }
     },
     "localname": "ContractManufacturedProductsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with Customer, Liability, Increase (Decrease) due to Additional Cash Payments",
        "label": "Contract with Customer, Liability, Increase (Decrease) due to Additional Cash Payments",
        "terseLabel": "Cash payments received in advance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ContractsandLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts and Liabilities [Abstract]",
        "label": "Contracts and Liabilities [Abstract]",
        "terseLabel": "Contracts and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ContractsandLiabilitiesAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_ContractwithCustomerAssetIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with Customer, Asset, Increase (Decrease)",
        "label": "Contract with Customer, Asset, Increase (Decrease)",
        "terseLabel": "Change in contract assets - increase (decrease)"
       }
      }
     },
     "localname": "ContractwithCustomerAssetIncreaseDecrease",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_CorporateAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarter items not allocated to segments and intersegment transactions (e.g. intersegment profits). Reconciliation of the total of reportable segments' amounts of revenues, measures of profits or loss, assets, or amounts for every other significant item of information disclosed, to the consolidated amount.",
        "label": "Corporate and Eliminations [Member]",
        "terseLabel": "Corporate and Eliminations [Member]"
       }
      }
     },
     "localname": "CorporateAndEliminationsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_CreditAvailableForIssuanceOfLettersOfCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "this refers to Credit available for the issuance of letters of credit",
        "label": "Credit available for the issuance of letters of credit",
        "terseLabel": "Credit available for the issuance of letters of credit"
       }
      }
     },
     "localname": "CreditAvailableForIssuanceOfLettersOfCredit",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_CreditFacilityIsAvailableForSwingLineLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This refers to credit facility is available for swing-line loans",
        "label": "Credit facility is available for swing-line loans",
        "terseLabel": "Credit Facility is available for swing-line loans"
       }
      }
     },
     "localname": "CreditFacilityIsAvailableForSwingLineLoans",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DaikyoSeikoLtdDaikyoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Daikyo Seiko, Ltd. (Daikyo) [Member]",
        "label": "Daikyo Seiko, Ltd. (Daikyo) [Member]",
        "terseLabel": "Daikyo Seiko, Ltd. [Member]"
       }
      }
     },
     "localname": "DaikyoSeikoLtdDaikyoMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails",
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_DebtYenDenominatedMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An obligation resulting from borrowing money.",
        "label": "Debt Yen Denominated [Member]",
        "verboseLabel": "Debt Yen Denominated [Member]"
       }
      }
     },
     "localname": "DebtYenDenominatedMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualNumberOfPlans": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Compensation Arrangement with Individual, Number of Plans",
        "label": "Deferred Compensation Arrangement with Individual, Number of Plans",
        "terseLabel": "Number of deferred compensation plans"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualNumberOfPlans",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Compensation Arrangement with Individual, Share Equivalents Balance",
        "label": "Deferred Compensation Arrangement with Individual, Share Equivalents Balance",
        "terseLabel": "Number of deferred stock units"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualShareEquivalentsBalance",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredCompensationArrangementwithIndividualConversionUnit": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Conversion unit of deferred stock units",
        "label": "Deferred Compensation Arrangement with Individual, Conversion Unit",
        "terseLabel": "Deferred compensation conversion unit"
       }
      }
     },
     "localname": "DeferredCompensationArrangementwithIndividualConversionUnit",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Federal, State and Local Income Tax Expense (Benefit)",
        "label": "Deferred Federal, State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Federal and state"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DeferredStockUnitsPayableinCash": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Stock Units Payable in Cash",
        "label": "Deferred Stock Units Payable in Cash",
        "terseLabel": "Number of deferred stock units payable in cash"
       }
      }
     },
     "localname": "DeferredStockUnitsPayableinCash",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring and Impairment Charges",
        "terseLabel": "Restructuring and impairment charges"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringAndImpairmentCharges",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets",
        "label": "Defined Benefit Plan, Assumptions Used in Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets, Percentage of Total Plan Assets",
        "terseLabel": "Percentage of global plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedInCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssetsPercentageOfTotalPlanAssets",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income",
        "label": "Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income",
        "terseLabel": "Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income",
        "totalLabel": "Total recognized in net periodic benefit cost and OCI"
       }
      }
     },
     "localname": "DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanExpectedFutureBenefitPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan, Expected Future Benefit Payments",
        "label": "Defined Benefit Plan, Expected Future Benefit Payments",
        "totalLabel": "Total benefit payments expected"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPayments",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year, Net Periodic Benefit Cost",
        "terseLabel": "Assumed healthcare cost trend rate, net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYearNetPeriodicBenefitCost",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate, Net Periodic Benefit Cost",
        "terseLabel": "Ultimate healthcare cost trend rate, net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRateNetPeriodicBenefitCost",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTextualsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_DeliveryDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Delivery Devices [Member]",
        "label": "Delivery Devices [Member]",
        "terseLabel": "Delivery Devices [Member]"
       }
      }
     },
     "localname": "DeliveryDevicesMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings within the next 12 months",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings within Twelve Months",
        "terseLabel": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings within Twelve Months"
       }
      }
     },
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarningsWithinTwelveMonths",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_Developmentandlicensingincome": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": 5.0,
       "parentTag": "wst_OtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.",
        "label": "Development and licensing income",
        "negatedTerseLabel": "Development and licensing income",
        "terseLabel": "Development and licensing income"
       }
      }
     },
     "localname": "Developmentandlicensingincome",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDetails",
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_DevelopmentandlicensingincomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Development and licensing income [Table]",
        "label": "Development and licensing income [Line Items]",
        "terseLabel": "Development and licensing income [Line Items]"
       }
      }
     },
     "localname": "DevelopmentandlicensingincomeLineItems",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_DevelopmentandlicensingincomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Development and licensing income [Table]",
        "label": "Development and licensing income [Table]",
        "terseLabel": "Development and licensing income [Table]"
       }
      }
     },
     "localname": "DevelopmentandlicensingincomeTable",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Document and Entity Information [Abstract]",
        "terseLabel": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, General Business Credits and Section 199 Deduction",
        "label": "Effective Income Tax Rate Reconciliation, General Business Credits and Section 199 Deduction",
        "terseLabel": "Other business credits and Section 199 Deduction"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Undistributed Earnings of Subsidiaries, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Undistributed Earnings of Subsidiaries, Percentage",
        "terseLabel": "Tax on undistributed earnings of subsidiaries"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_EmployeeStockPurchasePlanEsppMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan (ESPP) [Member]",
        "label": "Employee Stock Purchase Plan (ESPP) [Member]",
        "terseLabel": "Employee Stock Purchase Plan (ESPP) [Member]"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanEsppMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_EuroDenominatedRevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Euro-Denominated Revolver [Member]",
        "label": "Euro-Denominated Revolver [Member]",
        "terseLabel": "Euro-Denominated Revolver [Member]"
       }
      }
     },
     "localname": "EuroDenominatedRevolverMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ExpirationPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expiration Period [Axis]",
        "label": "Expiration Period [Axis]",
        "terseLabel": "Expiration Period [Axis]"
       }
      }
     },
     "localname": "ExpirationPeriodAxis",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ExpirationPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Expiration Period [Axis]",
        "label": "Expiration Period [Domain]",
        "terseLabel": "Expiration Period [Domain]"
       }
      }
     },
     "localname": "ExpirationPeriodDomain",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign currency-denominated debt designated as a hedge of our net investments in foreign operations.",
        "label": "Foreign Currency, Denominated Debt [Member]",
        "terseLabel": "Foreign Currency - Denominated Debt [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ForwardStartInterestRateSwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward-start interest rate swap",
        "label": "Forward Start Interest Rate Swap [Member]",
        "terseLabel": "Forward-Start Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "ForwardStartInterestRateSwapMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ForwardTreasuryLockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Forward treasury lock [Member]",
        "terseLabel": "Forward Treasury Lock [Member]"
       }
      }
     },
     "localname": "ForwardTreasuryLockMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_GenericsCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generics Customers [Member]",
        "label": "Generics Customers [Member]",
        "terseLabel": "Generics Customers [Member]"
       }
      }
     },
     "localname": "GenericsCustomersMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_HighValueComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "High-Value Components [Member]",
        "label": "High-Value Components [Member]",
        "terseLabel": "High-Value Components [Member]"
       }
      }
     },
     "localname": "HighValueComponentsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_IWPharmaGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "I&amp;W Pharma Group LLC",
        "label": "I&amp;W Pharma Group LLC [Member]",
        "terseLabel": "I&amp;W Pharma Group LLC"
       }
      }
     },
     "localname": "IWPharmaGroupLLCMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_IncentiveStockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incentive Stock Awards [Member]",
        "label": "Incentive Stock Awards [Member]",
        "terseLabel": "Incentive Stock Awards [Member]",
        "verboseLabel": "Annual Incentive Plan [Member]"
       }
      }
     },
     "localname": "IncentiveStockAwardsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_IndexedMutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indexed Mutual Funds [Member]",
        "label": "Indexed Mutual Funds [Member]",
        "terseLabel": "Indexed Mutual Funds [Member]"
       }
      }
     },
     "localname": "IndexedMutualFundsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_InternationalMutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "International Mutual Funds [Member]",
        "label": "International Mutual Funds [Member]",
        "terseLabel": "International Mutual Funds [Member]"
       }
      }
     },
     "localname": "InternationalMutualFundsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_LeaseOperatingLeaseTerminateTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "lease, operating lease, terminate term",
        "label": "Lease, operating lease, terminate term",
        "terseLabel": "Lease, operating lease, terminate term"
       }
      }
     },
     "localname": "LeaseOperatingLeaseTerminateTerm",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AdoptionofASC842Details"
     ],
     "xbrltype": "pureItemType"
    },
    "wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal Matters, Contingencies and Legal Costs [Policy Text Block]",
        "label": "Legal Matters, Contingencies and Legal Costs [Policy Text Block]",
        "terseLabel": "Litigation"
       }
      }
     },
     "localname": "LegalMattersContingenciesAndLegalCostsPolicyTextBlock",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "lessee, lease Cash Flow and Supplemental information [Table Text Block]",
        "label": "lessee, lease Cash Flow and Supplemental information [Table Text Block]",
        "terseLabel": "lessee, lease Cash Flow and Supplemental information"
       }
      }
     },
     "localname": "LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_LineofCreditFacilityAdditionalBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional borrowing capacity under the credit facility.",
        "label": "Line of Credit Facility Additional Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, additional borrowing capacity"
       }
      }
     },
     "localname": "LineofCreditFacilityAdditionalBorrowingCapacity",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_MutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Mutual Funds [Member]",
        "label": "Mutual Funds [Member]",
        "terseLabel": "Mutual Funds [Member]"
       }
      }
     },
     "localname": "MutualFundsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_NetSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net sales member",
        "label": "Net Sales [Member]",
        "terseLabel": "Net Sales [Member]"
       }
      }
     },
     "localname": "NetSalesMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_NotePayableDue2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Note Payable Due 2019 [Member]",
        "label": "Note Payable Due 2019 [Member]",
        "terseLabel": "Note Payable Due 2019 [Member]"
       }
      }
     },
     "localname": "NotePayableDue2019Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_NotesPayableAndOtherDebtCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notes Payable and Other Debt, Current",
        "label": "Notes Payable and Other Debt, Current",
        "terseLabel": "Notes payable and other current debt"
       }
      }
     },
     "localname": "NotesPayableAndOtherDebtCurrent",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes",
        "label": "OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax",
        "terseLabel": "Settlement effects arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The adjustment out of other comprehensive income for settlement effects recognized as a component of net periodic benefit cost during the period, net of tax.",
        "label": "Other Comprehensive Loss, Defined Benefit Plans Settlement Effects, Net of Tax",
        "negatedTerseLabel": "Settlement effects arising during period, net of tax of $0.8"
       }
      }
     },
     "localname": "OtherComprehensiveLossDefinedBenefitPlansSettlementEffectsNetofTax",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Non-European Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_OtherCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Current Liabilities [Abstract]",
        "label": "Other Current Liabilities [Abstract]",
        "terseLabel": "Other Current Liabilities [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_OtherEuropeCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Europe Countries [Member]",
        "label": "Other Europe Countries [Member]",
        "terseLabel": "Other European countries [Member]"
       }
      }
     },
     "localname": "OtherEuropeCountriesMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_OtherExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Expense (Income) [Abstract]",
        "label": "Other Expense (Income) [Abstract]",
        "terseLabel": "Other Expense (Income) [Abstract]"
       }
      }
     },
     "localname": "OtherExpenseIncomeAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_OtherFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Financial Instruments [Abstract]",
        "terseLabel": "Other Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "OtherFinancialInstrumentsAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_OtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.westpharma.com/role/OtherExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of other income and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Income Expense",
        "negatedTerseLabel": "Other (income) expense",
        "negatedTotalLabel": "Total other expense",
        "terseLabel": "Other Income Expense"
       }
      }
     },
     "localname": "OtherIncomeExpense",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails",
      "http://www.westpharma.com/role/OtherExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_OtherSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Securities [Member]",
        "label": "Other Securities [Member]",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherSecuritiesMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PatentsAndLicensingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patents and Licensing [Member]",
        "label": "Patents and Licensing [Member]",
        "terseLabel": "Patents and Licensing [Member]"
       }
      }
     },
     "localname": "PatentsAndLicensingMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PensionPlanAssetsInTheFairValueHierarchyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pension Plan Assets In The Fair Value Hierarchy [Member]",
        "label": "Pension Plan Assets In The Fair Value Hierarchy [Member]",
        "terseLabel": "Pension Plan Assets In The Fair Value Hierarchy [Member]"
       }
      }
     },
     "localname": "PensionPlanAssetsInTheFairValueHierarchyMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PensionandOtherPostretirementBenefitExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.",
        "label": "Pension and Other Postretirement Benefit Expense, Net",
        "terseLabel": "Pension and other retirement plans, net"
       }
      }
     },
     "localname": "PensionandOtherPostretirementBenefitExpenseNet",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_PensionplanassetsmeasuredatNAVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pension plan assets measured at NAV [Member]",
        "label": "Pension plan assets measured at NAV [Member]",
        "terseLabel": "Pension plan assets measured at NAV [Member]"
       }
      }
     },
     "localname": "PensionplanassetsmeasuredatNAVMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Performance-vesting Shares or Units Dividend Equivalents [Member]",
        "label": "Performance-vesting Shares or Units Dividend Equivalents [Member]",
        "terseLabel": "Performance-vesting Shares or Units Dividend Equivalents [Member]"
       }
      }
     },
     "localname": "PerformanceVestingSharesOrUnitsDividendEquivalentsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharma Customers [Member]",
        "label": "Pharma Customers [Member]",
        "terseLabel": "Pharma Customers [Member]"
       }
      }
     },
     "localname": "PharmaCustomersMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaRubberSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharma Rubber S.A. de C.V. [Member]",
        "label": "Pharma Rubber S.A. de C.V. [Member]",
        "terseLabel": "Pharma Rubber S.A. de C.V. [Member]"
       }
      }
     },
     "localname": "PharmaRubberSADeCVMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_PharmaTapSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharma Tap S.A de C.V. [Member]",
        "label": "Pharma Tap S.A de C.V. [Member]",
        "terseLabel": "Pharma Tap S.A de C.V. [Member]"
       }
      }
     },
     "localname": "PharmaTapSADeCVMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ProprietaryProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proprietary Products [Member]",
        "label": "Proprietary Products [Member]",
        "terseLabel": "Proprietary Products [Member]"
       }
      }
     },
     "localname": "ProprietaryProductsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails",
      "http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails",
      "http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ProvisionForProductReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Provision for Product Returns",
        "label": "Provision for Product Returns",
        "terseLabel": "Provision for product returns"
       }
      }
     },
     "localname": "ProvisionForProductReturns",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueVoluntaryRecallDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchases and Royalty Payments from Equity Method Investees",
        "label": "Purchases and Royalty Payments from Equity Method Investees",
        "terseLabel": "Purchases and royalty payments made to affiliates"
       }
      }
     },
     "localname": "PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_RatioOfDebtToEBITDA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ratio of debt to EBITDA",
        "label": "Ratio of debt to EBITDA",
        "terseLabel": "Ratio of debt to EBITDA"
       }
      }
     },
     "localname": "RatioOfDebtToEBITDA",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reduction in number of shares available for grant for each award granted.",
        "label": "Reduction in Number of Shares Available for Grant For Each Award Granted",
        "terseLabel": "Number of shares reduced for each award granted"
       }
      }
     },
     "localname": "ReductioninNumberofSharesAvailableforGrantForEachAwardGranted",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_RevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue [Abstract]",
        "label": "Revenue [Abstract]",
        "terseLabel": "Revenue [Abstract]"
       }
      }
     },
     "localname": "RevenueAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_RevolvingCreditFacilityDue2017Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving credit facility due on second date.",
        "label": "Revolving credit facility, due 2017 [Member]",
        "terseLabel": "Revolving Credit Facility Due 2017 [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDue2017Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_RevolvingCreditFacilityDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving credit facility, due 2024",
        "label": "Revolving credit facility, due 2024 [Member]",
        "terseLabel": "Revolving credit facility, due 2024 [Domain]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDue2024Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Revolvingcreditfacilitydue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving credit facility, due 2020.",
        "label": "Revolving credit facility, due 2020 [Member]",
        "terseLabel": "Revolving credit facility, due 2020 [Member]"
       }
      }
     },
     "localname": "Revolvingcreditfacilitydue2020Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails",
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SalesToEquityMethodInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales to Equity Method Investees",
        "label": "Sales to Equity Method Investees",
        "terseLabel": "Sales to affiliates"
       }
      }
     },
     "localname": "SalesToEquityMethodInvestees",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]",
        "label": "Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule of Intangible Assets by Major Class [Line Items]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table]",
        "label": "Schedule of Intangible Assets by Major Class [Table]",
        "terseLabel": "Schedule of Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ScheduleOfIntangibleAssetsByMajorClassTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Intangible Assets by Major Class [Table Text Block]",
        "label": "Schedule of Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets by Major Class"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsByMajorClassTableTextBlock",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Other Income and Expense, by Component [Table Text Block]",
        "label": "Schedule of Other Income and Expense, by Component [Table Text Block]",
        "terseLabel": "Schedule of Other Income and Expense"
       }
      }
     },
     "localname": "ScheduleofOtherIncomeandExpensebyComponentTableTextBlock",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "wst_SeniorBNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior B Notes Due 2024 [Member]",
        "label": "Senior B Notes Due 2024 [Member]",
        "terseLabel": "Senior B Notes Due 2024 [Member]"
       }
      }
     },
     "localname": "SeniorBNotesDue2024Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SeniorCNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior C Notes Due 2027 [Member]",
        "label": "Senior C Notes Due 2027 [Member]",
        "terseLabel": "Senior C Notes Due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorCNotesDue2027Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior A Notes Due 2022 [Member]",
        "label": "Senior A Notes Due 2022 [Member]",
        "terseLabel": "Senior A Notes Due 2022 [Member]"
       }
      }
     },
     "localname": "SeniorNotesDue2022Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Actual Payout, Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Actual Payout, Percentage",
        "terseLabel": "Actual payout range"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardActualPayoutPercentage",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target",
        "negatedTerseLabel": "Adjustments above/(below) target"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTarget",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Adjustments Above (Below) Target, Weighted Average Grant Date Fair Value",
        "terseLabel": "Adjustments above/(below) target"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsAboveBelowTargetWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number of Shares Issuable Upon Vesting",
        "verboseLabel": "Number of shares to be issued upon conversion"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestNumberOfSharesIssuableUponVesting",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount",
        "terseLabel": "Limitation on payroll deductions of employee's base salary, amount"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year",
        "terseLabel": "Maximum number of shares per employee, per year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Number",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Oustanding, ending (in USD per share)",
        "periodStartLabel": "Oustanding, beginning (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]",
        "terseLabel": "SARs, Weighted Average Exercise Price [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceRollForward",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Non-Option Equity Instruments, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "wst_SmartDoseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SmartDose [Member]",
        "label": "SmartDose [Member]",
        "terseLabel": "SmartDose [Member]"
       }
      }
     },
     "localname": "SmartDoseMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails",
      "http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails",
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StandardPackagingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Standard Packaging [Member]",
        "label": "Standard Packaging [Member]",
        "terseLabel": "Standard Packaging [Member]"
       }
      }
     },
     "localname": "StandardPackagingMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/RevenueRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockOptionAndAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Option and Appreciation Rights [Member]",
        "label": "Stock Option and Appreciation Rights [Member]",
        "terseLabel": "Stock Option and Appreciation Rights [Member]"
       }
      }
     },
     "localname": "StockOptionAndAppreciationRightsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockSettledPSUAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock-settled PSU awards",
        "label": "Stock-settled PSU awards [Member]",
        "terseLabel": "Stock-settled PSU awards [Member]"
       }
      }
     },
     "localname": "StockSettledPSUAwardsMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails",
      "http://www.westpharma.com/role/StockBasedCompensationTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_StockSettledStockAppreciationRightsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of stock-settled stock appreciation rights outstanding.",
        "label": "Stock-Settled Stock Appreciation Rights, Outstanding",
        "terseLabel": "Stock-settled SARs, outstanding"
       }
      }
     },
     "localname": "StockSettledStockAppreciationRightsOutstanding",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "wst_SupplyChainFinancingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supply Chain Financing [Abstract]",
        "label": "Supply Chain Financing [Abstract]",
        "terseLabel": "Supply Chain Financing [Abstract]"
       }
      }
     },
     "localname": "SupplyChainFinancingAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense",
        "label": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense",
        "terseLabel": "Discrete tax charge, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Deferred Tax Liability, Provisional Income Tax Expense",
        "label": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Deferred Tax Liability, Provisional Income Tax Expense",
        "terseLabel": "Provisional tax charge, Tax Cuts and Jobs Act of 2017"
       }
      }
     },
     "localname": "TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesTextualsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "wst_TermLoanDue2024Domain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan Due 2024 [Member]",
        "label": "Term Loan Due 2024 [Domain]",
        "terseLabel": "Term Loan Due 2024 [Domain]"
       }
      }
     },
     "localname": "TermLoanDue2024Domain",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_TermLoanDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan Due 2024",
        "label": "Term Loan Due 2024 [Member]",
        "terseLabel": "Term Loan Due 2024 [Member]"
       }
      }
     },
     "localname": "TermLoanDue2024Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/DebtDetails",
      "http://www.westpharma.com/role/DebtTextualsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_VoluntaryRecallAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Voluntary Recall [Abstract]",
        "label": "Voluntary Recall [Abstract]",
        "terseLabel": "Voluntary Recall [Abstract]"
       }
      }
     },
     "localname": "VoluntaryRecallAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "xbrltype": "stringItemType"
    },
    "wst_WeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Weighted average shares outstanding: [Abstract]",
        "verboseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "wst_WestCompanyMexicoSADeCVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The West Company Mexico, S.A. de C.V. [Member]",
        "label": "The West Company Mexico, S.A. de C.V. [Member]",
        "terseLabel": "The West Company Mexico, S.A. de C.V. [Member]"
       }
      }
     },
     "localname": "WestCompanyMexicoSADeCVMember",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/AffiliatedCompaniesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year 2019 [Member]",
        "label": "Year 2019 [Member]",
        "terseLabel": "Year 2018 [Member]"
       }
      }
     },
     "localname": "Year2019Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2020 [Member]",
        "label": "Year 2020 [Member]",
        "terseLabel": "Year 2020 [Member]"
       }
      }
     },
     "localname": "Year2020Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2022 [Member]",
        "label": "Year 2022 [Member]",
        "terseLabel": "Year 2022 [Member]"
       }
      }
     },
     "localname": "Year2022Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year 2023 [Member]",
        "label": "Year 2023 [Member]",
        "terseLabel": "Year 2023 [Member]"
       }
      }
     },
     "localname": "Year2023Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2037Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year 2037 [Member]",
        "label": "Year 2037 [Member]",
        "terseLabel": "Year 2037 [Member]"
       }
      }
     },
     "localname": "Year2037Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2038Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year 2038 [Member]",
        "label": "Year 2038 [Member]",
        "terseLabel": "Year 2038 [Member]"
       }
      }
     },
     "localname": "Year2038Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_Year2039Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year 2039 [Member]",
        "label": "Year 2039 [Member]",
        "terseLabel": "Year 2039 [Member]"
       }
      }
     },
     "localname": "Year2039Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_YearAfter2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Year After 2019 [Member]",
        "label": "Year After 2019 [Member]",
        "terseLabel": "Year After 2018 [Member]"
       }
      }
     },
     "localname": "YearAfter2019Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "wst_YearAfter2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "After 2023 [Member]",
        "label": "Year After 2023 [Member]",
        "terseLabel": "Year After 2023 [Member]"
       }
      }
     },
     "localname": "YearAfter2023Member",
     "nsuri": "http://www.westpharma.com/20191231",
     "presentation": [
      "http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=SL94080555-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(b))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e639-108305"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.10-01.(b)(6))",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e4975-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5212-111524"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5033-111524"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5093-111524"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13185-110859"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13231-110859"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6571209&loc=d3e13669-110860"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/subtopic&trid=2175709"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25287-109308"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25336-109308"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=77896938&loc=d3e25336-109308"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7656903&loc=SL6757479-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7656903&loc=SL6757497-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(s)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118136717&loc=SL108413206-114923"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79507997-165333"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79507997-165333"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508013-165333"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508013-165333"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508029-165333"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508029-165333"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508043-165333"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508043-165333"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508057-165333"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116863282&loc=SL79508057-165333"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28200-109314"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28446-109314"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31928-109318"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31958-109318"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(b))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(f))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(g))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "30",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-02)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-03)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-04)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355119-122828"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117415099&loc=d3e34841-113949"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41675-113959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=118875152&loc=SL5864739-113975"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061172-113977"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1),(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b,c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=84164758&loc=d3e45014-112735"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=6918054&loc=d3e56071-112765"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=6462270&loc=d3e57205-112772"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB Topic 5.W)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04.12(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12C)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r653": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r654": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r655": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r656": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r657": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r658": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r659": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r660": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r661": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-03(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843655008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business acquisition, transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business acquisition, recognized inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business acquisition, recognized property, plant, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business acquisition, recognized goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business acquisition, recognized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">100.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">37.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">97.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 235.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of finite-lived intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of finite-lived intangible assets</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6683151936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of net periodic benefit cost and other amounts recognized in OCI were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:43.032%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.498%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service credit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of actuarial loss (gain)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss (gain) arising during period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service credit arising during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service credit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of actuarial (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total recognized in OCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total recognized in net periodic benefit cost and OCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit cost by geographic location is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.711%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.082%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.493%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.498%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. plans</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock', window );">Schedule of Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the changes in the benefit obligation and the fair value of plan assets, as well as the funded status of the plans:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in benefit obligation:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit obligation, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(267.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(288.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Participants&#8217; contributions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actuarial (loss) gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amendments/transfers in</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefits/expenses paid</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit obligation, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(287.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(267.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets, January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actual return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employer contribution</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Participants&#8217; contributions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefits/expenses paid</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlement effects</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets, December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Funded status at end of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Amounts Recognized in Balance Sheet</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amounts recognized in the balance sheet were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Noncurrent assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Noncurrent liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amounts in accumulated other comprehensive loss, pre-tax, consisted of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net actuarial loss (gain)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service cost (credit)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Benefit payments expected to be paid under our defined benefit pension and other retirement benefit plans in the next ten years are as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.955%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.147%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.147%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.149%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Domestic </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2025 to 2029</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">158.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Assumptions Used</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average assumptions used to determine net periodic benefit cost were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:29.570%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.740%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.90&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of compensation increase</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.41&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.01&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term rate of return on assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.54&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Weighted average assumptions used to determine the benefit obligations were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.823%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other retirement benefits</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Discount rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Rate of compensation increase</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.49&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.01&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average asset allocations by asset category for our pension plans, at December 31, were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following are the U.S. target asset allocations and acceptable allocation ranges:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Target allocation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allocation range</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27% - 33%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67% - 73%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0% - 3%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present the fair value of our pension plan assets, utilizing the fair value hierarchy discussed in Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In accordance with U.S. GAAP, certain pension plan assets measured at net asset value (&#8220;NAV&#8221;) have not been classified in the fair value hierarchy.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.070%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.980%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.824%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets in the fair value hierarchy</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets measured at NAV</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">204.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets at fair value</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.230%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.820%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.824%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mutual funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets in the fair value hierarchy</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets measured at NAV</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">181.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension plan assets at fair value</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Changes in Fair Value of Plan Assets, Projected Benefit Obligations and Net Funded Status [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfChangesInFairValueOfPlanAssetsProjectedBenefitObligationsAndNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845571344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense Restructuring and Related Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments to Acquire Property, Plant, and Equipment</a></td>
<td class="nump">$ 126.4<span></span>
</td>
<td class="nump">$ 104.7<span></span>
</td>
<td class="nump">$ 130.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other restructuring charges</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2017</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Charges</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2018</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Severance and benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2017</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Charges</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2018</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember', window );">Asset-related charges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2017</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Charges</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2018</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other charges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2017</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Charges</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2018</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_A2018RestructuringPlanMember', window );">2018 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AssetImpairmentChargesPatentandEquipment', window );">Asset impairment charges, patent and equipment</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other restructuring charges</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2017</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Charges</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash asset write-downs</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2018</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_A2016RestructuringPlanMemberMember', window );">2016 Restructuring Plan [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance, December 31, 2018</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | 2018 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AssetImpairmentChargesPatentandEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of a patent and certain equipment, recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AssetImpairmentChargesPatentandEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=wst_AssetRelatedChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_A2018RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_A2018RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_A2016RestructuringPlanMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_A2016RestructuringPlanMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820019280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">41.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Operating lease liability payments due</a></td>
<td class="nump">88.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed lease interest</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 72.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844555936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Intangible Assets by Major Class) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 78.1<span></span>
</td>
<td class="nump">$ 65.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(48.3)<span></span>
</td>
<td class="num">(44.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">20.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember', window );">Patents and Licensing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">19.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(16.0)<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-Process Research and Development (IPR&amp;D) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">40.3<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(21.6)<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems', window );"><strong>Schedule of Intangible Assets by Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(7.4)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleOfIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Intangible Assets by Major Class [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleOfIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wst_PatentsAndLicensingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838088000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at January 1</a></td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase due to current year position</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase due to prior year position</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reduction for expiration of statute of limitations/audits</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at December 31</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837847280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Effective Income Tax Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal corporate tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Tax on international operations other than U.S. tax rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="num">(4.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Reversal of prior valuation allowance</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Adjustments to reserves for unrecognized tax benefits</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">U.S. tax on international earnings, net of foreign tax credits</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax effect</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">U.S. research and development credits</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Excess tax benefits on share-based payments</a></td>
<td class="num">(3.50%)<span></span>
</td>
<td class="num">(6.00%)<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Impact of 2017 Tax Act</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
<td class="nump">15.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage', window );">Tax on undistributed earnings of subsidiaries</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(1.30%)<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary', window );">Venezuela deconsolidation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction', window );">Other business credits and Section 199 Deduction</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">20.20%<span></span>
</td>
<td class="nump">17.20%<span></span>
</td>
<td class="nump">36.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, General Business Credits and Section 199 Deduction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationGeneralBusinessCreditsAndSection199Deduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Undistributed Earnings of Subsidiaries, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_EffectiveIncomeTaxRateReconciliationUndistributedEarningsofSubsidiariesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6841400688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Textuals) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding current portion</a></td>
<td class="nump">$ 255.0<span></span>
</td>
<td class="nump">$ 196.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">$ 10.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Aggregate annual maturities of long-term debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">44.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">133.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths', window );">Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member', window );">Senior A Notes Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Jul.  05,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member', window );">Senior B Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Jul.  05,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member', window );">Senior C Notes Due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Jul.  05,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2020Member', window );">Revolving credit facility, due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 168.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average of the coupon interest rate</a></td>
<td class="nump">3.87%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification', window );">Debt issuance costs</a></td>
<td class="text">0.5 million<span></span>
</td>
<td class="text">0.6 million<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Senior A Notes Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Senior B Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 53.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 53.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Senior C Notes Due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member', window );">Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of Credit Facility, current borrowing capacity</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LineofCreditFacilityAdditionalBorrowingCapacity', window );">Line of Credit Facility, additional borrowing capacity</a></td>
<td class="nump">350.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CreditAvailableForIssuanceOfLettersOfCredit', window );">Credit available for the issuance of letters of credit</a></td>
<td class="nump">30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Line of credit, noncurrent</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, unused commitment level</a></td>
<td class="nump">297.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment', window );">Debt issuance costs</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current portion</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment', window );">Debt issuance costs</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">2.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding current portion</a></td>
<td class="nump">$ 87.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Term Loan Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">87.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding amount</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember', window );">Domestic Line of Credit [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CreditFacilityIsAvailableForSwingLineLoans', window );">Credit Facility is available for swing-line loans</a></td>
<td class="nump">30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember', window );">Foreign Line of Credit [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_CreditFacilityIsAvailableForSwingLineLoans', window );">Credit Facility is available for swing-line loans</a></td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_FederalFundsEffectiveSwapRateMember', window );">Fed Funds Effective Rate Overnight Index Swap Rate [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Aggregate annual maturities of long-term debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RatioOfDebtToEBITDA', window );">Ratio of debt to EBITDA</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Base Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">8750.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Aggregate annual maturities of long-term debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RatioOfDebtToEBITDA', window );">Ratio of debt to EBITDA</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Base Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">3750.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member] | Revolving credit facility, due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable interest rate</a></td>
<td class="nump">13750.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=7656903&amp;loc=SL6757497-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If not separately presented, identifies the caption on the statement of financial position in which the unamortized balance of recognized deferred issuance costs related to an own-share lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, is included.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=7656903&amp;loc=SL6757479-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNetClassification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CreditAvailableForIssuanceOfLettersOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>this refers to Credit available for the issuance of letters of credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CreditAvailableForIssuanceOfLettersOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_CreditFacilityIsAvailableForSwingLineLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This refers to credit facility is available for swing-line loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_CreditFacilityIsAvailableForSwingLineLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LineofCreditFacilityAdditionalBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional borrowing capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LineofCreditFacilityAdditionalBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RatioOfDebtToEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio of debt to EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RatioOfDebtToEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_RevolvingCreditFacilityDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_DomesticLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_ForeignLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6833994368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Assumptions Used) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted average assumptions used in net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.91%<span></span>
</td>
<td class="nump">3.48%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.41%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.01%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Long-term rate of return on assets</a></td>
<td class="nump">5.54%<span></span>
</td>
<td class="nump">6.71%<span></span>
</td>
<td class="nump">6.47%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted average assumptions used in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.79%<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.49%<span></span>
</td>
<td class="nump">4.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted average assumptions used in net periodic benefit cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted average assumptions used in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6830211872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Textuals) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfMajorCustomers', window );">Disclosure of major customers</a></td>
<td class="text">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the extent of enterprise reliance on its major customers. For example, includes revenues from transactions with a single external customer amounting to 10 percent or more of the entity's revenues, the total amount of revenues from each such customer, and the identity of the segment or segments reporting the revenues. A group of entities that the entity knows to be under common control generally will be considered a single customer for inclusion in this item. The federal government, a state government, a local government (for example, a county or municipality), or a foreign government each will generally be considered as a single customer for inclusion in this item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9054-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6841425584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Allocation of Share-based Compensation Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 24.4<span></span>
</td>
<td class="nump">$ 15.1<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember', window );">Stock Option and Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Vesting Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember', window );">Cash-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember', window );">Performance-vesting Shares or Units Dividend Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockOptionAndAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_PerformanceVestingSharesOrUnitsDividendEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829611216">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
<td class="nump">$ 19.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred Tax Asset Valuation Allowance [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for Doubtful Accounts Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838060672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements Other Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherFinancialInstrumentsAbstract', window );"><strong>Other Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 255.0<span></span>
</td>
<td class="nump">$ 196.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term Debt, Fair Value</a></td>
<td class="nump">$ 263.3<span></span>
</td>
<td class="nump">$ 192.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820099696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">$ 214.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">244.1<span></span>
</td>
<td class="nump">$ 214.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(267.0)<span></span>
</td>
<td class="num">(288.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="num">$ (10.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(9.2)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
<td class="num">(9.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (loss) gain</a></td>
<td class="num">(30.8)<span></span>
</td>
<td class="nump">20.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Amendments/transfers in</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits/expenses paid</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(287.9)<span></span>
</td>
<td class="num">(267.0)<span></span>
</td>
<td class="num">(288.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">214.5<span></span>
</td>
<td class="nump">239.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on assets</a></td>
<td class="nump">41.3<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits/expenses paid</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">244.1<span></span>
</td>
<td class="nump">214.5<span></span>
</td>
<td class="nump">239.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(43.8)<span></span>
</td>
<td class="num">(52.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (loss) gain</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Amendments/transfers in</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits/expenses paid</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Balance</a></td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Participants&#8217; contributions</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits/expenses paid</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">$ (6.6)<span></span>
</td>
<td class="num">$ (6.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6608679840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease Cash Flow and Supplemental Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 12.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7003280192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Contracts Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, December 31, 2018</a></td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets, December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractwithCustomerAssetIncreaseDecrease', window );">Change in contract assets - increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December 31, 2018</a></td>
<td class="num">(33.4)<span></span>
</td>
<td class="num">(33.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized', window );">Change in deferred income - (increase) decrease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments', window );">Cash payments received in advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in the deferred income balance</a></td>
<td class="nump">$ 20.8<span></span>
</td>
<td class="nump">110.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Other increase (decrease) in deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_SmartDoseMember', window );">SmartDose [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income, December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred income, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred income, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Liability, Increase (Decrease) due to Additional Cash Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractWithCustomerLiabilityIncreaseDecreaseDueToAdditionalCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ContractwithCustomerAssetIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Asset, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ContractwithCustomerAssetIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_SmartDoseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_SmartDoseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818309712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Property, Plant and Equipment, Gross) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 1,820.1<span></span>
</td>
<td class="nump">$ 1,752.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">22.1<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 572.9<span></span>
</td>
<td class="nump">569.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 817.0<span></span>
</td>
<td class="nump">806.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and Dies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 123.8<span></span>
</td>
<td class="nump">115.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and Dies [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember', window );">Molds and Dies [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer Hardware and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 155.6<span></span>
</td>
<td class="nump">151.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer Hardware and Software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember', window );">Computer Hardware and Software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
<td class="text">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 128.7<span></span>
</td>
<td class="nump">$ 89.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ToolsDiesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wst_ComputerHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843591328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At December&#160;31, 2019, the following affiliated companies were accounted for under the equity method:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:55.371%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:19.314%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:19.315%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ownership interest</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The West Company Mexico, S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Aluplast S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma Tap S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma Rubber S.A. de C.V.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mexico</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">I&amp;W Pharma Group LLC</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Daikyo</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49%&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6606676640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_RevenueAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by market group:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:67.292%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.951%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.954%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Biologics</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Generics</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharma</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by product category: </span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:67.292%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.951%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.954%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">High-Value Components</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Standard Packaging</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delivery Devices</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the approximate percentage of our net sales by geographic location: </span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:67.292%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.951%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.954%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Americas</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe, Middle East, Africa</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia Pacific</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability [Table Text Block]</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.679%;"><tr><td style="width:1.0%;"/><td style="width:83.048%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.952%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract assets, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract assets, December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in contract assets - increase (decrease)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income, December 31, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in deferred income - (increase) decrease</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contract balances and changes in contract balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837889680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Outstanding Foreign Currency Contracts</a></td>
<td class="text">As of December&#160;31, 2019, we had outstanding foreign currency contracts to purchase and sell certain pairs of currencies, as follows:<table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:52.487%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.906%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sell</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Euro</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">USD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Yen</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,550.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SGD</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Effects of Derivative Instruments on Other Comprehensive Income ('OCI') and earnings</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:16.269%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.328%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain Recognized in Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Hedges:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges on OCI and earnings, net of tax, for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.587%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.306%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.466%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.105%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.105%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.598%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.239%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain (Loss) Recognized in OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of (Gain) Loss Reclassified from Accumulated OCI into Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Hedges:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash Flow Hedges:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency hedge contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward treasury locks</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Investment Hedges:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency-denominated debt</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross-currency swap</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments designated as fair value, cash flow, and net investment hedges by line item in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:57.455%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.873%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the effects of derivative instruments not designated as hedges in our consolidated statements of income for the years ended December 31:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:16.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.168%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Loss (Gain) Recognized in Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commodity call options</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837985312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Note 4:&#160;&#160;Net Income Per Share</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table reconciles the shares used in the calculation of basic net income per share to those used for diluted net income per share:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:61.942%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.060%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common shares outstanding</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-indent:-9pt;padding-left:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Dilutive effect of equity awards, based on the treasury stock method</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares assuming dilution</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, 2018 and 2017, there were 0.1 million, 0.4 million, and 0.4 million shares, respectively, from stock-based compensation plans not included in the computation of diluted net income per share because their impact was antidilutive. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, we announced a share repurchase program for calendar-year 2019 authorizing the repurchase of up to 800,000 shares of our common stock from time to time on the open market or in privately-negotiated transactions as permitted under Exchange Act Rule 10b-18. The number of shares repurchased and the timing of such transactions depended on a variety of factors, including market conditions. During 2019, we purchased 800,000 shares of our common stock under the now-completed program at a cost of $83.1 million, or an average price of $103.89 per share. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, we announced a share repurchase program for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of our common stock from time to time on the open market or in privately-negotiated </span></div>transactions as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. This share repurchase program is expected to be completed by December 31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>460</ContextCount>
  <ElementCount>653</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>150</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105102 - Disclosure - New Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NewAccountingStandards</Role>
      <ShortName>New Accounting Standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - Revenue Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueRevenue</Role>
      <ShortName>Revenue Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128107 - Disclosure - Affiliated Companies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompanies</Role>
      <ShortName>Affiliated Companies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132108 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2140110 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2144111 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2153113 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2157114 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2164115 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2174116 - Disclosure - Other Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpense</Role>
      <ShortName>Other Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2180117 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2188118 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2190119 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2196120 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - Revenue Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueRevenueTables</Role>
      <ShortName>Revenue Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/RevenueRevenue</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NetIncomePerShare</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Leases</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - Affiliated Companies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesTables</Role>
      <ShortName>Affiliated Companies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AffiliatedCompanies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2338308 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2341309 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/Debt</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2345310 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2349311 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/FairValueMeasurements</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2354312 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2358313 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2365314 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlans</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2375315 - Disclosure - Other Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseTables</Role>
      <ShortName>Other Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpense</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2381316 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2391317 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Revenue Adoption of ASC 606 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueAdoptionofASC606Details</Role>
      <ShortName>Revenue Adoption of ASC 606 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Revenue Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueRevenueRecognitionDetails</Role>
      <ShortName>Revenue Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Revenue Contracts Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueContractsAssetsandLiabilitiesDetails</Role>
      <ShortName>Revenue Contracts Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Revenue Supply Chain Financing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails</Role>
      <ShortName>Revenue Supply Chain Financing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Revenue Voluntary Recall (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/RevenueVoluntaryRecallDetails</Role>
      <ShortName>Revenue Voluntary Recall (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/NetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/NetIncomePerShareTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Property, Plant and Equipment (Property, Plant and Equipment, Gross) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentPropertyPlantandEquipmentGrossDetails</Role>
      <ShortName>Property, Plant and Equipment (Property, Plant and Equipment, Gross) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/PropertyPlantandEquipmentTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Property, Plant and Equipment (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/PropertyPlantandEquipmentTextualsDetails</Role>
      <ShortName>Property, Plant and Equipment (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/PropertyPlantandEquipmentTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Adoption of ASC 842 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AdoptionofASC842Details</Role>
      <ShortName>Adoption of ASC 842 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeaseCostDetails</Role>
      <ShortName>Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Lease Cash Flow and Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeaseCashFlowandSupplementalInformationDetails</Role>
      <ShortName>Lease Cash Flow and Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - Lease Weighted Average (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/LeaseWeightedAverageDetail</Role>
      <ShortName>Lease Weighted Average (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/MaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Affiliated Companies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesDetails</Role>
      <ShortName>Affiliated Companies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AffiliatedCompaniesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Affiliated Companies (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/AffiliatedCompaniesTextualsDetails</Role>
      <ShortName>Affiliated Companies (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/AffiliatedCompaniesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Goodwill and Intangible Assets (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Goodwill and Intangible Assets (Intangible Assets by Major Class) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsIntangibleAssetsbyMajorClassDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Intangible Assets by Major Class) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Goodwill and Intangible Assets (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/GoodwillandIntangibleAssetsTextualsDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherCurrentLiabilitiesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DebtTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2443423 - Disclosure - Debt (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DebtTextualsDetails</Role>
      <ShortName>Debt (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DebtTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2446424 - Disclosure - Derivative Financial Instruments (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsTextualsDetails</Role>
      <ShortName>Derivative Financial Instruments (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2447425 - Disclosure - Derivative Financial Instruments (Effects of Derivative Instruments Designated as Hedges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsDesignatedasHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments (Effects of Derivative Instruments Designated as Hedges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2450426 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsFairValueofAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements (Fair Value of Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2451427 - Disclosure - Fair Value Measurements (Changes in Level 3 Fair Value Measurements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsChangesinLevel3FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Changes in Level 3 Fair Value Measurements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2452428 - Disclosure - Fair Value Measurements Other Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/FairValueMeasurementsOtherFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements Other Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2455429 - Disclosure - (Components of AOCI) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ComponentsofAOCIDetails</Role>
      <ShortName>(Components of AOCI) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2456430 - Disclosure - (Reclassifications AOCI) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ReclassificationsAOCIDetails</Role>
      <ShortName>(Reclassifications AOCI) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2459431 - Disclosure - Stock-Based Compensation (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationTextualsDetails</Role>
      <ShortName>Stock-Based Compensation (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensationTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2460432 - Disclosure - Stock-Based Compensation (Allocation of Share-based Compensation Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationAllocationofSharebasedCompensationCostsDetails</Role>
      <ShortName>Stock-Based Compensation (Allocation of Share-based Compensation Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensationTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2461433 - Disclosure - Stock-Based Compensation (Stock Options Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationStockOptionsActivityDetails</Role>
      <ShortName>Stock-Based Compensation (Stock Options Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensationTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2462434 - Disclosure - Stock-Based Compensation (Stock Appreciation Rights Award Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationStockAppreciationRightsAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation (Stock Appreciation Rights Award Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensationTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2463435 - Disclosure - Stock-Based Compensation (Nonvested Performance-based Award Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/StockBasedCompensationNonvestedPerformancebasedAwardActivityDetails</Role>
      <ShortName>Stock-Based Compensation (Nonvested Performance-based Award Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/StockBasedCompensationTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2466436 - Disclosure - Benefit Plans (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansTextualsDetails</Role>
      <ShortName>Benefit Plans (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2467437 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Benefit Plans (Components of Net Periodic Benefit Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2468438 - Disclosure - Benefit Plans (Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansChangesinProjectedBenefitObligationFairValueofPlanAssetsandFundedStatusDetails</Role>
      <ShortName>Benefit Plans (Changes in Projected Benefit Obligation, Fair Value of Plan Assets and Funded Status) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2469439 - Disclosure - Benefit Plans (Amounts Recognized in Balance Sheet) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinBalanceSheetDetails</Role>
      <ShortName>Benefit Plans (Amounts Recognized in Balance Sheet) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2470440 - Disclosure - Benefit Plans (Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAmountsRecognizedinOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Benefit Plans (Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2471441 - Disclosure - Benefit Plans (Expected Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansExpectedBenefitPaymentsDetails</Role>
      <ShortName>Benefit Plans (Expected Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2472442 - Disclosure - Benefit Plans (Assumptions Used) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAssumptionsUsedDetails</Role>
      <ShortName>Benefit Plans (Assumptions Used) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2473443 - Disclosure - Benefit Plans (Allocation of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/BenefitPlansAllocationofPlanAssetsDetails</Role>
      <ShortName>Benefit Plans (Allocation of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/BenefitPlansTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2476444 - Disclosure - Other Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseDetails</Role>
      <ShortName>Other Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/OtherExpenseTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2477445 - Disclosure - Other Expense Restructuring and Related Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseRestructuringandRelatedChargesDetails</Role>
      <ShortName>Other Expense Restructuring and Related Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2478446 - Disclosure - Other Expense Other Items (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseOtherItemsTextualsDetails</Role>
      <ShortName>Other Expense Other Items (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2479447 - Disclosure - Other Expense Development and Licensing Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/OtherExpenseDevelopmentandLicensingIncomeDetails</Role>
      <ShortName>Other Expense Development and Licensing Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2482448 - Disclosure - Income Taxes (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesTextualsDetails</Role>
      <ShortName>Income Taxes (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxesTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2483449 - Disclosure - Income Taxes (Unrecognized Tax Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes (Unrecognized Tax Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxesTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2484450 - Disclosure - Income Taxes (Income Before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Income Before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2485451 - Disclosure - Income Taxes (Components of Income Tax Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes (Components of Income Tax Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2486452 - Disclosure - Income Taxes (Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>2487453 - Disclosure - Income Taxes (Effective Income Tax Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationDetails</Role>
      <ShortName>Income Taxes (Effective Income Tax Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/IncomeTaxesTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>2489454 - Disclosure - Commitments and Contingencies (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/CommitmentsandContingenciesTextualsDetails</Role>
      <ShortName>Commitments and Contingencies (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/CommitmentsandContingencies</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>2492455 - Disclosure - Segment Information (Textuals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationTextualsDetails</Role>
      <ShortName>Segment Information (Textuals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformationTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>2493456 - Disclosure - Segment Information (Sales by Product Group) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSalesbyProductGroupDetails</Role>
      <ShortName>Segment Information (Sales by Product Group) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformationTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>2494457 - Disclosure - Segment Information (Sales and PPE by Geographic Location) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSalesandPPEbyGeographicLocationDetails</Role>
      <ShortName>Segment Information (Sales and PPE by Geographic Location) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformationTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>2495458 - Disclosure - Segment Information (Segment Financial Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails</Role>
      <ShortName>Segment Information (Segment Financial Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/SegmentInformationTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="wst-20191231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>2497459 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.westpharma.com/role/ScheduleIIValuationandQualifyingAccountsNotes</ParentRole>
      <Position>104</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="wst-20191231.htm">wst-20191231.htm</File>
    <File>ex102firstamendmentand.htm</File>
    <File>ex21listofsubsidiaries.htm</File>
    <File>ex23consent2019.htm</File>
    <File>ex311ceo302certificati.htm</File>
    <File>ex312cfo302certificati.htm</File>
    <File>ex321ceo906certificati.htm</File>
    <File>ex322cfo906certificati.htm</File>
    <File>ex44descriptionofregis.htm</File>
    <File>wst-20191231.xsd</File>
    <File>wst-20191231_cal.xml</File>
    <File>wst-20191231_def.xml</File>
    <File>wst-20191231_lab.xml</File>
    <File>wst-20191231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>wst-20191231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6606585920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The changes in the carrying amount of goodwill by reportable segment were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proprietary Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contract-Manufactured Products</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill recorded due to acquisition</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded goodwill of $2.6&#160;million. The goodwill was recorded within our Proprietary Products reportable segment. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we had no accumulated goodwill impairment losses.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets and accumulated amortization as of December 31 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:24.121%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.461%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.461%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and licensing</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technology</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(48.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we acquired the business of our distributor in South Korea. As a result of the acquisition, we recorded a customer relationships intangible asset of $11.2&#160;million, which is being amortized over ten years. </span></div>The cost basis of intangible assets includes a foreign currency translation loss of $0.3 million and a foreign currency translation loss of $0.3 million for the years ended December&#160;31, 2019 and 2018, respectively. Amortization expense for the years ended December&#160;31, 2019, 2018 and 2017 was $3.4 million, $2.7 million and $2.4 million, respectively. Estimated annual amortization expense for the next five years is as follows: 2020 - $4.0 million, 2021 - $3.5 million, 2022 - $3.5 million, 2023 - $2.9 million and 2024 - $2.6 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6734844848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule of Valuation and Qualifying Accounts</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Schedule II - Valuation and Qualifying Accounts</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:96.153%;"><tr><td style="width:1.0%;"/><td style="width:42.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.000%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Balance at</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">beginning of</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">period</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Charged</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">to costs</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">and </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">expenses</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deductions (1)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Balance at</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">end of</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">period</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the year ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax asset valuation allowance</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total allowances deducted from assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax asset valuation allowance</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total allowances deducted from assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">For the year ended December 31, 2017</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowances deducted from assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax asset valuation allowance</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total allowances deducted from assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:20pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="padding-left:27pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">__________________________</span></div>(1)Includes accounts receivable written off, the write-off or write-down of valuation allowances, and translation adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6834706880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following fair value hierarchy classifies the inputs to valuation techniques used to measure fair value into one of three levels:</span></div><div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;">Level 1</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;">Level 2</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="text-indent:-18pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:14.5pt;">Level 3</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Unobservable inputs that reflect the reporting entity&#8217;s own assumptions.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commodity call options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross-currency swap</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,<br/>2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Deferred compensation assets are included within other noncurrent assets and are valued using a market approach based on quoted market prices in an active market. The fair value of our foreign currency contracts, included within other current and other noncurrent assets, as well as other current and other long-term liabilities, is valued using an income approach based on quoted forward foreign exchange rates and spot rates at the reporting date. The fair value of our commodity call options, included within other current and other noncurrent assets, is valued using a market approach. The fair value of our contingent consideration, included within other current and other long-term liabilities, is discussed further in the section related to Level 3 fair value measurements. The fair value of deferred compensation liabilities is based on quoted prices of the underlying employees&#8217; investment selections and is included within other long-term liabilities. The fair value of the cross-currency swap, included within other long-term liabilities, is valued using a market approach. Please refer to Note 11, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Derivative Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion of our derivatives.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Level 3 Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of the contingent consideration liability related to the SmartDose technology platform (the "SmartDose contingent consideration") was initially determined using a probability-weighted income approach, and is revalued at each reporting date or more frequently if circumstances dictate. Changes in the fair value of this </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">obligation are recorded as income or expense within other (income) expense in our consolidated statements of income. The significant unobservable inputs used in the fair value measurement of the SmartDose contingent consideration are the sales projections, the probability of success factors, and the discount rate. Significant increases or decreases in any of those inputs in isolation would result in a significantly lower or higher fair value measurement. As development and commercialization of the SmartDose technology platform progresses, we may need to update the sales projections, the probability of success factors, and the discount rate used. This could result in a material increase or decrease to the SmartDose contingent consideration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease in fair value recorded in earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in fair value recorded in earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other Financial Instruments</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that the carrying amounts of our cash and cash equivalents and accounts receivable approximate their fair values due to their near-term maturities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated fair value of long-term debt is based on quoted market prices for debt issuances with similar terms and maturities and is classified as Level 2 within the fair value hierarchy. At December&#160;31, 2019, the estimated fair value of long-term debt was $263.3 million compared to a carrying amount of $255.0 million. At December&#160;31, 2018, the estimated fair value of long-term debt was $192.6 million and the carrying amount was $196.0 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6677041024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other (Income) Expense</a></td>
<td class="text">Other (Income) Expense <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other (income) expense consisted of:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring and related charges:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance and post-employment benefits</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-related charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total restructuring and related charges</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Argentina currency devaluation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax recovery</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela deconsolidation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Development and licensing income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other items</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other (income) expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restructuring and Related Charges</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, our Board of Directors approved a restructuring plan designed to realign our manufacturing capacity with demand. These changes were expected to be implemented over a period of up to twenty-four months from the date of the approval. The plan was expected to require restructuring and related charges of approximately $16.0 million. Since its approval, we recorded $13.7&#160;million in restructuring and related charges associated with this plan. The plan is now considered complete.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded $4.9 million in restructuring and related charges associated with this plan, consisting of $2.6 million for severance charges, $0.3 million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $2.0 million for other non-cash charges. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2018, we recorded $8.8&#160;million in restructuring and related charges associated with this plan, consisting of $3.1&#160;million for severance charges, $2.2&#160;million for non-cash asset write-downs associated with the discontinued use of certain equipment, and $3.5&#160;million for other non-cash charges. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.980%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.908%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance    and benefits</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-related charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash asset write-downs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash asset write-downs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On February 15, 2016, our Board of Directors approved a restructuring plan designed to repurpose several of our production facilities in support of growing high-value proprietary products and to realign operational and commercial activities to meet the needs of our new market-focused commercial organization. During 2018, we recorded $0.3 million in additional charges related to this restructuring plan. Our remaining restructuring obligations related to our 2016 restructuring plan as of December 31, 2019 were $0.1 million.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Items</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded a charge of $1.0&#160;million as a result of the continued devaluation of Argentina&#8217;s currency. During 2018, we recorded a charge of $1.1 million related to the classification of Argentina&#8217;s economy as highly inflationary under U.S. GAAP as of July 1, 2018.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recognized a tax recovery of $4.7&#160;million related to previously-paid international excise taxes, following a favorable court ruling.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On February 17, 2016, the Venezuelan government announced a devaluation of the Bolivar, from the previously-prevailing official exchange rate of 6.3 Bolivars to USD to 10.0 Bolivars to USD, and streamlined the previous three-tiered currency exchange mechanism into a dual currency exchange mechanism. In 2017, as a result of the continued deterioration of conditions in Venezuela as well as our continued reduced access to USD settlement controlled by the Venezuelan government, we recorded a charge of $11.1 million related to the deconsolidation of our Venezuelan subsidiary, following our determination that we no longer met the U.S. GAAP criteria for control of that subsidiary. This charge included the derecognition of the carrying amounts of our Venezuelan subsidiary&#8217;s assets and liabilities, as well as the write-off of our investment in our Venezuelan subsidiary, related unrealized translation adjustments and the elimination of intercompany accounts. As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, 2018 and 2017, we recorded development income of $0.9 million, $0.9 million and $1.5 million, respectively, related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of the SmartDose technology platform within a specific therapeutic area. Please refer to Note 3, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information. In addition, during 2017, we recorded income of $9.1 million attributable to the reimbursement of certain costs related to a technology that we subsequently licensed to a third party. The license of technology to the third party may result in additional income in the future, contingent on commercialization of the related product. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Contingent consideration represents changes in the fair value of the SmartDose contingent consideration. Please refer to Note 12, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.   </span></div>Other items consist of foreign exchange transaction gains and losses, gains and losses on the sale of fixed assets, and miscellaneous income and charges. Other items primarily changed in 2019 as a result of foreign exchange transaction gains of $5.6 million in 2019 and a $1.9&#160;million gain on the sale of fixed assets as a result of our restructuring plan, as compared to foreign exchange transaction gains of $5.5 million in 2018 and a $1.1 million gain on the sale of fixed assets as a result of our restructuring plans.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6652342096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Principles of Consolidation:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 16, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for further discussion. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash and Cash Equivalents:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with maturities of three months or less at the time of purchase.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our accounts receivable balance was net of an allowance for doubtful accounts of $0.5 million and $2.0 million at December&#160;31, 2019 and 2018, respectively. We record the allowance based on a specific identification methodology.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value. The following is a summary of inventories at December 31:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"><tr><td style="width:1.0%;"/><td style="width:67.404%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.975%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.816%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work in process</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property, Plant and Equipment</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other (income) expense. Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2019. Please refer to Note 6, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Leases</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Long-Lived Assets</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other (income) expense for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Goodwill and Other Intangible Assets:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our 2017, 2018, and 2019 annual impairment tests. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment tests in 2017, 2018, and 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 5 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Employee Benefits:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for a more detailed discussion of our pension and other retirement plans. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency Translation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience. Please refer to Note 3, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Shipping and Handling Costs</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are expensed as incurred. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Environmental Remediation and Compliance Costs</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other (income) expense. The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for a more detailed discussion of our stock-based compensation plans.</span></div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Income Per Share</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7003149440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WEST PHARMACEUTICAL SERVICES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-1210010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">530 Herman O. West Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Exton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19341-0645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">594-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.25 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,218,126,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,837,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000105770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6818354656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 439.1<span></span>
</td>
<td class="nump">$ 337.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">319.3<span></span>
</td>
<td class="nump">288.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">235.7<span></span>
</td>
<td class="nump">214.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">64.6<span></span>
</td>
<td class="nump">54.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,058.7<span></span>
</td>
<td class="nump">894.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">1,820.1<span></span>
</td>
<td class="nump">1,752.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="nump">980.8<span></span>
</td>
<td class="nump">930.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">839.3<span></span>
</td>
<td class="nump">822.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">70.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in affiliated companies</a></td>
<td class="nump">192.7<span></span>
</td>
<td class="nump">91.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">107.8<span></span>
</td>
<td class="nump">105.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">20.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Pension and other postretirement benefits</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">24.7<span></span>
</td>
<td class="nump">20.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">2,341.4<span></span>
</td>
<td class="nump">1,978.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_NotesPayableAndOtherDebtCurrent', window );">Notes payable and other current debt</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">156.8<span></span>
</td>
<td class="nump">130.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Pension and other postretirement benefits</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AccruedSalariesWagesAndBenefitsCurrent', window );">Accrued Salaries, Wages, and Benefits, Current</a></td>
<td class="nump">73.0<span></span>
</td>
<td class="nump">64.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">91.3<span></span>
</td>
<td class="nump">76.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">341.6<span></span>
</td>
<td class="nump">283.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">255.0<span></span>
</td>
<td class="nump">196.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and other postretirement benefits</a></td>
<td class="nump">52.5<span></span>
</td>
<td class="nump">56.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">62.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">41.2<span></span>
</td>
<td class="nump">33.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">768.2<span></span>
</td>
<td class="nump">582.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding in 2019 and 2018</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.25 per share; 100.0 million shares authorized; shares issued: 75.3 million and 75.3 million in 2019 and 2018; shares outstanding: 74.1 million and 74.1 million in 2019 and 2018</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">18.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value</a></td>
<td class="nump">272.7<span></span>
</td>
<td class="nump">282.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,549.4<span></span>
</td>
<td class="nump">1,353.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(149.6)<span></span>
</td>
<td class="num">(154.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (1.2 million and 1.2 million shares in 2019 and 2018)</a></td>
<td class="num">(118.1)<span></span>
</td>
<td class="num">(103.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">1,573.2<span></span>
</td>
<td class="nump">1,396.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 2,341.4<span></span>
</td>
<td class="nump">$ 1,978.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31958-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31928-109318<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31958-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AccruedSalariesWagesAndBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Salaries, Wages, and Benefits, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AccruedSalariesWagesAndBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_NotesPayableAndOtherDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Payable and Other Debt, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_NotesPayableAndOtherDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820076304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense Development and Licensing Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DevelopmentandlicensingincomeLineItems', window );"><strong>Development and licensing income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_Developmentandlicensingincome', window );">Development and licensing income</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income</a></td>
<td class="nump">34.9<span></span>
</td>
<td class="nump">33.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember', window );">SmartDose [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DevelopmentandlicensingincomeLineItems', window );"><strong>Development and licensing income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_Developmentandlicensingincome', window );">Development and licensing income</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=wst_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DevelopmentandlicensingincomeLineItems', window );"><strong>Development and licensing income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_Developmentandlicensingincome', window );">Development and licensing income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_Developmentandlicensingincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period under a development, licensing and supply agreement entered into with a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_Developmentandlicensingincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DevelopmentandlicensingincomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Development and licensing income [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DevelopmentandlicensingincomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=wst_SmartDoseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=wst_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=wst_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820015472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Affiliated Companies (Textuals) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees', window );">Unremitted income of affiliated companies</a></td>
<td class="nump">$ 82.4<span></span>
</td>
<td class="nump">$ 75.8<span></span>
</td>
<td class="nump">$ 69.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends received from affiliated companies</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees', window );">Purchases and royalty payments made to affiliates</a></td>
<td class="nump">115.1<span></span>
</td>
<td class="nump">86.3<span></span>
</td>
<td class="nump">86.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrentAndNoncurrent', window );">Amount due and payable to affiliates</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_SalesToEquityMethodInvestees', window );">Sales to affiliates</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromAffiliates', window );">Amount receivable from affiliates</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">179.3<span></span>
</td>
<td class="nump">77.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostMethodInvestments', window );">Aggregate carrying amount of investment in affiliated companies that are not accounted for under the equity method</a></td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember', window );">Daikyo Seiko, Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect', window );">Equity in unrealized gains (losses) in securities available-for-sale and derivative instruments</a></td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.12(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6918054&amp;loc=d3e56071-112765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consolidated retained earnings that represent undistributed (not yet received) earnings from 50% or less owned persons accounted for by the equity method (equity method investees).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6462270&amp;loc=d3e57205-112772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment and Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentAndCumulativeChangesInNetGainLossFromCashFlowHedgesEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases and Royalty Payments from Equity Method Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_SalesToEquityMethodInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales to Equity Method Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_SalesToEquityMethodInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wst_DaikyoSeikoLtdDaikyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844142288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred income</a></td>
<td class="nump">$ 27.5<span></span>
</td>
<td class="nump">$ 25.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">11.3<span></span>
</td>
<td class="nump">$ 10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Accrued commissions, rebates and royalties</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent', window );">Accrued retirement plans (excluding pension)</a></td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Accrued taxes other than income</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring obligations</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">17.2<span></span>
</td>
<td class="nump">14.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 91.3<span></span>
</td>
<td class="nump">$ 76.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for retirement benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementBenefitsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6829081632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Components of Income Tax Expense) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">35.1<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax provision</a></td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">40.5<span></span>
</td>
<td class="nump">39.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit', window );">Federal and state</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">41.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">41.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 59.0<span></span>
</td>
<td class="nump">$ 41.4<span></span>
</td>
<td class="nump">$ 80.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Federal, State and Local Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredFederalStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837922816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of Beginning and Ending Liability for Unrecognized Tax Benefits</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase due to current year position</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase due to prior year position</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Components of Income Before Income Taxes</a></td>
<td class="text"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of income before income taxes are:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">291.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The related provision for income taxes consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Federal</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current income tax provision</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Federal and state</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income tax provision</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net operating loss carryforwards</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax credit carryforwards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension and deferred compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated depreciation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net deferred tax (liability) asset</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.365%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.227%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. federal corporate tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reversal of prior valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State income taxes, net of federal tax effect</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. research and development credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Excess tax benefits on share-based payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impact of 2017 Tax Act</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela deconsolidation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other business credits and Section 199 Deduction</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effective tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=117331294&amp;loc=d3e36027-109320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7004282240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.487%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.025%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.750%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.378%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.419%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Losses) gains on derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gains on investment securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(74.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(117.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(113.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(154.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(108.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(149.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.987%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:32.136%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Detail of components</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gains (losses) on derivatives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other expense&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6824842736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Revenue Recognition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 34.9<span></span>
</td>
<td class="nump">$ 33.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wst_SmartDoseMember', window );">SmartDose [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Revenue Benchmark [Member] | High-Value Components [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Revenue Benchmark [Member] | Standard Packaging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Revenue Benchmark [Member] | Delivery Devices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk [Member] | Revenue Benchmark [Member] | Contract Manufactured Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_BiologicsCustomersMember', window );">Biologics Customers [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_GenericsCustomersMember', window );">Generics Customers [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_PharmaCustomersMember', window );">Pharma Customers [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember', window );">Contract-Manufactured Customers [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas [Member] | Geographic Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA [Member] | Geographic Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific [Member] | Geographic Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of net sales</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_SmartDoseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_SmartDoseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_HighValueComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_HighValueComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_StandardPackagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_StandardPackagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_DeliveryDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_DeliveryDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_BiologicsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_BiologicsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_GenericsCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_GenericsCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_PharmaCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_PharmaCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=wst_ContractManufacturedCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838068736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the changes in the components of accumulated other comprehensive loss, net of tax:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.487%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.025%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.750%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.378%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.419%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Losses) gains on derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized gains on investment securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined benefit pension and other postretirement plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(74.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(117.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(113.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(154.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:4.5pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(108.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(149.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of the reclassifications out of accumulated other comprehensive loss is presented in the following table ($ in millions): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.987%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:32.136%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Detail of components</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location on Statement of Income</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gains (losses) on derivatives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net sales&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of goods and services sold&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other expense&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward treasury locks</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total before tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net of tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of defined benefit pension and other postretirement plans:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prior service credit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:9pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(a)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net of tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total reclassifications for the period, net of tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a) These components are included in the computation of net periodic benefit cost. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6652342096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesAs a global organization, we and our subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. During 2019, the statute of limitations for the 2015 U.S. federal tax year lapsed, leaving tax years 2016 through 2019 open to examination. For U.S. state and local jurisdictions, tax years 2015 through 2019 are open to examination. We are also subject to examination in various foreign jurisdictions for tax years 2012 through 2019.<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the beginning and ending amount of the liability for unrecognized tax benefits is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase due to current year position</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase due to prior year position</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reduction for expiration of statute of limitations/audits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we had balances in accrued liabilities for interest and penalties of $0.2 million at both December&#160;31, 2019 and 2018. As of December&#160;31, 2019, we had $5.0 million of total gross unrecognized tax benefits, which, if recognized, would favorably impact the effective income tax rate. It is reasonably possible that, due to the expiration of statutes and the closing of tax audits, the amount of gross unrecognized tax benefits may be reduced by approximately $0.5 million during the next twelve months, which would favorably impact our effective tax rate.</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of income before income taxes are:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total income before income taxes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">291.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">240.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The related provision for income taxes consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Federal</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current income tax provision</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Federal and state</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income tax provision</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The significant components of our deferred tax assets and liabilities at December 31 are</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net operating loss carryforwards</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax credit carryforwards</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pension and deferred compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated depreciation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total deferred tax liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net deferred tax (liability) asset</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A reconciliation of the U.S. federal corporate tax rate to our effective consolidated tax rate on income before income taxes follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.365%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.227%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. federal corporate tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on international operations other than U.S. tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reversal of prior valuation allowance</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reserves for unrecognized tax benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. tax on international earnings, net of foreign tax credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">State income taxes, net of federal tax effect</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. research and development credits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Excess tax benefits on share-based payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Impact of 2017 Tax Act</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax on undistributed earnings of subsidiaries</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela deconsolidation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other business credits and Section 199 Deduction</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effective tax rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we recorded a tax benefit of $0.3&#160;million due to the impact of federal law changes enacted during the year, as well as a tax benefit of $10.3&#160;million associated with stock-based compensation. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2018, we recorded a net tax benefit of $2.5 million for the estimated impact of the 2017 Tax Act and a tax benefit of $14.3 million associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2017, we recorded a discrete tax charge of $48.8 million related to the 2017 Tax Act and the impact of changes in enacted international tax rates on previously-recorded deferred tax asset and liability balances, as well as a tax benefit of $33.1 million associated with stock-based compensation.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2017 Tax Act, which was signed into law on December 22, 2017, has resulted in significant changes to the U.S. corporate income tax system. These changes include, but are not limited to, a federal statutory rate reduction from 35.0% to 21.0% effective for tax years beginning after December 31, 2017. Changes in tax rates and tax laws are accounted for in the period of enactment. As a result, during the year ended December 31, 2017, we recorded a discrete charge based upon our understanding of the 2017 Tax Act and the guidance available as of the date of that filing. A significant portion of the discrete tax liability was attributable to a one-time mandatory deemed repatriation tax of post-1986 undistributed foreign subsidiary earnings and profits (the &#8220;Transition Toll Tax&#8221;) of $27.9 million. Additionally, due to the reduction of the federal statutory rate, we revalued our deferred assets and liabilities and recorded a provisional $11.4 million federal tax expense, net of state tax impact, during the year ended December 31, 2017.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 to address the application of U.S. GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Tax Act. We recognized the provisional tax impacts related to deemed repatriated earnings and the revaluation of deferred tax assets and liabilities and included these amounts in our consolidated financial statements for the year ended December 31, 2017. As of December 31, 2018, we finalized our calculations and tax positions used in our analysis of the impact of the 2017 Tax Act in consideration of proposed regulations and other guidance issued during 2018. As a result, we recorded a $7.5 million tax benefit related to a reduction of the Transition Toll Tax and an incremental tax expense of $4.0 million related to other adjustments. The final measurement reduced the Transition Toll Tax expense to $20.4 million from $27.9 million. The net impact of these adjustments resulted in a benefit of 1.45% to the 2018 effective tax rate. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2017 Tax Act created a provision known as global intangible low-tax income (&#8220;GILTI&#8221;) that imposes a U.S. tax on certain earnings of controlled foreign subsidiaries. We made an accounting policy election to reflect GILTI taxes, if any, as a current income tax expense in the period incurred. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we have fully utilized all of our U.S. federal net operating loss carryforwards. State operating loss carryforwards of $226.9 million created a deferred tax asset of $15.5 million, while foreign operating loss carryforwards of $49.4 million created a deferred tax asset of $6.4 million. Management estimates that certain state and foreign operating loss carryforwards are unlikely to be utilized and the associated deferred tax assets have been fully reserved. State loss carryforwards expire as follows: $15.4 million in 2020 and $211.5 million thereafter. Foreign loss carryforwards will begin to expire in 2027, while $48.7 million of the total $49.4 million will not expire.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December&#160;31, 2019, we have utilized all available foreign tax credit carryforwards against the Transition Toll Tax. During 2019, we utilized all of our remaining U.S. federal research and development credit carryforwards. The $2.0 million of state research and development credits expire as follows: $0.5 million expire in 2023, $0.5 million expire in 2024, and $1.0 million expire after 2024.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is de minimis, and that position has not changed subsequent to the one-time transition tax under the 2017 Tax Act, except as noted above. Accordingly, no deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of approximately $214.2 million of undistributed earnings from foreign subsidiaries to the U.S., as those earnings continue to be permanently reinvested. Further, it is impracticable for us to estimate any future tax costs for any unrecognized deferred tax liabilities associated with our indefinite reinvestment assertion, because the actual tax liability, if any, would be dependent on complex analysis and calculations considering various tax laws, exchange rates, circumstances existing when there is a repatriation, sale or liquidation, or other factors.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6997637248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Principles of Consolidation:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The consolidated financial statements include the accounts of West after the elimination of intercompany transactions. We have no participation or other rights in variable interest entities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, we acquired the business of our distributor in South Korea for $18.9&#160;million. As a result of the acquisition, we recorded inventories, property, plant and equipment, goodwill and a customer relationships intangible asset of $4.5&#160;million, $0.6&#160;million, $2.6&#160;million and $11.2&#160;million, respectively. The goodwill was recorded within our Proprietary Products reportable segment. The results of this acquisition have been included in our consolidated financial statements since the acquisition date.</span></div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of April 1, 2017, our consolidated financial statements exclude the results of our Venezuelan subsidiary. Please refer to Note 16, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other (Income) Expense</span>, for further discussion.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The financial statements are prepared in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingencies in the financial statements. Actual amounts realized may differ from these estimates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash and Cash Equivalents:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  Cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with maturities of three months or less at the time of purchase.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our accounts receivable balance was net of an allowance for doubtful accounts of $0.5 million and $2.0 million at December&#160;31, 2019 and 2018, respectively. We record the allowance based on a specific identification methodology.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories: Inventories are valued at the lower of cost (on a first-in, first-out basis) and net realizable value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property, Plant and Equipment</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Property, plant and equipment assets are carried at cost. Maintenance and minor repairs and renewals are charged to expense as incurred. Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and immediately expensed for preliminary project activities or post-implementation activities. Upon sale or retirement of depreciable assets, costs and related accumulated depreciation are eliminated, and gains or losses are recognized in other (income) expense. Depreciation and amortization are computed principally using the straight-line method over the estimated useful lives of the assets, or the remaining term of the lease, if shorter.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Operating lease right-of-use assets are initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. Operating lease right-of-use assets are subsequently measured throughout the lease term at the carrying amount of the lease liability, plus initial direct costs, plus (minus) any prepaid (accrued) lease payments, less the unamortized balance of lease incentives received. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease liabilities are initially measured </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">at the present value of the unpaid lease payments at the lease commencement date. We had no finance leases as of December&#160;31, 2019. Please refer to Note 6, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Leases</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Long-Lived Assets</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Long-lived assets, including property, plant and equipment and operating lease right-of-use assets, are tested for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable. An asset is considered impaired if the carrying value of the asset exceeds the sum of the future expected undiscounted cash flows to be derived from the asset. Once an asset is considered impaired, an impairment loss is recorded within other (income) expense for the difference between the asset&#8217;s carrying value and its fair value. For assets held and used in the business, management determines fair value using estimated future cash flows to be derived from the asset, discounted to a net present value using an appropriate discount rate. For assets held for sale or for investment purposes, management determines fair value by estimating the proceeds to be received upon sale of the asset, less disposition costs.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Impairment of Goodwill and Other Intangible Assets</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impairment of Goodwill and Other Intangible Assets:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Goodwill is tested for impairment at least annually, following the completion of our annual budget and long-range planning process, or whenever circumstances indicate that the carrying value of these assets may not be recoverable. Goodwill is tested for impairment at the reporting unit level, which is the same as, or one level below, our operating segments. A goodwill impairment charge represents the amount by which a reporting unit&#8217;s carrying amount exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit. Accounting guidance also allows entities to first assess qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors, and overall financial performance, to determine whether it is necessary to perform the quantitative goodwill impairment test. We elected to follow this guidance for our 2017, 2018, and 2019 annual impairment tests. Based upon our assessment, we determined that it was not more likely than not that the fair value of each of our reporting units was less than its carrying amount and determined that it was not necessary to perform the quantitative goodwill impairment tests in 2017, 2018, and 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets with finite lives are amortized using the straight-line method over their estimated useful lives of 5 to 25 years, and reviewed for impairment whenever circumstances indicate that the carrying value of these assets may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Employee Benefits</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Employee Benefits:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> The measurement of the obligations under our defined benefit pension and postretirement medical plans are subject to a number of assumptions. These include the rate of return on plan assets (for funded plans) and the rate at which the future obligations are discounted to present value. For our funded plans, we consider the current and expected asset allocations of our plan assets, as well as historical and expected rates of return, in estimating the long-term rate of return on plan assets. U.S. GAAP requires the recognition of an asset or liability for the funded status of a defined benefit postretirement plan, as measured by the difference between the fair value of plan assets, if any, and the benefit obligation. For a pension plan, the benefit obligation is the projected benefit obligation; for any other postretirement plan, such as a retiree health plan, the benefit obligation is the accumulated postretirement benefit obligation. Please refer to Note 15, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Benefit Plans</span>, for a more detailed discussion of our pension and other retirement plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Financial Instruments</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: All derivatives are recognized as either assets or liabilities in the balance sheet and recorded at their fair value. For a derivative designated as hedging the exposure to variable cash flows of a forecasted transaction (referred to as a cash flow hedge), the effective portion of the derivative&#8217;s gain or loss is initially reported as a component of other comprehensive income (&#8220;OCI&#8221;), net of tax, and subsequently reclassified into earnings when the forecasted transaction affects earnings. For a derivative designated as hedging the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a fair value hedge), the derivative&#8217;s gain or loss is recognized in earnings in the period of change together with the offsetting loss or gain on the hedged item.&#160;For a derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the gain or loss is reported in OCI, net of tax, as part of the cumulative translation adjustment. The ineffective portion of any derivative used in a hedging transaction is recognized immediately into earnings. Derivative financial instruments that are not designated as hedges are also recorded at fair value, with the change in fair value recognized immediately into earnings. We do not purchase or hold any derivative financial instrument for investment or trading purposes.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency Translation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Foreign currency transaction gains and losses are recognized in the determination of net income. Foreign currency translation adjustments of subsidiaries and affiliates operating outside of the U.S. are accumulated in other comprehensive loss, a separate component of equity.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Our revenue results from the sale of goods or services and reflects the consideration to which we expect to be entitled in exchange for those goods or services. We record revenue based on a five-step model, in accordance with ASC 606. Following the identification of a contract with a customer, we identify the performance obligations (goods or services) in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize the revenue when (or as) we satisfy the performance obligations by transferring the promised goods or services to our customers. A good or service is transferred when (or as) the customer obtains control of that good or service. Some customers receive pricing rebates upon attaining established sales volumes. We record rebate costs when sales occur based on our assessment of the likelihood that the required volumes will be attained. We also maintain an allowance for product returns, as we believe that we are able to reasonably estimate the amount of returns based on our substantial historical experience. Please refer to Note 3, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue</span>, for additional information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text">Shipping and Handling Costs: Shipping and handling costs are included in cost of goods and services sold. Shipping and handling costs billed to customers in connection with the sale are included in net sales.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">Research and Development: Research and development expenditures are for the creation, engineering and application of new or improved products and processes. Expenditures include primarily salaries and outside services for those directly involved in research and development activities and are expensed as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EnvironmentalCostsPolicy', window );">Environmental Remediation and Compliance Costs</a></td>
<td class="text">Environmental Remediation and Compliance Costs: Environmental remediation costs are accrued when such costs are probable and reasonable estimates are determinable. Cost estimates include investigation, cleanup and monitoring activities; such estimates are adjusted, if necessary, based on additional findings. Environmental compliance costs are expensed as incurred as part of normal operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock', window );">Litigation</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: From time to time, we are involved in legal proceedings, investigations and claims generally incidental to our normal business activities. In accordance with U.S. GAAP, we accrue for loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These estimates are based on an analysis made by internal and external legal counsel considering information known at the time. Legal costs in connection with loss contingencies are expensed as incurred.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Income Taxes:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Deferred income taxes are recognized by applying enacted statutory tax rates to tax loss carryforwards and temporary differences between the tax basis and financial statement carrying values of our assets and liabilities. The enacted statutory tax rate applied is based on the rate expected to be applicable at the time of the forecasted utilization of the loss carryforward or reversal of the temporary difference. Valuation allowances on deferred tax assets are established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. The realizability of deferred tax assets is subject to our estimates of future taxable income, generally at the respective subsidiary company and the country level. In response to the 2017 Tax Act, we reevaluated our position regarding permanent reinvestment of foreign subsidiary earnings and profits through 2017 (with the exception of China and Mexico) and decided that those profits were no longer permanently reinvested. As of January 1, 2018, we reasserted indefinite reinvestment related to all post-2017 unremitted earnings in all of our foreign subsidiaries. Please refer to Note 17, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for additional information. We recognize interest costs related to income taxes in interest expense and penalties within other (income) expense. The tax law ordering approach is used for purposes of determining whether an excess tax benefit has been realized during the year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Stock-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Under the fair value provisions of U.S. GAAP, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options on the grant date, we use the Black-Scholes valuation model. Please refer to Note 14, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Stock-Based Compensation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, for a more detailed discussion of our stock-based compensation plans.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Income Per Share</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">: Basic net income per share is computed by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Net income per share assuming dilution considers the dilutive effect of outstanding stock options and other stock awards based on the treasury stock method. The treasury stock method assumes the use of exercise proceeds to repurchase common stock at the average fair market value in the period.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2175709<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13669-110860<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13185-110859<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13231-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32247-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32280-109318<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=SL6953423-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5033-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5212-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5093-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Matters, Contingencies and Legal Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LegalMattersContingenciesAndLegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7004393024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect', window );">Prior service credit arising during period, tax</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Net actuarial gain (loss) arising during period, tax</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax', window );">Settlement effects arising during period, tax</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Less: amortization of actuarial loss, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax', window );">Less: amortization of prior service credit, tax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Net gain (loss) on investment securities, tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Net gain (loss) on derivatives, tax</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plans, Settlement Effects Arising During Period, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlansSettlementEffectsArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843796992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 241.7<span></span>
</td>
<td class="nump">$ 206.9<span></span>
</td>
<td class="nump">$ 150.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">100.0<span></span>
</td>
<td class="nump">101.7<span></span>
</td>
<td class="nump">94.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">24.4<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash restructuring charges</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Pension settlement charge</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Venezuela deconsolidation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Contingent consideration payments in excess of acquisition-date liability</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on sales of equipment</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">41.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_PensionandOtherPostretirementBenefitExpenseNet', window );">Pension and other retirement plans, net</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(6.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in undistributed earnings of affiliates, net of dividends</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets/liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
<td class="num">(33.3)<span></span>
</td>
<td class="num">(43.8)<span></span>
</td>
<td class="num">(39.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(18.6)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase in accounts payable</a></td>
<td class="nump">25.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Changes in other assets and liabilities</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">28.3<span></span>
</td>
<td class="num">(11.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">367.2<span></span>
</td>
<td class="nump">288.6<span></span>
</td>
<td class="nump">263.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(126.4)<span></span>
</td>
<td class="num">(104.7)<span></span>
</td>
<td class="num">(130.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase of investment in affiliated companies</a></td>
<td class="num">(85.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisition of business</a></td>
<td class="nump">18.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDivestedFromDeconsolidation', window );">Cash related to deconsolidated Venezuelan subsidiary</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(228.0)<span></span>
</td>
<td class="num">(100.8)<span></span>
</td>
<td class="num">(133.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Borrowings under revolving credit agreements</a></td>
<td class="nump">108.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="num">(136.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Issuance of long-term debt</a></td>
<td class="nump">90.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(34.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividend payments</a></td>
<td class="num">(45.1)<span></span>
</td>
<td class="num">(42.1)<span></span>
</td>
<td class="num">(39.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Contingent consideration payments up to amount of acquisition-date liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock-based compensation awards</a></td>
<td class="nump">25.1<span></span>
</td>
<td class="nump">27.4<span></span>
</td>
<td class="nump">35.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Employee stock purchase plan contributions</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Shares repurchased under share repurchase program</a></td>
<td class="num">(83.1)<span></span>
</td>
<td class="num">(70.8)<span></span>
</td>
<td class="num">(74.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(36.8)<span></span>
</td>
<td class="num">(80.7)<span></span>
</td>
<td class="num">(109.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rates on cash</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">101.7<span></span>
</td>
<td class="nump">101.5<span></span>
</td>
<td class="nump">32.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, including cash equivalents at beginning of period</a></td>
<td class="nump">337.4<span></span>
</td>
<td class="nump">235.9<span></span>
</td>
<td class="nump">203.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, including cash equivalents at end of period</a></td>
<td class="nump">439.1<span></span>
</td>
<td class="nump">337.4<span></span>
</td>
<td class="nump">235.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid, net of amounts capitalized</a></td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net</a></td>
<td class="nump">47.5<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
<td class="nump">31.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued capital expenditures</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="nump">20.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends declared, not paid</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">11.3<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Purchase of investment in affiliated companies, treasury stock</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDivestedFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDivestedFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_PensionandOtherPostretirementBenefitExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of pension and other (such as medical, dental and life insurance) postretirement benefit costs recognized during the period for (1) defined benefit plans (periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss) on assets, prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments) and for (2) defined contribution plans (to the extent that a plan's defined contributions to an individual's account are to be made for periods in which that individual renders services, the net cost for a period is the contribution called for in that period; if a plan calls for contributions for periods after an individual retires or terminates, the estimated cost is accrued during the employee's service period); net of cash contributed during the reporting period by the entity to fund its benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_PensionandOtherPostretirementBenefitExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826786192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Textuals) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 59,000,000.0<span></span>
</td>
<td class="nump">$ 41,400,000<span></span>
</td>
<td class="nump">$ 80,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations', window );">Other Income Tax Expense (Benefit), Continuing Operations</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense', window );">Discrete tax charge, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,500,000)<span></span>
</td>
<td class="nump">48,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued liabilities for interest and penalties</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Total gross unrecognized tax benefits</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Estimated reduction in the liability for unrecognized tax benefits</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense', window );">Discrete tax charge, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,500,000)<span></span>
</td>
<td class="nump">48,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">59,000,000.0<span></span>
</td>
<td class="nump">41,400,000<span></span>
</td>
<td class="nump">80,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense', window );">Provisional Transition Tax, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense', window );">Provisional tax charge, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax', window );">Reduction in Transition Tax, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit', window );">Measurement period adjustment, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense', window );">Transitional Tax, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate', window );">Net impact to the 2018 effective tax rate, Tax Cuts and Jobs Act of 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign subsidiaries</a></td>
<td class="nump">214,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member', window );">Accounting Standards Update 2016-09 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(10,300,000)<span></span>
</td>
<td class="num">$ (14,300,000)<span></span>
</td>
<td class="num">(33,100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (10,300,000)<span></span>
</td>
<td class="num">$ (14,300,000)<span></span>
</td>
<td class="num">$ (33,100,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)-(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in deferred tax liability previously recognized attributable to taxable temporary differences from undistributed earnings of foreign subsidiary and other recognized entity now subject to transition tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017DecreaseInDeferredTaxLiabilityDueToTransitionTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reasonable estimate for income tax expense for which accounting for tax effect from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated is incomplete pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase (decrease) in effective tax rate for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28200-109314<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Deferred Tax Liability, Provisional Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_TaxCutsandJobsActof2017IncompleteAccountingDeferredTaxLiabilityProvisionalIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845161984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Goodwill) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">$ 105,800,000<span></span>
</td>
<td class="nump">$ 107,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(1,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">107,800,000<span></span>
</td>
<td class="nump">105,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">76,000,000.0<span></span>
</td>
<td class="nump">77,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(1,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">78,100,000<span></span>
</td>
<td class="nump">76,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning</a></td>
<td class="nump">29,800,000<span></span>
</td>
<td class="nump">30,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill recorded due to acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, ending</a></td>
<td class="nump">$ 29,700,000<span></span>
</td>
<td class="nump">$ 29,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>110
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !>755 ?(\\#P    !,"   +    7W)E;',O+G)E;'.MDD^+
MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V
M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F'
M.>RGGD7E2B.5^S3%":4A+<TXP)6E/S/WJVR;A5ND9T*YKCM+1[873T$7LF<;
M!I99-G\LCNVW<+ZT+/0:S>,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C
M-R."?S]PN -02P,$%     @ %Y=54"?HAPZ"    L0   !    !D;V-0<F]P
M<R]A<' N>&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(?
MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M'WY781>,W=M_;'P1[%KX=1?=%U!+ P04    "  7EU50F5R<(Q &  "<)P
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M#7&($H=FQA'NCU!_9&2<P(Q[23*A#& F&U/S0%,'_KVF*DJ<!,>-4=S8Q$T
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MYUPP22FWJ6T=92\^/I1L+]1M+._;OB'M'P1OAF;;'3O^U7]02P,$%     @
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M]>;3^2EC@#("J%@$X/ @%\G*_ZF6=C ^&>'3W6L8Y*>9?.UC0-G<AP@,4 8
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MVN8XP>C*Y3 38ZI[AYYPT@U]$8S-N?P+4$L#!!0    ( !>755 YWT-I904
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M]GLUO#<;+IKR9-\)AI<7D\O_ 5!+ P04    "  7EU50T=.:=&(&  !:)
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MR\;^-\9XP%22&QRA#C_8:DAH?#B^Q[.=QVPVO!F6'\36;US^ 5!+ P04
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MV/_:& \H97>#(]3B!UL,!;4/QSL\VVG,)L.;?OY!;/G&Q5]02P,$%     @
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M_VS&1YCK>4?)7/PGN(#"\* $<Y1&N;B2<G#>Z)D%I6CQ-NVRB_LXW>ROL&T
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M_0=;# FU"\=/_FRF,9L,A_W\@]CRC8O?4$L#!!0    ( !>755#/"08NMP$
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M8+.AH/+A>(-G.X[9:'C333^(S=\X_P=02P,$%     @ %Y=54#?)C[.T 0
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MY<+QDS^;<<Q&PV$W_2 V?^/\#5!+ P04    "  7EU50+WE;5;4!  #2 P
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M\6RG,9L,;_KY!['E&Q>_ %!+ P04    "  7EU50=)&P[K4!  #2 P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q]4V%OVR 0_2N('U 2DC919%MJ
M.DV;M$E1IVV?B7VV48'S ,?=OQ]@U_,V:U^ .^Z]>W<<V8#VQ;4 GKQJ95Q.
M6^^[$V.N;$$+=X<=F'!3H]7"!],VS'461)5 6C&^V3PP+:2A199\%UMDV'LE
M#5PL<;W6POX\@\(AIUOZYGB63>NC@Q59)QKX OYK=['!8C-+)348)]$0"W5.
M'[>G\S[&IX!O$@:W.)-8R17Q)1H?JYQNHB!04/K((,)V@R=0*A(%&3\F3CJG
MC,#E^8W]?:H]U'(5#IY0?9>5;W-ZI*2"6O3*/^/P :9Z[BF9BO\$-U A/"H)
M.4I4+JVD[)U'/;$$*5J\CKLT:1_&F]UA@JT#^ 3@,^"8\K Q45+^3GA19!8'
M8L?>=R(^\?;$0V_*Z$RM2'=!O O>6\'O'S)VBT13S'F,X8N8[1S! ON<@J^E
M./-_X'P=OEM5N$OPW1\*#^L$^U6"?2+8_[?$M9CC7TG8HJ<:;).FR9$2>Y,F
M>>&=!_:1IS?Y'3Y.^V=A&VD<N:(/+YOZ7R-Z"%(V=V&$VO#!9D-![>/Q$,YV
M'+/1\-A-/XC-W[CX!5!+ P04    "  7EU501K'2-[4!  #2 P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q."YX;6Q]4]MNW" 0_17$!P0ON]FD*]M2-E65
M2HVT2M7VF;7'-@H8!_ Z^?L.V'&MQLH+,,,Y9RX,Z6#LLVL /'G5JG49;;SO
M#HRYH@$MW)7IH,6;RE@M/)JV9JZS(,I(THKQ)-DS+61+\S3Z3C9/3>^5;.%D
MB>NU%O;M",H,&=W0=\>3K!L?'"Q/.U'#3_"_NI-%B\TJI=30.FE:8J'*Z-WF
M<-P%? 3\EC"XQ9F$2L[&/ ?C>YG1)"0$"@H?% 1N%[@'I8(0IO$R:=(Y9" N
MS^_JWV+M6,M9.+@WZH\L?9/16TI*J$2O_),9'F"JYYJ2J?@?< &%\) )QBB,
M<G$E1>^\T9,*IJ+%Z[C+-N[#>,-O)MHZ@4\$/A-N8QPV!HJ9?Q5>Y*DU [%C
M[SL1GGASX-B;(CAC*^(=)N_0>\GY]9>478+0A#F.&+[ ;&8$0_4Y!%\+<>0?
MZ'R=OEW-<!OIVR5]GZP+[%8%=E%@]VF)*YC]_T6R14\UV#I.DR.%Z=LXR0OO
M/+!W/+[)/_@X[8_"UK)UY&P\OFSL?V6,!TPEN<(1:O"#S8:"RH?C#9[M.&:C
MX4TW_2 V?^/\+U!+ P04    "  7EU50<=I5A+4!  #2 P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Q.2YX;6Q]4VUOVR 0_BN('U 2XF519%MJ6E6MM$E1
MIVV?B7U^48%S <?=OQ]@U_,VJU^ .^YY[KGC2 <T+[8!<.1-26TSVCC7'1FS
M10-*V!OL0/N;"HT2SINF9K8S(,H(4I+QS6;/E&@US=/H.YL\Q=[)5L/9$-LK
M)<RO$T@<,KJE[X[GMFY<<+ \[40-W\!][\[&6VQF*5L%VK:HB8$JH[?;XRD)
M\3'@1PN#79Q)J.2"^!*,IS*CFR ()!0N, B_7>$.I Q$7L;KQ$GGE &X/+^S
M/\3:?2T78>$.Y<^V=$U&#Y244(E>NF<<'F&JYQ,E4_%?X K2AP<E/D>!TL:5
M%+UUJ"86+T6)MW%O==R'\69_F&#K #X!^ PXQ#QL3!25WPLG\M3@0,S8^TZ$
M)]X>N>]-$9RQ%?'.B[?>>\WYGJ?L&HBFF-,8PQ<QVSF">?8Y!5]+<>+_P?DZ
M?+>J<!?AN[\4[M8)DE6")!(D'Y:X%I/\DX0M>JK U'&:+"FPUW&2%]YY8&]Y
M?),_X>.T?Q6F;K4E%W3^96/_*T0'7LKFQH]0XS_8;$BH7#A^]F<SCMEH..RF
M'\3F;YS_!E!+ P04    "  7EU50^[#MYK4!  #2 P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q]4V%OVR 0_2N('U 2XJ959%MJ6E6=M$E1JVV?
MB7VV4<'G HZ[?U_ KN=MUKX =]Q[]^XXT@'-JVT ''G7JK49;9SK#HS9H@$M
M[!5VT/J;"HT6SINF9K8S(,H(THKQS6;/M) MS=/H.YD\Q=XIV<+)$-MK+<RO
M(R@<,KJEGXYG63<N.%B>=J*&%W#?NY/Q%IM92JFAM1);8J#*Z-WV<$Q"? SX
M(6&PBS,)E9P17X/QI<SH)@@"!84+#,)O%[@'I0*1E_$V<=(Y90 NSY_LC[%V
M7\M96+A']5.6KLGH+24E5*)7[AF')YCJN:9D*OXK7$#Y\*#$YRA0V;B2HK<.
M]<3BI6CQ/NZRC?LPWNR2";8.X!. SX#;F(>-B:+R!^%$GAH<B!E[WXGPQ-L#
M][TI@C.V(MYY\=9[+SG?7Z?L$HBFF.,8PQ<QVSF">?8Y!5]+<>3_P/DZ?+>J
M<!?ANS\4[M<)DE6")!(D_RUQ+>;FKR1LT5,-IH[39$F!?1LG>>&=!_:.QS?Y
M'3Y.^S=A:ME:<D;G7S;VOT)TX*5LKOP(-?Z#S8:"RH7CC3^;<<Q&PV$W_2 V
M?^/\ U!+ P04    "  7EU509P%^SK8!  #2 P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q]4V%OVR 0_2N('U <DC599%MJ.DV=M$I1IVV?B7VV
M4<'G H[;?S_ KN=MUKX =]Q[]^XXT@'-LVT ''G5JK49;9SKCHS9H@$M[ UV
MT/J;"HT6SINF9K8S(,H(THKQ)+EE6LB6YFGTG4V>8N^4;.%LB.VU%N;M! J'
MC&[HN^-)UHT+#I:GG:CA&[COW=EXB\TLI=306HDM,5!E]&YS/.U"? SX(6&P
MBS,)E5P0GX/QI<QH$@2!@L(%!N&W*]R#4H'(RWB9..F<,@"7YW?VS[%V7\M%
M6+A']5.6KLGH@9(2*M$K]X3# TSU?*!D*OXK7$'Y\*#$YRA0V;B2HK<.]<3B
MI6CQ.NZRC?LPWFSW$VP=P"< GP&'F(>-B:+R3\*)/#4X$#/VOA/AB3='[GM3
M!&=L1;SSXJWW7G-^>TC9-1!-,:<QAB]B-G,$\^QS"KZ6XL3_@?-U^'95X3;"
MMW\H_+A.L%LEV$6"W7]+7(G9)W\E88N>:C!UG"9+"NS;.,D+[SRP=SR^R>_P
M<=H?A:EE:\D%G7_9V/\*T8&7DMSX$6K\!YL-!94+Q[T_FW',1L-A-_T@-G_C
M_!=02P,$%     @ %Y=54/@2X*:S 0  T@,  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL?5-A;]P@#/TKB!]0[DC65J<D4J_3M$F;=&JU[3.7. DJ
MQ"F02_?O"R1-LRW;%\#&[_G9F&Q$\V1; $=>M.IL3EOG^@-CMFQ!"WN%/73^
MID:CA?.F:9CM#8@J@K1B?+>[9EK(CA99])U,D>'@E.S@9(@=M!;FUQ$4CCG=
MTS?'@VQ:%QRLR'K1P".X[_W)>(LM+)74T%F)'3%0Y_1N?SBF(3X&_) PVM69
MA$K.B$_!^%+E=!<$@8+2!0;AMPO<@U*!R,MXGCGIDC( U^<W]D^Q=E_+65BX
M1_535J[-Z2TE%=1B4.X!Q\\PU_.!DKGXKW !Y<.#$I^C1&7C2LK!.M0SBY>B
MQ<NTRR[NXW23)C-L&\!G %\ MS$/FQ)%Y1^%$T5F<"1FZGTOPA/O#]SWI@S.
MV(IXY\5;[[T4_&:?L4L@FF..4PQ?Q;Q',,^^I.!;*8[\+SC?AB>;"I,(3WY3
M^ ^"=),@C03I?TO<BDG^2,)6/=5@FCA-EI0X='&25]YE8.]X?)/W\&G:OPG3
MR,Z2,SK_LK'_-:(#+V5WY4>H]1]L,134+AQO_-E,8S89#OOY!['E&Q>O4$L#
M!!0    ( !>755!XO"GAM0$  -(#   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;'U3VV[<(!#]%<0'A#7K7+2R+6535:W42*M$;9]9>WQ1@'$!KY._
M#V#'=5NK+\ ,<\Z<&89L1/-B6P!'7I74-J>M<_V!,5NVH(2]PAZTOZG1*.&\
M:1IF>P.BBB E&=_M;I@2G:9%%GTG4V0X.-EI.!EB!Z6$>3N"Q#&G"?UP/'5-
MZX*#%5DO&G@&][T_&6^QA:7J%&C;H28&ZIS>)X=C&N)CP(\.1KLZDU#)&?$E
M&%^KG.Z"()!0NL @_':!!Y R$'D9OV9.NJ0,P/7Y@_USK-W7<A86'E#^["K7
MYO2.D@IJ,4CWA.,7F.NYIF0N_AM<0/KPH,3G*%':N))RL [5S.*E*/$Z[9V.
M^SC=[),9M@W@,X O@+N8ATV)HO)/PHDB,S@2,_6^%^&)DP/WO2F#,[8BWGGQ
MUGLO!;]-,W8)1'/,<8KAJYADB6">?4G!MU(<^3]PO@W?;RK<1_C^#X77VP3I
M)D$:"=+_EK@5<_-7$K;JJ0+3Q&FRI,1!QTE>>9>!O>?Q37Z'3]/^*$S3:4O.
MZ/S+QO[7B Z\E-V5'Z'6?[#%D%"[<+SU9S.-V60X[.<?Q)9O7+P#4$L#!!0
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M0>=?-O:_0G3@I20W?H0:_\%F0T'EPG'OSV8<L]%PV$T_B,W?./\+4$L#!!0
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M_RM$!U[*YLJ/4.,_V&Q(J%PX?O9G,X[9:#CLIA_$YF^<_P502P,$%     @
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MX6E2B8/NAPLS5D,_.$RT;,=>-YD:[LU?4$L#!!0    ( !>755 ? X,DM@$
M -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;&U386_<( S]*X@?
M4!)RW:I3$JG7:=JD33IUVO:92YP$%>(,R*7[]P.2IFF7+X"-W_.S,?F$YLEV
M (X\:]7;@G;.#4?&;-6!%O8&!^C]38-&"^=-TS([&!!U!&G%>))\8%K(GI9Y
M])U-F>/HE.SA;(@=M1;F[PD43@5-Z8OC4;:="PY6YH-HX0>XG\/9>(NM++74
MT%N)/3'0%/0^/9X.(3X&_)(PV<V9A$HNB$_!^%H7- F"0$'E H/PVQ4>0*E
MY&7\63CIFC( M^<7]L^Q=E_+15AX0/5;UJXKZ!TE-31B5.X1IR^PU'-+R5+\
M-[B"\N%!B<]1H;)Q)=5H'>J%Q4O1XGG>91_W:;ZYY0ML'\ 7 %\!=S$/FQ-%
MY9^$$V5N<")F[OT@PA.G1^Y[4P5G;$6\\^*M]U[++$MR=@U$2\QICN&;F'2-
M8)Y]3<'W4ISX?W"^#\]V%681GFWA&X5O" Z[!(=(<'A38OJNQ+V8]RK9IJ<:
M3!NGR9(*QSY.\L:[#NQ]?$3V&CY/^W=A6ME;<D'G7S;VOT%TX*4D-WZ$.O_!
M5D-!X\+QHS^;><QFP^&P_""V?N/R'U!+ P04    "  7EU50?41ABL4!   W
M!   &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6QM5&UOFS 0_BN6?T"=
M0$BK")":5M4FK5+4:MMG!PZPZA=FF]#^^]J&,I;Y"_:=G^>Y.Y^/?%3ZS70
M%KT++DV!.VO[ R&FZD!0<Z-ZD.ZD45I0ZTS=$M-KH'4@"4Z2S69/!&42EWGP
MG729J\%R)N&DD1F$H/KC"%R-!=[B+\<+:SOK':3,>]K"*]B?_4D[BRPJ-1,@
M#5,2:6@*?+\]'#./#X!?#$:SVB-?R5FI-V]\KPN\\0D!A\IZ!>J6"SP YU[(
MI?%GUL1+2$]<[[_4GT+MKI8S-?"@^&]6VZ[ =QC5T-"!VQ<U?H.YG@RCN?@?
M< 'NX#X3%Z-2W(0OJ@9CE9A57"J"OD\KDV$=IY-].M/BA&0F) OA+L0A4Z"0
M^2.UM,RU&I&>[KZGOL7;0^+NIO+.<!7AS"5OG/=2IFF:DXL7FC''"9.L,-L%
M09SZ$B*)A3@F_]&3.#V-9I@&>KJFI[=Q@5U48!<$=O^4N+LJ,8;)XD&R:) L
M(K"_"A+#7%="5HT3H-OP9 VJU"##N*R\RU3<)Z'Q?^'32#U3W3)IT%E9]WQ"
MDQNE++A4-C<NE\Y-\6)P:*S?WKJ]GM[R9%C5SV-*EG]%^0E02P,$%     @
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M_QNM'?A4DBL_0IW_8(LAH''A>.//9AJSR7"ZGW\06;YQ^1M02P,$%     @
M%Y=54' ]@Q&U 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M;5/;;IPP$/T5RQ\0+X:TT0J0LJFB5FJE5:JVSUX8P(K-4-LLZ=_7-H30E!?;
M,S[GS,7C?$+S;#L 1UZTZFU!.^>&(V.VZD +>X,#]/ZF0:.%\Z9IF1T,B#J2
MM&+\</C M) ]+?/H.YLRQ]$IV</9$#MJ+<R?$RB<"IK05\>3;#L7'*S,!]'"
M=W _AK/Q%EM5:JFAMQ)[8J IZ'UR/&4!'P$_)4QV<R:AD@OB<S"^U 4]A(1
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M=',O<VAE970S-2YX;6QU4]MNG# 0_17+'Q#O&DBC%2!E4T6)U$BK5&V?O3"
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MUL[5]):GA9']W*9D^5<4?P%02P,$%     @ %Y=54/C4R)FY 0  T@,  !D
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M?O%G,XW99#C=SS^(+-^X_ =02P,$%     @ %Y=54$-:M:G/ 0  G 0  !D
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M00.K TD*0G>[ Y&,][C,0^RBRUR-5O >+AJ944JF?Y]!J*G >_P>>.%M9WV
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MA^&:"M:TI,Q][*#*7%X-;UHXJ$!?A6#JSQZX[ L2D7O@N;G4Q@5HF7?L C_
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MX[:9W:MAC@T'([MQ1M/I0U'^!5!+ P04    "  7EU50^W81SL8!   W!
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M3\42<*B,FQ[L7$T79@J,[.>W@"P/4OX74$L#!!0    ( !>755"*,O]OV0(
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MZ8-KCU?%N0(MZ&^T[5K?4%/!H%)F^Z#W8OQ.QT+QWEU!>+H'\[]02P,$%
M  @ %Y=54$IQU8!Q P  I!$  !D   !X;"]W;W)K<VAE971S+W-H965T-#DN
M>&ULE5C;CILP%/P5Q <$;'/+*HFT256U4BNM6K5]9A,G00LX!2?9_GV-8=D
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MDA>,X+*! #>971.00XJ6YA8OE"?L<M*%38#ATH*!VN+LME$T6Z$TR!9 <.G
M0.THG3KI%@^TM*LQ7"\P5##L11Y%CULA<2I&^'!*Z&/[.^'GNA/>GDEUX)AC
MX<28I"HA"M1[?U%?"E.CH2>I;]7!YO'AN!P:DO7CIT X?8]L_@)02P,$%
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MIMDI9<'I)2MW@WKWON:$0V=]N'6QGF[9E%@UQ =$YE=<_0-02P,$%     @
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MNG\)*#3:3A_,7/H>\($6P]S>>/G'%/\ 4$L#!!0    ( !>755#G+'%XM0(
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MMCE3Y1'*>MU$P2I#5^UHQ.0#QI]A\(1 ROL4PH="Y+Y%]V\#;&U$O(#L $@
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MQ;WM;U0?>-,.CX6-+S;_!U!+ P04    "  7EU50K&YS#9$"  "T"0  &0
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MK&^)^HF@W=#N^6//N?P#4$L#!!0    ( !>755!;6:B$T (  & +   9
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M?:4VH=!U;/;?Z97F"JZ9J!A[E@OS[>PO0K+">E%4"O)>/[/2/&_UFPA;,]@
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M]*%TIE00Z3[P9+.HY(?--&G(6:AA)L=L.-V'B:#]^.7B3Y]/F[]02P,$%
M  @ %Y=54)Q 75]< P  6Q$  !D   !X;"]W;W)K<VAE971S+W-H965T-C<N
M>&ULE9CICILP%(5?!?$  2]LHR12)U752JTTFJKM;R9Q$C2 4W"2Z=O7+),2
M?%S!G[#DW.-[;3X;L[S*ZK4^"J&<MR(OZY5[5.KTX'GU]BB*M%[(DRCU/WM9
M%:G2E]7!JT^52'=M4)%[U/=#KTBSTETOVWM/U7HISRK/2O%4.?6Y*-+JSZ/(
MY77E$O?]QG-V.*KFAK=>GM*#^"[4C]-3I:^\F\LN*T199[)T*K%?N1_(PX;S
M)J!5_,S$M1Z<.TTI+U*^-A=?=BO7;S(2N=BJQB+5AXO8B#QOG'0>OWM3]]9F
M$S@\?W?_U!:OBWE):[&1^:]LIXXK-W:=G=BGYUP]R^MGT1<4N$Y?_5=Q$;F6
M-YGH-K8RK]M?9WNNE2QZ%YU*D;YUQZQLC]?NGR#JPW  [0/H+8#P_P:P/H"-
M KPNL[;4CZE*U\M*7IVJ&ZU3VCP4Y('ISMPV-]N^:__3U=;Z[F4=LFCI71JC
M7O/8:>A 0^\5&U,1_I-X.H%;%A1F0=MX=I=%C T8-&"M ;\S2$9E=)JHU92M
MQE^,2MT@38@3X3 1;B;"_5$BG288-$*#8)1(IPD'&I)8$@E@(@%(A&"#$!J$
MT\<D@@81R&#TX#PB#<.-Q+"1&!AP;)! @V1ZF<3'"/D3"H6BP-*.!54"+"S/
M!,&<D1F@$4P: :B9U2)19&D'@T002;94,0(DF%$MAH"$((MD//MUHOANUK"P
M1C K!( 0^!8+3 *)9U2+62#)E&H3HUH:VR9)BI&A@(; TF,4TT#)]'*I9=6A
M$QYE*+),410C0Q$-XV[M1<,9G]O64$P,!<0$-@M,#)U!#,7$4),8PLBX4T-C
M"0QL?8J!H5-6%RBR3+H44T71 F.,76R,G;4<3!X%Y-DL&&:*^3->HC!3S%QA
MS+'K1<.QBVR98N[8%.Z@R+*$,,M+X13N>M&D<C!W#'%G>0=AF#LV@SN&N6-3
MN&,F=XEEE6&8.X:0LLS<#"/%9BQ4#./"3%Q L<GD&95CI#A:IBSS!\=(\1G+
M%,>X<$2"L:>@QLXECA867CCFA4]YM4.BP+9%LNR1T*O=>+?&S5V2\:AZ@UUN
M\]GA6UH=LK)V7J32&^9V6[N74@GMYR^TTU&DN]M%+O:J.8WT>=5M][L+)4_]
MIPSO]CUE_1=02P,$%     @ %Y=54'1?/J<E!@  *R8  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C@N>&ULE9K=;N,V$(5?Q? #V.(_N7 "Q F*%FB!8(NV
MUXK#Q,;:EBLIR?;M*\F*5^:<64A[L;:50PZ'FH\SI+3Z*,IOU3;&>O;]L#]6
M-_-M79^^+)?59AL/>;4H3O'8_.6E* ]YW?PL7Y?5J8SY<]?HL%_*++/+0[X[
MSF]7W;7'\G95O-7[W3$^EK/J[7#(R__6<5]\W,S%_//"U]WKMFXO+&]7I_PU
M_AGKOTZ/9?-K>>GE>7>(QVI7'&=E?+F9WXDO#R+K6G22OW?QHQI\G[6^/!7%
MM_;';\\W\ZP=4MS'3=WVD3<?[_$^[O=M5\U _NU[G5^,M@V'WS][_Z7SOO'F
M*:_B?;'_9_=<;V_F?CY[CB_YV[[^6GS\&GN/S'S6N_][?(_[1MZ.I+&Q*?95
M]_]L\U;5Q:'OI1G*(?]^_MP=N\^/OO_/9KB![!O(2P-A?]I ]0W4CP;ZIPUT
MWT G#99G5[JY><CK_'95%A^S\GQ_3WD;1N*+;F9_TU[L)KO[6S,]57/U_=8:
MMUJ^MQWUFO59(P<:<5$LF]XO)B0RL9:DN;PV<$\5-I$\ (G"@U#03]6U5U=^
M>MR!AAWHK@,][$!GR42=-:;3',^>&I/X2C4B6#P0 P=BR$"<2,9QEOB!C;#0
MR3B01F7#?TFO#^<6;CCR;&'PT"T<N@4W(> .'.S $=^-2R)E[8AC<L&$BH=&
M/#"B$B.>&-&:LQ*@E0"L)/=H'<:[(C*,=P;,F)3OC-@12BT8/ 2SD A@R::6
MSB([L.0XA^!B<B<DY="F'/8B-VKB\'HA%."=6?8$7C&$'K_F",RZH+!;F](.
M19*Q@\$4%GB;@@5%W*QB?@4%V&K-=('I%'["K&+T!&4/S"H2,=Y*#)^D\-%9
MA2)F5948/4G1LYK)*1)C)>7X6968& F((;,*14P 2(R51)F8S"H2.<8.9D\"
MK$S&=(&QDBCA<;.*B9&(F'#M[7TONEKO_(*+ ,R5I&G/6BX.,5<RC'=78604
MH,&F6:077=50EK.#D5$ &9O6O5#$V<%<*9JNI$B#%8BL3>\Q$CDF'!53 P/X
M#)/3%(9/3<AI"G.E %<DHGO1\!9K)J4IS)X"V8I&DAUO!O.I$)_D!B,1MWW!
M>"J I^&&BO%4$_#4&$]-\10J7>,UQ=,PSFI,IT8)+0T136M)U@R&4R/NTA#I
M1:.\P=AI5$JF(0)%S/*KF1TJR'GL4#&;VDP($<R=IMR!$*'<<?L C;G38_)B
M+QJSW= 8.XVR(@D1/]X;C*8&Q28-$21B:AJ#^34@O3HF QC,IA'C0\1@[@Q*
M9:FWAG*G,B;?&0R> 4R1G7PO&L:(XLH\@\$S #RRE^]%5W8X,\S!#TB<9"_?
MBX9F."N87P/R)MG']Z*KDXG@N,,@@Q$V%&%:&QEZG",6R7)R;VC]FW'EK\&@
M&Y1?.7\PQ&9"?K683XOX3,M22X]KV-,-BR&V-,'2J>]%_FI6F9+#8M(M(#U=
MI=>]:!BR@8E9BT&W:%>9QFPO,F/,8,[MF)TG$ADF%BT&W:(*.3WCLO0XUKL%
MDPXL<QZ+6.<B%D-LW82@Q^A9@)XC00)$GKM]F$\+\J=GDI_#?+ILO+<.H^=
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MO73^41>G_M6LY>7]L-O_ 5!+ P04    "  7EU50[>C&BL4#  "#$P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6R56-ENFT 4_17$!QAF88ML2W66
M)E(K1:W:/A-['*,"X\(D;O^^+!/$<B:!/(3%YYR9>[GGSL#Z(HO?Y4D(9?W-
MTKS<V">ESE>.4^Y/(HO+E3R+O/KE*(LL5M5E\>R4YT+$AX:4I0YU7=_)XB2W
MM^OFWF.Q7<L7E2:Y>"RL\B7+XN+?3J3RLK&)_7;C6_)\4O4-9[L^Q\_BNU _
MSH]%=>5T*H<D$WF9R-PJQ'%C?R)7#[PA-(B?B;B4O7.K#N5)RM_UQ<-A8[OU
MC$0J]JJ6B*O#J[@6:5HK5?/XHT7M;LR:V#]_4[]K@J^">8I+<2W37\E!G39V
M:%L'<8Q?4O5-7NZ%#LBS+1W]%_$JT@I>SZ0:8R_3LOEO[5]*)3.M4DTEB_^V
MQR1OCA>M_T;#!*H)M",P\BZ!:0*;2^":P.<2/$WPYA)\3? [ GV?$&A",)<0
M:D(XEQ!I0M012-"42/O\FH*XB56\71?R8A5M39_CVCKD*JI*;E_?;"JL^:VJ
MB;*Z^[H-7+)V7FLAC=FU&#K T"'F&F'8$'.#,'R(N448;XBY0QA_B/D\Q7@\
M&F+ND4XPQ#P@3-AAG"JW78(I3#!M!/A (,("# JP1H#U!8B+!3@4X-,9D/$C
M;C'$;4"YGN:JFFGO;_3$EU-NEE-N%U$&R?!@,CR0C%$M[UJ,WQN2,"_R1Z5Q
M/0]V,P]V.P_V,(4QC_HAQ3GP80Y\D .&!0(H$,POR1 *A& &HTYPUV((Z6?$
M,$@$!XG (!X6J.L+-4=W?J#$T%\)F(4_;HPM*!@\_!4?M[0/4,/IX&Y$0#LB
M@4$"]R.RH"$1W)$(:DF3I/!)J4>F8;#7"3*[H7D3;!7B+P@6FX4$<X(-Y@>+
M+460IPRMD6##D&A^L!0[AKHS@M6@L-_$0E,A4^PK"GQ%37,UK,QT0;C8"Y1]
M'.Y.@PCMQ\M6DZRP20F8)H-=18&K*#%(8,=0;T%*L&,H6%WH>+>H083UZSUT
M32-A8U%@+&I8QR@V#0T7Q(M-0\$R,XVW!1'>B]?W/-=4] R[BP%W49,$]@TC
M\R-FV#<,K2'CHM>@OL>I.ZEY@&+!RM"BF6%_##Q(#>L\P\YA?$%2L',86FM&
MX=YJ4'\%]UVR&KW?W'\(&TX(^Y A'_H&"6PPMF"?Q[#!&%J5)FD))_'2R&@-
M;$.&;&C8V'#L+KY@M\>QN_B,W=Y.@P;K 9]8@X/=GC^I :?WGE]_GOH:%\])
M7EI/4BF9-2_V1RF5J!3=5556)Q$?NHM4'%5]&E3G1?M9J+U0\JP_>3G==[?M
M?U!+ P04    "  7EU501=V3DI@$   ]&@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970W,"YX;6R565V/JS80_2N(]P9LCTFR2B)M4EVU4BNM;M7VF4V<#UW
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MG;<O--J;4E^[ES7!_8W1YG]02P,$%     @ %Y=54([22LI_ P  \1$  !D
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MONTN8WU=#Q\AAIM6G<8/+/[U*\_Z'U!+ P04    "  7EU50$^'+/"0"
M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q]5-N.FS 0_17D]W(Q
M"60C@K1A5;52*T5;M7UVR"2@-9C:3MC^?7TA+ ONOH ]G'/FS!A/UC/^(BH
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M+OV)]X46_7B9\?1'*?X"4$L#!!0    ( !>755!<:=<B4@0   P6   9
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MJ@YU^S5LOI?]15G_4!>7X1+0O=]$KOX'4$L#!!0    ( !>755#XO[S\DP0
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MSY8P4PDPU=HP!M!HL<2?Z#AA2A.!&9N[/03%CCB8]X0HG9AQ;)",7+G#O"=
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MFU$&#PUG]CK=7!XRO:W;VZBY+_OC[/ZA+D[#4;U_^7_!_#]02P,$%     @
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M=,'02,6C"9)9T+UFSG'? "#L@K8 *!D[9 AL((\(#R/&(\(CN/S1!^H?P0T
M =4]U"T99!L-SIH%I7V0J]K[//?QPKT$ <TDB48HX/)&Z0=4@PL<95-4RX!L
MW9<$"');VG] ]Q'#'04!+06-='$$USF:3]<-PX6.HPFZ6=!]MG-'MRF@+0@:
M*3$,]Q4,]961\X;A0L?X [K!A8[C*;K%@S=?XG;[C07->J#856W($P=NO&%O
M%*LH/YHQ5W@[=JZEGFAZN]TH_8CU*.?LK]6(W0[$_VC:^?P;X<>B%MX+DVI0
M-./<@3%)58Q1H!(XJ4^";E'2@]2WF;KG[5S<+B1K[,P?=A\>J[]02P,$%
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M(F*;-P)+$SY3B@ ON< _WH( +[J0(*X[EVP I3=D&0^8L%UW850$L>,Z H,
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MG(,/-XV^C&?\_OT?#>N?4$L#!!0    ( !>755"57&6\O04  *0B   9
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M_1</5ADH*PR_S6UJ6P$H"\:0JIBILA68LL*FLA6/*]M)R=@(1JRP*6L%A6)
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M$&-^;0HS% .\J:VV=S00/U':"C15DTK.&,1S8[9P&TIO))UF7SNY:D3.\E9
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M)%1'O%WW],A^,O&K?QQD*YZS[.N6=6/-NV!@ATWXB=S=0Z$&Z(C?-;N.B_M
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M-%*N2&2,+6VXO@;;$Q>T';Q(E!:_F'O=Z?O%O$'E8.8W2 >#=#0 ^;L&<#"
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M\3T5MVIP[[2IO$OYHWWXZ[!R@S8BD8E]W9I(FLN'V(HL:RTU<?RGC+IWG^W
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M&',C-P/E9I#<S)([@LJ;52Q+M8M)@L12ZV*B>VIS4&T.J<TMM;FK) HL2S4
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M-G8FXT#0P71=X=3ZK?X!4$L#!!0    ( !>755"XJ>-HP0,  +42   9
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MLP-0T_T"2S%J&E(S]8/A"L1\H.'YU#2B@LE2(XK3?0Y3P8QK7/88J'L1+20
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M3TD<C]_4/ZOB13%[Q/"65+_+ R]6=FQ;!WQ$YXH_D^X+[@M:V%9?_3=\P96
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MWX[G^_%!BK-^=^'?7J!L_@=02P,$%     @ %Y=54):42XR9!0  01\  !H
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M,2($101 VZ":K'8%M0U4TDO8Z&6O.4&1*/)8,GXY^H-Y)< NBKFB$.-*!)]
MGL#@$!0<!'F"IGIE5FGV1@/)6$)6[T FS1HM<-C&X!  '#;O!-TG*&)GAU2*
M3CV@BIT3#Q-$ (*0E'&?(/<EZ:QD:A431 ""D*EVGR#W)>FL9'J:@0DB 4%L
MV V:.:OW)>FL9&H54T-2:A#829KC0= B%0U:I'(&K<2TD'!'88>MI!R0L8TY
M23D@&=GLI4 FXM"U_Y2.0RY*"PH+27/Z2D:$%D@FZ+89R?AXO3_UC:D@*14
MY0;59"$0D<,UK+*/$Y'*/=H81)+NFXQK5Z!A$,GP$S"3F J24H' 3(+3(T9_
M<Z@B$^R.:NH94T$"*M@DD^B@*72M/H8>@#(1\]3<(L?1CJM#F!T2L(/D"WK&
M1 \NH8AD"RIR'ETJ3! %"&+/.$5W#>#T$JGH\252.1?Q"J-$ 938U%,T_=,C
M3" "9YA(Y3S$5)@DBI*$T$^!K8()VKF5^4ZA/8C-;E1QF+A.J12&BH);$#NV
M%>6 BA2-%2J3,B#I&<A$$#B'WG%A0ZE"H3*(QN-H9T4@69%0 1K'VEYAFBA(
M$V*W5XTOA:2=H'?_1Y1"D;TY]4?WB(6N7KL[VGJQ+]_.37L;-WIZNP=^$NT]
MI/5\RQ_2_C;W9S7]Y?(?6?5Z.M>+Y[)IRJ*[BWPIRT8;C\PS'H\Z.]R^Y/JE
M:3]&YG/57^KV7YKR,EQ8^[=;\\U_4$L#!!0    ( !>755#Y*'GA;0,  .D.
M   :    >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6R55VUOFS 0_BN([P5L
MWI(HB=0$IDW:I*K5ML\T<1)4P R<I/OW,\:EV#ZZ]$L"YKGS<\?=8VYYI<U+
M>R*$6:]E4;4K^\18O7#==G<B9=8ZM"85?W*@39DQ?ML<W;9N2+871F7A8L^+
MW#++*WN]%&L/S7I)SZS(*_+06.VY++/F[X84]+JRD?VV\)@?3ZQ;<-?+.CN2
M)\)^U@\-OW,'+_N\)%6;T\IJR&%EWZ-%BH6!0/S*R;4=75M=*,^4OG0WW_8K
MV^L8D8+L6.<BXW\7LB5%T7GB//Y(I_:P9V<XOG[S_D4$SX-YSEJRI<7O?,].
M*WMF6WMRR,X%>Z37KT0&%-J6C/X[N9""PSLF?(\=+5KQ:^W.+:.E],*IE-EK
M_Y]7XO\J_;^9P098&N!;#7QIX \&*/K0() &P;M!\*%!* U"S<#M8Q?)3#*6
MK9<-O5I-7P]UUI4=6H3\=>VZ1?%VQ#.>SY:O7M8(>\'2O72>)&C;@_ 8-"!<
M[G[8 T-[;+%ACM4-$A,1:9 4@/@P"1\,U!?VOAIH"'L(0 ^!\!"H'B(M53TH
M%*"J!\VT8'M(/()@Y&@I3TT0FCL360]!NB%$-];H]J#9:!MOM$O/U\3<8<?7
M^)J@,4:A&X%T(XBNEKJ-"8KG>K%&)EWD:'$G($@+/.U!T3@Y<$0Q&%$,1337
MV,8&$13IQ9#$!A&]J%+3CU)4"MT92'<&T$43 <]!#_-/M!CR8#GR;FDRB5(2
MHF$2B5$RXCE:^E, A6:C:E$Y3T@HNJ73) JN)DG9A-SI?28Q:J--Y1B4XWN$
M;VDU &7VF@0I?60*"(1"YJL ?4UH"()%'OFW])Q$*2\]U/DD$O51D:6 )Z7(
M5,[PL8*@<P5-2#V"M1Z%GVD]6( 1J,!&ZYFBJ!_FR!17;U2B,G,0:$*O$*RO
M"!18H^],900J% +%.F43Q L43W"&119!*FOVGHD">F\&=94A@R;*<_3# P1-
M=1ZL_6A^4^?-C<\:HS02"0JG2RS]CQ_UFU0_:=2GL*9C4].--[ !0+QS]8)P
M1Y_B)6F.8BYJK1T]5ZPS'JT.L]<&=Y_RVOJ6SV0(6+_'WB+!'O"$,^1/^JGK
M?>M^"/R1-<>\:JUGROAP(4:  Z6,\,!X*FWKQ.?.X:8@!]9=QORZZ8>O_H;1
M6@Z6[C#=KO\!4$L#!!0    ( !>755"0'MXU_\L  *%# P 4    >&PO<VAA
M<F5D4W1R:6YG<RYX;6SLO6ES&U>6*/CYS:_(\-#OD1$@C,1.N;LB*$IRJ5JV
M]$39CIJ.^9 $DF26@4Q4)D"*]>OGK/>>FPL 2JYE^G6$+9) YEW./??LR[]5
MU3;ZO%[EU;]_<[_=;EY\]UVUN$_72=4O-FD.W]P6Y3K9PI_EW7?5IDR3976?
MIMOUZKOA8##];IUD^3?1+L_^NDNOBEV^_?=OXF$\^N8/_U9E?_BW[1]>%8O=
M.LVW49(OH]?Y-ML^16]S'C0K\N@\^OGZ571Z<O9OWVW_\&_?X4O\8CR,?BSR
M[7T%;RW39?WK5^FB'XWB7C0<Q!?U+_^4Y/KE<-#X<H=?#MK?/+3<_[R\J;9E
MLMC^OYUO?GK:I(W-#,[_H_.%RSS?):OH8[HIRFW]J6VY:XSFWOR0EEF!ZUQ&
MKY)M\SF!T?_U/_['WKU^*I.\RFA_[8NX35958W2!SIMLE48_[=8W:=G8]?E\
M,)IVO/<QO<L0E##_3\FZ,?JOKZ\_11_^>/GQQ\NKUS]_>GMU^2ZZ?OWQE[=7
MKZ][T=N?KOH=X[[-%T4)FZ#SZD776P!,5)01(6?Y!#^7C<D^7'8,]BGY'+U=
M HRRVVS!&-"^U>'H'-!^,(@;Z"8C72Z795I5/?TE>I?E:?0^;ZQE,AI$?TP!
MW_+H?3_Z-87[^:K,'KK [\:]PK]@GY^*Q[SQ[.=MT?RP-H"#U(>R>,CRQ<$9
M/Q35%O#V_\DVK4"-+T;C^'PP'4_JW]!2+X&4M+XW;<+P7;& B3[<%WD7JDTN
MQN?#BT'CS4_9%M"SN(WBX>G-672=+G8ES-Y84;%>P]E>;XO%;[UHDY310[+:
MI=%)?SB)-FD95?=)V5@IW)MEEM]%UT_KFV+5P.#K3_6/=/KH]>?%?9+?I:VH
M_].?KU]WP/[7=+4Z_RV'(X:M)!7 8QF]K:I=$R!_3JN.,7XI5G 3DI*O;MEX
M[*>BX\6K75DBN6 :01L'E-EUS?,VWZ9(*0%WD3HE^OX>.@*W%'#PKB@;!_0N
M*0%:EXM%"D_!,TM^OF.LZW6R6D4O=Q7<L:IK?:_7:7F'N_BA+!ZW]X"+ZTV2
M-V;6(>\!] >>^;"[666+Z,VJ2+IV&2+:-6)5%;W?;>$FY8A+]=<N@4 OB4B_
M626-;_5$WF057I _IX"X7<S@' C4^2CN9 (RAK"4-_!Q W!O_GSH;5I!Z[MM
M#$AA @.4\/);X/.?H_](&^ =#)"P3F:SQO6^>O_3]?MW;U]=?GK]*KK^!#]^
M?/W3I^OH_1MD$>]_?.WE"[["593ET8_9:@6D'$C8B?USGX@QW_?EK'&%TFU4
M):OF%;P"DHG4Z(>B6%8D8URGY4.V@'5=%ZN&D .8"9QB4Q:W60.A/J85 'MQ
M3Z,LTX=T56S6+=?K&O 6$*L7W:5YBF#&YY/E.LN)_=+U3#^#K%<UE_M^>P]W
M\A280;%.S_2QQE,;O))XD]I72H0 ^5C'^^Y[GJ=]$7F1%VX>&<BMK#DB?AS=
MI""XI3)LM$T^-W?XUGW7M;K7?]TAD@*>Y*DN$8\PN;W-5AF1H@51A:PY^D]I
MUZ;\-YZ]O*@_]#*I@)S )J-EL5HE9>6?;6SY5;;:X5J.>_K7-+N[Q\>3!X I
M4%:Y'(6G1'M6PP_O74+'(WON*]S6#Q]?__'U3]=O?WG=O+U[;RJ)+D2'X&"0
M1I?I/9PEHK8<<+?<SNBU"%Z2DSE=P?4[Z]'!P\" ) V@O $$R^[R:$&4>/$4
MH41;K5A43)9_V55;7%=CQ1^ RL+A\.6'V0'[DS*K$+F7("+@72)";"?''R<-
M$HB8!/O:P>MPN7G)T1UH94<.>#KHCV"/^'-X1L3A).Z/FE1D"X(4@3B]O4T7
MV^K8]?8;I/,=\.074;)&(>)O#"F\3WX/N/JS"'?2'*Z'0XYXG8-^0[1L'WL3
M0KM,E]FV#1"Q &(B@*!?VP".:XM@["Q_2/F$8722[8 *M"Z:1I=1AQVCVL.#
MP9< T0<BT,TAZ;1Z>%03M]2X,>BS<+M%)FZ\]K7W^?1#@@++?;H%=6IU=NS]
M_M!R?EWXU[*3\(H0> 74QX]Q_ 5H>?D0QC.J'_UB.SIW;-QNMQMCCWLYP,@V
ME+'H\/+RW>5/5Z^CZS^^?@TH<>11JTB;5%6ZK1KT]BJI6.)9X"\I\&90U-H(
M+*@*J/!749DN4GCH9I42LC<%@ =XO2A;N+?<GF!!#16P0!5X_S.@3P-N;)]
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M5%[N,L$NCJ!T3=$?ABQX95\G1?:B;:"C-^&V7F/(%PQVG=WE%,Z(H:=>ZOX
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M$><_WPR0.*,UYUL =JR0."4,:9H<&;(PI'[DO)(?G:KT(GH/&-JB0T4W8IO
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MS6/LUL&U]4*P2)6$59*M*ZTL1TBT((8+[PH'D>6XB%<;F_*VR?:=!4B"9O'
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MXP$='!R/DN KS%YE$;[EK@2&FQNT9JT+KI64EN13=7:S2LUZVNC&E!Q =05
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MN&M3^#&2@+S!##C%&^DMRZFU"ZE4)P'RIT"6SJ+307]TAK]?G'6//X]F4[1
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MI)8V,2J%A^0_4AEQ:6?E&2IY?[(*B&YFC*Y6K/#!KYR09^&NA\([;2N/^4_
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M5X160^.Y*YJ^+;/?;!'HV: _BRD<@R?I1Z]]5<4..T"1&QW^@_)6!.A'Z;L
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M0B?>Z1!S;?A&S>?RVU2KAR"%#^0?2;R/![: 1;NH<\JU.2[H!4JNYW\_&.5
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M,WL*7^OI'C:Y:Y\.)=1BC7XAPC3LGY[?<B@THED]VT3R3G<K-9W-VX4 K?!
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M:L^ALP3@M60CP!(BQI?S+FGP$%$/5QRUT>[5L.^I8&R&3@+@#M</2JCK'/6
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MHE5V7>Q*BK=)K:,H1-ADVO%]5MJ>:)K[]K9OIG^R*#@(NR:&2L0_2,;@=H'
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M'50"-H<R%PX:09U/+DB!'HR+CR[*+O'+K IRLF&1X_>8UY[Z6*VDR@HJ,9!
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M?Q0&4$:6]$&^FZ48B#.!T]3&CEX&)J%F[,#FQNH4GJ Y87G6E2:G5$V=&C,
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M( [CFV^2]R8^*J4-=-ERMPG+/XG&I U#G1L'&6]XN]<C^QK?(BPL<"\R.P5
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M9X*N3,X2K&7,!%ND:A'9'W4=-72\#/*OA/C]]7Y+N;'7CT1+:-Z':\AL[26
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M31>/$PIQ4/\$="H;[P =#-SD2@H V0FX:.LEDIBG/Y?E[J__%U!+ P04
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MLKQ;.9 ] +)W0<B_ P>R#T#VSPCY97P[7DQF)/XZFSW$#F ( (87 R17*^I
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M)A4Y-J=;@(;$TK]D2N+7R2&_]"^4DAR:T\6$#-,_9V;2-'+ZD%CZYTQ1&NG
M>R%GS%4:X2"O])&]TI /-#)"4NECYRQ@*-MW,2&I])&E<@QAQVNYM^VH><?Q
MA$2=B%Q-O:$,:::/K)EZQ'W/$JD;M>IY'Q/23!]9,T<\DT4KFFC!'$(=$P#=
MNK=L0D@SX9GRE[C<[],W,ME1+H[Z%ELW+@LAS83(FCEB/LJTU,&C'DRZVZD.
M)W6/%]1K34@S(;)FFK,MBYAZ\U$(Z29$U@V8;GFA10AY)T3V#HSI5@!"\$X\
MLH'JT^6P'S1W.:2@$%E!-G75<U%>-+-!W@F1O7-@H_F.W*3RQ?:SG8YL8.[6
MS4+(.R&R=RK,OQC?[DQ,/GYFBF[?1[?7FI!W0F3OW-&B5%7*JB_(I1Y!U-Z.
MK_!OW94AD'<B[/2FL6C1<&E&D'8B9.V<**VPUZ*D-4Q(.Q&R=L#BBC>A1Y!W
M(F3OP)CNA!Y!WHF0O0-CNN%Z!'DG0O8.4*HRP\C%!-> (9NG*E4U#6S(.=%Y
M"FC'@=P,"-DFNF@QS1LKD&TB9-O F.Y8&4"V&2#;YF3-K]KA8D*Z&2#KYB2F
M3LO$UDUM!Y!N!LBZ.859S4@W+B:DFP&R;JZ,LJ6P:"8V7T[FS0-] -EF@&R;
M*YW(IC3/;57([O5(74S(-@/L.MOI.J^91%U,R#8#[%+;2<QQFLK$Q037'&,O
M%3B):?>XF)"$!MA+!2!,+ZX<0!(:8"\5.(FYD,);O36$)#1$EE#]'D0M^' Q
M(0D-D254P_0GT877FI"$AN>]HU,9,B=<D)62_WB8D(2&R!*J88XSLSP^/Q:M
M?[J8D(6&R!8",;V1/H0L-$2V4 W3W#%+3')^V.YB0A8:(ENHWIIY7F;[RNW?
M]23E8D(6&B);J(YI#$F/I<R5N]AA"#[[@FRAVMW1A@!N"-EGB&P?'^^>F=PG
M,34XL345! =S!-EGA&P?'[-Z-R]8=C"1BPG99X1L'Q]SRIY9*O?OCX>ZY<L1
M9)\1LGUJ]\3K=007$[+/"-D^/N9WH0[:T5.FWN;>W1M!]AF==87!X=T7IL_%
MS.TT%Q.RSPC9/CZF'QC5,"'[C)#MXV-.V88I=>AP4\)T,2'[C)#MXV/.-AMF
M'Y(_WC]U,2'[C)#M ZZ*]]:FCL!G+[%SH,9U,._SDH/9[< /82)[J!$TIJEN
MS*<WLO) P<<R.]@KVTZ#FNO  P6?T>P@NZ@9]+#QAGN@X'.:'60;@0](>$E&
MMP,^PMFQ/FK;P_//G]8ZBA5LO=!?DNOM"4V3E2+FQ9XKZ(?FV;=-F:83O6TI
M;B4UV^TYCO^FX_-_4$L#!!0    ( !>755!*FHJN# ,  *H]   :    >&PO
M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%VSMNVT 4A>&M&%J R7G/!+:K-&Z3
M;("0J0>L%T@&L7<?14T4P.:?0CC3B!!$S)Q&'XCA/0_?^ETW;8^'<;,]C7=O
M^]UA?%QLINGTI6G&Y:;?=^/]\=0?SK^LCL.^F\Y?AW5SZI:OW;IO;-O&9KA>
M8_'T<+WFW?/+XV)X?C&+NQ_=L.ZGQT7SMFM^'8?7<=/WT]A<+N;^O,'YEO=3
M_S_;'U>K[;+_>ES^W/>'Z8,4?S=8-!\'LO.!K#R0FP_DY('\?" O#Q3F P5Y
MH#@?*,H#I?E 21XHSP?*\D!E/E"1!S(MR-CJ(Q'6>JT-<&WT7AL V^C%-D"V
MT9MM &VC5]L VT;OM@&XC5YN W0;O=T&\#9ZO2WH;?5Z6]#;5GC6IH=MO=X6
M]+9ZO2WH;?5Z6]#;ZO6VH+?5ZVU!;ZO7VX+>5J^W!;VM7F\'>CN]W@[T=GJ]
M'>CM*IR5T&&)7F\'>CN]W@[T=GJ]'>CM]'H[T-OI]7:@M]/K[4!OI]?;@]Y>
MK[<'O;U>;P]Z>[W>'O3V%<ZZZ;!;K[<'O;U>;P]Z>[W>'O3V>KT]Z.WU>GO0
MV^OU#J!WT.L=0.^@USN WD&O=P"]@U[O 'J'"N\JZ66E7N\ >@>]W@'T#GJ]
M ^@=]'H'T#OH]8Z@=]3K'4'OJ-<[@MY1KW<$O:->[PAZ1[W>$?2.%69-:-A$
MKW<$O:->[PAZ1[W>$?2.>KT3Z)WT>B?0.^GU3J!WTNN=0.^DUSN!WDFO=P*]
MDU[O!'JG"K."-"RHUSN!WDFO=P*]DU[O#'IGO=X9],YZO3/HG?5Z9] [Z_7.
MH'?6ZYU![ZS7.X/>6:]W!KUSA5EO&O;6ZYU![ZS7NX#>1:]W ;V+7N\">A>]
MW@7T+GJ]"^A=]'H7T+OH]2Z@=]'K74#OHM>[@-ZE0E>'RCHUVCI8UZG0UVFI
ML--6:.RT5-EI*W1V6BKMM!5:.RW5=MH*O9WV"O)QTPW]R_=IV![6XZVC_+/X
MYW&N$!^G]UU_^QR753\/<$7V=-ZF;RZ?-_]C75;]DZ*YCC$^_0902P,$%
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M<U!+ 0(4 Q0    ( !>755 GZ(<.@@   +$    0              "  >D
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ %Y=54(QSPCWN    *P(
M !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ %Y=54)E<G",0!@  G"<  !,              ( !M@(  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    "  7EU50)!CUKG@#  #($   &
M        @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ %Y=54 BID&WB P  3A$  !@              ( !I0P  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( !>755 H060N#0,  /T+   8
M              "  ;T0  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    "  7EU50US.@=H("  #E"   &               @ $ %   >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ %Y=54)!1I^WN!
MOAD  !@              ( !N!8  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( !>755!$]+%V0@(  *@'   8              "  =P;
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  7EU50.=]#
M:64%  "D'   &               @ %4'@  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ %Y=54-'3FG1B!@  6B0  !@
M ( ![R,  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !>7
M55"?PMJ/M $  -(#   8              "  8<J  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    "  7EU50#/>;";8!  #2 P  &0
M        @ %Q+   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( !>755 ]BV*JMP$  -(#   9              "  5XN  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ %Y=54 A>MEFR 0  T@,
M !D              ( !3#   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    "  7EU505FD;*+0!  #2 P  &0              @ $U,@
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( !>755#/"08N
MMP$  -(#   9              "  2 T  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ %Y=54#?)C[.T 0  T@,  !D
M ( !#C8  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  7
MEU50+WE;5;4!  #2 P  &0              @ 'Y-P  >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( !>755!TD;#NM0$  -(#   9
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M970R,2YX;6Q02P$"% ,4    "  7EU50^!+@IK,!  #2 P  &0
M    @ &"0P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M !>755!XO"GAM0$  -(#   9              "  6Q%  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ %Y=54%2QN;RX 0  T@,  !D
M             ( !6$<  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    "  7EU50[+Y;P[0!  #2 P  &0              @ %'20  >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( !>755"O8)\CM0$
M -(#   9              "  3)+  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ %Y=54/SNO NU 0  T@,  !D              ( !
M'DT  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  7EU50
MC0[2$;<!  #2 P  &0              @ $*3P  >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( !>755"XYE? P@(  'P+   9
M      "  ?A0  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ %Y=54!\#@R2V 0  T@,  !D              ( !\5,  'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    "  7EU50?41ABL4!   W!
M&0              @ '>50  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( !>755#2\RH%N $  -(#   9              "  =I7  !X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ %Y=54' ]@Q&U
M 0  T@,  !D              ( !R5D  'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    "  7EU50&'[\2_8!  !M!0  &0
M@ &U6P  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !>7
M55#*)2[5MP$  -(#   9              "  >)=  !X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ %Y=54-Y7^X#& 0  -P0  !D
M         ( !T%\  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
M    "  7EU50^-3(F;D!  #2 P  &0              @ '-80  >&PO=V]R
M:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( !>755#?%LK_MP$  -(#
M   9              "  ;UC  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL
M4$L! A0#%     @ %Y=54$-:M:G/ 0  G 0  !D              ( !JV4
M 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  7EU50<8H2
M#\0!   W!   &0              @ &Q9P  >&PO=V]R:W-H965T<R]S:&5E
M=#0P+GAM;%!+ 0(4 Q0    ( !>755 A&!"?Q@$  #<$   9
M  "  :QI  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
M%Y=54!#^/F;O 0  9@4  !D              ( !J6L  'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    "  7EU504Z-H(08"   T!@  &0
M            @ '/;0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( !>755#[=A'.Q@$  #<$   9              "  0QP  !X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ %Y=54 <$2E?N 0
M9@4  !D              ( !"7(  'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    "  7EU508>-JH-,!  "<!   &0              @ $N
M=   >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( !>755"*
M,O]OV0(  -L*   9              "  3AV  !X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ %Y=54'J=TY'@ 0  $P4  !D
M     ( !2'D  'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !>755#G+'%XM0(  /P)   9              "
M ;"%  !X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ %Y=5
M4#&)C[:R P  1Q(  !D              ( !G(@  'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6Q02P$"% ,4    "  7EU50Y2,(U' "  !;"   &0
M        @ &%C   >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0
M   ( !>755#I[/.Z4@(  !$(   9              "  2R/  !X;"]W;W)K
M<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ %Y=54 3[GG(@ @  "P8
M !D              ( !M9$  'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q0
M2P$"% ,4    "  7EU50F2.?_] !   Z!   &0              @ $,E
M>&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( !>755!2>NPB
MI@$  +T#   9              "  1.6  !X;"]W;W)K<VAE971S+W-H965T
M-3DN>&UL4$L! A0#%     @ %Y=54*QN<PV1 @  M D  !D
M ( !\)<  'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  7
MEU50K=5YT<,"  !T"P  &0              @ &XF@  >&PO=V]R:W-H965T
M<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( !>755!RZEQ3T (  '\*   9
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M970V-BYX;6Q02P$"% ,4    "  7EU50G$!=7UP#  !;$0  &0
M    @ '$K   >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    (
M !>755!T7SZG)08  "LF   9              "  5>P  !X;"]W;W)K<VAE
M971S+W-H965T-C@N>&UL4$L! A0#%     @ %Y=54.WHQHK% P  @Q,  !D
M             ( !L[8  'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"
M% ,4    "  7EU501=V3DI@$   ]&@  &0              @ &ON@  >&PO
M=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( !>755".TDK*?P,
M /$1   9              "  7Z_  !X;"]W;W)K<VAE971S+W-H965T-S$N
M>&UL4$L! A0#%     @ %Y=54!/ARSPD @    8  !D              ( !
M-,,  'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    "  7EU50
M:$+!0<P!  !=!   &0              @ &/Q0  >&PO=V]R:W-H965T<R]S
M:&5E=#<S+GAM;%!+ 0(4 Q0    ( !>755!<:=<B4@0   P6   9
M      "  9+'  !X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%
M  @ %Y=54.?*E9A !   E10  !D              ( !&\P  'AL+W=O<FMS
M:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    "  7EU50^+^\_),$   [&
M&0              @ &2T   >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+
M 0(4 Q0    ( !>755#DRGUQ]@(  (0,   9              "  5S5  !X
M;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ %Y=54)QOYXQ5
M!   O!0  !D              ( !B=@  'AL+W=O<FMS:&5E=',O<VAE970W
M."YX;6Q02P$"% ,4    "  7EU50%;/HNY,#   )#P  &0
M@ $5W0  >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( !>7
M55 *IVZ=%P8  -\A   9              "  =_@  !X;"]W;W)K<VAE971S
M+W-H965T.# N>&UL4$L! A0#%     @ %Y=54(6M;\R1!   =!@  !D
M         ( !+><  'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4
M    "  7EU50E5QEO+T%  "D(@  &0              @ 'UZP  >&PO=V]R
M:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( !>755!TQ2UCS00  "H;
M   9              "  >GQ  !X;"]W;W)K<VAE971S+W-H965T.#,N>&UL
M4$L! A0#%     @ %Y=54+-F_[UV @  ( D  !D              ( ![?8
M 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q02P$"% ,4    "  7EU500+%3
MI+H"  "S"0  &0              @ &:^0  >&PO=V]R:W-H965T<R]S:&5E
M=#@U+GAM;%!+ 0(4 Q0    ( !>755!AD?C*X0(  'P,   9
M  "  8O\  !X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @
M%Y=54*TIR!*9 @  VPD  !D              ( !H_\  'AL+W=O<FMS:&5E
M=',O<VAE970X-RYX;6Q02P$"% ,4    "  7EU50/Y]!.P4%  "0'@  &0
M            @ %S @$ >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4
M Q0    ( !>755 $T=JOXP(   (+   9              "  :\' 0!X;"]W
M;W)K<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ %Y=54'#2O)IZ!
M&Q@  !D              ( !R0H! 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX
M;6Q02P$"% ,4    "  7EU50UY8VO8("  !\"   &0              @ %Z
M#P$ >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( !>755 +
M9?',;P(  $8(   9              "  3,2 0!X;"]W;W)K<VAE971S+W-H
M965T.3(N>&UL4$L! A0#%     @ %Y=54$&:=HLB P  6@T  !D
M     ( !V10! 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !>755#IAO5S$ ,  /<-   9              "
M ?4C 0!X;"]W;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ %Y=5
M4'=R:QYN @  4 @  !D              ( !/"<! 'AL+W=O<FMS:&5E=',O
M<VAE970Y.2YX;6Q02P$"% ,4    "  7EU50"L@#),X!   [!   &@
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M:&5E=#$P-"YX;6Q02P$"% ,4    "  7EU50D![>-?_+  "A0P, %
M        @ $7/ $ >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4    "  7
MEU50@.#)1J0"   Z$   #0              @ %(" ( >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( !>755!9AH:DI <  "I$   /              "  1<+
M @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  7EU502IJ*K@P#  "J/0
M&@              @ 'H$@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  7EU50-+K3:6X"  !S.P  $P              @ $L%@(
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     <0!Q  X?  #+& (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7003997968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance expense</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding current portion</a></td>
<td class="nump">$ 255.0<span></span>
</td>
<td class="nump">196.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member', window );">Senior A Notes Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member', window );">Senior B Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member', window );">Senior C Notes Due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_NotePayableDue2019Member', window );">Note Payable Due 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2020Member', window );">Revolving credit facility, due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Senior A Notes Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Senior B Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 53.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Senior C Notes Due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Domain', window );">Term Loan Due 2024 [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member', window );">Senior A Notes Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member', window );">Term Loan Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding current portion</a></td>
<td class="nump">$ 87.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="nump">2.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorBNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wst_SeniorCNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_NotePayableDue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_NotePayableDue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_Revolvingcreditfacilitydue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Domain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Domain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=wst_TermLoanDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6826799968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Operating loss carryforwards, foreign</a></td>
<td class="nump">$ 6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Operating loss carryforwards, state and local</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">21.9<span></span>
</td>
<td class="nump">$ 18.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Pension and deferred compensation</a></td>
<td class="nump">25.6<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(15.9)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">43.6<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Accelerated depreciation</a></td>
<td class="nump">37.9<span></span>
</td>
<td class="nump">31.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Tax on undistributed earnings of subsidiaries</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="nump">45.1<span></span>
</td>
<td class="nump">39.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax (liability) asset</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="nump">$ 11.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">226.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">49.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">48.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ExpirationPeriodAxis=wst_Year2019Member', window );">Year 2018 [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ExpirationPeriodAxis=wst_YearAfter2019Member', window );">Year After 2018 [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">211.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | Year 2022 [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | Year 2023 [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | Year After 2023 [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_Year2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_Year2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_YearAfter2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_YearAfter2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_Year2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_Year2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_Year2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_Year2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ExpirationPeriodAxis=wst_YearAfter2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ExpirationPeriodAxis=wst_YearAfter2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6821092064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Adoption of ASC 606 (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jan. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">$ 1,549.4<span></span>
</td>
<td class="nump">$ 1,353.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member', window );">Difference between Revenue Guidance in Effect before and after Topic 606 [Member] | Accounting Standards Update 2014-09 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6820045152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock', window );">Schedule of Other Income and Expense</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other (income) expense consisted of:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:51.685%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.907%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring and related charges:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance and post-employment benefits</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-related charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total restructuring and related charges</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Argentina currency devaluation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax recovery</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Venezuela deconsolidation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Development and licensing income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other items</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other (income) expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Obligations</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents activity related to our restructuring obligations related to our 2018 restructuring plan:</span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:35.980%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.908%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance    and benefits</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset-related charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other charges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash asset write-downs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charges</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash asset write-downs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Other Income and Expense, by Component [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ScheduleofOtherIncomeandExpensebyComponentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837936064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities at Fair Value</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables present the assets and liabilities recorded at fair value on a recurring basis:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commodity call options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross-currency swap</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:39.826%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.942%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.945%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basis of Fair Value Measurements</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31,<br/>2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Assets:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Liabilities:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred compensation liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency contracts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Changes in Level 3 Fair Value Measurements</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides a summary of changes in our Level 3 fair value measurements:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2017</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease in fair value recorded in earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2018</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in fair value recorded in earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838402944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans (Expected Benefit Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2019</a></td>
<td class="nump">$ 22.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2020</a></td>
<td class="nump">14.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2021</a></td>
<td class="nump">17.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2022</a></td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2023</a></td>
<td class="nump">15.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2025 to 2029</a></td>
<td class="nump">73.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">158.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2019</a></td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2020</a></td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2021</a></td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2022</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2023</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2025 to 2029</a></td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2019</a></td>
<td class="nump">21.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2020</a></td>
<td class="nump">13.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2021</a></td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2022</a></td>
<td class="nump">13.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2023</a></td>
<td class="nump">13.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2025 to 2029</a></td>
<td class="nump">60.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments', window );">Total benefit payments expected</a></td>
<td class="nump">$ 137.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits for defined benefit plan expected to be paid in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanExpectedFutureBenefitPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Expected Future Benefit Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanExpectedFutureBenefitPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6827209792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Sales by Product Group) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 1,839.9<span></span>
</td>
<td class="nump">$ 1,717.4<span></span>
</td>
<td class="nump">$ 1,599.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember', window );">Contract-Manufactured Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">441.5<span></span>
</td>
<td class="nump">409.1<span></span>
</td>
<td class="nump">362.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember', window );">Proprietary Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">1,398.6<span></span>
</td>
<td class="nump">1,308.6<span></span>
</td>
<td class="nump">1,236.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ContractManufacturedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wst_ProprietaryProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846079488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Textuals) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>plan </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant/issuance</a></td>
<td class="nump">3,119,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense for all nonvested awards | $</a></td>
<td class="nump">$ 21,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted', window );">Number of shares reduced for each award granted</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Awards, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</a></td>
<td class="nump">35,993<span></span>
</td>
<td class="nump">39,819<span></span>
</td>
<td class="nump">51,368<span></span>
</td>
<td class="nump">116,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember', window );">Award Types Other than Stock Options and Stock Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted', window );">Number of shares reduced for each award granted</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember', window );">Employee Stock Purchase Plan (ESPP) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant/issuance</a></td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of current market price for sales to eligible employees</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Limitation on payroll deductions of employee's base salary, percent</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount', window );">Limitation on payroll deductions of employee's base salary, amount | $</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear', window );">Maximum number of shares per employee, per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchases of shares</a></td>
<td class="nump">51,391<span></span>
</td>
<td class="nump">55,669<span></span>
</td>
<td class="nump">56,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">13,308<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember', window );">Annual Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember', window );">Cash-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">806<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember', window );">Stock-settled PSU awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">84,309<span></span>
</td>
<td class="nump">102,307<span></span>
</td>
<td class="nump">92,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="nump">16,204<span></span>
</td>
<td class="nump">23,946<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredCompensationArrangementwithIndividualConversionUnit', window );">Deferred compensation conversion unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans', window );">Number of deferred compensation plans | plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance', window );">Number of deferred stock units</a></td>
<td class="nump">366,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DeferredStockUnitsPayableinCash', window );">Number of deferred stock units payable in cash</a></td>
<td class="nump">6,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred Compensation Plans [Member] | Non-Employee Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted at target level</a></td>
<td class="nump">14,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement with Individual, Number of Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement with Individual, Share Equivalents Balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementWithIndividualShareEquivalentsBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredCompensationArrangementwithIndividualConversionUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion unit of deferred stock units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredCompensationArrangementwithIndividualConversionUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DeferredStockUnitsPayableinCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Stock Units Payable in Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DeferredStockUnitsPayableinCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in number of shares available for grant for each award granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ReductioninNumberofSharesAvailableforGrantForEachAwardGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares per Employee per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployeePerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_AwardTypesOtherThanStockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_EmployeeStockPurchasePlanEsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_IncentiveStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_CashSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wst_StockSettledPSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6832651792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Changes in Level 3 Fair Value Measurements) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Level 3 Fair Value Measurements [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Increase (reduction) in fair value recorded in earnings</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, ending</a></td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845112064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Components of Net Periodic Benefit Cost) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Curtailment</a></td>
<td class="num">$ (3.5)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="num">(12.0)<span></span>
</td>
<td class="num">(15.7)<span></span>
</td>
<td class="num">(13.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial loss (gain)</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss (gain) arising during period</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="num">(9.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service credit arising during period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service credit</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial (loss) gain</a></td>
<td class="num">(2.1)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges', window );">Foreign currency translation</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in OCI</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</a></td>
<td class="num">$ (3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.49%<span></span>
</td>
<td class="nump">4.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service credit</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of actuarial loss (gain)</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss (gain) arising during period</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service credit arising during period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Amortization of prior service credit</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Amortization of actuarial (loss) gain</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges', window );">Foreign currency translation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in OCI</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="num">$ (1.2)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.49%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plan [Member] | Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Foreign Plan [Member] | Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Other changes in plan assets and benefit obligations recognized in OCI, pre-tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States [Member] | Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States [Member] | Other Postretirement Benefits Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Period Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">$ (2.8)<span></span>
</td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="num">$ (3.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Excess of Net Periodic Benefit Cost Over Other Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DefinedBenefitPlanExcessOfNetPeriodicBenefitCostOverOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Exchange Rate Changes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6626492112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Supply Chain Financing (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_SupplyChainFinancingAbstract', window );"><strong>Supply Chain Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount', window );">Transfer of accounts receivable under supply chain financing agreements</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_SupplyChainFinancingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supply Chain Financing [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_SupplyChainFinancingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7003282544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Textuals) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
<td class="nump">$ 101,700,000<span></span>
</td>
<td class="nump">$ 94,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsGross', window );">Capitalized leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Capitalized interest</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (Loss) on Disposition of Assets</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset-related charges</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=wst_A2018RestructuringPlanMember', window );">2018 Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_AssetImpairmentChargesPatentandEquipment', window );">Asset impairment charges, patent and equipment</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasedAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84164758&amp;loc=d3e45014-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasedAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_AssetImpairmentChargesPatentandEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of a patent and certain equipment, recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_AssetImpairmentChargesPatentandEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=wst_A2018RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=wst_A2018RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6835340784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease Weighted Average (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term for operating leases</a></td>
<td class="text">11 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate for operating leases</a></td>
<td class="nump">3.76%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6676982256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term Debt Obligations , Net of Current Maturities</a></td>
<td class="text"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes our long-term debt obligations, net of unamortized debt issuance costs and current maturities, at December 31. The interest rates shown in parentheses are as of December&#160;31, 2019. </span></div><div style="text-align:justify;"><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.711%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Note payable, due December 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Facility, due October 15, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Term Loan, due December 31, 2024 (2.78%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series A notes, due July 5, 2022 (3.67%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series B notes, due July 5, 2024 (3.82%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Series C notes, due July 5, 2027 (4.02%)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">258.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: unamortized debt issuance costs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">257.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current portion of long-term debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7004397248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of lease expense were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term lease cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Variable lease cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock', window );">lessee, lease Cash Flow and Supplemental information</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Supplemental information related to leases was as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating cash flows from operating leases</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Maturities of lease liabilities as of December&#160;31, 2019 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed lease interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Maturities of future minimum rental payments under non-cancelable operating leases as of December&#160;31, 2018 were as follows:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:83.096%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.904%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>lessee, lease Cash Flow and Supplemental information [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_LesseeLeaseCashFlowAndSupplementalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837873600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text">The following is a summary of inventories at December 31:<table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.519%;"><tr><td style="width:1.0%;"/><td style="width:67.404%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.975%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.605%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.816%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work in process</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">214.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6627156320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of gross property, plant and equipment at December 31 is presented in the following table:</span></div><div><span><br/></span></div><div><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:55.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:15.307%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.701%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected useful lives (years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Land</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Buildings and improvements</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15-35</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">572.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">569.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Machinery and equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5-12</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">817.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">806.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Molds and dies</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4-7</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer hardware and software</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3-10</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">155.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">151.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,820.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,752.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciation expense for the years ended December&#160;31, 2019, 2018 and 2017 was $100.0 million, $101.7 million and $94.3 million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no capitalized leases included in buildings and improvements and machinery and equipment at December&#160;31, 2019 and 2018. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We capitalize interest on borrowings during the active construction period of major capital projects. Capitalized interest is added to the cost of the underlying assets and is amortized over the useful lives of the assets. Capitalized interest for the years ended December&#160;31, 2019, 2018 and 2017 was $1.0 million, $0.9 million and $2.7 million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019 and 2018, as part of our 2018 restructuring plan, we recorded within other (income) expense $0.3 million and $2.2 million, respectively, for non-cash asset write-downs associated with the discontinued use of certain equipment. During 2019 and 2018, as part of our restructuring plans, we recorded within other (income) expense $1.9&#160;million and $1.1&#160;million, respectively, for gains on the sale of fixed assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838068736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_OtherCurrentLiabilitiesAbstract', window );"><strong>Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">Other Current Liabilities<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other current liabilities as of December 31 included the following:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.391%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.903%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.905%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">($ in millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued commissions, rebates and royalties</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued retirement plans (excluding pension)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued taxes other than income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued professional services</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring obligations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other current liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_OtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_OtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
